PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Belogus, T; Haviv, H; Karlish, SJD				Belogus, Talya; Haviv, Haim; Karlish, Steven J. D.			Neutralization of the Charge on Asp(369) of Na+,K+-ATPase Triggers E-1 <-> E-2 Conformational Changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; TRANSPORT ADENOSINE-TRIPHOSPHATASE; FE2+-CATALYZED OXIDATIVE CLEAVAGE; SITE-DIRECTED MUTAGENESIS; SODIUM-POTASSIUM PUMP; PICHIA-PASTORIS; CRYSTAL-STRUCTURE; ALPHA-SUBUNIT; ION-TRANSPORT; CALCIUM-PUMP	This work investigates the role of charge of the phosphorylated aspartate, Asp369, of Na+,K+-ATPase on E-1 <-> E-2 conformational changes. Wild type (porcine alpha(1)/His(10)-beta(1)), D369N/D369A/D369E, and T212A mutants were expressed in Pichia pastoris, labeled with fluorescein 5'-isothiocyanate (FITC), and purified. Conformational changes of wild type and mutant proteins were analyzed using fluorescein fluorescence (Karlish, S. J. (1980) J. Bioenerg. Biomembr. 12, 111-136). One central finding is that the D369N/D369A mutants are strongly stabilized in E2 compared with wild type and D369E or T212A mutants. Stabilization of E-2(Rb) is detected by a reduced K0.5Rb for the Rb+-induced E-1 <-> E-2(2Rb) transition. The mechanism involves a greatly reduced rate of E-2(2Rb) -> E1Na with no effect on E-1 -> E-2(2Rb). Lowering the pH from 7.5 to 5.5 strongly stabilizes wild type in E-2 but affects the D369N mutant only weakly. Thus, this "Bohr" effect of pH on E-1 <-> E-2 is due largely to protonation of Asp369. Two novel effects of phosphate and vanadate were observed with the D369N/D369A mutants as follows. (a) E-1 -> E-2 center dot P is induced by phosphate without Mg2+ ions by contrast with wild type, which requires Mg2+. (b) Both phosphate and vanadate induce rapid E-1 -> E-2 transitions compared with slow rates for the wild type. With reference to crystal structures of Ca2+-ATPase and Na+,K+-ATPase, negatively charged Asp369 favors disengagement of the A domain from N and P domains (E-1), whereas the neutral D369N/D369A mutants favor association of the A domain (TGES sequence) with P and N domains (E-2). Changes in charge interactions of Asp369 may play an important role in triggering E1P(3Na) <-> E2P and E-2(2K) -> E1Na transitions in native Na+,K+-ATPase.	[Belogus, Talya; Haviv, Haim; Karlish, Steven J. D.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Karlish, SJD (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	Steven.Karlish@weizmann.ac.il			Israel Science Foundation [538/04]	Israel Science Foundation(Israel Science Foundation)	This work was supported by Grant 538/04 from the Israel Science Foundation.	BUHLER R, 1991, J MEMBRANE BIOL, V121, P141, DOI 10.1007/BF01870529; Clarke RJ, 2003, ANN NY ACAD SCI, V986, P159, DOI 10.1111/j.1749-6632.2003.tb07154.x; Cohen E, 2005, J BIOL CHEM, V280, P16610, DOI 10.1074/jbc.M414290200; DUPONT Y, 1976, BIOCHEM BIOPH RES CO, V71, P544, DOI 10.1016/0006-291X(76)90821-4; DUPONT Y, 1978, NATURE, V273, P396, DOI 10.1038/273396a0; FARLEY RA, 1984, J BIOL CHEM, V259, P9532; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; GLYNN IM, 1990, ANNU REV BIOCHEM, V59, P171, DOI 10.1146/annurev.bi.59.070190.001131; Haviv H, 2007, BIOCHEMISTRY-US, V46, P12855, DOI 10.1021/bi701248y; HEGYVARY C, 1981, J BIOL CHEM, V256, P6296; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jacobsen MD, 2002, BIOCHEMISTRY-US, V41, P1451, DOI 10.1021/bi015891h; Jorgensen PL, 1998, BBA-BIOENERGETICS, V1365, P65, DOI 10.1016/S0005-2728(98)00043-7; JORGENSEN PL, 1975, BIOCHIM BIOPHYS ACTA, V401, P399, DOI 10.1016/0005-2736(75)90239-4; KAPAKOS JG, 1986, J BIOL CHEM, V261, P2090; KAPAKOS JG, 1986, J BIOL CHEM, V261, P2084; KAPLAN JH, 1982, ANN NY ACAD SCI, V402, P292, DOI 10.1111/j.1749-6632.1982.tb25750.x; Karlish SJD, 2003, ANN NY ACAD SCI, V986, P39, DOI 10.1111/j.1749-6632.2003.tb07137.x; KARLISH SJD, 1980, J BIOENERG BIOMEMBR, V12, P111, DOI 10.1007/BF00744678; KARLISH SJD, 1978, BIOCHIM BIOPHYS ACTA, V525, P252, DOI 10.1016/0005-2744(78)90219-X; KARLISH SJD, 1978, BIOCHIM BIOPHYS ACTA, V527, P115, DOI 10.1016/0005-2744(78)90261-9; KARLISH SJD, 1979, NATURE, V282, P333, DOI 10.1038/282333a0; KUNTZWEILER TA, 1995, J BIOL CHEM, V270, P16206, DOI 10.1074/jbc.270.27.16206; Lifshitz Y, 2007, BIOCHEMISTRY-US, V46, P14937, DOI 10.1021/bi701812c; Lifshitz Y, 2006, J BIOL CHEM, V281, P15790, DOI 10.1074/jbc.M601993200; Marchand A, 2008, J BIOL CHEM, V283, P14867, DOI 10.1074/jbc.M710165200; McIntosh DB, 1999, J BIOL CHEM, V274, P25227, DOI 10.1074/jbc.274.36.25227; MCINTOSH DB, 1992, J BIOL CHEM, V267, P22328; MINTZ E, 1995, J BIOL CHEM, V270, P27160, DOI 10.1074/jbc.270.45.27160; Montigny C, 2008, BIOCHEMISTRY-US, V47, P12159, DOI 10.1021/bi8006498; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; OHTSUBO M, 1990, BIOCHIM BIOPHYS ACTA, V1021, P157, DOI 10.1016/0005-2736(90)90028-M; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; ORLOWSKI S, 1993, FEBS LETT, V328, P296, DOI 10.1016/0014-5793(93)80947-S; Pedersen PA, 1996, BIOCHEMISTRY-US, V35, P16085, DOI 10.1021/bi961614c; Pedersen PA, 2000, J BIOL CHEM, V275, P37588, DOI 10.1074/jbc.M005610200; PICK U, 1980, BIOCHIM BIOPHYS ACTA, V626, P255, DOI 10.1016/0005-2795(80)90216-0; PICK U, 1982, J BIOL CHEM, V257, P6120; POST RL, 1972, J BIOL CHEM, V247, P6530; RABON EC, 1990, J BIOL CHEM, V265, P19594; REPHAELI A, 1986, J BIOL CHEM, V261, P6248; SCOFANO HM, 1979, J BIOL CHEM, V254, P227; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SKOU JC, 1980, BIOCHIM BIOPHYS ACTA, V601, P386, DOI 10.1016/0005-2736(80)90543-X; SKOU JC, 1981, BIOCHIM BIOPHYS ACTA, V647, P232, DOI 10.1016/0005-2736(81)90251-0; SMIRNOVA IN, 1993, J BIOL CHEM, V268, P16120; STEINBERG M, 1989, J BIOL CHEM, V264, P2726; STEKHOVEN FMAHS, 1986, BIOCHIM BIOPHYS ACTA, V861, P259, DOI 10.1016/0005-2736(86)90428-1; Strugatsky D, 2003, J BIOL CHEM, V278, P46064, DOI 10.1074/jbc.M308303200; STURMER W, 1991, J MEMBRANE BIOL, V121, P163, DOI 10.1007/BF01870530; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008	53	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31038	31051		10.1074/jbc.M109.050054	http://dx.doi.org/10.1074/jbc.M109.050054			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19726667	hybrid, Green Published			2022-12-27	WOS:000271378400033
J	Roostaee, A; Cote, S; Roucou, X				Roostaee, Alireza; Cote, Sebastien; Roucou, Xavier			Aggregation and Amyloid Fibril Formation Induced by Chemical Dimerization of Recombinant Prion Protein in Physiological-like Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; PHYSICAL-PROPERTIES; SCRAPIE; CONVERSION; PRPSC; MECHANISM; DISEASE; DOMAIN; HETERODIMERIZATION; CONFORMATION	Prion diseases are caused by the conversion of a cellular protein (PrPC) into a misfolded, aggregated isoform (PrPRes). Misfolding of recombinant PrPC in the absence of PrPRes template, cellular factors, denaturing agents, or at neutral pH has not been achieved. A number of studies indicate that dimerization of PrPC may be a key step in the aggregation process. In an effort to understand the molecular event that may activate misfolding of PrPC in more relevant physiological conditions, we tested if enforced dimerization of PrPC may induce a conformational change reminiscent of the conversion of PrPC to PrPRes. We used a well described inducible dimerization strategy whereby a chimeric PrPC composed of a modified FK506-binding protein (Fv) fused with PrPC and termed Fv-PrP is incubated in the presence of a monomeric FK506 or dimerizing AP20187 ligand. Addition of AP20187 but not FK506 to recombinant Fv-PrP (rFv-PrP) in physiological-like conditions resulted in a rapid conformational change characterized by an increase in beta-sheet structure and simultaneous aggregation of the protein. Aggregates were partially resistant to proteinase K and induced the conversion of soluble rFv-PrP in serial seeding experiments. As judged from thioflavin T binding and electron microscopy, aggregates converted to amyloid fibers. Aggregates were toxic to cultured cells, whereas soluble rFv-PrP and amyloid fibers were harmless. This study strongly supports the proposition that dimerization of PrPC is a key pathological primary event in the conversion of PrPC and may initiate the pathogenesis of prion diseases.	[Roostaee, Alireza; Cote, Sebastien; Roucou, Xavier] Univ Sherbrooke, Fac Med, Dept Biochem, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Roucou, X (corresponding author), Univ Sherbrooke, Fac Med, Dept Biochem, 3001 12th Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	xavier.roucou@usherbrooke.ca			Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from Canadian Institutes for Health Research (to X. R.).	Abalos GC, 2008, J BIOL CHEM, V283, P34021, DOI 10.1074/jbc.M804475200; Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Baskakov IV, 2007, FEBS J, V274, P576, DOI 10.1111/j.1742-4658.2007.05630.x; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Baskakov IV, 2001, J BIOL CHEM, V276, P19687, DOI 10.1074/jbc.C100180200; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; BENDHEIM PE, 1986, P NATL ACAD SCI USA, V83, P2214, DOI 10.1073/pnas.83.7.2214; Bocharova OV, 2006, J BIOL CHEM, V281, P2373, DOI 10.1074/jbc.M510840200; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Cobb NJ, 2008, J BIOL CHEM, V283, P34704, DOI 10.1074/jbc.M806701200; Cordeiro Y, 2005, BIOPHYS J, V89, P2667, DOI 10.1529/biophysj.105.067603; Daugherty DL, 1998, J BIOL CHEM, V273, P33961, DOI 10.1074/jbc.273.51.33961; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; GODT RE, 1988, AM J PHYSIOL, V254, pC591, DOI 10.1152/ajpcell.1988.254.5.C591; Goggin K, 2007, J NEUROCHEM, V102, P1195, DOI 10.1111/j.1471-4159.2007.04611.x; GOMEZ J, 1995, PROTEINS, V22, P404, DOI 10.1002/prot.340220410; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Ho JGS, 2005, J BIOL CHEM, V280, P31999, DOI 10.1074/jbc.M504403200; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Kundu B, 2003, P NATL ACAD SCI USA, V100, P12069, DOI 10.1073/pnas.2033281100; Lavigne P, 1998, J MOL BIOL, V281, P165, DOI 10.1006/jmbi.1998.1914; LAVIGNE P, 1995, J MOL BIOL, V254, P505, DOI 10.1006/jmbi.1995.0634; Leffers KW, 2005, BIOL CHEM, V386, P569, DOI 10.1515/BC.2005.067; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; LU S, 1991, J BIOL CHEM, V266, P10054; Luhrs TT, 2006, J MOL BIOL, V357, P833, DOI 10.1016/j.jmb.2006.01.016; May BCH, 2004, TRENDS BIOCHEM SCI, V29, P162, DOI 10.1016/j.tibs.2004.02.008; Meier P, 2003, CELL, V113, P49, DOI 10.1016/S0092-8674(03)00201-0; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PRIOLA SA, 1995, J BIOL CHEM, V270, P3299, DOI 10.1074/jbc.270.7.3299; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rezaei H, 2005, J MOL BIOL, V347, P665, DOI 10.1016/j.jmb.2005.01.043; Roostaee A, 2008, BIOCHEM J, V412, P553, DOI 10.1042/BJ20071264; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; SKLAVIADIS TK, 1989, J VIROL, V63, P1212, DOI 10.1128/JVI.63.3.1212-1222.1989; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Solforosi L, 2007, J BIOL CHEM, V282, P7465, DOI 10.1074/jbc.M610051200; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; Stohr J, 2008, P NATL ACAD SCI USA, V105, P2409, DOI 10.1073/pnas.0712036105; Supattapone S, 2004, J MOL MED, V82, P348, DOI 10.1007/s00109-004-0534-3; Swietnicki W, 1998, J BIOL CHEM, V273, P31048, DOI 10.1074/jbc.273.47.31048; Swietnicki W, 2000, BIOCHEMISTRY-US, V39, P424, DOI 10.1021/bi991967m; Tompa P, 2002, BIOPHYS J, V82, P1711, DOI 10.1016/S0006-3495(02)75523-9; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6	54	23	23	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30907	30916		10.1074/jbc.M109.057950	http://dx.doi.org/10.1074/jbc.M109.057950			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19710507	Green Published, hybrid			2022-12-27	WOS:000271378400019
J	Nishiyama, Y; Planque, S; Mitsuda, Y; Nitti, G; Taguchi, H; Jin, L; Symersky, J; Boivin, S; Sienczyk, M; Salas, M; Hanson, CV; Paul, S				Nishiyama, Yasuhiro; Planque, Stephanie; Mitsuda, Yukie; Nitti, Giovanni; Taguchi, Hiroaki; Jin, Lei; Symersky, Jindrich; Boivin, Stephane; Sienczyk, Marcin; Salas, Maria; Hanson, Carl V.; Paul, Sudhir			Toward Effective HIV Vaccination INDUCTION OF BINARY EPITOPE REACTIVE ANTIBODIES WITH BROAD HIV NEUTRALIZING ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SUPERANTIGEN-BINDING-SITE; HUMAN MONOCLONAL-ANTIBODY; B-CELL SUPERANTIGEN; VASOACTIVE-INTESTINAL-PEPTIDE; GP120 ENVELOPE GLYCOPROTEIN; TYPE-1 GP120; LIGHT-CHAIN; PROTEOLYTIC ANTIBODIES; SYNTHETIC PEPTIDES	We describe murine monoclonal antibodies (mAbs) raised by immunization with an electrophilic gp120 analog (E-gp120) expressing the rare ability to neutralize genetically heterologous human immunodeficiency virus (HIV) strains. Unlike gp120, E-gp120 formed covalent oligomers. The reactivity of gp120 and E-gp120 with mAbs to reference neutralizing epitopes was markedly different, indicating their divergent structures. Epitope mapping with synthetic peptides and electrophilic peptide analogs indicated binary recognition of two distinct gp120 regions by anti-E-gp120 mAbs, the 421-433 and 288-306 peptide regions. Univalent Fab and single chain Fv fragments expressed the ability to recognize both peptides. X-ray crystallography of an anti-E-gp120 Fab fragment revealed two neighboring cavities, the typical antigen-binding cavity formed by the complementarity determining regions (CDRs) and another cavity dominated by antibody heavy chain variable (V-H) domain framework (FR) residues. Substitution of the FR cavity V-H Lys-19 residue by an Ala residue resulted in attenuated binding of the 421-433 region peptide probe. The CDRs and V-H FR replacement/silent mutation ratios exceeded the ratio for a random mutation process, suggesting adaptive development of both putative binding sites. All mAbs studied were derived from V(H)1 family genes, suggesting biased recruitment of the V gene germ line repertoire by E-gp120. The conserved 421-433 region of gp120 is essential for HIV binding to host CD4 receptors. This region is recognized weakly by the FR of antibodies produced without exposure to HIV, but it usually fails to induce adaptive synthesis of neutralizing antibodies. We present models accounting for improved CD4-binding site recognition and broad HIV neutralizing activity of the mAbs, long sought goals in HIV vaccine development.	[Nishiyama, Yasuhiro; Planque, Stephanie; Mitsuda, Yukie; Nitti, Giovanni; Taguchi, Hiroaki; Jin, Lei; Symersky, Jindrich; Boivin, Stephane; Sienczyk, Marcin; Paul, Sudhir] Univ Texas Houston, Sch Med, Chem Immunol Res Ctr, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Salas, Maria; Hanson, Carl V.] Calif Dept Publ Hlth, Viral & Rickettsial Dis Lab, Ctr Infect Dis, Richmond, CA 94804 USA	University of Texas System; University of Texas Health Science Center Houston; California Department of Public Health	Paul, S (corresponding author), 6431 Fannin, Houston, TX 77030 USA.	Sudhir.Paul@uth.tmc.edu	Sienczyk, Marcin/I-3869-2012; Boivin, Stephane/K-4018-2012	Boivin, Stephane/0000-0003-1460-326X	National Institutes of Health [AI058684, AG025304, AI82515, AI62455, AI31268, AI058865]; Texas Higher Education Coordinating Board; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI062455, R01AI031268, R15AI082515, R01AI058865, R21AI031268, R21AI058684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025304] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Higher Education Coordinating Board; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AI058684, AG025304, AI82515, AI62455, AI31268, and AI058865. This work was also supported by the Texas Higher Education Coordinating Board.	Bangale Y, 2003, FASEB J, V17, P628, DOI 10.1096/fj.02-0475com; Bangale Y, 2002, PEPTIDES, V23, P2251, DOI 10.1016/S0196-9781(02)00265-6; BERBERIAN L, 1991, BLOOD, V78, P175; BERBERIAN L, 1994, J ACQ IMMUN DEF SYND, V7, P641; BERBERIAN L, 1993, SCIENCE, V261, P1588, DOI 10.1126/science.7690497; Berisha HI, 2002, PULM PHARMACOL THER, V15, P121, DOI 10.1006/pupt.2001.0337; BERMAS BL, 1994, AIDS RES HUM RETROV, V10, P1071, DOI 10.1089/aid.1994.10.1071; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Bose B, 2005, IMMUNOLOGY, V116, P172, DOI 10.1111/j.1365-2567.2005.02208.x; Brezski RJ, 2008, ADV EXP MED BIOL, V640, P12, DOI 10.1007/978-0-387-09789-3_2; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Bures R, 2000, AIDS RES HUM RETROV, V16, P2019, DOI 10.1089/088922200750054756; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; CHANG B, 1994, IMMUNOL TODAY, V15, P367, DOI 10.1016/0167-5699(94)90175-9; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; Chuenchitra T, 2003, AIDS RES HUM RETROV, V19, P293, DOI 10.1089/088922203764969492; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; FOSTER MH, 1991, J IMMUNOL, V147, P1504; GAO QS, 1995, J MOL BIOL, V253, P658, DOI 10.1006/jmbi.1995.0580; GEONNOTTI AR, 2009, 16 C RETR OPP INF MO; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; GOODGLICK L, 1995, J IMMUNOL, V155, P5151; Goodyear CS, 2007, J IMMUNOL, V178, P2636, DOI 10.4049/jimmunol.178.5.2636; Goodyear CS, 2003, J EXP MED, V197, P1125, DOI 10.1084/jem.20020552; GORNY MK, 1991, P NATL ACAD SCI USA, V88, P3238, DOI 10.1073/pnas.88.8.3238; Gorse GJ, 1999, AIDS RES HUM RETROV, V15, P115, DOI 10.1089/088922299311547; Harwood NE, 2008, IMMUNITY, V28, P609, DOI 10.1016/j.immuni.2008.04.007; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Herrera C, 2003, J VIROL, V77, P1084, DOI 10.1128/JVI.77.2.1084-1091.2003; Hifumi E, 2008, J BIOL CHEM, V283, P899, DOI 10.1074/jbc.M705674200; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Juompan L, 1998, FASEB J, V12, P1473, DOI 10.1096/fasebj.12.14.1473; Karle S, 2004, AIDS, V18, P329, DOI 10.1097/00002030-200401230-00026; Karle S, 2003, VACCINE, V21, P1213, DOI 10.1016/S0264-410X(02)00504-2; Karray S, 1997, P NATL ACAD SCI USA, V94, P1356, DOI 10.1073/pnas.94.4.1356; Karray S, 1998, J IMMUNOL, V161, P6681; KERR JA, 1995, CRC HDB CHEM PHYS, P51; KOMISAR JL, 1989, J IMMUNOL, V143, P340; Koning FA, 2003, J INFECT DIS, V188, P864, DOI 10.1086/377105; Krakauer T, 2002, CLIN DIAGN LAB IMMUN, V9, P126, DOI 10.1128/CDLI.9.1.126-131.2002; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Lacroix-Desmazes S, 2006, J IMMUNOL, V177, P1355, DOI 10.4049/jimmunol.177.2.1355; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Maizels N, 2005, ANNU REV GENET, V39, P23, DOI 10.1146/annurev.genet.39.073003.110544; MATTHEWS TJ, 1986, P NATL ACAD SCI USA, V83, P9709, DOI 10.1073/pnas.83.24.9709; Mitsuda Y, 2004, BIOTECHNOL BIOENG, V86, P217, DOI 10.1002/bit.20031; MONTEFIORI DC, 1992, J CLIN IMMUNOL, V12, P429, DOI 10.1007/BF00918855; Moore JP, 1996, J VIROL, V70, P1863, DOI 10.1128/JVI.70.3.1863-1872.1996; MOORE JP, 1994, J VIROL, V68, P469, DOI 10.1128/JVI.68.1.469-484.1994; Moore JP, 2001, J VIROL, V75, P5721, DOI 10.1128/JVI.75.13.5721-5729.2001; MORROW WJW, 1992, IMMUNOLOGY, V75, P557; Neshat MN, 2000, INT IMMUNOL, V12, P305, DOI 10.1093/intimm/12.3.305; NEURATH AR, 1990, J GEN VIROL, V71, P85, DOI 10.1099/0022-1317-71-1-85; Nishiyama Y, 2005, J MOL RECOGNIT, V18, P295, DOI 10.1002/jmr.734; Nishiyama Y, 2004, J BIOL CHEM, V279, P7877, DOI 10.1074/jbc.M310950200; Nishiyama Y, 2002, ARCH BIOCHEM BIOPHYS, V402, P281, DOI 10.1016/S0003-9861(02)00087-5; Nishiyama Y, 2007, J BIOL CHEM, V282, P31250, DOI 10.1074/jbc.M706471200; Nishiyama Y, 2007, MOL IMMUNOL, V44, P2707, DOI 10.1016/j.molimm.2006.12.005; Nishiyama Y, 2006, J MOL RECOGNIT, V19, P423, DOI 10.1002/jmr.795; OLSHEVSKY U, 1990, J VIROL, V64, P5701, DOI 10.1128/JVI.64.12.5701-5707.1990; PALKER TJ, 1989, J IMMUNOL, V142, P3612; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Paul S, 2004, J BIOL CHEM, V279, P39611, DOI 10.1074/jbc.M406719200; Paul S, 2003, J BIOL CHEM, V278, P20429, DOI 10.1074/jbc.M300870200; Paul S, 2001, J BIOL CHEM, V276, P28314, DOI 10.1074/jbc.M102530200; Planque S, 2004, J BIOL CHEM, V279, P14024, DOI 10.1074/jbc.M312152200; Planque S, 2003, J BIOL CHEM, V278, P20436, DOI 10.1074/jbc.M301468200; PLANQUE S, 2008, AIDS 2008 17 INT AID; Planque S, 2007, AIDS RES HUM RETROV, V23, P1541, DOI 10.1089/aid.2007.0081; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Saphire EO, 2007, J MOL BIOL, V369, P696, DOI 10.1016/j.jmb.2007.01.060; SATTENTAU QJ, 1995, J EXP MED, V182, P185, DOI 10.1084/jem.182.1.185; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Stanfield RL, 2004, STRUCTURE, V12, P193, DOI 10.1016/j.str.2004.01.003; Taguchi H, 2002, BIOORG MED CHEM LETT, V12, P3167, DOI 10.1016/S0960-894X(02)00640-6; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; WEISS RA, 1986, NATURE, V324, P572, DOI 10.1038/324572a0; WILSON IA, 1991, CIBA F SYMP, V159, P13; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Xiang SH, 2002, AIDS RES HUM RETROV, V18, P1207, DOI 10.1089/08892220260387959; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zolla-Pazner S, 2004, AIDS RES HUM RETROV, V20, P1254, DOI 10.1089/aid.2004.20.1254	88	14	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30627	30642		10.1074/jbc.M109.032185	http://dx.doi.org/10.1074/jbc.M109.032185			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19726674	hybrid, Green Published			2022-12-27	WOS:000271090000065
J	Pastor, MM; Proft, M; Pascual-Ahuir, A				Pastor, Mar Martinez; Proft, Markus; Pascual-Ahuir, Amparo			Mitochondrial Function Is an Inducible Determinant of Osmotic Stress Adaptation in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; SNF1 PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; GLUCOSE REPRESSION; OXIDATIVE-STRESS; HIGH-OSMOLARITY; TRANSCRIPTIONAL RESPONSE; ENA1 GENE; SUBCELLULAR-LOCALIZATION; ION HOMEOSTASIS	Hyperosmotic stress triggers a great variety of adaptive responses in eukaryotic cells that affect many different physiological functions. Here we investigate the role of the mitochondria during osmostress adaptation in budding yeast. Mitochondrial function is generally required for proper salt and osmotic stress adaptation because mutants with defects in many different mitochondrial components show hypersensitivity to increased NaCl and KCl concentrations. Mitochondrial protein abundance rapidly increases upon osmoshock in a selective manner, because it affects Calvin cycle enzymes (Sdh2 and Cit1) and components of the electron transport chain (Cox6) but not the ATP synthase complex (Atp5). Transcription of the SDH2, CIT1, and COX6 genes is severalfold induced within the first minutes of osmotic shock, dependent to various degree on the Hog1 and Snf1 protein kinases. Mitochondrial succinate dehydrogenase enzyme activity is stimulated upon osmostress in a Snf1-dependent manner. The osmosensitivity of mitochondrial mutants is not caused by impaired stress-activated transcription or by a general depletion of the cellular ATP pool during osmostress. We finally show that the growth defect of mitochondrial mutants in high salt medium can be partially rescued by supplementation of glutathione. Additionally, mitochondrial defects cause the hyperaccumulation of reactive oxygen species during salt stress. Our results indicate that the antioxidant function of the mitochondria might play an important role in adaptation to hyperosmotic stress.	[Pastor, Mar Martinez; Proft, Markus; Pascual-Ahuir, Amparo] Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, CSIC, Valencia 46022, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Proft, M (corresponding author), Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, CSIC, Ingn Fausto Elio S-N, Valencia 46022, Spain.	mproft@ibmcp.upv.es	Pascual-ahuir, Amparo/K-1338-2014; Proft, Markus/K-2323-2014	Proft, Markus/0000-0002-6788-5830; PASCUAL-AHUIR, AMPARO/0000-0001-6173-1526	Ministerio de Educacion y Ciencia [BFU2005-0174]; Ministerio de Ciencia e Innovacion [BFU2008-00271]; Generalitat de Valencia [ACOMP07-198]	Ministerio de Educacion y Ciencia(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Valencia	This work was supported by Ministerio de Educacion y Ciencia Grant BFU2005-0174, Ministerio de Ciencia e Innovacion Grant BFU2008-00271, and Generalitat de Valencia Grant ACOMP07-198.	Alepuz PM, 1997, MOL MICROBIOL, V26, P91, DOI 10.1046/j.1365-2958.1997.5531917.x; AMBROSIO G, 1993, J BIOL CHEM, V268, P18532; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barros MH, 2004, J BIOL CHEM, V279, P49883, DOI 10.1074/jbc.M408918200; Bilsland-Marchesan E, 2000, MOL CELL BIOL, V20, P3887, DOI 10.1128/MCB.20.11.3887-3895.2000; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Clotet J, 2007, METHOD ENZYMOL, V428, P63, DOI 10.1016/S0076-6879(07)28004-8; Clotet J, 2006, EMBO J, V25, P2338, DOI 10.1038/sj.emboj.7601095; de Nadal E, 2002, EMBO REP, V3, P735, DOI 10.1093/embo-reports/kvf158; DEFONTAINE A, 1991, NUCLEIC ACIDS RES, V19, P185, DOI 10.1093/nar/19.1.185; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; DIECKMANN CL, 1994, INT REV CYTOL, V152, P145, DOI 10.1016/S0074-7696(08)62556-5; Escote X, 2004, NAT CELL BIOL, V6, P997, DOI 10.1038/ncb1174; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; Ganster RW, 1998, GENETICS, V150, P31; GAXIOLA R, 1992, EMBO J, V11, P3157, DOI 10.1002/j.1460-2075.1992.tb05392.x; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Grant CM, 1997, FEBS LETT, V410, P219, DOI 10.1016/S0014-5793(97)00592-9; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; HARO R, 1991, FEBS LETT, V291, P189, DOI 10.1016/0014-5793(91)81280-L; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Hohmann S, 2002, INT REV CYTOL, V215, P149; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hong SP, 2007, J BIOL CHEM, V282, P16838, DOI 10.1074/jbc.M700146200; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jia YK, 1997, MOL CELL BIOL, V17, P1110, DOI 10.1128/MCB.17.3.1110; Koziol S, 2005, FREE RADICAL RES, V39, P365, DOI 10.1080/10715760500045855; Krantz M, 2004, EUKARYOT CELL, V3, P1381, DOI 10.1128/EC.3.6.1381-1390.2004; LI F, 1989, J CHROMATOGR, V461, P353, DOI 10.1016/S0021-9673(00)94302-4; Liu ZC, 1999, MOL CELL BIOL, V19, P6720; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; MUELLER DM, 1986, J BIOL CHEM, V261, P1756; NAKAI T, 1995, MOL CELL BIOL, V15, P4441; Norbeck J, 1998, FEMS MICROBIOL LETT, V158, P121, DOI 10.1016/S0378-1097(97)00511-9; O'Rourke SM, 2002, TRENDS GENET, V18, P405, DOI 10.1016/S0168-9525(02)02723-3; Pandey G, 2007, APPL MICROBIOL BIOT, V75, P415, DOI 10.1007/s00253-007-0837-8; Pascual-Ahuir M, 2001, MOL CELL BIOL, V21, P16, DOI 10.1128/MCB.21.1.16-25.2001; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Perrone GG, 2008, BBA-MOL CELL RES, V1783, P1354, DOI 10.1016/j.bbamcr.2008.01.023; PINKHAM JL, 1985, MOL CELL BIOL, V5, P3410, DOI 10.1128/MCB.5.12.3410; Platara M, 2006, J BIOL CHEM, V281, P36632, DOI 10.1074/jbc.M606483200; Posas F, 2000, J BIOL CHEM, V275, P17249, DOI 10.1074/jbc.M910016199; Proft M, 2004, CELL, V118, P351, DOI 10.1016/j.cell.2004.07.016; Proft M, 1999, MOL CELL BIOL, V19, P537; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Rep M, 2001, MOL MICROBIOL, V40, P1067, DOI 10.1046/j.1365-2958.2001.02384.x; Sanz P, 2003, BIOCHEM SOC T, V31, P178; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Sedensky MM, 2006, EXP GERONTOL, V41, P237, DOI 10.1016/j.exger.2006.01.004; Sekito T, 2000, MOL BIOL CELL, V11, P2103, DOI 10.1091/mbc.11.6.2103; Teige M, 2001, P NATL ACAD SCI USA, V98, P5625, DOI 10.1073/pnas.091610798; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; TRAWICK JD, 1989, J BIOL CHEM, V264, P7005; Tsujimoto Y, 2000, J BACTERIOL, V182, P5121, DOI 10.1128/JB.182.18.5121-5126.2000; ULERY TL, 1994, MOL CELL BIOL, V14, P1160, DOI 10.1128/MCB.14.2.1160; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WRIGHT RM, 1990, MOL CELL BIOL, V10, P1297, DOI 10.1128/MCB.10.3.1297; Yale J, 2001, J BIOL CHEM, V276, P15996, DOI 10.1074/jbc.M008209200; Ye T, 2008, MICROBIOL-SGM, V154, P2814, DOI 10.1099/mic.0.2008/020149-0; Ye T, 2006, EUKARYOT CELL, V5, P1611, DOI 10.1128/EC.00215-06; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200; Zuin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002842	69	57	58	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30307	30317		10.1074/jbc.M109.050682	http://dx.doi.org/10.1074/jbc.M109.050682			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19720830	hybrid, Green Published			2022-12-27	WOS:000271090000034
J	Takazawa, T; Yamauchi, T; Tsuchida, A; Takata, M; Hada, Y; Iwabu, M; Okada-Iwabu, M; Ueki, K; Kadowaki, T				Takazawa, Takeshi; Yamauchi, Toshimasa; Tsuchida, Atsushi; Takata, Makoto; Hada, Yusuke; Iwabu, Masato; Okada-Iwabu, Miki; Ueki, Kohjiro; Kadowaki, Takashi			Peroxisome Proliferator-activated Receptor gamma Agonist Rosiglitazone Increases Expression of Very Low Density Lipoprotein Receptor Gene in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; ADIPOSE-TISSUE; PPAR-GAMMA; APOLIPOPROTEIN-E; VLDL RECEPTOR; ADIPONECTIN RECEPTORS; DEFICIENT MICE; OBESITY; DIFFERENTIATION; ADIPOGENESIS	Apolipoprotein E (apoE) and its receptor, very low density lipoprotein receptor (VLDLR), are involved in fat accumulation in adipocytes. Here, we investigated the effect of a peroxisome proliferator-activated receptor (PPAR) gamma agonist, rosiglitazone, on regulation of VLDLR expression both in white adipose tissue (WAT) of obese mice and in cultured adipocytes. Furthermore, to determine whether rosiglitazone directly regulates transcription of the VLDLR gene, we carried out luciferase assay with a reporter gene containing mouse VLDLR promoter region, electrophoretic mobility shift assay, and chromatin immunoprecipitation assay. Four-day treatment with rosiglitazone increased the expression of VLDLR in WAT of ob/ob mice. Moreover, rosiglitazone increased the expression of VLDLR in cultured adipocytes. The PPAR-responsive element (PPRE)-directed mutagenesis analyses revealed that the PPRE motif in the VLDLR promoter region plays a significant role in transcriptional activation of the VLDLR gene in adipocytes. In addition, electrophoretic mobility shift assay and chromatin immunoprecipitation assay demonstrated that endogenous PPAR gamma directly binds to this functional PPRE motif in the VLDLR promoter region. We also investigated the effects of rosiglitazone on insulin sensitivity and lipid accumulation in both ob/ob mice and apoE-deficient ob/ob mice. Rosiglitazone ameliorated insulin sensitivity in both ob/ob mice and apoE-deficient ob/ob mice, possibly through decreasing the expression of monocyte chemoattractant protein-1 (MCP-1), increasing the expression of superoxide dismutase 1 (SOD1) in WAT, and increasing plasma adiponectin concentration. In ob/ob mice, body weight and WAT weight were significantly higher in the mice treated with rosiglitazone than those treated with vehicle. However, in apoE-deficient ob/ob mice, no significant difference in body weight or WAT weight was observed between the vehicle-treated group and the rosiglitazone-treated group. Moreover, rosiglitazone did not increase body weight and WAT weight in VLDLR-deficient mice. These findings indicate that rosiglitazone directly increases VLDLR expression, thereby enhancing apoE-VLDLR-dependent lipid accumulation in adipocytes.	[Takazawa, Takeshi; Yamauchi, Toshimasa; Hada, Yusuke; Iwabu, Masato; Okada-Iwabu, Miki; Ueki, Kohjiro; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Metab Dis, Bunkyo Ku, Tokyo 1138655, Japan; [Yamauchi, Toshimasa] Univ Tokyo, Century Med & Res Ctr 22, Dept Integrated Mol Sci Metab Dis, Tokyo 1138655, Japan; [Tsuchida, Atsushi; Takata, Makoto] Dainippon Sumitomo Pharma Co Ltd, Pharmacol Res Labs, Osaka 5540022, Japan; [Kadowaki, Takashi] Natl Inst Hlth & Nutr, Tokyo 1628636, Japan	University of Tokyo; University of Tokyo; Dainippon Sumitomo Pharmaceutical Company; National Institute of Health & Nutrition - Japan	Kadowaki, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Metab Dis, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kadowaki-3im@h.u-tokyo.ac.jp			Organization for Pharmaceutical Safety and Research of Japan; Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labor and Welfare	Organization for Pharmaceutical Safety and Research of Japan; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a grant from the Program for Promotion of Fundamental Studies in Health Sciences of the Organization for Pharmaceutical Safety and Research of Japan (to T. K.), a grant-in aid for the Development of Innovative Technology from the Ministry of Education, Culture, Sports, Science and Technology (to T. K.), and health science research grants (Research on Human Genome and Gene Therapy) from the Ministry of Health, Labor and Welfare (to T. K.).	Auwerx J, 1999, DIABETOLOGIA, V42, P1033, DOI 10.1007/s001250051268; BRESLOW JL, 1985, ANNU REV BIOCHEM, V54, P699, DOI 10.1146/annurev.biochem.54.1.699; Chao L, 2000, J CLIN INVEST, V106, P1221, DOI 10.1172/JCI11245; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Chiba T, 2003, ARTERIOSCL THROM VAS, V23, P1423, DOI 10.1161/01.ATV.0000085040.58340.36; de Souza CJ, 2001, DIABETES, V50, P1863, DOI 10.2337/diabetes.50.8.1863; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; GAFVELS ME, 1994, ENDOCRINOLOGY, V135, P387, DOI 10.1210/en.135.1.387; Gao JH, 2007, DIABETES, V56, P24, DOI 10.2337/db06-0144; Goudriaan JR, 2004, J LIPID RES, V45, P1475, DOI 10.1194/jlr.M400009-JLR200; Goudriaan JR, 2001, ARTERIOSCL THROM VAS, V21, P1488, DOI 10.1161/hq0901.095147; HUSSAIN MM, 1991, J BIOL CHEM, V266, P13936; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; KRAFT HG, 1989, J CLIN INVEST, V83, P137, DOI 10.1172/JCI113849; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lowell BB, 1999, CELL, V99, P239, DOI 10.1016/S0092-8674(00)81654-2; Moore GBT, 2001, BIOCHEM BIOPH RES CO, V286, P735, DOI 10.1006/bbrc.2001.5460; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; SAKAI J, 1994, J BIOL CHEM, V269, P2173; Sato O, 2002, J BIOL CHEM, V277, P15703, DOI 10.1074/jbc.M110158200; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; TAKAHASHI S, 1995, J BIOL CHEM, V270, P15747, DOI 10.1074/jbc.270.26.15747; TAKAHASHI S, 1992, P NATL ACAD SCI USA, V89, P9252, DOI 10.1073/pnas.89.19.9252; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; Way JM, 2001, ENDOCRINOLOGY, V142, P1269, DOI 10.1210/en.142.3.1269; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yagyu H, 2002, J BIOL CHEM, V277, P10037, DOI 10.1074/jbc.M109966200; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, J CLIN INVEST, V108, P1001, DOI 10.1172/JCI12864; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; ZECHNER R, 1991, J BIOL CHEM, V266, P10583; Zenimaru Y, 2008, BIOCHEM BIOPH RES CO, V368, P716, DOI 10.1016/j.bbrc.2008.01.154	37	30	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30049	30057		10.1074/jbc.M109.047993	http://dx.doi.org/10.1074/jbc.M109.047993			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19706614	Green Published, hybrid			2022-12-27	WOS:000271090000007
J	Ruprecht, J; Yankovskaya, V; Maklashina, E; Iwata, S; Cecchini, G				Ruprecht, Jonathan; Yankovskaya, Victoria; Maklashina, Elena; Iwata, So; Cecchini, Gary			Structure of Escherichia coli Succinate: Quinone Oxidoreductase with an Occupied and Empty Quinone-binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX-II SUCCINATE; FUMARATE REDUCTASE; UBIQUINONE OXIDOREDUCTASE; STRUCTURE VALIDATION; CRYSTALLIZATION; LIGAND; DEHYDROGENASE; REFINEMENT; MECHANISM; REPLACEMENT	Three new structures of Escherichia coli succinate-quinone oxidoreductase (SQR) have been solved. One with the specific quinone-binding site (Q-site) inhibitor carboxin present has been solved at 2.4 angstrom resolution and reveals how carboxin inhibits the Q-site. The other new structures are with the Q-site inhibitor pentachlorophenol and with an empty Q-site. These structures reveal important details unresolved in earlier structures. Comparison of the new SQR structures shows how subtle rearrangements of the quinone-binding site accommodate the different inhibitors. The position of conserved water molecules near the quinone binding pocket leads to a reassessment of possible water-mediated proton uptake networks that complete reduction of ubiquinone. The dicarboxylate-binding site in the soluble domain of SQR is highly similar to that seen in high resolution structures of avian SQR (PDB 2H88) and soluble flavocytochrome c (PDB 1QJD) showing mechanistically significant structural features conserved across prokaryotic and eukaryotic SQRs.	Univ London Imperial Coll Sci Technol & Med, Mol Biosci Div, Membrane Prot Crystallog Grp, London SW7 2AZ, England; [Yankovskaya, Victoria; Maklashina, Elena; Cecchini, Gary] Vet Adm Med Ctr, Div Mol Biol, San Francisco, CA 94121 USA; [Maklashina, Elena; Cecchini, Gary] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	Imperial College London; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco		s.iwata@imperial.ac.uk; Gary.Cecchini@ucsf.edu		Ruprecht, Jonathan/0000-0002-1838-7245	National Institutes of Health [GM61606]; Department of Veterans Affairs, Office of Research and Development, Biomedical Laboratory Research Division; Human Receptor Crystallography Project, ERATO, Japan Science and Technology Agency [B17935]; Biotechnology and Biological Sciences Research Council [BB/C505116/1, B17935] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061606] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Office of Research and Development, Biomedical Laboratory Research Division(US Department of Veterans Affairs); Human Receptor Crystallography Project, ERATO, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM61606. This work was also supported by the Department of Veterans Affairs, Office of Research and Development, Biomedical Laboratory Research Division (to G. C.). The work in the UK was supported primarily by the Biotechnology and Biological Sciences Research Council (#B17935) with important contributions from the Human Receptor Crystallography Project, ERATO, Japan Science and Technology Agency.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine PV, 2005, CCP4 NEWSL, V42; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bamford V, 1999, NAT STRUCT BIOL, V6, P1104; BELIKOVA YO, 1988, BIOCHIM BIOPHYS ACTA, V936, P1, DOI 10.1016/0005-2728(88)90245-9; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Cecchini G, 2002, BBA-BIOENERGETICS, V1553, P140, DOI 10.1016/S0005-2728(01)00238-9; Cheng VWT, 2008, BIOCHEMISTRY-US, V47, P9107, DOI 10.1021/bi801008e; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Evrard GX, 2007, ACTA CRYSTALLOGR D, V63, P108, DOI 10.1107/S0907444906023389; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Horsefield R, 2006, J BIOL CHEM, V281, P7309, DOI 10.1074/jbc.M508173200; Horsefield R, 2004, CURR PROTEIN PEPT SC, V5, P107, DOI 10.2174/1389203043486847; Horsefield R, 2003, ACTA CRYSTALLOGR D, V59, P600, DOI 10.1107/S0907444903002075; HOWLIN B, 1993, J APPL CRYSTALLOGR, V26, P622, DOI 10.1107/S0021889893002729; Huang LS, 2006, BBA-BIOENERGETICS, V1757, P1073, DOI 10.1016/j.bbabio.2006.06.015; Huang LS, 2006, J BIOL CHEM, V281, P5965, DOI 10.1074/jbc.M511270200; Huang LS, 2005, ACTA CRYSTALLOGR D, V61, P380, DOI 10.1107/S0907444905000181; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jormakka M, 2008, NAT STRUCT MOL BIOL, V15, P730, DOI 10.1038/nsmb.1434; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; KUHLBRANDT W, 1988, Q REV BIOPHYS, V21, P429, DOI 10.1017/S0033583500004625; Lamzin V. S., 2001, INT TABLES CRYSTALLO, VF, P720; Lancaster CRD, 2002, BBA-BIOENERGETICS, V1553, P1, DOI 10.1016/S0005-2728(01)00240-7; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Leys D, 1999, NAT STRUCT BIOL, V6, P1113; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maklashina E, 1998, J BACTERIOL, V180, P5989, DOI 10.1128/JB.180.22.5989-5996.1998; Maklashina E, 2006, J BIOL CHEM, V281, P11357, DOI 10.1074/jbc.M512544200; Maklashina E, 1999, ARCH BIOCHEM BIOPHYS, V369, P223, DOI 10.1006/abbi.1999.1359; Maklashina E, 2001, J BIOL CHEM, V276, P18968, DOI 10.1074/jbc.M011270200; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MICHEL H, 1983, TRENDS BIOCHEM SCI, V8, P56, DOI 10.1016/0968-0004(83)90390-0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Taylor P, 1999, NAT STRUCT BIOL, V6, P1108; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tornroth S, 2002, BBA-BIOENERGETICS, V1553, P171, DOI 10.1016/S0005-2728(01)00236-5; Vibat CRT, 1998, BIOCHEMISTRY-US, V37, P4148, DOI 10.1021/bi9716635; Wiener MC, 2004, METHODS, V34, P364, DOI 10.1016/j.ymeth.2004.03.025; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605	51	67	71	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29836	29846		10.1074/jbc.M109.010058	http://dx.doi.org/10.1074/jbc.M109.010058			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19710024	hybrid, Green Published			2022-12-27	WOS:000270896800064
J	Umetsu, Y; Aizawa, T; Muto, K; Yamamoto, H; Kamiya, M; Kumaki, Y; Mizuguchi, M; Demura, M; Hayakawa, Y; Kawano, K				Umetsu, Yoshitaka; Aizawa, Tomoyasu; Muto, Kaori; Yamamoto, Hiroko; Kamiya, Masakatsu; Kumaki, Yasuhiro; Mizuguchi, Mineyuki; Demura, Makoto; Hayakawa, Yoichi; Kawano, Keiichi			C-terminal Elongation of Growth-blocking Peptide Enhances Its Biological Activity and Micelle Binding Affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMATOCYTE-SPREADING PEPTIDE; RECEPTOR-BINDING; DOPAMINE LEVELS; TMV RNA; INSECT; NMR; CYTOKINE; SYSTEM; RESIDUES; IDENTIFICATION	Growth-blocking peptide (GBP) is a hormone-like peptide that suppresses the growth of the host armyworm. Although the 23-amino acid GBP (1-23 GBP) is expressed in nonparasitized armyworm plasma, the parasitization by wasp produces the 28-amino acid GBP (1-28 GBP) through an elongation of the C-terminal amino acid sequence. In this study, we characterized the GBP variants, which consist of various lengths of the C-terminal region, by comparing their biological activities and three-dimensional structures. The results of an injection study indicate that 1-28 GBP most strongly suppresses larval growth. NMR analysis shows that these peptides have basically the same tertiary structures and that the extension of the C-terminal region is disordered. However, the C-terminal region of 1-28 GBP undergoes a conformational transition from a random coiled state to an alpha-helical state in the presence of dodecylphosphocholine micelles. This suggests that binding of the C-terminal region would affect larval growth activity.	[Kumaki, Yasuhiro; Demura, Makoto; Kawano, Keiichi] Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Aizawa, Tomoyasu; Kamiya, Masakatsu; Kumaki, Yasuhiro; Demura, Makoto; Kawano, Keiichi] Hokkaido Univ, Grad Sch Life Sci, Div Mol Life Sci, Sapporo, Hokkaido 0600810, Japan; [Muto, Kaori; Mizuguchi, Mineyuki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan; [Hayakawa, Yoichi] Saga Univ, Dept Appl Biol Sci, Saga 8408502, Japan	Hokkaido University; Hokkaido University; University of Toyama; Saga University	Kawano, K (corresponding author), Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Kita Ku, Kita 10,Nishi 8, Sapporo, Hokkaido 0600810, Japan.	kawano@sci.hokudai.ac.jp	Demura, Makoto/F-5272-2011; Aizawa, Tomoyasu/F-5278-2011; Kamiya, Masakatsu/F-5274-2011	Demura, Makoto/0000-0003-0912-9284; Aizawa, Tomoyasu/0000-0001-9134-7576; 	KAKENHI [19770123]; Program for the Promotion of Basic Research Activities for Innovative Biosciences	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Program for the Promotion of Basic Research Activities for Innovative Biosciences	This work was supported in part by KAKENHI Grant 19770123 and the Program for the Promotion of Basic Research Activities for Innovative Biosciences.	Aizawa T, 2001, J BIOL CHEM, V276, P31813, DOI 10.1074/jbc.M105251200; Aizawa T, 1999, J BIOL CHEM, V274, P1887, DOI 10.1074/jbc.274.4.1887; BEIER H, 1984, EMBO J, V3, P351, DOI 10.1002/j.1460-2075.1984.tb01810.x; BEIER H, 1984, EMBO J, V3, P1091, DOI 10.1002/j.1460-2075.1984.tb01934.x; Besenicar M, 2006, CHEM PHYS LIPIDS, V141, P169, DOI 10.1016/j.chemphyslip.2006.02.010; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clark KD, 2004, J BIOL CHEM, V279, P33246, DOI 10.1074/jbc.M401157200; Clark KD, 1997, J BIOL CHEM, V272, P23440, DOI 10.1074/jbc.272.37.23440; Clark KD, 2001, J BIOL CHEM, V276, P37431, DOI 10.1074/jbc.M105235200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Goddard T., 2001, SPARKY; Gololobov G, 1998, J PHARMACOL EXP THER, V285, P753; HAARER BK, 1993, MOL CELL BIOL, V13, P7864, DOI 10.1128/MCB.13.12.7864; Hayakawa Y, 1998, BIOCHEM BIOPH RES CO, V250, P194, DOI 10.1006/bbrc.1998.8959; HAYAKAWA Y, 1995, J INSECT PHYSIOL, V41, P1, DOI 10.1016/0022-1910(94)00077-T; HAYAKAWA Y, 1990, J BIOL CHEM, V265, P10813; HAYAKAWA Y, 1991, J BIOL CHEM, V266, P7982; HAYAKAWA Y, 1995, FEBS LETT, V376, P185, DOI 10.1016/0014-5793(95)01273-7; HAYAKAWA Y, 1993, INSECT BIOCHEM MOLEC, V23, P225, DOI 10.1016/0965-1748(93)90003-B; Hayakawa Y, 1998, J INSECT PHYSIOL, V44, P859, DOI 10.1016/S0022-1910(98)00017-1; Hayakawa Y, 1998, EUR J BIOCHEM, V253, P810, DOI 10.1046/j.1432-1327.1998.2530810.x; KAISER ET, 1983, P NATL ACAD SCI USA, V80, P1137, DOI 10.1073/pnas.80.4.1137; KAISER ET, 1984, SCIENCE, V223, P249, DOI 10.1126/science.6322295; KAY LE, 1989, J MAGN RESON, V84, P72, DOI 10.1016/0022-2364(89)90006-1; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lerch M, 2005, BIOCHEMISTRY-US, V44, P9255, DOI 10.1021/bi0501232; Lerch M, 2004, J MOL BIOL, V339, P1153, DOI 10.1016/j.jmb.2004.04.032; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; MACURA S, 1981, J MAGN RESON, V43, P259, DOI 10.1016/0022-2364(81)90037-8; Matsumoto Y, 2003, J BIOL CHEM, V278, P38579, DOI 10.1074/jbc.M305986200; Mozsolits H, 2001, BBA-BIOMEMBRANES, V1512, P64, DOI 10.1016/S0005-2736(01)00303-0; Noguchi H, 1996, INSECT BIOCHEM MOLEC, V26, P659, DOI 10.1016/S0965-1748(96)00016-1; NOGUCHI H, 1995, INSECT BIOCHEM MOLEC, V25, P197, DOI 10.1016/0965-1748(94)00054-L; Ohnishi A, 1995, INSECT BIOCHEM MOLEC, V25, P1121, DOI 10.1016/0965-1748(95)00054-2; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; SARGENT DF, 1986, P NATL ACAD SCI USA, V83, P5774, DOI 10.1073/pnas.83.16.5774; SCHWYZER R, 1995, J MOL RECOGNIT, V8, P3, DOI 10.1002/jmr.300080103; Sekiya T, 1990, Tanpakushitsu Kakusan Koso, V35, P2977; SKINNER WS, 1991, J BIOL CHEM, V266, P12873; Strand MR, 2000, J INSECT PHYSIOL, V46, P817, DOI 10.1016/S0022-1910(99)00171-7; Tada M, 2003, J BIOL CHEM, V278, P10778, DOI 10.1074/jbc.M211251200; WAGNER G, 1982, J MOL BIOL, V160, P343, DOI 10.1016/0022-2836(82)90180-2; Yoshida M, 2004, J BIOL CHEM, V279, P51331, DOI 10.1074/jbc.M409382200	48	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29625	29634		10.1074/jbc.M109.011148	http://dx.doi.org/10.1074/jbc.M109.011148			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19710009	Green Published, hybrid			2022-12-27	WOS:000270896800044
J	Chang, MH; Plata, C; Sindic, A; Ranatunga, WK; Chen, AP; Zandi-Nejad, K; Chan, KW; Thompson, J; Mount, DB; Romero, MF				Chang, Min-Hwang; Plata, Consuelo; Sindic, Aleksandra; Ranatunga, Wasantha K.; Chen, An-Ping; Zandi-Nejad, Kambiz; Chan, Kim W.; Thompson, James; Mount, David B.; Romero, Michael F.			Slc26a Is Inhibited by the R-region of the Cystic Fibrosis Transmembrane Conductance Regulator via the STAS Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL CHLORIDE DIARRHEA; ELECTROGENIC NA+-HCO3-COTRANSPORTER; MULTIFUNCTIONAL ANION-EXCHANGERS; SULFATE-TRANSPORTER; PENDRED-SYNDROME; DIASTROPHIC DYSPLASIA; WNK KINASES; SUBUNIT STOICHIOMETRY; FUNCTIONAL EXPRESSION; BICARBONATE SECRETION	SLC26 proteins function as anion exchangers, channels, and sensors. Previous cellular studies have shown that Slc26a3 and Slc26a6 interact with the R-region of the cystic fibrosis transmembrane conductance regulator (CFTR), (R)CFTR, via the Slc26-STAS (sulfate transporter anti-sigma) domain, resulting in mutual transport activation. We recently showed that Slc26a9 has both nCl(-)-HCO3- exchanger and Cl- channel function. In this study, we show that the purified STAS domain of Slc26a9 (a9STAS) binds purified (R)CFTR. When Slc26a9 and (R)CFTR fragments are co-expressed in Xenopus oocytes, both Slc26a9-mediated nCl(-)-HCO3- exchange and Cl- currents are almost fully inhibited. Deletion of the Slc26a9 STAS domain (a9-Delta STAS) virtually eliminated the Cl- currents with only a modest affect on nCl(-)-HCO3- exchange activity. Co-expression of a9-Delta STAS and the (R)CFTR fragment did not alter the residual a9-Delta STAS function. Replacing the Slc26a9 STAS domain with the Slc26a6 STAS domain (a6-a9-a6) does not change Slc26a9 function and is no longer inhibited by (R)CFTR. These data indicate that the Slc26a9-STAS domain, like other Slc26-STAS domains, binds CFTR in the R-region. However, unlike previously reported data, this binding interaction inhibits Slc26a9 ion transport activity. These results imply that Slc26-STAS domains may all interact with (R)CFTR but that the physiological outcome is specific to differing Slc26 proteins, allowing for dynamic and acute fine tuning of ion transport for various epithelia.	[Chang, Min-Hwang; Sindic, Aleksandra; Ranatunga, Wasantha K.; Chen, An-Ping; Thompson, James; Romero, Michael F.] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Chang, Min-Hwang; Plata, Consuelo; Sindic, Aleksandra; Chan, Kim W.; Romero, Michael F.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Plata, Consuelo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City 14000, DF, Mexico; [Zandi-Nejad, Kambiz; Mount, David B.] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; [Mount, David B.] Vet Affairs Boston Healthcare Syst, Div Renal, W Roxbury, MA 02132 USA	Mayo Clinic; Case Western Reserve University; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Romero, MF (corresponding author), Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, 200 1st St SW, Rochester, MN 55905 USA.	romero.michael@mayo.edu	Plata, Consuelo/M-4482-2015; Dugandzic, Aleksandra/AAL-7581-2020; Plata, Consuelo/M-6461-2019; Chen, An-Ping/I-6455-2013	Plata, Consuelo/0000-0001-9340-8950; Chen, An-Ping/0000-0002-4577-3205	National Institutes of Health [DK056218, DK060845, EY017732, DK038226, DK57708]; Veterans Affairs; American Heart Association; Cystic Fibrosis Foundation [ROMERO-06GO, SINDIC-06F0]; NATIONAL EYE INSTITUTE [R01EY017732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056218, R01DK057708, P01DK038226, R21DK060845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); American Heart Association(American Heart Association); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK056218, DK060845, EY017732 (to M. F. R.), and DK038226 and DK57708 (to D. B. M.). This work was also supported by grants from the Veterans Affairs (to D. B. M.), a grant-in-aid from the American Heart Association (to D. B. M.), a postdoctoral fellowship from the American Heart Association (to M. H. C. and K. Z.), and Cystic Fibrosis Foundation Grants ROMERO-06GO and SINDIC-06F0.	Aronson PS, 2006, KIDNEY INT, V70, P1207, DOI 10.1038/sj.ki.5001741; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Bertrand CA, 2009, J GEN PHYSIOL, V133, P421, DOI 10.1085/jgp.200810097; BISSIG M, 1994, J BIOL CHEM, V269, P3017; Cai GM, 1998, AM J MED GENET, V78, P58, DOI 10.1002/(SICI)1096-8628(19980616)78:1<58::AID-AJMG12>3.3.CO;2-F; Chan KM, 2000, J GEN PHYSIOL, V116, P163, DOI 10.1085/jgp.116.2.163; Chang MH, 2008, J BIOL CHEM, V283, P18402, DOI 10.1074/jbc.M709819200; Chang MH, 2009, J MEMBRANE BIOL, V228, P125, DOI 10.1007/s00232-009-9165-5; Chen AP, 2009, FASEB J, V23; Chernova MN, 2003, J PHYSIOL-LONDON, V549, P3, DOI 10.1113/jphysiol.2003.039818; Choate KA, 2003, P NATL ACAD SCI USA, V100, P663, DOI 10.1073/pnas.242728499; Coyle B, 1998, HUM MOL GENET, V7, P1105, DOI 10.1093/hmg/7.7.1105; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; Detro-Dassen S, 2008, J BIOL CHEM, V283, P4177, DOI 10.1074/jbc.M704924200; Dinour D, 2004, J BIOL CHEM, V279, P52238, DOI 10.1074/jbc.M406591200; Donnelly MI, 2006, PROTEIN EXPRES PURIF, V47, P446, DOI 10.1016/j.pep.2005.12.011; Dorwart MR, 2008, J BIOL CHEM, V283, P8711, DOI 10.1074/jbc.M704328200; Dorwart MR, 2007, J PHYSIOL-LONDON, V584, P333, DOI 10.1113/jphysiol.2007.135855; Drexl M, 2008, J NEUROPHYSIOL, V99, P1607, DOI 10.1152/jn.01216.2007; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Everett LA, 2001, HUM MOL GENET, V10, P153, DOI 10.1093/hmg/10.2.153; Hastbacka J, 1999, EUR J HUM GENET, V7, P664, DOI 10.1038/sj.ejhg.5200361; Hastbacka J, 1996, AM J HUM GENET, V58, P255; Hoglund P, 2001, HUM MUTAT, V18, P233, DOI 10.1002/humu.1179; Hoglund P, 2001, GUT, V48, P724, DOI 10.1136/gut.48.5.724; Huth JR, 1997, PROTEIN SCI, V6, P2359; Ishiguro H, 2007, AM J PHYSIOL-GASTR L, V292, pG447, DOI 10.1152/ajpgi.00286.2006; Jiang ZR, 2006, NAT GENET, V38, P474, DOI 10.1038/ng1762; Kahle KT, 2008, ANNU REV PHYSIOL, V70, P329, DOI 10.1146/annurev.physiol.70.113006.100651; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P14877, DOI 10.1073/pnas.0406172101; Kahle KT, 2003, NAT GENET, V35, P372, DOI 10.1038/ng1271; Ko SBH, 2004, NAT CELL BIOL, V6, P343, DOI 10.1038/ncb1115; Ko SBH, 2002, EMBO J, V21, P5662, DOI 10.1093/emboj/cdf580; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Liu XZ, 2003, HUM MOL GENET, V12, P1155, DOI 10.1093/hmg/ddg127; Lohi H, 2003, AM J PHYSIOL-CELL PH, V284, pC769, DOI 10.1152/ajpcell.00270.2002; Loriol C, 2008, CELL PHYSIOL BIOCHEM, V22, P15, DOI 10.1159/000149780; Makela S, 2005, MOL HUM REPROD, V11, P129, DOI 10.1093/molehr/gah140; Makela S, 2002, HUM MUTAT, V20, P425, DOI 10.1002/humu.10139; Monico CG, 2008, AM J KIDNEY DIS, V52, P1096, DOI 10.1053/j.ajkd.2008.07.041; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; PLATA C, 2008, FASEB J, V22; Romero MF, 2000, J BIOL CHEM, V275, P24552, DOI 10.1074/jbc.M003476200; Romero MF, 1998, AM J PHYSIOL-RENAL, V274, pF425, DOI 10.1152/ajprenal.1998.274.2.F425; ROMERO MF, 2006, NOVART FDN SYMP, V273, P138; ROMERO MF, 2009, PHYSL PATHOLOGY CHLO; ROMERO MF, 2006, NOVART FDN SYMP, V273, P261; Romero Michael F, 2006, Novartis Found Symp, V273, P126; Rossi A, 2003, PEDIATR PATHOL MOL M, V22, P311, DOI 10.1080/15227950307720; Rossi A, 1996, HUM GENET, V98, P657, DOI 10.1007/s004390050279; Royaux IE, 2001, P NATL ACAD SCI USA, V98, P4221, DOI 10.1073/pnas.071516798; Sciortino CM, 1999, AM J PHYSIOL-RENAL, V277, pF611, DOI 10.1152/ajprenal.1999.277.4.F611; Seidler U, 2008, PFLUG ARCH EUR J PHY, V455, P757, DOI 10.1007/s00424-007-0318-z; Shcheynikov N, 2004, J BIOL CHEM, V279, P21857, DOI 10.1074/jbc.M313323200; Shcheynikov N, 2006, NOVART FDN SYMP, V273, P261; Shcheynikov N., 2006, NOVART FDN SYMP, V273, P186; Shcheynikov Nikolay, 2006, Novartis Found Symp, V273, P177; Shibagaki N, 2006, J BIOL CHEM, V281, P22964, DOI 10.1074/jbc.M603462200; Singh AK, 2008, KIDNEY INT, V74, P438, DOI 10.1038/ki.2008.184; Soleimani M, 2008, J PHYSIOL-LONDON, V586, P1205, DOI 10.1113/jphysiol.2007.150565; Toure A, 2007, HUM MOL GENET, V16, P1783, DOI 10.1093/hmg/ddm117; Wagner CA, 2002, KIDNEY INT, V62, P2109, DOI 10.1046/j.1523-1755.2002.00671.x; Wang YX, 2006, EMBO J, V25, P5049, DOI 10.1038/sj.emboj.7601387; Wang ZH, 2005, AM J PHYSIOL-CELL PH, V288, pC957, DOI 10.1152/ajpcell.00505.2004; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wu XD, 2004, MOL BRAIN RES, V126, P30, DOI 10.1016/j.molbrainres.2004.03.020; Xie QH, 2002, AM J PHYSIOL-RENAL, V283, pF826, DOI 10.1152/ajprenal.00079.2002; Xu J, 2005, AM J PHYSIOL-CELL PH, V289, pC493, DOI 10.1152/ajpcell.00030.2005; Xu J, 2008, P NATL ACAD SCI USA, V105, P17955, DOI 10.1073/pnas.0800616105; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	70	60	61	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28306	28318		10.1074/jbc.M109.001669	http://dx.doi.org/10.1074/jbc.M109.001669			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19643730	Green Published, hybrid			2022-12-27	WOS:000270676300057
J	Endo, A; Kitamura, N; Komada, M				Endo, Akinori; Kitamura, Naomi; Komada, Masayuki			Nucleophosmin/B23 Regulates Ubiquitin Dynamics in Nucleoli by Recruiting Deubiquitylating Enzyme USP36	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARF TUMOR-SUPPRESSOR; PROTEIN B23; RIBOSOME BIOGENESIS; RNA; LOCALIZATION; DEGRADATION; CHAPERONE; SIGNAL; SENP3	The nucleolus is a subnuclear compartment with multiple cellular functions, including ribosome biogenesis. USP36 is a deubiquitylating enzyme that localizes to nucleoli and plays an essential role in regulating the structure and function of the organelle. However, how the localization of USP36 is regulated remains unknown. Here, we identified a short stretch of basic amino acids (RGKEKKIKKFKREKRR) that resides in the C-terminal region of USP36 and serves as a nucleolar localization signal for the protein. We found that this motif interacts with a central acidic region of nucleophosmin/B23, a major nucleolar protein involved in various nucleolar functions. Knockdown of nucleophosmin/B23 resulted in a significant reduction in the amount of USP36 in nucleoli, without affecting the cellular USP36 level. This was associated with elevated ubiquitylation levels of fibrillarin, a USP36 substrate protein in nucleoli. We conclude that nucleophosmin/B23 recruits USP36 to nucleoli, thereby serving as a platform for the regulation of nucleolar protein functions through ubiquitylation/deubiquitylation.	[Komada, Masayuki] Tokyo Inst Technol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Komada, M (corresponding author), Tokyo Inst Technol, Dept Biol Sci, Midori Ku, 4259-B16 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	makomada@bio.titech.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [19570178]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid 19570178 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. K.).	ADACHI Y, 1993, J BIOL CHEM, V268, P13930; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Catic A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000679; Chen M, 2002, MOL BIOL CELL, V13, P3576, DOI 10.1091/mbc.02-05-0083; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Endo A, 2009, J CELL SCI, V122, P678, DOI 10.1242/jcs.044461; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Haindl M, 2008, EMBO REP, V9, P273, DOI 10.1038/embor.2008.3; Herrera JE, 1996, BIOCHEMISTRY-US, V35, P2668, DOI 10.1021/bi9523320; Horke S, 2004, J BIOL CHEM, V279, P26563, DOI 10.1074/jbc.M401017200; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Maggi LB, 2008, MOL CELL BIOL, V28, P7050, DOI 10.1128/MCB.01548-07; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Savkur RS, 1998, NUCLEIC ACIDS RES, V26, P4508, DOI 10.1093/nar/26.19.4508; Stavreva DA, 2006, MOL CELL BIOL, V26, P5131, DOI 10.1128/MCB.02227-05; Szebeni A, 1999, PROTEIN SCI, V8, P905; Weber JD, 2000, MOL CELL BIOL, V20, P2517, DOI 10.1128/MCB.20.7.2517-2528.2000; Yun CW, 2008, J CELL BIOL, V183, P589, DOI 10.1083/jcb.200807185	23	32	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27918	27923		10.1074/jbc.M109.037218	http://dx.doi.org/10.1074/jbc.M109.037218			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19679658	Green Published, hybrid			2022-12-27	WOS:000270676300019
J	Sakai, S; Sugawara, T; Matsubara, K; Hirata, T				Sakai, Shota; Sugawara, Tatsuya; Matsubara, Kiminori; Hirata, Takashi			Inhibitory Effect of Carotenoids on the Degranulation of Mast Cells via Suppression of Antigen-induced Aggregation of High Affinity IgE Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; INFLAMMATORY GENE-EXPRESSION; BROWN-ALGAE FUCOXANTHIN; HUMAN INTESTINAL-CELLS; KAPPA-B ACTIVATION; MEMBRANE DOMAINS; IN-VITRO; CANCER CELLS; LIPID RAFTS; BETA	Carotenoids have been demonstrated to possess antioxidative and anti-inflammatory effects. However, there is no report that the effects of carotenoids on degranulation of mast cell is critical for type I allergy. In this study, we focused on the effect of carotenoids on antigen-induced degranulation of mast cells. Fucoxanthin, astaxanthin, zeaxanthin, and beta-carotene significantly inhibited the antigen-induced release of beta-hexosaminidase in rat basophilic leukemia 2H3 cells and mouse bone marrow-derived mast cells. Those carotenoids also inhibited antigen-induced aggregation of the high affinity IgE receptor (Fc epsilon RI), which is the most upstream of the degranulating signals of mast cells. Furthermore, carotenoids inhibited Fc epsilon RI-mediated intracellular signaling, such as phosphorylation of Lyn kinase and Fyn kinase. It suggests that the inhibitory effect of carotenoids on the degranulation of mast cells were mainly due to suppressing the aggregation of Fc epsilon RI followed by intracellular signaling. In addition, those carotenoids inhibited antigen-induced translocation of Fc epsilon RI to lipid rafts, which are known as platforms of the aggregation of Fc epsilon RI. We assume that carotenoids may modulate the function of lipid rafts and inhibit the translocation of Fc epsilon RI to lipid rafts. This is the first report that focused on the aggregation of Fc epsilon RI to investigate the mechanism of the inhibitory effects on the degranulation of mast cells and evaluated the functional activity of carotenoids associated with lipid rafts.	[Sakai, Shota; Sugawara, Tatsuya; Hirata, Takashi] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Kyoto 6068502, Japan; [Matsubara, Kiminori] Hiroshima Univ, Grad Sch Educ, Dept Human Life Sci Educ, Higashihiroshima 7398524, Japan	Kyoto University; Hiroshima University	Sugawara, T (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Kyoto 6068502, Japan.	sugawara@kais.kyoto-u.ac.jp	MATSUBARA, Kiminori/N-9804-2019	Sugawara, Tatsuya/0000-0002-1203-5521	Mishima Kaiun Memorial Foundation; Iijima Memorial Foundation for the Promotion of Food Science and Technology	Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Iijima Memorial Foundation for the Promotion of Food Science and Technology(Iijima Memorial Foundation for the Promotion of Food Science and Technology)	This work was supported in part by the Mishima Kaiun Memorial Foundation and the Iijima Memorial Foundation for the Promotion of Food Science and Technology.	Asai K, 2000, J HISTOCHEM CYTOCHEM, V48, P1705, DOI 10.1177/002215540004801213; Bai SK, 2005, EXP MOL MED, V37, P323, DOI 10.1038/emm.2005.42; Cho SH, 2004, J ALLERGY CLIN IMMUN, V114, P1085, DOI 10.1016/j.jaci.2004.07.035; Draber P, 2002, MOL IMMUNOL, V38, P1247, DOI 10.1016/S0161-5890(02)00071-8; Field KA, 1997, J BIOL CHEM, V272, P4276, DOI 10.1074/jbc.272.7.4276; Gehlhar K, 2005, INT ARCH ALLERGY IMM, V136, P311, DOI 10.1159/000083976; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Gomez G, 2005, J IMMUNOL, V175, P7602, DOI 10.4049/jimmunol.175.11.7602; Holowka D, 2005, BBA-MOL CELL RES, V1746, P252, DOI 10.1016/j.bbamcr.2005.06.007; HULTNER L, 1989, J IMMUNOL, V142, P3440; Iwaki S, 2005, J BIOL CHEM, V280, P40261, DOI 10.1074/jbc.M506063200; Kotake-Nara E, 2001, J NUTR, V131, P3303, DOI 10.1093/jn/131.12.3303; Kovarova M, 2001, MOL CELL BIOL, V21, P8318, DOI 10.1128/MCB.21.24.8318-8328.2001; Kurkinen K, 2001, NEUROCHEM RES, V26, P1139, DOI 10.1023/A:1012322906824; Lee SJ, 2003, MOL CELLS, V16, P97; Leitges M, 2002, MOL CELL BIOL, V22, P3970, DOI 10.1128/MCB.22.12.3970-3980.2002; Maeda-Yamamoto M, 2004, J IMMUNOL, V172, P4486, DOI 10.4049/jimmunol.172.7.4486; Nechushtan H, 2000, BLOOD, V95, P1752, DOI 10.1182/blood.V95.5.1752.005k18_1752_1757; Ohgami K, 2003, INVEST OPHTH VIS SCI, V44, P2694, DOI 10.1167/iovs.02-0822; Okabe T, 1996, BIOCHEM BIOPH RES CO, V223, P245, DOI 10.1006/bbrc.1996.0879; OZAWA K, 1993, J BIOL CHEM, V268, P2280; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; RAIZMAN MB, 1990, J IMMUNOL, V145, P1463; Sato Y, 2004, BIOL PHARM BULL, V27, P978, DOI 10.1248/bpb.27.978; Shiratori K, 2005, EXP EYE RES, V81, P422, DOI 10.1016/j.exer.2005.03.002; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Socaciu C, 2000, SPECTROCHIM ACTA A, V56, P2799, DOI 10.1016/S1386-1425(00)00375-9; Sugawara T, 2002, J NUTR, V132, P946, DOI 10.1093/jn/132.5.946; Sugawara T, 2001, J NUTR, V131, P2921, DOI 10.1093/jn/131.11.2921; Sugawara T, 2006, J AGR FOOD CHEM, V54, P9805, DOI 10.1021/jf062204q; Sugawara T, 2007, BIOSCI BIOTECH BIOCH, V71, P1069, DOI 10.1271/bbb.60597; Suzukawa M, 2005, INT IMMUNOL, V17, P1249, DOI 10.1093/intimm/dxh301; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Tkaczyk C, 2004, BLOOD, V104, P207, DOI 10.1182/blood-2003-08-2769; VANDEVEN M, 1984, BIOPHYS J, V45, P1203, DOI 10.1016/S0006-3495(84)84269-1; Wisniewska A, 2006, ACTA BIOCHIM POL, V53, P475; Wisniewska A, 2006, FREE RADICAL BIO MED, V40, P1820, DOI 10.1016/j.freeradbiomed.2006.01.016; Xu K, 1998, J CELL SCI, V111, P2385; Yamashita T, 2001, J BIOCHEM-TOKYO, V129, P861, DOI 10.1093/oxfordjournals.jbchem.a002930	39	71	76	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28172	28179		10.1074/jbc.M109.001099	http://dx.doi.org/10.1074/jbc.M109.001099			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19700409	hybrid, Green Published			2022-12-27	WOS:000270676300044
J	Yokooji, Y; Tomita, H; Atomi, H; Imanaka, T				Yokooji, Yuusuke; Tomita, Hiroya; Atomi, Haruyuki; Imanaka, Tadayuki			Pantoate Kinase and Phosphopantothenate Synthetase, Two Novel Enzymes Necessary for CoA Biosynthesis in the Archaea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A BIOSYNTHESIS; THERMOCOCCUS-KODAKARAENSIS KOD1; PANTOTHENATE KINASE; FEEDBACK-REGULATION; ESCHERICHIA-COLI; PATHWAY; FRUCTOSE-1,6-BISPHOSPHATASE; 4'-PHOSPHOPANTETHEINE; NEURODEGENERATION; GALACTOKINASE	Bacteria/eukaryotes share a common pathway for coenzyme A (CoA) biosynthesis. Although archaeal genomes harbor homologs for most of these enzymes, homologs of bacterial/eukaryotic pantothenate synthetase (PS) and pantothenate kinase (PanK) are missing. PS catalyzes the ATP-dependent condensation of pantoate and beta-alanine to produce pantothenate, whereas PanK catalyzes the ATP-dependent phosphorylation of pantothenate to produce 4'-phosphopantothenate. When we examined the cell-free extracts of the hyperthermophilic archaeon Thermococcus kodakaraensis, PanK activity could not be detected. A search for putative kinase-encoding genes widely distributed in Archaea, but not present in bacteria/eukaryotes, led to four candidate genes. Among these genes, TK2141 encoded a protein with relatively low PanK activity. However, higher levels of activity were observed when pantothenate was replaced with pantoate. V-max values were 7-fold higher toward pantoate, indicating that TK2141 encoded a novel enzyme, pantoate kinase (PoK). A search for genes with a distribution similar to TK2141 led to the identification of TK1686. The protein product catalyzed the ATP-dependent conversion of phosphopantoate and beta-alanine to produce 4'-phosphopantothenate and did not exhibit PS activity, indicating that TK1686 also encoded a novel enzyme, phosphopantothenate synthetase (PPS). Although the classic PS/PanK system performs condensation with beta-alanine prior to phosphorylation, the PoK/PPS system performs condensation after phosphorylation of pantoate. Gene disruption of TK2141 and TK1686 led to CoA auxotrophy, indicating that both genes are necessary for CoA biosynthesis in T. kodakaraensis. Homologs of both genes are widely distributed among the Archaea, suggesting that the PoK/PPS system represents the pathway for 4'-phosphopantothenate biosynthesis in the Archaea.	[Imanaka, Tadayuki] Ritsumeikan Univ, Coll Life Sci, Dept Biotechnol, Noji Higashi, Kusatsu 5258577, Japan; [Yokooji, Yuusuke; Tomita, Hiroya; Atomi, Haruyuki] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan	Ritsumeikan University; Kyoto University	Imanaka, T (corresponding author), Ritsumeikan Univ, Coll Life Sci, Dept Biotechnol, Noji Higashi, Kusatsu 5258577, Japan.	imanaka@sk.ritsumei.ac.jp	Zhang, Ning/F-1387-2014; Tomita, Hiroya/GQY-9725-2022	Atomi, Haruyuki/0000-0001-9687-6426	Japan Society for the Promotion of Science [18GS0421];  [19310126]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This work was supported in part by the Japan Society for the Promotion of Science under a grant-in-aid for Creative Scientific Research (project 18GS0421 to T.I.) and by a grant-in-aid for Scientific Research (B) (19310126 to H. A.).	Armengaud J, 2003, J BIOL CHEM, V278, P31078, DOI 10.1074/jbc.M301891200; Atomi Haruyuki, 2004, Archaea, V1, P263, DOI 10.1155/2004/204953; BORK P, 1993, PROTEIN SCI, V2, P31; Brand LA, 2005, J BIOL CHEM, V280, P20185, DOI 10.1074/jbc.C500044200; Calder RB, 1999, J BIOL CHEM, V274, P2014, DOI 10.1074/jbc.274.4.2014; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; Genschel U, 2004, MOL BIOL EVOL, V21, P1242, DOI 10.1093/molbev/msh119; Hartley A, 2004, J MOL BIOL, V337, P387, DOI 10.1016/j.jmb.2004.01.043; Hong BS, 2007, J BIOL CHEM, V282, P27984, DOI 10.1074/jbc.M701915200; Kotzbauer PT, 2005, J NEUROSCI, V25, P689, DOI 10.1523/JNEUROSCI.4265-04.2005; Kupke T, 2006, J BIOL CHEM, V281, P5435, DOI 10.1074/jbc.M510056200; Kupke T, 2003, J BIOL CHEM, V278, P38229, DOI 10.1074/jbc.M306321200; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Leonardi R, 2005, J BIOL CHEM, V280, P3314, DOI 10.1074/jbc.M411608200; Makarova KS, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-33; Matsumi R, 2007, J BACTERIOL, V189, P2683, DOI 10.1128/JB.01692-06; MORIKAWA M, 1994, APPL ENVIRON MICROB, V60, P4559, DOI 10.1128/AEM.60.12.4559-4566.1994; Neuwald AF, 1999, GENOME RES, V9, P27; Orita I, 2006, J BACTERIOL, V188, P4698, DOI 10.1128/JB.00492-06; Rashid N, 2002, J BIOL CHEM, V277, P30649, DOI 10.1074/jbc.M202868200; Robb Frank T., 1995, P167; Rock CO, 2003, J BACTERIOL, V185, P3410, DOI 10.1128/JB.185.11.3410-3415.2003; Rock CO, 2002, GENE, V291, P35, DOI 10.1016/S0378-1119(02)00564-4; Rock CO, 2000, J BIOL CHEM, V275, P1377, DOI 10.1074/jbc.275.2.1377; Ronconi S, 2008, FEBS J, V275, P2754, DOI 10.1111/j.1742-4658.2008.06416.x; Sato T, 2005, APPL ENVIRON MICROB, V71, P3889, DOI 10.1128/AEM.71.7.3889-3899.2005; Sato T, 2004, J BACTERIOL, V186, P5799, DOI 10.1128/JB.186.17.5799-5807.2004; Sato T, 2003, J BACTERIOL, V185, P210, DOI 10.1128/JB.185.1.210-220.2003; Sato T, 2007, SCIENCE, V315, P1003, DOI 10.1126/science.1135999; SONG WJ, 1994, J BIOL CHEM, V269, P27051; Spry C, 2008, FEMS MICROBIOL REV, V32, P56, DOI 10.1111/j.1574-6976.2007.00093.x; VALLARI DS, 1987, J BIOL CHEM, V262, P2468; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Yang D, 2002, J BIOL CHEM, V277, P9462, DOI 10.1074/jbc.M110787200; Yang K, 2006, J BACTERIOL, V188, P5532, DOI 10.1128/JB.00469-06	35	63	66	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28137	28145		10.1074/jbc.M109.009696	http://dx.doi.org/10.1074/jbc.M109.009696			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19666462	hybrid, Green Published			2022-12-27	WOS:000270676300040
J	Edreira, MM; Li, S; Hochbaum, D; Wong, S; Gorfe, AA; Ribeiro-Neto, F; Woods, VL; Altschuler, DL				Edreira, Martin M.; Li, Sheng; Hochbaum, Daniel; Wong, Sergio; Gorfe, Alemayehu A.; Ribeiro-Neto, Fernando; Woods, Virgil L., Jr.; Altschuler, Daniel L.			Phosphorylation-induced Conformational Changes in Rap1b ALLOSTERIC EFFECTS ON SWITCH DOMAINS AND EFFECTOR LOOP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; H-RAS; BINDING PROTEIN; CELL-GROWTH; K-RAS; INHIBITION; ACTIVATION; NUCLEOTIDE; DYNAMICS; PKA	Rap1b has been implicated in the transduction of the cAMP mitogenic response. Agonists that increase intracellular cAMP rapidly activate (i.e. GTP binding) and phosphorylate Rap1b on Ser(179) at its C terminus. cAMP-dependent protein kinase (PKA)-mediated phosphorylation of Rap1b is required for cAMP-dependent mitogenesis, tumorigenesis, and inhibition of AKT activity. However, the role of phosphorylation still remains unknown. In this study, we utilized amide hydrogen/deuterium exchange mass spectroscopy (DXMS) to assess potential conformational changes and/or mobility induced by phosphorylation. We report here DXMS data comparing exchange rates for PKA phosphorylated (Rap1-P) and S179D phosphomimetic (Rap1-D) Rap1b proteins. Rap1-P and Rap1-D behaved exactly the same, revealing an increased exchange rate in discrete regions along the protein; these regions include a domain around the phosphorylation site and unexpectedly the two switch loops. Thus, local effects induced by Ser(179) phosphorylation communicate allosterically with distal domains involved in effector interaction. These results provide a mechanistic explanation for the differential effects of Rap1 phosphorylation by PKA on effector protein interaction.	[Li, Sheng; Woods, Virgil L., Jr.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Li, Sheng; Woods, Virgil L., Jr.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Wong, Sergio; Gorfe, Alemayehu A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Wong, Sergio; Gorfe, Alemayehu A.] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Edreira, Martin M.; Hochbaum, Daniel; Ribeiro-Neto, Fernando; Altschuler, Daniel L.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Woods, VL (corresponding author), Univ Calif San Diego, Dept Med, 9500 Hillman Dr, La Jolla, CA 92093 USA.	vwoods@ucsd.edu; altschul@pitt.edu	Edreira, Martin/AAE-7816-2020	Edreira, Martin/0000-0002-9120-2649; Hochbaum, Daniel/0000-0001-6387-7529	National Institutes of Health [R01 CA071649, DK063069, AI076961, AI081982, AI2008031, AI072106, AI068730, GM037684, GM020501, GM066170]; Innovative Technologies for the Molecular Analysis of Cancer (IMAT) Program [CA099835, CA118595]; University of California IUCRP Program; NATIONAL CANCER INSTITUTE [R33CA099835, R01CA071649, R21CA099835, R21CA118595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076961, P01AI068730, R01AI081982, R01AI072106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066170, F32GM020501, R01GM020501, R01GM037684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Innovative Technologies for the Molecular Analysis of Cancer (IMAT) Program; University of California IUCRP Program(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 CA071649 and DK063069 (to D. L. A.); Innovative Technologies for the Molecular Analysis of Cancer (IMAT) Program Grants CA099835 and CA118595 (to V. L. W.); National Institutes of Health Grants AI076961, AI081982, AI2008031, AI072106, AI068730, GM037684, GM020501, and GM066170 (to V. L. W.); and Discovery Grant UC10591 from the University of California IUCRP Program, BiogenIDEC corporate sponsor (to V. L. W.).	Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; ALTSCHULER D, 1993, J BIOL CHEM, V268, P7527; ALTSCHULER DL, 1995, J BIOL CHEM, V270, P10373, DOI 10.1074/jbc.270.18.10373; Altschuler DL, 1998, P NATL ACAD SCI USA, V95, P7475, DOI 10.1073/pnas.95.13.7475; Arai Y, 2006, BIOCHEM BIOPH RES CO, V343, P809, DOI 10.1016/j.bbrc.2006.03.031; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; BOKOCH GM, 1991, SCIENCE, V254, P1794, DOI 10.1126/science.1763330; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Caron E, 2003, J CELL SCI, V116, P435, DOI 10.1242/jcs.00238; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; DeLano W.L, PYMOL MOL GRAPHICS S; Gallicchio E, 2002, J COMPUT CHEM, V23, P517, DOI 10.1002/jcc.10045; Ghosh A, 1998, J PHYS CHEM B, V102, P10983, DOI 10.1021/jp982533o; Gorfe AA, 2008, STRUCTURE, V16, P885, DOI 10.1016/j.str.2008.03.009; Harding A, 2008, CELL CYCLE, V7, P127, DOI 10.4161/cc.7.2.5237; Hattori M, 2003, J BIOCHEM, V134, P479, DOI 10.1093/jb/mvg180; Herrmann C, 2003, CURR OPIN STRUC BIOL, V13, P122, DOI 10.1016/S0959-440X(02)00007-6; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Hochbaum D, 2008, J BIOL CHEM, V283, P4464, DOI 10.1074/jbc.C700171200; Hu CD, 1999, J BIOL CHEM, V274, P48, DOI 10.1074/jbc.274.1.48; Ito Y, 1997, BIOCHEMISTRY-US, V36, P9109, DOI 10.1021/bi970296u; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; McAvoy T, 2009, P NATL ACAD SCI USA, V106, P3531, DOI 10.1073/pnas.0813263106; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; O'Connor C, 2008, BIOCHEMISTRY-US, V47, P10244, DOI 10.1021/bi801076c; Plowman SJ, 2008, MOL CELL BIOL, V28, P4377, DOI 10.1128/MCB.00050-08; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Ribeiro-Neto F, 2002, P NATL ACAD SCI USA, V99, P5418, DOI 10.1073/pnas.082122499; Schmitt JM, 2002, MOL CELL, V9, P85, DOI 10.1016/S1097-2765(01)00432-4; Schmitt JM, 2001, MOL CELL BIOL, V21, P3671, DOI 10.1128/MCB.21.11.3671-3683.2001; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Spoerner M, 2007, FEBS J, V274, P1419, DOI 10.1111/j.1742-4658.2007.05681.x; Stieglitz B, 2008, EMBO J, V27, P1995, DOI 10.1038/emboj.2008.125; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Tsutsui Y, 2007, CURR MED CHEM, V14, P2344, DOI 10.2174/092986707781745596	38	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27480	27486		10.1074/jbc.M109.011312	http://dx.doi.org/10.1074/jbc.M109.011312			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651783	Green Published, hybrid			2022-12-27	WOS:000270232300050
J	Kim, JH; Gurumurthy, CB; Naramura, M; Zhang, Y; Dudley, AT; Doglio, L; Band, H; Band, V				Kim, Jun Hyun; Gurumurthy, Channabasavaiah Basavaraju; Naramura, Mayumi; Zhang, Ying; Dudley, Andrew T.; Doglio, Lynn; Band, Hamid; Band, Vimla			Role of Mammalian Ecdysoneless in Cell Cycle Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOBLASTOMA TUMOR-SUPPRESSOR; DROSOPHILA DEVELOPMENT; FAMILY PROTEINS; GENE; CANCER; E2F; PRB; RB; DIFFERENTIATION; TARGETS	The Ecdysoneless (Ecd) protein is required for cell-autonomous roles in development and oogenesis in Drosophila, but the function of its evolutionarily conserved mammalian orthologs is not clear. To study the cellular function of Ecd in mammalian cells, we generated Ecd(lox/lox) mouse embryonic fibroblast cells from Ecd floxed mouse embryos. Cre-mediated deletion of Ecd in Ecd(lox/lox) mouse embryonic fibroblasts led to a proliferative block due to a delay in G1-S cell cycle progression; this defect was reversed by the introduction of human Ecd. Loss of Ecd led to marked down-regulation of E2F target gene expression. Furthermore, Ecd directly bound to Rb at the pocket domain and competed with E2F for binding to hypophosphorylated Rb. Our results demonstrate that mammalian Ecd plays a role in cell cycle progression via the Rb-E2F pathway.	[Kim, Jun Hyun; Gurumurthy, Channabasavaiah Basavaraju; Band, Vimla] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Naramura, Mayumi; Band, Hamid; Band, Vimla] Univ Nebraska Med Ctr, Eppley Inst Canc & Allied Dis, Omaha, NE 68198 USA; [Naramura, Mayumi; Band, Hamid; Band, Vimla] Univ Nebraska Med Ctr, Eppley Canc Ctr, Omaha, NE 68198 USA; [Kim, Jun Hyun; Dudley, Andrew T.; Band, Hamid; Band, Vimla] Northwestern Univ, Interdept Biol Sci Grad Program, Evanston, IL 60208 USA; [Zhang, Ying; Doglio, Lynn] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Northwestern University; Northwestern University; Feinberg School of Medicine	Band, V (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, 985805 Nebraska Med Ctr, Omaha, NE 68198 USA.	vband@unmc.edu	Gurumurthy, Channabasavaiah B/H-8268-2016; Gurumurthy, Channabasavaiah B/E-7205-2011	Gurumurthy, Channabasavaiah B/0000-0002-8022-4033; Naramura, Mayumi/0000-0003-3658-0767	Korea Science and Engineering Foundation [M06-2004-000-10547-0]; Department of Defense Predoctoral Traineeship [W81XWH-08-1-0366]; NATIONAL CANCER INSTITUTE [R01CA116552, R01CA096844, R01CA099163, R01CA094143, R01CA087986, R01CA099900, R01CA105489] Funding Source: NIH RePORTER	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Department of Defense Predoctoral Traineeship(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Korea Science and Engineering Foundation Grant M06-2004-000-10547-0 and Department of Defense Predoctoral Traineeship Grant W81XWH-08-1-0366.	Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Balciunaite E, 2005, MOL CELL BIOL, V25, P8166, DOI 10.1128/MCB.25.18.8166-8178.2005; Berthet C, 2006, DEV CELL, V10, P563, DOI 10.1016/j.devcel.2006.03.004; CHELLAPPAN S, 1992, P NATL ACAD SCI USA, V89, P4549, DOI 10.1073/pnas.89.10.4549; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Classon M, 2000, P NATL ACAD SCI USA, V97, P10826, DOI 10.1073/pnas.190343597; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Classon M, 2000, P NATL ACAD SCI USA, V97, P10820, DOI 10.1073/pnas.190343497; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Felsani A, 2006, ONCOGENE, V25, P5277, DOI 10.1038/sj.onc.1209621; GAREN A, 1977, P NATL ACAD SCI USA, V74, P5099, DOI 10.1073/pnas.74.11.5099; Gaziova I, 2004, DEVELOPMENT, V131, P2715, DOI 10.1242/dev.01143; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Hurford RK, 1997, GENE DEV, V11, P1447, DOI 10.1101/gad.11.11.1447; Kainou T, 2006, YEAST, V23, P35, DOI 10.1002/yea.1336; Kaye FJ, 2002, ONCOGENE, V21, P6908, DOI 10.1038/sj.onc.1205834; KOUZARIDES T, 1995, SEMIN CANCER BIOL, V6, P91, DOI 10.1006/scbi.1995.0012; Liggett WH, 1998, J CLIN ONCOL, V16, P1197, DOI 10.1200/JCO.1998.16.3.1197; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Nguyen DX, 2005, J CELL BIOCHEM, V94, P870, DOI 10.1002/jcb.20375; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; RILEY DJ, 1994, ANNU REV CELL BIOL, V10, P1, DOI 10.1146/annurev.cb.10.110194.000245; Sato T, 1999, MOL GEN GENET, V260, P535; Shiffman D, 1996, J BIOL CHEM, V271, P12199, DOI 10.1074/jbc.271.21.12199; Tikoo R, 2000, J NEUROSCI, V20, P4627, DOI 10.1523/JNEUROSCI.20-12-04627.2000; TODARO GJ, 1963, J CELL COMPAR PHYSL, V62, P257, DOI 10.1002/jcp.1030620305; Tsihlias J, 1999, ANNU REV MED, V50, P401; Tungteakkhun SS, 2008, ARCH VIROL, V153, P397, DOI 10.1007/s00705-007-0022-5; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wikenheiser-Brokamp KA, 2004, DEVELOPMENT, V131, P4299, DOI 10.1242/dev.01232; Wise-Draper TM, 2008, FRONT BIOSCI-LANDMRK, V13, P1003, DOI 10.2741/2739; Zhang Y, 2006, CANCER RES, V66, P7167, DOI 10.1158/0008-5472.CAN-06-0722; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; ZUR HH, 1994, ANNU REV MICROBIOL, V48, P427	36	23	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26402	26410		10.1074/jbc.M109.030551	http://dx.doi.org/10.1074/jbc.M109.030551			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19640839	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000269969600021
J	Wan, M; Qin, J; Songyang, Z; Liu, D				Wan, Ma; Qin, Jun; Songyang, Zhou; Liu, Dan			OB Fold-containing Protein 1 (OBFC1), a Human Homolog of Yeast Stn1, Associates with TPP1 and Is Implicated in Telomere Length Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOME END-PROTECTION; COMPLEX; DNA; POT1; CELLS; REPLICATION; INTERACTS; CDC13; TRF1	The telosome/shelterin, a six-protein complex formed by TRF1, TRF2, RAP1, TIN2, POT1, and TPP1, functions as the core of the telomere interactome, acting as the molecular platform for the assembly of higher order complexes and coordinating cross-talks between various protein subcomplexes. Within the telosome, there are two oligonucleotide-or oligosaccharide-binding ( OB) fold-containing proteins, TPP1 and POT1. They can form heterodimers that bind to the telomeric single-stranded DNA, an activity that is central for telomere end capping and telomerase recruitment. Through proteomic analyses, we found that in addition to POT1, TPP1 can associate with another OB fold-containing protein, OBFC1/AAF44. The yeast homolog of OBFC1 is Stn1, which plays a critical role in telomere regulation. We show here that OBFC1/AAF44 can localize to telomeres in human cells and bind to telomeric single-stranded DNA in vitro. Furthermore, overexpression of an OBFC1 mutant resulted in elongated telomeres in human cells, implicating OBFC1/AAF4 in telomere length regulation. Taken together, our studies suggest that OBFC1/AAF44 represents a new player in the telomere interactome for telomere maintenance.	[Wan, Ma; Qin, Jun; Songyang, Zhou; Liu, Dan] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Liu, Dan] Baylor Coll Med, Cell Based Assay Screening Serv Core, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Songyang, Z (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	songyang@bcm.edu; danl@bcm.edu			National Institutes of Health; American Heart Association; American Cancer Society; Welch Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); Welch Foundation(The Welch Foundation)	This work was supported, in whole or in part, by National Institutes of Health Grant. This work was also supported by grants from the American Heart Association, the American Cancer Society, and the Welch Foundation.	Bailey SM, 2004, CYTOGENET GENOME RES, V104, P109, DOI 10.1159/000077474; BLACKBURN EH, 1991, TRENDS BIOCHEM SCI, V16, P378, DOI 10.1016/0968-0004(91)90155-O; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Casteel DE, 2009, J BIOL CHEM, V284, P5807, DOI 10.1074/jbc.M807593200; Chen LY, 2007, MOL CELL BIOL, V27, P5898, DOI 10.1128/MCB.00603-07; Collins K, 2006, NAT REV MOL CELL BIO, V7, P484, DOI 10.1038/nrm1961; Court R, 2005, EMBO REP, V6, P39, DOI 10.1038/sj.embor.7400314; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Gao H, 2007, NAT STRUCT MOL BIOL, V14, P208, DOI 10.1038/nsmb1205; Grandin N, 1997, GENE DEV, V11, P512, DOI 10.1101/gad.11.4.512; Grandin N, 2001, EMBO J, V20, P1173, DOI 10.1093/emboj/20.5.1173; Granger MP, 2002, CRIT REV ONCOL HEMAT, V41, P29, DOI 10.1016/S1040-8428(01)00188-3; Grossi S, 2004, GENE DEV, V18, P992, DOI 10.1101/gad.300004; Hanaoka S, 2005, PROTEIN SCI, V14, P119, DOI 10.1110/ps.04983705; Harrington L, 2002, ONCOGENE, V21, P592, DOI 10.1038/sj.onc.1205084; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Martin V, 2007, P NATL ACAD SCI USA, V104, P14038, DOI 10.1073/pnas.0705497104; Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072; Petreaca RC, 2006, NAT CELL BIOL, V8, P748, DOI 10.1038/ncb1430; Song XY, 2008, P NATL ACAD SCI USA, V105, P19815, DOI 10.1073/pnas.0807867105; Veldman T, 2004, CURR BIOL, V14, P2264, DOI 10.1016/j.cub.2004.12.031; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wei C, 2003, CELL MOL LIFE SCI, V60, P2283, DOI 10.1007/s00018-003-3244-z; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Xin HW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-232; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zhou SY, 2006, CRIT REV EUKAR GENE, V16, P103, DOI 10.1615/CritRevEukarGeneExpr.v16.i2.10	35	99	106	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26725	26731		10.1074/jbc.M109.021105	http://dx.doi.org/10.1074/jbc.M109.021105			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19648609	Green Published, hybrid			2022-12-27	WOS:000269969600053
J	Savino, B; Borroni, EM; Torres, NM; Proost, P; Struyf, S; Mortier, A; Mantovani, A; Locati, M; Bonecchi, R				Savino, Benedetta; Borroni, Elena Monica; Torres, Nina Machado; Proost, Paul; Struyf, Sofie; Mortier, Anneleen; Mantovani, Alberto; Locati, Massimo; Bonecchi, Raffaella			Recognition Versus Adaptive Up-regulation and Degradation of CC Chemokines by the Chemokine Decoy Receptor D6 Are Determined by Their N-terminal Sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOFILTRATE CC-CHEMOKINE-1; INFLAMMATION; AGONISTS; ACTIVATION; LD78-BETA; PREVENTS; CLEAVAGE; LIGANDS; VARIANT; TUMORS	The chemokine decoy receptor D6 controls inflammatory responses by selective recognition and degradation of most CCR1 to CCR5 agonistic ligands. CCL14 is a homeostatic chemokine present at high concentrations in the serum with a weak agonist activity on CCR1. Under inflammatory conditions, plasmin and UPA-mediated truncation of 8 amino acids generates the potent CCR1/CCR3/CCR5 isoform CCL14(9-74), which is further processed and inactivated by dipeptidyl peptidase IV/CD26 that generates CCL14(11-74). Here we report that D6 efficiently binds both CCL14 and its truncated isoforms. Like other D6 ligands, the biologically active CCL14(9-74) induces adaptive up-regulation of D6 expression on the cell membrane and is rapidly and efficiently degraded. In contrast, the D6-mediated degradation of the biologically inactive isoforms CCL14(1-74) and CCL14(11-74) is very inefficient. Thus, D6 cooperates with CD26 in the negative regulation of CCL14 by the selective degradation of its biologically active isoform. Analysis of a panel of CC chemokines and their truncated isoforms revealed that D6-mediated chemokine degradation does not correlate with binding affinity. Conversely, degradation efficiency is positively correlated with D6 adaptive up-regulation. Sequence analysis indicated that a proline residue in position 2 of D6 ligands is dispensable for binding but crucial for D6 adaptive up-regulation and efficient degradation.	[Savino, Benedetta; Borroni, Elena Monica; Torres, Nina Machado; Mantovani, Alberto; Locati, Massimo; Bonecchi, Raffaella] Ist Clin Humanitas, Ist Ricovero & Cura Carattere Sci, I-20089 Rozzano, MI, Italy; [Savino, Benedetta; Borroni, Elena Monica; Torres, Nina Machado; Mantovani, Alberto; Locati, Massimo; Bonecchi, Raffaella] Univ Milan, Dept Translat Med, I-20089 Milan, Italy; [Proost, Paul; Struyf, Sofie; Mortier, Anneleen] Katholieke Univ Leuven, Lab Mol Immunol, Rega Inst, B-3000 Louvain, Belgium	IRCCS Humanitas Research Hospital; University of Milan; KU Leuven	Bonecchi, R (corresponding author), Ist Clin Humanitas, Ist Ricovero & Cura Carattere Sci, Via Manzoni 113, I-20089 Rozzano, MI, Italy.	raffaella.bonecchi@humanitas.it	Torres, Nina Patricia Machado/AAB-9215-2020; Mantovani, Alberto/HCI-7449-2022; Locati, Massimo/H-8404-2015; Proost, Paul/V-3052-2017; Borroni, Elena Monica/B-3600-2012; Locati, Massimo/ABF-6807-2021; Savino, Benedetta/K-4488-2014; Borroni, Elena Monica/O-7241-2019; Bonecchi, Raffaella/ABI-2390-2020; Struyf, Sofie/U-2455-2017	Mantovani, Alberto/0000-0001-5578-236X; Locati, Massimo/0000-0003-3077-590X; Proost, Paul/0000-0002-0133-5545; Borroni, Elena Monica/0000-0003-1157-8249; Savino, Benedetta/0000-0002-2996-9515; Borroni, Elena Monica/0000-0003-1157-8249; Struyf, Sofie/0000-0003-4558-0769; Mortier, Anneleen/0000-0002-9662-674X; Bonecchi, Raffaella/0000-0003-3346-5333	European Community [518167]; Ministero dell'Istruzione dell'Universita e della Ricerca [2002061255, 2007ENYMAN_003]; Fondo per gli Investimenti della Ricerca di Base [RBIN04EKCX]; Fondazione Cariplo; Centers of Excellence [EF/05/15]; Concerted Research Actions of the Regional Government of Flanders; Fund for Scientific Research of Flanders (FWO-Vlaanderen); Interuniversity Attraction Poles Programme, Belgian State, Belgian Science Policy; Fondazione Humanitas per la Ricerca; Italian Association for Cancer Research	European Community(European Commission); Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Fondo per gli Investimenti della Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Fondazione Cariplo(Fondazione Cariplo); Centers of Excellence; Concerted Research Actions of the Regional Government of Flanders; Fund for Scientific Research of Flanders (FWO-Vlaanderen)(FWO); Interuniversity Attraction Poles Programme, Belgian State, Belgian Science Policy(Belgian Federal Science Policy Office); Fondazione Humanitas per la Ricerca; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	This work was supported by research grants of the European Community (INNOCHEM project 518167), the Ministero dell'Istruzione dell'Universita e della Ricerca (Progetti di Ricerca di Interesse Nazionale projects 2002061255 and 2007ENYMAN_003; Fondo per gli Investimenti della Ricerca di Base project RBIN04EKCX), Fondazione Cariplo (NOBEL project), the Centers of Excellence (Credit EF/05/15) of the K. U. Leuven, the Concerted Research Actions of the Regional Government of Flanders, the Fund for Scientific Research of Flanders (FWO-Vlaanderen), and the Interuniversity Attraction Poles Programme, Belgian State, Belgian Science Policy. This work was conducted in the context and with the support of the Fondazione Humanitas per la Ricerca. This work was also supported by the Italian Association for Cancer Research.; A Fondazione Italiana per la Ricerca sul Cancro fellowship recipient.	Ahuja SK, 1996, J BIOL CHEM, V271, P20545, DOI 10.1074/jbc.271.34.20545; Berahovich RD, 2005, J IMMUNOL, V174, P7341, DOI 10.4049/jimmunol.174.11.7341; Blain KY, 2007, BIOCHEMISTRY-US, V46, P10008, DOI 10.1021/bi700936w; Blanpain C, 2003, J BIOL CHEM, V278, P5179, DOI 10.1074/jbc.M205684200; Bonecchi R, 2004, J IMMUNOL, V172, P4972, DOI 10.4049/jimmunol.172.8.4972; Bonecchi R, 2008, BLOOD, V112, P493, DOI 10.1182/blood-2007-08-108316; Bonecchi R, 2009, FRONT BIOSCI-LANDMRK, V14, P540, DOI 10.2741/3261; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; de la Torre YM, 2007, P NATL ACAD SCI USA, V104, P2319, DOI 10.1073/pnas.0607514104; de la Torre YM, 2005, EUR J IMMUNOL, V35, P1342, DOI 10.1002/eji.200526114; Detheux M, 2000, J EXP MED, V192, P1501, DOI 10.1084/jem.192.10.1501; Di Liberto D, 2008, J EXP MED, V205, P2075, DOI 10.1084/jem.20070608; Forssmann U, 2004, J IMMUNOL, V173, P3456, DOI 10.4049/jimmunol.173.5.3456; Forssmann U, 2001, J LEUKOCYTE BIOL, V70, P357; Jamieson T, 2005, NAT IMMUNOL, V6, P403, DOI 10.1038/ni1182; Jensen PC, 2008, J BIOL CHEM, V283, P23121, DOI 10.1074/jbc.M803458200; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Locati M, 2005, CYTOKINE GROWTH F R, V16, P679, DOI 10.1016/j.cytogfr.2005.05.003; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; McKimmie CS, 2008, J IMMUNOL, V181, P8170, DOI 10.4049/jimmunol.181.11.8170-a; Mortier A, 2008, PHARMACOL THERAPEUT, V120, P197, DOI 10.1016/j.pharmthera.2008.08.006; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nibbs RJB, 1999, J BIOL CHEM, V274, P17478, DOI 10.1074/jbc.274.25.17478; Nibbs RJB, 2001, AM J PATHOL, V158, P867, DOI 10.1016/S0002-9440(10)64035-7; Nibbs RJB, 2007, J CLIN INVEST, V117, P1884, DOI 10.1172/JCI30068; Proost P, 2000, BLOOD, V96, P1674, DOI 10.1182/blood.V96.5.1674.h8001674a_1674_1680; Proost P, 2006, BIOCHEM SOC T, V34, P997, DOI 10.1042/BST0340997; Proost P, 2008, J EXP MED, V205, P2085, DOI 10.1084/jem.20080305; Rosenkilde MM, 2000, MOL PHARMACOL, V57, P602, DOI 10.1124/mol.57.3.602; SchulzKnappe P, 1996, J EXP MED, V183, P295, DOI 10.1084/jem.183.1.295; Struyf S, 2003, ADV IMMUNOL, V81, P1, DOI 10.1016/S0065-2776(03)81001-5; Struyf S, 2009, EUR J IMMUNOL, V39, P843, DOI 10.1002/eji.200838660; Vakili J, 2001, J IMMUNOL, V167, P3406, DOI 10.4049/jimmunol.167.6.3406; VETRANO S, 2009, GUT IN PRESS	35	46	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26207	26215		10.1074/jbc.M109.029249	http://dx.doi.org/10.1074/jbc.M109.029249			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19632987	Green Published, hybrid			2022-12-27	WOS:000269738000075
J	Schutt, J; Falley, K; Richter, D; Kreienkamp, HJ; Kindler, S				Schuett, Janin; Falley, Katrin; Richter, Dietmar; Kreienkamp, Hans-Juergen; Kindler, Stefan			Fragile X Mental Retardation Protein Regulates the Levels of Scaffold Proteins and Glutamate Receptors in Postsynaptic Densities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC TARGETING ELEMENT; LONG-TERM POTENTIATION; SHANK1 MESSENGER-RNA; DEVELOPING RAT-BRAIN; NMDA RECEPTOR; SYNAPTIC PLASTICITY; MOUSE MODEL; DEPENDENT TRANSLATION; SPINE MORPHOGENESIS; KNOCKOUT MICE	Functional absence of fragile X mental retardation protein (FMRP) causes the fragile X syndrome, a hereditary form of mental retardation characterized by a change in dendritic spine morphology. The RNA-binding protein FMRP has been implicated in regulating postsynaptic protein synthesis. Here we have analyzed whether the abundance of scaffold proteins and neurotransmitter receptor subunits in postsynaptic densities (PSDs) is altered in the neocortex and hippocampus of FMRP-deficient mice. Whereas the levels of several PSD components are unchanged, concentrations of Shank1 and SAPAP scaffold proteins and various glutamate receptor subunits are altered in both adult and juvenile knock-out mice. With the exception of slightly increased hippocampal SAPAP2 mRNA levels in adult animals, altered postsynaptic protein concentrations do not correlate with similar changes in total and synaptic levels of corresponding mRNAs. Thus, loss of FMRP in neurons appears to mainly affect the translation and not the abundance of particular brain transcripts. Semi-quantitative analysis of RNA levels in FMRP immunoprecipitates showed that in the mouse brain mRNAs encoding PSD components, such as Shank1, SAPAP1-3, PSD-95, and the glutamate receptor subunits NR1 and NR2B, are associated with FMRP. Luciferase reporter assays performed in primary cortical neurons from knock-out and wild-type mice indicate that FMRP silences translation of Shank1 mRNAs via their 3'-untranslated region. Activation of metabotropic glutamate receptors relieves translational suppression. As Shank1 controls dendritic spine morphology, our data suggest that dysregulation of Shank1 synthesis may significantly contribute to the abnormal spine development and function observed in brains of fragile X syndrome patients.	[Schuett, Janin; Falley, Katrin; Kreienkamp, Hans-Juergen; Kindler, Stefan] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany; [Richter, Dietmar] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kindler, S (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, Campus Forsch N27,Martinistr 52, D-20246 Hamburg, Germany.	kindler@uke.uni-hamburg.de			Deutsche Forschungsgemeinschaft [Ki 488/2-6, KR 1321/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Grants Ki488/2-6 ( to S. K.) and KR 1321/4-1 ( to H.-J. K. and S. K.) and Thyssen-Stiftung Az. 10.05.2.185 ( to D. R. and S. K.). This article is based in part on a doctoral study by J.S. at the Faculty of Biology, University of Hamburg.	Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Bardoni Barbara, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010751; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bassell GJ, 2008, NAT MED, V14, P249, DOI 10.1038/nm0308-249; Bear MF, 2008, NEUROPSYCHOPHARMACOL, V33, P84, DOI 10.1038/sj.npp.1301610; Bechara EG, 2009, PLOS BIOL, V7, P133, DOI 10.1371/journal.pbio.1000016; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Blichenberg A, 2001, EUR J NEUROSCI, V13, P1881, DOI 10.1046/j.0953-816x.2001.01565.x; Bockers TM, 2004, MOL CELL NEUROSCI, V26, P182, DOI 10.1016/j.mcn.2004.01.009; Bonaglia MC, 2001, AM J HUM GENET, V69, P261, DOI 10.1086/321293; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Brendel C, 2004, BIOCHEM J, V384, P239, DOI 10.1042/BJ20040812; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; BURGIN KE, 1990, J NEUROSCI, V10, P1788; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Cuthbert PC, 2007, J NEUROSCI, V27, P2673, DOI 10.1523/JNEUROSCI.4457-06.2007; Darnell JC, 2005, GENES BRAIN BEHAV, V4, P341, DOI 10.1111/j.1601-183X.2005.00144.x; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Fahling M, 2009, J BIOL CHEM, V284, P4255, DOI 10.1074/jbc.M807354200; Falley K, 2009, TRAFFIC, V10, P844, DOI 10.1111/j.1600-0854.2009.00912.x; Garber KB, 2008, EUR J HUM GENET, V16, P666, DOI 10.1038/ejhg.2008.61; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; Groc L, 2009, NEUROSCIENCE, V158, P4, DOI 10.1016/j.neuroscience.2008.05.029; Grossman AW, 2006, J NEUROSCI, V26, P7151, DOI 10.1523/JNEUROSCI.1790-06.2006; Grossman AW, 2006, BRAIN RES, V1084, P158, DOI 10.1016/j.brainres.2006.02.044; Gundelfinger ED, 2006, TRENDS BIOCHEM SCI, V31, P366, DOI 10.1016/j.tibs.2006.05.007; Huang YS, 2007, METHOD ENZYMOL, V431, P143, DOI 10.1016/S0076-6879(07)31008-2; Iacoangeli A, 2008, P NATL ACAD SCI USA, V105, P734, DOI 10.1073/pnas.0803737105; Irwin SA, 2002, AM J MED GENET, V111, P140, DOI 10.1002/ajmg.10500; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; Kim MH, 2009, J NEUROSCI, V29, P1586, DOI 10.1523/JNEUROSCI.4306-08.2009; Kindler S, 2005, ANNU REV CELL DEV BI, V21, P223, DOI 10.1146/annurev.cellbio.21.122303.120653; Kindler S, 2004, MOL BRAIN RES, V126, P14, DOI 10.1016/j.molbrainres.2004.03.014; KISTNER U, 1993, J BIOL CHEM, V268, P4580; Kurth I, 2007, MOL CELL BIOL, V27, P1370, DOI 10.1128/MCB.01486-06; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lauterborn JC, 2007, J NEUROSCI, V27, P10685, DOI 10.1523/JNEUROSCI.2624-07.2007; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Monshausen M, 2002, J NEUROCHEM, V81, P557, DOI 10.1046/j.1471-4159.2002.00887.x; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Muddashetty RS, 2002, J MOL BIOL, V321, P433, DOI 10.1016/S0022-2836(02)00655-1; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Narayanan U, 2008, J BIOL CHEM, V283, P18478, DOI 10.1074/jbc.C800055200; Narayanan U, 2007, J NEUROSCI, V27, P14349, DOI 10.1523/JNEUROSCI.2969-07.2007; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Nosyreva ED, 2006, J NEUROPHYSIOL, V95, P3291, DOI 10.1152/jn.01316.2005; Okabe S, 2007, MOL CELL NEUROSCI, V34, P503, DOI 10.1016/j.mcn.2007.01.006; Oostra BA, 2009, BBA-GEN SUBJECTS, V1790, P467, DOI 10.1016/j.bbagen.2009.02.007; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Pedersen SK, 2002, BIOCHEM J, V363, P37, DOI 10.1042/0264-6021:3630037; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfeiffer BE, 2009, NEUROSCIENTIST, V15, P549, DOI 10.1177/1073858409333075; Redecker P, 2006, HISTOCHEM CELL BIOL, V126, P679, DOI 10.1007/s00418-006-0199-9; Roussignol G, 2005, J NEUROSCI, V25, P3560, DOI 10.1523/JNEUROSCI.4354-04.2005; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sambrook J., 2002, MOL CLONING LAB MANU; Sawallisch C, 2009, J BIOL CHEM, V284, P9225, DOI 10.1074/jbc.M808425200; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Soltau M, 2004, J NEUROCHEM, V90, P659, DOI 10.1111/j.1471-4159.2004.02523.x; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Tarpey P, 2004, AM J HUM GENET, V75, P318, DOI 10.1086/422703; Todd PK, 2003, P NATL ACAD SCI USA, V100, P14374, DOI 10.1073/pnas.2336265100; Valtschanoff JG, 2000, EUR J NEUROSCI, V12, P3605, DOI 10.1046/j.1460-9568.2000.00256.x; Wang HD, 2002, J NEUROSCI, V22, P10232; Waung MW, 2009, CURR OPIN NEUROBIOL, V19, P319, DOI 10.1016/j.conb.2009.03.011; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Welch JM, 2004, J COMP NEUROL, V472, P24, DOI 10.1002/cne.20060; West NC, 2002, J MOL BIOL, V321, P423, DOI 10.1016/S0022-2836(02)00542-9; Wilson BM, 2007, P NATL ACAD SCI USA, V104, P2454, DOI 10.1073/pnas.0610875104; Wilson HL, 2003, J MED GENET, V40, P575, DOI 10.1136/jmg.40.8.575; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zitzer H, 1999, J BIOL CHEM, V274, P32997, DOI 10.1074/jbc.274.46.32997	77	114	116	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25479	25487		10.1074/jbc.M109.042663	http://dx.doi.org/10.1074/jbc.M109.042663			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19640847	Green Published, hybrid			2022-12-27	WOS:000269738000005
J	Plank, J; Hsieh, TS				Plank, Jody; Hsieh, Tao-shih			Helicase-appended Topoisomerases: New Insight into the Mechanism of Directional Strand Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BLOOMS-SYNDROME HELICASE; REVERSE GYRASE; III-ALPHA; DNA TOPOISOMERASES; HOMOLOGOUS RECOMBINATION; BUBBLE SUBSTRATE; GENOME STABILITY; BREAK REPAIR; YEAST; PROMOTES	DNA strand passage through an enzyme-mediated gate is a key step in the catalytic cycle of topoisomerases to produce topological transformations in DNA. In most of the reactions catalyzed by topoisomerases, strand passage is not directional; thus, the enzyme simply provides a transient DNA gate through which DNA transport is allowed and thereby resolves the topological entanglement. When studied in isolation, the type IA topoisomerase family appears to conform to this rule. Interestingly, type IA enzymes can carry out directional strand transport as well. We examined here the biochemical mechanism for directional strand passage of two type IA topoisomerases: reverse gyrase and a protein complex of topoisomerase III alpha and Bloom helicase. These enzymes are able to generate vectorial strand transport independent of the supercoiling energy stored in the DNA molecule. Reverse gyrase is able to anneal single strands, thereby increasing linkage number of a DNA molecule. However, topoisomerase III alpha and Bloom helicase can dissolve DNA conjoined with a double Holliday junction, thus reducing DNA linkage. We propose here that the helicase or helicase-like component plays a determinant role in the directionality of strand transport. There is thus a common biochemical ground for the directional strand passage for the type IA topoisomerases.	[Plank, Jody; Hsieh, Tao-shih] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Hsieh, TS (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	hsieh@biochem.duke.edu	Wu, Wan-lin/G-8937-2012; Hsieh, Tao-shih/G-9305-2012					Atomi H, 2004, J BACTERIOL, V186, P4829, DOI 10.1128/JB.186.14.4829-4833.2004; Bussen W, 2007, J BIOL CHEM, V282, P31484, DOI 10.1074/jbc.M706116200; Campbell BJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000362; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Cheok CF, 2005, BIOCHEM SOC T, V33, P1456, DOI 10.1042/BST0331456; Cheok CF, 2005, NUCLEIC ACIDS RES, V33, P3932, DOI 10.1093/nar/gki712; CONFALONIERI F, 1993, P NATL ACAD SCI USA, V90, P4753, DOI 10.1073/pnas.90.10.4753; Declais AC, 2000, J BIOL CHEM, V275, P19498, DOI 10.1074/jbc.M910091199; Duany YD, 2008, NUCLEIC ACIDS RES, V36, P5882, DOI 10.1093/nar/gkn587; Forterre P, 2002, TRENDS GENET, V18, P236, DOI 10.1016/S0168-9525(02)02650-1; Gangloff S, 1999, EMBO J, V18, P1701, DOI 10.1093/emboj/18.6.1701; Harmon FG, 1999, MOL CELL, V3, P611, DOI 10.1016/S1097-2765(00)80354-8; Hsieh TS, 2006, J BIOL CHEM, V281, P5640, DOI 10.1074/jbc.M513252200; Hsieh TS, 2005, J BIOL CHEM, V280, P20467, DOI 10.1074/jbc.M502739200; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Kampmann M, 2004, NUCLEIC ACIDS RES, V32, P3537, DOI 10.1093/nar/gkh683; KIKUCHI A, 1984, NATURE, V309, P677, DOI 10.1038/309677a0; KIRKEGAARD K, 1985, J MOL BIOL, V185, P625, DOI 10.1016/0022-2836(85)90075-0; Kwan KY, 2003, P NATL ACAD SCI USA, V100, P2526, DOI 10.1073/pnas.0437998100; Li W, 1998, P NATL ACAD SCI USA, V95, P1010, DOI 10.1073/pnas.95.3.1010; LIMA CD, 1994, NATURE, V367, P138, DOI 10.1038/367138a0; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Mullen JR, 2005, MOL CELL BIOL, V25, P4476, DOI 10.1128/MCB.25.11.4476-4487.2005; Plank JL, 2005, J BIOL CHEM, V280, P3564, DOI 10.1074/jbc.M411337200; Plank JL, 2006, P NATL ACAD SCI USA, V103, P11118, DOI 10.1073/pnas.0604873103; Raynard S, 2008, J BIOL CHEM, V283, P15701, DOI 10.1074/jbc.M802127200; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Suski C, 2008, MOL CELL, V30, P779, DOI 10.1016/j.molcel.2008.04.020; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang Y, 2002, P NATL ACAD SCI USA, V99, P12114, DOI 10.1073/pnas.192449499; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Yin JH, 2005, EMBO J, V24, P1465, DOI 10.1038/sj.emboj.7600622	34	29	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30737	30741		10.1074/jbc.R109.051268	http://dx.doi.org/10.1074/jbc.R109.051268			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19726668	Green Published, hybrid			2022-12-27	WOS:000271378400001
J	Vomund, AN; Majerus, EM				Vomund, Anthony N.; Majerus, Elaine M.			ADAMTS13 Bound to Endothelial Cells Exhibits Enhanced Cleavage of von Willebrand Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC STELLATE CELLS; WEIBEL-PALADE BODIES; FLUID SHEAR-STRESS; VONWILLEBRAND-FACTOR; BLOOD-COAGULATION; FACTOR MULTIMERS; BINDING-SITE; PROTEIN-C; FACTOR-XA; RECEPTOR	ADAMTS13 is a plasma metalloprotease that cleaves ultralarge von Willebrand factor multimers to generate less thrombogenic fragments. Although this cleavage can occur at the surface of endothelial cells, it is currently unknown whether this process involves binding of the ADAMTS13 to the endothelial cell plasma membrane. Using different assay systems, we present evidence that ADAMTS13 binds to endothelial cells in a specific, reversible, and time-dependent manner with a K-d of 58 nM. This binding requires the COOH-terminal thrombospondin type 1 repeats of the protease. Binding is inhibited in the presence of heparin and by trypsin treatment of the cells. ADAMTS13 that was prebound to endothelial cells exhibited increased proteolysis of VWF as compared with ADAMTS13 present only in solution. These data support the notion that cleavage of VWF occurs mainly at the endothelial cell surface.	[Vomund, Anthony N.; Majerus, Elaine M.] Washington Univ, Sch Med, Div Hematol, Dept Internal Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Majerus, EM (corresponding author), Washington Univ, Sch Med, Div Hematol, Dept Internal Med, 660 S Euclid Ave,Box 8125, St Louis, MO 63110 USA.	emajerus@dom.wustl.edu			American Heart Association [0475035N]; Edward Mallinckrodt Jr. Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016634, R01HL016634] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Edward Mallinckrodt Jr. Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was also supported by American Heart Association Fellow to Faculty Transition Award 0475035N and by the Edward Mallinckrodt Jr. Foundation.	AHMAD SS, 1989, J BIOL CHEM, V264, P20012; ASCH AS, 1992, BIOCHEM BIOPH RES CO, V182, P1208, DOI 10.1016/0006-291X(92)91860-S; Bono F, 1997, J CELL PHYSIOL, V172, P36, DOI 10.1002/(SICI)1097-4652(199707)172:1<36::AID-JCP4>3.0.CO;2-E; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; CRAMER EM, 1985, BLOOD, V66, P710; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; DEBOER HC, 1992, J BIOL CHEM, V267, P2264; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; ESMON CT, 1989, J BIOL CHEM, V264, P4743; FOWLER WE, 1985, J CLIN INVEST, V76, P1491, DOI 10.1172/JCI112129; FUKUDOME K, 1994, J BIOL CHEM, V269, P26486; Hartigan N, 2003, J BIOL CHEM, V278, P18045, DOI 10.1074/jbc.M211448200; Huang J, 2009, BLOOD, V113, P1589, DOI 10.1182/blood-2008-05-158584; Hurskainen TL, 1999, J BIOL CHEM, V274, P25555, DOI 10.1074/jbc.274.36.25555; JAFFE EA, 1974, P NATL ACAD SCI USA, V71, P1906, DOI 10.1073/pnas.71.5.1906; Kristiansen M, 1999, J BIOL CHEM, V274, P20540, DOI 10.1074/jbc.274.29.20540; Liu L, 2005, J THROMB HAEMOST, V3, P2536, DOI 10.1111/j.1538-7836.2005.01561.x; Majerus EM, 2005, J BIOL CHEM, V280, P21773, DOI 10.1074/jbc.M502529200; MILETICH JP, 1978, J BIOL CHEM, V253, P6908; NACHMAN R, 1977, J CLIN INVEST, V60, P914, DOI 10.1172/JCI108846; NEMERSON Y, 1992, SEMIN HEMATOL, V29, P170; Niiya M, 2006, J THROMB HAEMOST, V4, P1063, DOI 10.1111/j.1538-7836.2006.01893.x; Padilla A, 2004, BLOOD, V103, P2150, DOI 10.1182/blood-2003-08-2956; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; SHANG D, 2005, BLOOD, V106, P2562; Shim K, 2008, BLOOD, V111, P651, DOI 10.1182/blood-2007-05-093021; Soejima K, 2003, BLOOD, V102, P3232, DOI 10.1182/blood-2003-03-0908; Tao ZY, 2005, BLOOD, V106, P4139, DOI 10.1182/blood-2005-05-2029; TSAI HM, 1994, BLOOD, V83, P2171; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; WAGNER DD, 1982, J CELL BIOL, V95, P355, DOI 10.1083/jcb.95.1.355; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; WEIGEL PH, 1981, J BIOL CHEM, V256, P2615; Zhang P, 2007, BLOOD, V110, P1887, DOI 10.1182/blood-2007-04-083329; Zhang WR, 2004, BLOOD, V104, p39A; Zheng XL, 2003, J BIOL CHEM, V278, P30136, DOI 10.1074/jbc.M305331200; Zhou WH, 2005, LAB INVEST, V85, P780, DOI 10.1038/labinvest.3700275	38	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30925	30932		10.1074/jbc.M109.000927	http://dx.doi.org/10.1074/jbc.M109.000927			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19729451	Green Published, hybrid			2022-12-27	WOS:000271378400021
J	Shin, SY; Song, H; Kim, CG; Choi, YK; Lee, KS; Lee, SJ; Lee, HJ; Lim, Y; Lee, YH				Shin, Soon Young; Song, Haengseok; Kim, Chang Gun; Choi, Yang-Kyu; Lee, Kyoung Sun; Lee, Seung-Jae; Lee, He-Jin; Lim, Yoongho; Lee, Young Han			Egr-1 Is Necessary for Fibroblast Growth Factor-2-induced Transcriptional Activation of the Glial Cell Line-derived Neurotrophic Factor in Murine Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMEDIATE-EARLY GENE; MICE LACKING GDNF; SIGNAL-REGULATED KINASE; CULTURED RAT ASTROCYTES; C6 GLIOBLASTOMA CELLS; SERUM RESPONSE FACTOR; NGFI-A; PROMOTER ACTIVITY; FACTOR EXPRESSION; NERVOUS-SYSTEM	Glial cell line-derived neurotrophic factor (Gdnf) promotes neurite outgrowth and survival of neuronal cells, but its transcriptional regulation is poorly understood. Here, we sought to investigate the mechanism underlying fibroblast growth factor-2 (FGF2) induction of Gdnf expression in astrocytes. We found that FGF2 stimulation of rat astrocytes induced expression of Egr-1 at a high level. Sequence analysis of the rat Gdnf gene identified three overlapping Egr-1-binding sites between positions -185 and -163 of the rat Gdnf promoter. Transfection studies using a series of deleted Gdnf promoters revealed that these Egr-1-binding sites are required for maximal activation of the Gdnf promoter by FGF2. Chromatin immunoprecipitation analysis indicated that Egr-1 binds to the Gdnf promoter. Furthermore, the induction of Gdnf expression by FGF2 is strongly attenuated both in C6 glioma cells stably expressing Egr-1-specific small interfering RNA and in primary cultured astrocytes from the Egr-1 knock-out mouse. Additionally, we found that stimulation of the ERK and JNK pathways by FGF2 is functionally linked to Gdnf expression through the induction of Egr-1. These data demonstrate that FGF2-induced Gdnf expression is mediated by the induction of Egr-1 through activation of the ERK and JNK/Elk-1 signaling pathways.	[Lee, Young Han] Konkuk Univ, Dept Biomed Sci & Technol, IBST, Res Ctr Transcript Control,BMIC, Seoul 143701, South Korea; [Shin, Soon Young; Lee, Seung-Jae; Lee, Young Han] Konkuk Univ Hosp, Dept Biomed Sci & Technol, IBST, Seoul 143729, South Korea; [Choi, Yang-Kyu; Lee, Kyoung Sun] Konkuk Univ, Dept Lab Anim Sci, Coll Vet Med, BMIC, Seoul 143701, South Korea; [Lee, He-Jin] Konkuk Univ, Dept Anat, Sch Med, BMIC, Seoul 143701, South Korea; [Lim, Yoongho] Konkuk Univ, Div Biosci & Biotechnol, BMIC, Seoul 143701, South Korea; [Song, Haengseok] Cheil Gen Hosp, Lab Reprod Biol & Infertil, Seoul 100380, South Korea; [Song, Haengseok] Kwandong Univ, Womens Healthcare Ctr, Coll Med, Seoul 100380, South Korea	Konkuk University; Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University; Konkuk University Medical Center; Konkuk University; Catholic Kwandong University	Lee, YH (corresponding author), Konkuk Univ, Dept Biomed Sci & Technol, IBST, Res Ctr Transcript Control,BMIC, 1 Hwang Dong, Seoul 143701, South Korea.	yhlee58@konkuk.ac.kr		Lee, Seung-Jae/0000-0002-5155-5335; Song, Haengseok/0000-0002-5027-7310	National Research Foundation of Korea [20090084181]; Ministry of Education, Science and Technology, Republic of Korea	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Disease Network Research Program Grant 20090084181 from the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology, Republic of Korea.	Bayatti N, 2001, J NEUROCHEM, V78, P972, DOI 10.1046/j.1471-4159.2001.00464.x; Beckmann AM, 1997, NEUROCHEM INT, V31, P477, DOI 10.1016/S0197-0186(96)00136-2; Biesiada E, 1996, J BIOL CHEM, V271, P18576, DOI 10.1074/jbc.271.31.18576; Bozon B, 2002, HIPPOCAMPUS, V12, P570, DOI 10.1002/hipo.10100; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Cen XB, 2006, J NEUROSCI, V26, P3335, DOI 10.1523/JNEUROSCI.5010-05.2006; Choi BH, 2008, CANCER RES, V68, P1369, DOI 10.1158/0008-5472.CAN-07-5222; Chung EY, 2007, NEUROSCI LETT, V422, P43, DOI 10.1016/j.neulet.2007.05.057; Cohen DM, 1996, P NATL ACAD SCI USA, V93, P11242, DOI 10.1073/pnas.93.20.11242; Darlington Cynthia L, 2005, Curr Opin Investig Drugs, V6, P700; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; Gentilella A, 2008, ONCOGENE, V27, P5011, DOI 10.1038/onc.2008.142; Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429; HIPSKIND RA, 1994, MOL CELL BIOL, V14, P6219, DOI 10.1128/MCB.14.9.6219; Hisaoka K, 2008, BRAIN RES, V1196, P53, DOI 10.1016/j.brainres.2007.12.019; Hisaoka K, 2007, J PHARMACOL EXP THER, V321, P148, DOI 10.1124/jpet.106.116558; Jin Y, 2000, MOL PHARMACOL, V57, P984; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kim CG, 2007, CELL SIGNAL, V19, P1290, DOI 10.1016/j.cellsig.2007.01.008; Kitagawa H, 1998, STROKE, V29, P1417, DOI 10.1161/01.STR.29.7.1417; Koyama Y, 2004, BIOCHEM PHARMACOL, V68, P275, DOI 10.1016/j.bcp.2004.03.023; Koyama Y, 2003, BIOCHEM BIOPH RES CO, V303, P1101, DOI 10.1016/S0006-291X(03)00491-1; Ledda F, 2007, NAT NEUROSCI, V10, P293, DOI 10.1038/nn1855; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Lee SL, 1996, MOL CELL BIOL, V16, P4566; Lim CP, 1998, ONCOGENE, V16, P2915, DOI 10.1038/sj.onc.1201834; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Ling Y, 1997, EMBO J, V16, P2431, DOI 10.1093/emboj/16.9.2431; MACK K, 1990, MOL BRAIN RES, V8, P177, DOI 10.1016/0169-328X(90)90062-I; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Naughton CK, 2006, BIOL REPROD, V74, P314, DOI 10.1095/biolreprod.105.047365; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Pozas E, 2005, NEURON, V45, P701, DOI 10.1016/j.neuron.2005.01.043; RUSSO MW, 1993, MOL CELL BIOL, V13, P6858, DOI 10.1128/MCB.13.11.6858; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Santiago FS, 1999, AM J PATHOL, V154, P937, DOI 10.1016/S0002-9440(10)65341-2; SCHLINGENSIEPEN KH, 1991, NEUROSCI LETT, V122, P67, DOI 10.1016/0304-3940(91)90195-Y; Schratt G, 2001, MOL CELL BIOL, V21, P2933, DOI 10.1128/MCB.21.8.2933-2943.2001; Shin SY, 2006, EMBO J, V25, P1093, DOI 10.1038/sj.emboj.7600987; Shin SY, 2001, J BIOL CHEM, V276, P7797, DOI 10.1074/jbc.M009465200; STROMBERG I, 1993, EXP NEUROL, V124, P401, DOI 10.1006/exnr.1993.1214; SuterCrazzolara C, 1996, MOL BRAIN RES, V41, P175, DOI 10.1016/0169-328X(96)00089-7; Tanaka M, 2000, MOL BRAIN RES, V85, P91, DOI 10.1016/S0169-328X(00)00250-3; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Tsai JC, 2000, AM J PHYSIOL-CELL PH, V279, pC1414, DOI 10.1152/ajpcell.2000.279.5.C1414; Tsuchioka M, 2008, J NEUROCHEM, V106, P244, DOI 10.1111/j.1471-4159.2008.05357.x; Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082; Verity AN, 1998, J NEUROCHEM, V70, P531; Watson DK, 1997, ONCOGENE, V14, P213, DOI 10.1038/sj.onc.1200839; Woodbury D, 1998, BRAIN RES, V803, P95, DOI 10.1016/S0006-8993(98)00627-1; Yamagata K, 2003, GLIA, V41, P199, DOI 10.1002/glia.10180; Yamagata K, 2007, NEUROSCI RES, V59, P467, DOI 10.1016/j.neures.2007.08.016; Yang SH, 2006, BIOCHEM SOC SYMP, V73, P121, DOI 10.1042/bss0730121; Yang SH, 2005, EMBO J, V24, P2161, DOI 10.1038/sj.emboj.7600690	54	22	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30583	30593		10.1074/jbc.M109.010678	http://dx.doi.org/10.1074/jbc.M109.010678			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19721135	Green Published, hybrid			2022-12-27	WOS:000271090000061
J	Carlile, CM; Pickart, CM; Matunis, MJ; Cohen, RE				Carlile, Candice M.; Pickart, Cecile M.; Matunis, Michael J.; Cohen, Robert E.			Synthesis of Free and Proliferating Cell Nuclear Antigen-bound Polyubiquitin Chains by the RING E3 Ubiquitin Ligase Rad5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMPLE REPETITIVE SEQUENCES; TRANSLESION DNA-SYNTHESIS; SACCHAROMYCES-CEREVISIAE; CONJUGATING ENZYME; POSTREPLICATION REPAIR; REPLICATION FORK; DAMAGED DNA; IN-VITRO; PROTEIN; COMPLEX	In replicating yeast, lysine 63-linked polyubiquitin (polyUb) chains are extended from the ubiquitin moiety of monoubiquitinated proliferating cell nuclear antigen (monoUb-PCNA) by the E2-E3 complex of (Ubc13-Mms2)-Rad5. This promotes error-free bypass of DNA damage lesions. The unusual ability of Ubc13-Mms2 to synthesize unanchored Lys(63)-linked polyUb chains in vitro allowed us to resolve the individual roles that it and Rad5 play in the catalysis and specificity of PCNA polyubiquitination. We found that Rad5 stimulates the synthesis of free polyUb chains by Ubc13-Mms2 in part by enhancing the reactivity of the Ubc13 similar to Ub thiolester bond. Polyubiquitination of monoUb-PCNA was further enhanced by interactions between the N-terminal domain of Rad5 and PCNA. Thus, Rad5 acts both to align monoUb-PCNA with Ub-charged Ubc13 and to stimulate Ub transfer onto Lys(63) of a Ub acceptor. We also found that Rad5 interacts with PCNA independently of the number of monoubiquitinated subunits in the trimer and that it binds to both unmodified and monoUb-PCNA with similar affinities. These findings indicate that Rad5-mediated recognition of monoUb-PCNA in vivo is likely to depend upon interactions with additional factors at stalled replication forks.	[Cohen, Robert E.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Carlile, Candice M.; Pickart, Cecile M.; Matunis, Michael J.; Cohen, Robert E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	Colorado State University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Cohen, RE (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, 141 MRB,1870 Campus Delivery, Ft Collins, CO 80523 USA.	bob.cohen@colostate.edu		Matunis, Michael/0000-0002-9350-6611	National Institutes of Health [R01GM060372]; American Heart Association [0715305U]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060372] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01GM060372 (to C. M. P. and M. J. M.). This work was also supported by American Heart Association Predoctoral Grant 0715305U (to C. M. C.).	Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Blastyak A, 2007, MOL CELL, V28, P167, DOI 10.1016/j.molcel.2007.07.030; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Chen S, 2005, NUCLEIC ACIDS RES, V33, P5878, DOI 10.1093/nar/gki902; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Gangavarapu V, 2006, MOL CELL BIOL, V26, P7783, DOI 10.1128/MCB.01260-06; Garg P, 2005, P NATL ACAD SCI USA, V102, P18361, DOI 10.1073/pnas.0505949102; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; HAAS AL, 1985, J BIOL CHEM, V260, P2464; Haldeman MT, 1997, BIOCHEMISTRY-US, V36, P10526, DOI 10.1021/bi970750u; Haracska L, 2006, P NATL ACAD SCI USA, V103, P6477, DOI 10.1073/pnas.0510924103; Haracska L, 2004, MOL CELL BIOL, V24, P4267, DOI 10.1128/MCB.24.10.4267-4274.2004; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Iyer LM, 2006, CELL CYCLE, V5, P775, DOI 10.4161/cc.5.7.2629; JOHNSON RE, 1992, MOL CELL BIOL, V12, P3807, DOI 10.1128/MCB.12.9.3807; JOHNSON RE, 1994, J BIOL CHEM, V269, P28259; McKenna S, 2001, J BIOL CHEM, V276, P40120, DOI 10.1074/jbc.M102858200; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Plosky BS, 2006, EMBO J, V25, P2847, DOI 10.1038/sj.emboj.7601178; Scaglione KM, 2007, MOL CELL BIOL, V27, P5860, DOI 10.1128/MCB.01555-06; Torres-Ramos CA, 2002, MOL CELL BIOL, V22, P2419, DOI 10.1128/MCB.22.7.2419-2426.2002; TorresRamos CA, 1996, P NATL ACAD SCI USA, V93, P9676, DOI 10.1073/pnas.93.18.9676; TSURIMOTO T, 1989, MOL CELL BIOL, V9, P3839, DOI 10.1128/MCB.9.9.3839; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Ulrich HD, 2003, J BIOL CHEM, V278, P7051, DOI 10.1074/jbc.M212195200; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Yin LM, 2000, BIOCHEMISTRY-US, V39, P10001, DOI 10.1021/bi0007019; You JX, 2001, J BIOL CHEM, V276, P19871, DOI 10.1074/jbc.M100034200; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	41	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29326	29334		10.1074/jbc.M109.043885	http://dx.doi.org/10.1074/jbc.M109.043885			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19706603	hybrid, Green Published			2022-12-27	WOS:000270896800012
J	Ayoub, MA; Damian, M; Gespach, C; Ferrandis, E; Lavergne, O; De Wever, O; Baneres, JL; Pin, JP; Prevost, GP				Ayoub, Mohammed Akli; Damian, Marjorie; Gespach, Christian; Ferrandis, Eric; Lavergne, Olivier; De Wever, Olivier; Baneres, Jean-Louis; Pin, Jean-Philippe; Prevost, Gregoire Pierre			Inhibition of Heterotrimeric G Protein Signaling by a Small Molecule Acting on G alpha Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; LIVING CELLS; CONFORMATIONAL-CHANGES; COUPLED RECEPTORS; DRUG TARGETS; SURAMIN ANALOGS; GAMMA-SUBUNIT; ACTIVATION; MASTOPARAN; COMPLEX	The simultaneous activation of many distinct G protein-coupled receptors (GPCRs) and heterotrimeric G proteins play a major role in various pathological conditions. Pan-inhibition of GPCR signaling by small molecules thus represents a novel strategy to treat various diseases. To better understand such therapeutic approach, we have characterized the biomolecular target of BIM-46187, a small molecule pan-inhibitor of GPCR signaling. Combining bioluminescence and fluorescence resonance energy transfer techniques in living cells as well as in reconstituted receptor-G protein complexes, we observed that, by direct binding to the G alpha subunit, BIM-46187 prevents the conformational changes of the receptor-G protein complex associated with GPCR activation. Such a binding prevents the proper interaction of receptors with the G protein heterotrimer and inhibits the agonist-promoted GDP/GTP exchange. These observations bring further evidence that inhibiting G protein activation through direct binding to the G alpha subunit is feasible and should constitute a new strategy for therapeutic intervention.	[Ferrandis, Eric; Lavergne, Olivier; Prevost, Gregoire Pierre] Inst Henri Beaufour, IPSEN Innovat, F-91966 Les Ulis, France; [Pin, Jean-Philippe] Univ Montpellier, CNRS, INSERM, Inst Genom Fonct,UMR5203,U661, F-34094 Montpellier, France; [Damian, Marjorie; Baneres, Jean-Louis] Univ Montpellier I, CNRS, UMR 5247, Inst Biomol M Mousseron, F-34093 Montpellier 5, France; [Damian, Marjorie; Baneres, Jean-Louis] Univ Montpellier 2, Fac Pharm, F-34093 Montpellier 5, France; [Gespach, Christian; De Wever, Olivier] Univ Paris 06, INSERM, Hop St Antoine, U673, F-75012 Paris, France; [Gespach, Christian; De Wever, Olivier] Univ Paris 06, INSERM, U893, F-75012 Paris, France; [De Wever, Olivier] Ghent Univ Hosp, Expt Oncol Lab, B-9000 Ghent, Belgium	Ipsen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Ghent University; Ghent University Hospital	Prevost, GP (corresponding author), Inst Henri Beaufour, IPSEN Innovat, 5 Ave Canada, F-91966 Les Ulis, France.	gregoire.prevost@ipsen.com	de wever, olivier/J-3094-2013; Pin, Jean-Philippe/Y-6668-2019	de wever, olivier/0000-0002-5453-760X; Pin, Jean-Philippe/0000-0002-1423-345X; Baneres, jean-louis/0000-0001-7078-1285; AYOUB, Mohammed Akli/0000-0003-0022-578X; Lavergne, Olivier/0000-0003-4922-5086				Ahmad Sultan, 2004, Curr Opin Investig Drugs, V5, P67; Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; Ayoub MA, 2002, J BIOL CHEM, V277, P21522, DOI 10.1074/jbc.M200729200; Ayoub MA, 2007, MOL PHARMACOL, V71, P1329, DOI 10.1124/mol.106.030304; Azpiazu I, 2004, J BIOL CHEM, V279, P27709, DOI 10.1074/jbc.M403712200; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Beindl W, 1996, MOL PHARMACOL, V50, P415; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Breitweg-Lehmann E, 2002, MOL PHARMACOL, V61, P628, DOI 10.1124/mol.61.3.628; Cotecchia S, 2003, ASSAY DRUG DEV TECHN, V1, P311, DOI 10.1089/15406580360545125; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; DANILENKO M, 1993, BIOCHEM BIOPH RES CO, V196, P1296, DOI 10.1006/bbrc.1993.2393; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Favre-Guilmard C, 2008, EUR J PHARMACOL, V594, P70, DOI 10.1016/j.ejphar.2008.07.016; Freissmuth M, 1996, MOL PHARMACOL, V49, P602; Freissmuth M, 1999, TRENDS PHARMACOL SCI, V20, P237, DOI 10.1016/S0165-6147(99)01337-1; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; GILMAN AG, 1995, BIOSCIENCE REP, V15, P65, DOI 10.1007/BF01200143; Grijelmo C, 2007, CELL SIGNAL, V19, P1722, DOI 10.1016/j.cellsig.2007.03.008; Hickerson MJ, 2000, MOL BIOL EVOL, V17, P639, DOI 10.1093/oxfordjournals.molbev.a026342; HIGASHIJIMA T, 1988, J BIOL CHEM, V263, P6491; HIGASHIJIMA T, 1990, J BIOL CHEM, V265, P14176; Hohenegger M, 1998, P NATL ACAD SCI USA, V95, P346, DOI 10.1073/pnas.95.1.346; Holler C, 1999, CELL MOL LIFE SCI, V55, P257, DOI 10.1007/s000180050288; Lundstrom K, 2006, CURR PROTEIN PEPT SC, V7, P465, DOI 10.2174/138920306778559403; Medkova M, 2002, BIOCHEMISTRY-US, V41, P9962, DOI 10.1021/bi0255726; Nanoff C, 2002, METHOD ENZYMOL, V344, P469; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Nguyen QD, 2002, FASEB J, V16, P565, DOI 10.1096/fj.01-0525com; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Prevost GP, 2006, CANCER RES, V66, P9227, DOI 10.1158/0008-5472.CAN-05-4205; Rodrigues S, 2003, FASEB J, V17, P7, DOI 10.1096/fj.02-0201com; Sommer ME, 2005, J BIOL CHEM, V280, P6861, DOI 10.1074/jbc.M411341200; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Taniguchi M, 2003, J ANTIBIOT, V56, P358, DOI 10.7164/antibiotics.56.358; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; Tesmer JJG, 2006, SCIENCE, V312, P377, DOI 10.1126/science.1126903	40	57	59	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29136	29145		10.1074/jbc.M109.042333	http://dx.doi.org/10.1074/jbc.M109.042333			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19648112	Green Published, hybrid			2022-12-27	WOS:000270678900069
J	Grillari, J; Loscher, M; Denegri, M; Lee, K; Fortschegger, K; Eisenhaber, F; Ajuh, P; Lamond, AI; Katinger, H; Grillari-Voglauer, R				Grillari, Johannes; Loescher, Marlies; Denegri, Marco; Lee, Kiseok; Fortschegger, Klaus; Eisenhaber, Frank; Ajuh, Paul; Lamond, Angus I.; Katinger, Hermann; Grillari-Voglauer, Regina			Blom7 alpha Is a Novel Heterogeneous Nuclear Ribonucleoprotein K Homology Domain Protein Involved in Pre-mRNA Splicing That Interacts with SNEVPrp19-Pso4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; IN-VIVO; FUNCTIONAL-ANALYSIS; B COMPLEXES; DNA-REPAIR; HUMAN PSO4; HNRNP-K; SPLICEOSOME; IDENTIFICATION; SITE	The removal of introns from pre-mRNA is performed by the spliceosome that stepwise assembles on the pre-mRNA before performing two catalytic steps. The spliceosome-associated CDC5L-SNEVPrp19-Pso4 complex is implicated in activation of the second catalytic step of pre-mRNA splicing, and one of its members, SNEVPrp19-Pso4, is also implicated in spliceosome assembly. To identify interaction partners of SNEVPrp19-Pso4, we have performed yeast two-hybrid screenings. Among the putative binding partners was a so far uncharacterized protein carrying two heterogeneous nuclear ribonucleoprotein K homology domains that we termed Blom7 alpha. Blom7 alpha is expressed in all tissues tested, and at least three splice variants exist. After confirming direct and physical interaction of SNEV and Blom7 alpha, we investigated if it plays a functional role during pre-mRNA splicing. Indeed, Blom7 alpha co-localizes and co-precipitates with splicing factors and pre-mRNA and is present in affinity-purified spliceosomes. More importantly, addition of Blom7 alpha to HeLa nuclear extracts increased splicing activity in a dose-dependent manner. Furthermore, we tested if Blom7 alpha influences splice site selection using two different minigene constructs. Indeed, both 5'- as well as 3'-site selection was altered upon Blom7 alpha overexpression. Thus we suggest that Blom7 alpha is a novel splicing factor of the K homology domain family that might be implicated in alternative splicing by helping to position the CDC5L-SNEVPrp19-Pso4 complex at the splice sites.	[Grillari, Johannes; Loescher, Marlies; Lee, Kiseok; Fortschegger, Klaus; Katinger, Hermann; Grillari-Voglauer, Regina] Univ Nat Resources & Appl Life Sci, Inst Appl Microbiol, A-1190 Vienna, Austria; [Denegri, Marco; Ajuh, Paul; Lamond, Angus I.] Univ Dundee, Div Gene Regulat & Express, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland; [Eisenhaber, Frank] Agcy Sci Technol & Res, Bioinformat Inst, Singapore 138671, Singapore; [Eisenhaber, Frank] Natl Univ Singapore, Dept Biol Sci, Singapore 117597, Singapore; [Eisenhaber, Frank] Nanyang Technol Univ, Sch Computater Engn, Singapore 637553, Singapore	University of Natural Resources & Life Sciences, Vienna; University of Dundee; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Grillari, J (corresponding author), Univ Nat Resources & Appl Life Sci, Inst Appl Microbiol, Muthgasse 18, A-1190 Vienna, Austria.	johannes.grillari@boku.ac.at	denegri, marco/D-9307-2019; Klaus, Fortschegger/J-2222-2019; Grillari, Johannes/B-2967-2011	denegri, marco/0000-0003-1665-0625; Klaus, Fortschegger/0000-0003-1276-0368; Grillari, Johannes/0000-0001-5474-6332; Lamond, Angus/0000-0001-6204-6045; Grillari, Regina/0000-0002-5487-2838	Austrian Science Fund [S93-06]; Austrian Genome Research [820982]; Herzfelder-sche Familienstiftung; Wellcome Trust; Polymun Scientific	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Genome Research; Herzfelder-sche Familienstiftung; Wellcome Trust(Wellcome TrustEuropean Commission); Polymun Scientific	This work was supported by the Austrian Science Fund Project S93-06, by Austrian Genome Research Grant 820982 (Noncoding RNAs), by a grant from Herzfelder-sche Familienstiftung (to R. G.-V.), by Wellcome Trust, and by Polymun Scientific.	Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Ajuh P, 2003, NUCLEIC ACIDS RES, V31, P6104, DOI 10.1093/nar/gkg817; Ajuh P, 2001, J BIOL CHEM, V276, P42370, DOI 10.1074/jbc.M105453200; Backe PH, 2005, STRUCTURE, V13, P1055, DOI 10.1016/j.str.2005.04.008; Bai YD, 1999, NUCLEIC ACIDS RES, V27, P1126, DOI 10.1093/nar/27.4.1126; Beck BD, 2008, J BIOL CHEM, V283, P9023, DOI 10.1074/jbc.M800150200; Bellare P, 2008, NAT STRUCT MOL BIOL, V15, P444, DOI 10.1038/nsmb.1401; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Bohm E, 2005, J IMMUNOL METHODS, V307, P13, DOI 10.1016/j.jim.2005.08.013; Braddock DT, 2002, EMBO J, V21, P3476, DOI 10.1093/emboj/cdf352; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; CALVIO C, 1995, RNA, V1, P724; Cazalla D, 2005, MOL CELL BIOL, V25, P2969, DOI 10.1128/MCB.25.8.2969-2980.2005; CHENG SC, 1993, MOL CELL BIOL, V13, P1876, DOI 10.1128/MCB.13.3.1876; CHIARA MD, 1995, NATURE, V375, P510, DOI 10.1038/375510a0; Chmiel NH, 2006, RNA, V12, P283, DOI 10.1261/rna.2175706; Cho SY, 2007, BIOCHEM BIOPH RES CO, V364, P844, DOI 10.1016/j.bbrc.2007.10.091; Cho SY, 2007, J BIOL CHEM, V282, P2456, DOI 10.1074/jbc.M608042200; Cortes A, 1999, EMBO J, V18, P3820, DOI 10.1093/emboj/18.13.3820; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; Eisenhaber Frank, 2006, P39; Expert-Bezancon A, 2002, J BIOL CHEM, V277, P16614, DOI 10.1074/jbc.M201083200; Fortschegger K, 2007, MOL CELL BIOL, V27, P3123, DOI 10.1128/MCB.01188-06; GIBSON TJ, 1993, TRENDS BIOCHEM SCI, V18, P331, DOI 10.1016/0968-0004(93)90068-X; Gotzmann J, 2000, EXP CELL RES, V261, P166, DOI 10.1006/excr.2000.5025; Grillari J, 2000, EXP GERONTOL, V35, P187, DOI 10.1016/S0531-5565(00)00080-2; Grillari J, 2005, NUCLEIC ACIDS RES, V33, P6868, DOI 10.1093/nar/gki986; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P638, DOI 10.1093/nar/29.3.638; Hartmuth K, 2002, P NATL ACAD SCI USA, V99, P16719, DOI 10.1073/pnas.262483899; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; He LS, 2000, NUCLEIC ACIDS RES, V28, P4558, DOI 10.1093/nar/28.22.4558; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; KANAZAWA M, 1993, ENZYME PROTEIN, V47, P9, DOI 10.1159/000468650; Kent OA, 2003, J BIOL CHEM, V278, P50572, DOI 10.1074/jbc.M307976200; KONARSKA MM, 1987, CELL, V49, P763, DOI 10.1016/0092-8674(87)90614-3; KONARSKA MM, 1986, CELL, V46, P845, DOI 10.1016/0092-8674(86)90066-8; Kralovicova J, 2004, HUM MOL GENET, V13, P3189, DOI 10.1093/hmg/ddh334; Kuraoka I, 2008, J BIOL CHEM, V283, P940, DOI 10.1074/jbc.M706647200; LAMOND AI, 1987, GENE DEV, V1, P532, DOI 10.1101/gad.1.6.532; LAMOND AI, 1988, P NATL ACAD SCI USA, V85, P411, DOI 10.1073/pnas.85.2.411; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; Loscher M, 2005, BIOCHEM J, V388, P593, DOI 10.1042/BJ20041517; Lu XY, 2007, BIOCHEM BIOPH RES CO, V354, P968, DOI 10.1016/j.bbrc.2007.01.097; Mahajan KN, 2003, P NATL ACAD SCI USA, V100, P10746, DOI 10.1073/pnas.1631060100; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Min HS, 1997, GENE DEV, V11, P1023, DOI 10.1101/gad.11.8.1023; Musco G, 1996, CELL, V85, P237, DOI 10.1016/S0092-8674(00)81100-9; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Ohi MD, 2005, MOL CELL BIOL, V25, P451, DOI 10.1128/MCB.25.1.451-460.2005; Ohi MD, 2002, RNA, V8, P798, DOI 10.1017/S1355838202025050; Peled-Zehavi H, 2001, MOL CELL BIOL, V21, P5232, DOI 10.1128/MCB.21.15.5232-5241.2001; Platani M, 2000, J CELL BIOL, V151, P1561, DOI 10.1083/jcb.151.7.1561; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Ribas G, 1999, J IMMUNOL, V163, P278; Robard C, 2006, BIOCHEM J, V400, P91, DOI 10.1042/BJ20060384; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schraml E, 2008, STEM CELLS DEV, V17, P355, DOI 10.1089/scd.2007.0107; Shitashige M, 2007, GASTROENTEROLOGY, V132, P1039, DOI 10.1053/j.gastro.2007.01.007; SIEBEL CW, 1994, GENE DEV, V8, P1713, DOI 10.1101/gad.8.14.1713; Sihn CR, 2007, BIOCHEM BIOPH RES CO, V356, P175, DOI 10.1016/j.bbrc.2007.02.134; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; TARN WY, 1994, EMBO J, V13, P2421, DOI 10.1002/j.1460-2075.1994.tb06527.x; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; URLAUB H, 1995, EMBO J, V14, P4578, DOI 10.1002/j.1460-2075.1995.tb00137.x; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Voglauer R, 2006, EXP CELL RES, V312, P746, DOI 10.1016/j.yexcr.2005.11.025; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wang P, 2002, BIOCHEM BIOPH RES CO, V294, P448, DOI 10.1016/S0006-291X(02)00495-3; Wu J, 1999, J BIOL CHEM, V274, P29202, DOI 10.1074/jbc.274.41.29202; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1; ZERLER B, 1986, MOL CELL BIOL, V6, P887, DOI 10.1128/MCB.6.3.887; Zhang NX, 2005, J BIOL CHEM, V280, P40559, DOI 10.1074/jbc.M508453200	80	10	12	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29193	29204		10.1074/jbc.M109.036632	http://dx.doi.org/10.1074/jbc.M109.036632			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19641227	Green Published, hybrid			2022-12-27	WOS:000270678900074
J	Lu, X; Kang, YB				Lu, Xin; Kang, Yibin			Chemokine (C-C Motif) Ligand 2 Engages CCR2(+) Stromal Cells of Monocytic Origin to Promote Breast Cancer Metastasis to Lung and Bone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGF-LIKE LIGANDS; CHEMOATTRACTANT PROTEIN-1; MACROPHAGE RECRUITMENT; FUNCTIONAL EXPRESSION; PARATHYROID-HORMONE; ENDOTHELIAL-CELLS; MOLECULAR-CLONING; TUMOR PROGRESSION; MOUSE MACROPHAGE; IN-VIVO	Metastatic spread of cancer to distant vital organs, including lung and bone, is the overwhelming cause of breast cancer mortality and morbidity. Effective treatment of systemic metastasis relies on the identification and functional characterization of metastasis mediators to multiple organs. Overexpression of the chemokine (C-C motif) ligand 2 (CCL2) is frequently associated with advanced tumor stage and metastatic relapse in breast cancer. However, the functional mechanism of CCL2 in promoting organ-specific metastasis of breast cancer has not been rigorously investigated. Here, we used organ-specific metastatic sub-lines of the MDA-MB-231 human breast cancer cell line to demonstrate that overexpression of CCL2 promotes breast cancer metastasis to both lung and bone. Conversely, blocking CCL2 function with a neutralizing antibody reduced lung and bone metastases. The enhancement of lung and bone metastases by CCL2 was associated with increased macrophage infiltration and osteoclast differentiation, respectively. By performing functional assays with primary cells isolated from the wild type, CCL2 and CCR2 knock-out mice, we showed that tumor cell-derived CCL2 depends on its receptor CCR2 (chemokine, CC motif, receptor 2) expressed on stromal cells to exert its function in promoting macrophage recruitment and osteoclast differentiation. Overall, these data demonstrated that CCL2-expressing breast tumor cells engage CCR2(+) stromal cells of monocytic origin, including macrophages and preosteoclasts, to facilitate colonization in lung and bone. Therefore, CCL2 and CCR2 are promising therapeutic targets for simultaneously inhibiting lung and bone metastasis of breast cancer.	[Lu, Xin; Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Kang, Yibin] Canc Inst New Jersey, Breast Canc Program, New Brunswick, NJ 08903 USA; [Kang, Yibin] Princeton Univ, Champalimaud Metastasis Program, Princeton, NJ 08544 USA	Princeton University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Princeton University	Kang, YB (corresponding author), Princeton Univ, Dept Mol Biol, WA Rd,LTL 255, Princeton, NJ 08544 USA.	ykang@princeton.edu	lu, xuemin/A-8741-2011	Kang, Yibin/0000-0002-1626-6730	National Institutes of Health [R01CA134519]; Department of Defense Era of Hope Scholar Award [BC051647]; American Cancer Society Research Scholar Award [MGO-110765]; NATIONAL CANCER INSTITUTE [R01CA134519] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Era of Hope Scholar Award(United States Department of Defense); American Cancer Society Research Scholar Award(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA134519 (to Y. K.). This work was also supported by Department of Defense Era of Hope Scholar Award BC051647 and American Cancer Society Research Scholar Award RSG MGO-110765.	Aubin JE, 2000, OSTEOPOROSIS INT, V11, P905, DOI 10.1007/s001980070028; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Cai Z, 2009, NEOPLASIA, V11, P228, DOI 10.1593/neo.81282; CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752; Chvatchko Y, 2000, J EXP MED, V191, P1755, DOI 10.1084/jem.191.10.1755; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Conti I, 2004, SEMIN CANCER BIOL, V14, P149, DOI 10.1016/j.semcancer.2003.10.009; Dwyer RM, 2007, CLIN CANCER RES, V13, P5020, DOI 10.1158/1078-0432.CCR-07-0731; Fujimoto H, 2009, INT J CANCER, V125, P1276, DOI 10.1002/ijc.24378; Guise Theresa A, 2005, Clin Breast Cancer, V5 Suppl, pS46, DOI 10.3816/CBC.2005.s.004; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Karnoub Antoine E, 2006, Breast Dis, V26, P75; Kim MS, 2005, J BIOL CHEM, V280, P16163, DOI 10.1074/jbc.M412713200; Kinder M, 2008, EXP CELL RES, V314, P173, DOI 10.1016/j.yexcr.2007.09.021; Kos CH, 2003, J CLIN INVEST, V111, P1021, DOI 10.1172/JCI200317416; Kuroda T, 2005, CLIN CANCER RES, V11, P7629, DOI 10.1158/1078-0432.CCR-05-0798; Lebrecht A, 2004, TUMOR BIOL, V25, P14, DOI 10.1159/000077718; Leek RD, 1996, CANCER RES, V56, P4625; LEENEN PJM, 1994, J IMMUNOL METHODS, V174, P5, DOI 10.1016/0022-1759(94)90005-1; Li X, 2007, J BIOL CHEM, V282, P33098, DOI 10.1074/jbc.M611781200; Li X, 2009, CANCER RES, V69, P1685, DOI 10.1158/0008-5472.CAN-08-2164; Loberg RD, 2007, CANCER RES, V67, P9417, DOI 10.1158/0008-5472.CAN-07-1286; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Lu X, 2007, J MAMMARY GLAND BIOL, V12, P153, DOI 10.1007/s10911-007-9047-3; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Lu X, 2009, P NATL ACAD SCI USA, V106, P9385, DOI 10.1073/pnas.0900108106; Lu Y, 2007, INT J CANCER, V121, P724, DOI 10.1002/ijc.22704; Lu Y, 2007, CANCER RES, V67, P3646, DOI 10.1158/0008-5472.CAN-06-1210; Lu Y, 2006, PROSTATE, V66, P1311, DOI 10.1002/pros.20464; Lu Y, 2009, CLIN EXP METASTAS, V26, P161, DOI 10.1007/s10585-008-9226-7; Melgarejo E, 2009, INT J BIOCHEM CELL B, V41, P998, DOI 10.1016/j.biocel.2008.07.018; Mestdagt M, 2006, INT J CANCER, V118, P35, DOI 10.1002/ijc.21291; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nam JS, 2006, CANCER RES, V66, P7176, DOI 10.1158/0008-5472.CAN-06-0825; POWER CA, 1995, J BIOL CHEM, V270, P19495, DOI 10.1074/jbc.270.33.19495; Rollins BJ, 2006, EUR J CANCER, V42, P760, DOI 10.1016/j.ejca.2006.01.002; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Saji H, 2001, CANCER, V92, P1085, DOI 10.1002/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; SCHLAPPACK OK, 1988, KLIN WOCHENSCHR, V66, P790, DOI 10.1007/BF01726581; SIBILLE Y, 1990, AM REV RESPIR DIS, V141, P471, DOI 10.1164/ajrccm/141.2.471; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Visscher DW, 1995, PATHOL RES PRACT, V191, P1133, DOI 10.1016/S0344-0338(11)80658-8; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Zhu J, 2007, J BIOL CHEM, V282, P26656, DOI 10.1074/jbc.M705064200	57	192	200	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29087	29096		10.1074/jbc.M109.035899	http://dx.doi.org/10.1074/jbc.M109.035899			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19720836	Green Published, hybrid			2022-12-27	WOS:000270678900065
J	Fan, HC; Zhang, XM; McNaughton, PA				Fan, Hueng-Chuen; Zhang, Xuming; McNaughton, Peter A.			Activation of the TRPV4 Ion Channel Is Enhanced by Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CAPSAICIN RECEPTOR VR1; HEAT-EVOKED ACTIVATION; CATION CHANNEL; NOCICEPTIVE NEURONS; SIGNALING PATHWAYS; INFLAMMATORY PAIN; HYPERALGESIA; SENSITIZATION; MODULATION	The TRPV4 (transient receptor potential vanilloid 4) ion channel, a member of the vanilloid subfamily of the transient receptor potential channels, is activated by membrane stretch, by non-noxious warm temperatures, and by a range of chemical activators. In the present study we examined the role of phosphorylation in modulating the activation of TRPV4. We expressed TRPV4 in HEK293 cells and activated the channel by cell swelling in a hypotonic solution. TRPV4 channel activation and serine phosphorylation were enhanced by exposure to the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate or by application of bradykinin, which activates PKC via a G-protein-coupled mechanism. The enhancement was inhibited by the PKC inhibitors staurosporine, bisindolylmaleimide I, and rottlerin or by mutation of the serine/threonine residues Ser(162), Thr(175), and Ser(189). The adenylate cyclase activator forskolin also enhanced activation of TRPV4, and the enhancement was antagonized by the selective cyclic AMP-dependent protein kinase (PKA) inhibitor H89 or by mutation of serine residue Ser(824). Sensitization of TRPV4 by both PKC and PKA depended on the scaffolding protein AKAP79, because channel activation and phosphorylation were enhanced by co-transfection of AKAP79 and were antagonized by removal of AKAP79 using small interfering RNA. We conclude that the serine/threonine kinases PKC and PKA enhance activation of the TRPV4 ion channel by phosphorylation at specific sites and that phosphorylation depends on assembly of PKC and PKA by AKAP79 into a signaling complex with TRPV4.	[Fan, Hueng-Chuen; Zhang, Xuming; McNaughton, Peter A.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Fan, Hueng-Chuen] Tri Serv Gen Hosp, Dept Pediat, Taipei 11490, Taiwan; [Fan, Hueng-Chuen] Natl Def Med Ctr, Taipei 11490, Taiwan	University of Cambridge; Tri-Service General Hospital; National Defense Medical Center	McNaughton, PA (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	pam42@cam.ac.uk		McNaughton, Peter/0000-0003-1946-9610; Zhang, Xuming/0000-0002-5331-8675	Biotechnology and Biological Sciences Research Council [BB/F003072/1, BB/C003217/1] Funding Source: Medline; BBSRC [BB/F003072/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alessandri-Haber N, 2006, J NEUROSCI, V26, P3864, DOI 10.1523/JNEUROSCI.5385-05.2006; Alessandri-Haber N, 2003, NEURON, V39, P497, DOI 10.1016/S0896-6273(03)00462-8; Aley KO, 1999, J NEUROSCI, V19, P2181; Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Birder L, 2007, J PHARMACOL EXP THER, V323, P227, DOI 10.1124/jpet.107.125435; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bonnington JK, 2003, J PHYSIOL-LONDON, V551, P433, DOI 10.1113/jphysiol.2003.039990; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Cesare P, 1999, NEURON, V23, P617, DOI 10.1016/S0896-6273(00)80813-2; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Cunha FQ, 1999, BRIT J PHARMACOL, V127, P671, DOI 10.1038/sj.bjp.0702601; Delany NS, 2001, PHYSIOL GENOMICS, V4, P165, DOI 10.1152/physiolgenomics.2001.4.3.165; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; Guler AD, 2002, J NEUROSCI, V22, P6408; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Huang JJ, 2006, SEMIN CELL DEV BIOL, V17, P638, DOI 10.1016/j.semcdb.2006.11.002; Huang JH, 2006, CURR NEUROPHARMACOL, V4, P197, DOI 10.2174/157015906778019554; Kim JH, 2004, BIOINFORMATICS, V20, P3179, DOI 10.1093/bioinformatics/bth382; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Nilius B, 2001, PFLUG ARCH EUR J PHY, V443, P227, DOI 10.1007/s004240100676; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; Smith FD, 2006, TRENDS BIOCHEM SCI, V31, P316, DOI 10.1016/j.tibs.2006.04.009; Smith PL, 2006, J BIOL CHEM, V281, P29897, DOI 10.1074/jbc.M605394200; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; TAIWO YO, 1991, NEUROSCIENCE, V44, P131, DOI 10.1016/0306-4522(91)90255-M; TAIWO YO, 1989, NEUROSCIENCE, V32, P577, DOI 10.1016/0306-4522(89)90280-7; Vellani V, 2001, J PHYSIOL-LONDON, V534, P813, DOI 10.1111/j.1469-7793.2001.00813.x; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; Xu F, 2003, BRIT J PHARMACOL, V140, P413, DOI 10.1038/sj.bjp.0705443; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhang XM, 2008, NEURON, V59, P450, DOI 10.1016/j.neuron.2008.05.015; Zhou FF, 2004, BIOCHEM BIOPH RES CO, V325, P1443, DOI 10.1016/j.bbrc.2004.11.001	47	132	134	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27884	27891		10.1074/jbc.M109.028803	http://dx.doi.org/10.1074/jbc.M109.028803			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19661060	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000270676300015
J	Huet, G; Constant, P; Malaga, W; Laneelle, MA; Kremer, K; Van Soolingen, D; Daffe, M; Guilhot, C				Huet, Gaelle; Constant, Patricia; Malaga, Wladimir; Laneelle, Marie-Antoinette; Kremer, Kristin; Van Soolingen, Dick; Daffe, Mamadou; Guilhot, Christophe			A Lipid Profile Typifies the Beijing Strains of Mycobacterium tuberculosis IDENTIFICATION OF A MUTATION RESPONSIBLE FOR A MODIFICATION OF THE STRUCTURES OF PHTHIOCEROL DIMYCOCEROSATES AND PHENOLIC GLYCOLIPIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR DISSECTION; IMMUNE-RESPONSE; PHTHIOCEROL; VIRULENCE; COMPLEX; GENOTYPE; LINEAGE; PHENOLGLYCOLIPIDS; BIOSYNTHESIS; PERMEABILITY	The Mycobacterium tuberculosis Beijing strains are a family highly prevalent in Asia and have recently spread worldwide, causing a number of epidemics, suggesting that they express virulence factors not found in other M. tuberculosis strains. Accordingly, we looked for putative characteristic compounds by comparing the lipid profiles of several Beijing and non-Beijing strains. All the Beijing strains analyzed were found to synthesize structural variants of two well known characteristic lipids of the tubercle bacillus, namely phthiocerol dimycocerosates (DIM) and eventually phenolglycolipids (PGL). These variants were not found in non-Beijing M. tuberculosis isolates. Structural elucidation of these variants showed that they consist of phthiotriol and glycosylated phenolphthiotriol dimycocerosates, eventually acylated with 1 mol of palmitic acid, in addition to the conventional acylation of the beta-diol by mycocerosic acids. We demonstrated that this unusual lipid profile resulted from a single point mutation in the Rv2952 gene, which encodes the S-adenosylmethionine-dependent methyltransferase participating to the O-methylation of the third hydroxyl of the phthiotriol and phenolphthiotriol in the biosynthetic pathway of DIM and PGL. Consistently, the mutated enzyme exhibited in vitro a much lower O-methyltransferase activity than did the wild-type Rv2952. We finally demonstrated that the structural variants of DIM and PGL fulfill the same function in the cell envelope and virulence than their conventional counterparts.	[Huet, Gaelle; Constant, Patricia; Malaga, Wladimir; Laneelle, Marie-Antoinette; Daffe, Mamadou; Guilhot, Christophe] IPBS, CNRS, F-31077 Toulouse 4, France; [Huet, Gaelle; Constant, Patricia; Malaga, Wladimir; Laneelle, Marie-Antoinette; Daffe, Mamadou; Guilhot, Christophe] Univ Toulouse 3, Univ Toulouse, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France; [Kremer, Kristin; Van Soolingen, Dick] Natl Inst Publ Hlth & Environm, Natl Mycobacteria Reference Lab, NL-3720 BA Bilthoven, Netherlands	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Netherlands National Institute for Public Health & the Environment	Guilhot, C (corresponding author), IPBS, CNRS, 205 Route Narbonne, F-31077 Toulouse 4, France.	Christophe.Guilhot@ipbs.fr			Agence Nationale de la Recherche [06 MIME 037 01]; CNRS [MIE 2006]	Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported in part by Agence Nationale de la Recherche Grant 06 MIME 037 01 and CNRS Grant MIE 2006.	Barczak AK, 2005, J INFECT DIS, V192, P600, DOI 10.1086/432006; Bifani PJ, 1999, JAMA-J AM MED ASSOC, V282, P2321, DOI 10.1001/jama.282.24.2321; Bifani PJ, 1996, JAMA-J AM MED ASSOC, V275, P452, DOI 10.1001/jama.275.6.452; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Caminero JA, 2001, AM J RESP CRIT CARE, V164, P1165, DOI 10.1164/ajrccm.164.7.2101031; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Constant P, 2002, J BIOL CHEM, V277, P38148, DOI 10.1074/jbc.M206538200; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; DAFFE M, 1987, EUR J BIOCHEM, V167, P155, DOI 10.1111/j.1432-1033.1987.tb13317.x; DAFFE M, 1988, J GEN MICROBIOL, V134, P2049; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dormans J, 2004, CLIN EXP IMMUNOL, V137, P460, DOI 10.1111/j.1365-2249.2004.02551.x; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Guilhot C, 2008, MYCOBACTERIAL CELL ENVELOPE, P273; Kong Y, 2007, J CLIN MICROBIOL, V45, P409, DOI 10.1128/JCM.01459-06; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Kremer K, 2009, EMERG INFECT DIS, V15, P335, DOI 10.3201/eid1502.080795; Laval F, 2001, ANAL CHEM, V73, P4537, DOI 10.1021/ac0105181; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Malaga W, 2008, J BIOL CHEM, V283, P15177, DOI 10.1074/jbc.M710275200; Malik AN, 2005, LANCET INFECT DIS, V5, P174, DOI 10.1016/S1473-3099(05)01310-1; Manca C, 2004, INFECT IMMUN, V72, P5511, DOI 10.1128/IAI.72.9.5511-5514.2004; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Perez E, 2004, J BIOL CHEM, V279, P42584, DOI 10.1074/jbc.M406134200; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06; Simeone R, 2007, FEBS J, V274, P1957, DOI 10.1111/j.1742-4658.2007.05740.x; Sinsimer D, 2008, INFECT IMMUN, V76, P3027, DOI 10.1128/IAI.01663-07; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Tsenova L, 2005, J INFECT DIS, V192, P98, DOI 10.1086/430614; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; 2006, EMERG INF DIS, V12, P736	34	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27101	27113		10.1074/jbc.M109.041939	http://dx.doi.org/10.1074/jbc.M109.041939			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19648652	Green Published, hybrid			2022-12-27	WOS:000270232300011
J	Lee, JH; Park, H; Chung, H; Choi, S; Kim, Y; Yoo, H; Kim, TY; Hann, HJ; Seong, I; Kim, J; Kang, KG; Han, IO; Oh, ES				Lee, Jung-Hyun; Park, Haein; Chung, Heesung; Choi, Sojoong; Kim, Younghwa; Yoo, Hyun; Kim, Tae-Yoon; Hann, Hoo-Jae; Seong, Ikjoo; Kim, Jaesang; Kang, Kathleen G.; Han, Inn-Oc; Oh, Eok-Soo			Syndecan-2 Regulates the Migratory Potential of Melanoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; CUTANEOUS MALIGNANT-MELANOMA; COLON-CARCINOMA CELLS; MURINE B16 MELANOMA; STIMULATING-HORMONE; METASTATIC PHENOTYPE; TUMORIGENIC ACTIVITY; CANCER-CELLS; EXPRESSION; ALPHA	Syndecan-2, a transmembrane heparan sulfate proteoglycan, is a critical mediator in the tumorigenesis of colon carcinoma cells. We explored the function of syndecan-2 in melanoma, one of the most invasive types of cancers, and found that the expression of this protein was elevated in tissue samples from both nevus and malignant human melanomas but not in melanocytes of the normal human skin tissues. Similarly, elevated syndecan-2 expression was observed in various melanoma cell lines. Overexpression of syndecan-2 enhanced migration and invasion of melanoma cells, whereas the opposite was observed when syndecan-2 levels were knocked down using small inhibitory RNAs. Syndecan-2 expression was enhanced by fibroblast growth factor-2, which is known to stimulate melanoma cell migration; however, alpha-melanocyte-stimulating hormone decreased syndecan-2 expression and melanoma cell migration and invasion in a melanin synthesis-independent manner. Furthermore, syndecan-2 overexpression rescued the migration defects induced by alpha-melanocyte-stimulating hormone treatment. Together, these data strongly suggest that syndecan-2 plays a crucial role in the migratory potential of melanoma cells.	[Lee, Jung-Hyun; Park, Haein; Chung, Heesung; Choi, Sojoong; Seong, Ikjoo; Kim, Jaesang; Oh, Eok-Soo] Ewha Womans Univ, Dept Life Sci, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Kim, Younghwa] Yonsei Univ, Coll Med, Dept Pharmacol, Seoul 120752, South Korea; [Yoo, Hyun; Kim, Tae-Yoon] Catholic Univ Korea, Catholic Res Inst Med Sci, Seoul 137701, South Korea; [Hann, Hoo-Jae] Ewha Womans Univ, Coll Med, Dept Anat, Seoul 158710, South Korea; [Kang, Kathleen G.] Torrey Pines High Sch, San Diego, CA 92130 USA; [Han, Inn-Oc] Inha Univ, Dept Physiol & Biophys, Inchon 402751, South Korea	Ewha Womans University; Yonsei University; Yonsei University Health System; Catholic University of Korea; Ewha Womans University; Inha University	Oh, ES (corresponding author), Ewha Womans Univ, Dept Life Sci, Div Life & Pharmaceut Sci, Seoul 120750, South Korea.	OhES@ewha.ac.kr	Lee, Jung-Hyun/AAL-2954-2021	Lee, Jung-Hyun/0000-0003-1913-0027	Korea Healthcare Technology R&D Projects, Ministry for Health, Welfare, and Family Affairs, Republic of Korea [A084292]	Korea Healthcare Technology R&D Projects, Ministry for Health, Welfare, and Family Affairs, Republic of Korea	This study was supported by a grant of the Korea Healthcare Technology R&D Projects, Ministry for Health, Welfare, and Family Affairs, Republic of Korea (A084292).	Agochiya M, 1999, ONCOGENE, V18, P5646, DOI 10.1038/sj.onc.1202957; Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Bass MD, 2002, BIOCHEM J, V368, P1, DOI 10.1042/BJ20021228; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Bohm M, 2004, HAUTARZT, V55, P436, DOI 10.1007/s00105-004-0729-0; Boukerche H, 2007, CANCER RES, V67, P1812, DOI 10.1158/0008-5472.CAN-06-3875; Contreras HR, 2001, BIOCHEM BIOPH RES CO, V286, P742, DOI 10.1006/bbrc.2001.5459; DONATIEN P, 1993, ARCH DERMATOL RES, V285, P385, DOI 10.1007/BF00372130; Dorr RT, 2004, ARCH DERMATOL, V140, P827, DOI 10.1001/archderm.140.7.827; Fears CY, 2006, J BIOL CHEM, V281, P14533, DOI 10.1074/jbc.C600075200; Guan JL, 1997, MATRIX BIOL, V16, P195, DOI 10.1016/S0945-053X(97)90008-1; Hauck CR, 2001, CANCER RES, V61, P7079; Hess AR, 2005, CANCER RES, V65, P9851, DOI 10.1158/0008-5472.CAN-05-2172; Hocker TL, 2008, J INVEST DERMATOL, V128, P2575, DOI 10.1038/jid.2008.226; Jayson GC, 1999, INT J CANCER, V82, P298, DOI 10.1002/(SICI)1097-0215(19990719)82:2<298::AID-IJC23>3.3.CO;2-0; KAMEYAMA K, 1990, INT J CANCER, V45, P1151, DOI 10.1002/ijc.2910450627; Kim Y, 2003, ONCOGENE, V22, P826, DOI 10.1038/sj.onc.1206068; Kusano Y, 2000, EXP CELL RES, V256, P434, DOI 10.1006/excr.2000.4802; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; LIU PY, 1995, J DERMATOL SCI, V10, P203, DOI 10.1016/0923-1811(95)00405-H; Markovic SN, 2007, MAYO CLIN PROC, V82, P364; Meier F, 2003, EXP DERMATOL, V12, P296, DOI 10.1034/j.1600-0625.2003.120310.x; Modrowski D, 2000, J BIOL CHEM, V275, P9178, DOI 10.1074/jbc.275.13.9178; Mueller SC, 1999, J BIOL CHEM, V274, P24947, DOI 10.1074/jbc.274.35.24947; Munesue S, 2002, BIOCHEM J, V363, P201, DOI 10.1042/0264-6021:3630201; Murata J, 1997, INVAS METAST, V17, P82; Nackaerts K, 1997, INT J CANCER, V74, P335, DOI 10.1002/(SICI)1097-0215(19970620)74:3<335::AID-IJC18>3.3.CO;2-4; Nagahama M, 1998, BRIT J DERMATOL, V138, P981; Nakahara H, 1996, J BIOL CHEM, V271, P27221, DOI 10.1074/jbc.271.44.27221; OWENS LV, 1995, CANCER RES, V55, P2752; Owens LV, 1996, ANN SURG ONCOL, V3, P100, DOI 10.1007/BF02409059; Park H, 2005, CANCER RES, V65, P9899, DOI 10.1158/0008-5472.CAN-05-1386; Park H, 2002, J BIOL CHEM, V277, P29730, DOI 10.1074/jbc.M202435200; Passeron T, 2007, P NATL ACAD SCI USA, V104, P13984, DOI 10.1073/pnas.0705117104; Price ER, 1998, J BIOL CHEM, V273, P33042, DOI 10.1074/jbc.273.49.33042; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Sato K, 2008, BIOL PHARM BULL, V31, P33, DOI 10.1248/bpb.31.33; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Sebestyen A, 2000, TUMOR BIOL, V21, P349, DOI 10.1159/000030140; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Stylli SS, 2008, J CLIN NEUROSCI, V15, P725, DOI 10.1016/j.jocn.2008.03.003; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Zhu N, 2004, BRIT J CANCER, V90, P1457, DOI 10.1038/sj.bjc.6601698	43	63	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27167	27175		10.1074/jbc.M109.034678	http://dx.doi.org/10.1074/jbc.M109.034678			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19641225	Green Published, hybrid			2022-12-27	WOS:000270232300017
J	Mascarenhas, JB; Young, KP; Littlejohn, EL; Yoo, BK; Salgia, R; Lang, D				Mascarenhas, Joseph B.; Young, Kacey P.; Littlejohn, Erica L.; Yoo, Brian K.; Salgia, Ravi; Lang, Deborah			PAX6 Is Expressed in Pancreatic Cancer and Actively Participates in Cancer Progression through Activation of the MET Tyrosine Kinase Receptor Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; C-MET; PAIRED DOMAIN; UP-REGULATION; TRANSCRIPTIONAL ACTIVATION; GLIOBLASTOMA CELLS; INVASIVE GROWTH; IDENTIFICATION; PROTOONCOGENE; SUPPRESSES	Tumors of the exocrine pancreas have a poor prognosis. Several proteins are overexpressed in this cancer type, including the MET tyrosine kinase receptor and the transcription factor PAX6. In this report, we find that PAX6(5a), an alternately spliced variant form of PAX6, is expressed in pancreatic carcinoma cell lines at higher levels than the canonical PAX6 protein. Both protein forms of PAX6 bind directly to an enhancer element in the MET promoter and activate the expression of the MET gene. In addition, inhibition of PAX6 transcripts leads to a decline in cell growth and survival, differentiation, and a concurrent reduction of MET protein expression. These data support a model for a neoplastic pathway, where expression of a transcription factor from development activates the MET receptor, a protein that has been directly linked to protumorigenic processes of resisting apoptosis, tumor growth, invasion, and metastasis.	[Mascarenhas, Joseph B.; Young, Kacey P.; Littlejohn, Erica L.; Yoo, Brian K.; Salgia, Ravi; Lang, Deborah] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Lang, D (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC 5067, Chicago, IL 60637 USA.	dlang@medicine.bsd.uchicago.edu		Lang, Deborah/0000-0003-1057-0923; LITTLEJOHN, ERICA/0000-0003-3255-8546; Mascarenhas, Joseph B/0000-0002-4735-3140	National Institutes of Health [R01CA130202, R01CA100750, R01CA125541, R21CA140003]; Schweppe Foundation; University of Chicago Cancer Center Pilot Program [P30 CA014599]; NATIONAL CANCER INSTITUTE [P30CA014599, R01CA125541, R01CA100750, R01CA130202, R21CA140003] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Schweppe Foundation; University of Chicago Cancer Center Pilot Program(University of Chicago); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA130202, R01CA100750, R01CA125541, and R21CA140003. This work was also supported by the Schweppe Foundation and the University of Chicago Cancer Center Pilot Program, Grant P30 CA014599.	Azuma N, 1999, AM J HUM GENET, V65, P656, DOI 10.1086/302529; Azuma N, 2005, HUM MOL GENET, V14, P735, DOI 10.1093/hmg/ddi069; Beuret L, 2007, J BIOL CHEM, V282, P14140, DOI 10.1074/jbc.M611563200; Chauhan BK, 2004, NUCLEIC ACIDS RES, V32, P1696, DOI 10.1093/nar/gkh334; Chauhan BK, 2004, INVEST OPHTH VIS SCI, V45, P385, DOI 10.1167/iovs.03-0968; DIRENZO MF, 1995, CANCER RES, V55, P1129; Duncan MK, 2000, J CELL SCI, V113, P3173; EBERT M, 1994, CANCER RES, V54, P5775; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; EPSTEIN JA, 1994, GENE DEV, V8, P2022, DOI 10.1101/gad.8.17.2022; FURUKAWA T, 1995, AM J PATHOL, V147, P889; GAMBAROTTA G, 1994, J BIOL CHEM, V269, P12852; Gambarotta G, 1996, ONCOGENE, V13, P1911; Gentile A, 2008, CANCER METAST REV, V27, P85, DOI 10.1007/s10555-007-9107-6; Ghaneh P, 2007, GUT, V56, P1134, DOI 10.1136/gut.2006.103333; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; Jaworski C, 1997, BIOCHEM BIOPH RES CO, V240, P196, DOI 10.1006/bbrc.1997.7623; Kozmik Z, 1997, EMBO J, V16, P6793, DOI 10.1093/emboj/16.22.6793; Lang D, 2008, MOL CARCINOGEN, V47, P148, DOI 10.1002/mc.20375; Liu N, 1998, AM J PATHOL, V153, P263, DOI 10.1016/S0002-9440(10)65567-8; Mayes DA, 2006, CANCER RES, V66, P9809, DOI 10.1158/0008-5472.CAN-05-3877; Morozov VM, 2008, ONCOGENE, V27, P2177, DOI 10.1038/sj.onc.1210865; Oshima Y, 2007, GASTROENTEROLOGY, V132, P720, DOI 10.1053/j.gastro.2006.11.027; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Pinson J, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-13; Pinto GR, 2007, GENET MOL RES, V6, P1019; Qian LW, 2003, INT J CANCER, V104, P542, DOI 10.1002/ijc.10997; Radaeva S, 2002, GASTROENTEROLOGY, V122, P1020, DOI 10.1053/gast.2002.32388; Salem CE, 2000, INT J CANCER, V87, P179, DOI 10.1002/1097-0215(20000715)87:2<179::AID-IJC4>3.0.CO;2-X; Schag K, 2004, CLIN CANCER RES, V10, P3658, DOI 10.1158/1078-0432.CCR-03-0640; Seol DW, 1999, J BIOL CHEM, V274, P3565, DOI 10.1074/jbc.274.6.3565; Seol DW, 2000, ONCOGENE, V19, P1132, DOI 10.1038/sj.onc.1203404; Singh S, 2002, P NATL ACAD SCI USA, V99, P6812, DOI 10.1073/pnas.102691299; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; Stanescu D, 2007, EYE, V21, P90, DOI 10.1038/sj.eye.6702166; Stella MC, 2005, MOL CELL BIOL, V25, P3982, DOI 10.1128/MCB.25.10.3982-3996.2005; Suzuki S, 2004, DIABETES, V53, pA214, DOI 10.2337/diabetes.53.8.2143; Tsuda M, 2007, CANCER RES, V67, P919, DOI 10.1158/0008-5472.CAN-06-2855; Verras M, 2007, CANCER RES, V67, P967, DOI 10.1158/0008-5472.CAN-06-3552; Zhang XH, 2005, AM J PHYSIOL-RENAL, V288, pF16, DOI 10.1152/ajprenal.00318.2003; Zhang XH, 2003, AM J PHYSIOL-RENAL, V284, pF1216, DOI 10.1152/ajprenal.00426.2002; Zhong XF, 2007, INT J CANCER, V121, P2125, DOI 10.1002/ijc.22880; Zhou YH, 2005, J NEURO-ONCOL, V71, P223, DOI 10.1007/s11060-004-1720-4; Zhou YH, 2003, CLIN CANCER RES, V9, P3369	45	40	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27524	27532		10.1074/jbc.M109.047209	http://dx.doi.org/10.1074/jbc.M109.047209			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651775	Green Published, hybrid			2022-12-27	WOS:000270232300054
J	Wong, SW; Kwon, MJ; Choi, AMK; Kim, HP; Nakahira, K; Hwang, DH				Wong, Scott W.; Kwon, Myung-Ja; Choi, Augustine M. K.; Kim, Hong-Pyo; Nakahira, Kiichi; Hwang, Daniel H.			Fatty Acids Modulate Toll-like Receptor 4 Activation through Regulation of Receptor Dimerization and Recruitment into Lipid Rafts in a Reactive Oxygen Species-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SIGNALING PATHWAYS; CUTTING EDGE; INNATE IMMUNITY; DIFFERENTIAL MODULATION; MICROBIAL LIPOPROTEINS; INSULIN-RESISTANCE; PLASMA-MEMBRANE; TOLL-LIKE-RECEPTOR-4; MACROPHAGES	The saturated fatty acids acylated on Lipid A of lipopolysaccharide (LPS) or bacterial lipoproteins play critical roles in ligand recognition and receptor activation for Toll-like Receptor 4 (TLR4) and TLR2. The results from our previous studies demonstrated that saturated and polyunsaturated fatty acids reciprocally modulate the activation of TLR4. However, the underlying mechanism has not been understood. Here, we report for the first time that the saturated fatty acid lauric acid induced dimerization and recruitment of TLR4 into lipid rafts, however, dimerization was not observed in non-lipid raft fractions. Similarly, LPS and lauric acid enhanced the association of TLR4 with MD-2 and downstream adaptor molecules, TRIF and MyD88, into lipid rafts leading to the activation of downstream signaling pathways and target gene expression. However, docosahexaenoic acid (DHA), an n-3 polyunsaturated fatty acid, inhibited LPS- or lauric acid-induced dimerization and recruitment of TLR4 into lipid raft fractions. Together, these results demonstrate that lauric acid and DHA reciprocally modulate TLR4 activation by regulation of the dimerization and recruitment of TLR4 into lipid rafts. In addition, we showed that TLR4 recruitment to lipid rafts and dimerization were coupled events mediated at least in part by NADPH oxidase-dependent reactive oxygen species generation. These results provide a new insight in understanding the mechanism by which fatty acids differentially modulate TLR4-mediated signaling pathway and consequent inflammatory responses which are implicated in the development and progression of many chronic diseases.	[Wong, Scott W.; Kwon, Myung-Ja; Hwang, Daniel H.] USDA ARS, Western Human Nutr Res Ctr, Davis, CA 95616 USA; [Wong, Scott W.; Kwon, Myung-Ja; Hwang, Daniel H.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Choi, Augustine M. K.; Kim, Hong-Pyo; Nakahira, Kiichi] Harvard Univ, Sch Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA	United States Department of Agriculture (USDA); University of California System; University of California Davis; Harvard University; Harvard Medical School	Hwang, DH (corresponding author), USDA ARS, Western Human Nutr Res Ctr, 430 W Hlth Sci Dr, Davis, CA 95616 USA.	daniel.hwang@ars.usda.gov			National Institutes of Health [DK064007, DK41868, CA75613, HL079904, HL55330, HL6234]; United States Dept. of Agriculture (USDA) [2001-35200-10721]; American Institutes for Cancer Research [01A095Rev]; Western Human Nutrition Research Center/ARS/USDA; National Center for Research Resources, NIH [C06 RR17348-01, C06 RR12088-01]; NATIONAL CANCER INSTITUTE [R01CA075613] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017348, C06RR012088] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL055330, R01HL055330, R01HL079904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041868, R01DK064007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Dept. of Agriculture (USDA)(United States Department of Agriculture (USDA)); American Institutes for Cancer Research; Western Human Nutrition Research Center/ARS/USDA(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK064007, DK41868, and CA75613. This work was also supported by Grant 2001-35200-10721 from the United States Dept. of Agriculture (USDA), Grant 01A095Rev from the American Institutes for Cancer Research, and program funds from the Western Human Nutrition Research Center/ARS/USDA (to D. H. H.) and by NIH Grants HL079904, HL55330, and HL6234 (to A. M. K. C.). This investigation was conducted in a facility constructed with support from Research Facilities Improvement Program Grants C06 RR17348-01 and C06 RR12088-01 from the National Center for Research Resources, NIH.	Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brunn GJ, 2005, FASEB J, V19, P872, DOI 10.1096/fj.04-3211fje; Davis JE, 2008, OBESITY, V16, P1248, DOI 10.1038/oby.2008.210; Fan YY, 2004, J IMMUNOL, V173, P6151, DOI 10.4049/jimmunol.173.10.6151; Gay NJ, 2006, NAT REV IMMUNOL, V6, P693, DOI 10.1038/nri1916; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; HANADA K, 1995, J BIOL CHEM, V270, P6254, DOI 10.1074/jbc.270.11.6254; Hwang D, 2001, FASEB J, V15, P2556, DOI 10.1096/fj.01-0432com; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; KITCHENS RL, 1992, J EXP MED, V176, P485, DOI 10.1084/jem.176.2.485; KRAUSS JH, 1989, EUR J BIOCHEM, V180, P519, DOI 10.1111/j.1432-1033.1989.tb14677.x; Kwon MJ, 2006, J IMMUNOL, V177, P950, DOI 10.4049/jimmunol.177.2.950; Laroux FS, 2005, J IMMUNOL, V175, P5596, DOI 10.4049/jimmunol.175.9.5596; Lee JY, 2004, J BIOL CHEM, V279, P16971, DOI 10.1074/jbc.M312990200; Lee JY, 2003, J LIPID RES, V44, P479, DOI 10.1194/jlr.M200361-JLR200; Lee JY, 2005, BIOCHEM PHARMACOL, V70, P1231, DOI 10.1016/j.bcp.2005.07.020; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Lee JY, 2003, J BIOL CHEM, V278, P37041, DOI 10.1074/jbc.M305213200; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; MIDDLEBROOK JL, 1984, MICROBIOL REV, V48, P199, DOI 10.1128/MMBR.48.3.199-221.1984; MUNFORD RS, 1986, SCIENCE, V234, P203, DOI 10.1126/science.3529396; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Powers KA, 2006, J EXP MED, V203, P1951, DOI 10.1084/jem.20060943; QURESHI N, 1991, INFECT IMMUN, V59, P441, DOI 10.1128/IAI.59.1.441-444.1991; Saitoh S, 2004, INT IMMUNOL, V16, P961, DOI 10.1093/intimm/dxh097; Saitoh SI, 2006, CHEM REC, V6, P311, DOI 10.1002/tcr.20093; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Stulnig TM, 2001, J BIOL CHEM, V276, P37335, DOI 10.1074/jbc.M106193200; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Tao X, 2002, BIOCHEM BIOPH RES CO, V299, P216, DOI 10.1016/S0006-291X(02)02581-0; Triantafilou M, 2002, J CELL SCI, V115, P2603; Uematsu S, 2006, J MOL MED-JMM, V84, P712, DOI 10.1007/s00109-006-0084-y; UHL B, 1992, EUR J CELL BIOL, V58, P90; WOLF B, 1989, IMMUNOL LETT, V20, P121, DOI 10.1016/0165-2478(89)90096-5; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Zhang HF, 2002, FEBS LETT, V532, P171, DOI 10.1016/S0014-5793(02)03669-4; Zhao L, 2007, J BIOL CHEM, V282, P11618, DOI 10.1074/jbc.M608644200	52	380	393	3	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27384	27392		10.1074/jbc.M109.044065	http://dx.doi.org/10.1074/jbc.M109.044065			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19648648	Green Published, hybrid			2022-12-27	WOS:000270232300040
J	Bossuyt, J; Despa, S; Han, F; Hou, ZJ; Robia, SL; Lingrel, JB; Bers, DM				Bossuyt, Julie; Despa, Sanda; Han, Fei; Hou, Zhanjia; Robia, Seth L.; Lingrel, Jerry B.; Bers, Donald M.			Isoform Specificity of the Na/K-ATPase Association and Regulation by Phospholemman	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; SITE-DIRECTED MUTAGENESIS; RAT VENTRICULAR MYOCYTES; PROTEIN-KINASE-C; CARDIAC MYOCYTES; ALPHA-SUBUNIT; PUMP FUNCTION; PHOSPHOLAMBAN OLIGOMERIZATION; HEART-FAILURE; SODIUM-PUMP	Phospholemman (PLM) phosphorylation mediates enhanced Na/K-ATPase (NKA) function during adrenergic stimulation of the heart. Multiple NKA isoforms exist, and their function/regulation may differ. We combined fluorescence resonance energy transfer (FRET) and functional measurements to investigate isoform specificity of the NKA-PLM interaction. FRET was measured as the increase in the donor fluorescence (CFP-NKA-alpha 1 or CFP-NKA-alpha 2) during progressive acceptor (PLM-YFP) photobleach in HEK-293 cells. Both pairs exhibited robust FRET (maximum of 23.6 +/- 3.4% for NKA-alpha 1 and 27.5 +/- 2.5% for NKA-alpha 2). Donor fluorescence depended linearly on acceptor fluorescence, indicating a 1: 1 PLM: NKA stoichiometry for both isoforms. PLM phosphorylation induced by cAMP-dependent protein kinase and protein kinase C activation drastically reduced the FRET with both NKA isoforms. However, submaximal cAMP-dependent protein kinase activation had less effect on PLM-NKA-alpha 2 versus PLM-NKA-alpha 1. Surprisingly, ouabain virtually abolished NKA-PLM FRET but only partially reduced co-immunoprecipitation. PLM-CFP also showed FRET to PLM-YFP, but the relationship during progressive photobleach was highly nonlinear, indicating oligomers involving >= 3 monomers. Using cardiac myocytes from wild-type mice and mice where NKA-alpha 1 is ouabain-sensitive and NKA-alpha 2 is ouabain-resistant, we assessed the effects of PLM phosphorylation on NKA-alpha 1 and NKA-alpha 2 function. Isoproterenol enhanced internal Na+ affinity of both isoforms (K-1/2 decreased from 18.1 +/- 2.0 to 11.5 +/- 1.9 mM for NKA-alpha 1 and from 16.4 +/- 2.5 to 10.4 +/- 1.5 mM for NKA-alpha 2) without altering maximum transport rate (V-max). Protein kinase C activation also decreased K-1/2 for both NKA-alpha 1 and NKA-alpha 2 (to 9.4 +/- 1.0 and 9.1 +/- 1.1 mM, respectively) but increased V-max only for NKA-alpha 2 (1.9 +/- 0.4 versus 1.2 +/- 0.5 mM/min). In conclusion, PLM associates with and modulates both NKA-alpha 1 and NKA-alpha 2 in a comparable but not identical manner.	[Bossuyt, Julie; Despa, Sanda; Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Han, Fei] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Hou, Zhanjia; Robia, Seth L.] Loyola Univ Chicago, Dept Physiol, Maywood, IL 60153 USA; [Lingrel, Jerry B.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	University of California System; University of California Davis; Northwestern University; Feinberg School of Medicine; Loyola University Chicago; University System of Ohio; University of Cincinnati	Bers, DM (corresponding author), Univ Calif Davis, Dept Pharmacol, Genome Bldg 3511, Davis, CA 95616 USA.	dmbers@ucdavis.edu	Bers, Donald M/C-4507-2012	Bers, Donald/0000-0002-2237-9483; Bossuyt, Julie/0000-0001-8874-4765	National Institutes of Health [HL-30077, HL-81526]; American Heart Association [0735084N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064724, R37HL030077, R01HL106189, R01HL030077, R01HL092321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K01EB006061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-30077 and HL-81526 (to D. M. B.). This work was also supported by American Heart Association Grant 0735084N (to S. D.).	Beevers AJ, 2006, PROTEIN SCI, V15, P1127, DOI 10.1110/ps.051899406; Berry RG, 2007, CARDIOVASC RES, V73, P92, DOI 10.1016/j.cardiores.2006.11.006; Bibert S, 2008, J BIOL CHEM, V283, P476, DOI 10.1074/jbc.M705830200; Bossuyt J, 2005, CIRC RES, V97, P558, DOI 10.1161/01.RES.0000181172.27931.c3; Bossuyt J, 2006, J BIOL CHEM, V281, P32765, DOI 10.1074/jbc.M606254200; Chen LSK, 1997, GENOMICS, V41, P435, DOI 10.1006/geno.1997.4665; Clayton JC, 2005, BIOCHEMISTRY-US, V44, P17016, DOI 10.1021/bi0511383; Cornea RL, 1997, BIOCHEMISTRY-US, V36, P2960, DOI 10.1021/bi961955q; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; DeSantiago J, 2002, J MOL CELL CARDIOL, V34, P975, DOI 10.1006/jmcc.2002.2034; Despa S, 2005, CIRC RES, V97, P252, DOI 10.1161/01.RES.0000176532.97731.e5; Despa S, 2002, CIRCULATION, V105, P2543, DOI 10.1161/01.CIR.0000016701.85760.97; Despa S, 2007, AM J PHYSIOL-CELL PH, V293, pC321, DOI 10.1152/ajpcell.00597.2006; Dostanic I, 2004, J BIOL CHEM, V279, P54053, DOI 10.1074/jbc.M410737200; Dostanic I, 2003, J BIOL CHEM, V278, P53026, DOI 10.1074/jbc.M308547200; Elangovan M, 2003, METHODS, V29, P58, DOI 10.1016/S1046-2023(02)00283-9; Feschenko MS, 2003, J NEUROSCI, V23, P2161; Fuller W, 2004, FASEB J, V18, P197, DOI 10.1096/fj.03-0213fje; Gao J, 1999, J PHYSIOL-LONDON, V516, P377, DOI 10.1111/j.1469-7793.1999.0377v.x; HAN F, 2006, BIOPHYS J, V90, pA281; HAN F, 2008, BIOPHYS J, V94, pA144; Han F, 2006, CIRC RES, V99, P1376, DOI 10.1161/01.RES.0000251667.73461.fb; HENSLEY CB, 1992, AM J PHYSIOL, V262, pC484, DOI 10.1152/ajpcell.1992.262.2.C484; Hou ZJ, 2008, J BIOL CHEM, V283, P28996, DOI 10.1074/jbc.M804782200; Ishizuka N, 1996, JPN J PHYSIOL, V46, P215, DOI 10.2170/jjphysiol.46.215; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; Juhaszova M, 1997, P NATL ACAD SCI USA, V94, P1800, DOI 10.1073/pnas.94.5.1800; Kelly EM, 2008, J BIOL CHEM, V283, P12202, DOI 10.1074/jbc.M707590200; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Li M, 1999, BIOPHYS J, V76, P2587, DOI 10.1016/S0006-3495(99)77411-4; Lifshitz Y, 2006, J BIOL CHEM, V281, P15790, DOI 10.1074/jbc.M601993200; Lindzen M, 2006, J BIOL CHEM, V281, P5947, DOI 10.1074/jbc.M512063200; McDonough AA, 1996, AM J PHYSIOL-CELL PH, V270, pC1221, DOI 10.1152/ajpcell.1996.270.4.C1221; MOORMAN JR, 1995, NATURE, V377, P737, DOI 10.1038/377737a0; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Moseley AE, 2005, CELL PHYSIOL BIOCHEM, V15, P145, DOI 10.1159/000083647; PALMER CJ, 1991, J BIOL CHEM, V266, P11126; PRESTI CF, 1985, J BIOL CHEM, V260, P3860; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; PRICE EM, 1990, J BIOL CHEM, V265, P6638; Robia SL, 2005, BIOCHEMISTRY-US, V44, P4302, DOI 10.1021/bi0478446; Silverman BD, 2005, CARDIOVASC RES, V65, P93, DOI 10.1016/j.cardiores.2004.09.005; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; SWEADNER KJ, 1994, CIRC RES, V74, P669, DOI 10.1161/01.RES.74.4.669; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Swift F, 2007, CARDIOVASC RES, V75, P109, DOI 10.1016/j.cardiores.2007.03.017; Teriete P, 2007, BIOCHEMISTRY-US, V46, P6774, DOI 10.1021/bi700391b; Traaseth NJ, 2007, P NATL ACAD SCI USA, V104, P14676, DOI 10.1073/pnas.0701016104; Wang JF, 2006, J BIOL CHEM, V281, P32004, DOI 10.1074/jbc.M606876200; Yamamoto T, 2005, J MOL CELL CARDIOL, V39, P113, DOI 10.1016/j.yjmcc.2005.03.023	50	57	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26749	26757		10.1074/jbc.M109.047357	http://dx.doi.org/10.1074/jbc.M109.047357			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19638348	Green Published, hybrid			2022-12-27	WOS:000269969600056
J	Bugreev, DV; Mazina, OM; Mazin, AV				Bugreev, Dmitry V.; Mazina, Olga M.; Mazin, Alexander V.			Bloom Syndrome Helicase Stimulates RAD51 DNA Strand Exchange Activity through a Novel Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID EXCHANGES; HOMOLOGOUS RECOMBINATION; BREAK REPAIR; BRANCH MIGRATION; RECQ HELICASES; BLM HELICASE; DROSOPHILA BLM; RESECT DNA; D-LOOPS; PROTEIN	Loss or inactivation of BLM, a helicase of the RecQ family, causes Bloom syndrome, a genetic disorder with a strong predisposition to cancer. Although the precise function of BLM remains unknown, genetic data has implicated BLM in the process of genetic recombination and DNA repair. Previously, we demonstrated that BLM can disrupt the RAD51-single-stranded DNA filament that promotes the initial steps of homologous recombination. However, this disruption occurs only if RAD51 is present in an inactive ADP-bound form. Here, we investigate interactions of BLM with the active ATP-bound form of the RAD51-single-stranded DNA filament. Surprisingly, we found that BLM stimulates DNA strand exchange activity of RAD51. In contrast to the helicase activity of BLM, this stimulation does not require ATP hydrolysis. These data suggest a novel BLM function that is stimulation of the RAD51 DNA pairing. Our results demonstrate the important role of the RAD51 nucleoprotein filament conformation in stimulation of DNA pairing by BLM.	[Bugreev, Dmitry V.; Mazina, Olga M.; Mazin, Alexander V.] Drexel Univ, Dept Biochem & Mol Biol, Coll Med, Philadelphia, PA 19102 USA; [Bugreev, Dmitry V.] Russian Acad Sci, Siberian Branch, Inst Chem Biol & Fundamental Med, Novosibirsk 630090, Russia	Drexel University; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Mazin, AV (corresponding author), Drexel Univ, Dept Biochem & Mol Biol, Coll Med, 245 N 15th St,NCB,Rm 10103, Philadelphia, PA 19102 USA.	amazin@drexelmed.edu			National Institutes of Health [CA100839, MH084119]; Leukemia and Lymphoma Society Scholar Award [1054-09]; NATIONAL CANCER INSTITUTE [R56CA100839, R01CA100839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH084119] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants CA100839 and MH084119. This work was also supported by Leukemia and Lymphoma Society Scholar Award 1054-09 (to A. V. M.).	Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; Bachrati CZ, 2006, NUCLEIC ACIDS RES, V34, P2269, DOI 10.1093/nar/gkl258; Bianco P R, 1998, Front Biosci, V3, pD570; Branzei D, 2007, GENE DEV, V21, P3019, DOI 10.1101/gad.1624707; Bugreev DV, 2008, J BIOL CHEM, V283, P20231, DOI 10.1074/jbc.M801582200; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Bugreev DV, 2007, NAT STRUCT MOL BIOL, V14, P746, DOI 10.1038/nsmb1268; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; BUGREEV DV, 2006, NAT PROT; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; CHAN KL, 2007, EMBO J; Cheok CF, 2005, NUCLEIC ACIDS RES, V33, P3932, DOI 10.1093/nar/gki712; Chi P, 2007, GENE DEV, V21, P1747, DOI 10.1101/gad.1563007; CHOW SA, 1985, P NATL ACAD SCI USA, V82, P5646, DOI 10.1073/pnas.82.17.5646; Cui S, 2003, J BIOL CHEM, V278, P1424, DOI 10.1074/jbc.M209407200; Davies SL, 2007, NAT STRUCT MOL BIOL, V14, P677, DOI 10.1038/nsmb1267; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Foiani M, 2003, NATURE, V423, P234, DOI 10.1038/423234a; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; Gonzalez-Barrera S, 2003, MOL CELL, V11, P1661, DOI 10.1016/S1097-2765(03)00183-7; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; He XD, 2001, P NATL ACAD SCI USA, V98, P3024, DOI 10.1073/pnas.061028298; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Kikuchi K, 2009, J BIOL CHEM, V284, P26360, DOI 10.1074/jbc.M109.029348; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Mazina OM, 2004, J BIOL CHEM, V279, P52042, DOI 10.1074/jbc.M410244200; McVey M, 2004, P NATL ACAD SCI USA, V101, P15694, DOI 10.1073/pnas.0406157101; Mcvey M, 2007, GENETICS, V176, P1979, DOI 10.1534/genetics.106.070052; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Moens PB, 2000, J CELL SCI, V113, P663; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Petukhova GV, 2005, NAT STRUCT MOL BIOL, V12, P449, DOI 10.1038/nsmb923; Pezza RJ, 2007, GENE DEV, V21, P1758, DOI 10.1101/gad.1562907; Ralf C, 2006, J BIOL CHEM, V281, P22839, DOI 10.1074/jbc.M604268200; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Rossi MJ, 2008, J BIOL CHEM, V283, P24698, DOI 10.1074/jbc.M800839200; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Sharma S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001297; Sharma S, 2006, BIOCHEM J, V398, P319, DOI 10.1042/BJ20060450; Shim KS, 2004, J BIOL CHEM, V279, P30385, DOI 10.1074/jbc.M306066200; Sigurdsson S, 2002, J BIOL CHEM, V277, P42790, DOI 10.1074/jbc.M208004200; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Steiner WW, 1998, J BACTERIOL, V180, P6269; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; TSANG SS, 1985, BIOCHEMISTRY-US, V24, P3226, DOI 10.1021/bi00334a023; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; van Brabant AJ, 2000, ANNU REV GENOM HUM G, V1, P409, DOI 10.1146/annurev.genom.1.1.409; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Whitby MC, 2005, BIOCHEM SOC T, V33, P1451, DOI 10.1042/BST0331451; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Wu L, 2006, ANNU REV GENET, V40, P279, DOI 10.1146/annurev.genet.40.110405.090636; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Yu X, 2001, P NATL ACAD SCI USA, V98, P8419, DOI 10.1073/pnas.111005398; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	59	40	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26349	26359		10.1074/jbc.M109.029371	http://dx.doi.org/10.1074/jbc.M109.029371			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19632996	Green Published, hybrid			2022-12-27	WOS:000269969600015
J	Sobeck, A; Stone, S; Landais, I; de Graaf, B; Hoatlin, ME				Sobeck, Alexandra; Stone, Stacie; Landais, Igor; de Graaf, Bendert; Hoatlin, Maureen E.			The Fanconi Anemia Protein FANCM Is Controlled by FANCD2 and the ATR/ATM Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; XENOPUS EGG EXTRACTS; DNA-DAMAGE RESPONSE; CORE COMPLEX; ATR ACTIVATION; CHECKPOINT; REPLICATION; PHOSPHORYLATION; REPAIR; MONOUBIQUITINATION	Genomic stability requires a functional Fanconi anemia (FA) pathway composed of an upstream "core complex" (FA proteins A/B/C/E/F/G/L/M) that mediates monoubiquitination of the downstream targets FANCD2 and FANCI. Unique among FA core complex members, FANCM has processing activities toward replication-associated DNA structures, suggesting a vital role for FANCM during replication. Using Xenopus egg extracts, we analyzed the functions of FANCM in replication and the DNA damage response. xFANCM binds chromatin in a replication-dependent manner and is phosphorylated in response to DNA damage structures. Chromatin binding and DNA damage-induced phosphorylation of xFANCM are mediated in part by the downstream FA pathway protein FANCD2. Moreover, phosphorylation and chromatin recruitment of FANCM is regulated by two mayor players in the DNA damage response: the cell cycle checkpoint kinases ATR and ATM. Our results indicate that functions of FANCM are controlled by FA- and non-FA pathways in the DNA damage response.	[Sobeck, Alexandra; Stone, Stacie; Landais, Igor; de Graaf, Bendert; Hoatlin, Maureen E.] Oregon Hlth & Sci Univ, Dept Biochem, Portland, OR 97239 USA	Oregon Health & Science University	Hoatlin, ME (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem, 3181 SW Sam Jackson Pk Rd,Med Res Bldg,Rm 518, Portland, OR 97239 USA.	hoatlinm@ohsu.edu	Ittershagen, Stacie/X-7658-2019	Ittershagen, Stacie (Stone)/0000-0003-3834-176X	National Institutes of Health [HL007781, CA101690, CA112775]; American Heart Association [0725942Z]; Fanconi Anemia Research Fund; NATIONAL CANCER INSTITUTE [T32CA101690, R01CA112775] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007781] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Fanconi Anemia Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL007781 ( to S. S.), CA101690 ( to I. L.), and CA112775 ( to M. E. H.). This work was also supported by American Heart Association Grant 0725942Z ( to A. S.) and by the Fanconi Anemia Research Fund ( to M. E. H.).	Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Ball HL, 2005, J BIOL CHEM, V280, P31390, DOI 10.1074/jbc.M504961200; Bomgarden RD, 2004, J BIOL CHEM, V279, P13346, DOI 10.1074/jbc.M311098200; Centurion SA, 2000, EXP CELL RES, V260, P216, DOI 10.1006/excr.2000.4995; Cimprich KA, 2007, CELL CYCLE, V6, P2348, DOI 10.4161/cc.6.19.4755; Collis SJ, 2008, MOL CELL, V32, P313, DOI 10.1016/j.molcel.2008.10.014; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Costanzo V, 2004, PLOS BIOL, V2, P600, DOI 10.1371/journal.pbio.0020110; Costanzo V, 2001, MOL CELL, V8, P137, DOI 10.1016/S1097-2765(01)00294-5; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Freie BW, 2004, J BIOL CHEM, V279, P50986, DOI 10.1074/jbc.M407160200; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gari K, 2008, MOL CELL, V29, P141, DOI 10.1016/j.molcel.2007.11.032; Gregory RC, 2003, SEMIN CANCER BIOL, V13, P77, DOI 10.1016/S1044-579X(02)00102-5; Guervilly JH, 2008, HUM MOL GENET, V17, P679, DOI 10.1093/hmg/ddm340; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Ho GPH, 2006, MOL CELL BIOL, V26, P7005, DOI 10.1128/MCB.02018-05; Kee Y, 2009, GENE DEV, V23, P555, DOI 10.1101/gad.1761309; Kim JM, 2008, BLOOD, V111, P5215, DOI 10.1182/blood-2007-09-113092; Kim SM, 2005, J BIOL CHEM, V280, P38355, DOI 10.1074/jbc.M508673200; Lavin MF, 2007, ONCOGENE, V26, P7749, DOI 10.1038/sj.onc.1210880; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lupardus PJ, 2007, METHODS, V41, P222, DOI 10.1016/j.ymeth.2006.07.024; Lupardus PJ, 2006, MOL BIOL CELL, V17, P1559, DOI 10.1091/mbc.E05-09-0865; Lupardus PJ, 2002, GENE DEV, V16, P2327, DOI 10.1101/gad.1013502; MacDougall CA, 2007, GENE DEV, V21, P898, DOI 10.1101/gad.1522607; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Mosedale G, 2005, NAT STRUCT MOL BIOL, V12, P763, DOI 10.1038/nsmb981; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; Rosselli F, 2003, BIOCHIMIE, V85, P1175, DOI 10.1016/j.biochi.2003.11.002; Sala-Trepat M, 2000, EXP CELL RES, V260, P208, DOI 10.1006/excr.2000.4994; Shechter D, 2005, CELL CYCLE, V4, P235; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Sobeck A, 2007, MOL CELL BIOL, V27, P4283, DOI 10.1128/MCB.02196-06; Sobeck A, 2006, MOL CELL BIOL, V26, P425, DOI 10.1128/MCB.26.2.425-437.2006; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wang XZ, 2007, MOL CELL BIOL, V27, P3098, DOI 10.1128/MCB.02357-06; Xue YT, 2008, HUM MOL GENET, V17, P1641, DOI 10.1093/hmg/ddn054; Yoo HY, 2006, GENE DEV, V20, P772, DOI 10.1101/gad.1398806; Zhu WG, 2006, MOL CELL BIOL, V26, P4601, DOI 10.1128/MCB.02141-05; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	47	34	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25560	25568		10.1074/jbc.M109.007690	http://dx.doi.org/10.1074/jbc.M109.007690			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19633289	hybrid, Green Published			2022-12-27	WOS:000269738000013
J	Campbell, ZT; Baldwin, TO				Campbell, Zachary T.; Baldwin, Thomas O.			Two Lysine Residues in the Bacterial Luciferase Mobile Loop Stabilize Reaction Intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; VIBRIO-HARVEYI; REDUCED FLAVIN; BIOLUMINESCENCE REACTION; NUCLEOTIDE-SEQUENCE; UNSTRUCTURED LOOP; CRYSTAL-STRUCTURE; LUX REGULON; MECHANISM; SUBUNIT	Bacterial luciferase catalyzes the reaction of FMNH2, O-2, and a long chain aliphatic aldehyde, yielding FMN, carboxylic acid, and blue-green light. The most conserved contiguous region of the primary sequence corresponds to a crystallographically disordered loop adjacent to the active center (Fisher, A. J., Raushel, F. M., Baldwin, T. O., and Rayment, I. (1995) Biochemistry 34, 6581-6586; Fisher, A. J., Thompson, T. B., Thoden, J. B., Baldwin, T. O., and Rayment, I. (1996) J. Biol. Chem. 271, 2195621968). Deletion of the mobile loop does not alter the chemistry of the reaction but decreases the total quantum yield of bioluminescence by 2 orders of magnitude (Sparks, J. M., and Baldwin, T. O. (2001) Biochemistry 40, 15436-15443). In this study, we attempt to localize the loss of activity observed in the loop deletion mutant to individual residues in the mobile loop. Using alanine mutagenesis, the effects of substitution at 15 of the 29 mobile loop residues were examined. Nine of the point mutants had reduced activity in vivo. Two mutations, K283A and K286A, resulted in a loss in quantum yield comparable with that of the loop deletion mutant. The bioluminescence emission spectrum of both mutants was normal, and both yielded the carboxylic acid chemical product at the same efficiency as the wild-type enzyme. Substitution of Lys(283) with alanine resulted in destabilization of intermediate II, whereas mutation of Lys(286) had an increase in exposure of reaction intermediates to a dynamic quencher. Based on a model of the enzyme-reduced flavin complex, the two critical lysine residues are adjacent to the quininoidal edge of the isoalloxazine.	[Baldwin, Thomas O.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Campbell, Zachary T.] Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA	University of California System; University of California Riverside; University of Arizona	Baldwin, TO (corresponding author), Coll Nat & Agr Sci, 900 Univ Ave,302 Coll Bldg N, Riverside, CA 92521 USA.	thomas.baldwin@ucr.edu		Campbell, Zachary/0000-0002-3768-6996				ABUSOUD HM, 1993, J BIOL CHEM, V268, P7699; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BALDWIN TO, 1989, J BIOLUM CHEMILUM, V4, P326, DOI 10.1002/bio.1170040145; BALDWIN TO, 1992, CHEM BIOCH FLAVOENZY, P467; BALNY C, 1975, BIOCHEMISTRY-US, V14, P4719, DOI 10.1021/bi00692a024; BANNER DW, 1975, NATURE, V255, P609, DOI 10.1038/255609a0; Campbell ZT, 2009, BIOCHEMISTRY-US, V48, P6085, DOI 10.1021/bi900003t; Campbell ZT, 2009, J BIOL CHEM, V284, P8322, DOI 10.1074/jbc.M808977200; CHEN LH, 1989, BIOCHEMISTRY-US, V28, P2684, DOI 10.1021/bi00432a048; CLINE TW, 1974, J BIOL CHEM, V249, P4668; CLINE TW, 1972, BIOCHEMISTRY-US, V11, P3359, DOI 10.1021/bi00768a008; COHN DH, 1985, J BIOL CHEM, V260, P6139; DEVINE JH, 1989, P NATL ACAD SCI USA, V86, P5688, DOI 10.1073/pnas.86.15.5688; EBERHARD A, 1972, BIOCHEM BIOPH RES CO, V47, P348, DOI 10.1016/0006-291X(72)90719-X; FARBER GK, 1990, TRENDS BIOCHEM SCI, V15, P228, DOI 10.1016/0968-0004(90)90035-A; Fisher AJ, 1996, J BIOL CHEM, V271, P21956, DOI 10.1074/jbc.271.36.21956; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P6581, DOI 10.1021/bi00020a002; Francisco WA, 1998, BIOCHEMISTRY-US, V37, P2596, DOI 10.1021/bi972266x; FRIEDLAND J, 1967, P NATL ACAD SCI USA, V58, P2336, DOI 10.1073/pnas.58.6.2336; GIBSON QH, 1962, BIOCHEM J, V83, P368, DOI 10.1042/bj0830368; Gordon S, 1998, METH MOL B, V101, P235, DOI 10.1385/0-89603-471-2:235; HASTINGS JW, 1969, BIOCHEMISTRY-US, V8, P4681, DOI 10.1021/bi00840a004; HASTINGS JW, 1973, P NATL ACAD SCI USA, V70, P3468, DOI 10.1073/pnas.70.12.3468; Hastings JW., 1978, METHOD ENZYMOL, V57, P135; HOLZMAN TF, 1980, P NATL ACAD SCI-BIOL, V77, P6363, DOI 10.1073/pnas.77.11.6363; Hosseinkhani S, 2005, BIOCHEM J, V385, P575, DOI 10.1042/BJ20040863; Huang SQ, 1998, BIOCHEMISTRY-US, V37, P8614, DOI 10.1021/bi985039j; Jeffers CE, 2003, BIOCHEMISTRY-US, V42, P529, DOI 10.1021/bi026877n; KASHA M, 1952, J CHEM PHYS, V20, P71, DOI 10.1063/1.1700199; LAKOWICZ JR, 2008, J BIOMED OPT, V13, P215; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lei BF, 1998, BIOCHEMISTRY-US, V37, P14623, DOI 10.1021/bi981841+; Lin LYC, 2004, BIOCHEMISTRY-US, V43, P3183, DOI 10.1021/bi030227h; Lin LYC, 2002, BIOCHEMISTRY-US, V41, P9938, DOI 10.1021/bi020295o; Lin LYC, 2001, PROTEIN SCI, V10, P1563, DOI 10.1110/ps.7201; LIU Y, 1995, J BACTERIOL, V177, P2080, DOI 10.1128/jb.177.8.2080-2086.1995; Low JC, 2002, BIOCHEMISTRY-US, V41, P1724, DOI 10.1021/bi011958p; MCELROY WD, 1953, SCIENCE, V118, P385, DOI 10.1126/science.118.3066.385; MEIGHEN EA, 1980, J BIOL CHEM, V255, P1181; MITCHELL GW, 1971, ANAL BIOCHEM, V39, P243, DOI 10.1016/0003-2697(71)90481-7; Moore C, 1999, ARCH BIOCHEM BIOPHYS, V370, P45, DOI 10.1006/abbi.1999.1379; NICOLI MZ, 1974, J BIOL CHEM, V249, P2385; RAUSHEL FM, 1989, BIOCHEM BIOPH RES CO, V164, P1137, DOI 10.1016/0006-291X(89)91787-7; SAMPSON NS, 1992, BIOCHEMISTRY-US, V31, P8488, DOI 10.1021/bi00151a015; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SINCLAIR JF, 1993, BIOCHEMISTRY-US, V32, P5036, DOI 10.1021/bi00070a010; SIROKMAN G, 1995, BIOCHEMISTRY-US, V34, P13074, DOI 10.1021/bi00040a019; Sparks JM, 2001, BIOCHEMISTRY-US, V40, P15436, DOI 10.1021/bi0111855; Sterner R, 2004, SCIENCE, V304, P1916, DOI 10.1126/science.1100482; Sullivan SM, 2008, P NATL ACAD SCI USA, V105, P13829, DOI 10.1073/pnas.0805364105; TU S, 1975, BIOCHEMISTRY-US, V14, P4310, DOI 10.1021/bi00690a027; Tu SC, 2001, ANTIOXID REDOX SIGN, V3, P881, DOI 10.1089/15230860152665046; TU SC, 1982, J BIOL CHEM, V257, P3719; TU SC, 1979, BIOCHEMISTRY-US, V18, P5940, DOI 10.1021/bi00593a028; Tu SC, 2000, J NUTR, V130, p331S, DOI 10.1093/jn/130.2.331S; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	57	17	17	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32827	32834		10.1074/jbc.M109.031716	http://dx.doi.org/10.1074/jbc.M109.031716			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19710008	Green Published, hybrid			2022-12-27	WOS:000272028400067
J	Wang, H; Hu, LP; Dalen, K; Dorward, H; Marcinkiewicz, A; Russell, D; Gong, DW; Londos, C; Yamaguchi, T; Holm, C; Rizzo, MA; Brasaemle, D; Sztalryd, C				Wang, Hong; Hu, Liping; Dalen, Knut; Dorward, Heidi; Marcinkiewicz, Amy; Russell, Deanna; Gong, Dawei; Londos, Constantine; Yamaguchi, Tomohiro; Holm, Cecilia; Rizzo, Mark A.; Brasaemle, Dawn; Sztalryd, Carole			Activation of Hormone-sensitive Lipase Requires Two Steps, Protein Phosphorylation and Binding to the PAT-1 Domain of Lipid Droplet Coat Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; FLUORESCENCE POLARIZATION MICROSCOPY; A-MEDIATED LIPOLYSIS; PERILIPIN-A; ENDOPLASMIC-RETICULUM; STIMULATED LIPOLYSIS; ADIPOCYTE LIPOLYSIS; 3T3-L1 ADIPOCYTES; STORAGE DROPLET; ALPHA-SYNUCLEIN	Lipolysis is an important metabolic pathway controlling energy homeostasis through degradation of triglycerides stored in lipid droplets and release of fatty acids. Lipid droplets of mammalian cells are coated with one or more members of the PAT protein family, which serve important functions in regulating lipolysis. In this study, we investigate the mechanisms by which PAT family members, perilipin A, adipose differentiation-related protein (ADFP), and LSDP5, control lipolysis catalyzed by hormone-sensitive lipase (HSL), a major lipase in adipocytes and several non-adipose cells. We applied fluorescence microscopic tools to analyze proteins in situ in cultured Chinese hamster ovary cells using fluorescence recovery after photo-bleaching and anisotropy Forster resonance energy transfer. Fluorescence recovery after photobleaching data show that ADFP and LSDP5 exchange between lipid droplet and cytoplasmic pools, whereas perilipin A does not. Differences in protein mobility do not correlate with PAT protein-mediated control of lipolysis catalyzed by HSL or endogenous lipases. Forster resonance energy transfer and co-immunoprecipitation experiments reveal that each of the three PAT proteins bind HSL through interaction of the lipase with amino acids within the highly conserved amino-terminal PAT-1 domain. ADFP and LSDP5 bind HSL under basal conditions, whereas phosphorylation of serine residues within three amino-terminal protein kinase A consensus sequences of perilipin A is required for HSL binding and maximal lipolysis. Finally, protein kinase A-mediated phosphorylation of HSL increases lipolysis in cells expressing ADFP or LSDP5; in contrast, phosphorylation of perilipin A exerts the major control over HSL-mediated lipolysis when perilipin is the main lipid droplet protein.	[Wang, Hong; Hu, Liping; Gong, Dawei; Sztalryd, Carole] Univ Maryland, Sch Med, Dept Med, Div Endocrinol, Baltimore, MD 21201 USA; [Wang, Hong; Hu, Liping; Sztalryd, Carole] Univ Maryland, Sch Med, Baltimore Vet Affairs Hlth Care Ctr, Geriatr Res Educ & Clin Ctr, Baltimore, MD 21201 USA; [Dalen, Knut; Dorward, Heidi; Londos, Constantine; Rizzo, Mark A.] NIDDK, Cellular & Dev Biol Lab, NIH, Bethesda, MD 20892 USA; [Marcinkiewicz, Amy; Russell, Deanna; Brasaemle, Dawn] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA; [Holm, Cecilia] Lund Univ, Dept Expt Med Sci, SE-22184 Lund, Sweden; [Rizzo, Mark A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Yamaguchi, Tomohiro] Hyogo Med Univ, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan	University System of Maryland; University of Maryland Baltimore; Geriatric Research Education & Clinical Center; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Rutgers State University New Brunswick; Lund University; University System of Maryland; University of Maryland Baltimore; University of Hyogo	Sztalryd, C (corresponding author), Univ Maryland, Sch Med, Dept Med, Div Endocrinol, Rm 445,Howard Hall,660 W Redwood St, Baltimore, MD 21201 USA.	csztalry@grecc.umaryland.edu	Gong, Dawei/AAB-4283-2020; Dalen, Knut Tomas/C-4719-2016	Dalen, Knut Tomas/0000-0002-0270-5982; Russell, Deanna/0000-0002-9650-2309; Brasaemle, Dawn/0000-0002-8553-8285	National Institutes of Health [RO1 DK075017, RO1 DK054797]; NIDDK Intramural Research Programs; American Diabetes Association [1-05-CD-17]; Geriatric Research, Education, and Clinical Center, Baltimore Veterans Affairs Health Care Center; Clinical Nutrition Research Unit of Maryland [DK072488]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK015615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK Intramural Research Programs; American Diabetes Association(American Diabetes Association); Geriatric Research, Education, and Clinical Center, Baltimore Veterans Affairs Health Care Center; Clinical Nutrition Research Unit of Maryland; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK075017 (to C. S.) and RO1 DK054797 (to D. L. B.) and NIDDK Intramural Research Programs. This work was also supported by Career Development Award 1-05-CD-17 from the American Diabetes Association (to C. S.), the Geriatric Research, Education, and Clinical Center, Baltimore Veterans Affairs Health Care Center, and the Clinical Nutrition Research Unit of Maryland Grant DK072488.	BECKER TC, 1994, METHOD CELL BIOL, V43, P161; BELFRAGE P, 1977, FEBS LETT, V75, P259, DOI 10.1016/0014-5793(77)80099-9; Bell M, 2008, DIABETES, V57, P2037, DOI 10.2337/db07-1383; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Brasaemle DL, 1997, J BIOL CHEM, V272, P9378; Bussell R, 2005, PROTEIN SCI, V14, P862, DOI 10.1110/ps.041255905; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Contreras JA, 1998, PROTEIN EXPRES PURIF, V12, P93, DOI 10.1006/prep.1997.0821; Dalen KT, 2007, BBA-MOL CELL BIOL L, V1771, P210, DOI 10.1016/j.bbalip.2006.11.011; EGAN JJ, 1992, P NATL ACAD SCI USA, V89, P8537, DOI 10.1073/pnas.89.18.8537; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Garcia A, 2003, J BIOL CHEM, V278, P625, DOI 10.1074/jbc.M206602200; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Krintel C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003756; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Miura S, 2002, J BIOL CHEM, V277, P32253, DOI 10.1074/jbc.M204410200; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Miyoshi H, 2006, J BIOL CHEM, V281, P15837, DOI 10.1074/jbc.M601097200; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; Osterlund T, 1996, BIOCHEM J, V319, P411, DOI 10.1042/bj3190411; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; Piston DW, 2008, METHOD CELL BIOL, V85, P415, DOI 10.1016/S0091-679X(08)85018-2; Prats C, 2006, J LIPID RES, V47, P2392, DOI 10.1194/jlr.M600247-JLR200; Rizzo MA, 2005, BIOPHYS J, V88, pL14, DOI 10.1529/biophysj.104.055442; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; SHEN WJ, 2009, J LIPID RES IN PRESS; Souza SC, 2002, J BIOL CHEM, V277, P8267, DOI 10.1074/jbc.M108329200; Su CL, 2003, J BIOL CHEM, V278, P43615, DOI 10.1074/jbc.M301809200; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Sztalryd C, 2006, J BIOL CHEM, V281, P34341, DOI 10.1074/jbc.M602497200; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Tansey JT, 2003, J BIOL CHEM, V278, P8401, DOI 10.1074/jbc.M211005200; Wu CC, 2000, ELECTROPHORESIS, V21, P3470, DOI 10.1002/1522-2683(20001001)21:16<3470::AID-ELPS3470>3.3.CO;2-7; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	44	122	126	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32116	32125		10.1074/jbc.M109.006726	http://dx.doi.org/10.1074/jbc.M109.006726			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19717842	Green Published, hybrid			2022-12-27	WOS:000271572700066
J	Khoo, KH; Mayer, S; Fersht, AR				Khoo, Kian Hoe; Mayer, Sebastian; Fersht, Alan R.			Effects of Stability on the Biological Function of p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR P53; COOPERATIVE DNA-BINDING; CORE DOMAIN; CANCER MUTATIONS; MUTANT P53; THERMODYNAMIC STABILITY; PROTEASOMAL DEGRADATION; ENHANCED STABILITY; STRUCTURAL BASIS; IN-VITRO	The core domain of the tumor suppressor p53 has low thermodynamic stability, and many oncogenic mutations cause it to denature rapidly at body temperature. We made a series of core domain mutants that are significantly less or more stable than wild type to investigate effects of stability on the transcriptional activity and levels of native full-length p53 in H1299 mammalian cells. The levels of transcriptionally inactive native protein with inactivating mutations in the N-terminal transactivation domain correlated strongly with stability. The levels of transcriptionally active proteins, however, depended on both their stability and the transcriptional activity that leads to the feedback loop of proteolytic degradation via transcription of E3 ligases. A very highly stabilized quadruple mutant and an even more stable hexamutant were more active than wild-type p53 in terms of Bax transcription and apoptotic activity, and reached higher levels than wild type in cells. The increased activity did not result from increased overall stability but was due to a single known suppressor mutation, N239Y. It is possible that the low intrinsic stability of p53 is a means of keeping its level low in the cell by spontaneous denaturation, by a route additional to that of proteolytic degradation via E3 ligase pathways. Denatured p53 does accumulate in cells, and there are pathways for the proteolysis of denatured proteins.	[Khoo, Kian Hoe; Mayer, Sebastian; Fersht, Alan R.] MRC, Ctr Prot Engn, Cambridge CB2 2QH, England	University of Cambridge	Fersht, AR (corresponding author), MRC, Ctr Prot Engn, Hills Rd, Cambridge CB2 2QH, England.	arf25@cam.ac.uk	Fersht, Alan R/B-2189-2008		Medical Research Council; Cancer Research UK; EC; Medical Research Council [MC_U105474168] Funding Source: researchfish; MRC [MC_U105474168] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); EC(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by the Medical Research Council and Cancer Research UK and EC FP6 funding.	Ang HC, 2006, J BIOL CHEM, V281, P21934, DOI 10.1074/jbc.M604209200; Asher G, 2005, CELL CYCLE, V4, P1015, DOI 10.4161/cc.4.8.1900; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Brachmann RK, 1998, EMBO J, V17, P1847, DOI 10.1093/emboj/17.7.1847; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Canadillas JMP, 2006, P NATL ACAD SCI USA, V103, P2109, DOI 10.1073/pnas.0510941103; Candau R, 1997, ONCOGENE, V15, P807, DOI 10.1038/sj.onc.1201244; David DC, 2002, J NEUROCHEM, V83, P176, DOI 10.1046/j.1471-4159.2002.01137.x; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Friedler A, 2003, J BIOL CHEM, V278, P24108, DOI 10.1074/jbc.M302458200; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Issaeva N, 2003, P NATL ACAD SCI USA, V100, P13303, DOI 10.1073/pnas.1835733100; Joerger AC, 2004, J BIOL CHEM, V279, P1291, DOI 10.1074/jbc.M309732200; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Joerger AC, 2006, P NATL ACAD SCI USA, V103, P15056, DOI 10.1073/pnas.0607286103; Khoo KH, 2009, PROTEIN ENG DES SEL, V22, P421, DOI 10.1093/protein/gzp018; Klein C, 2001, J BIOL CHEM, V276, P37390, DOI 10.1074/jbc.M103801200; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Levrero M, 2000, J CELL SCI, V113, P1661; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; MARINE JC, 2009, CELL DEATH IN PRESS; MAYER S, 2006, THESIS U CAMBRIDGE; Mayer S, 2007, J MOL BIOL, V372, P268, DOI 10.1016/j.jmb.2007.06.044; Menendez D, 2006, MOL CELL BIOL, V26, P2297, DOI 10.1128/MCB.26.6.2297-2308.2006; Nikolova PV, 2000, EMBO J, V19, P370, DOI 10.1093/emboj/19.3.370; Nikolova PV, 1998, P NATL ACAD SCI USA, V95, P14675, DOI 10.1073/pnas.95.25.14675; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Patel S, 2008, BIOCHEMISTRY-US, V47, P3235, DOI 10.1021/bi7023207; Tang KS, 1999, J MOL BIOL, V285, P1869, DOI 10.1006/jmbi.1998.2420; Tidow H, 2007, P NATL ACAD SCI USA, V104, P12324, DOI 10.1073/pnas.0705069104; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Venot C, 1999, ONCOGENE, V18, P2405, DOI 10.1038/sj.onc.1202539; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103; ZHANG W, 1994, EMBO J, V13, P2535, DOI 10.1002/j.1460-2075.1994.tb06543.x; Zhu JH, 1998, J BIOL CHEM, V273, P13030, DOI 10.1074/jbc.273.21.13030	44	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30974	30980		10.1074/jbc.M109.033183	http://dx.doi.org/10.1074/jbc.M109.033183			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19700401	hybrid, Green Published			2022-12-27	WOS:000271378400027
J	van Tetering, G; van Diest, P; Verlaan, I; van der Wall, E; Kopan, R; Vooijs, M				van Tetering, Geert; van Diest, Paul; Verlaan, Ingrid; van der Wall, Elsken; Kopan, Raphael; Vooijs, Marc			Metalloprotease ADAM10 Is Required for Notch1 Site 2 Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; GAMMA-SECRETASE INHIBITORS; ACUTE LYMPHOBLASTIC-LEUKEMIA; PROTEOLYTIC ACTIVATION; THYMOCYTE DEVELOPMENT; SIGNAL-TRANSDUCTION; REGULATORY REGION; DROSOPHILA NOTCH; MAMMALIAN NOTCH; LIGAND	Notch signaling is controlled by ligand binding, which unfolds a negative control region to induce proteolytic cleavage of the receptor. First, a membrane-proximal cleavage is executed by a metalloprotease, removing the extracellular domain. This allows gamma-secretase to execute a second cleavage within the Notch transmembrane domain, which releases the intracellular domain to enter the nucleus. Here we show that the ADAM10 metalloprotease Kuzbanian, but not ADAM17/tumor necrosis factor alpha-converting enzyme, plays an essential role in executing ligand-induced extracellular cleavage at site 2 (S2) in cells and localizes this step to the plasma membrane. Importantly, genetic or pharmacological inhibition of metalloproteases still allowed extracellular cleavage of Notch, indicating the presence of unknown proteases with the ability to cleave at S2. Gain of function mutations identified in human cancers and in model organisms that map to the negative control region alleviate the requirement for ligand binding for extracellular cleavage to occur. Because cancer-causing Notch1 mutations also depend on (rate-limiting) S2 proteolysis, the identity of these alternative proteases has important implications for understanding Notch activation in normal and cancer cells.	Univ Med Ctr Utrecht, Dept Pathol, NL-3584 CX Utrecht, Netherlands; [van der Wall, Elsken] Univ Med Ctr Utrecht, Dept Internal Med & Dermatol, NL-3584 CX Utrecht, Netherlands; [Kopan, Raphael] Washington Univ, Dept Mol Biol & Pharmacol, Sch Med, St Louis, MO 63110 USA	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Washington University (WUSTL)		m.vooijs@umcutrecht.nl	Kopan, Raphael/AFG-3275-2022; Kopan, Raphael/AAF-1357-2022; Vooijs, Marc/K-3522-2019	Kopan, Raphael/0000-0002-0350-2730	National Institutes of Health [GM55479]; Dutch Cancer Society [KWF UU2006-3623]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG013956, R01AG013956] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Cancer Society(KWF Kankerbestrijding); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant GM55479 (to R. K.) and by Dutch Cancer Society Grant KWF UU2006-3623 (to M. V. and G. v. T.).	Arribas J, 1996, J BIOL CHEM, V271, P11376, DOI 10.1074/jbc.271.19.11376; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; DE SB, 1999, NATURE, V398, P518; Delwig A, 2008, CELL MOL LIFE SCI, V65, P2232, DOI 10.1007/s00018-008-8127-x; Dontje W, 2006, BLOOD, V107, P2446, DOI 10.1182/blood-2005-05-2090; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Girard L, 1996, GENE DEV, V10, P1930, DOI 10.1101/gad.10.15.1930; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Gordon WR, 2009, BLOOD, V113, P4381, DOI 10.1182/blood-2008-08-174748; GREENWALD I, 1990, NATURE, V346, P197, DOI 10.1038/346197a0; Groot AJ, 2008, CELL ONCOL, V30, P397, DOI 10.3233/CLO-2008-0442; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Jarriault S, 2005, DEV BIOL, V287, P1, DOI 10.1016/j.ydbio.2005.08.014; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; Karlstrom H, 2002, J BIOL CHEM, V277, P6763, DOI 10.1074/jbc.C100649200; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; LaVoie MJ, 2003, J BIOL CHEM, V278, P34427, DOI 10.1074/jbc.M302659200; Li K, 2008, J BIOL CHEM, V283, P8046, DOI 10.1074/jbc.M800170200; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; Luty WH, 2007, J IMMUNOL, V179, P819, DOI 10.4049/jimmunol.179.2.819; Malecki MJ, 2006, MOL CELL BIOL, V26, P4642, DOI 10.1128/MCB.01655-05; Manilay JO, 2005, J IMMUNOL, V174, P6732, DOI 10.4049/jimmunol.174.11.6732; Merlos-Suarez A, 1998, J BIOL CHEM, V273, P24955, DOI 10.1074/jbc.273.38.24955; Merlos-Suarez A, 2001, J BIOL CHEM, V276, P48510, DOI 10.1074/jbc.M103488200; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Mishra-Gorur K, 2002, J CELL BIOL, V159, P313, DOI 10.1083/jcb.200203117; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Okochi M, 2002, EMBO J, V21, P5408, DOI 10.1093/emboj/cdf541; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Qi HL, 1999, SCIENCE, V283, P91, DOI 10.1126/science.283.5398.91; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Real PJ, 2009, NAT MED, V15, P50, DOI 10.1038/nm.1900; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sanchez-Irizarry C, 2004, MOL CELL BIOL, V24, P9265, DOI 10.1128/MCB.24.21.9265-9273.2004; Sapir A, 2005, DEVELOPMENT, V132, P123, DOI 10.1242/dev.01546; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Six E, 2003, P NATL ACAD SCI USA, V100, P7638, DOI 10.1073/pnas.1230693100; Sotillos S, 1997, DEVELOPMENT, V124, P4769; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Tagami S, 2008, MOL CELL BIOL, V28, P165, DOI 10.1128/MCB.00863-07; Tian L, 2008, INT IMMUNOL, V20, P1181, DOI 10.1093/intimm/dxn076; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Vooijs M, 2004, J BIOL CHEM, V279, P50864, DOI 10.1074/jbc.M409430200; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wilson A, 2006, FEBS LETT, V580, P2860, DOI 10.1016/j.febslet.2006.03.024	57	193	197	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31018	31027		10.1074/jbc.M109.006775	http://dx.doi.org/10.1074/jbc.M109.006775			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19726682	Green Published, hybrid			2022-12-27	WOS:000271378400031
J	Mikels, A; Minami, Y; Nusse, R				Mikels, Amanda; Minami, Yasuhiro; Nusse, Roel			Ror2 Receptor Requires Tyrosine Kinase Activity to Mediate Wnt5A Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRACHYDACTYLY TYPE-B; RECESSIVE ROBINOW-SYNDROME; MOUSE DEVELOPMENT; INSULIN-RECEPTOR; ENDOPLASMIC-RETICULUM; CELL POLARITY; PATHWAY; EXPRESSION; DISEASE; PHOSPHORYLATION	The Wnts include a large family of secreted proteins that serve as important signals during embryonic development and adult homeostasis. In the most well understood Wnt signaling pathway, Wnt binding to Frizzled and low density lipoprotein receptor-related protein induces beta-catenin protein stabilization and entry into the nucleus, resulting in changes in target gene transcription. Emerging evidence suggests that Wnt5a can inhibit Wnt/beta-catenin signaling through interaction with the receptor Ror2. The Ror2 protein belongs to the receptor tyrosine kinase superfamily and contains several recognizable structural motifs. However, limited information is available regarding which specific domains are required for the inhibitory signaling activity of Wnt5a. Through mutation and deletion analysis, we have analyzed which specific domains and residues, including those necessary for tyrosine kinase activity, mediate the Wnt5a signal. To determine whether Ror2 can inhibit canonical Wnt signaling in vivo, we examined the effect of Ror2 loss on the expression of the Wnt reporter Axin2(LacZ), finding increased reporter activity in Ror2 null mice, demonstrating that Ror2 can also inhibit Wnt/beta-catenin signaling in the context of intact tissues.	[Nusse, Roel] Stanford Univ, Beckman Ctr, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Mikels, Amanda; Nusse, Roel] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Minami, Yasuhiro] Kobe Univ, Fac Med Sci, Dept Physiol & Cell Biol, Chuo Ku, Kobe, Hyogo 6500017, Japan	Stanford University; Howard Hughes Medical Institute; Stanford University; Kobe University	Nusse, R (corresponding author), Stanford Univ, Beckman Ctr, Sch Med, Dept Dev Biol, 279 Campus Dr, Stanford, CA 94305 USA.	rnusse@stanford.edu			Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by the Howard Hughes Medical Institute.	Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; Afzal AR, 2003, HUM MUTAT, V22, P1, DOI 10.1002/humu.10233; Akbarzadeh S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001873; Al-Shawi R, 2001, DEV GENES EVOL, V211, P161, DOI 10.1007/s004270100140; Ali BR, 2007, HUM GENET, V122, P389, DOI 10.1007/s00439-007-0409-0; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; DeChiara TM, 2000, NAT GENET, V24, P271, DOI 10.1038/73488; Forrester WC, 2004, GENETICS, V168, P1951, DOI 10.1534/genetics.104.031781; Forrester WC, 2002, CELL MOL LIFE SCI, V59, P83, DOI 10.1007/s00018-002-8407-9; Fox S, 2006, FRONT BIOSCI-LANDMRK, V11, P2106, DOI 10.2741/1953; Green JL, 2008, CELL, V134, P646, DOI 10.1016/j.cell.2008.06.026; Hendrickx M, 2008, DEV GROWTH DIFFER, V50, P229, DOI [10.1111/j.1440-169x.2008.01016.x, 10.1111/j.1440-169X.2008.01016.x]; Hikasa H, 2002, DEVELOPMENT, V129, P5227; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kani S, 2004, J BIOL CHEM, V279, P50102, DOI 10.1074/jbc.M409039200; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Kim C, 2003, DEV BIOL, V264, P376, DOI 10.1016/j.ydbio.2003.09.007; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Liu Y, 2008, J CELL BIOCHEM, V105, P497, DOI 10.1002/jcb.21848; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Loscertales M, 2008, DEVELOPMENT, V135, P1365, DOI 10.1242/dev.010504; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Malanchi I, 2009, CURR OPIN ONCOL, V21, P41, DOI 10.1097/CCO.0b013e32831d1faf; Matsuda T, 2001, MECH DEVELOP, V105, P153, DOI 10.1016/S0925-4773(01)00383-5; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Nomi M, 2001, MOL CELL BIOL, V21, P8329, DOI 10.1128/MCB.21.24.8329-8335.2001; Oishi I, 1999, GENES CELLS, V4, P41, DOI 10.1046/j.1365-2443.1999.00234.x; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Oldridge M, 2000, NAT GENET, V24, P275, DOI 10.1038/73495; Polakis P, 2000, GENE DEV, V14, P1837; Saiga H, 2008, J IMMUNOL, V181, P8521, DOI 10.4049/jimmunol.181.12.8521; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SCHWARZER W, 2009, HUM MOL GENET; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Takeuchi S, 2000, GENES CELLS, V5, P71, DOI 10.1046/j.1365-2443.2000.00300.x; TORNQVIST HE, 1988, J BIOL CHEM, V263, P350; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; VIHINEN M, 1994, P NATL ACAD SCI USA, V91, P12803, DOI 10.1073/pnas.91.26.12803; WILDEN PA, 1990, P NATL ACAD SCI USA, V87, P3358, DOI 10.1073/pnas.87.9.3358; WILDEN PA, 1992, J BIOL CHEM, V267, P16660; Winkel A, 2008, CELL SIGNAL, V20, P2134, DOI 10.1016/j.cellsig.2008.08.009; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yamamoto H, 2007, GENES CELLS, V12, P1215, DOI 10.1111/j.1365-2443.2007.01128.x; Yamamoto S, 2008, DEV CELL, V15, P23, DOI 10.1016/j.devcel.2008.05.007; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786	51	125	129	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30167	30176		10.1074/jbc.M109.041715	http://dx.doi.org/10.1074/jbc.M109.041715			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19720827	Green Published, hybrid			2022-12-27	WOS:000271090000020
J	Burgoyne, JR; Eaton, P				Burgoyne, Joseph R.; Eaton, Philip			Transnitrosylating Nitric Oxide Species Directly Activate Type I Protein Kinase A, Providing a Novel Adenylate Cyclase-independent Cross-talk to beta-Adrenergic-like Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-NITROSYLATION; VENTRICULAR FIBERS; FROG-HEART; CYCLIC-GMP; PEROXYNITRITE; CARDIOMYOCYTES; DISULFIDE; MECHANISM; TRANSPORT; DONORS	The transnitrosylating nitric oxide (NO) donor nitrocysteine (CysNO) induced a disulfide bond between the two regulatory RI subunits of protein kinase A (PKA). The conventional NO donor S-nitroso-N-acetylpenicillamine failed to do this, consistent with our observation that it also did not promote protein S-nitrosylation. This disulfide oxidation event activated PKA and induced vasorelaxation independently of the classical beta-adrenergic or NO signaling pathway. Activation of PKA had also been anticipated to exert a positive inotropic effect on the myocardium but did not. The lack of positive inotropy was explained by CysNO concomitantly activating protein kinase G (PKG) I alpha. PKG was found to exert a partial negative inotropic influence regardless of whether PKA was activated by classical beta-receptor stimulation or by disulfide bond formation. This work demonstrates that NO molecules that can induce S-nitrosylation directly activate type I PKA, providing a novel cross-talk to beta-adrenergic-like signaling without receptor or adenylate cyclase stimulation. However, the expected positive inotropic consequences of PKA activation by this novel mechanism are countermanded by the simultaneous dual activation of PKGI alpha, which is also activated by CysNO.	[Burgoyne, Joseph R.; Eaton, Philip] Kings Coll London, St Thomas Hosp, Rayne Inst, Div Cardiovasc, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Eaton, P (corresponding author), Kings Coll London, St Thomas Hosp, Rayne Inst, Div Cardiovasc, London SE1 7EH, England.	philip.eaton@kcl.ac.uk	Eaton, Philip/I-5444-2015	Eaton, Philip/0000-0003-0748-2367; Burgoyne, Joseph/0000-0001-7325-7382	Wellcome Trust [085483/Z/08/Z]; Medical Research Council [G0700320]; MRC [G0600785, G0700320] Funding Source: UKRI; Medical Research Council [G0600785] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Sir Henry Wellcome postdoctoral fellowship from The Wellcome Trust (Sponsor Reference 085483/Z/08/Z; to J. R. B.) and the Medical Research Council (Sponsor Reference G0700320).	Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Angelone T, 2008, ACTA PHYSIOL, V193, P229, DOI 10.1111/j.1748-1716.2008.01838.x; Asada K, 2009, J BIOL CHEM, V284, P6014, DOI 10.1074/jbc.M807158200; Banky P, 1998, J BIOL CHEM, V273, P35048, DOI 10.1074/jbc.273.52.35048; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Brennan JP, 2006, J BIOL CHEM, V281, P21827, DOI 10.1074/jbc.M603952200; Brennan JP, 2006, MOL CELL PROTEOMICS, V5, P215, DOI 10.1074/mcp.M500212-MCP200; Brennan JP, 2004, J BIOL CHEM, V279, P41352, DOI 10.1074/jbc.M403827200; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Chesnais JM, 1999, J PHYSIOL-LONDON, V518, P449, DOI 10.1111/j.1469-7793.1999.0449p.x; Chesnais JM, 1999, J PHYSIOL-LONDON, V521, P375, DOI 10.1111/j.1469-7793.1999.00375.x; Eaton P, 2006, FREE RADICAL BIO MED, V40, P1889, DOI 10.1016/j.freeradbiomed.2005.12.037; Ebihara Y, 1996, CARDIOVASC RES, V32, P622, DOI 10.1016/S0008-6363(96)00117-4; Gow AJ, 2002, J BIOL CHEM, V277, P9637, DOI 10.1074/jbc.C100746200; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hess DT, 2001, NAT CELL BIOL, V3, pE46, DOI 10.1038/35055152; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Kohr MJ, 2008, CARDIOVASC RES, V77, P353, DOI 10.1093/cvr/cvm018; Moncada S, 2006, BRIT J PHARMACOL, V147, pS193, DOI 10.1038/sj.bjp.0706458; Paolocci N, 2000, AM J PHYSIOL-HEART C, V279, pH1982, DOI 10.1152/ajpheart.2000.279.4.H1982; Paolocci N, 2007, PHARMACOL THERAPEUT, V113, P442, DOI 10.1016/j.pharmthera.2006.11.002; Sandirasegarane L, 1999, J MOL CELL CARDIOL, V31, P799, DOI 10.1006/jmcc.1998.0919; Schipke JD, 2001, Z KARDIOL, V90, P319, DOI 10.1007/s003920170161; Schnell JR, 2005, PROTEIN SCI, V14, P2421, DOI 10.1110/ps.051528905; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Sun JH, 2007, CIRC RES, V101, P1155, DOI 10.1161/CIRCRESAHA.107.155879; Tocchetti CG, 2007, CIRC RES, V100, P96, DOI 10.1161/01.RES.0000253904.53601.c9; Vigil D, 2004, BIOCHEMISTRY-US, V43, P5629, DOI 10.1021/bi0499157; Viste K, 2005, J BIOL CHEM, V280, P13279, DOI 10.1074/jbc.M413065200; WHEATLEY RM, 1994, AM J PHYSIOL, V266, pH291, DOI 10.1152/ajpheart.1994.266.1.H291; Wright DH, 2001, AM J PHYSIOL-REG I, V281, pR1343, DOI 10.1152/ajpregu.2001.281.5.R1343; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; Yang L, 2007, CIRC RES, V101, P465, DOI 10.1161/CIRCRESAHA.107.156976; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P831, DOI 10.1016/j.freeradbiomed.2004.12.016; Zhang YH, 2004, P NATL ACAD SCI USA, V101, P7891, DOI 10.1073/pnas.0401167101	37	49	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29260	29268		10.1074/jbc.M109.046722	http://dx.doi.org/10.1074/jbc.M109.046722			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19726669	Green Published, hybrid			2022-12-27	WOS:000270896800005
J	Breitinger, HG; Villmann, C; Melzer, N; Rennert, J; Breitinger, U; Schwarzinger, S; Becker, CM				Breitinger, Hans-Georg; Villmann, Carmen; Melzer, Nima; Rennert, Janine; Breitinger, Ulrike; Schwarzinger, Stephan; Becker, Cord-Michael			Novel Regulatory Site within the TM3-4 Loop of Human Recombinant alpha 3 Glycine Receptors Determines Channel Gating and Domain Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; NICOTINIC ACETYLCHOLINE-RECEPTOR; 5-HT3A RECEPTOR; LIGAND-BINDING; HYPEREKPLEXIA; SUBUNIT; MUTATION; DESENSITIZATION; ASSOCIATION; SELECTIVITY	Glycine receptors are Cys loop ligand-gated ion channels that mediate fast inhibitory synaptic transmission in the mammalian central nervous system. The functionally distinct splice variants alpha 3L and alpha 3K of the human glycine receptor differ by a 15-amino acid insert within the long intracellular TM3-4 loop, a region of high intersubunit diversity. In a mutational study, effects of the insert on ion channel function and secondary structure of the TM3-4 loop were investigated. Whole cell current responses and protein surface expression data indicated that the major effect of mutations within the insert was on channel gating. Changes in channel gating correlated with the distribution of charged residues about the splice region. Analysis of complex molecular weight indicated that recombinant TM3-4 loops of alpha 3L and alpha 3K associated into oligomers of different stoichiometry. Secondary structure analysis suggested that the insert stabilized the overall fold of the large cytoplasmic domain of alpha 3L subunits. The absence of the insert resulted in a channel that was still functional, but the TM3-4 cytoplasmic domain appeared not stably folded. Thus, our data identified the spliced insert within the large TM 3-4 loop of alpha 3 Gly receptors as a novel regulatory motif that serves a 2-fold role: (i) the presence of the insert stabilizes the overall spatial structure of the domain, and (ii) the insert presents a control unit that regulates gating of the receptor ion channel.	[Breitinger, Hans-Georg; Villmann, Carmen; Melzer, Nima; Rennert, Janine; Breitinger, Ulrike; Becker, Cord-Michael] Univ Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, D-91054 Erlangen, Germany; [Schwarzinger, Stephan] Univ Bayreuth, Lehrstuhl Biopolymere, D-95440 Bayreuth, Germany	University of Erlangen Nuremberg; University of Bayreuth	Becker, CM (corresponding author), Fahrstr 17, D-91054 Erlangen, Germany.	cmb@biochem.uni-erlangen.de	Breitinger, Hans-Georg/ABD-3247-2021; Schwarzinger, Stephan/O-4318-2014; Schwarzinger, Stephan/GWV-5819-2022	Breitinger, Hans-Georg/0000-0003-0111-3528; Schwarzinger, Stephan/0000-0002-0894-5290	Deutsche Forschungsgemeinschaft [SFB 359-A13]; Fonds der Chemischen Industrie [SPG 1026, BR 1507/4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 359-A13 (to H.-G. B. and C.-M. B.), SPG 1026, and BR 1507/4 and by the Fonds der Chemischen Industrie.	Becker C. M., 1995, NEUROSCIENTIST, V1, P130; BECKER CM, 1989, J NEUROCHEM, V53, P124, DOI 10.1111/j.1471-4159.1989.tb07303.x; Becker K, 2000, CHANNELOPATHIES - COMMON MECHANISMS IN AURA, ARRHYTHMIA AND ALKALOSIS, P199, DOI 10.1016/B978-044450489-0/50010-0; Betz H, 1999, ANN NY ACAD SCI, V868, P667, DOI 10.1111/j.1749-6632.1999.tb11343.x; BETZ H, 1992, Q REV BIOPHYS, V25, P381, DOI 10.1017/S0033583500004340; Breitinger HG, 2002, CHEMBIOCHEM, V3, P1043, DOI 10.1002/1439-7633(20021104)3:11<1042::AID-CBIC1042>3.0.CO;2-7; Breitinger HG, 2002, J NEUROCHEM, V83, P30, DOI 10.1046/j.1471-4159.2002.01109.x; Breitinger HG, 2001, J BIOL CHEM, V276, P29657, DOI 10.1074/jbc.M100446200; Breitinger U, 2004, J BIOL CHEM, V279, P1627, DOI 10.1074/jbc.M303811200; Brune W, 1996, AM J HUM GENET, V58, P989; Buttner C, 2001, J BIOL CHEM, V276, P42978, DOI 10.1074/jbc.M102121200; Carland JE, 2009, J BIOL CHEM, V284, P2023, DOI 10.1074/jbc.M806618200; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Deeb TZ, 2007, J BIOL CHEM, V282, P6172, DOI 10.1074/jbc.M607698200; DELCASTILLO J, 1957, PROC R SOC SER B-BIO, V146, P339; Fucile S, 2000, NEURON, V28, P571, DOI 10.1016/S0896-6273(00)00134-3; Gee VJ, 2007, BRIT J PHARMACOL, V152, P501, DOI 10.1038/sj.bjp.0707429; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; HANNAPPEL E, 1988, ARCH BIOCHEM BIOPHYS, V260, P546, DOI 10.1016/0003-9861(88)90480-8; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; HESS GP, 1993, BIOCHEMISTRY-US, V32, P989, DOI 10.1021/bi00055a001; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hu XQ, 2006, J BIOL CHEM, V281, P21781, DOI 10.1074/jbc.M600676200; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Kukhtina V, 2006, J NEUROCHEM, V97, P63, DOI 10.1111/j.1471-4159.2005.03468.x; Lee DJS, 2003, NEUROSCI LETT, V351, P196, DOI 10.1016/j.neulet.2003.08.005; Lewis TM, 1998, J PHYSIOL-LONDON, V507, P25, DOI 10.1111/j.1469-7793.1998.025bu.x; Livesey MR, 2008, J BIOL CHEM, V283, P19301, DOI 10.1074/jbc.M802406200; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Moorhouse AJ, 1999, MOL PHARMACOL, V55, P386, DOI 10.1124/mol.55.2.386; Nikolic Z, 1998, J BIOL CHEM, V273, P19708, DOI 10.1074/jbc.273.31.19708; Sadtler S, 2003, J BIOL CHEM, V278, P16782, DOI 10.1074/jbc.M213077200; Saul B, 1999, J NEUROSCI, V19, P869; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; Sreerama N, 1999, PROTEIN SCI, V8, P370; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wotring VE, 2003, J PHYSIOL-LONDON, V548, P527, DOI 10.1113/jphysiol.2002.032045	42	22	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28624	28633		10.1074/jbc.M109.043174	http://dx.doi.org/10.1074/jbc.M109.043174			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19661067	hybrid, Green Published			2022-12-27	WOS:000270678900017
J	Liu, HL; Shim, AHR; He, XL				Liu, Heli; Shim, Ann H. R.; He, Xiaolin			Structural Characterization of the Ectodomain of a Disintegrin and Metalloproteinase-22 (ADAM22), a Neural Adhesion Receptor Instead of Metalloproteinase INSIGHTS ON ADAM FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC DOMAIN; CRYSTAL-STRUCTURES; FAMILY; PROTEINS; ARCHITECTURE; PRODOMAIN; REVEAL; INFLAMMATION; PROTEASE; LGI1	ADAMs (a disintegrin and metalloproteinases) are a family of multidomain transmembrane glycoproteins with diverse roles in physiology and diseases, with several members being drug targets for cancer and inflammation therapies. The spatial organization of the ADAM extracellular segment and its influence on the function of ADAMs have been unclear. Although most members of the ADAM family are active zinc metalloproteinases, 8 of 21 ADAMs lack functional metalloproteinase domains and are implicated in protein-protein interactions instead of membrane protein ectodomain shedding. One of such non-proteinase ADAMs, ADAM22, acts as a receptor on the surface of the postsynaptic neuron to regulate synaptic signal transmission. The crystal structure of the full ectodomain of mature human ADAM22 shows that it is a compact four-leaf clover with the metalloproteinase-like domain held in the concave face of a rigid module formed by the disintegrin, cysteine-rich, and epidermal growth factor-like domains. The loss of metalloproteinase activity is ensured by the absence of critical catalytic residues, the filling of the substrate groove, and the steric hindrance by the cysteine-rich domain. The structure, combined with calorimetric experiments, suggests distinct roles of three putative calcium ions bound to ADAM22, with one in the metalloproteinase-like domain being regulatory and two in the disintegrin domain being structural. The metalloproteinase-like domain contacts the rest of ADAM22 with discontinuous, hydrophilic, and poorly complemented interactions, suggesting the possibility of modular movement of ADAM22 and other ADAMs. The ADAM22 structure provides a framework for understanding how different ADAMs exert their adhesive function and shedding activities.	[Liu, Heli; Shim, Ann H. R.; He, Xiaolin] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	He, XL (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Searle 8-417,303 E Chicago Ave, Chicago, IL 60611 USA.	x-he@northwestern.edu						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao Y, 2002, J BIOL CHEM, V277, P26403, DOI 10.1074/jbc.M110814200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Duffy MJ, 2003, THROMB HAEMOSTASIS, V89, P622; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Egelman DM, 1999, BIOPHYS J, V76, P1856, DOI 10.1016/S0006-3495(99)77345-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukata Y, 2006, SCIENCE, V313, P1792, DOI 10.1126/science.1129947; Gerhardt S, 2007, J MOL BIOL, V373, P891, DOI 10.1016/j.jmb.2007.07.047; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; Igarashi T, 2007, FEBS LETT, V581, P2416, DOI 10.1016/j.febslet.2007.04.057; Jacobsen J, 2008, BIOCHEMISTRY-US, V47, P537, DOI 10.1021/bi701629c; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leonard JD, 2005, BIOCHEM J, V387, P797, DOI 10.1042/BJ20041727; Loechel F, 1999, J BIOL CHEM, V274, P13427, DOI 10.1074/jbc.274.19.13427; Lu X., 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P29; Maskos K, 1998, P NATL ACAD SCI USA, V95, P3408, DOI 10.1073/pnas.95.7.3408; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moss ML, 2004, BIOCHEMISTRY-US, V43, P7227, DOI 10.1021/bi049677f; Mosyak L, 2008, PROTEIN SCI, V17, P16, DOI 10.1110/ps.073287008; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Novak U, 2004, J CLIN NEUROSCI, V11, P227, DOI 10.1016/j.jocn.2003.10.006; Orth P, 2004, J MOL BIOL, V335, P129, DOI 10.1016/j.jmb.2003.10.037; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Reiss K, 2006, PHARMACOL THERAPEUT, V111, P985, DOI 10.1016/j.pharmthera.2006.02.009; Rocks N, 2008, BIOCHIMIE, V90, P369, DOI 10.1016/j.biochi.2007.08.008; Sagane K, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-33; Sagane K, 1999, GENE, V236, P79, DOI 10.1016/S0378-1119(99)00253-X; Sagane K, 2008, INT J BIOL SCI, V4, P387; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Shieh HS, 2008, J BIOL CHEM, V283, P1501, DOI 10.1074/jbc.M705879200; Sorensen HP, 2008, PROTEIN EXPRES PURIF, V61, P175, DOI 10.1016/j.pep.2008.05.020; Steinlein OK, 2004, NAT REV NEUROSCI, V5, P400, DOI 10.1038/nrn1388; Takeda S, 2007, FEBS LETT, V581, P5859, DOI 10.1016/j.febslet.2007.11.062; Takeda S, 2006, EMBO J, V25, P2388, DOI 10.1038/sj.emboj.7601131; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wewer UM, 2006, J BIOL CHEM, V281, P9418, DOI 10.1074/jbc.M513580200; White JM, 2003, CURR OPIN CELL BIOL, V15, P598, DOI 10.1016/j.ceb.2003.08.001; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200	44	47	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29077	29086		10.1074/jbc.M109.014258	http://dx.doi.org/10.1074/jbc.M109.014258			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19692335	hybrid, Green Published			2022-12-27	WOS:000270678900064
J	Tillgren, V; Onnerfjord, P; Haglund, L; Heinegard, D				Tillgren, Viveka; Onnerfjord, Patrik; Haglund, Lisbet; Heinegard, Dick			The Tyrosine Sulfate-rich Domains of the LRR Proteins Fibromodulin and Osteoadherin Bind Motifs of Basic Clusters in a Variety of Heparin-binding Proteins, Including Bioactive Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN TYPE-I; OLIGOMERIC MATRIX PROTEIN; ARTICULAR-CARTILAGE; BASEMENT-MEMBRANE; CELL-ADHESION; PRELP BINDS; PROTEOGLYCAN; DECORIN; REGION; THROMBOSPONDIN	The small leucine-rich repeat proteins, fibromodulin and osteoadherin, have N-terminal extensions with a variable number of O-sulfated tyrosine residues. This modification combined with a number of aspartic and glutamic acid residues results in a highly negatively charged domain of less than 30 amino acids. We hypothesized that this domain shares functional properties with heparin regarding binding to proteins and polypeptides containing clusters of basic amino acids. Two other family members, PRELP and chondroadherin, have distinctly different clusters of basic amino acids in their N and C termini, respectively, and PRELP is known to bind to heparin via this domain. Another heparin-binding protein is the cytokine Oncostatin M, with a different cluster of basic amino acids in its C terminus. We used polypeptides representing these basic domains in solid phase assays and demonstrate interactions with the negatively charged N-terminal domain of fibromodulin and full-length osteoadherin. The tyrosine sulfate domains also bound heparin-binding proteins such as basic fibroblast growth factor-2, thrombospondin I, MMP13, the NC4 domain of collagen IX, and interleukin-10. Fibronectin with large heparin-binding domains did not bind, neither did CILP containing a heparin-binding thrombospondin type I motif without clustered basic amino acids. Affinity depends on the number and position of the sulfated tyrosine residues shown by different binding properties of 10-kDa fragments subfractionated by ion-exchange chromatography. These interactions may sequester growth factors, cytokines, and matrix metalloproteinases in the extracellular matrix as well as contribute to its organization.	[Tillgren, Viveka; Onnerfjord, Patrik; Haglund, Lisbet; Heinegard, Dick] Lund Univ, Sect Rheumatol Mol Skeletal Biol, Dept Clin Sci, SE-22184 Lund, Sweden	Lund University	Heinegard, D (corresponding author), Lund Univ, Sect Rheumatol Mol Skeletal Biol, Dept Clin Sci, BMC Plan C12, SE-22184 Lund, Sweden.	dick.heinegard@med.lu.se	Onnerfjord, Patrik/R-3131-2019; Haglund, Lisbet/N-3095-2013	Onnerfjord, Patrik/0000-0002-2345-2937; Haglund, Lisbet/0000-0002-1288-2149	Swedish Research Council; Osterlund Foundation; Magnus Bergvall Foundation; IngaBritt and Arne Lundbergs Research Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Osterlund Foundation; Magnus Bergvall Foundation; IngaBritt and Arne Lundbergs Research Foundation	This work was supported by The Swedish Research Council, King Gustaf V's 80-year jubilee fund, the Osterlund Foundation, the Kock Foundation, the Magnus Bergvall Foundation, and Anamar Medical. Mass spectrometers were purchased through grants from the IngaBritt and Arne Lundbergs Research Foundation.	Bengtsson E, 2002, J BIOL CHEM, V277, P15061, DOI 10.1074/jbc.M108285200; Bengtsson E, 2000, J BIOL CHEM, V275, P40695, DOI 10.1074/jbc.M007917200; BLOCHBERGER TC, 1992, J BIOL CHEM, V267, P347; Chen RL, 2001, J BIOL CHEM, V276, P7507, DOI 10.1074/jbc.M008283200; DIXIT VM, 1984, J BIOL CHEM, V259, P100; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Ganu V, 1998, ARTHRITIS RHEUM, V41, P2143, DOI 10.1002/1529-0131(199812)41:12<2143::AID-ART9>3.0.CO;2-P; GomisRuth FX, 1996, J MOL BIOL, V264, P556, DOI 10.1006/jmbi.1996.0661; GUO NH, 1992, P NATL ACAD SCI USA, V89, P3040, DOI 10.1073/pnas.89.7.3040; HASSELL JR, 1980, P NATL ACAD SCI-BIOL, V77, P4494, DOI 10.1073/pnas.77.8.4494; Heathfield TF, 2004, J BIOL CHEM, V279, P6286, DOI 10.1074/jbc.M307765200; HEDBOM E, 1989, J BIOL CHEM, V264, P6898; HEDBOM E, 1993, J BIOL CHEM, V268, P27307; HEDLUND H, 1994, MATRIX BIOL, V14, P227, DOI 10.1016/0945-053X(94)90186-4; HEINEGARD D, 1986, J BIOL CHEM, V261, P3866; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; Kalamajski S, 2007, J BIOL CHEM, V282, P26740, DOI 10.1074/jbc.M704026200; Kalamajski S, 2007, J BIOL CHEM, V282, P16062, DOI 10.1074/jbc.M700073200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lorenzo P, 1998, J BIOL CHEM, V273, P23463, DOI 10.1074/jbc.273.36.23463; Lorenzo P, 2001, J BIOL CHEM, V276, P12201, DOI 10.1074/jbc.M010932200; Lorenzo P, 1998, J BIOL CHEM, V273, P23469, DOI 10.1074/jbc.273.36.23469; Mansson B, 2001, J BIOL CHEM, V276, P32883, DOI 10.1074/jbc.M101680200; Mostafavi-Pour Z, 2001, MATRIX BIOL, V20, P63, DOI 10.1016/S0945-053X(00)00131-1; Onnerfjord P, 2004, J BIOL CHEM, V279, P26, DOI 10.1074/jbc.M308689200; Pihlajamaa T, 2004, J BIOL CHEM, V279, P24265, DOI 10.1074/jbc.M402865200; RAPRAEGER A, 1985, J BIOL CHEM, V260, P1046; SCOTT JE, 1981, BIOCHEM J, V197, P213, DOI 10.1042/bj1970213; SVENSSON L, 1995, J BIOL CHEM, V270, P20712, DOI 10.1074/jbc.270.35.20712; TSEN G, 1995, J BIOL CHEM, V270, P3392, DOI 10.1074/jbc.270.7.3392; VAUGHAN L, 1988, J CELL BIOL, V106, P991, DOI 10.1083/jcb.106.3.991; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; Wiberg C, 2001, J BIOL CHEM, V276, P18947, DOI 10.1074/jbc.M100625200	33	38	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28543	28553		10.1074/jbc.M109.047076	http://dx.doi.org/10.1074/jbc.M109.047076			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19700767	Green Published, hybrid			2022-12-27	WOS:000270678900008
J	Friedman, MJ; Li, SH; Li, XJ				Friedman, Meyer J.; Li, Shihua; Li, Xiao-Jiang			Activation of Gene Transcription by Heat Shock Protein 27 May Contribute to Its Neuronal Protection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT CEREBELLAR-ATAXIA; TATA-BINDING PROTEIN; HUNTINGTONS-DISEASE; MOLECULAR CHAPERONES; MOUSE MODEL; ANDROGEN RECEPTOR; IN-VITRO; HSP27; POLYGLUTAMINE; EXPRESSION	Heat shock proteins are up-regulated as a physiological response to stressful stimuli and generally function as molecular chaperones for improperly folded protein substrates. The small heat shock protein HSP27 (or HSPB1) has multiple cytoplasmic roles. HSP27 also can translocate to the nucleus in response to stress, but the functional significance of this nuclear distribution has not been elucidated. We have previously implicated HSP27 as a genetic modifier of spinocerebellar ataxia 17 (SCA17), a neurological disease caused by a polyglutamine expansion in the TATA-binding protein (T]BP). Altered expression of HSP27 is also found in cell models of other polyglutamine diseases, including Huntington disease as well as SCA3 and SCA7. Here, we show that Hsp27, unlike Hsp70, is not detected in mutant TBP aggregates in primary cerebellar granule neurons from transgenic SCA17 mice. Although HSP27 overexpression does not reduce the aggregation of cotransfected mutant TBP containing 105 glutamines, it potentiates activated transcription from both TATA-containing and TATA-lacking promoters. Neither HSP40 nor HSP70 elicits the same transcriptional effect. Moreover, HSP27 interacts with the transcription factor SP1, and coexpression of SP1 and nuclear localization signal-tagged HSP27 synergistically activates reporter constructs for the SP1-responsive neurotrophic receptor genes Ngfr(p75) and TRKA. Overexpression of nuclear localization signal-tagged HSP27 also rescues mutant TBP-mediated down-regulation of TrkA in a PC12 cell model of SCA17. These results indicate that nuclear HSP27 can modulate SP1-dependent transcriptional activity to promote neuronal protection.	[Friedman, Meyer J.; Li, Shihua; Li, Xiao-Jiang] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Friedman, Meyer J.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	Emory University; University of California System; University of California San Diego	Li, SH (corresponding author), Emory Univ, Sch Med, Dept Human Genet, 615 Michael St, Atlanta, GA 30322 USA.	sli@emory.edu; xli2@emory.edu			National Institutes of Health [NS0465016, NS041669]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041669, R01NS045016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS0465016 (to S. L.) and NS041669 (to X.-J. L.).	Adhikari AS, 2004, EXP CELL RES, V299, P393, DOI 10.1016/j.yexcr.2004.05.032; Armstrong CL, 2001, J COMP NEUROL, V434, P262, DOI 10.1002/cne.1176; Benn CL, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-17; Bryantsev AL, 2007, BIOCHEM J, V407, P407, DOI 10.1042/BJ20070195; Carra S, 2005, HUM MOL GENET, V14, P1659, DOI 10.1093/hmg/ddi174; Chai YH, 1999, J NEUROSCI, V19, P10338; COLGAN J, 1992, GENE DEV, V6, P304, DOI 10.1101/gad.6.2.304; Dierick I, 2005, ANN MED, V37, P413, DOI 10.1080/07853890500296410; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Evert BO, 2003, J NEUROPATH EXP NEUR, V62, P1006, DOI 10.1093/jnen/62.10.1006; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Fontaine JM, 2006, FASEB J, V20, P2168, DOI 10.1096/fj.06-5911fje; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Friedman MJ, 2008, J BIOL CHEM, V283, P8283, DOI 10.1074/jbc.M709674200; Friedman MJ, 2007, NAT NEUROSCI, V10, P1519, DOI 10.1038/nn2011; Fujigasaki H, 2001, BRAIN, V124, P1939, DOI 10.1093/brain/124.10.1939; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Georget V, 2002, BIOCHEMISTRY-US, V41, P11824, DOI 10.1021/bi0259150; Geum D, 2002, J BIOL CHEM, V277, P19913, DOI 10.1074/jbc.M104396200; HAINAUT P, 1992, EMBO J, V11, P3513, DOI 10.1002/j.1460-2075.1992.tb05434.x; Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144; Helmlinger D, 2002, HUM MOL GENET, V11, P3351, DOI 10.1093/hmg/11.26.3351; Huang L, 2007, GENESIS, V45, P487, DOI 10.1002/dvg.20319; Latchman DS, 2005, INT J HYPERTHER, V21, P393, DOI 10.1080/02656730400023664; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; Li SH, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-19; MCCLAREN M, 1994, J INVEST DERMATOL, V102, P375, DOI 10.1111/1523-1747.ep12371798; Merienne K, 2003, J BIOL CHEM, V278, P16957, DOI 10.1074/jbc.M212049200; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Oesterreich S, 1996, BIOCHEM BIOPH RES CO, V222, P155, DOI 10.1006/bbrc.1996.0714; Orr AL, 2008, J BIOL CHEM, V283, P16027, DOI 10.1074/jbc.M710606200; Perrin V, 2007, MOL THER, V15, P903, DOI 10.1038/mt.sj.6300141; Quraishe S, 2008, NEUROSCIENCE, V153, P483, DOI 10.1016/j.neuroscience.2008.01.058; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; Rolfs A, 2003, ANN NEUROL, V54, P367, DOI 10.1002/ana.10676; Sakahira H, 2002, P NATL ACAD SCI USA, V99, P16412, DOI 10.1073/pnas.182426899; Seo HR, 2006, J BIOL CHEM, V281, P17220, DOI 10.1074/jbc.M600062200; SHAH AG, 2009, HUM MOL GEN IN PRESS; Stetler RA, 2008, J NEUROSCI, V28, P13038, DOI 10.1523/JNEUROSCI.4407-08.2008; Tsai HF, 2005, BIOCHEM BIOPH RES CO, V334, P1279, DOI 10.1016/j.bbrc.2005.06.207; Williams KL, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-24; Williams KL, 2006, J NEUROSCI RES, V84, P716, DOI 10.1002/jnr.20983; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Zhou H, 2001, J BIOL CHEM, V276, P48417, DOI 10.1074/jbc.M104140200; Zoubeidi A, 2007, CANCER RES, V67, P10455, DOI 10.1158/0008-5472.CAN-07-2057; Zourlidou A, 2007, HUM MOL GENET, V16, P1078, DOI 10.1093/hmg/ddm057	47	33	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27944	27951		10.1074/jbc.M109.037937	http://dx.doi.org/10.1074/jbc.M109.037937			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19656944	hybrid, Green Published			2022-12-27	WOS:000270676300022
J	Guo, P; Dong, XY; Zhao, KW; Sun, XD; Li, QN; Dong, JT				Guo, Peng; Dong, Xue-Yuan; Zhao, Kewen; Sun, Xiaodong; Li, Qunna; Dong, Jin-Tang			Opposing Effects of KLF5 on the Transcription of MYC in Epithelial Proliferation in the Context of Transforming Growth Factor beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR-5; HUMAN-BREAST-CANCER; CDK INHIBITOR P15(INK4B); HUMAN PROSTATE-CANCER; EMBRYONIC STEM-CELLS; C-MYC; TGF-BETA; SELF-RENEWAL; MEDIATED INDUCTION; TUMOR PROGRESSION	The proto-oncogene MYC plays a critical role in cell proliferation and tumorigenesis, and its down-regulation by transforming growth factor beta (TGF beta) signaling is necessary for TGF beta to inhibit cell proliferation. KLF5, on the other hand, is a pro-proliferative basic transcription factor that reverses function to become an anti-proliferative TGF beta cofactor upon TGF beta stimulation in epithelial homeostasis. In this study we investigated whether KLF5 directly regulates MYC transcription in epithelial cells in the context of TGF beta Knockdown of KLF5 significantly reduced MYC expression in the HaCaT epidermal epithelial cells. When TGF beta was applied, however, whereas MYC expression was significantly inhibited, knockdown of KLF5 increased MYC expression. Furthermore, re-expression of KLF5 restored the inhibitory effect of TGF beta on MYC expression in two cancer cell lines. Chromatin immunoprecipitation and oligo pulldown experiments demonstrated that whereas binding of KLF5 to both KLF5 binding element (KBE) and TGF beta inhibitory element (TIE) DNA elements was necessary for MYC transcription, binding to KBE was decreased by TGF beta and binding to TIE was increased by TGF beta These results suggest that KLF5 is not only essential for MYC transcription in proliferating epithelial cells but also mediates the inhibitory effect of TGF beta on MYC transcription. Furthermore, different binding sites mediate different effects of KLF5 in the context of TGF beta.	[Dong, Jin-Tang] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University	Dong, JT (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, 1365-C Clifton Rd, Atlanta, GA 30322 USA.	jdong2@emory.edu	Guo, Peng/GWC-0572-2022; guo, peng/AAG-4052-2019	Guo, Peng/0000-0002-4575-8443; Dong, Jin-Tang/0000-0003-2349-5782				Aizawa K, 2004, J BIOL CHEM, V279, P70, DOI 10.1074/jbc.M306621200; ALEXANDROW MG, 1995, CANCER RES, V55, P1452; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Bateman NW, 2004, J BIOL CHEM, V279, P12093, DOI 10.1074/jbc.M311532200; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Chen C, 2007, ONCOGENE, V26, P2386, DOI 10.1038/sj.onc.1210021; Chen C, 2002, ONCOGENE, V21, P6567, DOI 10.1038/sj.onc.1205817; Chen C, 2003, PROSTATE, V55, P81, DOI 10.1002/pros.10205; Chen CH, 2006, INT J CANCER, V118, P1346, DOI 10.1002/ijc.21533; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Chen CS, 2005, ONCOGENE, V24, P3319, DOI 10.1038/sj.onc.1208497; DUBIK D, 1988, J BIOL CHEM, V263, P12705; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Fusenig NE, 1998, MOL CARCINOGEN, V23, P144, DOI 10.1002/(SICI)1098-2744(199811)23:3<144::AID-MC3>3.0.CO;2-U; Guo P, 2009, J BIOL CHEM, V284, P18184, DOI 10.1074/jbc.M109.007096; Guo P, 2009, J BIOL CHEM, V284, P6071, DOI 10.1074/jbc.M806270200; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Miyamoto S, 2003, MOL CELL BIOL, V23, P8528, DOI 10.1128/MCB.23.23.8528-8541.2003; Murphy MJ, 2005, TRENDS CELL BIOL, V15, P128, DOI 10.1016/j.tcb.2005.01.008; Nandan MO, 2008, GASTROENTEROLOGY, V134, P120, DOI 10.1053/j.gastro.2007.10.023; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Parisi S, 2008, J CELL SCI, V121, P2629, DOI 10.1242/jcs.027599; Park BJ, 2000, CANCER RES, V60, P3031; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Sur I, 2002, EUR J CELL BIOL, V81, P323, DOI 10.1078/0171-9335-00257; Sur I, 2006, J CELL SCI, V119, P3593, DOI 10.1242/jcs.03070; Waikel RL, 1999, ONCOGENE, V18, P4870, DOI 10.1038/sj.onc.1203040; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Warner BJ, 1999, MOL CELL BIOL, V19, P5913; WATSON PH, 1991, CANCER RES, V51, P3996; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yagi K, 2002, J BIOL CHEM, V277, P854, DOI 10.1074/jbc.M104170200	47	40	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28243	28252		10.1074/jbc.M109.036160	http://dx.doi.org/10.1074/jbc.M109.036160			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19684017	Green Published, hybrid			2022-12-27	WOS:000270676300052
J	Liu, Y; Prasad, R; Beard, WA; Hou, EW; Horton, JK; McMurray, CT; Wilson, SH				Liu, Yuan; Prasad, Rajendra; Beard, William A.; Hou, Esther W.; Horton, Julie K.; McMurray, Cynthia T.; Wilson, Samuel H.			Coordination between Polymerase beta and FEN1 Can Modulate CAG Repeat Expansion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; HUMAN FLAP ENDONUCLEASE-1; DNA SECONDARY STRUCTURE; TRANSGENIC MOUSE MODEL; PROTEIN CROSS-LINKS; HUMAN-DISEASE; TRINUCLEOTIDE REPEATS; MYOTONIC-DYSTROPHY; TRIPLET REPEATS; IN-VITRO	The oxidized DNA base 8-oxoguanine (8-oxoG) is implicated in neuronal CAG repeat expansion associated with Huntington disease, yet it is unclear how such a DNA base lesion and its repair might cause the expansion. Here, we discovered size-limited expansion of CAG repeats during repair of 8-oxoG in a wildtype mouse cell extract. This expansion was deficient in extracts from cells lacking pol beta and HMGB1. We demonstrate that expansion is mediated through pol beta multinucleotide gap-filling DNA synthesis during long-patch base excision repair. Unexpectedly, FEN1 promotes expansion by facilitating ligation of hairpins formed by strand slippage. This alternate role of FEN1 and the polymerase beta (pol beta) multinucleotide gap-filling synthesis is the result of uncoupling of the usual coordination between pol beta and FEN1. HMGB1 probably promotes expansion by stimulating APEI and FEN1 in forming single strand breaks and ligatable nicks, respectively. This is the first report illustrating that disruption of pol beta and FEN1 coordination during long-patch BER results in CAG repeat expansion.	[Liu, Yuan; Prasad, Rajendra; Beard, William A.; Hou, Esther W.; Horton, Julie K.; Wilson, Samuel H.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [McMurray, Cynthia T.] Mayo Clin & Mayo Fdn, Dept Pharmacol & Expt Therapeut, Rochester, MN 55905 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Mayo Clinic	Wilson, SH (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Classen, Scott/AAY-8176-2020; Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293	NIEHS Intramural Research Program [Z01-ES050158, Z01-ES050159];  [GM066359];  [CA092584]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102546, ZIAES050158, ZIAES050159] Funding Source: NIH RePORTER	NIEHS Intramural Research Program; ; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Research Projects Z01-ES050158 and Z01-ES050159 from the NIEHS Intramural Research Program and Grants GM066359 and CA092584 (to C. T. M.).	Andersson P, 2006, EUR J CANCER, V42, P2833, DOI 10.1016/j.ejca.2006.06.030; ANVRET M, 1993, HUM MOL GENET, V2, P1397, DOI 10.1093/hmg/2.9.1397; Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Beard WA, 1995, METHOD ENZYMOL, V262, P98; Biade S, 1998, J BIOL CHEM, V273, P898, DOI 10.1074/jbc.273.2.898; Bogdanov MB, 2001, J NEUROCHEM, V79, P1246, DOI 10.1046/j.1471-4159.2001.00689.x; Brosh RM, 2001, EMBO J, V20, P5791; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; Cardozo-Pelaez F, 1999, MOVEMENT DISORD, V14, P972, DOI 10.1002/1531-8257(199911)14:6<972::AID-MDS1010>3.0.CO;2-0; Cleary JD, 2002, NAT GENET, V31, P37, DOI 10.1038/ng870; Delagoutte E, 2008, J BIOL CHEM, V283, P13341, DOI 10.1074/jbc.M800153200; Fortune MT, 2000, HUM MOL GENET, V9, P439, DOI 10.1093/hmg/9.3.439; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Gacy AM, 1998, BIOCHEMISTRY-US, V37, P9426, DOI 10.1021/bi980157s; GACY AM, 1995, CELL, V81, P533; Gonitel R, 2008, P NATL ACAD SCI USA, V105, P3467, DOI 10.1073/pnas.0800048105; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Hartenstine MJ, 2002, J BIOL CHEM, V277, P41379, DOI 10.1074/jbc.M207013200; Henricksen LA, 2000, J BIOL CHEM, V275, P16420, DOI 10.1074/jbc.M909635199; Henricksen LA, 2002, J BIOL CHEM, V277, P22361, DOI 10.1074/jbc.M201765200; Horton JK, 2000, J BIOL CHEM, V275, P2211, DOI 10.1074/jbc.275.3.2211; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Kennedy L, 2000, HUM MOL GENET, V9, P2539, DOI 10.1093/hmg/9.17.2539; KOVLUN IV, 2001, NAT GENET, V27, P407; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Krol J, 2007, MOL CELL, V25, P575, DOI 10.1016/j.molcel.2007.01.031; Lia AS, 1998, HUM MOL GENET, V7, P1285, DOI 10.1093/hmg/7.8.1285; Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Liu Y, 2004, MOL CELL BIOL, V24, P4049, DOI 10.1128/MCB.24.9.4049-4064.2004; Liu Y, 2003, J BIOL CHEM, V278, P13728, DOI 10.1074/jbc.M212061200; LIU Y, 2006, GENETIC INSTABILITIE, P667; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; MATSUMOTO Y, 1994, MOL CELL BIOL, V14, P6187, DOI 10.1128/MCB.14.9.6187; Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250; McMurray CT, 1999, P NATL ACAD SCI USA, V96, P1823, DOI 10.1073/pnas.96.5.1823; Meservy JL, 2003, MOL CELL BIOL, V23, P3152, DOI 10.1128/MCB.23.9.3152-3162.2003; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Moore H, 1999, P NATL ACAD SCI USA, V96, P1504, DOI 10.1073/pnas.96.4.1504; Parniewski P, 1999, NUCLEIC ACIDS RES, V27, P616, DOI 10.1093/nar/27.2.616; Paulson HL, 1996, ANNU REV NEUROSCI, V19, P79; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Piersen CE, 1996, J BIOL CHEM, V271, P17811, DOI 10.1074/jbc.271.30.17811; Prasad R, 2000, J BIOL CHEM, V275, P4460, DOI 10.1074/jbc.275.6.4460; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Prasad R, 2007, MOL CELL, V27, P829, DOI 10.1016/j.molcel.2007.06.029; Richard GF, 2000, EMBO J, V19, P2381, DOI 10.1093/emboj/19.10.2381; Ruggiero BL, 2004, J BIOL CHEM, V279, P23088, DOI 10.1074/jbc.M313170200; Schildkraut JM, 2007, CANCER EPIDEM BIOMAR, V16, P473, DOI 10.1158/1055-9965.EPI-06-0868; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Spiro C, 2003, MOL CELL BIOL, V23, P6063, DOI 10.1128/MCB.23.17.6063-6074.2003; Spiro C, 1999, MOL CELL, V4, P1079, DOI 10.1016/S1097-2765(00)80236-1; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Strauss PR, 1997, J BIOL CHEM, V272, P1302, DOI 10.1074/jbc.272.2.1302; Sung JS, 2005, J BIOL CHEM, V280, P39095, DOI 10.1074/jbc.M506480200; Sung JS, 2006, METHOD ENZYMOL, V408, P48, DOI 10.1016/S0076-6879(06)08004-9; Tom S, 2000, J BIOL CHEM, V275, P10498, DOI 10.1074/jbc.275.14.10498; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; WANG TSF, 1985, P NATL ACAD SCI USA, V82, P5270, DOI 10.1073/pnas.82.16.5270; Wells RD, 2005, NUCLEIC ACIDS RES, V33, P3785, DOI 10.1093/nar/gki697; Wells RD, 1996, J BIOL CHEM, V271, P2875, DOI 10.1074/jbc.271.6.2875; White PJ, 1999, MOL CELL BIOL, V19, P5675; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Wilson SH, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P693; Wilson SH, 1998, MUTAT RES-DNA REPAIR, V407, P203, DOI 10.1016/S0921-8777(98)00002-0; Xie YL, 2001, MOL CELL BIOL, V21, P4889, DOI 10.1128/MCB.21.15.4889-4899.2001	68	93	95	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28352	28366		10.1074/jbc.M109.050286	http://dx.doi.org/10.1074/jbc.M109.050286			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19674974	hybrid, Green Published			2022-12-27	WOS:000270676300061
J	Navarro, G; Aymerich, MS; Marcellino, D; Cortes, A; Casado, V; Mallol, J; Canela, EI; Agnati, L; Woods, AS; Fuxe, K; Lluis, C; Lanciego, JL; Ferre, S; Franco, R				Navarro, Gemma; Aymerich, Marisol S.; Marcellino, Daniel; Cortes, Antoni; Casado, Vicent; Mallol, Josefa; Canela, Enric I.; Agnati, Luigi; Woods, Amina S.; Fuxe, Kjell; Lluis, Carmen; Luis Lanciego, Jose; Ferre, Sergi; Franco, Rafael			Interactions between Calmodulin, Adenosine A(2A), and Dopamine D-2 Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; ENERGY-TRANSFER BRET; ELECTROSTATIC INTERACTION; HETEROMERIZATION; ACTIVATION; BINDING; LOOP; OLIGOMERIZATION; PHARMACOLOGY; RECOGNITION	The Ca2+-binding protein calmodulin (CaM) has been shown to bind directly to cytoplasmic domains of some G protein-coupled receptors, including the dopamine D-2 receptor. CaM binds to the N-terminal portion of the long third intracellular loop of the D-2 receptor, within an Arg-rich epitope that is also involved in the binding to G(i/o) proteins and to the adenosine A(2A) receptor, with the formation of A(2A)-D-2 receptor heteromers. In the present work, by using proteomics and bioluminescence resonance energy transfer (BRET) techniques, we provide evidence for the binding of CaM to the A(2A) receptor. By using BRET and sequential resonance energy transfer techniques, evidence was obtained for CaM-A(2A)-D-2 receptor oligomerization. BRET competition experiments indicated that, in the A(2A)-D-2 receptor heteromer, CaM binds preferentially to a proximal C terminus epitope of the A(2A) receptor. Furthermore, Ca2+ was found to induce conformational changes in the CaM-A(2A)-D-2 receptor oligomer and to selectively modulate A(2A) and D-2 receptor-mediated MAPK signaling in the A(2A)-D-2 receptor heteromer. These results may have implications for basal ganglia disorders, since A(2A)-D-2 receptor heteromers are being considered as a target for anti-parkinsonian agents.	[Aymerich, Marisol S.; Luis Lanciego, Jose; Franco, Rafael] Univ Navarra, CIMA Neurociencias, Pamplona 31008, Spain; [Navarro, Gemma; Cortes, Antoni; Casado, Vicent; Mallol, Josefa; Canela, Enric I.; Lluis, Carmen; Franco, Rafael] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; [Navarro, Gemma; Cortes, Antoni; Casado, Vicent; Mallol, Josefa; Canela, Enric I.; Lluis, Carmen; Franco, Rafael] Univ Barcelona, Fac Biol, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Inst Invest Biomed August Pi & Sunyer, E-08028 Barcelona, Spain; [Marcellino, Daniel; Agnati, Luigi; Fuxe, Kjell] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Woods, Amina S.; Ferre, Sergi] Natl Inst Drug Abuse, Intramural Res Program, NIH, Baltimore, MD 21224 USA	University of Navarra; University of Barcelona; CIBERNED; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Franco, R (corresponding author), Univ Navarra, CIMA Neurociencias, Avda Pio XII 55, Pamplona 31008, Spain.	rfranco@unav.es	Mallol, Josefa/I-4194-2015; Franco, Rafael/C-3694-2015; Marcellino, Daniel/HDM-8433-2022; Lanciego, Jose L./G-7759-2015; Casadó, Vicent/K-1660-2014; Ferre, Sergi/K-6115-2014; Aymerich, M. S./H-2873-2017; Navarro, Gemma/AAO-7866-2021; Canela, Enric I./M-8726-2013	Mallol, Josefa/0000-0002-2479-4162; Franco, Rafael/0000-0003-2549-4919; Marcellino, Daniel/0000-0002-4618-7267; Lanciego, Jose L./0000-0003-2301-5419; Casadó, Vicent/0000-0002-1764-3825; Ferre, Sergi/0000-0002-1747-1779; Aymerich, M. S./0000-0001-9750-1538; Navarro, Gemma/0000-0003-4654-0873; Canela, Enric I./0000-0003-4992-7440; Fuxe, Kjell/0000-0001-8491-4288	National Institutes of Health; NIDA; Spanish Ministry of Education and Science [SAF2008-00146, SAF2006-05481]; Fundacio La Marato de [060110]; NATIONAL INSTITUTE ON DRUG ABUSE [Z01DA000493, ZIADA000493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Spanish Ministry of Education and Science(Spanish Government); Fundacio La Marato de; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by the National Institutes of Health, NIDA, Intramural Research Program (to S. F. and A. S. W.). This work was also supported by Spanish Ministry of Education and Science Grants SAF2008-00146 (to E. I. C) and SAF2006-05481 (to R. F.) and Fundacio La Marato de TV3 Grant 060110 (to E. I. Q. The Proteomics Laboratory at CIMA belongs to the network of the Spanish National Institute of Proteomics Facilities, ProteoRed.	Agnati LF, 2003, PHARMACOL REV, V55, P509, DOI 10.1124/pr.55.3.2; Altamura AC, 2005, WORLD J BIOL PSYCHIA, V6, P23, DOI 10.1080/15622970510030027; Belcheva MM, 2001, J BIOL CHEM, V276, P33847, DOI 10.1074/jbc.M101535200; Bofill-Cardona E, 2000, J BIOL CHEM, V275, P32672, DOI 10.1074/jbc.M002780200; Canals M, 2003, J BIOL CHEM, V278, P46741, DOI 10.1074/jbc.M306451200; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Ciruela F, 2004, ANAL CHEM, V76, P5354, DOI 10.1021/ac049295f; Ferre S, 2008, CURR PHARM DESIGN, V14, P1468, DOI 10.2174/138161208784480108; Ferre S, 1997, TRENDS NEUROSCI, V20, P482, DOI 10.1016/S0166-2236(97)01096-5; FERRE S, 1991, P NATL ACAD SCI USA, V88, P7238, DOI 10.1073/pnas.88.16.7238; Ferre Sergi, 2007, ScientificWorldJournal, V7, P74; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Hillion J, 2002, J BIOL CHEM, V277, P18091, DOI 10.1074/jbc.M107731200; Kamiya T, 2003, BIOCHEM BIOPH RES CO, V306, P544, DOI 10.1016/S0006-291X(03)00991-4; Kocan M, 2008, J BIOMOL SCREEN, V13, P888, DOI 10.1177/1087057108324032; Lee SP, 2003, LIFE SCI, V74, P173, DOI 10.1016/j.lfs.2003.09.028; Liu Y, 2007, J RECEPT SIG TRANSD, V27, P47, DOI 10.1080/10799890601094152; Lucas JL, 2006, PHARM RES-DORDR, V23, P647, DOI 10.1007/s11095-006-9784-9; Milligan G, 2005, FEBS J, V272, P2914, DOI 10.1111/j.1742-4658.2005.04731.x; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Muller Christa E, 2007, Recent Pat CNS Drug Discov, V2, P1, DOI 10.2174/157488907779561772; Munoz J, 2008, PROTEOMICS, V8, P1898, DOI 10.1002/pmic.200701085; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Prinster SC, 2006, J PHARMACOL EXP THER, V318, P974, DOI 10.1124/jpet.106.106526; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Senogles SE, 2004, J BIOL CHEM, V279, P1601, DOI 10.1074/jbc.M309792200; Turner JH, 2004, J BIOL CHEM, V279, P17027, DOI 10.1074/jbc.M313919200; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Woods AS, 2008, J PROTEOME RES, V7, P3428, DOI 10.1021/pr8001782; Woods AS, 2004, J PROTEOME RES, V3, P478, DOI 10.1021/pr034091l; Woods AS, 2005, J MOL NEUROSCI, V26, P125, DOI 10.1385/JMN:26:2-3:125; Woods AS, 2005, J PROTEOME RES, V4, P1397, DOI 10.1021/pr050077s; Woods AS, 2001, J AM SOC MASS SPECTR, V12, P88, DOI 10.1016/S1044-0305(00)00197-5; Zimmermann T, 2002, FEBS LETT, V531, P245, DOI 10.1016/S0014-5793(02)03508-1	37	51	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28058	28068		10.1074/jbc.M109.034231	http://dx.doi.org/10.1074/jbc.M109.034231			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19632986	Green Published, hybrid			2022-12-27	WOS:000270676300033
J	Sabbadin, F; Jackson, R; Haider, K; Tampi, G; Turkenburg, JP; Hart, S; Bruce, NC; Grogan, G				Sabbadin, Federico; Jackson, Rosamond; Haider, Kamran; Tampi, Girish; Turkenburg, Johan P.; Hart, Sam; Bruce, Neil C.; Grogan, Gideon			The 1.5-angstrom Structure of XplA-heme, an Unusual Cytochrome P450 Heme Domain That Catalyzes Reductive Biotransformation of Royal Demolition Explosive	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEXAHYDRO-1,3,5-TRINITRO-1,3,5-TRIAZINE RDX; CRYSTAL-STRUCTURES; DIOXYGEN COMPLEX; WILD-TYPE; SYSTEM; DEGRADATION; DENITRATION; METABOLISM; MECHANISMS; REVEALS	XplA is a cytochrome P450 of unique structural organization, consisting of a heme- domain that is C-terminally fused to its native flavodoxin redox partner. XplA, along with flavodoxin reductase XplB, has been shown to catalyze the breakdown of the nitramine explosive and pollutant hexahydro-1,3,5-trinitro-1,3,5-triazine (royal demolition explosive) by reductive denitration. The structure of the heme domain of XplA (XplA-heme) has been solved in two crystal forms: as a dimer in space group P2(1) to a resolution of 1.9 angstrom and as a monomer in space group P2(1)2(1)2 to a resolution of 1.5 angstrom, with the ligand imidazole bound at the heme iron. Although it shares the overall fold of cytochromes P450 of known structure, XplA-heme is unusual in that the kinked I-helix that traverses the distal face of the heme is broken by Met-394 and Ala-395 in place of the well conserved Asp/Glu plus Thr/Ser, important in oxidative P450s for the scission of the dioxygen bond prior to substrate oxygenation. The heme environment of XplA-heme is hydrophobic, featuring a cluster of three methionines above the heme, including Met-394. Imidazole was observed bound to the heme iron and is in close proximity to the side chain of Gln-438, which is situated over the distal face of the heme. Imidazole is also hydrogen-bonded to a water molecule that sits in place of the threonine side-chain hydroxyl exemplified by Thr-252 in Cyt-P450cam. Both Gln-438 -> Ala and Ala-395 -> Thr mutants of XplA-heme displayed markedly reduced activity compared with the wild type for royal demolition explosive degradation when combined with surrogate electron donors.	[Sabbadin, Federico; Haider, Kamran; Turkenburg, Johan P.; Hart, Sam; Grogan, Gideon] Univ York, Dept Biol, York Struct Biol Lab, York YO10 5YW, N Yorkshire, England; [Sabbadin, Federico; Jackson, Rosamond; Tampi, Girish; Bruce, Neil C.] Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5YW, N Yorkshire, England	University of York - UK; University of York - UK	Grogan, G (corresponding author), Univ York, Dept Chem, York Struct Biol Lab, York YO10 5YW, N Yorkshire, England.	grogan@ysbl.york.ac.uk		Hart, Sam/0000-0002-3542-1126; Bruce, Neil Charles/0000-0003-0398-2997; Turkenburg, Johan/0000-0001-6992-6838	Strategic and Environmental Research and Development Program of the U.S. Dept. of Defense; Biotechnology and Biological Sciences Research Council; Centre of Excellence for Biocatalysis, Biotransformation, and Biomanufacture; Biotechnology and Biological Sciences Research Council [BB/E000576/1] Funding Source: researchfish; Medical Research Council [G0500367] Funding Source: researchfish; BBSRC [BB/E000576/1] Funding Source: UKRI; MRC [G0500367] Funding Source: UKRI	Strategic and Environmental Research and Development Program of the U.S. Dept. of Defense; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Centre of Excellence for Biocatalysis, Biotransformation, and Biomanufacture; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by the Strategic and Environmental Research and Development Program of the U.S. Dept. of Defense, by the Biotechnology and Biological Sciences Research Council, and by a studentship from the Centre of Excellence for Biocatalysis, Biotransformation, and Biomanufacture (to F. S.).	Abbott DW, 2009, J BIOL CHEM, V284, P11676, DOI 10.1074/jbc.M809663200; ALSTON TA, 1980, BIOCHEM BIOPH RES CO, V97, P294, DOI 10.1016/S0006-291X(80)80167-7; Andeer PF, 2009, APPL ENVIRON MICROB, V75, P3258, DOI 10.1128/AEM.02396-08; Atkin KE, 2008, J MOL BIOL, V384, P1218, DOI 10.1016/j.jmb.2008.09.090; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bairoch A, 1996, NUCLEIC ACIDS RES, V24, P21, DOI 10.1093/nar/24.1.21; Bhushan B, 2003, APPL ENVIRON MICROB, V69, P1347, DOI 10.1128/AEM.69.3.1347-1351.2003; BINKS PR, 1995, APPL ENVIRON MICROB, V61, P1318, DOI 10.1128/AEM.61.4.1318-1322.1995; Bonsor D, 2006, ORG BIOMOL CHEM, V4, P1252, DOI 10.1039/b517338h; Boopathy R, 1998, CURR MICROBIOL, V37, P127, DOI 10.1007/s002849900350; Buzukov AA, 1996, CHEM-BIOL INTERACT, V100, P113, DOI 10.1016/0009-2797(96)03694-0; Clarke TA, 2008, BIOCHEMISTRY-US, V47, P3789, DOI 10.1021/bi702175w; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cryle MJ, 2008, P NATL ACAD SCI USA, V105, P15696, DOI 10.1073/pnas.0805983105; Cupp-Vickery JR, 2001, J MOL BIOL, V311, P101, DOI 10.1006/jmbi.2001.4803; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; HOFFSOMMER JC, 1977, J PHYS CHEM-US, V81, P380, DOI 10.1021/j100520a003; Jackson RG, 2007, P NATL ACAD SCI USA, V104, P16822, DOI 10.1073/pnas.0705110104; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leys D, 2003, J BIOL CHEM, V278, P5141, DOI 10.1074/jbc.M209928200; LOCKHART RW, 1976, J CHEM SOC CHEM COMM, P52; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Makino M, 2007, P NATL ACAD SCI USA, V104, P11591, DOI 10.1073/pnas.0702946104; Meharenna YT, 2008, J BIOL CHEM, V283, P10804, DOI 10.1074/jbc.M709722200; Mellado E, 2004, ANTIMICROB AGENTS CH, V48, P2747, DOI 10.1128/AAC.48.7.2747-2750.2004; Munro AW, 2007, NAT PROD REP, V24, P585, DOI 10.1039/b604190f; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagano S, 2005, J BIOL CHEM, V280, P22102, DOI 10.1074/jbc.M501732200; Nagano S, 2005, J BIOL CHEM, V280, P31659, DOI 10.1074/jbc.M505261200; Obayashi E, 2000, J INORG BIOCHEM, V82, P103, DOI 10.1016/S0162-0134(00)00161-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peterson JA, 1998, STRUCTURE, V6, P1079, DOI 10.1016/S0969-2126(98)00109-9; POULOS TL, 1985, J BIOL CHEM, V260, P6122; Rylott EL, 2006, NAT BIOTECHNOL, V24, P216, DOI 10.1038/nbt1184; Santarelli LC, 2006, J PHYSIOL-LONDON, V571, P329, DOI 10.1113/jphysiol.2005.101089; SERVENT D, 1989, BIOCHEM BIOPH RES CO, V163, P1210, DOI 10.1016/0006-291X(89)91106-6; Seth-Smith HMB, 2008, APPL ENVIRON MICROB, V74, P4550, DOI 10.1128/AEM.00391-08; Seth-Smith HMB, 2002, APPL ENVIRON MICROB, V68, P4764, DOI 10.1128/AEM.68.10.4764-4771.2002; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vidakovic M, 1998, BIOCHEMISTRY-US, V37, P9211, DOI 10.1021/bi980189f; Winn PJ, 2002, P NATL ACAD SCI USA, V99, P5361, DOI 10.1073/pnas.082522999; Xiang H, 2000, J BIOL CHEM, V275, P35999, DOI 10.1074/jbc.M005811200; ZHANG MJ, 1994, J BIOL CHEM, V269, P15546; ZHAO JS, 2006, FEMS MICROBIOL ECOL, V39, P349	46	24	25	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28467	28475		10.1074/jbc.M109.031559	http://dx.doi.org/10.1074/jbc.M109.031559			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19692330	hybrid, Green Published			2022-12-27	WOS:000270676300071
J	Sturla, L; Fresia, C; Guida, L; Bruzzone, S; Scarfi, S; Usai, C; Fruscione, F; Magnone, M; Millo, E; Basile, G; Grozio, A; Jacchetti, E; Allegretti, M; De Flora, A; Zocchi, E				Sturla, Laura; Fresia, Chiara; Guida, Lucrezia; Bruzzone, Santina; Scarfi, Sonia; Usai, Cesare; Fruscione, Floriana; Magnone, Mirko; Millo, Enrico; Basile, Giovanna; Grozio, Alessia; Jacchetti, Emanuela; Allegretti, Marcello; De Flora, Antonio; Zocchi, Elena			LANCL2 Is Necessary for Abscisic Acid Binding and Signaling in Human Granulocytes and in Rat Insulinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; CELLULAR-SENSITIVITY; G-PROTEINS; RECEPTOR; INFLAMMATION; EXPRESSION; GPCR; 2ND-MESSENGER; BIOSYNTHESIS; ACTIVATION	Abscisic acid (ABA) is a plant hormone regulating fundamental physiological functions in plants, such as response to abiotic stress. Recently, ABA was shown to be produced and released by human granulocytes, by insulin-producing rat insulinoma cells, and by human and murine pancreatic beta cells. ABA autocrinally stimulates the functional activities specific for each cell type through a receptor-operated signal transduction pathway, sequentially involving a pertussis toxin-sensitive receptor/G-protein complex, cAMP, CD38-produced cADP-ribose and intracellular calcium. Here we show that the lanthionine synthetase C-like protein LANCL2 is required for ABA binding on the membrane of human granulocytes and that LANCL2 is necessary for transduction of the ABA signal into the cell-specific functional responses in granulocytes and in rat insulinoma cells. Co-expression of LANCL2 and CD38 in the human HeLa cell line reproduces the ABA-signaling pathway. Results obtained with granulocytes and CD38(+)/LANCL2(+) HeLa transfected with a chimeric G-protein (G alpha(q/i)) suggest that the pertussis toxin-sensitive G-protein coupled to LANCL2 is a G(i). Identification of LANCL2 as a critical component of the ABA-sensing protein complex will enable the screening of synthetic ABA antagonists as prospective new anti-inflammatory and anti-diabetic agents.	[Sturla, Laura; Fresia, Chiara; Guida, Lucrezia; Bruzzone, Santina; Scarfi, Sonia; Magnone, Mirko; Millo, Enrico; Basile, Giovanna; Grozio, Alessia; De Flora, Antonio; Zocchi, Elena] Univ Genoa, Dept Expt Med, Biochem Sect, I-16132 Genoa, Italy; [Sturla, Laura; Fresia, Chiara; Guida, Lucrezia; Bruzzone, Santina; Scarfi, Sonia; Magnone, Mirko; Millo, Enrico; Basile, Giovanna; Grozio, Alessia; De Flora, Antonio; Zocchi, Elena] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; [Scarfi, Sonia; Fruscione, Floriana; Zocchi, Elena] Adv Biotechnol Ctr, I-16132 Genoa, Italy; [Usai, Cesare; Jacchetti, Emanuela] CNR, Inst Biophys, I-16149 Genoa, Italy; [Allegretti, Marcello] Dompe Pharma, I-67100 Laquila, Italy	University of Genoa; University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Dompe	De Flora, A (corresponding author), Univ Genoa, Dept Expt Med, Biochem Sect, Viale Benedetto XV 1, I-16132 Genoa, Italy.	toninodf@unige.it; ezocchi@unige.it	Millo, Enrico/K-3218-2018; fruscione, floriana/AAA-8747-2020; JACCHETTI, Emanuela/AAP-2453-2021; Scarfi, Sonia/AAJ-2387-2020; Bruzzone, Santina/A-4264-2015	Millo, Enrico/0000-0002-4019-0051; JACCHETTI, Emanuela/0000-0001-5990-001X; Scarfi, Sonia/0000-0002-7079-6919; Bruzzone, Santina/0000-0003-2034-3716; Usai, Cesare/0000-0001-8863-7759; fruscione, floriana/0000-0002-4054-645X; FRESIA, CHIARA MARTA/0000-0002-9177-4655	Regione Liguria; Ministero dell'Istruzione; dell'Universita e della Ricerca; University of Genova; Fondazione Cassa di Risparmio di Genova e Imperia	Regione Liguria(Regione Liguria); Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); University of Genova; Fondazione Cassa di Risparmio di Genova e Imperia	This work was supported by grants from Regione Liguria, Ministero dell'Istruzione, dell'Universita e della Ricerca, the University of Genova and Fondazione Cassa di Risparmio di Genova e Imperia.	Bauer H, 2000, BIOCHEM BIOPH RES CO, V275, P69, DOI 10.1006/bbrc.2000.3260; Bodrato N, 2009, J BIOL CHEM, V284, P14777, DOI 10.1074/jbc.M802604200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruzzone S, 2003, BIOCHEM J, V375, P395, DOI 10.1042/BJ20030556; Bruzzone S, 2008, J BIOL CHEM, V283, P32188, DOI 10.1074/jbc.M802603200; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; Coward P, 1999, ANAL BIOCHEM, V270, P242, DOI 10.1006/abio.1999.4061; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Dorn GW, 1997, BIOCHEMISTRY-US, V36, P6415, DOI 10.1021/bi970080s; Escriba PV, 2007, BBA-BIOMEMBRANES, V1768, P836, DOI 10.1016/j.bbamem.2006.09.001; Gao YJ, 2007, PLANT J, V52, P1001, DOI 10.1111/j.1365-313X.2007.03291.x; GIERSCHIK P, 1989, J BIOL CHEM, V264, P21470; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; GUIDA L, 1995, FEBS LETT, V368, P481, DOI 10.1016/0014-5793(95)00715-L; Guo JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002982; Illingworth CJR, 2008, BIOPHYS CHEM, V133, P28, DOI 10.1016/j.bpc.2007.11.004; Johnston CA, 2007, SCIENCE, V318, DOI 10.1126/science.1143230; Katoh M, 2003, INT J MOL MED, V12, P399; Kim K, 2008, ARCH PHARM RES, V31, P310, DOI 10.1007/s12272-001-1157-x; Landlinger C, 2006, BBA-BIOMEMBRANES, V1758, P1759, DOI 10.1016/j.bbamem.2006.07.018; LeBrasseur N, 2007, J CELL BIOL, V179, P174, DOI 10.1083/jcb.1792pi; LEE HC, 2002, CYCLIC ADP RIBOSE NA, P23; Liu XG, 2007, SCIENCE, V315, P1712, DOI 10.1126/science.1135882; Magnone M, 2009, J BIOL CHEM, V284, P17808, DOI 10.1074/jbc.M809546200; Mayer H, 1998, BBA-GENE STRUCT EXPR, V1395, P301, DOI 10.1016/S0167-4781(97)00178-4; Mayer H, 2001, CYTOGENET CELL GENET, V93, P100, DOI 10.1159/000056958; McCourt P, 2008, CURR OPIN PLANT BIOL, V11, P474, DOI 10.1016/j.pbi.2008.06.014; Moreschi I, 2006, J BIOL CHEM, V281, P31419, DOI 10.1074/jbc.M606625200; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Park S, 2003, CANCER RES, V63, P723; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Sahl HG, 1998, ANNU REV MICROBIOL, V52, P41, DOI 10.1146/annurev.micro.52.1.41; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; SIMCHOWITZ L, 1980, J IMMUNOL, V124, P1482; Stahlberg A, 2005, EXPERT REV MOL DIAGN, V5, P221, DOI 10.1586/14737159.5.2.221; Tsu RC, 1996, J NEUROSCI, V16, P1317; Utsumi T, 2005, FEBS J, V272, P472, DOI 10.1111/j.1742-4658.2004.04487.x; Wu Y, 1997, SCIENCE, V278, P2126, DOI 10.1126/science.278.5346.2126; Zocchi E, 1998, J BIOL CHEM, V273, P8017, DOI 10.1074/jbc.273.14.8017	43	88	100	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28045	28057		10.1074/jbc.M109.035329	http://dx.doi.org/10.1074/jbc.M109.035329			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19667068	Green Published, hybrid			2022-12-27	WOS:000270676300032
J	Chen, L; Zhang, JJ; Rafii, S; Huang, XY				Chen, Lin; Zhang, J. Jillian; Rafii, Shahin; Huang, Xin-Yun			Suppression of Tumor Angiogenesis by G alpha(13) Haploinsufficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL PROGENITOR CELLS; GROWTH-FACTOR; BONE-MARROW; G-PROTEINS; NEOVASCULARIZATION; METASTASIS; MIGRATION; RECRUITMENT; SWITCH	Heterotrimeric G proteins are critical transducers of cellular signaling. Of the four families of G proteins, the physiological function of G alpha(13) is less well understood. G alpha(13) gene-deleted mice die at embryonic day similar to 9.5. Here, we show that heterozygous G alpha(+/-)(13) mice display defects in adult angiogenesis. Female G alpha(+/-)(13) mice showed a higher number of immature follicles and a lower density of blood vessels in the mature corpus luteum compared with G alpha(+/-)(13) mice. Furthermore, implanted tumors grew slower in G alpha(+/-)(13) host mice. These tumor tissues had many fewer blood vessels compared with those from G alpha(+/+)(13) host mice. Moreover, bone marrow-derived progenitor cells from G alpha(+/+)(13) mice rescued the failed growth of allografted tumors when reconstituted into irradiated G alpha(+/-)(13) mice. Hence, G alpha(13) is haploinsufficient for adult angiogenesis in both the female reproductive system and tumor angiogenesis.	[Chen, Lin; Zhang, J. Jillian; Huang, Xin-Yun] Cornell Univ, Dept Physiol, New York, NY 10065 USA; [Rafii, Shahin] Cornell Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Rafii, Shahin] Cornell Univ, Weill Med Coll, Dept Med Genet, New York, NY 10065 USA	Cornell University; Cornell University; Howard Hughes Medical Institute; Cornell University	Huang, XY (corresponding author), Cornell Univ, Dept Physiol, New York, NY 10065 USA.	xyhuang@med.cornell.edu			National Institutes of Health [HL91525]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL91525.	Adams GB, 2009, NATURE, V459, P103, DOI 10.1038/nature07859; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Ferrara N, 1998, NAT MED, V4, P336, DOI 10.1038/nm0398-336; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Fraser HM, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-18; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Gu JL, 2002, P NATL ACAD SCI USA, V99, P9352, DOI 10.1073/pnas.102291599; Guo DG, 2007, CELL, V128, P341, DOI 10.1016/j.cell.2006.11.048; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Radhika V, 2004, J BIOL CHEM, V279, P49406, DOI 10.1074/jbc.M408836200; Rafii S, 2008, SCIENCE, V319, P163, DOI 10.1126/science.1153615; Redmer D A, 1996, Rev Reprod, V1, P182; Ruppel KM, 2005, P NATL ACAD SCI USA, V102, P8281, DOI 10.1073/pnas.0503326102; Seandel M, 2008, CANCER CELL, V13, P181, DOI 10.1016/j.ccr.2008.02.016; Shan DD, 2006, DEV CELL, V10, P707, DOI 10.1016/j.devcel.2006.03.014; Shan DD, 2005, P NATL ACAD SCI USA, V102, P3772, DOI 10.1073/pnas.0500658102; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Spring H, 2005, P NATL ACAD SCI USA, V102, P18111, DOI 10.1073/pnas.0507158102; VRCIC H, 1992, GYNECOL OBSTET INVES, V33, P69; Wang DW, 2006, J BIOL CHEM, V281, P32660, DOI 10.1074/jbc.M604588200; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200	31	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27409	27415		10.1074/jbc.M109.025460	http://dx.doi.org/10.1074/jbc.M109.025460			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19654325	hybrid, Green Published			2022-12-27	WOS:000270232300043
J	Narasimhachar, Y; Coue, M				Narasimhachar, Yadushyla; Coue, Martine			Geminin Stabilizes Cdt1 during Meiosis in Xenopus Oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDK-DEPENDENT UBIQUITINATION; LICENSING FACTOR CDT1; CELL-CYCLE REGULATION; DNA-REPLICATION; EGG EXTRACTS; S-PHASE; PREVENTS REREPLICATION; TRANSLATIONAL CONTROL; RE-REPLICATION; NUCLEAR IMPORT	During the mitotic cell cycle, Geminin can act both as a promoter and inhibitor of initiation of DNA replication. As a promoter, Geminin stabilizes Cdt1 and facilitates its accumulation leading to the assembly of the pre-replication complex on DNA. As an inhibitor, Geminin prevents Cdt1 from loading the minichromosome maintenance complex onto pre-replication complexes in late S, G(2), and M phases. Here we show that during meiosis Geminin functions as a stabilizer of Cdt1 promoting its accumulation for the early division cycles of the embryo. Depletion of Geminin in Xenopus immature oocytes leads to a decrease of Cdt1 protein levels during maturation and after activation of these oocytes. Injection of exogenous recombinant Geminin into the depleted oocytes rescues Cdt1 levels demonstrating that Geminin stabilizes Cdt1 during meiosis and after fertilization. Furthermore, Geminin-depleted oocytes did not replicate their DNA after meiosis I indicating that Geminin does not act as an inhibitor of initiation of DNA replication between meiosis I and meiosis II.	[Narasimhachar, Yadushyla; Coue, Martine] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Narasimhachar, Y (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, 3601 4th St, Lubbock, TX 79430 USA.	yadushyla.narasimhachar@ttuhsc.edu; martine.coue@ttuhsc.edu			National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by a National Institutes of Health grant (to M. C.).	Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Auziol C, 2007, BIOCHEM BIOPH RES CO, V361, P276, DOI 10.1016/j.bbrc.2007.06.117; Ballabeni A, 2004, EMBO J, V23, P3122, DOI 10.1038/sj.emboj.7600314; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Chang HY, 2004, J CELL SCI, V117, P6289, DOI 10.1242/jcs.01567; Coue M, 1996, EMBO J, V15, P1085, DOI 10.1002/j.1460-2075.1996.tb00446.x; FURUNO N, 1994, EMBO J, V13, P2399, DOI 10.1002/j.1460-2075.1994.tb06524.x; Gopalakrishnan V, 2001, P NATL ACAD SCI USA, V98, P13114, DOI 10.1073/pnas.221467598; Gutierrez GJ, 2006, NAT CELL BIOL, V8, P1084, DOI 10.1038/ncb1472; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Hochegger H, 2001, DEVELOPMENT, V128, P3795; Hodgson B, 2002, CURR BIOL, V12, P678, DOI 10.1016/S0960-9822(02)00778-9; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Iwabuchi M, 2000, EMBO J, V19, P4513, DOI 10.1093/emboj/19.17.4513; Kim Y, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-18; Lemaitre JM, 2002, NATURE, V419, P718, DOI 10.1038/nature01046; Li A, 2005, EMBO J, V24, P395, DOI 10.1038/sj.emboj.7600520; Li A, 2004, CELL CYCLE, V3, P443; Li A, 2004, NAT CELL BIOL, V6, P260, DOI 10.1038/ncb1100; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Liu EB, 2004, J BIOL CHEM, V279, P17283, DOI 10.1074/jbc.C300549200; Lutzmann M, 2008, MOL CELL, V31, P190, DOI 10.1016/j.molcel.2008.07.001; Lutzmann M, 2006, EMBO J, V25, P5764, DOI 10.1038/sj.emboj.7601436; Lygerou Z, 2000, SCIENCE, V290, P2271; Machida YJ, 2007, GENE DEV, V21, P184, DOI 10.1101/gad.1495007; Madine M, 2001, NAT CELL BIOL, V3, pE49, DOI 10.1038/35055158; Maiorano D, 2005, CURR BIOL, V15, P146, DOI 10.1016/j.cub.2004.12.002; Marangos P, 2007, J CELL BIOL, V176, P65, DOI 10.1083/jcb.200607070; McGarry TJ, 2002, MOL BIOL CELL, V13, P3662, DOI 10.1091/mbc.E02-04-0199; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Melixetian M, 2004, CELL CYCLE, V3, P1002; Nakajo N, 2000, GENE DEV, V14, P328; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Nishitani H, 2004, J BIOL CHEM, V279, P30807, DOI 10.1074/jbc.M312644200; OHSUMI K, 1994, J CELL SCI, V107, P3005; Papin C, 2004, DEV BIOL, V272, P66, DOI 10.1016/j.ydbio.2004.04.018; Pereverzeva I, 2000, MOL CELL BIOL, V20, P3667, DOI 10.1128/MCB.20.10.3667-3676.2000; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Quinn LM, 2001, GENE DEV, V15, P2741, DOI 10.1101/gad.916201; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; Saxena S, 2005, MUTAT RES-FUND MOL M, V569, P111, DOI 10.1016/j.mrfmmm.2004.05.026; Saxena S, 2003, CELL CYCLE, V2, P283, DOI 10.4161/cc.2.4.443; Setoyama D, 2007, P NATL ACAD SCI USA, V104, P18001, DOI 10.1073/pnas.0706952104; Sugimoto N, 2008, MOL BIOL CELL, V19, P1007, DOI 10.1091/mbc.E07-09-0859; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Takeda DY, 2005, J BIOL CHEM, V280, P23416, DOI 10.1074/jbc.M501208200; Thomer M, 2004, DEVELOPMENT, V131, P4807, DOI 10.1242/dev.01348; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Whitmire E, 2002, NATURE, V419, P722, DOI 10.1038/nature01032; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Xouri G, 2007, EMBO J, V26, P1303, DOI 10.1038/sj.emboj.7601597; Yamamoto TM, 2005, DEV BIOL, V279, P345, DOI 10.1016/j.ydbio.2004.12.025; Yanagi K, 2005, J BIOL CHEM, V280, P19689, DOI 10.1074/jbc.C500070200; Yanagi K, 2002, J BIOL CHEM, V277, P40871, DOI 10.1074/jbc.M206202200; Yoshida K, 2005, GENES CELLS, V10, P63, DOI 10.1111/j.1365-2443.2005.00815.x; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747; Zhou Y, 2002, BIOCHEM BIOPH RES CO, V294, P120, DOI 10.1016/S0006-291X(02)00447-3; Zhu WG, 2009, CANCER RES, V69, P4870, DOI 10.1158/0008-5472.CAN-08-4559	58	9	11	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27235	27242		10.1074/jbc.M109.008854	http://dx.doi.org/10.1074/jbc.M109.008854			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19656945	Green Published, hybrid			2022-12-27	WOS:000270232300024
J	Tiwari, D; Singh, RK; Goswami, K; Verma, SK; Prakash, B; Nandicoori, VK				Tiwari, Divya; Singh, Rajnish Kumar; Goswami, Kasturi; Verma, Sunil Kumar; Prakash, Balaji; Nandicoori, Vinay Kumar			Key Residues in Mycobacterium tuberculosis Protein Kinase G Play a Role in Regulating Kinase Activity and Survival in the Host	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE/THREONINE KINASE; SER/THR KINASE; CELL-DIVISION; PATHOGENIC MYCOBACTERIA; PHOSPHORYLATION SITES; ACTIVATION MECHANISM; VIRULENCE FACTOR; IN-VIVO; PKNB; DOMAIN	Protein kinase G (PknG) in Mycobacterium tuberculosis has been shown to modulate phagosome-lysosome fusion. The protein has three distinct domains, an N-terminal Trx domain, a kinase domain, and a C-terminal TPR domain. The present study extensively analyzes the roles of these domains in regulating PknG kinase activity and function. We find that the kinase domain of PknG by itself is inactive, signifying the importance of the flanking domains. Although the deletion of the Trx domain severely impacts the activity of the protein, the C-terminal region also contributes significantly in regulating the activity of the kinase. Apart from this, PknG kinase activity is dependent on the presence of threonine 309 in the p + 1 loop of the activation segment. Mutating the conserved cysteine residues in the Trx motifs makes PknG refractory to changes in the redox environment. In vitro experiments identify threonine 63 as the major phosphorylation site of the protein. Importantly, we find that this is the only site in the protein that is phosphorylated in vivo. Macrophage infection studies reveal that the first 73 residues, the Trx motifs, and the threonine 63 residue are independently essential for modulating PknG-mediated survival of mycobacteria in its host. We have extended these studies to investigate the role of PknG and PknG mutants in the pathogenesis of mycobacteria in mice. Our results reinforce the findings from the macrophage infection experiments, and for the first time demonstrate that the expression of PknG in non-pathogenic mycobacteria allows the continued existence of these bacteria in host tissues.	[Tiwari, Divya; Singh, Rajnish Kumar; Goswami, Kasturi; Nandicoori, Vinay Kumar] Natl Inst Immunol, New Delhi 110067, India; [Verma, Sunil Kumar; Prakash, Balaji] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Nandicoori, VK (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	vinaykn@nii.res.in	Verma, Sunil Kumar/J-8838-2019	Verma, Sunil Kumar/0000-0001-9443-2493; SINGH, RAJNISH/0000-0001-7414-1170; Tiwari, Divya/0000-0001-7631-2471; Nandicoori, Vinay/0000-0002-5682-4178	Department of Biotechnology (DBT), India; International Research Fellowship; Wellcome Trust, United Kingdom	Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); International Research Fellowship; Wellcome Trust, United Kingdom(Wellcome Trust)	This work was supported by the Department of Biotechnology (DBT), India (to V. K. N. and B. P.) and by an International Research Fellowship grant from the Wellcome Trust, United Kingdom (to B. P.).	Av-Gay Y, 1999, INFECT IMMUN, V67, P5676, DOI 10.1128/IAI.67.11.5676-5682.1999; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Canova MJ, 2008, PROTEOMICS, V8, P521, DOI 10.1002/pmic.200700442; Canova MJ, 2009, J BACTERIOL, V191, P2876, DOI 10.1128/JB.01569-08; Chaba R, 2002, EUR J BIOCHEM, V269, P1078, DOI 10.1046/j.1432-1033.2002.02778.x; Cohen-Gonsaud M, 2009, J BIOL CHEM, V284, P19290, DOI 10.1074/jbc.M109.019653; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COLLINS FM, 1985, TUBERCLE, V66, P267, DOI 10.1016/0041-3879(85)90064-9; Cortajarena AL, 2006, PROTEIN SCI, V15, P1193, DOI 10.1110/ps.062092506; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Deol P, 2005, J BACTERIOL, V187, P3415, DOI 10.1128/JB.187.10.3415-3420.2005; Dheenadhayalan V, 2006, MICROBES INFECT, V8, P262, DOI 10.1016/j.micinf.2005.06.021; Duran R, 2005, BIOCHEM BIOPH RES CO, V333, P858, DOI 10.1016/j.bbrc.2005.05.173; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Fiuza M, 2008, J BIOL CHEM, V283, P18099, DOI 10.1074/jbc.M802615200; Gay LM, 2006, J MOL BIOL, V360, P409, DOI 10.1016/j.jmb.2006.05.015; Good MC, 2004, J MOL BIOL, V339, P459, DOI 10.1016/j.jmb.2004.03.063; Gopalaswamy R, 2004, PROTEIN EXPRES PURIF, V36, P82, DOI 10.1016/j.pep.2004.03.011; Gopalaswamy R, 2008, FEMS MICROBIOL LETT, V278, P121, DOI 10.1111/j.1574-6968.2007.00989.x; Gopalaswamy R, 2009, FEMS MICROBIOL LETT, V295, P23, DOI 10.1111/j.1574-6968.2009.01570.x; Greenstein AE, 2005, J MOL MICROB BIOTECH, V9, P167, DOI 10.1159/000089645; Greenstein AE, 2007, J BIOL CHEM, V282, P11427, DOI 10.1074/jbc.M610193200; Grundner C, 2005, PROTEIN SCI, V14, P1918, DOI 10.1110/ps.051413405; Houben ENG, 2009, MOL MICROBIOL, V72, P41, DOI 10.1111/j.1365-2958.2009.06612.x; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Koul A, 2001, MICROBIOL-SGM, V147, P2307, DOI 10.1099/00221287-147-8-2307; Krupa A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-129; Kumar P, 2009, J BIOL CHEM, V284, P11090, DOI 10.1074/jbc.M808705200; Lakshminarayan H, 2008, PROTEIN EXPRES PURIF, V58, P309, DOI 10.1016/j.pep.2007.12.012; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Mieczkowski C, 2008, EMBO J, V27, P3186, DOI 10.1038/emboj.2008.236; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Molle V, 2003, BIOCHEM BIOPH RES CO, V308, P820, DOI 10.1016/S0006-291X(03)01476-1; Molle V, 2006, PROTEOMICS, V6, P3754, DOI 10.1002/pmic.200500900; Nguyen L, 2005, J BACTERIOL, V187, P5852, DOI 10.1128/JB.187.16.5852-5856.2005; Niebisch A, 2006, J BIOL CHEM, V281, P12300, DOI 10.1074/jbc.M512515200; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Ortiz-Lombardia M, 2003, J BIOL CHEM, V278, P13094, DOI 10.1074/jbc.M300660200; Parikh A, 2009, J MOL BIOL, V386, P451, DOI 10.1016/j.jmb.2008.12.031; Park ST, 2008, P NATL ACAD SCI USA, V105, P13105, DOI 10.1073/pnas.0801143105; Peirs P, 2000, FEMS MICROBIOL LETT, V188, P135; Raghunand TR, 2006, J BACTERIOL, V188, P6966, DOI 10.1128/JB.00384-06; Scherr N, 2007, P NATL ACAD SCI USA, V104, P12151, DOI 10.1073/pnas.0702842104; Scherr N, 2009, J BACTERIOL, V191, P4546, DOI 10.1128/JB.00245-09; Sharma K, 2006, J BACTERIOL, V188, P2936, DOI 10.1128/JB.188.8.2936-2944.2006; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Thakur M, 2008, BIOCHEM J, V415, P27, DOI 10.1042/BJ20080234; Thakur M, 2008, J BIOL CHEM, V283, P8023, DOI 10.1074/jbc.M707535200; Thakur M, 2006, J BIOL CHEM, V281, P40107, DOI 10.1074/jbc.M607216200; Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200; Villarino A, 2005, J MOL BIOL, V350, P953, DOI 10.1016/j.jmb.2005.05.049; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Weldingh K, 1998, INFECT IMMUN, V66, P3492, DOI 10.1128/IAI.66.8.3492-3500.1998; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897	57	52	64	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27467	27479		10.1074/jbc.M109.036095	http://dx.doi.org/10.1074/jbc.M109.036095			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19638631	Green Published, hybrid			2022-12-27	WOS:000270232300049
J	Morikawa, RK; Aoki, J; Kano, F; Murata, M; Yamamoto, A; Tsujimoto, M; Arai, H				Morikawa, Rei K.; Aoki, Junken; Kano, Fumi; Murata, Masayuki; Yamamoto, Akitsugu; Tsujimoto, Masafumi; Arai, Hiroyuki			Intracellular Phospholipase A(1)gamma(iPLA(1)gamma) Is a Novel Factor Involved in Coat Protein Complex I- and Rab6-independent Retrograde Transport between the Endoplasmic Reticulum and the Golgi Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN SEC23P-INTERACTING PROTEIN; BREFELDIN-A; PHOSPHATIDIC-ACID; MEMBRANE TRAFFICKING; INTERMEDIATE COMPARTMENT; RECYCLING PATHWAY; PLASMA-MEMBRANE; CHOLERA-TOXIN; BOVINE TESTIS; CELL-SURFACE	The mammalian intracellular phospholipase A(1) (iPLA1) family consists of three members, iPLA(1)alpha/PA-PLA(1), iPLA(1)beta/p125, and iPLA(1)gamma/KIAA0725p. Although iPLA(1)beta has been implicated in organization of the ER-Golgi compartments, little is known about the physiological role of its closest paralog, iPLA(1)gamma. Here we show that iPLA(1)gamma mediates a specific retrograde membrane transport pathway between the endoplasmic reticulum (ER) and the Golgi complex. iPLA(1)gamma appeared to be localized to the cytosol, the cis-Golgi, and the ER-Golgi intermediate compartment (ERGIC). Time-lapse microscopy revealed that a population of GFP-iPLA(1)gamma was associated with transport carriers moving out from the Golgi complex. Knockdown of iPLA(1)gamma expression by RNAi did not affect the anterograde transport of VSVGts045 but dramatically delayed two types of Golgi-to-ER retrograde membrane transport; that is, transfer of the Golgi membrane into the ER in the presence of brefeldin A and delivery of cholera toxin B subunit from the Golgi complex to the ER. Notably, knockdown of iPLA(1)gamma did not impair COPI- and Rab6-dependent retrograde transports represented by ERGIC-53 recycling and ER delivery of Shiga toxin, respectively. Thus, iPLA(1)gamma is a novel membrane transport factor that contributes to a specific Golgi-to-ER retrograde pathway distinct from presently characterized COPI- and Rab6-dependent pathways.	[Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Morikawa, Rei K.; Aoki, Junken; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kano, Fumi; Murata, Masayuki] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; [Yamamoto, Akitsugu] Nagahama Inst Bio Sci & Technol, Dept Biosci, Nagahama 5260829, Japan; [Tsujimoto, Masafumi] RIKEN, Lab Cellular Biochem, Wako, Saitama 3510198, Japan; [Aoki, Junken] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Arai, Hiroyuki] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Tohoku University; University of Tokyo; University of Tokyo; RIKEN; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Aoki, J (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, 6-3 Aobayama, Sendai, Miyagi 9808578, Japan.	jaoki@mail.pharm.tohoku.ac.jp		Aoki, Junken/0000-0001-9435-1896	Ministry of Education, Culture, Sports, Science, and Technology; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported in part by research grants from the Ministry of Education, Culture, Sports, Science, and Technology and PRESTO from the Japan Science and Technology Agency.	Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; Bannykh SI, 1996, J CELL BIOL, V135, P19, DOI 10.1083/jcb.135.1.19; Basanez G, 1997, BIOPHYS J, V72, P2630, DOI 10.1016/S0006-3495(97)78906-9; Ben-Tekaya H, 2005, J CELL SCI, V118, P357, DOI 10.1242/jcs.01615; Bergmann JE, 1989, METHOD CELL BIOL, V32, P85; Blackwood RA, 1996, J LEUKOCYTE BIOL, V59, P663, DOI 10.1002/jlb.59.5.663; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Chambers K, 2005, J CELL SCI, V118, P3061, DOI 10.1242/jcs.02435; Chen A, 2003, J CELL SCI, V116, P3503, DOI 10.1242/jcs.00641; de Figueiredo P, 2000, TRAFFIC, V1, P504, DOI 10.1034/j.1600-0854.2000.010608.x; de Figueiredo P, 1998, P NATL ACAD SCI USA, V95, P8642, DOI 10.1073/pnas.95.15.8642; Del Nery E, 2006, TRAFFIC, V7, P394, DOI 10.1111/j.1600-0854.2006.00395.x; Drecktrah D, 2003, MOL BIOL CELL, V14, P3459, DOI 10.1091/mbc.E02-11-0711; Emoto K, 2000, J CELL BIOL, V149, P1215, DOI 10.1083/jcb.149.6.1215; Feng Y, 2004, EMBO REP, V5, P596, DOI 10.1038/sj.embor.7400152; Fujinaga Y, 2003, MOL BIOL CELL, V14, P4783, DOI 10.1091/mbc.E03-06-0354; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; Hauri HP, 2000, J CELL SCI, V113, P587; Higgs HN, 1998, J BIOL CHEM, V273, P5468, DOI 10.1074/jbc.273.10.5468; Higgs HN, 1996, J BIOL CHEM, V271, P10874, DOI 10.1074/jbc.271.18.10874; HIGGS HN, 1994, P NATL ACAD SCI USA, V91, P9574, DOI 10.1073/pnas.91.20.9574; Inoue A, 2006, FUTURE LIPIDOL, V1, P687, DOI 10.2217/17460875.1.6.687; INOUE K, 2004, PHOSPHOLIPASE A1 STR, P23; Johannes L, 2000, TRAFFIC, V1, P119, DOI 10.1034/j.1600-0854.2000.010204.x; Kanamori T, 2008, EMBO J, V27, P1647, DOI 10.1038/emboj.2008.102; Kano F, 2000, MOL BIOL CELL, V11, P3073, DOI 10.1091/mbc.11.9.3073; Kato T, 2002, PLANT CELL, V14, P33, DOI 10.1105/tpc.010215; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Klumperman J, 1998, J CELL SCI, V111, P3411; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lencer WI, 2003, TRENDS BIOCHEM SCI, V28, P639, DOI 10.1016/j.tibs.2003.10.002; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Luo H, 2006, CELL STRUCT FUNCT, V31, P63, DOI 10.1247/csf.31.63; Mardones GA, 2006, MOL BIOL CELL, V17, P525, DOI 10.1091/mbc.E05-05-0447; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Morikawa R, 2007, METHOD ENZYMOL, V434, P1, DOI 10.1016/S0076-6879(07)34001-9; Nakajima K, 2002, J BIOL CHEM, V277, P11329, DOI 10.1074/jbc.M111092200; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Pathre P, 2003, EMBO J, V22, P4059, DOI 10.1093/emboj/cdg390; PETE MJ, 1994, J BIOL CHEM, V269, P19494; PFANNER N, 1989, CELL, V59, P95, DOI 10.1016/0092-8674(89)90872-6; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; Sannerud R, 2003, CURR OPIN CELL BIOL, V15, P438, DOI 10.1016/S0955-0674(03)00077-2; SARASTE J, 1984, CELL, V38, P535, DOI 10.1016/0092-8674(84)90508-7; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Sciaky N, 1997, J CELL BIOL, V139, P1137, DOI 10.1083/jcb.139.5.1137; SESSO A, 1994, J CELL SCI, V107, P517; Shimoi W, 2005, J BIOL CHEM, V280, P10141, DOI 10.1074/jbc.M409673200; Stieglitz KA, 2001, BIOCHEMISTRY-US, V40, P13954, DOI 10.1021/bi011338o; Tani K, 1999, J BIOL CHEM, V274, P20505, DOI 10.1074/jbc.274.29.20505; Uchiyama S, 1999, J BIOCHEM-TOKYO, V125, P1001, DOI 10.1093/oxfordjournals.jbchem.a022378; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; Yang JS, 2008, NAT CELL BIOL, V10, P1146, DOI 10.1038/ncb1774; Young J, 2005, MOL BIOL CELL, V16, P162, DOI 10.1091/mbc.E04-03-0260	58	40	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26620	26630		10.1074/jbc.M109.038869	http://dx.doi.org/10.1074/jbc.M109.038869			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19632984	Green Published, hybrid			2022-12-27	WOS:000269969600043
J	Shanmugam, M; McBrayer, SK; Qian, J; Raikoff, K; Avram, MJ; Singhal, S; Gandhi, V; Schumacker, PT; Krett, NL; Rosen, ST				Shanmugam, Mala; McBrayer, Samuel K.; Qian, Jun; Raikoff, Kiril; Avram, Michael J.; Singhal, Seema; Gandhi, Varsha; Schumacker, Paul T.; Krett, Nancy L.; Rosen, Steven T.			Targeting Glucose Consumption and Autophagy in Myeloma with the Novel Nucleoside Analogue 8-Aminoadenosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OVERCOMES DRUG-RESISTANCE; MULTIPLE-MYELOMA; AEROBIC GLYCOLYSIS; CANCER-CELLS; PROTEIN-KINASE; APOPTOSIS; GROWTH; METABOLISM; INHIBITION; SURVIVAL	Multiple myeloma, an incurable plasma cell malignancy, is characterized by altered cellular metabolism and resistance to apoptosis. Recent connections between glucose metabolism and resistance to apoptosis provide a compelling rationale for targeting metabolic changes in cancer. In this study, we have examined the ability of the purine analogue 8-aminoadenosine to acutely reduce glucose consumption by regulating localization and expression of key glucose transporters. Myeloma cells counteracted the metabolic stress by activating autophagy. Co-treatment with inhibitors of autophagy results in marked enhancement of cell death. Glucose consumption by drug-resistant myeloma cells was unaffected by 8-aminoadenosine, and accordingly, no activation of autophagy was observed. However, these cells can be sensitized to 8-aminoadenosine under glucose-limiting conditions. The prosurvival autophagic response of myeloma to nutrient deprivation or to nucleoside analogue treatment has not been described previously. This study establishes the potential of metabolic targeting as a broader means to kill and sensitize myeloma and identifies a compound that can achieve this goal.	[Shanmugam, Mala; Schumacker, Paul T.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA; [Shanmugam, Mala; McBrayer, Samuel K.; Qian, Jun; Singhal, Seema; Krett, Nancy L.; Rosen, Steven T.] Univ Texas MD Anderson Canc Ctr, Robert H Lurie Comprehens Canc Ctr, Houston, TX 77030 USA; [Singhal, Seema; Rosen, Steven T.] Univ Texas MD Anderson Canc Ctr, Div Hematol & Oncol, Houston, TX 77030 USA; [Raikoff, Kiril; Avram, Michael J.] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol, Houston, TX 77030 USA; [Gandhi, Varsha] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Northwestern University; Feinberg School of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Shanmugam, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pediat, 3-250 Lurie Bldg,303 E Super St, Chicago, IL 60611 USA.	mala@northwestern.edu	Shanmugam, Mala/M-6491-2019; Avram, Michael/M-7681-2019	Shanmugam, Mala/0000-0002-4415-8083; Rosen, Steven/0000-0002-8818-7724	National Institutes of Health (NIH), NCI Cancer Nanotechnology Excellence (CCNE) Initiative [U54CA119341, T32CA09560, RO1CA 85919]; NATIONAL CANCER INSTITUTE [U54CA119341, T32CA009560] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NCI Cancer Nanotechnology Excellence (CCNE) Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NCI Cancer Nanotechnology Excellence (CCNE) Initiative Grant U54CA119341 (to M. S.), NIH (NCI) Grant T32CA09560 (to S. M.), and NIH Grant RO1CA 85919 (to S. R.).	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Bauer DE, 2004, FASEB J, V18, P1303, DOI 10.1096/fj.03-1001fje; Bredella MA, 2005, AM J ROENTGENOL, V184, P1199, DOI 10.2214/ajr.184.4.01841199; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Cao XH, 2007, CANCER CHEMOTH PHARM, V59, P495, DOI 10.1007/s00280-006-0291-9; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Deprez J, 1997, J BIOL CHEM, V272, P17269, DOI 10.1074/jbc.272.28.17269; Durie BGM, 2002, J NUCL MED, V43, P1457; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Galmarini CM, 2001, LEUKEMIA, V15, P875, DOI 10.1038/sj.leu.2402114; Gandhi V, 2001, CANCER RES, V61, P5474; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Ghias K, 2005, MOL CANCER THER, V4, P569, DOI 10.1158/1535-7163.MCT-04-0303; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Halgren RG, 1998, BLOOD, V92, P2893, DOI 10.1182/blood.V92.8.2893.420k01_2893_2898; Hideshima T, 2001, CANCER RES, V61, P3071; Hideshima T, 2002, NAT REV CANCER, V2, P927, DOI 10.1038/nrc952; Hu C, 2008, BIOORGAN MED CHEM, V16, P7888, DOI 10.1016/j.bmc.2008.07.076; HUNDAL HS, 1992, ENDOCRINOLOGY, V131, P1165, DOI 10.1210/en.131.3.1165; Jin S, 2007, J CELL SCI, V120, P379, DOI 10.1242/jcs.03349; Kawakami K, 2005, OBES RES, V13, P1661, DOI 10.1038/oby.2005.204; Kjer-Nielsen L, 1999, CURR BIOL, V9, P385, DOI 10.1016/S0960-9822(99)80168-7; Krett NL, 2004, MOL CANCER THER, V3, P1411; Lopez-Rios F, 2007, CANCER RES, V67, P9013, DOI 10.1158/0008-5472.CAN-07-1678; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maclean KH, 2008, J CLIN INVEST, V118, P79, DOI 10.1172/JCI33700; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; Nabhan C, 2001, CURR OPIN ONCOL, V13, P514, DOI 10.1097/00001622-200111000-00015; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Petit PX, 2001, BIOCHEM J, V353, P357, DOI 10.1042/0264-6021:3530357; Plas DR, 2002, TRENDS ENDOCRIN MET, V13, P74; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Richardson PG, 2005, ONCOLOGY-NY, V19, P1781; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; Stryer L., 1988, BIOCHEMISTRY-US, P320; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; TRAGANOS F, 1994, METHOD CELL BIOL, V41, P185; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Vezmar M, 2000, BIOCHEM PHARMACOL, V59, P1245, DOI 10.1016/S0006-2952(00)00270-7; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xu RH, 2005, CANCER RES, V65, P613; Yamauchi T, 2004, J CHROMATOGR B, V799, P81, DOI 10.1016/j.jchromb.2003.10.011; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07	49	34	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26816	26830		10.1074/jbc.M109.000646	http://dx.doi.org/10.1074/jbc.M109.000646			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19648108	Green Published, hybrid			2022-12-27	WOS:000269969600063
J	Shen, MQ; Yen, A				Shen, Miaoqing; Yen, Andrew			c-Cbl Tyrosine Kinase-binding Domain Mutant G306E Abolishes the Interaction of c-Cbl with CD38 and Fails to Promote Retinoic Acid-induced Cell Differentiation and G(o) Arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; ACUTE PROMYELOCYTIC LEUKEMIA; HL-60 CELLS; FACTOR RECEPTOR; RING FINGER; T-CELLS; PHOSPHOINOSITIDE 3-KINASE; MYELOID DIFFERENTIATION; PHOSPHORYLATED VAV; MAP KINASES	Retinoic acid (RA) causes HL-60 human myeloblastic leukemia cell myeloid differentiation that is dependent on MAPK signaling. The process is propelled by c-Cbl, which binds the CD38 receptor as part of a signaling complex generating MAPK signaling. Here we report that the capability of c-Cbl to do this is lost in the G306E tyrosine kinase-binding domain mutant. Unlike wild-type (WT) c-Cbl, the G306E mutant c-Cbl fails to propel RA-induced differentiation, and disrupts the normal association with CD38. The G306E mutant does, like WT c-Cbl, co-immunoprecipitate with Vav, Slp-76, and p38. But unlike WT c-Cbl, does not cause MAPK signaling. In contrast, the C381A Ring finger domain mutant functions like WT c-Cbl. It binds CD38 and is part of the same apparent c-Cbl/Slp-76/Vav/p38 signaling complex. The C381A mutant causes MAPK signaling and propels RA-induced differentiation. In addition to HL-60 cells and their WT or mutant c-Cbl stable transfectants, the c-Cbl/Vav/Slp-76 complex is also found in NB4 cells where c-Cbl was previously also found to bind CD38. The data are consistent with a model in which the G306E mutant c-Cbl forms a signaling complex that includes Slp-76, Vav, and p38; but does not drive MAPK signaling because it fails to bind the CD38 receptor. Without the G306E mutation the c-Cbl unites CD38 with the signaling complex and delivers a MAPK signal that drives RA-induced differentiation. The results demonstrate the importance of the Gly306 residue in the ability of c-Cbl to propel RA-induced differentiation.	[Shen, Miaoqing; Yen, Andrew] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA	Cornell University	Yen, A (corresponding author), VRT, T4-008, Ithaca, NY 14853 USA.	ay13@cornell.edu			National Institutes of Health of the USPHS; New York State Stem Cell Science	National Institutes of Health of the USPHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Stem Cell Science	This work was supported, in whole or in part, by grants from the National Institutes of Health of the USPHS and New York State Stem Cell Science.	Albeniz I, 2007, HEMATOLOGY, V12, P409, DOI 10.1080/10245330701383841; Battle TE, 2001, EUR J CELL BIOL, V80, P59, DOI 10.1078/0171-9335-00141; Bertagnolo V, 1998, FEBS LETT, V441, P480, DOI 10.1016/S0014-5793(98)01593-2; Bertagnolo V, 2001, CELL GROWTH DIFFER, V12, P193; Bhaumik SR, 2006, METHODS, V40, P353, DOI 10.1016/j.ymeth.2006.06.025; BIONDI A, 1991, BLOOD, V77, P1418; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; Brooks SC, 1996, BLOOD, V87, P227; Bustelo XR, 1997, ONCOGENE, V15, P2511, DOI 10.1038/sj.onc.1201430; Chiang YJ, 2004, J EXP MED, V200, P25, DOI 10.1084/jem.20040262; Chu J, 1998, BLOOD, V92, P1697, DOI 10.1182/blood.V92.5.1697.417a06_1697_1706; CLEVENGER CV, 1995, J BIOL CHEM, V270, P13246, DOI 10.1074/jbc.270.22.13246; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; DALTON WT, 1988, BLOOD, V71, P242; Daly JM, 1999, ONCOGENE, V18, P3440, DOI 10.1038/sj.onc.1202700; Damle RN, 2007, BLOOD, V110, P3352, DOI 10.1182/blood-2007-04-083832; Deaglio S, 2001, LEUKEMIA RES, V25, P1, DOI 10.1016/S0145-2126(00)00093-X; Dikic I, 2003, CELL MOL LIFE SCI, V60, P1805, DOI 10.1007/s00018-003-3029-4; FAGIOLI M, 1992, ONCOGENE, V7, P1083; Finkelstein LD, 2000, BIOCHEM J, V345, P385, DOI 10.1042/0264-6021:3450385; Frey MR, 2006, EMBO J, V25, P5683, DOI 10.1038/sj.emboj.7601457; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kontani K, 1996, J BIOL CHEM, V271, P1534; Lamkin TJ, 2006, J CELL BIOCHEM, V97, P1328, DOI 10.1002/jcb.20745; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; Liu YC, 1998, CELL SIGNAL, V10, P377, DOI 10.1016/S0898-6568(97)00179-4; Lupher ML, 1998, INT J BIOCHEM CELL B, V30, P439, DOI 10.1016/S1357-2725(97)00075-7; Mann G, 2001, ANN HEMATOL, V80, P417, DOI 10.1007/s002770100304; March S, 2007, AM J PATHOL, V170, P176, DOI 10.2353/ajpath.2007.051212; Marengere LEM, 1997, J IMMUNOL, V159, P70; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; Ng C, 2008, EMBO J, V27, P804, DOI 10.1038/emboj.2008.18; Ota S, 2000, J BIOL CHEM, V275, P414, DOI 10.1074/jbc.275.1.414; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; Rao N, 2000, J IMMUNOL, V164, P4616, DOI 10.4049/jimmunol.164.9.4616; Reedquist KA, 1996, J BIOL CHEM, V271, P8435, DOI 10.1074/jbc.271.14.8435; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Shen MQ, 2008, CANCER RES, V68, P8761, DOI 10.1158/0008-5472.CAN-08-1058; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Thien CBF, 2003, J EXP MED, V197, P503, DOI 10.1084/jem.20021498; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Tuosto L, 1996, J EXP MED, V184, P1161, DOI 10.1084/jem.184.3.1161; Visser GD, 2005, EXP CELL RES, V311, P281, DOI 10.1016/j.yexcr.2005.09.015; Wang JR, 2008, J BIOL CHEM, V283, P4375, DOI 10.1074/jbc.M708471200; Wightman J, 2002, MOL CANCER THER, V1, P493; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yen A, 1999, IN VITRO CELL DEV-AN, V35, P527; Yen A, 1998, CANCER RES, V58, P3163; Yen A, 1990, HEMATOL REV, V4, P5; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zubiaur M, 2002, J BIOL CHEM, V277, P13, DOI 10.1074/jbc.M107474200	54	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25664	25677		10.1074/jbc.M109.014241	http://dx.doi.org/10.1074/jbc.M109.014241			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19635790	Green Published, hybrid			2022-12-27	WOS:000269738000024
J	Chen, PI; Kong, C; Su, X; Stahl, PD				Chen, Pin-I; Kong, Chen; Su, Xiong; Stahl, Philip D.			Rab5 Isoforms Differentially Regulate the Trafficking and Degradation of Epidermal Growth Factor Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; SMALL GTPASE RAB5; EGF RECEPTOR; SIGNAL-TRANSDUCTION; ENDOCYTIC TRAFFICKING; ENDOSOMAL COMPARTMENT; MEDIATED ENDOCYTOSIS; CELL-MIGRATION; EFFECTOR EEA1; E-CADHERIN	Ligand-mediated endocytosis is an intricate regulatory mechanism for epidermal growth factor receptor (EGFR) signal transduction. Coordinated trafficking of EGFR ensures its temporal and spatial communication with downstream signaling effectors. We focused our work on Rab5, a monomeric GTPase shown to participate in early stages of the endocytic pathway. Rab5 has three isoforms (A, B, and C) sharing more than 90% of sequence identity. We individually ablated endogenous isoforms in HeLa cells with short interfering RNAs and examined the loss-of-function phenotypes. We found that suppression of Rab5A or 5B hampered the degradation of EGFR, whereas Rab5C depletion had very little effect. The differential delay of EGFR degradation also corresponds with retarded progression of EGFR from early to late endosomes. We investigated the activators/effectors of Rab5A that can potentially separate its potency in EGFR degradation from other isoforms and found that Rin1, a Rab5 exchange factor, preferably associated with Rab5A. Moreover, Rab5A activation is sensitive to EGF stimulation, and suppression of Rin1 diminished this sensitivity. Based on our results together with previous work showing that Rin1 interacts with signal transducing adapter molecule to facilitate the degradation of EGFR (Kong, C., Su, X., Chen, P. I., and Stahl, P. D. (2007) J. Biol. Chem. 282, 15294 - 15301), we hypothesize that the selective association of Rab5A and Rin1 contributes to the dominance of Rab5A in EGFR trafficking, whereas the other isoforms may have major functions unrelated to the EGFR degradation pathway.	[Chen, Pin-I; Kong, Chen; Su, Xiong; Stahl, Philip D.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Stahl, PD (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, Campus Box 8228,660 S Euclid, St Louis, MO 63110 USA.	pstahl@wustl.edu	Stahl, Philip/D-6315-2012		National Institutes of Health [2R01GM42259]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R01GM42259.	Alvarez-Dominguez C, 1998, J BIOL CHEM, V273, P33901, DOI 10.1074/jbc.273.51.33901; Alvarez-Dominguez C, 1999, J BIOL CHEM, V274, P11459, DOI 10.1074/jbc.274.17.11459; Arnett ALH, 2004, BRAIN RES, V1028, P59, DOI 10.1016/j.brainres.2004.08.064; Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; Barbieri MA, 2004, EUR J CELL BIOL, V83, P305, DOI 10.1078/0171-9335-00381; Barbieri MA, 2003, J BIOL CHEM, V278, P32027, DOI 10.1074/jbc.M304324200; Blaabjerg M, 2003, MOL BRAIN RES, V117, P196, DOI 10.1016/s0169-328X(03)00321-8; Bronfman FC, 2007, DEV NEUROBIOL, V67, P1183, DOI 10.1002/dneu.20513; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; Burgdorf S, 2008, CURR OPIN IMMUNOL, V20, P89, DOI 10.1016/j.coi.2007.12.002; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; Chiariello M, 1999, FEBS LETT, V453, P20, DOI 10.1016/S0014-5793(99)00686-9; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Dinneen JL, 2004, TRAFFIC, V5, P606, DOI 10.1111/j.1398-9219.2004.00204.x; Dinneen JL, 2004, EXP CELL RES, V294, P509, DOI 10.1016/j.yexcr.2003.12.006; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Gros-Louis F, 2003, ANN NEUROL, V53, P144, DOI 10.1002/ana.10422; Grovdal LM, 2004, EXP CELL RES, V300, P388, DOI 10.1016/j.yexcr.2004.07.003; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Gurkan C, 2005, MOL BIOL CELL, V16, P3847, DOI 10.1091/mbc.E05-01-0062; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Kajiho H, 2003, J CELL SCI, V116, P4159, DOI 10.1242/jcs.00718; Kimura T, 2006, J BIOL CHEM, V281, P10598, DOI 10.1074/jbc.M510531200; Kong C, 2007, J BIOL CHEM, V282, P15294, DOI 10.1074/jbc.M611538200; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lippe R, 2001, MOL BIOL CELL, V12, P2219, DOI 10.1091/mbc.12.7.2219; Liu J, 2007, MOL BIOL CELL, V18, P1375, DOI 10.1091/mbc.E06-08-0725; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Mills IG, 2001, J CELL SCI, V114, P1959; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Saito K, 2002, J BIOL CHEM, V277, P3412, DOI 10.1074/jbc.M106276200; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; Satoh D, 2008, NAT CELL BIOL, V10, P1164, DOI 10.1038/ncb1776; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Spaargaren M, 1999, MOL BIOL CELL, V10, P3239, DOI 10.1091/mbc.10.10.3239; STOSCHECK CM, 1984, J CELL BIOL, V98, P1048, DOI 10.1083/jcb.98.3.1048; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Tear G, 2008, NAT CELL BIOL, V10, P1131, DOI 10.1038/ncb1008-1131; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; Wainszelbaum MJ, 2006, EXP CELL RES, V312, P2238, DOI 10.1016/j.yexcr.2006.03.025; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zheng Y, 2008, NAT CELL BIOL, V10, P1172, DOI 10.1038/ncb1777	54	75	77	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30328	30338		10.1074/jbc.M109.034546	http://dx.doi.org/10.1074/jbc.M109.034546			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19723633	hybrid, Green Published			2022-12-27	WOS:000271090000036
J	Pratto, F; Suzuki, Y; Takeyasu, K; Alonso, JC				Pratto, Florencia; Suzuki, Yuki; Takeyasu, Kunio; Alonso, Juan C.			Single-molecule Analysis of Protein.DNA Complexes Formed during Partition of Newly Replicated Plasmid Molecules in Streptococcus pyogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; DNA SEGREGATION; PSM19035; GENES; ACTIN; MECHANISM; REPRESSOR; BINDING; SYSTEM; PARS	The Streptococcus pyogenes pSM19035 partition locus is ubiquitous among plasmids from vancomycin- or methicillin-resistant bacteria. An increasing understanding of this segregation system may highlight novel protein targets that could be blocked to curb bacterial proliferation. pSM19035 segregation depends on two homodimeric (delta(2) (ParA) and omega(2) (ParB)) proteins and six cis-acting centromeric noncurved parS sites. In the presence of ATP.Mg2+, delta(2) (delta.ATP.Mg2+)(2) binds DNA in a sequence-independent manner. Protein omega(2) binds with high affinity and cooperatively to B-form parS DNA. Atomic force microscopy experiments indicate that about 10 omega(2) molecules bind parS, consisting of 10 contiguous iterons. Protein (delta.ATP.Mg2+)(2), by interacting with the N terminus of omega(2) bound to parS, loses its association with DNA and relocalizes with omega(2).parS to form a ternary complex ((delta.ATP.Mg2+)(2).omega(2).parS) with the DNA remaining in straight B-form. Then, the interaction of two (delta.ATP.Mg2+)(2).omega(2).parS complexes via delta(2) promotes pairing of a plasmid subfraction. (delta D60A.ATP.Mg2+)(2), which binds but does not hydrolyze ATP, leads to accumulation of pairing intermediates, suggesting that ATP hydrolysis induces plasmid separation. We propose that the molar omega(2):delta(2) ratio regulates the different stages of pSM19035 segregation, pairing, and delta(2) polymerization, before cell division.	[Pratto, Florencia; Alonso, Juan C.] CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, E-28049 Madrid, Spain; [Suzuki, Yuki; Takeyasu, Kunio] Kyoto Univ, Grad Sch Biostudies, Lab Plasma Membrane & Nucl Signaling, Sakyo Ku, Kyoto 6068501, Japan	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Kyoto University	Alonso, JC (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, C Darwin 3, E-28049 Madrid, Spain.	jcalonso@cnb.csic.es	Alonso, Juan Carlos/D-2595-2009; Suzuki, Yuki/H-9950-2015	Alonso, Juan Carlos/0000-0002-5178-7179; Suzuki, Yuki/0000-0003-1848-0105; Pratto, Florencia/0000-0002-9678-8044	Ministerio de Ciencia e Innovacion [BFU2009-07167, CSD2007-00010]; Direccion General de Investigacion; Comunidad de Madrid [S-0505/-MAT0283]; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Direccion General de Investigacion(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants BFU2009-07167 and CSD2007-00010 from the Ministerio de Ciencia e Innovacion, Direccion General de Investigacion, and S-0505/-MAT0283 from Comunidad de Madrid (to J. C. A.) and Grant-in-aid for Priority Area from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to K. T.).	Alonso JC, 1996, FEMS MICROBIOL LETT, V142, P1; BARRETT SD, 2008, IMAGE SXM VERSION 1; CEGLOWSKI P, 1994, GENE, V145, P33, DOI 10.1016/0378-1119(94)90319-0; CEGLOWSKI P, 1993, GENE, V136, P1, DOI 10.1016/0378-1119(93)90441-5; CEGLOWSKI P, 1993, MOL GEN GENET, V241, P579, DOI 10.1007/BF00279900; DAVIS MA, 1990, EMBO J, V9, P991, DOI 10.1002/j.1460-2075.1990.tb08201.x; de la Hoz AB, 2000, P NATL ACAD SCI USA, V97, P728, DOI 10.1073/pnas.97.2.728; de la Hoz AB, 2004, NUCLEIC ACIDS RES, V32, P3136, DOI 10.1093/nar/gkh633; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Edgar R, 2006, MOL MICROBIOL, V59, P276, DOI 10.1111/j.1365-2958.2005.04933.x; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Hizume K, 2005, BIOCHEMISTRY-US, V44, P12978, DOI 10.1021/bi050623v; Jensen RB, 1998, P NATL ACAD SCI USA, V95, P8550, DOI 10.1073/pnas.95.15.8550; Kim SK, 1999, P NATL ACAD SCI USA, V96, P8557, DOI 10.1073/pnas.96.15.8557; Leonard TA, 2005, PHILOS T R SOC B, V360, P523, DOI 10.1098/rstb.2004.1608; LYNCH AS, 1994, J MOL BIOL, V236, P679, DOI 10.1006/jmbi.1994.1179; LYNCH AS, 1995, P NATL ACAD SCI USA, V92, P1896, DOI 10.1073/pnas.92.6.1896; Margeat E, 1998, BIOPHYS J, V75, P2712, DOI 10.1016/S0006-3495(98)77715-X; Meinhart A, 2003, P NATL ACAD SCI USA, V100, P1661, DOI 10.1073/pnas.0434325100; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Moller-Jensen J, 2007, EMBO J, V26, P4413, DOI 10.1038/sj.emboj.7601864; Murayama K, 2001, J MOL BIOL, V314, P789, DOI 10.1006/jmbi.2001.5157; Nettikadan S, 1996, BIOCHEM BIOPH RES CO, V226, P645, DOI 10.1006/bbrc.1996.1409; Pietrasanta LI, 1999, P NATL ACAD SCI USA, V96, P3757, DOI 10.1073/pnas.96.7.3757; Pratto F, 2008, NUCLEIC ACIDS RES, V36, P3676, DOI 10.1093/nar/gkn170; Rodionov O, 1999, SCIENCE, V283, P546, DOI 10.1126/science.283.5401.546; Salje J, 2008, EMBO J, V27, P2230, DOI 10.1038/emboj.2008.152; Schneider SW, 1998, PFLUG ARCH EUR J PHY, V435, P362, DOI 10.1007/s004240050524; Schumacher MA, 2008, BIOCHEM J, V412, P1, DOI 10.1042/BJ20080359; Schumacher MA, 2007, NATURE, V450, P1268, DOI 10.1038/nature06392; Schumacher MA, 2007, CURR OPIN STRUC BIOL, V17, P103, DOI 10.1016/j.sbi.2006.11.005; Sherratt DJ, 2003, SCIENCE, V301, P780, DOI 10.1126/science.1084780; Thanbichler M, 2008, NAT REV MICROBIOL, V6, P28, DOI 10.1038/nrmicro1795; VESENKA J, 1992, ULTRAMICROSCOPY, V42, P1243, DOI 10.1016/0304-3991(92)90430-R; Weihofen WA, 2006, NUCLEIC ACIDS RES, V34, P1450, DOI 10.1093/nar/gkl015; Welfle K, 2005, BIOL CHEM, V386, P881, DOI 10.1515/BC.2005.103; WYMAN C, 1995, EMBO J, V14, P117, DOI 10.1002/j.1460-2075.1995.tb06981.x	37	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30298	30306		10.1074/jbc.M109.035410	http://dx.doi.org/10.1074/jbc.M109.035410			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19726689	Green Published, hybrid			2022-12-27	WOS:000271090000033
J	Guo, RT; Chong, YE; Guo, M; Yang, XL				Guo, Rey-Ting; Chong, Yeeting E.; Guo, Min; Yang, Xiang-Lei			Crystal Structures and Biochemical Analyses Suggest a Unique Mechanism and Role for Human Glycyl-tRNA Synthetase in Ap4A Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSYL-TRANSFER-RNA; MARIE-TOOTH-DISEASE; ZINC-DEPENDENT SYNTHESIS; ACTIVATED MAST-CELLS; ESCHERICHIA-COLI; DIADENOSINE 5',5'''-P1,P4-TETRAPHOSPHATE; THERMUS-THERMOPHILUS; RAT-LIVER; TETRAPHOSPHATE; POLYPHOSPHATES	Aminoacyl-tRNA synthetases catalyze the attachment of amino acids to their cognate tRNAs for protein synthesis. However, the aminoacylation reaction can be diverted to produce diadenosine tetraphosphate (Ap4A), a universal pleiotropic signaling molecule needed for cell regulation pathways. The only known mechanism for Ap4A production by a tRNA synthetase is through the aminoacylation reaction intermediate aminoacyl-AMP, thus making Ap4A synthesis amino acid-dependent. Here, we demonstrate a new mechanism for Ap4A synthesis. Crystal structures and biochemical analyses show that human glycyl-tRNA synthetase (GlyRS) produces Ap4A by direct condensation of two ATPs, independent of glycine concentration. Interestingly, whereas the first ATP-binding pocket is conserved for all class II tRNA synthetases, the second ATP pocket is formed by an insertion domain that is unique to GlyRS, suggesting that GlyRS is the only tRNA synthetase catalyzing direct Ap4A synthesis. A special role for GlyRS in Ap4A homeostasis is proposed.	[Yang, Xiang-Lei] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Yang, XL (corresponding author), Scripps Res Inst, Dept Mol Biol, BCC110,N Torrey Pines Rd, La Jolla, CA 92037 USA.	xlyang@scripps.edu	Chong, Yeeting/AAE-3792-2020; Yang, Xiang-Lei/AAR-7107-2020	Guo, Rey-Ting/0000-0003-2942-7246; Yang, Xiang-Lei/0000-0003-2554-084X	National Institutes of Health [CA092577]; NCI [GM015539, U54RR025204]; NATIONAL CANCER INSTITUTE [R01CA092577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015539, R37GM015539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA092577 from NCI and Grants GM015539 and U54RR025204.	Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; Arnez JG, 1999, J MOL BIOL, V286, P1449, DOI 10.1006/jmbi.1999.2562; Barisic N, 2008, ANN HUM GENET, V72, P416, DOI 10.1111/j.1469-1809.2007.00412.x; Beebe K, 2007, ANAL BIOCHEM, V368, P111, DOI 10.1016/j.ab.2007.05.013; BELRHALI H, 1995, STRUCTURE, V3, P341, DOI 10.1016/S0969-2126(01)00166-6; BREVET A, 1982, J BIOL CHEM, V257, P4613; Brunger AT, 1998, CURR OPIN STRUC BIOL, V8, P606, DOI 10.1016/S0959-440X(98)80152-8; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Cader MZ, 2007, FEBS LETT, V581, P2959, DOI 10.1016/j.febslet.2007.05.046; CUSACK S, 1995, NAT STRUCT BIOL, V2, P824, DOI 10.1038/nsb1095-824; GOERLICH O, 1982, EUR J BIOCHEM, V126, P135, DOI 10.1111/j.1432-1033.1982.tb06757.x; Hausmann CD, 2008, FEMS MICROBIOL REV, V32, P705, DOI 10.1111/j.1574-6976.2008.00119.x; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; Kisselev LL, 1998, FEBS LETT, V427, P157, DOI 10.1016/S0014-5793(98)00420-7; Ko YG, 2001, J BIOL CHEM, V276, P6030, DOI 10.1074/jbc.M006189200; Kovaleski BJ, 2006, J BIOL CHEM, V281, P19449, DOI 10.1074/jbc.M601189200; LED JJ, 1983, EUR J BIOCHEM, V136, P469, DOI 10.1111/j.1432-1033.1983.tb07765.x; Lee YN, 2005, MOL CELL BIOL, V25, P8904, DOI 10.1128/MCB.25.20.8904-8912.2005; Lee YN, 2004, IMMUNITY, V20, P145, DOI 10.1016/S1074-7613(04)00020-2; LOGAN DT, 1995, EMBO J, V14, P4156, DOI 10.1002/j.1460-2075.1995.tb00089.x; Martin F, 1998, FASEB J, V12, P1499, DOI 10.1096/fasebj.12.14.1499; Mazauric MH, 1998, EUR J BIOCHEM, V251, P744, DOI 10.1046/j.1432-1327.1998.2510744.x; McLennan AG, 2000, PHARMACOL THERAPEUT, V87, P73, DOI 10.1016/S0163-7258(00)00041-3; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Miras-Portugal MT, 2003, J MEMBRANE BIOL, V194, P1, DOI 10.1007/s00232-003-2024-x; Nangle LA, 2007, P NATL ACAD SCI USA, V104, P11239, DOI 10.1073/pnas.0705055104; Nishimura A, 1997, GENES CELLS, V2, P401, DOI 10.1046/j.1365-2443.1997.1300328.x; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; PLATEAU P, 1982, BIOCHEMISTRY-US, V21, P5273, DOI 10.1021/bi00264a024; Roy H, 2009, MOL MICROBIOL, V71, P547, DOI 10.1111/j.1365-2958.2008.06563.x; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Schluter H, 1996, J AUTON PHARMACOL, V16, P357, DOI 10.1111/j.1474-8673.1996.tb00053.x; Sissler M, 2008, METHODS, V44, P176, DOI 10.1016/j.ymeth.2007.11.002; Tzima E, 2005, J BIOL CHEM, V280, P2405, DOI 10.1074/jbc.C400431200; VARSHAVSKY A, 1983, CELL, V34, P711, DOI 10.1016/0092-8674(83)90526-3; WAHAB SZ, 1985, J BIOL CHEM, V260, P2735; WAHAB SZ, 1985, J BIOL CHEM, V260, P5286; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wright M, 2006, FEBS J, V273, P3534, DOI 10.1111/j.1742-4658.2006.05361.x; Xie W, 2007, P NATL ACAD SCI USA, V104, P9976, DOI 10.1073/pnas.0703908104; Xie W, 2006, ACTA CRYSTALLOGR F, V62, P1243, DOI 10.1107/S1744309106046434; ZAMECNIK PC, 1966, BIOCHEM BIOPH RES CO, V24, P91, DOI 10.1016/0006-291X(66)90415-3	44	27	47	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28968	28976		10.1074/jbc.M109.030692	http://dx.doi.org/10.1074/jbc.M109.030692			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19710017	Green Published, hybrid			2022-12-27	WOS:000270678900054
J	Trevisson, E; Burlina, A; Doimo, M; Pertegato, V; Casarin, A; Cesaro, L; Navas, P; Basso, G; Sartori, G; Salviati, L				Trevisson, Eva; Burlina, Alberto; Doimo, Mara; Pertegato, Vanessa; Casarin, Alberto; Cesaro, Luca; Navas, Placido; Basso, Giuseppe; Sartori, Geppo; Salviati, Leonardo			Functional Complementation in Yeast Allows Molecular Characterization of Missense Argininosuccinate Lyase Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAGENIC COMPLEMENTATION; SACCHAROMYCES-CEREVISIAE; DEFICIENCY; GENE; IDENTIFICATION; METABOLISM; MODEL; SITE	Deficiency of argininosuccinate lyase (ASL) causes argininosuccinic aciduria, an urea cycle defect that may present with a severe neonatal onset form or with a late onset phenotype. To date phenotype-genotype correlations are still not clear because biochemical assays of ASL activity correlate poorly with clinical severity in patients. We employed a yeast-based functional complementation assay to assess the pathogenicity of 12 missense ASL mutations, to establish genotype-phenotype correlations, and to screen for intragenic complementation. Rather than determining ASL enzyme activity directly, we have measured the growth rate in arginine-free medium of a yeast ASL(null) strain transformed with individual mutant ASL alleles. Individual haploid strains were also mated to obtain diploid, "compound heterozygous" yeast. We show that the late onset phenotypes arise in patients because they harbor individual alleles retaining high residual enzymatic activity or because of intragenic complementation among different mutated alleles. In these cases complementation occurs because in the hybrid tetrameric enzyme at least one active site without mutations can be formed or because the differently mutated alleles can stabilize each other, resulting in partial recovery of enzymatic activity. Functional complementation in yeast is simple and reproducible and allows the analysis of large numbers of mutant alleles. Moreover, it can be easily adapted for the analysis of mutations in other genes involved in urea cycle disorders.	[Trevisson, Eva; Doimo, Mara; Pertegato, Vanessa; Casarin, Alberto; Salviati, Leonardo] Univ Padua, Dept Pediat, Clin Genet Unit, I-35128 Padua, Italy; [Trevisson, Eva; Doimo, Mara; Pertegato, Vanessa; Casarin, Alberto; Basso, Giuseppe; Salviati, Leonardo] Univ Padua, Dept Pediat, Pediat Oncol Lab, I-35128 Padua, Italy; [Burlina, Alberto] Univ Padua, Dept Pediat, Metab Disorders Unit, I-35128 Padua, Italy; [Cesaro, Luca; Sartori, Geppo] Univ Padua, Dept Biochem, I-35128 Padua, Italy; [Navas, Placido] Univ Pablo Olavide, CSIC, Inst Salud Carlos III, Ctr Andaluz Biol Desarrollo, Seville 41013, Spain; [Navas, Placido] Univ Pablo Olavide, CSIC, Inst Salud Carlos III, CIBERER, Seville 41013, Spain	University of Padua; University of Padua; University of Padua; University of Padua; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Salud Carlos III; Universidad Pablo de Olavide	Salviati, L (corresponding author), Univ Padua, Dept Pediat, Clin Genet Unit, Via Giustiniani 3, I-35128 Padua, Italy.	leonardo.salviati@unipd.it	burlina, alberto/AHE-6095-2022; NAVAS, PLACIDO/R-5943-2019; Salviati, Leonardo/L-1007-2016; Trevisson, Eva/K-8462-2016	NAVAS, PLACIDO/0000-0002-4115-7966; Salviati, Leonardo/0000-0001-5642-9963; Trevisson, Eva/0000-0002-5380-6265; BASSO, GIUSEPPE/0000-0002-2634-9302; Cesaro, Luca/0000-0002-6707-2282; Doimo, Mara/0000-0002-6771-5233	Telethon Italy [GGP06256]; Fondazione Citta della Speranza	Telethon Italy(Fondazione Telethon); Fondazione Citta della Speranza	This work was supported by Telethon Italy Grant GGP06256 and by Fondazione Citta della Speranza.	BARBOSA P, 1991, J BIOL CHEM, V266, P5286; BASTONE A, 1990, ANAL BIOCHEM, V191, P384, DOI 10.1016/0003-2697(90)90236-3; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Brusilow S., 2001, METABOLIC MOL BASES, V8th, P1909; BURKE D, 2000, METHODS YEAST GENETI, P113; Dimmer KS, 2008, HUM MOL GENET, V17, P201, DOI 10.1093/hmg/ddm297; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Kleijer WJ, 2002, J INHERIT METAB DIS, V25, P399, DOI 10.1023/A:1020108002877; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lanpher B, 2006, NAT REV GENET, V7, P449, DOI 10.1038/nrg1880; Linnebank M, 2000, J INHERIT METAB DIS, V23, P308, DOI 10.1023/A:1005690005439; Linnebank M, 2002, HUM GENET, V111, P350, DOI 10.1007/s00439-002-0793-4; Lodi T, 2006, BIOCHEM BIOPH RES CO, V341, P810, DOI 10.1016/j.bbrc.2006.01.034; MCINNES RR, 1984, P NATL ACAD SCI-BIOL, V81, P4480, DOI 10.1073/pnas.81.14.4480; Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JCI29089; Morillas M, 2002, J BIOL CHEM, V277, P11473, DOI 10.1074/jbc.M111628200; OBRIEN WE, 1986, P NATL ACAD SCI USA, V83, P7211, DOI 10.1073/pnas.83.19.7211; Sampaleanu LM, 2001, BIOCHEMISTRY-US, V40, P15570, DOI 10.1021/bi011525m; Trevisson E, 2007, HUM MUTAT, V28, P694, DOI 10.1002/humu.20498; Turner MA, 1997, P NATL ACAD SCI USA, V94, P9063, DOI 10.1073/pnas.94.17.9063; Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245; Walker DC, 1997, J BIOL CHEM, V272, P6777, DOI 10.1074/jbc.272.10.6777; WALKER DC, 1990, P NATL ACAD SCI USA, V87, P9625, DOI 10.1073/pnas.87.24.9625; Yu BM, 2004, J BIOL CHEM, V279, P40972, DOI 10.1074/jbc.M405300200	24	25	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28926	28934		10.1074/jbc.M109.050195	http://dx.doi.org/10.1074/jbc.M109.050195			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19703900	Green Published, hybrid			2022-12-27	WOS:000270678900049
J	Yang, XM; Li, HC; Liu, XS; Deng, AP; Liu, XQ				Yang, Xiaoming; Li, Hongchang; Liu, X. Shawn; Deng, Anping; Liu, Xiaoqi			Cdc2-mediated Phosphorylation of CLIP-170 Is Essential for Its Inhibition of Centrosome Reduplication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; IN-VIVO; MICROTUBULES; LOCALIZATION; DUPLICATION; PROTEINS; DYNAMICS; BINDING; KINASES; TUBULIN	CLIP-170, the founding member of microtubule "plus ends tracking" proteins, is involved in many critical microtubule-related functions, including recruitment of dynactin to the microtubule plus ends and formation of kinetochore-microtubule attachments during metaphase. Although it has been reported that CLIP-170 is a phosphoprotein, neither have individual phosphorylation sites been identified nor have the associated kinases been extensively studied. Herein, we identify Cdc2 as a kinase that phosphorylates CLIP-170. We show that Cdc2 interacts with CLIP-170 mediating its phosphorylation on Thr(287) in vivo. Significantly, expression of CLIP-170 with a threonine 287 to alanine substitution (T287A) results in its mislocalization, accumulation of Plk1 and cyclin B, and block of the G2/M transition. Finally, we found that depletion of CLIP-170 leads to centrosome reduplication and that Cdc2 phosphorylation of CLIP-170 is required for the process. These results demonstrate that Cdc2-mediated phosphorylation of CLIP-170 is essential for the normal function of this protein during cell cycle progression.	[Yang, Xiaoming; Li, Hongchang; Liu, X. Shawn; Liu, Xiaoqi] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; Sichuan Univ, Coll Chem, Chengdu 610064, Peoples R China	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Sichuan University	Liu, XQ (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ St, W Lafayette, IN 47907 USA.	liu8@purdue.edu	liu, shawn/J-3969-2016; Li, Hongchang/GQO-9662-2022		National Institutes of Health Howard Temin Award, NCI [K01 CA114401]; China Scholarship Council; NATIONAL CANCER INSTITUTE [K01CA114401] Funding Source: NIH RePORTER	National Institutes of Health Howard Temin Award, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Howard Temin Award K01 CA114401 from the NCI (to X. L.). This work was also supported by the China Scholarship Council (to X. Y.).	Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Choi JH, 2002, EMBO REP, V3, P988, DOI 10.1093/embo-reports/kvf197; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; Folker ES, 2005, MOL BIOL CELL, V16, P5373, DOI 10.1091/mbc.E04-12-1106; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Galjart N, 2005, NAT REV MOL CELL BIO, V6, P487, DOI 10.1038/nrm1664; GOLSTEYN RM, 1994, J CELL SCI, V107, P1509; Keshvara LM, 1998, J IMMUNOL, V161, P5276; Komarova YA, 2002, J CELL BIOL, V159, P589, DOI 10.1083/jcb.200208058; Lansbergen G, 2004, J CELL BIOL, V166, P1003, DOI 10.1083/jcb.200402082; Mimori-Kiyosue Yuko, 2006, Tanpakushitsu Kakusan Koso, V51, P543; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Peterson JR, 2002, CHEM BIOL, V9, P1275, DOI 10.1016/S1074-5521(02)00284-3; RICKARD JE, 1991, J BIOL CHEM, V266, P17597; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Tanenbaum ME, 2006, EMBO J, V25, P45, DOI 10.1038/sj.emboj.7600916; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Wieland G, 2004, MOL CELL BIOL, V24, P6620, DOI 10.1128/mcb.24.15.6620-6630.2004; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	22	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28775	28782		10.1074/jbc.M109.017681	http://dx.doi.org/10.1074/jbc.M109.017681			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19687009	Green Published, hybrid			2022-12-27	WOS:000270678900034
J	Chanvorachote, P; Nimmannit, U; Lu, YJ; Talbott, S; Jiang, BH; Rojanasakul, Y				Chanvorachote, Pithi; Nimmannit, Ubonthip; Lu, Yongju; Talbott, Siera; Jiang, Bing-Hua; Rojanasakul, Yon			Nitric Oxide Regulates Lung Carcinoma Cell Anoikis through Inhibition of Ubiquitin-Proteasomal Degradation of Caveolin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; MEDIATED S-NITROSYLATION; TUMOR-SUPPRESSOR GENE; MAP KINASE CASCADE; PROSTATE-CANCER; SCAFFOLDING DOMAIN; TRANSFORMED-CELLS; INDUCED APOPTOSIS; SYNTHASE ACTIVITY; GROWTH-FACTOR	Anoikis, a detachment-induced apoptosis, is a principal mechanism of inhibition of tumor cell metastasis. Tumor cells can acquire anoikis resistance which is frequently observed in metastatic lung cancer. This phenomenon becomes an important obstacle of efficient cancer therapy. Recently, signaling mediators such as caveolin-1 (Cav-1) and nitric oxide (NO) have garnered attention in metastasis research; however, their role and the underlying mechanisms of metastasis regulation are largely unknown. Using human lung carcinoma H460 cells, we show that NO impairs the apoptotic function of the cells after detachment. The NO donors sodium nitroprusside and diethylenetriamine NONOate inhibit detachment-induced apoptosis, whereas the NO inhibitors aminoguanidine and 2-(4-carboxyphenyl) tetramethylimidazoline-1-oxyl-3-oxide promote this effect. Resistance to anoikis in H460 cells is mediated by Cav-1, which is significantly down-regulated after cell detachment through a non-transcriptional mechanism involving ubiquitin-proteasomal degradation. NO inhibits this down-regulation by interfering with Cav-1 ubiquitination through a process that involves protein S-nitrosylation, which prevents its proteasomal degradation and induction of anoikis by cell detachment. These findings indicate a novel pathway for NO regulation of Cav-1, which could be a key mechanism of anoikis resistance in tumor cells.	[Chanvorachote, Pithi] Chulalongkorn Univ, Dept Physiol, Bangkok 10330, Thailand; [Nimmannit, Ubonthip] Chulalongkorn Univ, Pharmaceut Technol Int Program, Bangkok 10330, Thailand; [Talbott, Siera; Jiang, Bing-Hua; Rojanasakul, Yon] W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA; [Lu, Yongju; Talbott, Siera; Rojanasakul, Yon] W Virginia Univ, Dept Pharmaceut Sci, Morgantown, WV 26506 USA	Chulalongkorn University; Chulalongkorn University; West Virginia University; West Virginia University	Chanvorachote, P (corresponding author), Chulalongkorn Univ, Dept Physiol, Bangkok 10330, Thailand.	pithi_chan@yahoo.com; yrojan@hsc.wvu.edu		chanvorachote, pithi/0000-0002-3103-3249; Jiang, Bing-Hua/0000-0003-4526-2031; Rojanasakul, Yon/0000-0002-8839-6462	National Institutes of Health [R01-HL076340]; Thailand Research Fund; Commission on Higher Education [MRG G5080134]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076340] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thailand Research Fund(Thailand Research Fund (TRF)); Commission on Higher Education; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL076340. This work was also supported by Thailand Research Fund and Commission on Higher Education (MRG G5080134).	Ambs S, 1998, BRIT J CANCER, V78, P233, DOI 10.1038/bjc.1998.470; Ambs S, 1998, CANCER RES, V58, P334; Antonova GN, 2007, AM J PHYSIOL-HEART C, V292, pH893, DOI 10.1152/ajpheart.00498.2006; ARIASDIAZ J, 1994, CANCER, V74, P1546, DOI 10.1002/1097-0142(19940901)74:5<1546::AID-CNCR2820740509>3.0.CO;2-F; Azad N, 2006, J BIOL CHEM, V281, P34124, DOI 10.1074/jbc.M602551200; Borutaite V, 2003, FREE RADICAL BIO MED, V35, P1457, DOI 10.1016/j.freeradbiomed.2003.08.003; Campbell L, 1999, BIOCHEM BIOPH RES CO, V262, P744, DOI 10.1006/bbrc.1999.1280; Chanvorachote P, 2005, J BIOL CHEM, V280, P42044, DOI 10.1074/jbc.M510080200; Chanvorachote P, 2006, CANCER RES, V66, P6353, DOI 10.1158/0008-5472.CAN-05-4533; Choi BM, 2003, FREE RADICAL BIO MED, V34, P1136, DOI 10.1016/S0891-5849(03)00064-9; COBBS CS, 1995, CANCER RES, V55, P727; Dimmeler S, 1999, CELL DEATH DIFFER, V6, P964, DOI 10.1038/sj.cdd.4400581; Engelman JA, 1998, FEBS LETT, V428, P205, DOI 10.1016/S0014-5793(98)00470-0; Fiucci G, 2002, ONCOGENE, V21, P2365, DOI 10.1038/sj.onc.1205300; Fujimoto H, 1997, JPN J CANCER RES, V88, P1190, DOI 10.1111/j.1349-7006.1997.tb00348.x; Galbiati F, 2001, MOL BIOL CELL, V12, P2229, DOI 10.1091/mbc.12.8.2229; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; GLENNEY JR, 1989, J CELL BIOL, V108, P2401, DOI 10.1083/jcb.108.6.2401; Heigold S, 2002, CARCINOGENESIS, V23, P929, DOI 10.1093/carcin/23.6.929; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Ho CC, 2002, AM J PATHOL, V161, P1647, DOI 10.1016/S0002-9440(10)64442-2; Hurlstone AFL, 1999, ONCOGENE, V18, P1881, DOI 10.1038/sj.onc.1202491; Iyer AKV, 2008, NITRIC OXIDE-BIOL CH, V19, P146, DOI 10.1016/j.niox.2008.04.019; JENKINS DC, 1995, P NATL ACAD SCI USA, V92, P4392, DOI 10.1073/pnas.92.10.4392; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; KOLESKE AJ, 1995, P NATL ACAD SCI USA, V92, P1381, DOI 10.1073/pnas.92.5.1381; Lala PK, 2001, LANCET ONCOL, V2, P149, DOI 10.1016/S1470-2045(00)00256-4; Lee SW, 1998, ONCOGENE, V16, P1391, DOI 10.1038/sj.onc.1201661; Li JR, 1997, BIOCHEM BIOPH RES CO, V240, P419, DOI 10.1006/bbrc.1997.7672; Li LK, 2003, MOL CELL BIOL, V23, P9389, DOI 10.1128/MCB.23.24.9389-9404.2003; Li LK, 2001, CANCER RES, V61, P4386; Liu CY, 1998, BRIT J CANCER, V78, P534, DOI 10.1038/bjc.1998.528; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mikol DD, 1999, GLIA, V27, P39; Mocellin S, 2007, MED RES REV, V27, P317, DOI 10.1002/med.20092; Monteiro HP, 2004, NITRIC OXIDE-BIOL CH, V10, P1, DOI 10.1016/j.niox.2004.02.002; Moon KH, 2005, FEBS LETT, V579, P6115, DOI 10.1016/j.febslet.2005.09.082; Park SW, 2003, INT J CANCER, V107, P729, DOI 10.1002/ijc.11498; Racine C, 1999, BIOCHEM BIOPH RES CO, V255, P580, DOI 10.1006/bbrc.1999.0236; Ravid D, 2005, ONCOGENE, V24, P1338, DOI 10.1038/sj.onc.1208337; Razani B, 2001, BIOCHEM SOC T, V29, P494, DOI 10.1042/BST0290494; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Ryu SD, 2004, LIFE SCI, V75, P2559, DOI 10.1016/j.lfs.2004.05.018; Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131; Shack S, 2003, MOL CELL BIOL, V23, P2407, DOI 10.1128/MCB.23.7.2407-2414.2003; Souici AC, 2000, CARCINOGENESIS, V21, P281, DOI 10.1093/carcin/21.2.281; Thompson TC, 1998, CANCER METAST REV, V17, P439, DOI 10.1023/A:1006110326366; THOMSEN LL, 1995, BRIT J CANCER, V72, P41, DOI 10.1038/bjc.1995.274; Timme TL, 2000, ONCOGENE, V19, P3256, DOI 10.1038/sj.onc.1203654; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Williams TM, 2004, J BIOL CHEM, V279, P24745, DOI 10.1074/jbc.M402064200; Xu L, 2008, J BIOL CHEM, V283, P3077, DOI 10.1074/jbc.M705709200; Yang G, 1998, CLIN CANCER RES, V4, P1873; Zundel W, 2000, MOL CELL BIOL, V20, P1507, DOI 10.1128/MCB.20.5.1507-1514.2000	55	47	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28476	28484		10.1074/jbc.M109.050864	http://dx.doi.org/10.1074/jbc.M109.050864			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19706615	Green Published, hybrid			2022-12-27	WOS:000270676300072
J	Alencastre, IS; Rodrigues, TA; Grou, CP; Fransen, M; Sa-Miranda, C; Azevedo, JE				Alencastre, Ines S.; Rodrigues, Tony A.; Grou, Claudia P.; Fransen, Marc; Sa-Miranda, Clara; Azevedo, Jorge E.			Mapping the Cargo Protein Membrane Translocation Step into the PEX5 Cycling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEROXISOMAL TARGETING SIGNAL; RAT-LIVER PEROXISOMES; ACYL-COA OXIDASE; IN-VITRO IMPORT; PTS1 RECEPTOR; SACCHAROMYCES-CEREVISIAE; 3-KETOACYL-COA THIOLASE; 3-OXOACYL-COA THIOLASE; CONSERVED CYSTEINE; MASS-SPECTROMETRY	Newly synthesized peroxisomal matrix proteins are targeted to the organelle by PEX5, the peroxisomal cycling receptor. Over the last few years, valuable data on the mechanism of this process have been obtained using a PEX5-centered in vitro system. The data gathered until now suggest that cytosolic PEX5. cargo protein complexes dock at the peroxisomal docking/translocation machinery, where PEX5 becomes subsequently inserted in an ATP-independent manner. This PEX5 species is then monoubiquitinated at a conserved cysteine residue, a mandatory modification for the next step of the pathway, the ATP-dependent dislocation of the ubiquitin-PEX5 conjugate back into the cytosol. Finally, the ubiquitin moiety is removed, yielding free PEX5. Despite its usefulness, there are many unsolved mechanistic aspects that cannot be addressed with this in vitro system and that call for a cargo protein-centered perspective instead. Here we describe a robust peroxisomal in vitro import system that provides this perspective. The data obtained with it suggest that translocation of a cargo protein across the peroxisomal membrane, including its release into the organelle matrix, occurs prior to PEX5 ubiquitination.	[Alencastre, Ines S.; Rodrigues, Tony A.; Grou, Claudia P.; Sa-Miranda, Clara; Azevedo, Jorge E.] Univ Porto, Inst Biol Mol & Celular, P-4150180 Oporto, Portugal; [Alencastre, Ines S.; Grou, Claudia P.; Azevedo, Jorge E.] Univ Porto, ICBAS, P-4009003 Oporto, Portugal; [Fransen, Marc] Katholieke Univ Leuven, Dept Mol Celbiol, Fac Geneeskunde, B-3000 Louvain, Belgium	Universidade do Porto; Universidade do Porto; KU Leuven	Azevedo, JE (corresponding author), Univ Porto, Inst Biol Mol & Celular, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	jazevedo@ibmc.up.pt	Fransen, Marc/C-6262-2008; Azevedo, Jorge E/A-4113-2008; Grou, Claudia P/K-5472-2013; Rodrigues, Tony A. Q./K-1141-2014; sá Miranda, Maria Clara/K-3920-2013; Fransen, Marc/ADL-0723-2022	Fransen, Marc/0000-0001-9284-1197; Azevedo, Jorge E/0000-0001-7714-5302; Grou, Claudia P/0000-0001-5197-2270; Rodrigues, Tony A. Q./0000-0003-2311-8258; sá Miranda, Maria Clara/0000-0003-0123-5525; Alencastre, Ines/0000-0002-5591-5596	Fundacao para a Ciencia e Tecnologia; Fundo Europeu de Desenvolvimento Regional, Portugal; European Union VI Framework program [LSHG-CT-2004-512018]; Peroxisomes in Health and Disease	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundo Europeu de Desenvolvimento Regional, Portugal; European Union VI Framework program(European Commission); Peroxisomes in Health and Disease	The work was supported by grants from Fundacao para a Ciencia e Tecnologia (PTDC program) and Fundo Europeu de Desenvolvimento Regional, Portugal and by the European Union VI Framework program Grant LSHG-CT-2004-512018, Peroxisomes in Health and Disease.	Agah A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh159; Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; ALEXSON SEH, 1985, J CELL BIOL, V101, P294, DOI 10.1083/jcb.101.1.294; Antonenkov VD, 2006, BBA-MOL CELL RES, V1763, P1697, DOI 10.1016/j.bbamcr.2006.08.044; Antonenkov VD, 1997, J BIOL CHEM, V272, P26023, DOI 10.1074/jbc.272.41.26023; Azevedo JE, 2004, CELL BIOCHEM BIOPHYS, V41, P451, DOI 10.1385/CBB:41:3:451; BOUT A, 1988, NUCLEIC ACIDS RES, V16, P10369, DOI 10.1093/nar/16.21.10369; Braverman N, 1998, HUM MOL GENET, V7, P1195, DOI 10.1093/hmg/7.8.1195; BROCARD C, 1994, BIOCHEM BIOPH RES CO, V204, P1016, DOI 10.1006/bbrc.1994.2564; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; Brown LA, 2008, MOL MEMBR BIOL, V25, P363, DOI 10.1080/09687680802130583; Carvalho AF, 2006, J MOL BIOL, V356, P864, DOI 10.1016/j.jmb.2005.12.002; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; Carvalho AF, 2007, BBA-MOL CELL RES, V1773, P1141, DOI 10.1016/j.bbamcr.2007.04.011; Costa-Rodrigues J, 2004, J BIOL CHEM, V279, P46573, DOI 10.1074/jbc.M406399200; Costa-Rodrigues J, 2005, J BIOL CHEM, V280, P24404, DOI 10.1074/jbc.M501985200; Dammai V, 2001, CELL, V105, P187, DOI 10.1016/S0092-8674(01)00310-5; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; Dodt G, 2001, J BIOL CHEM, V276, P41769, DOI 10.1074/jbc.M106932200; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Fransen M, 2002, MOL CELL PROTEOMICS, V1, P243, DOI 10.1074/mcp.M100025-MCP200; Fransen M, 2001, MOL CELL BIOL, V21, P4413, DOI 10.1128/MCB.21.13.4413-4424.2001; FUJIKI Y, 1985, J BIOL CHEM, V260, P5603; Galland N, 2007, BBA-MOL CELL RES, V1773, P521, DOI 10.1016/j.bbamcr.2007.01.006; Gatto GJ, 2000, PROTEINS, V38, P241, DOI 10.1002/(SICI)1097-0134(20000215)38:3<241::AID-PROT1>3.0.CO;2-1; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Gouveia AM, 2003, J BIOL CHEM, V278, P226, DOI 10.1074/jbc.M209498200; Gouveia AM, 2003, J BIOL CHEM, V278, P4389, DOI 10.1074/jbc.C200650200; Gouveia AMM, 2000, J BIOL CHEM, V275, P32444, DOI 10.1074/jbc.M004366200; Grou CP, 2009, CELL MOL LIFE SCI, V66, P254, DOI 10.1007/s00018-008-8415-5; Grou CP, 2008, J BIOL CHEM, V283, P14190, DOI 10.1074/jbc.M800402200; Grou CP, 2009, J BIOL CHEM, V284, P10504, DOI 10.1074/jbc.M808978200; HAAS AL, 1983, BIOCHEMISTRY-US, V22, P4388, DOI 10.1021/bi00288a007; Helm M, 2007, P NATL ACAD SCI USA, V104, P11501, DOI 10.1073/pnas.0704733104; IMANAKA T, 1987, J CELL BIOL, V105, P2915, DOI 10.1083/jcb.105.6.2915; Islinger M, 2007, J BIOL CHEM, V282, P23055, DOI 10.1074/jbc.M610910200; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; KRUSE M, 1995, J BIOL CHEM, V270, P2588, DOI 10.1074/jbc.270.6.2588; Kurochkin IV, 2007, EMBO J, V26, P835, DOI 10.1038/sj.emboj.7601525; Lazarow PB, 2006, BBA-MOL CELL RES, V1763, P1599, DOI 10.1016/j.bbamcr.2006.08.011; Matsumura T, 2000, J BIOL CHEM, V275, P21715, DOI 10.1074/jbc.M000721200; MIURA S, 1994, J BIOCHEM-TOKYO, V115, P1064, DOI 10.1093/oxfordjournals.jbchem.a124458; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Miyata N, 2009, BBA-MOL CELL RES, V1793, P860, DOI 10.1016/j.bbamcr.2009.02.007; Nair DM, 2004, J CELL BIOL, V167, P599, DOI 10.1083/jcb.200407119; Oliveira ME, 2003, J BIOL CHEM, V278, P39483, DOI 10.1074/jbc.M305089200; Omi S, 2008, J BIOCHEM, V143, P649, DOI 10.1093/jb/mvn020; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Pinto MP, 2006, J BIOL CHEM, V281, P34492, DOI 10.1074/jbc.M607183200; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Reguenga C, 2001, J BIOL CHEM, V276, P29935, DOI 10.1074/jbc.M104114200; Rokka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005090; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; VANVELDHOVEN P, 1983, BIOCHEM J, V210, P685, DOI 10.1042/bj2100685; WALTON PA, 1992, MOL CELL BIOL, V12, P531, DOI 10.1128/MCB.12.2.531; Wang DY, 2003, J BIOL CHEM, V278, P43340, DOI 10.1074/jbc.M307789200; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Williams C, 2006, BBA-MOL CELL RES, V1763, P1585, DOI 10.1016/j.bbamcr.2006.09.007; Woodward AW, 2005, MOL BIOL CELL, V16, P573, DOI 10.1091/mbc.E04-05-0422	63	35	35	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27243	27251		10.1074/jbc.M109.032565	http://dx.doi.org/10.1074/jbc.M109.032565			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19632994	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000270232300025
J	Kobayashi, H; Utsunomiya, H; Yamanaka, H; Sei, Y; Katunuma, N; Okamoto, K; Tsuge, H				Kobayashi, Hidetomo; Utsunomiya, Hiroko; Yamanaka, Hiroyasu; Sei, Yoshihisa; Katunuma, Nobuhiko; Okamoto, Keinosuke; Tsuge, Hideaki			Structural Basis for the Kexin-like Serine Protease from Aeromonas sobria as Sepsis-causing Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROCESSING ENZYME; SECRETORY PATHWAY; CRYSTAL-STRUCTURE; GENE-PRODUCT; 3' END; FURIN; SPECIFICITY; CLEAVAGE; CONVERTASES; PROTEINASE	The anaerobic bacterium Aeromonas sobria is known to cause potentially lethal septic shock. We recently proposed that A. sobria serine protease (ASP) is a sepsis-related factor that induces vascular leakage, reductions in blood pressure via kinin release, and clotting via activation of prothrombin. ASP preferentially cleaves peptide bonds that follow dibasic amino acid residues, as do Kex2 (Saccharomyces cerevisiae serine protease) and furin, which are representative kexin family proteases. Here, we revealed the crystal structure of ASP at 1.65 angstrom resolution using the multiple isomorphous replacement method with anomalous scattering. Although the overall structure of ASP resembles that of Kex2, it has a unique extra occluding region close to its active site. Moreover, we found that a nicked ASP variant is cleaved within the occluding region. Nicked ASP shows a greater ability to cleave small peptide substrates than the native enzyme. On the other hand, the cleavage pattern for prekallikrein differs from that of ASP, suggesting the occluding region is important for substrate recognition. The extra occluding region of ASP is unique and could serve as a useful target to facilitate development of novel antisepsis drugs.	[Utsunomiya, Hiroko; Katunuma, Nobuhiko; Tsuge, Hideaki] Tokushima Bunri Univ, Inst Hlth Sci, Yamashiro, Tokushima 7708514, Japan; [Kobayashi, Hidetomo; Yamanaka, Hiroyasu] Hiroshima Int Univ, Lab Mol Microbiol Sci, Fac Pharmaceut Sci, Hiroshima 7370112, Japan; [Sei, Yoshihisa] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Kagawa 7692193, Japan; [Okamoto, Keinosuke] Okayama Univ, Fac Pharmaceut Sci, Okayama 7008530, Japan	Tokushima Bunri University; Tokushima Bunri University; Okayama University	Tsuge, H (corresponding author), Tokushima Bunri Univ, Inst Hlth Sci, 180 Yamashiro Cho, Yamashiro, Tokushima 7708514, Japan.	tsuge@tokushima.bunri-u.ac.jp	Yamanaka, Hiroyasu/AAG-7880-2021; OKAMOTO, Keinosuke/B-2257-2011; Tsuge, Hideaki/ABF-6424-2021	Tsuge, Hideaki/0000-0003-0166-9163; Kobayashi, Hidetomo/0000-0002-5918-4268	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and by the Academic Frontier Promotion Program of MEXT of Japan.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Brink AJ, 1998, S AFR MED J, V88, P1011; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chuang YC, 1997, MICROBIOL-SGM, V143, P803, DOI 10.1099/00221287-143-3-803; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujii Y, 1998, MICROBIOL IMMUNOL, V42, P703, DOI 10.1111/j.1348-0421.1998.tb02343.x; FULLER RS, 1988, ANNU REV PHYSIOL, V50, P345, DOI 10.1146/annurev.ph.50.030188.002021; FULLER RS, 1989, P NATL ACAD SCI USA, V86, P1434, DOI 10.1073/pnas.86.5.1434; Galindo CL, 2004, J BIOL CHEM, V279, P37597, DOI 10.1074/jbc.M404641200; GLUSCHANKOF P, 1994, EMBO J, V13, P2280, DOI 10.1002/j.1460-2075.1994.tb06510.x; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Holyoak T, 2004, BIOCHEMISTRY-US, V43, P2412, DOI 10.1021/bi035849h; Holyoak T, 2003, BIOCHEMISTRY-US, V42, P6709, DOI 10.1021/bi034434t; HOSAKA M, 1991, J BIOL CHEM, V266, P12127; Imamura T, 2006, J IMMUNOL, V177, P8723, DOI 10.4049/jimmunol.177.12.8723; Janda JM, 1998, CLIN INFECT DIS, V27, P332, DOI 10.1086/514652; JANDA JM, 1987, J INFECT DIS, V155, P589, DOI 10.1093/infdis/155.3.589; JONES BL, 1995, J ANTIMICROB CHEMOTH, V35, P453, DOI 10.1093/jac/35.4.453; Kobayashi H, 2006, FEMS MICROBIOL LETT, V256, P165, DOI 10.1111/j.1574-6968.2006.00134.x; Krysan DJ, 1999, J BIOL CHEM, V274, P23229, DOI 10.1074/jbc.274.33.23229; LEIBOWITZ MJ, 1976, P NATL ACAD SCI USA, V73, P2061, DOI 10.1073/pnas.73.6.2061; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MOSES AE, 1995, EUR J CLIN MICROBIOL, V14, P237, DOI 10.1007/BF02310364; Nitta H, 2008, J IMMUNOL, V181, P3602, DOI 10.4049/jimmunol.181.5.3602; Nitta H, 2007, FEBS LETT, V581, P5935, DOI 10.1016/j.febslet.2007.11.076; Nomura T, 2002, J BACTERIOL, V184, P7058, DOI 10.1128/JB.184.24.7058-7061.2002; Nomura T, 1999, MICROBIOL IMMUNOL, V43, P29, DOI 10.1111/j.1348-0421.1999.tb02369.x; Okamoto K, 2000, MICROBIOL IMMUNOL, V44, P787, DOI 10.1111/j.1348-0421.2000.tb02565.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rockwell NC, 2002, CHEM REV, V102, P4525, DOI 10.1021/cr010168i; ROEBROEK AJM, 1986, MOL BIOL REP, V11, P117, DOI 10.1007/BF00364823; Seshadri R, 2006, J BACTERIOL, V188, P8272, DOI 10.1128/JB.00621-06; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; VANDENOUWELAND AMW, 1990, NUCLEIC ACIDS RES, V18, P664, DOI 10.1093/nar/18.3.664; VANDEVEN WJM, 1991, ENZYME, V45, P257, DOI 10.1159/000468900; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yamada S, 1997, EPIDEMIOL INFECT, V119, P121, DOI 10.1017/S0950268897007942; Zhou A, 1998, J BIOL CHEM, V273, P11107, DOI 10.1074/jbc.273.18.11107	41	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27655	27663		10.1074/jbc.M109.006114	http://dx.doi.org/10.1074/jbc.M109.006114			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19654332	Green Published, hybrid			2022-12-27	WOS:000270232300067
J	Nakamura, S; Kuroki, K; Ohki, I; Sasaki, K; Kajikawa, M; Maruyama, T; Ito, M; Kameda, Y; Ikura, M; Yamamoto, K; Matsumoto, N; Maenaka, K				Nakamura, Seiko; Kuroki, Kimiko; Ohki, Izuru; Sasaki, Kaori; Kajikawa, Mizuho; Maruyama, Takuma; Ito, Masayuki; Kameda, Yosuke; Ikura, Mitsuhiko; Yamamoto, Kazuo; Matsumoto, Naoki; Maenaka, Katsumi			Molecular Basis for E-cadherin Recognition by Killer Cell Lectin-like Receptor G1 (KLRG1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CUTTING EDGE; ADHESION; BINDING; MECHANISM; INTEGRIN; INSIGHTS; COMPLEX; LIGAND; DOMAIN	The killer cell lectin-like receptor G1, KLRG1, is a cell surface receptor expressed on subsets of natural killer (NK) cells and T cells. KLRG1 was recently found to recognize E-cadherin and thus inhibit immune responses by regulating the effector function and the developmental processes of NK and T cells. E-cadherin is expressed on epithelial cells and exhibits Ca2+-dependent homophilic interactions that contribute to cell-cell junctions. However, the mechanism underlying the molecular recognition of KLRG1 by E-cadherin remains unclear. Here, we report structural, binding, and functional analyses of this interaction using multiple methods. Surface plasmon resonance demonstrated that KLRG1 binds the E-cadherin N-terminal domains 1 and 2 with low affinity (K-d similar to 7-12 mu M), typical of cell-cell recognition receptors. NMR binding studies showed that only a limited N-terminal region of E-cadherin, comprising the homodimer interface, exhibited spectrum perturbation upon KLRG1 complex formation. It was confirmed by binding studies using a series of E-cadherin mutants. Furthermore, killing assays using KLRG1(+)NK cells and reporter cell assays demonstrated the functional significance of the N-terminal region of E-cadherin. These results suggest that KLRG1 recognizes the N-terminal homodimeric interface of domain 1 of E-cadherin and binds only the monomeric form of E-cadherin to inhibit the immune response. This raises the possibility that KLRG1 detects monomeric E-cadherin at exposed cell surfaces to control the activation threshold of NK and T cells.	[Nakamura, Seiko; Kuroki, Kimiko; Ohki, Izuru; Sasaki, Kaori; Kajikawa, Mizuho; Maenaka, Katsumi] Kyushu Univ, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan; [Maruyama, Takuma; Ito, Masayuki; Kameda, Yosuke; Yamamoto, Kazuo; Matsumoto, Naoki] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan; [Ikura, Mitsuhiko] Univ Toronto, Ontario Canc Inst, Div Signaling Biol, Toronto, ON M5G 2M9, Canada; [Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	Kyushu University; University of Tokyo; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Maenaka, K (corresponding author), Kyushu Univ, Med Inst Bioregulat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	kmaenaka-umin@umin.net	Ohki, Izuru/C-7883-2013; Ohki, Izuru/O-4816-2019; Kuroki, Kimiko/F-6906-2012	Ohki, Izuru/0000-0002-0667-5936; Ikura, Mitsuhiko/0000-0002-9524-1303	Ministry of Education, Culture, Sports, Science and Technology; Japan Bio-oriented Technology Research Advancement Institute (BRAIN)	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Bio-oriented Technology Research Advancement Institute (BRAIN)	This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology and the Japan Bio-oriented Technology Research Advancement Institute (BRAIN).	Agace WW, 2000, CURR OPIN CELL BIOL, V12, P563, DOI 10.1016/S0955-0674(00)00132-0; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Colonna M, 2006, J EXP MED, V203, P261, DOI 10.1084/jem.20052559; Gooding JM, 2004, BIOESSAYS, V26, P497, DOI 10.1002/bies.20033; Grundemann C, 2006, J IMMUNOL, V176, P1311, DOI 10.4049/jimmunol.176.3.1311; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Huntington ND, 2007, J IMMUNOL, V178, P4764, DOI 10.4049/jimmunol.178.8.4764; Ito M, 2006, J EXP MED, V203, P289, DOI 10.1084/jem.20051986; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Matsumoto N, 2001, J EXP MED, V193, P147, DOI 10.1084/jem.193.2.147; Moretta L, 2004, CURR OPIN IMMUNOL, V16, P626, DOI 10.1016/j.coi.2004.07.010; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; Ohki I, 1999, EMBO J, V18, P6653, DOI 10.1093/emboj/18.23.6653; OVERDUIN M, 1995, SCIENCE, V267, P386, DOI 10.1126/science.7824937; Parisini E, 2007, J MOL BIOL, V373, P401, DOI 10.1016/j.jmb.2007.08.011; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Robbins SH, 2004, J IMMUNOL, V173, P259, DOI 10.4049/jimmunol.173.1.259; Robbins SH, 2002, J IMMUNOL, V168, P2585, DOI 10.4049/jimmunol.168.6.2585; Rosshart S, 2008, EUR J IMMUNOL, V38, P3354, DOI 10.1002/eji.200838690; Schwartzkopff S, 2007, J IMMUNOL, V179, P1022, DOI 10.4049/jimmunol.179.2.1022; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Yokoyama WM, 1998, CURR OPIN IMMUNOL, V10, P298, DOI 10.1016/S0952-7915(98)80168-4	27	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27327	27335		10.1074/jbc.M109.038802	http://dx.doi.org/10.1074/jbc.M109.038802			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19654330	Green Published, hybrid			2022-12-27	WOS:000270232300033
J	Wang, XX; Zhao, Q; Matta, R; Meng, XM; Liu, XP; Liu, CG; Nelin, LD; Liu, YS				Wang, Xianxi; Zhao, Qun; Matta, Ranyia; Meng, Xiaomei; Liu, Xiuping; Liu, Chang-Gong; Nelin, Leif D.; Liu, Yusen			Inducible Nitric-oxide Synthase Expression Is Regulated by Mitogen-activated Protein Kinase Phosphatase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMEDIATE-EARLY GENE; PROINFLAMMATORY CYTOKINE BIOSYNTHESIS; FACTOR-KAPPA-B; IFN-GAMMA; MESSENGER-RNA; INTERFERON-GAMMA; UNITED-STATES; MACROPHAGES; LIPOPOLYSACCHARIDE; MKP-1	Inducible nitric-oxide (NO) synthase (iNOS) plays a critical role in the eradication of intracellular pathogens. However, the excessive production of NO by iNOS has also been implicated in the pathogenesis of septic shock syndrome. Previously, we have demonstrated that mice deficient in mitogen-activated protein kinase phosphatase-1 (MKP-1) exhibit exaggerated inflammatory responses and rapidly succumb to lipopolysaccharide (LPS). In response to LPS, MKP-1(-/-) mice produce greater amounts of inflammatory cytokines and NO than do wild-type mice, and the MKP-1(-/-) mice exhibit severe hypotension. To understand the molecular basis for the increase in NO production, we studied the role of MKP-1 in the regulation of iNOS expression. We found that LPS challenge elicited a stronger iNOS induction in MKP-1 knock-out mice than in wild-type mice. Likewise, LPS treatment also resulted in greater iNOS expression in macrophages from MKP-1(-/-) mice than in macrophages from wild-type mice. Both accelerated gene transcription and enhanced mRNA stability contribute to the increases in iNOS expression in LPS-stimulated MKP-1(-/-) macrophages. We found that STAT-1, a transcription factor known to mediate iNOS induction by interferon-gamma, was more potently activated by LPS in MKP-1(-/-) macrophages than in wild-type cells. MicroRNA array analysis indicated that microRNA (miR)-155 expression was increased in MKP-1-deficient macrophages compared with wild-type macrophages. Transfection of miR-155 attenuated the expression of Suppressor of Cytokine Signal (SOCS)-1 and enhanced the expression of iNOS. Our results suggest that MKP-1 may negatively regulate iNOS expression by controlling the expression of miR-155 and consequently the STAT pathway via SOCS-1.	[Wang, Xianxi; Zhao, Qun; Meng, Xiaomei; Nelin, Leif D.; Liu, Yusen] Ohio State Univ, Ctr Perinatal Res, Res Inst, Nationwide Childrens Hosp,Dept Pediat,Coll Med, Columbus, OH 43205 USA; [Matta, Ranyia; Nelin, Leif D.; Liu, Yusen] Ohio State Univ, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA; [Liu, Yusen] Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA; [Liu, Xiuping; Liu, Chang-Gong] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Texas System; UTMD Anderson Cancer Center	Liu, YS (corresponding author), Ohio State Univ, Ctr Perinatal Res, Res Inst, Nationwide Childrens Hosp,Dept Pediat,Coll Med, 700 Childrens Dr, Columbus, OH 43205 USA.	yusen.liu@nationwidechildrens.org	Liu, Yusen/E-3527-2011; Nelin, Leif/AAC-8475-2020; Nelin, Leif/E-3747-2011	Liu, Yusen/0000-0002-0994-0109	National Institutes of Health [AI 57798, AI 68956, HL 75261]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057798, R01AI068956, R21AI057798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI 57798 and AI 68956 (to Y.L.) and HL 75261 (to L.D.N.).	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; Calvert TJ, 2008, AM J PHYSIOL-HEART C, V294, pH1621, DOI 10.1152/ajpheart.01008.2007; CHARLES CH, 1992, ONCOGENE, V7, P187; CHARLES CH, 1993, P NATL ACAD SCI USA, V90, P5292, DOI 10.1073/pnas.90.11.5292; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; Chen W, 1998, MOL CELL BIOL, V18, P5178, DOI 10.1128/MCB.18.9.5178; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; COLLART MA, 1986, J EXP MED, V164, P2113, DOI 10.1084/jem.164.6.2113; Di Marco S, 2005, MOL CELL BIOL, V25, P6533, DOI 10.1128/MCB.25.15.6533-6545.2005; Dorfman K, 1996, ONCOGENE, V13, P925; Fechir M, 2005, MOL PHARMACOL, V67, P2148, DOI 10.1124/mol.104.008763; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; Gavrilescu LC, 2004, INFECT IMMUN, V72, P1257, DOI 10.1128/IAI.72.3.1257-1264.2004; GORDON S, 1995, BIOESSAYS, V17, P977, DOI 10.1002/bies.950171111; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Hammer M, 2005, EUR J IMMUNOL, V35, P2991, DOI 10.1002/eji.200526192; Hecker M, 1996, BRIT J PHARMACOL, V118, P2178, DOI 10.1111/j.1476-5381.1996.tb15660.x; Heitmeier MR, 1999, J BIOL CHEM, V274, P29266, DOI 10.1074/jbc.274.41.29266; Hoefig KP, 2008, CURR OPIN IMMUNOL, V20, P281, DOI 10.1016/j.coi.2008.05.005; Hu XY, 2008, IMMUNOL REV, V226, P41, DOI 10.1111/j.1600-065X.2008.00707.x; JANEWAY CA, 2005, IMMUNOBIOLOGY, P37; JUN CD, 1994, J IMMUNOL, V153, P3684; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Lahti A, 2003, MOL PHARMACOL, V64, P308, DOI 10.1124/mol.64.2.308; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; LORSBACH RB, 1993, J BIOL CHEM, V268, P1908; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Malu S, 2003, J IMMUNOL METHODS, V272, P55, DOI 10.1016/S0022-1759(02)00424-6; MARTIN E, 1994, J EXP MED, V180, P977, DOI 10.1084/jem.180.3.977; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Ohmori Y, 2001, J LEUKOCYTE BIOL, V69, P598; Parrillo J E, 1993, N Engl J Med, V328, P1471; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Prabhu KS, 2002, BIOCHEM J, V366, P203, DOI 10.1042/BJ20020256; Salkowski CA, 1997, J IMMUNOL, V158, P905; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shepherd EG, 2004, J BIOL CHEM, V279, P54023, DOI 10.1074/jbc.M408444200; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Taylor LS, 1997, CANCER RES, V57, P2468; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Wang XX, 2007, J IMMUNOL, V178, P5312, DOI 10.4049/jimmunol.178.8.5312; Zhang YH, 2005, CELL IMMUNOL, V234, P16, DOI 10.1016/j.cellimm.2005.04.004; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhao Q, 2005, J BIOL CHEM, V280, P8101, DOI 10.1074/jbc.M411760200	51	47	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27123	27134		10.1074/jbc.M109.051235	http://dx.doi.org/10.1074/jbc.M109.051235			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651781	Green Published, hybrid			2022-12-27	WOS:000270232300013
J	King, EM; Holden, NS; Gong, W; Rider, CF; Newton, R				King, Elizabeth M.; Holden, Neil S.; Gong, Wei; Rider, Christopher F.; Newton, Robert			Inhibition of NF-kappa B-dependent Transcription by MKP-1 TRANSCRIPTIONAL REPRESSION BY GLUCOCORTICOIDS OCCURRING VIA p38 MAPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TUMOR-NECROSIS-FACTOR; SMOOTH-MUSCLE-CELLS; DUAL-SPECIFICITY PHOSPHATASE-1; AIRWAY INFLAMMATORY DISEASE; PULMONARY EPITHELIAL-CELLS; INDUCED LEUCINE-ZIPPER; GLUCOCORTICOID-RECEPTOR; DNA-BINDING; GENE-EXPRESSION	Acting via the glucocorticoid receptor (GR), glucocorticoids exert potent anti-inflammatory effects partly by repressing inflammatory gene transcription occurring via factors such as NF-kappa B. In the present study, the synthetic glucocorticoid, dexamethasone, induces expression of MKP-1 (mitogen-activated protein kinase (MAPK) phosphatase-1) in human bronchial epithelial (BEAS-2B) and pulmonary (A549) cells. This correlates with reduced TNF alpha-stimulated p38 MAPK phosphorylation. Since NF-kappa B-dependent transcription and IL-8 protein, mRNA, and unspliced RNA (a surrogate of transcription rate) are sensitive to p38 MAPK inhibitors (SB203580 and SB239063), we explored the role of MKP-1 in repression of these outputs. Repression of TNF alpha-induced p38 MAPK phosphorylation, NF-kappa B-dependent transcription, and IL-8 expression by dexamethasone are sensitive to transcriptional or translational inhibitors. This indicates a role for de novo gene synthesis. Adenoviral expression of MKP-1 profoundly reduces p38 MAPK phosphorylation and IL-8 expression. Similarly, NF-kappa B-dependent transcription is significantly reduced to levels consistent with maximal p38 MAPK inhibition. Thus, MKP-1 attenuates TNF alpha-dependent activation of p38 MAPK, induction of IL-8 expression, and NF-kappa B-dependent transcription. Small interfering RNA knockdown of dexamethasone-induced MKP-1 expression partially reverses the repression of TNF alpha-activated p38 MAPK, demonstrating that MKP-1 participates in the dexamethasone-dependent repression of this pathway. In the presence of MKK6 (MAPK kinase 6), a p38 MAPK activator, dexamethasone dramatically represses TNF alpha-induced NF-kappa B-dependent transcription, and this is significantly reversed by MKP-1-targeting small interfering RNA. This reveals an important and novel role for transcriptional activation (transactivation) of MKP-1 in the repression of NF-kappa B-dependent transcription by glucocorticoids. We conclude that GR transactivation is essential to the anti-inflammatory properties of GR ligands.	[Newton, Robert] Univ Calgary, Dept Cell Biol & Anat, Fac Med, Airways Inflammat Grp, Calgary, AB T2N 4N1, Canada	University of Calgary	Newton, R (corresponding author), Univ Calgary, Dept Cell Biol & Anat, Fac Med, Airways Inflammat Grp, Calgary, AB T2N 4N1, Canada.	rnewton@ucalgary.ca	Newton, Robert/C-6814-2012; Rider, Christopher F/H-7073-2019	Newton, Robert/0000-0002-4919-8498; Rider, Christopher F/0000-0003-0399-5931; Holden, Neil/0000-0001-5824-3417	Alberta Heritage Foundation for Medical Research (AHFMR); Canadian Institutes of Health Research (CIHR); Lung Association of Alberta and the North West Territories Studentship; Izaak Walton Killam Postdoctoral Fellowship; Canadian Fund of Innovation; Alberta Science and Research Authority	Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Lung Association of Alberta and the North West Territories Studentship; Izaak Walton Killam Postdoctoral Fellowship; Canadian Fund of Innovation; Alberta Science and Research Authority	This work was supported by a start-up grant from the Alberta Heritage Foundation for Medical Research (AHFMR) (to R. N.) and operating grants from the Canadian Institutes of Health Research (CIHR) (to R. N.), a Lung Association of Alberta and the North West Territories Studentship (to E. M. K.), and an Izaak Walton Killam Postdoctoral Fellowship (to N. S. H.). Real time PCR was performed by virtue of an equipment and infrastructure grant from the Canadian Fund of Innovation and the Alberta Science and Research Authority.	Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Beck IM, 2008, EMBO J, V27, P1682, DOI 10.1038/emboj.2008.95; Bergmann M, 1998, J BIOL CHEM, V273, P6607, DOI 10.1074/jbc.273.12.6607; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; Bratton MR, 2009, CARCINOGENESIS, V30, P106, DOI 10.1093/carcin/bgn213; Bueno OF, 2001, CIRC RES, V88, P88, DOI 10.1161/01.RES.88.1.88; Carter AB, 1999, J BIOL CHEM, V274, P30858, DOI 10.1074/jbc.274.43.30858; Catley MC, 2005, BRIT J PHARMACOL, V145, P114, DOI 10.1038/sj.bjp.0706170; Catley MC, 2004, J BIOL CHEM, V279, P18457, DOI 10.1074/jbc.M400765200; Chivers JE, 2004, EUR J BIOCHEM, V271, P4042, DOI 10.1111/j.1432-1033.2004.04342.x; Chivers JE, 2006, MOL PHARMACOL, V70, P2084, DOI 10.1124/mol.106.025841; Cho IJ, 2009, MOL ENDOCRINOL, V23, P86, DOI 10.1210/me.2008-0257; Clark AR, 2008, J BIOL CHEM, V283, P25765, DOI 10.1074/jbc.R700053200; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; DeBosscher K, 1997, P NATL ACAD SCI USA, V94, P13504, DOI 10.1073/pnas.94.25.13504; Diefenbacher M, 2008, MOL ENDOCRINOL, V22, P1767, DOI 10.1210/me.2007-0574; Eddleston J, 2007, J ALLERGY CLIN IMMUN, V119, P115, DOI 10.1016/j.jaci.2006.08.027; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Holden NS, 2007, BRIT J PHARMACOL, V152, P891, DOI 10.1038/sj.bjp.0707457; Issa R, 2007, J IMMUNOL, V178, P7366, DOI 10.4049/jimmunol.178.11.7366; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Ito K, 2001, J BIOL CHEM, V276, P30208, DOI 10.1074/jbc.M103604200; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Kaiser RA, 2004, J BIOL CHEM, V279, P15524, DOI 10.1074/jbc.M313717200; Kang BN, 2008, AM J PHYSIOL-LUNG C, V295, pL186, DOI 10.1152/ajplung.00352.2007; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Kaur M, 2008, MOL PHARMACOL, V73, P203, DOI 10.1124/mol.107.040121; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Newton R, 1998, EUR J BIOCHEM, V254, P81, DOI 10.1046/j.1432-1327.1998.2540081.x; Newton R, 1998, J BIOL CHEM, V273, P32312, DOI 10.1074/jbc.273.48.32312; Newton R, 1997, FEBS LETT, V418, P135, DOI 10.1016/S0014-5793(97)01362-8; Newton Robert, 2006, Drug Discov Today Dis Mech, V3, P53, DOI 10.1016/j.ddmec.2006.02.007; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Newton R, 2007, J PHARMACOL EXP THER, V321, P734, DOI 10.1124/jpet.106.118125; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Quante T, 2008, AM J RESP CELL MOL, V39, P208, DOI 10.1165/rcmb.2007-0014OC; Reber L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004393; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; Schmitz ML, 2004, CHEMBIOCHEM, V5, P1348, DOI 10.1002/cbic.200400144; Simons SS, 2006, CURR TOP MED CHEM, V6, P271, DOI 10.2174/156802606776173465; Tudhope SJ, 2007, J IMMUNOL, V179, P6237, DOI 10.4049/jimmunol.179.9.6237; Uings IJ, 2005, CURR OPIN PHARMACOL, V5, P221, DOI 10.1016/j.coph.2004.12.003; Underwood DC, 2000, AM J PHYSIOL-LUNG C, V279, pL895, DOI 10.1152/ajplung.2000.279.5.L895; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Vayssiere BM, 1997, MOL ENDOCRINOL, V11, P1245, DOI 10.1210/me.11.9.1245; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139	58	106	110	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26803	26815		10.1074/jbc.M109.028381	http://dx.doi.org/10.1074/jbc.M109.028381			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19648110	Green Published, hybrid			2022-12-27	WOS:000269969600062
J	Gong, HBA; He, JH; Lee, JH; Mallick, E; Gao, X; Li, S; Homanics, GE; Xie, W				Gong, Haibiao; He, Jinhan; Lee, Jung Hoon; Mallick, Edward; Gao, Xiang; Li, Song; Homanics, Gregg E.; Xie, Wen			Activation of the Liver X Receptor Prevents Lipopolysaccharide-induced Lung Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR; OXIDATIVE STRESS; GENE; LXR; GAMMA; EXPRESSION; MICE; INFLAMMATION; GLUTATHIONE; SURFACTANT	The liver X receptors (LXRs) have been known as sterol sensors that impact cholesterol and lipid homeostasis, as well as inflammation. Although the hepatic functions of LXRs are well documented, whether and how LXRs play a pathophysiological role in the lung remain largely unknown. Here we show that LXR alpha and LXR beta are expressed in both type I and type II mouse lung epithelial cells, as well as in human lung cancer cells. To study the role of LXR alpha in vivo including the pulmonary function of this LXR isoform, we created LXR alpha knock-in (LXR-KI) mice in which a constitutively activated LXR alpha (VP-LXR alpha) was inserted into the mouse LXR alpha locus. We show that activation of LXR in LXR-KI mice or LXR agonist-treated wild type mice induced pulmonary expression of genes encoding multiple antioxidant enzymes. Consistent with the induction of antioxidant enzymes, LXR-KI mice and LXR ligand-treated wild type mice showed a substantial resistance to lipopolysaccharide-induced lung injury and decreased production of reactive oxygen species. In summary, we have uncovered a novel role of LXR in regulating antioxidant enzymes in the lung and the implication of this regulation in pulmonary tissue protection.	[Gong, Haibiao; He, Jinhan; Lee, Jung Hoon; Gao, Xiang; Li, Song; Xie, Wen] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA; [Gong, Haibiao; He, Jinhan; Lee, Jung Hoon; Gao, Xiang; Li, Song; Xie, Wen] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Mallick, Edward; Homanics, Gregg E.] Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA 15261 USA; [Homanics, Gregg E.; Xie, Wen] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Xie, W (corresponding author), Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA.	wex6@pitt.edu	Xie, Wen/M-1768-2016	Homanics, Gregg/0000-0003-3641-8153	National Institutes of Health [ES014626, DK076962, N01-DK-7-0004/HHSN267200700004C]; National Institutes of Health Shared Instrument [S10RR022515]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Shared Instrument(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES014626 and DK076962 (to W. X.) and National Institutes of Health Shared Instrument Grant S10RR022515 (to Robert Gibbs).; We thank Carolyn Ferguson for technical assistance with the embryonic stem cell work, Dr. Robert Gibbs for assistance with the use of the confocal microscope, and Dr. Steve Strom for primary human hepatocytes. Normal human hepatocytes were obtained through the Liver Tissue Procurement and Distribution System, Pittsburgh, Pennsylvania, which was funded by National Institutes of Health Contract N01-DK-7-0004/HHSN267200700004C.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Albers M, 2006, J BIOL CHEM, V281, P4920, DOI 10.1074/jbc.M510101200; Asada K, 2004, AM J RESP CRIT CARE, V169, P195, DOI 10.1164/rccm.200207-740OC; Been JV, 2007, EUR J PEDIATR, V166, P889, DOI 10.1007/s00431-007-0501-4; Birrell MA, 2007, J BIOL CHEM, V282, P31882, DOI 10.1074/jbc.M703278200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Castrillo A, 2003, J BIOL CHEM, V278, P10443, DOI 10.1074/jbc.M213071200; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; Chow CW, 2003, AM J RESP CELL MOL, V29, P427, DOI 10.1165/rcmb.F278; Christensen PJ, 1999, AM J PATHOL, V155, P1773, DOI 10.1016/S0002-9440(10)65493-4; Christofidou-Solomidou Melpo, 2006, Treat Respir Med, V5, P47, DOI 10.2165/00151829-200605010-00004; Cummins CL, 2006, J CLIN INVEST, V116, P1902, DOI 10.1172/JCI28400; Gong HB, 2006, MOL ENDOCRINOL, V20, P279, DOI 10.1210/me.2005-0205; Gong HB, 2004, EXPERT OPIN THER TAR, V8, P49, DOI 10.1517/14728222.8.1.49; Guo RF, 2007, ANTIOXID REDOX SIGN, V9, P1991, DOI 10.1089/ars.2007.1785; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Homanics GE, 1997, MOL PHARMACOL, V51, P588, DOI 10.1124/mol.51.4.588; JENKINS JK, 1991, AM REV RESPIR DIS, V143, P155, DOI 10.1164/ajrccm/143.1.155; Jia LY, 2008, AM J PHYSIOL-CELL PH, V294, pC47, DOI 10.1152/ajpcell.00019.2007; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Kennedy MA, 2001, J BIOL CHEM, V276, P39438, DOI 10.1074/jbc.M105863200; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Lang JD, 2002, CHEST, V122, p314S, DOI 10.1378/chest.122.6_suppl.314S; Mastruzzo C, 2002, Monaldi Arch Chest Dis, V57, P173; Matsukawa A, 1999, J IMMUNOL, V163, P6148; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakamura T, 2005, ANTIOXID REDOX SIGN, V7, P60, DOI 10.1089/ars.2005.7.60; PAOLETTI F, 1990, METHOD ENZYMOL, V186, P209; Park EY, 2004, CANCER RES, V64, P3701, DOI 10.1158/0008-5472.CAN-03-3924; Rahman I, 2005, ANTIOXID REDOX SIGN, V7, P42, DOI 10.1089/ars.2005.7.42; Rahman Irfan, 2008, Ther Adv Respir Dis, V2, P351, DOI 10.1177/1753465808098224; Reddy RC, 2004, AM J PHYSIOL-LUNG C, V286, pL613, DOI 10.1152/ajplung.00206.2003; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243; Ritter C, 2004, CRIT CARE MED, V32, P342, DOI 10.1097/01.CCM.0000109454.13145.CA; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Szarka RJ, 1997, J IMMUNOL METHODS, V202, P49, DOI 10.1016/S0022-1759(96)00236-0; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Uppal H, 2007, HEPATOLOGY, V45, P422, DOI 10.1002/hep.21494; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; VOORHOUT WF, 1992, AM J PHYSIOL, V263, pL479, DOI 10.1152/ajplung.1992.263.4.L479; Wells Christine A, 2003, BMC Immunol, V4, P5, DOI 10.1186/1471-2172-4-5; Wesselkamper SC, 2006, AM J RESP CELL MOL, V34, P73, DOI 10.1165/rcmb.2005-0248OC; Willson DF, 2008, PEDIATR CLIN N AM, V55, P545, DOI 10.1016/j.pcl.2008.02.016; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200	54	36	39	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30113	30121		10.1074/jbc.M109.047753	http://dx.doi.org/10.1074/jbc.M109.047753			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19717840	hybrid, Green Published			2022-12-27	WOS:000271090000014
J	Masuda, T; Ito, Y; Terada, T; Shibata, T; Mikawa, T				Masuda, Tokiha; Ito, Yutaka; Terada, Tohru; Shibata, Takehiko; Mikawa, Tsutomu			A Non-canonical DNA Structure Enables Homologous Recombination in Various Genetic Systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI RECA PROTEIN; SINGLE-STRANDED-DNA; ELECTRON-MICROSCOPIC VISUALIZATION; MOLECULAR-STRUCTURE DETERMINATION; HUMAN RAD52 PROTEIN; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; DUPLEX DNA; BACTERIOPHAGE-LAMBDA; RNA RECOMBINATION	Homologous recombination, which is critical to genetic diversity, depends on homologous pairing (HP). HP is the switch from parental to recombinant base pairs, which requires expansion of inter-base pair spaces. This expansion unavoidably causes untwisting of the parental double-stranded DNA. RecA/Rad51-catalyzed ATP-dependent HP is extensively stimulated in vitro by negative supercoils, which compensates for untwisting. However, in vivo, double-stranded DNA is relaxed by bound proteins and thus is an unfavorable substrate for RecA/Rad51. In contrast, Mhr1, an ATP-independent HP protein required for yeast mitochondrial homologous recombination, catalyzes HP without the net untwisting of double-stranded DNA. Therefore, we questioned whether Mhr1 uses a novel strategy to promote HP. Here, we found that, like RecA, Mhr1 induced the extension of bound single-stranded DNA. In addition, this structure was induced by all evolutionarily and structurally distinct HP proteins so far tested, including bacterial RecO, viral RecT, and human Rad51. Thus, HP includes the common non-canonical DNA structure and uses a common core mechanism, independent of the species of HP proteins. We discuss the significance of multiple types of HP proteins.	[Mikawa, Tsutomu] RIKEN, Adv Sci Inst, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Masuda, Tokiha; Shibata, Takehiko; Mikawa, Tsutomu] Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Terada, Tohru] RIKEN, Computat Sci Res Program, Wako, Saitama 3510198, Japan; [Ito, Yutaka] Tokyo Metropolitan Univ, Dept Chem, Tokyo 1920397, Japan; [Terada, Tohru] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Mikawa, Tsutomu] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan	RIKEN; Yokohama City University; RIKEN; Tokyo Metropolitan University; University of Tokyo; RIKEN	Mikawa, T (corresponding author), RIKEN, Adv Sci Inst, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	mikawa@riken.jp	Mikawa, Tsutomu/E-6510-2013; Ito, Yutaka/P-2604-2015; Terada, Tohru/W-2956-2019	Mikawa, Tsutomu/0000-0003-2325-5084; Ito, Yutaka/0000-0002-1030-4660; Terada, Tohru/0000-0002-7091-0646	Japan Society for the Promotion of Science (JSPS); Research and Development of the Next-Generation Integrated Simulation of Living Matter; Ministry of Education, Culture, Sports, Science and Technology of Japan; JSPS	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research and Development of the Next-Generation Integrated Simulation of Living Matter(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a grant-in-aid from the Japan Society for the Promotion of Science (JSPS), and Research and Development of the Next-Generation Integrated Simulation of Living Matter, a part of the Development and Use of the Next-Generation Supercomputer Project of the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a grant from the JSPS.	Baumann P, 1997, EMBO J, V16, P5198, DOI 10.1093/emboj/16.17.5198; CARON F, 1979, P NATL ACAD SCI USA, V76, P4265, DOI 10.1073/pnas.76.9.4265; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Chetverin AB, 1999, FEBS LETT, V460, P1, DOI 10.1016/S0014-5793(99)01282-X; CLARK AJ, 1993, J BACTERIOL, V175, P7673, DOI 10.1128/JB.175.23.7673-7682.1993; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P3433, DOI 10.1073/pnas.78.6.3433; CUNNINGHAM RP, 1979, NATURE, V281, P191, DOI 10.1038/281191a0; DUNN K, 1982, CELL, V28, P757, DOI 10.1016/0092-8674(82)90055-1; Egel R, 2007, DNA REPAIR, V6, P669, DOI 10.1016/j.dnarep.2006.12.013; FISHER RP, 1992, J BIOL CHEM, V267, P3358; FLORY J, 1984, P NATL ACAD SCI-BIOL, V81, P7026, DOI 10.1073/pnas.81.22.7026; HEUSER J, 1989, J MOL BIOL, V210, P473, DOI 10.1016/0022-2836(89)90124-1; Inoue J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl350; Inoue J, 2008, NUCLEIC ACIDS RES, V36, P94, DOI 10.1093/nar/gkm1004; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Kagawa W, 2001, J BIOL CHEM, V276, P35201, DOI 10.1074/jbc.M104938200; Kagawa W, 2008, J BIOL CHEM, V283, P24264, DOI 10.1074/jbc.M802204200; KAHN R, 1981, P NATL ACAD SCI-BIOL, V78, P4786, DOI 10.1073/pnas.78.8.4786; KING AMQ, 1982, CELL, V29, P921, DOI 10.1016/0092-8674(82)90454-8; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; KRAULIS PJ, 1989, J MAGN RESON, V84, P627, DOI 10.1016/0022-2364(89)90130-3; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Kurumizaka H, 2001, P NATL ACAD SCI USA, V98, P5538, DOI 10.1073/pnas.091603098; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; LAI MMC, 1992, MICROBIOL REV, V56, P61, DOI 10.1128/MMBR.56.1.61-79.1992; Leiros I, 2005, EMBO J, V24, P906, DOI 10.1038/sj.emboj.7600582; Ling F, 2002, EMBO J, V21, P4730, DOI 10.1093/emboj/cdf466; Ling F, 2009, J BIOL CHEM, V284, P9341, DOI 10.1074/jbc.M900023200; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; LUISIDELUCA C, 1995, J BACTERIOL, V177, P566, DOI 10.1128/jb.177.3.566-572.1995; Matsuo Y, 2006, FEBS J, V273, P3148, DOI 10.1111/j.1742-4658.2006.05323.x; Mazloum N, 2008, P NATL ACAD SCI USA, V105, P524, DOI 10.1073/pnas.0707031105; MCENTEE K, 1979, P NATL ACAD SCI USA, V76, P2615, DOI 10.1073/pnas.76.6.2615; MIKAWA T, 1995, J MOL BIOL, V250, P471, DOI 10.1006/jmbi.1995.0391; Nishinaka T, 1997, P NATL ACAD SCI USA, V94, P6623, DOI 10.1073/pnas.94.13.6623; Nishinaka T, 1998, P NATL ACAD SCI USA, V95, P11071, DOI 10.1073/pnas.95.19.11071; Noirot P, 2003, EMBO J, V22, P324, DOI 10.1093/emboj/cdg027; Noirot P, 1998, J BIOL CHEM, V273, P12274, DOI 10.1074/jbc.273.20.12274; Passy SI, 1999, P NATL ACAD SCI USA, V96, P4279, DOI 10.1073/pnas.96.8.4279; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Post CB, 2003, CURR OPIN STRUC BIOL, V13, P581, DOI 10.1016/j.sbi.2003.09.012; ROUVIEREYANIV J, 1979, CELL, V17, P265, DOI 10.1016/0092-8674(79)90152-1; Rybalchenko N, 2004, P NATL ACAD SCI USA, V101, P17056, DOI 10.1073/pnas.0408046101; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P5100, DOI 10.1073/pnas.76.10.5100; SHIBATA T, 1981, J BIOL CHEM, V256, P7557; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P1638, DOI 10.1073/pnas.76.4.1638; Shibata T, 2001, P NATL ACAD SCI USA, V98, P8425, DOI 10.1073/pnas.111005198; SHIBATA T, 1981, J BIOL CHEM, V256, P7565; STASIAK A, 1982, NATURE, V299, P185, DOI 10.1038/299185a0; STASIAK A, 1981, J MOL BIOL, V151, P557, DOI 10.1016/0022-2836(81)90010-3; THRESHER RJ, 1995, J MOL BIOL, V254, P364, DOI 10.1006/jmbi.1995.0623; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Vlieghe D, 1996, SCIENCE, V273, P1702, DOI 10.1126/science.273.5282.1702; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Yoshimasu M, 2003, NUCLEIC ACIDS RES, V31, P1735, DOI 10.1093/nar/gkg256; YU X, 1992, J MOL BIOL, V227, P334, DOI 10.1016/0022-2836(92)90702-L	59	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30230	30239		10.1074/jbc.M109.043810	http://dx.doi.org/10.1074/jbc.M109.043810			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19729448	Green Published, hybrid			2022-12-27	WOS:000271090000026
J	Datta, K; Guan, T; Gerace, L				Datta, Kaustuv; Guan, Tinglu; Gerace, Larry			NET37, a Nuclear Envelope Transmembrane Protein with Glycosidase Homology, Is Involved in Myoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; LIVER MICROSOMAL GLUCOSIDASES; MUSCLE-CELL SURVIVAL; GROWTH-FACTOR-II; SKELETAL-MUSCLE; ALPHA-GLUCOSIDASE; MEMBRANE PROTEIN; LAMIN-A/C; MYOCYTE MATURATION; LEM-DOMAIN	The nuclear lamina and its associated proteins are important for nuclear structure and chromatin organization and also have been implicated in the regulation of cell signaling and gene expression. In this study we demonstrate that the lamina-associated nuclear envelope transmembrane protein NET37 is required for myogenic differentiation of C2C12 cells. NET37, a member of glycosidase family 31, is highly expressed in mouse skeletal muscle and is strongly up-regulated during C2C12 differentiation. By protease mapping we show that its glycosidase homology domain is located in the lumen of the nuclear envelope/endoplasmic reticulum. When NET37 is depleted from proliferating myoblasts by RNAi, myogenic differentiation is significantly impaired, and there is a concomitant delay in up-regulation of the late myogenic transcription factor myogenin. We expressed silencing-resistant NET37 mutated at a conserved residue in the glycosidase domain and found that this predicted catalytically inactive protein is unable to support myogenesis in cells depleted of wild type NET37. Therefore, the enzymatic function of NET37 appears to be important for myogenic differentiation. C2C12 cells depleted of NET37 have reduced activation of Akt after shifting to differentiation medium and are defective in insulin like growth factor-II (IGF-II) secretion, an autocrine/paracrine factor involved in Akt activation. We also observed that pro-IGF-II co-immunoprecipitates with NET37. Based on our results, we propose that NET37 has a role in IGF-II maturation in the secretory pathway during myoblast differentiation. The localization of NET37 at the nuclear envelope raises the possibility that it may coordinate myogenic events between the nuclear interior and the endoplasmic reticulum lumen via transmembrane communication.	[Gerace, Larry] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Gerace, L (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd IMM10, La Jolla, CA 92037 USA.	lgerace@scripps.edu	Datta, Kaustuv/GLT-0146-2022	Datta, Kaustuv/0000-0002-6834-2192	National Institutes of Health [GM28521]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028521] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM28521 (to L. G.).	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; BURNS DM, 1982, J BIOL CHEM, V257, P9991; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen IHB, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-38; Cohen TV, 2008, BIOCHEM SOC T, V36, P1329, DOI 10.1042/BST0361329; Crisp M, 2008, FEBS LETT, V582, P2023, DOI 10.1016/j.febslet.2008.05.001; Duguay SJ, 1998, J BIOL CHEM, V273, P18443, DOI 10.1074/jbc.273.29.18443; Erbay E, 2003, J CELL BIOL, V163, P931, DOI 10.1083/jcb.200307158; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; FLORINI JR, 1991, ANNU REV PHYSIOL, V53, P201, DOI 10.1146/annurev.ph.53.030191.001221; Frandsen TP, 1998, PLANT MOL BIOL, V37, P1, DOI 10.1023/A:1005925819741; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; GRINNA LS, 1980, J BIOL CHEM, V255, P2255; GRINNA LS, 1979, J BIOL CHEM, V254, P8814; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Guo K, 1997, J BIOL CHEM, V272, P791, DOI 10.1074/jbc.272.2.791; GUO K, 1995, MOL CELL BIOL, V15, P3823; Hellemans J, 2004, NAT GENET, V36, P1213, DOI 10.1038/ng1453; HENRISSAT B, 1995, BIOCHEM J, V311, P350, DOI 10.1042/bj3110350; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HERMANS MMP, 1991, J BIOL CHEM, V266, P13507; Lawlor MA, 2000, MOL CELL BIOL, V20, P8983, DOI 10.1128/MCB.20.23.8983-8995.2000; Lawlor MA, 2000, J CELL BIOL, V151, P1131, DOI 10.1083/jcb.151.6.1131; Lee SS, 2002, J AM CHEM SOC, V124, P4948, DOI 10.1021/ja0255610; Lee SS, 2001, BIOCHEM J, V359, P381, DOI 10.1042/0264-6021:3590381; Lin F, 2000, J BIOL CHEM, V275, P4840, DOI 10.1074/jbc.275.7.4840; Manilal S, 1996, HUM MOL GENET, V5, P801, DOI 10.1093/hmg/5.6.801; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mauro A, 2002, J CELL SCI, V115, P3587, DOI 10.1242/jcs.00037; Mounkes L, 2003, CURR OPIN GENET DEV, V13, P223, DOI 10.1016/S0959-437X(03)00058-3; Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453; Muchir A, 2007, HUM MOL GENET, V16, P1884, DOI 10.1093/hmg/ddm137; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Musaro A, 2004, P NATL ACAD SCI USA, V101, P1206, DOI 10.1073/pnas.0303792101; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Okuyama M, 2001, EUR J BIOCHEM, V268, P2270, DOI 10.1046/j.1432-1327.2001.02104.x; Ostrovsky O, 2009, MOL BIOL CELL, V20, P1855, DOI 10.1091/mbc.E08-04-0346; Pan D, 2005, J BIOL CHEM, V280, P15992, DOI 10.1074/jbc.M411234200; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Qiang L, 2007, MOL CELL BIOL, V27, P4698, DOI 10.1128/MCB.02279-06; Ren HX, 2008, J CELL BIOL, V182, P979, DOI 10.1083/jcb.200712110; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; SALAMITOU S, 1994, J BACTERIOL, V176, P2828, DOI 10.1128/JB.176.10.2828-2834.1994; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Shaklai S, 2007, FEBS J, V274, P1383, DOI 10.1111/j.1742-4658.2007.05697.x; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Trombetta ES, 2003, GLYCOBIOLOGY, V13, p77R, DOI 10.1093/glycob/cwg075; Wagner N, 2007, INT REV CYTOL, V261, P1, DOI 10.1016/S0074-7696(07)61001-8; Wang ZV, 2007, MOL CELL BIOL, V27, P3716, DOI 10.1128/MCB.00931-06; Waterham HR, 2003, AM J HUM GENET, V72, P1013, DOI 10.1086/373938; Wilson EM, 2007, J BIOL CHEM, V282, P5106, DOI 10.1074/jbc.C600315200; Wilson EM, 2004, MOL BIOL CELL, V15, P497, DOI 10.1091/mbc.E03-05-0351; Wilson EM, 2003, J BIOL CHEM, V278, P41109, DOI 10.1074/jbc.C300299200; Worman HJ, 2005, INT REV CYTOL, V246, P231, DOI 10.1016/S0074-7696(05)46006-4; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028	60	28	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29666	29676		10.1074/jbc.M109.034041	http://dx.doi.org/10.1074/jbc.M109.034041			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19706595	Green Published, hybrid			2022-12-27	WOS:000270896800048
J	Hutton, JC; O'Brien, RM				Hutton, John C.; O'Brien, Richard M.			Glucose-6-phosphatase Catalytic Subunit Gene Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GLYCOGEN-STORAGE-DISEASE; ISLETS IN-VIVO; PROTEIN IGRP; GLUCOSE-METABOLISM; T-CELLS; EXPRESSION; PROMOTER; MOUSE; IDENTIFICATION; TRANSCRIPTION	Glucose-6-phosphatase catalyzes the hydrolysis of glucose 6-phosphate (G6P) to glucose and inorganic phosphate. It is a multicomponent system located in the endoplasmic reticulum that comprises several integral membrane proteins, namely a catalytic subunit (G6PC) and transporters for G6P, inorganic phosphate, and glucose. The G6PC gene family contains three members, designated G6PC, G6PC2, and G6PC3. The tissue-specific expression patterns of these genes differ, and mutations in all three genes have been linked to distinct diseases in humans. This minireview discusses the disease association and transcriptional regulation of the G6PC genes as well as the biological functions of the encoded proteins.	[O'Brien, Richard M.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA; [Hutton, John C.] Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA	Vanderbilt University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	O'Brien, RM (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA.	richard.obrien@vanderbilt.edu			National Institutes of Health (NIH) [DK61645, DK56374, DK76027, P60 DK20593, DK076027, DK052068, P30 DK57516]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056374, R01DK061645, R01DK052068, R01DK076027, R56DK052068, P60DK020593, P30DK057516] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants DK61645, DK56374, and DK76027 (to R. M. O'B.); by NIH Grant P60 DK20593 (to the Vanderbilt Diabetes Center Core Laboratory); and by a Juvenile Diabetes Research Foundation Autoimmunity Prevention Center grant, NIH Grants DK076027 and DK052068, and the Barbara Davis Center Diabetes and Endocrinology Research Center (NIH Grant P30 DK57516) (to J. C. H.). This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Arden SD, 1999, DIABETES, V48, P531, DOI 10.2337/diabetes.48.3.531; Bischof LJ, 2001, DIABETES, V50, P502, DOI 10.2337/diabetes.50.3.502; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Boustead JN, 2004, J MOL ENDOCRINOL, V32, P33, DOI 10.1677/jme.0.0320033; Boztug K, 2009, NEW ENGL J MED, V360, P32, DOI 10.1056/NEJMoa0805051; Chen SY, 2008, FASEB J, V22, P2206, DOI 10.1096/fj.07-104851; Cherrington AD, 1999, DIABETES, V48, P1198, DOI 10.2337/diabetes.48.5.1198; Cheung YY, 2007, J CLIN INVEST, V117, P784, DOI 10.1172/JCI30443; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Chou JY, 2008, HUM MUTAT, V29, P921, DOI 10.1002/humu.20772; Chou JY, 2007, CURR GENE THER, V7, P79, DOI 10.2174/156652307780363152; Ebert DH, 1999, DIABETES, V48, P543, DOI 10.2337/diabetes.48.3.543; EFENDIC S, 1988, J CLIN INVEST, V81, P1953, DOI 10.1172/JCI113543; Foster JD, 1997, P SOC EXP BIOL MED, V215, P314; Frigeri C, 2004, DIABETES, V53, P1754, DOI 10.2337/diabetes.53.7.1754; Guionie O, 2003, FEBS LETT, V551, P159, DOI 10.1016/S0014-5793(03)00903-7; Han BY, 2005, NAT MED, V11, P645, DOI 10.1038/nm1250; Hornbuckle LA, 2004, AM J PHYSIOL-ENDOC M, V286, pE795, DOI 10.1152/ajpendo.00455.2003; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; Krishnamurthy B, 2006, J CLIN INVEST, V116, P3258, DOI 10.1172/JCI29602; Laybutt DR, 2002, J BIOL CHEM, V277, P10912, DOI 10.1074/jbc.M111751200; LEI KJ, 1993, SCIENCE, V262, P580, DOI 10.1126/science.8211187; Lei KJ, 1996, NAT GENET, V13, P203, DOI 10.1038/ng0696-203; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Magnuson MA, 2003, J BIOL CHEM, V278, P32485, DOI 10.1074/jbc.R300020200; Martin CC, 2004, J BIOL CHEM, V279, P34277, DOI 10.1074/jbc.M404830200; Martin CC, 2003, BIOCHEM J, V371, P675, DOI 10.1042/BJ20021585; Martin CC, 2002, J MOL ENDOCRINOL, V29, P205, DOI 10.1677/jme.0.0290205; Martin CC, 2001, J BIOL CHEM, V276, P25197, DOI 10.1074/jbc.M101549200; Martin CC, 2008, J MOL ENDOCRINOL, V41, P315, DOI 10.1677/JME-08-0062; Massillon D, 1998, J BIOL CHEM, V273, P228, DOI 10.1074/jbc.273.1.228; Mithieux G, 1997, EUR J ENDOCRINOL, V136, P137, DOI 10.1530/eje.0.1360137; O'Brien RM, 2001, BIOCHEM SOC T, V29, P552, DOI 10.1042/BST0290552; Onuma H, 2006, MOL ENDOCRINOL, V20, P2831, DOI 10.1210/me.2006-0085; Pan CJ, 1998, J BIOL CHEM, V273, P6144, DOI 10.1074/jbc.273.11.6144; Pedersen KB, 2007, AM J PHYSIOL-ENDOC M, V292, pE788, DOI 10.1152/ajpendo.00510.2006; Petrolonis AJ, 2004, J BIOL CHEM, V279, P13976, DOI 10.1074/jbc.M307756200; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Schilling MM, 2006, NATURE, V443, pE10, DOI 10.1038/nature05288; SHELLY LL, 1993, J BIOL CHEM, V268, P21482; Shieh JJ, 2004, FEBS LETT, V562, P160, DOI 10.1016/S0014-5793(04)00223-6; Shieh JJ, 2003, J BIOL CHEM, V278, P47098, DOI 10.1074/jbc.M309472200; Shieh JJ, 2004, J BIOL CHEM, V279, P26215, DOI 10.1074/jbc.M402036200; van de Werve G, 2000, EUR J BIOCHEM, V267, P1533, DOI 10.1046/j.1432-1327.2000.01160.x; Van Schaftingen E, 2002, BIOCHEM J, V362, P513, DOI 10.1042/0264-6021:3620513; Vander Kooi BT, 2005, MOL ENDOCRINOL, V19, P3001, DOI 10.1210/me.2004-0497; Wang Y, 2007, DIABETOLOGIA, V50, P774, DOI 10.1007/s00125-006-0564-1; Wang Y, 2008, DIABETES, V57, P133, DOI 10.2337/db07-0092; Wang YD, 2006, J BIOL CHEM, V281, P39982, DOI 10.1074/jbc.M605858200; Xu C, 2007, J NUTR, V137, P554, DOI 10.1093/jn/137.3.554; Yang JB, 2006, J IMMUNOL, V176, P2781, DOI 10.4049/jimmunol.176.5.2781	52	113	119	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29241	29245		10.1074/jbc.R109.025544	http://dx.doi.org/10.1074/jbc.R109.025544			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19700406	Green Published, hybrid			2022-12-27	WOS:000270896800002
J	O'Donnell, CD; Shukla, D				O'Donnell, Christopher D.; Shukla, Deepak			A Novel Function of Heparan Sulfate in the Regulation of Cell-Cell Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMPLEX-VIRUS TYPE-1; MYOBLAST FUSION; CYTOSKELETAL ORGANIZATION; SYNDECAN-1 EXPRESSION; SYNCYTIUM FORMATION; ENCEPHALITIS-VIRUS; GLYCOPROTEINS GB; MEMBRANE-FUSION; CO-RECEPTORS; GIANT-CELLS	Despite the important contribution of cell-cell fusion in the development and physiology of eukaryotes, little is known about the mechanisms that regulate this process. Our study shows that glycosaminoglycans and more specifically heparan sulfate (HS) expressed on the cell surface and extracellular matrix may act as negative regulator of cell-cell fusion. Using herpes simplex virus type-1 as a tool to enhance cell-cell fusion, we demonstrate that the absence of HS expression on the cell surface results in a significant increase in cell-cell fusion. An identical phenomenon was observed when other viruses or polyethylene glycol was used as fusion enhancer. Cells deficient in HS biosynthesis showed increased activity of two Rho GTPases, RhoA and Cdc42, both of which showed a correlation between increased activity and increased cell-cell fusion. This could serve as a possible explanation as to why HS-deficient cells showed significantly enhanced cell-cell fusion and suggests that HS could regulate fusion via fine tuning of RhoA and Cdc42 activities.	Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA; Univ Illinois, Coll Med, Dept Ophthalmol & Visual Sci, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Shukla, D (corresponding author), 1905 W Taylor St,LIERI 227, Chicago, IL 60612 USA.	dshukla@uic.edu		Shukla, Deepak/0000-0002-3039-6953	National Institutes of Health [RO1 AI057860]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI057860 (to D. S.).	Alexopoulou AN, 2007, INT J BIOCHEM CELL B, V39, P505, DOI 10.1016/j.biocel.2006.10.014; Ambrosius M, 2009, CLIN BIOCHEM, V42, P1, DOI 10.1016/j.clinbiochem.2008.10.013; Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008; Barretto N, 2003, VIROLOGY, V313, P33, DOI 10.1016/S0042-6822(03)00288-5; Bass MD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.264pe18; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Bernard KA, 2000, VIROLOGY, V276, P93, DOI 10.1006/viro.2000.0546; Blattman JN, 2004, SCIENCE, V305, P200, DOI 10.1126/science.1100369; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Bussey H, 2004, PHARMACOTHERAPY, V24, P103; Carey DJ, 1997, BIOCHEM J, V327, P1; Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Chen EH, 2004, TRENDS CELL BIOL, V14, P452, DOI 10.1016/j.tcb.2004.07.008; Clement C, 2006, J CELL BIOL, V174, P1009, DOI 10.1083/jcb.200509155; Day RM, 1999, VIRCHOWS ARCH, V434, P121, DOI 10.1007/s004280050315; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; ESKO JD, 1988, SCIENCE, V241, P1092, DOI 10.1126/science.3137658; FARKASBARGETON E, 1988, J NEUROL SCI, V83, P145, DOI 10.1016/0022-510X(88)90064-0; Forsberg E, 2001, J CLIN INVEST, V108, P175, DOI 10.1172/JCI13561; FUKUDOME K, 1992, J VIROL, V66, P1394, DOI 10.1128/JVI.66.3.1394-1401.1992; FULTON AB, 1981, J CELL BIOL, V91, P103, DOI 10.1083/jcb.91.1.103; Geraghty RJ, 2000, VIROLOGY, V268, P147, DOI 10.1006/viro.1999.0157; Gotting C, 2007, CELL MOL LIFE SCI, V64, P1498, DOI 10.1007/s00018-007-7069-z; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Harris LK, 2008, PLACENTA, V29, P332, DOI 10.1016/j.placenta.2008.01.012; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; Hoppe S, 2006, J GEN VIROL, V87, P3483, DOI 10.1099/vir.0.82231-0; Horsley V, 2004, CELLS TISSUES ORGANS, V176, P67, DOI 10.1159/000075028; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Hulst MM, 2001, J VIROL, V75, P9585, DOI 10.1128/JVI.75.20.9585-9595.2001; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Kinzler ER, 2005, J VIROL, V79, P7827, DOI 10.1128/JVI.79.12.7827-7837.2005; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Larrain J, 1997, J BIOL CHEM, V272, P18418, DOI 10.1074/jbc.272.29.18418; Larrain J, 1998, J BIOL CHEM, V273, P32288, DOI 10.1074/jbc.273.48.32288; Lee E, 2002, J VIROL, V76, P4901, DOI 10.1128/JVI.76.10.4901-4911.2002; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; LIU N, 1993, VIROLOGY, V196, P703, DOI 10.1006/viro.1993.1527; Lopes CC, 2006, BRAZ J MED BIOL RES, V39, P157, DOI 10.1590/S0100-879X2006000200001; Miyado K, 2000, SCIENCE, V287, P321, DOI 10.1126/science.287.5451.321; Miyamoto Takeshi, 2003, Keio J Med, V52, P1; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Muggeridge MI, 2000, J GEN VIROL, V81, P2017, DOI 10.1099/0022-1317-81-8-2017; Mythreye K, 2009, CELL SIGNAL, V21, P1548, DOI 10.1016/j.cellsig.2009.05.001; Nackaerts K, 1997, INT J CANCER, V74, P335, DOI 10.1002/(SICI)1097-0215(19970620)74:3<335::AID-IJC18>3.3.CO;2-4; NAKAJIMA M, 1983, SCIENCE, V220, P611, DOI 10.1126/science.6220468; OKADA Y, 1962, EXP CELL RES, V26, P98, DOI 10.1016/0014-4827(62)90205-7; Peng T, 1998, J VIROL, V72, P6092, DOI 10.1128/JVI.72.7.6092-6103.1998; Pertel PE, 2001, VIROLOGY, V279, P313, DOI 10.1006/viro.2000.0713; Pomerantz J, 2004, NAT CELL BIOL, V6, P810, DOI 10.1038/ncb0904-810; Potgens AJG, 2002, PLACENTA, V23, pS107, DOI 10.1053/plac.2002.0772; Primakoff P, 2002, SCIENCE, V296, P2183, DOI 10.1126/science.1072029; Pulkkinen JO, 1997, ACTA OTO-LARYNGOL, V117, P312, DOI 10.3109/00016489709117794; Redman CWG, 2000, PLACENTA, V21, P597, DOI 10.1053/plac.2000.0560; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; Ryman KD, 2004, VIROLOGY, V322, P1, DOI 10.1016/j.virol.2004.01.003; SaCarvalho D, 1997, J VIROL, V71, P5115, DOI 10.1128/JVI.71.7.5115-5123.1997; Sanderson RD, 2001, SEMIN CELL DEV BIOL, V12, P89, DOI 10.1006/scdb.2000.0241; Scanlan PM, 2005, J VIROL METHODS, V128, P104, DOI 10.1016/j.jviromet.2005.04.008; Schroter RH, 2004, DEVELOPMENT, V131, P4501, DOI 10.1242/dev.01309; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; SPEAR PG, 1992, ADV EXP MED BIOL, V313, P341; Spear PG, 2003, J VIROL, V77, P10179, DOI 10.1128/JVI.77.19.10179-10185.2003; STANLEY MJ, 1995, J BIOL CHEM, V270, P5077, DOI 10.1074/jbc.270.10.5077; Sun JF, 2001, VIROLOGY, V284, P26, DOI 10.1006/viro.2001.0889; Tachibana I, 1999, J CELL BIOL, V146, P893, DOI 10.1083/jcb.146.4.893; Takahashi I, 2009, BIOCHEM BIOPH RES CO, V383, P113, DOI 10.1016/j.bbrc.2009.03.140; Takeda Y, 2003, J CELL BIOL, V161, P945, DOI 10.1083/jcb.200212031; TAKEICHI M, 1977, J CELL BIOL, V75, P464, DOI 10.1083/jcb.75.2.464; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Tiwari V, 2004, J GEN VIROL, V85, P805, DOI 10.1099/vir.0.19641-0; Trefzer U, 2004, INT J CANCER, V110, P730, DOI 10.1002/ijc.20191; Trefzer U, 2003, MOL BIOTECHNOL, V25, P63, DOI 10.1385/MB:25:1:63; Vignery A, 2000, INT J EXP PATHOL, V81, P291, DOI 10.1046/j.1365-2613.2000.00164.x; Vives RR, 2006, CURR GENE THER, V6, P35, DOI 10.2174/156652306775515565; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Wei G, 2000, J BIOL CHEM, V275, P27733; Wockel L, 1998, ACTA NEUROPATHOL, V95, P547, DOI 10.1007/s004010050836; Xiang YY, 2001, ONCOGENE, V20, P7408, DOI 10.1038/sj.onc.1204925; Yoneda A, 2003, MATRIX BIOL, V22, P25, DOI 10.1016/S0945-053X(03)00010-6; Yoon M, 2003, J VIROL, V77, P9221, DOI 10.1128/JVI.77.17.9221-9231.2003; Zimmermann P, 1999, FASEB J, V13, pS91	86	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29654	29665		10.1074/jbc.M109.037960	http://dx.doi.org/10.1074/jbc.M109.037960			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19726670	Green Published, hybrid			2022-12-27	WOS:000270896800047
J	Antonczak, AK; Simova, Z; Tippmann, EM				Antonczak, Alicja K.; Simova, Zuzana; Tippmann, Eric M.			A Critical Examination of Escherichia coli Esterase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; EARTHWORM LUMBRICUS-TERRESTRIS; SITE-SPECIFIC INCORPORATION; BINDING LECTIN EW29; GENETIC-CODE; STRUCTURAL BASIS; N-ACETYLGLUCOSAMINE; DIRECTED EVOLUTION; L-PHENYLALANINE; EXPRESSION	The ability of Escherichia coli to grow on a series of acetylated and glycosylated compounds has been investigated. It is surmised that E. coli maintains low levels of nonspecific esterase activity. This observation may have ramifications for previous reports that relied on nonspecific esterases from E. coli to genetically encode nonnatural amino acids. It had been reported that nonspecific esterases from E. coli deacetylate tri-acetyl O-linked glycosylated serine and threonine in vivo. The glycosylated amino acids were reported to have been genetically encoded into proteins in response to the amber stop codon. However, it is our contention that such amino acids are not utilized in this manner within E. coli. The current results report in vitro analysis of the original enzyme and an in vivo analysis of a glycosylated amino acid. It is concluded that the amber suppression method with nonnatural amino acids may require a caveat for use in certain instances.	[Antonczak, Alicja K.; Simova, Zuzana; Tippmann, Eric M.] Cardiff Univ, Sch Chem, Cardiff CF10 3AT, S Glam, Wales	Cardiff University	Tippmann, EM (corresponding author), Main Bldg,Pk Pl, Cardiff CF10 3AT, S Glam, Wales.	tippmann@cardiff.ac.uk			Engineering and Physical Sciences Research Council [EP/D001641]; EPSRC [EP/D001641/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D001641/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Engineering and Physical Sciences Research Council Grant EP/D001641.	Alvarez-Anorve LI, 2005, J BACTERIOL, V187, P2974, DOI 10.1128/JB.187.9.2974-2982.2005; Babinski KJ, 2002, J BIOL CHEM, V277, P25947, DOI 10.1074/jbc.M204068200; Baldwin AJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn358; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOOS W, 1974, ANNU REV BIOCHEM, V43, P123, DOI 10.1146/annurev.bi.43.070174.001011; Carinato ME, 1998, J BACTERIOL, V180, P3517, DOI 10.1128/JB.180.14.3517-3521.1998; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Hasona A, 2002, APPL ENVIRON MICROB, V68, P2651, DOI 10.1128/AEM.68.6.2651-2659.2002; ISENBERG S, 1974, J BACTERIOL, V118, P53, DOI 10.1128/JB.118.1.53-58.1974; Kanaya S, 1998, BIOCHEM J, V332, P75, DOI 10.1042/bj3320075; Kiick KL, 2001, FEBS LETT, V502, P25, DOI 10.1016/S0014-5793(01)02657-6; Kim HE, 2003, CURR MICROBIOL, V46, P291, DOI 10.1007/s00284-002-3886-3; Kobayashi T, 2003, NAT STRUCT BIOL, V10, P425, DOI 10.1038/nsb934; KOUKER G, 1987, APPL ENVIRON MICROB, V53, P211, DOI 10.1128/AEM.53.1.211-213.1987; Lamarre-Vincent N, 2003, J AM CHEM SOC, V125, P6612, DOI 10.1021/ja028200t; LAWRENCE RC, 1967, NATURE, V213, P1264, DOI 10.1038/2131264a0; Liu H, 2003, CHEMBIOCHEM, V4, P603, DOI 10.1002/cbic.200300557; Liu WS, 2007, ANGEW CHEM INT EDIT, V46, P6073, DOI 10.1002/anie.200701990; Moore JC, 1996, NAT BIOTECHNOL, V14, P458, DOI 10.1038/nbt0496-458; MOUREY A, 1976, J APPL BACTERIOL, V40, P47, DOI 10.1111/j.1365-2672.1976.tb00589.x; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Nozawa K, 2009, NATURE, V457, P1163, DOI 10.1038/nature07611; Peist R, 1997, J BACTERIOL, V179, P7679, DOI 10.1128/jb.179.24.7679-7686.1997; Plumbridge J, 1999, J BACTERIOL, V181, P47, DOI 10.1128/JB.181.1.47-54.1999; Prescher JA, 2004, NATURE, V430, P873, DOI 10.1038/nature02791; REDDY PG, 1989, GENE, V76, P145, DOI 10.1016/0378-1119(89)90016-4; Rodriguez S, 2000, J ORG CHEM, V65, P2586, DOI 10.1021/jo9917036; Roh C, 2008, J APPL MICROBIOL, V105, P116, DOI 10.1111/j.1365-2672.2007.03717.x; Samain E, 1999, J BIOTECHNOL, V72, P33, DOI 10.1016/S0168-1656(99)00048-6; Santoro SW, 2002, NAT BIOTECHNOL, V20, P1044, DOI 10.1038/nbt742; SARKAR AK, 1995, P NATL ACAD SCI USA, V92, P3323, DOI 10.1073/pnas.92.8.3323; STOOPS JK, 1969, BIOCHEMISTRY-US, V8, P2026, DOI 10.1021/bi00833a037; Suzuki R, 2004, ACTA CRYSTALLOGR D, V60, P1895, DOI 10.1107/S0907444904018979; Suzuki R, 2009, ACTA CRYSTALLOGR D, V65, P49, DOI 10.1107/S0907444908037451; TOONE EJ, 1990, J AM CHEM SOC, V112, P4946, DOI 10.1021/ja00168a047; Turner JM, 2006, P NATL ACAD SCI USA, V103, P6483, DOI 10.1073/pnas.0601756103; Turner JM, 2005, J AM CHEM SOC, V127, P14976, DOI 10.1021/ja0549042; Vocadlo DJ, 2003, P NATL ACAD SCI USA, V100, P9116, DOI 10.1073/pnas.1632821100; WANG HY, 1993, J BACTERIOL, V175, P1665, DOI 10.1128/JB.175.6.1665-1673.1993; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wang L, 2003, P NATL ACAD SCI USA, V100, P56, DOI 10.1073/pnas.0234824100; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Wells HG, 1912, J INFECT DIS, V11, P388, DOI 10.1093/infdis/11.3.388; WOLF RE, 1979, J BACTERIOL, V139, P1093, DOI 10.1128/JB.139.3.1093-1096.1979; Xie JM, 2006, NAT REV MOL CELL BIO, V7, P775, DOI 10.1038/nrm2005; Xie JM, 2004, NAT BIOTECHNOL, V22, P1297, DOI 10.1038/nbt1013; Xu R, 2004, J AM CHEM SOC, V126, P15654, DOI 10.1021/ja044711z; Zhang Y, 2005, PROTEIN SCI, V14, P1340, DOI 10.1110/ps.041239305; Zhang ZW, 2004, SCIENCE, V303, P371, DOI 10.1126/science.1089509	49	35	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28795	28800		10.1074/jbc.M109.027409	http://dx.doi.org/10.1074/jbc.M109.027409			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19666472	hybrid, Green Published			2022-12-27	WOS:000270678900036
J	Ewen, KM; Hannemann, F; Khatri, Y; Perlova, O; Kappl, R; Krug, D; Huttermann, J; Muller, R; Bernhardt, R				Ewen, Kerstin Maria; Hannemann, Frank; Khatri, Yogan; Perlova, Olena; Kappl, Reinhard; Krug, Daniel; Huettermann, Juergen; Mueller, Rolf; Bernhardt, Rita			Genome Mining in Sorangium cellulosum So ce56 IDENTIFICATION AND CHARACTERIZATION OF THE HOMOLOGOUS ELECTRON TRANSFER PROTEINS OF A MYXOBACTERIAL CYTOCHROME P450	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-COELICOLOR A3(2); IRON-SULFUR PROTEINS; ADRENODOXIN REDUCTASE; ESCHERICHIA-COLI; FERREDOXIN REDUCTASE; MYCOBACTERIUM-TUBERCULOSIS; CYTOCHROME-P450 COMPLEMENT; SCHIZOSACCHAROMYCES-POMBE; CLOSTRIDIUM-PASTEURIANUM; 2FE-2S FERREDOXIN	Myxobacteria, especially members of the genus Sorangium, are known for their biotechnological potential as producers of pharmaceutically valuable secondary metabolites. The biosynthesis of several of those myxobacterial compounds includes cytochrome P450 activity. Although class I cytochrome P450 enzymes occur wide-spread in bacteria and rely on ferredoxins and ferredoxin reductases as essential electron mediators, the study of these proteins is often neglected. Therefore, we decided to search in the Sorangium cellulosum So ce56 genome for putative interaction partners of cytochromes P450. In this work we report the investigation of eight myxobacterial ferredoxins and two ferredoxin reductases with respect to their activity in cytochrome P450 systems. Intriguingly, we found not only one, but two ferredoxins whose ability to sustain an endogenous So ce56 cytochrome P450 was demonstrated by CYP260A1-dependent conversion of nootkatone. Moreover, we could demonstrate that the two ferredoxins were able to receive electrons from both ferredoxin reductases. These findings indicate that S. cellulosum can alternate between different electron transport pathways to sustain cytochrome P450 activity.	[Bernhardt, Rita] Univ Saarland, Dept Biochem, D-66041 Saarbrucken, Germany; [Perlova, Olena; Krug, Daniel; Mueller, Rolf] Univ Saarland, Dept Pharmaceut Biotechnol, D-66041 Saarbrucken, Germany; [Kappl, Reinhard; Huettermann, Juergen] Univ Saarland, Dept Biophys, D-66421 Homburg, Germany	Saarland University; Saarland University; Saarland University	Bernhardt, R (corresponding author), Univ Saarland, Dept Biochem, FR 8-3 Biochem,Bldg B2-2, D-66041 Saarbrucken, Germany.	ritabern@mx.uni-saarland.de	Müller, Rolf/B-1559-2008; Mahmud, Taifo/A-1492-2015; khatri, Yogan/W-2218-2017	Müller, Rolf/0000-0002-1042-5665; Mahmud, Taifo/0000-0001-9639-526X; Krug, Daniel/0000-0002-3664-1884; Hannemann, Frank/0000-0001-7991-9033; Khatri, Yogan/0000-0002-2432-7679; Kappl, Reinhard/0000-0003-0223-6642	Fonds der Chemischen Industrie; Bundesministerium fur Bildung und Forschung	Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported in part by a grant from the Fonds der Chemischen Industrie (to R. B.) and by a grant from the Saarland LGF (to K. M. E.). Research in the Muller laboratory was funded by the Bundesministerium fur Bildung und Forschung.	Aliverti A, 1999, METH MOL B, V131, P9; ALTMAN KH, 2008, SOIL CLIN EPOTHILONE, P16; Arakawa T, 2007, AMINO ACIDS, V33, P587, DOI 10.1007/s00726-007-0506-3; Bell SG, 2006, BIOCHEM BIOPH RES CO, V342, P191, DOI 10.1016/j.bbrc.2006.01.133; Bernhardt R, 1996, REV PHYSIOL BIOCH P, V127, P137, DOI 10.1007/BFb0048267; BERNHARDT R, 2007, UBIQUITOUS ROLES CYT, P361; Bernhardt R, 2006, J BIOTECHNOL, V124, P128, DOI 10.1016/j.jbiotec.2006.01.026; Bode HB, 2004, ANGEW CHEM INT EDIT, V43, P4163, DOI 10.1002/anie.200454240; Bode HB, 2006, J IND MICROBIOL BIOT, V33, P577, DOI 10.1007/s10295-006-0082-7; Buntin K, 2008, ANGEW CHEM INT EDIT, V47, P4595, DOI 10.1002/anie.200705569; CASPERS P, 1994, CELL MOL BIOL, V40, P635; Chatelet C, 1999, J BIOL INORG CHEM, V4, P311, DOI 10.1007/s007750050317; Chun YJ, 2007, J BIOL CHEM, V282, P17486, DOI 10.1074/jbc.M700863200; Ewen KM, 2008, FEMS YEAST RES, V8, P432, DOI 10.1111/j.1567-1364.2008.00360.x; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Frank B, 2007, J MOL BIOL, V374, P24, DOI 10.1016/j.jmb.2007.09.015; Frank B, 2007, CHEM BIOL, V14, P221, DOI 10.1016/j.chembiol.2006.11.013; FUJINAGA J, 1993, BIOCHEM BIOPH RES CO, V192, P1115, DOI 10.1006/bbrc.1993.1532; Gaitatzis N, 2002, J BIOL CHEM, V277, P13082, DOI 10.1074/jbc.M111738200; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Grinberg AV, 2000, PROTEINS, V40, P590, DOI 10.1002/1097-0134(20000901)40:4<590::AID-PROT50>3.0.CO;2-P; Guigliarelli B, 1999, ADV INORG CHEM, V47, P421, DOI 10.1016/S0898-8838(08)60084-7; Hannemann F, 2007, BBA-GEN SUBJECTS, V1770, P330, DOI 10.1016/j.bbagen.2006.07.017; Hanukoglu I, 2006, DRUG METAB REV, V38, P171, DOI 10.1080/03602530600570040; HANUKOGLU I, 1993, ARCH BIOCHEM BIOPHYS, V305, P489, DOI 10.1006/abbi.1993.1452; HUANG K, 1969, BIOCHEM BIOPH RES CO, V34, P48, DOI 10.1016/0006-291X(69)90526-9; KITAGAWA T, 1982, J BIOL CHEM, V257, P2075; LAMBETH JD, 1976, J BIOL CHEM, V251, P4299; Leadbeater C, 2000, BIOCHEM J, V352, P257, DOI 10.1042/0264-6021:3520257; Lei L, 2004, P NATL ACAD SCI USA, V101, P494, DOI 10.1073/pnas.2435922100; Lovenberg W., 1973, IRON SULPHUR PROTEIN, VII; McLean KJ, 2006, BIOCHEMISTRY-US, V45, P8427, DOI 10.1021/bi0601609; McLean KJ, 2003, BIOCHEM J, V372, P317, DOI 10.1042/BJ20021692; Meyer J, 2008, J BIOL INORG CHEM, V13, P157, DOI 10.1007/s00775-007-0318-7; Murataliev MB, 1999, METH MOL B, V131, P97; Ogura H, 2004, BIOCHEMISTRY-US, V43, P14712, DOI 10.1021/bi048980d; Parajuli N, 2004, ARCH BIOCHEM BIOPHYS, V425, P233, DOI 10.1016/j.abb.2004.03.011; PORTER TD, 1991, METHOD ENZYMOL, V206, P108; RAMACHANDRA M, 1991, J BACTERIOL, V173, P7106, DOI 10.1128/jb.173.22.7106-7112.1991; Reichenbach H, 2001, J IND MICROBIOL BIOT, V27, P149, DOI 10.1038/sj.jim.7000025; SAGARA Y, 1993, BIOL PHARM BULL, V16, P627; Sambrook J., 2001, MOL CLONING LAB MANU, V3; Schiffler B, 2004, J INORG BIOCHEM, V98, P1229, DOI 10.1016/j.jinorgbio.2004.02.006; Schneiker S, 2007, NAT BIOTECHNOL, V25, P1281, DOI 10.1038/nbt1354; Schuster I, 2007, DRUG METAB REV, V39, P481, DOI 10.1080/03602530701498455; Sevrioukova IF, 2002, J BIOL CHEM, V277, P25831, DOI 10.1074/jbc.M201110200; Sielaff B, 2005, FEBS J, V272, P1148, DOI 10.1111/j.1742-4658.2005.04550.x; Simunovic V, 2006, CHEMBIOCHEM, V7, P1206, DOI 10.1002/cbic.200600075; Sticht H, 1998, PROG BIOPHYS MOL BIO, V70, P95, DOI 10.1016/S0079-6107(98)00027-3; Takubo K, 2003, PLANT MOL BIOL, V52, P817, DOI 10.1023/A:1025015811141; Thomas JG, 1997, PROTEIN EXPRES PURIF, V11, P289, DOI 10.1006/prep.1997.0796	51	35	35	5	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28590	28598		10.1074/jbc.M109.021717	http://dx.doi.org/10.1074/jbc.M109.021717			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19696019	Green Published, hybrid			2022-12-27	WOS:000270678900013
J	Ferreira, LT; Dale, LB; Ribeiro, FM; Babwah, AV; Pampillo, M; Ferguson, SSG				Ferreira, Lucimar T.; Dale, Lianne B.; Ribeiro, Fabiola M.; Babwah, Andy V.; Pampillo, Macarena; Ferguson, Stephen S. G.			Calcineurin Inhibitor Protein (CAIN) Attenuates Group I Metabotropic Glutamate Receptor Endocytosis and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION-INDEPENDENT REGULATION; SYNAPTIC VESICLE ENDOCYTOSIS; 2ND INTRACELLULAR LOOP; NEGATIVE REGULATOR; RGS PROTEINS; DESENSITIZATION; KINASE-2; BINDING; MGLUR5; SEQUESTRATION	Group I metabotropic glutamate receptors (mGluRs) are coupled via phospholipase C beta to the hydrolysis of phosphoinositides and function to modulate neuronal excitability and synaptic transmission at glutamatergic synapses. The desensitization of Group I mGluR signaling is thought to be mediated primarily via second messenger-dependent protein kinases and G protein-coupled receptor kinases. We show here that both mGluR1 and mGluR5 interact with the calcineurin inhibitor protein (CAIN). CAIN is co-immunoprecipitated in a complex with Group I mGluRs from both HEK 293 cells and mouse cortical brain lysates. Purified CAIN and its C-terminal domain specifically interact with glutathione S-transferase fusion proteins corresponding to the second intracellular loop and the distal C-terminal tail domains of mGluR1. The interaction of CAIN with mGluR1 could also be blocked using a Tat-tagged peptide corresponding to the mGluR1 second intracellular loop domain. Overexpression of full-length CAIN attenuates the agonist-stimulated endocytosis of both mGluR1a and mGluR5a in HEK 293 cells, but expression of the CAIN C-terminal domain does not alter mGluR5a internalization. In contrast, overexpression of either full-length CAIN or the CAIN C-terminal domain impairs agonist-stimulated inositol phosphate formation in HEK 293 cells expressing mGluR1a. This CAIN-mediated antagonism of mGluR1a signaling appears to involve the disruption of receptor-G alpha(q/11) complexes. Taken together, these observations suggest that the association of CAIN with intracellular domains involved in mGluR/G protein coupling provides an additional mechanism by which Group I mGluR endocytosis and signaling are regulated.	[Ferreira, Lucimar T.; Dale, Lianne B.; Ribeiro, Fabiola M.; Babwah, Andy V.; Pampillo, Macarena; Ferguson, Stephen S. G.] Robarts Res Inst, Mol Brain Res Grp, J Allyn Taylor Ctr Cell Biol, London, ON N6A 5K8, Canada; [Ferguson, Stephen S. G.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Ferguson, SSG (corresponding author), Robarts Res Inst, Mol Brain Res Grp, J Allyn Taylor Ctr Cell Biol, 100 Perth Dr,POB 5015, London, ON N6A 5K8, Canada.	ferguson@robarts.ca	Ribeiro, Fabiola/E-8831-2013	Ribeiro, Fabiola/0000-0001-7042-9433	Canadian Institutes of Health Research [MA-15506, MOP-62738]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grants MA-15506 and MOP-62738 (to S. S. G. F.).	Alagarsamy S, 2005, NEUROPHARMACOLOGY, V49, P135, DOI 10.1016/j.neuropharm.2005.05.005; Anborgh PH, 2005, J BIOL CHEM, V280, P34840, DOI 10.1074/jbc.M504508200; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Dale LB, 2001, J BIOL CHEM, V276, P35900, DOI 10.1074/jbc.M103847200; Dhami GK, 2005, J BIOL CHEM, V280, P24420, DOI 10.1074/jbc.M501650200; Dhami GK, 2004, J BIOL CHEM, V279, P16614, DOI 10.1074/jbc.M314090200; Dhami GK, 2002, J BIOL CHEM, V277, P25266, DOI 10.1074/jbc.M203593200; Dhami GK, 2006, PHARMACOL THERAPEUT, V111, P260, DOI 10.1016/j.pharmthera.2005.01.008; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; FERGUSON SSG, 1995, J BIOL CHEM, V270, P24782, DOI 10.1074/jbc.270.42.24782; Ferguson SSG, 2007, TRENDS PHARMACOL SCI, V28, P173, DOI 10.1016/j.tips.2007.02.008; Francesconi A, 1998, J BIOL CHEM, V273, P5615, DOI 10.1074/jbc.273.10.5615; Gereau RW, 1998, NEURON, V20, P143, DOI 10.1016/S0896-6273(00)80442-0; Gomeza J, 1996, J BIOL CHEM, V271, P2199, DOI 10.1074/jbc.271.4.2199; Hermans E, 2001, BIOCHEM J, V359, P465, DOI 10.1042/0264-6021:3590465; Ishikawa K, 1999, GENES CELLS, V4, P381, DOI 10.1046/j.1365-2443.1999.00269.x; Jang H, 2007, BIOCHEM BIOPH RES CO, V359, P129, DOI 10.1016/j.bbrc.2007.05.066; Krueger KM, 1997, J BIOL CHEM, V272, P5; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lai MM, 2000, J BIOL CHEM, V275, P34017, DOI 10.1074/jbc.C000429200; Lai MM, 1999, J BIOL CHEM, V274, P25963, DOI 10.1074/jbc.274.37.25963; Lai MM, 1998, J BIOL CHEM, V273, P18325, DOI 10.1074/jbc.273.29.18325; Lee JH, 2008, P NATL ACAD SCI USA, V105, P12575, DOI 10.1073/pnas.0712033105; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Minakami R, 1997, J BIOL CHEM, V272, P20291, DOI 10.1074/jbc.272.32.20291; NAKANISHI S, 1994, ANNU REV BIOPH BIOM, V23, P319, DOI 10.1146/annurev.bb.23.060194.001535; Ribeiro FM, 2009, J BIOL CHEM, V284, P23444, DOI 10.1074/jbc.M109.000778; Sato M, 2004, EUR J NEUROSCI, V20, P947, DOI 10.1111/j.1460-9568.2004.03552.x; Siderovski DP, 1999, CRIT REV BIOCHEM MOL, V34, P215, DOI 10.1080/10409239991209273; Sun L, 1998, IMMUNITY, V8, P703, DOI 10.1016/S1074-7613(00)80575-0; Youn HD, 1999, SCIENCE, V286, P790, DOI 10.1126/science.286.5440.790	35	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28986	28994		10.1074/jbc.M109.050872	http://dx.doi.org/10.1074/jbc.M109.050872			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19717561	hybrid, Green Published			2022-12-27	WOS:000270678900056
J	Madathil, S; Fahmy, K				Madathil, Sineej; Fahmy, Karim			Lipid Protein Interactions Couple Protonation to Conformation in a Conserved Cytosolic Domain of G Protein-coupled Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYLIC-ACID GROUP; RHODOPSIN ACTIVATION; CRYSTAL-STRUCTURE; BETA(2)-ADRENERGIC RECEPTOR; TRANSMEMBRANE SEGMENT-3; STRUCTURAL INSIGHTS; FUNCTIONAL-ROLE; BOND NETWORK; IONIC LOCK; HELIX	The visual photoreceptor rhodopsin is a prototypical class I (rhodopsin-like) G protein-coupled receptor. Photoisomerization of the covalently bound ligand 11-cis-retinal leads to restructuring of the cytosolic face of rhodopsin. The ensuing protonation of Glu-134 in the class-conserved D(E)RY motif at the C-terminal end of transmembrane helix-3 promotes the formation of the G protein-activating state. Using transmembrane segments derived from helix-3 of bovine rhodopsin, we show that lipid protein interactions play a key role in this cytosolic "proton switch." Infrared and fluorescence spectroscopic pK(a) determinations reveal that the D(E) RY motif is an autonomous functional module coupling side chain neutralization to conformation and helix positioning as evidenced by side chain to lipid headgroup Foerster resonance energy transfer. The free enthalpies of helix stabilization and hydrophobic burial of the neutral carboxyl shift the side chain pKa into the range typical of Glu134 in photoactivated rhodopsin. The lipid-mediated coupling mechanism is independent of interhelical contacts allowing its conservation without interference with the diversity of ligand-specific interactions in class I G protein-coupled receptors.	[Madathil, Sineej; Fahmy, Karim] Forschungszentrum Dresden Rossendorf, Inst Radiochem, Div Biophys, D-01314 Dresden, Germany	Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR)	Fahmy, K (corresponding author), Forschungszentrum Dresden Rossendorf, Inst Radiochem, Div Biophys, PF 510119, D-01314 Dresden, Germany.	k.fahmy@fzd.de	Fahmy, Karim/B-2708-2017	Fahmy, Karim/0000-0002-8752-5824	Deutsche Forschungsgemeinschaft [Fa 248-4]; Bundesministerium fur Bildung und Forschung [IND06/030]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported in part by the Deutsche Forschungsgemeinschaft Grant Fa 248-4 and in part by the Bundesministerium fur Bildung und Forschung Grant IND06/030.	Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; ARNIS S, 1994, J BIOL CHEM, V269, P23879; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Botelho AV, 2006, BIOPHYS J, V91, P4464, DOI 10.1529/biophysj.106.082776; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; Fahmy K, 2000, METHOD ENZYMOL, V315, P178; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; Fahmy K, 2000, BIOCHEMISTRY-US, V39, P10607, DOI 10.1021/bi000912d; Fahmy K., 2001, RRD BIOPHYS CHEM, V2, P1; GIBSON NJ, 1993, BIOCHEMISTRY-US, V32, P2438, DOI 10.1021/bi00060a040; Greasley PJ, 2002, MOL PHARMACOL, V61, P1025, DOI 10.1124/mol.61.5.1025; Huber T, 2004, BIOPHYS J, V86, P2078, DOI 10.1016/S0006-3495(04)74268-X; Isele J, 2000, BIOPHYS J, V79, P3063, DOI 10.1016/S0006-3495(00)76541-6; JAGER F, 1994, BIOCHEMISTRY-US, V33, P10878; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; Koike T, 1996, J AM CHEM SOC, V118, P12696, DOI 10.1021/ja962527a; Krishna AG, 2002, BIOCHEMISTRY-US, V41, P8298, DOI 10.1021/bi025534m; Krishnakumar SS, 2007, J MOL BIOL, V374, P1251, DOI 10.1016/j.jmb.2007.10.032; Kusnetzow AK, 2006, BIOCHEMISTRY-US, V45, P5538, DOI 10.1021/bi060101v; Lehmann N, 2007, J MOL BIOL, V366, P1129, DOI 10.1016/j.jmb.2006.11.098; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liu W, 2004, J MOL BIOL, V337, P713, DOI 10.1016/j.jmb.2004.02.001; Lowe MP, 2001, INORG CHIM ACTA, V317, P163, DOI 10.1016/S0020-1693(01)00346-2; Ludeke S, 2009, PHOTOCHEM PHOTOBIOL, V85, P437, DOI 10.1111/j.1751-1097.2008.00490.x; Madathil S, 2006, BIOPOLYMERS, V82, P329, DOI 10.1002/bip.20466; Mahalingam M, 2008, P NATL ACAD SCI USA, V105, P17795, DOI 10.1073/pnas.0804541105; Mustafi D, 2009, MOL PHARMACOL, V75, P1, DOI 10.1124/mol.108.051938; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Periole X, 2004, BIOCHEMISTRY-US, V43, P6858, DOI 10.1021/bi049949e; Rao VR, 1996, ANNU REV BIOPH BIOM, V25, P287; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Scheer A, 1997, P NATL ACAD SCI USA, V94, P808, DOI 10.1073/pnas.94.3.808; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SCHOLTZ JM, 1991, P NATL ACAD SCI USA, V88, P2854, DOI 10.1073/pnas.88.7.2854; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Shukla AK, 2008, MOL PHARMACOL, V73, P1333, DOI 10.1124/mol.108.045849; Soubias O, 2008, J AM CHEM SOC, V130, P12465, DOI 10.1021/ja803599x; Soubias O, 2006, J BIOL CHEM, V281, P33233, DOI 10.1074/jbc.M603059200; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Vogel R, 2007, PHOTOCHEM PHOTOBIOL, V83, P286, DOI 10.1562/2006-06-19-IR-937; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Weis WI, 2008, CURR OPIN STRUC BIOL, V18, P734, DOI 10.1016/j.sbi.2008.09.010; Wimley WC, 1996, BIOCHEMISTRY-US, V35, P5109, DOI 10.1021/bi9600153	48	18	18	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28801	28809		10.1074/jbc.M109.002030	http://dx.doi.org/10.1074/jbc.M109.002030			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19706606	hybrid, Green Published			2022-12-27	WOS:000270678900037
J	Ono, M; Matsubara, J; Honda, K; Sakuma, T; Hashiguchi, T; Nose, H; Nakamori, S; Okusaka, T; Kosuge, T; Sata, N; Nagai, H; Ioka, T; Tanaka, S; Tsuchida, A; Aoki, T; Shimahara, M; Yasunami, Y; Itoi, T; Moriyasu, F; Negishi, A; Kuwabara, H; Shoji, A; Hirohashi, S; Yamada, T				Ono, Masaya; Matsubara, Junichi; Honda, Kazufumi; Sakuma, Tomohiro; Hashiguchi, Tomoyo; Nose, Hiroshi; Nakamori, Shoji; Okusaka, Takuji; Kosuge, Tomoo; Sata, Naohiro; Nagai, Hideo; Ioka, Tatsuya; Tanaka, Sachiko; Tsuchida, Akihiko; Aoki, Tatsuya; Shimahara, Masashi; Yasunami, Yohichi; Itoi, Takao; Moriyasu, Fuminori; Negishi, Ayako; Kuwabara, Hideya; Shoji, Ayako; Hirohashi, Setsuo; Yamada, Tesshi			Prolyl 4-Hydroxylation of alpha-Fibrinogen A NOVEL PROTEIN MODIFICATION REVEALED BY PLASMA PROTEOMICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; QUANTITATIVE-ANALYSIS; BETA-CATENIN; COMPLEX; IDENTIFICATION; EXPRESSION; ABUNDANCE; PROLINE; ANTIGEN	Plasma proteome analysis requires sufficient power to compare numerous samples and detect changes in protein modification, because the protein content of human samples varies significantly among individuals, and many plasma proteins undergo changes in the bloodstream. A label-free proteomics platform developed in our laboratory, termed "Two-Dimensional Image Converted Analysis of Liquid chromatography and mass spectrometry (2DICAL)," is capable of these tasks. Here, we describe successful detection of novel prolyl hydroxylation of alpha-fibrinogen using 2DICAL, based on comparison of plasma samples of 38 pancreatic cancer patients and 39 healthy subjects. Using a newly generated monoclonal antibody 11A5, we confirmed the increase in prolyl-hydroxylated alpha-fibrinogen plasma levels and identified prolyl 4-hydroxylase A1 as a key enzyme for the modification. Competitive enzyme-linked immunosorbent assay of 685 blood samples revealed dynamic changes in prolyl-hydroxylated alpha-fibrinogen plasma level depending on clinical status. Prolyl-hydroxylated alpha-fibrinogen is presumably controlled by multiple biological mechanisms, which remain to be clarified in future studies.	[Ono, Masaya; Matsubara, Junichi; Honda, Kazufumi; Negishi, Ayako; Hirohashi, Setsuo; Yamada, Tesshi] Natl Canc Ctr, Natl Canc Ctr Res Inst, Div Chemotherapy, Chuo Ku, Tokyo 1040045, Japan; [Okusaka, Takuji] Natl Canc Ctr, Pancreat Oncol Div, Chuo Ku, Tokyo 1040045, Japan; [Kosuge, Tomoo] Natl Canc Ctr, Hepatobiliary & Pancreat Surg Div, Chuo Ku, Tokyo 1040045, Japan; [Sakuma, Tomohiro; Ioka, Tatsuya; Tanaka, Sachiko; Kuwabara, Hideya; Shoji, Ayako] Mitsui Knowledge Ind, Consulting Business Unit, Biosci Team, Minato Ku, Tokyo 1056215, Japan; [Hashiguchi, Tomoyo; Nose, Hiroshi] Transgenic Inc, Kobe Res Ctr, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Nakamori, Shoji] Osaka Natl Hosp, Dept Surg, Chuo Ku, Osaka 5400006, Japan; [Sata, Naohiro; Nagai, Hideo] Jichi Med Sch, Dept Surg, Minami Kawachi, Tochigi 3290498, Japan; [Ioka, Tatsuya; Tanaka, Sachiko] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Hepatobiliary & Pancreat Oncol, Osaka 5378511, Japan; [Tsuchida, Akihiko; Aoki, Tatsuya] Tokyo Med Univ, Dept Surg 3, Shinjuku Ku, Tokyo 1600023, Japan; [Itoi, Takao; Moriyasu, Fuminori; Yamada, Tesshi] Tokyo Med Univ, Dept Internal Med 4, Shinjuku Ku, Tokyo 1600023, Japan; [Shimahara, Masashi] Osaka Med Coll, Dept Oral Surg, Takatsuki, Osaka 5698686, Japan; [Yasunami, Yohichi] Fukuoka Univ, Fac Med, Dept Regenerat Med & Transplantat, Jonan Ku, Fukuoka 8140180, Japan	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Osaka National Hospital; Jichi Medical University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Tokyo Medical University; Tokyo Medical University; Osaka Medical College; Fukuoka University	Ono, M (corresponding author), Natl Canc Ctr, Natl Canc Ctr Res Inst, Div Chemotherapy, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	masono@ncc.go.jp			National Institute of Biomedical Innovation of Japan; Ministry of Health, Labor and Welfare of Japan	National Institute of Biomedical Innovation of Japan(National Institute of Biomedical Innovation); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the Program for Promotion of Fundamental Studies in Health Sciences conducted by the National Institute of Biomedical Innovation of Japan and by the Third-Term Comprehensive Control Research for Cancer conducted by the Ministry of Health, Labor and Welfare of Japan.	Blomback B, 2001, ANN NY ACAD SCI, V936, P1; DeSouza L, 2005, J PROTEOME RES, V4, P377, DOI 10.1021/pr049821j; Gao J, 2003, J PROTEOME RES, V2, P643, DOI 10.1021/pr034038x; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; HAKOMORI SI, 1989, ADV CANCER RES, V52, P257; Harlow E., 1988, ANTIBODIES LAB MANUA; HENSCHEN AH, 1991, THROMB HAEMOSTASIS, V65, P821; Henschen-Edman AH, 2001, ANN NY ACAD SCI, V936, P580; Honda K, 2005, CANCER RES, V65, P10613, DOI 10.1158/0008-5472.CAN-05-1851; Huang L, 2007, GASTROENTEROLOGY, V133, P1569, DOI 10.1053/j.gastro.2007.08.011; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Ishihama Y, 2005, J CHROMATOGR A, V1067, P73, DOI 10.1016/j.chroma.2004.10.107; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kukkola L, 2003, J BIOL CHEM, V278, P47685, DOI 10.1074/jbc.M306806200; Kumamoto K, 1998, BIOCHEM BIOPH RES CO, V247, P514, DOI 10.1006/bbrc.1998.8824; Kuwahara K, 2000, BLOOD, V95, P2321, DOI 10.1182/blood.V95.7.2321.007k33_2321_2328; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Matsubara J, 2009, J CLIN ONCOL, V27, P2261, DOI 10.1200/JCO.2008.19.9745; Mueller LN, 2008, J PROTEOME RES, V7, P51, DOI 10.1021/pr700758r; Myllyharju J, 1999, EMBO J, V18, P306, DOI 10.1093/emboj/18.2.306; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Nedelkov D, 2005, P NATL ACAD SCI USA, V102, P10852, DOI 10.1073/pnas.0500426102; Negishi A, 2009, CANCER SCI, V100, P514, DOI 10.1111/j.1349-7006.2008.01055.x; OGATA S, 1975, J BIOCHEM, V78, P687, DOI 10.1093/oxfordjournals.jbchem.a130956; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ono M, 2003, GLYCOCONJUGATE J, V20, P71, DOI 10.1023/B:GLYC.0000018019.22070.7d; Ono M, 2006, MOL CELL PROTEOMICS, V5, P1338, DOI 10.1074/mcp.T500039-MCP200; Qi HH, 2008, NATURE, V455, P421, DOI 10.1038/nature07186; Sakaguchi N, 2005, J IMMUNOL, V174, P4485, DOI 10.4049/jimmunol.174.8.4485; Sato S, 2005, GASTROENTEROLOGY, V129, P1225, DOI 10.1053/j.gastro.2005.07.025; Shitashige M, 2008, GASTROENTEROLOGY, V134, P1961, DOI 10.1053/j.gastro.2008.03.010; States DJ, 2006, NAT BIOTECHNOL, V24, P333, DOI 10.1038/nbt1183; Takahashi N, 2003, J NUTR, V133, p2090S, DOI 10.1093/jn/133.6.2090S; Zhang H, 2005, MOL CELL PROTEOMICS, V4, P144, DOI 10.1074/mcp.M400090-MCP200	34	42	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29041	29049		10.1074/jbc.M109.041749	http://dx.doi.org/10.1074/jbc.M109.041749			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19696023	hybrid, Green Published			2022-12-27	WOS:000270678900061
J	Wang, ZL; Kumamoto, Y; Wang, P; Gan, XQ; Lehmann, D; Smrcka, AV; Cohn, L; Iwasaki, A; Li, L; Wu, DQ				Wang, Zhenglong; Kumamoto, Yosuke; Wang, Ping; Gan, Xiaoqing; Lehmann, David; Smrcka, Alan V.; Cohn, Lauren; Iwasaki, Akiko; Li, Lin; Wu, Dianqing			Regulation of Immature Dendritic Cell Migration by RhoA Guanine Nucleotide Exchange Factor Arhgef5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY GTPASES; BONE-MARROW; ACTIVATION; PROTEIN; RAC; CDC42; P-REX1; NEUTROPHILS; GEF; ORGANIZATION	There are a large number of Rho guanine nucleotide exchange factors, most of which have no known functions. Here, we carried out a short hairpin RNA-based functional screen of Rho-GEFs for their roles in leukocyte chemotaxis and identified Arhgef5 as an important factor in chemotaxis of a macrophage phage-like RAW264.7 cell line. Arhgef5 can strongly activate RhoA and RhoB and weakly RhoC and RhoG, but not Rac1, RhoQ, RhoD, or RhoV, in transfected human embryonic kidney 293 cells. In addition, G beta gamma interacts with Arhgef5 and can stimulate Arhgef5-mediated activation of RhoA in an in vitro assay. In vivo roles of Arhgef5 were investigated using an Arhgef-5-null mouse line. Arhgef5 deficiency did not affect chemotaxis of mouse macrophages, T and B lymphocytes, and bone marrow-derived mature dendritic cells (DC), but it abrogated MIP1 alpha-induced chemotaxis of immature DCs and impaired migration of DCs from the skin to lymph node. In addition, Arhgef5 deficiency attenuated allergic airway inflammation. Therefore, this study provides new insights into signaling mechanisms for DC migration regulation.	[Li, Lin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Gan, Xiaoqing; Wu, Dianqing] Yale Univ, Sch Med, Program Vasc Biol & Therapeut, New Haven, CT 06520 USA; [Gan, Xiaoqing; Wu, Dianqing] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Kumamoto, Yosuke; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Cohn, Lauren] Yale Univ, Sch Med, Pulm & Crit Care Med Sect, New Haven, CT 06520 USA; [Lehmann, David; Smrcka, Alan V.] Univ Rochester, Dept Pharmacol, Rochester, NY 14642 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Yale University; Yale University; Yale University; Yale University; University of Rochester	Li, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China.	lli@sibs.ac.cn; Dan.Wu@Yale.edu	Li, Li/AEM-3636-2022; Iwasaki, Akiko/Z-1591-2019; LI, LI/GVS-5344-2022; li, li/HII-4157-2022	Iwasaki, Akiko/0000-0002-7824-9856; Lehmann, David/0000-0003-0174-344X; Kumamoto, Yosuke/0000-0001-9369-4934	National Institutes of Health [HL080706, HL070694]; American Heart Association; Ministry of Science and Technology of China [2002CB513000]; National Science Foundation of China [30521005]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070694, R01HL080706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054597, R01GM081772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL080706 and HL070694 (to D. W.), grants from the American Heart Association (to P. W.), Ministry of Science and Technology of China Grant 2002CB513000, and National Science Foundation of China Grant 30521005 (to L. L.).	Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Barber MA, 2007, J BIOL CHEM, V282, P29967, DOI 10.1074/jbc.M701877200; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Buchsbaum RJ, 2007, J CELL SCI, V120, P1149, DOI 10.1242/jcs.03428; Burns S, 2004, CURR BIOL, V14, pR965, DOI 10.1016/j.cub.2004.10.044; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Dong XM, 2005, CURR BIOL, V15, P1874, DOI 10.1016/j.cub.2005.09.014; Ellerbroek SM, 2004, MOL BIOL CELL, V15, P3309, DOI 10.1091/mbc.E04-02-0146; Erickson JW, 2004, BIOCHEMISTRY-US, V43, P837, DOI 10.1021/bi036026v; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feng QY, 2004, EMBO J, V23, P3492, DOI 10.1038/sj.emboj.7600331; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Iijima N, 2007, P NATL ACAD SCI USA, V104, P19061, DOI 10.1073/pnas.0707179104; Li Z, 2005, PROSTAG OTH LIPID M, V76, P95, DOI 10.1016/j.prostaglandins.2005.02.002; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; MACATONIA SE, 1987, J EXP MED, V166, P1654, DOI 10.1084/jem.166.6.1654; Mao JH, 1998, J BIOL CHEM, V273, P27118, DOI 10.1074/jbc.273.42.27118; Meili R, 2003, CELL, V114, P153, DOI 10.1016/S0092-8674(03)00553-1; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Obermeier A, 1998, EMBO J, V17, P4328, DOI 10.1093/emboj/17.15.4328; Ogita H, 2003, CIRC RES, V93, P23, DOI 10.1161/01.RES.0000079310.81429.C8; REMMERS AE, 1994, J BIOL CHEM, V269, P13771; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Rojas RJ, 2003, COMB CHEM HIGH T SCR, V6, P409; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sato A, 2004, P NATL ACAD SCI USA, V101, P16274, DOI 10.1073/pnas.0406268101; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schwartz M, 2004, J CELL SCI, V117, P5457, DOI 10.1242/jcs.01582; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Welch HCE, 2005, CURR BIOL, V15, P1867, DOI 10.1016/j.cub.2005.09.050; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Xie XZ, 2005, CELL SIGNAL, V17, P461, DOI 10.1016/j.cellsig.2004.09.012; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5	47	33	37	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28599	28606		10.1074/jbc.M109.047282	http://dx.doi.org/10.1074/jbc.M109.047282			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19713215	hybrid, Green Published			2022-12-27	WOS:000270678900014
J	Xie, YB; Park, JH; Kim, DK; Hwang, JH; Oh, S; Park, SB; Shong, M; Lee, IK; Choi, HS				Xie, Yuan-Bin; Park, Jeong-Hoh; Kim, Don-Kyu; Hwang, Jung Hwan; Oh, Sangmi; Park, Seung Bum; Shong, Minho; Lee, In-Kyu; Choi, Hueng-Sik			Transcriptional Corepressor SMILE Recruits SIRT1 to Inhibit Nuclear Receptor Estrogen Receptor-related Receptor gamma Transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-HETERODIMER-PARTNER; PROMOTES CELL-SURVIVAL; GENE-EXPRESSION; ERR-GAMMA; INTERACTING PROTEIN; RESPONSE ELEMENT; BINDING PROTEIN; MOLECULAR-BASIS; ALPHA; DEACETYLASE	SMILE (small heterodimer partner interacting leucine zipper protein) has been identified as a corepressor of the glucocorticoid receptor, constitutive androstane receptor, and hepatocyte nuclear factor 4 alpha. Here we show that SMILE also represses estrogen receptor-related receptor gamma (ERR gamma) transactivation. Knockdown of SMILE gene expression increases ERR gamma activity. SMILE directly interacts with ERR gamma in vitro and in vivo. Domain mapping analysis showed that SMILE binds to the AF2 domain of ERR gamma. SMILE represses ERR gamma transactivation partially through competition with coactivators PGC-1 alpha, PGC-1 beta, and GRIP1. Interestingly, the repression of SMILE on ERR gamma is released by SIRT1 inhibitors, a catalytically inactive SIRT1 mutant, and SIRT1 small interfering RNA but not by histone protein deacetylase inhibitor. In vivo glutathione S-transferase pulldown and coimmunoprecipitation assays validated that SMILE physically interacts with SIRT1. Furthermore, the ERR gamma inverse agonist GSK5182 enhances the interaction of SMILE with ERR gamma and SMILE-mediated repression. Knockdown of SMILE or SIRT1 blocks the repressive effect of GSK5182. Moreover, chromatin immunoprecipitation assays revealed that GSK5182 augments the association of SMILE and SIRT1 on the promoter of the ERR gamma target PDK4. GSK5182 and adenoviral overexpression of SMILE cooperate to repress ERR gamma-induced PDK4 gene expression, and this repression is released by overexpression of a catalytically defective SIRT1 mutant. Finally, we demonstrated that ERR gamma regulates SMILE gene expression, which in turn inhibits ERR gamma. Overall, these findings implicate SMILE as a novel corepressor of ERR gamma and recruitment of SIRT1 as a novel repressive mechanism for SMILE and ERR gamma inverse agonist.	[Xie, Yuan-Bin; Park, Jeong-Hoh; Kim, Don-Kyu; Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea; [Hwang, Jung Hwan; Shong, Minho] Chungnam Natl Univ, Sch Med, Dept Internal Med, Taejon 301721, South Korea; [Oh, Sangmi; Park, Seung Bum] Seoul Natl Univ, Coll Nat Sci, Dept Chem, Seoul 151747, South Korea; [Lee, In-Kyu] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Taegu 700721, South Korea	Chonnam National University; Chungnam National University; Seoul National University (SNU); Kyungpook National University	Choi, HS (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea.	hsc@chonnam.ac.kr	/H-7803-2012; Park, Seung Bum/N-1901-2014; Lee, In-Kyu/AAR-6374-2021	Park, Seung Bum/0000-0003-1753-1433; Oh, Sangmi/0000-0003-0895-1110; shong, minho/0000-0002-0247-7115	National Research Laboratory [ROA-2005-00010047-0]; Korea Research Foundation [KRF-2006-005-J03003]	National Research Laboratory(Korea Science and Engineering Foundation); Korea Research Foundation(National Research Foundation of Korea)	This work was supported by National Research Laboratory Grant ROA-2005-00010047-0 and the Korea Research Foundation Grant KRF-2006-005-J03003.	Akhova O, 2005, J VIROL, V79, P14708, DOI 10.1128/JVI.79.23.14708-14718.2005; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Castet A, 2006, MOL ENDOCRINOL, V20, P1035, DOI 10.1210/me.2005-0227; Chanda D, 2008, ENDOCR J, V55, P253, DOI 10.1507/endocrj.K07E-103; Chao EYH, 2006, BIOORG MED CHEM LETT, V16, P821, DOI 10.1016/j.bmcl.2005.11.030; Coward P, 2001, P NATL ACAD SCI USA, V98, P8880, DOI 10.1073/pnas.151244398; Dai Y, 2007, MOL ENDOCRINOL, V21, P1807, DOI 10.1210/me.2006-0467; Deppmann CD, 2006, MOL BIOL EVOL, V23, P1480, DOI 10.1093/molbev/msl022; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Heery DM, 2001, J BIOL CHEM, V276, P6695, DOI 10.1074/jbc.M009404200; Hentschke M, 2002, BIOCHEM BIOPH RES CO, V299, P872, DOI 10.1016/S0006-291X(02)02753-5; Hogan MR, 2006, FEBS LETT, V580, P58, DOI 10.1016/j.febslet.2005.11.046; Hong H, 1999, J BIOL CHEM, V274, P22618, DOI 10.1074/jbc.274.32.22618; Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200; Kwon HS, 2004, ADV ENZYME REGUL, V44, P109, DOI 10.1016/j.advenzreg.2003.11.020; Kwon HS, 2004, DIABETES, V53, P899, DOI 10.2337/diabetes.53.4.899; Lee CH, 1999, J BIOL CHEM, V274, P31320, DOI 10.1074/jbc.274.44.31320; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Liu XF, 2004, J BIOL CHEM, V279, P15050, DOI 10.1074/jbc.M311932200; Lu R, 2000, NUCLEIC ACIDS RES, V28, P2446, DOI 10.1093/nar/28.12.2446; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Misra V, 2005, J BIOL CHEM, V280, P15257, DOI 10.1074/jbc.M500728200; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Park YY, 2005, NUCLEIC ACIDS RES, V33, P6756, DOI 10.1093/nar/gki976; Pettersson K, 1996, MECH DEVELOP, V54, P211, DOI 10.1016/0925-4773(95)00479-3; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; Ruse MD, 2002, MOL CELL BIOL, V22, P1626, DOI 10.1128/MCB.22.6.1626-1638.2002; Sanyal S, 2002, J BIOL CHEM, V277, P1739, DOI 10.1074/jbc.M106140200; Savkur RS, 2004, J PEPT RES, V63, P207, DOI 10.1111/j.1399-3011.2004.00126.x; Senawong T, 2003, J BIOL CHEM, V278, P43041, DOI 10.1074/jbc.M307477200; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Tremblay GB, 2001, ENDOCRINOLOGY, V142, P4572, DOI 10.1210/en.142.10.4572; Wang JJ, 2009, FEBS LETT, V583, P643, DOI 10.1016/j.febslet.2009.01.030; Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010; Xie YB, 2009, NUCLEIC ACIDS RES, V37, P4100, DOI 10.1093/nar/gkp333; Xie YB, 2008, BIOCHEM J, V416, P463, DOI 10.1042/BJ20080782; Yamagata K, 2004, J BIOL CHEM, V279, P23158, DOI 10.1074/jbc.M314322200; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yu SA, 2007, CANCER RES, V67, P4904, DOI 10.1158/0008-5472.CAN-06-3855; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200; Zhang ZP, 2007, MOL CELL ENDOCRINOL, V264, P128, DOI 10.1016/j.mce.2006.11.002; Zhou DJ, 2006, NUCLEIC ACIDS RES, V34, P5974, DOI 10.1093/nar/gkl764	52	53	56	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28762	28774		10.1074/jbc.M109.034165	http://dx.doi.org/10.1074/jbc.M109.034165			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19690166	hybrid, Green Published			2022-12-27	WOS:000270678900033
J	Sengupta, A; Molkentin, JD; Yutzey, KE				Sengupta, Arunima; Molkentin, Jeffery D.; Yutzey, Katherine E.			FoxO Transcription Factors Promote Autophagy in Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CELL-DEATH; IN-VIVO; CARDIAC MYOCYTES; MYOCARDIAL ISCHEMIA/REPERFUSION; SIGNALING PATHWAYS; HEMODYNAMIC STRESS; ANOREXIA-NERVOSA; HEART-DISEASE; HYPERTROPHY	In the heart, autophagy is required for normal cardiac function and also has been implicated in cardiovascular disease. FoxO transcription factors promote autophagy in skeletal muscle and have additional roles in regulation of cell size, proliferation, and metabolism. Here we investigate the role of FoxO transcription factors in regulating autophagy and cell size in cardiomyocytes. In cultured rat neonatal cardiomyocytes, glucose deprivation leads to decreased cell size and induction of autophagy pathway genes LC3, Gabarapl1, and Atg12. Likewise, overexpression of either FoxO1 or FoxO3 reduces cardiomyocyte cell size and induces expression of autophagy pathway genes. Moreover, inhibition of FoxO activity by dominant negative FoxO1 (Delta 256) blocks cardiomyocyte cell size reduction upon starvation, suggesting the necessity of FoxO function in cardiomyocyte cell size regulation. Under starvation conditions, endogenous FoxO1 and FoxO3 are localized to the nucleus and bind to promoter sequences of Gabarapl1 and Atg12. In vivo studies show that cellular stress, such as starvation or ischemia/reperfusion in mice, results in induction of autophagy in the heart with concomitant dephosphorylation of FoxO, consistent with increased activity of nuclear FoxO transcription factors. Together these results provide evidence for an important role for FoxO1 and FoxO3 in regulating autophagy and cell size in cardiomyocytes.	[Sengupta, Arunima; Molkentin, Jeffery D.; Yutzey, Katherine E.] Cincinnati Childrens Med Ctr, Div Mol Cardiovasc Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Yutzey, KE (corresponding author), Cincinnati Childrens Med Ctr, Div Mol Cardiovasc Biol, ML 7020,240 Albert Sabin Way, Cincinnati, OH 45229 USA.	katherine.yutzey@cchmc.org		Molkentin, Jeffery/0000-0002-3558-6529; Yutzey, Katherine/0000-0002-1444-7124	National Institutes of Health [P01 HL069779]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL069779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 HL069779.	Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; De Windt LJ, 2000, J BIOL CHEM, V275, P13571, DOI 10.1074/jbc.275.18.13571; DESIMONE GD, 1994, BRIT HEART J, V71, P287; Elsasser A, 2004, J AM COLL CARDIOL, V43, P2191, DOI 10.1016/j.jacc.2004.02.053; Evans-Anderson HJ, 2008, CIRC RES, V102, P686, DOI 10.1161/CIRCRESAHA.107.163428; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Gustafsson AB, 2008, AUTOPHAGY, V4, P416, DOI 10.4161/auto.5655; Gustafsson AB, 2008, J MOL CELL CARDIOL, V44, P654, DOI 10.1016/j.yjmcc.2008.01.010; Gustafsson AB, 2009, CIRC RES, V104, P150, DOI 10.1161/CIRCRESAHA.108.187427; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Hannenhalli S, 2006, CIRCULATION, V114, P1269, DOI 10.1161/CIRCULATIONAHA.106.632430; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; HEMMERICH P, 1993, NUCLEIC ACIDS RES, V21, P223, DOI 10.1093/nar/21.2.223; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Kaiser RA, 2005, J BIOL CHEM, V280, P32602, DOI 10.1074/jbc.M500684200; Kaiser RA, 2004, J BIOL CHEM, V279, P15524, DOI 10.1074/jbc.M313717200; Kanfi Y, 2008, FEBS LETT, V582, P543, DOI [10.1016/j.febslet.2008.01.019, 10.1016/j.febslet.2008.06.005]; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kunapuli S, 2006, J CARD FAIL, V12, P381, DOI 10.1016/j.cardfail.2006.02.002; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Maruyama R, 2008, AM J PHYSIOL-HEART C, V295, pH1599, DOI 10.1152/ajpheart.91449.2007; Matsui T, 2001, CIRCULATION, V104, P330; Matsui Y, 2008, AUTOPHAGY, V4, P409, DOI 10.4161/auto.5638; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Melendez A, 2008, DEVELOPMENT, V135, P2347, DOI 10.1242/dev.016105; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Nishida K, 2009, CELL DEATH DIFFER, V16, P31, DOI 10.1038/cdd.2008.163; Nishida K, 2008, CIRC RES, V103, P343, DOI 10.1161/CIRCRESAHA.108.175448; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; PAPADIMITRIOU JM, 1974, CIRC RES, V35, P127, DOI 10.1161/01.RES.35.1.127; SANDRI M, 2004, CELL, P117; Senzaki H, 2006, CIRCULATION, V113, pE759, DOI 10.1161/CIRCULATIONAHA.105.555565; Shelton EL, 2007, DEV BIOL, V302, P376, DOI 10.1016/j.ydbio.2006.09.047; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Tsujita Y, 2006, P NATL ACAD SCI USA, V103, P11946, DOI 10.1073/pnas.0510138103; Valentim L, 2006, J MOL CELL CARDIOL, V40, P846, DOI 10.1016/j.yjmcc.2006.03.428; Vellai T, 2008, AUTOPHAGY, V4, P507, DOI 10.4161/auto.5670; Zafeiridis A, 1998, CIRCULATION, V98, P656, DOI 10.1161/01.CIR.98.7.656; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	62	318	334	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28319	28331		10.1074/jbc.M109.024406	http://dx.doi.org/10.1074/jbc.M109.024406			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19696026	hybrid, Green Published			2022-12-27	WOS:000270676300058
J	Hansen, C; Howlin, J; Tengholm, A; Dyachok, O; Vogel, WF; Nairn, AC; Greengard, P; Andersson, T				Hansen, Christian; Howlin, Jillian; Tengholm, Anders; Dyachok, Oleg; Vogel, Wolfgang F.; Nairn, Angus C.; Greengard, Paul; Andersson, Tommy			Wnt-5a-induced Phosphorylation of DARPP-32 Inhibits Breast Cancer Cell Migration in a CREB-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED NEURONAL PHOSPHOPROTEIN; PROTEIN PHOSPHATASE 1; TYROSINE KINASE DDR1; GLYCOGEN-SYNTHASE; TUMOR-SUPPRESSOR; CYCLIC-AMP; DOPAMINE; WNT-5A; WNT5A; CAMP	Tumor cell migration plays a central role in the process of cancer metastasis. We recently identified dopamine and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32) as an antimigratory phosphoprotein in breast cancer cells. Here we link this effect of DARPP-32 to Wnt-5a signaling by demonstrating that recombinant Wnt-5a triggers cAMP elevation at the plasma membrane and Thr34-DARPP-32 phosphorylation in MCF-7 cells. In agreement, both protein kinase A (PKA) inhibitors and siRNA-mediated knockdown of Frizzled-3 receptor or G alpha(s) expression abolished Wnt-5a-induced phosphorylation of DARPP-32. Furthermore, Wnt-5a induced DARPP-32-dependent inhibition of MCF-7 cell migration. Phospho-Thr-34-DARPP-32 interacted with protein phosphatase-1 (PP1) and potentiated the Wnt-5a-mediated phosphorylation of CREB, a well-known PP1 substrate, but had no effect on CREB phosphorylation by itself. Moreover, inhibition of the Wnt-5a/DARPP-32/CREB pathway, by expression of dominant negative CREB (DN-CREB), diminished the antimigratory effect of Wnt-5a-induced phospho-Thr-34-DARPP-32. Phalloidin-staining revealed that that the presence of phospho-Thr-34-DARPP-32 in MCF-7 cells results in reduced filopodia formation. In accordance, the activity of the Rho GTPase Cdc42, known to be crucial for filopodia formation, was reduced in MCF-7 cells expressing phospho-Thr-34-DARPP- 32. The effects of DARPP-32 on cell migration and filopodia formation could be reversed in T47D breast cancer cells that were depleted of their endogenous DARPP-32 by siRNA targeting. Consequently, Wnt-5a activates a Frizzled-3/G alpha(s)/cAMP/PKA signaling pathway that triggers a DARPP-32- and CREB-dependent antimigratory response in breast cancer cells, representing a novel mechanism whereby Wnt-5a can inhibit breast cancer cell migration.	[Hansen, Christian; Howlin, Jillian; Andersson, Tommy] Lund Univ, Dept Lab Med, CRC, S-20502 Malmo, Sweden; [Tengholm, Anders; Dyachok, Oleg] Uppsala Univ, Dept Med Cell Biol, BMC, SE-75123 Uppsala, Sweden; [Vogel, Wolfgang F.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Nairn, Angus C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA; [Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA	Lund University; Uppsala University; University of Toronto; Yale University; Rockefeller University	Andersson, T (corresponding author), Lund Univ, Dept Lab Med, CRC, S-20502 Malmo, Sweden.	tommy.andersson@med.lu.se	Dyachok, Oleg/B-5935-2017; Howlin, Jill/G-9665-2011	Howlin, Jill/0000-0002-2766-3002; Nairn, Angus/0000-0002-7075-0195; Andersson, Tommy/0000-0003-4032-5769	Swedish Cancer Foundation; Swedish Research Council; U-MAS Research Foundations; Gunnar Nilsson's Cancer Foundation; Royal Physiographic Society in Lund; Magnus Bergvall's Foundation; Canada Research Chair Program; National Institutes of Health [MH074866]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); U-MAS Research Foundations; Gunnar Nilsson's Cancer Foundation; Royal Physiographic Society in Lund; Magnus Bergvall's Foundation; Canada Research Chair Program(Canada Research Chairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the Swedish Cancer Foundation (to T. A.), the Swedish Research Council (to T. A. and A. T.), the U-MAS Research Foundations (to T. A.), the Gunnar Nilsson's Cancer Foundation (to T. A.), the Royal Physiographic Society in Lund (to C. H.), Magnus Bergvall's Foundation (to A. T.), the Canada Research Chair Program (to W. V.), and in part, by National Institutes of Health Grant MH074866 (to A. N. and P. G.).	APERIA A, 1990, AM J HYPERTENS, V3, pS11, DOI 10.1093/ajh/3.6.11S; Beckler A, 2003, CANCER, V98, P1547, DOI 10.1002/cncr.11654; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Brady MJ, 1997, J BIOL CHEM, V272, P29698, DOI 10.1074/jbc.272.47.29698; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Ebihara Y, 2004, BRIT J CANCER, V91, P119, DOI 10.1038/sj.bjc.6601899; El-Rifai W, 2002, CANCER RES, V62, P4061; Endo Y, 2008, MOL CELL BIOL, V28, P2368, DOI 10.1128/MCB.01780-07; Garcia-Jimenez C, 2005, MOL ENDOCRINOL, V19, P3060, DOI 10.1210/me.2005-0129; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Han JZ, 2007, J CELL BIOL, V176, P101, DOI 10.1083/jcb.200607128; Hansen C, 2006, EXP CELL RES, V312, P4011, DOI 10.1016/j.yexcr.2006.09.003; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; Hou GP, 2001, J CLIN INVEST, V107, P727, DOI 10.1172/JCI10720; Huang HB, 1999, J BIOL CHEM, V274, P7870, DOI 10.1074/jbc.274.12.7870; Jalvy S, 2007, CARDIOVASC RES, V75, P738, DOI 10.1016/j.cardiores.2007.05.019; Jansson M, 2001, J CELL SCI, V114, P2043; Jean D, 1998, J BIOL CHEM, V273, P24884, DOI 10.1074/jbc.273.38.24884; Jonsson M, 2002, CANCER RES, V62, P409; Klemm DJ, 2001, J BIOL CHEM, V276, P46132, DOI 10.1074/jbc.M104769200; Kremenevskaja N, 2005, ONCOGENE, V24, P2144, DOI 10.1038/sj.onc.1208370; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Li L, 2006, WORLD J SURG, V30, P1672, DOI 10.1007/s00268-006-0035-3; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Lilja L, 2005, BIOCHEM BIOPH RES CO, V329, P673, DOI 10.1016/j.bbrc.2005.02.017; Luo W, 2007, EMBO J, V26, P1511, DOI 10.1038/sj.emboj.7601607; Mayerhofer A, 2004, EXP CLIN ENDOCR DIAB, V112, P451, DOI 10.1055/s-2004-821205; MEISTER B, 1991, J ENDOCRINOL INVEST, V14, P655, DOI 10.1007/BF03347888; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Safholm A, 2006, J BIOL CHEM, V281, P2740, DOI 10.1074/jbc.M508386200; SNYDER GL, 1992, J NEUROSCI, V12, P3071, DOI 10.1523/JNEUROSCI.12-08-03071.1992; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Torii K, 2008, CELL SIGNAL, V20, P1256, DOI 10.1016/j.cellsig.2008.02.013; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Vijayaraghavan S, 1996, BIOL REPROD, V54, P709, DOI 10.1095/biolreprod54.3.709; WALAAS SI, 1983, J NEUROSCI, V3, P291; WALAAS SI, 1983, NATURE, V301, P69; Wang HY, 2006, CELL SIGNAL, V18, P934, DOI 10.1016/j.cellsig.2005.12.008; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0	43	61	65	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27533	27543		10.1074/jbc.M109.048884	http://dx.doi.org/10.1074/jbc.M109.048884			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651774	hybrid, Green Published			2022-12-27	WOS:000270232300055
J	Hoshino, D; Tomari, T; Nagano, M; Koshikawa, N; Seiki, M				Hoshino, Daisuke; Tomari, Taizo; Nagano, Makoto; Koshikawa, Naohiko; Seiki, Motoharu			A Novel Protein Associated with Membrane-type 1 Matrix Metalloproteinase Binds p27(kip1) and Regulates RhoA Activation, Actin Remodeling, and Matrigel Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CELL-MIGRATION; CANCER; INVADOPODIA; GTPASES; INHIBITION; MOTILITY; DOMAIN; ROCK; PODOSOMES; MT1-MMP	Pericellular proteolysis by membrane-type 1 matrix metalloproteinase (MT1-MMP) plays a pivotal role in tumor cell invasion. Localization of MT1-MMP at the invasion front of cells, e. g. on lamellipodia and invadopodia, has to be regulated in coordination with reorganization of the actin cytoskeleton. However, little is known about how such invasion-related actin structures are regulated at the sites where MT1-MMP localizes. During analysis of MT1-MMP-associated proteins, we identified a heretofore uncharacterized protein. This protein, which we call p27RF-Rho, enhances activation of RhoA by releasing it from inhibition by p27(kip1) and thereby regulates actin structures. p27(kip1) is a well known cell cycle regulator in the nucleus. In contrast, cytoplasmic p27(kip1) has been demonstrated to bind GDP-RhoA and inhibit GDP-GTP exchange mediated by guanine nucleotide exchange factors. p27RF-Rho binds p27(kip1) and prevents p27(kip1) from binding to RhoA, thereby freeing the latter for activation. Knockdown of p27RF-Rho expression renders cells resistant to RhoA activation stimuli, whereas overexpression of p27RF-Rho sensitizes cells to such stimulation. p27RF-Rho exhibits a punctate distribution in invasive human tumor cell lines. Stimulation of the cells with lysophosphatidic acid induces activation of RhoA and induces the formation of punctate actin structures within foci of p27RF-Rho localization. Some of the punctate actin structures co-localize with MT1-MMP and cortactin. Down-regulation of p27RF-Rho prevents both redistribution of actin into the punctate structures and tumor cell invasion. Thus, p27RF-Rho is a new potential target for cancer therapy development.	[Hoshino, Daisuke; Tomari, Taizo; Nagano, Makoto; Koshikawa, Naohiko; Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo 1088639, Japan	University of Tokyo	Seiki, M (corresponding author), Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo 1088639, Japan.	mseiki@ims.u-tokyo.ac.jp	Koshikawa, Naohiko/S-7306-2017; Seiki, Motoharu/K-9443-2015; Nagano, Makoto/J-7050-2015	Koshikawa, Naohiko/0000-0002-4539-888X; Nagano, Makoto/0000-0002-1948-1591	Specific Coordination Fund for Promoting Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Specific Coordination Fund for Promoting Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Specific Coordination Fund for Promoting Science (to D. H.), a grant-in-aid for Scientific Research on Priority Areas, "Integrative Research toward the Conquest of Cancer," and the Global COE Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. S.).	Abecassis I, 2003, EXP CELL RES, V291, P363, DOI 10.1016/j.yexcr.2003.08.006; Berdeaux RL, 2004, J CELL BIOL, V166, P317, DOI 10.1083/jcb.200312168; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fritz G, 2006, CURR CANCER DRUG TAR, V6, P1, DOI 10.2174/156800906775471752; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Lee SA, 2008, J CLIN INVEST, V118, P1354, DOI 10.1172/JCI33768; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; McAllister SS, 2003, MOL CELL BIOL, V23, P216, DOI 10.1128/MCB.23.1.216-228.2003; Ming XF, 2004, CIRCULATION, V110, P3708, DOI 10.1161/01.CIR.0000142867.26182.32; MONSKY WL, 1993, CANCER RES, V53, P3159; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Nakahara H, 1997, P NATL ACAD SCI USA, V94, P7959, DOI 10.1073/pnas.94.15.7959; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Overall CM, 2006, CANCER METAST REV, V25, P69, DOI 10.1007/s10555-006-7890-0; Papakonstanti EA, 2007, EMBO J, V26, P3050, DOI 10.1038/sj.emboj.7601763; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Sakurai-Yageta M, 2008, J CELL BIOL, V181, P985, DOI 10.1083/jcb.200709076; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Tomari T, 2009, CANCER SCI, V100, P1284, DOI 10.1111/j.1349-7006.2009.01173.x; Tsuji T, 2002, J CELL BIOL, V157, P819, DOI 10.1083/jcb.200112107; Uekita T, 2004, J BIOL CHEM, V279, P12734, DOI 10.1074/jbc.M309957200; Weaver AM, 2008, CURR BIOL, V18, pR362, DOI 10.1016/j.cub.2008.02.028; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Wu FY, 2006, CANCER RES, V66, P2162, DOI 10.1158/0008-5472.CAN-05-3304	34	53	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27315	27326		10.1074/jbc.M109.041400	http://dx.doi.org/10.1074/jbc.M109.041400			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19654316	Green Published, hybrid			2022-12-27	WOS:000270232300032
J	Zhang, L; Bowen, T; Grennan-Jones, F; Paddon, C; Giles, P; Webber, J; Steadman, R; Ludgate, M				Zhang, Lei; Bowen, Timothy; Grennan-Jones, Fiona; Paddon, Carol; Giles, Peter; Webber, Jason; Steadman, Robert; Ludgate, Marian			Thyrotropin Receptor Activation Increases Hyaluronan Production in Preadipocyte Fibroblasts CONTRIBUTORY ROLE IN HYALURONAN ACCUMULATION IN THYROID DYSFUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SKIN FIBROBLASTS; STIMULATING HORMONE; ORBITAL FIBROBLASTS; GLYCOSAMINOGLYCAN SYNTHESIS; BIOLOGICAL-ACTIVITY; CONNECTIVE-TISSUE; EPITHELIAL-CELLS; GRAVES-DISEASE; EXPRESSION; MYXEDEMA	The thyrotropin receptor (TSHR) is expressed during lineage-specific differentiation (e. g. adipogenesis) and is activated by TSH, thyroid-stimulating antibodies, and gain-of-function mutations (TSHR*). Comparison of gene expression profiles of nonmodified human preadipocytes (n = 4) with the parallel TSHR* population revealed significant up-regulation of 27 genes including hyaluronan (HA) synthases (HAS) 1 and 2. The array data were confirmed by quantitative PCR of HAS1 and HAS2 and enzyme-linked immunosorbent assay measurement of HA; all values were significantly increased (p < 0.03) in TSHR*-expressing preadipocytes (n = 10). Preadipocytes (n = 8) treated with dibutyryl (db)-cAMP display significantly increased HAS1 and HAS2 transcripts, HAS2 protein, and HA production (p < 0.02). HAS1 or HAS2 small interfering RNA treatment of db-cAMP-stimulated preadipocytes (n = 4) produced 80% knockdown in HAS1 or 61% knockdown in HAS2 transcripts (compared with scrambled), respectively; the corresponding HA production was reduced by 49 or 38%. Reporter assays using A293 cells transfected with HAS1 promoter-driven plasmids containing or not containing the proximal CRE and treated with db-cAMP revealed that it is functional. Chromatin immunoprecipitation, using a cAMP-responsive element-binding protein antibody, of db-cAMP-treated preadipocytes (n = 4) yielded products for HAS1 and HAS2 with relative fold increases of 3.3 +/- 0.8 and 2.6 +/- 0.9, respectively. HA accumulates in adipose/connective tissues of patients with thyroid dysfunction. We investigated the contributions of TSH andthyroid-stimulating antibodies and obtained small (9 - 24%) but significant (p < 0.02) increases in preadipocyte HA production with both ligands. Similar results were obtained with a TSHR monoclonal antibody lacking biological activity (p < 0.05). We conclude that TSHR activation is implicated in HA production in preadipocytes, which, along with thyroid hormone level variation, explains the HA overproduction in thyroid dysfunction.	[Zhang, Lei; Grennan-Jones, Fiona; Paddon, Carol; Ludgate, Marian] Cardiff Univ, Sch Med, Ctr Endocrine & Diabet Sci, Cardiff CF14 4XN, S Glam, Wales; [Bowen, Timothy; Webber, Jason; Steadman, Robert] Cardiff Univ, Sch Med, Inst Nephrol, Cardiff CF14 4XN, S Glam, Wales; [Giles, Peter] Cardiff Univ, Sch Med, Biostat & Bioinformat Unit, Cardiff CF14 4XN, S Glam, Wales	Cardiff University; Cardiff University; Cardiff University	Ludgate, M (corresponding author), Cardiff Univ, Sch Med, Ctr Endocrine & Diabet Sci, Cardiff CF14 4XN, S Glam, Wales.	ludgate@cf.ac.uk	Zhang, Lei/F-4055-2016; Webber, Jason P/O-1960-2017; Steadman, Robert/O-1614-2016	Zhang, Lei/0000-0003-3536-8692; Webber, Jason P/0000-0003-4772-3014; Steadman, Robert/0000-0002-1303-2496; Ludgate, Marian/0000-0002-7436-0821	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a grant from the Wellcome Trust.	Abe E, 2003, CELL, V115, P151, DOI 10.1016/S0092-8674(03)00771-2; Al-Khafaji F, 2005, J MOL ENDOCRINOL, V34, P209, DOI 10.1677/jme.1.01590; ARBOGAST B, 1975, BIOCHEM BIOPH RES CO, V67, P376, DOI 10.1016/0006-291X(75)90326-5; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Costagliola S, 1998, J IMMUNOL, V160, P1458; Crisp M, 2000, INVEST OPHTH VIS SCI, V41, P3249; Crisp MS, 1997, J CLIN ENDOCR METAB, V82, P2003; Daumerie C, 2002, EUR J ENDOCRINOL, V146, P35, DOI 10.1530/eje.0.1460035; FINKE R, 1991, J CLIN ENDOCR METAB, V73, P919, DOI 10.1210/jcem-73-4-919; Fuhrer D, 2003, ENDOCRINOLOGY, V144, P4018, DOI 10.1210/en.2003-0438; GABRILOVE JL, 1957, J CLIN ENDOCR METAB, V17, P925, DOI 10.1210/jcem-17-8-925; GABRILOVE JL, 1960, J CLIN ENDOCR METAB, V20, P825, DOI 10.1210/jcem-20-6-825; Gianoukakis AG, 2007, ENDOCRINOLOGY, V148, P54, DOI 10.1210/en.2006-0736; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jenkins RH, 2004, J BIOL CHEM, V279, P41453, DOI 10.1074/jbc.M401678200; Kaback LA, 1999, J CLIN ENDOCR METAB, V84, P4079, DOI 10.1210/jc.84.11.4079; LUND P, 1986, ACTA ENDOCRINOL-COP, V113, P56, DOI 10.1530/acta.0.1130056; Meran S, 2007, J BIOL CHEM, V282, P25687, DOI 10.1074/jbc.M700773200; METCALFE RA, 1993, THYROID, V3, P207, DOI 10.1089/thy.1993.3.207; PASCHKE R, 1994, J CLIN ENDOCR METAB, V79, P1234, DOI 10.1210/jc.79.5.1234; Paschke R, 1997, NEW ENGL J MED, V337, P1675, DOI 10.1056/NEJM199712043372307; SCHILLER S, 1962, BIOCHIM BIOPHYS ACTA, V58, P27, DOI 10.1016/0006-3002(62)90813-2; SHISHIBA Y, 1988, J BIOL CHEM, V263, P1745; SMITH TJ, 1989, ENDOCR REV, V10, P366, DOI 10.1210/edrv-10-3-366; SMITH TJ, 1989, J CLIN ENDOCR METAB, V69, P1019, DOI 10.1210/jcem-69-5-1019; Smith TJ, 2004, J CLIN ENDOCR METAB, V89, P5076, DOI 10.1210/jc.2004-0716; SMITH TJ, 1982, J CLIN INVEST, V70, P1066, DOI 10.1172/JCI110694; Stair-Nawy S, 1999, BIOCHEM BIOPH RES CO, V266, P268, DOI 10.1006/bbrc.1999.1802; Tinti C, 1997, J BIOL CHEM, V272, P19158, DOI 10.1074/jbc.272.31.19158; TOMIDA M, 1977, BIOCHEM J, V162, P539, DOI 10.1042/bj1620539; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; VASSART G, 1992, ENDOCR REV, V13, P596, DOI 10.1210/er.13.3.596; Wang HS, 2005, J CELL BIOCHEM, V95, P256, DOI 10.1002/jcb.20405; Webber J, 2009, AM J PATHOL, V175, P148, DOI 10.2353/ajpath.2009.080837; WEETMAN AP, 1993, Q J MED, V86, P473, DOI 10.1093/qjmed/86.8.473; WEGROWSKI J, 1989, CELL BIOL INT REP, V13, P881, DOI 10.1016/0309-1651(89)90130-6; Zhang L, 2006, INVEST OPHTH VIS SCI, V47, P5197, DOI 10.1167/iovs.06-0596	40	64	65	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26447	26455		10.1074/jbc.M109.003616	http://dx.doi.org/10.1074/jbc.M109.003616			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19633293	Green Published, hybrid			2022-12-27	WOS:000269969600026
J	Liu, XY; Daiho, T; Yamasaki, K; Wang, GL; Danko, S; Suzuki, H				Liu, Xiaoyu; Daiho, Takashi; Yamasaki, Kazuo; Wang, Guoli; Danko, Stefania; Suzuki, Hiroshi			Roles of Interaction between Actuator and Nucleotide Binding Domains of Sarco(endo)plasmic Reticulum Ca2+-ATPase as Revealed by Single and Swap Mutational Analyses of Serine 186 and Glutamate 439	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-INSENSITIVE PHOSPHOENZYME; MUSCLE SARCOPLASMIC-RETICULUM; 1ST TRANSMEMBRANE HELIX; CALCIUM-PUMP; SKELETAL-MUSCLE; ATP-BINDING; PHOSPHORYLATED INTERMEDIATE; CONFORMATIONAL TRANSITION; REACTION-MECHANISM; CRYSTAL-STRUCTURES	Roles of hydrogen bonding interaction between Ser(186) of the actuator (A) domain and Glu(439) of nucleotide binding (N) domain seen in the structures of ADP-insensitive phosphorylated intermediate (E2P) of sarco(endo)plasmic reticulum Ca2+-ATPase were explored by their double alanine substitution S186A/E439A, swap substitution S186E/E439S, and each of these single substitutions. All the mutants except the swap mutant S186E/E439S showed markedly reduced Ca2+-ATPase activity, and S186E/E439S restored completely the wild-type activity. In all the mutants except S186E/E439S, the isomerization of ADP-sensitive phosphorylated intermediate (E1P) to E2P was markedly retarded, and the E2P hydrolysis was largely accelerated, whereas S186E/E439S restored almost the wildtype rates. Results showed that the Ser(186)-Glu(439) hydrogen bond stabilizes the E2P ground state structure. The modulatory ATP binding at sub-mM similar to mM range largely accelerated the EP isomerization in all the alanine mutants and E439S. In S186E, this acceleration as well as the acceleration of the ATPase activity was almost completely abolished, whereas the swap mutation S186E/E439S restored the modulatory ATP acceleration with a much higher ATP affinity than the wild type. Results indicated that Ser(186) and Glu(439) are closely located to the modulatory ATP binding site for the EP isomerization, and that their hydrogen bond fixes their side chain configurations thereby adjusts properly the modulatory ATP affinity to respond to the cellular ATP level.	[Liu, Xiaoyu; Daiho, Takashi; Yamasaki, Kazuo; Wang, Guoli; Danko, Stefania; Suzuki, Hiroshi] Asahikawa Med Coll, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan	Asahikawa Medical College	Suzuki, H (corresponding author), Asahikawa Med Coll, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan.	hisuzuki@asahikawa-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research (B) (to H.S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	ANDERSEN JP, 1985, BIOCHIM BIOPHYS ACTA, V815, P9, DOI 10.1016/0005-2736(85)90467-5; CHAMPEIL P, 1988, J BIOL CHEM, V263, P12288; Clausen JD, 2007, J BIOL CHEM, V282, P20686, DOI 10.1074/jbc.M702365200; Clausen JD, 2008, J BIOL CHEM, V283, P35703, DOI 10.1074/jbc.M806795200; Daiho T, 1999, J BIOL CHEM, V274, P23910, DOI 10.1074/jbc.274.34.23910; Daiho T, 2003, J BIOL CHEM, V278, P39197, DOI 10.1074/jbc.M305200200; Daiho T, 1999, FEBS LETT, V444, P54, DOI 10.1016/S0014-5793(99)00027-7; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2001, FEBS LETT, V489, P277, DOI 10.1016/S0014-5793(01)02111-1; DEMEIS L, 1982, J BIOL CHEM, V257, P1289; Dode L, 2003, J BIOL CHEM, V278, P47877, DOI 10.1074/jbc.M306784200; EBASHI S, 1962, J CELL BIOL, V14, P389, DOI 10.1083/jcb.14.3.389; Fersht A, 1999, STRUCTURE MECH PROTE, P132; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INESI G, 1990, PHYSIOL REV, V70, P749, DOI 10.1152/physrev.1990.70.3.749; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; KANAZAWA T, 1970, J BIOCHEM-TOKYO, V67, P693, DOI 10.1093/oxfordjournals.jbchem.a129297; Kato S, 2003, J BIOL CHEM, V278, P9624, DOI 10.1074/jbc.M208861200; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma HL, 2003, J BIOL CHEM, V278, P28938, DOI 10.1074/jbc.M304120200; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; McIntosh D.B., 1998, ADV MOL CEL A&B, V23A, P33; Miyauchi Y, 2006, J BIOL CHEM, V281, P22882, DOI 10.1074/jbc.M601966200; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; OGURUSU T, 1991, J BIOCHEM-TOKYO, V109, P472, DOI 10.1093/oxfordjournals.jbchem.a123406; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; PICK U, 1982, J BIOL CHEM, V257, P6120; SHIGEKAWA M, 1976, J BIOL CHEM, V251, P6947; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1451; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Wang GL, 2005, J BIOL CHEM, V280, P26508, DOI 10.1074/jbc.M503789200; WEBER K, 1969, J BIOL CHEM, V244, P4406; YAMAMOTO T, 1967, J BIOCHEM-TOKYO, V62, P558, DOI 10.1093/oxfordjournals.jbchem.a128706; Yamasaki K, 2004, J BIOL CHEM, V279, P2202, DOI 10.1074/jbc.M309398200; Yamasaki K, 2008, J BIOL CHEM, V283, P29144, DOI 10.1074/jbc.M804596200	53	7	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25190	25198		10.1074/jbc.M109.034140	http://dx.doi.org/10.1074/jbc.M109.034140			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19628462	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000269734000053
J	Panasyuk, G; Nemazanyy, I; Zhyvoloup, A; Filonenko, V; Davies, D; Robson, M; Pedley, RB; Waterfield, M; Gout, I				Panasyuk, Ganna; Nemazanyy, Ivan; Zhyvoloup, Aleksander; Filonenko, Valeriy; Davies, Derek; Robson, Mathew; Pedley, R. Barbara; Waterfield, Michael; Gout, Ivan			mTOR beta Splicing Isoform Promotes Cell Proliferation and Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TARGET; RAPAMYCIN; PHOSPHORYLATION; PATHWAY; KINASE; RAPTOR; LOCALIZATION; COMPLEX; CANCER; RICTOR	The mTOR (mammalian target of rapamycin) promotes growth in response to nutrients and growth factors and is deregulated in numerous pathologies, including cancer. The mechanisms by which mTOR senses and regulates energy metabolism and cell growth are relatively well understood, whereas the molecular events underlining how it mediates survival and proliferation remain to be elucidated. Here, we describe the existence of the mTOR splicing isoform, TOR beta, which, in contrast to the full-length protein(mTOR beta), has the potential to regulate the G(1) phase of the cell cycle and to stimulate cell proliferation. mTOR beta is an active protein kinase that mediates downstream signaling through complexing with Rictor and Raptor proteins. Remarkably, overexpression of mTOR beta transforms immortal cells and is tumorigenic in nude mice and therefore could be a proto-oncogene.	[Gout, Ivan] Natl Acad Sci Ukraine, Inst Mol Biol & Genet, UA-143 Kiev, Ukraine; [Panasyuk, Ganna; Gout, Ivan] UCL, Inst Struct & Mol Biol, London WC1E 6BT, England; [Robson, Mathew; Pedley, R. Barbara] UCL, Dept Tumor Biol, Inst Canc, London WC1E 6BT, England; [Waterfield, Michael] UCL, Prote Unit, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Davies, Derek] Canc Res UK London Res Inst, FACS Lab, London WC2A 3PX, England; [Zhyvoloup, Aleksander] Piramed Pharma, Slough SL1 4NL, Berks, England	National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; University of London; Birkbeck University London; University College London; University of London; University College London; University of London; University College London; Cancer Research UK	Gout, I (corresponding author), Natl Acad Sci Ukraine, Inst Mol Biol & Genet, UA-143 Kiev, Ukraine.	i.gout@ucl.ac.uk	Filonenko, Valeriy V/D-5447-2015; Panasyuk, Ganna/AAF-4350-2021; Panasyuk, Ganna/A-4133-2018	Filonenko, Valeriy V/0000-0003-1839-3335; Panasyuk, Ganna/0000-0002-5591-848X; Panasyuk, Ganna/0000-0002-5591-848X; Davies, Derek/0000-0002-6977-4181	New Independent States of the former Soviet; Atlantic Philanthropies/Ludwig Institute for Cancer Research Clinical Discovery Program	New Independent States of the former Soviet; Atlantic Philanthropies/Ludwig Institute for Cancer Research Clinical Discovery Program	We thank P. Driscoll, D. Saggerson, J. Brockes, and N. Shaikh for critical comments on the manuscript and J. Downward for providing NIH 3T3 RasG12/C40 cells.; This work was supported in part by an International Association for the promotion of co-operation with scientists from the New Independent States of the former Soviet grant and the Atlantic Philanthropies/Ludwig Institute for Cancer Research Clinical Discovery Program ( to I. G.).	Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Desai BN, 2002, P NATL ACAD SCI USA, V99, P4319, DOI 10.1073/pnas.261702698; Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555; El Emir E, 2007, CANCER RES, V67, P11896, DOI 10.1158/0008-5472.CAN-07-2967; GRATZNER HG, 1975, EXP CELL RES, V95, P88, DOI 10.1016/0014-4827(75)90612-6; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harris Thurl E, 2003, Sci STKE, V2003, pre15; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Liu XY, 2007, MOL BIOL CELL, V18, P1073, DOI 10.1091/mbc.E06-05-0406; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Nemazanyy I, 2008, HYBRIDOMA, V27, P395, DOI 10.1089/hyb.2008.0035; Obaya AJ, 1999, ONCOGENE, V18, P2934, DOI 10.1038/sj.onc.1202749; Reynolds TH, 2002, J BIOL CHEM, V277, P17657, DOI 10.1074/jbc.M201142200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sekulic A, 2000, CANCER RES, V60, P3504; Takahara T, 2006, J BIOL CHEM, V281, P28605, DOI 10.1074/jbc.M606087200; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Zhang XW, 2002, J BIOL CHEM, V277, P28127, DOI 10.1074/jbc.M202625200	26	28	29	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30807	30814		10.1074/jbc.M109.056085	http://dx.doi.org/10.1074/jbc.M109.056085			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19726679	Green Published, hybrid			2022-12-27	WOS:000271378400008
J	Link, S; Meissner, M; Held, B; Beck, A; Weissgerber, P; Freichel, M; Flockerzi, V				Link, Sabine; Meissner, Marcel; Held, Brigitte; Beck, Andreas; Weissgerber, Petra; Freichel, Marc; Flockerzi, Veit			Diversity and Developmental Expression of L-type Calcium Channel beta 2 Proteins and Their Influence on Calcium Current in Murine Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CA2+ CHANNEL; ALPHA(1) SUBUNIT; FUNCTIONAL EXPRESSION; CA(V)1.2 CHANNEL; SPLICE VARIANTS; BETA(2) SUBUNIT; TRANSGENIC MICE; CONTRACTION; MODULATION; SITES	By now, little is known on L-type calcium channel (LTCC) subunits expressed in mouse heart. We show that CaV beta 2 proteins are the major CaV beta components of the LTCC in embryonic and adult mouse heart, but that in embryonic heart CaV beta 3 proteins are also detectable. At least two CaV beta 2 variants of similar to 68 and similar to 72 kDa are expressed. To identify the underlying CaV beta 2 variants, cDNA libraries were constructed from poly(A)(+) RNA isolated from hearts of 7-day-old and adult mice. Screening identified 60 independent CaV beta 2 cDNA clones coding for four types of CaV beta 2 proteins only differing in their 5' sequences. CaV beta 2-N1, -N4, and -N5 but not -N3 were identified in isolated cardiomyocytes by RT-PCR and were sufficient to reconstitute the CaV beta 2 protein pattern in vitro. Significant L-type Ca2+ currents (I-Ca) were recorded in HEK293 cells after co-expression of CaV1.2 and CaV beta 2. Current kinetics were determined by the type of CaV beta 2 protein, with the similar to 72-kDa CaV beta 2a-N1 shifting the activation of I-Ca significantly to depolarizing potentials compared with the other CaV beta 2 variants. Inactivation of I-Ca was accelerated by CaV beta 2a-N1 and -N4, which also lead to slower activation compared with CaV beta 2a-N3 and -N5. In summary, this study reveals the molecular LTCC composition in mouse heart and indicates that expression of various CaV beta 2 proteins may be used to adapt the properties of LTCCs to changing myocardial requirements during development and that CaV beta 2a-N1-induced changes of I-Ca kinetics might be essential in embryonic heart.	[Link, Sabine; Flockerzi, Veit] Univ Saarland, Klin Pharmakol & Toxikol, D-66421 Homburg, Germany	Saarland University	Link, S (corresponding author), Univ Saarland, Klin Pharmakol & Toxikol, D-66421 Homburg, Germany.	sabine.link@uks.eu; veit.flockerzi@uks.eu	Tuluc, Petronel/C-2527-2011		HOMFOR; Deutsche Forschungsgemeinschaft; Forschungskommission der Universitat des Saarlandes; Fonds der Chemischen Industrie	HOMFOR; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungskommission der Universitat des Saarlandes; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported in part by HOMFOR (to M. M. and V. F.), Deutsche Forschungsgemeinschaft and Forschungskommission der Universitat des Saarlandes (to V. F.), and Fonds der Chemischen Industrie (to V. F.).	Allen TJA, 1998, PFLUG ARCH EUR J PHY, V436, P238, DOI 10.1007/s004240050628; Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen XW, 2005, CIRC RES, V97, P1009, DOI 10.1161/01.RES.0000189270.72915.D1; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; Colecraft HM, 2002, J PHYSIOL-LONDON, V541, P435, DOI 10.1113/jphysiol.2002.018515; Cordeiro JM, 2009, J MOL CELL CARDIOL, V46, P695, DOI 10.1016/j.yjmcc.2009.01.014; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; Ding S, 1999, J BIOCHEM, V125, P750, DOI 10.1093/oxfordjournals.jbchem.a022346; Dolphin AC, 2003, PHARMACOL REV, V55, P607, DOI 10.1124/pr.55.4.3; FABIATO A, 1979, ANNU REV PHYSIOL, V41, P473, DOI 10.1146/annurev.ph.41.030179.002353; Foell JD, 2004, PHYSIOL GENOMICS, V17, P183, DOI 10.1152/physiolgenomics.00207.2003; Gerhardstein BL, 1999, BIOCHEMISTRY-US, V38, P10361, DOI 10.1021/bi990896o; Gong HC, 2001, J MEMBRANE BIOL, V184, P35, DOI 10.1007/s00232-001-0072-7; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; Groner F, 2004, BIOCHEM BIOPH RES CO, V314, P878, DOI 10.1016/j.bbrc.2003.12.174; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; Haase H, 2000, J CELL BIOCHEM, V76, P695, DOI 10.1002/(SICI)1097-4644(20000315)76:4<695::AID-JCB17>3.0.CO;2-Q; Hanlon MR, 1999, FEBS LETT, V445, P366, DOI 10.1016/S0014-5793(99)00156-8; Harry JB, 2004, J BIOL CHEM, V279, P46367, DOI 10.1074/jbc.M409523200; Herzig S, 2007, FASEB J, V21, P1527, DOI 10.1096/fj.06-7377com; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; Hullin R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000292; Jaleel N, 2008, CIRC RES, V103, P1109, DOI 10.1161/CIRCRESAHA.108.185611; Jones LP, 1998, J GEN PHYSIOL, V112, P125, DOI 10.1085/jgp.112.2.125; KAESTNER L, 2007, P SPIE, V6633; MASSA E, 1995, MOL PHARMACOL, V47, P707; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MITTERDORFER J, 1994, FEBS LETT, V352, P141, DOI 10.1016/0014-5793(94)00938-4; Murakami M, 2003, J BIOL CHEM, V278, P43261, DOI 10.1074/jbc.M211380200; Muth JN, 1999, J BIOL CHEM, V274, P21503, DOI 10.1074/jbc.274.31.21503; Namkung Y, 1998, P NATL ACAD SCI USA, V95, P12010, DOI 10.1073/pnas.95.20.12010; PEARSON HA, 1993, PFLUG ARCH EUR J PHY, V425, P518, DOI 10.1007/BF00374880; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Qin N, 1998, P NATL ACAD SCI USA, V95, P4690, DOI 10.1073/pnas.95.8.4690; REUTER H, 1983, NATURE, V301, P569, DOI 10.1038/301569a0; Takahashi SX, 2003, BIOPHYS J, V84, P3007, DOI 10.1016/S0006-3495(03)70027-7; Takemura H, 2005, CIRC J, V69, P1405, DOI 10.1253/circj.69.1405; Tang ZZ, 2008, BBA-MOL CELL RES, V1783, P118, DOI 10.1016/j.bbamcr.2007.11.003; Tang ZZ, 2004, J BIOL CHEM, V279, P44335, DOI 10.1074/jbc.M407023200; Viatchenko-Karpinski S, 1999, P NATL ACAD SCI USA, V96, P8259, DOI 10.1073/pnas.96.14.8259; WAHLER GM, 1994, AM J PHYSIOL, V267, pH1157, DOI 10.1152/ajpheart.1994.267.3.H1157; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; Weissgerber P, 2006, CIRC RES, V99, P749, DOI 10.1161/01.RES.0000243978.15182.c1	49	44	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30129	30137		10.1074/jbc.M109.045583	http://dx.doi.org/10.1074/jbc.M109.045583			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19723630	Green Published, hybrid			2022-12-27	WOS:000271090000016
J	Lee, KS; Iijima-Ando, K; Iijima, K; Lee, WJ; Lee, JH; Yu, K; Lee, DS				Lee, Kyu-Sun; Iijima-Ando, Kanae; Iijima, Koichi; Lee, Won-Jae; Lee, Joon H.; Yu, Kweon; Lee, Dong-Seok			JNK/FOXO-mediated Neuronal Expression of Fly Homologue of Peroxiredoxin II Reduces Oxidative Stress and Extends Life Span	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; MITOCHONDRIAL DYSFUNCTION; GENE FAMILY; DROSOPHILA; PROTEIN; CELLS; JNK; GROWTH; BRAIN; BODY	Activation of c-Jun N-terminal kinase (JNK) signaling in neurons increases stress resistance and extends life span, in part through FOXO-mediated transcription in Drosophila. However, the JNK/FOXO target genes are unknown. Here, we identified Jafrac1, a Drosophila homolog of human Peroxiredoxin II (hPrxII), as a downstream effecter of JNK/FOXO signaling in neurons that enhances stress resistance and extends life span. We found that Jafrac1 was expressed in the adult brain and induced by paraquat, a reactive oxygen species-generating chemical. RNA interference-mediated neuronal knockdown of Jafrac1 enhanced, while neuronal overexpression of Jafrac1 and hPrxII suppressed, paraquat-induced lethality in flies. Neuronal expression of Jafrac1 also significantly reduced ROS levels, restored mitochondrial function, and attenuated JNK activation caused by paraquat. Activation of JNK/FOXO signaling in neurons increased the Jafrac1 expression level under both normal and oxidative stressed conditions. Moreover, neuronal knockdown of Jafrac1 shortened, while overexpression of Jafrac1 and hPrxII extended, the life span in flies. These results support the hypothesis that JNK/FOXO signaling extends life span via amelioration of oxidative damage and mitochondrial dysfunction in neurons.	[Lee, Won-Jae] Natl Creat Res Initiat Ctr Symbiosyst, Seoul 120750, South Korea; [Lee, Won-Jae] Ewha Womans Univ, Dept Life Sci, Seoul 120750, South Korea; [Lee, Dong-Seok] Kyungpook Natl Univ, Coll Nat Sci, Taegu 702701, South Korea; [Lee, Joon H.] Konyang Univ, Coll Med, Kims Eye Hosp, Myung Gok Eye Res Inst, Chungnam 302718, South Korea; [Lee, Kyu-Sun; Yu, Kweon] Korea Res Inst Biosci & Biotechnol, Aging Res Ctr, Taejon 305806, South Korea; [Iijima, Koichi] Thomas Jefferson Univ, Farber Inst Neurosci, Dept Biochem & Mol Biol, Lab Neurodegenerat & Metab Dis, Philadelphia, PA 19107 USA; [Iijima-Ando, Kanae] Thomas Jefferson Univ, Farber Inst Neurosci, Dept Biochem & Mol Biol, Lab Neurogenet & Pathobiol, Philadelphia, PA 19107 USA	Ewha Womans University; Kyungpook National University; Konyang University; Konyang University Hospital; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Jefferson University; Jefferson University	Yu, K (corresponding author), 111 Gwahangno Yuseong Gu, Taejon 305806, South Korea.	kweonyu@kribb.re.kr; lee1@knu.ac.kr		Yu, Kweon/0000-0002-4942-2576	National Institutes of Health [R01AG032279]; Korea Science & Engineering Foundation [2009-0074555, R01-2008-000-21076-0]; BioGreen21 Program [20080401034-050-008-01-00]; Rural Development Administration; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program, Republic of Korea [KGM3310912]; Thomas Jefferson University; Gilbert Foundation/the American Federation for Aging Research; Alzheimer's Association [NIRG-08-91985]; NATIONAL INSTITUTE ON AGING [R01AG032279] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Science & Engineering Foundation(Korea Science and Engineering Foundation); BioGreen21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Korea Research Institute of Bioscience and Biotechnology Research Initiative Program, Republic of Korea; Thomas Jefferson University; Gilbert Foundation/the American Federation for Aging Research; Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AG032279 (to K. I. and K. I.-A.). This work was also supported by the Korea Science & Engineering Foundation (Grants 2009-0074555 and R01-2008-000-21076-0), by the BioGreen21 Program (Grant 20080401034-050-008-01-00), by the Rural Development Administration, and by the Korea Research Institute of Bioscience and Biotechnology Research Initiative Program (Grant KGM3310912), Republic of Korea, by a pilot research grant from the Thomas Jefferson University (to K. I.), and by grants from the Gilbert Foundation/the American Federation for Aging Research (to K. I.) and the Alzheimer's Association (Grant NIRG-08-91985 to K. I.).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Anderson PR, 2008, P NATL ACAD SCI USA, V105, P611, DOI 10.1073/pnas.0709691105; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Fridell YWC, 2005, CELL METAB, V1, P145, DOI 10.1016/j.cmet.2005.01.005; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Jin MH, 2005, NEUROSCI LETT, V381, P252, DOI 10.1016/j.neulet.2005.02.048; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; LIM YS, 1993, BIOCHEM BIOPH RES CO, V192, P273, DOI 10.1006/bbrc.1993.1410; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Matsumoto A, 1999, FEBS LETT, V443, P246, DOI 10.1016/S0014-5793(98)01736-0; Morrow G, 2004, FASEB J, V18, P598, DOI 10.1096/fj.03-0860fje; Mourikis P, 2006, P NATL ACAD SCI USA, V103, P1307, DOI 10.1073/pnas.0510564103; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Radyuk SN, 2003, BIOCHEM J, V371, P743, DOI 10.1042/BJ20021522; Radyuk SN, 2001, FREE RADICAL BIO MED, V31, P1090, DOI 10.1016/S0891-5849(01)00692-X; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; Salvaterra Paul M., 2001, Gene Expression Patterns, V1, P73, DOI 10.1016/S1567-133X(01)00011-4; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Strayer A, 2003, FASEB J, V17, P2305, DOI 10.1096/fj.03-0376fje; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273	30	101	106	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29454	29461		10.1074/jbc.M109.028027	http://dx.doi.org/10.1074/jbc.M109.028027			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19720829	Green Published, hybrid			2022-12-27	WOS:000270896800027
J	Rossignol, JF; La Frazia, S; Chiappa, L; Ciucci, A; Santoro, MG				Rossignol, Jean Francois; La Frazia, Simone; Chiappa, Lucia; Ciucci, Alessandra; Santoro, M. Gabriella			Thiazolides, a New Class of Anti-influenza Molecules Targeting Viral Hemagglutinin at the Post-translational Level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-VIRUS HEMAGGLUTININ; KAPPA-B KINASE; EPITHELIAL-CELLS; DOUBLE-BLIND; HEPATITIS-B; NITAZOXANIDE; INHIBITORS; INFECTION; REPLICATION; DIARRHEA	The emergence of highly contagious influenza A virus strains, such as the new H1N1 swine influenza, represents a serious threat to global human health. Efforts to control emerging influenza strains focus on surveillance and early diagnosis, as well as development of effective vaccines and novel antiviral drugs. Herein we document the anti-influenza activity of the anti-infective drug nitazoxanide and its active circulating-metabolite tizoxanide and describe a class of second generation thiazolides effective against influenza A virus. Thiazolides inhibit the replication of H1N1 and different other strains of influenza A virus by a novel mechanism: they act at post-translational level by selectively blocking the maturation of the viral hemagglutinin at a stage preceding resistance to endoglycosidase H digestion, thus impairing hemagglutinin intracellular trafficking and insertion into the host plasma membrane, a key step for correct assembly and exit of the virus from the host cell. Targeting the maturation of the viral glycoprotein offers the opportunity to disrupt the production of infectious viral particles attacking the pathogen at a level different from the currently available anti-influenza drugs. The results indicate that thiazolides may represent a new class of antiviral drugs effective against influenza A infection.	[La Frazia, Simone; Chiappa, Lucia; Ciucci, Alessandra; Santoro, M. Gabriella] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA	University of Rome Tor Vergata; Stanford University	Santoro, MG (corresponding author), Univ Roma Tor Vergata, Dept Biol, Via Ric Sci, I-00133 Rome, Italy.	santoro@bio.uniroma2.it	Pham, Van/ABB-4933-2020	Santoro, Maria Gabriella/0000-0003-1432-4949; La Frazia, Simone/0000-0002-6987-5409	Romark Laboratories, LC; Italian Ministry of University and Scientific Research	Romark Laboratories, LC; Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by Romark Laboratories, LC and by the Italian Ministry of University and Scientific Research.	Bernasconi D, 2005, J BIOL CHEM, V280, P24127, DOI 10.1074/jbc.M413726200; Caselli E, 2007, BLOOD, V109, P2718, DOI 10.1182/blood-2006-03-012500; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; COPELAND CS, 1986, J CELL BIOL, V103, P1179, DOI 10.1083/jcb.103.4.1179; COPELAND CS, 1988, CELL, V53, P197, DOI 10.1016/0092-8674(88)90381-9; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; Donatelli I, 2001, J GEN VIROL, V82, P623, DOI 10.1099/0022-1317-82-3-623; Fiore Anthony E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Fox LM, 2005, CLIN INFECT DIS, V40, P1173, DOI 10.1086/428839; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Glaser L, 2007, VIRUS RES, V126, P9, DOI 10.1016/j.virusres.2007.01.011; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Jin H, 1997, EMBO J, V16, P1236, DOI 10.1093/emboj/16.6.1236; Korba BE, 2008, ANTIVIR RES, V77, P56, DOI 10.1016/j.antiviral.2007.08.005; Kreitzer G, 2003, NAT CELL BIOL, V5, P126, DOI 10.1038/ncb917; La Frazia S, 2006, ANTIVIR THER, V11, P995; Mishin VP, 2005, J VIROL, V79, P12416, DOI 10.1128/JVI.79.19.12416-12424.2005; Ohuchi R, 1997, J VIROL, V71, P3719, DOI 10.1128/JVI.71.5.3719-3725.1997; Palese P., 2007, FIELDS VIROLOGY, P1647; Pica F, 2000, ANTIMICROB AGENTS CH, V44, P200, DOI 10.1128/AAC.44.1.200-204.2000; Regoes RR, 2006, SCIENCE, V312, P389, DOI 10.1126/science.1122947; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Rossi A, 2006, CANCER RES, V66, P7678, DOI 10.1158/0008-5472.CAN-05-4282; Rossignol JF, 2008, FUTURE MICROBIOL, V3, P539, DOI 10.2217/17460913.3.5.539; Rossignol JF, 2009, GASTROENTEROLOGY, V136, P856, DOI 10.1053/j.gastro.2008.11.037; Rossignol JF, 2006, LANCET, V368, P124, DOI 10.1016/S0140-6736(06)68852-1; Rossignol JF, 2006, CLIN GASTROENTEROL H, V4, P320, DOI 10.1016/j.cgh.2005.12.020; Rossignol JF, 2001, J INFECT DIS, V184, P381, DOI 10.1086/322038; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Schulze Irene T., 1997, Journal of Infectious Diseases, V176, pS24, DOI 10.1086/514170; SEKIKAWA K, 1983, P NATL ACAD SCI-BIOL, V80, P3563, DOI 10.1073/pnas.80.12.3563; Steinhauer DA, 2002, ANNU REV GENET, V36, P305, DOI 10.1146/annurev.genet.36.052402.152757; Subbarao K, 2007, NAT REV IMMUNOL, V7, P267, DOI 10.1038/nri2054; TATU U, 1995, EMBO J, V14, P1340, DOI 10.1002/j.1460-2075.1995.tb07120.x; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691	39	166	180	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29798	29808		10.1074/jbc.M109.029470	http://dx.doi.org/10.1074/jbc.M109.029470			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19638339	Green Published, hybrid			2022-12-27	WOS:000270896800060
J	Home, P; Ray, S; Dutta, D; Bronshteyn, I; Larson, M; Paul, S				Home, Pratik; Ray, Soma; Dutta, Debasree; Bronshteyn, Illya; Larson, Melissa; Paul, Soumen			GATA3 Is Selectively Expressed in the Trophectoderm of Peri-implantation Embryo and Directly Regulates Cdx2 Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-2; MOUSE BLASTOCYST; CELL DIFFERENTIATION; TARGETED MUTATION; TROPHOBLAST; LINEAGE; MICE; SPECIFICATION; FATE; DOWNSTREAM	During early mammalian development, genesis of the first two cell lineages, inner cell mass (ICM) and trophectoderm (TE), is dependent upon functions of key transcription factors that are expressed in a regulated and spatially restricted fashion. In this study, we demonstrate that during early mouse development, mRNA expression of transcription factor GATA3 is induced at the 4-cell stage and is consistently present during pre-implantation embryonic development. Interestingly, at the blastocyst stage, Gata3 mRNAis selectively up-regulated within the TE lineage, and GATA3 protein is abundantly present only in the TE but not in the ICM. Using mouse trophoblast stem cells (TS cells) as a model, we found that, knockdown of GATA3 by RNA interference (RNAi) down-regulates expression of caudal-type homeobox 2 (CDX2), a key regulator of the TE lineage. Chromatin immunoprecipitation (ChIP) analyses revealed that, in TS cells, GATA3 directly regulates Cdx2 transcription from a conserved GATA motif at the intron 1 region of the Cdx2 locus. ChIP analyses with mouse blastocysts also detected GATA3 occupancy at intron 1 of the Cdx2 locus. In addition, down-regulation of GATA3 in pre-implantation mouse embryos reduces Cdx2 expression and inhibits morula to blastocyst transformation. Our results indicate a novel function of GATA3, in which it is selectively expressed in TE, regulates expression of key genes in TE lineage, and is involved in morula to blastocyst transformation.	[Home, Pratik; Ray, Soma; Dutta, Debasree; Paul, Soumen] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Inst Maternal Fetal Biol, Kansas City, KS 66160 USA; [Bronshteyn, Illya; Larson, Melissa] Univ Kansas, Med Ctr, Transgen & Gene Targeting Inst Facil, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Paul, S (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Inst Maternal Fetal Biol, Kansas City, KS 66160 USA.	spaul2@kumc.edu	Home, Pratik/D-5061-2014		National Institutes of Health [P20 RRO16475, P20 RRO24214]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475, P20RR024214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 RRO16475 and P20 RRO24214.	Acevedo LG, 2007, BIOTECHNIQUES, V43, P791, DOI 10.2144/000112625; Asnagli H, 2002, J IMMUNOL, V168, P4268, DOI 10.4049/jimmunol.168.9.4268; Benahmed F, 2008, GASTROENTEROLOGY, V135, P1238, DOI 10.1053/j.gastro.2008.06.045; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Donnison M, 2005, DEVELOPMENT, V132, P2299, DOI 10.1242/dev.01819; Dutta D, 2008, J BIOL CHEM, V283, P25404, DOI 10.1074/jbc.M804349200; Ferreira R, 2007, BLOOD, V109, P5481, DOI 10.1182/blood-2006-11-060491; Flavell RA, 1999, COLD SPRING HARB SYM, V64, P563, DOI 10.1101/sqb.1999.64.563; Fujiwara Y, 2004, BLOOD, V103, P583, DOI 10.1182/blood-2003-08-2870; GEORGE KM, 1994, DEVELOPMENT, V120, P2673; Jedrusik A, 2008, GENE DEV, V22, P2692, DOI 10.1101/gad.486108; Kobayashi-Osaki M, 2005, MOL CELL BIOL, V25, P7005, DOI 10.1128/MCB.25.16.7005-7020.2005; Kunath T, 2004, PLACENTA, V25, pS32, DOI 10.1016/j.placenta.2004.01.015; Ma GT, 1997, DEVELOPMENT, V124, P907; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; NG YK, 1994, DEVELOPMENT, V120, P3257; Nishioka N, 2008, MECH DEVELOP, V125, P270, DOI 10.1016/j.mod.2007.11.002; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Ralston A, 2008, DEV BIOL, V313, P614, DOI 10.1016/j.ydbio.2007.10.054; Ray S, 2009, J BIOL CHEM, V284, P4978, DOI 10.1074/jbc.M807329200; Rossant J, 2004, SEMIN CELL DEV BIOL, V15, P573, DOI 10.1016/j.semcdb.2004.04.003; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Scheinman EJ, 2009, J BIOL CHEM, V284, P3037, DOI 10.1074/jbc.M807302200; SIMON MC, 1992, NAT GENET, V1, P92, DOI 10.1038/ng0592-92; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Wang WCH, 2007, J EXP ZOOL PART B, V308B, P308, DOI 10.1002/jez.b.21154; Wen F, 2007, DEV BIOL, V312, P284, DOI 10.1016/j.ydbio.2007.09.024; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Zernicka-Goetz MZ, 2005, NAT REV MOL CELL BIO, V6, P919, DOI 10.1038/nrm1782; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	37	149	155	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28729	28737		10.1074/jbc.M109.016840	http://dx.doi.org/10.1074/jbc.M109.016840			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19700764	hybrid, Green Published			2022-12-27	WOS:000270678900029
J	Mairhofer, M; Steiner, M; Salzer, U; Prohaska, R				Mairhofer, Mario; Steiner, Marianne; Salzer, Ulrich; Prohaska, Rainer			Stomatin-like Protein-1 Interacts with Stomatin and Is Targeted to Late Endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OVERHYDRATED HEREDITARY STOMATOCYTOSIS; INTEGRAL MEMBRANE-PROTEIN; CAENORHABDITIS-ELEGANS; LIPID RAFTS; BAND 7.2B; CHOLESTEROL TRANSPORT; VOLATILE ANESTHETICS; GLUCOSE-TRANSPORTER; RECEPTOR NEURONS; PLASMA-MEMBRANE	The human stomatin-like protein-1 (SLP-1) is a membrane protein with a characteristic bipartite structure containing a stomatin domain and a sterol carrier protein-2 (SCP-2) domain. This structure suggests a role for SLP-1 in sterol/lipid transfer and transport. Because SLP-1 has not been investigated, we first studied the molecular and cell biological characteristics of the expressed protein. We show here that SLP-1 localizes to the late endosomal compartment, like stomatin. Unlike stomatin, SLP-1 does not localize to the plasma membrane. Overexpression of SLP-1 leads to the redistribution of stomatin from the plasma membrane to late endosomes suggesting a complex formation between these proteins. We found that the targeting of SLP-1 to late endosomes is caused by a GYXX Phi (Phi being a bulky, hydrophobic amino acid) sorting signal at the N terminus. Mutation of this signal results in plasma membrane localization. SLP-1 and stomatin co-localize in the late endosomal compartment, they co-immunoprecipitate, thus showing a direct interaction, and they associate with detergent-resistant membranes. In accordance with the proposed lipid transfer function, we show that, under conditions of blocked cholesterol efflux from late endosomes, SLP-1 induces the formation of enlarged, cholesterol-filled, weakly LAMP-2-positive, acidic vesicles in the perinuclear region. This massive cholesterol accumulation clearly depends on the SCP-2 domain of SLP-1, suggesting a role for this domain in cholesterol transfer to late endosomes.	[Mairhofer, Mario; Salzer, Ulrich; Prohaska, Rainer] Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, A-1030 Vienna, Austria; [Steiner, Marianne] Med Univ Vienna, Ctr Anat & Cell Biol, Dept Nucl & Dev Biol & Funct Microscopy, A-1090 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna	Prohaska, R (corresponding author), Dr Bohr Gasse 9-3, A-1030 Vienna, Austria.	rainer.prohaska@meduniwien.ac.at		Mairhofer, Mario/0000-0002-7218-6284; Salzer, Ulrich/0000-0002-3721-7225	Austrian Science Fund/Fonds zur Foerderung der wissenschaftlichen Forschung (FWF)	Austrian Science Fund/Fonds zur Foerderung der wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from the Austrian Science Fund/Fonds zur Foerderung der wissenschaftlichen Forschung (FWF).	Alpy F, 2006, BIOCHEM SOC T, V34, P343, DOI 10.1042/BST0340343; Bandyopadhyay U, 2008, MOL CELL BIOL, V28, P5747, DOI 10.1128/MCB.02070-07; Barnes TM, 1996, J NEUROCHEM, V67, P46; Bauer M, 2006, FEBS LETT, V580, P5559, DOI 10.1016/j.febslet.2006.08.077; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; BONIFACINO JS, 2001, CURRENT PROTOCOLS CE; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Bruce LJ, 2009, BLOOD, V113, P1350, DOI 10.1182/blood-2008-07-171140; Das K, 1999, J BIOL CHEM, V274, P18721, DOI 10.1074/jbc.274.26.18721; Epand RF, 2006, BIOCHEMISTRY-US, V45, P6105, DOI 10.1021/bi060245+; Epand RM, 2006, PROG LIPID RES, V45, P279, DOI 10.1016/j.plipres.2006.02.001; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Fricke B, 2003, BLOOD, V102, P2268, DOI 10.1182/blood-2002-06-1705; Fricke B, 2005, BRIT J HAEMATOL, V131, P265, DOI 10.1111/j.1365-2141.2005.05742.x; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Gilles F, 2000, EUR J HAEMATOL, V64, P104, DOI 10.1034/j.1600-0609.2000.90054.x; Goldstein BJ, 2003, JARO-J ASSOC RES OTO, V4, P74, DOI 10.1007/s10162-002-2039-5; Green JB, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-44; HIEBLDIRSCHMIED CM, 1991, BIOCHIM BIOPHYS ACTA, V1065, P195, DOI 10.1016/0005-2736(91)90230-6; HIEBLDIRSCHMIED CM, 1991, BIOCHIM BIOPHYS ACTA, V1090, P123, DOI 10.1016/0167-4781(91)90047-P; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; Huber TB, 2003, HUM MOL GENET, V12, P3397, DOI 10.1093/hmg/ddg360; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Kobayakawa K, 2002, J NEUROSCI, V22, P5931; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Liu J, 2005, J BIOL CHEM, V280, P16125, DOI 10.1074/jbc.M500940200; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; LOWRY OH, 1957, METHOD ENZYMOL, V4, P366, DOI 10.1016/0076-6879(57)04065-3; Meyers JM, 2002, J BIOL CHEM, V277, P49003, DOI 10.1074/jbc.M205728200; Montel-Hagen A, 2008, CELL, V132, P1039, DOI 10.1016/j.cell.2008.01.042; MORGAN PG, 1990, P NATL ACAD SCI USA, V87, P2965, DOI 10.1073/pnas.87.8.2965; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Price MP, 2004, J BIOL CHEM, V279, P53886, DOI 10.1074/jbc.M407708200; Rajaram S, 1998, P NATL ACAD SCI USA, V95, P8761, DOI 10.1073/pnas.95.15.8761; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Salzer U., 2007, DYN CELL BIOL, V1, P20; Schroeder F, 2007, BBA-MOL CELL BIOL L, V1771, P700, DOI 10.1016/j.bbalip.2007.04.005; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI12849; Scott C, 2004, BBA-MOL CELL BIOL L, V1685, P8, DOI 10.1016/j.bbalip.2004.08.006; Sedensky MM, 2001, AM J PHYSIOL-CELL PH, V280, pC1340, DOI 10.1152/ajpcell.2001.280.5.C1340; Seidel G, 1998, GENE, V225, P23, DOI 10.1016/S0378-1119(98)00532-0; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Smith M, 2000, AM J MED GENET, V96, P765, DOI 10.1002/1096-8628(20001204)96:6<765::AID-AJMG13>3.0.CO;2-L; Snyers L, 1997, EUR J CELL BIOL, V73, P281; Snyers L, 1999, EUR J CELL BIOL, V78, P802, DOI 10.1016/S0171-9335(99)80031-4; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; STEINER M, 1994, HISTOCHEM J, V26, P934; Stewart GW, 2004, CURR OPIN HEMATOL, V11, P244, DOI 10.1097/01.moh.0000132240.20671.33; STEWART GW, 1992, BLOOD, V79, P1593, DOI 10.1182/blood.V79.6.1593.bloodjournal7961593; Tavernarakis N, 1999, TRENDS BIOCHEM SCI, V24, P425, DOI 10.1016/S0968-0004(99)01467-X; Tomiyama Y, 2004, CELL TISSUE RES, V317, P253, DOI 10.1007/s00441-004-0941-3; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; Umlauf E, 2006, J BIOL CHEM, V281, P23349, DOI 10.1074/jbc.M513720200; Wang YJ, 2000, J BIOL CHEM, V275, P8062, DOI 10.1074/jbc.275.11.8062; Wirtz KWA, 2006, FEBS LETT, V580, P5436, DOI 10.1016/j.febslet.2006.06.065; Yokoyama H, 2008, J MOL BIOL, V376, P868, DOI 10.1016/j.jmb.2007.12.024; Zhang JZ, 1999, ARCH BIOCHEM BIOPHYS, V372, P173, DOI 10.1006/abbi.1999.1489; Zhang JZ, 2001, AM J PHYSIOL-CELL PH, V280, pC1277, DOI 10.1152/ajpcell.2001.280.5.C1277; Zhang M, 2002, J BIOL CHEM, V277, P33300, DOI 10.1074/jbc.M200003200; Zhang SF, 2004, CURR BIOL, V14, P1888, DOI 10.1016/j.cub.2004.10.030	67	27	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29218	29229		10.1074/jbc.M109.014993	http://dx.doi.org/10.1074/jbc.M109.014993			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19696025	hybrid, Green Published			2022-12-27	WOS:000270678900076
J	Shimada, H; Hirai, KI; Simamura, E; Hatta, T; Iwakiri, H; Mizuki, K; Hatta, T; Sawasaki, T; Matsunaga, S; Endo, Y; Shimizu, S				Shimada, Hiroki; Hirai, Kei-Ichi; Simamura, Eriko; Hatta, Toshihisa; Iwakiri, Hiroki; Mizuki, Keiji; Hatta, Taizo; Sawasaki, Tatsuya; Matsunaga, Satoko; Endo, Yaeta; Shimizu, Shigeomi			Paraquat Toxicity Induced by Voltage-dependent Anion Channel 1 Acts as an NADH-dependent Oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; PROTEIN-SYNTHESIS SYSTEM; SUPEROXIDE-DISMUTASE; HERBICIDE PARAQUAT; MEDIATED TOXICITY; RADICAL FORMATION; OUTER-MEMBRANE; CELLS; LIVER; LUNG	Paraquat (PQ), a herbicide used worldwide, causes fatal injury to organs upon high dose ingestion. Treatments for PQ poisoning areunreliable, and numerous deaths have been attributed inappropriate usage of the agent. It is generally speculated that a microsomal drug-metabolizing enzyme system is responsible for PQ toxicity. However, recent studies have demonstrated cytotoxicity via mitochondria, and therefore, the cytotoxic mechanism remains controversial. Here, we demonstrated that mitochondrial NADH-dependent PQ reductase containing a voltage-dependent anion channel 1 (VDAC1) is responsible for PQ cytotoxicity. When mitochondria were incubated with NADH and PQ, superoxide anion (O-(2) over dot(-)) was produced, and the mitochondria ruptured. Outer membrane extract oxidized NADH in a PQ dose-dependent manner, and oxidation was suppressed by VDAC inhibitors. Zymographic analysis revealed the presence of VDAC1 protein in the oxidoreductase, and the direct binding of PQ to VDAC1 was demonstrated using biotinylated PQ. VDAC1-overexpressing cells showed increased O-(2) over dot(-). production and cytotoxicity, both of which were suppressed in VDAC1 knockdown cells. These results indicated that a VDAC1-containing mitochondrial system is involved in PQ poisoning. These insights into the mechanism of PQ poisoning not only demonstrated novel physiological functions of VDAC protein, but they may facilitate the development of new therapeutic approaches.	Kanazawa Med Univ, Mol & Cell Struct Sci, Uchinada, Ishikawa 9200293, Japan; [Hirai, Kei-Ichi] Niwa Inst Immunol, Kochi 7870306, Japan; [Iwakiri, Hiroki; Mizuki, Keiji; Hatta, Taizo] Sojo Univ, Dept Neurosci, Kumamoto 8600082, Japan; [Sawasaki, Tatsuya; Matsunaga, Satoko; Endo, Yaeta] Ehime Univ, Venture Business Lab, Matsuyama, Ehime 7908577, Japan; [Sawasaki, Tatsuya; Matsunaga, Satoko; Endo, Yaeta] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime 7908577, Japan; [Sawasaki, Tatsuya; Endo, Yaeta] RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan; [Shimizu, Shigeomi] Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol Cell Biol, Bunkyo Ku, Tokyo 1138510, Japan	Kanazawa Medical University; Sojo University; Ehime University; Ehime University; RIKEN; Tokyo Medical & Dental University (TMDU)	Shimada, H (corresponding author), Kanazawa Med Univ, Mol & Cell Struct Sci, Uchinada, Ishikawa 9200293, Japan.	simada-h@kanazawa-med.ac.jp		Sawasaki, Tatsuya/0000-0002-7952-0556	Japan Society for the Promotion of Science [15591664, 17591899, 19390291, 21791045]; Kanazawa Medical University [S2003-12, S2004-12, C2007-4, S2007-9, C2008-1, S2008-10, C2009-3, S2009-10]; High-Tech Research Center of Kanazawa Medical University [H2009-14]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [S0801085]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kanazawa Medical University; High-Tech Research Center of Kanazawa Medical University; Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research 15591664, 17591899, 19390291, and 21791045 from the Japan Society for the Promotion of Science, Grants for Promoted Research S2003-12, S2004-12, C2007-4, S2007-9, C2008-1, S2008-10, C2009-3, and S2009-10 from Kanazawa Medical University, Grant for Project Research H2009-14 from High-Tech Research Center of Kanazawa Medical University, and in part by The Ministry of Education, Culture, Sports, Science, and Technology, Japan Grant S0801085.	Ariyama J, 2000, INTENS CARE MED, V26, P981, DOI 10.1007/s001340051291; Baker MA, 2004, J BIOL CHEM, V279, P4811, DOI 10.1074/jbc.M311020200; BALDWIN RC, 1975, TOXICOL APPL PHARM, V32, P298, DOI 10.1016/0041-008X(75)90220-3; BUS JS, 1976, TOXICOL APPL PHARM, V35, P501, DOI 10.1016/0041-008X(76)90073-9; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Dinis-Oliveira RJ, 2008, CRIT REV TOXICOL, V38, P13, DOI 10.1080/10408440701669959; GAGE JC, 1968, BIOCHEM J, V109, P757, DOI 10.1042/bj1090757; HIRAI KI, 1985, EXP MOL PATHOL, V43, P242, DOI 10.1016/0014-4800(85)90044-9; HIRAI KI, 1992, TOXICOLOGY, V72, P1, DOI 10.1016/0300-483X(92)90081-O; Hirai KI, 1999, J ELECTRON MICROSC, V48, P289, DOI 10.1093/oxfordjournals.jmicro.a023680; Lee AC, 1996, J BIOL CHEM, V271, P26724, DOI 10.1074/jbc.271.43.26724; LEE AC, 1994, J BIOL CHEM, V269, P30974; McCormack AL, 2002, NEUROBIOL DIS, V10, P119, DOI 10.1006/nbdi.2002.0507; Nakayama S, 2002, BIOCHEM BIOPH RES CO, V290, P23, DOI 10.1006/bbrc.2001.6185; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; OLIVER PD, 1992, INVEST OPHTH VIS SCI, V33, P1909; SAOTOME K, 1989, TOXICOL IN VITRO, V3, P317, DOI 10.1016/0887-2333(89)90039-8; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Sawasaki T, 2002, FEBS LETT, V514, P102, DOI 10.1016/S0014-5793(02)02329-3; Sawasaki T, 2008, FEBS LETT, V582, P221, DOI 10.1016/j.febslet.2007.12.004; Sawasaki T, 2005, METH MOL B, V310, P131; Shimada H, 1998, ARCH BIOCHEM BIOPHYS, V351, P75, DOI 10.1006/abbi.1997.0557; Shimada H, 2002, ARCH BIOCHEM BIOPHYS, V402, P149, DOI 10.1016/S0003-9861(02)00059-0; Simamura E, 2008, ANAT SCI INT, V83, P261, DOI 10.1111/j.1447-073X.2008.00241.x; Simamura E, 2006, CANCER BIOL THER, V5, P1523, DOI 10.4161/cbt.5.11.3302; STCLAIR DK, 1991, FEBS LETT, V293, P199, DOI 10.1016/0014-5793(91)81186-C; Teraoka K, 1999, Nihon Rinsho, V57 Suppl, P784; Vyssokikh M, 2004, MOL CELL BIOCHEM, V256, P117, DOI 10.1023/B:MCBI.0000009863.69249.d9; WANG GY, 1992, J ELECTRON MICROSC, V41, P181; Wesseling C, 2001, Int J Occup Environ Health, V7, P275; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Yamamoto T, 2006, J PROTEOME RES, V5, P3336, DOI 10.1021/pr060291w; Yang WS, 2005, J TOXICOL ENV HEAL A, V68, P1939, DOI 10.1080/15287390500226987; Yehezkel G, 2006, J BIOL CHEM, V281, P5938, DOI 10.1074/jbc.M510104200; Zizi M, 1998, BIOPHYS J, V75, P704, DOI 10.1016/S0006-3495(98)77560-5	35	21	34	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28642	28649		10.1074/jbc.M109.033431	http://dx.doi.org/10.1074/jbc.M109.033431			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19717555	Green Published, hybrid			2022-12-27	WOS:000270678900019
J	Sirianni, R; Chimento, A; De Luca, A; Zolea, F; Carpino, A; Rago, V; Maggiolini, M; Ando, S; Pezzi, V				Sirianni, Rosa; Chimento, Adele; De Luca, Arianna; Zolea, Fabiana; Carpino, Amalia; Rago, Vittoria; Maggiolini, Marcello; Ando, Sebastiano; Pezzi, Vincenzo			Inhibition of Cyclooxygenase-2 Down-regulates Aromatase Activity and Decreases Proliferation of Leydig Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; CONTROL BRAIN AROMATASE; CONSTITUTIVE EXPRESSION; BINDING-PROTEIN; GENE-EXPRESSION; RAT TESTIS; FACTOR-I; ESTROGEN; RECEPTOR; CARCINOMA	Our recent studies have revealed that estrogens stimulate an autocrine mechanism determining Leydig tumor cell proliferation. Estrogen overproduction is due to an elevated steroidogenic factor-1 (SF-1) expression and cAMP-response element-binding protein (CREB) phosphorylation, both inducing aromatase overexpression. Although we have shown that increased SF-1 expression depends mainly on higher local insulin-like growth factor I production, the mechanisms and factors determining increased CREB activation in Leydig tumor cells are not completely understood. In this study, we investigated the role of cyclooxygenase-2 (COX-2) in CREB dependent- aromatase expression in Leydig tumor cells. We found that COX-2 is expressed in rat and human Leydigiomas as well as in the rat Leydig tumor cell line R2C, but not in normal testis. Our data indicate that in R2C cells the COX-2-derived prostaglandin E2 (PGE2) binds the PGE2 receptor EP4 and activates protein kinase A (PKA) and ultimately CREB. Inhibitors for COX-2 (NS398), EP4 (AH23848), and PKA (H89) decreased aromatase expression and activity as a consequence of a decreased phosphorylated CREB recruitment to the PII promoter of the aromatase gene. The COX-2/PGE2/PKA pathway also seems to be involved in aromatase post-translational activation, an observation that requires further studies. The reduction in aromatase activity was responsible for a drop in estrogen production and subsequent reduction in cyclin E expression resulting in a decrease in tumor Leydig cell proliferation. Furthermore, COX-2 silencing caused a significant decrease in CREB phosphorylation, aromatase expression, and R2C cell proliferation. These novel findings clarify the mechanisms involved in the growth of Leydig cell tumors and should be taken into account in determining new therapeutic approaches.	[Maggiolini, Marcello; Pezzi, Vincenzo] Univ Calabria, Dept Pharmacobiol, I-87036 Arcavacata Di Rende, CS, Italy; [Carpino, Amalia; Rago, Vittoria; Ando, Sebastiano] Univ Calabria, Dept Cell Biol, I-87036 Arcavacata Di Rende, CS, Italy	University of Calabria; University of Calabria	Pezzi, V (corresponding author), Univ Calabria, Dept Pharmacobiol, I-87036 Arcavacata Di Rende, CS, Italy.	v.pezzi@unical.it	Pezzi, Vincenzo/AAL-4017-2020; Maggiolini, Marcello/Z-4729-2019; Rago, Vittoria/AAE-5924-2020	Rago, Vittoria/0000-0003-3971-7378; pezzi, Vincenzo/0000-0003-2311-2286; SIRIANNI, Rosa/0000-0002-8966-350X; De Luca, Arianna/0000-0003-2388-6564; Carpino, Amalia/0000-0002-5006-3216; Maggiolini, Marcello/0000-0002-7485-854X	Progetti di Ricerca di Interesse Nazionale (PRIN) del Ministero dell'Universita e della Ricerca (MIUR); Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Progetti di Ricerca di Interesse Nazionale (PRIN) del Ministero dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Progetti di Ricerca di Interesse Nazionale (PRIN) del Ministero dell'Universita e della Ricerca (MIUR) and by grants from the Associazione Italiana per la Ricerca sul Cancro.	Agarwal VR, 1996, J CLIN ENDOCR METAB, V81, P3843, DOI 10.1210/jc.81.11.3843; Alshafie GA, 2000, ONCOL REP, V7, P1377; Ascoli M, 2007, MOL CELL ENDOCRINOL, V260, P244, DOI 10.1016/j.mce.2005.09.016; Balthazart J, 2003, J STEROID BIOCHEM, V86, P367, DOI 10.1016/S0960-0760(03)00346-7; Balthazart J, 2003, EUR J NEUROSCI, V17, P1591, DOI 10.1046/j.1460-9568.2003.02598.x; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Brueggemeier RW, 1999, CANCER LETT, V140, P27, DOI 10.1016/S0304-3835(99)00050-6; Carlone DL, 1997, MOL ENDOCRINOL, V11, P292, DOI 10.1210/me.11.3.292; Carpino A, 2007, EUR J ENDOCRINOL, V157, P239, DOI 10.1530/EJE-07-0029; Chandras C, 2007, J ENDOCRINOL, V194, P595, DOI 10.1677/JOE-07-0128; Chandrasekharan NV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-241; Chen HL, 2007, ENDOCRINOLOGY, V148, P735, DOI 10.1210/en.2006-0925; COLEMAN GL, 1977, J GERONTOL, V32, P258, DOI 10.1093/geronj/32.3.258; COLEMAN RA, 1995, ADV PROSTAG THROMB L, V23, P283; Davis TL, 2000, BRIT J PHARMACOL, V130, P1919, DOI 10.1038/sj.bjp.0703525; Diaz-Cruz ES, 2005, J CLIN ENDOCR METAB, V90, P2563, DOI 10.1210/jc.2004-2029; DUFAU ML, 1984, J STEROID BIOCHEM, V20, P161, DOI 10.1016/0022-4731(84)90203-6; Farley JH, 2006, GYNECOL ONCOL, V103, P425, DOI 10.1016/j.ygyno.2006.03.036; Fowler KA, 2000, AM J PATHOL, V156, P347, DOI 10.1016/S0002-9440(10)64736-0; Frungieri MB, 2002, P NATL ACAD SCI USA, V99, P15072, DOI 10.1073/pnas.232422999; FULTON AM, 1991, CANCER RES, V51, P2047; Gobbetti A, 2002, J EXP ZOOL, V293, P73, DOI 10.1002/jez.10100; Harada N, 1997, J STEROID BIOCHEM, V61, P175; Hase T, 2003, EUR J CANCER, V39, P2043, DOI 10.1016/S0959-8049(03)00485-4; Hawkins C, 1996, Oncol Nurs Forum, V23, P1203; Hida T, 1998, CANCER RES, V58, P3761; Hwang D, 1998, J NATL CANCER I, V90, P455, DOI 10.1093/jnci/90.6.455; Inoue H, 1999, J ENDOCRINOL, V161, P231, DOI 10.1677/joe.0.1610231; Jo Y, 2005, BIOL REPROD, V73, P244, DOI 10.1095/biolreprod.104.037721; Koga H, 1999, HEPATOLOGY, V29, P688, DOI 10.1002/hep.510290355; LEPHART ED, 1991, METHOD ENZYMOL, V206, P477; Liu CH, 2001, J BIOL CHEM, V276, P18563, DOI 10.1074/jbc.M010787200; O'Donnell L, 2001, ENDOCR REV, V22, P289, DOI 10.1210/er.22.3.289; Pan MR, 2008, CELL SIGNAL, V20, P1134, DOI 10.1016/j.cellsig.2008.02.004; Pedram A, 2002, J BIOL CHEM, V277, P50768, DOI 10.1074/jbc.M210106200; Pezzi V, 2004, ENDOCRINOLOGY, V145, P2186, DOI 10.1210/en.2003-1366; Prosperi JR, 2006, PROSTAG OTH LIPID M, V81, P55, DOI 10.1016/j.prostaglandins.2006.07.003; RICHARDS JA, 2003, J CLIN ENDOCR METAB, V88, P2010; Ristimaki A, 1997, CANCER RES, V57, P1276; Ristimaki A, 2002, CANCER RES, V62, P632; Salhab M, 2007, J SURG ONCOL, V96, P424, DOI 10.1002/jso.20740; SANO H, 1995, CANCER RES, V55, P3785; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Simpson ER, 2002, ANNU REV PHYSIOL, V64, P93, DOI 10.1146/annurev.physiol.64.081601.142703; Sirianni R, 2007, CANCER RES, V67, P8368, DOI 10.1158/0008-5472.CAN-06-4064; SMITH WL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P1, DOI 10.1016/0005-2760(91)90119-3; Song KH, 2004, MOL ENDOCRINOL, V18, P1929, DOI 10.1210/me.2004-0043; Stolina M, 2000, J IMMUNOL, V164, P361, DOI 10.4049/jimmunol.164.1.361; Su B, 2008, STEROIDS, V73, P104, DOI 10.1016/j.steroids.2007.09.011; Tsuji S, 2001, J EXP CLIN CANC RES, V20, P117; Tucker ON, 1999, CANCER RES, V59, P987; VANLANDEGHEM AAJ, 1985, CANCER RES, V45, P2900; Winnall WR, 2007, BIOL REPROD, V76, P759, DOI 10.1095/biolreprod.106.053124; WOODWARD DF, 1995, BIOCHEM PHARMACOL, V50, P1731, DOI 10.1016/0006-2952(95)02035-7; Young M, 1998, ENDOCRINOLOGY, V139, P5082, DOI 10.1210/en.139.12.5082; Young M, 1997, J STEROID BIOCHEM, V63, P37, DOI 10.1016/S0960-0760(97)00069-1; Yue W, 2003, J STEROID BIOCHEM, V86, P265, DOI 10.1016/S0960-0760(03)00366-2; Zhao Y, 1996, ENDOCRINOLOGY, V137, P5739, DOI 10.1210/en.137.12.5739; Zimmermann KC, 1999, CANCER RES, V59, P198	61	34	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28905	28916		10.1074/jbc.M109.041020	http://dx.doi.org/10.1074/jbc.M109.041020			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19679653	hybrid, Green Published			2022-12-27	WOS:000270678900047
J	Baisamy, L; Cavin, S; Jurisch, N; Diviani, D				Baisamy, Laurent; Cavin, Sabrina; Jurisch, Nathalie; Diviani, Dario			The Ubiquitin-like Protein LC3 Regulates the Rho-GEF Activity of AKAP-Lbc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; KINASE-A; ACTIN CYTOSKELETON; SIGNALING COMPLEX; ANCHORING PROTEIN; SCAFFOLD PROTEIN; BINDING; AUTOPHAGY; GTPASES; IDENTIFICATION	AKAP-Lbc is a member of the A-kinase anchoring protein (AKAP) family that has been recently associated with the development of pathologies, such as cardiac hypertrophy and cancer. We have previously demonstrated that, at the molecular level, AKAP-Lbc functions as a guanine nucleotide exchange factor (GEF) that promotes the specific activation of RhoA. In the present study, we identified the ubiquitin-like protein LC3 as a novel regulatory protein interacting with AKAP-Lbc. Mutagenesis studies revealed that LC3, through its NH2-terminal alpha-helical domain, interacts with two binding sites located within the NH2-terminal regulatory region of AKAP-Lbc. Interestingly, LC3 overexpression strongly reduced the ability of AKAP-Lbc to interact with RhoA, profoundly impairing the Rho-GEF activity of the anchoring protein and, as a consequence, its ability to promote cytoskeletal rearrangements associated with the formation of actin stress fibers. Moreover, AKAP-Lbc mutants that fail to interact with LC3 show a higher basal Rho-GEF activity as compared with the wild type protein and become refractory to the inhibitory effect of LC3. This suggests that LC3 binding maintains AKAP-Lbc in an inactive state that displays a reduced ability to promote downstream signaling. Collectively, these findings provide evidence for a previously uncharacterized role of LC3 in the regulation of Rho signaling and in the reorganization of the actin cytoskeleton.	[Baisamy, Laurent; Cavin, Sabrina; Jurisch, Nathalie; Diviani, Dario] Fac Biol & Med, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland		Diviani, D (corresponding author), Fac Biol & Med, Dept Pharmacol & Toxicol, Rue Bugnon 27, CH-1005 Lausanne, Switzerland.	Dario.diviani@unil.ch	Jurisch-Yaksi, Nathalie/A-3219-2019; Cavin, Sabrina/AAE-9866-2019	Jurisch-Yaksi, Nathalie/0000-0002-8767-6120; Cavin, Sabrina/0000-0002-1993-4503; Diviani, Dario/0000-0003-4375-3718	Fonds National Suisse de la Recherche Scientifique [3100A0-109440, 3100A0-122020]	Fonds National Suisse de la Recherche Scientifique	This work was supported by Fonds National Suisse de la Recherche Scientifique Grants 3100A0-109440 and 3100A0-122020 (to D. D.).	Appert-Collin A, 2007, P NATL ACAD SCI USA, V104, P10140, DOI 10.1073/pnas.0701099104; Baisamy L, 2005, J BIOL CHEM, V280, P15405, DOI 10.1074/jbc.M414440200; Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; Birkenfeld J, 2008, TRENDS CELL BIOL, V18, P210, DOI 10.1016/j.tcb.2008.02.006; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; Chahdi A, 2008, MOL CELL BIOL, V28, P1679, DOI 10.1128/MCB.00898-07; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Diviani D, 2004, EMBO J, V23, P2811, DOI 10.1038/sj.emboj.7600287; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Furuta S, 2002, ONCOGENE, V21, P7060, DOI 10.1038/sj.onc.1205790; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Kouno T, 2005, J BIOL CHEM, V280, P24610, DOI 10.1074/jbc.M413565200; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Longhurst DM, 2006, J BIOL CHEM, V281, P12030, DOI 10.1074/jbc.M513756200; MANN SS, 1994, J BIOL CHEM, V269, P11492; Marino G, 2004, CELL MOL LIFE SCI, V61, P1439, DOI 10.1007/s00018-004-4012-4; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Nassar N, 2006, CURR TOP MED CHEM, V6, P1109, DOI 10.2174/156802606777812095; Nauert JB, 1997, CURR BIOL, V7, P52, DOI 10.1016/S0960-9822(06)00027-3; Nymann-Andersen J, 2002, NEUROPHARMACOLOGY, V43, P476, DOI 10.1016/S0028-3908(02)00165-X; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; SHIRAZI A, 1994, J BIOL CHEM, V269, P31598; Smith FD, 2006, TRENDS BIOCHEM SCI, V31, P316, DOI 10.1016/j.tibs.2006.04.009; Takahashi M, 1999, J BIOL CHEM, V274, P17267, DOI 10.1074/jbc.274.24.17267; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; TOKSOZ D, 1994, ONCOGENE, V9, P621; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Zenke FT, 2004, J BIOL CHEM, V279, P18392, DOI 10.1074/jbc.M400084200; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	40	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28232	28242		10.1074/jbc.M109.054668	http://dx.doi.org/10.1074/jbc.M109.054668			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19696020	Green Published, hybrid			2022-12-27	WOS:000270676300051
J	Cui, GL; Qin, X; Zhang, YB; Gong, ZW; Ge, BX; Zang, YQ				Cui, Guoliang; Qin, Xia; Zhang, Yuebo; Gong, Zhenwei; Ge, Baoxue; Zang, Ying Qin			Berberine Differentially Modulates the Activities of ERK, p38 MAPK, and JNK to Suppress Th17 and Th1 T Cell Differentiation in Type 1 Diabetic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ARYL-HYDROCARBON RECEPTOR; NEUTRAL SULFATE BERBERINE; ACTIVATED PROTEIN-KINASE; IFN-GAMMA; SIGNALING PATHWAY; 3T3-L1 ADIPOCYTE; HELPER-CELLS; NOD MOUSE; ROR-GAMMA	Berberine, an alkaloid derivative from Berberis vulgaris L., has been used extensively in traditional Chinese medicine to treat diarrhea and diabetes, but the underlying mechanisms for treating diabetes are not fully understood. Recent studies suggested that berberine has many beneficial biological effects, including anti-inflammation. Because type 1 diabetes is caused by T cell-mediated destruction of beta cells and severe islet inflammation, we hypothesized that berberine could ameliorate type 1 diabetes through its immune regulation properties. Here we reported that 2 weeks of oral administration of berberine prevented the progression of type I diabetes in half of the NOD mice and decreased Th17 and Th1 cytokine secretion. Berberine suppressed Th17 and Th1 differentiation by reducing the expression of lineage markers. We found that berberine inhibited Th17 differentiation by activating ERK1/2 and inhibited Th1 differentiation by inhibiting p38 MAPK and JNK activation. Berberine down-regulated the activity of STAT1 and STAT4 through the suppression of p38 MAPK and JNK activation, and it controlled the stability of STAT4 through the ubiquitin-proteasome pathway. Our findings indicate that berberine targets MAPK to suppress Th17 and Th1 differentiation in type 1 diabetic NOD mice. This study revealed a novel role of ERK in Th17 differentiation through down-regulation of STAT3 phosphorylation and ROR gamma t expression.	[Cui, Guoliang; Zhang, Yuebo; Gong, Zhenwei; Zang, Ying Qin] Chinese Acad Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai Inst Biol Sci,Grad Sch, Shanghai 200031, Peoples R China; [Ge, Baoxue] Chinese Acad Sci, Inst Hlth Sci, Key Lab Nutr & Metab, Shanghai Inst Biol Sci,Grad Sch, Shanghai 200031, Peoples R China; [Qin, Xia] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Jiao Tong University	Zang, YQ (corresponding author), Chinese Acad Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai Inst Biol Sci,Grad Sch, 294 Taiyuan Rd, Shanghai 200031, Peoples R China.	yqin@sibs.ac.cn	Gong, Zhenwei/G-2435-2012	Cui, Guoliang/0000-0001-5559-7957	Hundred Talent Project; Chinese Academy of Sciences [KSCX2-YW-R-116, KSCX1-YW-R-44]; Ministry of Science and Technology of China [2009CB919000, STCSM 07JC14011]	Hundred Talent Project(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported in part by grants from the Hundred Talent Project, Chinese Academy of Sciences Grants KSCX2-YW-R-116 and KSCX1-YW-R-44, and Ministry of Science and Technology of China Grants 2009CB919000 and STCSM 07JC14011.	Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Choi BH, 2006, EXP MOL MED, V38, P599, DOI 10.1038/emm.2006.71; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Ellison CA, 1998, J IMMUNOL, V161, P631; Enk R, 2007, J ETHNOPHARMACOL, V109, P170, DOI 10.1016/j.jep.2006.07.013; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Higaki Shuichi, 1995, Journal of Dermatology (Tokyo), V22, P4, DOI 10.1111/j.1346-8138.1995.tb03332.x; Hsiang CY, 2005, J BIOMED SCI, V12, P791, DOI 10.1007/s11373-005-9003-4; Huang C, 2006, BIOCHEM BIOPH RES CO, V348, P571, DOI 10.1016/j.bbrc.2006.07.095; Hultgren B, 1996, DIABETES, V45, P812, DOI 10.2337/diabetes.45.6.812; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jain R, 2008, J EXP MED, V205, P207, DOI 10.1084/jem.20071878; Kang BY, 2002, BIOCHEM PHARMACOL, V63, P1901, DOI 10.1016/S0006-2952(02)00982-6; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Lee S, 2007, BIOCHEM BIOPH RES CO, V362, P853, DOI 10.1016/j.bbrc.2007.08.060; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Li F, 2006, ACTA PHARMACOL SIN, V27, P1199, DOI 10.1111/j.1745-7254.2006.00368.x; Lin SK, 2004, MOL PHARMACOL, V66, P612; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; Mensah-Brown EPK, 2006, EUR J IMMUNOL, V36, P216, DOI 10.1002/eji.200535325; Miljkovic D, 2005, CELL MOL LIFE SCI, V62, P2658, DOI 10.1007/s00018-005-5259-0; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; NISHINO H, 1986, ONCOLOGY, V43, P131, DOI 10.1159/000226349; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Pandey MK, 2008, CANCER RES, V68, P5370, DOI 10.1158/0008-5472.CAN-08-0511; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Ren YP, 2008, J IMMUNOL, V181, P1491, DOI 10.4049/jimmunol.181.2.1491; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Spolski R, 2008, P NATL ACAD SCI USA, V105, P14028, DOI 10.1073/pnas.0804358105; Srinivasan S, 2008, DIABETES, V57, P484, DOI 10.2337/db07-0855; Stojanovic I, 2009, IMMUNOLOGY, V126, P74, DOI 10.1111/j.1365-2567.2008.02879.x; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vukkadapu SS, 2005, PHYSIOL GENOMICS, V21, P201, DOI 10.1152/physiolgenomics.00173.2004; Wang B, 1997, P NATL ACAD SCI USA, V94, P13844, DOI 10.1073/pnas.94.25.13844; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Yamashita M, 2005, J BIOL CHEM, V280, P29409, DOI 10.1074/jbc.M502333200; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Yang J, 2006, ACTA PHARMACOL SIN, V27, P173, DOI 10.1111/j.1745-7254.2006.00257.x; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yu HH, 2005, J MED FOOD, V8, P454, DOI 10.1089/jmf.2005.8.454	46	154	161	5	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28420	28429		10.1074/jbc.M109.012674	http://dx.doi.org/10.1074/jbc.M109.012674			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19661066	Green Published, hybrid			2022-12-27	WOS:000270676300067
J	Lvov, A; Greitzer, D; Berlin, S; Chikvashvili, D; Tsuk, S; Lotan, I; Michaelevski, I				Lvov, Anatoli; Greitzer, Dafna; Berlin, Shai; Chikvashvili, Dodo; Tsuk, Sharon; Lotan, Ilana; Michaelevski, Izhak			Rearrangements in the Relative Orientation of Cytoplasmic Domains Induced by a Membrane-anchored Protein Mediate Modulations in Kv Channel Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-GATED CHANNELS; RESONANCE ENERGY-TRANSFER; KV2.1 POTASSIUM CHANNEL; C-TERMINAL DOMAINS; K+ CHANNEL; SNARE COMPLEX; TARGETING SIGNAL; BETA-SUBUNIT; SYNTAXIN 1A; LIVE CELLS	Interdomain interactions between intracellular N and C termini have been described for various K+ channels, including the voltage-gated Kv2.1, and suggested to affect channel gating. However, no channel regulatory protein directly affecting N/C interactions has been demonstrated. Most Kv2.1 channel interactions with regulatory factors occur at its C terminus. The vesicular SNARE that is also present at a high concentration in the neuronal plasma membrane, VAMP2, is the only protein documented to affect Kv2.1 gating by binding to its N terminus. As its binding target has been mapped near a site implicated in Kv2.1 N/C interactions, we hypothesized that VAMP2 binding to the N terminus requires concomitant conformational. changes in the C terminus, which wraps around the N terminus from the outside, to give VAMP2 access. Here, we first determined that the Kv2.1 N terminus, although crucial, is not sufficient to convey functional interaction with VAMP2, and that, concomitant to its binding to the "docking loop" at the Kv2.1 N terminus, VAMP2 binds to the proximal part of the Kv2.1 C terminus, C1a. Next, using computational biology approaches (ab initio modeling, docking, and molecular dynamics simulations) supported by molecular biology, biochemical, electrophysiological, and fluorescence resonance energy transfer analyses, we mapped the interaction sites on both VAMP2 and Kv2.1 and found that this interaction is accompanied by rearrangements in the relative orientation of Kv2.1 cytoplasmic domains. We propose that VAMP2 modulates Kv2.1 inactivation by interfering with the interaction between the docking loop and C1a, a mechanism for gating regulation that may pertain also to other Kv channels.	[Greitzer, Dafna; Berlin, Shai; Chikvashvili, Dodo; Tsuk, Sharon; Lotan, Ilana] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Ramat Aviv, Israel; [Lvov, Anatoli] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Michaelevski, Izhak] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Tel Aviv University; Sackler Faculty of Medicine; University of Massachusetts System; University of Massachusetts Worcester; Weizmann Institute of Science	Lotan, I (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Ramat Aviv, Israel.	ilotan@post.tau.ac.il; izhak.michaelevski@weizmann.ac.il	Michaelevski, Izhak/G-8940-2018	Michaelevski, Izhak/0000-0002-0783-1443; Berlin, shai/0000-0002-5153-4876	Public Committee for Allocation of Estate Funds [3-4181]; Ministry of Justice, Israel	Public Committee for Allocation of Estate Funds; Ministry of Justice, Israel	This work was supported by Grant 3-4181 from the Public Committee for Allocation of Estate Funds, Ministry of Justice, Israel (to I. L.).	Adair B, 2008, BIOPHYS J, V94, P2106, DOI 10.1529/biophysj.107.118562; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Callsen B, 2005, J PHYSIOL-LONDON, V568, P397, DOI 10.1113/jphysiol.2005.094359; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Fili O, 2001, J NEUROSCI, V21, P1964, DOI 10.1523/JNEUROSCI.21-06-01964.2001; Frei E, 2006, CELL PHYSIOL BIOCHEM, V18, P165, DOI 10.1159/000097665; GROTE E, 1995, CELL, V81, P581, DOI 10.1016/0092-8674(95)90079-9; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Hazzard J, 1999, J BIOMOL NMR, V14, P203, DOI 10.1023/A:1008382027065; Jerng HH, 1997, BIOPHYS J, V72, P163, DOI 10.1016/S0006-3495(97)78655-7; Ju M, 2003, J BIOL CHEM, V278, P12769, DOI 10.1074/jbc.M212973200; Kammer B, 2003, MOL CELL NEUROSCI, V23, P333, DOI 10.1016/S1044-7431(03)00064-2; Klemic KG, 1998, BIOPHYS J, V74, P1779, DOI 10.1016/S0006-3495(98)77888-9; Kobrinsky E, 2006, J BIOL CHEM, V281, P19233, DOI 10.1074/jbc.M601231200; Kurata HT, 2002, J BIOL CHEM, V277, P29045, DOI 10.1074/jbc.M111470200; Leng Q, 2006, P NATL ACAD SCI USA, V103, P1982, DOI 10.1073/pnas.0510610103; LEVIN G, 1995, J BIOL CHEM, V270, P14611, DOI 10.1074/jbc.270.24.14611; Levin G, 1996, J BIOL CHEM, V271, P29321, DOI 10.1074/jbc.271.46.29321; LEVITT M, 1981, J MOL BIOL, V145, P251, DOI 10.1016/0022-2836(81)90342-9; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lvov A, 2008, PFLUG ARCH EUR J PHY, V456, P1121, DOI 10.1007/s00424-008-0468-7; McCrossan ZA, 2003, J NEUROSCI, V23, P8077; Michaelevski I, 2003, J BIOL CHEM, V278, P34320, DOI 10.1074/jbc.M304943200; Mohapatra DP, 2006, J NEUROSCI, V26, P685, DOI 10.1523/JNEUROSCI.4620-05.2006; Mohapatra DP, 2008, J NEUROSCI, V28, P4982, DOI 10.1523/JNEUROSCI.0186-08.2008; Murakoshi H, 1997, MOL PHARMACOL, V52, P821, DOI 10.1124/mol.52.5.821; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; Pedretti A, 2003, THEOR CHEM ACC, V109, P229, DOI 10.1007/s00214-002-0402-6; Pedretti A, 2002, J MOL GRAPH MODEL, V21, P47, DOI 10.1016/S1093-3263(02)00123-7; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qu ZQ, 2000, J BIOL CHEM, V275, P31573, DOI 10.1074/jbc.M003473200; Ritchie DW, 1999, J COMPUT CHEM, V20, P383, DOI 10.1002/(SICI)1096-987X(199903)20:4<383::AID-JCC1>3.0.CO;2-M; Scannevin RH, 2004, NEURON, V41, P587, DOI 10.1016/S0896-6273(04)00049-2; Scholle A, 2004, BIOPHYS J, V87, P873, DOI 10.1529/biophysj.104.040550; Sobko A, 1998, EMBO J, V17, P4723, DOI 10.1093/emboj/17.16.4723; Takanishi CL, 2006, BRAIN RES, V1091, P132, DOI 10.1016/j.brainres.2006.01.119; Tsien RY, 1998, SCIENCE, V280, P1954, DOI 10.1126/science.280.5371.1954; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tsuboi T, 2004, P NATL ACAD SCI USA, V101, P76, DOI 10.1073/pnas.0306347101; Tsuk S, 2005, MOL PHARMACOL, V67, P480, DOI 10.1124/mol.104.005314; Tsuk S, 2008, BIOCHEMISTRY-US, V47, P8342, DOI 10.1021/bi800512p; Wang GY, 2006, J GEN PHYSIOL, V127, P391, DOI 10.1085/jgp.200509442; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Wible BA, 1998, J BIOL CHEM, V273, P11745, DOI 10.1074/jbc.273.19.11745; Wolf-Goldberg T, 2006, MOL PHARMACOL, V70, P818, DOI 10.1124/mol.105.021717; Zhang Y, 2003, BBA-BIOMEMBRANES, V1614, P182, DOI 10.1016/S0005-2736(03)00177-9; Zheng J, 2004, NEURON, V42, P411, DOI 10.1016/S0896-6273(04)00253-3; Zheng J, 2002, NEURON, V36, P891, DOI 10.1016/S0896-6273(02)01099-1	51	7	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28276	28291		10.1074/jbc.M109.028761	http://dx.doi.org/10.1074/jbc.M109.028761			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19690160	hybrid, Green Published			2022-12-27	WOS:000270676300055
J	Ra, HJ; Harju-Baker, S; Zhang, FM; Linhardt, RJ; Wilson, CL; Parks, WC				Ra, Hyun-Jeong; Harju-Baker, Susanna; Zhang, Fuming; Linhardt, Robert J.; Wilson, Carole L.; Parks, William C.			Control of Promatrilysin (MMP7) Activation and Substrate-specific Activity by Sulfated Glycosaminoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASES; E-CADHERIN; PERICELLULAR ACTIVATION; CHOLESTEROL SULFATE; SECRETORY GRANULE; PROGELATINASE-A; ALPHA-DEFENSINS; HOST-DEFENSE; CANCER CELLS; FAS LIGAND	Matrix metalloproteinases are maintained in an inactive state by a bond between the thiol of a conserved cysteine in the prodomain and a zinc atom in the catalytic domain. Once this bond is disrupted, MMPs become active proteinases and can act on a variety of extracellular protein substrates. In vivo, matrilysin (MMP7) activates pro-alpha-defensins (procryptdins), but in vitro, processing of these peptides is slow, with about 50% conversion in 8-12 h. Similarly, autolytic activation of promatrilysin in vitro can take up to 12-24 It for 50% conversion. These inefficient reactions suggest that natural cofactors enhance the activation and activity of matrilysin. We determined that highly sulfated glycosaminoglycans (GAG), such as heparin, chondroitin-4,6-sulfate (CS-E), and dermatan sulfate, markedly enhanced (> 50-fold) the intermolecular autolytic activation of promatrilysin and the activity of fully active matrilysin to cleave specific physiologic substrates. In contrast, heparan sulfate and less sulfated forms of chondroitin sulfate did not augment matrilysin activation or activity. Chondroitin-2,6-sulfate (CS-D) also did not enhance matrilysin activity, suggesting that the presentation of sulfates is more important than the overall degree of sulfation. Surface plasmon resonance demonstrated that promatrilysin bound heparin (K-D, 400 nM) and CS-E (K-D, 630 nM). Active matrilysin bound heparin (K-D, 150 nM) but less so to CS-E (K-D, 60 mu M). Neither form bound heparan sulfate. These observations demonstrate that sulfated GAGs regulate matrilysin activation and its activity against specific substrates.	[Ra, Hyun-Jeong; Harju-Baker, Susanna; Parks, William C.] Univ Washington, Ctr Lung Biol, Seattle, WA 98109 USA; [Wilson, Carole L.] Univ Washington, Dept Pathol, Seattle, WA 98109 USA; [Zhang, Fuming; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Zhang, Fuming; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biol & Chem Engn, Troy, NY 12180 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Parks, WC (corresponding author), Univ Washington, Ctr Lung Biol, 815 Mercer St, Seattle, WA 98109 USA.	parksw@u.washington.edu	Parks, William C./AAH-6786-2021	Kosamo, Susanna/0000-0001-5151-9361	National Institutes of Health [HL029594, GM038060, F32-HL083665]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL083665, P01HL029594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL029594 (to W. C. P.), GM038060 (to R. J. L.), and F32-HL083665 (to S. H. B.).	Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; ALTER SC, 1987, BIOCHEM J, V248, P821, DOI 10.1042/bj2480821; Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Cauwe B, 2007, CRIT REV BIOCHEM MOL, V42, P113, DOI 10.1080/10409230701340019; CRABBE T, 1994, BIOCHEMISTRY-US, V33, P14419, DOI 10.1021/bi00252a007; CRABBE T, 1993, EUR J BIOCHEM, V218, P431, DOI 10.1111/j.1432-1033.1993.tb18393.x; Davies G, 2001, CLIN CANCER RES, V7, P3289; Dumin JA, 2001, J BIOL CHEM, V276, P29368, DOI 10.1074/jbc.M104179200; Dunsmore SE, 1998, J CLIN INVEST, V102, P1321, DOI 10.1172/JCI1516; Filippov S, 2003, J EXP MED, V198, P925, DOI 10.1084/jem.20030626; Fujita Y, 2006, ARTHRITIS RHEUM-US, V54, P3233, DOI 10.1002/art.22140; Grujic M, 2005, J BIOL CHEM, V280, P33411, DOI 10.1074/jbc.M501708200; Hasegawa M, 2007, LAB INVEST, V87, P882, DOI 10.1038/labinvest.3700657; Higashi S, 2008, J BIOL CHEM, V283, P35735, DOI 10.1074/jbc.M806285200; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Itoh F, 1996, CANCER, V77, P1717; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Manicone AM, 2008, SEMIN CELL DEV BIOL, V19, P34, DOI 10.1016/j.semcdb.2007.07.003; McGuire JK, 2003, AM J PATHOL, V162, P1831, DOI 10.1016/S0002-9440(10)64318-0; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; Mitsiades N, 2001, CANCER RES, V61, P577; Noe V, 2001, J CELL SCI, V114, P111; Ouellette AJ, 1996, FASEB J, V10, P1280, DOI 10.1096/fasebj.10.11.8836041; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; PERVIN A, 1995, GLYCOBIOLOGY, V5, P83, DOI 10.1093/glycob/5.1.83; Powell WC, 1999, CURR BIOL, V9, P1441, DOI 10.1016/S0960-9822(00)80113-X; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; SCHICK BP, 1995, J CELL PHYSIOL, V165, P96, DOI 10.1002/jcp.1041650113; Shiomi T, 2005, LAB INVEST, V85, P1489, DOI 10.1038/labinvest.3700351; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; Stricker TP, 2001, J BIOL CHEM, V276, P29375, DOI 10.1074/jbc.M102217200; ToyamaSorimachi N, 1997, J BIOL CHEM, V272, P26714, DOI 10.1074/jbc.272.42.26714; Van Lint P, 2007, J LEUKOCYTE BIOL, V82, P1375, DOI 10.1189/jlb.0607338; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; VONBREDOW DC, 1995, EXP CELL RES, V221, P83, DOI 10.1006/excr.1995.1355; Wilson CL, 2009, J BIOL CHEM, V284, P8301, DOI 10.1074/jbc.M809744200; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Yamamoto K, 2006, J BIOL CHEM, V281, P9170, DOI 10.1074/jbc.M510377200; Yu Q, 2000, GENE DEV, V14, P163; Yu WH, 2000, J BIOL CHEM, V275, P4183, DOI 10.1074/jbc.275.6.4183; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702; Zernichow L, 2006, J BIOL CHEM, V281, P26792, DOI 10.1074/jbc.M512889200	46	54	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27924	27932		10.1074/jbc.M109.035147	http://dx.doi.org/10.1074/jbc.M109.035147			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19654318	hybrid, Green Published			2022-12-27	WOS:000270676300020
J	Scharl, M; Paul, G; Barrett, KE; McCole, DF				Scharl, Michael; Paul, Gisela; Barrett, Kim E.; McCole, Declan F.			AMP-activated Protein Kinase Mediates the Interferon-gamma-induced Decrease in Intestinal Epithelial Barrier Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; NECROSIS-FACTOR-ALPHA; LIGHT-CHAIN KINASE; PANCREATIC BETA-CELLS; CROHNS-DISEASE; TIGHT JUNCTION; ULCERATIVE-COLITIS; CHLORIDE SECRETION; IFN-GAMMA; PHOSPHATIDYLINOSITOL 3-KINASE	Impaired epithelial barrier function plays a crucial role in the pathogenesis of inflammatory bowel disease. Elevated levels of the pro-inflammatory cytokine, interferon-gamma (IFN gamma), are believed to be prominently involved in the pathogenesis of Crohn disease. Treatment of T-84 intestinal epithelial cells with IFN gamma severely impairs their barrier properties measured as transepithelial electrical resistance (TER) or permeability and reduces the expression of tight junction proteins such as occludin and zonula occludens-1 (ZO-1). However, little is known about the signaling events that are involved. The cellular energy sensor, AMP-activated protein kinase (AMPK), is activated in response to cellular stress, as occurs during inflammation. The aim of this study was to investigate a possible role for AMPK in mediating IFN gamma-induced effects on the intestinal epithelial barrier. We found that IFN gamma activates AMPK by phosphorylation, independent of intracellular energy levels. Inhibition of AMPK prevents, at least in part, the IFN gamma-induced decrease in TER. Furthermore, AMPK knockdown prevented the increased epithelial permeability, the decreased TER, and the decrease in occludin and ZO-1 caused by IFN gamma treatment of T-84 cells. However, AMPK activity alone was not sufficient to cause alterations in epithelial barrier function. These data show a novel role for AMPK, in concert with other signals induced by IFN gamma, in mediating reduced epithelial barrier function in a cell model of chronic intestinal inflammation. These findings may implicate AMPK in the pathogenesis of chronic intestinal inflammatory conditions, such as inflammatory bowel disease.	[McCole, Declan F.] Univ Calif San Diego, Div Gastroenterol, Dept Med, Sch Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	McCole, DF (corresponding author), Univ Calif San Diego, Div Gastroenterol, Dept Med, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dmccole@ucsd.edu	McCole, Declan/AAL-2454-2020; Barrett, Kim/AAE-2794-2022; Barrett, Kim Elaine/AAE-7762-2019	Barrett, Kim Elaine/0000-0002-6704-998X; Scharl, Michael/0000-0002-6729-1469	National Institutes of Health [DK080506]; Crohn's and Colitis Foundation of America; German Research Foundation (Deutsche Forschungsgemeinschaft); UCSD Digestive Diseases Research Development Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); UCSD Digestive Diseases Research Development Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK080506. This work was also supported by a Career Development Award and a Senior Research Award from the Crohn's and Colitis Foundation of America (to D. F. M.), scholarships from the German Research Foundation (Deutsche Forschungsgemeinschaft) (to M. S. and G. P.), and by the UCSD Digestive Diseases Research Development Center.	Amasheh S, 2004, GASTROENTEROLOGY, V126, P1711, DOI 10.1053/j.gastro.2004.03.010; Beaurepaire C, 2009, J INTERF CYTOK RES, V29, P133, DOI 10.1089/jir.2008.0057; Bertelsen LS, 2004, AM J PHYSIOL-GASTR L, V286, pG157, DOI 10.1152/ajpgi.00227.2003; Blume C, 2007, J BIOL CHEM, V282, P4601, DOI 10.1074/jbc.M608866200; Boivin MA, 2009, J INTERF CYTOK RES, V29, P45, DOI 10.1089/jir.2008.0128; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; CARTWRIGHT CA, 1985, J CLIN INVEST, V76, P1837, DOI 10.1172/JCI112176; Cheng PY, 2007, BIOCHEM PHARMACOL, V74, P1758, DOI 10.1016/j.bcp.2007.08.004; Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544; Clayburgh DR, 2004, J BIOL CHEM, V279, P55506, DOI 10.1074/jbc.M408822200; CORTON JM, 1994, CURR BIOL, V4, P315, DOI 10.1016/S0960-9822(00)00070-1; Datta K, 1996, J BIOL CHEM, V271, P30835, DOI 10.1074/jbc.271.48.30835; Duvall MD, 1998, AM J PHYSIOL-CELL PH, V275, pC1313, DOI 10.1152/ajpcell.1998.275.5.C1313; Emerling BM, 2007, FEBS LETT, V581, P5727, DOI 10.1016/j.febslet.2007.11.038; Fish SM, 1999, GUT, V45, P191, DOI 10.1136/gut.45.2.191; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Fryer LGD, 2000, DIABETES, V49, P1978, DOI 10.2337/diabetes.49.12.1978; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Greig ER, 2004, J PATHOL, V204, P84, DOI 10.1002/path.1613; Hallows KR, 2003, AM J PHYSIOL-CELL PH, V284, pC1297, DOI 10.1152/ajpcell.00227.2002; Hardie DG, 2002, BIOCHEM SOC T, V30, P1064, DOI 10.1042/BST0301064; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 1999, BIOCHEM J, V338, P717, DOI 10.1042/0264-6021:3380717; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Horman S, 2008, J BIOL CHEM, V283, P18505, DOI 10.1074/jbc.M802053200; Huang NL, 2009, INT J CARDIOL, V134, P169, DOI 10.1016/j.ijcard.2008.04.010; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; MADARA JL, 1985, J CELL BIOL, V101, P2124, DOI 10.1083/jcb.101.6.2124; MADARA JL, 1989, J CLIN INVEST, V83, P724, DOI 10.1172/JCI113938; MARIN ML, 1983, AM J GASTROENTEROL, V78, P355; MARIN ML, 1983, AM J GASTROENTEROL, V78, P537; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; McKay DM, 2007, J PHARMACOL EXP THER, V320, P1013, DOI 10.1124/jpet.106.113639; Nam M, 2008, ARCH BIOCHEM BIOPHYS, V479, P74, DOI 10.1016/j.abb.2008.07.029; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Prasad S, 2005, LAB INVEST, V85, P1139, DOI 10.1038/labinvest.3700316; Riboulet-Chavey A, 2008, DIABETES, V57, P415, DOI 10.2337/db07-0993; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; SASAKI T, 1992, GASTROENTEROL JPN, V27, P29; Schmitz H, 2000, ANN NY ACAD SCI, V915, P312; Schwarz BT, 2007, GASTROENTEROLOGY, V132, P2383, DOI 10.1053/j.gastro.2007.02.052; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Sugi K, 2001, GASTROENTEROLOGY, V120, P1393, DOI 10.1053/gast.2001.24045; Taylor CT, 1998, GASTROENTEROLOGY, V114, P657, DOI 10.1016/S0016-5085(98)70579-7; Tuzun A, 2002, CLIN BIOCHEM, V35, P569, DOI 10.1016/S0009-9120(02)00361-2; Uribe JM, 1996, J BIOL CHEM, V271, P26588, DOI 10.1074/jbc.271.43.26588; Uribe JM, 2002, AM J PHYSIOL-GASTR L, V283, pG923, DOI 10.1152/ajpgi.00237.2002; Utech M, 2005, MOL BIOL CELL, V16, P5040, DOI 10.1091/mbc.E05-03-0193; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; Vucicevic L, 2009, BIOCHEM PHARMACOL, V77, P1684, DOI 10.1016/j.bcp.2009.03.005; Walker J, 2003, AM J PHYSIOL-GASTR L, V285, pG850, DOI 10.1152/ajpgi.00077.2003; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Watson CJ, 2005, J CELL SCI, V118, P5221, DOI 10.1242/jcs.02630; Watson JL, 2004, AM J PHYSIOL-GASTR L, V287, pG954, DOI 10.1152/ajpgi.00302.2003; Wehkamp J, 2005, J LEUKOCYTE BIOL, V77, P460, DOI 10.1189/jlb.0904543; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Woollhead AM, 2006, J BIOL CHEM, V281, P5158, DOI 10.1074/jbc.M509947200; Youakim A, 1999, AM J PHYSIOL-GASTR L, V276, pG1279, DOI 10.1152/ajpgi.1999.276.5.G1279; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375; Zhang L, 2006, P NATL ACAD SCI USA, V103, P17272, DOI 10.1073/pnas.0608531103; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	66	79	82	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27952	27963		10.1074/jbc.M109.046292	http://dx.doi.org/10.1074/jbc.M109.046292			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19654324	hybrid, Green Published			2022-12-27	WOS:000270676300023
J	Fernando, P; Sandoz, JS; Ding, W; de Repentigny, Y; Brunette, S; Kelly, JF; Kothary, R; Megeney, LA				Fernando, Pasan; Sandoz, Jacqueline S.; Ding, Wen; de Repentigny, Yves; Brunette, Steve; Kelly, John F.; Kothary, Rashmi; Megeney, Lynn A.			Bin1 Src Homology 3 Domain Acts as a Scaffold for Myofiber Sarcomere Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR BIN1; SYNAPTIC VESICLE ENDOCYTOSIS; MYC-INTERACTING PROTEIN; RING-FINGER PROTEIN; C-TERMINAL REGION; SKELETAL-MUSCLE; SH3 DOMAIN; STRIATED-MUSCLE; SARCOPLASMIC-RETICULUM; M-CADHERIN	In skeletal muscle development, the genes and regulatory factors that govern the specification of myocytes are well described. Despite this knowledge, the mechanisms that regulate the coordinated assembly of myofiber proteins into the functional contractile unit or sarcomere remain undefined. Here we explored the hypothesis that modular domain proteins such as Bin1 coordinate protein interactions to promote sarcomere formation. We demonstrate that Bin1 facilitates sarcomere organization through protein-protein interactions as mediated by the Src homology 3 (SH3) domain. We observed a profound disorder in myofiber size and structural organization in a murine model expressing the Bin1 SH3 region. In addition, satellite cell-derived myogenesis was limited despite the accumulation of skeletal muscle-specific proteins. Our experiments revealed that the Bin1 SH3 domain formed transient protein complexes with both actin and myosin filaments and the pro-myogenic kinase Cdk5. Bin1 also associated with a Cdk5 phosphorylation domain of titin. Collectively, these observations suggest that Bin1 displays protein scaffold-like properties and binds with sarcomeric factors important in directing sarcomere protein assembly and myofiber maturation.	[Fernando, Pasan; Brunette, Steve; Megeney, Lynn A.] Sprott Ctr Stem Cell Res, Regenerat Med Program, Ottawa, ON K1H 8L6, Canada; [Sandoz, Jacqueline S.; de Repentigny, Yves; Kothary, Rashmi] Ottawa Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada; [Ding, Wen; Kelly, John F.] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; National Research Council Canada	Fernando, P (corresponding author), Univ Ottawa, MDS Nord, Inst Heart, 40 Ruskin St, Ottawa, ON NK1Y 4W7, Canada.	pasan.fernando@mdsinc.com		Fernando, Pasan/0000-0001-8792-9637; Kothary, Rashmi/0000-0002-9239-7310; Megeney, Lynn/0000-0002-6824-8569	Canadian Institutes of Health Research; Muscular Dystrophy Association	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Muscular Dystrophy Association(Muscular Dystrophy Association)	This work was supported in part by grants from the Canadian Institutes of Health Research ( to L. A. M. and R. K.) and the Muscular Dystrophy Association ( to L. A. M.).	Armani A, 2006, EXP CELL RES, V312, P3546, DOI 10.1016/j.yexcr.2006.07.027; Au Y, 2004, CELL MOL LIFE SCI, V61, P3016, DOI 10.1007/s00018-004-4282-x; Bagnato P, 2003, J CELL BIOL, V160, P245, DOI 10.1083/jcb.200208109; Bang ML, 2002, J STRUCT BIOL, V137, P119, DOI 10.1006/jsbi.2002.4457; Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981; Barnett P, 2000, EMBO J, V19, P6382, DOI 10.1093/emboj/19.23.6382; Bowman AL, 2008, MOL BIOL CELL, V19, P3782, DOI 10.1091/mbc.E08-03-0237; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Butler MH, 1997, J CELL BIOL, V137, P1355, DOI 10.1083/jcb.137.6.1355; Chang MY, 2007, CANCER RES, V67, P7605, DOI 10.1158/0008-5472.CAN-07-1100; Chang MY, 2007, CANCER RES, V67, P100, DOI 10.1158/0008-5472.CAN-06-2742; Charrasse S, 2007, MOL BIOL CELL, V18, P1734, DOI 10.1091/mbc.E06-08-0766; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Duhadaway J, 1999, CELL ADHES COMMUN, V7, P99, DOI 10.3109/15419069909034394; DuHadaway JB, 2001, CANCER RES, V61, P3151; Elliott K, 1999, ONCOGENE, V18, P3564, DOI 10.1038/sj.onc.1202670; Elliott K, 2000, ONCOGENE, V19, P4669, DOI 10.1038/sj.onc.1203681; Feng SB, 1995, P NATL ACAD SCI USA, V92, P12408, DOI 10.1073/pnas.92.26.12408; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; FRANZINIARMSTRONG C, 1991, DEV BIOL, V146, P353, DOI 10.1016/0012-1606(91)90237-W; Fukuda N, 2008, J PHYSIOL SCI, V58, P151, DOI 10.2170/physiolsci.RV005408; Galderisi U, 1999, J CELL BIOCHEM, V74, P313, DOI 10.1002/(SICI)1097-4644(19990901)74:3<313::AID-JCB1>3.3.CO;2-Q; GAUTEL M, 1993, EMBO J, V12, P3827, DOI 10.1002/j.1460-2075.1993.tb06061.x; Ge K, 2000, INT J CANCER, V86, P155, DOI 10.1002/(SICI)1097-0215(20000415)86:2<155::AID-IJC2>3.0.CO;2-M; Ge K, 1999, P NATL ACAD SCI USA, V96, P9689, DOI 10.1073/pnas.96.17.9689; Granzier HL, 2005, ADV PROTEIN CHEM, V71, P89, DOI 10.1016/S0065-3233(04)71003-7; Guy LG, 1996, EMBO J, V15, P3713, DOI 10.1002/j.1460-2075.1996.tb00741.x; HELLMICH MR, 1992, P NATL ACAD SCI USA, V89, P10867, DOI 10.1073/pnas.89.22.10867; Hogarty MD, 2000, MED PEDIATR ONCOL, V35, P559, DOI 10.1002/1096-911X(20001201)35:6<559::AID-MPO14>3.3.CO;2-A; Hollnagel A, 2002, MOL CELL BIOL, V22, P4760, DOI 10.1128/MCB.22.13.4760-4770.2002; Jia CYH, 2005, MOL CELL PROTEOMICS, V4, P1155, DOI 10.1074/mcp.M500108-MCP200; Kami K, 2002, EMBO J, V21, P4268, DOI 10.1093/emboj/cdf428; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kojima C, 2004, EMBO J, V23, P4413, DOI 10.1038/sj.emboj.7600442; Kontrogianni-Konstantopoulos A, 2003, MOL BIOL CELL, V14, P1138, DOI 10.1091/mbc.E02-07-0411; Kontrogianni-Konstantopoulos A, 2006, FASEB J, V20, P2102, DOI 10.1096/fj.06-5761com; LABEIT S, 1991, FEBS LETT, V282, P313, DOI 10.1016/0014-5793(91)80503-U; Ladbury JE, 2000, CHEM BIOL, V7, pR3, DOI 10.1016/S1074-5521(00)00067-3; Lange S, 2006, TRENDS CELL BIOL, V16, P11, DOI 10.1016/j.tcb.2005.11.007; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Ma K, 2002, FEBS LETT, V532, P273, DOI 10.1016/S0014-5793(02)03655-4; Ma K, 2006, J BIOL CHEM, V281, P27539, DOI 10.1074/jbc.M604525200; MARUYAMA K, 1994, J BIOCHEM-TOKYO, V115, P147, DOI 10.1093/oxfordjournals.jbchem.a124290; Mayer BJ, 2001, J CELL SCI, V114, P1253; McElhinny AS, 2004, J CELL SCI, V117, P3175, DOI 10.1242/jcs.01158; McElhinny AS, 2005, J CELL BIOL, V170, P947, DOI 10.1083/jcb.200502158; Moncalian G, 2006, J BIOL CHEM, V281, P38845, DOI 10.1074/jbc.M606411200; Muller AJ, 2004, CANCER BIOL THER, V3, P1236, DOI 10.4161/cbt.3.12.1232; Muller AJ, 2003, MOL CELL BIOL, V23, P4295, DOI 10.1128/MCB.23.12.4295-4306.2003; NAVE R, 1990, FEBS LETT, V269, P163, DOI 10.1016/0014-5793(90)81144-D; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; Pineda-Lucena A, 2005, J MOL BIOL, V351, P182, DOI 10.1016/j.jmb.2005.05.046; Pizon V, 2002, J CELL SCI, V115, P4469, DOI 10.1242/jcs.00131; Politou AS, 1998, J MOL BIOL, V276, P189, DOI 10.1006/jmbi.1997.1521; Ramalingam A, 2007, CELL CYCLE, V6, P1914, DOI 10.4161/cc.6.15.4514; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sakamuro D, 1996, NAT GENET, V14, P69, DOI 10.1038/ng0996-69; SASSOON D, 1989, NATURE, V341, P303, DOI 10.1038/341303a0; Sharma P, 1999, J BIOL CHEM, V274, P9600, DOI 10.1074/jbc.274.14.9600; SHETTY KT, 1993, P NATL ACAD SCI USA, V90, P6844, DOI 10.1073/pnas.90.14.6844; Sinz A, 2001, BIOCHEMISTRY-US, V40, P7903, DOI 10.1021/bi010259+; Spencer JA, 2000, J CELL BIOL, V150, P771, DOI 10.1083/jcb.150.4.771; Tajiri T, 2003, CLIN CANCER RES, V9, P3345; Telfer JF, 2005, CELL SIGNAL, V17, P701, DOI 10.1016/j.cellsig.2004.10.009; Tian LJ, 2006, FASEB J, V20, P2588, DOI 10.1096/fj.06-6152fje; Wechsler-Reya RJ, 1998, MOL CELL BIOL, V18, P566, DOI 10.1128/MCB.18.1.566; WechslerReya R, 1997, J BIOL CHEM, V272, P31453, DOI 10.1074/jbc.272.50.31453; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Wrobel E, 2007, EUR J CELL BIOL, V86, P99, DOI 10.1016/j.ejcb.2006.11.004; Young P, 2001, J CELL BIOL, V154, P123, DOI 10.1083/jcb.200102110; YU HT, 1992, SCIENCE, V258, P1665, DOI 10.1126/science.1280858; Zelhof AC, 2001, DEVELOPMENT, V128, P5005; ZESCHNIGK M, 1995, J CELL SCI, V108, P2973; Zhao P, 2004, DEV DYNAM, V229, P380, DOI 10.1002/dvdy.10457	82	23	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27674	27686		10.1074/jbc.M109.029538	http://dx.doi.org/10.1074/jbc.M109.029538			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19633357	Green Published, hybrid			2022-12-27	WOS:000270232300069
J	Liu, Q; Graeff, R; Kriksunov, IA; Jiang, H; Zhang, B; Oppenheimer, N; Lin, HN; Potter, BVL; Lee, HC; Hao, Q				Liu, Qun; Graeff, Richard; Kriksunov, Irina A.; Jiang, Hong; Zhang, Bo; Oppenheimer, Norman; Lin, Hening; Potter, Barry V. L.; Lee, Hon Cheung; Hao, Quan			Structural Basis for Enzymatic Evolution from a Dedicated ADP-ribosyl Cyclase to a Multifunctional NAD Hydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-DENSITY MAPS; HUMAN CD38; ACTIVE-SITE; GLYCOHYDROLASE; FERMENTATION; HYDROLYSIS; MECHANISM; ENZYMES; BST-1; GENE	Cyclic ADP-ribose (cADPR) is a universal calcium messenger molecule that regulates many physiological processes. The production and degradation of cADPR are catalyzed by a family of related enzymes, including the ADP-ribosyl cyclase from Aplysia california (ADPRAC) and CD38 from human. Although ADPRC and CD38 share a common evolutionary ancestor, their enzymatic functions toward NAD and cADPR homeostasis have evolved divergently. Thus, ADPRC can only generate cADPR from NAD (cyclase), whereas CD38, in contrast, has multiple activities, i.e. in cADPR production and degradation, as well as NAD hydrolysis (NADase). In this study, we determined a number of ADPRC and CD38 structures bound with various nucleotides. From these complexes, we elucidated the structural features required for the cyclization (cyclase) reaction of ADPRC and the NADase reaction of CD38. Using the structural approach in combination with site-directed mutagenesis, we identified Phe-174 in ADPRC as a critical residue in directing the folding of the substrate during the cyclization reaction. Thus, a point mutation of Phe-174 to glycine can turn ADPRC from a cyclase toward an NADase. The equivalent residue in CD38, Thr-221, is shown to disfavor the cyclizing folding of the substrate, resulting in NADase being the dominant activity. The comprehensive structural comparison of CD38 and APDRC presented in this study thus provides insights into the structural determinants for the functional evolution from a cyclase to a hydrolase.	[Lee, Hon Cheung; Hao, Quan] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Liu, Qun; Kriksunov, Irina A.; Hao, Quan] Cornell Univ, Cornell High Energy Synchrotron Source, MacCHESS, Ithaca, NY 14853 USA; [Jiang, Hong; Lin, Hening] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Graeff, Richard] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Lee, Hon Cheung] Univ Minnesota, Dept Physiol, Minneapolis, MN 55455 USA; [Zhang, Bo; Potter, Barry V. L.] Univ Bath, Wolfson Lab Med Chem, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England; [Oppenheimer, Norman] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of Hong Kong; Cornell University; Cornell University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Bath; University of California System; University of California San Francisco	Lee, HC (corresponding author), Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China.	leehc@hku.hk; qhao@hku.hk	Hao, Quan/C-4304-2009; Lee, Hon Cheung/C-4329-2009; Liu, Qun/A-8757-2011; Graeff, Richard Milton/B-3425-2011; Potter, Barry VL/A-1845-2012; Potter, Barry/AAX-4781-2020	Liu, Qun/0000-0002-1179-290X; Hao, Quan/0000-0002-9642-0514	National Institutes of Health [GM061568]; National Science Foundation of China/Research Grant Council of Hong Kong (NSFC/RGC) Joint Research Scheme; Wellcome Trust [084068]; Dreyfus Foundation New Faculty Award; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China/Research Grant Council of Hong Kong (NSFC/RGC) Joint Research Scheme(Hong Kong Research Grants CouncilNational Natural Science Foundation of China (NSFC)); Wellcome Trust(Wellcome TrustEuropean Commission); Dreyfus Foundation New Faculty Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM061568 (to H. C. L. and Q. H.). This work was also supported by Hong Kong General Research Fund grants from the National Science Foundation of China/Research Grant Council of Hong Kong (NSFC/RGC) Joint Research Scheme (to Q. H. and H. C. L.), Project Grant 084068 from the Wellcome Trust (to B. V. L. P.), and the Dreyfus Foundation New Faculty Award (to H. L.).	Adebanjo OA, 1999, NAT CELL BIOL, V1, P409, DOI 10.1038/15640; Barbosa MTP, 2007, FASEB J, V21, P3629, DOI 10.1096/fj.07-8290com; Cakir-Kiefer C, 2000, BIOCHEM J, V349, P203, DOI 10.1042/0264-6021:3490203; Ferrero E, 1999, IMMUNOGENETICS, V49, P597, DOI 10.1007/s002510050654; Graeff R, 2001, J BIOL CHEM, V276, P12169, DOI 10.1074/jbc.M011299200; HIRATA Y, 1994, FEBS LETT, V356, P244, DOI 10.1016/0014-5793(94)01279-2; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LEE HC, 1995, BIOCHIMIE, V77, P345, DOI 10.1016/0300-9084(96)88145-4; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Lee HC, 2006, MOL MED, V12, P317, DOI 10.2119/2006-00086.Lee; Liu Q, 2005, STRUCTURE, V13, P1331, DOI 10.1016/j.str.2005.05.012; Liu Q, 2008, CHEM BIOL, V15, P1068, DOI 10.1016/j.chembiol.2008.08.007; Liu Q, 2007, J BIOL CHEM, V282, P24825, DOI 10.1074/jbc.M701653200; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Munshi C, 1997, PROTEIN EXPRES PURIF, V11, P104, DOI 10.1006/prep.1997.0773; Munshi C, 1999, J BIOL CHEM, V274, P30770, DOI 10.1074/jbc.274.43.30770; Munshi CB, 1997, METHOD ENZYMOL, V280, P318; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sauve AA, 1998, BIOCHEMISTRY-US, V37, P13239, DOI 10.1021/bi981248s; Schuber F, 2004, CURR MOL MED, V4, P249, DOI 10.2174/1566524043360708; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SLEATH PR, 1991, J ORG CHEM, V56, P3608, DOI 10.1021/jo00011a029; STATES DJ, 1992, TRENDS BIOCHEM SCI, V17, P495, DOI 10.1016/0968-0004(92)90337-9; Wagner GK, 2005, J ORG CHEM, V70, P4810, DOI 10.1021/jo050085s; Zhang B, 2007, BIOCHEMISTRY-US, V46, P4100, DOI 10.1021/bi061933w	29	50	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27637	27645		10.1074/jbc.M109.031005	http://dx.doi.org/10.1074/jbc.M109.031005			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19640846	Green Published, hybrid			2022-12-27	WOS:000270232300065
J	Nelsen, SM; Christian, JL				Nelsen, Sylvia M.; Christian, Jan L.			Site-specific Cleavage of BMP4 by Furin, PC6, and PC7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-4; VERTEBRATE EMBRYONIC-DEVELOPMENT; PROPROTEIN CONVERTASE; XENOPUS DEVELOPMENT; PRODOMAIN; MOUSE; ALPHA(1)-ANTITRYPSIN; EMBRYOGENESIS; EXPRESSION; MESODERM	Bone morphogenetic proteins (BMPs) require proteolytic activation by members of the proprotein convertase (PC) family. Pro-BMP4 is initially cleaved at a site adjacent to the mature ligand domain (S1) and then at an upstream site (S2) within the prodomain. Cleavage at the S2 site, which appears to occur in a tissue-specific fashion, regulates the activity and signaling range of mature BMP4. To test the hypothesis that tissue-specific cleavage of pro-BMP4 is regulated by differential expression of a site-specific protease, we identified the PCs that cleave each site in vivo. In Xenopus oocytes, furin and PC6 function redundantly to cleave both the S1 and S2 sites of pro-BMP4, as evidenced by the results of antisense-mediated gene knockdown and the use of the furin-and PC6-selective inhibitor alpha(1)-PDX. By contrast, alpha(1)-PDX blocked cleavage of the S2 but not the S1 site of pro-BMP4 in embryos, suggesting the existence of a developmentally regulated S1 site-specific convertase. This protease is likely to be PC7 based on knowledge of its required substrate cleavage motif and resistance to alpha(1)-PDX. Consistent with this prediction, an alpha(1)-PDX variant engineered to target PC7, in addition to furin and PC6, completely inhibited cleavage of BMP4 in oocytes and embryos. Further studies showed that pc7 transcripts are expressed and polyadenylated, and that the PC7 precursor protein undergoes efficient autocatalytic activation in both oocytes and embryos. These results suggest that PC7, or a convertase with similar substrate specificity, functions to selectively cleave the S1 site of pro-BMP4 in a developmentally regulated fashion.	[Christian, Jan L.] Oregon Hlth & Sci Univ, Sch Med, Dept Cell & Dev Biol, Portland, OR 97239 USA; [Nelsen, Sylvia M.] Oregon Hlth & Sci Univ, Sch Med, Dept Mol & Med Genet, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Christian, JL (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Cell & Dev Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	christia@ohsu.edu	Nelsen, Sylvia/AAD-6878-2022	Nelsen, Sylvia/0000-0002-3770-4728	National Institutes of Health [RO1HD037976]; Shriners Hospitals for Children [8530]; American Heart Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037976] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1HD037976 (to J.L.C.). This work was also supported by the Shriners Hospitals for Children Grant 8530 and by a predoctoral fellowship from the American Heart Association (to S.M.N.).	ANDERSON ED, 1993, J BIOL CHEM, V268, P24887; Beck S, 2002, NAT CELL BIOL, V4, P981, DOI 10.1038/ncb890; Birsoy B, 2005, DEVELOPMENT, V132, P591, DOI 10.1242/dev.01599; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; Constam DB, 1996, J CELL BIOL, V134, P181, DOI 10.1083/jcb.134.1.181; Constam DB, 2000, GENE DEV, V14, P1146; Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139; Cui YZ, 1998, EMBO J, V17, P4735, DOI 10.1093/emboj/17.16.4735; Cui YZ, 2001, GENE DEV, V15, P2797; Degnin C, 2004, MOL BIOL CELL, V15, P5012, DOI 10.1091/mbc.E04-08-0673; Dufour EK, 2001, J BIOL CHEM, V276, P38971, DOI 10.1074/jbc.M102959200; Dunn NR, 1997, DEV BIOL, V188, P235, DOI 10.1006/dbio.1997.8664; Essalmani R, 2008, P NATL ACAD SCI USA, V105, P5750, DOI 10.1073/pnas.0709428105; Goldman DC, 2006, DEVELOPMENT, V133, P1933, DOI 10.1242/dev.02368; Goldman DC, 2009, MECH DEVELOP, V126, P117, DOI 10.1016/j.mod.2008.11.008; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Lee SN, 2008, ENDOCRINOLOGY, V149, P4116, DOI 10.1210/en.2008-0064; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Liu W, 2004, P NATL ACAD SCI USA, V101, P4489, DOI 10.1073/pnas.0308466101; Mbikay M, 2001, BIOCHEM J, V357, P329, DOI 10.1042/0264-6021:3570329; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Moon R. T., 1989, TECHNIQUE, V1, P76; Nelsen S, 2005, DEV DYNAM, V233, P1038, DOI 10.1002/dvdy.20378; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; Rockwell NC, 2002, CHEM REV, V102, P4525, DOI 10.1021/cr010168i; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Salles FJ, 1999, METH MOL B, V118, P441; Sopory S, 2006, J BIOL CHEM, V281, P34021, DOI 10.1074/jbc.M605330200; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Szumska D, 2008, GENE DEV, V22, P1465, DOI 10.1101/gad.479408; Taylor NA, 2003, FASEB J, V17, P1215, DOI 10.1096/fj.02-0831rev; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tian Q, 1999, DEVELOPMENT, V126, P3371; Tsuji A, 1999, J BIOCHEM, V126, P591, DOI 10.1093/oxfordjournals.jbchem.a022491; vandeLoo JWHP, 1997, J BIOL CHEM, V272, P27116, DOI 10.1074/jbc.272.43.27116; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212; Xiang Y, 2000, MOL BIOL CELL, V11, P1257, DOI 10.1091/mbc.11.4.1257	43	55	56	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27157	27166		10.1074/jbc.M109.028506	http://dx.doi.org/10.1074/jbc.M109.028506			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651771	Green Published, hybrid			2022-12-27	WOS:000270232300016
J	Sonoda, A; Iwamoto, T; Nakamura, T; Fukumoto, E; Yoshizaki, K; Yamada, A; Arakaki, M; Harada, H; Nonaka, K; Nakamura, S; Yamada, Y; Fukumoto, S				Sonoda, Akira; Iwamoto, Tsutomu; Nakamura, Takashi; Fukumoto, Emiko; Yoshizaki, Keigo; Yamada, Aya; Arakaki, Makiko; Harada, Hidemitsu; Nonaka, Kazuaki; Nakamura, Seiji; Yamada, Yoshihiko; Fukumoto, Satoshi			Critical Role of Heparin Binding Domains of Ameloblastin for Dental Epithelium Cell Adhesion and Ameloblastoma Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAMININ ALPHA-1 CHAIN; ODONTOGENIC-TUMORS; ENAMEL PROTEINS; IMMUNOHISTOCHEMICAL-DEMONSTRATION; TOOTH DEVELOPMENT; CALCIUM-BINDING; ROOT SHEATH; GENE; DIFFERENTIATION; EXPRESSION	AMBN (ameloblastin) is an enamel matrix protein that regulates cell adhesion, proliferation, and differentiation of ameloblasts. In AMBN-deficient mice, ameloblasts are detached from the enamel matrix, continue to proliferate, and form a multiple cell layer; often, odontogenic tumors develop in the maxilla with age. However, the mechanism of AMBN functions in these biological processes remains unclear. By using recombinant AMBN proteins, we found that AMBN had heparin binding domains at the C-terminal half and that these domains were critical for AMBN binding to dental epithelial cells. Overexpression of full-length AMBN protein inhibited proliferation of human ameloblastoma AM-1 cells, but overexpression of heparin binding domain-deficient AMBN protein had no inhibitory effect. In full-length AMBN-overexpressing AM-1 cells, the expression of Msx2, which is involved in the dental epithelial progenitor phenotype, was decreased, whereas the expression of cell proliferation inhibitors p21 and p27 was increased. We also found that the expression of enamelin, a marker of differentiated ameloblasts, was induced, suggesting that AMBN promotes odontogenic tumor differentiation. Thus, our results suggest that AMBN promotes cell binding through the heparin binding sites and plays an important role in preventing odontogenic tumor development by suppressing cell proliferation and maintaining differentiation phenotype through Msx2, p21, and p27.	[Sonoda, Akira; Yoshizaki, Keigo; Nonaka, Kazuaki; Fukumoto, Satoshi] Kyushu Univ, Sect Pediat Dent, Div Oral Hlth Growth & Dev, Fukuoka 8128582, Japan; [Sonoda, Akira; Nakamura, Seiji] Kyushu Univ, Dept Oral & Maxillofacial Surg 1, Fac Dent Sci, Fukuoka 8128582, Japan; [Iwamoto, Tsutomu; Nakamura, Takashi; Fukumoto, Emiko; Yamada, Aya; Arakaki, Makiko; Fukumoto, Satoshi] Tohoku Univ, Grad Sch Dent, Dept Oral Hlth & Dev Sci, Div Pediat Dent, Sendai, Miyagi 9808575, Japan; [Nakamura, Takashi; Yamada, Yoshihiko] NIDCR, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA; [Harada, Hidemitsu] Iwate Med Coll, Sch Dent, Dept Oral Anat 2, Morioka, Iwate 0208505, Japan	Kyushu University; Kyushu University; Tohoku University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Iwate Medical University	Fukumoto, S (corresponding author), Kyushu Univ, Sect Pediat Dent, Div Oral Hlth Growth & Dev, Fukuoka 8128582, Japan.	fukumoto@mail.tains.tohoku.ac.jp	Iwamoto, Tsutomu/AAA-6597-2019; Iwamoto, Tsutomu/AAI-8952-2021; Nakamura, Takashi/P-7796-2016; Harada, Hidemitsu/P-5692-2017; Nakamura, Takashi/A-8931-2012	Iwamoto, Tsutomu/0000-0001-8472-605X; Nakamura, Takashi/0000-0001-9904-1037; Harada, Hidemitsu/0000-0002-9724-8568; Nakamura, Takashi/0000-0001-9904-1037; Fukumoto, Satoshi/0000-0002-5046-6891; Yoshizaki, Keigo/0000-0002-0598-5879	Intramural Program of the National Institutes of Health, NIDCR; Ministry of Education, Science and Culture of Japan [17689058]; Japan Society for the Promotion of Science [20679006]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000720] Funding Source: NIH RePORTER	Intramural Program of the National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by the Intramural Program of the National Institutes of Health, NIDCR (to Y.Y.). This work was also supported in part by Ministry of Education, Science and Culture of Japan Grants-in-aid for Research Fellows of the Japan Society for the Promotion of Science 17689058 and 20679006 (to S. F.).	Arikawa-Hirasawa E, 2001, NAT GENET, V27, P431, DOI 10.1038/86941; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Cerny R, 1996, J BONE MINER RES, V11, P883; Damsky CH, 1991, CURR OPIN CELL BIOL, V3, P777, DOI 10.1016/0955-0674(91)90049-5; de Vega S, 2007, J BIOL CHEM, V282, P30878, DOI 10.1074/jbc.M705847200; Fong CD, 1996, J BONE MINER RES, V11, P892; Fukae M, 1987, Adv Dent Res, V1, P261; Fukumoto S, 2005, CELLS TISSUES ORGANS, V181, P189, DOI 10.1159/000091380; Fukumoto S, 2005, CONNECT TISSUE RES, V46, P220, DOI 10.1080/03008200500344017; Fukumoto S, 2006, J BIOL CHEM, V281, P5008, DOI 10.1074/jbc.M509295200; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; GOLDBLATT LI, 1982, ORAL SURG ORAL MED O, V54, P187, DOI 10.1016/0030-4220(82)90216-X; Hoffman MP, 2001, J BIOL CHEM, V276, P22077, DOI 10.1074/jbc.M100774200; Hozumi K, 2006, J BIOL CHEM, V281, P32929, DOI 10.1074/jbc.M605708200; Hu GZ, 2001, DEVELOPMENT, V128, P2373; Iwata T, 2007, J DENT RES, V86, P153, DOI 10.1177/154405910708600209; Kobayashi C, 2006, BIOPHYS J, V90, P3043, DOI 10.1529/biophysj.105.078071; Krebsbach PH, 1996, J BIOL CHEM, V271, P4431; Li SH, 2005, J CELL BIOL, V169, P179, DOI 10.1083/jcb.200501098; Maas R, 1997, CRIT REV ORAL BIOL M, V8, P4, DOI 10.1177/10454411970080010101; MacDougall M, 2000, EUR J ORAL SCI, V108, P303, DOI 10.1034/j.1600-0722.2000.108004303.x; Melrose RJ, 1999, SEMIN DIAGN PATHOL, V16, P271; Nagano T, 2003, J DENT RES, V82, P982, DOI 10.1177/154405910308201209; Nakamura Y, 2006, CALCIFIED TISSUE INT, V78, P278, DOI 10.1007/s00223-005-0144-2; Nanci A, 1998, J HISTOCHEM CYTOCHEM, V46, P911, DOI 10.1177/002215549804600806; NEWMAN L, 1995, BRIT J ORAL MAX SURG, V33, P47, DOI 10.1016/0266-4356(95)90087-X; Nishiguchi M, 2007, ARCH ORAL BIOL, V52, P237, DOI 10.1016/j.archoralbio.2006.09.016; Okazaki I, 2002, J BIOL CHEM, V277, P37070, DOI 10.1074/jbc.M201672200; Paine ML, 2003, J BIOL CHEM, V278, P19447, DOI 10.1074/jbc.M300445200; Perdigao PF, 2004, ORAL ONCOL, V40, P841, DOI 10.1016/j.oraloncology.2004.03.004; RAMADAS K, 1990, CANCER, V66, P1475, DOI 10.1002/1097-0142(19901001)66:7<1475::AID-CNCR2820660707>3.0.CO;2-D; Ravindranath HH, 2004, BIOCHEM BIOPH RES CO, V323, P1075, DOI 10.1016/j.bbrc.2004.08.207; Ravindranath RMH, 2007, J BIOL CHEM, V282, P36370, DOI 10.1074/jbc.M704731200; Rincon JC, 2006, J PERIODONTAL RES, V41, P245, DOI 10.1111/j.1600-0765.2006.00880.x; SAKU T, 1992, J ORAL PATHOL MED, V21, P113, DOI 10.1111/j.1600-0714.1992.tb00993.x; Shinmura Y, 2008, J CELL PHYSIOL, V217, P728, DOI 10.1002/jcp.21546; Takata T, 2000, VIRCHOWS ARCH, V436, P324, DOI 10.1007/s004280050454; Toyosawa S, 2000, GENE, V256, P1, DOI 10.1016/S0378-1119(00)00379-6; Utani A, 2001, J BIOL CHEM, V276, P28779, DOI 10.1074/jbc.M101420200; Vymetal J, 2008, EUR J ORAL SCI, V116, P124, DOI 10.1111/j.1600-0722.2008.00526.x; Yamada Yoshihiko, 1992, Current Opinion in Cell Biology, V4, P819, DOI 10.1016/0955-0674(92)90105-L; Yamakoshi Y, 2001, ARCH ORAL BIOL, V46, P1005, DOI 10.1016/S0003-9969(01)00070-X; Yuasa K, 2004, J BIOL CHEM, V279, P10286, DOI 10.1074/jbc.M310013200; Zeichner-David M, 2003, DEV DYNAM, V228, P651, DOI 10.1002/dvdy.10404; Zeichner-David M, 2006, EUR J ORAL SCI, V114, P244, DOI 10.1111/j.1600-0722.2006.00322.x	45	47	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27176	27184		10.1074/jbc.M109.033464	http://dx.doi.org/10.1074/jbc.M109.033464			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19648121	Green Published, hybrid			2022-12-27	WOS:000270232300018
J	Xu, JD; Litterst, C; Georgakopoulos, A; Zaganas, I; Robakis, NK				Xu, Jindong; Litterst, Claudia; Georgakopoulos, Anastasios; Zaganas, Ioannis; Robakis, Nikolaos K.			Peptide EphB2/CTF2 Generated by the gamma-Secretase Processing of EphB2 Receptor Promotes Tyrosine Phosphorylation and Cell Surface Localization of N-Methyl-D-aspartate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC-FAMILY KINASES; NMDA-RECEPTORS; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; CALCIUM INFLUX; EXPRESSION; NR2B; TRAFFICKING; MUTATIONS; RETENTION	Presenilin 1, a protein involved in the development of familial Alzheimer disease, is an important functional component of the gamma-secretase complex that processes many cell surface receptors including the EphB2 tyrosine kinase receptors (Litterst, C., Georgakopoulos, A., Shioi, J., Ghersi, E., Wisniewski, T., Wang, R., Ludwig, A., and Robakis, N. K. (2007) J. Biol. Chem. 282, 16155-16163). Recent evidence reveals that cytosolic peptides produced by the combined metalloproteinase/gamma-secretase processing of cell surface proteins function in signal transduction and protein phosphorylation. Here we show that peptide EphB2/CTF2 released to the cytosol by the gamma-secretase processing of EphB2 receptor, has tyrosine kinase activity, and directly phosphorylates the N-methyl-D-aspartate receptor (NMDAR) subunits in both cell lines and primary neuronal cultures. This phosphorylation occurs in the absence of Src kinases and is resistant to Src inhibitors revealing a novel pathway of NMDAR tyrosine phosphorylation independent of Src activity. EphB2/CTF2, but not a kinase-deficient mutant of EphB2/CTF2, promotes the cell surface expression of NMDAR. Because NMDAR plays central roles in synaptic plasticity and function, our results provide a potential link between the gamma-secretase function of presenilin 1 and learning and memory.	[Robakis, Nikolaos K.] Mt Sinai Sch Med, Ctr Mol Biol & Genet Neurodegenerat, Dept Psychiat, New York, NY 10029 USA; Mt Sinai Sch Med, Ctr Mol Biol & Genet Neurodegenerat, Dept Neurosci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Robakis, NK (corresponding author), Mt Sinai Sch Med, Ctr Mol Biol & Genet Neurodegenerat, Dept Psychiat, 1 Gustave Levy Pl,Box 1229, New York, NY 10029 USA.	nikos.robakis@mssm.edu	Robakis, Nikolaos/AAA-1838-2021; Zaganas, Ioannis/AAE-5441-2020	Zaganas, Ioannis/0000-0002-0774-5772	National Institutes of Health [AG-17926, AG-08200, AG-05138]; NATIONAL INSTITUTE ON AGING [R01AG017926, P50AG005138, R01AG008200, R37AG017926] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG-17926, AG-08200, and AG-05138.	Aoto J, 2007, BRAIN RES, V1184, P72, DOI 10.1016/j.brainres.2006.11.033; Baki L, 2008, J NEUROSCI, V28, P483, DOI 10.1523/JNEUROSCI.4067-07.2008; CIK M, 1993, BIOCHEM J, V296, P877, DOI 10.1042/bj2960877; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; DE SB, 1999, NATURE, V398, P518; Elder GA, 1996, J NEUROSCI RES, V45, P308; Ellis C, 1996, ONCOGENE, V12, P1727; Fukaya M, 2003, P NATL ACAD SCI USA, V100, P4855, DOI 10.1073/PNAS.0830996100; Gao C, 2008, J NEUROCHEM, V106, P2489, DOI 10.1111/j.1471-4159.2008.05597.x; Georgakopoulos A, 2006, EMBO J, V25, P1242, DOI 10.1038/sj.emboj.7601031; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Kalo MS, 1999, BIOCHEMISTRY-US, V38, P14396, DOI 10.1021/bi991628t; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lin KT, 2008, J BIOL CHEM, V283, P28969, DOI 10.1074/jbc.M804401200; Litterst C, 2007, J BIOL CHEM, V282, P16155, DOI 10.1074/jbc.M611449200; Marambaud P, 2005, GENES BRAIN BEHAV, V4, P134, DOI 10.1111/j.1601-183X.2005.00086.x; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Okabe S, 1999, J NEUROSCI, V19, P7781; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Slack S, 2008, NEUROSCIENCE, V156, P175, DOI 10.1016/j.neuroscience.2008.07.023; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P11223, DOI 10.1021/bi991080q; Zhang S, 2008, J NEUROSCI, V28, P415, DOI 10.1523/JNEUROSCI.1900-07.2008; Zisch AH, 1998, ONCOGENE, V16, P2657, DOI 10.1038/sj.onc.1201823	39	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27220	27228		10.1074/jbc.M109.048728	http://dx.doi.org/10.1074/jbc.M109.048728			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19661068	hybrid, Green Published			2022-12-27	WOS:000270232300022
J	Guerin, ME; Kaur, D; Somashekar, BS; Gibbs, S; Gest, P; Chatterjee, D; Brennan, PJ; Jackson, M				Guerin, Marcelo E.; Kaur, Devinder; Somashekar, B. S.; Gibbs, Sara; Gest, Petra; Chatterjee, Delphi; Brennan, Patrick J.; Jackson, Mary			New Insights into the Early Steps of Phosphatidylinositol Mannoside Biosynthesis in Mycobacteria PimB' IS AN ESSENTIAL ENZYME OF MYCOBACTERIUM SMEGMATIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-CALMETTE-GUERIN; ACYLATION STATE; MANNOSYLTRANSFERASE; TUBERCULOSIS; LIPOARABINOMANNAN; LIPOMANNAN; MUTANT; GENE; GLYCOSYLTRANSFERASES; MANNOPHOSPHOLIPIDS	Phosphatidyl-myo-inositol mannosides (PIMs) are key glycolipids of the mycobacterial cell envelope. They are considered not only essential structural components of the cell but also important molecules implicated in host-pathogen interactions. Although their chemical structures are well established, knowledge of the enzymes and sequential events leading to their biosynthesis is still incomplete. Here we show for the first time that although both mannosyltransferases PimA and PimB' (MSMEG_4253) recognize phosphatidyl-myo-inositol (PI) as a lipid acceptor, PimA specifically catalyzes the transfer of a Manp residue to the 2-position of the myo-inositol ring of PI, whereas PimB' exclusively transfers to the 6-position. Moreover, whereas PimB' can catalyze the transfer of a Manp residue onto the PI-monomannoside (PIM1) product of PimA, PimA is unable in vitro to transfer Manp onto the PIM1 product of PimB'. Further assays using membranes from Mycobacterium smegmatis and purified PimA and PimB' indicated that the acylation of the Manp residue transferred by PimA preferentially occurs after the second Manp residue has been added by PimB'. Importantly, genetic evidence is provided that pimB' is an essential gene of M. smegmatis. Altogether, our results support a model wherein Ac1PIM2, a major form of PIMs produced by mycobacteria, arises from the consecutive action of PimA, followed by PimB', and finally the acyltransferase MSMEG_2934. The essentiality of these three enzymes emphasizes the interest of novel anti-tuberculosis drugs targeting the initial steps of PIM biosynthesis.	[Guerin, Marcelo E.; Kaur, Devinder; Somashekar, B. S.; Gibbs, Sara; Gest, Petra; Chatterjee, Delphi; Brennan, Patrick J.; Jackson, Mary] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University	Guerin, ME (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	mrcguerin@gmail.com; Mary.Jackson@colostate.edu	Guerin, Marcelo M/N-7245-2016; Jackson, Mary/D-5345-2017	Guerin, Marcelo M/0000-0001-9524-3184; Jackson, Mary/0000-0002-9212-0258	NIAID [AI064798]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064798] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI064798 from NIAID.	BRENNAN P, 1967, J BIOL CHEM, V242, P3046; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Gilleron M, 1999, J MOL BIOL, V285, P2147, DOI 10.1006/jmbi.1998.2438; Gilleron M, 2003, J BIOL CHEM, V278, P29880, DOI 10.1074/jbc.M303446200; Gilleron M, 2001, J BIOL CHEM, V276, P34896, DOI 10.1074/jbc.M103908200; Gilleron M, 2008, MYCOBACTERIAL CELL ENVELOPE, P75; GOREN MB, 1984, MYCOBACTERIA SOURCEB, V1, P379; Goude R, 2008, J BACTERIOL, V190, P4335, DOI 10.1128/JB.01825-07; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; Guerin ME, 2005, ACTA CRYSTALLOGR F, V61, P518, DOI 10.1107/S1744309105012364; GUILHOT C, 1994, J BACTERIOL, V176, P535, DOI 10.1128/JB.176.2.535-539.1994; HILL DL, 1966, J BIOL CHEM, V241, P895; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; KAUR D, 2009, ADV APPL MI IN PRESS; Kaur D, 2007, J BIOL CHEM, V282, P27133, DOI 10.1074/jbc.M703389200; Kordulakova J, 2003, J BIOL CHEM, V278, P36285, DOI 10.1074/jbc.M303639200; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Kremer L, 2002, BIOCHEM J, V363, P437, DOI 10.1042/0264-6021:3630437; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lea-Smith DJ, 2008, J BIOL CHEM, V283, P6773, DOI 10.1074/jbc.M707139200; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; Mishra AK, 2009, J BACTERIOL, V191, P4465, DOI 10.1128/JB.01729-08; Morita YS, 2006, J BIOL CHEM, V281, P25143, DOI 10.1074/jbc.M604214200; Parish T, 1997, J BACTERIOL, V179, P7827, DOI 10.1128/jb.179.24.7827-7833.1997; Schaeffer ML, 1999, J BIOL CHEM, V274, P31625, DOI 10.1074/jbc.274.44.31625; TAKAYAMA K, 1969, BIOCHIM BIOPHYS ACTA, V176, P196, DOI 10.1016/0005-2760(69)90089-7; Tatituri RVV, 2007, J BIOL CHEM, V282, P4561, DOI 10.1074/jbc.M608695200; Torrelles JB, 2009, GLYCOBIOLOGY, V19, P743, DOI 10.1093/glycob/cwp042; Zhang N, 2003, MOL MICROBIOL, V50, P69, DOI 10.1046/j.1365-2958.2003.03681.x	30	58	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25687	25696		10.1074/jbc.M109.030593	http://dx.doi.org/10.1074/jbc.M109.030593			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19638342	Green Published, hybrid			2022-12-27	WOS:000269738000026
J	Monaghan-Benson, E; Burridge, K				Monaghan-Benson, Elizabeth; Burridge, Keith			The Regulation of Vascular Endothelial Growth Factor-induced Microvascular Permeability Requires Rac and Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CADHERIN TYROSINE PHOSPHORYLATION; ADHERENS-TYPE JUNCTIONS; CELL-CELL ADHESION; VE-CADHERIN; NADPH OXIDASE; BETA-CATENIN; PARACELLULAR PATHWAY; LEUKOCYTE TRANSMIGRATION; DEPENDENT ENDOCYTOSIS; SIGNAL-TRANSDUCTION	Vascular permeability is a complex process involving the coordinated regulation of multiple signaling pathways in the endothelial cell. It has long been documented that vascular endothelial growth factor (VEGF) greatly enhances microvascular permeability; however, the molecular mechanisms controlling VEGF-induced permeability remain unknown. Treatment of microvascular endothelial cells with VEGF led to an increase in reactive oxygen species (ROS) production. ROS are required for VEGF-induced permeability as treatment with the free radical scavenger, N-acetylcysteine, inhibited this effect. Additionally, treatment with VEGF caused ROS-dependent tyrosine phosphorylation of both vascular-endothelial (VE)-cadherin and beta-catenin. Rac1 was required for the VEGF-induced increase in permeability and adherens junction protein phosphorylation. Knockdown of Rac1 inhibited VEGF-induced ROS production consistent with Rac lying upstream of ROS in this pathway. Collectively, these data suggest that VEGF leads to a Rac-mediated generation of ROS, which, in turn, elevates the tyrosine phosphorylation of VE-cadherin and beta-catenin, ultimately regulating adherens junction integrity.	[Monaghan-Benson, Elizabeth] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Monaghan-Benson, E (corresponding author), Univ N Carolina, Dept Cell & Dev Biol, 12-026 Lineberger Canc Ctr, Chapel Hill, NC 27599 USA.	ebenson@med.unc.edu			National Institutes of Health [HL080166, HL045100]; NATIONAL CANCER INSTITUTE [T32CA009156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL045100, P01HL080166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL080166 and HL045100 (to K. B.).	Abid MR, 2001, FASEB J, V15, P2548, DOI 10.1096/fj.01-0338fje; Abid MR, 2000, FEBS LETT, V486, P252, DOI 10.1016/S0014-5793(00)02305-X; Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; Babior BM, 2000, IUBMB LIFE, V50, P267, DOI 10.1080/15216540051080976; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Balsamo J, 1996, J CELL BIOL, V134, P801, DOI 10.1083/jcb.134.3.801; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Bogatcheva NV, 2002, VASC PHARMACOL, V39, P201, DOI 10.1016/S1537-1891(03)00009-0; Bokoch GM, 2002, BLOOD, V100, P2692, DOI 10.1182/blood-2002-04-1149; Braga VMM, 1999, MOL BIOL CELL, V10, P9, DOI 10.1091/mbc.10.1.9; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Crosby CV, 2005, BLOOD, V105, P2771, DOI 10.1182/blood-2004-06-2244; Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016/S0968-0004(03)00193-2; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Esser S, 1998, J CELL SCI, V111, P1853; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Garcia JGN, 2000, J APPL PHYSIOL, V89, P2333, DOI 10.1152/jappl.2000.89.6.2333; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gorlach A, 2000, CIRC RES, V87, P26, DOI 10.1161/01.RES.87.1.26; Gotsch U, 1997, J CELL SCI, V110, P583; Hordijk PL, 1999, J CELL SCI, V112, P1915; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Irani K, 1998, BIOCHEM PHARMACOL, V55, P1339; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; Li AE, 1999, CIRC RES, V85, P304, DOI 10.1161/01.RES.85.4.304; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Lum H, 2001, AM J PHYSIOL-CELL PH, V280, pC719; May C, 2005, BLOOD, V105, P4337, DOI 10.1182/blood-2005-01-0010; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406; Ozawa M, 1998, J BIOL CHEM, V273, P6166, DOI 10.1074/jbc.273.11.6166; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; RHEE SG, 2000, SCI STKE, pE1; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; SENGER DR, 1983, NATURE, V302, P714, DOI 10.1038/302714a0; SENGER DR, 1986, CANCER RES, V46, P5629; Sohn HY, 2000, J BIOL CHEM, V275, P18745, DOI 10.1074/jbc.M000026200; Stockton RA, 2004, J BIOL CHEM, V279, P46621, DOI 10.1074/jbc.M408877200; Sui XF, 2005, AM J PATHOL, V166, P1247, DOI 10.1016/S0002-9440(10)62343-7; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; Ukropec JA, 2000, J BIOL CHEM, V275, P5983, DOI 10.1074/jbc.275.8.5983; Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8; van Wetering S, 2003, AM J PHYSIOL-CELL PH, V285, pC343, DOI 10.1152/ajpcell.00048.2003; van Wetering S, 2002, J CELL SCI, V115, P1837; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; VOLBERG T, 1991, CELL REGUL, V2, P105, DOI 10.1091/mbc.2.2.105; VOLBERG T, 1992, EMBO J, V11, P1733, DOI 10.1002/j.1460-2075.1992.tb05225.x; Vouret-Craviari V, 2002, J CELL SCI, V115, P2475; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440; Yeh LH, 1999, AM J PHYSIOL-CELL PH, V276, pC838, DOI 10.1152/ajpcell.1999.276.4.C838; Young BA, 2003, AM J PHYSIOL-LUNG C, V285, pL63, DOI 10.1152/ajplung.00423.2002; Young BA, 1998, BIOCHEM BIOPH RES CO, V251, P320, DOI 10.1006/bbrc.1998.9475; Zeng HY, 2002, J BIOL CHEM, V277, P4003, DOI 10.1074/jbc.M110842200	62	157	165	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25602	25611		10.1074/jbc.M109.009894	http://dx.doi.org/10.1074/jbc.M109.009894			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19633358	Green Published, hybrid			2022-12-27	WOS:000269738000018
J	Sakamoto, T; Seiki, M				Sakamoto, Takeharu; Seiki, Motoharu			Mint3 Enhances the Activity of Hypoxia-inducible Factor-1 (HIF-1) in Macrophages by Suppressing the Activity of Factor Inhibiting HIF-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS PRECURSOR PROTEIN; TRANS-GOLGI NETWORK; ASPARAGINYL HYDROXYLASE; TRANSCRIPTIONAL ACTIVITY; PDZ-DOMAINS; FIH; HIF-1-ALPHA; SUBSTRATE; RECEPTOR; MECHANISMS	Hypoxia-inducible factor-1 (HIF-1) is a key transcription factor regulating cellular responses to hypoxia and is composed of alpha and beta subunits. During normoxia, factor inhibiting HIF-1 (FIH-1) inhibits the activity of HIF-1 by preventing HIF-1 alpha binding to p300/CBP via modification of the Asn(803) residue. However, it is not known whether FIH-1 activity can be regulated in an oxygen-independent manner. In this study, we survey possible binding proteins to FIH-1 and identify Mint3/APBA3, which has been reported to bind Alzheimer beta-amyloid precursor protein. Purified Mint3 binds FIH-1 and inhibits the ability of FIH-1 to modify HIF-1 alpha in vitro. In a reporter assay, the activity of HIF-1 alpha is suppressed because of endogenous FIH-1 in HEK293 cells, and expression of Mint3 antagonizes this suppression. Macrophages are known to depend on glycolysis for ATP production because of elevated HIF-1 activity. FIH-1 activity is suppressed in macrophages by Mint3 so as to maintain HIF-1 activity. FIH-1 forms a complex with Mint3, and these two factors co-localize within the perinuclear region. Knockdown of Mint3 expression in macrophages leads to redistribution of FIH-1 to the cytoplasm and decreases glycolysis and ATP production. Thus, Mint3 regulates the FIH-1-HIF-1 pathway, which controls ATP production in macrophages and therefore represents a potential new therapeutic target to regulate macrophagemediated inflammation.	[Sakamoto, Takeharu; Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo 1088639, Japan	University of Tokyo	Seiki, M (corresponding author), 4-6-1 Shirokanedai,Minato Ku, Tokyo 1088639, Japan.	mseiki@ims.u-tokyo.ac.jp	Sakamoto, Takeharu/Y-6062-2019; Seiki, Motoharu/K-9443-2015	Sakamoto, Takeharu/0000-0002-1225-1902; 	Specific Coordination Fund for Promoting Science; Ministry of Education, Culture, Sports, Science and Technology of Japan	Specific Coordination Fund for Promoting Science; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Specific Coordination Fund for Promoting Science (to T. S.), by a Grant-in-Aid for Scientific Research on Priority Areas (to M. S.), and by the Global COE (Centers of Excellence) Program "Center of Education and Research for the Advanced Genome-Based Medicine, for personalized medicine and the control of worldwide infectious diseases (to T. S. and M. S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aragones J, 2009, CELL METAB, V9, P11, DOI 10.1016/j.cmet.2008.10.001; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Dann CE, 2002, P NATL ACAD SCI USA, V99, P15351, DOI 10.1073/pnas.202614999; Ferguson JE, 2007, MOL CELL BIOL, V27, P6407, DOI 10.1128/MCB.00511-07; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Han JB, 2008, J CELL SCI, V121, P2217, DOI 10.1242/jcs.019745; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hill K, 2003, J BIOL CHEM, V278, P36032, DOI 10.1074/jbc.M301632200; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kasper LH, 2005, EMBO J, V24, P3846, DOI 10.1038/sj.emboj.7600846; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lancaster DE, 2004, BIOCHEM J, V383, P429, DOI 10.1042/BJ20040735; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Linke S, 2004, J BIOL CHEM, V279, P14391, DOI 10.1074/jbc.M313614200; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Malmberg EK, 2004, J CELL SCI, V117, P5535, DOI 10.1242/jcs.01472; MICHL J, 1976, J EXP MED, V144, P1465, DOI 10.1084/jem.144.6.1465; Miller CCJ, 2006, TRENDS NEUROSCI, V29, P280, DOI 10.1016/j.tins.2006.03.001; Okamoto M, 2001, NEUROSCIENCE, V104, P653, DOI 10.1016/S0306-4522(01)00124-5; Okamoto M, 1998, EUR J CELL BIOL, V77, P161, DOI 10.1016/S0171-9335(98)80103-9; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Shrivastava-Ranjan P, 2008, MOL BIOL CELL, V19, P51, DOI 10.1091/mbc.E07-05-0465; Tanahashi H, 1999, BIOCHEM BIOPH RES CO, V255, P663, DOI 10.1006/bbrc.1999.0265	29	46	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30350	30359		10.1074/jbc.M109.019216	http://dx.doi.org/10.1074/jbc.M109.019216			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19726677	Green Published, hybrid			2022-12-27	WOS:000271090000038
J	Hayashi, H; Campenot, RB; Vance, DE; Vance, JE				Hayashi, Hideki; Campenot, Robert B.; Vance, Dennis E.; Vance, Jean E.			Protection of Neurons from Apoptosis by Apolipoprotein E-containing Lipoproteins Does Not Require Lipoprotein Uptake and Involves Activation of Phospholipase C gamma 1 and Inhibition of Calcineurin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; GLYCOGEN-SYNTHASE KINASE-3; LONG-TERM POTENTIATION; DENSITY-LIPOPROTEIN; ALZHEIMERS-DISEASE; CHOLESTEROL-METABOLISM; SIGNALING MECHANISMS; PARKINSONS-DISEASE; NEURITE OUTGROWTH; DEFICIENT MICE	Apolipoprotein E-containing lipoproteins (LpE) are generated in the central nervous system by glial cells, primarily astrocytes, and are recognized as key players in lipid metabolism and transport in the brain. We previously reported that LpE protect retinal ganglion neurons from apoptosis induced by withdrawal of trophic additives (Hayashi, H., Campenot, R. B., Vance, D. E., and Vance, J. E. (2007) J. Neurosci. 27, 1933-1941). LpE bind to low density lipoprotein receptor-related protein-1 and initiate a signaling pathway that involves activation of protein kinase C delta and inhibition of the pro-apoptotic glycogen synthase kinase 3 beta. We now show that uptake of LpE is not required for the neuroprotection. Experiments with inhibitors of phospholipase C gamma 1 and RNAi knockdown studies demonstrate that activation of phospholipase C gamma 1 is required for the anti-apoptotic signaling pathway induced by LpE. In addition, the protein phosphatase-2B, calcineurin, is involved in a neuronal death pathway induced by removal of trophic additives, and LpE inhibit calcineurin activation. LpE also attenuate neuronal death caused by oxidative stress. Moreover, physiologically relevant apoE3-containing lipoproteins generated by apoE3 knock-in mouse astrocytes more effectively protect neurons from apoptosis than do apoE4-containing lipoproteins. Because inheritance of the apoE4 allele is the strongest known genetic risk factor for Alzheimer disease, the reduced neuroprotection afforded by apoE4-containing LpE might contribute to the neurodegeneration characteristic of this disease.	[Hayashi, Hideki; Vance, Dennis E.; Vance, Jean E.] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Vance, Dennis E.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada; [Campenot, Robert B.] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2S2, Canada; [Hayashi, Hideki; Vance, Jean E.] Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada; [Hayashi, Hideki] Kumamoto Univ, Prior Org Innovat & Excellence, Kumamoto 8608556, Japan	University of Alberta; University of Alberta; University of Alberta; University of Alberta; Kumamoto University	Vance, JE (corresponding author), Univ Alberta, Grp Mol & Cell Biol Lipids, 328 Heritage Med Res Ctr, Edmonton, AB T6G 2S2, Canada.	jean.vance@ualberta.ca			Canadian Institutes for Health Research [20890174]; Ministry of Education, Culture, Sport, Science and Technology, Japan	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ministry of Education, Culture, Sport, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Canadian Institutes for Health Research and in part by Grant-in-aid for Young Scientists (Start-up) 20890174 and the Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sport, Science and Technology, Japan.	Agostinho P, 2008, NEUROCHEM INT, V52, P1226, DOI 10.1016/j.neuint.2008.01.005; Albanesi D, 2004, J BACTERIOL, V186, P2655, DOI 10.1128/JB.186.9.2655-2663.2004; Almeida S, 2004, NEUROBIOL DIS, V17, P435, DOI 10.1016/j.nbd.2004.07.002; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Belinson H, 2007, NEUROBIOL AGING, V28, P689, DOI 10.1016/j.neurobiolaging.2006.06.027; Bi XN, 2007, AUTOPHAGY, V3, P646, DOI 10.4161/auto.5074; BOYLES JK, 1989, J CLIN INVEST, V83, P1015, DOI 10.1172/JCI113943; BROWN MS, 1976, SCIENCE, V191, P150, DOI 10.1126/science.174194; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cserepes J, 2004, BIOCHEM BIOPH RES CO, V320, P860, DOI 10.1016/j.bbrc.2004.06.037; de Chaves EIP, 1997, J BIOL CHEM, V272, P30766, DOI 10.1074/jbc.272.49.30766; DeMattos RB, 1998, J BIOL CHEM, V273, P4206, DOI 10.1074/jbc.273.7.4206; DeMattos RB, 2001, J LIPID RES, V42, P976; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Ellman PI, 2008, J AM COLL SURGEONS, V206, P993, DOI 10.1016/j.jamcollsurg.2007.12.010; ENAN E, 1992, BIOCHEM PHARMACOL, V43, P1777, DOI 10.1016/0006-2952(92)90710-Z; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gong JS, 2002, J BIOL CHEM, V277, P29919, DOI 10.1074/jbc.M203934200; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Han X, 2004, CELL MOL LIFE SCI, V61, P1896, DOI 10.1007/s00018-004-4009-z; Hayashi H, 2004, J BIOL CHEM, V279, P14009, DOI 10.1074/jbc.M313828200; Hayashi H, 2007, J NEUROSCI, V27, P1933, DOI 10.1523/JNEUROSCI.5471-06.2007; Herz J, 2001, NEURON, V29, P571, DOI 10.1016/S0896-6273(01)00234-3; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Huang W, 2005, P NATL ACAD SCI USA, V102, P12242, DOI 10.1073/pnas.0505138102; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; Ito J, 1999, J NEUROCHEM, V72, P2362, DOI 10.1046/j.1471-4159.1999.0722362.x; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Jordan J, 1998, J NEUROSCI, V18, P195; Koch S, 2001, J LIPID RES, V42, P1143; Krzywkowski P, 1999, NEUROSCIENCE, V92, P1273, DOI 10.1016/S0306-4522(99)00061-5; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MASLIAH E, 1995, EXP NEUROL, V136, P107, DOI 10.1006/exnr.1995.1088; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Mora A, 2001, J NEUROCHEM, V78, P199, DOI 10.1046/j.1471-4159.2001.00410.x; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Norris CM, 2005, J NEUROSCI, V25, P4649, DOI 10.1523/JNEUROSCI.0365-05.2005; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Poulter MO, 2004, NEUROSCIENCE, V128, P1, DOI 10.1016/j.neuroscience.2004.06.016; Qiu ZH, 2002, J BIOL CHEM, V277, P14458, DOI 10.1074/jbc.M112066200; Ruiz J, 2005, J LIPID RES, V46, P1721, DOI 10.1194/jlr.M500114-JLR200; Sheng HX, 1999, STROKE, V30, P1118, DOI 10.1161/01.STR.30.5.1118; Shioda N, 2006, J NEUROCHEM, V98, P310, DOI 10.1111/j.1471-4159.2006.03874.x; Shou Y, 2004, BIOCHEM J, V379, P805, DOI 10.1042/BJ20031107; Siegel GJ, 2000, BRAIN RES REV, V33, P199, DOI 10.1016/S0165-0173(00)00030-8; Springer JE, 2000, J NEUROSCI, V20, P7246; STRITTMATTER WJ, 1995, P NATL ACAD SCI USA, V92, P4725, DOI 10.1073/pnas.92.11.4725; Su Y, 2004, BIOCHEMISTRY-US, V43, P6899, DOI 10.1021/bi035627j; Sun X, 2002, NEUROSCI LETT, V321, P61, DOI 10.1016/S0304-3940(01)02583-6; Szaszi K, 2002, J BIOL CHEM, V277, P42623, DOI 10.1074/jbc.M206629200; Szydlowska K, 2006, J NEUROCHEM, V99, P965, DOI 10.1111/j.1471-4159.2006.04136.x; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wu ZZ, 2006, NEUROSCIENCE, V141, P407, DOI 10.1016/j.neuroscience.2006.03.023; Zachary I, 2005, NEUROSIGNALS, V14, P207, DOI 10.1159/000088637; Zhuo M, 2000, J NEUROSCI, V20, P542, DOI 10.1523/JNEUROSCI.20-02-00542.2000	62	46	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29605	29613		10.1074/jbc.M109.039560	http://dx.doi.org/10.1074/jbc.M109.039560			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19717566	Green Published, hybrid			2022-12-27	WOS:000270896800042
J	Motamedi-Shad, N; Monsellier, E; Torrassa, S; Relini, A; Chiti, F				Motamedi-Shad, Neda; Monsellier, Elodie; Torrassa, Silvia; Relini, Annalisa; Chiti, Fabrizio			Kinetic Analysis of Amyloid Formation in the Presence of Heparan Sulfate FASTER UNFOLDING AND CHANGE OF PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRIL FORMATION; IN-VITRO; MUSCLE ACYLPHOSPHATASE; ALZHEIMERS-DISEASE; EXTRACELLULAR-MATRIX; PROTEIN AGGREGATION; PRION PROTEIN; GLYCOSAMINOGLYCANS; PROTEOGLYCANS; INSIGHTS	A number of human diseases are associated with the conversion of proteins from their native state into well defined fibrillar aggregates, depositing in the extracellular space and generally termed amyloid fibrils. Heparan sulfate (HS), a glycosaminoglycan normally present in the extracellular matrix, has been found to be universally associated with amyloid deposits and to promote amyloid fibril formation by all studied protein systems. We have studied the impact of HS on the amyloidogenesis of human muscle acylphosphatase, monitoring the process with an array of techniques, such as normal and stopped-flow far-UV circular dichroism, thioflavin T fluorescence, static and dynamic light scattering, and atomic force microscopy. The results show that HS accelerates the conversion of the studied protein from the native state into the amyloidogenic, yet monomeric, partially folded state. They also indicate that HS does not simply accelerate the conversion of the resulting partially folded state into amyloid species but splits the process into two distinct pathways occurring in parallel: a very fast phase in which HS interacts with a fraction of protein molecules, causing their rapid aggregation into ThT-positive and beta-sheet containing oligomers, and a slow phase resulting from the normal aggregation of partially folded molecules that cannot interact with HS. The HS-mediated aggregation pathway is several-fold faster than that observed in the absence of HS. Two aggregation phases are generally observed when proteins aggregate in the presence of HS, underlying the importance of a detailed kinetic analysis to fully understand the effect of this glycosaminoglycan on amyloidogenesis.	[Motamedi-Shad, Neda; Monsellier, Elodie; Chiti, Fabrizio] Univ Florence, Dept Biochem, I-50134 Florence, Italy; [Torrassa, Silvia; Relini, Annalisa] Univ Genoa, Dipartimento Fis, I-16146 Genoa, Italy; [Relini, Annalisa; Chiti, Fabrizio] Consorzio Interuniv Ist Nazl Biostrutture & Biosi, I-00136 Rome, Italy	University of Florence; University of Genoa	Chiti, F (corresponding author), Univ Florence, Dept Biochem, Viale Morgagni 50, I-50134 Florence, Italy.	fabrizio.chiti@unifi.it	Monsellier, Elodie/GRF-5106-2022; Relini, Annalisa/AHC-3105-2022	Monsellier, Elodie/0000-0001-7944-7531; RELINI, ANNALISA/0000-0002-4040-9279	Italian Ministero dell'Istruzione; dell'Universita e della Ricerca [PRIN 2006058958, FIRB RBNE03PX83]; European Union; European Molecular Biology Organization Young Investigator Program	Italian Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); European Union(European Commission); European Molecular Biology Organization Young Investigator Program(European Molecular Biology Organization (EMBO))	This work was supported in part by grants from the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (Projects PRIN 2006058958 and FIRB RBNE03PX83), the European Union (Project EURAMY), and the European Molecular Biology Organization Young Investigator Program (YIP 2005).	Alexandrescu AT, 2005, PROTEIN SCI, V14, P1; Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; Bemporad F, 2006, PROTEIN SCI, V15, P862, DOI 10.1110/ps.051915806; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437; Calamai M, 2005, BIOPHYS J, V89, P4201, DOI 10.1529/biophysj.105.068726; Calamai M, 2003, BIOCHEMISTRY-US, V42, P15078, DOI 10.1021/bi030135s; Calamai M, 2006, BIOCHEMISTRY-US, V45, P12806, DOI 10.1021/bi0610653; Castillo GM, 1998, DIABETES, V47, P612, DOI 10.2337/diabetes.47.4.612; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Chiti F, 1999, NAT STRUCT BIOL, V6, P380; Chiti F, 2002, P NATL ACAD SCI USA, V99, P16419, DOI 10.1073/pnas.212527999; Chiti F, 2002, NAT STRUCT BIOL, V9, P137, DOI 10.1038/nsb752; Chiti F, 2001, PROTEIN SCI, V10, P879, DOI 10.1110/ps.42401; Chiti F, 2000, EMBO J, V19, P1441, DOI 10.1093/emboj/19.7.1441; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Cotman SL, 2000, MOL CELL NEUROSCI, V15, P183, DOI 10.1006/mcne.1999.0816; DEBEER MC, 1993, J BIOL CHEM, V268, P20606; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Kim YS, 2002, J BIOL CHEM, V277, P27240, DOI 10.1074/jbc.M202492200; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; MAGNUS JH, 1991, SCAND J IMMUNOL, V34, P63, DOI 10.1111/j.1365-3083.1991.tb01521.x; MCCUBBIN WD, 1988, BIOCHEM J, V256, P775, DOI 10.1042/bj2560775; McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Meng F, 2007, BIOCHEMISTRY-US, V46, P12091, DOI 10.1021/bi7004834; Modesti A, 1995, PROTEIN EXPRES PURIF, V6, P799, DOI 10.1006/prep.1995.0011; Monti M, 2004, J MOL BIOL, V336, P253, DOI 10.1016/j.jmb.2003.10.082; PASTORE A, 1992, J MOL BIOL, V224, P427, DOI 10.1016/0022-2836(92)91005-A; Raffen R, 1999, PROTEIN SCI, V8, P509; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Smith DP, 2003, J MOL BIOL, V330, P943, DOI 10.1016/S0022-2836(03)00687-9; SNOW AD, 1987, LAB INVEST, V56, P665; SNOW AD, 1988, AM J PATHOL, V133, P456; SNOW AD, 1990, LAB INVEST, V63, P601; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stefani M, 1997, CELL MOL LIFE SCI, V53, P141, DOI 10.1007/PL00000585; Suk JY, 2006, BIOCHEMISTRY-US, V45, P2234, DOI 10.1021/bi0519295; Taddei N, 2001, J BIOL CHEM, V276, P37149, DOI 10.1074/jbc.M105720200; Takase K, 1998, FEBS LETT, V441, P271, DOI 10.1016/S0014-5793(98)01563-4; van Nuland NAJ, 1998, J MOL BIOL, V283, P883, DOI 10.1006/jmbi.1998.2009; VANDUINEN SG, 1995, LAB INVEST, V73, P183; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; Yamaguchi I, 2003, KIDNEY INT, V64, P1080, DOI 10.1046/j.1523-1755.2003.00167.x; YOUNG ID, 1992, ARCH PATHOL LAB MED, V116, P951; YOUNG ID, 1989, ACTA NEUROPATHOL, V78, P202, DOI 10.1007/BF00688210	49	51	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29921	29934		10.1074/jbc.M109.018747	http://dx.doi.org/10.1074/jbc.M109.018747			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19700762	hybrid, Green Published			2022-12-27	WOS:000270896800071
J	Zhang, SB; Hisatsune, C; Matsu-Ura, T; Mikoshiba, K				Zhang, Songbai; Hisatsune, Chihiro; Matsu-ura, Toru; Mikoshiba, Katsuhiko			G-protein-coupled Receptor Kinase-interacting Proteins Inhibit Apoptosis by Inositol 1,4,5-Triphosphate Receptor-mediated Ca2+ Signal Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1,4,5-TRISPHOSPHATE RECEPTOR; TRISPHOSPHATE RECEPTOR; ENDOPLASMIC-RETICULUM; CALCIUM-RELEASE; TERMINAL TAIL; IP3 RECEPTOR; CELL-DEATH; ACTIVATION; TYPE-1; NEF	The inositol 1,4,5-trisphosphate (IP3) receptor (IP3R) is an intracellular IP3-gated calcium (Ca2+) release channel and plays important roles in regulation of numerous Ca2+-dependent cellular responses. Many intracellular modulators and IP3R-binding proteins regulate the IP3R channel function. Here we identified G-protein-coupled receptor kinase-interacting proteins (GIT), GIT1 and GIT2, as novel IP3R-binding proteins. We found that both GIT1 and GIT2 directly bind to all three sub-types of IP3R. The interaction was favored by the cytosolic Ca2+ concentration and it functionally inhibited IP3R activity. Knockdown of GIT induced and accelerated caspase-dependent apoptosis in both unstimulated and staurosporine-treated cells, which was attenuated by wild-type GIT1 overexpression or pharmacological inhibitors of IP3R, but not by a mutant form of GIT1 that abrogates the interaction. Thus, we conclude that GIT inhibits apoptosis by modulating the IP3R-mediated Ca2+ signal through a direct interaction with IP3R in a cytosolic Ca2+-dependent manner.	[Zhang, Songbai; Hisatsune, Chihiro; Mikoshiba, Katsuhiko] RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; [Zhang, Songbai; Hisatsune, Chihiro; Matsu-ura, Toru; Mikoshiba, Katsuhiko] Japan Sci & Technol Agcy, Calcium Oscillat Project, Int Cooperat Res Project Solut Oriented Res Sci &, Wako, Saitama 3510198, Japan	RIKEN; Japan Science & Technology Agency (JST)	Mikoshiba, K (corresponding author), RIKEN, Brain Sci Inst, Dev Neurobiol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	Mikosiba@brain.riken.jp	Matsu-ura, Toru/P-3461-2017; Mikoshiba, Katsuhiko/N-7943-2015; Hisatsune, Chihiro/C-6661-2017	Matsu-ura, Toru/0000-0002-9876-3086; Hisatsune, Chihiro/0000-0001-7811-7784; Zhang, Songbai/0000-0002-2033-8389	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Albertinazzi C, 2003, MOL BIOL CELL, V14, P1295, DOI 10.1091/mbc.E02-07-0406; Ando H, 2006, MOL CELL, V22, P795, DOI 10.1016/j.molcel.2006.05.017; Assefa Z, 2004, J BIOL CHEM, V279, P43227, DOI 10.1074/jbc.M403872200; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Brown A, 1999, J VIROL, V73, P9899, DOI 10.1128/JVI.73.12.9899-9907.1999; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Greenway AL, 2003, J BIOSCIENCES, V28, P323, DOI 10.1007/BF02970151; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Hamada K, 2002, J BIOL CHEM, V277, P21115, DOI 10.1074/jbc.C200244200; Hattori M, 2004, J BIOL CHEM, V279, P11967, DOI 10.1074/jbc.M311456200; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; Joseph SK, 2007, APOPTOSIS, V12, P951, DOI 10.1007/s10495-007-0719-7; Kuroda Y, 2008, P NATL ACAD SCI USA, V105, P8643, DOI 10.1073/pnas.0800642105; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Luzzi V, 1998, J BIOL CHEM, V273, P28657, DOI 10.1074/jbc.273.44.28657; Manninen A, 2002, J EXP MED, V195, P1023, DOI 10.1084/jem.20012039; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Nakayama T, 2004, BIOCHEM J, V377, P299, DOI 10.1042/BJ20030599; Nutt LK, 2002, J BIOL CHEM, V277, P20301, DOI 10.1074/jbc.M201604200; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Rong YP, 2008, MOL CELL, V31, P255, DOI 10.1016/j.molcel.2008.06.014; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; SUGIYAMA T, 1994, FEBS LETT, V349, P191, DOI 10.1016/0014-5793(94)00662-8; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002; Zhang SB, 2003, J BIOL CHEM, V278, P4048, DOI 10.1074/jbc.M209960200; Zhang SB, 2006, J BIOL CHEM, V281, P21954, DOI 10.1074/jbc.M601578200	38	27	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29158	29169		10.1074/jbc.M109.041509	http://dx.doi.org/10.1074/jbc.M109.041509			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19706611	Green Published, hybrid			2022-12-27	WOS:000270678900071
J	Jama, AM; Fenton, J; Robertson, SD; Torok, K				Jama, Abdirahman M.; Fenton, Jon; Robertson, Saralili D.; Torok, Katalin			Time-dependent Autoinactivation of Phospho-Thr(286)-alpha Ca2+/Calmodulin-dependent Protein Kinase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; ALPHA-CAMKII; CALMODULIN; AUTOPHOSPHORYLATION; ACTIVATION; CALCIUM; INACTIVATION; MEMORY; CA2+/CALMODULIN	Ca2+/calmodulin-dependent protein kinase II (alpha CaMKII) is thought to exert its role in memory formation by autonomous Ca2+-independent persistent activity conferred by Thr(286) autophosphorylation, allowing the enzyme to remain active even when intracellular [Ca2+] has returned to resting levels. Ca2+ sequestration-induced inhibition, caused by a burst of Thr(305/306) autophosphorylation via calmodulin (CaM) dissociation from the Thr(305/306) sites, is in conflict with this view. The processes of CaM binding, autophosphorylation, and inactivation are dissected to resolve this conflict. Upon Ca2+ withdrawal, CaM sequential domain dissociation is observed, starting with the rapid release of the first (presumed N-terminal) CaM lobe, thought to be bound at the Thr(305/306) sites. The time courses of Thr(305/306) autophosphorylation and inactivation, however, correlate with the slow dissociation of the second (presumed C-terminal) CaM lobe. Exposure of the Thr(305/306) sites is thus not sufficient for their autophosphorylation. Moreover, Thr(305/306) autophosphorylation and autoinactivation are shown to occur in the continuous presence of Ca2+ and bound Ca2+/CaM by time courses similar to those seen following Ca2+ sequestration. Our investigation of the activity and mechanisms of phospho-Thr(286)-alpha CaMKII thus shows time-dependent autoinactivation, irrespective of the continued presence of Ca2+ and CaM, allowing a very short, if any, time window for Ca2+/CaM-free phospho-Thr(286)-alpha CaMKII activity. Physiologically, the time-dependent autoinactivation mechanisms of phospho-Thr(286)-alpha CaMKII (t(1/2) of similar to 50 s at 37 degrees C) suggest a transient kinase activity of similar to 1 min duration in the induction of long term potentiation and thus memory formation.	[Jama, Abdirahman M.; Fenton, Jon; Robertson, Saralili D.; Torok, Katalin] Univ London, Div Basic Med Sci, London SW17 0RE, England	University of London	Torok, K (corresponding author), Univ London, Div Basic Med Sci, London SW17 0RE, England.	k.torok@sgul.ac.uk		Torok, Katalin/0000-0002-3107-4534	Wellcome Trust Project [075931]	Wellcome Trust Project(Wellcome Trust)	This work was supported by Wellcome Trust Project Grant 075931 (to K.T.).	Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bradshaw JM, 2003, P NATL ACAD SCI USA, V100, P10512, DOI 10.1073/pnas.1932759100; Fukunaga K, 1999, JPN J PHARMACOL, V79, P7, DOI 10.1254/jjp.79.7; Grant PAA, 2008, CELL CALCIUM, V44, P465, DOI 10.1016/j.ceca.2008.03.003; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HASHIMOTO Y, 1987, ARCH BIOCHEM BIOPHYS, V252, P418, DOI 10.1016/0003-9861(87)90048-8; HASHIMOTO Y, 1987, J BIOL CHEM, V262, P8051; Hudmon A, 1996, J BIOL CHEM, V271, P8800, DOI 10.1074/jbc.271.15.8800; Ishida A, 1996, BBA-MOL CELL RES, V1311, P211, DOI 10.1016/0167-4889(95)00197-2; ISHIDA A, 1995, J BIOL CHEM, V270, P2163, DOI 10.1074/jbc.270.5.2163; Johnson LN, 2001, E SCHERING RES FDN W, V34, P47; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lengyel I, 2004, EUR J NEUROSCI, V20, P3063, DOI 10.1111/j.1460-9568.2004.03748.x; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Morris EP, 2001, J MOL BIOL, V308, P1, DOI 10.1006/jmbi.2001.4584; MUKHERJI S, 1995, J BIOL CHEM, V270, P14062, DOI 10.1074/jbc.270.23.14062; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; Pradeep KK, 2009, BIOCHEM J, V419, P123, DOI 10.1042/BJ20081707; Roberts LA, 1998, MOL BRAIN RES, V56, P38, DOI 10.1016/S0169-328X(98)00026-6; Robison AJ, 2005, J BIOL CHEM, V280, P39316, DOI 10.1074/jbc.M508189200; SCHULMAN H, 1989, TRENDS BIOCHEM SCI, V14, P62, DOI 10.1016/0968-0004(89)90045-5; Shifman JM, 2006, P NATL ACAD SCI USA, V103, P13968, DOI 10.1073/pnas.0606433103; SMITH GL, 1985, BIOCHIM BIOPHYS ACTA, V839, P287, DOI 10.1016/0304-4165(85)90011-X; Strack S, 1997, J NEUROCHEM, V68, P2119; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Torok K, 2001, BIOCHEMISTRY-US, V40, P14878, DOI 10.1021/bi010920+; Torok K, 1998, CURR BIOL, V8, P692, DOI 10.1016/S0960-9822(98)70275-1; Tse JKY, 2007, BIOCHEMISTRY-US, V46, P4017, DOI 10.1021/bi700013y; Tzortzopoulos A, 2004, BIOCHEMISTRY-US, V43, P6404, DOI 10.1021/bi036224m; Tzortzopoulos A, 2004, BIOCHEMISTRY-US, V43, P6270, DOI 10.1021/bi035449u; Wang HM, 2008, CURR BIOL, V18, P1546, DOI 10.1016/j.cub.2008.08.064; Wang ZW, 2008, MOL NEUROBIOL, V38, P153, DOI 10.1007/s12035-008-8039-7	36	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28146	28155		10.1074/jbc.M109.005900	http://dx.doi.org/10.1074/jbc.M109.005900			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19654320	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000270676300041
J	Mima, J; Wickner, W				Mima, Joji; Wickner, William			Complex Lipid Requirements for SNARE- and SNARE Chaperone-dependent Membrane Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOTYPIC VACUOLE FUSION; VERTEX RING DOMAIN; YEAST VACUOLE; T-SNARE; PLASMA-MEMBRANE; VESICLE FUSION; SACCHAROMYCES-CEREVISIAE; SUBCELLULAR MEMBRANES; REGULATORY LIPIDS; PHOSPHOLIPASE-C	Membrane fusion without lysis has been reconstituted with purified yeast vacuolar SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptors), the SNARE chaperones Sec17p/Sec18p and the multifunctional HOPS complex, which includes a subunit of the SNARE-interactive Sec1-Munc18 family, and vacuolar lipids: phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI), phosphatidylserine (PS), phosphatidic acid (PA), cardiolipin (CL), ergosterol (ERG), diacylglycerol (DAG), and phosphatidylinositol 3-phosphate (PI3P). We now report that many of these lipids are required for rapid and efficient fusion of the reconstituted SNARE proteoliposomes in the presence of SNARE chaperones. Omission of either PE, PA, or PI3P from the complete set of lipids strongly reduces fusion, and PC, PE, PA, and PI3P constitute a minimal set of lipids for fusion. PA could neither be replaced by other lipids with small headgroups such as DAG or ERG nor by the acidic lipids PS or PI. PA is needed for full association of HOPS and Sec18p with proteoliposomes having a minimal set of lipids. Strikingly, PA and PE are as essential for SNARE complex assembly as for fusion, suggesting that these lipids facilitate functional interactions among SNAREs and SNARE chaperones.	[Mima, Joji; Wickner, William] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Wickner, W (corresponding author), Dartmouth Med Sch, Dept Biochem, 7200 Vail Bldg,Rm 425 Remsen, Hanover, NH 03755 USA.	Bill.Wickner@dartmouth.edu			National Institutes of Health [R01-GM23377]; TOYOBO BIO Foundation; Osaka University Life Science Young Independent Researcher Support Program (Japan Science and Technology Agency); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023377] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TOYOBO BIO Foundation; Osaka University Life Science Young Independent Researcher Support Program (Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM23377.; Supported by TOYOBO BIO Foundation long-term research grants and the Osaka University Life Science Young Independent Researcher Support Program (Japan Science and Technology Agency). Current address: Institute for Protein Research, Osaka University, Suita, Osaka 565-0871, Japan.	ALLAN D, 1978, NATURE, V276, P289, DOI 10.1038/276289a0; Armstrong RT, 2000, J CELL BIOL, V151, P425, DOI 10.1083/jcb.151.2.425; Boeddinghaus C, 2002, J CELL BIOL, V157, P79, DOI 10.1083/jcb.200112098; BURGESS SW, 1992, BIOCHEMISTRY-US, V31, P2653, DOI 10.1021/bi00125a004; Chang JY, 2009, BIOPHYS J, V96, P1839, DOI 10.1016/j.bpj.2008.11.033; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Collins KM, 2005, EMBO J, V24, P1775, DOI 10.1038/sj.emboj.7600658; Dennison SM, 2006, BIOPHYS J, V90, P1661, DOI 10.1529/biophysj.105.069617; Dulubova I, 2001, NAT STRUCT BIOL, V8, P258, DOI 10.1038/85012; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Fukuda R, 2000, NATURE, V407, P198, DOI 10.1038/35025084; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Haas A, 1996, EMBO J, V15, P3296, DOI 10.1002/j.1460-2075.1996.tb00694.x; INGOLIA TD, 1978, J BIOL CHEM, V253, P3821; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Jun Y, 2004, J BIOL CHEM, V279, P53186, DOI 10.1074/jbc.M411363200; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Lau WL, 2004, BIOPHYS J, V86, P272, DOI 10.1016/S0006-3495(04)74103-X; Liu S, 2007, TRAFFIC, V8, P1630, DOI 10.1111/j.1600-0854.2007.00628.x; Mayer A, 2000, MOL BIOL CELL, V11, P807, DOI 10.1091/mbc.11.3.807; Mayer A, 1997, J CELL BIOL, V136, P307, DOI 10.1083/jcb.136.2.307; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; Meers P, 2000, BBA-BIOMEMBRANES, V1467, P227, DOI 10.1016/S0005-2736(00)00224-8; Melikyan GB, 1997, J CELL BIOL, V136, P995, DOI 10.1083/jcb.136.5.995; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Nakanishi H, 2006, J CELL SCI, V119, P1406, DOI 10.1242/jcs.02841; Nickel W, 1999, P NATL ACAD SCI USA, V96, P12571, DOI 10.1073/pnas.96.22.12571; Ostrowicz CW, 2008, AUTOPHAGY, V4, P5, DOI 10.4161/auto.5054; Predescu SA, 2005, J BIOL CHEM, V280, P37130, DOI 10.1074/jbc.M505659200; Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231; Puri N, 2006, TRAFFIC, V7, P1482, DOI 10.1111/j.1600-0854.2006.00490.x; SANCHEZMIGALLON MP, 1995, BIOPHYS J, V68, P558, DOI 10.1016/S0006-3495(95)80217-1; Sato TK, 2000, MOL CELL, V6, P661, DOI 10.1016/S1097-2765(00)00064-2; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Schwartz ML, 2009, J CELL BIOL, V185, P535, DOI 10.1083/jcb.200811082; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; Starai VJ, 2008, MOL BIOL CELL, V19, P2500, DOI 10.1091/mbc.E08-01-0077; Starai VJ, 2007, P NATL ACAD SCI USA, V104, P13551, DOI 10.1073/pnas.0704741104; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tong JS, 2009, P NATL ACAD SCI USA, V106, P5141, DOI 10.1073/pnas.0813138106; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; Vicogne J, 2006, P NATL ACAD SCI USA, V103, P14761, DOI 10.1073/pnas.0606881103; Villar AV, 2000, BIOCHEMISTRY-US, V39, P14012, DOI 10.1021/bi992515c; WADA Y, 1992, J BIOL CHEM, V267, P18665; Wang L, 2003, J CELL BIOL, V160, P365, DOI 10.1083/jcb.200209095; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	59	49	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27114	27122		10.1074/jbc.M109.010223	http://dx.doi.org/10.1074/jbc.M109.010223			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19654322	Green Published, hybrid			2022-12-27	WOS:000270232300012
J	Nakano, T; Katafuchi, A; Matsubara, M; Terato, H; Tsuboi, T; Masuda, T; Tatsumoto, T; Pack, SP; Makino, K; Croteau, DL; Van Houten, B; Iijima, K; Tauchi, H; Ide, H				Nakano, Toshiaki; Katafuchi, Atsushi; Matsubara, Mayumi; Terato, Hiroaki; Tsuboi, Tomohiro; Masuda, Tasuku; Tatsumoto, Takahiro; Pack, Seung Pil; Makino, Keisuke; Croteau, Deborah L.; Van Houten, Bennett; Iijima, Kenta; Tauchi, Hiroshi; Ide, Hiroshi			Homologous Recombination but Not Nucleotide Excision Repair Plays a Pivotal Role in Tolerance of DNA-Protein Cross-links in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE LESIONS; UVRABC NUCLEASE; IN-VIVO; DAMAGE; METHYLTRANSFERASE; PATHWAY; 5-AZA-2'-DEOXYCYTIDINE; FORMALDEHYDE; INHIBITION; ACTIVATION	DNA-protein cross-links (DPCs) are unique among DNA lesions in their unusually bulky nature. The steric hindrance imposed by cross-linked proteins (CLPs) will hamper DNA transactions, such as replication and transcription, posing an enormous threat to cells. In bacteria, DPCs with small CLPs are eliminated by nucleotide excision repair (NER), whereas oversized DPCs are processed exclusively by RecBCD-dependent homologous recombination (HR). Here we have assessed the roles of NER and HR for DPCs in mammalian cells. We show that the upper size limit of CLPs amenable to mammalian NER is relatively small (8-10 kDa) so that NER cannot participate in the repair of chromosomal DPCs in mammalian cells. Moreover, CLPs are not polyubiquitinated and hence are not subjected to proteasomal degradation prior to NER. In contrast, HR constitutes the major pathway in tolerance of DPCs as judged from cell survival and RAD51 and gamma-H2AX nuclear foci formation. Induction of DPCs results in the accumulation of DNA double strand breaks in HR-deficient but not HR-proficient cells, suggesting that fork breakage at the DPC site initiates HR and reactivates the stalled fork. DPCs activate both ATR and ATM damage response pathways, but there is a time lag between two responses. These results highlight the differential involvement of NER in the repair of DPCs in bacterial and mammalian cells and demonstrate the versatile and conserved role of HR in tolerance of DPCs among species.	[Nakano, Toshiaki; Katafuchi, Atsushi; Matsubara, Mayumi; Terato, Hiroaki; Tsuboi, Tomohiro; Masuda, Tasuku; Tatsumoto, Takahiro; Ide, Hiroshi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 7398526, Japan; [Pack, Seung Pil] Korea Univ, Dept Biotechnol & Bioinformat, Jochiwon 339700, Chungnam, South Korea; [Makino, Keisuke] Kyoto Univ, Inst Adv Energy, Uji 6110011, Japan; [Croteau, Deborah L.; Van Houten, Bennett] NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA; [Iijima, Kenta; Tauchi, Hiroshi] Ibaraki Univ, Fac Sci, Dept Environm Sci, Mito, Ibaraki 3108512, Japan	Hiroshima University; Korea University; Kyoto University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Ibaraki University	Ide, H (corresponding author), Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 7398526, Japan.	ideh@hiroshima-u.ac.jp	Ide, Hiroshi/G-9042-2019; Croteau, Deb/AAP-5933-2020; Van Houten, Bennett/K-2284-2019	Terato, Hiroaki/0000-0002-7070-5263; Croteau, Deborah/0000-0002-6094-4084; Nakano, Toshiaki/0000-0002-5274-2909	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science (to T. N., H. T., and H. I.) and by a Grant-in-aid for the Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology (to H. I.).	Baker DJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702856200; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; Bergstralh DT, 2008, TRENDS GENET, V24, P70, DOI 10.1016/j.tig.2007.11.003; Chvalova K, 2007, NUCLEIC ACIDS RES, V35, P1812, DOI 10.1093/nar/gkm032; Debethune L, 2002, NUCLEIC ACIDS RES, V30, P1198, DOI 10.1093/nar/30.5.1198; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Gowher H, 2004, CANCER BIOL THER, V3, P1062, DOI 10.4161/cbt.3.11.1308; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Karpf AR, 2001, MOL PHARMACOL, V59, P751, DOI 10.1124/mol.59.4.751; Kiziltepe T, 2007, MOL CANCER THER, V6, P1718, DOI 10.1158/1535-7163.MCT-07-0010; Kobayashi J, 2002, CURR BIOL, V12, P1846, DOI 10.1016/S0960-9822(02)01259-9; Kuo HK, 2007, CANCER RES, V67, P8248, DOI 10.1158/0008-5472.CAN-07-1038; Lambert S, 2005, BIOCHIMIE, V87, P591, DOI 10.1016/j.biochi.2004.10.020; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Liu K, 2003, MOL CELL BIOL, V23, P2709, DOI 10.1128/MCB.23.8.2709-2719.2003; Lundin C, 2002, MOL CELL BIOL, V22, P5869, DOI 10.1128/MCB.22.16.5869-5878.2002; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Minko IG, 2005, BIOCHEMISTRY-US, V44, P3000, DOI 10.1021/bi0478805; Minko IG, 2002, P NATL ACAD SCI USA, V99, P1905, DOI 10.1073/pnas.042700399; Morishima K, 2007, BIOCHEM BIOPH RES CO, V362, P872, DOI 10.1016/j.bbrc.2007.08.086; Nakano T, 2005, NUCLEIC ACIDS RES, V33, P2181, DOI 10.1093/nar/gki513; Nakano T, 2005, MUTAGENESIS, V20, P209, DOI 10.1093/mutage/gei027; Nakano T, 2003, J BIOL CHEM, V278, P25264, DOI 10.1074/jbc.M212847200; Nakano T, 2007, MOL CELL, V28, P147, DOI 10.1016/j.molcel.2007.07.029; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Novakova O, 2003, NUCLEIC ACIDS RES, V31, P6450, DOI 10.1093/nar/gkg863; Oka M, 2005, ONCOGENE, V24, P3091, DOI 10.1038/sj.onc.1208540; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Palii SS, 2008, MOL CELL BIOL, V28, P752, DOI 10.1128/MCB.01799-07; Quievryn G, 2000, CARCINOGENESIS, V21, P1573, DOI 10.1093/carcin/21.8.1573; Reardon JT, 2006, CELL CYCLE, V5, P1366, DOI 10.4161/cc.5.13.2892; Reardon JT, 2006, P NATL ACAD SCI USA, V103, P4056, DOI 10.1073/pnas.0600538103; Ridpath JR, 2007, CANCER RES, V67, P11117, DOI 10.1158/0008-5472.CAN-07-3028; Saintigny Y, 2001, EMBO J, V20, P3861, DOI 10.1093/emboj/20.14.3861; Schneider-Stock R, 2005, J PHARMACOL EXP THER, V312, P525, DOI 10.1124/jpet.104.074195; Skorvaga M, 2002, J BIOL CHEM, V277, P1553, DOI 10.1074/jbc.M108847200; Speit G, 2007, MUTAGENESIS, V22, P387, DOI 10.1093/mutage/gem031; Speit Gunter, 2006, Methods Mol Biol, V314, P275; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Truglio JJ, 2004, EMBO J, V23, P2498, DOI 10.1038/sj.emboj.7600263; Zhu WG, 2004, J BIOL CHEM, V279, P15161, DOI 10.1074/jbc.M311703200	41	88	89	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27065	27076		10.1074/jbc.M109.019174	http://dx.doi.org/10.1074/jbc.M109.019174			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19674975	Green Published, hybrid			2022-12-27	WOS:000270232300008
J	Mnatsakanyan, N; Hook, JA; Quisenberry, L; Weber, J				Mnatsakanyan, Nelli; Hook, Jonathon A.; Quisenberry, Leah; Weber, Joachim			ATP Synthase with Its gamma Subunit Reduced to the N-terminal Helix Can Still Catalyze ATP Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI F-1-ATPASE; BOVINE HEART-MITOCHONDRIA; PROTON MOTIVE FORCE; EPSILON-SUBUNIT; NUCLEOTIDE-BINDING; F0F1-ATP SYNTHASE; F1F0-ATP SYNTHASE; MUTANT STRAINS; BETA-SUBUNITS; DELTA-SUBUNIT	ATP synthase uses a unique rotary mechanism to couple ATP synthesis and hydrolysis to transmembrane proton translocation. As part of the synthesis mechanism, the torque of the rotor has to be converted into conformational rearrangements of the catalytic binding sites on the stator to allow synthesis and release of ATP. The gamma subunit of the rotor, which plays a central role in the energy conversion, consists of two long helices inside the central cavity of the stator cylinder plus a globular portion outside the cylinder. Here, we show that the N-terminal helix alone is able to fulfill the function of full-length gamma in ATP synthesis as long as it connects to the rest of the rotor. This connection can occur via the epsilon subunit. No direct contact between gamma and the c ring seems to be required. In addition, the results indicate that the epsilon subunit of the rotor exists in two different conformations during ATP synthesis and ATP hydrolysis.	[Weber, Joachim] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; Texas Tech Univ, Hlth Sci Ctr, Ctr Membrane Prot Res, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Weber, J (corresponding author), Texas Tech Univ, Dept Chem & Biochem, Box 41061, Lubbock, TX 79409 USA.	joachim.weber@ttuhsc.edu			National Institutes of Health [GM071462]; Texas Tech University Health Sciences Center; Laura Bush Institute for Women's Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Tech University Health Sciences Center; Laura Bush Institute for Women's Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM071462 (to J. W.).; Supported by the Summer Accelerated Biomedical Research program of the Texas Tech University Health Sciences Center and the Laura Bush Institute for Women's Health.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; AlShawi MK, 1997, BIOCHEMISTRY-US, V36, P12954, DOI 10.1021/bi971477z; Andrews SH, 2001, BIOCHEMISTRY-US, V40, P10664, DOI 10.1021/bi0155697; Boltz KW, 2006, BIOCHEMISTRY-US, V45, P11190, DOI 10.1021/bi052592+; Boltz KW, 2005, BIOCHEMISTRY-US, V44, P9497, DOI 10.1021/bi050070o; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Cipriano DJ, 2006, J BIOL CHEM, V281, P501, DOI 10.1074/jbc.M509986200; DUNCAN TM, 2009, ASBMB ANN M NEW ORL; Duvezin-Caubet S, 2003, P NATL ACAD SCI USA, V100, P13235, DOI 10.1073/pnas.2135169100; Feniouk BA, 2007, J BIOL CHEM, V282, P764, DOI 10.1074/jbc.M606321200; Feniouk BA, 2006, BBA-BIOENERGETICS, V1757, P326, DOI 10.1016/j.bbabio.2006.03.022; Furuike S, 2008, SCIENCE, V319, P955, DOI 10.1126/science.1151343; Gao YQ, 2005, CELL, V123, P195, DOI 10.1016/j.cell.2005.10.001; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; GOELZ SE, 1982, BIOCHEMISTRY-US, V21, P189, DOI 10.1021/bi00530a032; Greene MD, 2003, J BIOL CHEM, V278, P51594, DOI 10.1074/jbc.M309948200; Hossain MD, 2008, BIOPHYS J, V95, P4837, DOI 10.1529/biophysj.108.140061; Iino R, 2005, J BIOL CHEM, V280, P40130, DOI 10.1074/jbc.M506160200; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Kato-Yamada Y, 1999, J BIOL CHEM, V274, P33991, DOI 10.1074/jbc.274.48.33991; Ketchum CJ, 1998, J BIOL CHEM, V273, P22292, DOI 10.1074/jbc.273.35.22292; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; Lowry DS, 2005, BIOCHEMISTRY-US, V44, P7275, DOI 10.1021/bi047293j; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mao HZ, 2008, J BIOL CHEM, V283, P24781, DOI 10.1074/jbc.M804142200; Mao HZ, 2007, P NATL ACAD SCI USA, V104, P18478, DOI 10.1073/pnas.0709322104; Mao HZ, 2006, FEBS LETT, V580, P4131, DOI 10.1016/j.febslet.2006.06.059; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Mnatsakanyan N, 2009, J BIOL CHEM, V284, P11336, DOI 10.1074/jbc.M900374200; Mulkidjanian AY, 2007, NAT REV MICROBIOL, V5, P892, DOI 10.1038/nrmicro1767; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Noji H, 2001, J BIOL CHEM, V276, P1665, DOI 10.1074/jbc.R000021200; Peskova YB, 2000, BIOCHEMISTRY-US, V39, P11830, DOI 10.1021/bi0013694; Pogoryelov D, 2008, FEBS J, V275, P4850, DOI 10.1111/j.1742-4658.2008.06623.x; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; Scanlon JAB, 2007, BIOCHEMISTRY-US, V46, P8785, DOI 10.1021/bi700610m; SENIOR AE, 1983, BIOCHEM J, V210, P395, DOI 10.1042/bj2100395; SENIOR AE, 1984, ARCH BIOCHEM BIOPHYS, V228, P49, DOI 10.1016/0003-9861(84)90045-6; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Suzuki T, 2002, J BIOL CHEM, V277, P13281, DOI 10.1074/jbc.M111210200; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; Vinogradov AD, 2000, J EXP BIOL, V203, P41; WALKER JE, 1986, CHEM SCR, V268, P263; Weber J, 2000, BBA-BIOENERGETICS, V1458, P300, DOI 10.1016/S0005-2728(00)00082-7; Weber J, 2003, J BIOL CHEM, V278, P13409, DOI 10.1074/jbc.M212037200; Weber J, 2004, METHOD ENZYMOL, V380, P132; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; WEBER J, 1993, J BIOL CHEM, V268, P20126; Weber J, 1999, J BIOL CHEM, V274, P19124, DOI 10.1074/jbc.274.27.19124; Weber J, 2006, BBA-BIOENERGETICS, V1757, P1162, DOI 10.1016/j.bbabio.2006.04.007; Wilkens S, 2005, ADV PROTEIN CHEM, V71, P345, DOI 10.1016/S0065-3233(04)71009-8; Xiao Y, 2000, J BIOL CHEM, V275, P6963, DOI 10.1074/jbc.275.10.6963; Yagi H, 2007, P NATL ACAD SCI USA, V104, P11233, DOI 10.1073/pnas.0701045104; Yang W, 2003, P NATL ACAD SCI USA, V100, P874, DOI 10.1073/pnas.0337432100; YOSHIDA M, 1977, P NATL ACAD SCI USA, V74, P936, DOI 10.1073/pnas.74.3.936	56	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26519	26525		10.1074/jbc.M109.030528	http://dx.doi.org/10.1074/jbc.M109.030528			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19636076	hybrid, Green Published			2022-12-27	WOS:000269969600033
J	Undurti, A; Huang, Y; Lupica, JA; Smith, JD; DiDonato, JA; Hazen, SL				Undurti, Arundhati; Huang, Ying; Lupica, Joseph A.; Smith, Jonathan D.; DiDonato, Joseph A.; Hazen, Stanley L.			Modification of High Density Lipoprotein by Myeloperoxidase Generates a Pro-inflammatory Particle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; REVERSE CHOLESTEROL TRANSPORT; RECEPTOR CLASS-B; CYTOKINE-INDUCED EXPRESSION; CELL-ADHESION MOLECULE-1; ESTER TRANSFER PROTEIN; NITRIC-OXIDE SYNTHASE; SCAVENGER RECEPTOR; ENDOTHELIAL-CELLS; ANTIINFLAMMATORY PROPERTIES	High density lipoprotein (HDL) is the major atheroprotective particle in plasma. Recent studies demonstrate that myeloperoxidase (MPO) binds to HDL in vivo, selectively targeting apolipoprotein A1 (apoA1) of HDL for oxidative modification and concurrent loss in cholesterol efflux and lecithin cholesterol acyl transferase activating activities, generating a "dysfunctional HDL" particle. We now show that (patho) physiologically relevant levels of MPO-catalyzed oxidation result in loss of non-cholesterol efflux activities of HDL including anti-apoptotic and anti-inflammatory functions. One mechanism responsible is shown to involve the loss of modified HDL binding to the HDL receptor, scavenger receptor B1, and concurrent acquisition of saturable and specific binding to a novel unknown receptor independent of scavenger receptors CD36 and SR-A1. HDL modification by MPO is further shown to confer pro-inflammatory gain of function activities as monitored by NF-kappa B activation and surface vascular cell adhesion molecule levels on aortic endothelial cells exposed to MPO-oxidized HDL. The loss of non-cholesterol efflux activities and the gain of pro-inflammatory functions requires modification of the entire particle and can be recapitulated by oxidation of reconstituted HDL particles comprised of apoA1 and nonoxidizable phosphatidylcholine species. Multiple site-directed mutagenesis studies of apoA1 suggest that the pro-inflammatory activity of MPO-modified HDL does not involve methionine, tyrosine, or tryptophan, oxidant-sensitive residues previously mapped as sites of apoA1 oxidation within human atheroma. Thus, MPO-catalyzed oxidation of HDL results not only in the loss of classic atheroprotective reverse cholesterol transport activities of the lipoprotein but also both the loss of non-cholesterol efflux related activities and the gain of pro-inflammatory functions.	[Hazen, Stanley L.] Cleveland Clin, Dept Cell Biol, Cleveland, OH 44195 USA; [Smith, Jonathan D.; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Undurti, Arundhati; Huang, Ying; Lupica, Joseph A.; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; [Undurti, Arundhati] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University	Hazen, SL (corresponding author), Cleveland Clin, Dept Cell Biol, 9500 Euclid Ave,NE10, Cleveland, OH 44195 USA.	hazens@ccf.org	Hazen, Stanley L/ABD-5845-2021; Smith, Jonathan D./H-9723-2013	Lupica, Joseph/0000-0003-1476-037X; Smith, Jonathan D./0000-0002-0415-386X	National Institutes of Health [P01 HL076491-055328, P01 HL077107-050004, P01 HL087018-02001]; Case Western Reserve University; Cleveland Clinic Clinical and Translational Science [1KL2RR024990]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024990] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491, P50HL077107, P01HL087018, R01HL066082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Reserve University; Cleveland Clinic Clinical and Translational Science; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL076491-055328, P01 HL077107-050004, P01 HL087018-02001. This work was also supported by Case Western Reserve University/Cleveland Clinic Clinical and Translational Science Award 1KL2RR024990.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Askari AT, 2003, J EXP MED, V197, P615, DOI 10.1084/jem.20021426; Baker PW, 1999, J LIPID RES, V40, P345; Baldus S, 2003, CIRCULATION, V108, P1440, DOI 10.1161/01.CIR.0000090690.67322.51; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Bauer JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001313; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; BLANCHE PJ, 1981, BIOCHIM BIOPHYS ACTA, V665, P408, DOI 10.1016/0005-2760(81)90253-8; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; COCKERILL GW, 1995, ARTERIOSCL THROM VAS, V15, P1987, DOI 10.1161/01.ATV.15.11.1987; Cockerill GW, 2001, CIRCULATION, V103, P108; CYBULSKY MI, 1991, SCIENCE, V251, P788, DOI 10.1126/science.1990440; de Winther MPJ, 2000, ARTERIOSCL THROM VAS, V20, P290, DOI 10.1161/01.ATV.20.2.290; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; FIELDING CJ, 1995, J LIPID RES, V36, P211; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Gu XJ, 1998, J BIOL CHEM, V273, P35388, DOI 10.1074/jbc.273.41.26338; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; HESSLER JR, 1979, ATHEROSCLEROSIS, V32, P213, DOI 10.1016/0021-9150(79)90166-7; IADEMARCO MF, 1992, J BIOL CHEM, V267, P16323; Kimura T, 2008, J IMMUNOL, V181, P7332, DOI 10.4049/jimmunol.181.10.7332; Li XA, 2005, J BIOL CHEM, V280, P19087, DOI 10.1074/jbc.M500944200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATZ CE, 1982, J BIOL CHEM, V257, P4535; McGillicuddy FC, 2009, CIRCULATION, V119, P1135, DOI 10.1161/CIRCULATIONAHA.108.810721; Meuwese MC, 2007, J AM COLL CARDIOL, V50, P159, DOI 10.1016/j.jacc.2007.03.033; Mineo C, 2003, J BIOL CHEM, V278, P9142, DOI 10.1074/jbc.M211394200; Nakashima Y, 1998, ARTERIOSCL THROM VAS, V18, P842, DOI 10.1161/01.ATV.18.5.842; Navab M, 2009, J LIPID RES, V50, pS145, DOI 10.1194/jlr.R800036-JLR200; Nicholls SJ, 2005, TRENDS CARDIOVAS MED, V15, P212, DOI 10.1016/j.tcm.2005.06.004; Nofer JR, 2001, J BIOL CHEM, V276, P34480, DOI 10.1074/jbc.M103782200; OSBORNE JCJ, 1968, METHODS ENZYMOL A, V128, P213; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Paromov VM, 2003, J BIOL CHEM, V278, P40859, DOI 10.1074/jbc.M306580200; Peng DQ, 2008, ARTERIOSCL THROM VAS, V28, P2063, DOI 10.1161/ATVBAHA.108.173815; Peng DQ, 2005, J BIOL CHEM, V280, P33775, DOI 10.1074/jbc.M504092200; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Rosen H, 2002, J BIOL CHEM, V277, P30463, DOI 10.1074/jbc.M202331200; RYE KA, 1992, J LIPID RES, V33, P215; Shao BH, 2008, P NATL ACAD SCI USA, V105, P12224, DOI 10.1073/pnas.0802025105; Shao BH, 2006, J BIOL CHEM, V281, P9001, DOI 10.1074/jbc.C600011200; STELMASZYNSKA T, 1978, EUR J BIOCHEM, V92, P301, DOI 10.1111/j.1432-1033.1978.tb12748.x; Tall AR, 1998, EUR HEART J, V19, pA31; Tolle M, 2008, ARTERIOSCL THROM VAS, V28, P1542, DOI 10.1161/ATVBAHA.107.161042; Van Lenten BJ, 2001, CIRCULATION, V103, P2283; VanLenten BJ, 1995, J CLIN INVEST, V96, P2758, DOI 10.1172/JCI118345; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Tang WHW, 2007, J AM COLL CARDIOL, V49, P2364, DOI 10.1016/j.jacc.2007.02.053; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	57	205	210	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30825	30835		10.1074/jbc.M109.047605	http://dx.doi.org/10.1074/jbc.M109.047605			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19726691	Green Published, hybrid			2022-12-27	WOS:000271378400010
J	Arumugam, SR; Lee, TH; Benkovic, SJ				Arumugam, Sri Ranjini; Lee, Tae-Hee; Benkovic, Stephen J.			Investigation of Stoichiometry of T4 Bacteriophage Helicase Loader Protein (gp59)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE GP43; LOADING PROTEIN; T4 HELICASE; BACTERIOPHAGE-T4 PRIMOSOME; DEPENDENT REPLICATION; SINGLE-MOLECULE; COMPLEX; ARCHITECTURE; RECOMBINATION; REPLISOME	The T4 bacteriophage helicase loader (gp59) is one of the main eight proteins that play an active role in the replisome. gp59 is a small protein (26 kDa) that exists as a monomer in solution and in the crystal. It binds preferentially to forked DNA and interacts directly with the T4 helicase (gp41), single-stranded DNA-binding protein (gp32), and polymerase (gp43). However, the stoichiometry and structure of the functional form are not very well understood. There is experimental evidence for a hexameric structure for the helicase (gp41) and the primase (gp61), inferring that the gp59 structure might also be hexameric. Various experimental approaches, including gel shift, fluorescence anisotropy, light scattering, and fluorescence correlation spectroscopy, have not provided a clearer understanding of the stoichiometry. In this study, we employed single-molecule photobleaching (smPB) experiments to elucidate the stoichiometry of gp59 on a forked DNA and to investigate its interaction with other proteins forming the primosome complex. smPB studies were performed with Alexa 555-labeled gp59 proteins and a forked DNA substrate. Co-localization experiments were performed using Cy5-labeled forked DNA and Alexa 555-labeled gp59 in the presence and absence of gp32 and gp41 proteins. A systematic study of smPB experiments and subsequent data analysis using a simple model indicated that gp59 on the forked DNA forms a hexamer. In addition, the presence of gp32 and gp41 proteins increases the stability of the gp59 complex, emphasizing their functional role in T4 DNA replication machinery.	[Arumugam, Sri Ranjini; Lee, Tae-Hee; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Lee, TH (corresponding author), Penn State Univ, Dept Chem, 414 Wartik Lab, University Pk, PA 16802 USA.	txl18@psu.edu; sjb1@psu.edu	Lee, Tae-Hee/A-1266-2010		National Institutes of Health [GM13306]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM013306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM13306 (to S. J. B.).	Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; BIOCHEXU H, 2001, BIOCHEMISTRY-US, V40, P7651; Chastain PD, 2003, J BIOL CHEM, V278, P21276, DOI 10.1074/jbc.M301573200; Das SK, 2007, CHEMBIOCHEM, V8, P994, DOI 10.1002/cbic.200600474; Delagoutte E, 2005, J MOL BIOL, V347, P257, DOI 10.1016/j.jmb.2005.01.036; Dudas KC, 2005, J BIOL CHEM, V280, P21561, DOI 10.1074/jbc.m502351200; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Ishmael FT, 2002, J BIOL CHEM, V277, P20555, DOI 10.1074/jbc.M111951200; Ishmael FT, 2001, J BIOL CHEM, V276, P25236, DOI 10.1074/jbc.M100783200; Jones CE, 2001, P NATL ACAD SCI USA, V98, P8312, DOI 10.1073/pnas.121009398; Jones CE, 2000, J BIOL CHEM, V275, P27145; Kreuzer KN, 2000, TRENDS BIOCHEM SCI, V25, P165, DOI 10.1016/S0968-0004(00)01559-0; KREUZER KN, 1988, J BIOL CHEM, V263, P11366; Lefebvre SD, 1999, J BIOL CHEM, V274, P22830, DOI 10.1074/jbc.274.32.22830; Mueser TC, 2000, J MOL BIOL, V296, P597, DOI 10.1006/jmbi.1999.3438; Nelson SW, 2006, J BIOL CHEM, V281, P8697, DOI 10.1074/jbc.M512185200; Norcum MT, 2005, P NATL ACAD SCI USA, V102, P3623, DOI 10.1073/pnas.0500713102; Nossal NG, 2007, J BIOL CHEM, V282, P1098, DOI 10.1074/jbc.M606772200; Raney KD, 1996, J BIOL CHEM, V271, P14074, DOI 10.1074/jbc.271.24.14074; San Martin C, 1998, STRUCTURE, V6, P501; Shu D, 2007, EMBO J, V26, P527, DOI 10.1038/sj.emboj.7601506; van Oijen AM, 2008, NAT CHEM BIOL, V4, P440, DOI 10.1038/nchembio0808-440; Xi J, 2005, BIOCHEMISTRY-US, V44, P7747, DOI 10.1021/bi047296w; Xi J, 2005, BIOCHEMISTRY-US, V44, P2305, DOI 10.1021/bi0479508; Yang JS, 2003, J BIOL CHEM, V278, P49828, DOI 10.1074/jbc.M307406200; YONESAKI T, 1994, J BIOL CHEM, V269, P1284; Zhang ZQ, 2005, P NATL ACAD SCI USA, V102, P3254, DOI 10.1073/pnas.0500327102	27	19	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29283	29289		10.1074/jbc.M109.029926	http://dx.doi.org/10.1074/jbc.M109.029926			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19700405	hybrid, Green Published			2022-12-27	WOS:000270896800007
J	Gell, DA; Feng, L; Zhou, SP; Jeffrey, PD; Bendak, K; Gow, A; Weiss, MJ; Shi, YG; Mackay, JP				Gell, David A.; Feng, Liang; Zhou, Suiping; Jeffrey, Philip D.; Bendak, Katerina; Gow, Andrew; Weiss, Mitchell J.; Shi, Yigong; Mackay, Joel P.			A cis-Proline in alpha-Hemoglobin Stabilizing Protein Directs the Structural Reorganization of alpha-Hemoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATE PROLYL ISOMERIZATION; LIGAND-BINDING PROPERTIES; TRANS ISOMERIZATION; CRYSTAL-STRUCTURE; BETA-THALASSEMIA; REVERSIBLE HEXACOORDINATION; SECONDARY STRUCTURE; ESCHERICHIA-COLI; RIBONUCLEASE-A; GLOBIN	alpha-Hemoglobin (alpha Hb) stabilizing protein (AHSP) is expressed in erythropoietic tissues as an accessory factor in hemoglobin synthesis. AHSP forms a specific complex with alpha Hb and suppresses the heme-catalyzed evolution of reactive oxygen species by converting alpha Hb to a conformation in which the heme is coordinated at both axial positions by histidine side chains (bis-histidyl coordination). Currently, the detailed mechanism by which AHSP induces structural changes in alpha Hb has not been determined. Here, we present x-ray crystallography, NMR spectroscopy, and mutagenesis data that identify, for the first time, the importance of an evolutionarily conserved proline, Pro(30), in loop 1 of AHSP. Mutation of Pro(30) to a variety of residue types results in reduced ability to convert alpha Hb. In complex with alpha Hb, AHSP Pro(30) adopts a cis-peptidyl conformation and makes contact with the N terminus of helix G in alpha Hb. Mutations that stabilize the cis-peptidyl conformation of free AHSP, also enhance the alpha Hb conversion activity. These findings suggest that AHSP loop 1 can transmit structural changes to the heme pocket of alpha Hb, and, more generally, highlight the importance of cis-peptidyl prolyl residues in defining the conformation of regulatory protein loops.	[Gell, David A.; Mackay, Joel P.] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; [Gow, Andrew] Rutgers State Univ, Dept Pharmacol & Toxicol, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA; [Zhou, Suiping; Weiss, Mitchell J.] Univ Penn, Philadelphia, PA 19104 USA; [Zhou, Suiping; Weiss, Mitchell J.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Feng, Liang; Jeffrey, Philip D.; Shi, Yigong] Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA	University of Sydney; Rutgers State University New Brunswick; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Princeton University	Gell, DA (corresponding author), Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia.	dagell@mail.usyd.edu.au	Gow, Andrew/N-8566-2013; Weiss, Mitchell J/W-9814-2018; Weiss, Mitchell J/A-1245-2013; Mackay, Joel P/D-6834-2011; Gow, Andrew/AAR-2309-2020	Gow, Andrew/0000-0003-0876-5158; Weiss, Mitchell J/0000-0003-2460-3036; Mackay, Joel P/0000-0001-7508-8033; Gow, Andrew/0000-0003-0876-5158; Gell, David/0000-0003-0382-1181; Shi, Yigong/0000-0003-2030-168X; Jeffrey, Philip/0000-0002-4351-5341	National Institutes of Health [R01 DK61692, R01 HL087427]; Australian Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK61692 and R01 HL087427 (to M. J. W.). This work was also supported by grants from the Australian Research Council (to D. A. G. and J. P. M.).	Alayash AI, 2004, NAT REV DRUG DISCOV, V3, P152, DOI 10.1038/nrd1307; Bacik JP, 2007, J MOL BIOL, V365, P1545, DOI 10.1016/j.jmb.2006.11.002; Balagopalakrishna C, 1996, BIOCHEMISTRY-US, V35, P6393, DOI 10.1021/bi952875+; Bauer F, 2007, FEBS LETT, V581, P1555, DOI 10.1016/j.febslet.2007.03.012; BRANTLEY RE, 1993, J BIOL CHEM, V268, P6995; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrell RW, 1999, SCIENCE, V285, P1861, DOI 10.1126/science.285.5435.1861; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; de Sanctis D, 2004, IUBMB LIFE, V56, P643, DOI 10.1080/15216540500059640; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; DOU Y, 1995, J BIOL CHEM, V270, P15993, DOI 10.1074/jbc.270.27.15993; Feng L, 2005, NATURE, V435, P697, DOI 10.1038/nature03609; Feng L, 2004, CELL, V119, P629, DOI 10.1016/j.cell.2004.11.025; FESSAS P, 1963, BLOOD, V21, P21, DOI 10.1182/blood.V21.1.21.21; Fischer G, 2000, CHEM SOC REV, V29, P119, DOI 10.1039/a803742f; FOTHERGILL J, 1982, NATURE, V298, P705, DOI 10.1038/298705a0; GABUZDA TG, 1963, J CLIN INVEST, V42, P1678, DOI 10.1172/JCI104854; Gell D, 2002, J BIOL CHEM, V277, P40602, DOI 10.1074/jbc.M206084200; GRATHWOHL C, 1981, BIOPOLYMERS, V20, P2623, DOI 10.1002/bip.1981.360201209; Halder P, 2007, PROTEINS, V66, P172, DOI 10.1002/prot.21210; Hamdane D, 2007, J BIOL CHEM, V282, P6398, DOI 10.1074/jbc.M610543200; Jakob RP, 2008, J MOL BIOL, V377, P1560, DOI 10.1016/j.jmb.2008.02.010; Jakob RP, 2009, J MOL BIOL, V387, P1017, DOI 10.1016/j.jmb.2009.02.021; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kadokura H, 2005, J BACTERIOL, V187, P1519, DOI 10.1128/JB.187.4.1519-1522.2005; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kong Y, 2004, J CLIN INVEST, V114, P1457, DOI 10.1172/JCI200421982; Krieger F, 2005, J AM CHEM SOC, V127, P3346, DOI 10.1021/ja042798i; Lecomte JTJ, 2001, BIOCHEMISTRY-US, V40, P6541, DOI 10.1021/bi010226u; LEVY A, 1985, BIOCHEMISTRY-US, V24, P6050, DOI 10.1021/bi00343a005; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Luzzatto L, 2002, NATURE, V417, P703, DOI 10.1038/417703a; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; McHarg J, 1999, EUR J BIOCHEM, V259, P939, DOI 10.1046/j.1432-1327.1999.00133.x; MONTELIONE GT, 1992, J AM CHEM SOC, V114, P10974, DOI 10.1021/ja00053a051; Mulcair MD, 2006, CELL, V125, P1309, DOI 10.1016/j.cell.2006.04.040; Nam GH, 2003, BIOCHEM J, V375, P297, DOI 10.1042/BJ20030263; NATHAN DG, 1969, J CLIN INVEST, V48, P33, DOI 10.1172/JCI106156; Nathaniel C, 2003, BIOCHEM J, V372, P241, DOI 10.1042/BJ20021765; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Noble CG, 2005, NAT STRUCT MOL BIOL, V12, P144, DOI 10.1038/nsmb887; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouyang N, 2006, PROTEINS, V65, P1021, DOI 10.1002/prot.21184; Pahlke D, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-8; Paoli M, 1996, J MOL BIOL, V256, P775, DOI 10.1006/jmbi.1996.0124; Pesce A, 2004, IUBMB LIFE, V56, P657, DOI 10.1080/15216540500078830; PETERSONKENNEDY SE, 1986, J AM CHEM SOC, V108, P1739, DOI 10.1021/ja00268a004; RACHMILEWITZ EA, 1971, J BIOL CHEM, V246, P3356; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; Riccio A, 2002, P NATL ACAD SCI USA, V99, P9801, DOI 10.1073/pnas.132182099; Rifkind JM, 2003, REDOX REP, V8, P234, DOI 10.1179/135100003225002817; Robinson VL, 2003, BIOCHEMISTRY-US, V42, P10113, DOI 10.1021/bi030059t; Russell BS, 2003, J BIOL INORG CHEM, V8, P156, DOI 10.1007/s00775-002-0401-z; Sadelain M, 2007, HUM GENE THER, V18, P1, DOI 10.1089/hum.2006.151; Santiveri CM, 2004, J BIOL CHEM, V279, P34963, DOI 10.1074/jbc.M405016200; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; Schultz DA, 2005, PROTEIN SCI, V14, P2862, DOI 10.1110/ps.051610505; SCHULTZ DA, 1992, PROTEIN SCI, V1, P910, DOI 10.1002/pro.5560010709; Seidman JG, 2002, J CLIN INVEST, V109, P451, DOI 10.1172/JC1200215043; Shan L, 2007, BIOCHEMISTRY-US, V46, P11504, DOI 10.1021/bi7009794; Shaw PE, 2007, EMBO REP, V8, P40, DOI 10.1038/sj.embor.7400873; Smith CA, 2006, ACTA CRYSTALLOGR D, V62, P548, DOI 10.1107/S0907444906009796; STURGEON P, 1957, BLOOD, V12, P64, DOI 10.1182/blood.V12.1.64.64; Su D, 2007, BIOCHEMISTRY-US, V46, P6903, DOI 10.1021/bi700152b; Wedemeyer WJ, 2002, BIOCHEMISTRY-US, V41, P14637, DOI 10.1021/bi020574b; Yu X, 2007, J CLIN INVEST, V117, P1856, DOI 10.1172/JCI31664; Zhou SP, 2006, J BIOL CHEM, V281, P32611, DOI 10.1074/jbc.M607311200	69	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29462	29469		10.1074/jbc.M109.027045	http://dx.doi.org/10.1074/jbc.M109.027045			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19706593	Green Published, hybrid			2022-12-27	WOS:000270896800028
J	Jeong, KW; Lee, YH; Stallcup, MR				Jeong, Kwang Won; Lee, Young-Ho; Stallcup, Michael R.			Recruitment of the SWI/SNF Chromatin Remodeling Complex to Steroid Hormone-regulated Promoters by Nuclear Receptor Coactivator Flightless-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-RELATED PROTEINS; BREAST-CANCER CELLS; ESTROGEN-RECEPTOR; TRANSCRIPTIONAL ACTIVATION; GLUCOCORTICOID-RECEPTOR; MEDIATOR REQUIREMENT; BINDING; GENES; ATP; TRANSACTIVATION	ATP-dependent chromatin remodeling complexes, such as SWI/SNF, are required for transcriptional activation of specific genes and are believed to be recruited to gene promoters by direct interaction with DNA binding transcription factors. However, we report here that recruitment of SWI/SNF to target genes of estrogen receptor alpha (ER alpha) requires the previously described nuclear receptor coactivator protein Flightless-I (Fli-I). Fli-I can bind directly to both ER and BAF53, an actin-related component of the SWI/SNF complex, suggesting that Fli-I may recruit SWI/SNF to ER target genes via interaction with BAF53. Point mutations in Fli-I that disrupt binding to ER or BAF53 compromised the ability of Fli-I to enhance ER-mediated activation of a transiently transfected reporter gene. Depletion of endogenous Fli-I or BAF53 inhibited estrogen-responsive expression of endogenous target genes of ER, indicating a critical role for Fli-I and BAF53. Moreover, depletion of endogenous Fli-I or BAF53 specifically eliminated part of the complex cyclical pattern of recruitment of SWI/SNF to estrogen-responsive promoters in a way that indicates multiple roles and multiple mechanisms of recruitment for SWI/SNF in estrogen-dependent target gene expression. These results begin to establish the functional relationships and interdependencies that coordinate the actions of the many coactivators participating in the transcriptional activation process.	[Stallcup, Michael R.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA	University of Southern California	Stallcup, MR (corresponding author), Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Keck Sch Med, Dept Biochem & Mol Biol, 1441 Eastlake Ave,NOR 6316, Los Angeles, CA 90089 USA.	stallcup@usc.edu	Lee, Young-Ho/G-2361-2014	Lee, Young-Ho/0000-0001-6415-4912	National Institutes of Health [DK43093]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK43093 (to M. R. S.).	Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; Burakov D, 2002, J BIOL CHEM, V277, P14359, DOI 10.1074/jbc.C200099200; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen YH, 2005, MOL CELL BIOL, V25, P5965, DOI 10.1128/MCB.25.14.5965-5972.2005; CHIBA H, 1994, NUCLEIC ACIDS RES, V22, P1815, DOI 10.1093/nar/22.10.1815; Davy DA, 2001, J CELL SCI, V114, P549; Davy DA, 2000, IMMUNOL CELL BIOL, V78, P423, DOI 10.1046/j.1440-1711.2000.00926.x; DiRenzo J, 2000, MOL CELL BIOL, V20, P7541, DOI 10.1128/MCB.20.20.7541-7549.2000; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Eberharter A, 2004, J CELL SCI, V117, P3707, DOI 10.1242/jcs.01175; Fan HY, 2003, MOL CELL, V11, P1311, DOI 10.1016/S1097-2765(03)00192-8; Garcia-Pedrero JM, 2006, J BIOL CHEM, V281, P22656, DOI 10.1074/jbc.M602561200; Goodson HV, 2002, J CELL SCI, V115, P2619; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; He QY, 2008, J BIOL CHEM, V283, P5276, DOI 10.1074/jbc.M708266200; Hong CY, 2005, MOL CELL BIOL, V25, P4841, DOI 10.1128/MCB.25.12.4841-4852.2005; Hsiao PW, 2003, MOL CELL BIOL, V23, P6210, DOI 10.1128/MCB.23.17.6210-6220.2003; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Ito M, 2001, TRENDS ENDOCRIN MET, V12, P127, DOI 10.1016/S1043-2760(00)00355-6; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Johnson TA, 2008, MOL BIOL CELL, V19, P3308, DOI 10.1091/mbc.E08-02-0123; Kim JH, 2008, MOL CELL, V31, P510, DOI 10.1016/j.molcel.2008.08.001; Lee YH, 2004, MOL CELL BIOL, V24, P2103, DOI 10.1128/MCB.24.5.2103-2117.2004; Lemieux K, 2004, EMBO J, V23, P4040, DOI 10.1038/sj.emboj.7600416; Link KA, 2005, MOL CELL BIOL, V25, P2200, DOI 10.1128/MCB.25.6.2200-2215.2005; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Oxelmark E, 2006, MOL CELL BIOL, V26, P5205, DOI 10.1128/MCB.00009-06; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Rae JM, 2005, BREAST CANCER RES TR, V92, P141, DOI 10.1007/s10549-005-1483-4; Rando OJ, 2002, P NATL ACAD SCI USA, V99, P2824, DOI 10.1073/pnas.032662899; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Stallcup MR, 2003, J STEROID BIOCHEM, V85, P139, DOI 10.1016/S0960-0760(03)00222-X; Sun J, 2007, MOL ENDOCRINOL, V21, P2651, DOI 10.1210/me.2007-0082; Takata H, 2007, FEBS LETT, V581, P3783, DOI 10.1016/j.febslet.2007.06.076; Trotter KW, 2007, MOL CELL ENDOCRINOL, V265, P162, DOI 10.1016/j.mce.2006.12.015; Trotter Kevin W, 2008, Nucl Recept Signal, V6, pe004, DOI 10.1621/nrs.06004; Urosev D, 2006, J MOL BIOL, V357, P765, DOI 10.1016/j.jmb.2006.01.027; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; WAY M, 1992, J CELL BIOL, V116, P1135, DOI 10.1083/jcb.116.5.1135; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Yoon S, 2003, MOL CELL BIOL, V23, P8829, DOI 10.1128/MCB.23.23.8829-9945.2003; YOSHINAGA SK, 1992, SCIENCE, V258, P1598, DOI 10.1126/science.1360703; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	50	42	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29298	29309		10.1074/jbc.M109.037010	http://dx.doi.org/10.1074/jbc.M109.037010			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19720835	Green Published, hybrid			2022-12-27	WOS:000270896800009
J	Karlsson, C; Eliasson, M; Olin, AI; Morgelin, M; Karlsson, A; Malmsten, M; Egesten, A; Frick, IM				Karlsson, Christofer; Eliasson, Mette; Olin, Anders I.; Morgelin, Matthias; Karlsson, Anna; Malmsten, Martin; Egesten, Arne; Frick, Inga-Maria			SufA of the Opportunistic Pathogen Finegoldia magna Modulates Actions of the Antibacterial Chemokine MIG/CXCL9, Promoting Bacterial Survival during Epithelial Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO ACTIVITY; STREPTOCOCCUS-PYOGENES; ANAEROBIC COCCI; INNATE IMMUNITY; M1 PROTEIN; MIG; RECEPTOR; CELLS; OLIGOMERIZATION; ACTIVATION	The anaerobic bacterium Finegoldia magna is part of the human commensal microbiota, but is also an important opportunistic pathogen. This bacterium expresses a subtilisin-like serine proteinase, SufA, which partially degrade the antibacterial chemokine MIG/CXCL9. Here, we show that MIG/CXCL9 is produced by human keratinocytes in response to inflammatory stimuli. In contrast to the virulent human pathogen Streptococcus pyogenes, the presence of F. magna had no enhancing effect on the MIG/CXCL9 expression by keratinocytes, suggesting poor detection of the latter by pathogen-recognition receptors. When MIG/CXCL9 was exposed to SufA-expressing F. magna, the molecule was processed into several smaller fragments. Analysis by mass spectrometry showed that SufA cleaves MIG/CXCL9 at several sites in the COOH-terminal region of the molecule. At equimolar concentrations, SufA-generated MIG/CXCL9 fragments were not bactericidal against F. magna, but retained their ability to kill S. pyogenes. Moreover, the SufA-generated MIG/CXCL9 fragments were capable of activating the angiostasis-mediating CXCR3 receptor, which is expressed on endothelial cells, in an order of magnitude similar to that of intact MIG/CXCL9. F. magna expresses a surface protein called FAF that is released from the bacterial surface by SufA. Soluble FAF was found to bind and inactivate the antibacterial activity of MIG/CXCL9, thereby further potentially promoting the survival of F. magna. The findings suggest that SufA modulation of the inflammatory response could be a mechanism playing an important role in creating an ecologic niche for F. magna, decreasing antibacterial activity and suppressing angiogenesis, thus providing advantage in survival for this anaerobic opportunist compared with competing pathogens during inflammation.	[Malmsten, Martin] Uppsala Univ, Dept Pharm, SE-75123 Uppsala, Sweden; [Karlsson, Anna] Univ Gothenburg, Dept Rheumatol & Inflammat Res, SE-41346 Gothenburg, Sweden; [Eliasson, Mette; Egesten, Arne] Lund Univ, Dept Clin Sci Lund, Div Resp Med, SE-22184 Lund, Sweden; [Karlsson, Christofer; Olin, Anders I.; Morgelin, Matthias; Frick, Inga-Maria] Lund Univ, Div Infect, SE-22184 Lund, Sweden	Uppsala University; University of Gothenburg; Lund University; Lund University	Frick, IM (corresponding author), BMC B14,Tornavagen 10, SE-22184 Lund, Sweden.	Inga-Maria.Frick@med.lu.se	Karlsson, Anna/A-4130-2012	Karlsson, Anna/0000-0001-6796-1154	Swedish Research Council [7480, 2007-2880, 621-2003-4022]; Swedish Heart and Lung Foundation; Medical Faculty; Foundations of Bergh, Bergvall, Crafoord, Ihre, Hedberg, Kock, O. E. and Edla Johansson, Marcus and Marianne Wallenberg, and Osterlund; Hansa Medical AB	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Medical Faculty; Foundations of Bergh, Bergvall, Crafoord, Ihre, Hedberg, Kock, O. E. and Edla Johansson, Marcus and Marianne Wallenberg, and Osterlund; Hansa Medical AB	This work was supported by grants from the Swedish Research Council (Projects 7480, 2007-2880, and 621-2003-4022), the Swedish Heart and Lung Foundation, the Medical Faculty at Lund University, the Foundations of Bergh, Bergvall, Crafoord, Ihre, Hedberg, Kock, O. E. and Edla Johansson, Marcus and Marianne Wallenberg, and Osterlund, and Hansa Medical AB.	Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bowler PG, 2001, CLIN MICROBIOL REV, V14, P244, DOI 10.1128/CMR.14.2.244-269.2001; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Campanella GSV, 2006, J IMMUNOL, V177, P6991, DOI 10.4049/jimmunol.177.10.6991; CARLEMALM E, 1989, TECHNIQUES IMMUNOCYT; Clark-Lewis I, 2003, J BIOL CHEM, V278, P289, DOI 10.1074/jbc.M209470200; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dahlgren C, 2000, BLOOD, V95, P1810, DOI 10.1182/blood.V95.5.1810.005k06_1810_1818; Egesten A, 2007, J INFECT DIS, V195, P684, DOI 10.1086/510857; Eliasson M, 2007, MICROB PATHOGENESIS, V43, P224, DOI 10.1016/j.micpath.2007.06.007; Engelhardt E, 1998, AM J PATHOL, V153, P1849, DOI 10.1016/S0002-9440(10)65699-4; Fernandez-Fuentes N, 2007, NUCLEIC ACIDS RES, V35, pW363, DOI 10.1093/nar/gkm341; Frick IM, 2008, MOL MICROBIOL, V70, P695, DOI 10.1111/j.1365-2958.2008.06439.x; Goebeler M, 1998, J PATHOL, V184, P89, DOI 10.1002/(SICI)1096-9896(199801)184:1<89::AID-PATH975>3.0.CO;2-Z; Higaki S, 2003, DRUG EXP CLIN RES, V29, P153; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Karlsson C, 2007, MICROBIOL-SGM, V153, P4208, DOI 10.1099/mic.0.2007/010322-0; Karlsson C, 2009, MICROBIOL-SGM, V155, P238, DOI 10.1099/mic.0.021311-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIAO F, 1995, J EXP MED, V182, P1301, DOI 10.1084/jem.182.5.1301; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Malkowski MG, 1997, J MOL BIOL, V266, P367, DOI 10.1006/jmbi.1996.0796; Murdoch DA, 1998, CLIN MICROBIOL REV, V11, P81, DOI 10.1128/CMR.11.1.81; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Pahlman LI, 2008, CELL MICROBIOL, V10, P404, DOI 10.1111/j.1462-5822.2007.01053.x; Potempa J, 2009, J INNATE IMMUN, V1, P70, DOI 10.1159/000181144; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Romagnani P, 2001, J CLIN INVEST, V107, P53, DOI 10.1172/JCI9775; Sauty A, 1999, J IMMUNOL, V162, P3549; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Stephens P, 2003, BRIT J DERMATOL, V148, P456, DOI 10.1046/j.1365-2133.2003.05232.x; Stone, 1998, EFFICIENT LIB PARALL; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005	36	25	25	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29499	29508		10.1074/jbc.M109.025957	http://dx.doi.org/10.1074/jbc.M109.025957			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19628464	Green Published, hybrid			2022-12-27	WOS:000270896800032
J	Kinne, M; Poraj-Kobielska, M; Ralph, SA; Ullrich, R; Hofrichter, M; Hammel, KE				Kinne, Matthias; Poraj-Kobielska, Marzena; Ralph, Sally A.; Ullrich, Rene; Hofrichter, Martin; Hammel, Kenneth E.			Oxidative Cleavage of Diverse Ethers by an Extracellular Fungal Peroxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3,4-DIMETHOXYBENZYL ALCOHOL; PHANEROCHAETE-CHRYSOSPORIUM; LIGNIN; BIODEGRADATION; HALOPEROXIDASE; CHROMATOGRAPHY; DEMETHYLATION; 1,4-DIOXANE; GROUNDWATER; MECHANISMS	Many litter-decay fungi secrete heme-thiolate peroxygenases that oxidize various organic chemicals, but little is known about the role or mechanism of these enzymes. We found that the extracellular peroxygenase of Agrocybe aegerita catalyzed the H2O2-dependent cleavage of environmentally significant ethers, including methyl t-butyl ether, tetrahydrofuran, and 1,4-dioxane. Experiments with tetrahydrofuran showed the reaction was a two-electron oxidation that generated one aldehyde group and one alcohol group, yielding the ring-opened product 4-hydroxybutanal. Investigations with several model substrates provided information about the route for ether cleavage: (a) steady-state kinetics results with methyl 3,4-dimethoxybenzyl ether, which was oxidized to 3,4-dimethoxybenzaldehyde, gave parallel double reciprocal plots suggestive of a ping-pong mechanism (K-m(peroxide), 1.99 +/- 0.25 mM; K-m(ether), 1.43 +/- 0.23 mM; kcat, 720 +/- 87 s(-1)), (b) the cleavage of methyl 4-nitrobenzyl ether in the presence of H-2 O-18(2) resulted in incorporation of O-18 into the carbonyl group of the resulting 4-nitrobenzaldehyde, and (c) the demethylation of 1-methoxy-4-trideuteromethoxybenzene showed an observed intramolecular deuterium isotope effect [(k(H)/k(D))(obs)] of 11.9 +/- 0.4. These results suggest a hydrogen abstraction and oxygen rebound mechanism that oxidizes ethers to hemiacetals, which subsequently hydrolyze. The peroxygenase appeared to lack activity on macromolecular ethers, but otherwise exhibited a broad substrate range. It may accordingly have a role in the biodegradation of natural and anthropogenic low molecular weight ethers in soils and plant litter.	[Ralph, Sally A.; Hammel, Kenneth E.] USDA, Forest Prod Lab, Madison, WI 53726 USA; [Kinne, Matthias; Poraj-Kobielska, Marzena; Ullrich, Rene; Hofrichter, Martin] Int Grad Sch Zittau, Unit Environm Biotechnol, D-02763 Zittau, Germany; [Hammel, Kenneth E.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	United States Department of Agriculture (USDA); United States Forest Service; Technische Universitat Dresden; University of Wisconsin System; University of Wisconsin Madison	Hammel, KE (corresponding author), USDA, Forest Prod Lab, 1 Gifford Pinchot Dr, Madison, WI 53726 USA.	kehammel@wisc.edu	Hammel, Kenneth E/G-1890-2011	Hammel, Kenneth E/0000-0002-2935-5847; Hofrichter, Martin/0000-0001-5174-7604	Deutsche Bundesstiftung Umwelt Project [13225-32]; European Union; Office of Biological and Environmental Research, United States Dept. of Energy [DE-AI02-07ER64480]; Konrad Adenauer Foundation; German-American Fulbright Commission	Deutsche Bundesstiftung Umwelt Project; European Union(European Commission); Office of Biological and Environmental Research, United States Dept. of Energy; Konrad Adenauer Foundation; German-American Fulbright Commission	This work was supported in part by Deutsche Bundesstiftung Umwelt Project Number 13225-32 (to M. H.), European Union Integrated Project Biorenew (to M. H.), and Grant DE-AI02-07ER64480 from the Office of Biological and Environmental Research, United States Dept. of Energy (to K. E. H.).; Supported by the Konrad Adenauer Foundation.; Supported by the German-American Fulbright Commission.	Anh DH, 2007, APPL ENVIRON MICROB, V73, P5477, DOI 10.1128/AEM.00026-07; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; COOKE MP, 1974, BIOCHEM BIOPH RES CO, V57, P1032, DOI 10.1016/0006-291X(74)90800-6; Delserone LM, 1999, PHYSIOL MOL PLANT P, V55, P317, DOI 10.1006/pmpp.1999.0237; Ferreira NL, 2006, APPL MICROBIOL BIOT, V72, P252, DOI 10.1007/s00253-006-0494-3; FOSTER AB, 1974, CHEM-BIOL INTERACT, V9, P327, DOI 10.1016/0009-2797(74)90128-8; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Hernandez A, 1998, BIOINFORMATICS, V14, P227, DOI 10.1093/bioinformatics/14.2.227; Hofrichter M, 2006, APPL MICROBIOL BIOT, V71, P276, DOI 10.1007/s00253-006-0417-3; Isaacson C, 2006, ENVIRON SCI TECHNOL, V40, P7305, DOI 10.1021/es0615270; Kerem Z, 1999, FEBS LETT, V446, P49, DOI 10.1016/S0014-5793(99)00180-5; Kim D, 2004, ARCH BIOCHEM BIOPHYS, V432, P102, DOI 10.1016/j.abb.2004.09.001; Kinne M, 2008, TETRAHEDRON LETT, V49, P5950, DOI 10.1016/j.tetlet.2008.07.152; Kinne M, 2009, BIOORG MED CHEM LETT, V19, P3085, DOI 10.1016/j.bmcl.2009.04.015; Kluge M, 2009, APPL MICROBIOL BIOT, V81, P1071, DOI 10.1007/s00253-008-1704-y; KOK GL, 1980, ATMOS ENVIRON, V14, P653, DOI 10.1016/0004-6981(80)90048-7; LAWSON T, 1995, J AGR FOOD CHEM, V43, P2627, DOI 10.1021/jf00058a014; Leonowicz A, 1999, FUNGAL GENET BIOL, V27, P175, DOI 10.1006/fgbi.1999.1150; Li H, 2007, J CHROMATOGR A, V1175, P133, DOI 10.1016/j.chroma.2007.10.040; Mahendra S, 2007, ENVIRON SCI TECHNOL, V41, P7330, DOI 10.1021/es0705745; McLafferty F. W., 1993, INTERPRETATION MASS; Nelson SD, 2003, DRUG METAB DISPOS, V31, P1481, DOI 10.1124/dmd.31.12.1481; Ortiz de Montellano P.R., 2005, CYTOCHROME P450 STRU, P183, DOI [10.1007/b139087, DOI 10.1007/B139087]; PECYNA MJ, 2009, APPL MICROB IN PRESS; Pedersen DS, 2001, SYNTHESIS-STUTTGART, P2431, DOI 10.1055/s-2001-18722; SAMUEL D, 1965, ADV PHYS ORG CHEM, V3, P121; SCHMIDT HWH, 1989, BIOCHEMISTRY-US, V28, P1776, DOI 10.1021/bi00430a053; Scow KM, 2005, CURR OPIN BIOTECH, V16, P246, DOI 10.1016/j.copbio.2005.03.009; TIEN M, 1986, J BIOL CHEM, V261, P1687; TIEN M, 1984, P NATL ACAD SCI-BIOL, V81, P2280, DOI 10.1073/pnas.81.8.2280; Tortella GR, 2005, CRIT REV MICROBIOL, V31, P197, DOI 10.1080/10408410500304066; Ullrich R, 2005, FEBS LETT, V579, P6247, DOI 10.1016/j.febslet.2005.10.014; Ullrich R, 2007, CELL MOL LIFE SCI, V64, P271, DOI 10.1007/s00018-007-6362-1; Ulrich R, 2004, APPL ENVIRON MICROB, V70, P4575, DOI 10.1128/AEM.70.8.4575-4581.2004; White GF, 1996, MICROBIOL REV, V60, P216, DOI 10.1128/MMBR.60.1.216-232.1996; Whiting DA, 2001, NAT PROD REP, V18, P583, DOI 10.1039/b003686m; Yun CH, 2005, J BIOL CHEM, V280, P12279, DOI 10.1074/jbc.M411019200	37	70	70	3	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29343	29349		10.1074/jbc.M109.040857	http://dx.doi.org/10.1074/jbc.M109.040857			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19713216	Green Published, hybrid			2022-12-27	WOS:000270896800014
J	Farzan, SF; Stegman, MA; Ogden, SK; Ascano, M; Black, KE; Tacchelly, O; Robbins, DJ				Farzan, Shohreh F.; Stegman, Melanie A.; Ogden, Stacey K.; Ascano, Manuel, Jr.; Black, Kendall E.; Tacchelly, Ofelia; Robbins, David J.			A Quantification of Pathway Components Supports a Novel Model of Hedgehog Signal Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINESIN-RELATED PROTEIN; DROSOPHILA CUBITUS INTERRUPTUS; GLYCOGEN-SYNTHASE KINASE-3; SEGMENT POLARITY GENE; STEROL-SENSING DOMAIN; SUBCELLULAR-LOCALIZATION; REQUIRES PHOSPHORYLATION; VESICULAR TRAFFICKING; SMOOTHENED ACTIVITY; MEMBRANE-PROTEIN	The secreted protein Hedgehog (Hh) plays a critical instructional role during metazoan development. In Drosophila, Hh signaling is interpreted by a set of conserved, downstream effectors that differentially localize and interact to regulate the stability and activity of the transcription factor Cubitus interruptus. Two-essential models that integrate genetic, cell biological, and biochemical information have been proposed to explain how these signaling components relate to one another within the cellular context. As the molar ratios of the signaling effectors required in each of these models are quite different, quantitating the cellular ratio of pathway components could distinguish these two models. Here, we address this important question using a set of purified protein standards to perform a quantitative analysis of Drosophila cell lysates for each downstream pathway component. We determine each component's steady-state concentration within a given cell, demonstrate the molar ratio of Hh signaling effectors differs more than two orders of magnitude and that this ratio is conserved in vivo. We find that the G-protein-coupled transmembrane protein Smoothened, an activating component, is present in limiting amounts, while a negative pathway regulator, Suppressor of Fused, is present in vast molar excess. Interestingly, despite large differences in the steady-state ratio, all downstream signaling components exist in an equimolar membrane-associated complex. We use these quantitative results to re-evaluate the current models of Hh signaling and now propose a novel model of signaling that accounts for the stoichiometric differences observed between various Hh pathway components.	[Tacchelly, Ofelia; Robbins, David J.] Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA; [Robbins, David J.] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Robbins, DJ (corresponding author), Dartmouth Med Sch, Dept Pharmacol & Toxicol, HB 7650, Hanover, NH 03755 USA.	David.J.Robbins@Dartmouth.edu	Ascano, Manuel/ABA-3586-2020; Ogden, Stacey K/P-9585-2019; Ogden, Stacey K/N-2528-2018	Ascano, Manuel/0000-0002-9370-5493; Ogden, Stacey K/0000-0001-8991-3065; 	National Institutes of Health [CA8628]; Ryan Fellowship; Rosaline Borison Predoctoral Fellowship; NATIONAL CANCER INSTITUTE [R01CA082628] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ryan Fellowship; Rosaline Borison Predoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA8628 (to D. J. R.). This work was also supported by a Ryan Fellowship (to S. F. F.) and a Rosaline Borison Predoctoral Fellowship (to S. F. F.).	Aikin RA, 2008, EMBO REP, V9, P330, DOI 10.1038/embor.2008.38; Alberts B., 2010, MOL BIOL CELL; Alcedo J, 2000, MOL CELL, V6, P457, DOI 10.1016/S1097-2765(00)00044-7; Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Alexandre C, 1996, GENE DEV, V10, P2003, DOI 10.1101/gad.10.16.2003; Alves G, 1998, MECH DEVELOP, V78, P17, DOI 10.1016/S0925-4773(98)00130-0; Ascano M, 2004, MOL CELL BIOL, V24, P10397, DOI 10.1128/MCB.24.23.10397-10405.2004; Ascano M, 2002, MOL CELL BIOL, V22, P1555, DOI 10.1128/MCB.22.5.1555-1566.2002; AZA BP, 1997, CELL, V89, P1043; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chen Y, 1998, DEVELOPMENT, V125, P4943; CURRIE DA, 1988, DEVELOPMENT, V102, P805; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Dussillol-Godar F, 2006, DEV BIOL, V291, P53, DOI 10.1016/j.ydbio.2005.12.004; Farzan SF, 2008, CURR BIOL, V18, P1215, DOI 10.1016/j.cub.2008.07.026; FORBES AJ, 1993, DEVELOPMENT, P115; Fouix S, 2003, GENES CELLS, V8, P897, DOI 10.1046/j.1365-2443.2003.00685.x; Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200; HEEMSKERK J, 1994, CELL, V76, P449, DOI 10.1016/0092-8674(94)90110-4; Ho KS, 2005, DEVELOPMENT, V132, P1401, DOI 10.1242/dev.01689; Hooper JE, 2003, DEVELOPMENT, V130, P3951, DOI 10.1242/dev.00594; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; HOOPER JE, 1989, CELL, V59, P751, DOI 10.1016/0092-8674(89)90021-4; HORTSCH M, 1990, J BIOL CHEM, V265, P15104; Ingham PW, 2000, CURR BIOL, V10, P1315, DOI 10.1016/S0960-9822(00)00755-7; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; INGHAM PW, 1993, NATURE, V366, P560, DOI 10.1038/366560a0; Jia JH, 2003, GENE DEV, V17, P2709, DOI 10.1101/gad.1136603; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Kalderon D, 2004, CURR BIOL, V14, pR67, DOI 10.1016/j.cub.2003.12.047; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Lum L, 2003, MOL CELL, V12, P1261, DOI 10.1016/S1097-2765(03)00426-X; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Martin V, 2001, CURR BIOL, V11, P601, DOI 10.1016/S0960-9822(01)00178-6; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Meng XW, 2001, J BIOL CHEM, V276, P40113, DOI 10.1074/jbc.M105317200; Methot N, 2000, DEVELOPMENT, V127, P4001; Monnier V, 1998, CURR BIOL, V8, P583, DOI 10.1016/S0960-9822(98)70227-1; MOTZNY CK, 1995, MECH DEVELOP, V52, P137, DOI 10.1016/0925-4773(95)00397-J; Nakano Y, 2004, MECH DEVELOP, V121, P507, DOI 10.1016/j.mod.2004.04.015; Norton AW, 2005, J BIOL CHEM, V280, P1248, DOI 10.1074/jbc.M410475200; Ogden SK, 2006, J BIOL CHEM, V281, P7237, DOI 10.1074/jbc.M510169200; Ogden SK, 2004, BIOCHEM PHARMACOL, V67, P805, DOI 10.1016/j.bcp.2004.01.002; Ogden SK, 2003, CURR BIOL, V13, P1998, DOI 10.1016/j.cub.2003.10.004; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Ohlmeyer JT, 1998, NATURE, V396, P749, DOI 10.1038/25533; ORENIC TV, 1990, GENE DEV, V4, P1053, DOI 10.1101/gad.4.6.1053; PHAM A, 1995, GENETICS, V140, P587; PREAT T, 1992, GENETICS, V132, P725; PREAT T, 1993, GENETICS, V135, P1047; Price MA, 1999, DEVELOPMENT, V126, P4331; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Riches Z, 2009, DRUG METAB DISPOS, V37, P2255, DOI 10.1124/dmd.109.028399; Robbins DJ, 2007, EMBO REP, V8, P451, DOI 10.1038/sj.embor.7400959; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; ROSS EM, 1989, NEURON, V3, P141, DOI 10.1016/0896-6273(89)90027-5; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Ruel L, 2003, NAT CELL BIOL, V5, P907, DOI 10.1038/ncb1052; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sasse J., 2009, CURR PROT MOL BIOL, V85, P1; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; SHAFFER CD, 1994, METHOD CELL BIOL, V44, P99, DOI 10.1016/S0091-679X(08)60908-5; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; Smelkinson MG, 2007, DEV CELL, V13, P481, DOI 10.1016/j.devcel.2007.09.006; Stegman MA, 2000, J BIOL CHEM, V275, P21809, DOI 10.1074/jbc.C000043200; Stegman MA, 2004, J BIOL CHEM, V279, P7064, DOI 10.1074/jbc.M311794200; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Strutt H, 2001, CURR BIOL, V11, P608, DOI 10.1016/S0960-9822(01)00179-8; Therond PP, 1996, P NATL ACAD SCI USA, V93, P4224, DOI 10.1073/pnas.93.9.4224; Torroja C, 2005, J NEUROBIOL, V64, P334, DOI 10.1002/neu.20168; Umenishi F, 2002, KIDNEY INT, V62, P2288, DOI 10.1046/j.1523-1755.2002.00686.x; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; VANLEEUWEN F, 1994, NATURE, V368, P342, DOI 10.1038/368342a0; VonOhlen T, 1997, P NATL ACAD SCI USA, V94, P2404, DOI 10.1073/pnas.94.6.2404; Wang GL, 2000, GENE DEV, V14, P2893, DOI 10.1101/gad.843900; Wang QT, 1999, DEVELOPMENT, V126, P5097; Yao WD, 2001, J NEUROPHYSIOL, V85, P1384, DOI 10.1152/jn.2001.85.4.1384; Zhang WS, 2005, DEV CELL, V8, P267, DOI 10.1016/j.devcel.2005.01.001; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225	81	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28874	28884		10.1074/jbc.M109.041608	http://dx.doi.org/10.1074/jbc.M109.041608			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19717563	Green Published, hybrid			2022-12-27	WOS:000270678900044
J	Howlett, NG; Harney, JA; Rego, MA; Kolling, FW; Glover, TW				Howlett, Niall G.; Harney, Julie A.; Rego, Meghan A.; Kolling, Frederick W.; Glover, Thomas W.			Functional Interaction between the Fanconi Anemia D2 Protein and Proliferating Cell Nuclear Antigen (PCNA) via a Conserved Putative PCNA Interaction Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; CORE COMPLEX; POLYMERASE-ETA; S-PHASE; FANCD2 MONOUBIQUITINATION; CROSS-LINKS; REPAIR; REPLICATION; PATHWAY; BRCA2	Fanconi Anemia (FA) is a rare recessive disease characterized by congenital abnormalities, bone marrow failure, and cancer susceptibility. The FA proteins and the familial breast cancer susceptibility gene products, BRCA1 and FANCD1/BRCA2, function cooperatively in the FA-BRCA pathway to repair damaged DNA and to prevent cellular transformation. Activation of this pathway occurs via the mono-ubiquitination of the FANCD2 protein, targeting it to nuclear foci where it co-localizes with FANCD1/BRCA2, RAD51, and PCNA. The regulation of the mono-ubiquitination of FANCD2, as well as its function in DNA repair remain poorly understood. In this study, we have further characterized the interaction between the FANCD2 and PCNA proteins. We have identified a highly conserved, putative FANCD2 PCNA interaction motif (PIP-box), and demonstrate that mutation of this motif disrupts FANCD2-PCNA binding and precludes the mono-ubiquitination of FANCD2. Consequently, the FANCD2 PIP-box mutant protein fails to correct the mitomycin C hypersensitivity of FA-D2 patient cells. Our results suggest that PCNA may function as a molecular platform to facilitate the mono-ubiquitination of FANCD2 and activation of the FA-BRCA pathway.	[Howlett, Niall G.; Harney, Julie A.; Rego, Meghan A.; Kolling, Frederick W.] Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA; [Glover, Thomas W.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Glover, Thomas W.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA	University of Rhode Island; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Howlett, NG (corresponding author), 379 CBLS,120 Flagg Rd, Kingston, RI 02881 USA.	nhowlett@mail.uri.edu			National Institutes of Health [R01CA043222-21]; Fanconi Anemia Research Foundation; Leukemia Research Foundation New Investigator; RIINBRE, National Center for Research Resources [P20RR016457-09]; NATIONAL CANCER INSTITUTE [R01CA043222] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fanconi Anemia Research Foundation; Leukemia Research Foundation New Investigator; RIINBRE, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA043222-21 (to T. W. G.). This work was also supported by a Fanconi Anemia Research Foundation grant (to N. G. H. and T. W. G.), a Leukemia Research Foundation New Investigator grant (to N. G. H.), and a RIINBRE Grant P20RR016457-09 from the National Center for Research Resources.	Acharya N, 2008, P NATL ACAD SCI USA, V105, P17724, DOI 10.1073/pnas.0809844105; Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Alpi A, 2007, MOL CELL BIOL, V27, P8421, DOI 10.1128/MCB.00504-07; Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; de Oca RM, 2005, BLOOD, V105, P1003, DOI 10.1182/blood-2003-11-3997; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; *FANC AN RES FUND, FANC AN STAND CLIN C; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gary R, 1997, J BIOL CHEM, V272, P24522, DOI 10.1074/jbc.272.39.24522; Guo CX, 2006, MOL CELL, V23, P265, DOI 10.1016/j.molcel.2006.05.038; Haracska L, 2001, MOL CELL BIOL, V21, P7199, DOI 10.1128/MCB.21.21.7199-7206.2001; Ho GPH, 2006, MOL CELL BIOL, V26, P7005, DOI 10.1128/MCB.02018-05; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Howlett NG, 2005, HUM MOL GENET, V14, P693, DOI 10.1093/hmg/ddi065; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Hussain S, 2004, HUM MOL GENET, V13, P1241, DOI 10.1093/hmg/ddh135; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; Matsushita N, 2005, MOL CELL, V19, P841, DOI 10.1016/j.molcel.2005.08.018; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Mi J, 2005, BLOOD, V105, P759, DOI 10.1182/blood-2004-01-0001; Mirchandani KD, 2008, DNA REPAIR, V7, P902, DOI 10.1016/j.dnarep.2008.03.001; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Mosedale G, 2005, NAT STRUCT MOL BIOL, V12, P763, DOI 10.1038/nsmb981; Naf D, 1998, MOL CELL BIOL, V18, P5952; Nagaraju G, 2007, DNA REPAIR, V6, P1018, DOI 10.1016/j.dnarep.2007.02.020; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Oestergaard VH, 2007, MOL CELL, V28, P798, DOI 10.1016/j.molcel.2007.09.020; Pace P, 2002, EMBO J, V21, P3414, DOI 10.1093/emboj/cdf355; Rego MA, 2009, MUTAT RES-FUND MOL M, V668, P27, DOI 10.1016/j.mrfmmm.2008.11.018; Rothfuss A, 2004, MOL CELL BIOL, V24, P123, DOI 10.1128/MCB.24.1.123-134.2004; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wang XZ, 2007, MOL CELL BIOL, V27, P3098, DOI 10.1128/MCB.02357-06; Warbrick E, 1998, BIOESSAYS, V20, P195, DOI 10.1002/(SICI)1521-1878(199803)20:3<195::AID-BIES2>3.0.CO;2-R; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022	45	47	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28935	28942		10.1074/jbc.M109.016352	http://dx.doi.org/10.1074/jbc.M109.016352			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19704162	hybrid, Green Published			2022-12-27	WOS:000270678900050
J	Pardossi-Piquard, R; Bohm, C; Chen, FS; Kanemoto, S; Checler, F; Schmitt-Ulms, G; George-Hyslop, PS; Fraser, PE				Pardossi-Piquard, Raphaelle; Boehm, Christopher; Chen, Fusheng; Kanemoto, Soshi; Checler, Frederic; Schmitt-Ulms, Gerold; George-Hyslop, Peter St.; Fraser, Paul E.			TMP21 Transmembrane Domain Regulates gamma-Secretase Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; FAMILIAL ALZHEIMERS-DISEASE; BETA-APP; MISSENSE MUTATIONS; PRESENILIN; NICASTRIN; METABOLISM; COMPLEXES; EPSILON; APH-1	TMP21 has been shown to be associated with the gamma-secretase complex and can specifically regulate gamma-cleavage without affecting epsilon-mediated proteolysis. To explore the basis of this activity, TMP21 modulation of gamma-secretase activity was investigated independent of epsilon-cleavage using an amyloid-beta precursor protein epsilon (APP epsilon) construct which lacks the amyloid intracellular domain domain. The APP epsilon construct behaves similarly to the full-length precursor protein with respect to alpha-and beta-cleavages and is able to undergo normal gamma-processing. Co-expression of APP epsilon and TMP21 resulted in the accumulation of membrane-embedded higher molecular weight A beta-positive fragments, consistent with an inhibition of gamma-secretase cleavage. The APP epsilon system was used to examine the functional domains of TMP21 through the investigation of a series of TMP21-p24a chimera proteins. It was found that chimeras containing the transmembrane domain bound to the gamma-secretase complex and could decrease gamma-secretase proteolytic processing. This was confirmed though investigation of a synthetic peptide corresponding to the TMP21 transmembrane helix. The isolated TMP21 TM peptide but not the homologous p24a domain was able to reduce A beta production in a dose-dependent fashion. These observations suggest that the TMP21 transmembrane domain promotes its association with the presenilin complex that results in decreased gamma-cleavage activity.	[Schmitt-Ulms, Gerold; George-Hyslop, Peter St.; Fraser, Paul E.] Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; [Checler, Frederic] Equipe Labellisee Fdn Rech Med, CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Schmitt-Ulms, Gerold] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [George-Hyslop, Peter St.] Univ Hlth Network, Toronto Western Hosp, Dept Med, Res Inst,Div Neurol, Toronto, ON M5G 2M9, Canada; [Fraser, Paul E.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [George-Hyslop, Peter St.] Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 OXY, England	University of Toronto; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Cambridge	Fraser, PE (corresponding author), Univ Toronto, Ctr Res Neurodegenerat Dis, 6 Queens Pk Crescent W, Toronto, ON M5S 3H2, Canada.	paul.fraser@utoronto.ca	Pardossi-Piquard, Raphaëlle/ABA-4472-2021; Pardossi-Piquard, Raphaëlle/D-6263-2012; Checler, Frederic/C-1241-2009	Pardossi-Piquard, Raphaëlle/0000-0001-5292-4414; Checler, Frederic/0000-0003-2098-1750	Canadian Institutes of Health Research; Howard Hughes Medical Institute; Alzheimer Society of Ontario; Ontario Research and Development Challenge Fund; Canada Foundation for Innovation; Fondation pour la Recherche Medicale; Conseil General des Alpes Maritimes	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Alzheimer Society of Ontario; Ontario Research and Development Challenge Fund(General Electric); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Conseil General des Alpes Maritimes(Region Provence-Alpes-Cote d'Azur)	This work was supported by grants from the Canadian Institutes of Health Research, Howard Hughes Medical Institute, Alzheimer Society of Ontario, The Ontario Research and Development Challenge Fund and the Canada Foundation for Innovation, the Fondation pour la Recherche Medicale, and the Conseil General des Alpes Maritimes.	Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Blum R, 1996, J BIOL CHEM, V271, P17183, DOI 10.1074/jbc.271.29.17183; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Chen FS, 2001, NAT CELL BIOL, V3, P751, DOI 10.1038/35087069; da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dolcini V, 2008, BIOCHEM BIOPH RES CO, V371, P69, DOI 10.1016/j.bbrc.2008.03.151; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Gorman PM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-17; Grandori R, 1997, PROTEIN ENG, V10, P1099, DOI 10.1093/protein/10.9.1099; Gu YJ, 2004, J BIOL CHEM, V279, P31329, DOI 10.1074/jbc.M401548200; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; Lefranc-Jullien S, 2006, J NEUROCHEM, V97, P807, DOI 10.1111/j.1471-4159.2006.03748.x; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Pardossi-Piquard R, 2006, J NEUROCHEM, V97, P1052, DOI 10.1111/j.1471-4159.2006.03822.x; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Ren Z, 2007, J BIOL CHEM, V282, P35350, DOI 10.1074/jbc.M702739200; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Ryan KA, 2005, J CELL BIOL, V171, P327, DOI 10.1083/jcb.200505078; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Vardy ERLC, 2005, TRENDS MOL MED, V11, P464, DOI 10.1016/j.molmed.2005.08.004; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104; Zhao GJ, 2004, J BIOL CHEM, V279, P50647, DOI 10.1074/jbc.C400473200	36	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28634	28641		10.1074/jbc.M109.059345	http://dx.doi.org/10.1074/jbc.M109.059345			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19710022	Green Published, hybrid			2022-12-27	WOS:000270678900018
J	Sundriyal, A; Roberts, AK; Shone, CC; Acharya, KR				Sundriyal, Amit; Roberts, April K.; Shone, Clifford C.; Acharya, K. Ravi			Structural Basis for Substrate Recognition in the Enzymatic Component of ADP-ribosyltransferase Toxin CDTa from Clostridium difficile	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFRINGENS-IOTA-TOXIN; RIBOSYLATING TOXINS; ACTIN; BOTULINUM; MECHANISM; PROTEINS; DISEASE; SITE	ADP-ribosylation is one of the favored modes of cell intoxication employed by several bacteria. Clostridium difficile is recognized to be an important nosocomial pathogen associated with considerable morbidity and attributable mortality. Along with its two well known toxins, Toxin A and Toxin B, it produces an ADP-ribosylating toxin that targets monomeric actin of the target cell. Like other Clostridial actin ADP-ribosylating toxins, this binary toxin, known as C. difficile toxin (CDT), is composed of two subunits, CDTa and CDTb. In this study, we present high resolution crystal structures of CDTa in its native form (at pH 4.0, 8.5, and 9.0) and in complex with ADP-ribose donors, NAD and NADPH (at pH 9.0). The crystal structures of the native protein show "pronounced conformational flexibility" confined to the active site region of the protein and "enhanced" disorder at low pH, whereas the complex structures highlight significant differences in "ligand specificity" compared with the enzymatic subunit of a close homologue, Clostridium perfringens iota toxin. Specifically in CDTa, two of the suggested catalytically important residues (Glu-385 and Glu-387) seem to play no role or a less important role in ligand binding. These structural data provide the first detailed information on protein-donor substrate complex stabilization in CDTa, which may have implications in understanding CDT recognition.	[Sundriyal, Amit; Acharya, K. Ravi] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Sundriyal, Amit; Roberts, April K.; Shone, Clifford C.] Hlth Protect Agcy, Res Dept, Salisbury SP4 0JG, Wilts, England	University of Bath; Health Protection Agency	Acharya, KR (corresponding author), Univ Bath, Dept Biol & Biochem, Claverton Down, Bath BA2 7AY, Avon, England.	K.R.Acharya@bath.ac.uk	Roberts, April/AAD-7330-2019	Acharya, K. Ravi/0000-0002-3009-4058	Health Protection Agency and Biotechnology and Biological Sciences Research Council (United Kingdom); Royal Society (United Kingdom) Industry Fellowship	Health Protection Agency and Biotechnology and Biological Sciences Research Council (United Kingdom); Royal Society (United Kingdom) Industry Fellowship(Royal Society of London)	Supported by a joint postgraduate studentship from the Health Protection Agency and Biotechnology and Biological Sciences Research Council (United Kingdom).; Supported by a Royal Society (United Kingdom) Industry Fellowship.	AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Han S, 1999, NAT STRUCT BIOL, V6, P932, DOI 10.1038/13300; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; KNOOP FC, 1993, CLIN MICROBIOL REV, V6, P251, DOI 10.1128/CMR.6.3.251-265.1993; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LYERLY D M, 1988, Clinical Microbiology Reviews, V1, P1; LYERLY DM, 1985, INFECT IMMUN, V47, P349, DOI 10.1128/IAI.47.2.349-352.1985; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; MAUSS S, 1990, EUR J BIOCHEM, V194, P237, DOI 10.1111/j.1432-1033.1990.tb19448.x; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MCFARLAND LV, 1986, AM J INFECT CONTROL, V14, P99, DOI 10.1016/0196-6553(86)90018-0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagahama M, 2000, J BACTERIOL, V182, P2096, DOI 10.1128/JB.182.8.2096-2103.2000; OHISHI I, 1983, INFECT IMMUN, V40, P336, DOI 10.1128/IAI.40.1.336-339.1983; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POPOFF MR, 1988, INFECT IMMUN, V56, P2299, DOI 10.1128/IAI.56.9.2299-2306.1988; REUNER KH, 1987, EUR J CELL BIOL, V43, P134; Schleberger C, 2006, J MOL BIOL, V364, P705, DOI 10.1016/j.jmb.2006.09.002; SIMPSON LL, 1982, J PHARMACOL EXP THER, V223, P695; Tsuge H, 2003, J MOL BIOL, V325, P471, DOI 10.1016/S0022-2836(02)01247-0; Tsuge H, 2008, P NATL ACAD SCI USA, V105, P7399, DOI 10.1073/pnas.0801215105; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; vanDamme J, 1996, FEBS LETT, V380, P291, DOI 10.1016/0014-5793(96)00052-X; VANDEKERCKHOVE J, 1987, FEBS LETT, V225, P48, DOI 10.1016/0014-5793(87)81129-8; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005	32	40	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28713	28719		10.1074/jbc.M109.043018	http://dx.doi.org/10.1074/jbc.M109.043018			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19692332	Green Published, hybrid			2022-12-27	WOS:000270678900027
J	Mahimainathan, L; Ghosh-Choudhury, N; Venkatesan, B; Das, F; Mandal, CC; Dey, N; Habib, SL; Kasinath, BS; Abboud, HE; Choudhury, GG				Mahimainathan, Lenin; Ghosh-Choudhury, Nandini; Venkatesan, Balachandar; Das, Falguni; Mandal, Chandi C.; Dey, Nirmalya; Habib, Samy L.; Kasinath, Balakuntalam S.; Abboud, Hanna E.; Choudhury, Goutam Ghosh			TSC2 Deficiency Increases PTEN via H1F1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS SCLEROSIS COMPLEX; TUMOR-SUPPRESSOR GENE; INDUCIBLE FACTOR-I; CELL-SURVIVAL; RENAL ANGIOMYOLIPOMAS; 3-KINASE/AKT PATHWAY; SIGNALING PATHWAY; MESANGIAL CELLS; DOWN-REGULATION; S6 KINASE	Substantial evidence suggests roles of TSC2 and PTEN in the development of cancer predisposition syndromes. Loss of TSC2 results in benign tumors, neurological disorders, and angiomyolipomas. We found that PTEN mRNA and protein levels are elevated in Tsc2(-/-) mouse embryo fibroblasts with concomitant reduction in Akt phosphorylation. Reconstitution of TSC2 in Tsc2(-/-) mouse embryo fibroblasts decreases PTEN levels. Interestingly, increased HIF1 alpha activity present in Tsc2 null cells is required for PTEN transcription and protein expression. We identified a canonical hypoxia-responsive element in the PTEN promoter, which regulates the transcription of this tumor suppressor protein in a TSC2-dependent manner. Finally, we demonstrate a positive correlation between expression of HIF1 alpha and PTEN in renal angiomyolipomas from TSC patients. Our results reveal a unique function of HIF1 alpha in up-regulation of PTEN and provide a new mechanism of reduced Akt phosphorylation in Tsc2 null cells. These data suggest that PTEN may safeguard against developing malignant tumors in patients with TSC deficiency.	[Mahimainathan, Lenin; Venkatesan, Balachandar; Das, Falguni; Dey, Nirmalya; Kasinath, Balakuntalam S.; Abboud, Hanna E.; Choudhury, Goutam Ghosh] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Nandini; Mandal, Chandi C.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Nandini; Habib, Samy L.; Kasinath, Balakuntalam S.; Abboud, Hanna E.; Choudhury, Goutam Ghosh] S Texas Vet Hlth Care Syst, Vet Affairs Res, San Antonio, TX 78229 USA; [Habib, Samy L.; Choudhury, Goutam Ghosh] S Texas Vet Hlth Care Syst, Ctr Geriatr Res Educ & Clin, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Choudhury, GG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Mail Code 7882,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	choudhuryg@uthscsa.edu	Chen, Lingxin/H-5761-2019	Chen, Lingxin/0000-0002-3764-3515; /0000-0001-5077-3552; Mandal, Chandi/0000-0002-2292-6635	National Institutes of Health [RC1 DIK50190]; Juvenile Diabetes Research Foundation; Veterans Affairs Research Service Merit Review Grants; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078971, R01DK050190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Veterans Affairs Research Service Merit Review Grants(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RC1 DIK50190. This work was also supported by the Juvenile Diabetes Research Foundation and Veterans Affairs Research Service Merit Review Grants (to G. G. C.).	Arbiser JL, 2002, J AM ACAD DERMATOL, V46, P376, DOI 10.1067/mjd.2002.120530; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Cheadle JP, 2000, HUM GENET, V107, P97, DOI 10.1007/s004390000348; Chen ML, 2006, GENE DEV, V20, P1569, DOI 10.1101/gad.1395006; Choi JW, 2004, CANCER RES, V64, P35, DOI 10.1158/0008-5472.CAN-03-0145; Choudhury GG, 2004, J BIOL CHEM, V279, P27399, DOI 10.1074/jbc.M403530200; Choudhury GG, 1998, J CLIN INVEST, V101, P2751, DOI 10.1172/JCI1044; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; Das F, 2008, J CELL PHYSIOL, V214, P513, DOI 10.1002/jcp.21236; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Ghosh S, 2006, CANCER CELL, V10, P215, DOI 10.1016/j.ccr.2006.08.007; Ghosh-Choudhury N, 2006, J BIOL CHEM, V281, P20160, DOI 10.1074/jbc.M511071200; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Habib SL, 2008, AM J PHYSIOL-RENAL, V294, pF281, DOI 10.1152/ajprenal.00370.2007; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; HENSKE EP, 1995, GENE CHROMOSOME CANC, V13, P295, DOI 10.1002/gcc.2870130411; Hu J, 1998, BIOCHEM BIOPH RES CO, V245, P894, DOI 10.1006/bbrc.1998.8543; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Karbowniczek M, 2003, AM J PATHOL, V162, P491, DOI 10.1016/S0002-9440(10)63843-6; Kenerson HL, 2002, CANCER RES, V62, P5645; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x; Lee CH, 2007, EMBO J, V26, P4812, DOI 10.1038/sj.emboj.7601900; Lee L, 2005, GENE CHROMOSOME CANC, V42, P213, DOI 10.1002/gcc.20118; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma L, 2005, GENE DEV, V19, P1779, DOI 10.1101/gad.1314405; Maher ER, 1997, MEDICINE, V76, P381, DOI 10.1097/00005792-199711000-00001; Mahimainathan L, 2005, AM J PHYSIOL-RENAL, V289, pF72, DOI 10.1152/ajprenal.00277.2004; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Martignoni G, 1998, AM J SURG PATHOL, V22, P663, DOI 10.1097/00000478-199806000-00003; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Nguyen-Vu PA, 2001, J CUTAN PATHOL, V28, P470, DOI 10.1034/j.1600-0560.2001.028009470.x; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shin DH, 2007, CANCER LETT, V255, P107, DOI 10.1016/j.canlet.2007.03.026; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Venkatesan B, 2007, J CELL PHYSIOL, V211, P457, DOI 10.1002/jcp.20953; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Yeh WL, 2007, MOL PHARMACOL, V72, P440, DOI 10.1124/mol.107.036418; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zhou YD, 2005, J NAT PROD, V68, P947, DOI 10.1021/np050029m	60	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27790	27798		10.1074/jbc.M109.028860	http://dx.doi.org/10.1074/jbc.M109.028860			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19648120	hybrid, Green Published			2022-12-27	WOS:000270676300005
J	Nejak-Bowen, KN; Zeng, G; Tan, XP; Cieply, B; Monga, SP				Nejak-Bowen, Kari N.; Zeng, Gang; Tan, Xinping; Cieply, Benjamin; Monga, Satdarshan P.			beta-Catenin Regulates Vitamin C Biosynthesis and Cell Survival in Murine Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENESCENCE MARKER PROTEIN-30; DEOXYRIBONUCLEIC-ACID SYNTHESIS; REGUCALCIN MESSENGER-RNA; HEPATOCYTE GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; BINDING PROTEIN; RAT-LIVER; ENDOGENOUS REGUCALCIN; MOUSE HEPATOCYTES; SIGNALING PATHWAY	Because the Wnt/beta-catenin pathway plays multiple roles in liver pathobiology, it is critical to identify gene targets that mediate such diverse effects. Here we report a novel role of, beta-catenin in controlling ascorbic acid biosynthesis in murine liver through regulation of expression of regucalcin or senescence marker protein 30 and L-gulonolactone oxidase. Reverse transcription-PCR, Western blotting, and immunohistochemistry demonstrate decreased regucalcin expression in beta-catenin-null livers and greater expression in beta-catenin overexpressing transgenic livers, HepG2 hepatoma cells (contain constitutively active beta-catenin), regenerating livers, and in hepatocellular cancer tissues that exhibit beta-catenin activation. Interestingly, coprecipitation and immunofluorescence studies also demonstrate an association of beta-catenin and regucalcin. Luciferase reporter and chromatin immunoprecipitation assays verified a functional TCF-4-binding site located between -163 and -157 (CTTTGCA) on the regucalcin promoter to be critical for regulation by beta-catenin. Significantly lower serum ascorbate levels were observed in beta-catenin knockout mice secondary to decreased expression of regucalcin and also Of L-gulonolactone oxidase, the penultimate and last (also rate-limiting) steps in the synthesis of ascorbic acid, respectively. These mice also show enhanced basal hepatocyte apoptosis. To test if ascorbate deficiency secondary to beta-catenin loss and regucalcin decrease was contributing to apoptosis, beta-catenin-null hepatocytes or regucalcin small interfering RNA-transfected HepG2 cells were cultured, which exhibited significant apoptosis that was alleviated by the addition of ascorbic acid. Thus, through regucalcin and L-gulonolactone oxidase expression, beta-catenin regulates vitamin C biosynthesis in murine liver, which in turn may be one of the mechanisms contributing to the role of beta-catenin in cell survival.	[Monga, Satdarshan P.] Univ Pittsburgh, Dept Pathol, Div Expt Pathol, Sch Med, Pittsburgh, PA 15216 USA; [Monga, Satdarshan P.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15216 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Monga, SP (corresponding author), Univ Pittsburgh, Dept Pathol, Div Expt Pathol, Sch Med, 200 Lothrop St,S-421 BST, Pittsburgh, PA 15216 USA.	smonga@pitt.edu	Zeng, Gang G/J-9995-2018	Zeng, Gang G/0000-0002-2954-9051; Monga, Satdarshan/0000-0002-8437-3378; Nejak-Bowen, Kari/0000-0001-6051-5338	National Institutes of Health [1R01 DK62277, 1R01 CA1 24414]; Rango's Fund for the Enhancement of Pathology Research; NATIONAL CANCER INSTITUTE [R01CA124414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rango's Fund for the Enhancement of Pathology Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01 DK62277 and 1R01 CA1 24414 (to S. P. S. M.). This work was also supported by Rango's Fund for the Enhancement of Pathology Research.	Apte U, 2006, HEPATOLOGY, V44, P992, DOI 10.1002/hep.21317; Bajt ML, 2004, TOXICOL SCI, V80, P343, DOI 10.1093/toxsci/kfh151; Barroso MP, 1997, ARCH BIOCHEM BIOPHYS, V343, P243, DOI 10.1006/abbi.1997.0170; Behari J, 2007, J HEPATOL, V46, P849, DOI 10.1016/j.jhep.2006.11.017; Bell AW, 2006, HEPATOLOGY, V44, P186, DOI 10.1002/hep.21234; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Block GD, 1996, J CELL BIOL, V132, P1133, DOI 10.1083/jcb.132.6.1133; Cadoret A, 2002, ONCOGENE, V21, P8293, DOI 10.1038/sj.onc.1206118; Cieply B, 2009, HEPATOLOGY, V49, P821, DOI 10.1002/hep.22695; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Devereux TR, 1999, ONCOGENE, V18, P4726, DOI 10.1038/sj.onc.1202858; Dihlmann S, 2005, CARCINOGENESIS, V26, P1503, DOI 10.1093/carcin/bgi120; Elchuri S, 2007, PROTEOMICS, V7, P2121, DOI 10.1002/pmic.200601011; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Fujita T, 1999, BIOCHEM BIOPH RES CO, V254, P1, DOI 10.1006/bbrc.1998.9841; Fujita T, 1998, J GASTROEN HEPATOL, V13, pS124; Graveel CR, 2001, ONCOGENE, V20, P2704, DOI 10.1038/sj.onc.1204391; Hanada S, 2008, HEPATOLOGY, V48, P943, DOI 10.1002/hep.22436; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hurlstone A, 2002, EMBO J, V21, P2303, DOI 10.1093/emboj/21.10.2303; Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5; Izumi T, 2004, J CELL BIOCHEM, V92, P296, DOI 10.1002/jcb.20056; Kaimori A, 2007, J BIOL CHEM, V282, P22089, DOI 10.1074/jbc.M700998200; Koh TJ, 2000, J CLIN INVEST, V106, P533, DOI 10.1172/JCI9476; Kohler C, 2004, HEPATOLOGY, V39, P1056, DOI 10.1002/hep.20156; Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103; Lee HS, 2007, LIFE SCI, V80, P690, DOI 10.1016/j.lfs.2006.10.024; LIDA M, 2003, CARCINOGENESIS, V24, P757; Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Majer BJ, 2004, MUTAT RES-FUND MOL M, V551, P153, DOI 10.1016/j.mrfmmm.2004.02.022; Matsuyama S, 2004, BIOCHEM BIOPH RES CO, V321, P386, DOI 10.1016/j.bbrc.2004.06.161; Michalopoulos GK, 2001, AM J PATHOL, V159, P1877, DOI 10.1016/S0002-9440(10)63034-9; Monga SPS, 2003, GASTROENTEROLOGY, V124, P202, DOI 10.1053/gast.2003.50000; Monga SPS, 2001, HEPATOLOGY, V33, P1098, DOI 10.1053/jhep.2001.23786; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Murata T, 1998, BIOCHEM J, V329, P157, DOI 10.1042/bj3290157; Murata T, 1997, MOL CELL BIOCHEM, V175, P163, DOI 10.1023/A:1006844815743; Nejak-Bowen Kari, 2008, Organogenesis, V4, P92; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Ray R, 2003, CANCER RES, V63, P8085; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005; Takahasi H, 1996, MOL CELL BIOCHEM, V162, P133; Tan XP, 2008, HEPATOLOGY, V47, P1667, DOI 10.1002/hep.22225; Tan XP, 2006, GASTROENTEROLOGY, V131, P1561, DOI 10.1053/j.gastro.2006.08.042; Tan XP, 2005, GASTROENTEROLOGY, V129, P285, DOI 10.1053/j.gastro.2005.04.013; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; Toualbi K, 2007, ONCOGENE, V26, P3492, DOI 10.1038/sj.onc.1210133; Tsurusaki Y, 2004, INT J MOL MED, V14, P277; Tsurusaki Y, 2002, J CELL BIOCHEM, V85, P516, DOI 10.1002/jcb.10153; Tsurusaki Y, 2000, INT J MOL MED, V6, P295; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Yamaguchi M, 2005, INT J MOL MED, V15, P371; Yamaguchi M, 2002, MOL CELL BIOCHEM, V241, P61, DOI 10.1023/A:1020822610085; Yamaguchi M, 2000, BIOCHEM BIOPH RES CO, V276, P1, DOI 10.1006/bbrc.2000.3359; YAMAGUCHI M, 1995, J CELL BIOCHEM, V57, P185, DOI 10.1002/jcb.240570203; Yamaguchi M, 1996, MOL CELL BIOCHEM, V162, P121; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Yang JW, 2001, HEPATOLOGY, V33, P848, DOI 10.1053/jhep.2001.23438; Zeng G, 2007, NEOPLASIA, V9, P951, DOI 10.1593/neo.07469; Zeng G, 2007, HEPATOLOGY, V45, P195, DOI 10.1002/hep.21473; Zeng G, 2006, NEOPLASIA, V8, P279, DOI 10.1593/neo.05607	65	32	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28115	28127		10.1074/jbc.M109.047258	http://dx.doi.org/10.1074/jbc.M109.047258			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19690176	hybrid, Green Published			2022-12-27	WOS:000270676300038
J	Zhang, N; Khachigian, LM				Zhang, Ning; Khachigian, Levon M.			RETRACTED: Injury-induced Platelet-derived Growth Factor Receptor-alpha Expression Mediated by Interleukin-1 beta (IL-1 beta) Release and Cooperative Transactivation by NF-kappa B and ATF-4 IL-1 beta FACILITATES HDAC-1/2 DISSOCIATION FROM PROMOTER (Retracted Article. See vol 285, pg 21902, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							SMOOTH-MUSCLE-CELLS; BINDING PROTEIN-DELTA; ENDOTHELIAL-CELLS; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; EPITHELIAL-CELLS; CANCER CELLS; IN-VIVO; PDGF-AA; APOPTOSIS	Platelet-derived growth factors are a family of potent mitogens and chemoattractants for fibroblasts and other cells of mesenchymal origin. Platelet-derived growth factor (PDGF) dimeric ligands (composed of A-, B-, C-, and D-chains) exert their biological activity through high affinity interactions with cell surface receptor subunits (alpha and beta). PDGF-receptor-alpha is widely implicated in the pathogenesis of hyperplastic fibrotic disease, yet the molecular mechanisms controlling its expression in response to injury are poorly understood. Here we show that PDGF-R alpha expression is induced in fibroblasts by mechanical injury and interleukin (IL)-1 beta, which was abolished by neutralizing IL-1 beta antibodies in the culture supernatant or inhibitors of NF-kappa B Chromatin immunoprecipitation and electrophoretic mobility shift assays revealed the existence of a new NF-kappa B binding site at -531/-521 bp in the PDGF-R alpha promoter. We have recently shown that ATF-4 is also induced by injury (Malabanan, K. P., Kanellakis, P., Bobik, A., and Khachigian, L. M. (2008) Circ. Res. 103, 378-387), and we demonstrate here that ATF-4 binds a novel element -259/-254 and stimulates PDGF-R alpha transcription. ATF-4 and NF-kappa B interact, occupy the PDGF-R alpha promoter, and induce PDGF-R alpha transcription in a cooperative manner. IL-1 beta facilitates the dissociation of histone deacetylase (HDAC)-1/2 from the PDGF-R alpha promoter, whereas the HDAC inhibitors suberoylanilide hydroxamic acid and trichostatin A potentiate IL-1 beta induction of PDGF-R alpha transcription. These findings, taken together, demonstrate that injury stimulates IL-1 beta secretion by fibroblasts, which activates NF-kappa B and ATF-4 and stimulates interaction with the PDGF-R alpha promoter, triggering PDGF-R alpha transcription. Physical and functional interactions between NF-kappa B and ATF-4 have not been reported in any gene. This is also the first report of HDAC regulation of PDGF-R alpha transcription.	[Zhang, Ning; Khachigian, Levon M.] Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Khachigian, LM (corresponding author), Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia.	L.Khachigian@unsw.edu.au	Khachigian, Levon/AAZ-7458-2020	Khachigian, Levon/0000-0003-3446-0323	National Health and Medical Research Council (NHMRC); Australian Research Council; National Heart Foundation	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); National Heart Foundation(National Heart Foundation of Australia)	This work was supported by grants from the National Health and Medical Research Council (NHMRC), Australian Research Council, and National Heart Foundation.	Alvarez RH, 2006, MAYO CLIN PROC, V81, P1241, DOI 10.4065/81.9.1241; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Beer HD, 1997, J INVEST DERMATOL, V109, P132, DOI 10.1111/1523-1747.ep12319188; Betsholtz C, 2001, BIOESSAYS, V23, P494, DOI 10.1002/bies.1069; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bonello MR, 2004, J BIOL CHEM, V279, P2377, DOI 10.1074/jbc.M308254200; Bonello MR, 2005, AM J PATHOL, V167, P1149, DOI 10.1016/S0002-9440(10)61203-5; Brindle PK, 1992, CURR OPIN GENET DEV, V2, P199, DOI 10.1016/S0959-437X(05)80274-6; Choudhury P, 1997, INVEST OPHTH VIS SCI, V38, P824; Clark JD, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-28; Dai Y, 2004, BLOOD, V103, P2761, DOI 10.1182/blood-2003-09-3037; Delbridge GJ, 1997, CIRC RES, V81, P282, DOI 10.1161/01.RES.81.2.282; Dieguez-Acuna FJ, 2004, TOXICOL SCI, V82, P114, DOI 10.1093/toxsci/kfh236; Ding WX, 2007, MOL CANCER THER, V6, P1062, DOI 10.1158/1535-7163.MCT-06-0541; Englesbe MJ, 2004, J VASC SURG, V39, P1091, DOI 10.1016/j.jvs.2004.01.041; Fukuoka T, 1999, J BIOL CHEM, V274, P25576, DOI 10.1074/jbc.274.36.25576; GOLDBLUM SE, 1988, INFECT IMMUN, V56, P2255, DOI 10.1128/IAI.56.9.2255-2263.1988; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Ikezoe T, 2005, MOL CANCER THER, V4, P578, DOI 10.1158/1535-7163.MCT-04-0277; Kavurma MM, 2002, J BIOL CHEM, V277, P36244, DOI 10.1074/jbc.M200463200; KAWAGISHI J, 1995, GENOMICS, V30, P224, DOI 10.1006/geno.1995.9883; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; KHACHIGIAN LM, 1995, J CLIN INVEST, V96, P1169, DOI 10.1172/JCI118106; Kitami Y, 1999, CIRC RES, V84, P64; Letoha T, 2005, FREE RADICAL BIO MED, V39, P1142, DOI 10.1016/j.freeradbiomed.2005.06.003; Li J, 2000, J BIOL CHEM, V275, P2951, DOI 10.1074/jbc.275.4.2951; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Liu JW, 2007, INT IMMUNOPHARMACOL, V7, P945, DOI 10.1016/j.intimp.2007.03.001; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Luo RX, 1999, J NATL CANCER I, V91, P1288, DOI 10.1093/jnci/91.15.1288; Malabanan KP, 2008, CIRC RES, V103, P378, DOI 10.1161/CIRCRESAHA.107.168682; Masuoka HC, 2002, BLOOD, V99, P736, DOI 10.1182/blood.V99.3.736; Miyake S, 1999, J BIOL CHEM, V274, P16619, DOI 10.1074/jbc.274.23.16619; NEISH AS, 1995, J BIOL CHEM, V270, P28903, DOI 10.1074/jbc.270.48.28903; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; PERACCHIA F, 1991, EXP CELL RES, V193, P208, DOI 10.1016/0014-4827(91)90557-B; Rafty LA, 1998, J BIOL CHEM, V273, P5758, DOI 10.1074/jbc.273.10.5758; RAINES EW, 1989, SCIENCE, V243, P393, DOI 10.1126/science.2783498; Raines EW, 2004, CYTOKINE GROWTH F R, V15, P237, DOI 10.1016/j.cytogfr.2004.03.004; Resch ZT, 2006, ENDOCRINOLOGY, V147, P885, DOI 10.1210/en.2005-0908; Rutkowski DT, 2003, DEV CELL, V4, P442, DOI 10.1016/S1534-5807(03)00100-X; Soriano P, 1997, DEVELOPMENT, V124, P2691; Sumpio BE, 1998, ARTERIOSCL THROM VAS, V18, P349, DOI 10.1161/01.ATV.18.3.349; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; Wang XJ, 2005, ACTA PHARMACOL SIN, V26, P934, DOI 10.1111/j.1745-7254.2005.00152.x; Warshamana GS, 1998, AM J PHYSIOL-LUNG C, V274, pL499, DOI 10.1152/ajplung.1998.274.4.L499; Wente MN, 2005, ONCOL REP, V14, P1635; Yu JH, 2001, BIOCHEM BIOPH RES CO, V282, P697, DOI 10.1006/bbrc.2001.4622; Zheng X, 2008, INT J ONCOL, V32, P257; Zhou GB, 2007, CELL RES, V17, P274, DOI 10.1038/cr.2007.21	53	9	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27933	27943		10.1074/jbc.M109.025742	http://dx.doi.org/10.1074/jbc.M109.025742			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19648113	Green Published, hybrid			2022-12-27	WOS:000270676300021
J	Liu, HY; Cao, SY; Hong, T; Han, JM; Liu, ZQ; Cao, WH				Liu, Hui-Yu; Cao, Sophia Y.; Hong, Tao; Han, Jianmin; Liu, Zhenqi; Cao, Wenhong			Insulin Is a Stronger Inducer of Insulin Resistance than Hyperglycemia in Mice with Type 1 Diabetes Mellitus (T1DM)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDE TRANSLOCATION; ACTIVATED-RECEPTOR-GAMMA; PROTEIN-KINASE PLAYS; OXIDATIVE STRESS; SKELETAL-MUSCLE; GLUCOSE-TRANSPORT; IN-VIVO; GLUCOKINASE GENE; REVERSIBLE INHIBITION; MOLECULAR-MECHANISMS	Subjects with type 1 diabetes mellitus (T1DM) eventually develop insulin resistance and other features of T2DM such as cardiovascular disorders. The exact mechanism has been not been completely understood. In this study, we tested the hypothesis that excessive or inappropriate exposure to insulin is a primary mediator of insulin resistance in T1DM. We found that continuous exposure of mice with non-obese diabetes to insulin detemir, which is similar to some current conventional treatment of human T1DM, induced severe insulin resistance, whereas untreated hyperglycemia for the same amount of time (2 weeks) did not cause obvious insulin resistance. Insulin resistance was accompanied by decreased mitochondrial production as evaluated by mitochondrial DNA and levels of transcripts and proteins of mitochondrion-associated genes, increased ectopic fat accumulation in liver and skeletal muscle (gastrocnemius) evaluated by measurements of triglyceride content, and elevated oxidative stress detected by the GSH/GSSG ratio. Prolonged exposure of cultured hepatocytes to insulin induced significant insulin resistance, whereas the same length of exposure to a high level of glucose (33mM) did not cause obvious insulin resistance. Furthermore, our results showed that prolonged exposure to insulin caused oxidative stress, and blockade of mitochondrion-derived oxidative stress by overexpression of manganese-superoxide dismutase prevented insulin resistance induced by the prolonged exposure to insulin. Together, our results show that excessive exposure to insulin is a primary inducer of insulin resistance in T1DM in mice.	[Liu, Hui-Yu; Cao, Sophia Y.; Hong, Tao; Han, Jianmin; Cao, Wenhong] Hamner Inst Hlth Sci, Div Translat Biol, Res Triangle Pk, NC 27709 USA; [Liu, Zhenqi] Univ Virginia, Dept Med Endocrinol, Med Sci Ctr, Charlottesville, VA 22908 USA; [Cao, Wenhong] Duke Univ Med Syst, Dept Internal Med Endocrinol, Durham, NC 27705 USA	The Hamner Institutes for Health Sciences; University of Virginia; Duke University	Cao, WH (corresponding author), Hamner Inst Hlth Sci, Div Translat Biol, Res Triangle Pk, NC 27709 USA.	wcao@thehamner.org	Liu, Hui-Yu/D-1507-2009		National Institutes of Health [R01DK076039]; Investigator Development Fund from The Hamner Institutes for Health Sciences; American Heart Association [SDG-0530244N]; American Diabetes Association [7-09-BS-27]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Investigator Development Fund from The Hamner Institutes for Health Sciences; American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK076039 (to W. C.). This work was also supported by the Investigator Development Fund from The Hamner Institutes for Health Sciences (to W. C.), American Heart Association Grant SDG-0530244N (to W. C.), and American Diabetes Association Grant 7-09-BS-27 (to W. C.).	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Al-Regaiey KA, 2005, ENDOCRINOLOGY, V146, P851, DOI 10.1210/en.2004-1120; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; ANTONETTI DA, 1995, J CLIN INVEST, V95, P1383, DOI 10.1172/JCI117790; Barja G, 2007, REJUV RES, V10, P215, DOI 10.1089/rej.2006.0516; Boden G, 1996, DIABETES, V45, P1044, DOI 10.2337/diabetes.45.8.1044; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200; Ciaraldi TP, 1995, J CLIN INVEST, V96, P2820, DOI 10.1172/JCI118352; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200; Collins QF, 2006, J BIOL CHEM, V281, P24336, DOI 10.1074/jbc.M602177200; CRUZ AB, 1961, CIRC RES, V9, P39, DOI 10.1161/01.RES.9.1.39; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; DAVIDSON MB, 1994, BBA-GEN SUBJECTS, V1201, P113, DOI 10.1016/0304-4165(94)90159-7; DeFronzo RA, 1997, NETH J MED, V50, P191, DOI 10.1016/S0300-2977(97)00012-0; DEFRONZO RA, 1982, DIABETOLOGIA, V23, P313; DELPRATO S, 1983, J CLIN ENDOCR METAB, V57, P904; Diabet Control Complications Trial DCCT Res Grp, 1995, AM J CARDIOL, V75, P894; DUFF GL, 1950, J EXP MED, V92, P299, DOI 10.1084/jem.92.4.299; DUFF GL, 1949, J EXP MED, V89, P611, DOI 10.1084/jem.89.6.611; DUFF GL, 1954, J EXP MED, V100, P371, DOI 10.1084/jem.100.4.371; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Freitas HS, 2008, ENDOCRINOLOGY, V149, P717, DOI 10.1210/en.2007-1088; GARVEY WT, 1987, J BIOL CHEM, V262, P189; Goldstein BJ, 2005, DIABETES, V54, P311, DOI 10.2337/diabetes.54.2.311; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Heart E, 2000, AM J PHYSIOL-ENDOC M, V278, pE103, DOI 10.1152/ajpendo.2000.278.1.E103; Hebert LF, 1996, J CLIN INVEST, V98, P930, DOI 10.1172/JCI118876; HOLLOWAY BR, 1985, INT J OBESITY, V9, P423; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; IYNEDJIAN PB, 1989, J BIOL CHEM, V264, P21824; KAHN BB, 1991, J CLIN INVEST, V87, P561, DOI 10.1172/JCI115031; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kaneto H, 2007, CURR MOL MED, V7, P674, DOI 10.2174/156652407782564408; Katic M, 2007, AGING CELL, V6, P827, DOI 10.1111/j.1474-9726.2007.00346.x; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kim SY, 2004, J BIOL CHEM, V279, P30823, DOI 10.1074/jbc.M313223200; Kim TH, 2009, J BIOL CHEM, V284, P15071, DOI 10.1074/jbc.M109.006742; Kumashiro N, 2008, DIABETES, V57, P2083, DOI 10.2337/db08-0144; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; LERNER E, 1972, J BIOL CHEM, V247, P1513; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; LILLIOJA S, 1987, J CLIN INVEST, V80, P415, DOI 10.1172/JCI113088; Liu HY, 2008, J BIOL CHEM, V283, P30642, DOI 10.1074/jbc.M803698200; Liu HY, 2008, J BIOL CHEM, V283, P12056, DOI 10.1074/jbc.M801033200; Liu HY, 2007, J BIOL CHEM, V282, P14205, DOI 10.1074/jbc.M609701200; Liu HY, 2009, J BIOL CHEM, V284, P31484, DOI 10.1074/jbc.M109.033936; Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103; Maassen JA, 2007, CURR OPIN CLIN NUTR, V10, P693, DOI 10.1097/MCO.0b013e3282f0b774; MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; MARIN P, 1994, DIABETES CARE, V17, P382, DOI 10.2337/diacare.17.5.382; McClain DA, 1996, DIABETES, V45, P1003, DOI 10.2337/diabetes.45.8.1003; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; PANDE SV, 1971, J BIOL CHEM, V246, P402; PEDERSEN O, 1987, DIABETES CARE, V10, P516, DOI 10.2337/diacare.10.4.516; Perseghin G, 2003, AM J PHYSIOL-ENDOC M, V285, pE1174, DOI 10.1152/ajpendo.00279.2003; Peschke E, 2008, J PINEAL RES, V44, P26, DOI 10.1111/j.1600-079X.2007.00519.x; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Prasai MJ, 2008, DIABETES VASC DIS RE, V5, P89, DOI 10.3132/dvdr.2008.015; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; ROSSETTI L, 1990, DIABETES CARE, V13, P610, DOI 10.2337/diacare.13.6.610; ROSSETTI L, 1995, J CLIN INVEST, V96, P132, DOI 10.1172/JCI118013; ROSSETTI L, 1987, J CLIN INVEST, V79, P1510, DOI 10.1172/JCI112981; ROSSETTI L, 1989, J CLIN INVEST, V84, P892, DOI 10.1172/JCI114250; Saeed SA, 2007, PHARMACOL REP, V59, P238; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Schenk S, 2007, J CLIN INVEST, V117, P1690, DOI 10.1172/JCI30566; Seo JH, 2005, MOL BIOL CELL, V16, P348, DOI 10.1091/mbc.E04-05-0369; SHRAGO E, 1976, GLUCONEOGENESIS ITS, P221; SHUG AL, 1975, AM J PHYSIOL, V228, P689, DOI 10.1152/ajplegacy.1975.228.3.689; Southgate RJ, 2005, FASEB J, V19, P2072, DOI 10.1096/fj.05-3993fje; STAMLER J, 1960, CIRC RES, V8, P572, DOI 10.1161/01.RES.8.3.572; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; van der Valk M, 2004, ANTIVIR THER, V9, P385; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang MY, 2008, P NATL ACAD SCI USA, V105, P6139, DOI 10.1073/pnas.0801981105; WOJTCZAK L, 1967, BIOCHEM BIOPH RES CO, V28, P76, DOI 10.1016/0006-291X(67)90409-3; Wullaert A, 2007, ENDOCR REV, V28, P365, DOI 10.1210/er.2006-0031; Xiong Y, 2007, J BIOL CHEM, V282, P4975, DOI 10.1074/jbc.M606742200; Yang ZQ, 2007, MOL BIOL CELL, V18, P4681, DOI 10.1091/mbc.E06-12-1161; Ye Jianping, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P65; Yin XM, 2008, HEPATOLOGY, V47, P1773, DOI 10.1002/hep.22146; YKIJARVINEN H, 1986, NEW ENGL J MED, V315, P224, DOI 10.1056/NEJM198607243150404; Zierath JR, 2000, DIABETOLOGIA, V43, P821, DOI 10.1007/s001250051457; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	97	63	69	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27090	27100		10.1074/jbc.M109.016675	http://dx.doi.org/10.1074/jbc.M109.016675			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19654321	hybrid, Green Published			2022-12-27	WOS:000270232300010
J	Pikkarainen, S; Kennedy, RA; Marshall, AK; Tham, EL; Lay, K; Kriz, TA; Handa, BS; Clerk, A; Sugden, PH				Pikkarainen, Sampsa; Kennedy, Robert A.; Marshall, Andrew K.; Tham, El Li; Lay, Kenneth; Kriz, Thomas A.; Handa, Balvinder S.; Clerk, Angela; Sugden, Peter H.			Regulation of Expression of the Rat Orthologue of Mouse Double Minute 2 (MDM2) by H2O2-induced Oxidative Stress in Neonatal Rat Cardiac Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENIN-ANGIOTENSIN SYSTEM; OPEN READING FRAMES; TRANSCRIPTION FACTOR; HYDROGEN-PEROXIDE; GENE-EXPRESSION; VENTRICULAR CARDIOMYOCYTES; CELL-PROLIFERATION; SIGNALING PATHWAYS; UBIQUITIN LIGASE; JUN EXPRESSION	The Mdm2 ubiquitin ligase is an important regulator of p53 abundance and p53-dependent apoptosis. Mdm2 expression is frequently regulated by a p53 Mdm2 autoregulatory loop whereby p53 stimulates Mdm2 expression and hence its own degradation. Although extensively studied in cell lines, relatively little is known about Mdm2 expression in heart where oxidative stress (exacerbated during ischemia-reperfusion) is an important pro-apoptotic stimulus. We demonstrate that Mdm2 transcript and protein expression are induced by oxidative stress (0.2 mM H2O2) in neonatal rat cardiac myocytes. In other cells, constitutive Mdm2 expression is regulated by the P1 promoter (5' to exon 1), with inducible expression regulated by the P2 promoter (in intron 1). In myocytes, H2O2 increased Mdm2 expression from the P2 promoter, which contains two p53-response elements (REs), one AP-1 RE, and two Ets REs. H2O2 did not detectably increase expression of p53 mRNA or protein but did increase expression of several AP-1 transcription factors. H2O2 increased binding of AP-1 proteins (c-Jun, JunB, JunD, c-Fos, FosB, and Fra-1) to an Mdm2 AP-1 oligodeoxynucleotide probe, and chromatin immunoprecipitation assays showed it increased binding of c-Jun or JunB to the P2 AP-1 RE. Finally, antisense oligonucleotide-mediated reduction of H2O2-induced Mdm2 expression increased caspase 3 activation. Thus, increased Mdm2 expression is associated with transactivation at the P2 AP-1 RE (rather than the p53 or Ets REs), and Mdm2 induction potentially represents a cardioprotective response to oxidative stress.	[Pikkarainen, Sampsa; Kennedy, Robert A.; Marshall, Andrew K.; Tham, El Li; Lay, Kenneth; Kriz, Thomas A.; Handa, Balvinder S.; Clerk, Angela; Sugden, Peter H.] Univ London Imperial Coll Sci Technol & Med, Fac Med, NHLI Div, London SW7 2AZ, England	Imperial College London	Sugden, PH (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, NHLI Div, Flowers Bldg,4th Floor,Armstrong Rd, London SW7 2AZ, England.	p.sugden@imperial.ac.uk		Clerk, Angela/0000-0002-5658-0708	Sigrid Juse lius Foundation; Finnish Foundation for Cardiovascular Research; Instrumentarium Foundation; Aarne and Aili Turunen Foundation; Maud Kuistila Foundation; Paavo Nurmi Foundation; Fondation Leducq	Sigrid Juse lius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research; Instrumentarium Foundation; Aarne and Aili Turunen Foundation; Maud Kuistila Foundation; Paavo Nurmi Foundation; Fondation Leducq(Leducq Foundation)	Supported by fellowships from the Sigrid Juse lius Foundation, the Finnish Foundation for Cardiovascular Research, the Instrumentarium Foundation, the Aarne and Aili Turunen Foundation, the Maud Kuistila Foundation, and the Paavo Nurmi Foundation.; Supported in part by the Fondation Leducq.	ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; BARAK Y, 1994, GENE DEV, V8, P1739, DOI 10.1101/gad.8.15.1739; BOGOYEVITCH MA, 1995, BIOCHEM J, V309, P437, DOI 10.1042/bj3090437; Bonini P, 2004, J NEUROSCI RES, V75, P83, DOI 10.1002/jnr.10822; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown CY, 1999, ONCOGENE, V18, P5631, DOI 10.1038/sj.onc.1202949; CAHILLYSNYDER L, 1987, SOMAT CELL MOLEC GEN, V13, P235, DOI 10.1007/BF01535205; Clerk A, 2002, BIOCHEM J, V368, P101, DOI 10.1042/BJ20021083; CLERK A, 1994, J BIOL CHEM, V269, P32848; Clerk A, 1998, BIOCHEM J, V333, P581, DOI 10.1042/bj3330581; Clerk A, 2007, PHYSIOL GENOMICS, V29, P118, DOI 10.1152/physiolgenomics.00168.2006; Cook SA, 1999, CIRC RES, V85, P940; Cullingford TE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r32; Dey A, 2008, BRIT J CANCER, V98, P4, DOI 10.1038/sj.bjc.6604098; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; FAKHARZADEH SS, 1991, EMBO J, V10, P1565, DOI 10.1002/j.1460-2075.1991.tb07676.x; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Foo RSY, 2007, J BIOL CHEM, V282, P5529, DOI 10.1074/jbc.M609046200; Grier JD, 2006, MOL CELL BIOL, V26, P192, DOI 10.1128/MCB.26.1.192-198.2006; Halees AS, 2008, NUCLEIC ACIDS RES, V36, pD137, DOI 10.1093/nar/gkm959; Harrison JG, 2004, BBA-MOL CELL RES, V1644, P17, DOI 10.1016/j.bbamcr.2003.10.008; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; HROMAS R, 1991, J BIOL CHEM, V266, P14183; IWAKI K, 1990, J BIOL CHEM, V265, P13809; Jin XP, 2003, J BIOL CHEM, V278, P25716, DOI 10.1074/jbc.M300316200; Karin M, 2001, IUBMB LIFE, V52, P17; Kawamura T, 2004, BIOCHEM BIOPH RES CO, V315, P733, DOI 10.1016/j.bbrc.2004.01.105; Kemp TJ, 2003, BIOCHEM BIOPH RES CO, V307, P416, DOI 10.1016/S0006-291X(03)01215-4; Leri A, 1999, AM J PATHOL, V154, P567, DOI 10.1016/S0002-9440(10)65302-3; Leri A, 1999, CIRC RES, V84, P752; Long X, 2007, MOL CELL BIOCHEM, V303, P167, DOI 10.1007/s11010-007-9470-1; McNeill-Blue C, 2006, BRAIN RES, V1112, P1, DOI 10.1016/j.brainres.2006.07.024; Mendrysa SM, 2001, GENE, V264, P139, DOI 10.1016/S0378-1119(00)00589-8; MORRIS JF, 1994, MOL CELL BIOL, V14, P1786, DOI 10.1128/MCB.14.3.1786; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Peirce SK, 2009, INT J ONCOL, V34, P1395, DOI 10.3892/ijo_00000267; Phelps M, 2003, CANCER RES, V63, P2616; Poizat C, 2000, MOL CELL BIOL, V20, P8643, DOI 10.1128/MCB.20.23.8643-8654.2000; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Saucedo LJ, 1999, J BIOL CHEM, V274, P8161, DOI 10.1074/jbc.274.12.8161; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Siwik DA, 1999, CIRC RES, V85, P147, DOI 10.1161/01.RES.85.2.147; Solaini G, 2005, BIOCHEM J, V390, P377, DOI 10.1042/BJ20042006; Sugden PH, 2006, ANTIOXID REDOX SIGN, V8, P2111, DOI 10.1089/ars.2006.8.2111; Suzuki K, 2001, J MOL CELL CARDIOL, V33, P983, DOI 10.1006/jmcc.2001.1364; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tortora G, 2000, INT J CANCER, V88, P804, DOI 10.1002/1097-0215(20001201)88:5<804::AID-IJC19>3.0.CO;2-Z; Toth A, 2006, J BIOL CHEM, V281, P3679, DOI 10.1074/jbc.M509630200; Truong AHL, 2005, ONCOGENE, V24, P962, DOI 10.1038/sj.onc.1208323; Uberti D, 1999, MOL BRAIN RES, V65, P167, DOI 10.1016/S0169-328X(98)00339-8; Vanden Hoek TL, 1998, J BIOL CHEM, V273, P18092, DOI 10.1074/jbc.273.29.18092; Veprintsev DB, 2008, NUCLEIC ACIDS RES, V36, P1589, DOI 10.1093/nar/gkm1040; von Harsdorf R, 1999, CIRCULATION, V99, P2934, DOI 10.1161/01.CIR.99.22.2934; Yoneda K, 2003, J AM SOC NEPHROL, V14, pS284, DOI 10.1097/01.ASN.0000078023.30954.05	57	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27195	27210		10.1074/jbc.M109.037887	http://dx.doi.org/10.1074/jbc.M109.037887			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19638633	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000270232300020
J	Hatherley, D; Graham, SC; Harlos, K; Stuart, DI; Barclay, AN				Hatherley, Deborah; Graham, Stephen C.; Harlos, Karl; Stuart, David I.; Barclay, A. Neil			Structure of Signal-regulatory Protein alpha A LINK TO ANTIGEN RECEPTOR EVOLUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN SUPERFAMILY; MAXIMUM-LIKELIHOOD; DIFFRACTION DATA; CELL; GLYCOPROTEIN; DOMAINS; CD47; CRYSTALLIZATION; GLYCOSYLATION; REFINEMENT	Signal-regulatory protein alpha (SIRP alpha) is a myeloid membrane receptor that interacts with the membrane protein CD47, a marker of self. We have solved the structure of the complete extracellular portion of SIRP alpha,comprising three immunoglobulin superfamily domains, by x-ray crystallography to 2.5 angstrom resolution. These data, together with previous data on the N-terminal domain and its ligand CD47 (possessing a single immunoglobulin superfamily domain), show that the CD47-SIRP alpha interaction will span a distance of around 14 nm between interacting cells, comparable with that of an immunological synapse. The N-terminal (V-set) domain mediates binding to CD47, and the two others are found to be constant (C1-set) domains. C1-set domains are restricted to proteins involved in vertebrate antigen recognition: T cell antigen receptors, immunoglobulins, major histocompatibility complex antigens, tapasin, and beta 2-microglobulin. The domains of SIRP alpha (domains 2 and 3) are structurally more similar to C1-set domains than any cell surface protein not involved in antigen recognition. This strengthens the suggestion from sequence analysis that SIRP is evolutionarily closely related to antigen recognition proteins.	[Graham, Stephen C.; Harlos, Karl; Stuart, David I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England; [Graham, Stephen C.; Harlos, Karl; Stuart, David I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford Prot Prod Facil, Oxford OX3 7BN, England; [Hatherley, Deborah; Barclay, A. Neil] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Stuart, DI (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England.	dave@strubi.ox.ac.uk; neil.barclay@path.ox.ac.uk		Stuart, David/0000-0002-3426-4210; Graham, Stephen/0000-0003-4547-4034	Medical Research Council [G0400808]; Wellcome Trust [WT084194]; European Community [LSHG-CT-2006-031220]; MRC [G0400808, G0500365] Funding Source: UKRI; Medical Research Council [G0500365] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Community(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Medical Research Council Grant G0400808 and Wellcome Trust Grant WT084194 (to A. N. B., D. H., K. H., D. I. S., and the Oxford Protein Production Facility). This is a contribution of the European Community project SPINE2-Complexes (LSHG-CT-2006-031220).	Afonine PV, 2005, CCP4 NEWSL, V42; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Barclay AN, 2003, SEMIN IMMUNOL, V15, P215, DOI 10.1016/S1044-5323(03)00047-2; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Chandonia JM, 2004, NUCLEIC ACIDS RES, V32, pD189, DOI 10.1093/nar/gkh034; DAVIS SJ, 1993, PROTEIN ENG, V6, P229, DOI 10.1093/protein/6.2.229; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans EJ, 2005, NAT IMMUNOL, V6, P271, DOI 10.1038/ni1170; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Hatherley D, 2007, J BIOL CHEM, V282, P14567, DOI 10.1074/jbc.M611511200; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mankelow T, 2007, BLOOD, V110, P3398, DOI 10.1182/blood-2007-06-094748; Mayer WE, 2001, IMMUNOGENETICS, V53, P719, DOI 10.1007/s00251-001-0403-y; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Rebres RA, 2001, J BIOL CHEM, V276, P34607, DOI 10.1074/jbc.M106107200; Smith DK, 1997, J MOL BIOL, V274, P530, DOI 10.1006/jmbi.1997.1432; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; Theobald DL, 2006, BIOINFORMATICS, V22, P2171, DOI 10.1093/bioinformatics/btl332; Tronrud DE, 1996, J APPL CRYSTALLOGR, V29, P100, DOI 10.1107/S002188989501421X; Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Beek EM, 2005, J IMMUNOL, V175, P7781, DOI 10.4049/jimmunol.175.12.7781; van den Berg TK, 2004, TRENDS IMMUNOL, V25, P11, DOI 10.1016/j.it.2003.11.006; Walter TS, 2005, ACTA CRYSTALLOGR D, V61, P651, DOI 10.1107/S0907444905007808; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Wright GJ, 2000, IMMUNITY, V13, P233, DOI 10.1016/S1074-7613(00)00023-6	40	25	29	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26613	26619		10.1074/jbc.M109.017566	http://dx.doi.org/10.1074/jbc.M109.017566			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19628875	Green Published, hybrid			2022-12-27	WOS:000269969600042
J	Fukuda, H; Takamura-Enya, T; Masuda, Y; Nohmi, T; Seki, C; Kamiya, K; Sugimura, T; Masutani, C; Hanaoka, F; Nakagama, H				Fukuda, Hirokazu; Takamura-Enya, Takeji; Masuda, Yuji; Nohmi, Takehiko; Seki, Chiho; Kamiya, Kenji; Sugimura, Takashi; Masutani, Chikahide; Hanaoka, Fumio; Nakagama, Hitoshi			Translesional DNA Synthesis through a C8-Guanyl Adduct of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in Vitro REV1 INSERTS dC OPPOSITE THE LESION, AND DNA POLYMERASE kappa POTENTIALLY CATALYZES EXTENSION REACTION FROM THE 3 '-dC TERMINUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST REV1 PROTEIN; HETEROCYCLIC AMINES; 2-AMINO-1-METHYL-6-PHENYLIMIDAZO<4,5-B>PYRIDINE PHIP; ESCHERICHIA-COLI; COOKED FOOD; IDENTIFICATION; MUTATIONS; RAT; MUTAGENESIS; CARCINOGEN	2-Amino-1-methyl-6-phenylimidazo[4,5-b] pyridine ( PhIP) is the most abundant heterocyclic amine in cooked foods, and is both mutagenic and carcinogenic. It has been suspected that the carcinogenicity of PhIP is derived from its ability to form DNA adducts, principally dG-C8-PhIP. To shed further light on the molecular mechanisms underlying the induction of mutations by PhIP, in vitro DNA synthesis analyses were carried out using a dG-C8-PhIP-modified oligonucleotide template. In this template, the dG-C8-PhIP adduct was introduced into the second G of the TCC GGG AAC sequence located in the 5' region. This represents one of the mutation hot spots in the rat Apc gene that is targeted by PhIP. Guanine deletions at this site in the Apc gene have been found to be preferentially induced by PhIP in rat colon tumors. DNA synthesis with A- or B-family DNA polymerases, such as Escherichia coli polymerase (pol) I and human pol delta, was completely blocked at the adducted guanine base. Translesional synthesis polymerases of the Y-family, pol eta, pol iota, pol kappa, and REV1, were also used for in vitro DNA synthesis analyses with the same templates. REV1, pol eta, and pol kappa were able to insert dCTP opposite dG-C8-PhIP, although the efficiencies for pol eta and pol kappa were low. pol kappa was also able to catalyze the extension reaction from the dC opposite dG-C8-PhIP, during which it often skipped over one dG of the triple dG sequence on the template. This slippage probably leads to the single dG base deletion in colon tumors.	[Fukuda, Hirokazu; Seki, Chiho; Sugimura, Takashi; Nakagama, Hitoshi] Natl Canc Ctr, Res Inst, Div Biochem, Chuo Ku, Tokyo 1040045, Japan; [Takamura-Enya, Takeji] Kanagawa Inst Technol, Fac Engn, Dept Appl Chem, Kanagawa 2430292, Japan; [Masuda, Yuji; Kamiya, Kenji] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Expt Oncol, Minami Ku, Hiroshima 7348553, Japan; [Nohmi, Takehiko] Natl Inst Hlth Sci, Div Genet & Mutagenesis, Setagaya Ku, Tokyo 1588501, Japan; [Masutani, Chikahide; Hanaoka, Fumio] Osaka Univ, Cellular Biol Lab, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	National Cancer Center - Japan; Kanagawa Institute Technology; Hiroshima University; National Institute of Health Sciences - Japan; Osaka University	Nakagama, H (corresponding author), Natl Canc Ctr, Res Inst, Div Biochem, Chuo Ku, 1-1 Tsukiji 5, Tokyo 1040045, Japan.	hnakagam@ncc.go.jp	Masuda, Yuji/I-6315-2014; Takamura, Takeji/AAR-7391-2021; Masutani, Chikahide/I-6160-2014	Masuda, Yuji/0000-0002-6229-1988; Masutani, Chikahide/0000-0002-8600-8227	Kakenhi [19570144]	Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Kakenhi Grant 19570144.	Choi JY, 2006, J BIOL CHEM, V281, P25297, DOI 10.1074/jbc.M605699200; Dashwood RH, 1998, CANCER RES, V58, P1127; ENDO H, 1994, CANCER RES, V54, P3745; Felton J. S., 2000, Food borne carcinogens: heterocyclic amines., P31; FELTON JS, 1991, MUTAT RES, V259, P205, DOI 10.1016/0165-1218(91)90118-6; FELTON JS, 1986, CARCINOGENESIS, V7, P1081, DOI 10.1093/carcin/7.7.1081; FRANDSEN H, 1992, CARCINOGENESIS, V13, P629, DOI 10.1093/carcin/13.4.629; Fukuda H, 1997, GENES CELLS, V2, P735, DOI 10.1046/j.1365-2443.1997.1580356.x; Fukuda H, 2002, P NATL ACAD SCI USA, V99, P12685, DOI 10.1073/pnas.152456899; Haracska L, 2002, J BIOL CHEM, V277, P15546, DOI 10.1074/jbc.M112146200; Haracska L, 2001, GENE DEV, V15, P945, DOI 10.1101/gad.882301; HOLME JA, 1989, CARCINOGENESIS, V10, P1389, DOI 10.1093/carcin/10.8.1389; Imaida K, 1996, JPN J CANCER RES, V87, P1116, DOI 10.1111/j.1349-7006.1996.tb03120.x; ITO N, 1991, CARCINOGENESIS, V12, P1503, DOI 10.1093/carcin/12.8.1503; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; KAKIUCHI H, 1995, P NATL ACAD SCI USA, V92, P910, DOI 10.1073/pnas.92.3.910; Kim SR, 1997, P NATL ACAD SCI USA, V94, P13792, DOI 10.1073/pnas.94.25.13792; Kobayashi S, 2002, J BIOL CHEM, V277, P34198, DOI 10.1074/jbc.M204826200; LIN DX, 1992, CHEM RES TOXICOL, V5, P691, DOI 10.1021/tx00029a016; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Lynch AM, 1998, MUTAGENESIS, V13, P601, DOI 10.1093/mutage/13.6.601; Masuda Y, 2003, J BIOL CHEM, V278, P12356, DOI 10.1074/jbc.M211765200; Masuda Y, 2002, FEBS LETT, V520, P88, DOI 10.1016/S0014-5793(02)02773-4; Masuda Y, 2007, NUCLEIC ACIDS RES, V35, P6904, DOI 10.1093/nar/gkm822; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; MORGENTHALER PML, 1995, CARCINOGENESIS, V16, P713, DOI 10.1093/carcin/16.4.713; Mozzherin DJ, 1997, P NATL ACAD SCI USA, V94, P6126, DOI 10.1073/pnas.94.12.6126; Nagao M, 1997, MUTAT RES-FUND MOL M, V376, P161, DOI 10.1016/S0027-5107(97)00039-0; Nagao M., 2000, Food borne carcinogens: heterocyclic amines., P163; Nagao M, 1999, MUTAT RES-FUND MOL M, V431, P3, DOI 10.1016/S0027-5107(99)00154-2; Nakagama H, 2002, MUTAT RES-FUND MOL M, V506, P137, DOI 10.1016/S0027-5107(02)00160-4; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; NIIMI N, 2009, BIOCHEMISTRY-US, V48; Ogi T, 1999, GENES CELLS, V4, P607, DOI 10.1046/j.1365-2443.1999.00289.x; Ohashi E, 2000, J BIOL CHEM, V275, P39678, DOI 10.1074/jbc.M005309200; OHGAKI H, 1991, MUTAT RES, V259, P399, DOI 10.1016/0165-1218(91)90130-E; Okochi E, 1999, CARCINOGENESIS, V20, P1933, DOI 10.1093/carcin/20.10.1933; Okonogi H, 1997, MUTAT RES-GEN TOX EN, V395, P93, DOI 10.1016/S1383-5718(97)00146-0; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Sambrook J., 2002, MOL CLONING LAB MANU; SCHUT HAJ, 1992, CANCER LETT, V67, P117, DOI 10.1016/0304-3835(92)90134-H; Schut HAJ, 1999, CARCINOGENESIS, V20, P353, DOI 10.1093/carcin/20.3.353; SNYDERWINE EG, 1993, CARCINOGENESIS, V14, P1389, DOI 10.1093/carcin/14.7.1389; Sugimoto T., 2000, FOOD BORNE CARCINOGE, P1; Sugimura T, 2004, CANCER SCI, V95, P290, DOI 10.1111/j.1349-7006.2004.tb03205.x; Sugiyama H, 1996, J AM CHEM SOC, V118, P7063, DOI 10.1021/ja9609821; Takamura-Enya T, 2006, CHEM RES TOXICOL, V19, P770, DOI 10.1021/tx050296s; YadollahiFarsani M, 1996, CARCINOGENESIS, V17, P617, DOI 10.1093/carcin/17.4.617	48	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25585	25592		10.1074/jbc.M109.037259	http://dx.doi.org/10.1074/jbc.M109.037259			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19628463	hybrid, Green Published			2022-12-27	WOS:000269738000016
J	Myette, JR; Soundararajan, V; Shriver, Z; Raman, R; Sasisekharan, R				Myette, James R.; Soundararajan, Venkataramanan; Shriver, Zachary; Raman, Rahul; Sasisekharan, Ram			Heparin/Heparan Sulfate 6-O-Sulfatase from Flavobacterium heparinum INTEGRATED STRUCTURAL AND BIOCHEMICAL INVESTIGATION OF ENZYME ACTIVE SITE AND SUBSTRATE SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; RECOMBINANT EXPRESSION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY; HUMAN ARYLSULFATASE; MOLECULAR-CLONING; PURIFICATION; MECHANISM; COMPLEX	Heparin and heparan sulfate glycosaminoglycans (HSGAGs) comprise a chemically heterogeneous class of sulfated polysaccharides. The development of structure-activity relationships for this class of polysaccharides requires the identification and characterization of degrading enzymes with defined substrate specificity and enzymatic activity. Toward this end, we report here the molecular cloning and extensive structure-function analysis of a 6-O-sulfatase from the Gram-negative bacterium Flavobacterium heparinum. In addition, we report the recombinant expression of this enzyme in Escherichia coli in a soluble, active form and identify it as a specific HSGAG sulfatase. We further define the mechanism of action of the enzyme through biochemical and structural studies. Through the use of defined substrates, we investigate the kinetic properties of the enzyme. This analysis was complemented by homology-based molecular modeling studies that sought to rationalize the substrate specificity of the enzyme and mode of action through an analysis of the active-site topology of the enzyme including identifying key enzyme-substrate interactions and assigning key amino acids within the active site of the enzyme. Taken together, our structural and biochemical studies indicate that 6-O-sulfatase is a predominantly exolytic enzyme that specifically acts on N-sulfated or N-acetylated 6-O-sulfated glucosamines present at the non-reducing end of HSGAG oligosaccharide substrates. This requirement for the N-acetyl or N-sulfo groups on the glucosamine substrate can be explained through eliciting favorable interactions with key residues within the active site of the enzyme. These findings provide a framework that enables the use of 6-O-sulfatase as a tool for HSGAG structure-activity studies as well as expand our biochemical and structural understanding of this important class of enzymes.	MIT, Harvard Mit Div Hlth Sci & Technol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sasisekharan, R (corresponding author), 77 Massachusetts Ave,Rm 16-561, Cambridge, MA 02139 USA.	rams@mit.edu			National Institutes of Health [GM57073]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM057073, R01GM057073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM57073.	Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; BEIL S, 1995, EUR J BIOCHEM, V229, P385, DOI 10.1111/j.1432-1033.1995.0385k.x; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Boltes I, 2001, STRUCTURE, V9, P483, DOI 10.1016/S0969-2126(01)00609-8; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Dierks T, 2005, CELL, V121, P541, DOI 10.1016/j.cell.2005.03.001; Dierks T, 1998, J BIOL CHEM, V273, P25560, DOI 10.1074/jbc.273.40.25560; DIETRICH CP, 1973, J BIOL CHEM, V248, P6408; Ernst S, 1996, BIOCHEM J, V315, P589, DOI 10.1042/bj3150589; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Godavarti R, 1996, BIOCHEM BIOPH RES CO, V225, P751, DOI 10.1006/bbrc.1996.1246; Guda C, 2004, NUCLEIC ACIDS RES, V32, pW100, DOI 10.1093/nar/gkh464; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; HUIGE CJM, 1995, J COMPUT CHEM, V16, P56, DOI 10.1002/jcc.540160106; Kertesz MA, 2000, FEMS MICROBIOL REV, V24, P135, DOI 10.1016/S0168-6445(99)00033-9; Lai JP, 2004, GASTROENTEROLOGY, V126, P231, DOI 10.1053/j.gastro.2003.09.043; Liu J, 2002, J BIOL CHEM, V277, P33456, DOI 10.1074/jbc.M202034200; LOHSE DL, 1992, J BIOL CHEM, V267, P24347; Lukatela G, 1998, BIOCHEMISTRY-US, V37, P3654, DOI 10.1021/bi9714924; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Myette JR, 2009, J BIOL CHEM, V284, P35189, DOI 10.1074/jbc.M109.053835; Myette JR, 2003, J BIOL CHEM, V278, P12157, DOI 10.1074/jbc.M211420200; Myette JR, 2002, BIOCHEMISTRY-US, V41, P7424, DOI 10.1021/bi012147o; NAKAMURA T, 1988, J CLIN MICROBIOL, V26, P1070, DOI 10.1128/JCM.26.5.1070-1071.1988; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Prince JM, 2002, DEV DYNAM, V223, P497, DOI 10.1002/dvdy.10070; Raman R, 2003, J BIOL CHEM, V278, P12167, DOI 10.1074/jbc.M211425200; Roberton AM, 2000, METH MOL B, V125, P417; Rusnati M, 2005, CURR PHARM DESIGN, V11, P2489, DOI 10.2174/1381612054367553; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; SASISEKHARAN R, 1993, P NATL ACAD SCI USA, V90, P3660, DOI 10.1073/pnas.90.8.3660; Shaya D, 2006, J BIOL CHEM, V281, P15525, DOI 10.1074/jbc.M512055200; Shriver Z, 2002, TRENDS CARDIOVAS MED, V12, P71, DOI 10.1016/S1050-1738(01)00150-5; Uchimura Kenji, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-2; Venkataraman G, 1999, SCIENCE, V286, P537, DOI 10.1126/science.286.5439.537; Vives RR, 2006, CURR GENE THER, V6, P35, DOI 10.2174/156652306775515565; von Bulow R, 2001, J MOL BIOL, V305, P269, DOI 10.1006/jmbi.2000.4297	39	17	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35177	35188		10.1074/jbc.M109.053801	http://dx.doi.org/10.1074/jbc.M109.053801			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19726671	hybrid, Green Published			2022-12-27	WOS:000272439600071
J	Sato, M; Jiao, QB; Honda, T; Kurotani, R; Toyota, E; Okumura, S; Takeya, T; Minamisawa, S; Lanier, SM; Ishikawa, Y				Sato, Motohiko; Jiao, Qibin; Honda, Takashi; Kurotani, Reiko; Toyota, Eiji; Okumura, Satoshi; Takeya, Tatsuo; Minamisawa, Susumu; Lanier, Stephen M.; Ishikawa, Yoshihiro			Activator of G Protein Signaling 8 (AGS8) Is Required for Hypoxia-induced Apoptosis of Cardiomyocytes ROLE OF G beta gamma AND CONNEXIN 43 (CX43)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-INDEPENDENT ACTIVATOR; MITOCHONDRIAL-MEMBRANE; CARDIAC MYOCYTES; GROWTH-FACTOR; CONNEXIN-43; PHOSPHORYLATION; HEMICHANNELS; SELECTIVITY; ISCHEMIA; SUBUNITS	Ischemic injury of the heart is associated with activation of multiple signal transduction systems including the heterotrimeric G-protein system. Here, we report a role of the ischemia-inducible regulator of G beta gamma subunit, AGS8, in survival of cardiomyocytes under hypoxia. Cultured rat neonatal cardiomyocytes (NCM) were exposed to hypoxia or hypoxia/reoxygenation following transfection of AGS8siRNA or pcDNA::AGS8. Hypoxia-induced apoptosis of NCM was completely blocked by AGS8siRNA, whereas overexpression of AGS8 increased apoptosis. AGS8 formed complexes with G-proteins and channel protein connexin 43 (CX43), which regulates the permeability of small molecules under hypoxic stress. AGS8 initiated CX43 phosphorylation in a G beta gamma-dependent manner by providing a scaffold composed of G beta gamma and CX43. AGS8siRNA blocked internalization of CX43 following exposure of NCM to repetitive hypoxia; however it did not influence epidermal growth factor-mediated internalization of CX43. The decreased dye flux through CX43 that occurred with hypoxic stress was also prevented by AGS8siRNA. Interestingly, the G beta gamma inhibitor Gallein mimicked the effect of AGS8 knockdown on both the CX43 internalization and the changes in cell permeability elicited by hypoxic stress. These data indicate that AGS8 is required for hypoxia-induced apoptosis of NCM, and that AGS8-G beta gamma signal input increased the sensitivity of cells to hypoxic stress by influencing CX43 regulation and associated cell permeability. Under hypoxic stress, this unrecognized response program plays a critical role in the fate of NCM.	[Sato, Motohiko] Yokohama City Univ, Cardiovasc Res Inst, Sch Med, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Toyota, Eiji] Kawasaki Med Sch, Dept Cardiol, Kurashiki, Okayama 7010192, Japan; [Takeya, Tatsuo] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; [Minamisawa, Susumu] Waseda Univ, Dept Life Sci & Med Biosci, Tokyo 1628480, Japan; [Lanier, Stephen M.] Med Univ S Carolina, Dept Pharmacol, Charleston, SC 29425 USA	Yokohama City University; Kawasaki Medical School; Nara Institute of Science & Technology; Waseda University; Medical University of South Carolina	Sato, M (corresponding author), Yokohama City Univ, Cardiovasc Res Inst, Sch Med, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	motosato@yokohama-cu.ac.jp; yishikaw@med.yokohama-cu.ac.jp		Minamisawa, Susumu/0000-0003-4728-2116; Lanier, Stephen/0000-0002-2740-7607	National Institutes of Health [NS24821, DA025896]; Yokohama City University, Japan [18599006, 20590212, 18057018, 193902217, K18017, K19021]; Takeda Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024821, R29NS024821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025896] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yokohama City University, Japan; Takeda Science Foundation(Takeda Science Foundation (TSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants NS24821 and DA025896 (to S. M. L.). This work was also supported by Grants-in-Aid for Scientific Research (C) 18599006 and 20590212 (to M. S.) and 18057018 and 193902217 (to Y. I.), the Yokohama Foundation for Advancement of Medical Science (to M. S.), grants from the Strategic Research Project K18017 and K19021 of Yokohama City University, Japan (to M. S.), and a grant from the Takeda Science Foundation (to Y. I.).	Bao XY, 2007, P NATL ACAD SCI USA, V104, P4919, DOI 10.1073/pnas.0603154104; Birnbaumer L, 2007, BBA-BIOMEMBRANES, V1768, P772, DOI 10.1016/j.bbamem.2006.12.002; Bishopric Nanette H., 2001, Current Opinion in Pharmacology, V1, P141, DOI 10.1016/S1471-4892(01)00032-7; Blumer JB, 2008, ENDOCRINOLOGY, V149, P3842, DOI 10.1210/en.2008-0050; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Cismowski MJ, 2006, SEMIN CELL DEV BIOL, V17, P334, DOI 10.1016/j.semcdb.2006.03.003; Cook SA, 1999, CIRC RES, V85, P940; Ek-Vitorin JF, 2006, CIRC RES, V98, P1498, DOI 10.1161/01.RES.0000227572.45891.2c; Fernandes R, 2004, J BIOL CHEM, V279, P27219, DOI 10.1074/jbc.M400446200; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; Hausenloy DJ, 2007, PHARMACOL THERAPEUT, V116, P173, DOI 10.1016/j.pharmthera.2007.06.005; Heinzel FR, 2005, CIRC RES, V97, P583, DOI 10.1161/01.RES.0000181171.65293.65; Hendriks-Balk MC, 2008, EUR J PHARMACOL, V585, P278, DOI 10.1016/j.ejphar.2008.02.088; Heximer SP, 1999, J BIOL CHEM, V274, P34253, DOI 10.1074/jbc.274.48.34253; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; Lampe PD, 2006, J CELL SCI, V119, P3435, DOI 10.1242/jcs.03089; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Leithe E, 2004, J CELL SCI, V117, P1211, DOI 10.1242/jcs.00951; Li JX, 2008, J BIOL CHEM, V283, P34260, DOI 10.1074/jbc.M806087200; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Retamal MA, 2007, P NATL ACAD SCI USA, V104, P8322, DOI 10.1073/pnas.0702456104; Rodriguez-Sinovas A, 2007, PROG BIOPHYS MOL BIO, V94, P219, DOI 10.1016/j.pbiomolbio.2007.03.003; Rodriguez-Sinovas A, 2006, CIRC RES, V99, P93, DOI 10.1161/01.RES.0000230315.56904.de; Rogers JH, 1999, J CLIN INVEST, V104, P567, DOI 10.1172/JCI6713; Ruiz-Meana M, 2008, CARDIOVASC RES, V77, P325, DOI 10.1093/cvr/cvm062; Saffitz JE, 2005, ANN NY ACAD SCI, V1047, P336, DOI 10.1196/annals.1341.030; Sato M, 2006, P NATL ACAD SCI USA, V103, P797, DOI 10.1073/pnas.0507467103; Sato M, 2004, J BIOL CHEM, V279, P13375, DOI 10.1074/jbc.M312660200; Sato M, 1996, J BIOL CHEM, V271, P30052, DOI 10.1074/jbc.271.47.30052; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Sato Motohiko, 2010, Pathophysiology, V17, P89, DOI 10.1016/j.pathophys.2009.03.011; Schulz R, 2003, FASEB J, V17, P1355, DOI 10.1096/fj.02-0975fje; Schwanke U, 2002, AM J PHYSIOL-HEART C, V283, pH1740, DOI 10.1152/ajpheart.00442.2002; Shintani-Ishida K, 2007, AM J PHYSIOL-HEART C, V293, pH1714, DOI 10.1152/ajpheart.00022.2007; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Solan JL, 2007, J CELL BIOL, V179, P1301, DOI 10.1083/jcb.200707060; Toyota E, 2005, CIRCULATION, V112, P2108, DOI 10.1161/CIRCULATIONAHA.104.526954; Turner MS, 2004, CIRC RES, V95, P726, DOI 10.1161/01.RES.0000144805.11519.1e; Webster KA, 2007, TRENDS PHARMACOL SCI, V28, P492, DOI 10.1016/j.tips.2007.07.004; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yogo K, 2002, FEBS LETT, V531, P132, DOI 10.1016/S0014-5793(02)03441-5; Yuan CJ, 2007, J BIOL CHEM, V282, P19938, DOI 10.1074/jbc.M700396200	42	54	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31431	31440		10.1074/jbc.M109.014068	http://dx.doi.org/10.1074/jbc.M109.014068			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19723622	Green Published, hybrid			2022-12-27	WOS:000271378400068
J	Shiryaev, SA; Remacle, AG; Savinov, AY; Chernov, AV; Cieplak, P; Radichev, IA; Williams, R; Shiryaeva, TN; Gawlik, K; Postnova, TI; Ratnikov, BI; Eroshkin, AM; Motamedchaboki, K; Smith, JW; Strongin, AY				Shiryaev, Sergey A.; Remacle, Albert G.; Savinov, Alexei Y.; Chernov, Andrei V.; Cieplak, Piotr; Radichev, Ilian A.; Williams, Roy; Shiryaeva, Tatiana N.; Gawlik, Katarzyna; Postnova, Tatiana I.; Ratnikov, Boris I.; Eroshkin, Alexei M.; Motamedchaboki, Khatereh; Smith, Jeffrey W.; Strongin, Alex Y.			Inflammatory Proprotein Convertase-Matrix Metalloproteinase Proteolytic Pathway in Antigen-presenting Cells as a Step to Autoimmune Multiple Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN BASIC-PROTEIN; ALPHA-B-CRYSTALLIN; ALTERED PEPTIDE LIGANDS; ENCEPHALOMYELITIS; EXPRESSION; IMMUNE; FURIN; MICE; GENE; EPITOPE	Multiple sclerosis ( MS) is a disease of the central nervous system with autoimmune etiology. Susceptibility to MS is linked to viral and bacterial infections. Matrix metalloproteinases ( MMPs) play a significant role in the fragmentation of myelin basic protein (MBP) and demyelination. The splice variants of the single MBP gene are expressed in the oligodendrocytes of the central nervous system ( classic MBP) and in the immune cells (Golli-MBPs). Our data suggest that persistent inflammation caused by environmental risk factors is a step to MS. We have discovered biochemical evidence suggesting the presence of the inflammatory proteolytic pathway leading to MS. The pathway involves the self-activated furin and PC2 proprotein convertases and membrane type-6 MMP (MT6-MMP/MMP-25) that is activated by furin/PC2. These events are followed by MMP-25 proteolysis of the Golli-MBP isoforms in the immune system cells and stimulation of the specific autoimmune T cell clones. It is likely that the passage of these autoimmune T cell clones through the disrupted blood-brain barrier to the brain and the recognition of neuronal, classic MBP causes inflammation leading to the further up-regulation of the activity of the multiple individual MMPs, the massive cleavage of MBP in the brain, demyelination, and MS. In addition to the cleavage of Golli-MBPs, MMP-25 proteolysis readily inactivates crystallin alpha B that is a suppressor of MS. These data suggest that MMP-25 plays an important role in MS pathology and that MMP-25, especially because of its restricted cell/tissue expression pattern and cell surface/lipid raft localization, is a promising drug target in MS.	[Shiryaev, Sergey A.; Remacle, Albert G.; Savinov, Alexei Y.; Chernov, Andrei V.; Cieplak, Piotr; Radichev, Ilian A.; Williams, Roy; Shiryaeva, Tatiana N.; Gawlik, Katarzyna; Postnova, Tatiana I.; Ratnikov, Boris I.; Eroshkin, Alexei M.; Motamedchaboki, Khatereh; Smith, Jeffrey W.; Strongin, Alex Y.] Burnham Inst Med Res, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Strongin, AY (corresponding author), Burnham Inst Med Res, La Jolla, CA 92037 USA.	strongin@burnham.org	Strongin, Alex/R-6609-2019; Chernov, Andrei/I-1623-2019; Messier, Claude/A-2322-2008	Strongin, Alex/0000-0003-3765-3016; Chernov, Andrei/0000-0002-3294-5418; Messier, Claude/0000-0002-4791-1763; Williams, Roy/0000-0002-5442-9166	National Institutes of Health [CA83017, CA77470, RR020843]; NATIONAL CANCER INSTITUTE [R01CA083017, R01CA077470] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA83017 and CA77470 ( to A. Y. S.) and RR020843 ( to J. W. S. and A. Y. S.).	ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; Bar-Or A, 2007, ARCH NEUROL-CHICAGO, V64, P1407, DOI 10.1001/archneur.64.10.nct70002; CAMPAGNONI AT, 1993, J BIOL CHEM, V268, P4930; Chen EI, 2003, J BIOL CHEM, V278, P17158, DOI 10.1074/jbc.M210324200; Cheng M, 1997, INT J CANCER, V71, P966, DOI 10.1002/(SICI)1097-0215(19970611)71:6<966::AID-IJC10>3.3.CO;2-A; DaSliva AG, 2008, J NEUROIMMUNOL, V199, P24, DOI 10.1016/j.jneuroim.2008.04.034; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Feng JM, 2007, NEUROCHEM RES, V32, P273, DOI 10.1007/s11064-006-9164-1; Feng JM, 2004, J NEUROIMMUNOL, V152, P57, DOI 10.1016/j.jneuroim.2004.03.021; Folgueras AR, 2008, J BIOL CHEM, V283, P9465, DOI 10.1074/jbc.M709522200; Fugere M, 2002, J BIOL CHEM, V277, P7648, DOI 10.1074/jbc.M107467200; FUGGER L, 2009, NAT REV IMM IN PRESS; Gawlik K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005031; Goodin DS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004565; Hellings N, 2001, J NEUROSCI RES, V63, P290, DOI 10.1002/1097-4547(20010201)63:3<290::AID-JNR1023>3.0.CO;2-4; Jacobs EC, 2005, J NEUROSCI, V25, P7004, DOI 10.1523/JNEUROSCI.0288-05.2005; Katsara M, 2008, J MED CHEM, V51, P3971, DOI 10.1021/jm8000554; Kridel SJ, 2002, J BIOL CHEM, V277, P23788, DOI 10.1074/jbc.M111574200; Matsoukas J, 2005, J MED CHEM, V48, P1470, DOI 10.1021/jm040849g; Menezes JS, 2007, J CLIN INVEST, V117, P2176, DOI 10.1172/JCI28277; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; PRIBYL TM, 1993, P NATL ACAD SCI USA, V90, P10695, DOI 10.1073/pnas.90.22.10695; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; Rosenberg GA, 2002, NEUROSCIENTIST, V8, P586, DOI 10.1177/1073858402238517; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seo J, 2002, COMPUTER, V35, P80; Shiryaev SA, 2007, J BIOL CHEM, V282, P20847, DOI 10.1074/jbc.M703847200; Shiryaev SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004952; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Starckx S, 2003, J NEUROIMMUNOL, V141, P47, DOI 10.1016/S0165-5728(03)00217-0; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Steinman L, 2001, J CLIN IMMUNOL, V21, P93, DOI 10.1023/A:1011020225433; STEINMAN L, 1995, MOL MED TODAY, V1, P79, DOI 10.1016/S1357-4310(95)92366-7; Stoevring B, 2005, CLIN CHIM ACTA, V356, P95, DOI 10.1016/j.cccn.2005.01.034; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Thoua NM, 2000, J NEUROIMMUNOL, V104, P47, DOI 10.1016/S0165-5728(99)00246-5; Toft-Hansen H, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-24; Tselios T, 2002, J MED CHEM, V45, P275, DOI 10.1021/jm0102147; Ulrich R, 2006, J NEUROPATH EXP NEUR, V65, P783, DOI 10.1097/01.jnen.0000229990.32795.0d; van Horssen J, 2006, NEUROPATH APPL NEURO, V32, P585, DOI 10.1111/j.1365-2990.2006.00766.x; VANNOORT JM, 1995, NATURE, V375, P798, DOI 10.1038/375798a0; Vos CMP, 2003, J NEUROIMMUNOL, V138, P106, DOI 10.1016/S0165-5728(03)00036-5; Voskuhl RR, 1996, J NEUROIMMUNOL, V70, P103, DOI 10.1016/S0165-5728(96)00054-9; Weaver A, 2005, FASEB J, V19, P1668, DOI 10.1096/fj.04-2030fje; Werner SR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-83; Wucherpfennig KW, 1997, J CLIN INVEST, V100, P1114, DOI 10.1172/JCI119622	48	40	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30615	30626		10.1074/jbc.M109.041244	http://dx.doi.org/10.1074/jbc.M109.041244			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19726693	hybrid, Green Published			2022-12-27	WOS:000271090000064
J	Donkor, J; Zhang, PX; Wong, S; O'Loughlin, L; Dewald, J; Kok, BPC; Brindley, DN; Reue, K				Donkor, Jimmy; Zhang, Peixiang; Wong, Samantha; O'Loughlin, Lauren; Dewald, Jay; Kok, Bernard P. C.; Brindley, David N.; Reue, Karen			A Conserved Serine Residue Is Required for the Phosphatidate Phosphatase Activity but Not the Transcriptional Coactivator Functions of Lipin-1 and Lipin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECURRENT MULTIFOCAL OSTEOMYELITIS; DYSTROPHY FLD MUTATION; ENDOPLASMIC-RETICULUM; ACID PHOSPHATASE; MAJEED-SYNDROME; RAT-LIVER; GENE; METABOLISM; EXPRESSION; DISTINCT	Mammalian lipins (lipin-1, lipin-2, and lipin-3) are Mg2+-dependent phosphatidate phosphatase (PAP) enzymes, which catalyze a key reaction in glycerolipid biosynthesis. Lipin-1 also functions as a transcriptional coactivator in conjunction with members of the peroxisome proliferator-activated receptor family. An S734L mutation in LPIN2 causes Majeed syndrome, a human inflammatory disorder characterized by recurrent osteomyelitis, fever, dyserythropoietic anemia, and cutaneous inflammation. Here we demonstrate that mutation of the equivalent serine in mouse lipin-1 and lipin-2 to leucine or aspartate abolishes PAP activity but does not impair lipin association with microsomal membranes, the major site of glycerolipid synthesis. We also determined that lipin-2 has transcriptional coactivator activity for peroxisome proliferator-activated receptor-response elements similar to lipin-1 and that this activity is not affected by mutating the conserved serine. Therefore, our results indicate that the symptoms of the Majeed syndrome result from a loss of lipin-2 PAP activity. To characterize sites of lipin-2 action, we detected lipin-2 expression by in situ hybridization on whole mouse sections and by quantitative PCR of tissues relevant to Majeed syndrome. Lipin-2 was most prominently expressed in liver, where levels were much higher than lipin-1, and also in kidney, lung, gastrointestinal tract, and specific regions of the brain. Lipin-2 was also expressed in circulating red blood cells and sites of lymphopoiesis (bone marrow, thymus, and spleen). These results raise the possibility that the loss of lipin-2 PAP activity in erythrocytes and lymphocytes may contribute to the anemia and inflammation phenotypes observed in Majeed syndrome patients.	[Donkor, Jimmy; Zhang, Peixiang; Wong, Samantha; O'Loughlin, Lauren; Reue, Karen] Univ Calif Los Angeles, Dept Human Genet, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Donkor, Jimmy; Zhang, Peixiang; Wong, Samantha; O'Loughlin, Lauren; Reue, Karen] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Dewald, Jay; Kok, Bernard P. C.; Brindley, David N.] Univ Alberta, Signal Transduct Res Grp, Dept Biochem, Edmonton, AB T6G 252, Canada	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Alberta	Reue, K (corresponding author), Univ Calif Los Angeles, Dept Human Genet, David Geffen Sch Med, Gonda 6506A,,695 Charles E Young Dr S, Los Angeles, CA 90095 USA.	reuek@ucla.edu		Kok, Bernard/0000-0002-9073-9700	National Institutes of Health [HL28481, HL90553, S-T32-HG002536]; Canadian Institute of Health Research [MOP 89726]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090553, P01HL028481] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL28481 and HL90553 (to K. R.) and S-T32-HG002536 (to J. D.). This work was also supported by Canadian Institute of Health Research Grant MOP 89726 (to D. N. B.).	Al-Mosawi ZS, 2007, ARTHRITIS RHEUM, V56, P960, DOI 10.1002/art.22431; Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; Chen ZJ, 2008, ARTERIOSCL THROM VAS, V28, P1738, DOI 10.1161/ATVBAHA.108.171538; Donkor J, 2008, J CLIN ENDOCR METAB, V93, P233, DOI 10.1210/jc.2007-1535; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; El-Shanti HI, 2007, CLIN ORTHOP RELAT R, P11, DOI 10.1097/BLO.0b013e3180986d73; Ferguson PJ, 2005, J MED GENET, V42, P551, DOI 10.1136/jmg.2005.030759; Ferguson PJ, 2007, CURR OPIN RHEUMATOL, V19, P492, DOI 10.1097/BOR.0b013e32825f5492; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; GOMEZMUNOZ A, 1992, FEBS LETT, V301, P103, DOI 10.1016/0014-5793(92)80219-7; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Grkovich A, 2009, ADV ENZYME REGUL, V49, P114, DOI 10.1016/j.advenzreg.2009.01.005; Gropler MC, 2009, J BIOL CHEM, V284, P6763, DOI 10.1074/jbc.M807882200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; HOPEWELL R, 1985, BIOCHEM J, V232, P485, DOI 10.1042/bj2320485; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; Khalil MB, 2009, J LIPID RES, V50, P47, DOI 10.1194/jlr.M800204-JLR200; LANGNER CA, 1991, J BIOL CHEM, V266, P11955; LANGNER CA, 1989, J BIOL CHEM, V264, P7994; Manmontri B, 2008, J LIPID RES, V49, P1056, DOI 10.1194/jlr.M800013-JLR200; MARTIN A, 1991, METHOD ENZYMOL, V197, P553; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Reue K, 2000, J LIPID RES, V41, P1067; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Sciorra VA, 2002, BBA-MOL CELL BIOL L, V1582, P45, DOI 10.1016/S1388-1981(02)00136-1; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002	32	95	104	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29968	29978		10.1074/jbc.M109.023663	http://dx.doi.org/10.1074/jbc.M109.023663			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19717560	Green Published, hybrid			2022-12-27	WOS:000270896800075
J	Dries, DR; Shah, S; Han, YH; Yu, C; Yu, S; Shearman, MS; Yu, G				Dries, Daniel R.; Shah, Sanjiv; Han, Yu-Hong; Yu, Cong; Yu, Sophie; Shearman, Mark S.; Yu, Gang			Glu-333 of Nicastrin Directly Participates in gamma-Secretase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY INTRAMEMBRANE PROTEASE; ALZHEIMERS-DISEASE; PRESENILIN ENDOPROTEOLYSIS; TERMINAL FRAGMENTS; BINDING-SITE; COMPLEX; CLEAVAGE; PEN-2; MECHANISM; MEMBRANE	gamma-Secretase is a proteolytic membrane complex that processes a variety of substrates including the amyloid precursor protein and the Notch receptor. Earlier we showed that one of the components of this complex, nicastrin (NCT), functions as a receptor for gamma-secretase substrates. A recent report challenged this, arguing instead that the Glu-333 residue of NCT predicted to participate in substrate recognition only participates in gamma-secretase complex maturation and not in activity per se. Here, we present evidence that Glu-333 directly participates in gamma-secretase activity. By normalizing to the active pool of gamma-secretase with two separate methods, we establish that gamma-secretase complexes containing NCT-E333A are indeed deficient in intrinsic activity. We also demonstrate that the NCT-E333A mutant is deficient in its binding to substrates. Moreover, we find that the cleavage of substrates by gamma-secretase activity requires a free N-terminal amine but no minimal length of the extracellular N-terminal stub. Taken together, these studies provide further evidence supporting the role of NCT in substrate recognition. Finally, because gamma-secretase cleaves itself during its maturation and because NCT-E333A also shows defects in gamma-secretase complex maturation, we present a model whereby Glu-333 can serve a dual role via similar mechanisms in the recruitment of both Type 1 membrane proteins for activity and the presenilin intracellular loop during complex maturation.	[Yu, Gang] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Shah, Sanjiv; Yu, Sophie; Shearman, Mark S.] Merck Res Labs, Boston, MA 02115 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Merck & Company	Yu, G (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	Gang.Yu@UTSouthwestern.edu		DRIES, DANIEL/0000-0002-0530-5212	National Institutes of Health [F32 AG031625, R01 AG023104, R01 AG029547]; Welch Foundation [I-1566]; Ted Nash Long Life Foundation; NATIONAL INSTITUTE ON AGING [R01AG029547, F32AG031625, R01AG023104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Ted Nash Long Life Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants F32 AG031625 (to D. R. D.), R01 AG023104, and R01 AG029547. This work was also supported by the Welch Foundation (I-1566) and the Ted Nash Long Life Foundation.	ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Brunkan AL, 2005, MOL CELL NEUROSCI, V29, P65, DOI 10.1016/j.mcn.2004.12.012; Capell A, 2005, J BIOL CHEM, V280, P6471, DOI 10.1074/jbc.M409106200; Chavez-Gutierrez L, 2008, J BIOL CHEM, V283, P20096, DOI 10.1074/jbc.M803040200; Chen FS, 2001, NAT CELL BIOL, V3, P751, DOI 10.1038/35087069; Clarke EE, 2006, J BIOL CHEM, V281, P31279, DOI 10.1074/jbc.M605051200; Das C, 2003, J AM CHEM SOC, V125, P11794, DOI 10.1021/ja037131v; Dries DR, 2008, CURR ALZHEIMER RES, V5, P132, DOI 10.2174/156720508783954695; Dries DR, 2009, P NATL ACAD SCI USA, V106, P14737, DOI 10.1073/pnas.0908124106; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Fagan R, 2001, TRENDS BIOCHEM SCI, V26, P213, DOI 10.1016/S0968-0004(01)01789-3; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hayashi I, 2004, J BIOL CHEM, V279, P38040, DOI 10.1074/jbc.M405597200; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Hulko M, 2007, PROTEIN SCI, V16, P644, DOI 10.1110/ps.062478607; Khan AR, 1998, PROTEIN SCI, V7, P815; Kim SH, 2004, J BIOL CHEM, V279, P48615, DOI 10.1074/jbc.C400396200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Knappenberger KS, 2004, BIOCHEMISTRY-US, V43, P6208, DOI 10.1021/bi036072v; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Laudon H, 2004, J NEUROCHEM, V89, P44, DOI 10.1046/j.1471-4159.2003.02298.x; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Levitan D, 2001, P NATL ACAD SCI USA, V98, P12186, DOI 10.1073/pnas.211321898; Li XC, 2009, P NATL ACAD SCI USA, V106, P14837, DOI 10.1073/pnas.0903289106; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Luciani N, 1998, BIOCHEMISTRY-US, V37, P686, DOI 10.1021/bi971705p; Luo WJ, 2003, J BIOL CHEM, V278, P7850, DOI 10.1074/jbc.C200648200; Martin L, 2009, J BIOL CHEM, V284, P5662, DOI 10.1074/jbc.M807485200; Nyborg AC, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-3; PerezTur J, 1995, NEUROREPORT, V7, P297; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shiraishi H, 2004, J NEUROCHEM, V90, P1402, DOI 10.1111/j.1471-4159.2004.02597.x; Shirotani K, 2004, J NEUROCHEM, V89, P1520, DOI 10.1111/j.1471-4159.2004.02447.x; Steiner H, 2008, CURR ALZHEIMER RES, V5, P147, DOI 10.2174/156720508783954677; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Vazeux G, 1998, BIOCHEM J, V334, P407, DOI 10.1042/bj3340407; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Wolfe MS, 2006, BIOCHEMISTRY-US, V45, P7931, DOI 10.1021/bi060799c; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Yu G, 2000, J BIOL CHEM, V275, P27348; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zhang LL, 2005, BIOCHEMISTRY-US, V44, P4450, DOI 10.1021/bi0481500; Zhao GJ, 2007, J NEUROCHEM, V100, P1234, DOI 10.1111/j.1471-4159.2006.04302.x	57	54	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29714	29724		10.1074/jbc.M109.038737	http://dx.doi.org/10.1074/jbc.M109.038737			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19729449	Green Published, hybrid			2022-12-27	WOS:000270896800053
J	Pasquariello, N; Catanzaro, G; Marzano, V; Amadio, D; Barcaroli, D; Oddi, S; Federici, G; Urbani, A; Agro, AF; Maccarrone, M				Pasquariello, Nicoletta; Catanzaro, Giuseppina; Marzano, Valeria; Amadio, Daniele; Barcaroli, Daniela; Oddi, Sergio; Federici, Giorgio; Urbani, Andrea; Agro, Alessandro Finazzi; Maccarrone, Mauro			Characterization of the Endocannabinoid System in Human Neuronal Cells and Proteomic Analysis of Anandamide-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; NEUROBLASTOMA SH-SY5Y CELLS; CANNABINOID RECEPTOR CB1; HEAT-SHOCK PROTEINS; UP-REGULATION; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; NEURODEGENERATIVE DISEASES; TRIOSEPHOSPHATE ISOMERASE	Anandamide (AEA) is an endogenous agonist of type 1 cannabinoid receptors (CB1R) that, along with metabolic enzymes of AEA and congeners, compose the "endocannabinoid system." Here we report the biochemical, morphological, and functional characterization of the endocannabinoid system in human neuroblastoma SH-SY5Y cells that are an experimental model for neuronal cell damage and death, as well as for major human neurodegenerative disorders. We also show that AEA dose-dependently induced apoptosis of SH-SY5Y cells. Through proteomic analysis, we further demonstrate that AEA-induced apoptosis was paralleled by an similar to 3 to similar to 5-fold up-regulation or down-regulation of five genes; IgG heavy chain-binding protein, stress-induced phosphoprotein-1, and triose-phosphate isomerase-1, which were up-regulated, are known to act as antiapoptotic agents; actin-related protein 2/3 complex subunit 5 and peptidylprolyl isomerase-like protein 3 isoform PPIL3b were down-regulated, and the first is required for actin network formation whereas the second is still function-orphan. Interestingly, only the effect of AEA on BiP was reversed by the CB1R antagonist SR141716, in SH-SY5Y cells as well as in human neuroblastoma LAN-5 cells (that express a functional CB1R) but not in SK-NBE cells (which do not express CB1R). Silencing or overexpression of BiP increased or reduced, respectively, AEA-induced apoptosis of SH-SY5Y cells. In addition, the expression of BiP and of the BiP-related apoptotic markers p53 and PUMA was increased by AEA through a CB1R-dependent pathway that engages p38 and p42/44 mitogen-activated protein kinases. Consistently, this effect of AEA was minimized by SR141716. In conclusion, we identified BiP as a key protein in neuronal apoptosis induced by AEA.	[Pasquariello, Nicoletta; Catanzaro, Giuseppina; Oddi, Sergio; Maccarrone, Mauro] Univ Teramo, Dept Biomed Sci, I-64100 Teramo, Italy; [Pasquariello, Nicoletta; Catanzaro, Giuseppina; Marzano, Valeria; Amadio, Daniele; Oddi, Sergio; Federici, Giorgio; Urbani, Andrea; Maccarrone, Mauro] Fdn Santa Lucia, Ctr Europeo Ric Cervello, I-00143 Rome, Italy; [Marzano, Valeria; Federici, Giorgio] Univ Roma Tor Vergata, Dipartimento Med Interna, I-00133 Rome, Italy; [Urbani, Andrea] Fdn G DAnnunzio, Ctr Studi Invecchiamento, I-66013 Chieti, Italy; [Urbani, Andrea] Univ G DAnnunzio, Dipartimento Sci Biomed, I-66013 Chieti, Italy; [Amadio, Daniele; Barcaroli, Daniela; Agro, Alessandro Finazzi] Univ Roma Tor Vergata, Dipartimento Med Sperimentale & Sci Biochim, I-00133 Rome, Italy	University of Teramo; IRCCS Santa Lucia; University of Rome Tor Vergata; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Rome Tor Vergata	Maccarrone, M (corresponding author), Univ Teramo, Dept Biomed Sci, Piazza A Moro 45, I-64100 Teramo, Italy.	a.urbani@unich.it; mmaccarrone@unite.it	Oddi, Sergio/B-6668-2009; Urbani, Andrea/B-2953-2012; catanzaro, giuseppina/AGZ-8080-2022; Maccarrone, Mauro/K-5398-2012; Urbani, Andrea/AAD-1675-2022; Marzano, Valeria/K-5770-2016	Oddi, Sergio/0000-0002-6217-698X; catanzaro, giuseppina/0000-0001-8427-9691; Maccarrone, Mauro/0000-0002-3990-2963; Marzano, Valeria/0000-0001-6364-2121	Fondazione Cassa di Risparmio di Teramo [Tercas 2004, 2005]; Agenzia Spaziale Italiana Disturbi del Controllo Motorio e Cardiorespiratorio Project [2006]; Ministero dell'Istruzione; dell'Universita e della Ricerca Progretto di Ricerca di Interesse Nazionale; Fondo per gli Investimenti della Ricerca di Base Projects [2006]	Fondazione Cassa di Risparmio di Teramo; Agenzia Spaziale Italiana Disturbi del Controllo Motorio e Cardiorespiratorio Project; Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universita e della Ricerca Progretto di Ricerca di Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Fondo per gli Investimenti della Ricerca di Base Projects	This work was supported in part by Fondazione Cassa di Risparmio di Teramo Grants Tercas 2004 and 2005, Agenzia Spaziale Italiana Disturbi del Controllo Motorio e Cardiorespiratorio Project 2006, and Ministero dell'Istruzione, dell'Universita e della Ricerca Progretto di Ricerca di Interesse Nazionale, and Fondo per gli Investimenti della Ricerca di Base Projects 2006 (to M. M.).	Aguado T, 2007, J BIOL CHEM, V282, P6854, DOI 10.1074/jbc.M608900200; Bari M, 2005, J BIOL CHEM, V280, P12212, DOI 10.1074/jbc.M411642200; Bifulco M, 2002, NAT MED, V8, P547, DOI 10.1038/nm0602-547; Birse-Archbold JLA, 2005, J CEREBR BLOOD F MET, V25, P1356, DOI 10.1038/sj.jcbfm.9600133; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Biswas KK, 2003, HEPATOLOGY, V38, P1167, DOI 10.1053/jhep.2003.50459; BOUABOULA M, 1995, BIOCHEM J, V312, P637, DOI 10.1042/bj3120637; Bouaboula M, 1999, FEBS LETT, V449, P61, DOI 10.1016/S0014-5793(99)00395-6; Centonze D, 2008, CURR PHARM DESIGN, V14, P2370, DOI 10.2174/138161208785740018; Centonze D, 2007, TRENDS PHARMACOL SCI, V28, P180, DOI 10.1016/j.tips.2007.02.004; Colombo G, 2009, J MOL NEUROSCI, V37, P111, DOI 10.1007/s12031-008-9114-2; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Di Marzo V, 2007, CHEM BIOL, V14, P741, DOI 10.1016/j.chembiol.2007.05.014; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Fang F, 2008, ACTA PHARMACOL SIN, V29, P152, DOI 10.1111/j.1745-7254.2008.00714.x; Feng Z, 2004, J PINEAL RES, V37, P257, DOI 10.1111/j.1600-079X.2004.00164.x; Fezza F, 2005, ANAL BIOCHEM, V339, P113, DOI 10.1016/j.ab.2004.12.005; Galve-Roperh I, 2008, CURR PHARM DESIGN, V14, P2279, DOI 10.2174/138161208785740117; Gasperi V, 2007, CELL MOL LIFE SCI, V64, P219, DOI 10.1007/s00018-006-6445-4; Glaser ST, 2005, LIFE SCI, V77, P1584, DOI 10.1016/j.lfs.2005.05.007; Gomez C, 2001, J NEUROSCI RES, V63, P421, DOI 10.1002/1097-4547(20010301)63:5<421::AID-JNR1037>3.0.CO;2-4; Gomez-Santos C, 2002, BRAIN RES, V935, P32, DOI 10.1016/S0006-8993(02)02422-8; GRACY RW, 1982, ISOZYMES-CURR T BIOL, V6, P169; Guzman M, 2003, NAT REV CANCER, V3, P745, DOI 10.1038/nrc1188; HAMOS JE, 1991, NEUROLOGY, V41, P345, DOI 10.1212/WNL.41.3.345; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Huo DH, 2008, BIOCHEM BIOPH RES CO, V372, P14, DOI 10.1016/j.bbrc.2008.04.178; Jacobsson SOP, 2001, J PHARMACOL EXP THER, V299, P951; Jayachandran S., 2008, MOL PSYCHIATR, P1; Kalivendi SV, 2004, J BIOL CHEM, V279, P15240, DOI 10.1074/jbc.M312497200; Kaneda A, 2004, CANCER LETT, V212, P203, DOI 10.1016/j.canlet.2004.03.020; Katayama T, 2004, J CHEM NEUROANAT, V28, P67, DOI 10.1016/j.jchemneu.2003.12.004; Kerr LE, 2007, ONCOGENE, V26, P2554, DOI 10.1038/sj.onc.1210044; KOHNO K, 1993, MOL CELL BIOL, V13, P877, DOI 10.1128/MCB.13.2.877; Lacour P, 2007, J NEUROSCI METH, V166, P24, DOI 10.1016/j.jneumeth.2007.06.019; Liu J, 2000, BIOCHEM J, V346, P835, DOI 10.1042/0264-6021:3460835; Maccarrone M, 2000, J BIOL CHEM, V275, P31938, DOI 10.1074/jbc.M005722200; Maccarrone M, 2006, ENDOCANNABINOIDS: THE BRAIN AND BODY'S MARIJUANA AND BEYOND, P451; Maccarrone M, 2007, PROG NEUROBIOL, V81, P349, DOI 10.1016/j.pneurobio.2006.11.006; Massi P, 2004, J PHARMACOL EXP THER, V308, P838, DOI 10.1124/jpet.103.061002; Massi P, 2008, CURR PHARM DESIGN, V14, P2289, DOI 10.2174/138161208785740135; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Movsesyan VA, 2004, CELL DEATH DIFFER, V11, P1121, DOI 10.1038/sj.cdd.4401442; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Peng Y, 2008, NEUROSCI LETT, V434, P224, DOI 10.1016/j.neulet.2008.01.080; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Pettifer KM, 2007, PURINERG SIGNAL, V3, P399, DOI 10.1007/s11302-007-9073-z; Piomelli Daniele, 2005, Curr Opin Investig Drugs, V6, P672; Qi ZY, 2005, CHINESE MED J-PEKING, V118, P799; Rahmani M, 2007, MOL CELL BIOL, V27, P5499, DOI 10.1128/MCB.01080-06; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Reimertz C, 2003, J CELL BIOL, V162, P587, DOI 10.1083/jcb.200305149; Sheline CT, 1998, NEUROBIOL DIS, V5, P47, DOI 10.1006/nbdi.1998.0177; Short DM, 2007, PROTEOMICS, V7, P3085, DOI 10.1002/pmic.200600964; Shu CV, 2008, J CELL PHYSIOL, V215, P627, DOI 10.1002/jcp.21340; Siegmund SV, 2006, J BIOL CHEM, V281, P10431, DOI 10.1074/jbc.M509706200; SMYTH JD, 1989, PHYSL BIOCH CESTODES, P77; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Suzuki T, 2007, ARCH BIOCHEM BIOPHYS, V468, P1, DOI 10.1016/j.abb.2007.09.004; Takayama S, 2003, ONCOGENE, V22, P9041, DOI 10.1038/sj.onc.1207114; TATSUTA T, 1992, J BIOL CHEM, V267, P20383; Urbani A, 2005, PROTEOMICS, V5, P796, DOI 10.1002/pmic.200401147; Vadlamudi RK, 2004, EMBO REP, V5, P154, DOI 10.1038/sj.embor.7400079; Wang SF, 2008, TOXICOLOGY, V246, P234, DOI 10.1016/j.tox.2008.01.020; Werz O, 2002, BLOOD, V99, P1044, DOI 10.1182/blood.V99.3.1044; Wu CW, 2007, TOXICOL APPL PHARM, V220, P243, DOI 10.1016/j.taap.2007.01.011; Yamaji R, 2004, ARCH BIOCHEM BIOPHYS, V423, P332, DOI 10.1016/j.abb.2004.01.003; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu JH, 2008, INT J BIOCHEM CELL B, V40, P503, DOI 10.1016/j.biocel.2007.09.001; Yu ZF, 1999, EXP NEUROL, V155, P302, DOI 10.1006/exnr.1998.7002; Yuste VJ, 2002, J NEUROCHEM, V80, P126, DOI 10.1046/j.0022-3042.2001.00695.x; Zhou Z, 2001, CYTOGENET CELL GENET, V92, P231, DOI 10.1159/000056909	72	52	52	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29413	29426		10.1074/jbc.M109.044412	http://dx.doi.org/10.1074/jbc.M109.044412			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19690173	Green Published, hybrid			2022-12-27	WOS:000270896800023
J	Sabina, J; Johnston, M				Sabina, Jeffrey; Johnston, Mark			Asymmetric Signal Transduction through Paralogs That Comprise a Genetic Switch for Sugar Sensing in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE SENSORS; CATABOLITE REPRESSION; KLUYVEROMYCES-LACTIS; CANDIDA-ALBICANS; MESSENGER-RNAS; DNA-BINDING; YEAST; EXPRESSION; RGT1; MTH1	Efficient uptake of glucose is especially critical to Saccharomyces cerevisiae because its preference to ferment this carbon source demands high flux through glycolysis. Glucose induces expression of HXT genes encoding hexose transporters through a signal generated by the Snf3 and Rgt2 glucose sensors that leads to depletion of the transcriptional regulators Mth1 and Std1. These paralogous proteins bind to Rgt1 and enable it to repress expression of HXT genes. Here we show that Mth1 and Std1 can substitute for one another and provide nearly normal regulation of their targets. However, their roles in the glucose signal transduction cascade have diverged significantly. Mth1 is the prominent effector of Rgt1 function because it is the more abundant of the two paralogs under conditions in which both are active (in the absence of glucose). Moreover, the cellular level of Mth1 is quite sensitive to the amount of available glucose. The abundance of Std1 protein, on the other hand, remains essentially constant over a similar range of glucose concentrations. The signal generated by low levels of glucose is amplified by rapid depletion of Mth1; the velocity of this depletion is dependent on both its rate of degradation and swift repression of MTH1 transcription by the Snf1-Mig1 glucose repression pathway. Quantitation of the contributions of Mth1 and Std1 to regulation of HXT expression reveals the unique roles played by each paralog in integrating nutrient availability with metabolic capacity: Mth1 is the primary regulator; Std1 serves to buffer the response to glucose.	[Johnston, Mark] Univ Colorado Denver, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Sabina, Jeffrey; Johnston, Mark] Washington Univ, Dept Genet, St Louis, MO 63108 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Washington University (WUSTL)	Johnston, M (corresponding author), Univ Colorado Denver, Dept Biochem & Mol Genet, Anschutz Med Campus,Mail Stop 8101,POB 6511, Aurora, CO 80045 USA.	Mark.Johnston@ucdenver.edu	Johnston, Mark/K-3543-2019; Johnston, Mark/R-6156-2019	Johnston, Mark/0000-0002-4932-7229; 	National Institutes of Health [GM32540]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032540, F32GM076967] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32540 (to M. J.).	ALON U, 2007, INTRO SYSTEMS BIOL D, P5; Betina S, 2001, GENETICS, V158, P541; Brachmann CB, 1998, YEAST, V14, P115; Braud S, 2005, J PROTEOME RES, V4, P2137, DOI 10.1021/pr050230i; Brown V, 2006, EUKARYOT CELL, V5, P1726, DOI 10.1128/EC.00186-06; FLICK JS, 1991, MOL CELL BIOL, V11, P5101, DOI 10.1128/MCB.11.10.5101; Flick KM, 2003, MOL BIOL CELL, V14, P3230, DOI 10.1091/mbc.E03-03-0135; GAMO FJ, 1994, J BACTERIOL, V176, P7423, DOI 10.1128/JB.176.24.7423-7429.1994; Gancedo JM, 2008, FEMS MICROBIOL REV, V32, P673, DOI 10.1111/j.1574-6976.2008.00117.x; Gerke JP, 2006, GENETICS, V174, P985, DOI 10.1534/genetics.106.058453; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Gordon JL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000485; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Hnatova M, 2008, EUKARYOT CELL, V7, P1299, DOI 10.1128/EC.00454-07; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Kaniak A, 2004, EUKARYOT CELL, V3, P221, DOI 10.1128/EC.3.1.221-231.2004; KARPEISKY MY, 1994, FEBS LETT, V339, P209, DOI 10.1016/0014-5793(94)80417-6; Kelemen BR, 1999, NUCLEIC ACIDS RES, V27, P3696, DOI 10.1093/nar/27.18.3696; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kim JH, 2006, J BIOL CHEM, V281, P26144, DOI 10.1074/jbc.M603636200; Kim JH, 2009, BIOCHIMIE, V91, P300, DOI 10.1016/j.biochi.2008.09.002; Kim JH, 2006, EUKARYOT CELL, V5, P167, DOI 10.1128/EC.5.1.167-173.2006; Kim JH, 2003, MOL CELL BIOL, V23, P5208, DOI 10.1128/MCB.23.15.5208-5216.2003; Kuchin S, 2003, GENETICS, V163, P507; Lafuente MJ, 2000, MOL MICROBIOL, V35, P161, DOI 10.1046/j.1365-2958.2000.01688.x; Lakshmanan J, 2003, CURR GENET, V44, P19, DOI 10.1007/s00294-003-0423-2; Lindsley JE, 2004, COMP BIOCHEM PHYS B, V139, P543, DOI 10.1016/j.cbpc.2004.06.014; Lutfiyya LL, 1998, GENETICS, V150, P1377; Miller J. H, 1972, EXPT MOL GENETICS; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; OZCAN S, 1993, J BACTERIOL, V175, P5520, DOI 10.1128/JB.175.17.5520-5528.1993; Ozcan S, 1998, EMBO J, V17, P2566, DOI 10.1093/emboj/17.9.2566; OZCAN S, 1995, MOL CELL BIOL, V15, P1564; Ozcan S, 1996, P NATL ACAD SCI USA, V93, P12428, DOI 10.1073/pnas.93.22.12428; Pasula S, 2007, FEBS LETT, V581, P3230, DOI 10.1016/j.febslet.2007.06.013; Polish JA, 2005, GENETICS, V169, P583, DOI 10.1534/genetics.104.034512; Poulsen P, 2005, BIOCHEM SOC T, V33, P261, DOI 10.1042/BST0330261; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Schmidt MC, 1999, MOL CELL BIOL, V19, P4561; Schulte F, 2000, J BACTERIOL, V182, P540, DOI 10.1128/JB.182.2.540-542.2000; Sexton JA, 2007, YEAST, V24, P847, DOI 10.1002/yea.1514; SIKORSKI RS, 1989, GENETICS, V122, P19; Spielewoy N, 2004, MOL CELL BIOL, V24, P8994, DOI 10.1128/MCB.24.20.8994-9005.2004; Stasyk OG, 2008, EUKARYOT CELL, V7, P735, DOI 10.1128/EC.00028-08; ULLMANN A, 1967, J MOL BIOL, V24, P339, DOI 10.1016/0022-2836(67)90341-5; Westholm JO, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-601; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Yin ZK, 1996, MOL MICROBIOL, V20, P751, DOI 10.1111/j.1365-2958.1996.tb02514.x; Yin ZK, 2000, MOL MICROBIOL, V35, P553, DOI 10.1046/j.1365-2958.2000.01723.x	52	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29635	29643		10.1074/jbc.M109.032102	http://dx.doi.org/10.1074/jbc.M109.032102			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19720826	Green Published, hybrid			2022-12-27	WOS:000270896800045
J	Link, W; Oyarzabal, J; Serelde, BG; Albarran, MI; Rabal, O; Cebria, A; Alfonso, P; Fominaya, J; Renner, O; Peregrina, S; Soilan, D; Ceballos, PA; Hernandez, AI; Lorenzo, M; Pevarello, P; Granda, TG; Kurz, G; Carnero, A; Bischoff, JR				Link, Wolfgang; Oyarzabal, Julen; Serelde, Beatriz G.; Isabel Albarran, Maria; Rabal, Obdulia; Cebria, Antonio; Alfonso, Patricia; Fominaya, Jesus; Renner, Oliver; Peregrina, Sandra; Soilan, David; Ceballos, Placido A.; Hernandez, Ana-Isabel; Lorenzo, Milagros; Pevarello, Paolo; Granda, Teresa G.; Kurz, Guido; Carnero, Amancio; Bischoff, James R.			Chemical Interrogation of FOXO3a Nuclear Translocation Identifies Potent and Selective Inhibitors of Phosphoinositide 3-Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE B; SIGNALING PATHWAY; CELL-SURVIVAL; CANCER; EXPORT; TRANSFORMATION; ACTIVATION; SCREEN; PTEN; P110-ALPHA	Activation of the phosphoinositide 3-kinase (PI3K)/Akt signaling pathway is one the most frequent genetic events in human cancer. A cell-based imaging assay that monitored the translocation of the Akt effector protein, Forkhead box O (FOXO), from the cytoplasm to the nucleus was employed to screen a collection of 33,992 small molecules. The positive compounds were used to screen kinases known to be involved in FOXO translocation. Pyrazolopyrimidine derivatives were found to be potent FOXO relocators as well as biochemical inhibitors of PI3K alpha. A combination of virtual screening and molecular modeling led to the development of a structure-activity relationship, which indicated the preferred substituents on the pyrazolopyrimidine scaffold. This leads to the synthesis of ETP-45658, which is a potent and selective inhibitor of phosphoinositide 3-kinases and demonstrates mechanism of action in tumor cell lines and in vivo in treated mice.	[Link, Wolfgang; Oyarzabal, Julen; Serelde, Beatriz G.; Isabel Albarran, Maria; Rabal, Obdulia; Cebria, Antonio; Alfonso, Patricia; Fominaya, Jesus; Renner, Oliver; Peregrina, Sandra; Soilan, David; Ceballos, Placido A.; Hernandez, Ana-Isabel; Lorenzo, Milagros; Pevarello, Paolo; Granda, Teresa G.; Kurz, Guido; Carnero, Amancio; Bischoff, James R.] Spanish Natl Canc Res Ctr CNIO, Expt Therapeut Programme, Madrid 28029, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Bischoff, JR (corresponding author), Spanish Natl Canc Res Ctr CNIO, Expt Therapeut Programme, Melchor Fernandez Almagro 3, Madrid 28029, Spain.	jrbischoff@cnio.es	Higueras, Ana Isabel Hernandez/F-9372-2016; Albarrán, M Isabel M.I.Albarrán/F-3898-2016; IBIS, CANCER/P-3323-2015; Link, Wolfgang/F-4435-2012; Cebriá, Antonio/F-3757-2016; Cebriá, Antonio/AGE-3432-2022; Oyarzabal, Julen/K-7393-2017; Renner, Oliver/M-7002-2015; Rabal, Obdulia/D-3076-2017	Higueras, Ana Isabel Hernandez/0000-0003-2310-3718; Albarrán, M Isabel M.I.Albarrán/0000-0003-0750-3869; Link, Wolfgang/0000-0002-3340-5165; Cebriá, Antonio/0000-0001-8222-0848; Cebriá, Antonio/0000-0001-8222-0848; Oyarzabal, Julen/0000-0003-1941-7255; Renner, Oliver/0000-0002-4046-0517; Rabal, Obdulia/0000-0002-3224-0987; Carnero, Amancio/0000-0003-4357-3979; Granda, Teresa/0000-0002-7490-5932	Spanish Ministerio de Ciencias e Innovacion [BIO2006-02432]	Spanish Ministerio de Ciencias e Innovacion	This work was supported by funding from the Spanish Ministerio de Ciencias e Innovacion (Project BIO2006-02432).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Burgering B, 2008, ONCOGENE, V27, P2258, DOI 10.1038/onc.2008.29; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; DiMauro EF, 2006, J MED CHEM, V49, P5671, DOI 10.1021/jm0605482; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Garcia-Echeverria C, 2008, ONCOGENE, V27, P5511, DOI 10.1038/onc.2008.246; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Ho KK, 2008, ONCOGENE, V27, P2300, DOI 10.1038/onc.2008.23; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; KAROBATH M, 1974, P NATL ACAD SCI USA, V71, P2915, DOI 10.1073/pnas.71.7.2915; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kong D, 2007, CANCER SCI, V98, P1638, DOI 10.1111/j.1349-7006.2007.00580.x; Medvedev AE, 1998, J CHEM INF COMP SCI, V38, P1137, DOI 10.1021/ci9802068; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Raynaud FI, 2007, CANCER RES, V67, P5840, DOI 10.1158/0008-5472.CAN-06-4615; Renner O, 2008, CANCER RES, V68, P9643, DOI 10.1158/0008-5472.CAN-08-1539; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Turner JG, 2008, CURR MED CHEM, V15, P2648, DOI 10.2174/092986708786242859; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Yaguchi SI, 2006, JNCI-J NATL CANCER I, V98, P545, DOI 10.1093/jnci/djj133; Yang J, 2007, CHEM BIOL, V14, P371, DOI 10.1016/j.chembiol.2007.02.004; Zanella F, 2008, CHEMBIOCHEM, V9, P2229, DOI 10.1002/cbic.200800255; Zanella F, 2007, ASSAY DRUG DEV TECHN, V5, P333, DOI 10.1089/adt.2007.058; Zanella F, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-14; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244	34	73	80	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28392	28400		10.1074/jbc.M109.038984	http://dx.doi.org/10.1074/jbc.M109.038984			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19690175	Green Published, hybrid			2022-12-27	WOS:000270676300064
J	Fu, J; Zhang, JR; Jin, F; Patchefsky, J; Braunewell, KH; Klein-Szanto, AJ				Fu, Jian; Zhang, Jirong; Jin, Fang; Patchefsky, Jamie; Braunewell, Karl-Heinz; Klein-Szanto, Andres J.			Promoter Regulation of the Visinin-like Subfamily of Neuronal Calcium Sensor Proteins by Nuclear Respiratory Factor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL TRANSCRIPTION FACTOR; SQUAMOUS-CELL CARCINOMA; GENE-EXPRESSION; CA2+-SENSOR PROTEINS; MAMMALIAN-CELLS; BINDING PROTEIN; FMR1 PROMOTER; FACTOR-A; VILIP-1; BIOGENESIS	VILIP-1 (gene name VSNL1), a member of the neuronal Ca2+ sensor protein family, acts as a tumor suppressor gene by inhibiting cell proliferation, adhesion, and invasiveness. VILIP-1 expression is down-regulated in several types of human cancer. In human non-small cell lung cancer, we found that down-regulation was due to epigenetic changes. Consequently, in this study we analyzed the VSNL1 promoter and its regulation. Serial truncation of the proximal 2-kb VSNL1 promoter (VP-1998) from its 5' terminus disclosed that the last 3' terminal 100-bp promoter fragment maintained similar promoter activity as compared with VP-1998 and therefore was referred to as VSNL1 minimal promoter. When the 5' terminal 50 bp were deleted from the minimal promoter, the activity was dramatically decreased, suggesting that the deleted 50 bp contained a potential cis-acting element crucial for promoter activity. Deletion and site-directed mutagenesis combined with in silico transcription factor binding analysis of VSNL1 promoter identified nuclear respiratory factor (NRF)-1/alpha-PAL as a major player in regulating VSNL1 minimal promoter activity. The function of NRF-1 was further confirmed using dominant-negative NRF-1 overexpression and NRF-1 small interfering RNA knockdown. Electrophoretic mobility shift assay and chromatin immunoprecipitation provided evidence for direct NRF-1 binding to the VSNL1 promoter. Methylation of the NRF-1-binding site was found to be able to regulate VSNL1 promoter activity. Our results further indicated that NRF-1 could be a regulatory factor for gene expression of the other visinin-like subfamily members including HPCAL4, HPCAL1, HPCA, and NCALD.	[Fu, Jian; Zhang, Jirong; Jin, Fang; Patchefsky, Jamie; Klein-Szanto, Andres J.] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Fu, Jian; Klein-Szanto, Andres J.] Fox Chase Canc Ctr, Canc Genet & Signaling Program, Philadelphia, PA 19111 USA; [Braunewell, Karl-Heinz] So Res Inst, Birmingham, AL 35205 USA	Fox Chase Cancer Center; Fox Chase Cancer Center	Klein-Szanto, AJ (corresponding author), Fox Chase Canc Ctr, Dept Pathol, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	aj_klein-szanto@fccc.edu			National Institutes of Health [CA107257, CA06927]; Commonwealth of Pennsylvania; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [P30CA006927, R01CA107257] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA107257 and CA06927. This work was also supported by an appropriation from the Commonwealth of Pennsylvania and by a grant from the Pennsylvania Department of Health.	Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Asangani IA, 2008, GENE, V410, P197, DOI 10.1016/j.gene.2007.12.009; Becker TS, 1998, DEVELOPMENT, V125, P4369; Bernstein HG, 1999, J NEUROCYTOL, V28, P655, DOI 10.1023/A:1007056731551; Blesa JR, 2008, BIOCHEM CELL BIOL, V86, P46, DOI [10.1139/O07-151, 10.1139/o07-151]; Blesa JR, 2007, GENE, V391, P198, DOI 10.1016/j.gene.2006.12.024; Brackmann M, 2004, BIOCHEM BIOPH RES CO, V322, P1073, DOI 10.1016/j.bbrc.2004.08.028; Braunewell KH, 2009, CELL TISSUE RES, V335, P301, DOI 10.1007/s00441-008-0716-3; Braunewell KH, 2003, NEUROPHARMACOLOGY, V44, P707, DOI 10.1016/S0028-3908(03)00051-0; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; Braunewell KH, 2005, TRENDS PHARMACOL SCI, V26, P345, DOI 10.1016/j.tips.2005.04.008; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Chang WT, 2004, J BIOL CHEM, V279, P14542, DOI 10.1074/jbc.M309825200; Choi YS, 2004, BIOCHEM BIOPH RES CO, V314, P118, DOI 10.1016/j.bbrc.2003.12.065; COMB M, 1990, NUCLEIC ACIDS RES, V18, P3975, DOI 10.1093/nar/18.13.3975; Dai FHF, 2006, J BIOL CHEM, V281, P21942, DOI 10.1074/jbc.M512924200; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; DESIMONE SM, 1993, MOL CELL BIOL, V13, P3641, DOI 10.1128/MCB.13.6.3641; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Fatemi M, 2006, J CELL SCI, V119, P3033, DOI 10.1242/jcs.03099; FitzGerald PC, 2004, GENOME RES, V14, P1562, DOI 10.1101/gr.1953904; Fu J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001698; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gierke P, 2004, BIOCHEM BIOPH RES CO, V323, P38, DOI 10.1016/j.bbrc.2004.08.055; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Guerrico AMG, 2005, ONCOGENE, V24, P2307, DOI 10.1038/sj.onc.1208476; Haussmann IU, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r73; Huo L, 2001, MOL CELL BIOL, V21, P644, DOI 10.1128/MCB.21.2.644-654.2001; Izumi H, 2003, BIOCHEM J, V373, P713, DOI 10.1042/BJ20021902; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kherrouche Z, 2004, BIOCHEM J, V383, P529, DOI 10.1042/BJ20040935; Kobayashi M, 2005, NEUROSCIENCE, V133, P471, DOI 10.1016/j.neuroscience.2005.02.034; Kumari D, 2001, J BIOL CHEM, V276, P4357, DOI 10.1074/jbc.M009629200; KUZMIN I, 1995, ONCOGENE, V10, P2185; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Mahloogi H, 2003, CANCER RES, V63, P4997; Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224; Myers SJ, 1998, J NEUROSCI, V18, P6723; Palmer CL, 2005, NEURON, V47, P487, DOI 10.1016/j.neuron.2005.06.014; Piantadosi CA, 2006, J BIOL CHEM, V281, P324, DOI 10.1074/jbc.M508805200; Piantadosi CA, 2008, J BIOL CHEM, V283, P10967, DOI 10.1074/jbc.M709741200; Rozenberg JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-67; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Smith KT, 2004, HUM MOL GENET, V13, P1611, DOI 10.1093/hmg/ddh172; Spilker C, 2002, BBA-PROTEINS PROTEOM, V1600, P118, DOI 10.1016/S1570-9639(02)00452-1; Takahashi Y, 2002, BBA-GENE STRUCT EXPR, V1574, P359, DOI 10.1016/S0167-4781(01)00374-8; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wickborn C, 2006, MOL CARCINOGEN, V45, P572, DOI 10.1002/mc.20201; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yu ZY, 2004, J BIOL CHEM, V279, P46954, DOI 10.1074/jbc.M407192200	53	9	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27577	27586		10.1074/jbc.M109.049361	http://dx.doi.org/10.1074/jbc.M109.049361			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19674972	Green Published, hybrid			2022-12-27	WOS:000270232300059
J	Solt, LA; Madge, LA; May, MJ				Solt, Laura A.; Madge, Lisa A.; May, Michael J.			NEMO-binding Domains of Both IKK alpha and IKK beta Regulate I kappa B Kinase Complex Assembly and Classical NF-kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; DEPENDENT GENE-EXPRESSION; SEVERE LIVER DEGENERATION; PROTEIN PHOSPHATASE 2A; ESSENTIAL MODULATOR; GENOTOXIC STIMULI; P65 SUBUNIT; PHOSPHORYLATION; GAMMA; TRANSCRIPTION	Proinflammatory NF-kappa B activation requires the I kappa B (inhibitor of NF-kappa B) kinase (IKK) complex that contains two catalytic subunits named IKK alpha and IKK beta and a regulatory subunit named NF-kappa B essential modulator (NEMO). NEMO and IKK beta are essential for tumor necrosis factor (TNF)-induced NF-kappa B activation, and we recently demonstrated that NEMO and IKK alpha are sufficient for interleukin (IL)-1-induced signaling. IKK alpha and IKK beta both contain a functional NEMO-binding domain (NBD); however, the role of NEMO association with each kinase in NF-kappa B signaling and IKK complex formation remains unclear. To address this question, we stably reconstituted IKK alpha(-/-) and IKK beta(-/-) murine embryonic fibroblasts (MEFs) with wild-type (WT) or NBD-deficient (Delta NBD) versions of IKK alpha and IKK beta, respectively. TNF-induced classical NF-kappa B activation in IKK beta(-/-) MEFs was rescued by IKK beta(WT) but not IKK beta(Delta NBD), whereas neither IKK beta(WT) nor IKK beta(Delta NBD) affected IL-1-induced NF-kappa B signaling. As previously described, classical NF-kappa B transcriptional activity was absent in IKK alpha(-/-) cells. Reconstitution with either IKK alpha(WT) or IKK alpha(Delta NBD) rescued both IL-1 and TNF-induced transcription, demonstrating that NEMO association is not required for IKK alpha-dependent regulation of NF-kappa B-dependent transcription. Stably expressed IKK alpha(WT) or IKK beta(WT) associated with endogenous IKKs and NEMO in IKK alpha(-/-) or IKK beta(-/-) MEFs, respectively, resulting in formation of the heterotrimeric IKK alpha-IKK beta-NEMO complex. In contrast, although the IKK alpha(Delta NBD) and IKK beta(Delta NBD) mutants associated with endogenous IKKs containing an NBD, these dimeric endogenous IKK-IKK Delta NBD complexes did not associate with NEMO. These findings therefore demonstrate that formation of the heterotrimeric IKK alpha-IKK beta-NEMO holocomplex absolutely requires two intact NEMO-binding domains.	[Solt, Laura A.; Madge, Lisa A.; May, Michael J.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [May, Michael J.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	May, MJ (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, 3800 Spruce St,OVH 200E, Philadelphia, PA 19104 USA.	maym@vet.upenn.edu		May, Michael/0000-0002-2485-3716	National Institutes of Health [1RO1-HL-080612, T32-AI-055428-06]; W.W. Smith Charitable Trust [H0703]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055428] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.W. Smith Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants 1RO1-HL-080612 and T32-AI-055428-06. This work was also supported by W.W. Smith Charitable Trust Grant H0703.	Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Berchtold CM, 2007, MOL CELL BIOL, V27, P497, DOI 10.1128/MCB.01772-06; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bredemeyer AL, 2008, NATURE, V456, P819, DOI 10.1038/nature07392; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Fontan E, 2007, FEBS J, V274, P2540, DOI 10.1111/j.1742-4658.2007.05788.x; Fu DX, 2003, J BIOL CHEM, V278, P1487, DOI 10.1074/jbc.M210631200; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Higashimoto T, 2008, J BIOL CHEM, V283, P35354, DOI 10.1074/jbc.M806258200; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Hong S, 2007, J BIOL CHEM, V282, P12119, DOI 10.1074/jbc.M610392200; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Khoshnan A, 1999, J IMMUNOL, V163, P5444; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lam LT, 2008, P NATL ACAD SCI USA, V105, P20798, DOI 10.1073/pnas.0806491106; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Li HY, 2008, NAT IMMUNOL, V9, P533, DOI 10.1038/ni.1600; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Madge LA, 2008, J IMMUNOL, V180, P3467, DOI 10.4049/jimmunol.180.5.3467; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Marienfeld RB, 2006, MOL CELL BIOL, V26, P9209, DOI 10.1128/MCB.00478-06; May MJ, 2002, J BIOL CHEM, V277, P45992, DOI 10.1074/jbc.M206494200; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; Orange JS, 2008, CELL MOL LIFE SCI, V65, P3564, DOI 10.1007/s00018-008-8222-z; Palkowitsch L, 2008, J BIOL CHEM, V283, P76, DOI 10.1074/jbc.M708856200; Prajapati S, 2004, J BIOL CHEM, V279, P1739, DOI 10.1074/jbc.M306273200; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Rudolph D, 2000, GENE DEV, V14, P854; Rushe M, 2008, STRUCTURE, V16, P798, DOI 10.1016/j.str.2008.02.012; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Schomer-Miller B, 2006, J BIOL CHEM, V281, P15268, DOI 10.1074/jbc.M513793200; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; Solt LA, 2007, J BIOL CHEM, V282, P8724, DOI 10.1074/jbc.M609613200; Verma UN, 2004, J BIOL CHEM, V279, P3509, DOI 10.1074/jbc.M309300200; Wu C, 2003, J BIOL CHEM, V278, P31980, DOI 10.1074/jbc.M304278200; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	60	31	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27596	27608		10.1074/jbc.M109.047563	http://dx.doi.org/10.1074/jbc.M109.047563			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19666475	Green Published, hybrid			2022-12-27	WOS:000270232300061
J	Clement, M; Cabana, J; Holleran, BJ; Leduc, R; Guillemette, G; Lavigne, P; Escher, E				Clement, Martin; Cabana, Jerome; Holleran, Brian J.; Leduc, Richard; Guillemette, Gaetan; Lavigne, Pierre; Escher, Emanuel			Activation Induces Structural Changes in the Liganded Angiotensin II Type 1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; BETA(2) ADRENERGIC-RECEPTOR; 3RD TRANSMEMBRANE DOMAIN; CONTAINING AMINO-ACIDS; CRYSTAL-STRUCTURE; CONSTITUTIVE ACTIVATION; BINDING POCKET; AT(1) RECEPTOR; CONFORMATIONAL-CHANGES; RHODOPSIN ACTIVATION	The octapeptide hormone angiotensin II (AngII) binds to and activates the human angiotensin II type 1 receptor (hAT(1)) of the G protein-coupled receptor class A family. Several activation mechanisms have been proposed for this family, but they have not yet been experimentally validated. We previously used the methionine proximity assay to show that 11 residues in transmembrane domain (TMD) III, VI, and VII of the hAT(1) receptor reside in close proximity to the C-terminal residue of AngII. With the exception of a single change in TMD VI, the same contacts are present on N111G-hAT(1), a constitutively active mutant; this N111G-hAT(1) is a model for the active form of the receptor. In this study, two series of 53 individual methionine mutations were constructed in TMD I, II, IV, and V on both receptor forms. The mutants were photolabeled with a neutral antagonist, I-125-[Sar(1),p-benzoyl-L-Phe(8)] AngII, and the resulting complexes were digested with cyanogen bromide. Although no new contacts were found for the hAT(1) mutants, two were found in the constitutively active mutants, Phe-77 in TMD II and Asn-200 in TMD V. To our knowledge, this is the first time that a direct ligand contact with TMD II and TMD V has been reported. These contact point differences were used to identify the structural changes between the WT-hAT(1) and N111G-hAT(1) complexes through homology-based modeling and restrained molecular dynamics. The model generated revealed an important structural rearrangement of several TMDs from the basal to the activated form in the WT-hAT(1) receptor.	[Clement, Martin; Cabana, Jerome; Holleran, Brian J.; Leduc, Richard; Guillemette, Gaetan; Lavigne, Pierre; Escher, Emanuel] Univ Sherbrooke, Fac Med, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Escher, E (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, 3001 12th Ave N, Sherbrooke, PQ J1H 5N4, Canada.	Emanuel.Escher@USherbrooke.ca		Escher, Emanuel/0000-0001-6601-987X	Canadian Institutes of Health Research; Canadian Heart and Stroke Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	This work was supported in part by grants from the Canadian Institutes of Health Research and the Quebec Chapter of the Canadian Heart and Stroke Foundation.	Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Balmforth AJ, 1997, J BIOL CHEM, V272, P4245, DOI 10.1074/jbc.272.7.4245; BOBROWSKI K, 1992, J AM CHEM SOC, V114, P10279, DOI 10.1021/ja00052a025; BOSSE R, 1993, REGUL PEPTIDES, V44, P215, DOI 10.1016/0167-0115(93)90245-4; Boucard AA, 2000, BIOCHEMISTRY-US, V39, P9662, DOI 10.1021/bi000597v; Boucard AA, 2003, J BIOL CHEM, V278, P36628, DOI 10.1074/jbc.M305952200; Boucard AA, 2003, BIOCHEM J, V370, P829, DOI 10.1042/BJ20021566; Bremer AA, 2001, J BIOL CHEM, V276, P22857, DOI 10.1074/jbc.M100824200; Burnier M, 2001, CIRCULATION, V103, P904, DOI 10.1161/01.CIR.103.6.904; Charest G, 2006, BIOPOLYMERS, V81, P202, DOI 10.1002/bip.20401; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Clement M, 2005, J BIOL CHEM, V280, P27121, DOI 10.1074/jbc.M413653200; Clement M, 2006, J RECEPT SIG TRANSD, V26, P417, DOI 10.1080/10799890600923195; CORNELL WD, 1995, J AM CHEM SOC, V117, P5197; COTECCHIA S, 1990, P NATL ACAD SCI USA, V87, P2896, DOI 10.1073/pnas.87.8.2896; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Domazet I, 2009, J BIOL CHEM, V284, P11922, DOI 10.1074/jbc.M808113200; Dong MQ, 1999, J BIOL CHEM, V274, P903, DOI 10.1074/jbc.274.2.903; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; Elling CE, 2006, J BIOL CHEM, V281, P17337, DOI 10.1074/jbc.M512510200; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Feng YH, 1998, BIOCHEMISTRY-US, V37, P15791, DOI 10.1021/bi980863t; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Gloriam DE, 2009, J MED CHEM, V52, P4429, DOI 10.1021/jm900319e; Groblewski T, 1997, J BIOL CHEM, V272, P1822, DOI 10.1074/jbc.272.3.1822; Inoue Y, 1997, J HYPERTENS, V15, P703, DOI 10.1097/00004872-199715070-00001; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kennedy AP, 1996, MOL PHARMACOL, V50, P789; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laporte SA, 1999, MOL ENDOCRINOL, V13, P578, DOI 10.1210/me.13.4.578; Lin SW, 1996, BIOCHEMISTRY-US, V35, P11149, DOI 10.1021/bi960858u; Lodowski DT, 2009, PHOTOCHEM PHOTOBIOL, V85, P425, DOI 10.1111/j.1751-1097.2008.00516.x; MARCINIAK B, 1993, J PHYS CHEM-US, V97, P11937, DOI 10.1021/j100148a015; Martin SS, 2004, J BIOL CHEM, V279, P51415, DOI 10.1074/jbc.M407965200; Martin SS, 2007, MOL PHARMACOL, V72, P182, DOI 10.1124/mol.106.033670; Miura S, 2003, HYPERTENS RES, V26, P937, DOI 10.1291/hypres.26.937; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Perodin J, 2002, BIOCHEMISTRY-US, V41, P14348, DOI 10.1021/bi0258602; Rasmussen SGF, 1999, MOL PHARMACOL, V56, P175, DOI 10.1124/mol.56.1.175; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; SHENKIN PS, 1987, BIOPOLYMERS, V26, P2053, DOI 10.1002/bip.360261207; Tao YX, 2008, PHARMACOL THERAPEUT, V120, P129, DOI 10.1016/j.pharmthera.2008.07.005; Tsukamoto H, 2009, J BIOL CHEM, V284, P20676, DOI 10.1074/jbc.M109.016212; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wittelsberger A, 2006, FEBS LETT, V580, P1872, DOI 10.1016/j.febslet.2006.02.050; Ye SX, 2009, NAT CHEM BIOL, V5, P397, DOI 10.1038/nchembio.167	54	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26603	26612		10.1074/jbc.M109.012922	http://dx.doi.org/10.1074/jbc.M109.012922			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19635801	Green Published, hybrid			2022-12-27	WOS:000269969600041
J	Stark, R; Pasquel, F; Turcu, A; Pongratz, RL; Roden, M; Cline, GW; Shulman, GI; Kibbey, RG				Stark, Romana; Pasquel, Francisco; Turcu, Adina; Pongratz, Rebecca L.; Roden, Michael; Cline, Gary W.; Shulman, Gerald I.; Kibbey, Richard G.			Phosphoenolpyruvate Cycling via Mitochondrial Phosphoenolpyruvate Carboxykinase Links Anaplerosis and Mitochondrial GTP with Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUINEA-PIG LIVER; ADENINE-NUCLEOTIDE TRANSLOCASE; PANCREATIC-ISLETS CONTAIN; NMR ISOTOPOMER ANALYSIS; SENSITIVE-K+-CHANNELS; ATP-CITRATE LYASE; MALIC ENZYME; PYRUVATE-KINASE; BETA-CELLS; RAT-LIVER	Pancreatic beta-cells couple the oxidation of glucose to the secretion of insulin. Apart from the canonical K-ATP-dependent glucose-stimulated insulin secretion (GSIS), there are important K-ATP-independent mechanisms involving both anaplerosis and mitochondrial GTP (mtGTP). How mtGTP that is trapped within the mitochondrial matrix regulates the cytosolic calcium increases that drive GSIS remains a mystery. Here we have investigated whether the mitochondrial isoform of phosphoenolpyruvate carboxykinase (PEPCK-M) is the GTPase linking hydrolysis of mtGTP made by succinyl-CoA synthetase (SCS-GTP) to an anaplerotic pathway producing phosphoenolpyruvate (PEP). Although cytosolic PEPCK (PEPCK-C) is absent, PEPCK-M message and protein were detected in INS-1 832/13 cells, rat islets, and mouse islets. PEPCK enzymatic activity is half that of primary hepatocytes and is localized exclusively to the mitochondria. Novel C-13-labeling strategies in INS-1 832/13 cells and islets measured substantial contribution of PEPCK-M to the synthesis of PEP. As high as 30% of PEP in INS-1 832/13 cells and 41% of PEP in rat islets came from PEPCK-M. The contribution of PEPCK-M to overall PEP synthesis more than tripled with glucose stimulation. Silencing the PEPCK-M gene completely inhibited GSIS underscoring its central role in mitochondrial metabolism-mediated insulin secretion. Given that mtGTP synthesized by SCS-GTP is an indicator of TCA flux that is crucial for GSIS, PEPCK-M is a strong candidate to link mtGTP synthesis with insulin release through anaplerotic PEP cycling.	[Stark, Romana; Pasquel, Francisco; Turcu, Adina; Pongratz, Rebecca L.; Cline, Gary W.; Shulman, Gerald I.; Kibbey, Richard G.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Shulman, Gerald I.; Kibbey, Richard G.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Roden, Michael] German Diabet Ctr, Inst Clin Diabetol, D-40225 Dusseldorf, Germany	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Deutsches Diabetes-Zentrum (DDZ)	Kibbey, RG (corresponding author), Yale Univ, Sch Med, Dept Internal Med, POB 208020, New Haven, CT 06520 USA.	richard.kibbey@yale.edu	Shulman, Gerald I./P-7176-2019; Roden, Michael/AAD-3843-2019	Shulman, Gerald I./0000-0003-1529-5668; Stark, Romana/0000-0002-4264-0060	United States Public Health Service [R01 DK-40936, R01 DK-71071, K08 DK-80142, P30 DK-45735, P30 DK-34989]; American Diabetes Association [1-09-RA-86]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040936, P30DK034989, R01DK071071, P30DK045735, U24DK059635, K08DK080142] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by United States Public Health Service Grants R01 DK-40936, R01 DK-71071, K08 DK-80142, P30 DK-45735, and P30 DK-34989 and by American Diabetes Association Grant 1-09-RA-86.	BALLARD FJ, 1970, BIOCHEM J, V119, P735, DOI 10.1042/bj1190735; BALLARD FJ, 1967, BIOCHEM J, V104, P866, DOI 10.1042/bj1040866; BALY DL, 1984, J NUTR, V114, P1438, DOI 10.1093/jn/114.8.1438; BARZU O, 1976, BIOCHIM BIOPHYS ACTA, V452, P406, DOI 10.1016/0005-2744(76)90190-X; BOQUIST L, 1987, BIOCHEM INT, V14, P531; CHATTERTON TA, 1984, EXPERIENTIA, V40, P1426, DOI 10.1007/BF01951926; CHUDAPONGSE P, 1976, BIOCHIM BIOPHYS ACTA, V423, P196, DOI 10.1016/0005-2728(76)90178-X; CHUDAPONGSE P, 1973, BIOCHIM BIOPHYS ACTA, V307, P599, DOI 10.1016/0005-2736(73)90304-0; Cline GW, 2004, J BIOL CHEM, V279, P44370, DOI 10.1074/jbc.M311842200; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; CORNELL NW, 1986, J NUTR, V116, P1101, DOI 10.1093/jn/116.6.1101; DAVIS B, 1977, J PHYSIOL-LONDON, V271, P273, DOI 10.1113/jphysiol.1977.sp012000; DEACIUC IV, 1992, INT J BIOCHEM, V24, P129, DOI 10.1016/0020-711X(92)90238-V; EWART RBL, 1983, DIABETES, V32, P793, DOI 10.2337/diabetes.32.9.793; GARBER AJ, 1969, J BIOL CHEM, V244, P4696; GERMAN MS, 1993, P NATL ACAD SCI USA, V90, P1781, DOI 10.1073/pnas.90.5.1781; Ghanaat-Pour H, 2007, J MOL ENDOCRINOL, V39, P135, DOI 10.1677/JME-07-0002; GOTO Y, 1979, J BIOCHEM, V86, P71; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; Hanson R W, 1994, Adv Enzymol Relat Areas Mol Biol, V69, P203; Heart E, 2009, AM J PHYSIOL-ENDOC M, V296, pE1354, DOI 10.1152/ajpendo.90836.2008; Hedeskov C J, 1980, Horm Metab Res Suppl, VSuppl 10, P8; HEDESKOV CJ, 1984, BIOCHIM BIOPHYS ACTA, V791, P37, DOI 10.1016/0167-4838(84)90278-4; HEITZMAN RJ, 1972, FEBS LETT, V20, P19, DOI 10.1016/0014-5793(72)80006-1; Hlavaty JJ, 2000, BIOCHEMISTRY-US, V39, P1373, DOI 10.1021/bi991692a; HOHNADEL DC, 1973, FEBS LETT, V30, P18, DOI 10.1016/0014-5793(73)80609-X; HOLTEN DD, 1965, BIOCHEMISTRY-US, V4, P723, DOI 10.1021/bi00880a018; Holyoak T, 2004, BIOCHEMISTRY-US, V43, P7054, DOI 10.1021/bi049707e; Holyoak T, 2006, BIOCHEMISTRY-US, V45, P8254, DOI 10.1021/bi060269g; Horn DB, 1997, METABOLISM, V46, P414, DOI 10.1016/S0026-0495(97)90058-5; Ishihara H, 1999, J CLIN INVEST, V104, P1621, DOI 10.1172/JCI7515; ISHIHARA N, 1968, BIOCHIM BIOPHYS ACTA, V153, P733, DOI 10.1016/0005-2728(68)90001-7; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Joseph JW, 2007, J BIOL CHEM, V282, P31592, DOI 10.1074/jbc.M706080200; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Kebede M, 2008, DIABETES, V57, P1887, DOI 10.2337/db07-1326; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MACDONALD MJ, 1992, HORM METAB RES, V24, P158, DOI 10.1055/s-2007-1003284; MACDONALD MJ, 1985, DIABETES, V34, P246, DOI 10.2337/diabetes.34.3.246; MACDONALD MJ, 1985, MOL CELL BIOCHEM, V68, P115; Modaressi S, 1998, BIOCHEM J, V333, P359, DOI 10.1042/bj3330359; Newgard CB, 2002, DIABETES, V51, pS389, DOI 10.2337/diabetes.51.2007.S389; NORDLIE RC, 1963, J BIOL CHEM, V238, P2259; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Passarella S, 2003, MITOCHONDRION, V2, P319, DOI 10.1016/S1567-7249(03)00008-4; PENG CF, 1974, BIOCHEM BIOPH RES CO, V56, P134, DOI 10.1016/S0006-291X(74)80325-6; PETRESCU I, 1979, ANAL BIOCHEM, V96, P279, DOI 10.1016/0003-2697(79)90582-7; PLOWMAN KM, 1965, BIOCHEMISTRY-US, V4, P2809, DOI 10.1021/bi00888a035; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Pongratz RL, 2009, METHOD ENZYMOL, V457, P425, DOI 10.1016/S0076-6879(09)05024-1; PUNEKAR NS, 1987, J BIOL CHEM, V262, P6714; Ronnebaum SM, 2008, J BIOL CHEM, V283, P28909, DOI 10.1074/jbc.M804665200; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; ROOS I, 1978, FEBS LETT, V94, P418, DOI 10.1016/0014-5793(78)80990-9; SAGGERSON ED, 1975, BIOCHEM J, V146, P329, DOI 10.1042/bj1460329; SATO A, 1986, J BIOCHEM-TOKYO, V100, P671, DOI 10.1093/oxfordjournals.jbchem.a121759; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; SCHRAMM VL, 1982, TRENDS BIOCHEM SCI, V7, P369, DOI 10.1016/0968-0004(82)90117-7; She P, 2000, MOL CELL BIOL, V20, P6508, DOI 10.1128/MCB.20.17.6508-6517.2000; She PX, 2003, DIABETES, V52, P1649, DOI 10.2337/diabetes.52.7.1649; SHREEVE WW, 1964, J BIOL CHEM, V239, P729; SHUG AL, 1973, BIOCHEM BIOPH RES CO, V53, P659, DOI 10.1016/0006-291X(73)90712-2; SIES H, 1977, EUR J BIOCHEM, V72, P301, DOI 10.1111/j.1432-1033.1977.tb11253.x; SOLING HD, 1970, EUR J BIOCHEM, V16, P289, DOI 10.1111/j.1432-1033.1970.tb01084.x; SOLING HD, 1973, EUR J BIOCHEM, V37, P233, DOI 10.1111/j.1432-1033.1973.tb02980.x; SUGDEN MC, 1978, DIABETOLOGIA, V15, P173, DOI 10.1007/BF00421235; SUGDEN MC, 1977, DIABETOLOGIA, V13, P481, DOI 10.1007/BF01234500; SUL HS, 1976, ARCH BIOCHEM BIOPHYS, V172, P230, DOI 10.1016/0003-9861(76)90071-0; Suzuki M, 2004, GENE, V338, P157, DOI 10.1016/j.gene.2004.06.005; Szollosi A, 2007, J BIOL CHEM, V282, P14768, DOI 10.1074/jbc.M701382200; Szollosi A, 2007, J BIOL CHEM, V282, P1747, DOI 10.1074/jbc.M609875200; Tong WH, 2007, BIOMETALS, V20, P549, DOI 10.1007/s10534-006-9047-6; USATENKO MS, 1970, BIOCHEM MED METAB B, V3, P298, DOI 10.1016/0006-2944(70)90030-X; WIESE TJ, 1991, COMP BIOCHEM PHYS B, V100, P297, DOI 10.1016/0305-0491(91)90378-Q; WOOD HG, 1945, J BIOL CHEM, V159, P475	76	107	110	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26578	26590		10.1074/jbc.M109.011775	http://dx.doi.org/10.1074/jbc.M109.011775			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19635791	Green Published, hybrid			2022-12-27	WOS:000269969600039
J	Chen, HL; Li, CF; Grigorian, A; Tian, WQ; Demetriou, M				Chen, Hung-Lin; Li, Carey Fei; Grigorian, Ani; Tian, Wenqiang; Demetriou, Michael			T Cell Receptor Signaling Co-regulates Multiple Golgi Genes to Enhance N-Glycan Branching	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; ACETYLGLUCOSAMINYLTRANSFERASE-V; GLYCOPROTEIN-SYNTHESIS; IN-VIVO; GLYCOSYLATION; MICE; COMPLEX; ACTIVATION; BIOSYNTHESIS; ORGANIZATION	T cell receptor (TCR) signaling enhances beta 1,6GlcNAc-branching in N-glycans, a phenotype that promotes growth arrest and inhibits autoimmunity by increasing surface retention of cytotoxic T lymphocyte antigen-4 (CTLA-4) via interactions with galectins. N-Acetylglucosaminyltransferase V (MGAT5) mediates beta 1,6GlcNAc-branching by transferring N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to N-glycan substrates produced by the sequential action of Golgi alpha 1,2-mannosidase I (MIa,b,c), MGAT1, alpha 1,2-mannosidase II (MII, IIx), and MGAT2. Here we report that TCR signaling enhances mRNA levels of MIa, b, c and MII, IIx in parallel with MGAT5, whereas limiting levels of MGAT1 and MGAT2. Blocking the increase in MI or MII enzyme activity induced by TCR signaling with deoxymannojirimycin or swainsonine, respectively, limits beta 1,6GlcNAc-branching, suggesting that enhanced MI and MII activity are both required for this phenotype. MGAT1 and MGAT2 have an similar to 250- and similar to 20-fold higher affinity for UDP-GlcNAc than MGAT5, respectively, and increasing MGAT1 expression paradoxically inhibits beta 1,6GlcNAc branching by limiting UDP-GlcNAc supply to MGAT5, suggesting that restricted changes in MGAT1 and MGAT2 mRNA levels in TCR-stimulated cells serves to enhance availability of UDP-GlcNAc to MGAT5. Together, these data suggest that TCR signaling differentially regulates multiple N-glycan-processing enzymes at the mRNA level to cooperatively promote beta 1,6GlcNAc branching, and by extension, CTLA-4 surface expression, T cell growth arrest, and self-tolerance.	[Li, Carey Fei; Grigorian, Ani; Tian, Wenqiang; Demetriou, Michael] Univ Calif Irvine, Dept Neurol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Demetriou, M (corresponding author), Univ Calif Irvine, Dept Neurol, 250 Sprague Hall, Irvine, CA 92697 USA.	mdemetri@uci.edu		Demetriou, Michael/0000-0002-2224-7798; Chen, Hung-Lin/0000-0001-7900-3391	National Institutes of Health [AI053331, AI082266]; NIAID [F32AI081456]; National Institutes of Health Immunology [T32 AI-060573]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI081456, R56AI082266, R01AI053331, R01AI082266, T32AI060573] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health Immunology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI053331 and AI082266 (to M. D.) and F32AI081456 (to A. G. and M. D.) through the NIAID and National Institutes of Health Immunology Training Grant T32 AI-060573 (to C. L.).	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Akama TO, 2002, SCIENCE, V295, P124, DOI 10.1126/science.1065570; Akama TO, 2006, P NATL ACAD SCI USA, V103, P8983, DOI 10.1073/pnas.0603248103; Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; BENDIAK B, 1987, J BIOL CHEM, V262, P5784; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Buckhaults P, 1997, J BIOL CHEM, V272, P19575, DOI 10.1074/jbc.272.31.19575; Chen IJ, 2007, J BIOL CHEM, V282, P35361, DOI 10.1074/jbc.M706923200; Chui D, 2001, P NATL ACAD SCI USA, V98, P1142, DOI 10.1073/pnas.98.3.1142; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; CUMMINGS RD, 1984, J BIOL CHEM, V259, P6253; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; Granovsky M, 2000, NAT MED, V6, P306; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Grigorian A, 2009, IMMUNOL REV, V230, P232, DOI 10.1111/j.1600-065X.2009.00796.x; Herscovics A, 2001, BIOCHIMIE, V83, P757, DOI 10.1016/S0300-9084(01)01319-0; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Ko JH, 1999, J BIOL CHEM, V274, P22941, DOI 10.1074/jbc.274.33.22941; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Leclerc Guy J, 2002, Cancer Cell Int, V2, P1, DOI 10.1186/1475-2867-2-1; Lee SU, 2007, J BIOL CHEM, V282, P33725, DOI 10.1074/jbc.M704839200; METZLER M, 1994, EMBO J, V13, P2056, DOI 10.1002/j.1460-2075.1994.tb06480.x; Morgan R, 2004, J IMMUNOL, V173, P7200, DOI 10.4049/jimmunol.173.12.7200; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHACHTER H, 1991, Glycobiology, V1, P453, DOI 10.1093/glycob/1.5.453; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Tremblay LO, 2007, J BIOL CHEM, V282, P2558, DOI 10.1074/jbc.M608661200; Wang Y, 2001, GLYCOBIOLOGY, V11, P1051, DOI 10.1093/glycob/11.12.1051; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Yip B, 1997, BIOCHEM J, V321, P465, DOI 10.1042/bj3210465	38	43	48	5	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32454	32461		10.1074/jbc.M109.023630	http://dx.doi.org/10.1074/jbc.M109.023630			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19706602	Green Published, hybrid			2022-12-27	WOS:000272028400028
J	Draghetti, C; Salvat, C; Zanoguera, F; Curchod, ML; Vignaud, C; Peixoto, H; Di Cara, A; Fischer, D; Dhanabal, M; Andreas, G; Abderrahim, H; Rommel, C; Camps, M				Draghetti, Cristina; Salvat, Catherine; Zanoguera, Francisca; Curchod, Marie-Laure; Vignaud, Chloe; Peixoto, Helene; Di Cara, Alessandro; Fischer, David; Dhanabal, Mohanraj; Andreas, Goutopoulos; Abderrahim, Hadi; Rommel, Christian; Camps, Montserrat			Functional Whole-genome Analysis Identifies Polo-like Kinase 2 and Poliovirus Receptor as Essential for Neuronal Differentiation Upstream of the Negative Regulator alpha B-crystallin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; CYCLASE-ACTIVATING POLYPEPTIDE; INDUCED NEURITE OUTGROWTH; PROTEIN-KINASE; PC12 CELLS; GENE-EXPRESSION; PHEOCHROMOCYTOMA CELLS; MAP KINASE; CYCLIC-AMP; CANDIDATE AUTOANTIGEN	This study aimed at identifying transcriptional changes associated to neuronal differentiation induced by six distinct stimuli using whole-genome microarray hybridization analysis. Bioinformatics analyses revealed the clustering of these six stimuli into two categories, suggesting separate gene/pathway dependence. Treatment with specific inhibitors demonstrated the requirement of both Janus kinase and microtubule-associated protein kinase activation to trigger differentiation with nerve growth factor (NGF) and dibutyryl cAMP. Conversely, activation of protein kinase A, phosphatidylinositol-3-kinase alpha, and mammalian target of rapamycin, although required for dibutyryl cAMP-induced differentiation, exerted a negative feedback on NGF-induced differentiation. We identified Polo-like kinase 2 (Plk2) and poliovirus receptor (PVR) as indispensable for NGF-driven neuronal differentiation and alpha B-crystallin (Cryab) as an inhibitor of this process. Silencing of Plk2 or PVR blocked NGF-triggered differentiation and Cryab down-regulation, while silencing of Cryab enhanced NGF-induced differentiation. Our results position both Plk2 and PVR upstream of the negative regulator Cryab in the pathway(s) leading to neuronal differentiation triggered by NGF.	[Draghetti, Cristina; Rommel, Christian; Camps, Montserrat] Merck Serono Int SA, Dept Target Res, Geneva Res Ctr, CH-1202 Geneva, Switzerland; [Zanoguera, Francisca; Di Cara, Alessandro] Merck Serono Int SA, Dept Drug Discovery Informat & New Chem Entities, Geneva Res Ctr, CH-1202 Geneva, Switzerland; [Salvat, Catherine; Curchod, Marie-Laure; Peixoto, Helene; Abderrahim, Hadi] Merck Serono Int SA, Dept Genet & Biomarkers, Geneva Res Ctr, CH-1202 Geneva, Switzerland; [Vignaud, Chloe] Merck Serono Int SA, Dept Stratified Med, Geneva Res Ctr, CH-1202 Geneva, Switzerland; [Fischer, David; Dhanabal, Mohanraj] EMD Serono, Dept Lead Discovery, Rockland, MA 02370 USA; [Andreas, Goutopoulos] EMD Serono, Dept Chem, Rockland, MA 02370 USA	Merck & Company; Serono International S.A.; Merck KGaA; EMD Serono Inc.; Merck & Company; Serono International S.A.; Merck KGaA; EMD Serono Inc.; Merck & Company; Serono International S.A.; Merck KGaA; EMD Serono Inc.; Merck & Company; Serono International S.A.; Merck KGaA; EMD Serono Inc.	Camps, M (corresponding author), Merck Serono Int SA, Inflammat Dept, Geneva Res Ctr, 9 Chemin Mines, CH-1202 Geneva, Switzerland.	montserrat.camps@merckserono.net		Camps, Montserrat/0000-0002-9849-8657				AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Angelastro JM, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-3; Bajramovic JJ, 2000, J IMMUNOL, V164, P4359, DOI 10.4049/jimmunol.164.8.4359; Camps M, 1998, FEBS LETT, V425, P271, DOI 10.1016/S0014-5793(98)00250-6; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Dijkmans TF, 2008, J NEUROCHEM, V105, P2388, DOI 10.1111/j.1471-4159.2008.05338.x; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; FANGER GR, 1993, J NEUROCHEM, V61, P1977, DOI 10.1111/j.1471-4159.1993.tb09844.x; Farias-Eisner R, 2001, J NEUROSCI RES, V63, P341, DOI 10.1002/1097-4547(20010215)63:4<341::AID-JNR1028>3.0.CO;2-P; Farias-Eisner R, 2000, J NEUROSCI, V20, P230, DOI 10.1523/JNEUROSCI.20-01-00230.2000; Fischer D, 2008, MOL CELL NEUROSCI, V37, P471, DOI 10.1016/j.mcn.2007.11.002; Goold RG, 2005, MOL CELL NEUROSCI, V28, P524, DOI 10.1016/j.mcn.2004.11.005; Goold RG, 2001, J CELL SCI, V114, P4273; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Grumolato L, 2003, ENDOCRINOLOGY, V144, P2368, DOI 10.1210/en.2002-0106; GUNNING PW, 1981, J CELL BIOL, V89, P240, DOI 10.1083/jcb.89.2.240; Gutacker C, 1999, BIOCHEM J, V339, P759, DOI 10.1042/0264-6021:3390759; Hadari YR, 1998, MOL CELL BIOL, V18, P3966, DOI 10.1128/MCB.18.7.3966; Hansen TVO, 2008, J NEUROCHEM, V104, P1450, DOI 10.1111/j.1471-4159.2007.05076.x; Hansen TV, 2003, NEUROSCI LETT, V347, P57, DOI 10.1016/S0304-3940(03)00581-0; HASHIMOTO S, 1989, J NEUROCHEM, V53, P1675, DOI 10.1111/j.1471-4159.1989.tb09230.x; HENDERSON LP, 1994, J NEUROSCI, V14, P1153, DOI 10.1523/JNEUROSCI.14-03-01153.1994; HERNANDEZ A, 1995, PEPTIDES, V16, P927, DOI 10.1016/0196-9781(95)00059-S; IFUNE CK, 1990, BRAIN RES, V506, P243, DOI 10.1016/0006-8993(90)91257-H; Ihara S, 1996, J BIOCHEM, V120, P865; Jackson TR, 1996, J CELL SCI, V109, P289; Kang SW, 2005, EXP CELL RES, V309, P305, DOI 10.1016/j.yexcr.2005.06.012; Kiermayer S, 2005, MOL BIOL CELL, V16, P5639, DOI 10.1091/mbc.E05-05-0432; Lee KH, 2005, NEUROCHEM RES, V30, P533, DOI 10.1007/s11064-005-2688-y; LEONARD DGB, 1987, MOL CELL BIOL, V7, P3156, DOI 10.1128/MCB.7.9.3156; Levkovitz Y, 2002, J NEUROSCI, V22, P3845, DOI 10.1523/JNEUROSCI.22-10-03845.2002; Liedtke T, 2007, MOL CELL PROTEOMICS, V6, P895, DOI 10.1074/mcp.M600245-MCP200; LLAMAZARES S, 1991, GENE DEV, V5, P2153, DOI 10.1101/gad.5.12a.2153; Marampon F, 2008, MOL BIOL CELL, V19, P2566, DOI 10.1091/mbc.E06-12-1110; Nagamatsu Y, 2008, J BIOL CHEM, V283, P14532, DOI 10.1074/jbc.M801647200; NYE SH, 1992, MOL BIOL CELL, V3, P677, DOI 10.1091/mbc.3.6.677; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; PEUNOVA N, 1995, NATURE, V375, P68, DOI 10.1038/375068a0; Ravni A, 2008, MOL PHARMACOL, V73, P1688, DOI 10.1124/mol.107.044792; Ravni A, 2006, J NEUROCHEM, V98, P1229, DOI 10.1111/j.1471-4159.2006.03962.x; Ravni A, 2006, J NEUROCHEM, V98, P321, DOI 10.1111/J.1471-4159.2006.03884.X; RUECKLE T, 2004, Patent No. 2004007491; Seeburg DP, 2005, ONCOGENE, V24, P292, DOI 10.1038/sj.onc.1208277; Shin EY, 2002, J BIOL CHEM, V277, P44417, DOI 10.1074/jbc.M203754200; Shin KS, 2002, EXP MOL MED, V34, P172, DOI 10.1038/emm.2002.25; Sloan KE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-73; Stoevring B, 2005, CLIN CHIM ACTA, V356, P95, DOI 10.1016/j.cccn.2005.01.034; STRITTMATTER SM, 1995, CELL, V80, P445, DOI 10.1016/0092-8674(95)90495-6; Torocsik B, 2002, J NEUROSCI, V22, P8971; Uittenbogaard M, 2004, J NEUROCHEM, V91, P1332, DOI 10.1111/j.1471-4159.2004.02814.x; van Noort JM, 2006, MULT SCLER J, V12, P287, DOI 10.1191/135248506ms1271oa; VANNOORT JM, 1995, NATURE, V375, P798, DOI 10.1038/375798a0; Vaudry D, 2002, J NEUROCHEM, V83, P1272, DOI 10.1046/j.1471-4159.2002.01242.x; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Willard MD, 2007, EMBO J, V26, P2029, DOI 10.1038/sj.emboj.7601659; Wu YY, 2000, J BIOL CHEM, V275, P2147, DOI 10.1074/jbc.275.3.2147; Yan GZ, 1997, J NEUROSCI, V17, P6122; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zamvil SS, 2003, NEURON, V38, P685, DOI 10.1016/S0896-6273(03)00326-X; Zhang WS, 2007, J NEUROCHEM, V103, P1157, DOI 10.1111/j.1471-4159.2007.04813.x	62	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32053	32065		10.1074/jbc.M109.009324	http://dx.doi.org/10.1074/jbc.M109.009324			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19700763	Green Published, hybrid			2022-12-27	WOS:000271572700060
J	Kapur, A; Zhao, PW; Sharir, H; Bai, YS; Caron, MG; Barak, LS; Abood, ME				Kapur, Ankur; Zhao, Pingwei; Sharir, Haleli; Bai, Yushi; Caron, Marc G.; Barak, Larry S.; Abood, Mary E.			Atypical Responsiveness of the Orphan Receptor GPR55 to Cannabinoid Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; BETA-ARRESTIN; CLATHRIN ADAPTER; BINDING; CB1; IDENTIFICATION; VISUALIZATION; PHARMACOLOGY; TRAFFICKING; ENDOCYTOSIS	The cannabinoid receptor 1 (CB1) and CB2 cannabinoid receptors, associated with drugs of abuse, may provide a means to treat pain, mood, and addiction disorders affecting widespread segments of society. Whether the orphan G-protein coupled receptor GPR55 is also a cannabinoid receptor remains unclear as a result of conflicting pharmacological studies. GPR55 has been reported to be activated by exogenous and endogenous cannabinoid compounds but surprisingly also by the endogenous non-cannabinoid mediator lysophosphatidylinositol (LPI). We examined the effects of a representative panel of cannabinoid ligands and LPI on GPR55 using a beta-arrestin-green fluorescent protein biosensor as a direct readout of agonist- mediated receptor activation. Our data demonstrate that AM251 and SR141716A (rimonabant), which are cannabinoid antagonists, and the lipid LPI, which is not a cannabinoid receptor ligand, are GPR55 agonists. They possess comparable efficacy in inducing beta-arrestin trafficking and, moreover, activate the G-protein-dependent signaling of protein kinase C beta II. Conversely, the potent synthetic cannabinoid agonist CP55,940 acts as a GPR55 antagonist/partial agonist. CP55,940 blocks GPR55 internalization, the formation of beta-arrestin GPR55 complexes, and the phosphorylation of ERK1/2; CP55,940 produces only a slight amount of protein kinase C beta II membrane recruitment but does not stimulate membrane remodeling like LPI, AM251, or rimonabant. Our studies provide a paradigm for measuring the responsiveness of GPR55 to a variety of ligand scaffolds comprising cannabinoid and novel compounds and suggest that at best GPR55 is an atypical cannabinoid responder. The activation of GPR55 by rimonabant may be responsible for some of the off-target effects that led to its removal as a potential obesity therapy.	[Abood, Mary E.] Temple Univ, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA; Temple Univ, Ctr Subst Abuse Res, Philadelphia, PA 19140 USA; [Bai, Yushi; Caron, Marc G.; Barak, Larry S.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Duke University	Abood, ME (corresponding author), Temple Univ, Dept Anat & Cell Biol, 3400 N Broad St, Philadelphia, PA 19140 USA.	mabood@temple.edu		Abood, Mary/0000-0002-1744-2820	National Institutes of Health [DA023204, DA05274]; National Institute on Drug Abuse [DA022950]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023204, U01DA022950, P50DA005274] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA023204 and DA05274 (to M. E. A.) and DA022950 (National Institute on Drug Abuse; to M. G. C. and L. S. B.).	Baker D, 2006, TRENDS PHARMACOL SCI, V27, P1, DOI 10.1016/j.tips.2005.11.003; Barak LS, 1999, J BIOL CHEM, V274, P7565, DOI 10.1074/jbc.274.11.7565; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Breivogel CS, 2001, MOL PHARMACOL, V60, P155, DOI 10.1124/mol.60.1.155; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; FELDER CC, 1995, MOL PHARMACOL, V48, P443; Feng X, 1998, J BIOL CHEM, V273, P10755, DOI 10.1074/jbc.273.17.10755; GALLAGHER S, 2008, CURR PROTOC IMMUNOL, pCH8; Gonzalez-Maeso J, 2009, CURR MED CHEM, V16, P1017, DOI 10.2174/092986709787581851; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Goodman OB, 1997, J BIOL CHEM, V272, P15017, DOI 10.1074/jbc.272.23.15017; Griffin G, 1999, EUR J PHARMACOL, V377, P117, DOI 10.1016/S0014-2999(99)00402-1; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Haasen D, 2006, METHOD ENZYMOL, V414, P121, DOI 10.1016/S0076-6879(06)14008-2; Hajos N, 2002, CHEM PHYS LIPIDS, V121, P73, DOI 10.1016/S0009-3084(02)00149-4; Henstridge CM, 2009, FASEB J, V23, P183, DOI 10.1096/fj.08-108670; Hurst DP, 2002, MOL PHARMACOL, V62, P1274, DOI 10.1124/mol.62.6.1274; Johns DG, 2007, BRIT J PHARMACOL, V152, P825, DOI 10.1038/sj.bjp.0707419; Kapur A, 2008, J PHARMACOL EXP THER, V325, P341, DOI 10.1124/jpet.107.133256; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Lan RX, 1999, J MED CHEM, V42, P769, DOI 10.1021/jm980363y; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lauckner JE, 2008, P NATL ACAD SCI USA, V105, P2699, DOI 10.1073/pnas.0711278105; Luttrell DK, 2003, ASSAY DRUG DEV TECHN, V1, P327, DOI 10.1089/15406580360545143; Marion S, 2006, J BIOL CHEM, V281, P2932, DOI 10.1074/jbc.M508074200; McAllister SD, 2003, J MED CHEM, V46, P5139, DOI 10.1021/jm0302647; Mcguinness D, 2009, J BIOMOL SCREEN, V14, P49, DOI 10.1177/1087057108327329; Murray RM, 2007, NAT REV NEUROSCI, V8, P885, DOI 10.1038/nrn2253; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Offertaler L, 2003, MOL PHARMACOL, V63, P699, DOI 10.1124/mol.63.3.699; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Oka S, 2009, J BIOCHEM, V145, P13, DOI 10.1093/jb/mvn136; Ross RA, 2009, TRENDS PHARMACOL SCI, V30, P156, DOI 10.1016/j.tips.2008.12.004; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Sawzdargo M, 1999, MOL BRAIN RES, V64, P193, DOI 10.1016/S0169-328X(98)00277-0; Shenoy SK, 2005, NAT CELL BIOL, V7, P1159, DOI 10.1038/ncb1205-1159; Showalter VM, 1996, J PHARMACOL EXP THER, V278, P989; Staton PC, 2008, PAIN, V139, P225, DOI 10.1016/j.pain.2008.04.006; Sugiura T, 2000, CHEM PHYS LIPIDS, V108, P89, DOI 10.1016/S0009-3084(00)00189-4; van der Lee MMC, 2009, J BIOMOL SCREEN, V14, P811, DOI 10.1177/1087057109337937; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Wagner JA, 1999, HYPERTENSION, V33, P429, DOI 10.1161/01.HYP.33.1.429; Yin H, 2009, J BIOL CHEM, V284, P12328, DOI 10.1074/jbc.M806516200; Zhao ZZ, 1996, J BIOL CHEM, V271, P22251, DOI 10.1074/jbc.271.36.22251	45	204	213	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29817	29827		10.1074/jbc.M109.050187	http://dx.doi.org/10.1074/jbc.M109.050187			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19723626	Green Published, hybrid			2022-12-27	WOS:000270896800062
J	Yan, D; Dong, XD; Chen, XY; Wang, LH; Lu, CJ; Wang, J; Qu, J; Tu, LL				Yan, Dongsheng; Dong, Xiang Da (Eric); Chen, Xiaoyan; Wang, Lihua; Lu, Chunjing; Wang, Jiao; Qu, Jia; Tu, Lili			MicroRNA-1/206 Targets c-Met and Inhibits Rhabdomyosarcoma Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALVEOLAR RHABDOMYOSARCOMA; BREAST-CANCER; EXPRESSION; CELL; METASTASIS; RECEPTOR; DIFFERENTIATION; DYSREGULATION; PAX3; MICE	MicroRNAs (miRNAs) are endogenous short (similar to 22) nucleotide RNAs that regulate gene function by modification of target mRNAs. miRNA-1 (miR-1) and miRNA-206 (miR-206) are highly expressed in skeletal muscle. Due to the tissue-specific nature of miR-1/206 for skeletal muscles, we investigated the role of miR-1/206 in the development of rhabdomyosarcoma. Initially, we demonstrated that miR-1/206 expression was suppressed in rhabdomyosarcomas and found at very low levels in a rhabdomyosarcoma RD cell line. Transient transfection of miR-1/206 into cultured RD cells led to a significant decrease in cell growth and migration. Using bioinformatics, we identified two putative miR-1/206 binding sites within the 3'-untranslated region of the human c-Met mRNA. miR-1/206 was then shown to have activity on mRNA expression by targeting the c-Met 3'-untranslated region. The expression of c-Met protein was shown to be down-regulated by subsequent Western blot analysis. Conversely, up-regulation of c-Met was confirmed in tissue samples of human rhabdomyosarcoma, with its level inversely correlated with miR-1/206 expression. In vivo, miR-1/206-expressing tumor cells showed growth delay in comparison with negative control. Our results demonstrated that miR-1/206 suppressed c-Met expression in rhabdomyosarcoma and could function as a potent tumor suppressor in c-Met-overexpressing tumors. Inhibition of miR-1/206 function could contribute to aberrant cell proliferation and migration, leading to rhabdomyosarcoma development.	[Dong, Xiang Da (Eric)] Columbia Univ, Stamford Hosp, Dept Surg, Stamford, CT 06904 USA; [Tu, Lili] Wenzhou Med Coll, Hosp Eye, Sch Ophthalmol & Optometry, Wenzhou 325003, Zhejiang, Peoples R China; [Yan, Dongsheng; Chen, Xiaoyan; Wang, Lihua; Lu, Chunjing; Wang, Jiao; Qu, Jia; Tu, Lili] Zhejiang Prov Key Lab Ophthalmol & Optometry, Minist Hlth Peoples Republ China, Key Lab Vis Sci, Wenzhou 325003, Zhejiang, Peoples R China	Columbia University; Stamford Hospital; Wenzhou Medical University	Tu, LL (corresponding author), Wenzhou Med Coll, Hosp Eye, Sch Ophthalmol & Optometry, 270 Xueyuan Rd, Wenzhou 325003, Zhejiang, Peoples R China.	jqu@wzmc.net; tulili@mail.eye.ac.cn	Yan, Dongsheng/B-1861-2018; Vickers, Michael M/E-4095-2010	Yan, Dongsheng/0000-0003-0551-2219; 	National Natural Science Foundation of China [30772385]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported, in part, by the National Natural Science Foundation of China Grant 30772385.	Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Breitfeld PP, 2005, ONCOLOGIST, V10, P518, DOI 10.1634/theoncologist.10-7-518; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Danilkovitch-Miagkova A, 2002, J CLIN INVEST, V109, P863; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; Ferracini R, 1996, ONCOGENE, V12, P1697; Ferrari A, 2003, CANCER-AM CANCER SOC, V98, P571, DOI 10.1002/cncr.11550; Ginsberg JP, 1998, CANCER RES, V58, P3542; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Keller C, 2004, GENE DEV, V18, P2608, DOI 10.1101/gad.1243904; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kondo N, 2008, CANCER RES, V68, P5004, DOI 10.1158/0008-5472.CAN-08-0180; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mazzone M, 2006, FASEB J, V20, P1611, DOI 10.1096/fj.06-5947rev; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; NAITO S, 1986, CANCER RES, V46, P4109; Nasser MW, 2008, J BIOL CHEM, V283, P33394, DOI 10.1074/jbc.M804788200; Sharp R, 2002, NAT MED, V8, P1276, DOI 10.1038/nm787; Subramanian S, 2008, ONCOGENE, V27, P2015, DOI 10.1038/sj.onc.1210836; Taulli R, 2006, CANCER RES, V66, P4742, DOI 10.1158/0008-5472.CAN-05-4292; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	26	232	250	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29596	29604		10.1074/jbc.M109.020511	http://dx.doi.org/10.1074/jbc.M109.020511			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19710019	Green Published, hybrid			2022-12-27	WOS:000270896800041
J	Liu, YY; Mosher, DF				Liu, Yuanyuan; Mosher, Deane F.			Interactions among Stalk Modules of Thrombospondin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PLATELET THROMBOSPONDIN; N-TERMINAL DOMAIN; TYPE-1 REPEATS; O-FUCOSYLATION; BIOPHYSICAL CHARACTERIZATION; MONOCLONAL-ANTIBODIES; SIGNATURE DOMAINS; CRYSTAL-STRUCTURE; BINDING; POLYMORPHISM	Thrombospondin-1 is a trimeric, modular calcium-binding glycoprotein. The subunit is composed of an N-terminal module; oligomerization domain; stalk modules including a von Willebrand factor type C module, three properdin or thrombospondin type 1 repeat (TSR) modules, and two thrombospondin-type EGF-like modules; and a C-terminal signature domain comprising single copies of the epidermal growth factor (EGF)-like, wire, and lectin-like modules. Conformational changes in the signature domain influence ligand binding to the N-terminal modules. Interactions have been demonstrated among the modules of the signature domain and the thrombospondin-type EGF-like modules. We have extended this analysis to the rest of the stalk modules. Differential scanning calorimetry revealed interactions between the most C-terminal TSR module and the EGF-like modules. Calorimetry and differences in expression levels of single versus tandem modules indicated that the three TSRs interact with each other as well. No evidence of interactions between the von Willebrand factor type C and TSR modules were detected by differential scanning calorimetry, circular dichroism, or intrinsic fluorescence. These results indicate that the TSR and thrombospondin-type EGF-like stalk modules act as a unit that may relay conformational information between the N-terminal and C-terminal parts of the protein.	Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; Univ Wisconsin, Dept Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mosher, DF (corresponding author), 4285 Med Sci Ctr,1300 Univ Ave, Madison, WI 53706 USA.	dfmosher@wisc.edu	Liu, Yuanyuan/E-9439-2013		National Institutes of Health [ROIHL054462]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant ROIHL054462.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Annis DS, 2007, J BIOL CHEM, V282, P27067, DOI 10.1074/jbc.M703804200; Annis DS, 2006, J THROMB HAEMOST, V4, P459, DOI 10.1111/j.1538-7836.2006.01723.x; BEYCHOK S, 1966, SCIENCE, V154, P1288, DOI 10.1126/science.154.3754.1288; Bonnefoy A, 2008, CELL MOL LIFE SCI, V65, P713, DOI 10.1007/s00018-007-7487-y; Calzada MJ, 2008, MATRIX BIOL, V27, P339, DOI 10.1016/j.matbio.2007.12.002; Calzada MJ, 2004, J BIOL CHEM, V279, P41734, DOI 10.1074/jbc.M406267200; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Carlson CB, 2008, J BIOL CHEM, V283, P20069, DOI 10.1074/jbc.M800223200; Carlson CB, 2005, NAT STRUCT MOL BIOL, V12, P910, DOI 10.1038/nsmb997; COLIGAN JE, 1984, J BIOL CHEM, V259, P3944; GALVIN NJ, 1985, J CELL BIOL, V101, P1434, DOI 10.1083/jcb.101.4.1434; Hambleton S, 2004, STRUCTURE, V12, P2173, DOI 10.1016/j.str.2004.09.012; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; Huwiler KG, 2002, BIOCHEMISTRY-US, V41, P14329, DOI 10.1021/bi026463u; Isenberg JS, 2008, CELL MOL LIFE SCI, V65, P728, DOI 10.1007/s00018-007-7488-x; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5; LAWLER J, 1985, J BIOL CHEM, V260, P3762; LAWLER J, 1992, BIOCHEMISTRY-US, V31, P1173, DOI 10.1021/bi00119a029; Lee NV, 2006, EMBO J, V25, P5270, DOI 10.1038/sj.emboj.7601400; Liu YY, 2009, J BIOL CHEM, V284, P22206, DOI 10.1074/jbc.M109.026120; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; MARRIOTT G, 1988, BIOCHEMISTRY-US, V27, P6214, DOI 10.1021/bi00417a004; Misenheimer TM, 2005, J BIOL CHEM, V280, P41229, DOI 10.1074/JBC.M504696200; Misenheimer TM, 2000, J BIOL CHEM, V275, P40938, DOI 10.1074/jbc.M007022200; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; Narizhneva NV, 2004, J BIOL CHEM, V279, P21651, DOI 10.1074/jbc.M311090200; NISHIMURA H, 1992, J BIOCHEM-TOKYO, V111, P460, DOI 10.1093/oxfordjournals.jbchem.a123780; O'Leary JM, 2004, J BIOL CHEM, V279, P53857, DOI 10.1074/jbc.M409225200; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; Roszmusz E, 2002, BIOCHEM BIOPH RES CO, V296, P156, DOI 10.1016/S0006-291X(02)00826-4; SMITH CA, 1984, J BIOL CHEM, V259, P4582; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; Sun Z, 2004, J MOL BIOL, V343, P1327, DOI 10.1016/j.jmb.2004.09.001; Tan K, 2006, STRUCTURE, V14, P33, DOI 10.1016/j.str.2005.09.017; Tan K, 2008, J BIOL CHEM, V283, P3932, DOI 10.1074/jbc.M705203200; Tan KM, 2009, FASEB J, V23, P2490, DOI 10.1096/fj.08-128090; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200; Young GD, 2004, J BIOL CHEM, V279, P47633, DOI 10.1074/jbc.M404918200; Zhang JL, 2008, DEV CELL, V14, P739, DOI 10.1016/j.devcel.2008.02.017	43	5	5	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28563	28570		10.1074/jbc.M109.035089	http://dx.doi.org/10.1074/jbc.M109.035089			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19706610	hybrid, Green Published			2022-12-27	WOS:000270678900010
J	Xu, Y; Zhang, SL; Malhotra, A; Edelman-Novemsky, I; Ma, JP; Kruppa, A; Cernicica, C; Blais, S; Neubert, TA; Ren, MD; Schlame, M				Xu, Yang; Zhang, Shali; Malhotra, Ashim; Edelman-Novemsky, Irit; Ma, Jinping; Kruppa, Antonina; Cernicica, Carolina; Blais, Steven; Neubert, Thomas A.; Ren, Mindong; Schlame, Michael			Characterization of Tafazzin Splice Variants from Humans and Fruit Flies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRIC ANALYSIS; BARTH-SYNDROME; GENE; CARDIOLIPIN; TRANSACYLATION; EXPRESSION; DROSOPHILA; PATTERN; PROTEIN; MUTANT	The tafazzin gene encodes a phospholipid-lysophospholipid transacylase involved in cardiolipin metabolism, but it is not known why it forms multiple transcripts as a result of alternative splicing. Here we studied the intracellular localization, enzymatic activity, and metabolic function of four isoforms of human tafazzin and three isoforms of Drosophila tafazzin upon expression in different mammalian and insect systems. When expressed in HeLa cells, all isoforms were localized in mitochondria except for the B-form of Drosophila tafazzin, which was associated with multiple intracellular membranes. Among the human isoforms, only full-length tafazzin (FL) and tafazzin lacking exon 5 (Delta 5) had transacylase activity, and only these two isoforms were able to restore a normal cardiolipin pattern, normal respiratory activity of mitochondria, and male fertility in tafazzin-deficient flies. Both FL and Delta 5 were associated with large protein complexes in 293T cell mitochondria, but treatment with alkali and proteinase K suggested that the Delta 5 isoform was more integrated into the hydrophobic core of the membrane than the FL isoform. Although all Drosophila isoforms showed transacylase activity in vitro, only the A-form supported cardiolipin remodeling in flies. The data suggest that humans express two mitochondrial isoenzymes of tafazzin that have similar transacylase activities but different membrane topologies. Furthermore, the data show that the expression of human tafazzin in flies creates cardiolipin with a Drosophila pattern, suggesting that the characteristic fatty acid profile of cardiolipin is not determined by the substrate specificity of tafazzin.	[Zhang, Shali; Edelman-Novemsky, Irit; Ma, Jinping; Kruppa, Antonina; Ren, Mindong; Schlame, Michael] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Cernicica, Carolina; Schlame, Michael] NYU, Sch Med, Dept Anesthesiol, New York, NY 10016 USA; [Blais, Steven; Neubert, Thomas A.] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; [Blais, Steven; Neubert, Thomas A.] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA	New York University; New York University; New York University; New York University	Ren, MD (corresponding author), NYU, Sch Med, Dept Cell Biol, 550 1st Ave, New York, NY 10016 USA.	mindong.ren@nyumc.org; michael.schlame@med.nyu.edu			National Institutes of Health [R01 HL078788, S10 RR14662, P30 NS050276]; Barth Syndrome Foundation; United Mitochondrial Disease Foundation; Howard Hughes Medical Institute Summer Research Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR014662] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050276] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barth Syndrome Foundation; United Mitochondrial Disease Foundation; Howard Hughes Medical Institute Summer Research Fellowship(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL078788 ( to M. S.) and S10 RR14662 and P30 NS050276 ( to T. A. N.). This work was also supported by the Barth Syndrome Foundation and the United Mitochondrial Disease Foundation ( both to M. R.) and a Howard Hughes Medical Institute Summer Research Fellowship ( to A. K.).	BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRAND AH, 1993, DEVELOPMENT, V118, P401; Claypool SM, 2008, MOL BIOL CELL, V19, P5143, DOI 10.1091/mbc.E08-09-0896; Claypool SM, 2006, J CELL BIOL, V174, P379, DOI 10.1083/jcb.200605043; Gonzalez IL, 2005, AM J MED GENET A, V134A, P409, DOI 10.1002/ajmg.a.30661; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; KELLEY RI, 1991, J PEDIATR-US, V119, P738, DOI 10.1016/S0022-3476(05)80289-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu B, 2004, BIOCHEM CELL BIOL, V82, P569, DOI 10.1139/O04-055; Ma LN, 2004, J BIOL CHEM, V279, P44394, DOI 10.1074/jbc.M405479200; Magalhaes PJ, 1998, MOL BIOL CELL, V9, P2375, DOI 10.1091/mbc.9.9.2375; Malhotra A, 2009, BBA-MOL CELL BIOL L, V1791, P314, DOI 10.1016/j.bbalip.2009.01.004; Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106; Oberstein A, 2005, NAT METHODS, V2, P583, DOI 10.1038/NMETH775; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schlame M, 2009, BBA-MOL CELL BIOL L, V1791, P321, DOI 10.1016/j.bbalip.2009.01.018; Spencer CT, 2006, PEDIATRICS, V118, pE337, DOI 10.1542/peds.2005-2667; Sun G, 2008, ANAL CHEM, V80, P7576, DOI 10.1021/ac801200w; Testet E, 2005, BIOCHEM J, V387, P617, DOI 10.1042/BJ20041491; Tress ML, 2007, P NATL ACAD SCI USA, V104, P5495, DOI 10.1073/pnas.0700800104; Vaz FM, 2003, J BIOL CHEM, V278, P43089, DOI 10.1074/jbc.M305956200; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Xu Y, 2006, P NATL ACAD SCI USA, V103, P11584, DOI 10.1073/pnas.0603242103; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200	28	50	59	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29230	29239		10.1074/jbc.M109.016642	http://dx.doi.org/10.1074/jbc.M109.016642			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19700766	Green Published, hybrid			2022-12-27	WOS:000270678900077
J	Zhang, GQ; Kernan, KA; Thomas, A; Collins, S; Song, YM; Li, L; Zhu, WZ; LeBoeuf, RC; Eddy, AA				Zhang, Guoqiang; Kernan, Kelly A.; Thomas, Alison; Collins, Sarah; Song, Yumei; Li, Ling; Zhu, Weizhong; LeBoeuf, Renee C.; Eddy, Allison A.			A Novel Signaling Pathway FIBROBLAST NICOTINIC RECEPTOR alpha 1 BINDS UROKINASE AND PROMOTES RENAL FIBROSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR SYSTEM; MUSCLE-CELLS; ACETYLCHOLINE-RECEPTORS; EXPRESSION; GENE; SUBUNIT; UPA; FIBRINOLYSIS; FIBROGENESIS; CONTRACTION	The nicotinic acetylcholine receptor alpha 1 (nAChR alpha 1) was investigated as a potential fibrogenic molecule in the kidney, given reports that it may be an alternative urokinase (urokinase plasminogen activator; uPA) receptor in addition to the classical receptor uPAR. In a mouse obstructive uropathy model of chronic kidney disease, interstitial fibroblasts were identified as the primary cell type that bears nAChR alpha 1 during fibrogenesis. Silencing of the nAChR alpha 1 gene led to significantly fewer interstitial alpha SMA(+) myofibroblasts (2.8 times decreased), reduced interstitial cell proliferation (2.6 times decreased), better tubular cell preservation (E-cadherin 14 times increased), and reduced fibrosis severity (24% decrease in total collagen). The myofibroblast-inhibiting effect of nAChR alpha 1 silencing in uPA-sufficient mice disappeared in uPA-null mice, suggesting that a uPA-dependent fibroblastic nAChR alpha 1 pathway promotes renal fibrosis. To further establish this possible ligand-receptor relationship and to identify downstream signaling pathways, in vitro studies were performed using primary cultures of renal fibroblasts. S-35-Labeled uPA bound to nAChR alpha 1 with a K-d of 1.6 x 10(-8) M, which was displaced by the specific nAChR alpha 1 inhibitor D-tubocurarine in a dose-dependent manner. Pre-exposure of uPA to the fibroblasts inhibited [H-3] nicotine binding. The uPA binding induced a cellular calcium influx and an inward membrane current that was entirely prevented by D-tubocurarine preincubation or nAChR alpha 1 silencing. By mass spectrometry phosphoproteome analyses, uPA stimulation phosphorylated nAChR alpha 1 and a complex of signaling proteins, including calcium-binding proteins, cytoskeletal proteins, and a nucleoprotein. This signaling pathway appears to regulate the expression of a group of genes that transform renal fibroblasts into more active myofibroblasts characterized by enhanced proliferation and contractility. This new fibrosis-promoting pathway may also be relevant to disorders that extend beyond chronic kidney disease.	[Eddy, Allison A.] Seattle Childrens Hosp, Res Inst, Div Nephrol, Seattle, WA 98101 USA; [Song, Yumei] Seattle Childrens Hosp, Res Inst, Div Immunol, Seattle, WA 98101 USA; [Zhu, Weizhong] Univ Washington, Dept Pathol, Seattle, WA 98105 USA; [LeBoeuf, Renee C.] Univ Washington, Div Endocrine & Metab Dis, Dept Med, Seattle, WA 98105 USA; [Li, Ling] Seattle Biomed Res Inst, Seattle, WA 98101 USA	Seattle Children's Hospital; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Center for Infectious Disease Research	Zhang, GQ (corresponding author), C9S,1900 9th Ave, Seattle, WA 98101 USA.	guoqiang.zhang@seattlechildrens.org	Zhu, Wei-Zhong/G-4919-2011	Eddy, Allison/0000-0002-3560-7510	National Institutes of Health [DK54500, DK44757]; American Heart Association National Center; Seattle Children's Hospital and Regional Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079382, R01HL055362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK054500, P50DK044757, R01DK054500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association National Center(American Heart Association); Seattle Children's Hospital and Regional Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK54500 and DK44757 (to A. A. E.). This work was also supported by a scientist development grant from the American Heart Association National Center (to G. Z.) and the Young Investigator Award from Seattle Children's Hospital and Regional Medical Center (to G. Z.).	Akk G, 2003, J PHYSIOL-LONDON, V551, P155, DOI 10.1113/jphysiol.2003.043885; Annecke K, 2008, ADV CLIN CHEM, V45, P31, DOI 10.1016/S0065-2423(07)00002-9; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; ASTRUP T, 1955, SCAND J CLIN LAB INV, V7, P239, DOI 10.3109/00365515509134516; BROMMER EJP, 1994, THROMB HAEMOSTASIS, V71, P19; CARLIN BE, 1986, P NATL ACAD SCI USA, V83, P498, DOI 10.1073/pnas.83.2.498; Carlisle DL, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-27; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; CAULEY K, 1989, J CELL BIOL, V108, P637, DOI 10.1083/jcb.108.2.637; Chaurasia SS, 2009, EXP EYE RES, V89, P133, DOI 10.1016/j.exer.2009.02.022; Dai CS, 2002, J AM SOC NEPHROL, V13, P411, DOI 10.1681/ASN.V132411; Duner E, 1997, HYPERTENSION, V29, P1007, DOI 10.1161/01.HYP.29.4.1007; DuToit PJ, 1997, MED HYPOTHESES, V49, P57, DOI 10.1016/S0306-9877(97)90253-X; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Eyden B., 2005, Journal of Submicroscopic Cytology and Pathology, V37, P1; Franco P, 2006, J CELL SCI, V119, P3424, DOI 10.1242/jcs.03067; Gou DM, 2003, FEBS LETT, V548, P113, DOI 10.1016/S0014-5793(03)00630-6; Jin T, 2005, J INFECT DIS, V192, P429, DOI 10.1086/431600; Kalamida D, 2007, FEBS J, V274, P3799, DOI 10.1111/j.1742-4658.2007.05935.x; Killeen S, 2008, DRUG NEWS PERSPECT, V21, P107, DOI 10.1358/dnp.2008.21.2.1188197; KIVIRIKKO KI, 1967, ANAL BIOCHEM, V19, P249, DOI 10.1016/0003-2697(67)90160-1; Koopman JL, 1998, J BIOL CHEM, V273, P33267, DOI 10.1074/jbc.273.50.33267; Lee IH, 2008, J BIOL CHEM, V283, P6312, DOI 10.1074/jbc.M706878200; Lengronne A, 2001, NUCLEIC ACIDS RES, V29, P1433, DOI 10.1093/nar/29.7.1433; Liang OD, 2003, BIOL CHEM, V384, P229, DOI 10.1515/BC.2003.025; Mang GQ, 2004, J AM SOC NEPHROL, V15, P2090, DOI 10.1097/01.ASN.0000135057; Matsuo S, 2005, KIDNEY INT, V67, P2221, DOI 10.1111/j.1523-1755.2005.00327.x; Mazzieri R, 2006, MOL BIOL CELL, V17, P367, DOI 10.1091/mbc.E05-07-0635; MILES K, 1994, J NEUROSCI, V14, P3271; Mondino A, 2004, TRENDS IMMUNOL, V25, P450, DOI 10.1016/j.it.2004.06.004; MONTESANO R, 1988, P NATL ACAD SCI USA, V85, P4894, DOI 10.1073/pnas.85.13.4894; Morgan D, 2001, BIOCHEM PHARMACOL, V61, P733, DOI 10.1016/S0006-2952(00)00587-6; Mukhina S, 2000, J BIOL CHEM, V275, P16450, DOI 10.1074/jbc.M909080199; PANG IH, 1993, INVEST OPHTH VIS SCI, V34, P1876; Pawlak K, 2007, THROMB RES, V120, P871, DOI 10.1016/j.thromres.2007.01.011; Plekhanova OS, 2006, J VASC RES, V43, P437, DOI 10.1159/000094906; PLOUG M, 1994, FEBS LETT, V349, P163, DOI 10.1016/0014-5793(94)00674-1; Poliakov AA, 1999, J RECEPT SIGNAL TR R, V19, P939, DOI 10.3109/10799899909038433; Steins MB, 2004, BLOOD COAGUL FIBRIN, V15, P383, DOI 10.1097/01.mbc.0000114441.59147.56; Stempien-Otero A, 2006, J BIOL CHEM, V281, P15345, DOI 10.1074/jbc.M512818200; Strutz F, 2000, KIDNEY INT, V57, P1521, DOI 10.1046/j.1523-1755.2000.00997.x; VASSALLI JD, 1985, J CELL BIOL, V100, P86, DOI 10.1083/jcb.100.1.86; WANG XM, 1990, EMBO J, V9, P783, DOI 10.1002/j.1460-2075.1990.tb08174.x; Yamaguchi I, 2007, AM J PHYSIOL-RENAL, V293, pF12, DOI 10.1152/ajprenal.00380.2006; Yeboah MM, 2008, KIDNEY INT, V74, P62, DOI 10.1038/ki.2008.94; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734; Zhang GQ, 2003, J AM SOC NEPHROL, V14, P1254, DOI 10.1097/01.ASN.0000064292.37793.FB; Zhang GQ, 2003, J AM SOC NEPHROL, V14, P1234, DOI 10.1097/01.ASN.0000064701.70231.3F; Zhang GQ, 2008, FRONT BIOSCI-LANDMRK, V13, P5462, DOI 10.2741/3093; Zhang GQ, 2007, J AM SOC NEPHROL, V18, P846, DOI 10.1681/ASN.2006080886	50	24	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29050	29064		10.1074/jbc.M109.010249	http://dx.doi.org/10.1074/jbc.M109.010249			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19690163	Green Published, hybrid			2022-12-27	WOS:000270678900062
J	Ma, YJ; Doni, A; Hummelshoj, T; Honore, C; Bastone, A; Mantovani, A; Thielens, NM; Garred, P				Ma, Ying Jie; Doni, Andrea; Hummelshoj, Tina; Honore, Christian; Bastone, Antonio; Mantovani, Alberto; Thielens, Nicole M.; Garred, Peter			Synergy between Ficolin-2 and Pentraxin 3 Boosts Innate Immune Recognition and Complement Deposition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-REACTIVE PROTEIN; MANNOSE-BINDING LECTIN; HAKATA ANTIGEN; PTX3; MOLECULE; BACTERIA; PATHWAY; POLYMORPHISMS; SIMILARITIES; DEFICIENCY	The long pentraxin 3 (PTX3) is a multifunctional soluble pattern recognition molecule that is crucial in innate immune protection against opportunistic fungal pathogens such as Aspergillus fumigatus. The mechanisms that mediate downstream effects of PTX3 are largely unknown. However, PTX3 interacts with C1q from the classical pathway of the complement. The ficolins are recognition molecules of the lectin complement pathway sharing structural and functional characteristics with C1q. Thus, we investigated whether the ficolins (Ficolin-1, -2, and -3) interact with PTX3 and whether the complexes are able to modulate complement activation on A. fumigatus. Ficolin-2 could be affinity-isolated from human plasma on immobilized PTX3. In binding studies, Ficolin-1 and particularly Ficolin-2 interacted with PTX3 in a calcium-independent manner. Ficolin-2, but not Ficolin-1 and Ficolin-3, bound A. fumigatus directly, but this binding was enhanced by PTX3 and vice versa. Ficolin-2-dependent complement deposition on the surface of A. fumigatus was enhanced by PTX3. A polymorphism in the FCN2 gene causing a T236M amino acid change in the fibrinogen-like binding domain of Ficolin-2, which affects the binding to GlcNAc, reduced Ficolin-2 binding to PTX3 andA.fumigatus significantly. These results demonstrate that PTX3 and Ficolin-2 may recruit each other on pathogens. The effect was alleviated by a common amino acid change in the fibrinogen-like domain of Ficolin-2. Thus, components of the humoral innate immune system, which activate different complement pathways, cooperate and amplify microbial recognition and effector functions.	[Ma, Ying Jie; Hummelshoj, Tina; Honore, Christian; Garred, Peter] Univ Copenhagen, Mol Med Lab, Dept Clin Immunol, Fac Hlth Sci,Rigshosp,Sect 7631, DK-2100 Copenhagen, Denmark; [Doni, Andrea; Mantovani, Alberto] Ist Clin Humanitas, I-20089 Rozzano, Italy; [Bastone, Antonio] Mario Negri Inst Pharmacol Res, Dept Mol Pharmacol & Biochem, I-20157 Milan, Italy; [Thielens, Nicole M.] Univ Grenoble 1, Lab Enzymol Mol, Inst Biol Struct Jean Pierre Ebel, CNRS,CEA,UMR 5075, F-5075 Grenoble, France	Rigshospitalet; University of Copenhagen; IRCCS Humanitas Research Hospital; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Garred, P (corresponding author), Univ Copenhagen, Mol Med Lab, Dept Clin Immunol, Fac Hlth Sci,Rigshosp,Sect 7631, DK-2100 Copenhagen, Denmark.	garred@post5.tele.dk	Mantovani, Alberto/HCI-7449-2022; Thielens, Nicole M/F-2512-2013; Jie, Ying/AAJ-4697-2021	Mantovani, Alberto/0000-0001-5578-236X; Thielens, Nicole M/0000-0002-7354-0302; Jie, Ying/0000-0003-4003-2579; Honore, Christian/0000-0003-4846-1319; Garred, Peter/0000-0002-2876-8586; Doni, Andrea/0000-0001-9203-5814	The Benzon Foundation; The Lundbeck foundation; The Carlsberg Foundation; Rigshospitalet; The Capital Region of Denmark; The European Commission; Telethon; Italian Ministry of Health	The Benzon Foundation; The Lundbeck foundation(Lundbeckfonden); The Carlsberg Foundation(Carlsberg Foundation); Rigshospitalet; The Capital Region of Denmark; The European Commission(European CommissionEuropean Commission Joint Research Centre); Telethon(Fondazione Telethon); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the grants from The Benzon Foundation, The Lundbeck foundation, The Carlsberg Foundation, Rigshospitalet, The Capital Region of Denmark, The European Commission (Project Tolerage), Telethon, and the Italian Ministry of Health.	Beauvais A, 2001, DRUG RESIST UPDATE, V4, P38, DOI 10.1054/drup.2001.0185; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; Deban L, 2008, J IMMUNOL, V181, P8433, DOI 10.4049/jimmunol.181.12.8433; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Endo Y, 2007, IMMUNOBIOLOGY, V212, P371, DOI 10.1016/j.imbio.2006.11.014; Frederiksen PD, 2005, SCAND J IMMUNOL, V62, P462, DOI 10.1111/j.1365-3083.2005.01685.x; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Gaziano R, 2004, ANTIMICROB AGENTS CH, V48, P4414, DOI 10.1128/AAC.48.11.4414-4421.2004; Goldman RC, 1999, CURR PHARM DESIGN, V5, P473; Honore C, 2008, MOL IMMUNOL, V45, P2782, DOI 10.1016/j.molimm.2008.02.005; Hummelshoj T, 2005, HUM MOL GENET, V14, P1651, DOI 10.1093/hmg/ddi173; Hummelshoj T, 2008, MOL IMMUNOL, V45, P2508, DOI 10.1016/j.molimm.2008.01.003; Hummelshoj T, 2008, MOL IMMUNOL, V45, P1623, DOI 10.1016/j.molimm.2007.10.006; Hummelshoj T, 2007, MOL IMMUNOL, V44, P401, DOI 10.1016/j.molimm.2006.02.023; Inforzato A, 2008, J BIOL CHEM, V283, P10147, DOI 10.1074/jbc.M708535200; Inforzato A, 2006, BIOCHEMISTRY-US, V45, P11540, DOI 10.1021/bi0607453; Krarup A, 2005, INFECT IMMUN, V73, P1052, DOI 10.1128/IAI.73.2.1052-1060.2005; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsen F, 2004, J BIOL CHEM, V279, P21302, DOI 10.1074/jbc.M400520200; Liu Y, 2005, J IMMUNOL, V175, P3150, DOI 10.4049/jimmunol.175.5.3150; Lu JH, 1996, BIOCHEM J, V313, P473, DOI 10.1042/bj3130473; Lynch NJ, 2004, J IMMUNOL, V172, P1198, DOI 10.4049/jimmunol.172.2.1198; Ma YG, 2004, J BIOL CHEM, V279, P25307, DOI 10.1074/jbc.M400701200; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Marquart HV, 2007, CLIN IMMUNOL, V124, P33, DOI 10.1016/j.clim.2007.03.547; Matsushita M, 1996, J BIOL CHEM, V271, P2448, DOI 10.1074/jbc.271.5.2448; Munthe-Fog L, 2007, SCAND J IMMUNOL, V65, P383, DOI 10.1111/j.1365-3083.2007.01915.x; Munthe-Fog L, 2008, MOL IMMUNOL, V45, P2660, DOI 10.1016/j.molimm.2007.12.012; Nauta AJ, 2003, EUR J IMMUNOL, V33, P465, DOI 10.1002/immu.200310022; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Ng PML, 2007, EMBO J, V26, P3431, DOI 10.1038/sj.emboj.7601762; Runza VL, 2008, IMMUNOBIOLOGY, V213, P297, DOI 10.1016/j.imbio.2007.10.009; Sugimoto R, 1998, J BIOL CHEM, V273, P20721, DOI 10.1074/jbc.273.33.20721; Teh C, 2000, IMMUNOLOGY, V101, P225, DOI 10.1046/j.1365-2567.2000.00099.x; VOLANAKIS JE, 1982, ANN NY ACAD SCI, V389, P235, DOI 10.1111/j.1749-6632.1982.tb22140.x; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; YING SC, 1993, J IMMUNOL, V150, P169; Zhang J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000282	41	143	144	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28263	28275		10.1074/jbc.M109.009225	http://dx.doi.org/10.1074/jbc.M109.009225			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19632990	Green Published, hybrid			2022-12-27	WOS:000270676300054
J	Tang, FQ; Wang, DS; Duan, CJ; Huang, DM; Wu, Y; Chen, Y; Wang, WW; Xie, CL; Meng, JJ; Wang, L; Wu, B; Liu, SJ; Tian, DF; Zhu, F; He, ZW; Deng, FL; Cao, Y				Tang, Faqing; Wang, Dongsheng; Duan, Chaojun; Huang, Damao; Wu, Yuan; Chen, Yu; Wang, Weiwei; Xie, Chunlei; Meng, Jingjing; Wang, Lei; Wu, Bin; Liu, Shujin; Tian, Daofa; Zhu, Feng; He, Zhiwei; Deng, Fuliang; Cao, Ya			Berberine Inhibits Metastasis of Nasopharyngeal Carcinoma 5-8F Cells by Targeting Rho Kinase-mediated Ezrin Phosphorylation at Threonine 567	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; LUNG-CANCER CELLS; ORGANIZER EZRIN; LINKER EZRIN; CYCLE ARREST; ERM PROTEINS; IN-VITRO; EXPRESSION; CYTOSKELETON; INVASION	Ezrin is highly expressed in metastatic tumors and is involved in filopodia formation as well as promotion of tumor metastasis. Thus, Ezrin may serve as a potential target for anti-metastatic therapy. This study demonstrates that berberine reduces filopodia formation of a nasopharyngeal carcinoma (NPC) cell line, 5-8F, at non-cytotoxic concentrations. Furthermore, invasion and motility of 5-8F cells are decreased in a dose-and time-dependent manner, resulting in 73.0% invasion and 67.0% motility inhibition at 20 mu M. The inhibitory effects of berberine on 5-8F cell metastasis were further confirmed in a mouse model of metastasis. Berberine treatment in vivo resulted in a 51.1% inhibition of tumor metastasis to the lymph nodes and decreased Ezrin phosphorylation at threonine 567 in metastatic samples. Berberine suppressed the presence of phosphorylated Ezrin (phospho-Ezrin) in a dose-and time-dependent manner but had no effect on total Ezrin protein expression at non-cytotoxic concentrations. Furthermore, the inhibitory effects of berberine on phospho-Ezrin were dependent on the suppression of Rho kinase activity. Reduction of Ezrin phosphorylation at Thr(567) by berberine was associated with its inhibitory effect on filopodia formation in 5-8F cells. However, berberine did not effectively inhibit the motility and invasion of NPC cells containing Ezrin Thr(567) mutants. These results confirm that berberine inhibits Ezrin phosphorylation at Thr(567). Nonetheless, berberine reduces motility and invasion of cells and inhibits tumor metastasis. The reduction of Rho kinase-mediated Ezrin phosphorylation mediated by berberine may be a novel anti-metastatic pathway in NPC 5-8F cells.			Tang, FQ (corresponding author), Xiangya Hosp, Dept Clin Lab, Xiangya Rd 87th, Changsha 410008, Hunan, Peoples R China.	tangfaqing33@hotmail.com			National Natural Science Foundation of China [30572455]; Program for New Century Excellent Talents in University [NCET-06-0685]; Traditional Chinese Medicine Foundation of Hunan [2008039]; Science and Technology Foundation of Hunan [08FJ3176]; Science Foundation of Central South University [08SDF07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Traditional Chinese Medicine Foundation of Hunan; Science and Technology Foundation of Hunan; Science Foundation of Central South University	This work was supported in part by National Natural Science Foundation of China Grant 30572455, Program for New Century Excellent Talents in University Grant NCET-06-0685, Traditional Chinese Medicine Foundation of Hunan Grant 2008039, Science and Technology Foundation of Hunan Grant 08FJ3176, and Science Foundation of Central South University Grant 08SDF07.	Attiga FA, 2000, CANCER RES, V60, P4629; Belkina NV, 2009, P NATL ACAD SCI USA, V106, P4707, DOI 10.1073/pnas.0805963106; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; CHEN J, 1995, P NATL ACAD SCI USA, V92, P7495, DOI 10.1073/pnas.92.16.7495; Chuan YC, 2006, J BIOL CHEM, V281, P29938, DOI 10.1074/jbc.M602237200; Deng XY, 2007, CLIN EXP METASTAS, V24, P107, DOI 10.1007/s10585-007-9059-9; Elzagheid A, 2008, HUM PATHOL, V39, P1737, DOI 10.1016/j.humpath.2008.04.020; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Furutani Y, 2007, J NEUROSCI, V27, P8866, DOI 10.1523/JNEUROSCI.1047-07.2007; Gallo G, 2008, DEV NEUROBIOL, V68, P926, DOI 10.1002/dneu.20631; GOULD KL, 1989, EMBO J, V8, P4133, DOI 10.1002/j.1460-2075.1989.tb08598.x; Hwang JM, 2002, ARCH TOXICOL, V76, P664, DOI 10.1007/s00204-002-0351-9; Iizuka N, 2000, CANCER LETT, V148, P19, DOI 10.1016/S0304-3835(99)00264-5; Ishii S, 2005, J BIOL CHEM, V280, P9083, DOI 10.1074/jbc.M407832200; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Jimenez-Sainz MC, 2006, MOL BIOL CELL, V17, P25, DOI 10.1091/mbc.e05-05-0399; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; KOBAYASHI Y, 1995, PLANTA MED, V61, P414, DOI 10.1055/s-2006-958127; Kocher HM, 2009, GUT, V58, P271, DOI 10.1136/gut.2008.159871; Kuo CL, 2005, IN VIVO, V19, P247; Kuo CL, 2004, CANCER LETT, V203, P127, DOI 10.1016/j.canlet.2003.09.002; Kupeli E, 2002, LIFE SCI, V72, P645, DOI 10.1016/S0024-3205(02)02200-2; Lau CW, 2001, CARDIOVASC DRUG REV, V19, P234; Lee DU, 2003, LIFE SCI, V73, P1401, DOI 10.1016/S0024-3205(03)00435-1; Letasiova S, 2006, CANCER LETT, V239, P254, DOI 10.1016/j.canlet.2005.08.024; Leung TW, 2005, HEAD NECK-J SCI SPEC, V27, P555, DOI 10.1002/hed.20189; Li Q, 2008, CANCER LETT, V261, P55, DOI 10.1016/j.canlet.2007.11.018; Lin JP, 2006, WORLD J GASTROENTERO, V12, P21, DOI 10.3748/wjg.v12.i1.21; Lin SS, 2005, PHYTOMEDICINE, V12, P351, DOI 10.1016/j.phymed.2003.11.008; Liu SJ, 2008, BRIT J CANCER, V98, P363, DOI 10.1038/sj.bjc.6604167; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Mitani N, 2001, CANCER LETT, V165, P35, DOI 10.1016/S0304-3835(00)00710-2; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; PALOU J, 2008, EUR UROL IN PRESS; Park EJ, 2004, J IMMUNOL, V173, P5697, DOI 10.4049/jimmunol.173.9.5697; Peng PL, 2006, TOXICOL APPL PHARM, V214, P8, DOI 10.1016/j.taap.2005.11.010; Peng SP, 2007, CANCER SCI, V98, P341, DOI 10.1111/j.1349-7006.2007.00410.x; Ridley AJ, 1999, BIOCHEM SOC SYMP, V65, P111; Roumier A, 2001, IMMUNITY, V15, P715, DOI 10.1016/S1074-7613(01)00225-4; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Schafer C, 2009, EXP CELL RES, V315, P1212, DOI 10.1016/j.yexcr.2008.11.008; Slaninova I, 2001, CELL BIOL TOXICOL, V17, P51, DOI 10.1023/A:1010907231602; Wang GF, 2008, FEBS LETT, V582, P3663, DOI 10.1016/j.febslet.2008.09.051; Yang XY, 2005, CELL ONCOL, V27, P215; Yonemura S, 2002, J CELL SCI, V115, P2569; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zh LX, 2007, AM J PHYSIOL-CELL PH, V293, pC874, DOI 10.1152/ajpcell.00111.2007; Zhang Y, 2006, J CANCER RES CLIN, V132, P685, DOI 10.1007/s00432-006-0117-5	52	75	76	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27456	27466		10.1074/jbc.M109.033795	http://dx.doi.org/10.1074/jbc.M109.033795			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651779	Green Published, hybrid			2022-12-27	WOS:000270232300048
J	Bourguignon, LYW; Spevak, CC; Wong, G; Xia, WL; Gilad, E				Bourguignon, Lilly Y. W.; Spevak, Christina C.; Wong, Gabriel; Xia, Weiliang; Gilad, Eli			Hyaluronan-CD44 Interaction with Protein Kinase C epsilon Promotes Oncogenic Signaling by the Stem Cell Marker Nanog and the Production of MicroRNA-21, Leading to Down-regulation of the Tumor Suppressor Protein PDCD4, Anti-apoptosis, and Chemotherapy Resistance in Breast Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED CD44 INTERACTION; MULTIDRUG-RESISTANCE; GENE-EXPRESSION; HYALURONIC-ACID; CANCER-CELLS; TRANSMEMBRANE GLYCOPROTEIN; CYTOSKELETON FUNCTION; HOMING RECEPTOR; P-GLYCOPROTEIN; MIGRATION	Multidrug resistance and disease relapse is a challenging clinical problem in the treatment of breast cancer. In this study, we investigated the hyaluronan (HA)-induced interaction between CD44 (a primary HA receptor) and protein kinase C epsilon (PKC epsilon), which regulates a number of human breast tumor cell functions. Our results indicate that HA binding to CD44 promotes PKC epsilon activation, which, in turn, increases the phosphorylation of the stem cell marker, Nanog, in the breast tumor cell line MCF-7. Phosphorylated Nanog is then translocated from the cytosol to the nucleus and becomes associated with RNase III DROSHA and the RNA helicase p68. This process leads to microRNA-21 (miR-21) production and a tumor suppressor protein (e. g. PDCD4 (program cell death 4)) reduction. All of these events contribute to up-regulation of inhibitors of apoptosis proteins (IAPs) and MDR1 (multidrug-resistant protein), resulting in anti-apoptosis and chemotherapy resistance. Transfection of MCF-7 cells with PKC epsilon or Nanog-specific small interfering RNAs effectively blocks HA-mediated PKC epsilon-Nanog signaling events, abrogates miR-21 production, and increases PDCD4 expression/eIF4A binding. Subsequently, this PKC epsilon-Nanog signaling inhibition causes IAP/MDR1 down-regulation, apoptosis, and chemosensitivity. To further evaluate the role of miR-21 in oncogenesis and chemoresistance, MCF-7 cells were also transfected with a specific anti-miR-21 inhibitor in order to silence miR-21 expression and inhibit its target functions. Our results indicate that anti-miR-21 inhibitor not only enhances PDCD4 expression/eIF4A binding but also blocks HA-CD44-mediated tumor cell behaviors. Thus, this newly discovered HA-CD44 signaling pathway should provide important drug targets for sensitizing tumor cell apoptosis and overcoming chemotherapy resistance in breast cancer cells.	Univ Calif San Francisco, Dept Med, Endocrine Unit, San Francisco, CA 94121 USA; Vet Affairs Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Bourguignon, LYW (corresponding author), Univ Calif San Francisco, Dept Med, Endocrine Unit 111N, 4150 Clement St, San Francisco, CA 94121 USA.	lilly.bourguignon@ucsf.edu	Xia, Weiliang/C-2650-2008; XIA, WEILIANG/AEA-0835-2022	Xia, Weiliang/0000-0002-0256-4219; XIA, WEILIANG/0000-0002-0256-4219	National Institutes of Health [R01 CA66163, R01 CA 78633, P01 AR39448]; Veterans Affairs Merit Review; Department of Defense; NATIONAL CANCER INSTITUTE [R01CA066163, R01CA078633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR039448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA66163, R01 CA 78633, and P01 AR39448. This work was also supported by a Veterans Affairs Merit Review grant and a Department of Defense grant.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Baker EK, 2004, CANCER BIOL THER, V3, P819, DOI 10.4161/cbt.3.9.1101; Basu A, 2001, BIOCHEM BIOPH RES CO, V280, P883, DOI 10.1006/bbrc.2000.4209; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Bourguignon LYW, 2009, HYALURONAN IN CANCER BIOLOGY, 1ST EDITION, P89, DOI 10.1016/B978-012374178-3.10006-7; Bourguignon LYW, 2009, J BIOL CHEM, V284, P2657, DOI 10.1074/jbc.M806708200; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Bourguignon LYW, 2003, J BIOL CHEM, V278, P29420, DOI 10.1074/jbc.M301885200; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P48679, DOI 10.1074/jbc.M106759200; Bourguignon LYW, 1999, CELL MOTIL CYTOSKEL, V43, P269, DOI 10.1002/(SICI)1097-0169(1999)43:4<269::AID-CM1>3.0.CO;2-5; Bourguignon LYW, 1997, J BIOL CHEM, V272, P27913, DOI 10.1074/jbc.272.44.27913; BOURGUIGNON LYW, 1992, MOL CELL BIOL, V12, P4464, DOI 10.1128/MCB.12.10.4464; Bourguignon LYW, 2001, J MAMMARY GLAND BIOL, V6, P287, DOI 10.1023/A:1011371523994; Bourguignon LYW, 1998, J CELL PHYSIOL, V176, P206, DOI 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Chuthapisith S, 2006, SURG-J R COLL SURG E, V4, P211, DOI 10.1016/S1479-666X(06)80062-4; Cowland JB, 2007, APMIS, V115, P1090, DOI 10.1111/j.1600-0463.2007.apm_775.xml.x; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; DELPECH B, 1990, INT J CANCER, V46, P388, DOI 10.1002/ijc.2910460309; Do JT, 2006, E SCHERING RES FDN W, V60, P35; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Fanning A, 2005, INT IMMUNOL, V17, P449, DOI 10.1093/intimm/dxh225; FOJO AT, 1987, P NATL ACAD SCI USA, V84, P265, DOI 10.1073/pnas.84.1.265; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gorin MA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-9; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haylock DN, 2006, REGEN MED, V1, P437, DOI 10.2217/17460751.1.4.437; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hofmann J, 2004, CURR CANCER DRUG TAR, V4, P125, DOI 10.2174/1568009043481579; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Iida N, 1997, J CELL PHYSIOL, V171, P152, DOI 10.1002/(SICI)1097-4652(199705)171:2<152::AID-JCP5>3.3.CO;2-6; IIDA N, 1995, J CELL PHYSIOL, V162, P127, DOI 10.1002/jcp.1041620115; Itano N, 1996, J BIOL CHEM, V271, P9875, DOI 10.1074/jbc.271.17.9875; Itano N, 1998, TRENDS GLYCOSCI GLYC, V10, P23, DOI 10.4052/tigg.10.23; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; KALISH ED, 1999, FRONT BIOSCI, V4, P1; KALOMIRIS EL, 1989, J BIOL CHEM, V264, P8113; Kuo MT, 2007, ADV EXP MED BIOL, V608, P23; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Loh PG, 2009, EMBO J, V28, P274, DOI 10.1038/emboj.2008.278; Lonning PE, 2003, LANCET ONCOL, V4, P177; Lu DM, 2007, APOPTOSIS, V12, P1893, DOI 10.1007/s10495-007-0111-7; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Mackay HJ, 2003, ENDOCR-RELAT CANCER, V10, P389, DOI 10.1677/erc.0.0100389; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Miletti-Gonzalez KE, 2005, CANCER RES, V65, P6660, DOI 10.1158/0008-5472.CAN-04-3478; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Misra S, 2003, J BIOL CHEM, V278, P25285, DOI 10.1074/jbc.C300173200; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Ohashi R, 2007, CANCER LETT, V252, P225, DOI 10.1016/j.canlet.2006.12.025; Pardo OE, 2006, EMBO J, V25, P3078, DOI 10.1038/sj.emboj.7601198; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Russo RIC, 2008, INT J CANCER, V122, P1012, DOI 10.1002/ijc.23122; Salzman DW, 2007, J BIOL CHEM, V282, P32773, DOI 10.1074/jbc.M705054200; SCREATON GR, 1993, J BIOL CHEM, V268, P12235; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Smith H S, 1991, Basic Life Sci, V57, P329; Spicer AP, 1999, BIOCHEM SOC T, V27, P109, DOI 10.1042/bst0270109; STABEL S, 1991, PHARMACOL THERAPEUT, V51, P71, DOI 10.1016/0163-7258(91)90042-K; Steinberg R, 2007, J BIOL CHEM, V282, P32288, DOI 10.1074/jbc.M704001200; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Suzuki C, 2008, P NATL ACAD SCI USA, V105, P3274, DOI 10.1073/pnas.0712235105; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang SJ, 2006, ARCH OTOLARYNGOL, V132, P19, DOI 10.1001/archotol.132.1.19; Wang SJ, 2007, ARCH OTOLARYNGOL, V133, P281, DOI 10.1001/archotol.133.3.281; Wang SJ, 2006, ARCH OTOLARYNGOL, V132, P771, DOI 10.1001/archotol.132.7.771; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; Wickramasinghe NS, 2009, NUCLEIC ACIDS RES, V37, P2584, DOI 10.1093/nar/gkp117; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Zhang JY, 2006, FEBS J, V273, P1723, DOI 10.1111/j.1742-4658.2006.05186.x; ZHANG LR, 1995, CANCER RES, V55, P428	91	246	264	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26533	26546		10.1074/jbc.M109.027466	http://dx.doi.org/10.1074/jbc.M109.027466			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19633292	Green Published, hybrid			2022-12-27	WOS:000269969600035
J	Mwaikambo, BR; Yang, C; Chemtob, S; Hardy, P				Mwaikambo, Bupe R.; Yang, Chun; Chemtob, Sylvain; Hardy, Pierre			Hypoxia Up-regulates CD36 Expression and Function via Hypoxia-inducible Factor-1-and Phosphatidylinositol 3-Kinase-dependent Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINAL-PIGMENT EPITHELIUM; NF-KAPPA-B; OXIDATIVE STRESS; HIF-1-ALPHA ACCUMULATION; MEMBRANE-PROTEIN; OUTER SEGMENTS; COMPLEX-III; FATTY-ACIDS; VITAMIN-E; PHAGOCYTOSIS	Neovascular and degenerative diseases of the eye are leading causes of impaired vision and blindness in the world. Hypoxia or reduced oxygen tension is considered central to the pathogenesis of these disorders. Although the CD36 scavenger receptor features prominently in ocular homeostasis and pathology, little is known regarding its modulation by hypoxia. Herein we investigated the role and regulation of CD36 by hypoxia and by the major hypoxia effector, hypoxia-inducible factor (HIF)-1. In vivo, hypoxia markedly induced CD36 mRNA in corneal and retinal tissue. Subsequent experiments on human retinal pigment epithelial cells revealed that hypoxia time-dependently increased CD36 mRNA, protein, and surface expression; these responses were reliant upon reactive oxygen species production. As an important novel finding, we demonstrate that hypoxic stimulation of CD36 is mediated by HIF-1; HIF-1 alpha down-regulation abolished CD36 induction by both hypoxia and cobalt chloride. Sequence analysis of the human CD36 promoter region revealed a functional HIF-1 binding site. A luciferase reporter construct containing this promoter fragment was activated by hypoxia, whereas mutation at the HIF-1 consensus site decreased promoter activation. Specific binding of HIF-1 to this putative site in hypoxic cells was detected by a chromatin immunoprecipitation assay. Interestingly, inhibition of the phosphatidylinositol 3-kinase pathway blocked the hypoxia-dependent induction of CD36 expression and promoter activity. Functional ramifications of CD36 hypoxic accumulation were evinced by CD36-dependent increases in scavenging and anti-angiogenic activities. Together, our findings indicate a novel mechanism by which hypoxia induces CD36 expression via activation of HIF-1 and the phosphatidylinositol 3-kinase pathway.	[Mwaikambo, Bupe R.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Mwaikambo, Bupe R.; Yang, Chun; Chemtob, Sylvain; Hardy, Pierre] Ctr Hop Univ St Justine, Res Ctr, Dept Pediat, Montreal, PQ H3T 1C5, Canada; [Mwaikambo, Bupe R.; Yang, Chun; Chemtob, Sylvain; Hardy, Pierre] Ctr Hop Univ St Justine, Res Ctr, Dept Ophthalmol, Montreal, PQ H3T 1C5, Canada; [Mwaikambo, Bupe R.; Yang, Chun; Chemtob, Sylvain; Hardy, Pierre] CHU St Justine, Res Ctr, Dept Pharmacol, Montreal, PQ H3T 1C5, Canada	McGill University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Hardy, P (corresponding author), 3175 Cote St Catherine,Rm 2714, Montreal, PQ H3T 1C5, Canada.	pierre.hardy@recherche-ste-justine.qc.ca			Fight for Sight Foundation [GA05003]; Canadian Institutes of Health [MOP-79332]; Hospital for Sick Children [XG 03-105]; Canadian National Institute for the Blind (CNIB_E.A. Baker Foundation)	Fight for Sight Foundation; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Hospital for Sick Children; Canadian National Institute for the Blind (CNIB_E.A. Baker Foundation)	This work was supported in part by Fight for Sight Foundation Grant GA05003, Canadian Institutes of Health Research Grant MOP-79332, Hospital for Sick Children Grant XG 03-105, and the Canadian National Institute for the Blind (CNIB_E.A. Baker Foundation).	ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Al-Shabrawey M, 2005, AM J PATHOL, V167, P599, DOI 10.1016/S0002-9440(10)63001-5; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Bazan HEP, 2005, EXP EYE RES, V80, P453, DOI 10.1016/j.exer.2004.12.023; Becker LB, 1999, AM J PHYSIOL-HEART C, V277, pH2240, DOI 10.1152/ajpheart.1999.277.6.H2240; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Behn C, 2007, RESP PHYSIOL NEUROBI, V158, P143, DOI 10.1016/j.resp.2007.06.001; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Boyer JF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2133; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chabowski A, 2006, FEBS LETT, V580, P3617, DOI 10.1016/j.febslet.2006.05.045; Chachami G, 2004, AM J RESP CELL MOL, V31, P544, DOI 10.1165/rcmb.2003-0426OC; Chandel NS, 2007, FREE RADICAL BIO MED, V42, P165, DOI 10.1016/j.freeradbiomed.2006.10.048; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Cho S, 2005, J NEUROSCI, V25, P2504, DOI 10.1523/JNEUROSCI.0035-05.2005; Cho S, 2007, J BIOL CHEM, V282, P4634, DOI 10.1074/jbc.M609388200; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Favier J, 2005, J PATHOL, V207, P358, DOI 10.1002/path.1833; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Finneman SC, 2001, J EXP MED, V194, P1289, DOI 10.1084/jem.194.9.1289; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Gerasimovskaya EV, 2005, J APPL PHYSIOL, V98, P722, DOI 10.1152/japplphysiol.00715.2004; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Houssier M, 2008, PLOS MED, V5, P323, DOI 10.1371/journal.pmed.0050039; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Kwapiszewska G, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-109; Lejmi E, 2008, P NATL ACAD SCI USA, V105, P12491, DOI 10.1073/pnas.0804008105; Lin X, 2008, P NATL ACAD SCI USA, V105, P174, DOI 10.1073/pnas.0706585104; Milne GL, 2005, BIOMARKERS, V10, pS10, DOI 10.1080/13547500500216546; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; Montuschi P, 2004, FASEB J, V18, P1791, DOI 10.1096/fj.04-2330rev; MORROW JD, 1992, J CLIN INVEST, V90, P2502, DOI 10.1172/JCI116143; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Mwaikambo BR, 2008, CORNEA, V27, P1037, DOI 10.1097/ICO.0b013e31817780b6; Mwaikambo BR, 2006, INVEST OPHTH VIS SCI, V47, P4356, DOI 10.1167/iovs.05-1656; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; Phelan MW, 1998, J LAB CLIN MED, V132, P519, DOI 10.1016/S0022-2143(98)90131-7; Ricciarelli R, 2000, CIRCULATION, V102, P82, DOI 10.1161/01.CIR.102.1.82; Ryeom SW, 1996, J CELL SCI, V109, P387; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Sennlaub F, 2003, CIRCULATION, V108, P198, DOI 10.1161/01.CIR.0000080735.93327.00; Singh U, 2005, ANNU REV NUTR, V25, P151, DOI 10.1146/annurev.nutr.24.012003.132446; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Sun HL, 2007, ONCOGENE, V26, P3941, DOI 10.1038/sj.onc.1210169; Sun K, 2007, MOL VIS, V13, P2310; Sun MJ, 2006, J BIOL CHEM, V281, P4222, DOI 10.1074/jbc.M509769200; Treins C, 2005, MOL ENDOCRINOL, V19, P1304, DOI 10.1210/me.2004-0239; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Ward JPT, 2006, J APPL PHYSIOL, V101, P993, DOI 10.1152/japplphysiol.00480.2006; Yang C, 2008, AM J PHYSIOL-REG I, V294, pR467, DOI 10.1152/ajpregu.00432.2007; Yeh WL, 2007, MOL PHARMACOL, V72, P440, DOI 10.1124/mol.107.036418; Yeo EJ, 2004, BIOCHEM PHARMACOL, V68, P1061, DOI 10.1016/j.bcp.2004.02.040; Yeo EJ, 2003, J NATL CANCER I, V95, P516, DOI 10.1093/jnci/95.7.516; Zampetaki A, 2004, FASEB J, V18, P1090, DOI 10.1096/fj.03-0991fje	70	50	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26695	26707		10.1074/jbc.M109.033480	http://dx.doi.org/10.1074/jbc.M109.033480			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19640849	hybrid, Green Published			2022-12-27	WOS:000269969600050
J	Endo, R; Saito, T; Asada, A; Kawahara, H; Ohshima, T; Hisanaga, S				Endo, Ryo; Saito, Taro; Asada, Akiko; Kawahara, Hiroyuki; Ohshima, Toshio; Hisanaga, Shin-ichi			Commitment of 1-Methyl-4-phenylpyrinidinium Ion-induced Neuronal Cell Death by Proteasome-mediated Degradation of p35 Cyclin-dependent Kinase 5 Activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; ORNITHINE-DECARBOXYLASE; INDUCED APOPTOSIS; SUBSTANTIA-NIGRA; CDK5 ACTIVITY; LEWY-BODIES; MOUSE MODEL; NEUROTOXICITY; PROTEIN	The dysfunction of proteasomes and mitochondria has been implicated in the pathogenesis of Parkinson disease. However, the mechanism by which this dysfunction causes neuronal cell death is unknown. We studied the role of cyclin-dependent kinase 5 (Cdk5)-p35 in the neuronal cell death induced by 1-methyl-4-phenylpyrinidinium ion (MPP+), which has been used as an in vitro model of Parkinson disease. When cultured neurons were treated with 100 mu M MPP+, p35 was degraded by proteasomes at 3 h, much earlier than the neurons underwent cell death at 12-24 h. The degradation of p35 was accompanied by the down-regulation of Cdk5 activity. We looked for the primary target of MPP+ that triggered the proteasome-mediated degradation of p35. MPP+ treatment for 3 h induced the fragmentation of the mitochondria, reduced complex I activity of the respiratory chain without affecting ATP levels, and impaired the mitochondrial import system. The dysfunction of the mitochondrial import system is suggested to up-regulate proteasome activity, leading to the ubiquitin-independent degradation of p35. The overexpression of p35 attenuated MPP+-induced neuronal cell death. In contrast, depletion of p35 with short hairpin RNA not only induced cell death but also sensitized to MPP+ treatment. These results indicate that a brief MPP+ treatment triggers the delayed neuronal cell death by the down-regulation of Cdk5 activity via mitochondrial dysfunction-induced up-regulation of proteasome activity. We propose a role for Cdk5-p35 as a survival factor in countering MPP+-induced neuronal cell death.	[Endo, Ryo; Saito, Taro; Asada, Akiko; Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Grad Sch Sci, Lab Mol Neurosci, Tokyo 1920397, Japan; [Kawahara, Hiroyuki] Tokyo Metropolitan Univ, Grad Sch Sci, Lab Cellular Biochem, Dept Biol Sci, Tokyo 1920397, Japan; [Ohshima, Toshio] Waseda Univ, Dept Life Sci & Med Biosci, Sch Adv Sci & Engn, Tokyo 1628480, Japan	Tokyo Metropolitan University; Tokyo Metropolitan University; Waseda University	Endo, R (corresponding author), Minami Osawa 1-1, Tokyo 1920397, Japan.	endo-ryo@ed.tmu.ac.jp; hisanaga-shinichi@tmu.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research on priority area from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Asher G, 2005, MOL CELL, V17, P645, DOI 10.1016/j.molcel.2005.01.020; Asher G, 2002, P NATL ACAD SCI USA, V99, P13125, DOI 10.1073/pnas.202480499; Bai J, 2004, J BIOL CHEM, V279, P38710, DOI 10.1074/jbc.M403329200; BRION JP, 1995, AM J PATHOL, V147, P1465; Bu BT, 2002, J NEUROSCI, V22, P6515; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chalmers-Redman RME, 1999, BIOCHEM BIOPH RES CO, V257, P440, DOI 10.1006/bbrc.1999.0487; Cheung ZH, 2008, J NEUROSCI, V28, P4872, DOI 10.1523/JNEUROSCI.0689-08.2008; Cheung Zelda H., 2007, Biotechnology Journal, V2, P949, DOI 10.1002/biot.200700056; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; da Costa CA, 2006, J BIOL CHEM, V281, P9824, DOI 10.1074/jbc.M513903200; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Granot Z, 2007, MOL ENDOCRINOL, V21, P2164, DOI 10.1210/me.2005-0458; Hirata Y, 2007, J NEUROCHEM, V102, P1606, DOI 10.1111/j.1471-4159.2007.04695.x; Hisanaga S, 2003, NEUROSIGNALS, V12, P221, DOI 10.1159/000074624; Hoglinger GU, 2003, J NEUROCHEM, V86, P1297, DOI 10.1046/j.1471-4159.2003.01952.x; Hood DA, 2004, P NUTR SOC, V63, P293, DOI 10.1079/PNS2004342; Ishiguro K, 1995, NEUROSCI LETT, V202, P81, DOI 10.1016/0304-3940(95)12206-0; Jackson-Lewis V, 2005, NEUROTOX RES, V7, P193, DOI 10.1007/BF03036449; Kahana C, 2005, CELL CYCLE, V4, P1461, DOI 10.4161/cc.4.11.2115; Kikukawa Y, 2005, FEBS J, V272, P6373, DOI 10.1111/j.1742-4658.2005.05032.x; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Li BS, 2002, EMBO J, V21, P324, DOI 10.1093/emboj/21.3.324; Li BS, 2003, J BIOL CHEM, V278, P35702, DOI 10.1074/jbc.M302004200; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; MYTILINEOU C, 1985, NEUROSCI LETT, V57, P19, DOI 10.1016/0304-3940(85)90034-5; Nakamura S, 1997, ACTA NEUROPATHOL, V94, P153, DOI 10.1007/s004010050687; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Neystat M, 2001, J NEUROCHEM, V77, P1611, DOI 10.1046/j.1471-4159.2001.00376.x; Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9; O'Hare MJ, 2005, J NEUROSCI, V25, P8954, DOI 10.1523/JNEUROSCI.2899-05.2005; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Patrick GN, 1998, J BIOL CHEM, V273, P24057, DOI 10.1074/jbc.273.37.24057; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Saito T, 1998, BIOCHEM BIOPH RES CO, V252, P775, DOI 10.1006/bbrc.1998.9739; Saito T, 2003, J NEUROSCI, V23, P1189, DOI 10.1523/JNEUROSCI.23-04-01189.2003; Saito T, 2007, J NEUROCHEM, V102, P133, DOI 10.1111/j.1471-4159.2007.04540.x; Sawada H, 2004, J BIOL CHEM, V279, P10710, DOI 10.1074/jbc.M308434200; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Smith PD, 2006, J NEUROSCI, V26, P440, DOI 10.1523/JNEUROSCI.2875-05.2006; Tanaka T, 2001, J NEUROSCI, V21, P550, DOI 10.1523/JNEUROSCI.21-02-00550.2001; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Tiesong SS, 2005, J BIOL CHEM, V280, P34644, DOI 10.1074/jbc.M506466200; TURSKI L, 1991, NATURE, V349, P414, DOI 10.1038/349414a0; Vila M, 2008, J NEUROCHEM, V107, P317, DOI 10.1111/j.1471-4159.2008.05604.x; Wang CX, 2006, CELL DEATH DIFFER, V13, P1203, DOI 10.1038/sj.cdd.4401804; Wei FY, 2005, J NEUROCHEM, V93, P502, DOI 10.1111/j.1471-4159.2005.03058.x; Wright G, 2001, EXP CELL RES, V263, P107, DOI 10.1006/excr.2000.5096	54	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26029	26039		10.1074/jbc.M109.026443	http://dx.doi.org/10.1074/jbc.M109.026443			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19638632	Green Published, hybrid			2022-12-27	WOS:000269738000059
J	Goto, M; Yamauchi, T; Kamiya, N; Miyahara, I; Yoshimura, T; Mihara, H; Kurihara, T; Hirotsu, K; Esaki, N				Goto, Masaru; Yamauchi, Takae; Kamiya, Nobuo; Miyahara, Ikuko; Yoshimura, Tohru; Mihara, Hisaaki; Kurihara, Tatsuo; Hirotsu, Ken; Esaki, Nobuyoshi			Crystal Structure of a Homolog of Mammalian Serine Racemase from Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ACETYLSERINE SULFHYDRYLASE; COLI ASPARTATE-AMINOTRANSFERASE; D-AMINO ACIDS; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; THREONINE SYNTHASE; ALPHA(2)BETA(2) COMPLEX; CONFORMATIONAL-CHANGES; TRYPTOPHAN SYNTHASE; ALANINE RACEMASE	D-Serine is an endogenous coagonist for the N-methyl-D-as-partate receptor and is involved in excitatory neurotransmission in the brain. Mammalian pyridoxal 5'-phosphate-dependent serine racemase, which is localized in the mammalian brain, catalyzes the racemization of L-serine to yield D-serine and vice versa. The enzyme also catalyzes the dehydration of D- and L-serine. Both reactions are enhanced by Mg.ATP in vivo. We have determined the structures of the following three forms of the mammalian enzyme homolog from Schizosaccharomyces pombe: the wild-type enzyme, the wild-type enzyme in the complex with an ATP analog, and the modified enzyme in the complex with serine at 1.7, 1.9, and 2.2 angstrom resolution, respectively. On binding of the substrate, the small domain rotates toward the large domain to close the active site. The ATP binding site was identified at the domain and the subunit interface. Computer graphics models of the wild-type enzyme complexed with L-serine and D- serine provided an insight into the catalytic mechanisms of both reactions. Lys-57 and Ser-82 located on the protein and solvent sides, respectively, with respect to the cofactor plane, are acid-base catalysts that shuttle protons to the substrate. The modified enzyme, which has a unique "lysino-D-alanyl" residue at the active site, also exhibits catalytic activities. The crystal-soaking experiment showed that the substrate serine was actually trapped in the active site of the modified enzyme, suggesting that the lysino-D-alanyl residue acts as a catalytic base in the same manner as inherent Lys-57 of the wild-type enzyme.	[Goto, Masaru; Kamiya, Nobuo; Miyahara, Ikuko; Yoshimura, Tohru; Hirotsu, Ken] Osaka City Univ, Dept Chem, Grad Sch Sci, Osaka 5588585, Japan; [Yamauchi, Takae; Mihara, Hisaaki; Kurihara, Tatsuo; Esaki, Nobuyoshi] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan	Osaka Metropolitan University; Kyoto University	Hirotsu, K (corresponding author), RIKEN SPring 8 Ctr, Harima Inst, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.	hirotsu@spring8.or.jp; esakin@scl.kyoto-u.ac.jp	Mihara, Hisaaki/F-2172-2010	Mihara, Hisaaki/0000-0002-5153-4403	Japan Society for the Promotion of Science; National Project on Protein Structural and Functional Analyses	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Project on Protein Structural and Functional Analyses(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by research grants from the Japan Society for the Promotion of Science and National Project on Protein Structural and Functional Analyses (to N.E. and to K.H.).	Baumgart F, 2008, FEBS J, V275, P3538, DOI 10.1111/j.1742-4658.2008.06517.x; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burkhard P, 1999, J MOL BIOL, V291, P941, DOI 10.1006/jmbi.1999.3002; Burkhard P, 1998, J MOL BIOL, V283, P121, DOI 10.1006/jmbi.1998.2037; Claus MT, 2005, BIOCHEMISTRY-US, V44, P8620, DOI 10.1021/bi050485+; Daum S, 2003, BIOCHEMISTRY-US, V42, P106, DOI 10.1021/bi0268044; DE MJ, 2002, P NATL ACAD SCI USA, V99, P14542; DeLano W.L, PYMOL MOL GRAPHICS S; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Foltyn VN, 2005, J BIOL CHEM, V280, P1754, DOI 10.1074/jbc.M405726200; Gallagher DT, 1998, STRUCTURE, V6, P465, DOI 10.1016/S0969-2126(98)00048-3; Garrido-Franco M, 2002, J BIOL CHEM, V277, P12396, DOI 10.1074/jbc.M108734200; GOLDBERG JM, 1991, BIOCHEMISTRY-US, V30, P305, DOI 10.1021/bi00215a041; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; HASHIMOTO A, 1992, J CHROMATOGR-BIOMED, V582, P41, DOI 10.1016/0378-4347(92)80300-F; HASHIMOTO A, 1993, J NEUROCHEM, V60, P783, DOI 10.1111/j.1471-4159.1993.tb03219.x; Heine A, 2004, PROTEINS, V56, P387, DOI 10.1002/prot.20003; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Huang B, 2005, J BACTERIOL, V187, P3201, DOI 10.1128/JB.187.9.3201-3205.2005; INOUE K, 1991, J BIOCHEM, V109, P570, DOI 10.1093/oxfordjournals.jbchem.a123421; Inoue R, 2008, J NEUROSCI, V28, P14486, DOI 10.1523/JNEUROSCI.5034-08.2008; JAGER J, 1994, J MOL BIOL, V239, P285, DOI 10.1006/jmbi.1994.1368; Jansonius J.N., 1987, BIOL MACROMOLECULES, P187; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SJ, 2005, BIOCHEMISTRY-US, V44, P11417, DOI 10.1021/bi050317h; Mas-Droux C, 2006, J BIOL CHEM, V281, P5188, DOI 10.1074/jbc.M509798200; Mehta PK, 2000, ADV ENZYMOL RAMB, V74, P129; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MITCHELL JBO, 1992, J MOL BIOL, V226, P251, DOI 10.1016/0022-2836(92)90137-9; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; OKAMOTO A, 1994, J BIOCHEM, V116, P95, DOI 10.1093/oxfordjournals.jbchem.a124509; Omi R, 2003, J BIOL CHEM, V278, P46035, DOI 10.1074/jbc.M308065200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panizzutti R, 2001, P NATL ACAD SCI USA, V98, P5294, DOI 10.1073/pnas.091002298; Rhee S, 1997, BIOCHEMISTRY-US, V36, P7664, DOI 10.1021/bi9700429; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Shaw JP, 1997, BIOCHEMISTRY-US, V36, P1329, DOI 10.1021/bi961856c; Simanshu DK, 2006, J BIOL CHEM, V281, P39630, DOI 10.1074/jbc.M605721200; Sun SX, 1999, BIOCHEMISTRY-US, V38, P4058, DOI 10.1021/bi982924t; Uo T, 1998, BIOCHEM BIOPH RES CO, V246, P31, DOI 10.1006/bbrc.1998.8561; Uo T, 2002, BIOSCI BIOTECH BIOCH, V66, P2639, DOI 10.1271/bbb.66.2639; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Wolosker H, 2002, NEUROCHEM INT, V41, P327, DOI 10.1016/S0197-0186(02)00055-4; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; WOLOSKER H, 2006, SCI STKE, pPE41; Yamada T, 2003, BIOCHEMISTRY-US, V42, P12854, DOI 10.1021/bi035324p; Yamada T, 2008, BBA-GEN SUBJECTS, V1780, P809, DOI 10.1016/j.bbagen.2008.01.020; Yamauchi T, 2009, J BIOCHEM, V145, P421, DOI 10.1093/jb/mvp010; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Yoshimura T, 2008, FEBS J, V275, P3527, DOI 10.1111/j.1742-4658.2008.06516.x	56	68	71	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25944	25952		10.1074/jbc.M109.010470	http://dx.doi.org/10.1074/jbc.M109.010470			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19640845	Green Published, hybrid			2022-12-27	WOS:000269738000051
J	Molnar, KS; Karabacak, NM; Johnson, JL; Wang, Q; Tiwari, A; Hayward, LJ; Coales, SJ; Hamuro, Y; Agar, JN				Molnar, Kathleen S.; Karabacak, N. Murat; Johnson, Joshua L.; Wang, Qi; Tiwari, Ashutosh; Hayward, Lawrence J.; Coales, Stephen J.; Hamuro, Yoshitomo; Agar, Jeffrey N.			A Common Property of Amyotrophic Lateral Sclerosis-associated Variants DESTABILIZATION OF THE COPPER/ZINC SUPEROXIDE DISMUTASE ELECTROSTATIC LOOP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMIDE HYDROGEN-EXCHANGE; MOTOR-NEURON DISEASE; TRANSGENIC MICE; MASS-SPECTROMETRY; FAMILIAL ALS; CU,ZN-SUPEROXIDE DISMUTASE; AXONAL-TRANSPORT; BINDING-SITE; SOD1 MUTANTS; MOUSE MODEL	At least 119 mutations in the gene encoding copper/zinc superoxide dismutase (SOD1) cause amyotrophic lateral sclerosis by an unidentified toxic gain of function. We compared the dynamic properties of 13 as-isolated, partially metallated, SOD1 variant enzymes using hydrogen-deuterium exchange. We identified a shared property of these familial amyotrophic lateral sclerosis-related SOD1 variants, namely structural and dynamic change affecting the electrostatic loop (loop VII) of SOD1. Furthermore, SOD1 variants that have severely compromised metal binding affinities demonstrated additional structural and dynamic changes to the zinc-binding loop (loop IV) of SOD1. Although the biological consequences of increased loop VII mobility are not fully understood, this common property is consistent with the hypotheses that SOD1 mutations exert toxicity via aggregation or aberrant association with other cellular constituents.	[Karabacak, N. Murat; Wang, Qi; Agar, Jeffrey N.] Brandeis Univ, Dept Chem, Waltham, MA 02454 USA; [Johnson, Joshua L.] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [Johnson, Joshua L.] Brandeis Univ, Volen Ctr, Waltham, MA 02454 USA; [Molnar, Kathleen S.; Coales, Stephen J.; Hamuro, Yoshitomo] ExSAR Corp, Monmouth Jct, NJ 08852 USA; [Tiwari, Ashutosh; Hayward, Lawrence J.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01655 USA	Brandeis University; Brandeis University; Brandeis University; University of Massachusetts System; University of Massachusetts Worcester	Agar, JN (corresponding author), Brandeis Univ, Dept Chem, Waltham, MA 02454 USA.	agar@brandeis.edu	Tiwari, Ashutosh/A-7458-2008; Karabacak, Murat/AAG-2891-2019; Karabacak, N Murat/D-4184-2009; Karabacak, N Murat/D-7227-2013; Wang, Qi/A-2340-2012	Tiwari, Ashutosh/0000-0001-7373-349X; Karabacak, Murat/0000-0003-2761-5593; Karabacak, N Murat/0000-0003-2761-5593; Wang, Qi/0000-0001-8566-1120; Agar, Jeffery/0000-0003-2645-1873; Hayward, Lawrence/0000-0003-0579-0358; coales, stephen/0000-0002-8272-5456	National Institutes of Health [R01NS065263]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044170, R01NS065263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS065263.	Antonyuk S, 2005, PROTEIN SCI, V14, P1201, DOI 10.1110/ps.041256705; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Banci L, 2003, BIOCHEMISTRY-US, V42, P9543, DOI 10.1021/bi034324m; Banci L, 2005, J BIOL CHEM, V280, P35815, DOI 10.1074/jbc.M506637200; Bartnikas TB, 2003, J BIOL CHEM, V278, P33602, DOI 10.1074/jbc.M305435200; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruening W, 1999, J NEUROCHEM, V72, P693, DOI 10.1046/j.1471-4159.1999.0720693.x; Cao XH, 2008, J BIOL CHEM, V283, P16169, DOI 10.1074/jbc.M801522200; Cardoso RMF, 2002, J MOL BIOL, V324, P247, DOI 10.1016/S0022-2836(02)01090-2; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; Crow JP, 1997, J NEUROCHEM, V69, P1945; Crow JP, 1997, J NEUROCHEM, V69, P1936; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Elam JS, 2003, J BIOL CHEM, V278, P21032, DOI 10.1074/jbc.M300484200; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Hamuro Y, 2002, J MOL BIOL, V321, P703, DOI 10.1016/S0022-2836(02)00419-9; Hamuro Yoshitomo, 2003, J Biomol Tech, V14, P171; Hart PJ, 1998, PROTEIN SCI, V7, P545; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Hough MA, 2004, P NATL ACAD SCI USA, V101, P5976, DOI 10.1073/pnas.0305143101; Hyun DH, 2003, J NEUROCHEM, V86, P363, DOI 10.1046/j.1471-4159.2003.01841.x; Jaarsma D, 2001, ACTA NEUROPATHOL, V102, P293; Kabashi E, 2004, J NEUROCHEM, V89, P1325, DOI 10.1111/j.1471-4159.2004.02453.x; Kong JM, 1998, J NEUROSCI, V18, P3241; KUROBE N, 1990, CLIN CHIM ACTA, V187, P11, DOI 10.1016/0009-8981(90)90257-S; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Mourelatos Z, 1996, P NATL ACAD SCI USA, V93, P5472, DOI 10.1073/pnas.93.11.5472; NISHIDA CR, 1994, P NATL ACAD SCI USA, V91, P9906, DOI 10.1073/pnas.91.21.9906; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Petrovic N, 1996, J BIOL CHEM, V271, P28335, DOI 10.1074/jbc.271.45.28335; Petrovic N, 1996, J BIOL CHEM, V271, P28331, DOI 10.1074/jbc.271.45.28331; Ray SS, 2004, BIOCHEMISTRY-US, V43, P4899, DOI 10.1021/bi030246r; Roberts BR, 2007, J MOL BIOL, V373, P877, DOI 10.1016/j.jmb.2007.07.043; Rodriguez JA, 2002, J BIOL CHEM, V277, P15932, DOI 10.1074/jbc.M112088200; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; ROTHSTEIN JD, 1993, P NATL ACAD SCI USA, V90, P6591, DOI 10.1073/pnas.90.14.6591; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Shaw BF, 2006, J BIOL CHEM, V281, P18167, DOI 10.1074/jbc.M600623200; Shibata N, 1996, DEV NEUROSCI-BASEL, V18, P492, DOI 10.1159/000111445; Shibata N, 1996, J NEUROPATH EXP NEUR, V55, P481, DOI 10.1097/00005072-199604000-00011; Shipp EL, 2003, BIOCHEMISTRY-US, V42, P1890, DOI 10.1021/bi026704y; Sivaraman T, 2001, NAT STRUCT BIOL, V8, P331, DOI 10.1038/86208; Strange RW, 2003, J MOL BIOL, V328, P877, DOI 10.1016/S0022-2836(03)00355-3; Strom AL, 2008, J NEUROCHEM, V106, P495, DOI 10.1111/j.1471-4159.2008.05393.x; Taylor DM, 2007, J BIOL CHEM, V282, P16329, DOI 10.1074/jbc.M610119200; Tiwari A, 2005, J BIOL CHEM, V280, P29771, DOI 10.1074/jbc.M504039200; Tiwari A, 2005, NEURODEGENER DIS, V2, P115, DOI 10.1159/000089616; Tobisawa S, 2003, BIOCHEM BIOPH RES CO, V303, P496, DOI 10.1016/S0006-291X(03)00353-X; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Wang J, 2007, J BIOL CHEM, V282, P345, DOI 10.1074/jbc.M604503200; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Yates JR, 1996, J AM SOC MASS SPECTR, V7, P1089, DOI 10.1016/S1044-0305(96)00079-7; YOSHIDA E, 1994, J NEUROL SCI, V124, P25, DOI 10.1016/0022-510X(94)90006-X; Zhang FJ, 2007, J BIOL CHEM, V282, P16691, DOI 10.1074/jbc.M609743200; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	65	47	47	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30965	30973		10.1074/jbc.M109.023945	http://dx.doi.org/10.1074/jbc.M109.023945			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19635794	Green Published, hybrid			2022-12-27	WOS:000271378400026
J	Yang, PF; Yang, C; Wirschell, M; Davis, S				Yang, Pinfen; Yang, Chun; Wirschell, Maureen; Davis, Stephanie			Novel LC8 Mutations Have Disparate Effects on the Assembly and Stability of Flagellar Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNEIN LIGHT-CHAIN; RETROGRADE INTRAFLAGELLAR TRANSPORT; INTERMEDIATE CHAIN; CHLAMYDOMONAS FLAGELLA; RADIAL SPOKES; ARM DYNEIN; I1 DYNEIN; MOTOR; DIMERIZATION; IDENTIFICATION	LC8 functions as a dimer crucial for a variety of molecular motors and non-motor complexes. Emerging models, founded on structural studies, suggest that the LC8 dimer promotes the stability and refolding of dimeric target proteins in molecular complexes, and its interactions with selective target proteins, including dynein subunits, is regulated by LC8 phosphorylation, which is proposed to prevent LC8 dimerization. To test these hypotheses in vivo, we determine the impacts of two new LC8 mutations on the assembly and stability of defined LC8-containing complexes in Chlamydomonas flagella. The three types of dyneins and the radial spoke are disparately affected by dimeric LC8 with a C-terminal extension. The defects include the absence of specific subunits, complex instability, and reduced incorporation into the axonemal super complex. Surprisingly, a phosphomimetic LC8 mutation, which is largely monomeric in vitro, is still dimeric in vivo and does not significantly change flagellar generation and motility. The differential defects in these flagellar complexes support the structural model and indicate that modulation of target proteins by LC8 leads to the proper assembly of complexes and ultimately higher level complexes. Furthermore, the ability of flagellar complexes to incorporate the phosphomimetic LC8 protein and the modest defects observed in the phosphomimetic LC8 mutant suggest that LC8 phosphorylation is not an effective mechanism for regulating molecular complexes.	Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA; [Wirschell, Maureen] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA	Marquette University; Emory University	Yang, PF (corresponding author), 530 N 15th St, Milwaukee, WI 53233 USA.	pinfen.yang@marquette.edu			National Institutes of Health [GM068101]; National Research Service Award Postdoctoral Fellowship [GM075446]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068101, F32GM075446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM068101 (to P. Y.) and National Research Service Award Postdoctoral Fellowship GM075446 (to M. W.).	Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Benashski SE, 1997, J BIOL CHEM, V272, P20929, DOI 10.1074/jbc.272.33.20929; Bower R, 2009, MOL BIOL CELL, V20, P3055, DOI 10.1091/mbc.E09-04-0277; Delanoue R, 2007, DEV CELL, V13, P523, DOI 10.1016/j.devcel.2007.08.022; DiBella LM, 2005, MOL BIOL CELL, V16, P5661, DOI 10.1091/mbc.E05-08-0732; Dick T, 1996, MOL CELL BIOL, V16, P1966; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Ghosh-Roy A, 2005, MOL BIOL CELL, V16, P3107, DOI 10.1091/mbc.E05-02-0103; HARRIS HH, 2009, CHLAMYDOMONAS SOURCE, V1, P242; Harrison A, 1998, J CELL BIOL, V140, P1137, DOI 10.1083/jcb.140.5.1137; Hendrickson TW, 2004, MOL BIOL CELL, V15, P5431, DOI 10.1091/mbc.E04-08-0694; Hou YQ, 2004, MOL BIOL CELL, V15, P4382, DOI 10.1091/mbc.E04-05-0377; HUANG B, 1981, J CELL BIOL, V88, P80, DOI 10.1083/jcb.88.1.80; Jaffrey SR, 1996, SCIENCE, V274, P774, DOI 10.1126/science.274.5288.774; Kamiya R, 2002, INT REV CYTOL, V219, P115; KING SM, 1995, J BIOL CHEM, V270, P11445, DOI 10.1074/jbc.270.19.11445; Lechtreck KF, 2007, J CELL BIOL, V176, P473, DOI 10.1083/jcb.200611115; LEDIZET M, 1995, MOL BIOL CELL, V6, P697, DOI 10.1091/mbc.6.6.697; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lo KWH, 2006, J BIOL CHEM, V281, P9552, DOI 10.1074/jbc.M511721200; Lo KWH, 2005, J BIOL CHEM, V280, P8172, DOI 10.1074/jbc.M411408200; Pazour GJ, 1998, J CELL BIOL, V141, P979, DOI 10.1083/jcb.141.4.979; Perrone CA, 2003, MOL BIOL CELL, V14, P2041, DOI 10.1091/mbc.e02-10-0682; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; PIPERNO G, 1979, J BIOL CHEM, V254, P3084; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Qin HM, 2004, J CELL BIOL, V164, P255, DOI 10.1083/jcb.200308132; Rodriguez-Crespo I, 2001, FEBS LETT, V503, P135, DOI 10.1016/S0014-5793(01)02718-1; Rompolas P, 2007, J CELL SCI, V120, P3653, DOI 10.1242/jcs.012773; Song CY, 2008, J BIOL CHEM, V283, P4004, DOI 10.1074/jbc.M704512200; Song YJ, 2007, J BIOL CHEM, V282, P17272, DOI 10.1074/jbc.M610445200; Stelter P, 2007, NAT CELL BIOL, V9, P788, DOI 10.1038/ncb1604; Tan GS, 2007, P NATL ACAD SCI USA, V104, P7229, DOI 10.1073/pnas.0701397104; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; Wang WN, 2003, J BIOL CHEM, V278, P41491, DOI 10.1074/jbc.M307118200; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Wirschell M, 2009, MOL BIOL CELL, V20, P3044, DOI 10.1091/mbc.E09-04-0276; Yang C, 2008, J CELL BIOL, V180, P403, DOI 10.1083/jcb.200705069; Yang PF, 2006, J CELL SCI, V119, P1165, DOI 10.1242/jcs.02811; Yang PF, 1998, MOL BIOL CELL, V9, P3335, DOI 10.1091/mbc.9.12.3335; Yang PF, 2001, J CELL BIOL, V153, P1315, DOI 10.1083/jcb.153.6.1315	41	13	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31412	31421		10.1074/jbc.M109.050666	http://dx.doi.org/10.1074/jbc.M109.050666			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19696030	hybrid, Green Published			2022-12-27	WOS:000271378400066
J	Eichinger, CS; Mizuno, T; Mizuno, K; Miyake, Y; Yanagi, K; Imamoto, N; Hanaoka, F				Eichinger, Christian S.; Mizuno, Takeshi; Mizuno, Keiko; Miyake, Yasuyuki; Yanagi, Ken-ichiro; Imamoto, Naoko; Hanaoka, Fumio			Aberrant DNA Polymerase alpha Is Excluded from the Nucleus by Defective Import and Degradation in the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEMPERATURE-SENSITIVE MUTANT; UBIQUITIN-PROTEASOME SYSTEM; MOUSE FM3A CELLS; HEAT-LABILE; TSFT20 STRAIN; CATALYTIC SUBUNIT; PRIMASE COMPLEX; RESTRICTIVE TEMPERATURE; PROTEIN STABILITY; EUKARYOTIC CELLS	DNA polymerase alpha is essential for the onset of eukaryotic DNA replication. Its correct folding and assembly within the nuclear replication pre-initiation complex is crucial for normal cell cycle progression and genome maintenance. Due to a single point mutation in the largest DNA polymerase alpha subunit, p180, the temperature-sensitive mouse cell line tsFT20 exhibits heat-labile DNA polymerase alpha activity and S phase arrest at restrictive temperature. In this study, we show that an aberrant form of endogenous p180 in tsFT20 cells (p180(tsFT20)) is strictly localized in the cytoplasm while its wild-type counterpart enters the nucleus. Time-lapse fluorescence microscopy with enhanced green fluorescent protein-tagged or photoactivatable green fluorescent protein-tagged p180(tsFT20) variants and inhibitor analysis revealed that the exclusion of aberrant p180(tsFT20) from the nucleus is due to two distinct mechanisms: first, the inability of newly synthesized ( cytoplasmic) p180(tsFT20) to enter the nucleus and second, proteasome-dependent degradation of nuclear-localized protein. The nuclear import defect seems to result from an impaired association of aberrant de novo synthesized p180(tsFT20) with the second subunit of DNA polymerase alpha, p68. In accordance, we show that RNA interference of p68 results in a decrease of the overall p180 protein level and in a specific increase of cytoplasmic localized p180 in NIH3T3 cells. Taken together, our data suggest two mechanisms that prevent the nuclear expression of aberrant DNA polymerase alpha.	[Mizuno, Takeshi; Mizuno, Keiko; Yanagi, Ken-ichiro; Imamoto, Naoko] Japan Sci & Technology Corp, Cellular Dynam Lab, Adv Sci Inst, RIKEN, Wako, Saitama 3510198, Japan; [Eichinger, Christian S.; Mizuno, Takeshi; Miyake, Yasuyuki; Yanagi, Ken-ichiro; Hanaoka, Fumio] Japan Sci & Technology Corp, Cellular Physiol Lab, Wako, Saitama 3510198, Japan; [Mizuno, Takeshi; Hanaoka, Fumio] Japan Sci & Technology Corp, SORST, Wako, Saitama 3510198, Japan; [Hanaoka, Fumio] Osaka Univ, Grad Sch Frontier Biosci, Osaka 5650871, Japan	Japan Science & Technology Agency (JST); RIKEN; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Osaka University	Mizuno, T (corresponding author), Japan Sci & Technology Corp, Cellular Dynam Lab, Adv Sci Inst, RIKEN, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tmizuno@riken.jp	Miyake, Yasuyuki/AAS-1504-2021; Mizuno, Takeshi/I-4432-2017; Imamoto, Naoko/A-7458-2015	Miyake, Yasuyuki/0000-0001-6250-0260; Mizuno, Takeshi/0000-0003-3664-7212; Imamoto, Naoko/0000-0002-2886-3022	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Human Frontier Science Program; Bioarchitect Research Project and the Chemical Biology Project of RIKEN; RIKEN; Studienstiftung des deutschen Volkes ( German National Merit Foundation); Center of Excellence (COE) from the Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program(Human Frontier Science Program); Bioarchitect Research Project and the Chemical Biology Project of RIKEN; RIKEN; Studienstiftung des deutschen Volkes ( German National Merit Foundation); Center of Excellence (COE) from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, a grant from the Human Frontier Science Program, grants from the Bioarchitect Research Project and the Chemical Biology Project of RIKEN ( to T. M. and N. I.) and the director fund of RIKEN ( to T. M.), research fellowships from the Studienstiftung des deutschen Volkes ( German National Merit Foundation) ( to C. S. E.) and the Center of Excellence (COE) from the Japan Society for the Promotion of Science ( to Y. M.).	Arezi B, 2000, TRENDS BIOCHEM SCI, V25, P572, DOI 10.1016/S0968-0004(00)01680-7; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Dahlen M, 2003, MOL CELL BIOL, V23, P3031, DOI 10.1128/MCB.23.9.3031-3042.2003; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; EKI T, 1988, ARCH BIOCHEM BIOPHYS, V260, P552, DOI 10.1016/0003-9861(88)90481-X; EKI T, 1987, EXP CELL RES, V171, P24, DOI 10.1016/0014-4827(87)90248-5; EKI T, 1986, J BIOL CHEM, V261, P8888; EKI T, 1987, CANCER RES, V47, P5162; EKI T, 1990, J BIOL CHEM, V265, P26; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; GORBY GL, 1994, J HISTOCHEM CYTOCHEM, V42, P297, DOI 10.1177/42.3.7508470; Grossi S, 2004, GENE DEV, V18, P992, DOI 10.1101/gad.300004; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hua XH, 1997, J CELL BIOL, V137, P183, DOI 10.1083/jcb.137.1.183; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Ikehata H, 1997, MOL CELL BIOL, V17, P1484, DOI 10.1128/MCB.17.3.1484; Izumi M, 2000, BBA-GENE STRUCT EXPR, V1492, P341, DOI 10.1016/S0167-4781(00)00117-2; IZUMI M, 1994, J BIOL CHEM, V269, P7639; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Martin AD, 2000, MOL CELL BIOL, V20, P786, DOI 10.1128/MCB.20.3.786-796.2000; MIYAZAWA H, 1986, BIOCHEM BIOPH RES CO, V139, P637, DOI 10.1016/S0006-291X(86)80038-9; Mizuno T, 1999, MOL CELL BIOL, V19, P7886; Mizuno T, 1998, MOL CELL BIOL, V18, P3552, DOI 10.1128/MCB.18.6.3552; MURAKAMI Y, 1986, EXP CELL RES, V163, P135, DOI 10.1016/0014-4827(86)90565-3; MURAKAMI Y, 1985, P NATL ACAD SCI USA, V82, P1761, DOI 10.1073/pnas.82.6.1761; Nakamura M, 2005, MOL CELL BIOL, V25, P11073, DOI 10.1128/MCB.25.24.11073-11088.2005; Nakayama J, 2001, EMBO J, V20, P2857, DOI 10.1093/emboj/20.11.2857; Ott RD, 2002, MOL CELL BIOL, V22, P5669, DOI 10.1128/MCB.22.16.5669-5678.2002; Parsons JL, 2008, MOL CELL, V29, P477, DOI 10.1016/j.molcel.2007.12.027; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; PEARSON BE, 1991, MOL CELL BIOL, V11, P2081, DOI 10.1128/MCB.11.4.2081; PENDERGRASS WR, 1994, J CELL PHYSIOL, V158, P270, DOI 10.1002/jcp.1041580209; Qi HY, 2000, GENE DEV, V14, P1777; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Schub O, 2001, J BIOL CHEM, V276, P38076; TAKADATAKAYAMA R, 1991, J BIOL CHEM, V266, P15716; Voitenleitner C, 1999, MOL CELL BIOL, V19, P646; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WANG TSF, 1991, ANNU REV BIOCHEM, V60, P513, DOI 10.1146/annurev.biochem.60.1.513; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wimmer U, 2008, EMBO REP, V9, P1027, DOI 10.1038/embor.2008.148; YAGURA T, 1987, BIOCHEMISTRY-US, V26, P7749, DOI 10.1021/bi00398a032; YAMAGUCHI K, 1995, CELL STRUCT FUNCT, V20, P285, DOI 10.1247/csf.20.285; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zhou YJ, 2004, MOL CELL BIOL, V24, P9568, DOI 10.1128/MCB.24.21.9568-9579.2004; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	54	5	5	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30604	30614		10.1074/jbc.M109.024760	http://dx.doi.org/10.1074/jbc.M109.024760			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19726690	hybrid, Green Published			2022-12-27	WOS:000271090000063
J	AbuOun, M; Suthers, PF; Jones, GI; Carter, BR; Saunders, MP; Maranas, CD; Woodward, MJ; Anjum, MF				AbuOun, Manal; Suthers, Patrick F.; Jones, Gareth I.; Carter, Ben R.; Saunders, Mark P.; Maranas, Costas D.; Woodward, Martin J.; Anjum, Muna F.			Genome Scale Reconstruction of a Salmonella Metabolic Model COMPARISON OF SIMILARITY AND DIFFERENCES WITH A COMMENSAL ESCHERICHIA COLI STRAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; HISTIDINE DEGRADATION; TRANSPORT-SYSTEM; HIGH-THROUGHPUT; GENE-CLUSTER; K-12; SEQUENCE; IDENTIFICATION; REGULON; MICROARRAY	Salmonella are closely related to commensal Escherichia coli but have gained virulence factors enabling them to behave as enteric pathogens. Less well studied are the similarities and differences that exist between the metabolic properties of these organisms that may contribute toward niche adaptation of Salmonella pathogens. To address this, we have constructed a genome scale Salmonella metabolic model (iMA945). The model comprises 945 open reading frames or genes, 1964 reactions, and 1036 metabolites. There was significant overlap with genes present in E. coli MG1655 model iAF1260. In silico growth predictions were simulated using the model on different carbon, nitrogen, phosphorous, and sulfur sources. These were compared with substrate utilization data gathered from high throughput phenotyping microarrays revealing good agreement. Of the compounds tested, the majority were utilizable by both Salmonella and E. coli. Nevertheless a number of differences were identified both between Salmonella and E. coli and also within the Salmonella strains included. These differences provide valuable insight into differences between a commensal and a closely related pathogen and within different pathogenic strains opening new avenues for future explorations.	[Woodward, Martin J.; Anjum, Muna F.] Vet Labs Agcy Weybridge, Dept Food & Environm Safety, Weybridge KT15 3NB, Surrey, England; [Suthers, Patrick F.; Maranas, Costas D.] Penn State Univ, University Pk, PA 16802 USA; [Carter, Ben R.] Cardiff Univ, Sch Med, SE Wales Trials Unit, Cardiff CF14 4XN, S Glam, Wales	Veterinary Laboratories Agency; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Cardiff University		m.abuoun@vla.defra.gsi.gov.uk	anjum, muna/C-5213-2011; Maranas, Costas D/A-4774-2011; ABUOUN, MANAL/D-8456-2011; Woodward, Martin J/E-8955-2010	Maranas, Costas D/0000-0002-1508-1398; Carter, Ben/0000-0003-0318-8865; Suthers, Patrick/0000-0002-5560-9986	United Kingdom Department of Environment, Food, and Rural Affairs [OZ0324]; United States Department of Energy [DOE DE-FG02-05ER25684]	United Kingdom Department of Environment, Food, and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); United States Department of Energy(United States Department of Energy (DOE))	This work was supported by United Kingdom Department of Environment, Food, and Rural Affairs Grant OZ0324 and the United States Department of Energy Grant DOE DE-FG02-05ER25684.	Anjum MF, 2005, INFECT IMMUN, V73, P7894, DOI 10.1128/IAI.73.12.7894-7905.2005; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Boyd D, 2001, J BACTERIOL, V183, P5725, DOI 10.1128/JB.183.19.5725-5732.2001; BURLINGAME RP, 1983, THESIS U MINNESOTA; CAMPBELL JH, 1973, P NATL ACAD SCI USA, V70, P1841, DOI 10.1073/pnas.70.6.1841; Carinato ME, 1998, J BACTERIOL, V180, P3517, DOI 10.1128/JB.180.14.3517-3521.1998; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Chan K, 2003, J BACTERIOL, V185, P553, DOI 10.1128/JB.185.2.553-563.2003; CHEN P, 1994, J BACTERIOL, V176, P5474, DOI 10.1128/JB.176.17.5474-5482.1994; Christensen M, 2003, J BACTERIOL, V185, P6042, DOI 10.1128/JB.185.20.6042-6050.2003; COLLINOSDOBY P, 1994, MOL GEN GENET, V243, P674, DOI 10.1007/BF00279577; COOPER RA, 1980, J BACTERIOL, V143, P302, DOI 10.1128/JB.143.1.302-306.1980; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; CROSA JH, 1973, J BACTERIOL, V115, P307, DOI 10.1128/JB.115.1.307-315.1973; Diaz E, 2001, MICROBIOL MOL BIOL R, V65, P523, DOI 10.1128/MMBR.65.4.523-569.2001; Doolittle RF, 1996, SCIENCE, V271, P470, DOI 10.1126/science.271.5248.470; Doublet B, 2005, MOL MICROBIOL, V55, P1911, DOI 10.1111/j.1365-2958.2005.04520.x; Eichhorn E, 1997, J BIOL CHEM, V272, P23031, DOI 10.1074/jbc.272.37.23031; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; HALL BG, 1978, GENETICS, V90, P673; HUMPHREY TJ, 1992, VET REC, V131, P386, DOI 10.1136/vr.131.17.386; IWANICKANOWICKA R, 1995, GENE, V166, P11, DOI 10.1016/0378-1119(95)00606-8; JENNINGS MP, 1993, MOL MICROBIOL, V9, P165, DOI 10.1111/j.1365-2958.1993.tb01678.x; Joyce AR, 2006, J BACTERIOL, V188, P8259, DOI 10.1128/JB.00740-06; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim CH, 1997, J BACTERIOL, V179, P7631, DOI 10.1128/jb.179.24.7631-7637.1997; Kumar VS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-212; Kumar VS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000308; LAMARK T, 1992, FEMS MICROBIOL LETT, V96, P149; Lewis JA, 2004, J BACTERIOL, V186, P1629, DOI 10.1128/JB.186.6.1629-1637.2004; LIN ECC, 1996, ESCHERICHIA COLI SAL, V2, P307; LINK CD, 1983, MOL GEN GENET, V189, P337, DOI 10.1007/BF00337827; MASTERS PS, 1981, J BACTERIOL, V147, P805, DOI 10.1128/JB.147.3.805-819.1981; Matiasovicova J, 2007, ARCH MICROBIOL, V187, P415, DOI 10.1007/s00203-006-0205-6; MAYER C, 2005, HEXOSE PENTOSE HEXIT; McClelland M, 1998, INFECT IMMUN, V66, P4305; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; McClelland M, 2000, NUCLEIC ACIDS RES, V28, P4974, DOI 10.1093/nar/28.24.4974; MEISS HK, 1969, J BIOL CHEM, V244, P5382; Muse WB, 1998, J BACTERIOL, V180, P1166, DOI 10.1128/JB.180.5.1166-1173.1998; NEMOZ G, 1976, J BACTERIOL, V127, P706, DOI 10.1128/JB.127.2.706-718.1976; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; PARROTT S, 1987, J GEN MICROBIOL, V133, P347; Plumbridge J, 1999, J BACTERIOL, V181, P47, DOI 10.1128/JB.181.1.47-54.1999; Porwollik S, 2004, J BACTERIOL, V186, P5883, DOI 10.1128/JB.186.17.5883-5898.2004; Poulsen TS, 1999, J BACTERIOL, V181, P7126, DOI 10.1128/JB.181.22.7126-7130.1999; Price-Carter M, 2001, J BACTERIOL, V183, P2463, DOI 10.1128/JB.183.8.2463-2475.2001; Prieto MA, 1996, J BACTERIOL, V178, P111, DOI 10.1128/jb.178.1.111-120.1996; Puchalka J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000210; Raghunathan A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-38; Reed JL, 2006, P NATL ACAD SCI USA, V103, P17480, DOI 10.1073/pnas.0603364103; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Reed JL, 2006, NAT REV GENET, V7, P130, DOI 10.1038/nrg1769; REYNOLDS CH, 1983, J BACTERIOL, V156, P1019, DOI 10.1128/JB.156.3.1019-1024.1983; RODRIGUE DC, 1990, EPIDEMIOL INFECT, V105, P21, DOI 10.1017/S0950268800047609; SMITH GR, 1971, J BIOL CHEM, V246, P3320; STEWART V, 1985, J BACTERIOL, V164, P731, DOI 10.1128/JB.164.2.731-740.1985; Suthers PF, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000285; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Teusink B, 2006, NAT REV MICROBIOL, V4, P46, DOI 10.1038/nrmicro1319; Threlfall E.J., 1997, Euro Surveill, V2, P81; TIPTON PA, 1990, BIOCHEMISTRY-US, V29, P1749, DOI 10.1021/bi00459a013; UNDEN G, 2004, AEROBIC ANAEROBIC GR; VALLINO JJ, 1993, BIOTECHNOL BIOENG, V41, P633, DOI 10.1002/bit.260410606; van der Ploeg JR, 2001, ARCH MICROBIOL, V176, P1, DOI 10.1007/s002030100298; van der Ploeg JR, 1999, J BIOL CHEM, V274, P29358, DOI 10.1074/jbc.274.41.29358; vanderPloeg JR, 1996, J BACTERIOL, V178, P5438, DOI 10.1128/jb.178.18.5438-5446.1996; WOODWARD MJ, 1983, J GEN MICROBIOL, V129, P75; Yamashita M, 1996, J BACTERIOL, V178, P2941, DOI 10.1128/jb.178.10.2941-2947.1996; Zhou L, 2003, J BACTERIOL, V185, P4956, DOI 10.1128/JB.185.16.4956-4972.2003	76	69	70	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29480	29488		10.1074/jbc.M109.005868	http://dx.doi.org/10.1074/jbc.M109.005868			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19690172	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000270896800030
J	Collier, DM; Snyder, PM				Collier, Daniel M.; Snyder, Peter M.			Extracellular Chloride Regulates the Epithelial Sodium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ SELF-INHIBITION; INTRACELLULAR SODIUM; HISTIDINE-RESIDUES; OPEN PROBABILITY; ACTIVATION; EXPRESSION; BINDING; CLONING; ENAC	The extracellular domain of the epithelial sodium channel ENaC is exposed to a wide range of Cl- concentrations in the kidney and in other epithelia. We tested whether Cl- alters ENaC activity. In Xenopus oocytes expressing human ENaC, replacement of Cl- with SO42-, H2PO4-, or SCN- produced a large increase in ENaC current, indicating that extracellular Cl- inhibits ENaC. Extracellular Cl- also inhibited ENaC in Na+-transporting epithelia. The anion selectivity sequence was SCN- < SO42- < H2PO4- < F- < I- < Cl- < Br-. Crystallization of ASIC1a revealed a Cl- binding site in the extracellular domain. We found that mutation of corresponding residues in ENaC (alpha(H418A) and beta(R388A)) disrupted the response to Cl-, suggesting that Cl- might regulate ENaC through an analogous binding site. Maneuvers that lock ENaC in an open state (a DEG mutation and trypsin) abolished ENaC regulation by Cl-. The response to Cl- was also modulated by changes in extracellular pH; acidic pH increased and alkaline pH reduced ENaC inhibition by Cl-. Cl- regulated ENaC activity in part through enhanced Na+ self-inhibition, a process by which extracellular Na+ inhibits ENaC. Together, the data indicate that extracellular Cl- regulates ENaC activity, providing a potential mechanism by which changes in extracellular Cl- might modulate epithelial Na+ absorption.	[Snyder, Peter M.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Snyder, PM (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, 371 EMRB, Iowa City, IA 52242 USA.	peter-snyder@uiowa.edu	Collier, Daniel/GVU-0199-2022		National Institutes of Health [HL058812, HL72256]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072256, R29HL058812, R01HL058812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL058812 and HL72256 (to P. M. S.).	Abriel H, 1999, J PHYSIOL-LONDON, V516, P31, DOI 10.1111/j.1469-7793.1999.031aa.x; Anantharam A, 2006, J PHYSIOL-LONDON, V574, P333, DOI 10.1113/jphysiol.2006.109173; Awayda MS, 1999, AM J PHYSIOL-CELL PH, V277, pC216, DOI 10.1152/ajpcell.1999.277.2.C216; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; DANI JA, 1983, J GEN PHYSIOL, V81, P255, DOI 10.1085/jgp.81.2.255; DINUDOM A, 1993, J MEMBRANE BIOL, V135, P289; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; HILLE B, 1992, IONIC CHANNELS EXCIT, P288; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Kellenberger S, 1998, J CLIN INVEST, V101, P2741, DOI 10.1172/JCI2837; Knight KK, 2008, J BIOL CHEM, V283, P27477, DOI 10.1074/jbc.M804176200; Komwatana P, 1996, P NATL ACAD SCI USA, V93, P8107, DOI 10.1073/pnas.93.15.8107; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; Rose B. D., 1984, CLIN PHYSL ACID BASE, P274; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2002, J BIOL CHEM, V277, P50098, DOI 10.1074/jbc.M209975200; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Tavernarakis N, 1997, ANNU REV PHYSIOL, V59, P659, DOI 10.1146/annurev.physiol.59.1.659; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329	31	58	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29320	29325		10.1074/jbc.M109.046771	http://dx.doi.org/10.1074/jbc.M109.046771			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19713212	hybrid, Green Published			2022-12-27	WOS:000270896800011
J	Park, JH; Mangal, D; Frey, AJ; Harvey, RG; Blair, IA; Penning, TM				Park, Jong-Heum; Mangal, Dipti; Frey, Alexander J.; Harvey, Ronald G.; Blair, Ian A.; Penning, Trevor M.			Aryl Hydrocarbon Receptor Facilitates DNA Strand Breaks and 8-Oxo-2 '-deoxyguanosine Formation by the Aldo-Keto Reductase Product Benzo[a]pyrene-7,8-dione	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; PAH O-QUINONES; TOBACCO-SMOKE CARCINOGENS; GENE-EXPRESSION; NUCLEAR TRANSLOCATOR; HYDANTOIN PRODUCTS; CYTOCHROME P4501B1; P53 MUTATIONS; ABASIC SITES; DIOL-EPOXIDE	Polycyclic aromatic hydrocarbon (PAH) o-quinones produced by aldo-keto reductases are ligands for the aryl hydrocarbon receptor (AhR) (Burczynski, M. E., and Penning, T. M. (2000) Cancer Res. 60, 908-915). They induce oxidative DNA lesions (reactive oxygen species-mediated DNA strand breaks and 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dGuo) formation) in human lung cells. We tested whether the AhR enhances PAH o-quinone-mediated oxidative DNA damage by translocating these ligands to the nucleus. Using the single cell gel electrophoresis (comet) assay to detect DNA strand breaks in murine hepatoma Hepa1c1c7 cells and its AhR-and aryl hydrocarbon receptor nuclear translocator-deficient variants, benzo[a] pyrene-7,8-dione (B[a] P-7,8-dione) produced fewer DNA strand breaks in AhR-deficient cells compared with aryl hydrocarbon receptor nuclear translocator-deficient and wild type Hepa1c1c7 cells. Decreased DNA strand breaks were also observed in human bronchoalveolar H358 cells in which the AhR was silenced by siRNA. The antioxidant alpha-tocopherol and the iron chelator/antioxidant desferal decreased the formation of B[a] P-7,8-dione-mediated DNA strand breaks indicating that they were reactive oxygen species-dependent. By coupling the comet assay to 8-oxoguanine glycosylase (hOGG1), which excises 8-oxo-Gua, strand breaks dependent upon this lesion were measured. hOGG1 treatment produced more DNA single strand breaks in B[a] P-7,8- dione-treated Hepa cells and H358 cells than in its absence. The levels of hOGG1-dependent DNA strand breaks mediated by B[a] P-7,8-dione were lower in AhR-deficient Hepa and AhR knockdown H358 cells. The AhR antagonist alpha-naphthoflavone also attenuated B[a] P-7,8-dione-mediated DNA strand breaks. The decrease in 8-oxo-dGuo levels in AhR-deficient Hepa cells and AhR knockdown H358 cells was validated by immunoaffinity capture stable isotope dilution ([N-15(5)] 8-oxo-dGuo) liquid chromatography-electrospray ionization/multiple reaction monitoring/mass spectrometry. We conclude that the AhR shuttles PAH o-quinone genotoxins to the nucleus and enhances oxidative DNA damage.	[Park, Jong-Heum; Mangal, Dipti; Blair, Ian A.; Penning, Trevor M.] Univ Penn, Dept Pharmacol, Sch Med, Philadelphia, PA 19104 USA; [Park, Jong-Heum; Mangal, Dipti; Frey, Alexander J.; Blair, Ian A.; Penning, Trevor M.] Univ Penn, Ctr Excellence Environm Toxicol, Sch Med, Philadelphia, PA 19104 USA; [Mangal, Dipti; Frey, Alexander J.; Blair, Ian A.; Penning, Trevor M.] Univ Penn, Ctr Canc Pharmacol, Sch Med, Philadelphia, PA 19104 USA; [Harvey, Ronald G.] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Chicago	Penning, TM (corresponding author), Univ Penn, Dept Pharmacol, Sch Med, 130C John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	penning@mail.med.upenn.edu	Blair, Ian A/B-3320-2010	Penning, Trevor/0000-0002-3937-1066	National Institutes of Health [RO1-CA39504, P30-ES013508, RO1-CA130038]; NATIONAL CANCER INSTITUTE [R01CA039504, R01CA130038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-CA39504 and P30-ES013508 (to T. M. P.) and RO1-CA130038 (to I. A. B.).	Balu N, 2004, CHEM RES TOXICOL, V17, P827, DOI 10.1021/tx034207s; Balu N, 2006, ANAL BIOCHEM, V355, P213, DOI 10.1016/j.ab.2006.05.023; Bjoras M, 1997, EMBO J, V16, P6314, DOI 10.1093/emboj/16.20.6314; Bohonowych JE, 2007, TOXICOL SCI, V98, P99, DOI 10.1093/toxsci/kfm085; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burczynski ME, 2000, CANCER RES, V60, P908; Burrows CJ, 2002, ENVIRON HEALTH PERSP, V110, P713, DOI 10.1289/ehp.02110s5713; CONNEY AH, 1982, CANCER RES, V42, P4875; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; DIPPLE A, 1983, CANCER RES, V43, P2422; Flowers L, 1996, BIOCHEMISTRY-US, V35, P13664, DOI 10.1021/bi961077w; GRIMMER G, 1975, J ASSOC OFF ANA CHEM, V58, P725; Hailer MK, 2005, CHEM RES TOXICOL, V18, P1378, DOI 10.1021/tx0501379; Harvey RG, 2004, J ORG CHEM, V69, P2024, DOI 10.1021/jo030348n; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; JENNETTE KW, 1977, BIOCHEMISTRY-US, V16, P932, DOI 10.1021/bi00624a019; Jiang H, 2006, CHEM RES TOXICOL, V19, P68, DOI 10.1021/tx0502488; KOREEDA M, 1978, SCIENCE, V199, P778, DOI 10.1126/science.622566; Liu XM, 2002, CHEM RES TOXICOL, V15, P512, DOI 10.1021/tx0101649; Luo WC, 2001, CHEM RES TOXICOL, V14, P927, DOI 10.1021/tx010072j; Mangal D, 2009, CHEM RES TOXICOL, V22, P788, DOI 10.1021/tx800343c; MARSHALL CJ, 1984, NATURE, V310, P586, DOI 10.1038/310586a0; McCoull KD, 1999, CHEM RES TOXICOL, V12, P237, DOI 10.1021/tx980182z; MERCHANT M, 1990, ARCH BIOCHEM BIOPHYS, V281, P84, DOI 10.1016/0003-9861(90)90416-V; Neeley WL, 2006, CHEM RES TOXICOL, V19, P491, DOI 10.1021/tx0600043; NumayamaTsuruta K, 1997, EUR J BIOCHEM, V246, P486, DOI 10.1111/j.1432-1033.1997.00486.x; Ohnishi S, 2002, BIOCHEM BIOPH RES CO, V290, P778, DOI 10.1006/bbrc.2001.6249; Palackal NT, 2002, J BIOL CHEM, V277, P24799, DOI 10.1074/jbc.M112424200; Palackal NT, 2001, BIOCHEMISTRY-US, V40, P10901, DOI 10.1021/bi010872t; Park JH, 2005, CHEM RES TOXICOL, V18, P1026, DOI 10.1021/tx050001a; Park JH, 2008, CHEM RES TOXICOL, V21, P1039, DOI 10.1021/tx700404a; Park JH, 2008, P NATL ACAD SCI USA, V105, P6846, DOI 10.1073/pnas.0802776105; Park JH, 2006, CHEM RES TOXICOL, V19, P719, DOI 10.1021/tx0600245; Penning TM, 1999, CHEM RES TOXICOL, V12, P1, DOI 10.1021/tx980143n; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; ROTHMAN N, 1990, CARCINOGENESIS, V11, P1241, DOI 10.1093/carcin/11.7.1241; Seike K, 2003, CHEM RES TOXICOL, V16, P1470, DOI 10.1021/tx034103h; SHIBUTANI S, 1993, BIOCHEMISTRY-US, V32, P7531, DOI 10.1021/bi00080a027; Shimada T, 1999, CHEM RES TOXICOL, V12, P623, DOI 10.1021/tx990028s; Shimada T, 2001, DRUG METAB DISPOS, V29, P1176; SHOU M, 1993, CARCINOGENESIS, V14, P475, DOI 10.1093/carcin/14.3.475; Smith CC, 2006, MUTAGENESIS, V21, P185, DOI 10.1093/mutage/gel019; Soshilov A, 2008, J BIOL CHEM, V283, P32995, DOI 10.1074/jbc.M802414200; Wang ZC, 2009, J BIOL CHEM, V284, P8624, DOI 10.1074/jbc.M807860200; Wood SM, 1996, J BIOL CHEM, V271, P15117, DOI 10.1074/jbc.271.25.15117; Xie ZW, 2003, BIOCHEMISTRY-US, V42, P11253, DOI 10.1021/bi0346704; Yu DS, 2002, CHEM RES TOXICOL, V15, P832, DOI 10.1021/tx010177m; Zhang JZ, 1996, MOL PHARMACOL, V50, P1454	49	55	55	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29725	29734		10.1074/jbc.M109.042143	http://dx.doi.org/10.1074/jbc.M109.042143			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19726680	hybrid, Green Published			2022-12-27	WOS:000270896800054
J	Rafikova, ER; Melikov, K; Ramos, C; Dye, L; Chernomordik, LV				Rafikova, Elvira R.; Melikov, Kamran; Ramos, Corinne; Dye, Louis; Chernomordik, Leonid V.			Transmembrane Protein-free Membranes Fuse into Xenopus Nuclear Envelope and Promote Assembly of Functional Pores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; CELL-CYCLE; EGG EXTRACTS; FORMATION INVITRO; FUSION; COMPLEXES; SNARE; CHROMATIN; DYNAMICS; ROLES	Post-mitotic reassembly of nuclear envelope (NE) and the endoplasmic reticulum (ER) has been reconstituted in a cell-free system based on interphase Xenopus egg extract. To evaluate the relative contributions of cytosolic and transmembrane proteins in NE and ER assembly, we replaced a part of native membrane vesicles with ones either functionally impaired by trypsin or N-ethylmaleimide treatments or with protein-free liposomes. Although neither impaired membrane vesicles nor liposomes formed ER and nuclear membrane, they both supported assembly reactions by fusing with native membrane vesicles. At membrane concentrations insufficient to generate full-sized functional nuclei, addition of liposomes and their fusion with membrane vesicles resulted in an extensive expansion of NE, further chromatin decondensation, restoration of the functionality, and spatial distribution of the nuclear pore complexes (NPCs), and, absent newly delivered transmembrane proteins, an increase in NPC numbers. This rescue of the nuclear assembly by liposomes was inhibited by wheat germ agglutinin and thus required active nuclear transport, similarly to the assembly of full-sized functional NE with membrane vesicles. Mechanism of fusion between liposomes and between liposomes and membrane vesicles was investigated using lipid mixing assay. This fusion required interphase cytosol and, like fusion between native membrane vesicles, was inhibited by guanosine 5'-3-O-(thio) triphosphate, soluble N-ethylmaleimide-sensitive factor attachment protein, and N-ethylmaleimide. Our findings suggest that interphase cytosol contains proteins that mediate the fusion stage of ER and NE reassembly, emphasize an unexpected tolerance of nucleus assembly to changes in concentrations of transmembrane proteins, and reveal the existence of a feedback mechanism that couples NE expansion with NPC assembly.	[Rafikova, Elvira R.; Melikov, Kamran; Chernomordik, Leonid V.] Eunice Kennedy Shriver NICHD, Sect Membrane Biol, Lab Cellular & Mol Biophys, NIH, Bethesda, MD 20892 USA; [Ramos, Corinne] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California San Diego	Chernomordik, LV (corresponding author), Bldg 10,Rm 10D04A,10 Ctr Dr, Bethesda, MD 20892 USA.	chernoml@mail.nih.gov			National Institutes of Health Intramural Research Program of the Eunice Kennedy Shriver NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001501] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001501] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program of the Eunice Kennedy Shriver NICHD (to L. V. C.).	Anderson DJ, 2008, CURR OPIN CELL BIOL, V20, P386, DOI 10.1016/j.ceb.2008.03.016; Anderson DJ, 2008, J CELL SCI, V121, P137, DOI 10.1242/jcs.005777; Anderson DJ, 2007, NAT CELL BIOL, V9, P1160, DOI 10.1038/ncb1636; Antonin W, 2005, MOL CELL, V17, P83, DOI 10.1016/j.molcel.2004.12.010; Antonin W, 2008, FEBS LETT, V582, P2004, DOI 10.1016/j.febslet.2008.02.067; Barszczewski M, 2008, MOL BIOL CELL, V19, P776, DOI 10.1091/mbc.E07-05-0498; Baur T, 2007, J CELL SCI, V120, P2895, DOI 10.1242/jcs.010181; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Brandhorst D, 2006, P NATL ACAD SCI USA, V103, P2701, DOI 10.1073/pnas.0511138103; Brugger B, 2000, EMBO J, V19, P1272, DOI 10.1093/emboj/19.6.1272; Burger KNJ, 2000, TRAFFIC, V1, P605, DOI 10.1034/j.1600-0854.2000.010804.x; Burke B, 2006, ANNU REV GENOM HUM G, V7, P369, DOI 10.1146/annurev.genom.7.080505.115732; Byrne RD, 2007, CELL SIGNAL, V19, P913, DOI 10.1016/j.cellsig.2006.10.011; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; D'Angelo MA, 2006, SCIENCE, V312, P440, DOI 10.1126/science.1124196; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; Dreier L, 2000, J CELL BIOL, V148, P883, DOI 10.1083/jcb.148.5.883; Drummond S, 1999, J CELL BIOL, V144, P225, DOI 10.1083/jcb.144.2.225; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; FINLAY DR, 1987, J CELL BIOL, V104, P189, DOI 10.1083/jcb.104.2.189; FOLCH J, 1957, J BIOL CHEM, V226, P497; Franz C, 2005, EMBO J, V24, P3519, DOI 10.1038/sj.emboj.7600825; Fukasawa M, 2004, P NATL ACAD SCI USA, V101, P4815, DOI 10.1073/pnas.0401183101; Gant TM, 1999, J CELL BIOL, V144, P1083, DOI 10.1083/jcb.144.6.1083; GOLDBERG M, 1995, J CELL SCI, V108, P3451; Goldberg MW, 1997, J CELL SCI, V110, P409; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Haraguchi T, 2000, J CELL SCI, V113, P779; Hawryluk-Gara LA, 2008, MOL BIOL CELL, V19, P1753, DOI 10.1091/mbc.E07-08-0820; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; Howe JA, 1996, P NATL ACAD SCI USA, V93, P2060, DOI 10.1073/pnas.93.5.2060; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Jun Y, 2007, EMBO J, V26, P4935, DOI 10.1038/sj.emboj.7601915; Larijani B, 2001, BIOCHEM J, V356, P495, DOI 10.1042/0264-6021:3560495; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; Liu Q, 2007, J CELL BIOL, V178, P785, DOI 10.1083/jcb.200704108; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; LOHKA MJ, 1984, J CELL BIOL, V98, P1222, DOI 10.1083/jcb.98.4.1222; LOHKA MJ, 1988, CELL BIOL INT REP, V12, P833, DOI 10.1016/0309-1651(88)90091-4; Ma Y, 2007, J CELL SCI, V120, P520, DOI 10.1242/jcs.03355; Macaulay C, 1996, J CELL BIOL, V132, P5, DOI 10.1083/jcb.132.1.5; Maeshima K, 2006, J CELL SCI, V119, P4442, DOI 10.1242/jcs.03207; Mansfeld J, 2006, MOL CELL, V22, P93, DOI 10.1016/j.molcel.2006.02.015; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Mattaj IW, 2004, NAT REV MOL CELL BIO, V5, P65, DOI 10.1038/nrm1263; MILLER M, 1991, PHYSIOL REV, V71, P909, DOI 10.1152/physrev.1991.71.3.909; Murakami MS, 1998, DEVELOPMENT, V125, P237; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; NEWMEYER DD, 1986, J CELL BIOL, V103, P2091, DOI 10.1083/jcb.103.6.2091; NEWPORT J, 1992, J CELL BIOL, V116, P295, DOI 10.1083/jcb.116.2.295; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Otter-Nilsson M, 1999, EMBO J, V18, P2074, DOI 10.1093/emboj/18.8.2074; POWERS M, 2001, CURR PROTOC CELL BIO, V11; Prescott GR, 2009, J NEUROCHEM, V110, P1135, DOI 10.1111/j.1471-4159.2009.06205.x; Pyrpasopoulou A, 1996, EMBO J, V15, P7108, DOI 10.1002/j.1460-2075.1996.tb01102.x; Ramos C, 2006, BIOCHEM J, V400, P393, DOI 10.1042/BJ20061218; RIZZO AM, 1994, CELL BIOL INT, V18, P1085, DOI 10.1006/cbir.1994.1032; Rothman JE, 1996, PROTEIN SCI, V5, P185; Salpingidou G, 2008, J CELL SCI, V121, P706, DOI 10.1242/jcs.019968; Sapir A, 2008, DEV CELL, V14, P11, DOI 10.1016/j.devcel.2007.12.008; Sasagawa S, 1999, EUR J CELL BIOL, V78, P593, DOI 10.1016/S0171-9335(99)80025-9; Scarcelli JJ, 2007, J CELL BIOL, V178, P799, DOI 10.1083/jcb.200702120; Segura-Totten M, 2002, J CELL BIOL, V158, P475, DOI 10.1083/jcb.200202019; SHEEHAN MA, 1988, J CELL BIOL, V106, P1, DOI 10.1083/jcb.106.1.1; Shen S, 2009, MOL BIOL CELL, V20, P2438, DOI 10.1091/mbc.E08-10-0987; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stavru F, 2006, J CELL BIOL, V173, P509, DOI 10.1083/jcb.200601001; VIGERS GPA, 1991, J CELL BIOL, V112, P545, DOI 10.1083/jcb.112.4.545; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Vogel K, 2000, J BIOL CHEM, V275, P2959, DOI 10.1074/jbc.275.4.2959; Whyte JRC, 2002, J CELL SCI, V115, P2627; Wiese C, 1997, J CELL SCI, V110, P1489; WILSON KL, 1988, J CELL BIOL, V107, P57, DOI 10.1083/jcb.107.1.57; Xie LX, 2009, INFLAMM RES, V58, P407, DOI 10.1007/s00011-009-0006-x; Zhang CM, 2000, SCIENCE, V288, P1429, DOI 10.1126/science.288.5470.1429; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18526, DOI 10.1073/pnas.0706441104	78	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29847	29859		10.1074/jbc.M109.044453	http://dx.doi.org/10.1074/jbc.M109.044453			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19696024	Green Published, hybrid			2022-12-27	WOS:000270896800065
J	Taniguchi, K; Takeya, R; Suetsugu, S; Kan-o, M; Narusawa, M; Shiose, A; Tominaga, R; Sumimoto, H				Taniguchi, Kenichiro; Takeya, Ryu; Suetsugu, Shiro; Kan-o, Meikun; Narusawa, Megumi; Shiose, Akira; Tominaga, Ryuji; Sumimoto, Hideki			Mammalian Formin Fhod3 Regulates Actin Assembly and Sarcomere Organization in Striated Muscles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; THIN FILAMENT LENGTH; HOMOLOGY-2 DOMAIN; CARDIAC MYOCYTES; CAPPING PROTEIN; ARP2/3 COMPLEX; FISSION YEAST; POINTED ENDS; POLYMERIZATION; ELONGATION	Actin filament assembly in nonmuscle cells is regulated by the actin polymerization machinery, including the Arp2/3 complex and formins. However, little is known about the regulation of actin assembly in muscle cells, where straight actin filaments are organized into the contractile unit sarcomere. Here, we show that Fhod3, a myocardial formin that localizes to thin actin filaments in a striated pattern, regulates sarcomere organization in cardiomyocytes. RNA interference-mediated depletion of Fhod3 results in a marked reduction in filamentous actin and disruption of the sarcomeric structure. These defects are rescued by expression of wild-type Fhod3 but not by that of mutant proteins carrying amino acid substitution for conserved residues for actin assembly. These findings suggest that actin dynamics regulated by Fhod3 are critical for sarcomere organization in striated muscle cells.	[Sumimoto, Hideki] Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Higashi Ku, Fukuoka 8128582, Japan; [Taniguchi, Kenichiro; Shiose, Akira; Tominaga, Ryuji] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Surg, Higashi Ku, Fukuoka 8128582, Japan; [Taniguchi, Kenichiro; Takeya, Ryu; Kan-o, Meikun; Narusawa, Megumi; Sumimoto, Hideki] Kyushu Univ, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan; [Suetsugu, Shiro] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Membrane & Cytoskeleton Dynam, Bunkyo Ku, Tokyo 1130032, Japan; [Suetsugu, Shiro] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Kyushu University; Kyushu University; Kyushu University; University of Tokyo; Japan Science & Technology Agency (JST)	Sumimoto, H (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hsumi@med.kyushu-u.ac.jp	Suetsugu, Shiro/B-3300-2010; Suetsugu, Shiro/ABB-6033-2020; Suetsugu, Shiro/AAF-4427-2019	Suetsugu, Shiro/0000-0002-4612-0628; Suetsugu, Shiro/0000-0002-4612-0628	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Kyushu University Interdisciplinary Programs in Education and Projects in Research Development; Takeda Science Foundation; CREST of Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kyushu University Interdisciplinary Programs in Education and Projects in Research Development; Takeda Science Foundation(Takeda Science Foundation (TSF)); CREST of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by Grants-in-aid for Scientific Research and Targeted Proteins Research Program (TPRP) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by Kyushu University Interdisciplinary Programs in Education and Projects in Research Development, by the Takeda Science Foundation, and by CREST of Japan Science and Technology Agency.	Bai J, 2007, DEV CELL, V13, P828, DOI 10.1016/j.devcel.2007.10.003; Chereau D, 2008, SCIENCE, V320, P239, DOI 10.1126/science.1155313; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; GREGORIO CC, 1995, NATURE, V377, P83, DOI 10.1038/377083a0; Gregorio CC, 2000, TRENDS CELL BIOL, V10, P355, DOI 10.1016/S0962-8924(00)01793-1; GROVE BK, 1984, J CELL BIOL, V98, P518, DOI 10.1083/jcb.98.2.518; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Kanaya H, 2005, GENES CELLS, V10, P665, DOI 10.1111/j.1365-2443.2005.00867.x; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; LIN DC, 1980, ANAL BIOCHEM, V103, P316; Littlefield R, 2001, NAT CELL BIOL, V3, P544, DOI 10.1038/35078517; Littlefield RS, 2008, SEMIN CELL DEV BIOL, V19, P511, DOI 10.1016/j.semcdb.2008.08.009; MANASEK FJ, 1972, P NATL ACAD SCI USA, V69, P308, DOI 10.1073/pnas.69.2.308; MARKWALD RR, 1973, J MOL CELL CARDIOL, V5, P341, DOI 10.1016/0022-2828(73)90026-6; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Sanger JW, 2005, J MUSCLE RES CELL M, V26, P343, DOI 10.1007/s10974-005-9016-7; SCHAFER DA, 1995, J CELL BIOL, V128, P61, DOI 10.1083/jcb.128.1.61; SIMPSON P, 1985, CIRC RES, V56, P884, DOI 10.1161/01.RES.56.6.884; Skau CT, 2009, MOL BIOL CELL, V20, P2160, DOI 10.1091/mbc.E08-12-1201; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Suematsu N, 2003, CIRCULATION, V107, P1418, DOI 10.1161/01.CIR.0000055318.09997.1F; Suetsugu S, 2001, J BIOL CHEM, V276, P33175, DOI 10.1074/jbc.M102866200; Takeya R, 2003, J CELL SCI, V116, P4567, DOI 10.1242/jcs.00769; Westendorf JJ, 2001, J BIOL CHEM, V276, P46453, DOI 10.1074/jbc.M105162200; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057	32	72	74	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29873	29881		10.1074/jbc.M109.059303	http://dx.doi.org/10.1074/jbc.M109.059303			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19706596	Green Published, hybrid			2022-12-27	WOS:000270896800067
J	Wells, J; Lee, B; Cai, AQ; Karapetyan, A; Lee, WJ; Rugg, E; Sinha, S; Nie, Q; Dai, X				Wells, Julie; Lee, Briana; Cai, Anna Qianyao; Karapetyan, Adrine; Lee, Wan-Ju; Rugg, Elizabeth; Sinha, Satrajit; Nie, Qing; Dai, Xing			Ovol2 Suppresses Cell Cycling and Terminal Differentiation of Keratinocytes by Directly Repressing c-Myc and Notch1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL STEM-CELLS; GROWTH-FACTOR-BETA; DROSOPHILA-OVO; MOUSE HOMOLOG; GENE; TRANSCRIPTION; EXPRESSION; ACTIVATION; INHIBITORS; COMPLEX	Ovol2 belongs to the Ovo family of evolutionarily conserved zinc finger transcription factors that act downstream of key developmental signaling pathways including Wg/Wnt and BMP/TGF-beta. We previously reported Ovol2 expression in the basal layer of epidermis, where epidermal stem/progenitor cells reside. In this work, we use HaCaT human keratinocytes to investigate the cellular and molecular functions of Ovol2. We show that depletion of Ovol2 leads to transient cell expansion but a loss of cells with long term proliferation potential. Mathematical modeling and experimental findings suggest that both faster cycling and precocious withdrawal from the cell cycle underlie this phenotype. Ovol2 depletion also accelerates extracellular signal-induced terminal differentiation in two-and three-dimensional culture models. By chromatin immunoprecipitation, luciferase reporter, and functional rescue assays, we demonstrate that Ovol2 directly represses two critical downstream targets, c-Myc and Notch1, thereby suppressing keratinocyte transient proliferation and terminal differentiation, respectively. These findings shed light on how an epidermal cell maintains a proliferation-competent and differentiation-resistant state.	[Dai, Xing] Univ Calif Irvine, Dept Biol Chem, Sch Med, Irvine, CA 92697 USA; [Cai, Anna Qianyao; Nie, Qing] Univ Calif Irvine, Dept Math, Irvine, CA 92697 USA; [Cai, Anna Qianyao; Nie, Qing] Univ Calif Irvine, Ctr Math & Computat Biol, Irvine, CA 92697 USA; [Karapetyan, Adrine; Rugg, Elizabeth] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92697 USA; [Sinha, Satrajit] SUNY Buffalo, Dept Biochem, Buffalo, NY 14203 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Dai, X (corresponding author), Univ Calif Irvine, Dept Biol Chem, Sch Med, D250 Med Sci 1, Irvine, CA 92697 USA.	xdai@uci.edu		Dai, Xing/0000-0001-8134-1365	National Institutes of Health [R01-AR47320, K02-AR51482, R01-AR47320-08S1, R01GM75309, R01GM67247, P50GM76516]; National Science Foundation [DMS0511169]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060555] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K02AR051482, R01AR047320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067247, R01GM075309, P50GM076516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AR47320 and K02-AR51482 (to X. D.); R01-AR47320-08S1 (to X. D. and Q. N.); and R01GM75309, R01GM67247, and P50GM76516 (to Q. N.). This work was also supported by National Science Foundation Grant DMS0511169 (to Q. N.).	Andrews J, 2000, DEVELOPMENT, V127, P881; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chidambaram A, 1997, MAMM GENOME, V8, P950, DOI 10.1007/s003359900620; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Dai X, 1998, GENE DEV, V12, P3452, DOI 10.1101/gad.12.21.3452; Descargues P, 2008, P NATL ACAD SCI USA, V105, P2487, DOI 10.1073/pnas.0712044105; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; EUSTICE DC, 1991, BIOTECHNIQUES, V11, P739; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Frye M, 2003, DEVELOPMENT, V130, P2793, DOI 10.1242/dev.00462; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Hirata A, 2004, J HISTOCHEM CYTOCHEM, V52, P1503, DOI 10.1369/jhc.4A6285.2004; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Jones P, 2008, NAT REV MOL CELL BIO, V9, P82, DOI 10.1038/nrm2292x; Jones PH, 2007, CELL STEM CELL, V1, P371, DOI 10.1016/j.stem.2007.09.014; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kolev V, 2008, NAT CELL BIOL, V10, DOI 10.1038/ncb1750; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Lander AD, 2009, PLOS BIOL, V7, P84, DOI 10.1371/journal.pbio.1000015; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; Li B, 2002, GENOMICS, V80, P319, DOI 10.1006/geno.2002.6831; Li BA, 2005, DEVELOPMENT, V132, P1463, DOI 10.1242/dev.01658; Li BA, 2002, P NATL ACAD SCI USA, V99, P6064, DOI 10.1073/pnas.092137099; Lo WC, 2009, MATH BIOSCI ENG, V6, P59, DOI 10.3934/mbe.2009.6.59; Maas-Szabowski N, 2003, J CELL SCI, V116, P2937, DOI 10.1242/jcs.00474; Mackay DR, 2006, DEV BIOL, V291, P38, DOI 10.1016/j.ydbio.2005.12.003; Margulis A, 2004, METH MOL B, V289, P61; Masu Y, 1998, FEBS LETT, V421, P224, DOI 10.1016/S0014-5793(97)01567-6; MEVELNINIO M, 1995, MECH DEVELOP, V49, P83, DOI 10.1016/0925-4773(94)00305-7; Moriyama M, 2008, DEV CELL, V14, P594, DOI 10.1016/j.devcel.2008.01.017; Nair M, 2006, J CELL BIOL, V173, P253, DOI 10.1083/jcb.200508196; Nair M, 2007, NUCLEIC ACIDS RES, V35, P1687, DOI 10.1093/nar/gkl1141; OLIVER B, 1994, DEVELOPMENT, V120, P3185; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Potten C S, 1981, Int Rev Cytol, V69, P271; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; RYLE CM, 1989, DIFFERENTIATION, V40, P42, DOI 10.1111/j.1432-0436.1989.tb00812.x; Schoop VM, 1999, J INVEST DERMATOL, V112, P343, DOI 10.1046/j.1523-1747.1999.00524.x; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; TENG A, 2006, BIOCHIM BIOPHYS ACTA, V1772, P89; Unezaki S, 2004, GENE, V336, P47, DOI 10.1016/j.gene.2004.03.013; Waikel RL, 1999, ONCOGENE, V18, P4870, DOI 10.1038/sj.onc.1203040; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Wan H, 2007, STEM CELLS, V25, P1286, DOI 10.1634/stemcells.2006-0304; Watt FM, 2008, NAT REV CANCER, V8, P234, DOI 10.1038/nrc2328; Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Yagi K, 2002, J BIOL CHEM, V277, P854, DOI 10.1074/jbc.M104170200; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641	60	41	45	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29125	29135		10.1074/jbc.M109.008847	http://dx.doi.org/10.1074/jbc.M109.008847			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19700410	Green Published, hybrid			2022-12-27	WOS:000270678900068
J	Frese, MA; Milz, F; Dick, M; Lamanna, WC; Dierks, T				Frese, Marc-Andre; Milz, Fabian; Dick, Marina; Lamanna, William C.; Dierks, Thomas			Characterization of the Human Sulfatase Sulf1 and Its High Affinity Heparin/Heparan Sulfate Interaction Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; GROWTH; BINDING; QSULF1; 6-O-ENDOSULFATASES; GENE; PROTEOGLYCANS; DEFICIENCY; PROMOTE	The extracellular sulfartases Sulf1 and Sulf2 remodel the 60-sulfation state of heparan sulfate proteoglycans on the cell surface, thereby modulating growth factor signaling. Different from all other sulfartases, the Sulfs contain a unique, positively charged hydrophilic domain (HD) of about 320 amino acid residues. Using various HD deletion mutants and glutathione S-transferase (GST)-HD fusion proteins, this study demonstrates that the HD is required for enzymatic activity and acts as a high affinity heparin/heparan sulfate interaction domain. Association of the HD with the cell surface is sensitive to heparinase treatment, underlining specificity toward heparan sulfate chains. Correspondingly, isolated GST-HD binds strongly to both heparin and heparan sulfate in vitro and also to living cells. Surface plasmon resonance studies indicate nanomolar affinity of GST-HD toward immobilized heparin. The comparison of different mutants reveals that especially the outer regions of the HD mediate heparan sulfate binding, probably involving "tandem" interactions. Interestingly, binding to heparan sulfate depends on the presence of 60-sulfate substrate groups, suggesting that substrate turnover facilitates release of the enzyme from its substrate. Deletion of the inner, less conserved region of the HD drastically increases Sulf1 secretion without affecting enzymatic activity or substrate specificity, thus providing a tool for the in vitro modulation of HS-dependent signaling as demonstrated here for the signal transduction of fibroblast growth factor 2. Taken together, the present study shows that specific regions of the HD influence different aspects of HS binding, cellular localization, and enzyme function.	[Frese, Marc-Andre; Milz, Fabian; Dick, Marina; Lamanna, William C.; Dierks, Thomas] Univ Bielefeld, Fak Chem, D-33615 Bielefeld, Germany	University of Bielefeld	Dierks, T (corresponding author), Univ Bielefeld, Fak Chem, D-33615 Bielefeld, Germany.	thomas.dierks@uni-bielefeld.de	Dierks, Thomas/A-3596-2012	Dierks, Thomas/0000-0001-6426-1339	Deutsche Forschungsgemeinschaft; Fonds der Chemischen Inclustrie; Shire Human Genetic Therapies, Inc. (Cambridge, MA)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Inclustrie; Shire Human Genetic Therapies, Inc. (Cambridge, MA)	This work was supported by the Deutsche Forschungsgemeinschaft, the Fonds der Chemischen Inclustrie, and Shire Human Genetic Therapies, Inc. (Cambridge, MA).	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; Ambasta RK, 2007, J BIOL CHEM, V282, P34492, DOI 10.1074/jbc.M706744200; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Cosma MP, 2003, CELL, V113, P445, DOI 10.1016/S0092-8674(03)00348-9; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Dierks T, 2003, CELL, V113, P435, DOI 10.1016/S0092-8674(03)00347-7; Dierks T, 2009, BBA-MOL CELL RES, V1793, P710, DOI 10.1016/j.bbamcr.2008.11.015; Diez-Roux G, 2005, ANNU REV GENOM HUM G, V6, P355, DOI 10.1146/annurev.genom.6.080604.162334; Eckert R, 2003, FEBS LETT, V541, P121, DOI 10.1016/S0014-5793(03)00322-3; EISENTHAL R, 1974, BIOCHEM J, V139, P715, DOI 10.1042/bj1390715; Frese MA, 2008, J BIOL CHEM, V283, P11388, DOI 10.1074/jbc.M709917200; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Holst CR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000575; Kalus I, 2009, J CELL MOL MED, V13, P4505, DOI 10.1111/j.1582-4934.2008.00558.x; Klagsbrun M, 1990, CURR OPIN CELL BIOL, V2, P857, DOI 10.1016/0955-0674(90)90084-R; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lamanna WC, 2008, J BIOL CHEM, V283, P27724, DOI 10.1074/jbc.M802130200; Lamanna WC, 2007, J BIOTECHNOL, V129, P290, DOI 10.1016/j.jbiotec.2007.01.022; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Lum DH, 2007, MOL CELL BIOL, V27, P678, DOI 10.1128/MCB.01279-06; LUNDQUIST P, 1980, CLIN CHEM, V26, P1178; Melcher K, 2000, ANAL BIOCHEM, V277, P109, DOI 10.1006/abio.1999.4383; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Morimoto-Tomita M, 2005, NEOPLASIA, V7, P1001, DOI 10.1593/neo.05496; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Narita K, 2006, CANCER RES, V66, P6025, DOI 10.1158/0008-5472.CAN-05-3582; Nawroth R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000392; Osmond RIW, 2002, ANAL BIOCHEM, V310, P199, DOI 10.1016/S0003-2697(02)00396-2; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Preusser-Kunze A, 2005, J BIOL CHEM, V280, P14900, DOI 10.1074/jbc.M413383200; Ratzka A, 2008, DEV DYNAM, V237, P339, DOI 10.1002/dvdy.21423; Sasisekharan R, 2006, ANNU REV BIOMED ENG, V8, P181, DOI 10.1146/annurev.bioeng.8.061505.095745; SOBEL M, 1992, J BIOL CHEM, V267, P8857; Tang RH, 2009, J BIOL CHEM, V284, P21505, DOI 10.1074/jbc.M109.028472; Uchimura Kenji, 2006, BMC Biochem, V7, P2, DOI 10.1186/1471-2091-7-2; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101	41	56	58	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28033	28044		10.1074/jbc.M109.035808	http://dx.doi.org/10.1074/jbc.M109.035808			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19666466	hybrid, Green Published			2022-12-27	WOS:000270676300031
J	Jitkaew, S; Trebinska, A; Grzybowska, E; Carlsson, G; Nordstrom, A; Lehtio, J; Frojmark, AS; Dahl, N; Fadeel, B				Jitkaew, Siriporn; Trebinska, Alicja; Grzybowska, Ewa; Carlsson, Goeran; Nordstrom, Anders; Lehtio, Janne; Frojmark, Anne-Sophie; Dahl, Niklas; Fadeel, Bengt			N-alpha-Tosyl-L-phenylalanine Chloromethyl Ketone Induces Caspase-dependent Apoptosis in Transformed Human B Cell Lines with Transcriptional Down-regulation of Anti-apoptotic HS1-associated Protein X-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEVERE CONGENITAL NEUTROPENIA; MONOCYTIC THP.1 CELLS; CYTOCHROME-C; BCL-2; HAX-1; RELEASE; MITOCHONDRIA; INHIBITION; EXPRESSION; CLEAVAGE	N-alpha-ToSyl-L-phenylalanine chloromethylketone (TPCK) has been widely used to investigate signal transduction pathways that are involved in gene expression and cell survival/cell death. However, contradictory effects of TPCK on apoptosis have been reported, and the underlying signaling events leading to TPCK-induced promotion or prevention of apoptosis are not fully understood. Here, we show that TPCK induces caspase-dependent apoptosis in Epstein-Barr virus (EBV)-transformed human B cell lines with release of pro-apoptotic proteins from mitochondria. TPCK treatment also results in down-regulation of the anti-apoptotic proteins, cIAP1, cIAP2, and HAX-1, and caspase-dependent cleavage of the anti-apoptotic proteins, Bcl-2 and XIAP. Quantitative PCR analysis confirmed that the TPCK-induced down-regulation of HAX-1 occurred at the transcriptional level, and experiments using the specific pharmacological inhibitor, Bay 11-7082, suggested that HAX-1 expression is subject to regulation by the transcription factor, NF-kappa B cell lines derived from patients with homozygous HAX1 mutations were more sensitive to TPCK-induced apoptosis when compared with normal donor cell lines. Furthermore, N-acetylcysteine effectively blocked TPCK-induced apoptosis in EBV-transformed B cell lines and prevented the down-regulation or cleavage of anti-apoptotic proteins. Taken together, our studies demonstrate that TPCK induces apoptosis in human B cell lines and exerts multiple effects on pro- and anti-apoptotic factors.	[Jitkaew, Siriporn; Fadeel, Bengt] Karolinska Univ Hosp, Inst Environm Med, Div Mol Toxicol, S-17176 Stockholm, Sweden; [Carlsson, Goeran] Karolinska Univ Hosp, Childhood Canc Res Unit, Dept Woman & Child Hlth, S-17176 Stockholm, Sweden; [Nordstrom, Anders; Lehtio, Janne] Karolinska Univ Hosp, Dept Pathol & Oncol, Karolinska Inst, Karolinska Biom Ctr, S-17176 Stockholm, Sweden; [Jitkaew, Siriporn] Mahidol Univ, Siriraj Hosp, Dept Biochem, Fac Med, Bangkok 10700, Thailand; [Jitkaew, Siriporn] Mahidol Univ, Thalassemia Res Ctr, Inst Sci & Technol Res & Dev, Nakhonpothom 73170, Thailand; [Trebinska, Alicja; Grzybowska, Ewa] Maria Sklodowska Curie Mem Canc Ctr, Dept Mol Biol, PL-02781 Warsaw, Poland; [Trebinska, Alicja; Grzybowska, Ewa] Inst Oncol, PL-02781 Warsaw, Poland; [Frojmark, Anne-Sophie; Dahl, Niklas] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, S-75185 Uppsala, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Mahidol University; Mahidol University; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Uppsala University	Fadeel, B (corresponding author), Karolinska Univ Hosp, Inst Environm Med, Div Mol Toxicol, S-17176 Stockholm, Sweden.	bengt.fadeel@ki.se	Grzybowska, Ewa/F-2711-2013; Trebinska-Stryjewska, Alicja A/F-3007-2013	Trebinska-Stryjewska, Alicja A/0000-0001-7847-049X; Lehtio, Janne/0000-0002-8100-9562	Swedish Cancer Foundation; Swedish Children's Cancer Foundation; Swedish Research Council; Stockholm County Council; Polish Committee for Scientific Research [N30100432/0437]	Swedish Cancer Foundation; Swedish Children's Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Polish Committee for Scientific Research(Polish State Committee for Scientific Research)	This work was supported, in part, by grants from the Swedish Cancer Foundation, Swedish Children's Cancer Foundation, Swedish Research Council, Stockholm County Council, and Polish Committee for Scientific Research (Grant N30100432/0437).	Ballif BA, 2001, J BIOL CHEM, V276, P12466, DOI 10.1074/jbc.M009939200; Carlsson G, 2008, J INTERN MED, V264, P388, DOI 10.1111/j.1365-2796.2008.01982.x; Carlsson G, 2004, BLOOD, V103, P3355, DOI 10.1182/blood-2003-04-1011; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Cilenti L, 2004, J BIOL CHEM, V279, P50295, DOI 10.1074/jbc.M406006200; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Fadeel B, 1999, LEUKEMIA, V13, P719, DOI 10.1038/sj.leu.2401411; Frydrych I, 2008, J CELL BIOCHEM, V103, P1646, DOI 10.1002/jcb.21550; Grabe Niels, 2002, In Silico Biology, V2, pS1; Grzybowska EA, 2006, GENE, V371, P84, DOI 10.1016/j.gene.2005.11.035; Han YC, 2006, CIRC RES, V99, P415, DOI 10.1161/01.RES.0000237387.05259.a5; Heussler VT, 1999, CELL DEATH DIFFER, V6, P342, DOI 10.1038/sj.cdd.4400501; Jones RA, 1998, HEPATOLOGY, V27, P1632, DOI 10.1002/hep.510270624; Kagan VE, 2001, CANCER RES, V61, P7777; Kim K, 2003, BIOCHEM BIOPH RES CO, V306, P954, DOI 10.1016/S0006-291X(03)01088-X; King MA, 2004, CELL CYCLE, V3, P1566, DOI 10.4161/cc.3.12.1276; Kirsch DG, 1999, J BIOL CHEM, V274, P21155, DOI 10.1074/jbc.274.30.21155; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Lees DM, 2008, J MOL BIOL, V379, P645, DOI 10.1016/j.jmb.2008.04.020; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; Rokhlin OW, 2004, CANCER BIOL THER, V3, P761, DOI 10.4161/cbt.3.8.970; SCHOELLMANN G, 1963, BIOCHEMISTRY-US, V2, P252, DOI 10.1021/bi00902a008; Sharp TV, 2002, J VIROL, V76, P802, DOI 10.1128/JVI.76.2.802-816.2002; Sun Y, 2005, BLOOD, V105, P4070, DOI 10.1182/blood-2004-10-4075; Suzuki Y, 1997, J IMMUNOL, V158, P2736; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Wu M, 1996, MOL CELL BIOL, V16, P5015; Wu M, 1996, EMBO J, V15, P4682, DOI 10.1002/j.1460-2075.1996.tb00845.x; Zhu HJ, 1997, CELL DEATH DIFFER, V4, P590, DOI 10.1038/sj.cdd.4400284; Zhuang JG, 1998, CELL DEATH DIFFER, V5, P953, DOI 10.1038/sj.cdd.4400440	32	24	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27827	27837		10.1074/jbc.M109.027912	http://dx.doi.org/10.1074/jbc.M109.027912			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19679660	Green Published, hybrid			2022-12-27	WOS:000270676300009
J	Poncet, S; Soret, M; Mervelet, P; Deutscher, J; Noirot, P				Poncet, Sandrine; Soret, Maryline; Mervelet, Peggy; Deutscher, Josef; Noirot, Philippe			Transcriptional Activator YesS Is Stimulated by Histidine-phosphorylated HPr of the Bacillus subtilis Phosphotransferase System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATABOLITE REPRESSION RESISTANCE; ESCHERICHIA-COLI; PROTEIN-KINASE; INDUCER EXCLUSION; SER/THR/TYR PHOSPHOPROTEOME; PHOSPHOCARRIER PROTEIN; ALLOSTERIC REGULATION; BIFUNCTIONAL ENZYME; GENE; CCPA	In low GC content Gram-positive bacteria, the HPr protein is the master regulator of carbon metabolism. HPr is a key component of the phosphoenolpyruvate (PEP):sugar phosphotransferase system that interacts with and/or phosphorylates proteins relevant to carbon catabolite repression. HPr can be phosphorylated by two distinct kinases as follows: the bifunctional enzyme HPr kinase/Ser(P)-HPr phosphorylase (HprK/P) phosphorylating the serine 46 residue (Ser(P)-HPr) and acting as a phosphorylase on Ser(P)-HPr; and the PEP-requiring enzyme I (EI) generating histidine 15-phosphorylated HPr (His(P)-HPr). The various HPr forms interact with numerous enzymes and modulate their activity. By carrying out a genome-wide yeast two-hybrid screen of a Bacillus subtilis library, we identified a novel HPr-interacting protein, the transcriptional activator YesS, which regulates the expression of pectin/rhamnogalacturonan utilization genes. Remarkably, yeast tri-hybrid assays involving the ATP-dependent HprK/P and the PEP-dependent EI suggested that YesS interacts with HPr and His(P)-HPr but not with Ser(P)-HPr. These findings were confirmed by in vitro interaction assays using the purified HPr-binding domain of the YesS protein. Furthermore, pectin utilization and in vivo YesS-mediated transcriptional activation depended upon the presence of His(P)-HPr, indicating that HPr-mediated YesS regulation serves as a novel type of carbon catabolite repression. In the yeast two-hybrid assays, B. subtilis HprK/P and EI were active and specifically recognized their substrates. Both kinases formed long lived complexes only with the corresponding non-phosphorylatable mutant HPr. These findings suggest that two-hybrid assays can be used for the identification of unknown kinases of phosphorylated bacterial proteins detected in phosphoproteome analyses.	[Poncet, Sandrine; Deutscher, Josef] INRA AgroParisTech CNRS, Lab Microbiol & Genet Mol, F-78850 Thiverval Grignon, France; [Soret, Maryline; Mervelet, Peggy; Noirot, Philippe] INRA, Lab Genet Microbienne, F-78352 Jouy En Josas, France	AgroParisTech; INRAE; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Deutscher, J (corresponding author), INRA AgroParisTech CNRS, Lab Microbiol & Genet Mol, F-78850 Thiverval Grignon, France.	Josef.Deutscher@grignon.inra.fr; Philippe.Noirot@jouy.inra.fr		PONCET, Sandrine/0000-0002-2813-0793	European BaSysBio [LSHG-CT-2006-037469]; INRA	European BaSysBio; INRA	This work was supported in part by European BaSysBio Project LSHG-CT-2006-037469 (to P. N.) and in part by funding from the INRA Programme Transversalite-AGMIAL (to P. N. and J. D.).	AYMERICH S, 1986, J BACTERIOL, V166, P993, DOI 10.1128/jb.166.3.993-998.1986; Chaptal V, 2007, J BIOL CHEM, V282, P34952, DOI 10.1074/jbc.M705979200; Cochu A, 2005, APPL ENVIRON MICROB, V71, P1364, DOI 10.1128/AEM.71.3.1364-1372.2005; Darbon E, 2002, MOL MICROBIOL, V43, P1039, DOI 10.1046/j.1365-2958.2002.02800.x; Darbon E, 2001, J MOL MICROB BIOTECH, V3, P439; DEUTSCHER J, 1994, J BACTERIOL, V176, P3336, DOI 10.1128/jb.176.11.3336-3344.1994; DEUTSCHER J, 1984, FEMS MICROBIOL LETT, V23, P157; DEUTSCHER J, 1995, MOL MICROBIOL, V15, P1049, DOI 10.1111/j.1365-2958.1995.tb02280.x; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Egan SM, 2002, J BACTERIOL, V184, P5529, DOI 10.1128/JB.184.20.5529-5532.2002; Eymann C, 2007, PROTEOMICS, V7, P3509, DOI 10.1002/pmic.200700232; Fieulaine S, 2001, EMBO J, V20, P3917, DOI 10.1093/emboj/20.15.3917; Galinier A, 1997, P NATL ACAD SCI USA, V94, P8439, DOI 10.1073/pnas.94.16.8439; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; GUTHRIE C, 1991, GUIDE YEAST GENETICS, P3; Herro R, 2005, J MOL MICROB BIOTECH, V9, P224, DOI 10.1159/000089650; Hogema BM, 1998, MOL MICROBIOL, V30, P487, DOI 10.1046/j.1365-2958.1998.01053.x; James P, 1996, GENETICS, V144, P1425; Jones BE, 1997, J BIOL CHEM, V272, P26530, DOI 10.1074/jbc.272.42.26530; Joshi MV, 2007, MOL MICROBIOL, V66, P633, DOI 10.1111/j.1365-2958.2007.05942.x; Kolin A, 2008, MOL MICROBIOL, V68, P448, DOI 10.1111/j.1365-2958.2008.06164.x; Kravanja M, 1999, MOL MICROBIOL, V31, P59, DOI 10.1046/j.1365-2958.1999.01146.x; Levine A, 2006, PROTEOMICS, V6, P2157, DOI 10.1002/pmic.200500352; Lorca GL, 2005, J BACTERIOL, V187, P7826, DOI 10.1128/JB.187.22.7826-7839.2005; Ludwig H, 2002, MOL MICROBIOL, V45, P543, DOI 10.1046/j.1365-2958.2002.03034.x; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200; Martin-Verstraete I, 1999, J BACTERIOL, V181, P2966, DOI 10.1128/JB.181.9.2966-2969.1999; MIWA Y, 1994, MICROBIOL-UK, V140, P2567, DOI 10.1099/00221287-140-10-2567; Monedero V, 2001, EMBO J, V20, P3928, DOI 10.1093/emboj/20.15.3928; Monedero V, 2008, RES MICROBIOL, V159, P94, DOI 10.1016/j.resmic.2007.10.002; Muller W, 2006, FEBS J, V273, P1251, DOI 10.1111/j.1742-4658.2006.05148.x; Noirot-Gros MF, 2002, P NATL ACAD SCI USA, V99, P8342, DOI 10.1073/pnas.122040799; Ochiai A, 2007, APPL ENVIRON MICROB, V73, P3803, DOI 10.1128/AEM.00147-07; OGDEN S, 1980, P NATL ACAD SCI-BIOL, V77, P3346, DOI 10.1073/pnas.77.6.3346; Park YH, 2006, J BIOL CHEM, V281, P6448, DOI 10.1074/jbc.M512672200; Plamondon P, 1999, J BACTERIOL, V181, P6914, DOI 10.1128/JB.181.22.6914-6921.1999; PLATT T, 1972, EXPT MOL GENETICS, P352; Pompeo F, 2007, J BACTERIOL, V189, P1154, DOI 10.1128/JB.01575-06; Presecan-Siedel E, 1999, J BACTERIOL, V181, P6889, DOI 10.1128/JB.181.22.6889-6897.1999; REIZER J, 1992, J BIOL CHEM, V267, P9158; Reizer J, 1996, J BACTERIOL, V178, P5480, DOI 10.1128/jb.178.18.5480-5486.1996; Schumacher MA, 2006, J BIOL CHEM, V281, P6793, DOI 10.1074/jbc.M509977200; Seok YJ, 1997, J BIOL CHEM, V272, P26511, DOI 10.1074/jbc.272.42.26511; Soufi B, 2008, PROTEOMICS, V8, P3486, DOI 10.1002/pmic.200800069; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Yoshida K, 2001, NUCLEIC ACIDS RES, V29, P683, DOI 10.1093/nar/29.3.683	47	16	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28188	28197		10.1074/jbc.M109.046334	http://dx.doi.org/10.1074/jbc.M109.046334			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19651770	hybrid, Green Published			2022-12-27	WOS:000270676300046
J	Almeida, M; Ambrogini, E; Han, L; Manolagas, SC; Jilka, RL				Almeida, Maria; Ambrogini, Elena; Han, Li; Manolagas, Stavros C.; Jilka, Robert L.			Increased Lipid Oxidation Causes Oxidative Stress, Increased Peroxisome Proliferator-activated Receptor-gamma Expression, and Diminished Pro-osteogenic Wnt Signaling in the Skeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; E-DEFICIENT MICE; PPAR-GAMMA; BONE LOSS; BETA-CATENIN; OSTEOBLAST DIFFERENTIATION; AORTIC CALCIFICATION; APOLIPOPROTEIN-E; ADVANCED ATHEROSCLEROSIS; OXIDIZED PHOSPHOLIPIDS	Loss of bone mass with advancing age in mice is because of decreased osteoblast number and is associated with increased oxidative stress and decreased canonical Wnt signaling. However, the underlying mechanisms are poorly understood. We report an age-related increase in the lipid oxidation product 4-hydroxynonenal (4-HNE) as well as increased expression of lipoxygenase and peroxisome proliferator-activated receptor-gamma (PPAR gamma) in the murine skeleton. These changes together with decreased Wnt signaling are reproduced in 4-month-old mice bearing a high expressing allele of the lipoxygenase Alox15. The addition of 4-HNE to cultured osteoblastic cells increases oxidative stress, which in turn diverts beta-catenin from T-cell-specific transcription factors to Forkhead box O (FoxO) transcription factors, thereby attenuating the suppressive effect of beta-catenin on PPAR gamma gene expression. Oxidized lipids, acting as ligands of PPAR gamma, promote binding of PPAR gamma 2 to beta-catenin and reduce the levels of the latter, and they attenuate Wnt3a-stimulated proliferation and osteoblast differentiation. Furthermore, oxidized lipids and 4-HNE stimulate apoptosis of osteoblastic cells. In view of the role of oxidized lipids in atherogenesis, the adverse effects of lipoxygenase-mediated lipid oxidation on the differentiation and survival of osteoblasts may provide a mechanistic explanation for the link between atherosclerosis and osteoporosis.	[Almeida, Maria; Ambrogini, Elena; Han, Li; Manolagas, Stavros C.; Jilka, Robert L.] Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Div Endocrinol & Metab, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Jilka, RL (corresponding author), 4301 W Markham,Slot 587, Little Rock, AR 72205 USA.	rljilka@uams.edu		Almeida, Maria/0000-0002-6722-9200; Warren, Aaron D./0000-0002-0042-9021	National Institutes of Health [P01-AG13918]; Department of Veterans Affairs; NATIONAL INSTITUTE ON AGING [P01AG013918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-AG13918 (to S. C. M.). This work was also supported by the Veterans Affairs merit review grants from the Office of Research and Development of the Department of Veterans Affairs (to R. L. J. and S. C. M.).	Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Ali AA, 2005, ENDOCRINOLOGY, V146, P1226, DOI 10.1210/en.2004-0735; Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Almeida M, 2007, J BIOL CHEM, V282, P27285, DOI 10.1074/jbc.M702810200; Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Andersen TL, 2009, AM J PATHOL, V174, P239, DOI 10.2353/ajpath.2009.080627; Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Berliner JA, 2005, NEW ENGL J MED, V353, P9, DOI 10.1056/NEJMp058118; Bodine PVN, 2008, CELL RES, V18, P248, DOI 10.1038/cr.2008.13; Brodeur MR, 2008, FREE RADICAL BIO MED, V44, P506, DOI 10.1016/j.freeradbiomed.2007.08.030; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Coleman JD, 2007, FREE RADICAL BIO MED, V42, P1155, DOI 10.1016/j.freeradbiomed.2007.01.003; Cyrus T, 2001, CIRCULATION, V103, P2277; Dowell P, 2003, J BIOL CHEM, V278, P45485, DOI 10.1074/jbc.M309069200; Duque G, 2009, EXP GERONTOL, V44, P183, DOI 10.1016/j.exger.2008.10.004; Farhat GN, 2006, J BONE MINER RES, V21, P1839, DOI 10.1359/JBMR.060903; Funk CD, 2002, PROSTAG OTH LIPID M, V68-9, P303, DOI 10.1016/S0090-6980(02)00036-9; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Giaginis C, 2007, FUND CLIN PHARMACOL, V21, P231, DOI 10.1111/j.1472-8206.2007.00486.x; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Glass DA, 2006, CURR TOP DEV BIOL, V73, P43, DOI 10.1016/S0070-2153(05)73002-7; Griesser M, 2009, J LIPID RES, V50, P2455, DOI 10.1194/jlr.M900181-JLR200; Hak AE, 2000, ARTERIOSCL THROM VAS, V20, P1926, DOI 10.1161/01.ATV.20.8.1926; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Huang MS, 2007, J BIOL CHEM, V282, P21237, DOI 10.1074/jbc.M701341200; Huo YQ, 2004, CIRCULATION, V110, P2024, DOI 10.1161/01.CIR.0000143628.37680.F6; JILKA RL, 2002, BONEKEY OSTEOVISION, DOI DOI 10.1138/2002024; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kiel DP, 2001, CALCIFIED TISSUE INT, V68, P271, DOI 10.1007/BF02390833; Kim SH, 2006, TOXICOL APPL PHARM, V215, P198, DOI 10.1016/j.taap.2006.03.001; Klein BY, 2003, J CELL BIOCHEM, V90, P42, DOI 10.1002/jcb.10603; Klein RF, 2004, SCIENCE, V303, P229, DOI 10.1126/science.1090985; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kousteni S, 2003, J CLIN INVEST, V111, P1651, DOI 10.1172/JCI200317261; Kuhn H, 2002, FREE RADICAL BIO MED, V33, P154, DOI 10.1016/S0891-5849(02)00855-9; Lecka-Czernik B, 2002, ENDOCRINOLOGY, V143, P2376, DOI 10.1210/en.143.6.2376; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Lee JY, 2006, TOXICOL LETT, V166, P212, DOI 10.1016/j.toxlet.2006.07.305; Limor R, 2008, AM J HYPERTENS, V21, P219, DOI 10.1038/ajh.2007.39; LIPS P, 1978, CALC TISS RES, V26, P13, DOI 10.1007/BF02013227; Magoori K, 2003, J BIOL CHEM, V278, P11331, DOI 10.1074/jbc.M211987200; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Meier C, 2008, ARCH INTERN MED, V168, P820, DOI 10.1001/archinte.168.8.820; MEUNIER P, 1971, CLIN ORTHOP RELAT R, P147, DOI 10.1097/00003086-197110000-00021; Miller JD, 2008, J AM COLL CARDIOL, V52, P843, DOI 10.1016/j.jacc.2008.05.043; Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mueller E, 2002, J BIOL CHEM, V277, P41925, DOI 10.1074/jbc.M206950200; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Navab M, 2004, J LIPID RES, V45, P993, DOI 10.1194/jlr.R400001-JLR200; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; Parfitt AM., 1990, BONE TREATISE, VI, P351; Parhami F, 2001, J BONE MINER RES, V16, P182, DOI 10.1359/jbmr.2001.16.1.182; Perrien DS, 2007, AM J PHYSIOL-REG I, V292, pR988, DOI 10.1152/ajpregu.00302.2006; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Robinson CE, 1998, BIOCHEM BIOPH RES CO, V244, P671, DOI 10.1006/bbrc.1998.8305; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Rzonca SO, 2004, ENDOCRINOLOGY, V145, P401, DOI 10.1210/en.2003-0746; Sampey BP, 2007, MOL PHARMACOL, V71, P871, DOI 10.1124/mol.106.029686; Satoh K, 1999, ANAL BIOCHEM, V270, P323, DOI 10.1006/abio.1999.4073; Schild RL, 2002, J CLIN ENDOCR METAB, V87, P1105, DOI 10.1210/jc.87.3.1105; Schneider C, 2008, J BIOL CHEM, V283, P15539, DOI 10.1074/jbc.R800001200; Schulz E, 2004, J CLIN ENDOCR METAB, V89, P4246, DOI 10.1210/jc.2003-030964; Schwartz AV, 2006, J CLIN ENDOCR METAB, V91, P3349, DOI 10.1210/jc.2005-2226; Sharma A, 2008, ARCH BIOCHEM BIOPHYS, V480, P85, DOI 10.1016/j.abb.2008.09.016; Sharma C, 2004, J BIOL CHEM, V279, P35583, DOI 10.1074/jbc.M403143200; Siddappa R, 2008, P NATL ACAD SCI USA, V105, P7281, DOI 10.1073/pnas.0711190105; Soroceanu MA, 2004, J ENDOCRINOL, V183, P203, DOI 10.1677/joe.1.05723; Spiteller G, 2001, EXP GERONTOL, V36, P1425, DOI 10.1016/S0531-5565(01)00131-0; Steinberg D, 2009, J LIPID RES, V50, pS376, DOI 10.1194/jlr.R800087-JLR200; Tanko LB, 2003, CALCIFIED TISSUE INT, V73, P15, DOI 10.1007/s00223-002-2070-x; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Towler DA, 2008, J AM COLL CARDIOL, V52, P851, DOI 10.1016/j.jacc.2008.05.044; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Uchida K, 1999, J BIOL CHEM, V274, P2234, DOI 10.1074/jbc.274.4.2234; Verma S, 2002, J CLIN PATHOL, V55, P693, DOI 10.1136/jcp.55.9.693; VOGT MT, 1992, J CLIN EPIDEMIOL, V45, P529, DOI 10.1016/0895-4356(92)90102-S; Weinstein RS, 2008, J BONE MINER RES, V23, pS70; XI H, 1993, TOXICOL APPL PHARM, V120, P29, DOI 10.1006/taap.1993.1083	80	198	214	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27438	27448		10.1074/jbc.M109.023572	http://dx.doi.org/10.1074/jbc.M109.023572			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19657144	hybrid, Green Published			2022-12-27	WOS:000270232300046
J	Katoh, Y; Ritter, B; Gaffry, T; Blondeau, F; Honing, S; McPherson, PS				Katoh, Yohei; Ritter, Brigitte; Gaffry, Thomas; Blondeau, Francois; Hoening, Stefan; McPherson, Peter S.			The Clavesin Family, Neuron-specific Lipid-and Clathrin-binding Sec14 Proteins Regulating Lysosomal Morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE MEG2; PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; IDENTIFICATION; DISTINCT; CVAK104; COMPLEX; KINASE; VAC14; YEAST; TGN	Clathrin-coated vesicles (CCVs) originating from the trans-Golgi network (TGN) provide a major transport pathway from the secretory system to endosomes/lysosomes. Herein we describe paralogous Sec14 domain-bearing proteins, clavesin 1/CRALBPL and clavesin 2, identified through a proteomic analysis of CCVs. Clavesins are enriched on CCVs and form a complex with clathrin heavy chain (CHC) and adaptor protein-1, major coat components of TGN-derived CCVs. The proteins co-localize with markers of endosomes and the TGN as well as with CHC and adaptor protein-1. A membrane mimic assay using the Sec14 domain of clavesin 1 reveals phosphatidylinositol 3,5-bisphosphate as a specific lipid partner. Phosphatidylinositol 3,5-bisphosphate is localized to late endosomes/lysosomes, and interestingly, isoform-specific knockdown of clavesins in neurons using lentiviral delivery of interfering RNA leads to enlargement of a lysosome-associated membrane protein 1-positive membrane compartment with no obvious influence on the CCV machinery at the TGN. Since clavesins are expressed exclusively in neurons, this new protein family appears to provide a unique neuron-specific regulation of late endosome/lysosome morphology.	[Katoh, Yohei; Ritter, Brigitte; Blondeau, Francois; McPherson, Peter S.] McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Gaffry, Thomas; Hoening, Stefan] Univ Cologne, Inst Biochem 1, D-50931 Cologne, Germany; [Gaffry, Thomas; Hoening, Stefan] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany	McGill University; University of Cologne; University of Cologne	McPherson, PS (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst, 3801 Univ, Montreal, PQ H3A 2B4, Canada.	peter.mcpherson@mcgill.ca	Katoh, Yohei/AAA-3378-2020	Katoh, Yohei/0000-0003-1649-4917; Ritter, Brigitte/0000-0002-0094-0460	Canadian Institutes of Health Research (CIHR) [MOP-62684]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) Grant MOP-62684 (to P. S. M.).	Au CE, 2007, CURR OPIN CELL BIOL, V19, P376, DOI 10.1016/j.ceb.2007.05.004; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Borner GHH, 2007, TRAFFIC, V8, P893, DOI 10.1111/j.1600-0854.2007.00576.x; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Burman JL, 2005, FEBS LETT, V579, P2177, DOI 10.1016/j.febslet.2005.03.008; Conner SD, 2005, J BIOL CHEM, V280, P21539, DOI 10.1074/jbc.M502462200; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; Cook NR, 2004, TRAFFIC, V5, P685, DOI 10.1111/j.1600-0854.2004.00212.x; Curwin AJ, 2009, J BIOL CHEM, V284, P7364, DOI 10.1074/jbc.M808732200; Donaldson JG, 2009, EMBO REP, V10, P132, DOI 10.1038/embor.2008.248; Dove SK, 2009, BIOCHEM J, V419, P1, DOI 10.1042/BJ20081950; Duwel M, 2006, MOL BIOL CELL, V17, P4513, DOI 10.1091/mbc.E06-05-0390; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; Gillooly DJ, 2003, HISTOCHEM CELL BIOL, V120, P445, DOI 10.1007/s00418-003-0591-7; HILLEREHFELD A, 1995, BBA-REV BIOMEMBRANES, V1241, P177, DOI 10.1016/0304-4157(95)00004-B; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Huynh H, 2003, J IMMUNOL, V171, P6661, DOI 10.4049/jimmunol.171.12.6661; Ikonomov OC, 2006, AM J PHYSIOL-CELL PH, V291, pC393, DOI 10.1152/ajpcell.00019.2006; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Jin N, 2008, EMBO J, V27, P3221, DOI 10.1038/emboj.2008.248; Kalthoff C, 2002, MOL BIOL CELL, V13, P4060, DOI 10.1091/mbc.E02-03-0171; Karlsson K, 1998, J BIOL CHEM, V273, P18966, DOI 10.1074/jbc.273.30.18966; Kong YH, 2006, BIOTECHNOL LETT, V28, P1327, DOI 10.1007/s10529-006-9096-5; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; Kruger JM, 2002, J BIOL CHEM, V277, P2620, DOI 10.1074/jbc.M104550200; Lemaire JF, 2006, FEBS LETT, V580, P6948, DOI 10.1016/j.febslet.2006.11.061; Michell RH, 2009, EMBO J, V28, P86, DOI 10.1038/emboj.2008.270; Micheva KD, 1997, J BIOL CHEM, V272, P27239, DOI 10.1074/jbc.272.43.27239; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Mills IG, 1998, CURR BIOL, V8, P881, DOI 10.1016/S0960-9822(07)00351-X; Mousley CJ, 2007, BBA-MOL CELL BIOL L, V1771, P727, DOI 10.1016/j.bbalip.2007.04.002; Patki V, 1998, NATURE, V394, P433, DOI 10.1038/28771; PattonVogt JL, 1997, J BIOL CHEM, V272, P20873, DOI 10.1074/jbc.272.33.20873; Phillips SE, 2006, CRIT REV BIOCHEM MOL, V41, P21, DOI 10.1080/10409230500519573; Pivtoraiko VN, 2009, ANTIOXID REDOX SIGN, V11, P481, DOI [10.1089/ars.2008.2263, 10.1089/ARS.2008.2263]; Ramjaun AR, 1998, J NEUROCHEM, V70, P2369; Ridley SH, 2001, J CELL SCI, V114, P3991; Ritter B, 2004, TOP CURR GENET, V10, P9; Ritter B, 2004, EMBO J, V23, P3701, DOI 10.1038/sj.emboj.7600378; Ritter B, 2003, EMBO REP, V4, P1089, DOI 10.1038/sj.embor.7400004; Ritter B, 2007, EMBO J, V26, P4066, DOI 10.1038/sj.emboj.7601836; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Saito K, 2007, BBA-MOL CELL BIOL L, V1771, P719, DOI 10.1016/j.bbalip.2007.02.010; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Thomas S, 2009, J BIOL CHEM, V284, P12410, DOI 10.1074/jbc.M809746200; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Wasiak S, 2002, J CELL BIOL, V158, P855, DOI 10.1083/jcb.200205078; Wen PJ, 2008, MOL BIOL CELL, V19, P5593, DOI 10.1091/mbc.E08-06-0595; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275104	55	29	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27646	27654		10.1074/jbc.M109.034884	http://dx.doi.org/10.1074/jbc.M109.034884			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651769	Green Published, hybrid			2022-12-27	WOS:000270232300066
J	Chen, R; Feldstein, AE; McIntyre, TM				Chen, Rui; Feldstein, Ariel E.; McIntyre, Thomas M.			Suppression of Mitochondrial Function by Oxidatively Truncated Phospholipids Is Reversible, Aided by Bid, and Suppressed by Bcl-X-L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING-FACTOR-ACETYLHYDROLASE; SMOOTH-MUSCLE-CELLS; PERMEABILITY TRANSITION PORE; OXIDIZED PHOSPHOLIPIDS; LIPID-PEROXIDATION; IN-VIVO; ACID SPHINGOMYELINASE; INDUCED APOPTOSIS; BILAYER PACKING; FREE-RADICALS	Oxidatively truncated phospholipids are present in atherosclerotic lesions, apoptotic cells, and oxidized low density lipoproteins. Some of these lipids rapidly enter cells to induce apoptosis by the intrinsic pathway, but how such lipids initiate this process is unknown. We show the truncated phospholipid hexadecyl azelaoyl glycerophosphocholine (Az-LPAF), derived from the fragmentation of abundant sn-2 linoleoyl residues, depolarized mitochondria of intact cells. Az-LPAF also depolarized isolated mitochondria and allowed NADH loss, but did not directly interfere with complex I function. Cyclosporin A blockade of the mitochondrial permeability transition pore partially prevented the loss of electrochemical potential. Depolarization of isolated mitochondria by the truncated phospholipid was readily reversed by the addition of albumin that sequestered this lipid. Ectopic expression of the anti-apoptotic protein Bcl-XL in HL-60 cells reduced apoptosis by the truncated phospholipid by protecting their mitochondria. Mitochondria isolated from these cells were also protected from Az-LPAF-induced depolarization. Conversely mitochondria isolated from Bid(-/-) animals that lack this pro-apoptotic Bcl-2 family member were resistant to Az-LPAF depolarization. Addition of recombinant full-length Bid, which has phospholipid transfer activity, restored this sensitivity. Thus, phospholipid oxidation products physically interact with mitochondria to continually depolarize this organelle without permanent harm, and Bcl-2 family members modulate this interaction with full-length Bid acting as a cofactor for pro-apoptotic, oxidatively truncated phospholipids.	[McIntyre, Thomas M.] Cleveland Clin, Lerner Coll Med, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation	McIntyre, TM (corresponding author), Cleveland Clin, Lerner Coll Med, Lerner Res Inst, Dept Cell Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	mcintyt@ccf.org			National Institutes of Health [R01AA017748, R01HL092747, 1R01DK076852]; National Center for Research Resources (Cleveland, OH) [CTSA 1UL1RR024989]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (Cleveland, OH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AA017748, R01HL092747, and 1R01DK076852 and National Center for Research Resources Grant CTSA 1UL1RR024989 (Cleveland, OH).	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brookes PS, 2002, PROTEOMICS, V2, P969, DOI 10.1002/1615-9861(200208)2:8<969::AID-PROT969>3.0.CO;2-3; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; Chen R, 2007, J BIOL CHEM, V282, P24842, DOI 10.1074/jbc.M702865200; Chen R, 2009, ARTERIOSCL THROM VAS, V29, P363, DOI 10.1161/ATVBAHA.108.178731; Chen X, 2008, J LIPID RES, V49, P832, DOI 10.1194/jlr.M700598-JLR200; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Echtay KS, 2007, FREE RADICAL BIO MED, V43, P1351, DOI 10.1016/j.freeradbiomed.2007.08.011; Esposti MD, 2001, MOL CELL BIOL, V21, P7268, DOI 10.1128/MCB.21.21.7268-7276.2001; Esposti MD, 2002, BBA-BIOENERGETICS, V1553, P331, DOI 10.1016/S0005-2728(02)00187-1; Fruhwirth GO, 2006, BBA-MOL CELL BIOL L, V1761, P1060, DOI 10.1016/j.bbalip.2006.06.001; Garofalo T, 2005, CELL DEATH DIFFER, V12, P1378, DOI 10.1038/sj.cdd.4401672; Goonesinghe A, 2005, BIOCHEM J, V387, P109, DOI 10.1042/BJ20041389; Greenberg ME, 2008, J BIOL CHEM, V283, P2385, DOI 10.1074/jbc.M707348200; Gutierrez J, 2006, CIRC RES, V99, P924, DOI 10.1161/01.RES.0000248212.86638.e9; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Hirashima Y, 2000, BRAIN RES, V885, P128, DOI 10.1016/S0006-8993(00)02852-3; ITABE H, 1988, BIOCHIM BIOPHYS ACTA, V962, P8; Jaburek M, 2004, J BIOL CHEM, V279, P53097, DOI 10.1074/jbc.M405339200; Ji H, 2006, MAGN RESON CHEM, V44, pS101, DOI 10.1002/mrc.1856; Kim TH, 2000, J BIOL CHEM, V275, P39474, DOI 10.1074/jbc.M003370200; Kinsey GR, 2008, J LIPID RES, V49, P1477, DOI 10.1194/jlr.M800030-JLR200; Kogure K, 2003, CHEM PHYS LIPIDS, V126, P29, DOI 10.1016/S0009-3084(03)00091-4; Kono N, 2008, J BIOL CHEM, V283, P1628, DOI 10.1074/jbc.M708622200; Korge P, 2003, AM J PHYSIOL-HEART C, V285, pH259, DOI 10.1152/ajpheart.01028.2002; Kroemer G, 1999, BIOCHEM SOC SYMP, V66, P1; KUGIYAMA K, 1993, CIRC RES, V73, P335, DOI 10.1161/01.RES.73.2.335; Loidl A, 2003, J BIOL CHEM, V278, P32921, DOI 10.1074/jbc.M306088200; Marathe GK, 2003, J BIOL CHEM, V278, P3937, DOI 10.1074/jbc.M211126200; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; Matsuzawa A, 1997, J BIOL CHEM, V272, P32315, DOI 10.1074/jbc.272.51.32315; Mattila JP, 2008, BBA-BIOMEMBRANES, V1778, P2041, DOI 10.1016/j.bbamem.2008.03.020; McIntyre TM, 2009, J LIPID RES, V50, pS255, DOI 10.1194/jlr.R800024-JLR200; Megli FM, 2005, FEBS LETT, V579, P4577, DOI 10.1016/j.febslet.2005.07.022; Megli FM, 2004, FEBS LETT, V573, P68, DOI 10.1016/j.febslet.2004.07.057; Megli FM, 2003, FEBS LETT, V550, P185, DOI 10.1016/S0014-5793(03)00861-5; Megli FA, 2008, BBA-BIOMEMBRANES, V1778, P143, DOI 10.1016/j.bbamem.2007.09.014; Megli FM, 2009, BBA-BIOMEMBRANES, V1788, P371, DOI 10.1016/j.bbamem.2008.10.002; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Moumtzi A, 2007, J LIPID RES, V48, P565, DOI 10.1194/jlr.M600394-JLR200; MULLER E, 1991, BIOCHEM BIOPH RES CO, V181, P1580, DOI 10.1016/0006-291X(91)92119-5; Novgorodov SA, 2005, J BIOL CHEM, V280, P16096, DOI 10.1074/jbc.M411707200; PFEIFFER DR, 1995, J BIOL CHEM, V270, P4923, DOI 10.1074/jbc.270.9.4923; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Reis A, 2004, RAPID COMMUN MASS SP, V18, P2849, DOI 10.1002/rcm.1686; Rhode S, 2009, J BIOL CHEM, V284, P2258, DOI 10.1074/jbc.M807591200; Sabatini K, 2006, BIOPHYS J, V90, P4488, DOI 10.1529/biophysj.105.080176; Salomon R G, 1985, Adv Prostaglandin Thromboxane Leukot Res, V15, P323; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Shimizu S, 2000, ONCOGENE, V19, P4309, DOI 10.1038/sj.onc.1203788; Shimizu S, 1998, P NATL ACAD SCI USA, V95, P1455, DOI 10.1073/pnas.95.4.1455; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Stafforini DM, 2009, CARDIOVASC DRUG THER, V23, P73, DOI 10.1007/s10557-008-6133-8; STREMLER KE, 1991, J BIOL CHEM, V266, P11095; Tokumura A, 1996, LIPIDS, V31, P1251, DOI 10.1007/BF02587909; Umemura K, 2007, STROKE, V38, P1063, DOI 10.1161/01.STR.0000257981.09329.d2; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Waldmeier PC, 2003, CURR MED CHEM, V10, P1485, DOI 10.2174/0929867033457160; Wieckowski MR, 2000, FEBS LETT, V484, P61, DOI 10.1016/S0014-5793(00)02127-X; Wong-Ekkabut J, 2007, BIOPHYS J, V93, P4225, DOI 10.1529/biophysj.107.112565; YAMASHITA A, 2009, BIOCH BIOPH IN PRESS; Zhai DY, 2001, EUR J BIOCHEM, V268, P48, DOI 10.1046/j.1432-1327.2001.01841.x	63	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26297	26308		10.1074/jbc.M109.018978	http://dx.doi.org/10.1074/jbc.M109.018978			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19654426	hybrid, Green Published			2022-12-27	WOS:000269969600009
J	Kim, M; Suh, H; Cho, EJ; Buratowski, S				Kim, Minkyu; Suh, Hyunsuk; Cho, Eun-Jung; Buratowski, Stephen			Phosphorylation of the Yeast Rpb1 C-terminal Domain at Serines 2, 5, and 7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; PRE-MESSENGER-RNA; TRANSCRIPTIONAL ELONGATION; SACCHAROMYCES-CEREVISIAE; HISTONE METHYLATION; PROCESSING FACTORS; P-TEFB; CTD; KINASE; TFIIH	The C-terminal domain (CTD) of Rpb1, the largest subunit of RNA polymerase II, acts as a binding platform for various mRNA processing and histone-modifying enzymes that act co-transcriptionally. These factors are targeted to specific phosphorylation states of the CTD that predominate at different stages of transcription. Within the repeating sequence YSPTSPS, serines 2 and 5 are major phosphorylation sites, but serine 7 phosphorylation was recently discovered in mammalian cells. Here we show that CTD serine 7 is also phosphorylated in yeast and that Ser-7(P) chromatin immunoprecipitation patterns resemble those of Ser-5(P). The basal factor TFIIH can phosphorylate Ser-7 in vitro and is necessary for Ser-7(P) in vivo. Interestingly, deletion of the CTD Ser-5(P) phosphatase Rtr1 leads to an increase in Ser-5(P) but not Ser-7(P).	[Kim, Minkyu; Suh, Hyunsuk; Buratowski, Stephen] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kim, Minkyu] Seoul Natl Univ, Dept Biophys & Chem Biol, Seoul 151742, South Korea; [Cho, Eun-Jung] Sungkyunkwan Univ, Coll Pharm, Suwon 440746, South Korea	Harvard University; Harvard Medical School; Seoul National University (SNU); Sungkyunkwan University (SKKU)	Buratowski, S (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	SteveB@hms.harvard.edu	Cho, Eun-Jung/AAR-1785-2020	Cho, Eun-Jung/0000-0002-6610-5329	National Institutes of Health [GM46498, GM56663]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM046498, R01GM046498, R01GM056663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM46498 and GM56663 (to S.B.).	Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; ALLISON LA, 1988, MOL CELL BIOL, V8, P321, DOI 10.1128/MCB.8.1.321; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Fabrega C, 2003, MOL CELL, V11, P1549, DOI 10.1016/S1097-2765(03)00187-4; Gerber M, 2003, J BIOL CHEM, V278, P26303, DOI 10.1074/jbc.R300014200; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Jones JC, 2004, J BIOL CHEM, V279, P24957, DOI 10.1074/jbc.M402218200; Kanin EI, 2007, P NATL ACAD SCI USA, V104, P5812, DOI 10.1073/pnas.0611505104; Keogh MC, 2002, MOL CELL BIOL, V22, P1288, DOI 10.1128/MCB.22.5.1288-1297.2002; Kim E, 1997, J CELL BIOL, V136, P19, DOI 10.1083/jcb.136.1.19; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Liu Y, 2004, MOL CELL BIOL, V24, P1721, DOI 10.1128/MCB.24.4.1721-1735.2004; Meinhart A, 2004, NATURE, V430, P223, DOI 10.1038/nature02679; Mosley AL, 2009, MOL CELL, V34, P168, DOI 10.1016/j.molcel.2009.02.025; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Noble CG, 2005, NAT STRUCT MOL BIOL, V12, P144, DOI 10.1038/nsmb887; Patturajan M, 1998, J BIOL CHEM, V273, P4689, DOI 10.1074/jbc.273.8.4689; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; Schaft D, 2003, NUCLEIC ACIDS RES, V31, P2475, DOI 10.1093/nar/gkg372; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; SVEJSTRUP JQ, 1994, J BIOL CHEM, V269, P28044; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Viladevall L, 2009, MOL CELL, V33, P738, DOI 10.1016/j.molcel.2009.01.029; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503	34	104	106	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26421	26426		10.1074/jbc.M109.028993	http://dx.doi.org/10.1074/jbc.M109.028993			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19679665	Green Published, hybrid			2022-12-27	WOS:000269969600023
J	Nishida, Y; Ito, S; Ohtsuki, S; Yamamoto, N; Takahashi, T; Iwata, N; Jishage, K; Yamada, H; Sasaguri, H; Yokota, S; Piao, WY; Tomimitsu, H; Saido, TC; Yanagisawa, K; Terasaki, T; Mizusawa, H; Yokota, T				Nishida, Yoichiro; Ito, Shingo; Ohtsuki, Sumio; Yamamoto, Naoki; Takahashi, Tsubura; Iwata, Nobuhisa; Jishage, Kou-ichi; Yamada, Hiromi; Sasaguri, Hiroki; Yokota, Shigefumi; Piao, Wenying; Tomimitsu, Hiroyuki; Saido, Takaomi C.; Yanagisawa, Katsuhiko; Terasaki, Tetsuya; Mizusawa, Hidehiro; Yokota, Takanori			Depletion of Vitamin E Increases Amyloid beta Accumulation by Decreasing Its Clearances from Brain and Blood in a Mouse Model of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN-1; OXIDATIVE STRESS; IN-VIVO; TRANSGENIC MICE; PHARMACOKINETIC ANALYSIS; SECRETASE ACTIVITY; ENDOTHELIAL-CELLS; PRECURSOR PROTEIN; PLAQUE-FORMATION; BARRIER	Increased oxidative damage is a prominent and early feature in Alzheimer disease. We previously crossed Alzheimer disease transgenic (APPsw) model mice with alpha-tocopherol transfer protein knock-out (Ttpa(-/-)) mice in which lipid peroxidation in the brain was significantly increased. The resulting double-mutant (Ttpa(-/-) APPsw) mice showed increased amyloid beta (A beta) deposits in the brain, which was ameliorated with alpha-tocopherol supplementation. To investigate the mechanism of the increased A beta accumulation, we here studied generation, degradation, aggregation, and efflux of A beta in the mice. The clearance of intracerebral-microinjected I-125-A beta(1-40) from brain was decreased in Ttpa(-/-) mice to be compared with wildtype mice, whereas the generation of A beta was not increased in Ttpa(-/-) APPsw mice. The activity of an A beta-degrading enzyme, neprilysin, did not decrease, but the expression level of insulin-degrading enzyme was markedly decreased in Ttpa(-/-) mouse brain. In contrast, A beta aggregation was accelerated in Ttpa(-/-) mouse brains compared with wild-type brains, and well known molecules involved in A beta transport from brain to blood, low density lipoprotein receptor-related protein-1 (LRP-1) and p-glycoprotein, were up-regulated in the small vascular fraction of Ttpa(-/-) mouse brains. Moreover, the disappearance of intravenously administered I-125-A beta(1-40) was decreased in Ttpa(-/-) mice with reduced translocation of LRP-1 in the hepatocytes. These results suggest that lipid peroxidation due to depletion of alpha-tocopherol impairs A beta clearances from the brain and from the blood, possibly causing increased A beta accumulation in Ttpa(-/-) APPsw mouse brain and plasma.	[Nishida, Yoichiro; Takahashi, Tsubura; Yamada, Hiromi; Sasaguri, Hiroki; Yokota, Shigefumi; Piao, Wenying; Tomimitsu, Hiroyuki; Mizusawa, Hidehiro; Yokota, Takanori] Tokyo Med & Dent Univ, Grad Sch, Dept Neurol & Neurol Sci, Bunkyo Ku, Tokyo 1138519, Japan; [Ito, Shingo; Ohtsuki, Sumio; Terasaki, Tetsuya] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Mol Biopharm & Genet, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Yamamoto, Naoki; Yanagisawa, Katsuhiko] Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Aichi 4748522, Japan; [Iwata, Nobuhisa; Saido, Takaomi C.] RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan; [Jishage, Kou-ichi] Chugai Res Inst Med Sci Inc, Shizuoka 4128513, Japan	Tokyo Medical & Dental University (TMDU); Tohoku University; National Center for Geriatrics & Gerontology; RIKEN; Chugai Pharmaceutical Co., Ltd.; Chugai Research Institute for Medical Science, Inc.	Yokota, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Neurol & Neurol Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	tak-yokota.nuro@tmd.ac.jp	Sado, Takaomi/AAN-2759-2021; Terasaki, Tetsuya/K-6730-2012; Saido, Takaomi C/N-5472-2015; Ohtsuki, Sumio/S-4360-2016	Sado, Takaomi/0000-0003-1970-6903; Terasaki, Tetsuya/0000-0002-6332-7575; Saido, Takaomi C/0000-0003-1970-6903; Ohtsuki, Sumio/0000-0003-4634-7133; Yokota, Takanori/0000-0002-6490-3263	Ministry of Health, Labor, and Welfare of Japan; 21st Century COE Program on Brain Integration and Its Disorders; Ministry of Education, Science, and Culture; Japan Science and Technology Agency	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); 21st Century COE Program on Brain Integration and Its Disorders(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Science, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported in part by a grant for Research on Psychiatric and Neurological Disease and Mental Health from the Ministry of Health, Labor, and Welfare of Japan ( to T. Y. and H. M.), a grant from the 21st Century COE Program on Brain Integration and Its Disorders to Tokyo Medical and Dental University ( to Y. N., H. S., and H. M.), a grant from the Ministry of Education, Science, and Culture ( to N. I., H. T., T. Y., and H. T.), and a grant of the SORST of Japan Science and Technology Agency ( to S. O. and T. Terasaki).	Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Apelt J, 2004, INT J DEV NEUROSCI, V22, P475, DOI 10.1016/j.ijdevneu.2004.07.006; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Cirrito JR, 2005, J CLIN INVEST, V115, P3285, DOI 10.1172/JCI25247; DOWSON JH, 1992, NEUROBIOL AGING, V13, P493, DOI 10.1016/0197-4580(92)90077-B; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Ghiso J, 2004, J BIOL CHEM, V279, P45897, DOI 10.1074/jbc.M407668200; Ghiso J, 1997, FEBS LETT, V408, P105, DOI 10.1016/S0014-5793(97)00400-6; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Hino T, 2006, BIOCHEM BIOPH RES CO, V340, P263, DOI 10.1016/j.bbrc.2005.11.173; Hone E, 2003, J ALZHEIMERS DIS, V5, P1, DOI 10.3233/JAD-2003-5101; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Igbavboa U, 1996, J NEUROCHEM, V66, P1717; Iwata N, 2005, PHARMACOL THERAPEUT, V108, P129, DOI 10.1016/j.pharmthera.2005.03.010; Kakee A, 1996, J PHARMACOL EXP THER, V277, P1550; KANDA T, 1994, J CELL BIOL, V126, P235, DOI 10.1083/jcb.126.1.235; Kandimalla KK, 2005, J PHARMACOL EXP THER, V313, P1370, DOI 10.1124/jpet.104.081901; KATZMAN R, 1991, FASEB J, V5, P278, DOI 10.1096/fasebj.5.3.2001787; Kuo YM, 1999, BIOCHEM BIOPH RES CO, V257, P787, DOI 10.1006/bbrc.1999.0552; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; LOVELL MA, 1995, NEUROLOGY, V45, P1594, DOI 10.1212/WNL.45.8.1594; Matsubara E, 2004, NEUROBIOL AGING, V25, P833, DOI 10.1016/j.neurobiolaging.2003.10.004; Matsubara E, 1999, ANN NEUROL, V45, P537, DOI 10.1002/1531-8249(199904)45:4<537::AID-ANA20>3.0.CO;2-2; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Moreira PI, 2005, ANN NY ACAD SCI, V1043, P545, DOI 10.1196/annals.1333.062; Naiki H, 1999, METHOD ENZYMOL, V309, P305; Nishida Y, 2006, BIOCHEM BIOPH RES CO, V350, P530, DOI 10.1016/j.bbrc.2006.09.083; Ogawa T, 2005, J NEUROCHEM, V95, P1156, DOI 10.1111/j.1471-4159.2005.03436.x; PARDRIDGE WM, 1990, J BIOL CHEM, V265, P18035; Sagare A, 2007, NAT MED, V13, P1029, DOI 10.1038/nm1635; Sayre LM, 1997, J NEUROCHEM, V68, P2092; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Shiiki T, 2004, J NEUROSCI, V24, P9632, DOI 10.1523/JNEUROSCI.2236-04.2004; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Tabata K., 1999, XENOBIO METABOL DISP, V14, P286, DOI DOI 10.2133/DMPK.14.286; Tamaki C, 2007, MOL PHARMACOL, V72, P850, DOI 10.1124/mol.107.036913; Tamaki C, 2006, PHARM RES-DORDR, V23, P1407, DOI 10.1007/s11095-006-0208-7; Traber MG, 2004, ANN NY ACAD SCI, V1031, P1, DOI 10.1196/annals.1331.001; Van Uden E, 2002, J NEUROSCI, V22, P9298; Vogelgesang S, 2002, PHARMACOGENETICS, V12, P535, DOI 10.1097/00008571-200210000-00005; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537; YAMAOKA K, 1978, J PHARMACOKINET BIOP, V6, P547, DOI 10.1007/BF01062109; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879, DOI 10.1248/bpb1978.4.879; Yokota T, 2001, P NATL ACAD SCI USA, V98, P15185, DOI 10.1073/pnas.261456098; Zlokovic BV, 2004, J NEUROCHEM, V89, P807, DOI 10.1111/j.1471-4159.2004.02385.x	45	75	79	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33400	33408		10.1074/jbc.M109.054056	http://dx.doi.org/10.1074/jbc.M109.054056			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19679659	Green Published, hybrid			2022-12-27	WOS:000272028500046
J	Ma, ZZ; Li, QF; An, HQ; Pankonin, MS; Wang, JJ; Loeb, JA				Ma, Zhenzhong; Li, Qunfang; An, Haiqian; Pankonin, Mark S.; Wang, Jiajing; Loeb, Jeffrey A.			Targeting Human Epidermal Growth Factor Receptor Signaling with the Neuregulin's Heparin-binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METASTATIC BREAST-CANCER; EPITHELIAL-CELLS; NERVOUS-SYSTEM; IN-VIVO; HEREGULIN; TUMORIGENICITY; ANTIBODY; FORMS; ARIA; HER2	A major limitation in biopharmaceutical development is selectively targeting drugs to diseased tissues. Growth factors and viruses have solved this problem by targeting tissue-specific cell-surface heparan sulfates. Neuregulin (NRG), a growth factor important in both nervous system development and cancer, has a unique heparin-binding domain (HBD) that targets to cell surfaces expressing its HER2/3/4 receptors (Esper, R. M., Pankonin, M. S., and Loeb, J. A. (2006) Brain Res. Rev. 51, 161-175). We have harnessed this natural targeting ability of NRG by fusing the HBD of NRG to soluble HER4. This fusion protein retains high affinity heparin binding to heparin and to cells that express heparan sulfates resulting in a more potent NRG antagonist. In vivo, it is targeted to peripheral nerve segments where it blocks the activity of NRG as a Schwann cell survival factor. The fusion protein also efficiently blocks autocrine and paracrine signaling and reduces the proliferation of MCF10CA1 breast cancer cells. These findings demonstrate the utility of the HBD of NRG in biopharmaceutical targeting and provide a new way to block HER signaling in cancer cells.	[An, Haiqian; Loeb, Jeffrey A.] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Loeb, JA (corresponding author), 421 E Canfield,3122 Elliman Bldg, Detroit, MI 48201 USA.	jloeb@med.wayne.edu	Ma, Zhenzhong/ABA-7242-2021; Ma, Zhenzhong Zack/AEO-1528-2022	Ma, Zhenzhong Zack/0000-0002-1235-3765	National Multiple Sclerosis Society [RG 3410B3]; Michigan Universities Commercialization Initiative	National Multiple Sclerosis Society(National Multiple Sclerosis Society); Michigan Universities Commercialization Initiative	This work was supported by the National Multiple Sclerosis Society (Grant RG 3410B3) and the Michigan Universities Commercialization Initiative.	Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; Atlas E, 2003, MOL CANCER RES, V1, P165; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Esper RM, 2006, BRAIN RES REV, V51, P161, DOI 10.1016/j.brainresrev.2005.11.006; Esper RM, 2004, J NEUROSCI, V24, P6218, DOI 10.1523/JNEUROSCI.1692-04.2004; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gorsi B, 2007, TRENDS CELL BIOL, V17, P173, DOI 10.1016/j.tcb.2007.02.006; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Krane IM, 1996, ONCOGENE, V12, P1781; Li QF, 2004, CANCER RES, V64, P7078, DOI 10.1158/0008-5472.CAN-04-1152; Li QF, 2001, J BIOL CHEM, V276, P38068; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; LOEB JA, 1995, J CELL BIOL, V130, P127, DOI 10.1083/jcb.130.1.127; Loeb JA, 1999, DEVELOPMENT, V126, P781; Lupu R, 1996, BREAST CANCER RES TR, V38, P57, DOI 10.1007/BF01803784; Mahoney DJ, 2004, ANAL BIOCHEM, V330, P123, DOI 10.1016/j.ab.2004.03.055; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Montero JC, 2008, CLIN CANCER RES, V14, P3237, DOI 10.1158/1078-0432.CCR-07-5133; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Pankonin MS, 2009, BRAIN RES, V1258, P1, DOI 10.1016/j.brainres.2008.12.047; Pankonin MS, 2005, J BIOL CHEM, V280, P383, DOI 10.1074/jbc.M402645200; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Tsai MS, 2003, ONCOGENE, V22, P761, DOI 10.1038/sj.onc.1206130; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Winseck AK, 2002, J NEUROSCI, V22, P4509, DOI 10.1523/JNEUROSCI.22-11-04509.2002; Yao B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-99	31	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32108	32115		10.1074/jbc.M109.032714	http://dx.doi.org/10.1074/jbc.M109.032714			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19717564	Green Published, hybrid			2022-12-27	WOS:000271572700065
J	Kang, DS; Kern, RC; Puthenveedu, MA; von Zastrow, M; Williams, JC; Benovic, JL				Kang, Dong Soo; Kern, Ronald C.; Puthenveedu, Manojkumar A.; von Zastrow, Mark; Williams, John C.; Benovic, Jeffrey L.			Structure of an Arrestin2-Clathrin Complex Reveals a Novel Clathrin Binding Domain That Modulates Receptor Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BETA-ARRESTIN; CRYSTAL-STRUCTURE; VISUAL ARRESTIN; TERMINAL DOMAIN; ARRESTIN/CLATHRIN INTERACTION; MACROMOLECULAR STRUCTURES; ANOMALOUS DIFFRACTION; MODEL; AP-2	Non-visual arrestins play a pivotal role as adaptor proteins in regulating the signaling and trafficking of multiple classes of receptors. Although arrestin interaction with clathrin, AP-2, and phosphoinositides contributes to receptor trafficking, little is known about the configuration and dynamics of these interactions. Here, we identify a novel interface between arrestin2 and clathrin through x-ray diffraction analysis. The intrinsically disordered clathrin binding box of arrestin2 interacts with a groove between blades 1 and 2 in the clathrin beta-propeller domain, whereas an 8-amino acid splice loop found solely in the long isoform of arrestin2 (arrestin2L) interacts with a binding pocket formed by blades 4 and 5 in clathrin. The apposition of the two binding sites in arrestin2L suggests that they are exclusive and may function in higher order macromolecular structures. Biochemical analysis demonstrates direct binding of clathrin to the splice loop in arrestin2L, whereas functional analysis reveals that both binding domains contribute to the receptor-dependent redistribution of arrestin2L to clathrin-coated pits. Mutagenesis studies reveal that the clathrin binding motif in the splice loop is (L/I)(2)GXL. Taken together, these data provide a framework for understanding the dynamic interactions between arrestin2 and clathrin and reveal an essential role for this interaction in arrestin-mediated endocytosis.	[Williams, John C.] City Hope Natl Med Ctr, Dept Mol Med, Duarte, CA 91010 USA; [Benovic, Jeffrey L.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Puthenveedu, Manojkumar A.; von Zastrow, Mark] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Puthenveedu, Manojkumar A.; von Zastrow, Mark] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA	City of Hope; Jefferson University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Williams, JC (corresponding author), City Hope Natl Med Ctr, Dept Mol Med, 1500 E Duarte Rd, Duarte, CA 91010 USA.	JWilliams@coh.org; benovic@mail.jci.tju.edu	Puthenveedu, Manojkumar/A-3795-2016	Puthenveedu, Manojkumar/0000-0002-3177-4231	National Institutes of Health [GM047417, GM068857, DA010711]; Pennsylvania Department of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047417, R37GM047417, R01GM068857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010711, R37DA010711, R29DA010711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants GM047417 and GM068857 (to J. L. B.) and DA010711 (M. v. Z.). This project was also funded, in part, under a grant with the Pennsylvania Department of Health.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burtey A, 2007, TRAFFIC, V8, P914, DOI 10.1111/j.1600-0854.2007.00578.x; Carter JM, 2005, J MOL BIOL, V351, P865, DOI 10.1016/j.jmb.2005.06.048; Cheng YF, 2007, J MOL BIOL, V365, P892, DOI 10.1016/j.jmb.2006.10.036; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; Drake MT, 2000, J BIOL CHEM, V275, P6479, DOI 10.1074/jbc.275.9.6479; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Edeling MA, 2006, DEV CELL, V10, P329, DOI 10.1016/j.devcel.2006.01.016; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Gaidarov I, 1999, EMBO J, V18, P871, DOI 10.1093/emboj/18.4.871; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Goodman OB, 1997, J BIOL CHEM, V272, P15017, DOI 10.1074/jbc.272.23.15017; Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kern RC, 2009, BIOCHEMISTRY-US, V48, P7190, DOI 10.1021/bi900369c; Kim YM, 2002, J BIOL CHEM, V277, P16340, DOI 10.1074/jbc.M200678200; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Krupnick JG, 1997, J BIOL CHEM, V272, P15011, DOI 10.1074/jbc.272.23.15011; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Miele AE, 2004, NAT STRUCT MOL BIOL, V11, P242, DOI 10.1038/nsmb736; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; MORRIS SA, 1993, EMBO J, V12, P667, DOI 10.1002/j.1460-2075.1993.tb05700.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Orem NR, 2006, J CELL SCI, V119, P3141, DOI 10.1242/jcs.03052; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmitessa A, 2005, J BIOL CHEM, V280, P24649, DOI 10.1074/jbc.M502637200; Penn RB, 2001, J BIOL CHEM, V276, P32648, DOI 10.1074/jbc.M104143200; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Ramjaun AR, 1997, J BIOL CHEM, V272, P16700, DOI 10.1074/jbc.272.26.16700; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Shih W, 1995, J BIOL CHEM, V270, P31083, DOI 10.1074/jbc.270.52.31083; Shilton BH, 2002, EUR J BIOCHEM, V269, P3801, DOI 10.1046/j.1432-1033.2002.03071.x; STERNEMARR R, 1993, J BIOL CHEM, V268, P15640; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; ter Haar E, 1998, CELL, V95, P563, DOI 10.1016/S0092-8674(00)81623-2; Terwilliger TC, 2004, ACTA CRYSTALLOGR D, V60, P2144, DOI 10.1107/S0907444904019535; Trapani S, 2008, ACTA CRYSTALLOGR D, V64, P11, DOI 10.1107/S0907444907044460; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Xiao KH, 2004, J BIOL CHEM, V279, P55744, DOI 10.1074/jbc.M409785200	59	84	85	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29860	29872		10.1074/jbc.M109.023366	http://dx.doi.org/10.1074/jbc.M109.023366			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19710023	Green Published, hybrid			2022-12-27	WOS:000270896800066
J	Roy, H; Ibba, M				Roy, Herve; Ibba, Michael			Broad Range Amino Acid Specificity of RNA-dependent Lipid Remodeling by Multiple Peptide Resistance Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSYL-PHOSPHATIDYLGLYCEROL; ANTIMICROBIAL PEPTIDES; BACILLUS-SUBTILIS; MEMBRANE; MPRF; DAPTOMYCIN; PROTEIN; SUSCEPTIBILITY; IDENTIFICATION; ADAPTATION	Aminoacylphosphatidylglycerol synthases (aaPGSs) are multiple peptide resistance factors that transfer amino acids from aminoacyl-tRNAs to phosphatidylglycerol (PG) in the cytoplasmic membrane. Aminoacylation of PG is used by bacteria to decrease the net negative charge of the cell envelope, diminishing affinity for charged molecules and allowing for adaptation to environmental changes. Lys-PGS, which transfers lysine to PG, is essential for the virulence of certain pathogens, providing resistance to both host cationic antimicrobial peptides and therapeutic antibiotics. Ala-PGS was also recently described, but little is known about the possible activities of other members of the highly diverse aaPGS family of proteins. Systematic deletion of the predicted membrane-inserted domains of several aaPGSs revealed that the carboxyl-terminal hydrophilic domain alone is sufficient for aminoacylphosphatidylglycerol transferase catalytic activity. In contrast to previously characterized aaPGSs, the Enterococcus faecium enzyme used an expanded repertoire of amino acids to modify PG with Ala, Arg, or Lys. Reexamination of previously characterized aaPGSs also revealed broader than anticipated substrate specificity, for example Bacillus subtilis Lys-PGS was shown to also catalyze Ala-PG synthesis. The relaxed substrate specificities of these aaPGSs allows for more elaborate remodeling of membrane lipids than previously thought, potentially providing bacteria that harbor these enzymes resistance to a broad spectrum of antibiotics and environmental stresses.	[Roy, Herve; Ibba, Michael] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Ibba, Michael] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Roy, Herve; Ibba, Michael] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ibba, M (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	ibba.1@osu.edu			National Institutes of Health [GM 65183]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 65183.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ataide SF, 2004, BIOCHEMISTRY-US, V43, P11836, DOI 10.1021/bi0490542; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cui LZ, 2006, ANTIMICROB AGENTS CH, V50, P1079, DOI 10.1128/AAC.50.3.1079-1082.2006; DOSSANTO.JM, 1970, J BACTERIOL, V104, P611, DOI 10.1128/JB.104.2.611-619.1970; Fischer AE, 1999, J BIOL CHEM, V274, P37093, DOI 10.1074/jbc.274.52.37093; Hachmann AB, 2009, ANTIMICROB AGENTS CH, V53, P1598, DOI 10.1128/AAC.01329-08; Hendrickson TL, 2003, MOL B INT U, P34; Hogg J, 2008, PROTEIN EXPRES PURIF, V61, P163, DOI 10.1016/j.pep.2008.05.008; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Jones T, 2008, ANTIMICROB AGENTS CH, V52, P269, DOI 10.1128/AAC.00719-07; Klein S, 2009, MOL MICROBIOL, V71, P551, DOI 10.1111/j.1365-2958.2008.06562.x; Komatsuzawa H, 2001, FEMS MICROBIOL LETT, V203, P49, DOI 10.1111/j.1574-6968.2001.tb10819.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LENNARZ WJ, 1966, P NATL ACAD SCI USA, V55, P934, DOI 10.1073/pnas.55.4.934; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lloyd AJ, 2008, J BIOL CHEM, V283, P6402, DOI 10.1074/jbc.M708105200; Mishra NN, 2009, ANTIMICROB AGENTS CH, V53, P2312, DOI 10.1128/AAC.01682-08; Nishi H, 2004, ANTIMICROB AGENTS CH, V48, P4800, DOI 10.1128/AAC.48.12.4800-4807.2004; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Reeve WG, 2006, MICROBIOL-SGM, V152, P3049, DOI 10.1099/mic.0.28764-0; ROY H, 2009, IUBMB LIFE IN PRESS; Roy H, 2008, P NATL ACAD SCI USA, V105, P4667, DOI 10.1073/pnas.0800006105; Roy H, 2008, METHODS, V44, P164, DOI 10.1016/j.ymeth.2007.09.002; Roy H, 2009, MOL MICROBIOL, V71, P547, DOI 10.1111/j.1365-2958.2008.06563.x; Salzberg LI, 2008, J BACTERIOL, V190, P7797, DOI 10.1128/JB.00720-08; Samant S, 2009, J BACTERIOL, V191, P1311, DOI 10.1128/JB.01345-08; Sohlenkamp C, 2007, MOL PLANT MICROBE IN, V20, P1421, DOI 10.1094/MPMI-20-11-1421; Staubitz P, 2004, FEMS MICROBIOL LETT, V231, P67, DOI 10.1016/S0378-1097(03)00921-2; Thedieck K, 2006, MOL MICROBIOL, V62, P1325, DOI 10.1111/j.1365-2958.2006.05452.x; THOMPSON JD, 2003, CURRENT PROTOCOLS BI; Villet R, 2007, NUCLEIC ACIDS RES, V35, P6870, DOI 10.1093/nar/gkm778; Weidenmaier C, 2005, INFECT IMMUN, V73, P8033, DOI 10.1128/IAI.73.12.8033-8038.2005; Yang SJ, 2009, ANTIMICROB AGENTS CH, V53, P2636, DOI 10.1128/AAC.01415-08; Zemansky J, 2009, J BACTERIOL, V191, P3950, DOI 10.1128/JB.00016-09	36	50	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29677	29683		10.1074/jbc.M109.046367	http://dx.doi.org/10.1074/jbc.M109.046367			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19734140	Green Published, hybrid			2022-12-27	WOS:000270896800049
J	Yasuda, S; Kai, M; Imai, S; Takeishi, K; Taketomi, A; Toyota, M; Kanoh, H; Sakane, F				Yasuda, Satoshi; Kai, Masahiro; Imai, Shin-ichi; Takeishi, Kazuki; Taketomi, Akinobu; Toyota, Minoru; Kanoh, Hideo; Sakane, Fumio			Diacylglycerol Kinase eta Augments C-Raf Activity and B-Raf/C-Raf Heterodimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL ESTER; ACTIVATION; ZETA; IDENTIFICATION; MUTATIONS; MEMBRANE; GROWTH; ALPHA; DELTA; PHOSPHORYLATION	The Ras/B-Raf/C-Raf/MEK/ERK signaling cascade is critical for the control of many fundamental cellular processes, including proliferation, survival, and differentiation. This study demonstrated that small interfering RNA-dependent knockdown of diacylglycerol kinase eta (DGK eta) impaired the Ras/B-Raf/C-Raf/MEK/ERK pathway activated by epidermal growth factor (EGF) in HeLa cells. Conversely, the overexpression of DGK eta 1 could activate the Ras/B-Raf/C-Raf/MEK/ERK pathway in a DGK activity-independent manner, suggesting that DGK eta serves as a scaffold/adaptor protein. By determining the activity of all the components of the pathway in DGK eta-silenced HeLa cells, this study revealed that DGK eta activated C-Raf but not B-Raf. Moreover, this study demonstrated that DGK eta enhanced EGF-induced heterodimerization of C-Raf with B-Raf, which transmits the signal to C-Raf. DGK eta physically interacted with B-Raf and C-Raf, regulating EGF-induced recruitment of B-Raf and C-Raf from the cytosol to membranes. The DGK eta-dependent activation of C-Raf occurred downstream or independently of the already known C-Raf modifications, such as dephosphorylation at Ser-259, phosphorylation at Ser-338, and interaction with 14-3-3 protein. Taken together, the results obtained strongly support that DGK eta acts as a novel critical regulatory component of the Ras/B-Raf/C-Raf/MEK/ERK signaling cascade via a previously unidentified mechanism.	[Kanoh, Hideo] Sapporo Med Univ, Sch Med, Dept Biochem, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Sakane, Fumio] Chiba Univ, Grad Sch Sci, Dept Chem, Inage Ku, Chiba 2638522, Japan; [Takeishi, Kazuki; Taketomi, Akinobu] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan	Sapporo Medical University; Chiba University; Kyushu University		sayasu@sapmed.ac.jp; sakane@faculty.chiba-u.jp	Takeishi, Kazuki/AAC-9087-2019; Sakane, Fumio/H-2693-2017	Takeishi, Kazuki/0000-0002-8448-5396; Sakane, Fumio/0000-0003-0857-0377; YASUDA, Satoshi/0000-0002-1011-0815	Ministry of Education, Culture, Sports, Science and Technology of Japan; Northern Advancement Center for Science and Technology of Hokkaido, Japan; Japan Diabetes Foundation; Suhara Memorial Foundation; Novo Nordisk Pharma Ltd. (Japan); Takeda Science Foundation; Suzuken Memorial Foundation; Akiyama Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Northern Advancement Center for Science and Technology of Hokkaido, Japan; Japan Diabetes Foundation; Suhara Memorial Foundation; Novo Nordisk Pharma Ltd. (Japan)(Novo Nordisk); Takeda Science Foundation(Takeda Science Foundation (TSF)); Suzuken Memorial Foundation; Akiyama Foundation	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Northern Advancement Center for Science and Technology of Hokkaido, Japan, the Japan Diabetes Foundation, The Suhara Memorial Foundation, Novo Nordisk Pharma Ltd. (Japan), The Takeda Science Foundation, The Suzuken Memorial Foundation, and The Akiyama Foundation.	Balan V, 2006, MOL BIOL CELL, V17, P1141, DOI 10.1091/mbc.E04-12-1123; Chong H, 2001, EMBO J, V20, P3716, DOI 10.1093/emboj/20.14.3716; Crotty T, 2006, P NATL ACAD SCI USA, V103, P15485, DOI 10.1073/pnas.0604104103; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Fischer A, 2009, J BIOL CHEM, V284, P3183, DOI 10.1074/jbc.M804795200; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Hagemann C, 1999, EXP CELL RES, V253, P34, DOI 10.1006/excr.1999.4689; Imai S, 2005, J BIOL CHEM, V280, P39870, DOI 10.1074/jbc.M500669200; Imai S, 2002, J BIOL CHEM, V277, P35323, DOI 10.1074/jbc.M202035200; Karbowniczek M, 2006, J BIOL CHEM, V281, P25447, DOI 10.1074/jbc.M605273200; Kawasaki T, 2008, BIOCHEM J, V409, P471, DOI 10.1042/BJ20070755; Kim K, 2009, EMBO J, V28, P1170, DOI 10.1038/emboj.2009.44; Klauck TM, 1996, J BIOL CHEM, V271, P19781, DOI 10.1074/jbc.271.33.19781; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; Luo B, 2004, CELL SIGNAL, V16, P891, DOI 10.1016/j.cellsig.2004.01.010; Luo B, 2003, J CELL BIOL, V160, P929, DOI 10.1083/jcb.200208120; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Mizutani S, 2001, FEBS LETT, V507, P295, DOI 10.1016/S0014-5793(01)02992-1; Murakami T, 2003, J BIOL CHEM, V278, P34364, DOI 10.1074/jbc.M301542200; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Regier DS, 2005, P NATL ACAD SCI USA, V102, P7595, DOI 10.1073/pnas.0500663102; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Sakane F, 2002, J BIOL CHEM, V277, P43519, DOI 10.1074/jbc.M206895200; Sakane F, 1996, J BIOL CHEM, V271, P8394, DOI 10.1074/jbc.271.14.8394; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Sanjuan MA, 2003, J IMMUNOL, V170, P2877, DOI 10.4049/jimmunol.170.6.2877; Sharma A, 2005, CANCER RES, V65, P2412, DOI 10.1158/0008-5472.CAN-04-2423; Terai K, 2005, EMBO REP, V6, P251, DOI 10.1038/sj.embor.7400349; Topham MK, 2009, BBA-GEN SUBJECTS, V1790, P416, DOI 10.1016/j.bbagen.2009.01.010; Topham MK, 2001, J CELL BIOL, V152, P1135, DOI 10.1083/jcb.152.6.1135; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Yasuda S, 2008, BIOCHEM J, V409, P95, DOI 10.1042/BJ20070848; Yasuda S, 2007, FEBS LETT, V581, P551, DOI 10.1016/j.febslet.2007.01.022; Zebisch A, 2006, CANCER RES, V66, P3401, DOI 10.1158/0008-5472.CAN-05-0115	43	49	55	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29559	29570		10.1074/jbc.M109.043604	http://dx.doi.org/10.1074/jbc.M109.043604			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19710016	Green Published, hybrid			2022-12-27	WOS:000270896800038
J	Mishima, Y; Quintin, J; Aimanianda, V; Kellenberger, C; Coste, F; Clavaud, C; Hetru, C; Hoffmann, JA; Latge, JP; Ferrandon, D; Roussel, A				Mishima, Yumiko; Quintin, Jessica; Aimanianda, Vishukumar; Kellenberger, Christine; Coste, Franck; Clavaud, Cecile; Hetru, Charles; Hoffmann, Jules A.; Latge, Jean-Paul; Ferrandon, Dominique; Roussel, Alain			The N-terminal Domain of Drosophila Gram-negative Binding Protein 3 (GNBP3) Defines a Novel Family of Fungal Pattern Recognition Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPHENOLOXIDASE ACTIVATING SYSTEM; LYSINE-TYPE PEPTIDOGLYCAN; BETA-GLUCAN RECEPTOR; INNATE IMMUNITY; CRYSTAL-STRUCTURE; BOMBYX-MORI; POSITIVE BACTERIA; PGRP-SD; BETA-1,3-GLUCAN; TOLL	Gram-negative binding protein 3 (GNBP3), a pattern recognition receptor that circulates in the hemolymph of Drosophila, is responsible for sensing fungal infection and triggering Toll pathway activation. Here, we report that GNBP3 N-terminal domain binds to fungi upon identifying long chains of beta-1,3-glucans in the fungal cell wall as a major ligand. Interestingly, this domain fails to interact strongly with short oligosaccharides. The crystal structure of GNBP3-Nter reveals an immunoglobulin-like fold in which the glucan binding site is masked by a loop that is highly conserved among glucan-binding proteins identified in several insect orders. Structure-based mutagenesis experiments reveal an essential role for this occluding loop in discriminating between short and long polysaccharides. The displacement of the occluding loop is necessary for binding and could explain the specificity of the interaction with long chain structured polysaccharides. This represents a novel mechanism for beta-glucan recognition.	[Mishima, Yumiko; Kellenberger, Christine; Coste, Franck; Roussel, Alain] CNRS, CBM, UPR 4301, F-45071 Orleans 2, France; [Quintin, Jessica; Hetru, Charles; Hoffmann, Jules A.; Ferrandon, Dominique] CNRS, UPR9022, Inst Biol Mole culaire & Cellulaire, F-67084 Strasbourg, France; [Aimanianda, Vishukumar; Clavaud, Cecile; Latge, Jean-Paul] Inst Pasteur, Unite Aspergillus, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Roussel, A (corresponding author), CNRS, CBM, UPR 4301, Rue Charles 631-517, F-45071 Orleans 2, France.	roussel@cnrs-orleans.fr	kellenberger, christine/AAV-9304-2020; Aimanianda, Vishukumar/E-9204-2011; Latge, Jean Paul/C-9846-2014; coste, franck/ABC-1407-2020; coste, franck/F-6832-2015	Aimanianda, Vishukumar/0000-0001-5813-7497; coste, franck/0000-0002-7409-0470; coste, franck/0000-0002-7409-0470; FERRANDON, Dominique/0000-0001-7680-7773	National Institutes of Health [PO1 AI44220]; Action Thematique et Incitative sur Programme of the CNRS; Agence Nationale de la Recherche; Ministere de l'Enseignement et de la Recherche; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Action Thematique et Incitative sur Programme of the CNRS; Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministere de l'Enseignement et de la Recherche; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 AI44220. This work was also supported by an Action Thematique et Incitative sur Programme of the CNRS (2005-2008, to A. R.), by a grant from the Agence Nationale de la Recherche (ANR-MIME, to A. R. and C. H.), by the CNRS, and by a grant from the Ministere de l'Enseignement et de la Recherche ( Programme de Recherche en Microbiologie).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bischoff V, 2004, NAT IMMUNOL, V5, P1175, DOI 10.1038/ni1123; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Chang CI, 2006, SCIENCE, V311, P1761, DOI 10.1126/science.1123056; Chang CI, 2004, PLOS BIOL, V2, P1293, DOI 10.1371/journal.pbio.0020277; de Pereda JM, 1999, EMBO J, V18, P4087, DOI 10.1093/emboj/18.15.4087; El Chamy L, 2008, NAT IMMUNOL, V9, P1165, DOI 10.1038/ni.1643; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabrick JA, 2004, J BIOL CHEM, V279, P26605, DOI 10.1074/jbc.M403382200; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Gobert V, 2003, SCIENCE, V302, P2126, DOI 10.1126/science.1085432; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim MS, 2003, NAT IMMUNOL, V4, P787, DOI 10.1038/ni952; Lee SH, 2006, PROTEIN SCI, V15, P304, DOI 10.1110/ps.051813506; Lee WJ, 1996, P NATL ACAD SCI USA, V93, P7888, DOI 10.1073/pnas.93.15.7888; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Leone P, 2008, MOL IMMUNOL, V45, P2521, DOI 10.1016/j.molimm.2008.01.015; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; Machovic M, 2006, CELL MOL LIFE SCI, V63, P2710, DOI 10.1007/s00018-006-6246-9; Martin-Cuadrado AB, 2008, MOL MICROBIOL, V69, P188, DOI 10.1111/j.1365-2958.2008.06275.x; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Mishima Y, 2009, ACTA CRYSTALLOGR F, V65, P870, DOI 10.1107/S1744309109014997; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MUTA T, 1995, J BIOL CHEM, V270, P892, DOI 10.1074/jbc.270.2.892; OCHIAI M, 1988, J BIOL CHEM, V263, P12056; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Okobira T, 2008, BIOMACROMOLECULES, V9, P783, DOI 10.1021/bm700511d; Palma AS, 2006, J BIOL CHEM, V281, P5771, DOI 10.1074/jbc.M511461200; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; Ramirez MG, 2004, J MICROBIOL METH, V56, P213, DOI 10.1016/j.mimet.2003.10.011; ROUSSEL A, 1991, SILICON GRAPHICS GEO; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; Takaki Y, 2002, J BIOL CHEM, V277, P14281, DOI 10.1074/jbc.M200177200; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; van Bueren AL, 2007, J MOL BIOL, V365, P555, DOI 10.1016/j.jmb.2006.10.018; YOSHIDA H, 1986, BIOCHEM BIOPH RES CO, V141, P1177, DOI 10.1016/S0006-291X(86)80168-1	51	50	55	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28687	28697		10.1074/jbc.M109.034587	http://dx.doi.org/10.1074/jbc.M109.034587			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19692333	Green Published, hybrid			2022-12-27	WOS:000270678900024
J	Peiro-Chova, L; Estruch, F				Peiro-Chova, Lorena; Estruch, Francisco			The Yeast RNA Polymerase II-associated Factor Iwr1p Is Involved in the Basal and Regulated Transcription of Specific Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; IN-VIVO; PHO5 PROMOTER; ACID-PHOSPHATASE; FINGER PROTEINS; COMPLEX; NC2; REPRESSION; EXPRESSION	RNA polymerase II (RNA pol II) is a multisubunit enzyme that requires many auxiliary factors for its activity. Over the years, these factors have been identified using both biochemical and genetic approaches. Recently, the systematic characterization of protein complexes by tandem affinity purification and mass spectroscopy has allowed the identification of new components of well established complexes, including the RNA pol II holoenzyme. Using this approach, a novel and highly conserved factor, Iwr1p, that physically interacts with most of the RNA pol II subunits has been described in yeast. Here we show that Iwr1p genetically interacts with components of the basal transcription machinery and plays a role in both basal and regulated transcription. We report that mutation of the IWR1 gene is able to bypass the otherwise essential requirement for the transcriptional regulator negative cofactor 2, which occurs with different components of the basal transcription machinery, including TFIIA and subunits of the mediator complex. Deletion of the IWR1 gene leads to an altered expression of specific genes, including phosphate-responsive genes and SUC2. Our results show that Iwr1p is a nucleocytoplasmic shuttling protein and suggest that Iwr1p acts early in the formation of the pre-initiation complex by mediating the interaction of certain activators with the basal transcription apparatus.	[Peiro-Chova, Lorena; Estruch, Francisco] Univ Valencia, Dept Biochem & Mol Biol, E-46100 Burjassot, Spain	University of Valencia	Estruch, F (corresponding author), Fac Biol, C Dr Moliner 50, Valencia 46100, Spain.	estruch@uv.es	Estruch, Francisco/R-4569-2018		Spanish Ministry of Education and Science [BFU2007-61525, BFU2008-04082-C02-01]	Spanish Ministry of Education and Science(Spanish Government)	This work was supported in part by Spanish Ministry of Education and Science Grants BFU2007-61525 and BFU2008-04082-C02-01 (to F. E.).	Adkins MW, 2007, MOL CELL BIOL, V27, P6372, DOI 10.1128/MCB.00981-07; Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; Amoros M, 2001, MOL MICROBIOL, V39, P1523, DOI 10.1046/j.1365-2958.2001.02339.x; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Balciunas D, 1999, P NATL ACAD SCI USA, V96, P376, DOI 10.1073/pnas.96.2.376; Barbaric S, 2007, J BIOL CHEM, V282, P27610, DOI 10.1074/jbc.M700623200; Beve J, 2005, J BIOL CHEM, V280, P41366, DOI 10.1074/jbc.M511181200; BURNS N, 1994, GENE DEV, V8, P1087, DOI 10.1101/gad.8.9.1087; Cang Y, 2002, P NATL ACAD SCI USA, V99, P12727, DOI 10.1073/pnas.202236699; Conaway JW, 2000, TRENDS BIOCHEM SCI, V25, P375, DOI 10.1016/S0968-0004(00)01615-7; CRABEEL M, 1995, YEAST, V11, P1367, DOI 10.1002/yea.320111405; CRABEEL M, 1990, MOL CELL BIOL, V10, P1226, DOI 10.1128/MCB.10.3.1226; Dhasarathy A, 2005, MOL CELL BIOL, V25, P2698, DOI 10.1128/MCB.25.7.2698-2707.2005; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; Gadbois EL, 1997, P NATL ACAD SCI USA, V94, P3145, DOI 10.1073/pnas.94.7.3145; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Geisberg JV, 2001, MOL CELL BIOL, V21, P2736, DOI 10.1128/MCB.21.8.2736-2742.2001; Geng FQ, 2004, EMBO J, V23, P127, DOI 10.1038/sj.emboj.7600035; Gligoris T, 2007, MOL CELL BIOL, V27, P4198, DOI 10.1128/MCB.00238-07; Goppelt A, 1996, EMBO J, V15, P3105, DOI 10.1002/j.1460-2075.1996.tb00673.x; Goppelt A, 1996, NUCLEIC ACIDS RES, V24, P4450, DOI 10.1093/nar/24.22.4450; Gregory PD, 1999, METHOD ENZYMOL, V304, P365; HAGUENAUERTSAPIS R, 1984, MOL CELL BIOL, V4, P2668, DOI 10.1128/MCB.4.12.2668; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; HINNEBUSCH AG, 1988, MICROBIOL REV, V52, P248, DOI 10.1128/MMBR.52.2.248-273.1988; Kamada K, 2001, CELL, V106, P71, DOI 10.1016/S0092-8674(01)00417-2; Kim S, 2000, MOL CELL BIOL, V20, P2455, DOI 10.1128/MCB.20.7.2455-2465.2000; Korber P, 2006, J BIOL CHEM, V281, P5539, DOI 10.1074/jbc.M513340200; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Lee TI, 1998, MOL CELL BIOL, V18, P4455, DOI 10.1128/MCB.18.8.4455; Lemaire M, 2000, MOL MICROBIOL, V36, P163, DOI 10.1046/j.1365-2958.2000.01839.x; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Magbanua JPV, 1997, J BIOCHEM, V121, P1182; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; Mermelstein F, 1996, GENE DEV, V10, P1033, DOI 10.1101/gad.10.8.1033; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Neef DW, 2003, MOL CELL BIOL, V23, P3788, DOI 10.1128/MCB.23.11.3788-3797.2003; NEHLIN JO, 1990, EMBO J, V9, P2891, DOI 10.1002/j.1460-2075.1990.tb07479.x; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Peiro-Chova L, 2007, GENETICS, V176, P125, DOI 10.1534/genetics.106.066829; Prelich G, 1997, MOL CELL BIOL, V17, P2057, DOI 10.1128/MCB.17.4.2057; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Pugh BF, 2000, GENE, V255, P1, DOI 10.1016/S0378-1119(00)00288-2; Qiu HF, 2004, MOL CELL BIOL, V24, P4104, DOI 10.1128/MCB.24.10.4104-4117.2004; Reinke H, 2004, BBA-GENE STRUCT EXPR, V1677, P24, DOI 10.1016/j.bbaexp.2003.09.014; Riego L, 2002, BIOCHEM BIOPH RES CO, V293, P79, DOI 10.1016/S0006-291X(02)00174-2; SCHMID A, 1992, CELL, V71, P853, DOI 10.1016/0092-8674(92)90560-Y; Serrano R, 2002, MOL MICROBIOL, V46, P1319, DOI 10.1046/j.1365-2958.2002.03246.x; Springer M, 2003, PLOS BIOL, V1, P261, DOI 10.1371/journal.pbio.0000028; TREITEL MA, 1995, P NATL ACAD SCI USA, V92, P3132, DOI 10.1073/pnas.92.8.3132; UEDA Y, 1975, J BACTERIOL, V122, P911, DOI 10.1128/JB.122.3.911-922.1975; Velours J, 2000, J BIOENERG BIOMEMBR, V32, P383, DOI 10.1023/A:1005580020547; Xie J, 2000, EMBO J, V19, P672, DOI 10.1093/emboj/19.4.672; YOUNG RA, 1991, ANNU REV BIOCHEM, V60, P689, DOI 10.1146/annurev.biochem.60.1.689	61	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28958	28967		10.1074/jbc.M109.012153	http://dx.doi.org/10.1074/jbc.M109.012153			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19679657	Green Published, hybrid			2022-12-27	WOS:000270678900053
J	Schmeisser, MJ; Grabrucker, AM; Bockmann, J; Boeckers, TM				Schmeisser, Michael J.; Grabrucker, Andreas M.; Bockmann, Juergen; Boeckers, Tobias M.			Synaptic Cross-talk between N-Methyl-D-aspartate Receptors and LAPSER1-beta-Catenin at Excitatory Synapses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTSYNAPTIC DENSITY; BETA-CATENIN; TRANSLATIONAL CONTROL; TRANSCRIPTION FACTORS; TUMOR-SUPPRESSOR; WNT; PROTEIN; PLASTICITY; GENE; DIFFERENTIATION	Memory formation in the brain is thought to be depending upon long lasting plastic changes of synaptic contacts that require alterations on the transcriptional level. Here, we characterize LAPSER1, a putative cytokinetic tumor suppressor that binds directly to ProSAP2/Shank3 and the synaptic Rap-Gap protein SPAR1 as a novel postsynaptic density component. Postsynaptic LAPSER1 is in complex with all important members of the canonical Wnt pathway including beta-catenin. Upon N-methyl-D-aspartate receptor-dependent activation, LAPSER1 and beta-catenin comigrate from the postsynaptic density to the nucleus and induce the transcription and translation of known beta-catenin target genes, including Tcfe2a and c-Myc. The nuclear export and cytoplasmic redistribution of beta-catenin is tightly regulated by LAPSER1. We postulate a postsynaptic cross-talk between N-methyl-D-aspartate receptors and a LAPSER1-beta-catenin complex that results in a self-regulated, synaptic activity-dependent expression of beta-catenin target genes. This calls for a novel role of Tcfe2a and c-Myc in plastic changes of neural tissue.	[Schmeisser, Michael J.; Grabrucker, Andreas M.; Bockmann, Juergen; Boeckers, Tobias M.] Univ Ulm, Inst Anat & Cell Biol, D-89081 Ulm, Germany	Ulm University	Boeckers, TM (corresponding author), Univ Ulm, Inst Anat & Cell Biol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	tobias.boeckers@uni-ulm.de	Schmeisser, Michael/S-6347-2019	Grabrucker, Andreas/0000-0003-0005-4810	Deutsche Forschungsgemeinschaft [SFB497-B8, BO 1718;3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB497-B8 (to T. M. B.) and BO 1718;3-1.	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; Alberini CM, 1999, J EXP BIOL, V202, P2887; Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Baudino TA, 2001, MOL CELL BIOL, V21, P691, DOI 10.1128/MCB.21.3.691-702.2001; Boeckers TM, 2006, CELL TISSUE RES, V326, P409, DOI 10.1007/s00441-006-0274-5; Boeckers TM, 2002, J NEUROCHEM, V81, P903, DOI 10.1046/j.1471-4159.2002.00931.x; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Cabeza-Arvelaiz Y, 2001, ONCOGENE, V20, P6707, DOI 10.1038/sj.onc.1204866; Caricasole A, 2005, BIOSCIENCE REP, V25, P309, DOI 10.1007/s10540-005-2893-6; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; De Ferrari GV, 2006, ONCOGENE, V25, P7545, DOI 10.1038/sj.onc.1210064; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; DIETERICH DC, 2008, BIOLOGY, V6, pE34; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Dresbach T, 2003, MOL CELL NEUROSCI, V23, P279, DOI 10.1016/S1044-7431(03)00015-0; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Gundelfinger ED, 2006, TRENDS BIOCHEM SCI, V31, P366, DOI 10.1016/j.tibs.2006.05.007; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Ishii H, 2001, P NATL ACAD SCI USA, V98, P10374, DOI 10.1073/pnas.181222898; Jordan BA, 2007, NAT NEUROSCI, V10, P427, DOI 10.1038/nn1867; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Knoepfler PS, 2007, CANCER RES, V67, P5061, DOI 10.1158/0008-5472.CAN-07-0426; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Konno D, 2002, J CELL SCI, V115, P4695, DOI 10.1242/jcs.00127; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Murillas R, 2002, J BIOL CHEM, V277, P2897, DOI 10.1074/jbc.M110047200; Nishimura W, 2002, J NEUROSCI, V22, P757, DOI 10.1523/JNEUROSCI.22-03-00757.2002; Packard M, 2003, NAT REV NEUROSCI, V4, P113, DOI 10.1038/nrn1036; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Proepper C, 2007, EMBO J, V26, P1397, DOI 10.1038/sj.emboj.7601569; Salinas PC, 2005, CURR OPIN NEUROBIOL, V15, P73, DOI 10.1016/j.conb.2005.01.001; Seidenbecher CI, 1998, J BIOL CHEM, V273, P21324, DOI 10.1074/jbc.273.33.21324; Sheng M, 2000, J CELL SCI, V113, P1851; Speese SD, 2007, TRENDS NEUROSCI, V30, P268, DOI 10.1016/j.tins.2007.04.003; Spilker C, 2008, J NEUROCHEM, V104, P187, DOI 10.1111/j.1471-4159.2007.04991.x; Sudo H, 2007, FASEB J, V21, P2086, DOI 10.1096/fj.06-7254com; Takeichi M, 2005, TRENDS CELL BIOL, V15, P216, DOI 10.1016/j.tcb.2005.02.002; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tang SJ, 2007, SYNAPSE, V61, P866, DOI 10.1002/syn.20434; Thyssen G, 2006, MOL CELL BIOL, V26, P8857, DOI 10.1128/MCB.01031-06; Tsai IC, 2007, DEV CELL, V12, P335, DOI 10.1016/j.devcel.2007.02.009; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wendholt D, 2006, J BIOL CHEM, V281, P13805, DOI 10.1074/jbc.M601101200; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Wu H, 2007, FEBS J, V274, P3218, DOI 10.1111/j.1742-4658.2007.05891.x; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522	56	43	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29146	29157		10.1074/jbc.M109.020628	http://dx.doi.org/10.1074/jbc.M109.020628			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19703901	Green Published, hybrid			2022-12-27	WOS:000270678900070
J	Du, ZY; Fan, MY; Kim, JG; Eckerle, D; Lothstein, L; Wei, L; Pfeffer, LM				Du, Ziyun; Fan, Meiyun; Kim, Jong-Gwan; Eckerle, Dara; Lothstein, Leonard; Wei, Lai; Pfeffer, Lawrence M.			Interferon-resistant Daudi Cell Line with a Stat2 Defect Is Resistant to Apoptosis Induced by Chemotherapeutic Agents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ALPHA-INTERFERON; ANTIPROLIFERATIVE ACTION; PHOSPHATIDYLINOSITOL 3-KINASE; BINDING; TRANSCRIPTION; DNA; RESPONSIVENESS; IDENTIFICATION; TRAFFICKING	Interferon-alpha (IFN alpha) has shown promise in the treatment of various cancers. However, the development of IFN resistance is a significant drawback. Using conditions that mimic in vivo selection of IFN-resistant cells, the RST2 IFN-resistant cell line was isolated from the highly IFN-sensitive Daudi human Burkitt lymphoma cell line. The RST2 cell line was resistant to the antiviral, antiproliferative, and gene-induction actions of IFNa. Although STAT2 mRNA was present, STAT2 protein expression was deficient in RST2 cells. A variant STAT2 mRNA, which resulted from alternative splicing within the intron between exon 19 and 20, was expressed in several human cell lines but at relatively high levels in RST2 cells. Most importantly, the RST2 line showed an intrinsic resistance to apoptosis induced by a number of chemotherapeutic agents (camptothecin, staurosporine, and doxorubicin). Expression of STAT2 in RST2 cells not only rescued their sensitivity to the biological activities of IFNs but also restored sensitivity to apoptosis induced by these chemotherapeutic agents. The intrinsic resistance of the RST2 cells to IFN as well as chemotherapeutic agents adds a new dimension to our knowledge of the role of STAT2 as it relates to not only biological actions of IFN but also resistance to chemotherapy-induced apoptosis.	Univ Tennessee, Hlth Sci Ctr, Dept Pathol & Lab Med, Memphis, TN 38163 USA; Ctr Canc Res, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Pfeffer, LM (corresponding author), 19 S Manassas Ave,Rm 154, Memphis, TN 38163 USA.	lpfeffer@utmem.edu	Wei, Lai/D-1088-2014	Pfeffer, Lawrence/0000-0003-2809-1234	National Institutes of Health [CA73753]; Muirhead Chair Endowment at the University of Tennessee Health Science Center; NATIONAL CANCER INSTITUTE [R01CA073753, R01CA133322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muirhead Chair Endowment at the University of Tennessee Health Science Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA73753 (to L. M. P.). This work was also supported by funds from the Muirhead Chair Endowment at the University of Tennessee Health Science Center (to L. M. P.).	Banninger G, 2004, J BIOL CHEM, V279, P39199, DOI 10.1074/jbc.M400815200; Binaschi M., 2001, Current Medicinal Chemistry - Anti-Cancer Agents, V1, P113, DOI 10.2174/1568011013354723; Brierley MM, 2005, J BIOL CHEM, V280, P13029, DOI 10.1074/jbc.M500426200; Caldenhoven E, 1996, J BIOL CHEM, V271, P13221, DOI 10.1074/jbc.271.22.13221; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; De Clercq E, 2004, J CLIN VIROL, V30, P115, DOI 10.1016/j.jcv.2004.02.009; Du ZY, 2007, J CELL BIOCHEM, V102, P1087, DOI 10.1002/jcb.21535; EISENKRAFT BL, 1991, CANCER RES, V51, P5881; Johnson LR, 1999, AM J PHYSIOL-CELL PH, V276, pC419, DOI 10.1152/ajpcell.1999.276.2.C419; Khodarev NN, 2007, CANCER RES, V67, P9214, DOI 10.1158/0008-5472.CAN-07-1019; Kingma PS, 1999, BIOCHEMISTRY-US, V38, P3457, DOI 10.1021/bi982855i; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; Mack JT, 2007, CURR DRUG METAB, V8, P47, DOI 10.2174/138920007779315044; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; PFEFFER LM, 1990, CANCER RES, V50, P2654; Pfeffer LM, 1996, J UROLOGY, V156, P1867, DOI 10.1016/S0022-5347(01)65555-1; Pfeffer LM, 1998, CANCER RES, V58, P2489; Pfeffer LM, 1997, SCIENCE, V276, P1418, DOI 10.1126/science.276.5317.1418; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; SCHINDLER C, 1992, P NATL ACAD SCI USA, V89, P7836, DOI 10.1073/pnas.89.16.7836; Stark G R, 1997, Harvey Lect, V93, P1; Sugiyama T, 1996, FEBS LETT, V381, P191, DOI 10.1016/0014-5793(96)00121-4; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wei L, 2006, J BIOL CHEM, V281, P11678, DOI 10.1074/jbc.M513286200; Wong LH, 1997, J BIOL CHEM, V272, P28779, DOI 10.1074/jbc.272.45.28779; XU B, 1994, BLOOD, V84, P1942; YAN RQ, 1995, NUCLEIC ACIDS RES, V23, P459, DOI 10.1093/nar/23.3.459; Yang CH, 1998, P NATL ACAD SCI USA, V95, P5568, DOI 10.1073/pnas.95.10.5568; Yang CH, 1996, J BIOL CHEM, V271, P8057, DOI 10.1074/jbc.271.14.8057; Yang CH, 2000, P NATL ACAD SCI USA, V97, P13631, DOI 10.1073/pnas.250477397; Yang CH, 2007, J IMMUNOL, V178, P986, DOI 10.4049/jimmunol.178.2.986; Yang CL, 2001, J BIOL CHEM, V276, P47277, DOI 10.1074/jbc.M105396200; Yang J, 2005, CANCER RES, V65, P939; Zelcer N, 2003, BIOCHEM J, V371, P361, DOI 10.1042/BJ20021886; ZHONG Z, 1994, P NATL ACAD SCI USA, V91, P4806, DOI 10.1073/pnas.91.11.4806	40	22	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27808	27815		10.1074/jbc.M109.028324	http://dx.doi.org/10.1074/jbc.M109.028324			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19687011	Green Published, hybrid			2022-12-27	WOS:000270676300007
J	Li, LO; Ellis, JM; Paich, HA; Wang, SL; Gong, N; Altshuller, G; Thresher, RJ; Koves, TR; Watkins, SM; Muoio, DM; Cline, GW; Shulman, GI; Coleman, RA				Li, Lei O.; Ellis, Jessica M.; Paich, Heather A.; Wang, Shuli; Gong, Nan; Altshuller, George; Thresher, Randy J.; Koves, Timothy R.; Watkins, Steven M.; Muoio, Deborah M.; Cline, Gary W.; Shulman, Gerald I.; Coleman, Rosalind A.			Liver-specific Loss of Long Chain Acyl-CoA Synthetase-1 Decreases Triacylglycerol Synthesis and beta-Oxidation and Alters Phospholipid Fatty Acid Composition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC INSULIN-RESISTANCE; RAT-LIVER; MESSENGER-RNA; PHOSPHATIDYLCHOLINE SYNTHESIS; MICROSOMAL-ENZYMES; SELECTIVE CHANGES; KNOCKOUT MICE; EXPRESSION; METABOLISM; PROTEIN	In mammals, a family of five acyl-CoA synthetases (ACSLs), each the product of a separate gene, activates long chain fatty acids to form acyl-CoAs. Because the ACSL isoforms have overlapping preferences for fatty acid chain length and saturation and are expressed in many of the same tissues, the individual function of each isoform has remained uncertain. Thus, we constructed a mouse model with a liver-specific knock-out of ACSL1, a major ACSL isoform in liver. Eliminating ACSL1 in liver resulted in a 50% decrease in total hepatic ACSL activity and a 25-35% decrease in long chain acyl-CoA content. Although the content of triacylglycerol was unchanged in Acsl1(L-/-) liver after mice were fed either low or high fat diets, in isolated primary hepatocytes the absence of ACSL1 diminished the incorporation of [C-14]oleate into triacylglycerol. Further, small but consistent increases were observed in the percentage of 16:0 in phosphatidylcholine and phosphatidylethanolamine and of 18:1 in phosphatidylethanolamine and lysophosphatidylcholine, whereas concomitant decreases were seen in 18:0 in phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and lysophosphatidylcholine. In addition, decreases in long chain acylcarnitine content and diminished production of acid-soluble metabolites from [C-14]oleate suggested that hepatic ACSL1 is important for mitochondrial beta-oxidation of long chain fatty acids. Because the Acsl1(L-/-) mice were not protected from developing either high fat diet-induced hepatic steatosis or insulin resistance, our study suggests that lowering the content of hepatic acyl-CoA without a concomitant decrease in triacylglycerol and other lipid intermediates is insufficient to protect against hepatic insulin resistance.	[Li, Lei O.; Ellis, Jessica M.; Paich, Heather A.; Wang, Shuli; Gong, Nan; Coleman, Rosalind A.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA; [Altshuller, George; Thresher, Randy J.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Koves, Timothy R.; Muoio, Deborah M.] Duke Univ, Dept Med, Durham, NC 27710 USA; [Watkins, Steven M.] Lip Technol Inc, W Sacramento, CA 95691 USA; [Cline, Gary W.; Shulman, Gerald I.] Yale Univ, Howard Hughes Med Inst, Dept Internal Med & Cellular & Mol Physiol, New Haven, CT 06510 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Howard Hughes Medical Institute; Yale University	Coleman, RA (corresponding author), Univ N Carolina, Dept Nutr, CB 7461, Chapel Hill, NC 27599 USA.	rcoleman@unc.edu	Koves, Tim/I-4806-2012; Shulman, Gerald I./P-7176-2019; Muoio, Debbie Marie/E-1147-2012; Li, Lei/B-5164-2010	Koves, Tim/0000-0001-8763-5866; Shulman, Gerald I./0000-0003-1529-5668; Muoio, Deborah/0000-0003-3760-9277	National Institutes of Health [DK59935, DK40936, U24 DK59635, P30 DK34987]; American Diabetes Association; American Heart Association Mid-Atlantic Region; Precloctoral Training Grant [HL069768, P30 DK034987, P30 DK056350]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040936, U24DK059635, P30DK034987, P30DK056350, R01DK059935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association Mid-Atlantic Region(American Heart Association); Precloctoral Training Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK59935 (to R. A. Q, DK40936 (to G. 1. S.), U24 DK59635 (to G. 1. S.), P30 DK34987 (to G. 1. S.), a grant from the American Diabetes Association (to D. M. M.), a postdoctoral fellowship from the American Heart Association Mid-Atlantic Region (to L. O. L.), Precloctoral Training Grant HL069768 in Integrative Vascular Biology (to J. M. E.) and P30 DK034987 and P30 DK056350.	Agarwal AK, 2006, ARCH BIOCHEM BIOPHYS, V449, P64, DOI 10.1016/j.abb.2006.03.014; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buhl ES, 2002, DIABETES, V51, P2199, DOI 10.2337/diabetes.51.7.2199; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Coleman RA, 2002, J NUTR, V132, P2123, DOI 10.1093/jn/132.8.2123; COLEMAN RA, 1978, J BIOL CHEM, V253, P7256; COLEMAN RA, 1983, J BIOL CHEM, V258, P450; Distler AM, 2006, ANAL BIOCHEM, V356, P18, DOI 10.1016/j.ab.2006.03.053; Faergeman NJ, 1997, BIOCHEM J, V323, P1; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frederiksen KS, 2004, J LIPID RES, V45, P592, DOI 10.1194/jlr.M300239-JLR200; Fujino T, 1996, J BIOL CHEM, V271, P16748, DOI 10.1074/jbc.271.28.16748; Hammond LE, 2002, MOL CELL BIOL, V22, P8204, DOI 10.1128/MCB.22.23.8204-8214.2002; Iijima H, 1996, EUR J BIOCHEM, V242, P186, DOI 10.1111/j.1432-1033.1996.0186r.x; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Kos CH, 2004, NUTR REV, V62, P243, DOI 10.1301/nr2004.jun243-246; Kuriyama H, 1998, HEPATOLOGY, V27, P557, DOI 10.1002/hep.510270233; Lewin TM, 2001, J BIOL CHEM, V276, P24674, DOI 10.1074/jbc.M102036200; Li LO, 2006, J BIOL CHEM, V281, P37246, DOI 10.1074/jbc.M604427200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marszalek JR, 2004, J BIOL CHEM, V279, P23882, DOI 10.1074/jbc.M313460200; Mashek DG, 2006, J BIOL CHEM, V281, P945, DOI 10.1074/jbc.M507646200; Mashek DG, 2004, J LIPID RES, V45, P1958, DOI 10.1194/jlr.E400002-JLR200; Mashek DG, 2006, J LIPID RES, V47, P2004, DOI 10.1194/jlr.M600150-JLR200; Mashek DG, 2006, CURR OPIN LIPIDOL, V17, P274, DOI 10.1097/01.mol.0000226119.20307.2b; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Neschen S, 2005, CELL METAB, V2, P55, DOI 10.1016/j.cmet.2005.06.006; Parkes HA, 2006, AM J PHYSIOL-ENDOC M, V291, pE737, DOI 10.1152/ajpendo.00112.2006; Petrescu AD, 2002, J BIOL CHEM, V277, P23988, DOI 10.1074/jbc.M201241200; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; SCHOONJANS K, 1995, J BIOL CHEM, V270, P19269, DOI 10.1074/jbc.270.33.19269; SCHOONJANS K, 1993, EUR J BIOCHEM, V216, P615, DOI 10.1111/j.1432-1033.1993.tb18181.x; SHIMOMURA I, 1992, BIOCHIM BIOPHYS ACTA, V1124, P112, DOI 10.1016/0005-2760(92)90086-B; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Souza SC, 2002, J BIOL CHEM, V277, P8267, DOI 10.1074/jbc.M108329200; SUZUKI H, 1990, J BIOL CHEM, V265, P8681; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Thompson AL, 2000, DIABETES, V49, P1761, DOI 10.2337/diabetes.49.11.1761; Timmers S, 2008, PHYSIOL BEHAV, V94, P242, DOI 10.1016/j.physbeh.2007.12.002; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yao HB, 2008, J BIOL CHEM, V283, P849, DOI 10.1074/jbc.M706160200	47	155	164	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27816	27826		10.1074/jbc.M109.022467	http://dx.doi.org/10.1074/jbc.M109.022467			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19648649	Green Published, hybrid			2022-12-27	WOS:000270676300008
J	Maryon, EB; Zhang, J; Jellison, JW; Kaplan, JH				Maryon, Edward B.; Zhang, Jing; Jellison, John W.; Kaplan, Jack H.			Human Copper Transporter 1 Lacking O-Linked Glycosylation Is Proteolytically Cleaved in a Rab9-positive Endosomal Compartment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; TRANSFERRIN RECEPTOR; PROTEASE INHIBITOR; SECRETORY PATHWAY; CELLS; HCTR1; MECHANISM; CTR1; ACTIVATION; FURIN	The human copper transporter hCTR1 is a homotrimer composed of a plasma membrane protein of 190 amino acids that contains three transmembrane segments. The extracellular 65-amino acid amino terminus of hCTR1 contains both N-linked (at Asn(15)) and O-linked (at Thr(27)) sites of glycosylation. If O-glycosylation at Thr(27) is prevented, hCTR1 is efficiently cleaved, removing similar to 30 amino acids from the amino terminus. We have now investigated (i) the site of this cleavage, determining which peptide bonds are cleaved, (ii) the mechanism by which glycosylation prevents cleavage, and (iii) where in the cell the proteolytic cleavage takes place. Cleavage occurs in the sequence Ala-Ser-His-Ser-His (residues 29-33), which does not contain previously recognized protease cleavage sites. Using a series of hCTR1 mutants, we show that cleavage occurs preferentially between residues Ala(29)-Ser(30)-His(31). We also show that the O-linked polysaccharide at Thr(27) blocks proteolysis due to its proximity to the cleavage site. Moving the cleavage site away from the Thr(27) polysaccharide by insertion of as few as 5 amino acids allows cleavage to occur in the presence of glycosylation. Imaging studies using immunofluorescence in fixed cells and a functional green fluorescent protein-tagged hCTR1 transporter in live cells showed that the cleaved peptide accumulates in punctate structures in the cytoplasm. These puncta overlap compartments were stained by Rab9, indicating that hCTR1 cleavage occurs in a late endosomal compartment prior to delivery of the transporter to the plasma membrane.	[Maryon, Edward B.; Zhang, Jing; Jellison, John W.; Kaplan, Jack H.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kaplan, JH (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA.	kaplanj@uic.edu		Kaplan, Jack/0000-0002-7048-6574	National Institutes of Health [P01 GM 067166]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM067166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 GM 067166 (to J. H. K.).	Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; Aller SG, 2004, J BIOL CHEM, V279, P53435, DOI 10.1074/jbc.M409421200; Bass J, 2000, P NATL ACAD SCI USA, V97, P11905, DOI 10.1073/pnas.97.22.11905; Bergin DA, 2008, J BIOL CHEM, V283, P31736, DOI 10.1074/jbc.M803732200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown CL, 1998, J BIOL CHEM, V273, P17258, DOI 10.1074/jbc.273.27.17258; Cabrera A, 2008, BIOMETALS, V21, P525, DOI 10.1007/s10534-008-9139-6; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Eisses JF, 2005, J BIOL CHEM, V280, P37159, DOI 10.1074/jbc.M508822200; Eisses JF, 2002, J BIOL CHEM, V277, P29162, DOI 10.1074/jbc.M203652200; Ganley IG, 2004, MOL BIOL CELL, V15, P5420, DOI 10.1091/mbc.E04-08-0747; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Haremaki T, 2007, P NATL ACAD SCI USA, V104, P12029, DOI 10.1073/pnas.0701413104; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; Iijima R, 1999, J BIOCHEM-TOKYO, V126, P912, DOI 10.1093/oxfordjournals.jbchem.a022534; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Kesmir C, 2002, PROTEIN ENG, V15, P287, DOI 10.1093/protein/15.4.287; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Koo BH, 2006, J BIOL CHEM, V281, P12485, DOI 10.1074/jbc.M511083200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lauer-Fields JL, 2007, J BIOL CHEM, V282, P142, DOI 10.1074/jbc.M605236200; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee LW, 2001, P NATL ACAD SCI USA, V98, P6842, DOI 10.1073/pnas.111058698; Lin KI, 1998, CELL DEATH DIFFER, V5, P577, DOI 10.1038/sj.cdd.4400384; Linder MC, 1998, AM J CLIN NUTR, V67, p965S, DOI 10.1093/ajcn/67.5.965S; Maryon EB, 2007, BIOMETALS, V20, P355, DOI 10.1007/s10534-006-9066-3; Maryon EB, 2007, J BIOL CHEM, V282, P20376, DOI 10.1074/jbc.M701806200; Matsuo M, 2006, CANCER SCI, V97, P155, DOI 10.1111/j.1349-7006.2006.00152.x; Maxson JE, 2009, BLOOD, V113, P1786, DOI 10.1182/blood-2008-08-174565; McNiven MA, 2006, SCIENCE, V313, P1591, DOI 10.1126/science.1118133; Mikolajczyk J, 2007, J BIOL CHEM, V282, P26217, DOI 10.1074/jbc.M702444200; Momiyama J, 2006, TOHOKU J EXP MED, V209, P89, DOI 10.1620/tjem.209.89; Petris MJ, 2004, PFLUG ARCH EUR J PHY, V447, P752, DOI 10.1007/s00424-003-1092-1; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Puente XS, 2005, BIOCHEM SOC T, V33, P331, DOI 10.1042/BST0330331; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; RUTLEDGE EA, 1994, BLOOD, V83, P580; RUTLEDGE EA, 1994, J BIOL CHEM, V269, P31864; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; Seidah NG, 2006, BIOL CHEM, V387, P871, DOI 10.1515/BC.2006.110; SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364; TAUB ME, 1993, J CELL SCI, V106, P1313; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; VEY M, 1994, J CELL BIOL, V127, P1829, DOI 10.1083/jcb.127.6.1829; Yamada T, 1996, J IMMUNOL, V157, P901; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745; Zhou B, 1997, P NATL ACAD SCI USA, V94, P7481, DOI 10.1073/pnas.94.14.7481	48	23	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28104	28114		10.1074/jbc.M109.044925	http://dx.doi.org/10.1074/jbc.M109.044925			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19684018	hybrid, Green Published			2022-12-27	WOS:000270676300037
J	Simona, F; Magistrato, A; Dal Peraro, M; Cavalli, A; Vila, AJ; Carloni, P				Simona, Fabio; Magistrato, Alessandra; Dal Peraro, Matteo; Cavalli, Andrea; Vila, Alejandro J.; Carloni, Paolo			Common Mechanistic Features among Metallo-beta-lactamases A COMPUTATIONAL STUDY OF AEROMONAS HYDROPHILA CphA ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; STANDARD NUMBERING SCHEME; DENSITY-FUNCTIONAL THEORY; BACILLUS-CEREUS; SUBSTRATE-BINDING; ANTIBIOTIC-RESISTANCE; BACTEROIDES-FRAGILIS; CATALYTIC MECHANISM; INHIBITOR-RESISTANT; BIOLOGICAL-SYSTEMS	Metallo-beta-lactamases (M beta Ls) constitute an increasingly serious clinical threat by giving rise to beta-lactam antibiotic resistance. They accommodate in their catalytic pocket one or two zinc ions, which are responsible for the hydrolysis of beta-lactams. Recent x-ray studies on a member of the mono-zinc B2 M beta Ls, CphA from Aeromonas hydrophila, have paved the way to mechanistic studies of this important subclass, which is selective for carbapenems. Here we have used hybrid quantum mechanical/molecular mechanical methods to investigate the enzymatic hydrolysis by CphA of the antibiotic biapenem. Our calculations describe the entire reaction and point to a new mechanistic description, which is in agreement with the available experimental evidence. Within our proposal, the zinc ion properly orients the antibiotic while directly activating a second catalytic water molecule for the completion of the hydrolytic cycle. This mechanism provides an explanation for a variety of mutagenesis experiments and points to common functional facets across B2 and B1 M beta Ls.	[Simona, Fabio] Univ Bern, Dept Chem & Biochem, Lab Computat Chem & Biochem, CH-3012 Bern, Switzerland; [Magistrato, Alessandra; Carloni, Paolo] SISSA, I-34014 Trieste, Italy; [Magistrato, Alessandra] CNR INFM Democritos Natl Simulat Ctr, I-34014 Trieste, Italy; [Dal Peraro, Matteo] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lab Biomol Modeling, CH-1015 Lausanne, Switzerland; [Cavalli, Andrea] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy; [Cavalli, Andrea] Italian Inst Technol, Dept Drug Discovery & Dev, I-16163 Genoa, Italy; [Vila, Alejandro J.] Univ Nacl Rosario, Fac Bioquim & Farmaceut, Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Santa Fe, Argentina	University of Bern; International School for Advanced Studies (SISSA); Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Bologna; Istituto Italiano di Tecnologia - IIT; National University of Rosario	Carloni, P (corresponding author), Via Beirut 2-4, I-34014 Trieste, Italy.	carloni@sissa.it	Magistrato, Alessandra/U-9756-2019; Carloni, Paolo/H-8736-2013	Vila, Alejandro/0000-0002-7978-3233; CAVALLI, ANDREA/0000-0002-6370-1176	Distributed European Infrastructure for Supercomputing Applications (DELSA); Consorzio Interuniversitario (CINECA)	Distributed European Infrastructure for Supercomputing Applications (DELSA); Consorzio Interuniversitario (CINECA)	We thank Distributed European Infrastructure for Supercomputing Applications (DELSA) and Consorzio Interuniversitario (CINECA) and its staff for CPU time and support.	Abriata LA, 2008, BIOCHEMISTRY-US, V47, P8590, DOI 10.1021/bi8006912; Babic M, 2006, DRUG RESIST UPDATE, V9, P142, DOI 10.1016/j.drup.2006.05.005; Badarau A, 2008, J BIOL INORG CHEM, V13, P919, DOI 10.1007/s00775-008-0379-2; Bebrone C, 2005, J BIOL CHEM, V280, P28195, DOI 10.1074/jbc.M414052200; Bebrone C, 2008, BIOCHEM J, V414, P151, DOI 10.1042/BJ20080375; Bebrone C, 2007, BIOCHEM PHARMACOL, V74, P1686, DOI 10.1016/j.bcp.2007.05.021; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; CARFI A, 1995, EMBO J, V14, P4914, DOI 10.1002/j.1460-2075.1995.tb00174.x; Carloni P, 2002, ACCOUNTS CHEM RES, V35, P455, DOI 10.1021/ar010018u; CASE DA, 2002, AMBER VERSION 9 0; CICCOTTI G, 1989, CHEM PHYS, V129, P241, DOI 10.1016/0301-0104(89)80010-2; Costello AL, 2006, BIOCHEMISTRY-US, V45, P13650, DOI 10.1021/bi061547e; Crowder MW, 2006, ACCOUNTS CHEM RES, V39, P721, DOI 10.1021/ar0400241; Dal Peraro M, 2004, J AM CHEM SOC, V126, P12661, DOI 10.1021/ja048071b; Dal Peraro M, 2004, PROTEINS, V54, P412, DOI 10.1002/prot.10554; Dal Peraro M, 2007, CURR OPIN STRUC BIOL, V17, P149, DOI 10.1016/j.sbi.2007.03.018; Dal Peraro M, 2007, J AM CHEM SOC, V129, P2808, DOI 10.1021/ja0657556; Diaz N, 2001, J AM CHEM SOC, V123, P9867, DOI 10.1021/ja0113246; Elstner M, 1998, PHYS REV B, V58, P7260, DOI 10.1103/PhysRevB.58.7260; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Galleni M, 2001, ANTIMICROB AGENTS CH, V45, P660, DOI 10.1128/AAC.45.3.660-663.2001; Garau G, 2005, ANTIMICROB AGENTS CH, V49, P2778, DOI 10.1128/AAC.49.7.2778-2784.2005; Garau G, 2005, J MOL BIOL, V345, P785, DOI 10.1016/j.jmb.2004.10.070; Garau G, 2004, ANTIMICROB AGENTS CH, V48, P2347, DOI 10.1128/AAC.48.7.2347-2349.2004; Georgopapadakou NH, 2004, EXPERT OPIN INV DRUG, V13, P1307, DOI 10.1517/13543784.13.10.1307; Gonzalez JM, 2007, J MOL BIOL, V373, P1141, DOI 10.1016/j.jmb.2007.08.031; Hata M, 2006, BIOL PHARM BULL, V29, P2151, DOI 10.1248/bpb.29.2151; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Krauss M, 2003, J PHYS CHEM B, V107, P1215, DOI 10.1021/jp027097r; Laio A, 2002, J CHEM PHYS, V116, P6941, DOI 10.1063/1.1462041; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Llarrull LI, 2007, J BIOL CHEM, V282, P18276, DOI 10.1074/jbc.M700742200; Llarrull LI, 2008, J AM CHEM SOC, V130, P15842, DOI 10.1021/ja801168r; Magistrato A, 2000, INORG CHEM, V39, P5553, DOI 10.1021/ic000754e; Moran-Barrio J, 2007, J BIOL CHEM, V282, P18286, DOI 10.1074/jbc.M700467200; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Oelschlaeger P, 2003, PROTEIN ENG, V16, P341, DOI 10.1093/protein/gzg049; Olsen L, 2004, J PHYS CHEM B, V108, P17639, DOI 10.1021/jp0482215; Pagan-Rodriguez D, 2004, J BIOL CHEM, V279, P19494, DOI 10.1074/jbc.M311669200; Park H, 2005, J AM CHEM SOC, V127, P4232, DOI 10.1021/ja042607b; Piana S, 2004, J PHYS CHEM B, V108, P11139, DOI 10.1021/jp037651c; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Sharma NP, 2006, BIOCHEMISTRY-US, V45, P10729, DOI 10.1021/bi060893t; Simona F, 2007, PROTEINS, V69, P595, DOI 10.1002/prot.21476; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; Suarez D, 2002, J COMPUT CHEM, V23, P1587, DOI 10.1002/jcc.10157; Suarez D, 2001, J AM CHEM SOC, V123, P3759, DOI 10.1021/ja003796a; Sulton D, 2005, J BIOL CHEM, V280, P35528, DOI 10.1074/jbc.M501251200; Tamames B, 2007, PROTEINS, V69, P466, DOI 10.1002/prot.21536; Tioni MF, 2008, J AM CHEM SOC, V130, P15852, DOI 10.1021/ja801169j; Tomatis PE, 2008, P NATL ACAD SCI USA, V105, P20605, DOI 10.1073/pnas.0807989106; Toney Jeffrey H, 2004, Curr Opin Investig Drugs, V5, P823; TROULLIER N, 1991, PHYS REV B, V43, P1993, DOI 10.1103/PhysRevB.43.1993; Xu DG, 2006, J BIOL CHEM, V281, P8740, DOI 10.1074/jbc.M512517200; Xu DG, 2005, J MED CHEM, V48, P6679, DOI 10.1021/jm0505112	57	53	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28164	28171		10.1074/jbc.M109.049502	http://dx.doi.org/10.1074/jbc.M109.049502			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19671702	Green Published, hybrid			2022-12-27	WOS:000270676300043
J	Caccamo, A; Majumder, S; Deng, JJ; Bai, YD; Thornton, FB; Oddo, S				Caccamo, Antonella; Majumder, Smita; Deng, Janice J.; Bai, Yidong; Thornton, Fiona B.; Oddo, Salvatore			Rapamycin Rescues TDP-43 Mislocalization and the Associated Low Molecular Mass Neurofilament Instability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; TAR-DNA-BINDING; MOTOR-NEURON DISEASE; NUCLEAR FACTOR TDP-43; LIFE-SPAN; FUNCTIONAL IMPLICATIONS; PROTEIN-DEGRADATION; ALZHEIMERS-DISEASE; SIGNALING PATHWAY	TDP-43 is a nuclear protein involved in exon skipping and alternative splicing. Recently, TDP-43 has been identified as the pathological signature protein in frontotemporal lobar degeneration with ubiquitin-positive inclusions and in amyotrophic lateral sclerosis. In addition, TDP-43-positive inclusions are present in Parkinson disease, dementia with Lewy bodies, and 30% of Alzheimer disease cases. Pathological TDP-43 is redistributed from the nucleus to the cytoplasm, where it accumulates. An similar to 25-kDa C-terminal fragment of TDP-43 accumulates in affected brain regions, suggesting that it may be involved in the disease pathogenesis. Here, we show that overexpression of the 25-kDa C-terminal fragment is sufficient to cause the mislocalization and cytoplasmic accumulation of endogenous full-length TDP-43 in two different cell lines, thus recapitulating a key biochemical characteristic of TDP-43 proteinopathies. We also found that TDP-43 mislocalization is associated with a reduction in the low molecular mass neurofilament mRNA levels. Notably, we show that the autophagic system plays a role in TDP-43 metabolism. Specifically, we found that autophagy inhibition increases the accumulation of the C-terminal fragments of TDP-43, whereas inhibition of mTOR, a key protein kinase involved in autophagy regulation, reduces the 25-kDa C-terminal fragment accumulation and restores TDP-43 localization. Our results suggest that autophagy induction may be a valid therapeutic target for TDP-43 proteinopathies.	[Caccamo, Antonella; Majumder, Smita; Thornton, Fiona B.; Oddo, Salvatore] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Deng, Janice J.; Bai, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Oddo, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	oddo@uthscsa.edu	Bai, Yidong/A-4959-2012	Oddo, Salvatore/0000-0001-7304-7430				Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Arias-Vasquez A, 2007, NEUROSCI LETT, V424, P1, DOI 10.1016/j.neulet.2007.07.015; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bigio EH, 2008, ACTA NEUROPATHOL, V116, P135, DOI 10.1007/s00401-008-0405-z; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Cui Q, 2007, J PHARMACOL SCI, V105, P317, DOI 10.1254/jphs.FP0070336; Davidson Y, 2007, ACTA NEUROPATHOL, V113, P521, DOI 10.1007/s00401-006-0189-y; Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555; Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144; Doi H, 2004, FEBS LETT, V571, P171, DOI 10.1016/j.febslet.2004.06.077; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Higashi S, 2007, BRAIN RES, V1184, P284, DOI 10.1016/j.brainres.2007.09.048; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; Inukai Y, 2008, FEBS LETT, V582, P2899, DOI 10.1016/j.febslet.2008.07.027; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kim SH, 2009, J BIOL CHEM, V284, P8083, DOI 10.1074/jbc.M808064200; Kwong LK, 2007, ACTA NEUROPATHOL, V114, P63, DOI 10.1007/s00401-007-0226-5; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lu A, 2009, J MOL NEUROSCI, V38, P19, DOI 10.1007/s12031-008-9155-6; Mah AL, 2000, J CELL BIOL, V151, P847, DOI 10.1083/jcb.151.4.847; Martinez-Vicente M, 2005, EXP GERONTOL, V40, P622, DOI 10.1016/j.exger.2005.07.005; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Monaco AP, 2009, TRANSPLANTATION, V87, P157, DOI 10.1097/TP.0b013e318193886e; Neumann M, 2007, ARCH NEUROL-CHICAGO, V64, P1388, DOI 10.1001/archneur.64.10.1388; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P152, DOI 10.1097/nen.0b013e31803020b9; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Oddo S, 2006, AM J PATHOL, V168, P184, DOI 10.2353/ajpath.2006.050593; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Seelaar H, 2007, BRAIN, V130, P1375, DOI 10.1093/brain/awm024; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Uryu K, 2008, J NEUROPATH EXP NEUR, V67, P555, DOI 10.1097/NEN.0b013e31817713b5; Wali RK, 2008, CURR OPIN ORGAN TRAN, V13, P614, DOI 10.1097/MOT.0b013e3283193bad; Wang H, 2006, HUM MOL GENET, V15, P1025, DOI 10.1093/hmg/ddl017; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wang IF, 2002, P NATL ACAD SCI USA, V99, P13583, DOI 10.1073/pnas.212483099; Ward Walter F, 2002, Prog Mol Subcell Biol, V29, P35; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007	57	121	138	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27416	27424		10.1074/jbc.M109.031278	http://dx.doi.org/10.1074/jbc.M109.031278			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651785	hybrid, Green Published			2022-12-27	WOS:000270232300044
J	Chamberland, A; Wang, E; Jones, AR; Collins-Racie, LA; LaVallie, ER; Huang, Y; Liu, L; Morris, EA; Flannery, CR; Yang, ZY				Chamberland, Angela; Wang, Eunice; Jones, Aled R.; Collins-Racie, Lisa A.; LaVallie, Edward R.; Huang, Ying; Liu, Lin; Morris, Elisabeth A.; Flannery, Carl R.; Yang, Zhiyong			Identification of a Novel HtrA1-susceptible Cleavage Site in Human Aggrecan EVIDENCE FOR THE INVOLVEMENT OF HtrA1 IN AGGRECAN PROTEOLYSIS IN VIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HTRA1 SERINE-PROTEASE; HUMAN SYNOVIAL-FLUID; CARTILAGE; EXPRESSION; QUANTIFICATION; OSTEOARTHRITIS; DEGRADATION; FRAGMENTS; ADAMTS-4; FAMILY	Mass spectrometry-based proteomic analyses performed on cartilage tissue extracts identified the serine protease HtrA1/PRSS11 as a major protein component of human articular cartilage, with elevated levels occurring in association with osteoarthritis. Overexpression of a catalytically active form of HtrA1, but not an active site mutant (S328A), caused a marked reduction in proteoglycan content in chondrocyte-seeded alginate cultures. Aggrecan degradation fragments were detected in conditioned media from the alginate cultures overexpressing active HtrA1. Incubation of native or recombinant aggrecan with wild type HtrA1 resulted in distinct cleavage of these substrates. Cleavage of aggrecan by HtrA1 was strongly enhanced by HtrA1 agonists such as CPII, a C-terminal hexapeptide derived from the C-propeptide of procollagen II alpha 1 (i.e. chondrocalcin). A novel HtrA1-susceptible cleavage site within the interglobular domain (IGD) of aggrecan was identified, and an antibody that specifically recognizes the neoepitope sequence(VQTV(356)) generated at the HtrA1 cleavage site was developed. Western blot analysis demonstrated that HtrA1-generated aggrecan fragments containing the VQTV356 neoepitope were significantly more abundant in osteoarthritic cartilage compared with cartilage from healthy joints, implicating HtrA1 as a critical protease involved in proteoglycan turnover and cartilage degradation during degenerative joint disease.	[Chamberland, Angela; Wang, Eunice; Jones, Aled R.; Morris, Elisabeth A.; Flannery, Carl R.; Yang, Zhiyong] Wyeth Res, Dept Tissue Repair, Cambridge, MA 02140 USA; [Collins-Racie, Lisa A.; LaVallie, Edward R.; Huang, Ying; Liu, Lin] Wyeth Res, Dept Biol Technol, Cambridge, MA 02140 USA	Pfizer; Pfizer	Yang, ZY (corresponding author), Wyeth Res, Dept Tissue Repair, 200 Cambridge Pk Dr, Cambridge, MA 02140 USA.	ZYyang@wyeth.com						Baldi A, 2002, ONCOGENE, V21, P6684, DOI 10.1038/sj.onc.1205911; Bowden MA, 2006, GYNECOL ONCOL, V103, P253, DOI 10.1016/j.ygyno.2006.03.006; Chelius D, 2003, ANAL CHEM, V75, P6658, DOI 10.1021/ac034607k; Chien J, 2004, ONCOGENE, V23, P1636, DOI 10.1038/sj.onc.1207271; Chockalingam PS, 2004, ARTHRITIS RHEUM-US, V50, P2839, DOI 10.1002/art.20496; Chubinskaya S, 2001, J HISTOCHEM CYTOCHEM, V49, P1165, DOI 10.1177/002215540104900910; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Enobakhare BO, 1996, ANAL BIOCHEM, V243, P189, DOI 10.1006/abio.1996.0502; GANU V, 2001, ORTH RES SOC 47 ANN, V26, P266; GOLDBERG R, 2000, ORTH RES SOC 46 ANN, V25, P164; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Hadfield KD, 2008, J BIOL CHEM, V283, P5928, DOI 10.1074/jbc.M709299200; Hou J, 2005, J CELL BIOCHEM, V94, P470, DOI 10.1002/jcb.20328; Hu SI, 1998, J BIOL CHEM, V273, P34406, DOI 10.1074/jbc.273.51.34406; LOHMANDER LS, 1993, ARTHRITIS RHEUM, V36, P1214; Murwantoko, 2004, BIOCHEM J, V381, P895, DOI 10.1042/BJ20040435; Nelson F, 1998, J CLIN INVEST, V102, P2115, DOI 10.1172/JCI4853; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; SANDY JD, 1992, J CLIN INVEST, V89, P1512, DOI 10.1172/JCI115742; Song RH, 2007, ARTHRITIS RHEUM-US, V56, P575, DOI 10.1002/art.22334; Tocharus J, 2004, DEV GROWTH DIFFER, V46, P257; Tsuchiya A, 2005, BONE, V37, P323, DOI 10.1016/j.bone.2005.03.015; Wu J, 2007, ARTHRITIS RHEUM-US, V56, P3675, DOI 10.1002/art.22876; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811	26	59	64	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27352	27359		10.1074/jbc.M109.037051	http://dx.doi.org/10.1074/jbc.M109.037051			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19657146	hybrid, Green Published			2022-12-27	WOS:000270232300036
J	Sim, H; Hu, B; Viapiano, MS				Sim, Hosung; Hu, Bin; Viapiano, Mariano S.			Reduced Expression of the Hyaluronan and Proteoglycan Link Proteins in Malignant Gliomas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRAIN EXTRACELLULAR-MATRIX; CHONDROITIN SULFATE PROTEOGLYCANS; CENTRAL-NERVOUS-SYSTEM; PERINEURONAL NETS; CELL MOTILITY; IN-VITRO; PROTEOLYTIC CLEAVAGE; RAT CEREBELLUM; CDNA CLONING; BEHAB/BREVICAN	Malignant gliomas have a distinctive ability to infiltrate the brain parenchyma and disrupt the neural extracellular matrix that inhibits motility of axons and normal neural cells. Chondroitin sulfate proteoglycans (CSPGs) are among the major inhibitory components in the neural matrix, but surprisingly, some are up-regulated in gliomas and act as pro-invasive signals. In the normal brain, CSPGs are thought to associate with hyaluronic acid and glycoproteins such as the tenascins and link proteins to form the matrix scaffold. Here, we examined for the first time the expression of link proteins in human brain and malignant gliomas. Our results indicate that HAPLN4 and HAPLN2 are the predominant members of this family in the adult human brain but are strongly reduced in the tumor parenchyma. To test if their absence was related to a pro-invasive gain of function of CSPGs, we expressed HAPLN4 in glioma cells in combination with the CSPG brevican. Surprisingly, HAPLN4 increased glioma cell adhesion and migration and even potentiated the motogenic effect of brevican. Further characterization revealed that HAPLN4 expressed in glioma cells was largely soluble and did not reproduce the strong, hyaluronan-independent association of the native protein to brain subcellular membranes. Taken together, our results suggest that the tumor parenchyma is rich in CSPGs that are not associated to HAPLNs and could instead interact with other extracellular matrix proteins produced by glioma cells. This dissociation may contribute to changes in the matrix scaffold caused by invasive glioma cells.	[Viapiano, Mariano S.] Ohio State Univ, Ctr Mol Neurobiol, Med Ctr, Columbus, OH 43210 USA; [Viapiano, Mariano S.] Ohio State Univ, Dept Neurol Surg, Med Ctr, Columbus, OH 43210 USA; James Comprehens Canc Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Viapiano, MS (corresponding author), Ohio State Univ, Ctr Mol Neurobiol, Med Ctr, 226B Rightmire Hall,1060 Carmack Rd, Columbus, OH 43210 USA.	viapiano.1@osu.edu	Hu, Bin/H-8804-2013; Viapiano, Mariano/AAE-5787-2019	Viapiano, Mariano/0000-0002-8756-388X	Dardinger Center; American Cancer Society [IRG-67003-44]; American Brain Tumor Association; NATIONAL CANCER INSTITUTE [R01CA152065] Funding Source: NIH RePORTER	Dardinger Center; American Cancer Society(American Cancer Society); American Brain Tumor Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by seed grants from the Dardinger Center Fund for Neuro-Oncology Research and American Cancer Society Grant IRG-67003-44 (to M. S. V.) and a Joel A. Gringras fellowship from the American Brain Tumor Association (to B. H.).	Bekku Y, 2003, MOL CELL NEUROSCI, V24, P148, DOI 10.1016/S1044-7431(03)00133-7; Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013; BIGNAMI A, 1993, ANAT EMBRYOL, V188, P419; BINETTE F, 1994, J BIOL CHEM, V269, P19116; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Carulli D, 2006, J COMP NEUROL, V494, P559, DOI 10.1002/cne.20822; Carulli D, 2007, J COMP NEUROL, V501, P83, DOI 10.1002/cne.21231; Chicoine MR, 1997, J NEURO-ONCOL, V35, P249, DOI 10.1023/A:1005808315821; CHICOINE MR, 1995, J NEUROSURG, V82, P615, DOI 10.3171/jns.1995.82.4.0615; Galtrey CM, 2008, EUR J NEUROSCI, V27, P1373, DOI 10.1111/j.1460-9568.2008.06108.x; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Gary SC, 2000, GENE, V256, P139, DOI 10.1016/S0378-1119(00)00362-0; Hahn MA, 2008, CANCER RES, V68, P10280, DOI 10.1158/0008-5472.CAN-08-1957; Hirakawa S, 2000, BIOCHEM BIOPH RES CO, V276, P982, DOI 10.1006/bbrc.2000.3583; Hu B, 2008, J BIOL CHEM, V283, P24848, DOI 10.1074/jbc.M801433200; JAWORSKI DM, 1995, J NEUROSCI, V15, P1352; Kearns SM, 2003, EXP NEUROL, V182, P240, DOI 10.1016/S0014-4886(03)00124-9; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Maleski M, 1997, GLIA, V20, P193, DOI 10.1002/(SICI)1098-1136(199707)20:3<193::AID-GLIA3>3.0.CO;2-9; NEAME PJ, 1993, EXPERIENTIA, V49, P393, DOI 10.1007/BF01923584; Oohashi T, 2002, MOL CELL NEUROSCI, V19, P43, DOI 10.1006/mcne.2001.1061; OOHASHI T, 2005, HYALURONAN ITS STRUC, P766; Rauch U, 2004, MATRIX BIOL, V22, P629, DOI 10.1016/j.matbio.2003.11.007; Rauch U, 2004, CELL MOL LIFE SCI, V61, P2031, DOI 10.1007/s00018-004-4043-x; Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489; Shi SL, 2004, J BIOL CHEM, V279, P12060, DOI 10.1074/jbc.M310091200; Spicer AP, 2003, J BIOL CHEM, V278, P21083, DOI 10.1074/jbc.M213100200; Stein AM, 2007, APPL OPTICS, V46, P5110, DOI 10.1364/AO.46.005110; Thon N, 2000, EUR J NEUROSCI, V12, P2547, DOI 10.1046/j.1460-9568.2000.00109.x; Tso CL, 2006, MOL CANCER RES, V4, P607, DOI 10.1158/1541-7786.MCR-06-0005; Viapiano MS, 2006, TRENDS MOL MED, V12, P488, DOI 10.1016/j.molmed.2006.08.007; Viapiano MS, 2008, J NEURO-ONCOL, V88, P261, DOI 10.1007/s11060-008-9575-8; Viapiano MS, 2005, CANCER RES, V65, P6726, DOI 10.1158/0008-5472.CAN-05-0585; Viapiano MS, 2003, J BIOL CHEM, V278, P33239, DOI 10.1074/jbc.M303480200; Watanabe H, 1999, NAT GENET, V21, P225, DOI 10.1038/6016; Wu YJ, 2004, J CELL SCI, V117, P2227, DOI 10.1242/jcs.01057; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690; Yang BB, 1998, MATRIX BIOL, V16, P541, DOI 10.1016/S0945-053X(98)90066-X; Zimmermann DR, 2008, HISTOCHEM CELL BIOL, V130, P635, DOI 10.1007/s00418-008-0485-9	41	30	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26547	26556		10.1074/jbc.M109.013185	http://dx.doi.org/10.1074/jbc.M109.013185			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19633295	Green Published, hybrid			2022-12-27	WOS:000269969600036
J	Zhao, LQ; Dong, HY; Zhang, CC; Kinch, L; Osawa, M; Iacovino, M; Grishin, NV; Kyba, M; Huang, LJS				Zhao, Lequn; Dong, Hongyun; Zhang, Cheng Cheng; Kinch, Lisa; Osawa, Mitsujiro; Iacovino, Michelina; Grishin, Nikolai V.; Kyba, Michael; Huang, Lily Jun-shen			A JAK2 Interdomain Linker Relays Epo Receptor Engagement Signals to Kinase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ERYTHROPOIETIN RECEPTOR; POLYCYTHEMIA-VERA; TYROSINE KINASE; PSEUDOKINASE DOMAIN; MYELOPROLIFERATIVE DISORDERS; CYTOKINE RECEPTOR; SWISS-MODEL; SURFACE EXPRESSION; EXON-12 MUTATIONS	JAK2 (Janus kinase 2) is essential for cytokine receptor signaling, and several lines of evidence support a causal role of an activating JAK2 mutation in myeloproliferative disorders. JAK2 activity is autoinhibited by its pseudokinase domain in the basal state, and the inhibition is released by cytokine stimulation; how engagement of the cognate receptor triggers this release is unknown. From a functional screen for gain-of-function JAK2 mutations, we discovered 13 missense mutations, nine in the pseudokinase domain and four in the Src homology 2 (SH2)-pseudokinase domain linker. These mutations identified determinants for autoinhibition and inducible activation in JAK2. Two of the mutants, K539I and N622I, resulted in erythrocytosis in mice. Scanning mutagenesis of the SH2-pseudokinase domain linker indicated that its N-terminal part was essential for interaction of JAK2 with the Epo receptor, whereas certain mutations in the C-terminal region conferred constitutive activation. We further showed that substitutions for Glu543-Asp544 in this linker or Leu611, Arg683, or Phe694 in the hinge proximal region of the pseudokinase domain resulted in activated JAK2 mutants that could not be further stimulated by Epo. These results suggest that the SH2-pseudokinase domain linker acts as a switch that relays cytokine engagement to JAK2 activation by flexing the pseudokinase domain hinge.	[Huang, Lily Jun-shen] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Zhang, Cheng Cheng] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Zhang, Cheng Cheng; Osawa, Mitsujiro; Iacovino, Michelina; Kyba, Michael] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Kinch, Lisa; Grishin, Nikolai V.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Huang, LJS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Lily.Huang@utsouthwestern.edu	Zhang, Cheng/GRS-8698-2022	iacovino, michelina/0000-0002-1076-3146; Kinch, Lisa/0000-0003-3041-2615; Kyba, Michael/0000-0002-5579-7534	National Institutes of Health [R01 HL089966]; American Cancer Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089966, R01HL081186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL089966 (to L. J. H.). This work was also supported by the American Cancer Society (to L. J. H.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Argetsinger LS, 2004, MOL CELL BIOL, V24, P4955, DOI 10.1128/MCB.24.11.4955-4967.2004; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Azam Mohammad, 2003, Biol Proced Online, V5, P204, DOI 10.1251/bpo63; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bercovich D, 2008, LANCET, V372, P1484, DOI 10.1016/S0140-6736(08)61341-0; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Butcher CM, 2008, LEUKEMIA, V22, P870, DOI 10.1038/sj.leu.2404971; Cazzola M, 2007, HAEMATOLOGICA, V92, P1585, DOI 10.3324/haematol.11506; Constantinescu SN, 1999, TRENDS ENDOCRIN MET, V10, P18, DOI 10.1016/S1043-2760(98)00101-5; Constantinescu SN, 2001, MOL CELL, V7, P377, DOI 10.1016/S1097-2765(01)00185-X; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Dusa A, 2008, J BIOL CHEM, V283, P12941, DOI 10.1074/jbc.M709302200; Feener EP, 2004, MOL CELL BIOL, V24, P4968, DOI 10.1128/MCB.24.11.4968-4978.2004; Funakoshi-Tago M, 2008, MOL CELL BIOL, V28, P1792, DOI 10.1128/MCB.01447-07; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Giordanetto F, 2002, PROTEIN ENG, V15, P727, DOI 10.1093/protein/15.9.727; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haan C, 2006, BIOCHEM PHARMACOL, V72, P1538, DOI 10.1016/j.bcp.2006.04.013; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Ishida-Takahashi R, 2006, MOL CELL BIOL, V26, P4063, DOI 10.1128/MCB.01589-05; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Koh EY, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf142; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kratz CP, 2006, LEUKEMIA, V20, P381, DOI 10.1038/sj.leu.2404060; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Lee JW, 2006, ONCOGENE, V25, P1434, DOI 10.1038/sj.onc.1209163; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lindauer K, 2001, PROTEIN ENG, V14, P27, DOI 10.1093/protein/14.1.27; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; Lu XH, 2008, J BIOL CHEM, V283, P5258, DOI 10.1074/jbc.M707125200; Lucet IS, 2006, BLOOD, V107, P176, DOI 10.1182/blood-2005-06-2413; Malinge S, 2007, BLOOD, V109, P2202, DOI 10.1182/blood-2006-09-045963; Mazurkiewicz-Munoz AM, 2006, MOL CELL BIOL, V26, P4052, DOI 10.1128/MCB.01591-05; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Pietra D, 2008, BLOOD, V111, P1686, DOI 10.1182/blood-2007-07-101576; Royer Y, 2005, J BIOL CHEM, V280, P27251, DOI 10.1074/jbc.M501376200; Saharinen P, 2000, MOL CELL BIOL, V20, P3387, DOI 10.1128/MCB.20.10.3387-3395.2000; Saharinen P, 2003, MOL BIOL CELL, V14, P1448, DOI 10.1091/mbc.E02-06-0342; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Tong W, 2006, J BIOL CHEM, V281, P38930, DOI 10.1074/jbc.M607524200; Vainchenker William, 2005, Hematology Am Soc Hematol Educ Program, P195; Walrafen P, 2005, BLOOD, V105, P600, DOI 10.1182/blood-2004-03-1216; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Wormald S, 2004, J BIOL CHEM, V279, P821, DOI 10.1074/jbc.R300030200; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Yamaoka K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-253; Zaleskas VM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000018; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	54	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26988	26998		10.1074/jbc.M109.011387	http://dx.doi.org/10.1074/jbc.M109.011387			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19638629	hybrid, Green Published			2022-12-27	WOS:000269969600078
J	Russwurm, C; Zoidl, G; Koesling, D; Russwurm, M				Russwurm, Corina; Zoidl, Georg; Koesling, Doris; Russwurm, Michael			Dual Acylation of PDE2A Splice Variant 3 TARGETING TO SYNAPTIC MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; LONG-TERM POTENTIATION; NITRIC-OXIDE SYNTHASE; HUMAN ATRIAL MYOCYTES; GUANOSINE 3',5'-MONOPHOSPHATE; STIMULATED PHOSPHODIESTERASE; SUBCELLULAR-LOCALIZATION; BOVINE-TISSUES; RAT-BRAIN; CGMP	The cGMP-stimulated PDE2A hydrolyzes both cyclic nucleotides, cGMP and cAMP. Three splice variants have been cloned from several species. Whereas PDE2A1 is soluble, PDE2A2 and PDE2A3 are membrane-bound enzymes of rat and bovine origin, respectively. To date it is unclear whether one species expresses all three variants. The splice variants only differ in their N termini, which likely determine the subcellular localization. However, the mechanism for membrane attachment remains unknown. Here, we show that myristoylation underlies membrane targeting of PDE2A3. The myristoylated enzyme was bound to plasma membranes, whereas mutation of the myristoyl recipient Gly(2) prevented incorporation of [H-3]myristate and turned PDE2A3 completely soluble. Additionally, Cys(5) and to a minor extent Cys(11) are required for targeting of PDE2A3. Substitution of the putatively palmitoylated cysteines partially solubilized the enzyme and led to an accumulation in the endoplasmic reticulum/Golgi compartment, as shown by fluorescence microscopy in HEK 293 and PC12 cells. In vivo, PDE2A is expressed in many tissues. By using newly generated antibodies selectively detecting the splice variants PDE2A3 or PDE2A1, respectively, we demonstrate on the protein level PDE2A3 expression in mouse brain where it is entirely membrane-associated and a widespread expression of soluble PDE2A1 in mouse tissues. We show that PDE2A localizes to synaptosomal membranes and in primary cultures of hippocampal neurons partially overlaps with the presynaptic marker synaptophysin as demonstrated by immunofluorescence. In sum, these results demonstrate dual acylation as mechanism targeting neuronal PDE2A3 to synapses thereby ensuring local control of cyclic nucleotides.	[Russwurm, Michael] Ruhr Univ Bochum, MAN1, Fak Med, Inst Pharmakol & Toxikol, D-44780 Bochum, Germany; [Zoidl, Georg] Ruhr Univ Bochum, Fak Med, Abt Neuroanat & Mol Hirnforsch, Inst Anat, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Russwurm, M (corresponding author), Ruhr Univ Bochum, MAN1, Fak Med, Inst Pharmakol & Toxikol, D-44780 Bochum, Germany.	michael.russwurm@ruhr-uni-bochum.de			Deutsche Forschungsgemeinschaft [Ko1157]; Kommission fur Finanzautonomie und Erganzungsmittel of the Medical Faculty	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Kommission fur Finanzautonomie und Erganzungsmittel of the Medical Faculty	This work was supported by the Deutsche Forschungsgemeinschaft (Grant Ko1157) and the Kommission fur Finanzautonomie und Erganzungsmittel of the Medical Faculty.	ALLAND L, 1994, J BIOL CHEM, V269, P16701; BEAVO JA, 1970, J BIOL CHEM, V245, P5649; BEAVO JA, 1971, J BIOL CHEM, V246, P3841; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; Boess FG, 2004, NEUROPHARMACOLOGY, V47, P1081, DOI 10.1016/j.neuropharm.2004.07.040; Bon CLM, 2003, J NEUROSCI, V23, P1941; DEGTYAREV MY, 1994, J BIOL CHEM, V269, P30898; Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1; ERNEUX C, 1981, EUR J BIOCHEM, V115, P503; Fraser IDC, 1998, EMBO J, V17, P2261, DOI 10.1093/emboj/17.8.2261; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; KOEGL M, 1994, BIOCHEM J, V303, P749, DOI 10.1042/bj3030749; MACFARLAND RT, 1991, J BIOL CHEM, V266, P136; Makhinson M, 2006, NEUROSCIENCE, V140, P415, DOI 10.1016/j.neuroscience.2006.02.018; MARTINS TJ, 1982, J BIOL CHEM, V257, P1973; Mongillo M, 2006, CIRC RES, V98, P226, DOI 10.1161/01.RES.0000200178.34179.93; Mullershausen F, 2001, J CELL BIOL, V155, P271, DOI 10.1083/jcb.200107001; MURASHIMA S, 1990, BIOCHEMISTRY-US, V29, P5285, DOI 10.1021/bi00474a010; Navarro-Lerida I, 2002, J CELL SCI, V115, P3119; Nikolaev VO, 2005, J BIOL CHEM, V280, P1716, DOI 10.1074/jbc.C400505200; Noyama K, 2003, NEUROSCI RES, V45, P141, DOI 10.1016/S0168-0102(02)00208-0; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; PYNE NJ, 1986, BIOCHEM J, V234, P325, DOI 10.1042/bj2340325; REPASKE DR, 1993, NEUROSCIENCE, V56, P673, DOI 10.1016/0306-4522(93)90364-L; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RivetBastide M, 1997, J CLIN INVEST, V99, P2710, DOI 10.1172/JCI119460; ROBINSON LJ, 1995, P NATL ACAD SCI USA, V92, P11776, DOI 10.1073/pnas.92.25.11776; Rosman GJ, 1997, GENE, V191, P89, DOI 10.1016/S0378-1119(97)00046-2; Russwurm M, 2001, J BIOL CHEM, V276, P44647, DOI 10.1074/jbc.M105587200; SHAHINIAN S, 1995, BIOCHEMISTRY-US, V34, P3813, DOI 10.1021/bi00011a039; SONNENBURG WK, 1991, J BIOL CHEM, V266, P17655; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; TRONG HL, 1990, BIOCHEMISTRY-US, V29, P10280, DOI 10.1021/bi00496a018; Vaandrager AB, 1996, J BIOL CHEM, V271, P7025, DOI 10.1074/jbc.271.12.7025; Vandecasteele G, 2001, J PHYSIOL-LONDON, V533, P329, DOI 10.1111/j.1469-7793.2001.0329a.x; Verde I, 1999, BRIT J PHARMACOL, V127, P65, DOI 10.1038/sj.bjp.0702506; WHALIN ME, 1988, BIOCHIM BIOPHYS ACTA, V972, P79; YAMAMOTO T, 1983, J BIOL CHEM, V258, P2526; YANG Q, 1994, BIOCHEM BIOPH RES CO, V205, P1850, DOI 10.1006/bbrc.1994.2886; Zoidl G, 2002, J NEUROSCI RES, V69, P448, DOI 10.1002/jnr.10284	42	42	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25782	25790		10.1074/jbc.M109.017194	http://dx.doi.org/10.1074/jbc.M109.017194			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19632989	Green Published, hybrid			2022-12-27	WOS:000269738000036
J	Liu, RJ; Ramani, B; Soto, D; De Arcangelis, V; Xiang, Y				Liu, Ruijie; Ramani, Biswarathan; Soto, Dagoberto; De Arcangelis, Vania; Xiang, Yang			Agonist Dose-dependent Phosphorylation by Protein Kinase A and G Protein-coupled Receptor Kinase Regulates beta(2) Adrenoceptor Coupling to G(i) Proteins in Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2)-ADRENERGIC RECEPTOR; CARDIAC MYOCYTES; CELL-DEATH; DESENSITIZATION; BINDING; STIMULATION; TRAFFICKING; ACTIVATION; ARRESTINS; MICE	Adrenoceptors receptors (ARs) play a pivotal role in regulating cardiovascular response to catecholamines during stress. beta(2)ARs, prototypical G protein-coupled receptors (GPCRs), expressed in animal hearts, display dual coupling to both G(s) and G(i) proteins to control the adenylyl cyclase-cAMP dependent protein kinase A (PKA) pathway to regulate contraction responses. Here, we showed that the beta(2)AR coupling to G(i) proteins was agonist dose-dependent and occurred only at high concentrations in mouse cardiac myocytes. Both the beta(2)AR-induced PKA activity, measured by fluorescence resonance energy transfer (FRET) imaging, and the increase in myocyte contraction rate displayed sensitivity to the G(i) inhibitor pertussis toxin (PTX). Further studies revealed that activated beta(2)ARs underwent PKA phosphorylation at a broad range of agonist concentrations. Disruption of the PKA phosphorylation sites on the beta(2)AR blocked receptor/G(i) coupling. However, a sufficient beta 2AR/G(i) coupling was also dependent on the G protein-coupled receptor kinase (GRK)-mediated phosphorylation of the receptors, which only occurred at high concentrations of agonist (>= 100 nM). Disruption of the GRK phosphorylation sites on the beta(2)AR blocked receptor internalization and coupling to G(i) proteins, probably by preventing the receptor's transportation to access G(i) proteins. Furthermore, neither PKA nor GRK site mutated receptors displayed sensitivity to the G(i)-specific inhibitor, G(i)CT. Together, our studies revealed distinct roles of PKA and GRK phosphorylation of the beta(2)AR for agonist dose-dependent coupling to G(i) proteins in cardiac myocytes, which may protect cells from overstimulation under high concentrations of catecholamines.	[Liu, Ruijie; Ramani, Biswarathan; Soto, Dagoberto; De Arcangelis, Vania] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Xiang, Yang] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Xiang, Y (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, 523 Burrill Hall,407 S Goodwin Ave, Urbana, IL 61801 USA.	kevinyx@illinois.edu	Soto, Dagoberto I/N-6817-2014	Soto, Dagoberto I/0000-0002-7350-1530; liu, ruijie/0000-0002-2468-0579	National Institutes of Health [HL082846, AHA 0635331N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL082846 and AHA 0635331N (to Y.X.).	ASANO T, 1984, J BIOL CHEM, V259, P9351; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Chesley A, 2000, CIRC RES, V87, P1172, DOI 10.1161/01.RES.87.12.1172; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; DeGeorge BR, 2008, CIRCULATION, V117, P1378, DOI 10.1161/CIRCULATIONAHA.107.752618; Devic E, 2001, MOL PHARMACOL, V60, P577; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Geng YJ, 1999, CIRC RES, V84, P34; HAUSDORFF WP, 1990, SYM SOC EXP BIOL, V44, P225; Iyer V, 2006, BRIT J PHARMACOL, V147, P249, DOI 10.1038/sj.bjp.0706551; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Singh K, 2001, J CELL PHYSIOL, V189, P257, DOI 10.1002/jcp.10024; Soto D, 2009, CIRC RES, V104, P770, DOI 10.1161/CIRCRESAHA.108.187880; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Tepe NM, 2000, J RECEPT SIGNAL TR R, V20, P75, DOI 10.3109/10799890009150038; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Vaughan DJ, 2006, J BIOL CHEM, V281, P7684, DOI 10.1074/jbc.M500328200; Wang Y, 2008, J BIOL CHEM, V283, P1799, DOI 10.1074/jbc.M705747200; Wang YY, 2007, MOL PHARMACOL, V72, P429, DOI 10.1124/mol.107.037747; Xiang Y, 2003, P NATL ACAD SCI USA, V100, P10776, DOI 10.1073/pnas.1831718100; Xiang Y, 2002, J BIOL CHEM, V277, P34280, DOI 10.1074/jbc.M201644200; Xiao R P, 2001, Sci STKE, V2001, pre15, DOI 10.1126/stke.2001.104.re15; Zamah AM, 2002, J BIOL CHEM, V277, P31249, DOI 10.1074/jbc.M202753200; Zhu WZ, 2003, J CLIN INVEST, V111, P617, DOI 10.1172/JCI200316326; Zhu WZ, 2001, P NATL ACAD SCI USA, V98, P1607, DOI 10.1073/pnas.98.4.1607	27	47	48	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32279	32287		10.1074/jbc.M109.021428	http://dx.doi.org/10.1074/jbc.M109.021428			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19706594	hybrid, Green Published			2022-12-27	WOS:000272028400009
J	Klundt, T; Bocola, M; Lutge, M; Beuerle, T; Liu, BY; Beerhues, L				Klundt, Tim; Bocola, Marco; Luetge, Maren; Beuerle, Till; Liu, Benye; Beerhues, Ludger			A Single Amino Acid Substitution Converts Benzophenone Synthase into Phenylpyrone Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III POLYKETIDE SYNTHASES; CENTAURIUM-ERYTHRAEA RAFN; CHAIN-LENGTH CONTROL; CHALCONE SYNTHASE; HYPERICUM-ANDROSAEMUM; CELL-CULTURES; SWISS-MODEL; FORCE-FIELD; BIOSYNTHESIS; PLANT	Benzophenone metabolism provides a number of plant natural products with fascinating chemical structures and intriguing pharmacological activities. Formation of the carbon skeleton of benzophenone derivatives from benzoyl-CoA and three molecules of malonyl-CoA is catalyzed by benzophenone synthase (BPS), a member of the superfamily of type III polyketide synthases. A point mutation in the active site cavity (T135L) transformed BPS into a functional phenylpyrone synthase (PPS). The dramatic change in both substrate and product specificities of BPS was rationalized by homology modeling. The mutation may open a new pocket that accommodates the phenyl moiety of the triketide intermediate but limits polyketide elongation to two reactions, resulting in phenylpyrone formation. 3-Hydroxybenzoyl-CoA is the second best starter molecule for BPS but a poor substrate for PPS. The aryl moiety of the triketide intermediate may be trapped in the new pocket by hydrogen bond formation with the backbone, thereby acting as an inhibitor. PPS is a promising biotechnological tool for manipulating benzoate-primed biosynthetic pathways to produce novel compounds.	[Liu, Benye] Chinese Acad Sci, Key Lab Photosynth & Environm Mol Physiol, Inst Bot, Beijing 100093, Peoples R China; Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmaceut Biol, D-38106 Braunschweig, Germany; [Bocola, Marco] Max Planck Inst Coal Res, D-45470 Mulheim, Germany	Chinese Academy of Sciences; Institute of Botany, CAS; Braunschweig University of Technology; Max Planck Society	Liu, BY (corresponding author), Chinese Acad Sci, Key Lab Photosynth & Environm Mol Physiol, Inst Bot, Nanxincun 20, Beijing 100093, Peoples R China.	benyel@ibcas.ac.cn; l.beerhues@tu-bs.de	Liu, Benye/AAF-4840-2020	Beuerle, Till/0000-0001-5037-6653; Liu, Benye/0000-0001-8527-565X; Beerhues, Ludger/0000-0002-2147-2731	Deutsche Forschungsgemeinschaft [SPP 1152]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Priority Programme "Evolution of Metabolic Diversity" (SPP 1152) of the Deutsche Forschungsgemeinschaft.	Abd El-Mawla AMA, 2002, PLANTA, V214, P727, DOI 10.1007/s004250100657; Abd El-Mawla AMA, 2001, PLANTA, V212, P288, DOI 10.1007/s004250000394; Abe I, 2006, FEBS J, V273, P208, DOI 10.1111/j.1742-4658.2005.05059.x; Abe I, 2005, J AM CHEM SOC, V127, P12709, DOI 10.1021/ja053945v; Abe I, 2001, EUR J BIOCHEM, V268, P3354, DOI 10.1046/j.1432-1327.2001.02255.x; Abe I, 2007, J AM CHEM SOC, V129, P5976, DOI 10.1021/ja070375l; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Austin MB, 2004, CHEM BIOL, V11, P1179, DOI 10.1016/j.chembiol.2004.05.024; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Beerhues L, 1996, FEBS LETT, V383, P264, DOI 10.1016/0014-5793(96)00265-7; DURL L, 2004, FITOTERAPIA, V75, P520; Eckermann S, 1998, NATURE, V396, P387, DOI 10.1038/24652; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Gerber PR, 1998, J COMPUT AID MOL DES, V12, P37, DOI 10.1023/A:1007902804814; GERBER PR, 1995, J COMPUT AID MOL DES, V9, P251, DOI 10.1007/BF00124456; Gronquist M, 2001, P NATL ACAD SCI USA, V98, P13745, DOI 10.1073/pnas.231471698; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Helariutta Y, 1996, P NATL ACAD SCI USA, V93, P9033, DOI 10.1073/pnas.93.17.9033; Hong JG, 2006, CARCINOGENESIS, V27, P278, DOI 10.1093/carcin/bgi208; Hu LH, 2000, TETRAHEDRON, V56, P1379, DOI 10.1016/S0040-4020(00)00010-7; Jez JM, 2002, P NATL ACAD SCI USA, V99, P5319, DOI 10.1073/pnas.082590499; Jez JM, 2000, CHEM BIOL, V7, P919, DOI 10.1016/S1074-5521(00)00041-7; Jez JM, 2001, BIOCHEMISTRY-US, V40, P14829, DOI 10.1021/bi015621z; JUNGHANNS KT, 1995, PLANT MOL BIOL, V27, P681, DOI 10.1007/BF00020222; LEETE E, 1982, TETRAHEDRON LETT, V23, P2635, DOI 10.1016/S0040-4039(00)87416-X; Liu B, 2007, PLANTA, V225, P1495, DOI 10.1007/s00425-006-0435-5; Liu BY, 2003, PLANT J, V34, P847, DOI 10.1046/j.1365-313X.2003.01771.x; MCINNES AG, 1965, TETRAHEDRON, V21, P2939, DOI 10.1016/S0040-4020(01)98380-2; Moore BS, 2002, NAT PROD REP, V19, P70, DOI 10.1039/b003939j; Morita H, 2007, CHEM BIOL, V14, P359, DOI 10.1016/j.chembiol.2007.02.003; Peters S, 1998, PLANTA, V204, P64, DOI 10.1007/s004250050230; PRASAD JVNV, 1995, J AM CHEM SOC, V117, P11070, DOI 10.1021/ja00150a005; Rebecca W, 2003, PHYTOCHEM ANALYSIS, V14, P83, DOI 10.1002/pca.682; Schroder J., 1999, COMPREHENSIVE NATURA, V1, P749, DOI DOI 10.1016/b978-0-08-091283-7.00029-1; Yamazaki Y, 2001, PLANTA, V214, P75, DOI 10.1007/s004250100586; Yoshida K, 2005, CANCER LETT, V221, P29, DOI 10.1016/j.canlet.2004.08.016; Zhang HZ, 2004, BIOORGAN MED CHEM, V12, P309, DOI 10.1016/j.bmc.2003.11.013	37	19	22	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30957	30964		10.1074/jbc.M109.038927	http://dx.doi.org/10.1074/jbc.M109.038927			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19710020	Green Published, hybrid			2022-12-27	WOS:000271378400025
J	De Rosa, L; Antonini, D; Ferone, G; Russo, MT; Yu, PB; Han, R; Missero, C				De Rosa, Laura; Antonini, Dario; Ferone, Giustina; Russo, Monia T.; Yu, Paul B.; Han, Rong; Missero, Caterina			p63 Suppresses Non-epidermal Lineage Markers in a Bone Morphogenetic Protein-dependent Manner via Repression of Smad7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOGENIC PROTEIN-1; HAIR FOLLICLE; SIGNALING PATHWAYS; GENE-EXPRESSION; I RECEPTORS; P53 HOMOLOG; STEM-CELLS; MOUSE; DIFFERENTIATION; TARGET	p63, a p53 family member, plays an essential role in epidermal development by regulating its transcriptional program. Here we report a previously uncovered role of p63 in controlling bone morphogenetic protein (BMP) signaling, which is required for maintaining low expression levels of several non-epidermal genes. p63 represses transcription of the inhibitory Smad7 and activates Bmp7, thereby sustaining BMP signaling. In the absence of p63, compromised BMP signaling leads to inappropriate non-epidermal gene expression in postnatal mouse keratinocytes and in embryonic epidermis. Reactivation of BMP signaling by Smad7 knockdown and/or, to a lesser extent, by BMP treatment suppresses expression of non-epidermal genes in the absence of p63. Canonical BMP/Smad signaling is essential for control of non-epidermal genes as use of a specific inhibitor, or simultaneous knockdown of Smad1 and Smad5 counteract suppression of non-epidermal genes. Our data indicate that p63 prevents ectopic expression of non-epidermal genes by a mechanism involving Smad7 repression and, to a lesser extent, Bmp7 induction, with consequent enhancement of BMP/Smad signaling.	[De Rosa, Laura; Antonini, Dario; Ferone, Giustina; Russo, Monia T.; Missero, Caterina] CEINGE Biotecnol Avanzate, I-80145 Naples, Italy; [De Rosa, Laura; Missero, Caterina] IRCCS Fdn SDN, I-80143 Naples, Italy; [Yu, Paul B.] Harvard Univ, Div Cardiol, Massachusetts Gen Hosp, Sch Med, Boston, MA 02114 USA; [Han, Rong] Harvard Univ, Cutaneous Biol Res Ctr, Massachusetts Gen Hosp, Sch Med, Charlestown, MA 02129 USA	CEINGE Biotecnologie Avanzate; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Missero, C (corresponding author), CEINGE Biotecnol Avanzate, Via Comunale Margherita 482, I-80145 Naples, Italy.	missero@ceinge.unina.it	Russo, Monia Teresa/AGI-3134-2022; Yu, Paul B./J-7540-2019; russo, monia t/Q-5774-2016; De Rosa, Laura/H-7504-2015	Yu, Paul B./0000-0003-2145-4944; russo, monia t/0000-0003-2001-5384; De Rosa, Laura/0000-0001-9020-8451; Missero, Caterina/0000-0003-0905-5123; Han, Rong/0000-0002-5766-8277	Italian Telethon Foundation [GGP06243]; National Foundation for Ectodermal Dysplasia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079943] Funding Source: NIH RePORTER	Italian Telethon Foundation(Fondazione Telethon); National Foundation for Ectodermal Dysplasia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by Italian Telethon Foundation Grant GGP06243 and the National Foundation for Ectodermal Dysplasia.	Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Antonini D, 2006, MOL CELL BIOL, V26, P3308, DOI 10.1128/MCB.26.8.3308-3318.2006; Antonini D, 2008, J INVEST DERMATOL, V128, P1676, DOI 10.1038/jid.2008.12; AONO A, 1995, BIOCHEM BIOPH RES CO, V210, P670, DOI 10.1006/bbrc.1995.1712; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Brancaccio A, 2004, HUM MOL GENET, V13, P2595, DOI 10.1093/hmg/ddh292; Della Gatta G, 2008, GENOME RES, V18, P939, DOI 10.1101/gr.073601.107; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; DEWULF N, 1995, ENDOCRINOLOGY, V136, P2652, DOI 10.1210/en.136.6.2652; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Han GW, 2006, DEV CELL, V11, P301, DOI 10.1016/j.devcel.2006.06.014; He W, 2002, EMBO J, V21, P2580, DOI 10.1093/emboj/21.11.2580; Helton ES, 2006, J BIOL CHEM, V281, P2533, DOI 10.1074/jbc.M507964200; Hoover LL, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.146pe48; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Kobielak K, 2003, J CELL BIOL, V163, P609, DOI 10.1083/jcb.200309042; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Koster MI, 2007, P NATL ACAD SCI USA, V104, P3255, DOI 10.1073/pnas.0611376104; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Liu X, 2003, CANCER RES, V63, P7760; Liu XB, 2007, BBA-GENE STRUCT EXPR, V1769, P149, DOI 10.1016/j.bbaexp.2007.01.001; LYONS KM, 1989, GENE DEV, V3, P1657, DOI 10.1101/gad.3.11.1657; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mitu GM, 2007, AM J PHYSIOL-RENAL, V293, pF1641, DOI 10.1152/ajprenal.00179.2007; Mou C, 2006, P NATL ACAD SCI USA, V103, P9075, DOI 10.1073/pnas.0600825103; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Perez CA, 2007, CELL CYCLE, V6, P246, DOI 10.4161/cc.6.3.3801; Romano RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005623; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shukla A, 2008, MOL CANCER RES, V6, P509, DOI 10.1158/1541-7786.MCR-07-0396; Stern CD, 2006, CURR OPIN CELL BIOL, V18, P692, DOI 10.1016/j.ceb.2006.09.002; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suzuki K, 2008, EUR J HUM GENET, V16, P36, DOI 10.1038/sj.ejhg.5201925; Takahashi H, 1996, DEV DYNAM, V207, P439, DOI 10.1002/(SICI)1097-0177(199612)207:4<439::AID-AJA8>3.0.CO;2-I; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; VERSCHUEREN K, 1995, MECH DEVELOP, V52, P109, DOI 10.1016/0925-4773(95)00395-H; Vukicevic S, 1998, J CLIN INVEST, V102, P202, DOI 10.1172/JCI2237; WALL NA, 1993, J CELL BIOL, V120, P493, DOI 10.1083/jcb.120.2.493; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Yabe T, 2002, J NEUROSCI RES, V68, P161, DOI 10.1002/jnr.10210; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217; Yan WS, 2007, CANCER RES, V67, P9117, DOI 10.1158/0008-5472.CAN-07-0996; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018; Yang S, 2008, CANCER RES, V68, P198, DOI 10.1158/0008-5472.CAN-07-5074; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888	54	30	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30574	30582		10.1074/jbc.M109.049619	http://dx.doi.org/10.1074/jbc.M109.049619			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19717565	hybrid, Green Published			2022-12-27	WOS:000271090000060
J	Catalucci, D; Latronico, MVG; Ceci, M; Rusconi, F; Young, HS; Gallo, P; Santonastasi, M; Bellacosa, A; Brown, JH; Condorelli, G				Catalucci, Daniele; Latronico, Michael V. G.; Ceci, Marcello; Rusconi, Francesca; Young, Howard S.; Gallo, Paolo; Santonastasi, Marco; Bellacosa, Alfonso; Brown, Joan Heller; Condorelli, Gianluigi			At Increases Sarcoplasmic Reticulum Ca2+ Cycling by Direct Phosphorylation of Phospholamban at Thr(17)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-II; GROWTH-FACTOR-I; CARDIAC MYOCYTES; MYOCARDIAL-CONTRACTILITY; SER(16) PHOSPHORYLATION; MOLECULAR DETERMINANTS; TRANSGENIC MICE; HEART GROWTH; CELL-SIZE; AKT	Cardiomyocytes adapt to physical stress by increasing their size while maintaining cell function. The serine/threonine kinase Akt plays a critical role in this process of adaptation. We previously reported that transgenic overexpression of an active form of Akt (Akt-E40K) in mice results in increased cardiac contractility and cell size, as well as improved sarcoplasmic reticulum (SR) Ca2+ handling. Because it is not fully elucidated, we decided to study the molecular mechanism by which Akt-E40K overexpression improves SR Ca2+ handling. To this end, SR Ca2+ uptake and the phosphorylation status of phospholamban (PLN) were evaluated in heart extracts from wild-type and Akt-E40K mice and mice harboring inducible and cardiac specific knock-out of phosphatidylinositol-dependent kinase-1, the upstream activator of Akt. Moreover, the effect of Akt was assessed in vitro by overexpressing a mutant Akt targeted preferentially to the SR, and by biochemical assays to evaluate potential interaction with PLN. We found that when activated, Akt interacts with and phosphorylates PLN at Thr(17), the Ca2+-calmodulin-dependent kinase II delta site, whereas silencing Akt signaling, through the knock-out of phosphatidylinositol-dependent kinase-1, resulted in reduced phosphorylation of PLN at Thr(17). Furthermore, overexpression of SR-targeted Akt in cardiomyocytes improved Ca2+ handling without affecting cell size. Thus, we describe here a new mechanism whereby the preferential translocation of Akt to the SR is responsible for enhancement of contractility without stimulation of hypertrophy.	[Catalucci, Daniele; Rusconi, Francesca; Condorelli, Gianluigi] CNR, Ist Tecnol Biomed, I-20090 Milan, Italy; [Catalucci, Daniele; Latronico, Michael V. G.; Ceci, Marcello; Rusconi, Francesca; Gallo, Paolo; Santonastasi, Marco; Condorelli, Gianluigi] Ist Ric & Cura Carattere Sci Multimed, I-20138 Milan, Italy; [Catalucci, Daniele; Condorelli, Gianluigi] Univ Calif San Diego, Dept Med, Div Cardiol, La Jolla, CA 92093 USA; [Young, Howard S.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Bellacosa, Alfonso] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Brown, Joan Heller] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of California System; University of California San Diego; University of Alberta; Fox Chase Cancer Center; University of California System; University of California San Diego	Catalucci, D (corresponding author), CNR, Ist Tecnol Biomed, Via Fratelli Cervi 93, I-20090 Milan, Italy.	daniele.catalucci@itb.cnr.it; gcondorelli@ucsd.edu	Catalucci, Daniele/AAA-6056-2022; Catalucci, Daniele/B-6745-2015; Latronico, Michael/AAB-3691-2019; Condorelli, Gianluigi/Q-6736-2017	Catalucci, Daniele/0000-0001-7041-6114; Catalucci, Daniele/0000-0001-7041-6114; Condorelli, Gianluigi/0000-0003-0481-6843; Ceci, Marcello/0000-0002-5066-1590; Latronico, Michele/0000-0003-4017-5764; Young, Howard/0000-0002-5990-8422	National Institutes of Health [HL078797-01A1]; Marie Curie International Fellowship; Italian Ministry of University and Research, the Italian Ministry of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Curie International Fellowship(European Commission); Italian Ministry of University and Research, the Italian Ministry of Health(Ministry of Health, Italy); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL078797-01A1. This work was also supported in part by a Marie Curie International Fellowship within the 6th European Framework Programme (to D. C.) and the Italian Ministry of University and Research, the Italian Ministry of Health.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Aoki M, 1998, P NATL ACAD SCI USA, V95, P14950, DOI 10.1073/pnas.95.25.14950; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Catalucci D, 2008, FRONT BIOSCI-LANDMRK, V13, P312, DOI 10.2741/2681; Catalucci D, 2006, CIRC RES, V99, P339, DOI 10.1161/01.RES.0000239409.90634.a9; Catalucci D, 2009, J CELL BIOL, V184, P923, DOI 10.1083/jcb.200805063; Ceci M, 2004, J MOL CELL CARDIOL, V37, P905, DOI 10.1016/j.yjmcc.2004.06.020; Chu GX, 2000, J BIOL CHEM, V275, P38938, DOI 10.1074/jbc.M004079200; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; Douglas JL, 2005, PROTEIN EXPRES PURIF, V40, P118, DOI 10.1016/j.pep.2004.11.015; Drago GA, 1998, ANN NY ACAD SCI, V853, P273, DOI 10.1111/j.1749-6632.1998.tb08278.x; Gao MH, 2008, J BIOL CHEM, V283, P33527, DOI 10.1074/jbc.M805825200; Hagemann D, 2000, J BIOL CHEM, V275, P22532, DOI 10.1074/jbc.C000253200; Ji Y, 2003, J BIOL CHEM, V278, P25063, DOI 10.1074/jbc.M302193200; Kanemitsu N, 2006, J HEART LUNG TRANSPL, V25, P1253, DOI 10.1016/j.healun.2006.05.012; Kim YK, 2003, J BIOL CHEM, V278, P47622, DOI 10.1074/jbc.M305909200; Luo WS, 1998, J BIOL CHEM, V273, P4734, DOI 10.1074/jbc.273.8.4734; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; McMullen JR, 2004, J BIOL CHEM, V279, P4782, DOI 10.1074/jbc.M310405200; McMullen JR, 2003, P NATL ACAD SCI USA, V100, P12355, DOI 10.1073/pnas.1934654100; Morisco C, 2000, J BIOL CHEM, V275, P14466, DOI 10.1074/jbc.275.19.14466; Netticadan T, 1999, AM J PHYSIOL-CELL PH, V277, pC384, DOI 10.1152/ajpcell.1999.277.3.C384; PAGANI ED, 1984, METHOD PHARMACOL, V5, P49; Richey PA, 1998, J SPORT SCI, V16, P129; Rota M, 2005, CIRC RES, V97, P1332, DOI 10.1161/01.RES.0000196568.11624.ae; Said M, 2003, AM J PHYSIOL-HEART C, V285, pH1198, DOI 10.1152/ajpheart.00209.2003; SCHWORER CM, 1993, J BIOL CHEM, V268, P14443; Serneri GGN, 2001, CIRC RES, V89, P977, DOI 10.1161/hh2301.100982; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Shiojima I, 2002, J BIOL CHEM, V277, P37670, DOI 10.1074/jbc.M204572200; Sun H, 2006, CIRC RES, V98, P1390, DOI 10.1161/01.RES.0000223321.34482.8c; Yu J, 2006, ACTA PHARMACOL SIN, V27, P919, DOI 10.1111/j.1745-7254.2006.00388.x; Zhang T, 2002, J BIOL CHEM, V277, P1261, DOI 10.1074/jbc.M108525200	38	51	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28180	28187		10.1074/jbc.M109.036566	http://dx.doi.org/10.1074/jbc.M109.036566			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19696029	Green Published, hybrid			2022-12-27	WOS:000270676300045
J	Tsunoyama, Y; Bernat, G; Dyczmons, NG; Schneider, D; Rogner, M				Tsunoyama, Yuichi; Bernat, Gabor; Dyczmons, Nina G.; Schneider, Dirk; Roegner, Matthias			Multiple Rieske Proteins Enable Short- and Long-term Light Adaptation of Synechocystis sp PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME B(6)F COMPLEX; CYCLIC ELECTRON FLOW; IRON-SULFUR PROTEIN; ALGA CHLAMYDOMONAS-REINHARDTII; STATE TRANSITIONS; PHOTOSYSTEM-I; SP PCC-6803; GREEN-ALGA; SIGNAL-TRANSDUCTION; PLASTOQUINONE POOL	In contrast to eukaryotes, most cyanobacteria contain several isoforms of the Rieske iron-sulfur protein, PetC, resulting in heterogeneity in the composition of the cytochrome b(6)f complexes. Of three isoforms in the mesophilic cyanobacterium Synechocystis PCC 6803, PetC1 is the major Rieske protein in the cytochrome b(6)f complex, whereas the physiological function of PetC2 and PetC3 is still uncertain. Comparison of wild type and various petC-deficient strains under selected light conditions revealed distinct functional differences: high-light exposure of wild type cells resulted in a significantly enhanced petC2 transcript level, whereas a Delta petC1 mutant showed a low cytochrome b(6)f content, low electron flux, and a considerably increased accumulation of cytochrome-bd oxidase. In contrast to wild type and Delta petC1, Delta petC2 and Delta petC3 strains still grew fast under high-light conditions although all three Rieske proteins are required for maximal electron transport rates. Although the presence of PetC3 appears to be required for activation of the cyclic electron transport, state transitions were more effective in the absence of PetC2 and/or PetC3. In summary, our data suggest defined roles of the various PetC proteins in short- and long-term light adaptation.	[Tsunoyama, Yuichi; Bernat, Gabor; Dyczmons, Nina G.; Roegner, Matthias] Ruhr Univ Bochum, Dept Plant Biochem, D-44780 Bochum, Germany; [Tsunoyama, Yuichi] Kyoto Univ, Div Biol, Radioisotope Res Ctr, Sakyo Ku, Kyoto 6068502, Japan; [Schneider, Dirk] Univ Freiburg, ZBMZ, Dept Biochem & Mol Biol, D-79104 Freiburg, Germany	Ruhr University Bochum; Kyoto University; University of Freiburg	Rogner, M (corresponding author), Ruhr Univ Bochum, Dept Plant Biochem, D-44780 Bochum, Germany.	Matthias.Roegner@rub.de	Bernat, Gabor/J-6333-2017	Bernat, Gabor/0000-0001-6147-9391	German Research Foundation Deutsche Forschungsgemeinschaft [SFB 480, SCHN 690/3-1]; Federal Ministry of Education and Research (BMBF) [Bio-H2]; Kyoto University Foundation; EU/NEST	German Research Foundation Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Kyoto University Foundation; EU/NEST(European Commission)	This work was supported by German Research Foundation Deutsche Forschungsgemeinschaft Grant SFB 480, project CI (to M. R.) and SCHN 690/3-1 (to D.S.), grants from the Federal Ministry of Education and Research (BMBF) project Bio-H2 (to G. B.), the Kyoto University Foundation (to Y. T.), and the EU/NEST project Solar-H (to M. R.).	Aldridge C, 2008, MOL MICROBIOL, V70, P140, DOI 10.1111/j.1365-2958.2008.06401.x; Alfonso M, 2000, PLANT PHYSIOL, V122, P505, DOI 10.1104/pp.122.2.505; Allen JF, 2004, TRENDS PLANT SCI, V9, P130, DOI 10.1016/j.tplants.2004.01.009; Allen JF, 2003, SCIENCE, V299, P1530, DOI 10.1126/science.1082833; BENNETT A, 1973, J CELL BIOL, V58, P419, DOI 10.1083/jcb.58.2.419; Bernat G, 2009, PHOTOSYNTH RES, V99, P205, DOI 10.1007/s11120-008-9398-7; Berry S, 2002, BIOCHEMISTRY-US, V41, P3422, DOI 10.1021/bi011683d; BONAVENTURA C, 1969, BIOCHIM BIOPHYS ACTA, V189, P366, DOI 10.1016/0005-2728(69)90168-6; Bukhov N, 2004, PHOTOSYNTH RES, V82, P17, DOI 10.1023/B:PRES.0000040442.59311.72; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Cape JL, 2006, TRENDS PLANT SCI, V11, P46, DOI 10.1016/j.tplants.2005.11.007; Cramer W, 2008, PHOTOSYNTHETIC PROTE, P155, DOI [10.1002/9783527623464.ch7, DOI 10.1002/9783527623464.CH7]; Cramer WA, 2006, BBA-BIOENERGETICS, V1757, P339, DOI 10.1016/j.bbabio.2006.04.020; Cramer WA, 2006, ANNU REV BIOCHEM, V75, P769, DOI 10.1146/annurev.biochem.75.103004.142756; de Vitry C, 2004, J BIOL CHEM, V279, P44621, DOI 10.1074/jbc.M406955200; de Vitry C, 1999, PLANT CELL, V11, P2031, DOI 10.1105/tpc.11.10.2031; Finazzi G, 2004, PHOTOSYNTH RES, V82, P327, DOI 10.1007/s11120-004-0359-5; Finazzi G, 2002, EMBO REP, V3, P280, DOI 10.1093/embo-reports/kvf047; FORK DC, 1993, PHOTOSYNTH RES, V36, P149, DOI 10.1007/BF00033035; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; Gutthann F, 2007, BBA-BIOENERGETICS, V1767, P161, DOI 10.1016/j.bbabio.2006.12.003; Howitt CA, 1998, BIOCHEMISTRY-US, V37, P17944, DOI 10.1021/bi981486n; Joliot P, 2006, BBA-BIOENERGETICS, V1757, P362, DOI 10.1016/j.bbabio.2006.02.018; KALLAS T, 1988, J BIOL CHEM, V263, P14334; Kaneko T, 1996, DNA Res, V3, P109; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; KURAS R, 1994, EMBO J, V13, P1019, DOI 10.1002/j.1460-2075.1994.tb06350.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; Mao HB, 2002, FEBS LETT, V519, P82, DOI 10.1016/S0014-5793(02)02715-1; Mogi T, 2009, J BIOCHEM, V145, P395, DOI 10.1093/jb/mvn179; Mullineaux CW, 2008, PHOTOSYNTH RES, V95, P175, DOI 10.1007/s11120-007-9249-y; Mullineaux CW, 2005, J EXP BOT, V56, P389, DOI 10.1093/jxb/eri064; MULLINEAUX CW, 1986, FEBS LETT, V205, P155, DOI 10.1016/0014-5793(86)80885-7; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; MURATA N, 1969, BIOCHIM BIOPHYS ACTA, V172, P242, DOI 10.1016/0005-2728(69)90067-X; MYERS J, 1978, J PHYCOL, V14, P513, DOI 10.1111/j.1529-8817.1978.tb02478.x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; Schneider D, 2004, J BIOL CHEM, V279, P39383, DOI 10.1074/jbc.M406288200; Schneider D, 2002, J BIOL CHEM, V277, P10949, DOI 10.1074/jbc.M104076200; Schneider D, 2001, J BIOL CHEM, V276, P16780, DOI 10.1074/jbc.M009503200; Schneider D, 2005, BBA-BIOENERGETICS, V1710, P1, DOI 10.1016/j.bbabio.2005.09.003; Schneider D, 2007, RES MICROBIOL, V158, P45, DOI 10.1016/j.resmic.2006.10.002; SCHULTZE M, 2009, BIOCH BIOPH IN PERSS; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; van Thor JJ, 1998, BOT ACTA, V111, P430, DOI 10.1111/j.1438-8677.1998.tb00731.x; Vener AV, 1998, CURR OPIN PLANT BIOL, V1, P217, DOI 10.1016/S1369-5266(98)80107-6; Vener AV, 1997, P NATL ACAD SCI USA, V94, P1585, DOI 10.1073/pnas.94.4.1585; VENER AV, 1995, J BIOL CHEM, V270, P25225, DOI 10.1074/jbc.270.42.25225; Volkmer T, 2007, J BIOL CHEM, V282, P3730, DOI 10.1074/jbc.M604948200; Whitelegge JP, 2002, MOL CELL PROTEOMICS, V1, P816, DOI 10.1074/mcp.M200045-MCP200; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623; Yan JS, 2003, J BIOL CHEM, V278, P20925, DOI 10.1074/jbc.M212616200; Yeremenko N, 2005, PLANT CELL PHYSIOL, V46, P1433, DOI 10.1093/pcp/pci147; Zhang HM, 2001, J BIOL CHEM, V276, P38159; Zito F, 1999, EMBO J, V18, P2961, DOI 10.1093/emboj/18.11.2961	60	22	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27875	27883		10.1074/jbc.M109.011189	http://dx.doi.org/10.1074/jbc.M109.011189			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19674969	hybrid, Green Published			2022-12-27	WOS:000270676300014
J	Masson, S; Kern, T; Le Gouellec, A; Giustini, C; Simorre, JP; Callow, P; Vernet, T; Gabel, F; Zapun, A				Masson, Soizic; Kern, Thomas; Le Gouellec, Audrey; Giustini, Cecile; Simorre, Jean-Pierre; Callow, Philip; Vernet, Thierry; Gabel, Frank; Zapun, Andre			Central Domain of DivIB Caps the C-terminal Regions of the FtsL/DivIC Coiled-coil Rod	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION PROTEIN; MEMBRANE-BOUND DIVISION; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; SOLUTION SCATTERING; X-RAY; BIOLOGICAL MACROMOLECULES; FTSL; LOCALIZATION; DIVISOME	DivIB(FtsQ), FtsL, and DivIC(FtsB) are enigmatic membrane proteins that are central to the process of bacterial cell division. DivIB(FtsQ) is dispensable in specific conditions in some species, and appears to be absent in other bacterial species. The presence of FtsL and DivIC(FtsB) appears to be conserved despite very low sequence conservation. The three proteins form a complex at the division site, FtsL and DivIC(FtsB) being associated through their extracellular coiled-coil region. We report here structural investigations by NMR, small-angle neutron and x-ray scattering, and interaction studies by surface plasmon resonance, of the complex of DivIB, FtsL, and DivIC from Streptococcus pneumoniae, using soluble truncated forms of the proteins. We found that one side of the "bean"-shaped central beta-domain of DivIB interacts with the C-terminal regions of the dimer of FtsL and DivIC. This finding is corroborated by sequence comparisons across bacterial genomes. Indeed, DivIB is absent from species with shorter FtsL and DivIC proteins that have an extracellular domain consisting only of the coiled-coil segment without C-terminal conserved regions (Campylobacterales). We propose that the main role of the interaction of DivIB with FtsL and DivIC is to help the formation, or to stabilize, the coiled-coil of the latter proteins. The coiled-coil of FtsL and DivIC, itself or with transmembrane regions, could be free to interact with other partners.	[Masson, Soizic; Le Gouellec, Audrey; Vernet, Thierry; Zapun, Andre] Univ Grenoble 1, CNRS, CEA, Lab Ingenierie Macromol,Inst Biol Struct,UMR 5075, F-38027 Grenoble, France; [Kern, Thomas; Giustini, Cecile; Simorre, Jean-Pierre] Univ Grenoble 1, CNRS, Lab Resonance Magnet Nucl, CEA,Inst Biol Struct,UMR 5075, F-38027 Grenoble, France; [Gabel, Frank] Univ Grenoble 1, CNRS, CEA, Lab Biophys Mol,Inst Biol Struct,UMR 5075, F-38027 Grenoble, France; [Callow, Philip] Keele Univ, Inst Sci & Technol, Med Res Inst, Keele ST5 5BG, Staffs, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Keele University	Vernet, T (corresponding author), Univ Grenoble 1, CNRS, CEA, Lab Ingenierie Macromol,Inst Biol Struct,UMR 5075, 41 Rue Jules Horowitz, F-38027 Grenoble, France.	thierry.vernet@ibs.fr	le gouellec, audrey/M-6072-2014; Vernet, Thierry/G-1118-2012; Le Gouellec, audrey/AAC-3013-2019	Le Gouellec, audrey/0000-0002-4905-3854; Gabel, Frank/0000-0003-3446-2601; Zapun, Andre/0000-0001-8953-4399; simorre, jean-pierre/0000-0002-7943-1342	European Union [LSMH-CT-EUR-INTAFAR 2004-512138]; Ministry of Research "allocation de recherche"; Engineering and Physical Sciences Research Council [GR/R99393/01, EP/C015452/1]; EPSRC [EP/C015452/1] Funding Source: UKRI	European Union(European Commission); Ministry of Research "allocation de recherche"; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by European Union Grant LSMH-CT-EUR-INTAFAR 2004-512138 (to T. V. and J.P.S.), a grant from tthe Ministry of Research "allocation de recherche" (to S. M.), and Engineering and Physical Sciences Research Council Grants GR/R99393/01 and EP/C015452/1 (to P. C.).	Aarsman MEG, 2005, MOL MICROBIOL, V55, P1631, DOI 10.1111/j.1365-2958.2005.04502.x; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BEALL B, 1989, J BACTERIOL, V171, P6821, DOI 10.1128/jb.171.12.6821-6834.1989; Buddelmeijer N, 2004, MOL MICROBIOL, V52, P1315, DOI 10.1111/j.1365-2958.2004.04044.x; Buddelmeijer N, 2002, P NATL ACAD SCI USA, V99, P6316, DOI 10.1073/pnas.092128499; CARSON MJ, 1991, J BACTERIOL, V173, P2187, DOI 10.1128/JB.173.7.2187-2195.1991; Chao HM, 1996, BIOCHEMISTRY-US, V35, P12175, DOI 10.1021/bi9530604; Daniel RA, 2000, MOL MICROBIOL, V36, P278, DOI 10.1046/j.1365-2958.2000.01857.x; Daniel RA, 1996, J BACTERIOL, V178, P2343, DOI 10.1128/jb.178.8.2343-2350.1996; Daniel RA, 2006, J BACTERIOL, V188, P7396, DOI 10.1128/JB.01031-06; den Blaauwen T, 2008, FEMS MICROBIOL REV, V32, P321, DOI 10.1111/j.1574-6976.2007.00090.x; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Ghigo JM, 1999, MOL MICROBIOL, V31, P725, DOI 10.1046/j.1365-2958.1999.01213.x; GHOSH R, 2006, ILL06GH05T; GLATTER O, 1979, J APPL CRYSTALLOGR, V12, P166, DOI 10.1107/S0021889879012139; Goehring NW, 2007, J BACTERIOL, V189, P633, DOI 10.1128/JB.00991-06; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Gonzalez MD, 2009, J BACTERIOL, V191, P2815, DOI 10.1128/JB.01597-08; Guinier A., 1939, ANN PHYS, V12, P166; Guzman LM, 1997, J BACTERIOL, V179, P5094, DOI 10.1128/jb.179.16.5094-5103.1997; GUZMAN LM, 1992, J BACTERIOL, V174, P7716, DOI 10.1128/JB.174.23.7717-7728.1992; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Harry E., 2006, INT REV CYTOL, V253, P27; JACROT B, 1981, BIOPOLYMERS, V20, P2413, DOI 10.1002/bip.1981.360201110; Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Katis VL, 1999, J BACTERIOL, V181, P2710, DOI 10.1128/JB.181.9.2710-2718.1999; Katis VL, 2000, J BACTERIOL, V182, P3607, DOI 10.1128/JB.182.12.3607-3611.2000; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Konarev PV, 2001, J APPL CRYSTALLOGR, V34, P527, DOI 10.1107/S0021889801006100; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lau WL, 2004, BIOPHYS J, V86, P272, DOI 10.1016/S0006-3495(04)74103-X; Le Gouellec A, 2008, J BACTERIOL, V190, P4501, DOI 10.1128/JB.00376-08; LEVIN PA, 1994, J BACTERIOL, V176, P1451, DOI 10.1128/jb.176.5.1451-1459.1994; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Noirclerc-Savoye M, 2005, MOL MICROBIOL, V55, P413, DOI 10.1111/j.1365-2958.2004.04408.x; Nyholm TKM, 2007, BIOCHEMISTRY-US, V46, P1457, DOI 10.1021/bi061941c; Robson SA, 2006, P NATL ACAD SCI USA, V103, P6700, DOI 10.1073/pnas.0601397103; Robson SA, 2002, MOL MICROBIOL, V44, P663, DOI 10.1046/j.1365-2958.2002.02920.x; Sanchez-Pulido L, 2003, TRENDS BIOCHEM SCI, V28, P523, DOI 10.1016/j.tibs.2003.08.003; Scheffers DJ, 2007, J BACTERIOL, V189, P7273, DOI 10.1128/JB.00723-07; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van den Ent F, 2008, MOL MICROBIOL, V68, P110, DOI 10.1111/j.1365-2958.2008.06141.x; Wadsworth KD, 2008, MOL MICROBIOL, V67, P1143, DOI 10.1111/j.1365-2958.2008.06114.x	49	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27687	27700		10.1074/jbc.M109.019471	http://dx.doi.org/10.1074/jbc.M109.019471			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19635793	hybrid, Green Published			2022-12-27	WOS:000270232300070
J	Rijken, PJ; Houtkooper, RH; Akbari, H; Brouwers, JF; Koorengevel, MC; de Kruijff, B; Frentzen, M; Vaz, FM; de Kroon, AIPM				Rijken, Pieter J.; Houtkooper, Riekelt H.; Akbari, Hana; Brouwers, Jos F.; Koorengevel, Martijn C.; de Kruijff, Ben; Frentzen, Margrit; Vaz, Frederic M.; de Kroon, Anton I. P. M.			Cardiolipin Molecular Species with Shorter Acyl Chains Accumulate in Saccharomyces cerevisiae Mutants Lacking the Acyl Coenzyme A-binding Protein Acb1p NEW INSIGHTS INTO ACYL CHAIN REMODELING OF CARDIOLIPIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER MEMBRANES; BARTH-SYNDROME; PHOSPHOLIPID BIOSYNTHESIS; SUBCELLULAR MEMBRANES; CDP-DIACYLGLYCEROL; INNER MEMBRANE; BOVINE HEART; YEAST; METABOLISM; SYNTHASE	The function of the mitochondrial phospholipid cardiolipin (CL) is thought to depend on its acyl chain composition. The present study aims at a better understanding of the way the CL species profile is established in Saccharomyces cerevisiae by using depletion of the acyl-CoA-binding protein Acb1p as a tool to modulate the cellular acyl chain content. Despite the presence of an intact CL remodeling system, acyl chains shorter than 16 carbon atoms (C16) were found to accumulate in CL in cells lacking Acb1p. Further experiments revealed that Taz1p, a key CL remodeling enzyme, was not responsible for the shortening of CL in the absence of Acb1p. This left de novo CL synthesis as the only possible source of acyl chains shorter than C16 in CL. Experiments in which the substrate specificity of the yeast cardiolipin synthase Crd1p and the acyl chain composition of individual short CL species were investigated, indicated that both CL precursors (i.e. phosphatidylglycerol and CDP-diacylglycerol) contribute to comparable extents to the shorter acyl chains in CL in acb1 mutants. Based on the findings, we conclude that the fatty acid composition of mature CL in yeast is governed by the substrate specificity of the CL-specific lipase Cld1p and the fatty acid composition of the Taz1p substrates.	[Rijken, Pieter J.; Koorengevel, Martijn C.; de Kruijff, Ben; de Kroon, Anton I. P. M.] Univ Utrecht, Dept Membrane Biochem, Bijvoet Inst, NL-3584 CH Utrecht, Netherlands; [Rijken, Pieter J.; Koorengevel, Martijn C.; de Kruijff, Ben; de Kroon, Anton I. P. M.] Univ Utrecht, Biomembrane Inst, NL-3584 CH Utrecht, Netherlands; [Houtkooper, Riekelt H.; Vaz, Frederic M.] Univ Amsterdam, Dept Clin Chem, Lab Genet Metab Dis, Acad Med Ctr, NL-1100 DE Amsterdam, Netherlands; [Houtkooper, Riekelt H.; Vaz, Frederic M.] Univ Amsterdam, Dept Pediat, Lab Genet Metab Dis, Acad Med Ctr, NL-1100 DE Amsterdam, Netherlands; [Akbari, Hana; Frentzen, Margrit] Univ Aachen, Unit Bot, Inst Biol 1, Rhein Westfal TH, D-52056 Aachen, Germany; [Brouwers, Jos F.] Univ Utrecht, Fac Vet Med, Dept Biochem & Cell Biol, NL-3584 CL Utrecht, Netherlands	Utrecht University; Utrecht University; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; RWTH Aachen University; Utrecht University	de Kroon, AIPM (corresponding author), POB 80-053, NL-3508 TB Utrecht, Netherlands.	a.i.p.m.dekroon@uu.nl	Brouwers, Jos F/AAH-1444-2019; Houtkooper, Riekelt/P-5001-2019; de Kroon, Anton I/O-4119-2016; Houtkooper, Riekelt H/E-1602-2011	Brouwers, Jos F/0000-0003-2924-3279; Houtkooper, Riekelt H/0000-0001-9961-0842; de Kroon, Anton/0000-0003-1209-756X; Vaz, Frederic/0000-0002-9048-1041	Dutch Organization for Scientific Research (NWO); Prinses Beatrix Fonds [WAR05-0126]; Barth Syndrome Foundation	Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Prinses Beatrix Fonds; Barth Syndrome Foundation	This work was supported by an Earth and Life Sciences (ALW) grant with financial aid from the Dutch Organization for Scientific Research (NWO). This work was also supported by Prinses Beatrix Fonds Grant WAR05-0126 and the Barth Syndrome Foundation (to F. M. V.).	Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200; Boumann HA, 2006, MOL BIOL CELL, V17, P1006, DOI 10.1091/mbc.E05-04-0344; Boumann HA, 2003, BIOCHEMISTRY-US, V42, P3054, DOI 10.1021/bi026801r; Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; Chen SL, 2008, MOL MICROBIOL, V68, P1061, DOI 10.1111/j.1365-2958.2008.06216.x; Choi JY, 1996, J BIOL CHEM, V271, P3581; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; de Kroon AIPM, 1999, MOL MEMBR BIOL, V16, P205; deKroon AIPM, 1997, BBA-BIOMEMBRANES, V1325, P108, DOI 10.1016/S0005-2736(96)00240-4; Faergeman NJ, 2004, BIOCHEM J, V380, P907, DOI 10.1042/BJ20031949; Feddersen S, 2007, BIOCHEM J, V407, P219, DOI 10.1042/BJ20070315; FRENTZEN M, 1994, PLANT PHYSIOL, V106, P1527, DOI 10.1104/pp.106.4.1527; Gaigg B, 2001, MOL BIOL CELL, V12, P1147, DOI 10.1091/mbc.12.4.1147; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gohil VM, 2009, J CELL BIOL, V184, P468, DOI 10.1083/jcb.200901127; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; Haiens TH, 2002, FEBS LETT, V528, P35, DOI 10.1016/S0014-5793(02)03292-1; Hauff KD, 2006, PROG LIPID RES, V45, P91, DOI 10.1016/j.plipres.2005.12.001; Houtkooper RH, 2006, FEBS LETT, V580, P3059, DOI 10.1016/j.febslet.2006.04.054; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jiang F, 1999, MOL MICROBIOL, V31, P373, DOI 10.1046/j.1365-2958.1999.01181.x; KLIG LS, 1988, J BACTERIOL, V170, P1878, DOI 10.1128/jb.170.4.1878-1886.1988; KUCHLER K, 1986, J BACTERIOL, V165, P901, DOI 10.1128/jb.165.3.901-910.1986; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Ma LN, 2004, J BIOL CHEM, V279, P44394, DOI 10.1074/jbc.M405479200; Malhotra A, 2009, BBA-MOL CELL BIOL L, V1791, P314, DOI 10.1016/j.bbalip.2009.01.004; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nowicki M, 2005, FEBS LETT, V579, P2161, DOI 10.1016/j.febslet.2005.03.007; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Schjerling CK, 1996, J BIOL CHEM, V271, P22514, DOI 10.1074/jbc.271.37.22514; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Shen HF, 1996, J BIOL CHEM, V271, P789, DOI 10.1074/jbc.271.2.789; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Simockova M, 2008, J BIOL CHEM, V283, P17107, DOI 10.1074/jbc.M800868200; TAMAI KT, 1990, BIOCHIM BIOPHYS ACTA, V1046, P214, DOI 10.1016/0005-2760(90)90192-Z; Testet E, 2005, BIOCHEM J, V387, P617, DOI 10.1042/BJ20041491; Tuller G, 1998, FEBS LETT, V421, P15, DOI 10.1016/S0014-5793(97)01525-1; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; VASILENKO I, 1982, BIOCHIM BIOPHYS ACTA, V684, P282, DOI 10.1016/0005-2736(82)90018-9; Vaz FM, 2003, J BIOL CHEM, V278, P43089, DOI 10.1074/jbc.M305956200; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Welti R, 2003, ANAL BIOCHEM, V314, P149, DOI 10.1016/S0003-2697(02)00623-1; Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhong Q, 2004, J BIOL CHEM, V279, P32294, DOI 10.1074/jbc.M403275200; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	59	17	17	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27609	27619		10.1074/jbc.M109.016311	http://dx.doi.org/10.1074/jbc.M109.016311			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19656950	hybrid, Green Published			2022-12-27	WOS:000270232300062
J	Scholtmeijer, K; de Vocht, ML; Rink, R; Robillard, GT; Wosten, HAB				Scholtmeijer, Karin; de Vocht, Marcel L.; Rink, Rick; Robillard, George T.; Wosten, Han A. B.			Assembly of the Fungal SC3 Hydrophobin into Functional Amyloid Fibrils Depends on Its Concentration and Is Promoted by Cell Wall Polysaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Class I hydrophobins function in fungal growth and development by self-assembling at hydrophobic-hydrophilic interfaces into amyloid-like fibrils. SC3 of the mushroom-forming fungus Schizophyllum commune is the best studied class I hydrophobin. This protein spontaneously adopts the amyloid state at the water-air interface. In contrast, SC3 is arrested in an intermediate conformation at the interface between water and a hydrophobic solid such as polytetrafluoroethylene (PTFE; Teflon). This finding prompted us to study conditions that promote assembly of SC3 into amyloid fibrils. Here, we show that SC3 adopts the amyloid state at the water-PTFE interface at high concentration (300 mu g ml(-1)) and prolonged incubation (16 h). Moreover, we show that amyloid formation at both the water-air and water-PTFE interfaces is promoted by the cell wall components schizophyllan (beta(1-3), beta(1-6)-glucan) and beta(1-3)-glucan. Hydrophobin concentration and cell wall polysaccharides thus contribute to the role of SC3 in formation of aerial hyphae and in hyphal attachment.	[Scholtmeijer, Karin; Robillard, George T.] Univ Utrecht, Groningen Biomol Sci & Biotechnol Inst, NL-3584 CH Utrecht, Netherlands; [Wosten, Han A. B.] Univ Utrecht, Dept Microbiol, NL-3584 CH Utrecht, Netherlands	University of Groningen; Utrecht University; Utrecht University	Scholtmeijer, K (corresponding author), Univ Utrecht, Groningen Biomol Sci & Biotechnol Inst, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	K.Scholtmeijer@uu.nl	Wösten, Han AB/K-2769-2016	Wösten, Han AB/0000-0002-0399-3648; Scholtmeijer, Karin/0000-0002-8510-1809				Alexandrescu AT, 2005, PROTEIN SCI, V14, P1; Ancsin JB, 1999, J BIOL CHEM, V274, P7172, DOI 10.1074/jbc.274.11.7172; Bellotti V, 2008, CURR OPIN STRUC BIOL, V18, P771, DOI 10.1016/j.sbi.2008.10.001; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Claessen D, 2004, MOL MICROBIOL, V53, P433, DOI 10.1111/j.1365-2958.2004.04143.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Martin GG, 2000, BIOMACROMOLECULES, V1, P49, DOI 10.1021/bm005505w; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Relini A, 2008, J BIOL CHEM, V283, P4912, DOI 10.1074/jbc.M702712200; Talbot NJ, 1996, PLANT CELL, V8, P985, DOI 10.1105/tpc.8.6.985; Teertstra WR, 2009, J BIOL CHEM, V284, P9153, DOI 10.1074/jbc.M900095200	11	39	39	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26309	26314		10.1074/jbc.M109.005553	http://dx.doi.org/10.1074/jbc.M109.005553			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19654326	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000269969600010
J	Ablonczy, Z; Prakasam, A; Fant, J; Fauq, A; Crosson, C; Sambamurti, K				Ablonczy, Zsolt; Prakasam, Annamalai; Fant, James; Fauq, Abdul; Crosson, Craig; Sambamurti, Kumar			Pigment Epithelium-derived Factor Maintains Retinal Pigment Epithelium Function by Inhibiting Vascular Endothelial Growth Factor-R2 Signaling through gamma-Secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; FACTOR VEGF EXPRESSION; MACULAR DEGENERATION; AMYLOID-BETA; CHOROIDAL NEOVASCULARIZATION; DIABETIC-RETINOPATHY; OXIDATIVE STRESS; FACTOR PEDF; A-BETA; CELLS	Wet age-related macular degeneration (AMD) attacks the integrity of the retinal pigment epithelium (RPE) barrier system. The pathogenic process was hypothesized to be mediated by vascular endothelial growth factor (VEGF) and antagonized by pigment epithelium-derived factor (PEDF). To dissect these functional interactions, monolayer cultures of RPE cells were established, and changes in transepithelial resistance were evaluated after administration of PEDF, placenta growth factor (VEGF-R1 agonist), and VEGF-E (VEGF-R2 agonist). A recently described mechanism of VEGF inhibition in endothelia required the release of VEGF-R1 intracellular domain by gamma-secretase. To evaluate this pathway in the RPE, cells were pretreated with inhibitors DAPT or LY411575. Processing of VEGF receptors was assessed by Western blot analysis. Administration of VEGF-E rapidly increased RPE permeability, and PEDF inhibited the VEGF-E response dose-dependently. Both gamma-secretase antagonists prevented the inhibitory effects of PEDF. The co-administration of PEDF and VEGF-E depleted the amount of VEGF-R2 in the membrane and increased the amount of VEGF-R2 ectodomain in the media. Therefore, the inhibitory effect of PEDF appears to be mediated via the processing of VEGF-R2 by gamma-secretase. gamma-Secretase generates the amyloid-beta(A beta) peptide of Alzheimer disease from its precursor (amyloid precursor protein). This peptide is also a component of drusen in dry AMD. The results support the hypothesis that misregulation of gamma-secretase may not only lead to A beta deposits in dry AMD but can also be damaging to RPE function by blocking the protective effects of PEDF to prevent VEGF from driving the dry to wet AMD transition.	[Ablonczy, Zsolt; Fant, James; Crosson, Craig] Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; [Prakasam, Annamalai; Sambamurti, Kumar] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Fauq, Abdul] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	Medical University of South Carolina; Medical University of South Carolina; Mayo Clinic	Ablonczy, Z (corresponding author), 167 Ashley Ave,SEI 518E, Charleston, SC 29425 USA.	ablonczy@musc.edu	Sambamurti, Kumar/A-1620-2012	Sambamurti, Kumar/0000-0001-9507-9214	National Institutes of Health [EY14793, AG023055, EY009741]; NEI; NIA; Medical University of South Carolina (MUSC) [P28918]; Research to Prevent Blindness, New York, NY; NIH/NEI [EY13520]; NATIONAL EYE INSTITUTE [R01EY013520, R01EY009741, R24EY014793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical University of South Carolina (MUSC); Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants EY14793, AG023055, and EY009741 from NEI, NIA, and NEI, respectively. This work was also supported by Medical University of South Carolina (MUSC) Grant URC P28918 and an unrestricted grant to MUSC from Research to Prevent Blindness, New York, NY. The Leica DM LFSA confocal microscope was obtained through a supplement to NIH/NEI EY13520.	Ablonczy Z, 2007, EXP EYE RES, V85, P762, DOI 10.1016/j.exer.2007.08.010; Ahir A, 2002, INVEST OPHTH VIS SCI, V43, P458; Alberdi E, 1999, J BIOL CHEM, V274, P31605, DOI 10.1074/jbc.274.44.31605; Anderson DH, 2004, EXP EYE RES, V78, P243, DOI 10.1016/j.exer.2003.10.011; Antcliff R J, 1999, Semin Ophthalmol, V14, P223, DOI 10.3109/08820539909069541; Augustin AJ, 2007, RETINA-J RET VIT DIS, V27, P133, DOI 10.1097/IAE.0b013e3180323de7; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Blaauwgeers HGT, 1999, AM J PATHOL, V155, P421, DOI 10.1016/S0002-9440(10)65138-3; Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; De Strooper B, 2003, NATURE, V423, P392, DOI 10.1038/423392a; Dentchev T, 2003, MOL VIS, V9, P184; Dijkstra A, 2009, VIRCHOWS ARCH, V454, P441, DOI 10.1007/s00428-009-0748-4; Ebos JML, 2004, MOL CANCER RES, V2, P315; Ghassemifar R, 2006, CELL TISSUE RES, V323, P117, DOI 10.1007/s00441-005-0046-7; Gillies MC, 1999, DOC OPHTHALMOL, V97, P251, DOI 10.1023/A:1002196930726; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Hartnett ME, 2003, EXP EYE RES, V77, P593, DOI 10.1016/S0014-4835(03)00189-1; HEIER JS, 2006, OPHTHALMOLOGY, V642, pE641; Johnson LV, 2002, P NATL ACAD SCI USA, V99, P11830, DOI 10.1073/pnas.192203399; Kannan R, 2006, MOL VIS, V12, P1649; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kou BJ, 2004, EXP MOL PATHOL, V76, P129, DOI 10.1016/j.yexmp.2003.10.010; Maminishkis A, 2006, INVEST OPHTH VIS SCI, V47, P3612, DOI 10.1167/iovs.05-1622; Marmor MF, 1999, DOC OPHTHALMOL, V97, P239, DOI 10.1023/A:1002192829817; Marneros AG, 2005, AM J PATHOL, V167, P1451, DOI 10.1016/S0002-9440(10)61231-X; Miyamoto N, 2007, DIABETOLOGIA, V50, P461, DOI 10.1007/s00125-006-0539-2; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Ohno-Matsui K, 2001, J CELL PHYSIOL, V189, P323, DOI 10.1002/jcp.10026; Pinnix I, 2001, J BIOL CHEM, V276, P481, DOI 10.1074/jbc.M005968200; Sambamurti K, 2002, NEUROMOL MED, V1, P1, DOI 10.1385/NMM:1:1:1; Sambamurti Kumar, 2006, Current Alzheimer Research, V3, P81, DOI 10.2174/156720506775697142; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Slomiany MG, 2004, INVEST OPHTH VIS SCI, V45, P2838, DOI 10.1167/iovs.03-0565; Small DH, 2002, PEPTIDES, V23, P1317, DOI 10.1016/S0196-9781(02)00072-4; Spaide RF, 2006, RETINA-J RET VIT DIS, V26, P383, DOI 10.1097/00006982-200604000-00001; Swendeman S, 2008, CIRC RES, V103, P916, DOI 10.1161/CIRCRESAHA.108.184416; Thurman JM, 2009, J BIOL CHEM, V284, P16939, DOI 10.1074/jbc.M808166200; Tombran-Tink J, 2005, FRONT BIOSCI-LANDMRK, V10, P2131, DOI 10.2741/1686; TOMBRANTINK J, 1995, J NEUROSCI, V15, P4992; TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D; Tranos PG, 2004, SURV OPHTHALMOL, V49, P470, DOI 10.1016/j.survophthal.2004.06.002; Wang RS, 2006, P NATL ACAD SCI USA, V103, P353, DOI 10.1073/pnas.0509822102; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Yamagishi S, 2006, MICROVASC RES, V71, P222, DOI 10.1016/j.mvr.2006.03.001; Yoshida T, 2005, J CLIN INVEST, V115, P2793, DOI 10.1172/JCI24635; Zhang SX, 2006, J MOL ENDOCRINOL, V37, P1, DOI 10.1677/jme.1.02008; Zhou Y, 2008, FASEB J, V22, P47, DOI 10.1096/fj.07-8175com	47	55	61	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30177	30186		10.1074/jbc.M109.032391	http://dx.doi.org/10.1074/jbc.M109.032391			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19723623	hybrid, Green Published			2022-12-27	WOS:000271090000021
J	Biswas, T; Yi, L; Aggarwal, P; Wu, J; Rubin, JR; Stuckey, JA; Woodard, RW; Tsodikov, OV				Biswas, Tapan; Yi, Li; Aggarwal, Parag; Wu, Jing; Rubin, John R.; Stuckey, Jeanne A.; Woodard, Ronald W.; Tsodikov, Oleg V.			The Tail of KdsC CONFORMATIONAL CHANGES CONTROL THE ACTIVITY OF A HALOACID DEHALOGENASE SUPERFAMILY PHOSPHATASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAD SUPERFAMILY; PHOSPHATASE; ASPARTATE; YRBI	The phosphatase KdsC cleaves 3-deoxy-D-manno-octulosonate 8-phosphate to generate a molecule of inorganic phosphate and Kdo. Kdo is an essential component of the lipopolysaccharide envelope in Gram-negative bacteria. Because lipopolysaccharide is an important determinant of bacterial resistance and toxicity, KdsC is a potential target for novel antibacterial agents. KdsC belongs to the broad haloacid dehalogenase superfamily. In haloacid dehalogenase superfamily enzymes, substrate specificity and catalytic efficiency are generally dictated by a fold feature called the cap domain. It is therefore not clear why KdsC, which lacks a cap domain, is catalytically efficient and highly specific to 3-deoxy-D-manno-octulosonate 8-phosphate. Here, we present a set of seven structures of tetrameric Escherichia coli KdsC ( ranging from 1.4 to 3.06 angstrom in resolution) that model different intermediate states in its catalytic mechanism. A crystal structure of product-bound E. coli KdsC shows how the interface between adjacent monomers defines the active site pocket. Kdo is engaged in a network of polar and nonpolar interactions with residues at this interface, which explains substrate specificity. Furthermore, this structural and kinetic analysis strongly suggests that the binding of the flexible C-terminal region ( tail) to the active site makes KdsC catalytically efficient by facilitating product release.	[Biswas, Tapan; Yi, Li; Aggarwal, Parag; Wu, Jing; Woodard, Ronald W.; Tsodikov, Oleg V.] Univ Michigan, Dept Med Chem, Coll Pharm, Ann Arbor, MI 48109 USA; [Rubin, John R.; Stuckey, Jeanne A.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Woodard, RW (corresponding author), 428 Church St, Ann Arbor, MI 48109 USA.	rww@umich.edu; olegt@umich.edu		Woodard, Ronald/0000-0002-7472-3653	National Institutes of Health [AI61531]; College of Pharmacy, University of Michigan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061531] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Pharmacy, University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI61531 ( to R. W. W.). This work was also supported by the start-up funds from the College of Pharmacy, University of Michigan ( to O.V.T.).	Allen KN, 2004, TRENDS BIOCHEM SCI, V29, P495, DOI 10.1016/j.tibs.2004.07.008; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Cho H, 2001, P NATL ACAD SCI USA, V98, P8525, DOI 10.1073/pnas.131213698; Deshpande RA, 2004, BIOCHEMISTRY-US, V43, P8579, DOI 10.1021/bi049434n; Diaz AR, 2008, J BIOL CHEM, V283, P2962, DOI 10.1074/jbc.M709032200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghosh A, 2008, MOL CELL, V32, P478, DOI 10.1016/j.molcel.2008.09.021; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; Lahiri SD, 2004, BIOCHEMISTRY-US, V43, P2812, DOI 10.1021/bi0356810; Lahiri SD, 2002, BIOCHEMISTRY-US, V41, P8351, DOI 10.1021/bi0202373; Lu ZB, 2009, J BIOL CHEM, V284, P1224, DOI 10.1074/jbc.M807056200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen HP, 2003, NAT STRUCT BIOL, V10, P1019, DOI 10.1038/nsb1014; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsons JF, 2002, PROTEINS, V46, P393, DOI 10.1002/prot.10057; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Wu J, 2003, J BIOL CHEM, V278, P18117, DOI 10.1074/jbc.M301983200	21	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30594	30603		10.1074/jbc.M109.012278	http://dx.doi.org/10.1074/jbc.M109.012278			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19726684	hybrid, Green Published			2022-12-27	WOS:000271090000062
J	Naamati, A; Regev-Rudzki, N; Galperin, S; Lill, R; Pines, O				Naamati, Adi; Regev-Rudzki, Neta; Galperin, Shlomi; Lill, Roland; Pines, Ophry			Dual Targeting of Nfs1 and Discovery of Its Novel Processing Enzyme, Icp55	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE-T-ANTIGEN; MITOCHONDRIAL PROTEINS; SACCHAROMYCES-CEREVISIAE; NUCLEAR-LOCALIZATION; SYNTHETIC PEPTIDE; THIO-MODIFICATION; YEAST FUMARASE; LOCATION; SEQUENCE; IMPORT	In eukaryotes, each subcellular compartment harbors a specific group of proteins that must accomplish specific tasks. Nfs1 is a highly conserved mitochondrial cysteine desulfurase that participates in iron-sulfur cluster assembly as a sulfur donor. Previous genetic studies, in Saccharomyces cerevisiae, have suggested that this protein distributes between the mitochondria and the nucleus with biochemically undetectable amounts in the nucleus (termed "eclipsed distribution"). Here, we provide direct evidence for Nfs1 nuclear localization (in addition to mitochondria) using both alpha-complementation and subcellular fractionation. We also demonstrate that mitochondrial and nuclear Nfs1 are derived from a single translation product. Our data suggest that the Nfs1 distribution mechanism involves at least partial entry of the Nfs1 precursor into mitochondria, and then retrieval of a minor subpopulation (probably by reverse translocation) into the cytosol and then the nucleus. To further elucidate the mechanism of Nfs1 distribution we determined the N-terminal mitochondrial sequence of Nfs1 by Edman degradation. This led to the discovery of a novel mitochondrial processing enzyme, Icp55. This enzyme removes three amino acids from the N terminus of Nfs1 after cleavage by mitochondrial processing peptidase. Intriguingly, Icp55 protease (like its substrate Nfs1) appears to be dual distributed between the nucleus and mitochondria.	[Naamati, Adi; Regev-Rudzki, Neta; Galperin, Shlomi; Pines, Ophry] Hebrew Univ Jerusalem, Fac Med, IMRIC, Dept Microbiol & Mol Genet, IL-91120 Jerusalem, Israel; [Lill, Roland] Univ Marburg, Inst Cytobiol & Cytopathol, D-35033 Marburg, Germany	Hebrew University of Jerusalem; Philipps University Marburg	Pines, O (corresponding author), Hebrew Univ Jerusalem, Sch Med, Dept Mol Biol, IL-91120 Jerusalem, Israel.	ophryp@ekmd.huji.ac.il	pines, ophry/C-4086-2011	pines, ophry/0000-0001-7126-2575; Lill, Roland/0000-0002-8345-6518; Naamati, Adi/0000-0001-6989-3634	Deutsche Forschungsgemeinschaft [SFB 593, TR1, GRK 1216]; Rhon Klinikum AG; von Behring-Rontgen Stiftung; Max-Planck Gesellschaft; Fonds der chemischen Industrie; German Israeli Foundation; Israel Science Foundation; The Niedersachsen-Israeli Research Cooperation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Rhon Klinikum AG; von Behring-Rontgen Stiftung; Max-Planck Gesellschaft(Max Planck Society); Fonds der chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); German Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); The Niedersachsen-Israeli Research Cooperation	Supported by the Deutsche Forschungsgemeinschaft (Grants SFB 593 and TR1, Gottfried-Wilhelm Leibniz program, and Grant GRK 1216), Rhon Klinikum AG, von Behring-Rontgen Stiftung, Max-Planck Gesellschaft, and Fonds der chemischen Industrie.; Supported by the German Israeli Foundation.; Supported by the Israel Science Foundation and The Niedersachsen-Israeli Research Cooperation.	Andreoli C, 2004, NUCLEIC ACIDS RES, V32, pD459, DOI 10.1093/nar/gkh137; DANPURE CJ, 1995, TRENDS CELL BIOL, V5, P230, DOI 10.1016/S0962-8924(00)89016-9; DINGWALL C, 1988, J CELL BIOL, V107, P841, DOI 10.1083/jcb.107.3.841; Fosset C, 2006, J BIOL CHEM, V281, P25398, DOI 10.1074/jbc.M602979200; Ito A, 1999, BIOCHEM BIOPH RES CO, V265, P611, DOI 10.1006/bbrc.1999.1703; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kambacheld M, 2005, J BIOL CHEM, V280, P20132, DOI 10.1074/jbc.M500398200; Karniely S, 2006, J MOL BIOL, V358, P396, DOI 10.1016/j.jmb.2006.02.023; Karniely S, 2005, EMBO REP, V6, P420, DOI 10.1038/sj.embor.7400394; Karniely S, 2006, EXP CELL RES, V312, P3835, DOI 10.1016/j.yexcr.2006.08.021; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Knox C, 1998, J BIOL CHEM, V273, P25587, DOI 10.1074/jbc.273.40.25587; Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452; Land T, 1998, MOL CELL, V2, P807, DOI 10.1016/S1097-2765(00)80295-6; LANFORD RE, 1986, CELL, V46, P575, DOI 10.1016/0092-8674(86)90883-4; Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nakai Y, 2004, J BIOL CHEM, V279, P12363, DOI 10.1074/jbc.M312448200; Nakai Y, 1998, FEBS LETT, V433, P143, DOI 10.1016/S0014-5793(98)00897-7; Nakai Y, 2001, J BIOL CHEM, V276, P8314, DOI 10.1074/jbc.M007878200; Nakai Y, 2007, MOL CELL BIOL, V27, P2841, DOI 10.1128/MCB.01321-06; NIIDOME T, 1994, J BIOL CHEM, V269, P24719; Prokisch H, 2006, NUCLEIC ACIDS RES, V34, pD705, DOI 10.1093/nar/gkj127; Regev-Rudzki N, 2005, MOL BIOL CELL, V16, P4163, DOI 10.1091/mbc.e04-11-1028; Regev-Rudzki N, 2008, J CELL SCI, V121, P2423, DOI 10.1242/jcs.029207; Regev-Rudzki N, 2007, BIOESSAYS, V29, P772, DOI 10.1002/bies.20609; Sass E, 2003, J BIOL CHEM, V278, P45109, DOI 10.1074/jbc.M302344200; Sass E, 2001, J BIOL CHEM, V276, P46111, DOI 10.1074/jbc.M106061200; Schricker R, 2002, J BIOL CHEM, V277, P28757, DOI 10.1074/jbc.M201561200; Shlevin L, 2007, TRAFFIC, V8, P169, DOI 10.1111/j.1600-0854.2006.00518.x; Yogev O, 2007, J BIOL CHEM, V282, P29222, DOI 10.1074/jbc.M704201200; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754	34	63	65	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30200	30208		10.1074/jbc.M109.034694	http://dx.doi.org/10.1074/jbc.M109.034694			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19720832	Green Published, hybrid			2022-12-27	WOS:000271090000023
J	Griessmeier, K; Cuny, H; Rotzer, K; Griesbeck, O; Harz, H; Biel, M; Wahl-Schott, C				Griessmeier, Kristina; Cuny, Hartmut; Roetzer, Katrin; Griesbeck, Oliver; Harz, Hartmann; Biel, Martin; Wahl-Schott, Christian			Calmodulin Is a Functional Regulator of Cav1.4 L-type Ca2+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATIONARY NIGHT BLINDNESS; GREEN FLUORESCENT PROTEINS; EF-HAND MOTIF; CALCIUM-CHANNEL; CA2+-DEPENDENT INACTIVATION; SYNAPTIC-TRANSMISSION; MOUSE RETINA; FRET; DOMAIN; COMPLEX	Cav1.4 channels are unique among the high voltage-activated Ca2+ channel family because they completely lack Ca2+-dependent inactivation and display very slow voltage-dependent inactivation. Both properties are of crucial importance in ribbon synapses of retinal photoreceptors and bipolar cells, where sustained Ca2+ influx through Cav1.4 channels is required to couple slow graded changes of the membrane potential with tonic glutamate release. Loss of Cav1.4 function causes severe impairment of retinal circuitry function and has been linked to night blindness in humans and mice. Recently, an inhibitory domain (ICDI: inhibitor of Ca2+-dependent inactivation) in the C-terminal tail of Cav1.4 has been discovered that eliminates Ca2+-dependent inactivation by binding to upstream regulatory motifs within the proximal C terminus. The mechanism underlying the action of ICDI is unclear. It was proposed that ICDI competitively displaces the Ca2+ sensor calmodulin. Alternatively, the ICDI domain and calmodulin may bind to different portions of the C terminus and act independently of each other. In the present study, we used fluorescence resonance energy transfer experiments with genetically engineered cyan fluorescent protein variants to address this issue. Our data indicate that calmodulin is preassociated with the C terminus of Cav1.4 but may be tethered in a different steric orientation as compared with other Ca2+ channels. We also find that calmodulin is important for Cav1.4 function because it increases current density and slows down voltage-dependent inactivation. Our data show that the ICDI domain selectively abolishes Ca2+-dependent inactivation, whereas it does not interfere with other calmodulin effects.	[Biel, Martin; Wahl-Schott, Christian] Univ Munich, Dept Pharm, Zentrum Pharmaforsch, D-81377 Munich, Germany; [Wahl-Schott, Christian] Univ Munich, CIPS M, D-81377 Munich, Germany; [Harz, Hartmann] Univ Munich, BioImaging Zentrum, D-81377 Munich, Germany; [Griesbeck, Oliver] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	University of Munich; University of Munich; University of Munich; Max Planck Society	Biel, M (corresponding author), Univ Munich, Dept Pharm, Zentrum Pharmaforsch, Butenandtstr 5-13, D-81377 Munich, Germany.	martin.biel@cup.uni-muenchen.de; christian.wahl@cup.uni-muenchen.de	Wahl-Schott, Christian A/J-2623-2015; Biel, Martin/G-1175-2014	Biel, Martin/0000-0002-9974-3052; Griesbeck, Oliver/0000-0001-5883-5594; Cuny, Hartmut/0000-0002-1551-2354	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG).	Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Barnes S, 2002, ADV EXP MED BIOL, V514, P465; Baumann L, 2004, INVEST OPHTH VIS SCI, V45, P708, DOI 10.1167/iovs.03-0937; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Bernatchez G, 1998, BIOPHYS J, V75, P1727, DOI 10.1016/S0006-3495(98)77614-3; BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; Doering CJ, 2007, CHANNELS, V1; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Erickson MG, 2003, BIOPHYS J, V85, P599, DOI 10.1016/S0006-3495(03)74504-4; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Fallon JL, 2003, STRUCTURE, V11, P1303, DOI 10.1016/j.str.2003.09.004; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Hamilton S. L., 2005, SCI STKE; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Mank M, 2006, BIOPHYS J, V90, P1790, DOI 10.1529/biophysj.105.073536; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; Mc Intyre J, 2007, EMBO J, V26, P3783, DOI 10.1038/sj.emboj.7601793; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Mori MX, 2008, STRUCTURE, V16, P607, DOI 10.1016/j.str.2008.01.011; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Pedersen M, 2008, J BIOL CHEM, V283, P2663, DOI 10.1074/jbc.M708194200; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Thoreson WB, 2007, MOL NEUROBIOL, V36, P205, DOI 10.1007/s12035-007-0019-9; Topell S, 1999, FEBS LETT, V457, P283, DOI 10.1016/S0014-5793(99)01044-3; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Van Petegem F, 2006, BIOCHEM SOC T, V34, P887, DOI 10.1042/BST0340887; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Wahl-Schott C, 2006, P NATL ACAD SCI USA, V103, P15657, DOI 10.1073/pnas.0604621103; Wang HG, 2007, J NEUROSCI, V27, P9086, DOI 10.1523/JNEUROSCI.1720-07.2007; Wang L, 2008, MOL BIOL CELL, V19, P3944, DOI 10.1091/mbc.E08-04-0344; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zuhlke RD, 1998, P NATL ACAD SCI USA, V95, P3287, DOI 10.1073/pnas.95.6.3287	43	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29809	29816		10.1074/jbc.M109.048082	http://dx.doi.org/10.1074/jbc.M109.048082			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19717559	Green Published, hybrid			2022-12-27	WOS:000270896800061
J	Kassiri, Z; Defamie, V; Hariri, M; Oudit, GY; Anthwal, S; Dawood, F; Liu, P; Khokha, R				Kassiri, Zamaneh; Defamie, Virginie; Hariri, Mehrdad; Oudit, Gavin Y.; Anthwal, Shalini; Dawood, Fayez; Liu, Peter; Khokha, Rama			Simultaneous Transforming Growth Factor beta-Tumor Necrosis Factor Activation and Cross-talk Cause Aberrant Remodeling Response and Myocardial Fibrosis in Timp3-deficient Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; TISSUE INHIBITOR; GROWTH-FACTOR-BETA-1 GENE; MATRIX METALLOPROTEINASES; DIFFERENTIAL EXPRESSION; INTERSTITIAL FIBROSIS; CARDIAC FIBROBLASTS; COLLAGEN PRODUCTION; SYSTOLIC FUNCTION; TRANSGENIC MICE	The pleiotropic cytokines, transforming growth factor beta 1 (TGF beta 1), and tumor necrosis factor (TNF) play critical roles in tissue homeostasis in response to injury and are implicated in multiple human diseases and cancer. We reported that the loss of Timp3 (tissue inhibitor of metalloproteinase 3) leads to abnormal TNF signaling and cardiovascular function. Here we show that parallel deregulation of TGF beta 1 and TNF signaling in Timp3(-/-) mice amplifies their cross-talk at the onset of cardiac response to mechanical stress (pressure overload), resulting in fibrosis and early heart failure. Microarray analysis showed a distinct gene expression profile in Timp3(-/-) hearts, highlighting activation of TGF beta 1 signaling as a potential mechanism underlying fibrosis. Neonatal cardiomyocyte-cardiofibroblast co-cultures were established to measure fibrogenic response to agonists known to be induced following mechanical stress in vivo. A stronger response occurred in neonatal Timp3(-/-) cocultures, as determined by increased Smad signaling and collagen expression, due to increased TNF processing and precocious proteolytic maturation of TGF beta 1 to its active form. The relationship between TGF beta 1 and TNF was dissected using genetic and pharmacological manipulations. Timp3(-/-)/Tnf(-/-) mice had lower TGF beta 1 than Timp3(-/-), and anti-TGF beta 1 antibody (1D11) negated the abnormal TNF response, indicating their reciprocal stimulatory effects, with each manipulation abolishing fibrosis and improving heart function. Thus, TIMP3 is a common innate regulator of TGF beta 1 and TNF in tissue response to injury. The matrix-bound TIMP3 balances the anti-inflammatory and proinflammatory processes toward constructive tissue remodeling.	[Kassiri, Zamaneh; Defamie, Virginie; Hariri, Mehrdad; Oudit, Gavin Y.; Anthwal, Shalini; Khokha, Rama] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Dawood, Fayez; Liu, Peter] Univ Toronto, Div Cardiol, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Khokha, R (corresponding author), Univ Toronto, Ontario Canc Inst, 610 Univ Ave,10-330, Toronto, ON M5G 2M9, Canada.	rkhokha@uhnres.utoronto.ca		Khokha, Rama/0000-0002-6028-1524; Defamie, Virginie/0000-0002-6405-0539	Heart and Stroke Foundation; Tailored Advanced Collaborative Training in Cardiovascular Sciences fellowship	Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Tailored Advanced Collaborative Training in Cardiovascular Sciences fellowship	This work was supported by funding from the Heart and Stroke Foundation (to R. K.) and a Tailored Advanced Collaborative Training in Cardiovascular Sciences fellowship (to Z. K.).	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aras Omer, 2008, Curr Cardiol Rep, V10, P128, DOI 10.1007/s11886-008-0022-4; Asano Y, 2004, J CLIN INVEST, V113, P253, DOI 10.1172/JCI200416269; Awad MR, 1998, TRANSPLANTATION, V66, P1014, DOI 10.1097/00007890-199810270-00009; Billet S, 2008, KIDNEY INT, V74, P1379, DOI 10.1038/ki.2008.358; Bitzer M, 2000, GENE DEV, V14, P187; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Brooks A, 2003, HEART, V89, P1255, DOI 10.1136/heart.89.10.1255; El Chaar M, 2007, AM J PHYSIOL-RENAL, V292, pF1291, DOI 10.1152/ajprenal.00327.2005; Gauldie J, 2007, BIOCHEM SOC T, V35, P661, DOI 10.1042/BST0350661; Ghosh AK, 2007, J CELL PHYSIOL, V213, P663, DOI 10.1002/jcp.21162; Goldberg MT, 2007, J INVEST DERMATOL, V127, P2645, DOI 10.1038/sj.jid.5700890; GRAHAM CH, 1992, BIOL REPROD, V46, P561, DOI 10.1095/biolreprod46.4.561; Herpel E, 2006, HISTOPATHOLOGY, V48, P736, DOI 10.1111/j.1365-2559.2006.02398.x; Hogg K, 2004, J AM COLL CARDIOL, V43, P317, DOI 10.1016/j.jacc.2003.07.046; Holweg CTJ, 2001, J HEART LUNG TRANSPL, V20, P979, DOI 10.1016/S1053-2498(01)00296-0; Hyytiainen M, 2004, CRIT REV CL LAB SCI, V41, P233, DOI 10.1080/10408360490460933; INAGAKI Y, 1995, J BIOL CHEM, V270, P3353, DOI 10.1074/jbc.270.7.3353; Jenkins G, 2008, INT J BIOCHEM CELL B, V40, P1068, DOI 10.1016/j.biocel.2007.11.026; Jester JV, 1997, CORNEA, V16, P177; Ju HS, 1996, MOL CELL BIOCHEM, V164, P231, DOI 10.1007/BF00408663; Kassiri Z, 2005, CIRC RES, V97, P380, DOI 10.1161/01.RES.0000178789.16929.cf; Kassiri Z, 2002, CIRC RES, V90, P578, DOI 10.1161/01.RES.0000012223.86441.A1; Katz AM, 2006, CIRCULATION, V113, P1922, DOI 10.1161/CIRCULATIONAHA.106.620765; Kopp JB, 1996, LAB INVEST, V74, P991; Kuhl U, 1995, EUR HEART J, V16, P100, DOI 10.1093/eurheartj/16.suppl_O.100; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Lavoie P, 2005, J HYPERTENS, V23, P1895, DOI 10.1097/01.hjh.0000182521.44440.c5; Leco KJ, 2001, J CLIN INVEST, V108, P817, DOI 10.1172/JCI12067; Li BG, 1999, HYPERTENSION, V33, P271, DOI 10.1161/01.HYP.33.1.271; Li YY, 1998, CIRCULATION, V98, P1728, DOI 10.1161/01.CIR.98.17.1728; Mandinov L, 2000, CARDIOVASC RES, V45, P813, DOI 10.1016/S0008-6363(99)00399-5; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Murphy G, 2008, TRENDS IMMUNOL, V29, P75, DOI 10.1016/j.it.2007.10.009; Nuttall RK, 2004, FEBS LETT, V563, P129, DOI 10.1016/S0014-5793(04)00281-9; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Osadchii OE, 2007, HEART FAIL REV, V12, P66, DOI 10.1007/s10741-007-9007-4; OVERALL CM, 1991, J BIOL CHEM, V266, P14064; Pathak M, 2001, HYPERTENSION, V37, P833, DOI 10.1161/01.HYP.37.3.833; Petrov VV, 2002, HYPERTENSION, V39, P258, DOI 10.1161/hy0202.103268; Roman-Blas JA, 2007, OSTEOARTHR CARTILAGE, V15, P1367, DOI 10.1016/j.joca.2007.04.011; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; SANDERSON N, 1995, P NATL ACAD SCI USA, V92, P2572, DOI 10.1073/pnas.92.7.2572; Senni M, 2001, J AM COLL CARDIOL, V38, P1277, DOI 10.1016/S0735-1097(01)01567-4; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Smookler DS, 2006, J IMMUNOL, V176, P721, DOI 10.4049/jimmunol.176.2.721; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Stawowy P, 2004, CIRCULATION, V109, P770, DOI 10.1161/01.CIR.0000112583.50762.DE; Stawowy P, 2004, CARDIOVASC RES, V63, P87, DOI 10.1016/j.cardiores.2004.03.010; Stramer BM, 2007, J INVEST DERMATOL, V127, P1009, DOI 10.1038/sj.jid.5700811; Sugimoto H, 2007, DIABETES, V56, P1825, DOI 10.2337/db06-1226; Swiderski RE, 1998, AM J PATHOL, V152, P821; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Yamada Y, 1998, J BONE MINER RES, V13, P1569, DOI 10.1359/jbmr.1998.13.10.1569; Young DA, 2002, BIOCHEM J, V364, P89, DOI 10.1042/bj3640089; Yu L, 2004, KIDNEY INT, V66, P1774, DOI 10.1111/j.1523-1755.2004.00901.x; Yu Q, 2000, GENE DEV, V14, P163; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566	59	75	75	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29893	29904		10.1074/jbc.M109.028449	http://dx.doi.org/10.1074/jbc.M109.028449			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19625257	Green Published, hybrid			2022-12-27	WOS:000270896800069
J	Ulijasz, AT; Cornilescu, G; von Stetten, D; Cornilescu, C; Escobar, FV; Zhang, JR; Stankey, RJ; Rivera, M; Hildebrandt, P; Vierstra, RD				Ulijasz, Andrew T.; Cornilescu, Gabriel; von Stetten, David; Cornilescu, Claudia; Escobar, Francisco Velazquez; Zhang, Junrui; Stankey, Robert J.; Rivera, Mario; Hildebrandt, Peter; Vierstra, Richard D.			Cyanochromes Are Blue/Green Light Photoreversible Photoreceptors Defined by a Stable Double Cysteine Linkage to a Phycoviolobilin-type Chromophore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; GAF DOMAIN; BINDING DOMAIN; CYANOBACTERIOCHROME TEPIXJ; LINEAR TETRAPYRROLES; VIBRATIONAL-SPECTRA; HISTIDINE KINASES; CRYSTAL-STRUCTURE; PHYTOCHROME; BACTERIOPHYTOCHROME	Phytochromes are a collection of bilin-containing photoreceptors that regulate a diverse array of processes in microorganisms and plants through photoconversion between two stable states, a red light-absorbing Pr form, and a far red light-absorbing Pfr form. Recently, a novel set of phytochrome-like chromoproteins was discovered in cyanobacteria, designated here as cyanochromes, that instead photoconvert between stable blue and green light-absorbing forms Pb and Pg, respectively. Here, we show that the distinctive absorption properties of cyanochromes are facilitated through the binding of phycocyanobilin via two stable cysteine-based thioether linkages within the cGMP phosphodiesterase/adenyl cyclase/FhlA domain. Absorption, resonance Raman and infrared spectroscopy, and molecular modeling of the Te-PixJ GAF (cGMP phosphodiesterase/adenyl cyclase/FhlA) domain assembled with phycocyanobilin are consistent with attachments to the C3(1) carbon of the ethylidene side chain and the C4 or C5 carbons in the A-B methine bridge to generate a double thioether-linked phycoviolobilin-type chromophore. These spectroscopic methods combined with NMR data show that the bilin is fully protonated in the Pb and Pg states and that numerous conformation changes occur during Pb -> Pg photoconversion. Also identified were a number of photochromically inactive mutants with strong yellow or red fluorescence that may be useful for fluorescence-based cell biological assays. Phylogenetic analyses detected cyanochromes capable of different signaling outputs in a wide range of cyanobacterial species. One unusual case is the Synechocystis cyanochrome Etr1 that also binds ethylene, suggesting that it works as a hybrid receptor to simultaneously integrate light and hormone signals.	[Ulijasz, Andrew T.; Zhang, Junrui; Stankey, Robert J.; Vierstra, Richard D.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Cornilescu, Gabriel; Cornilescu, Claudia] Natl Magnet Resonance Facil Madison, Madison, WI 53706 USA; [von Stetten, David; Escobar, Francisco Velazquez; Hildebrandt, Peter] Tech Univ Berlin, D-10623 Berlin, Germany; [Rivera, Mario] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA	University of Wisconsin System; University of Wisconsin Madison; Technical University of Berlin; University of Kansas	Vierstra, RD (corresponding author), Univ Wisconsin, Dept Genet, 425-G Henry Mall, Madison, WI 53706 USA.	vierstra@wisc.edu	Cornilescu, Gabriel/H-3113-2011; Zhang, Junrui/J-2684-2012; Hildebrandt, Peter/J-5658-2014; Cornilescu, Claudia/K-1981-2015; Cornilescu, Claudia/H-1959-2012	Cornilescu, Gabriel/0000-0002-1204-8904; Hildebrandt, Peter/0000-0003-1030-5900; Cornilescu, Claudia/0000-0002-2401-7806; Stankey, Robert/0000-0003-1259-2296; von Stetten, David/0000-0001-7906-9788; Ulijasz, Andrew/0000-0003-0739-1297; Velazquez Escobar, Francisco/0000-0003-0365-8118	National Science Foundation [07191530]; Deutsche Forschungsgemeinschaft [SFB498]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002781, S10RR008438, P41RR002301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066326] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant MCB 07191530 (to R. D. V.) and Deutsche Forschungsgemeinschaft Grant SFB498 (to P. H.).	Andel F, 1996, BIOCHEMISTRY-US, V35, P15997, DOI 10.1021/bi962175k; Bhaya D, 2001, P NATL ACAD SCI USA, V98, P7540, DOI 10.1073/pnas.131201098; Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cornilescu G, 2008, J MOL BIOL, V383, P403, DOI 10.1016/j.jmb.2008.08.034; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; FELSENSTEIN J, 1989, CLADISTICS, V5, P166; Fischer AJ, 2005, BIOCHEMISTRY-US, V44, P15203, DOI 10.1021/bi051633z; Fischer AJ, 2004, P NATL ACAD SCI USA, V101, P17334, DOI 10.1073/pnas.0407645101; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; Giraud E, 2005, J BIOL CHEM, V280, P32389, DOI 10.1074/jbc.M506890200; Giraud E, 2002, NATURE, V417, P202, DOI 10.1038/417202a; Hirose Y, 2008, P NATL ACAD SCI USA, V105, P9528, DOI 10.1073/pnas.0801826105; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ikeuchi M, 2008, PHOTOCH PHOTOBIO SCI, V7, P1159, DOI 10.1039/b802660m; Ishizuka T, 2007, PLANT CELL PHYSIOL, V48, P1385, DOI 10.1093/pcp/pcm106; Ishizuka T, 2006, PLANT CELL PHYSIOL, V47, P1251, DOI 10.1093/pcp/pcj095; Karniol B, 2005, BIOCHEM J, V392, P103, DOI 10.1042/BJ20050826; Karniol B, 2003, P NATL ACAD SCI USA, V100, P2807, DOI 10.1073/pnas.0437914100; Kehoe DM, 1996, SCIENCE, V273, P1409, DOI 10.1126/science.273.5280.1409; Kneip C, 1999, BIOCHEMISTRY-US, V38, P15185, DOI 10.1021/bi990688w; Magdo I, 1999, J PHYS CHEM A, V103, P289, DOI 10.1021/jp983101g; Miller AE, 2006, P NATL ACAD SCI USA, V103, P11136, DOI 10.1073/pnas.0604724103; MIZUTANI Y, 1994, BIOCHEMISTRY-US, V33, P153, DOI 10.1021/bi00167a020; Mroginski MA, 2004, J AM CHEM SOC, V126, P16734, DOI 10.1021/ja043959l; Mroginski MA, 2006, J PHYS CHEM A, V110, P10564, DOI 10.1021/jp063128x; Mutsuda M, 2003, J BIOL CHEM, V278, P19102, DOI 10.1074/jbc.M213255200; Nagy F., 2006, PHOTOMORPHOGENESIS P, P65; Narikawa R, 2008, J MOL BIOL, V380, P844, DOI 10.1016/j.jmb.2008.05.035; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; Rockwell NC, 2008, BIOCHEMISTRY-US, V47, P7304, DOI 10.1021/bi800088t; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rockwell NC, 2009, P NATL ACAD SCI USA, V106, P6123, DOI 10.1073/pnas.0902370106; Rodriguez FI, 1999, SCIENCE, V283, P996, DOI 10.1126/science.283.5404.996; RUDIGER W, 1983, P NATL ACAD SCI-BIOL, V80, P6244, DOI 10.1073/pnas.80.20.6244; Schmitz O, 2000, SCIENCE, V289, P765, DOI 10.1126/science.289.5480.765; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Strauss HM, 2005, BIOCHEMISTRY-US, V44, P8244, DOI 10.1021/bi050457r; Su YS, 2007, PLANT CELL, V19, P2124, DOI 10.1105/tpc.107.051516; Terauchi K, 2004, MOL MICROBIOL, V51, P567, DOI 10.1046/j.1365-2958.2003.03853.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ulijasz AT, 2008, J BIOL CHEM, V283, P21251, DOI 10.1074/jbc.M801592200; van Thor JJ, 2006, BIOPHYS J, V91, P1811, DOI 10.1529/biophysj.106.084335; VIERSTRA RD, 1983, PLANT PHYSIOL, V72, P264, DOI 10.1104/pp.72.1.264; Vierstra RD, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P171, DOI 10.1002/352760510X.ch8; von Stetten D, 2007, J BIOL CHEM, V282, P2116, DOI 10.1074/jbc.M608878200; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; WILSON DF, 1970, SCIENCE, V168, P1577, DOI 10.1126/science.168.3939.1577; Wu SH, 2000, BIOCHEMISTRY-US, V39, P13487, DOI 10.1021/bi001123z; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505; Yoshihara S, 2004, PLANT CELL PHYSIOL, V45, P1729, DOI 10.1093/pcp/pch214; Yoshihara S, 2000, PLANT CELL PHYSIOL, V41, P1299, DOI 10.1093/pcp/pce010; ZHAO KH, 1995, BBA-BIOENERGETICS, V1228, P244, DOI 10.1016/0005-2728(94)00180-D	62	68	71	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29757	29772		10.1074/jbc.M109.038513	http://dx.doi.org/10.1074/jbc.M109.038513			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19671704	Green Published, hybrid			2022-12-27	WOS:000270896800057
J	Angelow, S; Yu, ASL				Angelow, Susanne; Yu, Alan S. L.			Structure-Function Studies of Claudin Extracellular Domains by Cysteine-scanning Mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT-JUNCTION; PARACELLULAR PORES; SELECTIVE CHANNELS; EPITHELIAL-CELLS; ION; RECEPTOR; EXPRESSION; KIDNEY; IDENTIFICATION; PERMEABILITY	Claudins form size- and charge-selective pores in the tight junction that control the paracellular flux of inorganic ions and small molecules. However, the structural basis for ion selectivity of paracellular pores is poorly understood. Here we applied cysteine scanning to map the paracellular pathway of ion permeation across claudin-2-transfected Madin-Darby canine kidney type I cells. Four potential pore-lining amino acid residues in the first extracellular loop were mutated to cysteine and screened for their accessibility to thiol-reactive reagents. All mutants were functional except D65C, which formed dimers by intermolecular disulfide bonding, leading to a loss of charge and size selectivity. This suggests that claudin-2 pores are multimeric and that Asp(65) lies close to a protein-protein interface. Methanethiosulfonate reagents of different size and charge and the organic mercury derivate, p-(chloromercuri) benzenesulfonic acid, significantly decreased paracellular ion permeation across I66C-transfected cells by a mechanism that suggests steric blocking of the pore. The conductance of wild-type claudin-2 and the other cysteine mutants was only weakly affected. The rate of reaction with I66C decreased dramatically with increasing size of the reagent, suggesting that Ile(66) is buried deep within a narrow segment of the pore with its side group facing into the lumen. Furthermore, labeling with N-biotinoylaminoethyl methanethiosulfonate showed that I66C was weakly reactive, whereas Y35C was strongly reactive, suggesting that Tyr(35) is located at the protein surface outside of the pore.	Univ So Calif, Keck Sch Med, Div Nephrol, Dept Med, Los Angeles, CA 90089 USA; [Yu, Alan S. L.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Yu, ASL (corresponding author), 2025 Zonal Ave,RMR 406, Los Angeles, CA 90089 USA.	alanyu@usc.edu	Yu, Alan/AID-7467-2022	Yu, Alan/0000-0002-1776-2533	National Institutes of Health [DK062283, DK48522]; National Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522, R01DK062283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK062283 (to A. Y.) and DK48522 (to the USC Center for Liver Diseases, for the Confocal Microscopy Sub-Core). This work was also supported by a postdoctoral research grant by the National Kidney Foundation (to S. A.).	AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Alexandre MD, 2007, BIOCHEM BIOPH RES CO, V357, P87, DOI 10.1016/j.bbrc.2007.03.078; Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Angelow S, 2006, J PHYSIOL-LONDON, V571, P15, DOI 10.1113/jphysiol.2005.099135; Angelow S, 2007, AM J PHYSIOL-RENAL, V293, pF166, DOI 10.1152/ajprenal.00087.2007; Blasig IE, 2006, CELL MOL LIFE SCI, V63, P505, DOI 10.1007/s00018-005-5472-x; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; Colegio OR, 2002, AM J PHYSIOL-CELL PH, V283, pC142, DOI 10.1152/ajpcell.00038.2002; Coyne CB, 2003, AM J PHYSIOL-LUNG C, V285, pL1166, DOI 10.1152/ajplung.00182.2003; Daugherty BL, 2007, J BIOL CHEM, V282, P30005, DOI 10.1074/jbc.M703547200; DIAMOND JM, 1969, ANNU REV PHYSIOL, V31, P581, DOI 10.1146/annurev.ph.31.030169.003053; EISENMAN G, 1983, J MEMBRANE BIOL, V76, P197, DOI 10.1007/BF01870364; Enck AH, 2001, AM J PHYSIOL-RENAL, V281, pF966, DOI 10.1152/ajprenal.0021.2001; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; GREEN WN, 1991, ANNU REV PHYSIOL, V53, P341, DOI 10.1146/annurev.ph.53.030191.002013; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Hou JH, 2005, J CELL SCI, V118, P5109, DOI 10.1242/jcs.02631; Karlin A, 1998, METHOD ENZYMOL, V293, P123; KIMIZUKA H, 1964, J THEOR BIOL, V6, P290, DOI 10.1016/0022-5193(64)90035-9; Konrad M, 2006, AM J HUM GENET, V79, P949, DOI 10.1086/508617; Mitic LL, 2003, PROTEIN SCI, V12, P218, DOI 10.1110/ps.0233903; MORENO JH, 1975, J MEMBRANE BIOL, V21, P197, DOI 10.1007/BF01941070; Nagamori S, 2000, J BIOCHEM-TOKYO, V128, P129, DOI 10.1093/oxfordjournals.jbchem.a022723; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; Tsukita S, 2000, J CELL BIOL, V149, P13, DOI 10.1083/jcb.149.1.13; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; Van Itallie CM, 2006, AM J PHYSIOL-RENAL, V291, pF1288, DOI 10.1152/ajprenal.00138.2006; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195; Yu ASL, 2009, J GEN PHYSIOL, V133, P111, DOI 10.1085/jgp.200810154; Yu ASL, 2003, J BIOL CHEM, V278, P17350, DOI 10.1074/jbc.M213286200; Zhou XW, 1997, BIOPHYS J, V72, P1946, DOI 10.1016/S0006-3495(97)78840-4	34	65	68	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29205	29217		10.1074/jbc.M109.043752	http://dx.doi.org/10.1074/jbc.M109.043752			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19690347	Green Published, hybrid			2022-12-27	WOS:000270678900075
J	Angelucci, F; Sayed, AA; Williams, DL; Boumis, G; Brunori, M; Dimastrogiovanni, D; Miele, AE; Pauly, F; Bellelli, A				Angelucci, Francesco; Sayed, Ahmed A.; Williams, David L.; Boumis, Giovanna; Brunori, Maurizio; Dimastrogiovanni, Daniela; Miele, Adriana E.; Pauly, Frida; Bellelli, Andrea			Inhibition of Schistosoma mansoni Thioredoxin-glutathione Reductase by Auranofin STRUCTURAL AND KINETIC ASPECTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLD(I) COMPLEXES; DRUGS; MITOCHONDRIAL; PRAZIQUANTEL; MECHANISM; SELENIUM; LIGANDS; SYSTEMS	Schistosomiasis is a parasitic disease affecting over 200 million people currently treated with one drug, praziquantel. A possible drug target is the seleno-protein thioredoxin-glutathione reductase (TGR), a key enzyme in the pathway of the parasite for detoxification of reactive oxygen species. The enzyme is a unique fusion of a glutaredoxin domain with a thioredoxin reductase domain, which contains a selenocysteine (Sec) as the penultimate amino acid. Auranofin (AF), a gold-containing compound already in clinical use as an anti-arthritic drug, has been shown to inhibit TGR and to substantially reduce worm burden in mice. Using x-ray crystallography we solved (at 2.5 angstrom resolution) the structure of wild type TGR incubated with AF. The electron density maps show that the actual inhibitor is gold, released from AF. Gold is bound at three different sites not directly involving the C-terminal Sec residue; however, because the C terminus in the electron density maps is disordered, we cannot exclude the possibility that gold may also bind to Sec. To investigate the possible role of Sec in the inactivation kinetics, we tested the effect of AF on a model enzyme of the same superfamily, i.e. the naturally Sec-lacking glutathione reductase, and on truncated TGR. We demonstrate that the role of selenium in the onset of inhibition by AF is catalytic and can be mimicked by an external source of selenium (benzeneselenol). Therefore, we propose that Sec mediates the transfer of gold from its ligands in AF to the redox-active Cys couples of TGR.	[Angelucci, Francesco; Boumis, Giovanna; Brunori, Maurizio; Dimastrogiovanni, Daniela; Miele, Adriana E.; Pauly, Frida; Bellelli, Andrea] Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, I-00185 Rome, Italy; [Angelucci, Francesco; Boumis, Giovanna; Brunori, Maurizio; Dimastrogiovanni, Daniela; Miele, Adriana E.; Pauly, Frida; Bellelli, Andrea] Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Sayed, Ahmed A.; Williams, David L.] Illinois State Univ, Dept Biol Sci, Normal, IL 61790 USA; [Williams, David L.] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60302 USA	Sapienza University Rome; Fondazione Cenci Bolognetti; Illinois State University; Rush University	Bellelli, A (corresponding author), Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, P Le Aldo Moro 5, I-00185 Rome, Italy.	andrea.bellelli@uniroma1.it	Bellelli, Andrea/D-2785-2009; Miele, Adriana E./F-4083-2011	Miele, Adriana E./0000-0002-4637-2606; BOUMIS, Giovanna/0000-0001-5323-7288; Brunori, Maurizio/0000-0002-7795-1635	National Institutes of Health [AI065622]; Fondazione Roma Project "Rational Approach to the Specific Inhibition of Plasmodium falciparum and Schistosoma mansoni,"; "Sapienza" University of Rome Progetto Universita; Progetto Ateneo Federato; Ministero dell'Universita e della Ricerca Italy Fondo per gli Investimenti della Ricerca di Base/Proteomica [2007-protRBRN07BMCT]; European Community Research Infrastructure [R II 3-CT-2004-506008]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065622] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondazione Roma Project "Rational Approach to the Specific Inhibition of Plasmodium falciparum and Schistosoma mansoni,"; "Sapienza" University of Rome Progetto Universita; Progetto Ateneo Federato; Ministero dell'Universita e della Ricerca Italy Fondo per gli Investimenti della Ricerca di Base/Proteomica(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); European Community Research Infrastructure(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI065622. This work was also supported by the Fondazione Roma Project "Rational Approach to the Specific Inhibition of Plasmodium falciparum and Schistosoma mansoni," the "Sapienza" University of Rome Progetto Universita 2006 and 2007 and Progetto Ateneo Federato 2006 and 2007, the Ministero dell'Universita e della Ricerca Italy Fondo per gli Investimenti della Ricerca di Base/Proteomica 2007-protRBRN07BMCT, and the European Community Research Infrastructure Action under FP6 "Structuring the European Research Area" Contract R II 3-CT-2004-506008.	Alger HM, 2002, MOL BIOCHEM PARASIT, V121, P129, DOI 10.1016/S0166-6851(02)00031-2; Angelucci F, 2007, PARASITOLOGY, V134, P1215, DOI 10.1017/S0031182007002600; Angelucci F, 2008, PROTEINS, V72, P936, DOI 10.1002/prot.21986; Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Becker K, 2000, EUR J BIOCHEM, V267, P6118, DOI 10.1046/j.1432-1327.2000.01703.x; Biterova EI, 2005, P NATL ACAD SCI USA, V102, P15018, DOI 10.1073/pnas.0504218102; Bonilla M, 2008, J BIOL CHEM, V283, P17898, DOI 10.1074/jbc.M710609200; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Cioli D, 2008, TRENDS PARASITOL, V24, P379, DOI 10.1016/j.pt.2008.05.006; COFFER MT, 1987, J INORG BIOCHEM, V30, P177, DOI 10.1016/0162-0134(87)80062-4; Deponte M, 2005, J BIOL CHEM, V280, P20628, DOI 10.1074/jbc.M412519200; Doenhoff MJ, 2002, T ROY SOC TROP MED H, V96, P465, DOI 10.1016/S0035-9203(02)90405-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engst S, 1999, BIOCHEMISTRY-US, V38, P3519, DOI 10.1021/bi982680c; Filipovska A, 2005, J BIOL CHEM, V280, P24113, DOI 10.1074/jbc.M501148200; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; Ho YP, 1999, INT J MASS SPECTROM, V182, P175, DOI 10.1016/S1387-3806(98)14245-8; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; ISAB AA, 1988, J AM CHEM SOC, V110, P3278, DOI 10.1021/ja00218a044; Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lothrop AP, 2009, BIOCHEMISTRY-US, V48, P6213, DOI 10.1021/bi802146w; Loukas A, 2008, NAT MED, V14, P365, DOI 10.1038/nm0408-365; Mezailles N, 1999, ANGEW CHEM INT EDIT, V38, P3194, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3194::AID-ANIE3194>3.0.CO;2-O; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Rendon JL, 2004, MOL BIOCHEM PARASIT, V133, P61, DOI 10.1016/j.molbiopara.2003.09.003; Salinas G, 2004, TRENDS PARASITOL, V20, P340, DOI 10.1016/j.pt.2004.05.002; Sayed AA, 2008, NAT MED, V14, P407, DOI 10.1038/nm1737; Schroder D, 1998, INORG CHEM, V37, P624, DOI 10.1021/ic970986m; SCHRODER D, 1995, ORGANOMETALLICS, V14, P312, DOI 10.1021/om00001a045; Sharma M, 2009, J MOL GRAPH MODEL, V27, P665, DOI 10.1016/j.jmgm.2008.10.009; Shaw CF, 1999, CHEM REV, V99, P2589, DOI 10.1021/cr980431o; SIMCONOV A, 2008, PLOS NEGL TROP, V2, pE127; Sun QA, 2001, P NATL ACAD SCI USA, V98, P3673, DOI 10.1073/pnas.051454398; Urig S, 2006, ANGEW CHEM INT EDIT, V45, P1881, DOI 10.1002/anie.200502756; Viry E, 2008, CHEMMEDCHEM, V3, P1667, DOI 10.1002/cmdc.200800210	39	146	153	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28977	28985		10.1074/jbc.M109.020701	http://dx.doi.org/10.1074/jbc.M109.020701			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19710012	Green Published, hybrid			2022-12-27	WOS:000270678900055
J	Botelho, RJ; Harrison, RE; Stone, JC; Hancock, JF; Philips, MR; Jongstra-Bilen, J; Mason, D; Plumb, J; Gold, MR; Grinstein, S				Botelho, Roberto J.; Harrison, Rene E.; Stone, James C.; Hancock, John F.; Philips, Mark R.; Jongstra-Bilen, Jenny; Mason, David; Plumb, Jonathan; Gold, Michael R.; Grinstein, Sergio			Localized Diacylglycerol-dependent Stimulation of Ras and Rap1 during Phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; RECEPTOR-MEDIATED PHAGOCYTOSIS; NUCLEOTIDE-RELEASING PROTEIN; KAPPA-B ACTIVATION; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNALING SYSTEMS; RESPIRATORY BURST; CELL-DEVELOPMENT; PHORBOL ESTERS; BINDING MOTIFS	We describe a role for diacylglycerol in the activation of Ras and Rap1 at the phagosomal membrane. During phagocytosis, Ras density was similar on the surface and invaginating areas of the membrane, but activation was detectable only in the latter and in sealed phagosomes. Ras activation was associated with the recruitment of RasGRP3, a diacylglycerol-dependent Ras/ Rap1 exchange factor. Recruitment to phagosomes of RasGRP3, which contains a C1 domain, parallels and appears to be due to the formation of diacylglycerol. Accordingly, Ras and Rap1 activation was precluded by antagonists of phospholipase C and of diacylglycerol binding. Ras is dispensable for phagocytosis but controls activation of extracellular signal-regulated kinase, which is partially impeded by diacylglycerol inhibitors. By contrast, cross-activation of complement receptors by stimulation of Fc gamma receptors requires Rap1 and involves diacylglycerol. We suggest a role for diacylglycerol-dependent exchange factors in the activation of Ras and Rap1, which govern distinct processes induced by Fc gamma receptor-mediated phagocytosis to enhance the innate immune response.	[Botelho, Roberto J.] Ryerson Univ, Dept Biol & Chem, Toronto, ON M5B 2K3, Canada; [Harrison, Rene E.] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON M1C 1A4, Canada; [Jongstra-Bilen, Jenny] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON M5S 1A1, Canada; [Jongstra-Bilen, Jenny] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A1, Canada; [Mason, David] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A1, Canada; [Mason, David; Plumb, Jonathan; Grinstein, Sergio] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Stone, James C.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2R3, Canada; [Hancock, John F.] Univ Texas Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77225 USA; [Philips, Mark R.] NYU, Sch Med, Dept Med Cell Biol & Pharmacol, New York, NY 10016 USA; [Gold, Michael R.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z4, Canada	Toronto Metropolitan University; University of Toronto; University Toronto Scarborough; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Alberta; University of Texas System; University of Texas Health Science Center Houston; New York University; University of British Columbia	Botelho, RJ (corresponding author), Ryerson Univ, Dept Biol & Chem, 350 Victoria St, Toronto, ON M5B 2K3, Canada.	rbotelho@ryerson.ca	Gold, Michael/AAF-2081-2021; Botelho, Roberto J/B-9145-2013	Gold, Michael/0000-0003-1222-3191; Botelho, Roberto J/0000-0002-7820-0999; Mark, Philips/0000-0002-1179-8156; Mason, David/0000-0002-8773-5274; Hancock, John/0000-0003-0542-4710	National Institutes of Health [GM55279, CA116034]; Canadian Institutes of Health Research (CIHR) [7075]; Natural Sciences and Engineering Research Council of Canada; NATIONAL CANCER INSTITUTE [R01CA116034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055279, R01GM066717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM55279 and CA116034 (to the laboratory of M. R. P.). This work was also supported by Canadian Institutes of Health Research (CIHR) grant 7075. Work in the laboratory of R. E. H. was supported by CIHR.; Supported by the Natural Sciences and Engineering Research Council of Canada.	Aiba Y, 2004, P NATL ACAD SCI USA, V101, P16612, DOI 10.1073/pnas.0407468101; Allen LAH, 1996, CURR OPIN IMMUNOL, V8, P36, DOI 10.1016/S0952-7915(96)80102-6; ARECES LB, 1994, J BIOL CHEM, V269, P19553; Bivona TG, 2003, CURR OPIN CELL BIOL, V15, P136, DOI 10.1016/S0955-0674(03)00016-4; Bivona TG, 2004, J CELL BIOL, V164, P461, DOI 10.1083/jcb.200311093; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Booth JW, 2002, EMBO J, V21, P251, DOI 10.1093/emboj/21.3.251; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Brumell JH, 1999, J IMMUNOL, V163, P3388; Caloca MJ, 2003, EMBO J, V22, P3326, DOI 10.1093/emboj/cdg316; Caron E, 2000, CURR BIOL, V10, P974, DOI 10.1016/S0960-9822(00)00641-2; Castellano F, 2001, SEMIN IMMUNOL, V13, P347, DOI 10.1006/smim.2001.0331; Cheeseman KL, 2006, MOL BIOL CELL, V17, P799, DOI 10.1091/mbc.E04-12-1100; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; DELLABIANCA V, 1990, J IMMUNOL, V144, P1411; DELLABIANCA V, 1993, J LEUKOCYTE BIOL, V53, P427; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; DIVIRGILIO F, 1988, J CELL BIOL, V106, P657, DOI 10.1083/jcb.106.3.657; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Drechsler Y, 2002, J LEUKOCYTE BIOL, V72, P657; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Ebinu JO, 2000, BLOOD, V95, P3199; Garcia-Garcia E, 2001, J LEUKOCYTE BIOL, V70, P649; Gessner JE, 1998, ANN HEMATOL, V76, P231, DOI 10.1007/s002770050396; Gong K, 2001, NAT IMMUNOL, V2, P29, DOI 10.1038/83134; GREENBERG S, 1991, J CELL BIOL, V113, P757, DOI 10.1083/jcb.113.4.757; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Jongstra-Bilen J, 2003, J BIOL CHEM, V278, P45720, DOI 10.1074/jbc.M303704200; Karimi K, 1998, INFLAMMATION, V22, P67, DOI 10.1023/A:1022347808042; Karimi K, 1999, J LEUKOCYTE BIOL, V65, P854, DOI 10.1002/jlb.65.6.854; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P10777, DOI 10.1074/jbc.270.18.10777; Larsen EC, 2002, J CELL BIOL, V159, P939, DOI 10.1083/jcb.200205140; Larsen EC, 2000, J IMMUNOL, V165, P2809, DOI 10.4049/jimmunol.165.5.2809; Lorenzo PS, 2000, MOL PHARMACOL, V57, P840; Lorenzo PS, 2001, CANCER RES, V61, P943; Marshall JG, 2001, J CELL BIOL, V153, P1369, DOI 10.1083/jcb.153.7.1369; Massol P, 1998, EMBO J, V17, P6219, DOI 10.1093/emboj/17.21.6219; Matallanas D, 2003, J BIOL CHEM, V278, P4572, DOI 10.1074/jbc.M209807200; McLeod SJ, 1998, J BIOL CHEM, V273, P29218, DOI 10.1074/jbc.273.44.29218; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; Oh-Hora M, 2003, J EXP MED, V198, P1841, DOI 10.1084/jem.20031547; Park RK, 1999, J IMMUNOL, V163, P6023; Patel JC, 2002, MOL BIOL CELL, V13, P1215, DOI 10.1091/mbc.02-01-0002; PIZON V, 1994, J CELL SCI, V107, P1661; Prior IA, 2001, J CELL SCI, V114, P1603; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Rose DM, 1997, J IMMUNOL, V158, P3433; Seastone DJ, 1999, MOL BIOL CELL, V10, P393, DOI 10.1091/mbc.10.2.393; Teixeira C, 2003, BLOOD, V102, P1414, DOI 10.1182/blood-2002-11-3621; Topham MK, 2001, J CELL BIOL, V152, P1135, DOI 10.1083/jcb.152.6.1135; Trotta R, 1996, J EXP MED, V184, P1027, DOI 10.1084/jem.184.3.1027; Yamanashi Y, 2000, GENE DEV, V14, P11; Yamashita S, 2000, J BIOL CHEM, V275, P25488, DOI 10.1074/jbc.M003414200; Yang Y, 2002, J BIOL CHEM, V277, P25756, DOI 10.1074/jbc.M202575200; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zheng Y, 2005, BLOOD, V105, P3648, DOI 10.1182/blood-2004-10-3916; Zhong XP, 2002, J BIOL CHEM, V277, P31089, DOI 10.1074/jbc.M203818200	61	23	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28522	28532		10.1074/jbc.M109.009514	http://dx.doi.org/10.1074/jbc.M109.009514			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19700408	Green Published, hybrid			2022-12-27	WOS:000270678900006
J	Stucki, M; Suormala, T; Fowler, B; Valle, D; Baumgartner, MR				Stucki, Martin; Suormala, Terttu; Fowler, Brian; Valle, David; Baumgartner, Matthias R.			Cryptic Exon Activation by Disruption of Exon Splice Enhancer NOVEL MECHANISM CAUSING 3-METHYLCROTONYL-CoA CARBOXYLASE DEFICIENCY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY; GENE-EXPRESSION; IN-VIVO; MUTATIONS; NONSENSE; MECHANISM; DEFECTS; DISEASE; IDENTIFICATION; THERAPY	3-Methylcrotonyl-CoA carboxylase (MCC) deficiency is an autosomal recessive disorder of leucine catabolism. MCC is a heteromeric mitochondrial enzyme composed of biotin-containing alpha (MCCA) and smaller beta (MCCB) subunits encoded by MCCA and MCCB, respectively. We report studies of the c.1054G -> A mutation in exon 11 of MCCB detected in the homozygous state in a patient with MCC deficiency. Sequence analysis of MCCB cDNA revealed two overlapping transcripts, one containing the normal 73 bp of exon 11 including the missense mutation c.1054G -> A (p.G352R), the other with exon 11 replaced by a 64-bp sequence from intron 10 (cryptic exon 10a) that maintains the reading frame and is flanked by acceptable splice consensus sites. In expression studies, we show that both transcripts lack detectable MCC activity. Western blot analysis showed slightly reduced levels of MCCB using the transcript containing the missense mutation, whereas no MCCB was detected with the transcript containing the cryptic exon 10a. Analysis of the region harboring the mutation revealed that the c.1054G -> A mutation is located in an exon splice enhancer sequence. Using MCCB minigene constructs to transfect MCCB-deficient fibroblasts, we demonstrate that the reduction in utilization of exon 11 associated with the c.1054G -> A mutation is due to alteration of this exon splice enhancer. Further, we show that optimization of the weak splice donor site of exon 11 corrects the splicing defect. To our knowledge, this is the first demonstration of a point mutation disrupting an exon splice enhancer that causes exon skipping along with utilization of a cryptic exon.	[Stucki, Martin; Baumgartner, Matthias R.] Univ Childrens Hosp, Div Metab, CH-8032 Zurich, Switzerland; [Stucki, Martin] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; [Suormala, Terttu; Fowler, Brian] Univ Childrens Hosp, Metab Unit, CH-4005 Basel, Switzerland; [Valle, David] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA	University Children's Hospital Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Johns Hopkins University	Baumgartner, MR (corresponding author), Univ Childrens Hosp, Div Metab, Steinwiesstr 75, CH-8032 Zurich, Switzerland.	Matthias.Baumgartner@kispi.uzh.ch	Baumgartner, Matthias/Q-2855-2017	Baumgartner, Matthias/0000-0002-9270-0826	Swiss National Science Foundation [3200AO-109219/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grant 3200AO-109219/1.	Antonarakis S. E., 2001, METABOLIC MOL BASES, P343; Baumgartner MR, 2001, J CLIN INVEST, V107, P495, DOI 10.1172/JCI11948; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Black DL, 2005, P NATL ACAD SCI USA, V102, P4927, DOI 10.1073/pnas.0501414102; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Buratti E, 2007, NUCLEIC ACIDS RES, V35, P4369, DOI 10.1093/nar/gkm447; Buratti E, 2006, NUCLEIC ACIDS RES, V34, P3494, DOI 10.1093/nar/gkl498; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2003, NAT STRUCT BIOL, V10, P120, DOI 10.1038/nsb887; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; Dantas Maria Fernanda, 2005, Hum Mutat, V26, P164, DOI 10.1002/humu.9352; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; Fairbrother WG, 2004, NUCLEIC ACIDS RES, V32, pW187, DOI 10.1093/nar/gkh393; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Goyenvalle A, 2009, MOL THER, V17, P1234, DOI 10.1038/mt.2009.113; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Gregersen N, 2001, J INHERIT METAB DIS, V24, P189, DOI 10.1023/A:1010319001722; HIGHSMITH WE, 1994, NEW ENGL J MED, V331, P974, DOI 10.1056/NEJM199410133311503; Lim LP, 2001, P NATL ACAD SCI USA, V98, P11193, DOI 10.1073/pnas.201407298; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Metherell Louise A., 2001, American Journal of Human Genetics, V69, P641, DOI 10.1086/323266; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; Nielsen KB, 2007, AM J HUM GENET, V80, P416, DOI 10.1086/511992; Ridout CK, 2008, HUM MUTAT, V29, P451, DOI 10.1002/humu.9525; Schaal TD, 1999, MOL CELL BIOL, V19, P1705; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Skordis LA, 2003, P NATL ACAD SCI USA, V100, P4114, DOI 10.1073/pnas.0633863100; Stadler SC, 2006, HUM MUTAT, V27, P748, DOI 10.1002/humu.20349; Sun HZ, 2000, MOL CELL BIOL, V20, P6414, DOI 10.1128/MCB.20.17.6414-6425.2000; SUORMALA T, 1985, CLIN CHIM ACTA, V145, P151, DOI 10.1016/0009-8981(85)90282-7; Teraoka SN, 1999, AM J HUM GENET, V64, P1617, DOI 10.1086/302418; Tran VK, 2005, J HUM GENET, V50, P425, DOI 10.1007/s10038-005-0272-6; Wimmer K, 2007, HUM MUTAT, V28, P599, DOI 10.1002/humu.20493	36	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28953	28957		10.1074/jbc.M109.050674	http://dx.doi.org/10.1074/jbc.M109.050674			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19706617	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000270678900052
J	Chen, XP; El Gazzar, M; Yoza, BK; McCall, CE				Chen, Xiaoping; El Gazzar, Mohamed; Yoza, Barbara K.; McCall, Charles E.			The NF-kappa B Factor RelB and Histone H3 Lysine Methyltransferase G9a Directly Interact to Generate Epigenetic Silencing in Endotoxin Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; CHROMATIN; TRANSCRIPTION; METHYLATION; IL-1-BETA; COMPLEXES; RECRUITS; GENES	The interplay of transcription factors, histone modifiers, and DNA modification can alter chromatin structure that epigenetically controls gene transcription. During severe systemic inflammatory (SSI), the generation of facultative heterochromatin from euchromatin reversibly silences transcription of a set of acute proinflammatory genes. This gene-specific silencing is a salient feature of the endotoxin tolerant phenotype that is found in blood leukocytes of SSI patients and in a human THP-1 cell model of SSL We previously reported that de novo induction of the NF-kappa B transcription factor RelB by endotoxin activation is necessary and sufficient for silencing transcription of acute proinflammatory genes in the endotoxin tolerant SSI phenotype. Here, we examined how RelB silences gene expression and found that RelB induces facultative heterochromatin formation by directly interacting with the histone H3 lysine 9 methyltransferase G9a. We found that heterochromatin protein 1 (HP1) and G9a formed a complex at the interleukin-1 beta promoter that is dependent on the Rel homology domain (RHD) of RelB. RelB knockdown disassociated the complex and reversed transcription silencing. We also observed that whereas RelB chromatin binding was independent of G9a, RelB transcriptional silencing required G9a accumulation at the silenced promoter. Binding between RelB and G9a was confirmed by glutathione S-transferase pulldown in vitro and coimmunoprecipitation in vivo. These data provide novel insight into how RelB is required to initiate silencing in the phenotype associated with severe systemic inflammation in humans, a disease with major morbidity and mortality.	[Chen, Xiaoping; El Gazzar, Mohamed; Yoza, Barbara K.; McCall, Charles E.] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA; [Yoza, Barbara K.] Wake Forest Univ, Bowman Gray Sch Med, Dept Gen Surg, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	McCall, CE (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Mol Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	chmccall@wfubmc.edu			National Institutes of Health [RO1A1-09169, RO1A1-065791]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065791, R01AI009169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1A1-09169 and RO1A1-065791 (to C.E.M.).	Akbarian S, 2009, BIOL PSYCHIAT, V65, P198, DOI 10.1016/j.biopsych.2008.08.015; Chan C, 2005, J IMMUNOL, V175, P461, DOI 10.4049/jimmunol.175.1.461; Chen XP, 2009, CLIN VACCINE IMMUNOL, V16, P104, DOI 10.1128/CVI.00320-08; Cobb J P, 2000, Surg Infect (Larchmt), V1, P207, DOI 10.1089/109629600750018132; Duan ZJ, 2005, MOL CELL BIOL, V25, P10338, DOI 10.1128/MCB.25.23.10338-10351.2005; El Gazzar M, 2008, J BIOL CHEM, V283, P32198, DOI 10.1074/jbc.M803446200; El Gazzar M, 2007, J BIOL CHEM, V282, P26857, DOI 10.1074/jbc.M704584200; El Gazzar M, 2009, MOL CELL BIOL, V29, P1959, DOI 10.1128/MCB.01862-08; Eskeland R, 2007, MOL CELL BIOL, V27, P453, DOI 10.1128/MCB.01576-06; Esteve PO, 2005, NUCLEIC ACIDS RES, V33, P3211, DOI 10.1093/nar/gki635; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Fusco AJ, 2008, J BIOL CHEM, V283, P12324, DOI 10.1074/jbc.M707898200; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Kim JK, 2009, CELL MOL LIFE SCI, V66, P596, DOI 10.1007/s00018-008-8432-4; Ko M, 2008, MUTAT RES-FUND MOL M, V647, P59, DOI 10.1016/j.mrfmmm.2008.08.004; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KRUYS V, 1993, J EXP MED, V177, P1383, DOI 10.1084/jem.177.5.1383; LARUE KEA, 1994, J EXP MED, V180, P2269, DOI 10.1084/jem.180.6.2269; Lee H, 2004, SCIENCE, V304, P1675, DOI 10.1126/science.1098096; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li HW, 2006, J BIOL CHEM, V281, P19489, DOI 10.1074/jbc.M513249200; McCall CE, 2007, AM J RESP CRIT CARE, V175, P763, DOI 10.1164/rccm.200610-1436CP; MILNER CM, 1993, BIOCHEM J, V290, P811, DOI 10.1042/bj2900811; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; RYSECK RP, 1995, MOL CELL BIOL, V15, P3100; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; Trojer P, 2009, J BIOL CHEM, V284, P8395, DOI 10.1074/jbc.M807818200; Wen HT, 2008, BLOOD, V111, P1797, DOI 10.1182/blood-2007-08-106443; Xia YY, 1999, MOL CELL BIOL, V19, P7688; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080; Zemojtel T, 2009, TRENDS GENET, V25, P63, DOI 10.1016/j.tig.2008.11.005	35	143	149	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27857	27865		10.1074/jbc.M109.000950	http://dx.doi.org/10.1074/jbc.M109.000950			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19690169	Green Published, hybrid			2022-12-27	WOS:000270676300012
J	Crabtree, MJ; Tatham, AL; Hale, AB; Alp, NJ; Channon, KM				Crabtree, Mark J.; Tatham, Amy L.; Hale, Ashley B.; Alp, Nicholas J.; Channon, Keith M.			Critical Role for Tetrahydrobiopterin Recycling by Dihydrofolate Reductase in Regulation of Endothelial Nitric-oxide Synthase Coupling RELATIVE IMPORTANCE OF THE DENOVO BIOPTERIN SYNTHESIS VERSUS SALVAGE PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOHYDROLASE-I EXPRESSION; CELLS; SUPEROXIDE; ATHEROSCLEROSIS; BIOSYNTHESIS; METABOLISM; MICE; ENOS; 7,8-DIHYDROBIOPTERIN; OVEREXPRESSION	Tetrahyrobiopterin (BH4) is a required cofactor for the synthesis of nitric oxide by endothelial nitric-oxide synthase (eNOS), and BH4 bioavailability within the endothelium is a critical factor in regulating the balance between NO and superoxide production by eNOS (eNOS coupling). BH4 levels are determined by the activity of GTP cyclohydrolase I (GTPCH), the rate-limiting enzyme in de novo BH4 biosynthesis. However, BH4 levels may also be influenced by oxidation, forming 7,8-dihydrobiopterin (BH2), which promotes eNOS uncoupling. Conversely, dihydrofolate reductase (DHFR) can regenerate BH4 from BH2, but the functional importance of DHFR in maintaining eNOS coupling remains unclear. We investigated the role of DHFR in regulating BH4 versus BH2 levels in endothelial cells and in cell lines expressing eNOS combined with tet-regulated GTPCH expression in order to compare the effects of low or high levels of de novo BH4 biosynthesis. Pharmacological inhibition of DHFR activity by methotrexate or genetic knockdown of DHFR protein by RNA interference reduced intracellular BH4 and increased BH2 levels resulting in enzymatic uncoupling of eNOS, as indicated by increased eNOS-dependent superoxide but reduced NO production. In contrast to the decreased BH4:BH2 ratio induced by DHFR knockdown, GTPCH knockdown greatly reduced total biopterin levels but with no change in BH4:BH2 ratio. In cells expressing eNOS with low biopterin levels, DHFR inhibition or knockdown further diminished the BH4:BH2 ratio and exacerbated eNOS uncoupling. Taken together, these data reveal a key role for DHFR in eNOS coupling by maintaining the BH4:BH2 ratio, particularly in conditions of low total biopterin availability.	[Crabtree, Mark J.; Tatham, Amy L.; Hale, Ashley B.; Alp, Nicholas J.; Channon, Keith M.] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England	University of Oxford	Channon, KM (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England.	keith.channon@cardiov.ox.ac.uk		Crabtree, Mark/0000-0003-3298-2697; channon, keith/0000-0002-1043-4342	British Heart Foundation [PG/05/141/20098, RG/07/003/23133]; Wellcome Trust Clinician Scientist Fellowship [GR074428/Z/04/Z]	British Heart Foundation(British Heart Foundation); Wellcome Trust Clinician Scientist Fellowship(Wellcome Trust)	This work was supported by British Heart Foundation Project Grant PG/05/141/20098, British Heart Foundation Programme Grant RG/07/003/23133, and a Wellcome Trust Clinician Scientist Fellowship GR074428/Z/04/Z.	Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P445, DOI 10.1161/01.ATV.0000115637.48689.77; Brand MP, 1996, J NEUROCHEM, V66, P1150; Chalupsky K, 2005, P NATL ACAD SCI USA, V102, P9056, DOI 10.1073/pnas.0409594102; Crabtree MJ, 2008, AM J PHYSIOL-HEART C, V294, pH1530, DOI 10.1152/ajpheart.00823.2007; Crabtree MJ, 2009, J BIOL CHEM, V284, P1136, DOI 10.1074/jbc.M805403200; CURTIUS HC, 1985, EUR J BIOCHEM, V148, P413, DOI 10.1111/j.1432-1033.1985.tb08855.x; de Bono JP, 2007, NITRIC OXIDE-BIOL CH, V16, P1, DOI 10.1016/j.niox.2006.03.008; Fink B, 2004, AM J PHYSIOL-CELL PH, V287, pC895, DOI 10.1152/ajpcell.00028.2004; HEALES S, 1989, J CHROMATOGR-BIOMED, V494, P77, DOI 10.1016/S0378-4347(00)82658-4; Huang AN, 2005, CIRC RES, V96, P164, DOI 10.1161/01.RES.0000153669.24827.DF; Hurshman AR, 1999, BIOCHEMISTRY-US, V38, P15689, DOI 10.1021/bi992026c; Ionova IA, 2008, AM J PHYSIOL-HEART C, V295, pH2178, DOI 10.1152/ajpheart.00748.2008; Katusic ZS, 1998, ARTERIOSCL THROM VAS, V18, P27, DOI 10.1161/01.ATV.18.1.27; KAUFMAN S, 1983, ANN NEUROL, V14, P308, DOI 10.1002/ana.410140309; Linscheid P, 1998, CIRCULATION, V98, P1703, DOI 10.1161/01.CIR.98.17.1703; Maetzel A, 2000, RHEUMATOLOGY, V39, P975, DOI 10.1093/rheumatology/39.9.975; McDonald DM, 2004, PHARMACOGENETICS, V14, P831, DOI 10.1097/00008571-200412000-00006; McGuire JJ, 2003, CURR PHARM DESIGN, V9, P2593, DOI 10.2174/1381612033453712; Newsome Grace, 2002, J Am Acad Nurse Pract, V14, P432; NICHOL CA, 1983, P NATL ACAD SCI-BIOL, V80, P1546, DOI 10.1073/pnas.80.6.1546; Nzila A, 2005, TRENDS PARASITOL, V21, P292, DOI 10.1016/j.pt.2005.04.002; OHARA Y, 1993, J CLIN INVEST, V91, P2546, DOI 10.1172/JCI116491; Ozaki M, 2002, J CLIN INVEST, V110, P331, DOI 10.1172/JCI200215215; PANZA JA, 1995, CIRCULATION, V91, P1732, DOI 10.1161/01.CIR.91.6.1732; Ren J, 2008, AM J PHYSIOL-REG I, V294, pR793, DOI 10.1152/ajpregu.00713.2007; Sawabe K, 2004, J PHARMACOL SCI, V96, P124, DOI 10.1254/jphs.FP0040280; Schmidt PP, 2001, J BIOL INORG CHEM, V6, P151, DOI 10.1007/s007750000185; Sugiyama T, 2009, J BIOL CHEM, V284, P12691, DOI 10.1074/jbc.M809295200; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; TZENG E, 1995, P NATL ACAD SCI USA, V92, P11771, DOI 10.1073/pnas.92.25.11771; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Vasquez-Vivar J, 2002, BIOCHEM J, V362, P733, DOI 10.1042/0264-6021:3620733; Vasquez-Vivar J, 2002, ARTERIOSCL THROM VAS, V22, P1655, DOI 10.1161/01.ATV.0000029122.79665.D9; WHITE CR, 1994, P NATL ACAD SCI USA, V91, P1044, DOI 10.1073/pnas.91.3.1044; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102	35	157	162	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28128	28136		10.1074/jbc.M109.041483	http://dx.doi.org/10.1074/jbc.M109.041483			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19666465	Green Published, hybrid			2022-12-27	WOS:000270676300039
J	Cushman, I; Casey, PJ				Cushman, Ian; Casey, Patrick J.			Role of Isoprenylcysteine Carboxylmethyltransferase-catalyzed Methylation in Rho Function and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; CARBOXYL METHYLTRANSFERASE; FARNESYLTRANSFERASE INHIBITORS; TRANSFERASE INHIBITORS; CELL-MIGRATION; CANCER-CELLS; K-RAS; PRENYLATION; INVASION; TARGETS	A number of proteins that play key roles in biological regulatory events undergo a process of post-translational modifications termed prenylation. The prenylation pathway consists of three enzymatic steps; the final processed protein is isoprenoid-modified and methylated on the C-terminal cysteine. This protein modification pathway plays a significant role in cancer biology because many oncogenic proteins undergo prenylation. Methylation of the C terminus by isoprenylcysteine carboxylmethyltransferase (Icmt) is the final step in the prenylation pathway. Cysmethynil, a specific Icmt inhibitor discovered in our laboratory, is able to inhibit Ras-mediated signaling, cell growth, and oncogenesis. We sought to examine the role of Icmt-mediated methylation on the behaviors of cancer cells associated with metastatic potential. Our results indicate that inhibition of methylation reduces migration of the highly metastatic MDA-MB-231 breast cancer cell line. In addition, cell adhesion and cell spreading are also significantly impacted by cysmethynil. To examine the mechanism of Icmt-dependent migration we focused on RhoA and Rac1, prenylated proteins that are important mediators of cell migration through their control of the actin cytoskeleton. Inhibition of Icmt significantly decreases the activation of both RhoA and Rac1; an increase in Rho GDP-dissociation inhibitor (RhoGDI) binding in the absence of methylation appears to contribute to this effect. Furthermore, in the absence of Icmt activity the addition of exogenous RhoA or Rac1 is able to partially rescue directed and random migration, respectively. These findings establish a role for Icmt-mediated methylation in cell migration and advance our understanding of the biological consequences of Rho methylation.	[Cushman, Ian; Casey, Patrick J.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Cushman, Ian; Casey, Patrick J.] Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore 169857, Singapore	Duke University; National University of Singapore	Casey, PJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Res Dr, Durham, NC 27710 USA.	casey006@mc.duke.edu		Casey, Patrick/0000-0002-7366-9309	National Institutes of Health [GM46372]; American Cancer Society Postdoctoral Fellow Award [PF-06-068-01-TBE]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046372] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Postdoctoral Fellow Award(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM46372 (to P. J. C.) and an American Cancer Society Postdoctoral Fellow Award PF-06-068-01-TBE (to I.C.).	Allal C, 2000, J BIOL CHEM, V275, P31001, DOI 10.1074/jbc.M005264200; Ashby MN, 1998, CURR OPIN LIPIDOL, V9, P99, DOI 10.1097/00041433-199804000-00004; Baron RA, 2007, BIOCHEMISTRY-US, V46, P554, DOI 10.1021/bi060344n; Baron Rudi A., 2004, BMC Biochemistry, V5, P19, DOI 10.1186/1471-2091-5-19; Bergo MO, 2004, J CLIN INVEST, V113, P539, DOI 10.1172/JCI200418829; Bergo MO, 2000, J BIOL CHEM, V275, P17605, DOI 10.1074/jbc.C000079200; Bergo MO, 2001, J BIOL CHEM, V276, P5841, DOI 10.1074/jbc.C000831200; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Clarke S, 2004, J CLIN INVEST, V113, P513, DOI 10.1072/JCI200421059; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Collisson EA, 2003, MOL CANCER THER, V2, P941; Doll RJ, 2004, CURR OPIN DRUG DISC, V7, P478; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; GLOMSET JA, 1994, ANNU REV CELL BIOL, V10, P181, DOI 10.1146/annurev.cellbio.10.1.181; JAMES GL, 1995, J BIOL CHEM, V270, P6221, DOI 10.1074/jbc.270.11.6221; Kloog Y, 2004, SEMIN CANCER BIOL, V14, P253, DOI 10.1016/j.semcancer.2004.04.004; Lebowitz PF, 1997, J BIOL CHEM, V272, P16093, DOI 10.1074/jbc.272.26.16093; Lin M, 2004, BREAST CANCER RES TR, V84, P49, DOI 10.1023/B:BREA.0000018424.43445.f3; Lu Q, 2004, CIRC RES, V94, P306, DOI 10.1161/01.RES.0000113923.85084.C1; Matozaki T, 2000, CELL SIGNAL, V12, P515, DOI 10.1016/S0898-6568(00)00102-9; Mazieres J, 2004, CANCER LETT, V206, P159, DOI 10.1016/j.canlet.2003.08.033; Meigs TE, 2005, J BIOL CHEM, V280, P18049, DOI 10.1074/jbc.M500445200; Michaelson D, 2005, MOL BIOL CELL, V16, P1606, DOI 10.1091/mbc.e04-11-0960; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Papaharalambus C, 2005, J BIOL CHEM, V280, P18790, DOI 10.1074/jbc.M410081200; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Rolli-Derkinderen M, 2005, CIRC RES, V96, P1152, DOI 10.1161/01.RES.0000170084.88780.ea; Sebti SM, 2003, NAT REV CANCER, V3, P945, DOI 10.1038/nrc1234; Walker K, 2005, CURR OPIN GENET DEV, V15, P62, DOI 10.1016/j.gde.2004.11.001; Wang M, 2008, J BIOL CHEM, V283, P18678, DOI 10.1074/jbc.M801855200; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Windler-Hart SL, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-14; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Winter-Vann AM, 2005, P NATL ACAD SCI USA, V102, P4336, DOI 10.1073/pnas.0408107102; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Young S. G., 2001, ENZYMES, V21, P156; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	37	30	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27964	27973		10.1074/jbc.M109.025296	http://dx.doi.org/10.1074/jbc.M109.025296			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19651782	Green Published, hybrid			2022-12-27	WOS:000270676300024
J	Naismith, TV; Dalal, S; Hanson, PI				Naismith, Teresa V.; Dalal, Seerna; Hanson, Phyllis I.			Interaction of TorsinA with Its Major Binding Partners Is Impaired by the Dystonia-associated Delta GAG Deletion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER NUCLEAR-MEMBRANE; AAA PLUS PROTEIN; MUTANT TORSINA; DYT1 DYSTONIA; SECRETORY PATHWAY; CAENORHABDITIS-ELEGANS; ENDOPLASMIC-RETICULUM; PC12 CELLS; ENVELOPE; MUTATION	Early onset (DYT1) torsion dystonia is a dominantly inherited movement disorder associated with a three-base pair (Delta GAG) deletion that removes a glutamic acid residue from the protein torsinA. TorsinA is an essential AAA(+) (ATPases associated with a variety of cellular activities) ATPase found in the endoplasmic reticulum and nuclear envelope of higher eukaryotes, but what it does and how changes caused by the Delta GAG deletion lead to dystonia are not known. Here, we asked how the DYT1 mutation affects association of torsinA with interacting proteins. Using immunoprecipitation and mass spectrometry, we first established that the related transmembrane proteins LULL1 and LAP1 are prominent binding partners for torsinA in U2OS cells. Comparative analysis demonstrates that these two proteins are targeted to the endoplasmic reticulum or nuclear envelope by their divergent N-terminal domains. Binding of torsinA to their C-terminal lumenal domains is stabilized when residues in any one of three motifs implicated in ATP hydrolysis (Walker B, sensor 1, and sensor 2) are mutated. Importantly, the Delta GAG deletion does not stabilize this binding. Indeed, deleting the Delta GAG encoded glutamic acid residue from any of the three ATP hydrolysis mutants destabilizes their association with LULL1 and LAP1C, suggesting a possible basis for loss of torsinA function. Impaired interaction of torsinA with LULL1 and/or LAP1 may thus contribute to the development of dystonia.	[Naismith, Teresa V.; Dalal, Seerna; Hanson, Phyllis I.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Hanson, PI (corresponding author), WA Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave,Campus Box 8228, St Louis, MO 63110 USA.	phanson22@wustl.edu	Hanson, Phyllis/E-9420-2012		NINDS; National Institutes of Health [R01 NS050717]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050717] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by NINDS, National Institutes of Health Grant R01 NS050717 (to P. I. H.).	Bragg DC, 2004, NEUROSCIENCE, V125, P651, DOI 10.1016/j.neuroscience.2004.01.053; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Bressman SB, 2000, NEUROLOGY, V54, P1746, DOI 10.1212/WNL.54.9.1746; Caldwell GA, 2003, HUM MOL GENET, V12, P307, DOI 10.1093/hmg/ddg027; Callan AC, 2007, BIOCHEM J, V401, P607, DOI 10.1042/BJ20061313; Cao SS, 2005, J NEUROSCI, V25, P3801, DOI 10.1523/JNEUROSCI.5157-04.2005; Chen IHB, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-38; Dalal S, 2004, MOL BIOL CELL, V15, P637, DOI 10.1091/mbc.E03-02-0097; Dang MT, 2005, EXP NEUROL, V196, P452, DOI 10.1016/j.expneurol.2005.08.025; FOISNER R, 1993, CELL, V73, P1267, DOI 10.1016/0092-8674(93)90355-T; Giles LM, 2008, HUM MOL GENET, V17, P2712, DOI 10.1093/hmg/ddn173; Gonzalez-Alegre P, 2004, J NEUROSCI, V24, P2593, DOI 10.1523/JNEUROSCI.4461-03.2004; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Goodchild RE, 2005, J CELL BIOL, V168, P855, DOI 10.1083/jcb.200411026; Goodchild RE, 2004, P NATL ACAD SCI USA, V101, P847, DOI 10.1073/pnas.0304375101; Gordon KL, 2008, NEUROSCIENCE, V157, P588, DOI 10.1016/j.neuroscience.2008.09.028; Granata A, 2008, J BIOL CHEM, V283, P7568, DOI 10.1074/jbc.M704097200; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hewett J, 2000, HUM MOL GENET, V9, P1403, DOI 10.1093/hmg/9.9.1403; Hewett J, 2003, J NEUROSCI RES, V72, P158, DOI 10.1002/jnr.10567; Hewett JW, 2008, HUM MOL GENET, V17, P1436, DOI 10.1093/hmg/ddn032; Hewett JW, 2007, P NATL ACAD SCI USA, V104, P7271, DOI 10.1073/pnas.0701185104; Hewett JW, 2004, J NEUROCHEM, V89, P1186, DOI 10.1111/j.1471-4159.2004.02404.x; Kock N, 2006, HUM MOL GENET, V15, P1355, DOI 10.1093/hmg/ddl055; Kondo Y, 2002, BIOCHEM BIOPH RES CO, V294, P770, DOI 10.1016/S0006-291X(02)00563-6; Kuner R, 2003, NEUROSCI LETT, V350, P153, DOI 10.1016/S0304-3940(03)00904-2; Kustedjo K, 2000, J BIOL CHEM, V275, P27933; Kustedjo K, 2003, BIOCHEMISTRY-US, V42, P15333, DOI 10.1021/bi0349569; Maison C, 1997, EMBO J, V16, P4839, DOI 10.1093/emboj/16.16.4839; MARTIN L, 1995, J BIOL CHEM, V270, P8822, DOI 10.1074/jbc.270.15.8822; Nagy M, 2009, PROTEIN SCI, V18, P287, DOI 10.1002/pro.36; Naismith TV, 2004, P NATL ACAD SCI USA, V101, P7612, DOI 10.1073/pnas.0308760101; Nery FC, 2008, J CELL SCI, V121, P3476, DOI 10.1242/jcs.029454; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Torres GE, 2004, P NATL ACAD SCI USA, V101, P15650, DOI 10.1073/pnas.0308088101; Ulbert S, 2006, J CELL BIOL, V173, P469, DOI 10.1083/jcb.200512078; Vander Heyden AB, 2009, MOL BIOL CELL, V20, P2661, DOI 10.1091/mbc.E09-01-0094; Vasudevan A, 2006, BRAIN RES, V1073, P139, DOI 10.1016/j.brainres.2005.12.087; Zhu L, 2008, MOL BIOL CELL, V19, P3599, DOI 10.1091/mbc.E08-01-0015	42	62	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27866	27874		10.1074/jbc.M109.020164	http://dx.doi.org/10.1074/jbc.M109.020164			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19651773	hybrid, Green Published			2022-12-27	WOS:000270676300013
J	Weng, TT; Gao, L; Bhaskaran, M; Guo, YJ; Gou, DM; Narayanaperumal, J; Chintagari, NR; Zhang, KX; Liu, L				Weng, Tingting; Gao, Li; Bhaskaran, Manoj; Guo, Yujie; Gou, Deming; Narayanaperumal, Jeyaparthasarathy; Chintagari, Narendranath Reddy; Zhang, Kexiong; Liu, Lin			Pleiotrophin Regulates Lung Epithelial Cell Proliferation and Differentiation during Fetal Lung Development via beta-Catenin and Dlk1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR PLEIOTROPHIN; GENE-EXPRESSION; TYROSINE PHOSPHORYLATION; MYOGENIC DIFFERENTIATION; MESSENGER-RNA; CANCER-CELLS; II CELLS; HB-GAM; WNT; MORPHOGENESIS	The role of pleiotrophin in fetal lung development was investigated. We found that pleiotrophin and its receptor, protein-tyrosine phosphatase receptor beta/zeta, were highly expressed in mesenchymal and epithelial cells of the fetal lungs, respectively. Using isolated fetal alveolar epithelial type II cells, we demonstrated that pleiotrophin promoted fetal type II cell proliferation and arrested type II cell trans-differentiation into alveolar epithelial type I cells. Pleiotrophin also increased wound healing of injured type II cell monolayer. Knockdown of pleiotrophin influenced lung branching morphogenesis in a fetal lung organ culture model. Pleiotrophin increased the tyrosine phosphorylation of beta-catenin, promoted beta-catenin translocation into the nucleus, and activated T cell factor/lymphoid enhancer factor transcription factors. DIU, a membrane ligand that initiates the Notch signaling pathway, was identified as a downstream target of the pleiotrophin/beta-catenin pathway by endogenous dlk1 expression, promoter assay, and chromatin immunoprecipitation. These results provide evidence that pleiotrophin regulates fetal type II cell proliferation and differentiation via integration of multiple signaling pathways including pleiotrophin, beta-catenin, and Notch pathways.	[Weng, Tingting; Gao, Li; Bhaskaran, Manoj; Guo, Yujie; Gou, Deming; Narayanaperumal, Jeyaparthasarathy; Chintagari, Narendranath Reddy; Zhang, Kexiong; Liu, Lin] Oklahoma State Univ, Dept Physiol Sci, Lundberg Kienlen Lung Biol & Toxicol Lab, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Liu, L (corresponding author), Oklahoma State Univ, Dept Physiol Sci, Lundberg Kienlen Lung Biol & Toxicol Lab, 264 McElroy Hall, Stillwater, OK 74078 USA.	lin.liu@okstate.edu		Guo, Yujie/0000-0002-0307-9266; Zhang, Kexiong/0000-0001-9517-8386	National Institutes of Health [R01 HIL-052146, R01 HIL-071628, R01 HL-083188]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071628, R01HL083188, R01HL052146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HIL-052146, R01 HIL-071628, and R01 HL-083188 (to L. L.).	Aoyama K, 2007, STEM CELLS, V25, P2488, DOI 10.1634/stemcells.2007-0102; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Barth AIM, 1999, P NATL ACAD SCI USA, V96, P4947, DOI 10.1073/pnas.96.9.4947; BATENBURG JJ, 1988, BIOCHIM BIOPHYS ACTA, V960, P441, DOI 10.1016/0005-2760(88)90053-7; Bellusci S, 1997, DEVELOPMENT, V124, P4867; Cheng P, 2008, IMMUNOL RES, V41, P1, DOI 10.1007/s12026-007-8011-z; Cohen ED, 2008, DEVELOPMENT, V135, P789, DOI 10.1242/dev.016865; De Langhe SP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001516; Deuel TF, 2002, ARCH BIOCHEM BIOPHYS, V397, P162, DOI 10.1006/abbi.2001.2705; Eberhart CG, 2001, PEDIATR DEVEL PATHOL, V4, P351, DOI 10.1007/s10024001-0037-y; Eijken M, 2008, J CELL BIOCHEM, V104, P568, DOI 10.1002/jcb.21651; FRASLON C, 1991, IN VITRO CELL DEV B, V27, P843; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; Gou DM, 2007, J GENE MED, V9, P751, DOI 10.1002/jgm.1080; Heller H, 2001, J BIOL CHEM, V276, P37307, DOI 10.1074/jbc.M103195200; Herradon G, 2004, BIOCHEM BIOPH RES CO, V324, P1041, DOI 10.1016/j.bbrc.2004.09.161; Hilfer SR, 1996, ANNU REV PHYSIOL, V58, P93, DOI 10.1146/annurev.ph.58.030196.000521; Hofmann M, 2004, GENE DEV, V18, P2712, DOI 10.1101/gad.1248604; Jager R, 1997, INT J CANCER, V73, P537; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; MILNER PG, 1989, BIOCHEM BIOPH RES CO, V165, P1096, DOI 10.1016/0006-291X(89)92715-0; Mucenski ML, 2005, AM J PHYSIOL-LUNG C, V289, pL971, DOI 10.1152/ajplung.00172.2005; Neth P, 2007, STEM CELL REV, V3, P18, DOI 10.1007/s12015-007-0001-y; Osborne BA, 2007, NAT REV IMMUNOL, V7, P64, DOI 10.1038/nri1998; Perez-Pinera P, 2006, P NATL ACAD SCI USA, V103, P17795, DOI 10.1073/pnas.0607299103; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Piedra J, 2001, J BIOL CHEM, V276, P20436, DOI 10.1074/jbc.M100194200; Pongracz JE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-15; RAO SS, 1994, MOL CELL BIOL, V14, P5259, DOI 10.1128/MCB.14.8.5259; RAUVALA H, 1989, EMBO J, V8, P2933, DOI 10.1002/j.1460-2075.1989.tb08443.x; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; SACHS L, 1980, P NATL ACAD SCI-BIOL, V77, P6152, DOI 10.1073/pnas.77.10.6152; Sakural H, 2001, DEVELOPMENT, V128, P3283; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Seykora JT, 2003, AM J DERMATOPATH, V25, P6, DOI 10.1097/00000372-200302000-00002; Shannon JM, 1998, DEV DYNAM, V212, P482, DOI 10.1002/(SICI)1097-0177(199808)212:4<482::AID-AJA2>3.0.CO;2-D; Shannon JM, 2004, ANNU REV PHYSIOL, V66, P625, DOI 10.1146/annurev.physiol.66.032102.135749; SilosSantiago I, 1996, J NEUROBIOL, V31, P283, DOI 10.1002/(SICI)1097-4695(199611)31:3<283::AID-NEU2>3.0.CO;2-6; Stoica GE, 2001, J BIOL CHEM, V276, P16772, DOI 10.1074/jbc.M010660200; VANDERWINDEN JM, 1992, ANAT EMBRYOL, V186, P387; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; WELLSTEIN A, 1992, J BIOL CHEM, V267, P2582; Weng TT, 2006, AM J PHYSIOL-LUNG C, V291, pL1027, DOI 10.1152/ajplung.00435.2005; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yeh HJ, 1998, J NEUROSCI, V18, P3699	49	22	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28021	28032		10.1074/jbc.M109.052530	http://dx.doi.org/10.1074/jbc.M109.052530			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19661059	Green Published, hybrid			2022-12-27	WOS:000270676300030
J	Kedinger, V; Sansregret, L; Harada, R; Vadnais, C; Cadieux, C; Fathers, K; Park, M; Nepveu, A				Kedinger, Valerie; Sansregret, Laurent; Harada, Ryoko; Vadnais, Charles; Cadieux, Chantal; Fathers, Kelly; Park, Morag; Nepveu, Alain			p110 CUX1 Homeodomain Protein Stimulates Cell Migration and Invasion in Part through a Regulatory Cascade Culminating in the Repression of E-cadherin and Occludin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; CDP/CUX TRANSCRIPTION FACTOR; DNA-BINDING; CUT HOMEODOMAIN; S-PHASE; TUMOR PROGRESSION; CATHEPSIN-L; SNAIL TRANSCRIPTION; GENE-EXPRESSION; KINASE-C	In this study, we investigated the mechanism by which the CUX1 transcription factor can stimulate cell migration and invasion. The full-length p200 CUX1 had a weaker effect than the proteolytically processed p110 isoform; moreover, treatments that affect processing similarly impacted cell migration. We conclude that the stimulatory effect of p200 CUX1 is mediated in part, if not entirely, through the generation of p110 CUX1. We established a list of putative transcriptional targets with functions related to cell motility, and we then identified those targets whose expression was directly regulated by CUX1 in a cell line whose migratory potential was strongly stimulated by CUX1. We identified 18 genes whose expression was directly modulated by p110 CUX1, and its binding to all target promoters was validated in independent chromatin immunoprecipitation assays. These genes code for regulators of Rho-GTPases, cell-cell and cell-matrix adhesion proteins, cytoskeleton-associated proteins, and markers of epithelial-to-mesenchymal transition. Interestingly, p110 CUX1 activated the expression of genes that promote cell motility and at the same time repressed genes that inhibit this process. Therefore, the role of p110 CUX1 in cell motility involves its functions in both activation and repression of transcription. This was best exemplified in the regulation of the E-cadherin gene. Indeed, we uncovered a regulatory cascade whereby p110 CUX1 binds to the snail and slug gene promoters, activates their expression, and then cooperates with these transcription factors in the repression of the E-cadherin gene, thereby causing disorganization of cell-cell junctions.	[Nepveu, Alain] McGill Univ, Goodman Canc Ctr, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Kedinger, Valerie; Sansregret, Laurent; Harada, Ryoko; Vadnais, Charles; Cadieux, Chantal; Fathers, Kelly; Park, Morag; Nepveu, Alain] McGill Univ Canc Pavil, Montreal, PQ H3A 1A3, Canada; [Park, Morag; Nepveu, Alain] McGill Univ, Dept Oncol, Montreal, PQ H3A 1A3, Canada; [Park, Morag; Nepveu, Alain] McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada	McGill University; McGill University; McGill University	Nepveu, A (corresponding author), McGill Univ, Goodman Canc Ctr, Dept Biochem, 1160 Pine Ave W,Rm 410, Montreal, PQ H3A 1A3, Canada.	alain.nepveu@mcgill.ca	/AAB-8315-2020		Canadian Institute of Health Research [CTP-79857]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Team Grant CTP-79857 from the Canadian Institute of Health Research ( to A.N.).	Aleksic T, 2007, ONCOGENE, V26, P5939, DOI 10.1038/sj.onc.1210398; Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cavallaro U, 2004, ANN NY ACAD SCI, V1014, P58, DOI 10.1196/annals.1294.006; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Coqueret O, 1996, J BIOL CHEM, V271, P24862, DOI 10.1074/jbc.271.40.24862; Coqueret O, 1998, EMBO J, V17, P4680, DOI 10.1093/emboj/17.16.4680; Coqueret O, 1998, J BIOL CHEM, V273, P2561, DOI 10.1074/jbc.273.5.2561; Dankort D, 2001, J BIOL CHEM, V276, P38921, DOI 10.1074/jbc.M106239200; Defilippi P, 1999, MICROSC RES TECHNIQ, V47, P67, DOI 10.1002/(SICI)1097-0029(19991001)47:1<67::AID-JEMT7>3.3.CO;2-G; Goulet B, 2004, CELL CYCLE, V3, P986; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Goulet B, 2002, CANCER RES, V62, P6625; Goulet B, 2007, MOL CANCER RES, V5, P899, DOI 10.1158/1541-7786.MCR-07-0160; Goulet B, 2006, BIOL CHEM, V387, P1285, DOI 10.1515/BC.2006.159; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; HACKETT AJ, 1977, J NATL CANCER I, V58, P1795, DOI 10.1093/jnci/58.6.1795; Hajra KM, 2002, CANCER RES, V62, P1613; Harada R, 2008, NUCLEIC ACIDS RES, V36, P189, DOI 10.1093/nar/gkm970; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Li S, 1999, J BIOL CHEM, V274, P7803, DOI 10.1074/jbc.274.12.7803; Li SD, 2000, P NATL ACAD SCI USA, V97, P7166, DOI 10.1073/pnas.130028697; Mazzoni E, 2003, MOL CANCER RES, V1, P776; Michl P, 2005, CANCER CELL, V7, P521, DOI 10.1016/j.ccr.2005.05.018; Michl P, 2006, J BIOL CHEM, V281, P15138, DOI 10.1074/jbc.M600908200; Moon NS, 2000, J BIOL CHEM, V275, P31325, DOI 10.1074/jbc.M002912200; Moon NS, 2001, MOL CELL BIOL, V21, P6332, DOI 10.1128/MCB.21.18.6332-6345.2001; Nepveu A, 2001, GENE, V270, P1, DOI 10.1016/S0378-1119(01)00485-1; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; Peinado H, 2004, J CELL SCI, V117, P2827, DOI 10.1242/jcs.01145; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Poser I, 2001, J BIOL CHEM, V276, P24661, DOI 10.1074/jbc.M011224200; Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255; ROYAL I, 1995, J BIOL CHEM, V270, P27780, DOI 10.1074/jbc.270.46.27780; Sansregret L, 2006, MOL CELL BIOL, V26, P2441, DOI 10.1128/MCB.26.6.2441-2455.2006; Sansregret L, 2008, GENE, V412, P84, DOI 10.1016/j.gene.2008.01.017; Santaguida M, 2005, J BIOL CHEM, V280, P32712, DOI 10.1074/jbc.M505417200; Santaguida M, 2001, J BIOL CHEM, V276, P45780, DOI 10.1074/jbc.M107978200; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Truscott M, 2003, MOL CELL BIOL, V23, P3013, DOI 10.1128/MCB.23.8.3013-3028.2003; Truscott M, 2008, MOL CELL BIOL, V28, P3127, DOI 10.1128/MCB.02089-07; Truscott M, 2007, J BIOL CHEM, V282, P30216, DOI 10.1074/jbc.M702328200; Vallin J, 2001, J BIOL CHEM, V276, P30350, DOI 10.1074/jbc.M103167200; vanWijnen AJ, 1996, P NATL ACAD SCI USA, V93, P11516, DOI 10.1073/pnas.93.21.11516; vanWijnen AJ, 1997, J CELL BIOCHEM, V66, P512, DOI 10.1002/(SICI)1097-4644(19970915)66:4<512::AID-JCB10>3.0.CO;2-D; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yokoyama K, 2001, ORAL ONCOL, V37, P65, DOI 10.1016/S1368-8375(00)00059-2	54	45	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27701	27711		10.1074/jbc.M109.031849	http://dx.doi.org/10.1074/jbc.M109.031849			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19635798	hybrid, Green Published			2022-12-27	WOS:000270232300071
J	Tsukumo, Y; Tsukahara, S; Saito, S; Tsuruo, T; Tomida, A				Tsukumo, Yoshinori; Tsukahara, Satomi; Saito, Sakae; Tsuruo, Takashi; Tomida, Akihiro			A Novel Endoplasmic Reticulum Export Signal PROLINE AT THE + 2-POSITION FROM THE SIGNAL PEPTIDE CLEAVAGE SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; MULTIPLE EF-HAND; CA2+-BINDING PROTEIN; SECRETORY PATHWAY; BINDING PROTEIN; COATED VESICLES; GOLGI; COPII; ER; NUCLEOBINDIN	NUCB1 (nucleobindin 1) is a Golgi-localized soluble protein with a signal peptide and multiple functional domains. We reported recently that NUCB1 is a negative regulator of the unfolded protein response that activates various endoplasmic reticulum (ER)-originating signaling pathways. In that report, we also showed that Golgi localization of NUCB1 was essential to regulate the unfolded protein response. However, the localization mechanism of NUCB1 is still unknown. Here, we report that the proline residue at the +2-position (Pro(+2)) from the signal peptide cleavage site is the determinant of NUCB1 protein export from the ER and subsequent transport to the Golgi. Fusion of the N-terminal amino acids 1-35 peptide region, including both signal peptide (amino acids 1-26) and Pro(+2), was sufficient for enhanced green fluorescent protein to localize in the Golgi, whereas single amino acid mutation of Pro(+2) resulted in defective export from the ER without affecting the protein maturation process. Furthermore, we demonstrated that Pro(+2) was important for the enhanced green fluorescent protein fusion protein to concentrate at a transport vesicle formation site within the ER, often termed the ER exit site. Interestingly, such a Pro(+2) has also been functionally conserved in other Golgi-localized soluble proteins, Cab45 (Ca2+-binding protein of 45 kDa), reticulocalbin 1, and calumenin. Our findings indicate that Pro(+2) can function as a novel ER export signal of some Golgi proteins.	[Tsukumo, Yoshinori; Tsukahara, Satomi; Saito, Sakae; Tsuruo, Takashi; Tomida, Akihiro] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Tokyo 1358550, Japan	Japanese Foundation for Cancer Research	Tomida, A (corresponding author), Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Tokyo 1358550, Japan.	akihiro.tomida@jfcr.or.jp			Ministry of Health, Labour, and Welfare; New Energy and Industrial Technology Development Organization (NEDO) of Japan; Ishizu Scholarship Foundation	Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Ishizu Scholarship Foundation	This work was supported in part by Grant-in-aid for Cancer Research 21-3-1 from the Ministry of Health, Labour, and Welfare (to A. T.), a Grant-in-aid for scientific research on priority areas for cancer (to T. T. and A. T.), a grant from the New Energy and Industrial Technology Development Organization (NEDO) of Japan, and aid from the Ishizu Scholarship Foundation (to Y.T.).	Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Ballif BA, 1996, P NATL ACAD SCI USA, V93, P5544, DOI 10.1073/pnas.93.11.5544; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Caldwell SR, 2001, J BIOL CHEM, V276, P23296, DOI 10.1074/jbc.M102962200; Cheung JC, 2008, BIOCHEMISTRY-US, V47, P1465, DOI 10.1021/bi702209s; Hammond AT, 2000, MOL BIOL CELL, V11, P3013, DOI 10.1091/mbc.11.9.3013; Honore B, 2000, FEBS LETT, V466, P11, DOI 10.1016/S0014-5793(99)01780-9; KANAI Y, 1992, IMMUNOL LETT, V32, P43; KANAI Y, 1993, BIOCHEM BIOPH RES CO, V196, P729, DOI 10.1006/bbrc.1993.2310; Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Laskowski RA, 2008, NAT REV GENET, V9, P141, DOI 10.1038/nrg2273; Lavoie C, 2002, MOL ENDOCRINOL, V16, P2462, DOI 10.1210/me.2002-0079; Lin P, 1999, J CELL BIOL, V145, P279, DOI 10.1083/jcb.145.2.279; Lin P, 1998, J CELL BIOL, V141, P1515, DOI 10.1083/jcb.141.7.1515; Malkus P, 2002, J CELL BIOL, V159, P915, DOI 10.1083/jcb.200208074; Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; MIURA K, 1992, BIOCHEM BIOPH RES CO, V187, P375, DOI 10.1016/S0006-291X(05)81503-7; Miura K, 1996, GENOMICS, V34, P181, DOI 10.1006/geno.1996.0263; MIZUNO M, 1993, P NATL ACAD SCI USA, V90, P5732, DOI 10.1073/pnas.90.12.5732; MOCHIZUKI N, 1995, FEBS LETT, V373, P155, DOI 10.1016/0014-5793(95)01031-9; Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925; Nadanaka S, 2004, MOL BIOL CELL, V15, P2537, DOI 10.1091/mbc.E03-09-0693; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Otte S, 2004, NAT CELL BIOL, V6, P1189, DOI 10.1038/ncb1195; OZAWA M, 1993, J BIOL CHEM, V268, P699; PERLMAN D, 1983, J MOL BIOL, V167, P391, DOI 10.1016/S0022-2836(83)80341-6; Petersson U, 2004, BONE, V34, P949, DOI 10.1016/j.bone.2004.01.019; Sato K, 2002, MOL BIOL CELL, V13, P2518, DOI 10.1091/mbc.E02-01-0027; Scherer PE, 1996, J CELL BIOL, V133, P257, DOI 10.1083/jcb.133.2.257; SHEN LM, 1991, BIOCHEMISTRY-US, V30, P11775, DOI 10.1021/bi00115a006; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsukumo Y, 2007, J BIOL CHEM, V282, P29264, DOI 10.1074/jbc.M705038200; WANG SN, 1994, PATHOL INT, V44, P844, DOI 10.1111/j.1440-1827.1994.tb01682.x; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; WENDEL M, 1995, J BIOL CHEM, V270, P6125, DOI 10.1074/jbc.270.11.6125; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8; Yabe D, 1997, J BIOL CHEM, V272, P18232, DOI 10.1074/jbc.272.29.18232; Zhang ZM, 2004, PROTEIN SCI, V13, P2819, DOI 10.1110/ps.04682504	43	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27500	27510		10.1074/jbc.M109.021592	http://dx.doi.org/10.1074/jbc.M109.021592			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19656946	Green Published, hybrid			2022-12-27	WOS:000270232300052
J	Cazanave, SC; Mott, JL; Elmi, NA; Bronk, SF; Werneburg, NW; Akazawa, Y; Kahraman, A; Garrison, SP; Zambetti, GP; Charlton, MR; Gores, GJ				Cazanave, Sophie C.; Mott, Justin L.; Elmi, Nafisa A.; Bronk, Steven F.; Werneburg, Nathan W.; Akazawa, Yuko; Kahraman, Alisan; Garrison, Sean P.; Zambetti, Gerard P.; Charlton, Michael R.; Gores, Gregory J.			JNK1-dependent PUMA Expression Contributes to Hepatocyte Lipoapoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY LIVER-DISEASE; BCL-2 FAMILY-MEMBERS; N-TERMINAL KINASE; NONALCOHOLIC STEATOHEPATITIS; BH3-ONLY PROTEIN; CELL-DEATH; INSULIN-RESISTANCE; BAX ACTIVATION; MITOCHONDRIAL ABNORMALITIES; JNK PHOSPHORYLATION	Free fatty acids (FFA) induce hepatocyte lipoapoptosis by a c-Jun N-terminal kinase (JNK)-dependent mechanism. However, the cellular processes by which JNK engages the core apoptotic machinery during lipotoxicity, especially activation of BH3-only proteins, remain incompletely understood. Thus, our aim was to determine whether JNK mediates induction of BH3-only proteins during hepatocyte lipoapoptosis. The saturated FFA palmitate, but not the monounsaturated FFA oleate, induces an increase in PUMA mRNA and protein levels. Palmitate induction of PUMA was JNK1-dependent in primary murine hepatocytes. Palmitate-mediated PUMA expression was inhibited by a dominant negative c-Jun, and direct binding of a phosphorylated c-Jun containing the activator protein 1 complex to the PUMA promoter was identified by electrophoretic mobility shift assay and a chromatin immunoprecipitation assay. Short hairpin RNA-targeted knockdown of PUMA attenuated Bax activation, caspase 3/7 activity, and cell death. Similarly, the genetic deficiency of Puma rendered murine hepatocytes resistant to lipoapoptosis. PUMA expression was also increased in liver biopsy specimens from patients with non-alcoholic steatohepatitis as compared with patients with simple steatosis or controls. Collectively, the data implicate JNK1-dependent PUMA expression as a mechanism contributing to hepatocyte lipoapoptosis.	[Kahraman, Alisan; Charlton, Michael R.; Gores, Gregory J.] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Miles & Shirley Fitterman Ctr Digest Dis, Rochester, MN 55905 USA; [Garrison, Sean P.; Zambetti, Gerard P.] St Jude Childrens Hosp, Dept Biochem, Memphis, TN 38105 USA	Mayo Clinic; St Jude Children's Research Hospital	Gores, GJ (corresponding author), Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Miles & Shirley Fitterman Ctr Digest Dis, 200 1st St SW, Rochester, MN 55905 USA.	gores.gregory@mayo.edu	Zambetti, Gerard/N-8093-2018	Zambetti, Gerard/0000-0002-0929-5007; Mott, Justin/0000-0002-2927-6962	National Institutes of Health [DK41876, DK069757-05, DK079875]; Mayo Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK041876, R01DK069757, R01DK041876, R29DK041876, K01DK079875, P30DK084567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK41876 (to G. J. G.), DK069757-05 (to M. R. C.), and DK079875 (to J. L. M.). This work was also supported by the Mayo Foundation.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Akhtar RS, 2006, J NEUROSCI, V26, P7257, DOI 10.1523/JNEUROSCI.0196-06.2006; Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bookman ID, 2006, LIVER INT, V26, P566, DOI 10.1111/j.1478-3231.2006.01256.x; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Caldwell SH, 1999, J HEPATOL, V31, P430, DOI 10.1016/S0168-8278(99)80033-6; Caldwell Stephen H, 2004, Clin Liver Dis, V8, P595, DOI 10.1016/j.cld.2004.04.009; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Czaja MJ, 2007, SEMIN LIVER DIS, V27, P378, DOI 10.1055/s-2007-991514; Czaja MJ, 2003, AM J PHYSIOL-GASTR L, V284, pG875, DOI 10.1152/ajpgi.00549.2002; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Doege H, 2008, J BIOL CHEM, V283, P22186, DOI 10.1074/jbc.M803510200; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Donovan N, 2002, J BIOL CHEM, V277, P40944, DOI 10.1074/jbc.M206113200; Ekoff M, 2007, BLOOD, V110, P3209, DOI 10.1182/blood-2007-02-073957; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Erlacher M, 2006, J EXP MED, V203, P2939, DOI 10.1084/jem.20061552; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798; Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200; Hansson MD, 2008, ANAL BIOCHEM, V375, P373, DOI 10.1016/j.ab.2007.12.005; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Jabbour AM, 2009, CELL DEATH DIFFER, V16, P555, DOI 10.1038/cdd.2008.179; Jaeschke A, 2007, MOL CELL, V27, P498, DOI 10.1016/j.molcel.2007.07.008; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Karin M, 2005, IUBMB LIFE, V57, P283, DOI 10.1080/15216540500097111; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kodama Y, 2009, GASTROENTEROLOGY, V136, P1423, DOI 10.1053/j.gastro.2008.12.064; Krishnan A, 2007, HEPATOL RES, V37, P854, DOI 10.1111/j.1872-034X.2007.00139.x; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Luo X, 2005, CELL DEATH DIFFER, V12, P1310, DOI 10.1038/sj.cdd.4401659; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Malhi H, 2007, GUT, V56, P1124, DOI 10.1136/gut.2006.118059; Melino G, 2004, J BIOL CHEM, V279, P8076, DOI 10.1074/jbc.M307469200; Michalak EM, 2008, CELL DEATH DIFFER, V15, P1019, DOI 10.1038/cdd.2008.16; Ming L, 2006, J BIOL CHEM, V281, P16034, DOI 10.1074/jbc.M513587200; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nehra V, 2001, DIGEST DIS SCI, V46, P2347, DOI 10.1023/A:1012338828418; Neise D, 2008, ONCOGENE, V27, P1387, DOI 10.1038/sj.onc.1210773; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Ratziu V, 2006, HEPATOLOGY, V44, P802, DOI 10.1002/hep.21391; RICHIERI GV, 1995, J LIPID RES, V36, P229; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Schachter KA, 2006, J BIOL CHEM, V281, P19134, DOI 10.1074/jbc.M603324200; Schattenberg JM, 2006, HEPATOLOGY, V43, P163, DOI 10.1002/hep.20999; Singh R, 2009, HEPATOLOGY, V49, P87, DOI 10.1002/hep.22578; Steckley D, 2007, J NEUROSCI, V27, P12989, DOI 10.1523/JNEUROSCI.3400-07.2007; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vikhanskaya F, 2007, NAT CELL BIOL, V9, P698, DOI 10.1038/ncb1598; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Xu ZH, 2005, MOL CELL BIOL, V25, P9949, DOI 10.1128/MCB.25.22.9949-9959.2005; Yamaguchi H, 2002, J BIOL CHEM, V277, P41604, DOI 10.1074/jbc.M207516200; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	68	150	153	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26591	26602		10.1074/jbc.M109.022491	http://dx.doi.org/10.1074/jbc.M109.022491			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19638343	Green Published, hybrid			2022-12-27	WOS:000269969600040
J	Ideo, H; Fukushima, K; Gengyo-Ando, K; Mitani, S; Dejima, K; Nomura, K; Yamashita, K				Ideo, Hiroko; Fukushima, Keiko; Gengyo-Ando, Keiko; Mitani, Shohei; Dejima, Katsufumi; Nomura, Kazuya; Yamashita, Katsuko			A Caenorhabditis elegans Glycolipid-binding Galectin Functions in Host Defense against Bacterial Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-THURINGIENSIS; MEMBRANE MICRODOMAINS; SPECIFICITY; MUTANTS; PROTEIN; GLYCOSPHINGOLIPIDS; EXPRESSION; SULFATIDES; NEMATODES; DOMAINS	Galectins are a family of beta-galactoside-binding proteins that are widely found among animal species and that regulate diverse biological phenomena. To study the biological function of glycolipid-binding galectins, we purified recombinant Caenorhabditis elegans galectins (LEC-1-11) and studied their binding to C. elegans glycolipids. We found that LEC-8 binds to glycolipids in C. elegans through carbohydrate recognition. It has been reported that Cry5B-producing Bacillus thuringiensis strains can infect C. elegans and that the C. elegans Cry5B receptor molecules are glycolipids. We found that Cry5B and LEC-8 bound to C. elegans glycolipid-coated plates in a dose-dependent manner and that Cry5B binding to glycolipids was inhibited by the addition of LEC-8. LEC-8 is usually expressed strongly in the pharyngeal-intestinal valve and intestinal-rectal valve and is expressed weakly in intestine. However, when C. elegans were fed Escherichia coli expressing Cry5B, intestinal LEC-8::EGFP protein levels increased markedly. In contrast, LEC-8::EGFP expression triggered by Cry5B was reduced in toxin-resistant C. elegans mutants, which had mutations in genes involved in biosynthesis of glycolipids. Moreover, the LEC-8-deficient mutant was more susceptible to Cry5B than wild-type worms. These results suggest that the glycolipid-binding lectin LEC-8 contributes to host defense against bacterial infection by competitive binding to target glycolipid molecules.	[Yamashita, Katsuko] Tokyo Inst Technol, Innovat Res Initiat, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Gengyo-Ando, Keiko; Mitani, Shohei; Nomura, Kazuya; Yamashita, Katsuko] Core Res Evolut Sci & Technol, Saitama 3320012, Japan; [Gengyo-Ando, Keiko; Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan; [Dejima, Katsufumi; Nomura, Kazuya] Kyushu Univ, Fac Sci 33, Dept Biol, Fukuoka 8128581, Japan	Tokyo Institute of Technology; Japan Science & Technology Agency (JST); Tokyo Women's Medical University; Kyushu University	Yamashita, K (corresponding author), Tokyo Inst Technol, Innovat Res Initiat, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan.	kyamashi@bio.titech.ac.jp	Gengyo-Ando, Keiko/B-2753-2012; Gengyo-Ando, Keiko/AAC-4504-2019		New Energy and Industrial Technology Development Organization (NEDO) in Japan	New Energy and Industrial Technology Development Organization (NEDO) in Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by the New Energy and Industrial Technology Development Organization (NEDO) in Japan.	Ahmed H, 2002, GLYCOBIOLOGY, V12, P451, DOI 10.1093/glycob/cwf052; Arata Y, 2001, J BIOL CHEM, V276, P3068, DOI 10.1074/jbc.M008602200; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Boonserm P, 2005, J MOL BIOL, V348, P363, DOI 10.1016/j.jmb.2005.02.013; BORGONIE G, 1995, J INVERTEBR PATHOL, V65, P61, DOI 10.1006/jipa.1995.1008; Borgonie G, 1996, FUND APPL NEMATOL, V19, P391; Braccia A, 2003, J BIOL CHEM, V278, P15679, DOI 10.1074/jbc.M211228200; BRENNAN MJ, 1991, J BIOL CHEM, V266, P18827; COX GN, 1980, GENETICS, V95, P317; Crickmore N, 1998, MICROBIOL MOL BIOL R, V62, P807, DOI 10.1128/MMBR.62.3.807-813.1998; Danielsen EM, 2003, BBA-BIOMEMBRANES, V1617, P1, DOI 10.1016/j.bbamem.2003.09.005; de Maagd RA, 2003, ANNU REV GENET, V37, P409, DOI 10.1146/annurev.genet.37.110801.143042; Delacour D, 2005, J CELL BIOL, V169, P491, DOI 10.1083/jcb.200407073; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Griffitts JS, 2005, SCIENCE, V307, P922, DOI 10.1126/science.1104444; Haslam SM, 2003, BIOCHIMIE, V85, P25, DOI 10.1016/S0300-9084(03)00041-5; Haslam SM, 2002, BIOCHEM SOC SYMP, V69, P117; Hernandez JD, 2002, GLYCOBIOLOGY, V12, p127R, DOI 10.1093/glycob/cwf081; HIDARI KIPJ, 1994, EUR J BIOCHEM, V221, P603, DOI 10.1111/j.1432-1033.1994.tb18772.x; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Ideo H, 2005, J BIOL CHEM, V280, P4730, DOI 10.1074/jbc.M410362200; Ideo H, 2002, GLYCOBIOLOGY, V12, P199, DOI 10.1093/glycob/12.3.199; Ideo H, 2007, J BIOL CHEM, V282, P21081, DOI 10.1074/jbc.M703770200; Ishizuka I, 1997, PROG LIPID RES, V36, P245, DOI 10.1016/S0163-7827(97)00011-8; Izumikawa T, 2004, J BIOL CHEM, V279, P53755, DOI 10.1074/jbc.M409615200; KARLSSON KA, 1989, ANNU REV BIOCHEM, V58, P309, DOI 10.1146/annurev.bi.58.070189.001521; KNIBBS RN, 1993, J BIOL CHEM, V268, P14940; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Marroquin LD, 2000, GENETICS, V155, P1693; Marza E, 2009, J CELL SCI, V122, P822, DOI 10.1242/jcs.042754; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Nemoto-Sasaki Y, 2008, BBA-GEN SUBJECTS, V1780, P1131, DOI 10.1016/j.bbagen.2008.07.003; ODA Y, 1993, J BIOL CHEM, V268, P5929; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Skipski V P, 1975, Methods Enzymol, V35, P396, DOI 10.1016/0076-6879(75)35178-1; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Suzuki T, 1996, BIOCHEM J, V318, P389, DOI 10.1042/bj3180389; Teneberg S, 1997, J BIOL CHEM, V272, P19067, DOI 10.1074/jbc.272.30.19067	39	47	52	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26493	26501		10.1074/jbc.M109.038257	http://dx.doi.org/10.1074/jbc.M109.038257			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19635802	Green Published, hybrid			2022-12-27	WOS:000269969600030
J	Okada, A; Okada, K; Miyamoto, K; Koga, J; Shibuya, N; Nojiri, H; Yamane, H				Okada, Atsushi; Okada, Kazunori; Miyamoto, Koji; Koga, Jinichiro; Shibuya, Naoto; Nojiri, Hideaki; Yamane, Hisakazu			OsTGAP1, a bZIP Transcription Factor, Coordinately Regulates the Inductive Production of Diterpenoid Phytoalexins in Rice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-ANALYSIS; DISEASE RESISTANCE; GENE-EXPRESSION; PLASMA-MEMBRANE; PLANT DEFENSE; ORYZA-SATIVA; DNA-BINDING; BIOSYNTHESIS; ARABIDOPSIS; ELICITOR	Production of major diterpenoid phytoalexins, momilactones and phytocassanes, is induced in rice upon recognition of pathogenic invasion as plant defense-related compounds. We recently showed that biosynthetic genes for momilactones are clustered on rice chromosome 4 and co-expressed after elicitation, mimicking pathogen attack. Because genes for most metabolic pathways in plants are not organized in gene clusters, examination of the mechanism(s) regulating the expression of such clustered genes is needed. Here, we report a chitin oligosaccharide elicitor-inducible basic leucine zipper transcription factor, OsTGAP1, which is essential for momilactone biosynthesis and regulates the expression of the five genes in the cluster. The knock-out mutant for OsTGAP1 had almost no expression of the five clustered genes (OsCPS4, OsKSL4, CYP99A2, CYP99A3, and OsMAS) or production of momilactones upon elicitor treatment. Inductive expression of OsKSL7 for phytocassane biosynthesis was also largely affected in the ostgap1 mutant, although phytocassane accumulation still occurred. Conversely, OsTGAP1-overexpressing lines exhibited enhanced expression of the clustered genes and hyperaccumulation of momilactones in response to the elicitor. Furthermore, enhanced expression of OsKSL7 and hyperaccumulation of phytocassanes was also observed. We also found that OsTGAP1 overexpression can influence transcriptional up-regulation of OsDXS3 in the methylerythritol phosphate pathway, eventually leading to inductive production of diterpenoid phytoalexins. These results indicate that OsTGAP1 functions as a key regulator of the coordinated transcription of genes involved in inductive diterpenoid phytoalexin production in rice and mainly exerts an essential role on expression of the clustered genes for momilactone biosynthesis.	[Okada, Atsushi; Okada, Kazunori; Miyamoto, Koji; Nojiri, Hideaki; Yamane, Hisakazu] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan; [Koga, Jinichiro] Meiji Seika Kaisha Ltd, Bio Sci Labs, Saitama 3500289, Japan; [Shibuya, Naoto] Meiji Univ, Fac Agr, Dept Life Sci, Tama Ku, Kanagawa 2148571, Japan	University of Tokyo; Meiji Holdings Co., Ltd.; Meiji University	Okada, K (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	ukokada@mail.ecc.u-tokyo.ac.jp	Miyamoto, Koji/N-1504-2014	Miyamoto, Koji/0000-0002-9862-7412; Koga, Jinichiro/0000-0003-2106-9894	Program for the Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Japan Society for the Promotion of Science [18580102]	Program for the Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Program for the Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN) and Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research 18580102 (to H. Y.).	AKATSUKA T, 1985, AGR BIOL CHEM TOKYO, V49, P1689, DOI 10.1080/00021369.1985.10866951; CARTWRIGHT DW, 1981, PHYTOCHEMISTRY, V20, P535, DOI 10.1016/S0031-9422(00)84189-8; Cho EM, 2004, PLANT J, V37, P1, DOI 10.1046/j.1365-313X.2003.01926.x; Despres C, 2003, PLANT CELL, V15, P2181, DOI 10.1105/tpc.012849; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Field B, 2008, SCIENCE, V320, P543, DOI 10.1126/science.1154990; Frey M, 1997, SCIENCE, V277, P696, DOI 10.1126/science.277.5326.696; Hirochika H, 1997, PLANT MOL BIOL, V35, P231, DOI 10.1023/A:1005774705893; Hirochika H, 2001, CURR OPIN PLANT BIOL, V4, P118, DOI 10.1016/S1369-5266(00)00146-1; Ito Y, 1997, PLANT J, V12, P347, DOI 10.1046/j.1365-313X.1997.12020347.x; Jupin I, 1996, EMBO J, V15, P5679, DOI 10.1002/j.1460-2075.1996.tb00952.x; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; KATO H, 1993, PHYTOCHEMISTRY, V33, P79, DOI 10.1016/0031-9422(93)85399-C; KATO H, 1994, PHYTOCHEMISTRY, V36, P299, DOI 10.1016/S0031-9422(00)97064-X; KATO T, 1973, Tetrahedron Letters, V39, P3861; Kesarwani M, 2007, PLANT PHYSIOL, V144, P336, DOI 10.1104/pp.106.095299; Koga J, 1997, PHYTOCHEMISTRY, V44, P249, DOI 10.1016/S0031-9422(96)00534-1; KOGA J, 1995, TETRAHEDRON, V51, P7907, DOI 10.1016/0040-4020(95)00423-6; LAM E, 1989, PLANT CELL, V1, P1147, DOI 10.1105/tpc.1.12.1147; Lebel E, 1998, PLANT J, V16, P223, DOI 10.1046/j.1365-313x.1998.00288.x; Miyao A, 2007, PLANT MOL BIOL, V63, P625, DOI 10.1007/s11103-006-9118-7; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nemoto T, 2004, FEBS LETT, V571, P182, DOI 10.1016/j.febslet.2004.07.002; Okada A, 2007, PLANT MOL BIOL, V65, P177, DOI 10.1007/s11103-007-9207-2; Otomo K, 2004, PLANT J, V39, P886, DOI 10.1111/j.1365-313X.2004.02175.x; Peters RJ, 2006, PHYTOCHEMISTRY, V67, P2307, DOI 10.1016/j.phytochem.2006.08.009; Qi X, 2004, P NATL ACAD SCI USA, V101, P8233, DOI 10.1073/pnas.0401301101; Qi X, 2006, P NATL ACAD SCI USA, V103, P18848, DOI 10.1073/pnas.0607849103; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; Shikata M, 2003, BIOSCI BIOTECH BIOCH, V67, P2495, DOI 10.1271/bbb.67.2495; Shimizu T, 2008, PHYTOCHEMISTRY, V69, P973, DOI 10.1016/j.phytochem.2007.10.005; Shimura K, 2007, J BIOL CHEM, V282, P34013, DOI 10.1074/jbc.M703344200; TAMOGAMI S, 1993, TETRAHEDRON, V49, P2025, DOI 10.1016/S0040-4020(01)86302-X; VANETTEN HD, 1994, PLANT CELL, V6, P1191; Yajima A, 2000, EUR J ORG CHEM, V2000, P4079	37	107	115	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26510	26518		10.1074/jbc.M109.036871	http://dx.doi.org/10.1074/jbc.M109.036871			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19635799	Green Published, hybrid			2022-12-27	WOS:000269969600032
J	Romanova, L; Kellner, S; Katoku-Kikyo, N; Kikyo, N				Romanova, Liudmila; Kellner, Steven; Katoku-Kikyo, Nobuko; Kikyo, Nobuaki			Novel Role of Nucleostemin in the Maintenance of Nucleolar Architecture and Integrity of Small Nucleolar Ribonucleoproteins and the Telomerase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; DYSKERATOSIS-CONGENITA; PROTEIN; RNA; RNPS; PROLIFERATION; PURIFICATION; BIOGENESIS; PROMOTES; NUCLEAR	Nucleostemin (NS) is a nucleolar protein involved in the regulation of cell proliferation. Both overexpression and knockdown of NS increase the activity of the tumor suppressor protein p53, resulting in cell cycle arrest. In addition, NS regulates processing of pre-rRNA and consequently the level of total protein synthesis. Here, we describe a previously uncharacterized function of NS in the maintenance of the tripartite nucleolar structure as well as the integrity of small nucleolar ribonucleoproteins (snoRNPs). NS is also necessary to maintain the telomerase complex which shares common protein subunits with the H/ACA box snoRNPs. First, immunofluorescence microscopy and electron microscopy demonstrated that knockdown of NS disorganized the nucleolar architecture, in particular, the dense fibrillar component where snoRNPs are localized. Second, gel filtration chromatography and immunoprecipitation indicated that NS depletion leads to dissociation of the components of snoRNPs and the telomerase complex. Third, NS depletion reduced both telomerase activity and the cellular level of pseudouridine, an H/ACA snoRNP-mediated modification of rRNA and other RNAs that are important for their folding and stability. These morphological, biochemical and functional studies demonstrate that NS plays an important role to maintain nucleolar structure and function on a more fundamental level than previously thought.	[Romanova, Liudmila; Kellner, Steven; Katoku-Kikyo, Nobuko; Kikyo, Nobuaki] Univ Minnesota, Stem Cell Inst, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Kikyo, N (corresponding author), Univ Minnesota, Stem Cell Inst, Dept Med, Div Hematol Oncol & Transplantat, Rm 2-216,MTRF,Mail Code 2873,2001 6th St SE, Minneapolis, MN 55455 USA.	kikyo001@umn.edu			National Institutes of Health [R01 GM068027]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM068027 (to N. K.).	Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Beekman C, 2006, MOL CELL BIOL, V26, P9291, DOI 10.1128/MCB.01183-06; Collins K, 2006, NAT REV MOL CELL BIO, V7, P484, DOI 10.1038/nrm1961; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Dragon F, 2000, MOL CELL BIOL, V20, P3037, DOI 10.1128/MCB.20.9.3037-3048.2000; Fan Y, 2006, BRIT J CANCER, V94, P1658, DOI 10.1038/sj.bjc.6603145; Fu D, 2007, MOL CELL, V28, P773, DOI 10.1016/j.molcel.2007.09.023; Gerbi SA, 2004, MOL BIOL INTELL UNIT, P170; Gonda K, 2006, J BIOL CHEM, V281, P8153, DOI 10.1074/jbc.M512890200; Grosjean Henri, 2004, Methods Mol Biol, V265, P357; Hernandez-Verdun D, 2006, HISTOCHEM CELL BIOL, V126, P135, DOI 10.1007/s00418-006-0212-3; Kirwan M, 2008, CLIN GENET, V73, P103, DOI 10.1111/j.1399-0004.2007.00923.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lafontaine DLJ, 2000, MOL CELL BIOL, V20, P2650, DOI 10.1128/MCB.20.8.2650-2659.2000; Lafontaine DLJ, 1999, RNA, V5, P455, DOI 10.1017/S135583829998192X; Ma HH, 2008, MOL BIOL CELL, V19, P2870, DOI 10.1091/mbc.E08-02-0128; Ma HH, 2007, MOL BIOL CELL, V18, P2630, DOI 10.1091/mbc.E07-03-0244; Ma HH, 2008, TRENDS CELL BIOL, V18, P575, DOI 10.1016/j.tcb.2008.09.003; Maden B E, 1990, Prog Nucleic Acid Res Mol Biol, V39, P241, DOI 10.1016/S0079-6603(08)60629-7; Marrone A, 2005, CURR OPIN GENET DEV, V15, P249, DOI 10.1016/j.gde.2005.04.004; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Meier UT, 2005, CHROMOSOMA, V114, P1, DOI 10.1007/s00412-005-0333-9; Meng LJ, 2008, J CELL SCI, V121, P4037, DOI 10.1242/jcs.037952; Olson MOJ, 2002, INT REV CYTOL, V219, P199; PECULIS BA, 1993, CELL, V73, P1233, DOI 10.1016/0092-8674(93)90651-6; Pogacic V, 2000, MOL CELL BIOL, V20, P9028, DOI 10.1128/MCB.20.23.9028-9040.2000; Politz JCR, 2005, MOL BIOL CELL, V16, P3401, DOI 10.1091/mbc.E05-02-0106; Raska I, 2006, INT REV CYTOL, V255, P177, DOI 10.1016/S0074-7696(06)55004-1; Reichow SL, 2007, NUCLEIC ACIDS RES, V35, P1452, DOI 10.1093/nar/gkl1172; Romanova L, 2009, J BIOL CHEM, V284, P4968, DOI 10.1074/jbc.M804594200; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schnapp G, 1998, NUCLEIC ACIDS RES, V26, P3311, DOI 10.1093/nar/26.13.3311; SLEBOS RJC, 1994, P NATL ACAD SCI USA, V91, P5320, DOI 10.1073/pnas.91.12.5320; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; Vulliamy TJ, 2008, BIOCHIMIE, V90, P122, DOI 10.1016/j.biochi.2007.07.017; Watkins NJ, 2000, CELL, V103, P457, DOI 10.1016/S0092-8674(00)00137-9; Watkins NJ, 2002, MOL CELL BIOL, V22, P8342, DOI 10.1128/MCB.22.23.8342-8352.2002; Wong JMY, 2006, GENE DEV, V20, P2848, DOI 10.1101/gad.1476206; Zhang L, 2007, BIOCHEM BIOPH RES CO, V361, P611, DOI 10.1016/j.bbrc.2007.07.089; Zhu QB, 2006, MOL CELL BIOL, V26, P9279, DOI 10.1128/MCB.00724-06; Zhu YS, 2004, MOL BIOL CELL, V15, P81, DOI 10.1091/mbc.E03-07-0525	42	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26685	26694		10.1074/jbc.M109.013342	http://dx.doi.org/10.1074/jbc.M109.013342			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19648109	hybrid, Green Published			2022-12-27	WOS:000269969600049
J	Beck, L; Leroy, C; Salaun, C; Margall-Ducos, G; Desdouets, C; Friedlander, G				Beck, Laurent; Leroy, Christine; Salauen, Christine; Margall-Ducos, Germain; Desdouets, Chantal; Friedlander, Gerard			Identification of a Novel Function of PiT1 Critical for Cell Proliferation and Independent of Its Phosphate Transport Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APE LEUKEMIA-VIRUS; RETROVIRUS RECEPTOR; INORGANIC-PHOSPHATE; VITAMIN-D; EXPRESSION; CLONING; PROTEIN; KIDNEY; MOUSE; LOOP	PiT1 is a Na+-phosphate (P-i) cotransporter located at the plasma membrane that enables P-i entry into the cell. Its broad tissue expression pattern has led to the idea that together with the closely related family member PiT2, PiT1 is the ubiquitous supplier of P-i to the cell. Moreover, the role of P-i in phosphorylation reactions, ATP production, DNA structure, and synthesis has led to the view that P-i availability could be an important determinant of cell growth. However, these issues have not been clearly addressed to date, and the role of either P-i or PiT proteins in cell proliferation is unknown. Using RNA interference in HeLa and HepG2 cells, we show that transient or stable PiT1 depletion markedly reduces cell proliferation, delays cell cycle, and impairs mitosis and cytokinesis. In vivo, PiT1 depletion greatly reduced tumor growth when engineered HeLa cells were injected into nude mice. We provide evidence that this effect on cell proliferation is specific to PiT1 and not shared by PiT2 and is not the consequence of impaired membrane Na+-Pi transport. Moreover, we show that modulation of cell proliferation by PiT1 is independent from its transport function because the proliferation of PiT1-depleted cells can be rescued by nontransporting PiT1 mutants. PiT1 depletion leads to the phosphorylation of p38 mitogen-activated protein (MAP) kinase, whereas other MAP kinases and downstream targets of mammalian target of rapamycin (mTOR) remain unaffected. This study is the first to describe the effects of a P-i transporter in cell proliferation, tumor growth, and cell signaling.	[Beck, Laurent; Leroy, Christine; Salauen, Christine; Friedlander, Gerard] INSERM, Growth & Signalling Res Ctr, U845, F-75015 Paris, France; [Beck, Laurent; Leroy, Christine; Salauen, Christine; Margall-Ducos, Germain; Desdouets, Chantal; Friedlander, Gerard] INSERM, U567, Cochin Inst, F-75015 Paris, France; [Margall-Ducos, Germain; Desdouets, Chantal] CNRS, UMR8104, Cochin Inst, F-75015 Paris, France; [Beck, Laurent] Univ Paris 05, Ctr Rech, INSERM, Fac Med,U845, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Beck, L (corresponding author), Univ Paris 05, Ctr Rech, INSERM, Fac Med,U845, 156 Rue Vaugirard, F-75015 Paris, France.	laurent.beck@inserm.fr	BECK, Laurent/P-2952-2014; Desdouets, Chantal/M-3430-2017	BECK, Laurent/0000-0002-6730-2762; Friedlander, Gerard/0000-0002-6854-4261; Salaun, Christine/0000-0003-3002-6810	INSERM; CNRS; Universite Paris Descartes; Association Laboratoire de Recherches Physiologiques; Agence Nationale pour la Recherche (ANR)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris Descartes; Association Laboratoire de Recherches Physiologiques; Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by grants from INSERM, CNRS, Universite Paris Descartes, Association Laboratoire de Recherches Physiologiques, and Agence Nationale pour la Recherche (ANR).	Barac-Nieto M, 2001, EXP NEPHROL, V9, P258; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Beck L, 2000, J BIOL CHEM, V275, P11880, DOI 10.1074/jbc.275.16.11880; BINGGELI R, 1986, J THEOR BIOL, V123, P377, DOI 10.1016/S0022-5193(86)80209-0; Bottger P, 2005, FEBS J, V272, P3060, DOI 10.1111/j.1742-4658.2005.04720.x; Bottger P, 2002, J BIOL CHEM, V277, P42741, DOI 10.1074/jbc.M207096200; Bottger P, 2006, AM J PHYSIOL-CELL PH, V291, pC1377, DOI 10.1152/ajpcell.00015.2006; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Cha HJ, 2007, J BIOL CHEM, V282, P22984, DOI 10.1074/jbc.M700735200; Chien ML, 1997, J VIROL, V71, P4564, DOI 10.1128/JVI.71.6.4564-4570.1997; CONE CD, 1971, J THEOR BIOL, V30, P151, DOI 10.1016/0022-5193(71)90042-7; Crook M, 1996, ANN CLIN BIOCHEM, V33, P376, DOI 10.1177/000456329603300502; Dreyer K, 2000, J VIROL, V74, P2926, DOI 10.1128/JVI.74.6.2926-2929.2000; ESCOUBET B, 1992, J ENDOCRINOL, V133, P301, DOI 10.1677/joe.0.1330301; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Guillemain G, 2000, J CELL SCI, V113, P841; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MILLER DG, 1994, P NATL ACAD SCI USA, V91, P78, DOI 10.1073/pnas.91.1.78; OHARA B, 1990, CELL GROWTH DIFFER, V1, P119; Palmer G, 1999, BONE, V24, P1, DOI 10.1016/S8756-3282(98)00151-3; Prie D, 2009, KIDNEY INT, V75, P882, DOI 10.1038/ki.2008.643; Ravera S, 2007, AM J PHYSIOL-CELL PH, V293, pC606, DOI 10.1152/ajpcell.00064.2007; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Salaun C, 2004, J MOL BIOL, V340, P39, DOI 10.1016/j.jmb.2004.04.050; Salaun C, 2001, J VIROL, V75, P5584, DOI 10.1128/JVI.75.12.5584-5592.2001; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sundelacruz S, 2009, STEM CELL REV REP, V5, P231, DOI 10.1007/s12015-009-9080-2; TENENHOUSE HS, 1989, BIOCHIM BIOPHYS ACTA, V984, P207, DOI 10.1016/0005-2736(89)90218-6; THORENS B, 1988, CELL, V55, P281, DOI 10.1016/0092-8674(88)90051-7; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Uckert W, 1998, HUM GENE THER, V9, P2619, DOI 10.1089/10430349850019454; Virkki LV, 2007, AM J PHYSIOL-RENAL, V293, pF643, DOI 10.1152/ajprenal.00228.2007; Werner A, 2001, AM J PHYSIOL-REG I, V280, pR301, DOI 10.1152/ajpregu.2001.280.2.R301; Whitfield ML, 2000, MOL CELL BIOL, V20, P4188, DOI 10.1128/MCB.20.12.4188-4198.2000	39	81	85	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31363	31374		10.1074/jbc.M109.053132	http://dx.doi.org/10.1074/jbc.M109.053132			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19726692	Green Published, hybrid			2022-12-27	WOS:000271378400062
J	Nagelin, MH; Srinivasan, S; Nadler, JL; Hedrick, CC				Nagelin, Melissa H.; Srinivasan, Suseela; Nadler, Jerry L.; Hedrick, Catherine C.			Murine 12/15-Lipoxygenase Regulates ATP-binding Cassette Transporter G1 Protein Degradation through p38-and JNK2-dependent Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; 12-HYDROXYEICOSATETRAENOIC ACID; DEPENDENT DEGRADATION; ANGIOTENSIN-II; MONOCYTE/ENDOTHELIAL INTERACTIONS; MACROPHAGE 12/15-LIPOXYGENASE; 15-LIPOXYGENASE EXPRESSION; 12-LIPOXYGENASE PRODUCT; CELLULAR CHOLESTEROL; ENDOTHELIAL-CELLS	12/15-Lipoxygenase (12/15LO) plays a role in the pathogenesis of atherosclerosis and diabetes and has been implicated in low density lipoprotein oxidation. Murine macrophages express high levels of 12/15LO and are key cells involved in the accumulation and efflux of oxidized low density lipoprotein in the arterial wall. During this process, macrophages up-regulates cavenger receptors that regulate lipid uptake, and ATP-binding cassette (ABC) transporters, that regulate lipid efflux. We have previously demonstrated that 12/15LO enhances the turnover and serine phosphorylation of ABCG1. In the current study, we further elucidate the mechanisms by which 12/15LO regulates ABCG1. Proteasomal inhibitors blocked the down-regulation of ABCG1 expression and resulted in accumulation of phosphorylated ABCG1. Macrophages that lack 12/15LO have enhanced transporter expression, reduced ABCG1 phosphorylation, and increased cholesterol efflux. Conversely, macrophages that overexpress 12/15LO have reduced ABCG1 expression, increased transporter phosphorylation, and reduced cholesterol efflux. 12/15LO plays a key role in activating the MAPK pathway. Inhibition of the p38 or JNK pathways with pharmacological inhibitors or dominant negative constructs blocked 12S-hydroxyeicosatetranoic acid-mediated degradation of ABCG1. Moreover, we isolated macrophages from JNK1-, JNK2-, and MKK3-deficient mice to analyze the involvement of specific MAPK pathways. JNK2- and MKK3-, but not JNK1-deficient macrophages were resistant to the down-regulation of ABCG1 protein, reduction in efflux, and increase in serine phosphorylation by 12S-hydroxyeicosatetranoic acid. These findings provide evidence that 12/15LO regulates ABCG1 expression and function through p38- and JNK2-dependent mechanisms, and that targeting these pathways may provide novel approaches for regulating cholesterol homeostasis.	[Nagelin, Melissa H.; Hedrick, Catherine C.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Nagelin, Melissa H.; Srinivasan, Suseela; Hedrick, Catherine C.] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Hedrick, Catherine C.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Nadler, Jerry L.] Eastern Virginia Med Sch, Dept Med, Norfolk, VA 23501 USA	University of Virginia; University of Virginia; University of Virginia; Eastern Virginia Medical School	Hedrick, CC (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, 9420 Athena Circle, La Jolla, CA 92037 USA.	Hedrick@liai.org	Hedrick, Catherine/D-1106-2012		National Institutes of Health [P01 HL55798, R01 HL085790]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL055798, R01HL085790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL55798 (to C. C. H. and to J. L. N.) and R01 HL085790 (to C. C. H.).	ALVAREZ E, 1991, J BIOL CHEM, V266, P15277; ANGEL A, 1974, J LIPID RES, V15, P491; Antonipillai I, 1996, J CLIN ENDOCR METAB, V81, P1940, DOI 10.1210/jc.81.5.1940; Belkner J, 2005, ARTERIOSCL THROM VAS, V25, P797, DOI 10.1161/01.ATV.0000157580.26858.2d; Brinckmann R, 1996, BIOCHEM J, V318, P305, DOI 10.1042/bj3180305; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; CHEN XS, 1994, J BIOL CHEM, V269, P13979; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; CONRAD DJ, 1992, P NATL ACAD SCI USA, V89, P217, DOI 10.1073/pnas.89.1.217; Cyrus T, 2001, CIRCULATION, V103, P2277; DEBRUIJN MFTR, 1994, EUR J IMMUNOL, V24, P2279, DOI 10.1002/eji.1830241003; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Funk CD, 1996, BBA-LIPID LIPID MET, V1304, P65, DOI 10.1016/S0005-2760(96)00107-5; Hatley ME, 2003, J BIOL CHEM, V278, P25369, DOI 10.1074/jbc.M301175200; Heydeck D, 1998, BLOOD, V92, P2503, DOI 10.1182/blood.V92.7.2503.2503_2503_2510; Huo YQ, 2004, CIRCULATION, V110, P2024, DOI 10.1161/01.CIR.0000143628.37680.F6; Kida A, 2007, ONCOGENE, V26, P6630, DOI 10.1038/sj.onc.1210490; KUHN H, 1994, J LIPID RES, V35, P1749; KUHN H, 1993, BIOCHIM BIOPHYS ACTA, V1168, P73, DOI 10.1016/0005-2760(93)90268-E; Kuma Y, 2004, BIOCHEM J, V379, P133, DOI 10.1042/BJ20031559; Lange CA, 2000, P NATL ACAD SCI USA, V97, P1032, DOI 10.1073/pnas.97.3.1032; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Marchetti S, 2005, MOL CELL BIOL, V25, P854, DOI 10.1128/MCB.25.2.854-864.2005; Martinez LO, 2003, J BIOL CHEM, V278, P37368, DOI 10.1074/jbc.M307161200; Mauldin JP, 2006, J BIOL CHEM, V281, P21216, DOI 10.1074/jbc.M510952200; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; MILLIKEN GA, 1995, STAT MED, V14, P701, DOI 10.1002/sim.4780140530; Nagelin MH, 2008, ARTERIOSCL THROM VAS, V28, P1811, DOI 10.1161/ATVBAHA.108.167908; NATARAJAN R, 1994, MOL CELL ENDOCRINOL, V101, P59, DOI 10.1016/0303-7207(94)90219-4; NICHOLS AB, 1976, JAMA-J AM MED ASSOC, V236, P1948, DOI 10.1001/jama.236.17.1948; Obinata H, 2005, J BIOL CHEM, V280, P40676, DOI 10.1074/jbc.M507787200; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; PARKS JS, 1979, J BIOL CHEM, V254, P6716; Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24; Rao GN, 1996, J BIOL CHEM, V271, P27760, DOI 10.1074/jbc.271.44.27760; Reddy MA, 2002, J BIOL CHEM, V277, P9920, DOI 10.1074/jbc.M111305200; Reilly KB, 2004, J BIOL CHEM, V279, P9440, DOI 10.1074/jbc.M303857200; Ricci R, 2004, SCIENCE, V306, P1558, DOI 10.1126/science.1101909; Roosbeek S, 2004, J BIOL CHEM, V279, P37779, DOI 10.1074/jbc.M401821200; Schwabedissen HEMZ, 2006, DRUG METAB DISPOS, V34, P524, DOI 10.1124/dmd.105.007591; See RH, 2002, J BIOL CHEM, V277, P41835, DOI 10.1074/jbc.M204923200; SETTY BNY, 1987, J BIOL CHEM, V262, P17613; Shen JH, 1996, J CLIN INVEST, V98, P2201, DOI 10.1172/JCI119029; Spanbroek R, 2003, P NATL ACAD SCI USA, V100, P1238, DOI 10.1073/pnas.242716099; SPECTOR AA, 1988, PROG LIPID RES, V27, P271, DOI 10.1016/0163-7827(88)90009-4; Srinivasan S, 2004, J BIOL CHEM, V279, P31930, DOI 10.1074/jbc.M400753200; Toda A, 2002, PROSTAG OTH LIPID M, V68-9, P575, DOI 10.1016/S0090-6980(02)00056-4; Vaughan AM, 2005, J BIOL CHEM, V280, P30150, DOI 10.1074/jbc.M505368200; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Wang YT, 2007, J LIPID RES, V48, P1062, DOI 10.1194/jlr.M600437-JLR200; Weibel GL, 2009, ARTERIOSCL THROM VAS, V29, P837, DOI 10.1161/ATVBAHA.109.186163; Wen Y, 2000, BIOCHEM J, V349, P481, DOI 10.1042/0264-6021:3490481; Wen YS, 2007, ENDOCRINOLOGY, V148, P1313, DOI 10.1210/en.2006-0665; Wen YS, 1996, AM J PHYSIOL-CELL PH, V271, pC1212, DOI 10.1152/ajpcell.1996.271.4.C1212; Wen YS, 1997, CIRC RES, V81, P651; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Xie Y, 2008, J BIOL CHEM, V283, P3349, DOI 10.1074/jbc.M707773200; Yamamoto SY, 1997, ADV EXP MED BIOL, V400, P127; YLAHERTTUALA S, 1990, P NATL ACAD SCI USA, V87, P6959, DOI 10.1073/pnas.87.18.6959; Yoshimoto T, 2002, PROSTAG OTH LIPID M, V68-9, P245, DOI 10.1016/S0163-7827(97)00002-7	64	35	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31303	31314		10.1074/jbc.M109.028910	http://dx.doi.org/10.1074/jbc.M109.028910			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19713213	hybrid, Green Published			2022-12-27	WOS:000271378400057
J	Aiken, CT; Steffan, JS; Guerrero, CM; Khashwji, H; Lukacsovich, T; Simmons, D; Purcell, JM; Menhaji, K; Zhu, YZ; Green, K; LaFerla, F; Huang, L; Thompson, LM; Marsh, JL				Aiken, Charity T.; Steffan, Joan S.; Guerrero, Cortnie M.; Khashwji, Hasan; Lukacsovich, Tamas; Simmons, Danielle; Purcell, Judy M.; Menhaji, Kimia; Zhu, Ya-Zhen; Green, Kim; LaFerla, Frank; Huang, Lan; Thompson, Leslie Michels; Marsh, J. Lawrence			Phosphorylation of Threonine 3 IMPLICATIONS FOR HUNTINGTIN AGGREGATION AND NEUROTOXICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; SUBCELLULAR-LOCALIZATION; MUTANT HUNTINGTIN; TRANSGENIC MICE; MASS-SPECTROMETRY; MOUSE MODEL; EARLY MOTOR; GERM-LINE; DISEASE; GENE	Huntingtin (Htt) is a widely expressed protein that causes tissue-specific degeneration when mutated to contain an expanded polyglutamine (poly(Q)) domain. Although Htt is large, 350 kDa, the appearance of amino-terminal fragments of Htt in extracts of postmortem brain tissue from patients with Huntington disease (HD), and the fact that an amino-terminal fragment, Htt exon 1 protein (Httex1p), is sufficient to cause disease in models of HD, points to the importance of the aminoterminal region of Htt in the disease process. The first exon of Htt encodes 17 amino acids followed by a poly(Q) repeat of variable length and culminating with a proline-rich domain of 50 amino acids. Because modifications to this fragment have the potential to directly affect pathogenesis in several ways, we have surveyed this fragment for potential post-translational modifications that might affect Htt behavior and detected several modifications of Httex1p. Here we report that the most prevalent modifications of Httex1p are NH2-terminal acetylation and phosphorylation of threonine 3 (pThr-3). We demonstrate that pThr-3 occurs on full-length Htt in vivo, and that this modification affects the aggregation and pathogenic properties of Htt. Thus, therapeutic strategies that modulate these events could in turn affect Htt pathogenesis.	[Aiken, Charity T.; Lukacsovich, Tamas; Purcell, Judy M.; Menhaji, Kimia; Huang, Lan; Marsh, J. Lawrence] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Steffan, Joan S.; Simmons, Danielle; Zhu, Ya-Zhen; Thompson, Leslie Michels] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA; [Guerrero, Cortnie M.; Huang, Lan] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Khashwji, Hasan; Green, Kim; LaFerla, Frank; Thompson, Leslie Michels] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Thompson, Leslie Michels] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Marsh, J. Lawrence] Univ Calif Irvine, Dept Pathol, Irvine, CA 92697 USA; [Marsh, J. Lawrence] Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Marsh, JL (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, 4244 McGaugh Hall, Irvine, CA 92697 USA.	jlmarsh@uci.edu			National Institutes of Health [NS52789, HD36081, NS045283, T32GM0731130, GM-74830]; Optical Biology Shared Resource of the Cancer Center [CA-62203]; Hereditary Disease Foundation; Fox Family Foundation; High Q Foundation; Huntington's Disease Society of America Coalition for the Cure; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036081] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052789, R01NS045283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Optical Biology Shared Resource of the Cancer Center; Hereditary Disease Foundation; Fox Family Foundation; High Q Foundation; Huntington's Disease Society of America Coalition for the Cure; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS52789 (to L. M. T. and J. L. M.), HD36081 (to J. L. M.), NS045283 (to J. L. M. and L. M. T.), T32GM0731130 (to C. T. A.), and GM-74830 (to L. H.). This work was also supported by Optical Biology Shared Resource of the Cancer Center Support Grant CA-62203 at the University of California, Irvine, and grants from the Hereditary Disease Foundation (to J. S. S., L. M. T., and J. L. M.), the Fox Family Foundation (to J. S. S.), the High Q Foundation (to J. S. S., L. M. T., and J. L. M.), and the Huntington's Disease Society of America Coalition for the Cure (to L. M. T.).	Agrawal N, 2005, P NATL ACAD SCI USA, V102, P3777, DOI 10.1073/pnas.0500055102; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; BARNES GT, 1994, SOMAT CELL MOLEC GEN, V20, P87, DOI 10.1007/BF02290678; BAYER TA, 1992, DEVELOPMENT, V115, P421; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chalkley RJ, 2005, MOL CELL PROTEOMICS, V4, P1194, DOI 10.1074/mcp.D500002-MCP200; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Ehrlich ME, 2001, EXP NEUROL, V167, P215, DOI 10.1006/exnr.2000.7551; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; FLINTA C, 1986, EUR J BIOCHEM, V154, P193, DOI 10.1111/j.1432-1033.1986.tb09378.x; Franceschini N., 1972, PUPIL PSEUDOPUPIL CO; Gafni J, 2002, J NEUROSCI, V22, P4842, DOI 10.1523/JNEUROSCI.22-12-04842.2002; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Green KN, 2008, J NEUROSCI, V28, P11500, DOI 10.1523/JNEUROSCI.3203-08.2008; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; Hazeki N, 2000, BIOCHEM BIOPH RES CO, V277, P386, DOI 10.1006/bbrc.2000.3682; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; Hickey MA, 2008, NEUROSCIENCE, V157, P280, DOI 10.1016/j.neuroscience.2008.08.041; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; JAENISCH R, 1981, CELL, V24, P519, DOI 10.1016/0092-8674(81)90343-3; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Kalchman MA, 1996, J BIOL CHEM, V271, P19385, DOI 10.1074/jbc.271.32.19385; LACY E, 1983, CELL, V34, P343, DOI 10.1016/0092-8674(83)90369-0; Luo SQ, 2005, J CELL BIOL, V169, P647, DOI 10.1083/jcb.200412071; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; Marsh JL, 2003, HUM MOL GENET, V12, pR187, DOI 10.1093/hmg/ddg271; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; Pardo R, 2006, J NEUROSCI, V26, P1635, DOI 10.1523/JNEUROSCI.3706-05.2006; PERSICHETTI F, 1995, MOL MED, V1, P374, DOI 10.1007/BF03401575; Petersen BO, 1999, EMBO J, V18, P396, DOI 10.1093/emboj/18.2.396; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Quelo I, 2005, GENE EXPRESSION, V12, P151, DOI 10.3727/000000005783992070; Reimer T, 2003, J MOL BIOL, V330, P955, DOI 10.1016/S0022-2836(03)00713-7; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Schilling B, 2006, J BIOL CHEM, V281, P23686, DOI 10.1074/jbc.M513507200; Schilling G, 2007, J NEUROPATH EXP NEUR, V66, P313, DOI 10.1097/nen.0b013e318040b2c8; Schroeder MJ, 2005, J PROTEOME RES, V4, P1832, DOI 10.1021/pr0502020; SHERMAN F, 1985, BIOESSAYS, V3, P27, DOI 10.1002/bies.950030108; Simmons DA, 2009, P NATL ACAD SCI USA, V106, P4906, DOI 10.1073/pnas.0811228106; Sipione S, 2002, HUM MOL GENET, V11, P1953, DOI 10.1093/hmg/11.17.1953; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Tagwerker C, 2006, MOL CELL PROTEOMICS, V5, P737, DOI 10.1074/mcp.M500368-MCP200; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Warby SC, 2005, HUM MOL GENET, V14, P1569, DOI 10.1093/hmg/ddi165; Wolfgang WJ, 2005, P NATL ACAD SCI USA, V102, P11563, DOI 10.1073/pnas.0505321102; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	59	117	120	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29427	29436		10.1074/jbc.M109.013193	http://dx.doi.org/10.1074/jbc.M109.013193			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19710014	Green Published, hybrid			2022-12-27	WOS:000270896800024
J	Feng, YJ; Cronan, JE				Feng, Youjun; Cronan, John E.			Escherichia coli Unsaturated Fatty Acid Synthesis COMPLEX TRANSCRIPTION OF THE fabA GENE AND IN VIVO IDENTIFICATION OF THE ESSENTIAL REACTION CATALYZED BY FabB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-ACP THIOESTERASES; CARRIER PROTEIN THIOESTERASE; SUBSTRATE-SPECIFICITY; BIOSYNTHESIS; PLANT; EXPRESSION; DEHYDRASE; CLONING; FADR; PHOSPHOLIPIDS	Although the unsaturated fatty acid (UFA) synthetic pathway of Escherichia coli is the prototype of such pathways, several unresolved issues have accumulated over the years. The key players are the fabA and fabB genes. Earlier studies of fabA transcription showed that the gene was transcribed from two promoters, with one being positively regulated by the FadR protein. The other weaker promoter (which could not be mapped with the technology then available) was considered constitutive because its function was independent of FadR. However, the FabR negative regulator was recently shown to represses fabA transcription. We report that the weak promoter overlaps the FadR-dependent promoter and is regulated by FabR. This promoter is strictly conserved in all E. coli and Salmonella enterica genomes sequenced to date and is thought to provide insurance against inappropriate regulation of fabA transcription by exogenous saturated fatty acids. Also, the fabAup promoter, a mutant promoter previously isolated by selection for increased FabA activity, was shown to be a promoter created de novo by a four-base deletion within the gene located immediately upstream of fabA. Demonstration of the key UFA synthetic reaction catalyzed by FabB has been elusive, although it was known to catalyze an elongation reaction. Strains lacking FabB are UFA auxotrophs indicating that the enzyme catalyzes an essential step in UFA synthesis. Using thioesterases specific for hydrolysis of short chain acyl-ACPs, the intermediates of the UFA synthetic pathway have been followed in vivo for the first time. These experiments showed that a fabB mutant strain accumulated less cis-5-dodecenoic acid than the parental wild-type strain. These data indicate that the key reaction in UFA synthesis catalyzed by FabB is elongation of the cis-3-decenoyl-ACP produced by FabA.	[Cronan, John E.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, B103,Chem & Life Sci Lab,601 S Goodwin Ave, Urbana, IL 61801 USA.	j-cronan@life.uiuc.edu	Cronan, John/V-6626-2019; Feng, Youjun/I-4134-2012; Feng, Youjun/E-8386-2010		National Institutes of Health, NIAID [AI15650]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015650, R01AI015650] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI15650 from the NIAID.	[Anonymous], 2003, LIPID ANAL; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BATCHELOR JG, 1973, BIOCHEM BIOPH RES CO, V52, P1374, DOI 10.1016/0006-291X(73)90653-0; BLOCH K, 1971, ENZYMES, P441; Cho BK, 2006, MICROBIOL-SGM, V152, P2207, DOI 10.1099/mic.0.28912-0; Clark D. P., 2005, ECOSAL ESCHERICHIA C; CLARK DP, 1983, BIOCHEMISTRY-US, V22, P5897, DOI 10.1021/bi00294a032; Cronan JE, 1998, MOL MICROBIOL, V29, P937, DOI 10.1046/j.1365-2958.1998.00917.x; CRONAN JE, 1988, J BIOL CHEM, V263, P4641; CRONAN JE, 1973, J BIOL CHEM, V248, P1188; CRONAN JE, 1969, J BACTERIOL, V100, P601, DOI 10.1128/JB.100.2.601-604.1969; Cronan Jr. JE, 2008, ECOSAL ESCHERICHIA C; DAGNOLO G, 1975, J BIOL CHEM, V250, P5289; DIRUSSO CC, 1993, MOL MICROBIOL, V7, P311, DOI 10.1111/j.1365-2958.1993.tb01122.x; DORMANN P, 1995, ARCH BIOCHEM BIOPHYS, V316, P612, DOI 10.1006/abbi.1995.1081; Edwards P, 1997, FEBS LETT, V402, P62, DOI 10.1016/S0014-5793(96)01437-8; Feng YJ, 2008, J BACTERIOL, V190, P7567, DOI 10.1128/JB.01532-07; GARWIN JL, 1980, J BIOL CHEM, V255, P3263; GARWIN JL, 1980, J BIOL CHEM, V255, P1949; GELMANN EP, 1972, J BACTERIOL, V112, P381, DOI 10.1128/JB.112.1.381-387.1972; Ghosh SK, 2007, PLANT PHYSIOL BIOCH, V45, P887, DOI 10.1016/j.plaphy.2007.09.003; GUERRA DJ, 1990, ARCH BIOCHEM BIOPHYS, V280, P336, DOI 10.1016/0003-9861(90)90339-Z; HEATH RJ, 1995, J BIOL CHEM, V270, P26538, DOI 10.1074/jbc.270.44.26538; HENRY MF, 1992, CELL, V70, P671, DOI 10.1016/0092-8674(92)90435-F; HENRY MF, 1991, J MOL BIOL, V222, P843, DOI 10.1016/0022-2836(91)90574-P; Ismail IA., 1967, CHEM PHYS LIPIDS, V1, P376, DOI [10.1016/0009-3084(67)90015-1, DOI 10.1016/0009-3084(67)90015-1]; Jha JK, 2006, PLANT PHYSIOL BIOCH, V44, P645, DOI 10.1016/j.plaphy.2006.09.017; JONES A, 1995, PLANT CELL, V7, P359, DOI 10.1105/tpc.7.3.359; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu XF, 2008, METAB ENG, V10, P333, DOI 10.1016/j.ymben.2008.08.006; Mayer KM, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-1; McCue LA, 2001, NUCLEIC ACIDS RES, V29, P774, DOI 10.1093/nar/29.3.774; Miller J.H., 1972, EXPT MOL GENETICS; MORRIS LJ, 1965, J CHROMATOGR, V20, P27, DOI 10.1016/S0021-9673(01)97362-5; NUNN WD, 1983, J BACTERIOL, V154, P554, DOI 10.1128/JB.154.2.554-560.1983; Rock CO, 1996, BBA-LIPID LIPID MET, V1302, P1, DOI 10.1016/0005-2760(96)00056-2; Salas JJ, 2002, ARCH BIOCHEM BIOPHYS, V403, P25, DOI 10.1016/S0003-9861(02)00017-6; SILBERT DF, 1967, P NATL ACAD SCI USA, V58, P1579, DOI 10.1073/pnas.58.4.1579; SINGER M, 1989, MICROBIOL REV, V53, P1; Voelker T, 1996, Genet Eng (N Y), V18, P111; VOELKER TA, 1994, J BACTERIOL, V176, P7320, DOI 10.1128/JB.176.23.7320-7327.1994; VOELKER TA, 1992, SCIENCE, V257, P72, DOI 10.1126/science.1621095; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Wang HH, 2003, J BACTERIOL, V185, P4930, DOI 10.1128/JB.185.16.4930-4937.2003; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; YOSHIKAWA W, 1985, BIOCHIM BIOPHYS ACTA, V821, P277, DOI 10.1016/0005-2736(85)90097-5; YUAN L, 1995, P NATL ACAD SCI USA, V92, P10639, DOI 10.1073/pnas.92.23.10639; Zhang YM, 2002, J BIOL CHEM, V277, P15558, DOI 10.1074/jbc.M201399200; Zhao MZ, 1998, TETRAHEDRON LETT, V39, P5323, DOI 10.1016/S0040-4039(98)00987-3	49	139	154	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29526	29535		10.1074/jbc.M109.023440	http://dx.doi.org/10.1074/jbc.M109.023440			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19679654	Green Published, hybrid			2022-12-27	WOS:000270896800035
J	Huang, YW; Su, P; Liu, GY; Crow, MR; Chaukos, D; Yan, H; Robinson, LA				Huang, Yi-Wei; Su, Paul; Liu, Guang Ying; Crow, Min Rui; Chaukos, Deanna; Yan, Harry; Robinson, Lisa A.			Constitutive Endocytosis of the Chemokine CX(3)CL1 Prevents Its Degradation by Cell Surface Metalloproteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; AMYLOID-PRECURSOR-PROTEIN; ALPHA-CONVERTING-ENZYME; TRANSMEMBRANE CONDUCTANCE REGULATOR; COATED VESICLE FORMATION; FRACTALKINE CX3CL1; ENDOTHELIAL-CELLS; RECEPTOR-BINDING; SORTING SIGNALS; DYNAMIN	CX(3)CL1, a chemokine with transmembrane and soluble species, plays a key role in inflammation by acting as both chemoattractant and adhesion molecule. CX(3)CL1 is the only chemokine known to undergo constitutive internalization, raising the possibility that dynamic equilibrium between the endocytic compartment and the plasma membrane critically regulates the availability and processing of CX(3)CL1 at the cell surface. We therefore investigated how transmembrane CX(3)CL1 is internalized. Inhibition of dynamin using a nonfunctional allele or of clathrin using specific small interfering RNA prevented endocytosis of the chemokine in CX(3)CL1-expressing human ECV-304 cells. Perusal of the cytoplasmic domain of CX(3)CL1 revealed two putative adaptor protein-2 (AP-2)-binding motifs. Accordingly, CX(3)CL1 co-localized with AP-2 at the plasma membrane. We generated a mutant allele of CX(3)CL1 lacking the cytoplasmic tail. Deletion of the cytosolic tail precluded internalization of the chemokine. We used site-directed mutagenesis to disrupt AP-2-binding motifs, singly or in combination, which resulted in diminished internalization of CX(3)CL1. Although CX(3)CL1 was present in both superficial and endomembrane compartments, ADAM10 (a disintegrin and metalloprotease 10) and tumor necrosis factor-converting enzyme, the two metalloproteases that cleave CX(3)CL1, localized predominantly to the plasmalemma. Inhibition of endocytosis using the dynamin inhibitor, Dynasore, promoted rapid metalloprotease-dependent shedding of CX(3)CL1 from the cell surface into the surrounding medium. These findings indicate that the cytoplasmic tail of CX(3)CL1 facilitates its constitutive clathrin-mediated endocytosis. Such regulation enables intracellular storage of a sizable pool of presynthesized CX(3)CL1 that protects the chemokine from degradation by metalloproteases at the plasma membrane.	[Huang, Yi-Wei; Su, Paul; Liu, Guang Ying; Crow, Min Rui; Chaukos, Deanna; Yan, Harry; Robinson, Lisa A.] Hosp Sick Children, Res Inst, Cell Biol Program, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Robinson, LA (corresponding author), Hosp Sick Children, Res Inst, Cell Biol Program, 555 Univ Ave,Rm 5264, Toronto, ON M5G 1X8, Canada.	lisa.robinson@sickkids.ca			Heart and Stroke Foundation of Canada	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by an operating grant from the Heart and Stroke Foundation of Canada.	Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Altschuler Y, 2000, MOL BIOL CELL, V11, P819, DOI 10.1091/mbc.11.3.819; Barlic J, 1999, J BIOL CHEM, V274, P16287, DOI 10.1074/jbc.274.23.16287; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; Chapman GA, 2000, EUR J PHARMACOL, V392, P189, DOI 10.1016/S0014-2999(00)00117-5; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Doedens JR, 2000, J BIOL CHEM, V275, P14598, DOI 10.1074/jbc.275.19.14598; Durkan AM, 2007, J AM SOC NEPHROL, V18, P74, DOI 10.1681/ASN.2006080862; Fan GH, 2003, BLOOD, V101, P2115, DOI 10.1182/blood-2002-07-1965; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Fong AM, 2000, J BIOL CHEM, V275, P3781, DOI 10.1074/jbc.275.6.3781; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Grbovic OM, 2003, J BIOL CHEM, V278, P31261, DOI 10.1074/jbc.M304122200; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Gutwein P, 2002, FASEB J, V16, P292, DOI 10.1096/fj.02-0430fje; Haller C, 1998, EUR J CELL BIOL, V75, P353, DOI 10.1016/S0171-9335(98)80068-X; Harrison JK, 1999, J LEUKOCYTE BIOL, V66, P937, DOI 10.1002/jlb.66.6.937; Harrison JK, 2001, J BIOL CHEM, V276, P21632, DOI 10.1074/jbc.M010261200; Haskell CA, 2001, J CLIN INVEST, V108, P679, DOI 10.1172/JCI12976; Haskell CA, 2000, J BIOL CHEM, V275, P34183, DOI 10.1074/jbc.M005731200; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hermand P, 2008, J BIOL CHEM, V283, P30225, DOI 10.1074/jbc.M802638200; Hughes SE, 1996, EXP CELL RES, V225, P171, DOI 10.1006/excr.1996.0168; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Inoue A, 2005, ARTHRITIS RHEUM-US, V52, P1522, DOI 10.1002/art.21007; JING SQ, 1990, J CELL BIOL, V110, P283, DOI 10.1083/jcb.110.2.283; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Liu GY, 2005, J BIOL CHEM, V280, P19858, DOI 10.1074/jbc.M413073200; Ludwig A, 2002, J IMMUNOL, V168, P604, DOI 10.4049/jimmunol.168.2.604; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; McDermott DH, 2003, J CLIN INVEST, V111, P1241, DOI 10.1172/JCI200316790; McDermott DH, 2001, CIRC RES, V89, P401, DOI 10.1161/hh1701.095642; Mero P, 2006, J BIOL CHEM, V281, P33242, DOI 10.1074/jbc.M605372200; Mizoue LS, 2001, J BIOL CHEM, V276, P33906, DOI 10.1074/jbc.M101348200; Moatti D, 2001, BLOOD, V97, P1925, DOI 10.1182/blood.V97.7.1925; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Muehlhoefer A, 2000, J IMMUNOL, V164, P3368, DOI 10.4049/jimmunol.164.6.3368; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Otero C, 2006, J IMMUNOL, V177, P2314, DOI 10.4049/jimmunol.177.4.2314; Pietrzyk MC, 2004, TRANSPLANT P, V36, P2659, DOI 10.1016/j.transproceed.2004.09.029; Robinson LA, 2000, J IMMUNOL, V165, P6067, DOI 10.4049/jimmunol.165.11.6067; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rodionov DG, 1998, J BIOL CHEM, V273, P6005, DOI 10.1074/jbc.273.11.6005; Rohde G, 2002, J CELL BIOL, V158, P209, DOI 10.1083/jcb.200203103; Schulte A, 2007, BIOCHEM BIOPH RES CO, V358, P233, DOI 10.1016/j.bbrc.2007.04.100; Signoret N, 2005, MOL BIOL CELL, V16, P902, DOI 10.1091/mbc.e04-08-0687; Signoret N, 2004, TRAFFIC, V5, P529, DOI 10.1111/j.1600-0854.2004.00200.x; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; Stoeck A, 2006, BIOCHEM J, V393, P609, DOI 10.1042/BJ20051013; Sun TX, 2002, AM J PHYSIOL-RENAL, V282, pF998, DOI 10.1152/ajprenal.00257.2001; TAKAHASHI K, 1990, IN VITRO CELL DEV, V25, P265; TAKAHASI K, 1992, IN VITRO CELL DEV-AN, V28A, P380; Terebiznik MR, 2002, NAT CELL BIOL, V4, P766, DOI 10.1038/ncb854; Teupser D, 2004, P NATL ACAD SCI USA, V101, P17795, DOI 10.1073/pnas.0408096101; Tsou CL, 2001, J BIOL CHEM, V276, P44622, DOI 10.1074/jbc.M107327200; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Walcheck B, 2006, EUR J IMMUNOL, V36, P968, DOI 10.1002/eji.200535257; Weixel KM, 2001, J BIOL CHEM, V276, P46251, DOI 10.1074/jbc.M104545200; Weixel KM, 2000, J BIOL CHEM, V275, P3655, DOI 10.1074/jbc.275.5.3655; Yang W, 1999, J BIOL CHEM, V274, P11328, DOI 10.1074/jbc.274.16.11328; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066	70	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29644	29653		10.1074/jbc.M109.045682	http://dx.doi.org/10.1074/jbc.M109.045682			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19723636	Green Published, hybrid			2022-12-27	WOS:000270896800046
J	Maghzal, GJ; Leck, MC; Collinson, E; Li, C; Stocker, R				Maghzal, Ghassan J.; Leck, Meng-Choo; Collinson, Emma; Li, Cheng; Stocker, Roland			Limited Role for the Bilirubin-Biliverdin Redox Amplification Cycle in the Cellular Antioxidant Protection by Biliverdin Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR PHYSIOLOGICAL CYTOPROTECTANT; ALBUMIN-BOUND BILIRUBIN; HUMAN-BLOOD-PLASMA; OXIDATIVE STRESS; HEME OXYGENASE-1; SACCHAROMYCES-CEREVISIAE; CONJUGATED BILIRUBIN; LIPID-PEROXIDATION; BILE-PIGMENTS; METABOLISM	In mammalian cells, heme is degraded by heme oxygenase to biliverdin, which is then reduced to bilirubin by biliverdin reductase (BVR). Both bile pigments have reducing properties, and bilirubin is now generally considered to be a potent antioxidant, yet it remains unclear how it protects cells against oxidative damage. A presently popular explanation for the antioxidant function of bilirubin is a redox cycle in which bilirubin is oxidized to biliverdin and then recycled by BVR. Here, we re-examined this putative BVR-mediated redox cycle. We observed that lipid peroxidation-mediated oxidation of bilirubin in chloroform, a model of cell membrane-bound bilirubin, did not yield biliverdin, a prerequisite for the putative redox cycle. Similarly, H2O2 did not oxidize albumin-bound bilirubin to biliverdin, and in vitro oxidation of albumin or ligandin-bound bilirubin by peroxyl radicals gave modest yields of biliverdin. In addition, decreasing cellular BVR protein and activity in HeLa cells using RNA interference did not alter H2O2-mediated cell death, just as BVR overexpression failed to enhance protection of these cells against H2O2-mediated damage, irrespective of whether bilirubin or biliverdin were added to the cells as substrate for the putative redox cycle. Similarly, transformation of human BVR into hmx1 (heme oxygenase) mutant yeast did not provide protection against H2O2 toxicity above that seen in hmx1 mutant yeast expressing human heme oxygenase-1. Together, these results argue against the BVR-mediated redox cycle playing a general or important role as cellular antioxidant defense mechanism.	[Stocker, Roland] Univ Sydney, Sch Med Sci Pathol, Ctr Vasc Res, Camperdown, NSW 2006, Australia; Univ Sydney, Sydney Med Sch, Bosch Inst, Camperdown, NSW 2006, Australia	University of Sydney; University of Sydney	Stocker, R (corresponding author), Univ Sydney, Sch Med Sci Pathol, Ctr Vasc Res, Med Fdn Bldg K25,92-94 Parramatta Rd, Camperdown, NSW 2006, Australia.	rstocker@med.usyd.edu.au	Stocker, Roland/AAV-4489-2021; maghzal, ghassan/A-9692-2015		National Health and Medical Research Council (NHMRC) [570861]; Australian Research Council Discovery Project [DP 0344964]; University of Sydney Professorial Fellowship; University of Sydney Medical Foundation	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Discovery Project(Australian Research Council); University of Sydney Professorial Fellowship(University of Sydney); University of Sydney Medical Foundation(University of Sydney)	This work was supported by National Health and Medical Research Council (NHMRC) Program Grant 570861 (to R. S.) and, in part, by Australian Research Council Discovery Project Grant DP 0344964 (to R. S.).; Supported by a NHMRC postgraduate scholarship.; Supported by a NHMRC Senior Principal Research Fellowship, a University of Sydney Professorial Fellowship, and the University of Sydney Medical Foundation.	ABERG F, 1992, ARCH BIOCHEM BIOPHYS, V295, P230, DOI 10.1016/0003-9861(92)90511-T; Ahmad Z, 2002, J BIOL CHEM, V277, P9226, DOI 10.1074/jbc.M108239200; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; BERNHARD K, 1954, HELV CHIM ACTA, V37, P306, DOI 10.1002/hlca.19540370139; BONNETT R, 1978, PROC R SOC SER B-BIO, V202, P249, DOI 10.1098/rspb.1978.0066; BRODERSEN R, 1979, CRC CR REV CL LAB SC, V11, P305; Dallner G, 2000, FREE RADICAL BIO MED, V29, P285, DOI 10.1016/S0891-5849(00)00307-5; De Matteis F, 2006, RAPID COMMUN MASS SP, V20, P1209, DOI 10.1002/rcm.2431; DENNERY PA, 1995, FREE RADICAL BIO MED, V19, P395, DOI 10.1016/0891-5849(95)00032-S; Djousse L, 2001, AM J CARDIOL, V87, P1196, DOI 10.1016/S0002-9149(01)01494-1; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; FEVERY J, 1977, BIOCHEM J, V164, P737, DOI 10.1042/bj1640737; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748; GOLLAN JL, 1982, PROG LIVER DIS, V7, P261; HSIEH YZ, 1988, J AM CHEM SOC, V110, P62, DOI 10.1021/ja00209a009; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; KAUFMANN HP, 1961, FETT SEIFEN ANSTR, V63, P334; Kim D, 2006, BIOCHEMISTRY-US, V45, P14772, DOI 10.1021/bi061429r; Kravets A, 2004, J BIOL CHEM, V279, P19916, DOI 10.1074/jbc.M314251200; KUTTY RK, 1984, BIOCHEM BIOPH RES CO, V122, P40, DOI 10.1016/0006-291X(84)90436-4; Lerner-Marmarosh N, 2005, P NATL ACAD SCI USA, V102, P7109, DOI 10.1073/pnas.0502173102; Liu YR, 2006, FREE RADICAL BIO MED, V40, P960, DOI 10.1016/j.freeradbiomed.2005.07.021; Maines MD, 2007, ANTIOXID REDOX SIGN, V9, P2187, DOI 10.1089/ars.2007.1805; Maines MD, 2005, PHYSIOLOGY, V20, P382, DOI 10.1152/physiol.00029.2005; May JM, 2001, FREE RADICAL BIO MED, V31, P117, DOI 10.1016/S0891-5849(01)00566-4; McDonagh A. F., 1979, PORPHYRINS, VVI; MCDONAGH AF, 1971, BIOCHEM BIOPH RES CO, V44, P1306, DOI 10.1016/S0006-291X(71)80228-0; MCDONAGH AF, 1972, BIOCHEM J, V129, P797, DOI 10.1042/bj1290797; Minetti M, 1998, ARCH BIOCHEM BIOPHYS, V352, P165, DOI 10.1006/abbi.1998.0584; Miralem T, 2005, J BIOL CHEM, V280, P17084, DOI 10.1074/jbc.M413121200; NEUZIL J, 1994, J BIOL CHEM, V269, P16712; NOGALES D, 1995, J BIOL CHEM, V270, P73, DOI 10.1074/jbc.270.1.73; OSTROW JD, 1961, J CLIN INVEST, V40, P1442, DOI 10.1172/JCI104375; Protchenko O, 2003, J BIOL CHEM, V278, P36582, DOI 10.1074/jbc.M306584200; REED GA, 1985, PROSTAGLANDINS, V30, P153, DOI 10.1016/S0090-6980(85)80019-8; Sedlak TW, 2009, P NATL ACAD SCI USA, V106, P5171, DOI 10.1073/pnas.0813132106; SINGLETON JW, 1965, J BIOL CHEM, V240, P4780; STOCKER R, 1990, METHOD ENZYMOL, V186, P301; Stocker R, 2004, ANTIOXID REDOX SIGN, V6, P841, DOI 10.1089/1523086041797999; STOCKER R, 1987, P NATL ACAD SCI USA, V84, P5918, DOI 10.1073/pnas.84.16.5918; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; STOCKER R, 1989, FREE RADICAL RES COM, V6, P57, DOI 10.3109/10715768909073428; STOCKER R, 1987, P NATL ACAD SCI USA, V84, P8130, DOI 10.1073/pnas.84.22.8130; STOCKER R, 1988, MED BIOCH CHEM ASPEC, P465; Tarpey MM, 2001, CIRC RES, V89, P224, DOI 10.1161/hh1501.094365; Vitek L, 2002, ATHEROSCLEROSIS, V160, P449, DOI 10.1016/S0021-9150(01)00601-3; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0	47	80	81	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29251	29259		10.1074/jbc.M109.037119	http://dx.doi.org/10.1074/jbc.M109.037119			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19690164	hybrid, Green Published			2022-12-27	WOS:000270896800004
J	Baron, D; LaBelle, E; Coursolle, D; Gralnick, JA; Bond, DR				Baron, Daniel; LaBelle, Edward; Coursolle, Dan; Gralnick, Jeffrey A.; Bond, Daniel R.			Electrochemical Measurement of Electron Transfer Kinetics by Shewanella oneidensis MR-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE CYTOCHROMES MTRC; METAL-REDUCING BACTERIUM; C-TYPE CYTOCHROMES; ANAEROBIC RESPIRATION; PUTREFACIENS MR-1; IRON REDUCTION; FE(III)-REDUCING BACTERIUM; DISSIMILATORY FE(III); OMCA; PROTEIN	Shewanella oneidensis strain MR-1 can respire using carbon electrodes and metal oxyhydroxides as electron acceptors, requiring mechanisms for transferring electrons from the cell interior to surfaces located beyond the cell. Although purified outer membrane cytochromes will reduce both electrodes and metals, S. oneidensis also secretes flavins, which accelerate electron transfer to metals and electrodes. We developed techniques for detecting direct electron transfer by intact cells, using turnover and single turnover voltammetry. Metabolically active cells attached to graphite electrodes produced thin (submonolayer) films that demonstrated both catalytic and reversible electron transfer in the presence and absence of flavins. In the absence of soluble flavins, electron transfer occurred in a broad potential window centered at similar to 0 V (versus standard hydrogen electrode), and was altered in single (Delta omcA, Delta mtrC) and double deletion (Delta omcA/Delta mtrC) mutants of outer membrane cytochromes. The addition of soluble flavins at physiological concentrations significantly accelerated electron transfer and allowed catalytic electron transfer to occur at lower applied potentials (- 0.2 V). Scan rate analysis indicated that rate constants for direct electron transfer were slower than those reported for pure cytochromes (similar to 1 s(-1)). These observations indicated that anodic current in the higher (> 0 V) window is due to activation of a direct transfer mechanism, whereas electron transfer at lower potentials is enabled by flavins. The electrochemical dissection of these activities in living cells into two systems with characteristic midpoint potentials and kinetic behaviors explains prior observations and demonstrates the complementary nature of S. oneidensis electron transfer strategies.	[Bond, Daniel R.] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA; [Coursolle, Dan] Univ Minnesota, Dept Biochem Biophys & Mol Biol, St Paul, MN 55108 USA; [Gralnick, Jeffrey A.; Bond, Daniel R.] Univ Minnesota, Dept Microbiol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bond, DR (corresponding author), Univ Minnesota, Inst Biotechnol, 140 Gortner,1479 Gortner Ave, St Paul, MN 55108 USA.	dbond@umn.edu		Bond, Daniel/0000-0001-8083-7107	National Institutes of Health [2T32-GM008347-16]; Office of Naval Research [N000140810166, N000140810162]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2T32-GM008347-16 (to D. C.). This work was also supported by Office of Naval Research Grants N000140810166 (to J. A. G.) and N000140810162 (to D. R. B.).	Armstrong FA, 2005, CURR OPIN CHEM BIOL, V9, P110, DOI 10.1016/j.cbpa.2005.02.011; Armstrong FA, 1999, BIOCHEM SOC T, V27, P206, DOI 10.1042/bst0270206; Armstrong FA, 2000, FARADAY DISCUSS, V116, P191, DOI 10.1039/b002290j; Armstrong FA, 1997, CHEM SOC REV, V26, P169, DOI 10.1039/cs9972600169; Bard A. J., 2001, ELECTROCHEMICAL METH; Baymann F, 2003, FEBS LETT, V539, P91, DOI 10.1016/S0014-5793(03)00206-0; Blanford CF, 2006, J SOLID STATE ELECTR, V10, P826, DOI 10.1007/s10008-006-0183-2; Bonneville S, 2006, GEOCHIM COSMOCHIM AC, V70, P5842, DOI 10.1016/j.gca.2006.04.029; Busalmen JP, 2008, ANGEW CHEM INT EDIT, V47, P4874, DOI 10.1002/anie.200801310; Busalmen JP, 2008, ENVIRON SCI TECHNOL, V42, P2445, DOI 10.1021/es702569y; Dumas C, 2008, ELECTROCHIM ACTA, V53, P5235, DOI 10.1016/j.electacta.2008.02.056; Eggleston CM, 2008, INORG CHIM ACTA, V361, P769, DOI 10.1016/j.ica.2007.07.015; El-Naggar MY, 2008, BIOPHYS J, V95, pL10, DOI 10.1529/biophysj.108.134411; Firer-Sherwood M, 2008, J BIOL INORG CHEM, V13, P849, DOI 10.1007/s00775-008-0398-z; Fourmond V, 2009, BIOELECTROCHEMISTRY, V76, P141, DOI 10.1016/j.bioelechem.2009.02.010; Fricke K, 2008, ENERG ENVIRON SCI, V1, P144, DOI 10.1039/b802363h; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Gralnick JA, 2007, MOL MICROBIOL, V65, P1, DOI 10.1111/j.1365-2958.2007.05778.x; Haas JR, 2002, ENVIRON SCI TECHNOL, V36, P373, DOI 10.1021/es0109287; Hartshorne RS, 2007, J BIOL INORG CHEM, V12, P1083, DOI 10.1007/s00775-007-0278-y; Hau HH, 2008, APPL ENVIRON MICROB, V74, P6880, DOI 10.1128/AEM.00840-08; Heering HA, 1998, J PHYS CHEM B, V102, P6889, DOI 10.1021/jp981023r; Heering HA, 1997, J AM CHEM SOC, V119, P11628, DOI 10.1021/ja9723242; Hirst J, 1996, J AM CHEM SOC, V118, P5031, DOI 10.1021/ja9534361; Hirst J, 1998, J AM CHEM SOC, V120, P7085, DOI 10.1021/ja980380c; Jeuken LJC, 2002, J AM CHEM SOC, V124, P5702, DOI 10.1021/ja012638w; Kerisit S, 2007, J PHYS CHEM C, V111, P11363, DOI 10.1021/jp072060y; Kim BH, 1999, BIOTECHNOL TECH, V13, P475, DOI 10.1023/A:1008993029309; Kim BH, 1999, J MICROBIOL BIOTECHN, V9, P127; Kim HJ, 1999, J MICROBIOL BIOTECHN, V9, P365; Kim HJ, 2002, ENZYME MICROB TECH, V30, P145, DOI 10.1016/S0141-0229(01)00478-1; LAVIRON E, 1979, J ELECTROANAL CHEM, V101, P19, DOI 10.1016/S0022-0728(79)80075-3; Lies DP, 2005, APPL ENVIRON MICROB, V71, P4414, DOI 10.1128/AEM.71.8.4414-4426.2005; Lovley DR, 2004, ADV MICROB PHYSIOL, V49, P219, DOI 10.1016/S0065-2911(04)49005-5; Lower BH, 2007, J BACTERIOL, V189, P4944, DOI 10.1128/JB.01518-06; Marshall MJ, 2006, PLOS BIOL, V4, P1324, DOI 10.1371/journal.pbio.0040268; Marsili E, 2008, APPL ENVIRON MICROB, V74, P7329, DOI 10.1128/AEM.00177-08; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Murphy JN, 2007, J BACTERIOL, V189, P2283, DOI 10.1128/JB.01698-06; Myers JM, 1998, BBA-BIOMEMBRANES, V1373, P237, DOI 10.1016/S0005-2736(98)00111-4; Myers JM, 2001, APPL ENVIRON MICROB, V67, P260, DOI 10.1128/AEM.67.1.260-269.2001; Myers JM, 2000, J BACTERIOL, V182, P67, DOI 10.1128/JB.182.1.67-75.2000; Nealson KH, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P1133, DOI 10.1007/0-387-30746-x_45; NEALSON KH, 1994, ANNU REV MICROBIOL, V48, P311, DOI 10.1146/annurev.mi.48.100194.001523; Newman DK, 2000, NATURE, V405, P94, DOI 10.1038/35011098; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; Richter H, 2009, ENERG ENVIRON SCI, V2, P506, DOI 10.1039/b816647a; Ross DE, 2007, APPL ENVIRON MICROB, V73, P5797, DOI 10.1128/AEM.00146-07; Ross DE, 2009, APPL ENVIRON MICROB, V75, P5218, DOI 10.1128/AEM.00544-09; Ruebush SS, 2006, APPL ENVIRON MICROB, V72, P2925, DOI 10.1128/AEM.72.4.2925-2935.2006; Shi L, 2006, J BACTERIOL, V188, P4705, DOI 10.1128/JB.01966-05; Shi L, 2008, J BACTERIOL, V190, P5512, DOI 10.1128/JB.00514-08; Shi L, 2007, MOL MICROBIOL, V65, P12, DOI 10.1111/j.1365-2958.2007.05783.x; Srikanth S, 2008, BIOTECHNOL BIOENG, V99, P1065, DOI 10.1002/bit.21671; Taillefert M, 2007, J INORG BIOCHEM, V101, P1760, DOI 10.1016/j.jinorgbio.2007.07.020; von Canstein H, 2008, APPL ENVIRON MICROB, V74, P615, DOI 10.1128/AEM.01387-07; Wang ZM, 2008, APPL ENVIRON MICROB, V74, P6746, DOI 10.1128/AEM.01454-08; Wigginton NS, 2007, J PHYS CHEM B, V111, P12857, DOI 10.1021/jp0718698; Xing DF, 2008, ENVIRON SCI TECHNOL, V42, P4146, DOI 10.1021/es800312v; Xiong YJ, 2006, J AM CHEM SOC, V128, P13978, DOI 10.1021/ja063526d; Zhang HZ, 2008, J PROTEOME RES, V7, P1712, DOI 10.1021/pr7007658	61	212	216	6	158	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28865	28873		10.1074/jbc.M109.043455	http://dx.doi.org/10.1074/jbc.M109.043455			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19661057	Green Published, hybrid			2022-12-27	WOS:000270678900043
J	Crawford, NPS; Yang, HL; Mattaini, KR; Hunter, KW				Crawford, Nigel P. S.; Yang, Hailiu; Mattaini, Katherine R.; Hunter, Kent W.			The Metastasis Efficiency Modifier Ribosomal RNA Processing 1 Homolog B (RRP1B) Is a Chromatin-associated Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROMODOMAIN PROTEIN BRD4; TRANSGENIC MOUSE MODEL; BREAST-CANCER SURVIVAL; EXPRESSION SIGNATURE; IDENTIFICATION; NUCLEOPHOSMIN; POLYMORPHISMS; TRANSCRIPTION; LOCALIZATION; PROGRESSION	There is accumulating evidence for a role of germ line variation in breast cancer metastasis. We have recently identified a novel metastasis susceptibility gene, Rrp1b (ribosomal RNA processing 1 homolog B). Overexpression of Rrp1b in a mouse mammary tumor cell line induces a gene expression signature that predicts survival in breast cancer. Here we extend the analysis of RRP1B function by demonstrating that the Rrp1b activation gene expression signature accurately predicted the outcome in three of four publicly available breast carcinoma gene expression data sets. In addition, we provide insights into the mechanism of RRP1B. Tandem affinity purification demonstrated that RRP1B physically interacts with many nucleosome binding factors, including histone H1X, poly(ADP-ribose) polymerase 1, TRIM28 (tripartite motif-containing 28), and CSDA (cold shock domain protein A). Co-immunofluorescence and co-immunoprecipitation confirmed these interactions and also interactions with heterochromatin protein-1 alpha and acetyl-histone H4 lysine 5. Finally, we investigated the effects of ectopic expression of an RRP1B allelic variant previously associated with improved survival in breast cancer. Gene expression analyses demonstrate that, compared with ectopic expression of wild type RRP1B in HeLa cells, the variant RRP1B differentially modulates various transcription factors controlled by TRIM28 and CSDA. These data suggest that RRP1B, a tumor progression and metastasis susceptibility candidate gene, is potentially a dynamic modulator of transcription and chromatin structure.	[Hunter, Kent W.] NCI, Lab Canc Biol & Genet, CCR, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hunter, KW (corresponding author), NCI, Lab Canc Biol & Genet, CCR, NIH, Bldg 37,Rm 5046,37 Convent Dr, Bethesda, MD 20892 USA.	hunter@mail.nih.gov			National Institutes of Health; NCI; Center for Cancer Research; Intramural Research Program; NATIONAL CANCER INSTITUTE [ZIABC011255] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200366] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by the National Institutes of Health, NCI, Center for Cancer Research, Intramural Research Program.	ANDERSON DF, 2002, INT J COMMUTATIVE RI, V1, P11; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Crawford NPS, 2008, CLIN EXP METASTAS, V25, P357, DOI 10.1007/s10585-008-9146-6; Crawford NPS, 2007, PLOS GENET, V3, P2296, DOI 10.1371/journal.pgen.0030214; Crawford NPS, 2008, P NATL ACAD SCI USA, V105, P6380, DOI 10.1073/pnas.0710331105; Crawford NPS, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1389; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; DUMBAR TS, 1989, BIOCHEMISTRY-US, V28, P9495, DOI 10.1021/bi00450a037; Farina A, 2004, MOL CELL BIOL, V24, P9059, DOI 10.1128/MCB.24.20.9059-9069.2004; Gingras AC, 2005, MOL CELL PROTEOMICS, V4, P1725, DOI 10.1074/mcp.M500231-MCP200; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Gurumurthy M, 2008, J MOL BIOL, V378, P302, DOI 10.1016/j.jmb.2008.02.055; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Ho J, 2009, J PROTEOME RES, V8, P583, DOI 10.1021/pr8007368; Horsey EW, 2004, RNA, V10, P813, DOI 10.1261/rna.5255804; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Jing Z, 2004, J BIOCHEM MOL BIOL, V37, P663; Lifsted T, 1998, INT J CANCER, V77, P640, DOI 10.1002/(SICI)1097-0215(19980812)77:4<640::AID-IJC26>3.0.CO;2-8; Lukes L, 2009, CANCER RES, V69, P310, DOI 10.1158/0008-5472.CAN-08-3520; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; MUCENSKI ML, 1986, MOL CELL BIOL, V6, P4236, DOI 10.1128/MCB.6.12.4236; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Park YG, 2005, NAT GENET, V37, P1055, DOI 10.1038/ng1635; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Peralta-Leal A, 2008, CLIN TRANSL ONCOL, V10, P318, DOI 10.1007/s12094-008-0207-8; Pollard AJ, 2002, J BIOL CHEM, V277, P15241, DOI 10.1074/jbc.M109046200; Rae JM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1842; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Skotheim RI, 2007, INT J BIOCHEM CELL B, V39, P1432, DOI 10.1016/j.biocel.2007.02.016; Storck Sebastien, 2007, Subcell Biochem, V41, P125; Tobita H, 2006, INT J ONCOL, V29, P673; Tuteja R, 1998, CRIT REV BIOCHEM MOL, V33, P407, DOI 10.1080/10409239891204260; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vecerova J, 2004, MOL BIOL CELL, V15, P4904, DOI 10.1091/mbc.E04-07-0645; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Yang HY, 2005, CLIN EXP METASTAS, V22, P593, DOI 10.1007/s10585-005-6244-6; Yang HY, 2004, CLIN EXP METASTAS, V21, P719, DOI 10.1007/s10585-004-8251-4; Ye Q, 1996, J BIOL CHEM, V271, P14653, DOI 10.1074/jbc.271.25.14653; Zhou Mi, 2004, In Silico Biol, V4, P323	45	26	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28660	28673		10.1074/jbc.M109.023457	http://dx.doi.org/10.1074/jbc.M109.023457			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19710015	Green Published, hybrid			2022-12-27	WOS:000270678900021
J	Gayen, JR; Saberi, M; Schenk, S; Biswas, N; Vaingankar, SM; Cheung, WW; Najjar, SM; O'Connor, DT; Bandyopadhyay, G; Mahata, SK				Gayen, Jiaur R.; Saberi, Maziyar; Schenk, Simon; Biswas, Nilima; Vaingankar, Sucheta M.; Cheung, Wai W.; Najjar, Sonia M.; O'Connor, Daniel T.; Bandyopadhyay, Gautam; Mahata, Sushil K.			A Novel Pathway of Insulin Sensitivity in Chromogranin A Null Mice A CRUCIAL ROLE FOR PANCREASTATIN IN GLUCOSE HOMEOSTASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; RAT SKELETAL-MUSCLE; C-TERMINAL FRAGMENT; RECEPTOR SUBSTRATE-1; DIABETES-MELLITUS; HEPATOCYTES; RESISTANCE; ADIPONECTIN; CELLS	Chromogranin A (CHGA/Chga), a proprotein, widely distributed in endocrine and neuroendocrine tissues (not expressed in muscle, liver, and adipose tissues), generates at least four bioactive peptides. One of those peptides, pancreastatin (PST), has been reported to interfere with insulin action. We generated a Chga knock-out (KO) mouse by the targeted deletion of the Chga gene in neuroendocrine tissues. KO mice displayed hypertension, higher plasma catecholamine, and adipokine levels and lower IL-6 and lipid levels compared with wild type mice. Liver glycogen content was elevated, but the nitric oxide (NO) level was diminished. Glucose, insulin, and pyruvate tolerance tests and hyperinsulinemic-euglycemic clamp studies established increased insulin sensitivity in liver but decreased glucose disposal in muscle. Despite higher catecholamine and ketone body levels and muscle insulin resistance, KO mice maintained euglycemia due to increased liver insulin sensitivity. Suppressed mRNA abundance of phosphoenolpyruvate carboxykinase and glucose-6-phosphatase (G6Pase) in KO mice further support this conclusion. PST administration in KO mice stimulated phosphoenolpyruvate carboxykinase and G6Pase mRNA abundance and raised the blood glucose level. In liver cells transfected with G6Pase promoter, PST caused transcriptional activation in a protein kinase C (PKC)-and NO synthase-dependent manner. Thus, PST action may be mediated by suppressing IRS1/2-phosphatidylinositol 3-kinase-Akt-FOXO-1 signaling and insulin-induced maturation of SREBP1c by PKC and a high level of NO. The combined effects of conventional PKC and endothelial NO synthase activation by PST can suppress insulin signaling. The rise in blood PST level with age and in diabetes suggests that PST is a negative regulator of insulin sensitivity and glucose homeostasis.	[Gayen, Jiaur R.; Saberi, Maziyar; Schenk, Simon; Biswas, Nilima; Vaingankar, Sucheta M.; O'Connor, Daniel T.; Bandyopadhyay, Gautam; Mahata, Sushil K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Cheung, Wai W.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [O'Connor, Daniel T.] Univ Calif San Diego, Dept Mol Genet, La Jolla, CA 92093 USA; [O'Connor, Daniel T.; Mahata, Sushil K.] Vet Affairs San Diego Healthcare Syst, La Jolla, CA USA; [Najjar, Sonia M.] Univ Toledo, Coll Med, Ctr Diabet & Endocrine Res, Toledo, OH 43614 USA; [Najjar, Sonia M.] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Toledo, OH 43614 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Mahata, SK (corresponding author), Univ Calif San Diego, Sch Med, Dept Med 0838, 9500 Gilman Dr, La Jolla, CA 92093 USA.	smahata@ucsd.edu	Mahata, Sushil/AAF-8781-2021; Najjar, Sonia M/GXW-2217-2022	Schenk, Simon/0000-0002-8224-3203	National Institutes of Health [R01 DA011311, DK60702, P01 HL58120, U01 HL69758, DK54254]; Department of Veterans Affairs; United States Department of Agriculture [USDA 38903-02315]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058120, U01HL069758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054254, R01DK060702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DA011311 (to S. K. M.), DK60702 (to D. T. O.), P01 HL58120 and U01 HL69758 (to S. K. M. and D. T. O.), and DK54254 (to S. M. N.). This work was also supported by grants from the Department of Veterans Affairs (to S. K. M. and D. T. O.) and United States Department of Agriculture Grant USDA 38903-02315 (to S. M. N.).	AARDAL S, 1993, J NEUROENDOCRINOL, V5, P405, DOI 10.1111/j.1365-2826.1993.tb00501.x; Ahren B, 1996, ACTA PHYSIOL SCAND, V158, P63, DOI 10.1046/j.1365-201X.1996.525291000.x; Azzout-Marniche D, 2000, BIOCHEM J, V350, P389, DOI 10.1042/0264-6021:3500389; BACKER JM, 1992, J BIOL CHEM, V267, P1367; Bastard JP, 2000, J CLIN ENDOCR METAB, V85, P3338, DOI 10.1210/jc.85.9.3338; Carvalho MA, 2005, DIABETES, V54, P959, DOI 10.2337/diabetes.54.4.959; Ceddia RB, 2005, DIABETOLOGIA, V48, P132, DOI 10.1007/s00125-004-1609-y; Chakravarty K, 2007, NUTR REV, V65, pS47, DOI [10.1111/j.1753-4887.2007.tb00328.x, 10.1301/nr.2007.jun.S47-S56]; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; Cook S, 2004, DIABETES, V53, P2067, DOI 10.2337/diabetes.53.8.2067; EFENDIC S, 1987, P NATL ACAD SCI USA, V84, P7257, DOI 10.1073/pnas.84.20.7257; Finn PF, 2006, NUTRITION, V22, P830, DOI 10.1016/j.nut.2006.04.008; Fleischmann M, 2000, BIOCHEM J, V349, P13, DOI 10.1042/bj3490013; Fujimoto M, 2005, DIABETES, V54, P1340, DOI 10.2337/diabetes.54.5.1340; FUNAKOSHI A, 1990, REGUL PEPTIDES, V30, P159, DOI 10.1016/0167-0115(90)90056-3; Gonzalez-Yanes C, 1999, BBA-MOL CELL RES, V1451, P153, DOI 10.1016/S0167-4889(99)00084-1; Gonzalez-Yanes C, 2000, DIABETES, V49, P1288, DOI 10.2337/diabetes.49.8.1288; Hertelendy ZI, 1996, CELL CALCIUM, V19, P125, DOI 10.1016/S0143-4160(96)90081-0; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Higaki Y, 2001, DIABETES, V50, P241, DOI 10.2337/diabetes.50.2.241; Joost HG, 2007, ENDOCRINOLOGY, V148, P4545, DOI 10.1210/en.2007-0866; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; KARNIELI E, 1981, J BIOL CHEM, V256, P4772; Li HY, 2008, AM J HYPERTENS, V21, P471, DOI 10.1038/ajh.2008.5; Lira VA, 2007, AM J PHYSIOL-ENDOC M, V293, pE1062, DOI 10.1152/ajpendo.00045.2007; Ma HT, 1996, REGUL PEPTIDES, V61, P143, DOI 10.1016/0167-0115(95)00160-3; Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354; Mahata SK, 1997, J CLIN INVEST, V100, P1623, DOI 10.1172/JCI119686; Matsumoto M, 2002, DIABETES, V51, P1672, DOI 10.2337/diabetes.51.6.1672; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; O'Connor DT, 2005, J CLIN ENDOCR METAB, V90, P5414, DOI 10.1210/jc.2005-0408; Osei K, 2007, METABOLISM, V56, P24, DOI 10.1016/j.metabol.2006.08.018; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Poy MN, 2002, NAT GENET, V30, P270, DOI 10.1038/ng840; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Roden M, 2008, WIEN MED WOCHENSCHR, V158, P558, DOI 10.1007/s10354-008-0595-y; SACCA L, 1983, AM J PHYSIOL, V245, pE294, DOI 10.1152/ajpendo.1983.245.3.E294; SANCHEZ V, 1992, BIOCHEM J, V284, P659, DOI 10.1042/bj2840659; Sanchez-Margalet V, 1998, DIABETES CARE, V21, P1951, DOI 10.2337/diacare.21.11.1951; Sanchez-Margalet V, 1999, DIABETOLOGIA, V42, P317, DOI 10.1007/s001250051157; Sanchez-Margalet V, 1998, AM J PHYSIOL-ENDOC M, V275, pE1055, DOI 10.1152/ajpendo.1998.275.6.E1055; SanchezGutierrez JC, 1997, ENDOCRINOLOGY, V138, P2443, DOI 10.1210/en.138.6.2443; SANCHEZMARGALET V, 1992, GEN PHARMACOL, V23, P637, DOI 10.1016/0306-3623(92)90140-F; SANCHEZMARGALET V, 1992, HORM METAB RES, V24, P455, DOI 10.1055/s-2007-1003361; SANCHEZMARGALET V, 1994, BIOCHEM J, V303, P51, DOI 10.1042/bj3030051; SEIFTER S, 1950, ARCH BIOCHEM, V25, P191; SMEDSROD B, 1985, J LEUKOCYTE BIOL, V38, P213, DOI 10.1002/jlb.38.2.213; TATEMOTO K, 1986, NATURE, V324, P476, DOI 10.1038/324476a0; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; THOMPSON JR, 1991, COMP BIOCHEM PHYS B, V100, P209, DOI 10.1016/0305-0491(91)90363-I; Tsuchiya K, 2007, ENDOCRINOLOGY, V148, P4548, DOI 10.1210/en.2006-1371; WINKLER H, 1992, NEUROSCIENCE, V49, P497, DOI 10.1016/0306-4522(92)90222-N; Yamamoto T, 2004, J BIOL CHEM, V279, P12027, DOI 10.1074/jbc.M310333200; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Zhou H, 2005, BIOCHEM BIOPH RES CO, V338, P793, DOI 10.1016/j.bbrc.2005.10.007	57	75	77	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28498	28509		10.1074/jbc.M109.020636	http://dx.doi.org/10.1074/jbc.M109.020636			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19706599	hybrid, Green Published			2022-12-27	WOS:000270678900004
J	Ousingsawat, J; Martins, JR; Schreiber, R; Rock, JR; Harfe, BD; Kunzelmann, K				Ousingsawat, Jiraporn; Martins, Joana R.; Schreiber, Rainer; Rock, Jason R.; Harfe, Brian D.; Kunzelmann, Karl			Loss of TMEM16A Causes a Defect in Epithelial Ca2+-dependent Chloride Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGE-DEPENDENT DIARRHEA; CYSTIC-FIBROSIS; MOUSE AIRWAYS; CHANNEL; CELLS; SECRETION; MEMBRANE; GLANDS; CA2+; HEPATOCYTES	Molecular identification of the Ca2+-dependent chloride channel TMEM16A (ANO1) provided a fundamental step in understanding Ca2+-dependent Cl- secretion in epithelia. TMEM16A is an intrinsic constituent of Ca2+-dependent Cl- channels in cultured epithelia and may control salivary output, but its physiological role in native epithelial tissues remains largely obscure. Here, we demonstrate that Cl- secretion in native epithelia activated by Ca2+-dependent agonists is missing in mice lacking expression of TMEM16A. Ca2+-dependent Cl- transport was missing or largely reduced in isolated tracheal and colonic epithelia, as well as hepatocytes and acinar cells from pancreatic and submandibular glands of TMEM16A(-/-) animals. Measurement of particle transport on the surface of tracheas ex vivo indicated largely reduced mucociliary clearance in TMEM16A(-/-) mice. These results clearly demonstrate the broad physiological role of TMEM16A(-/-) for Ca2+-dependent Cl- secretion and provide the basis for novel treatments in cystic fibrosis, infectious diarrhea, and Sjoegren syndrome.	[Ousingsawat, Jiraporn; Martins, Joana R.; Schreiber, Rainer; Kunzelmann, Karl] Univ Regensburg, Inst Physiol, D-93053 Regensburg, Germany; [Rock, Jason R.; Harfe, Brian D.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA	University of Regensburg; State University System of Florida; University of Florida	Kunzelmann, K (corresponding author), Univ Regensburg, Inst Physiol, Univ Str 31, D-93053 Regensburg, Germany.	karl.kunzelmann@vkl.uni-regensburg.de	Martins, Joana/L-2965-2016	Martins, Joana/0000-0002-3784-9775; Kunzelmann, Karl/0000-0002-4583-7037	DFG [SFB699, KU 756/8-2]; Target-Screen2 [EU-FP6-2005-LH-037365]; Else Kroner-Fresenius-Stiftung [P36/05//A44/05]	DFG(German Research Foundation (DFG)); Target-Screen2; Else Kroner-Fresenius-Stiftung	This work was supported by DFG SFB699, DFG KU 756/8-2, Target-Screen2 (EU-FP6-2005-LH-037365), and Else Kroner-Fresenius-Stiftung P36/05//A44/05.	Aromataris EC, 2006, J PHYSIOL-LONDON, V573, P611, DOI 10.1113/jphysiol.2006.109819; Ball JM, 1996, SCIENCE, V272, P101, DOI 10.1126/science.272.5258.101; Barro-Soria R, 2008, BBA-MOL CELL RES, V1783, P1993, DOI 10.1016/j.bbamcr.2008.06.016; Boucher RC, 2003, PFLUG ARCH EUR J PHY, V445, P495, DOI 10.1007/s00424-002-0955-1; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Choi JY, 2007, J CLIN INVEST, V117, P3118, DOI 10.1172/JCI31992; Espinosa I, 2008, AM J SURG PATHOL, V32, P210, DOI 10.1097/PAS.0b013e3181238cec; Faria D, 2009, PFLUG ARCH EUR J PHY, V457, P1373, DOI 10.1007/s00424-008-0606-2; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; GREGER R, 1991, PFLUG ARCH EUR J PHY, V419, P209, DOI 10.1007/BF00373009; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; KOUMI SI, 1994, J GEN PHYSIOL, V104, P357, DOI 10.1085/jgp.104.2.357; Kunzelmann K, 1999, Rev Physiol Biochem Pharmacol, V137, P1; Kunzelmann K, 2002, PFLUG ARCH EUR J PHY, V444, P220, DOI 10.1007/s00424-002-0796-y; Kunzelmann K, 2007, PFLUG ARCH EUR J PHY, V454, P879, DOI 10.1007/s00424-007-0245-z; Kuruma A, 2000, J GEN PHYSIOL, V115, P59, DOI 10.1085/jgp.115.1.59; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; Milenkovic VM, 2009, PFLUG ARCH EUR J PHY, V458, P431, DOI 10.1007/s00424-008-0626-y; Morris AP, 1999, AM J PHYSIOL-GASTR L, V277, pG431, DOI 10.1152/ajpgi.1999.277.2.G431; PETERSEN OH, 1986, AM J PHYSIOL, V251, pG1, DOI 10.1152/ajpgi.1986.251.1.G1; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; SATO K, 1984, J CLIN INVEST, V73, P1763, DOI 10.1172/JCI111385; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Soria RB, 2009, J BIOL CHEM, V284, P29405, DOI 10.1074/jbc.M605716200; Wine JJ, 2007, AUTON NEUROSCI-BASIC, V133, P35, DOI 10.1016/j.autneu.2007.01.008; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	31	183	190	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28698	28703		10.1074/jbc.M109.012120	http://dx.doi.org/10.1074/jbc.M109.012120			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19679661	Green Published, hybrid			2022-12-27	WOS:000270678900025
J	Barbosa-Sicard, E; Fromel, T; Keseru, B; Brandes, RP; Morisseau, C; Hammock, BD; Braun, T; Kruger, M; Fleming, I				Barbosa-Sicard, Eduardo; Froemel, Timo; Keserue, Benjamin; Brandes, Ralf P.; Morisseau, Christophe; Hammock, Bruce D.; Braun, Thomas; Krueger, Marcus; Fleming, Ingrid			Inhibition of the Soluble Epoxide Hydrolase by Tyrosine Nitration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPOXYEICOSATRIENOIC ACIDS; ENDOTHELIAL-CELLS; PEPTIDE IDENTIFICATION; RETICULUM CA2+-ATPASE; BLOOD-PRESSURE; SHEAR-STRESS; IN-VIVO; EXPRESSION; ACTIVATION; METABOLISM	Inhibition of the soluble epoxide hydrolase (sEH) has beneficial effects on vascular inflammation and hypertension indicating that the enzyme may be a promising target for drug development. As the enzymatic core of the hydrolase domain of the human sEH contains two tyrosine residues (Tyr(383) and Tyr(466)) that are theoretically crucial for enzymatic activity, we addressed the hypothesis that the activity of the sEH may be affected by nitrosative stress. Epoxide hydrolase activity was detected in human and murine endothelial cells as well in HEK293 cells and could be inhibited by either authentic peroxynitrite (ONOO-) or the ONOO- generator 3-morpholinosydnonimine (SIN-1). Protection of the enzymatic core with 1-adamantyl-3-cyclohexylurea in vitro decreased sensitivity to SIN-1. Both ONOO- and SIN-1 elicited the tyrosine nitration of the sEH protein and mass spectrometry analysis of tryptic fragments revealed nitration on several tyrosine residues including Tyr(383) and Tyr(466). Mutation of the latter residues to phenylalanine was sufficient to abrogate epoxide hydrolase activity. In vivo, streptozotocin-induced diabetes resulted in the tyrosine nitration of the sEH in murine lungs and a significant decrease in its activity. Taken together, these data indicate that the activity of the sEH can be regulated by the tyrosine nitration of the protein. Moreover, nitrosative stress would be expected to potentiate the physiological actions of arachidonic acid epoxides by preventing their metabolism to the corresponding diols.	[Barbosa-Sicard, Eduardo; Froemel, Timo; Keserue, Benjamin; Fleming, Ingrid] Goethe Univ Frankfurt, Ctr Mol Med, Inst Vasc Signaling, D-60590 Frankfurt, Germany; [Brandes, Ralf P.] Goethe Univ Frankfurt, Inst Kardiovaskulare Physiol, D-60590 Frankfurt, Germany; [Braun, Thomas; Krueger, Marcus] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, D-61231 Bad Nauheim, Germany; [Morisseau, Christophe; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	Goethe University Frankfurt; Goethe University Frankfurt; Max Planck Society; University of California System; University of California Davis	Fleming, I (corresponding author), Goethe Univ Frankfurt, Ctr Mol Med, Inst Vasc Signaling, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	fleming@em.uni-frankfurt.de	Fleming, Ingrid/AAB-6123-2022; Braun, Thomas/B-2310-2008; Fleming, Ingrid/L-1225-2014; Brandes, Ralf P/L-3058-2017	Fleming, Ingrid/0000-0003-1881-3635; Fleming, Ingrid/0000-0003-1881-3635; Brandes, Ralf P/0000-0002-8035-0048; Braun, Thomas/0000-0002-6165-4804	National Institutes of Health [HL 85727, R37 ES02710, P42 ES004699, R01 ES013933]; NIEHS; Deutsche Forschungsgemeinschaft; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699, R37ES002710, R01ES013933] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institutes of Health Grant HL 85727 and by NIEHS, National Institutes of Health Grants R37 ES02710, P42 ES004699, R01 ES013933. This work was also supported by research grants from the Deutsche Forschungsgemeinschaft (Transiregional Collaborative Research Center 23, Project A6, Research Unit 784 and by Exzellenzcluster 147 "Cardio-PuImonary Systems").	Ai D, 2007, P NATL ACAD SCI USA, V104, P9018, DOI 10.1073/pnas.0703229104; Argiriadi MA, 2000, J BIOL CHEM, V275, P15265, DOI 10.1074/jbc.M000278200; Bartesaghi S, 2007, AMINO ACIDS, V32, P501, DOI 10.1007/s00726-006-0425-8; Ceriello A, 2001, DIABETOLOGIA, V44, P834; Corenblum MJ, 2008, HYPERTENSION, V51, P567, DOI 10.1161/HYPERTENSIONAHA.107.102160; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cronin A, 2003, P NATL ACAD SCI USA, V100, P1552, DOI 10.1073/pnas.0437829100; de Ross B, 2009, PROTEOMICS, V9, P3244, DOI 10.1002/pmic.200800761; Dixit M, 2005, CIRC RES, V97, P1236, DOI 10.1161/01.RES.0000195611.59811.ab; Enayetallah AE, 2004, J HISTOCHEM CYTOCHEM, V52, P447, DOI 10.1177/002215540405200403; Fang X, 2002, AM J PHYSIOL-HEART C, V283, pH2306, DOI 10.1152/ajpheart.00448.2002; Fang X, 2001, J BIOL CHEM, V276, P14867, DOI 10.1074/jbc.M011761200; Fleming I, 2005, J CELL SCI, V118, P4103, DOI 10.1242/jcs.02541; GILL SS, 1980, BIOCHEM PHARMACOL, V29, P389, DOI 10.1016/0006-2952(80)90518-3; Goldstein S, 2008, METHOD ENZYMOL, V436, P49, DOI 10.1016/S0076-6879(08)36004-2; Gschwendtner A, 2008, STROKE, V39, P1593, DOI 10.1161/STROKEAHA.107.502179; Hopmann KH, 2006, J PHYS CHEM B, V110, P21299, DOI 10.1021/jp063830t; Hutchens MP, 2008, RESUSCITATION, V76, P89, DOI 10.1016/j.resuscitation.2007.06.031; Imig JD, 2002, HYPERTENSION, V39, P690, DOI 10.1161/hy0202.103788; Jung O, 2005, HYPERTENSION, V45, P759, DOI 10.1161/01.HYP.0000153792.29478.1d; Liu Y, 2005, P NATL ACAD SCI USA, V102, P16747, DOI 10.1073/pnas.0508081102; Maresh JG, 2005, PHYSIOL GENOMICS, V21, P308, DOI 10.1152/physiolgenomics.00310.2004; Michaelis UR, 2006, PHARMACOL THERAPEUT, V111, P584, DOI 10.1016/j.pharmthera.2005.11.003; Morisseau C, 2002, BIOCHEM PHARMACOL, V63, P1599, DOI 10.1016/S0006-2952(02)00952-8; Morisseau C, 2001, CHEM RES TOXICOL, V14, P409, DOI 10.1021/tx0001732; Muller DN, 2007, BIOCHEM J, V403, P109, DOI 10.1042/BJ20061328; Newman JW, 2005, PROG LIPID RES, V44, P1, DOI 10.1016/j.plipres.2004.10.001; Newman JW, 2003, P NATL ACAD SCI USA, V100, P1558, DOI 10.1073/pnas.0437724100; Ohtoshi K, 2005, BIOCHEM BIOPH RES CO, V331, P347, DOI 10.1016/j.bbrc.2005.03.171; Olsen JV, 2004, P NATL ACAD SCI USA, V101, P13417, DOI 10.1073/pnas.0405549101; Peluffo G, 2007, CARDIOVASC RES, V75, P291, DOI 10.1016/j.cardiores.2007.04.024; Pokreisz P, 2006, HYPERTENSION, V47, P762, DOI 10.1161/01.HYP.0000208299.62535.58; Randriamboavonjy V, 2008, CIRCULATION, V117, P52, DOI 10.1161/CIRCULATIONAHA.107.719807; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rodriguez M, 2006, ANN NY ACAD SCI, V1079, P130, DOI 10.1196/annals.1375.019; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; SEIDEGARD J, 1984, CANCER RES, V44, P3654; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; Smith KR, 2005, P NATL ACAD SCI USA, V102, P2186, DOI 10.1073/pnas.0409591102; Spector AA, 2007, AM J PHYSIOL-CELL PH, V292, pC996, DOI 10.1152/ajpcell.00402.2006; Sura P, 2008, J HISTOCHEM CYTOCHEM, V56, P551, DOI 10.1369/jhc.2008.950659; THOMAS H, 1989, BIOCHEM PHARMACOL, V38, P4291, DOI 10.1016/0006-2952(89)90528-5; VANROLLINS M, 1993, J LIPID RES, V34, P1931; Viner RI, 1999, BIOCHEM J, V340, P657, DOI 10.1042/0264-6021:3400657; Weintraub NL, 1999, AM J PHYSIOL-HEART C, V277, pH2098, DOI 10.1152/ajpheart.1999.277.5.H2098; Yamada T, 2000, J BIOL CHEM, V275, P23082, DOI 10.1074/jbc.M001464200; Yu ZG, 2000, CIRC RES, V87, P992, DOI 10.1161/01.RES.87.11.992; Zhao XY, 2005, AM J PHYSIOL-REG I, V288, pR188, DOI 10.1152/ajpregu.00018.2004; Zheng J, 2001, AM J RESP CELL MOL, V25, P434, DOI 10.1165/ajrcmb.25.4.4104; Zou MH, 1997, BIOL CHEM, V378, P707, DOI 10.1515/bchm.1997.378.7.707	51	24	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28156	28163		10.1074/jbc.M109.054759	http://dx.doi.org/10.1074/jbc.M109.054759			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19704161	Green Published, hybrid			2022-12-27	WOS:000270676300042
J	Deng, S; Zhang, GF; Kasumov, T; Roe, CR; Brunengraber, H				Deng, Shuang; Zhang, Guo-Fang; Kasumov, Takhar; Roe, Charles R.; Brunengraber, Henri			Interrelations between C-4 Ketogenesis, C-5 Ketogenesis, and Anaplerosis in the Perfused Rat Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA ACETYLTRANSFERASE; KETONE-BODY PRODUCTION; FATTY ACID METABOLISM; GLUCONEOGENESIS INVIVO; MAMMALIAN-TISSUES; MASS ISOTOPOMER; COENZYME-A; MITOCHONDRIAL; ENZYMES; DEFICIENCY	We investigated the interrelations between C, ketogenesis (production of beta-hydroxybutyrate + acetoacetate), C-5 ketogenesis (production of beta-hydroxypentanoate + beta-ketopentanoate), and anaplerosis in isolated rat livers perfused with C-13-labeled octanoate, heptanoate, or propionate. Mass isotopomer analysis of C-4 and C-5 ketone bodies and of related acyl-CoA esters reveal that C-4 and C-5 ketogenesis share the same pool of acetyl-CoA. Although the uptake of octanoate and heptanoate by the liver are similar, the rate of C-5 ketogenesis from heptanoate is much lower than the rate of C-4 ketogenesis from octanoate. This results from the channeling of the propionyl moiety of heptanoate into anaplerosis of the citric acid cycle. C-5 ketogenesis from propionate is virtually nil because acetoacyl-CoA thiolase does not favor the formation of beta-ketopentanoyl-CoA from propionyl-CoA and acetyl-CoA. Anaplerosis and gluconeogenesis from heptanoate are inhibited by octanoate. The data have implications for the design of diets for the treatment of long chain fatty acid oxidation disorders, such as the triheptanoin-based diet.	[Deng, Shuang; Zhang, Guo-Fang; Kasumov, Takhar; Brunengraber, Henri] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Roe, Charles R.] Baylor Univ, Med Ctr, Inst Metab Dis, Dallas, TX 75226 USA	Case Western Reserve University; Baylor University; Baylor University Medical Center	Brunengraber, H (corresponding author), Case Western Reserve Univ, Sch Med, Dept Nutr, WG 48,10900 Euclid Ave, Cleveland, OH 44106 USA.	hxb8@case.edu			National Institutes of Health [5R33DK070291, 5ROIDK069752]; Cleveland Mt. Sinai Health Care Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070291, R01DK069752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cleveland Mt. Sinai Health Care Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant Road Map Grant 5R33DK070291 and Grant 5ROIDK069752. This work was also supported by the Cleveland Mt. Sinai Health Care Foundation.	BAKER FC, 1981, BIOCHIM BIOPHYS ACTA, V664, P356, DOI 10.1016/0005-2760(81)90058-8; BALASSE EO, 1989, DIABETES METAB REV, V5, P247, DOI 10.1002/dmr.5610050304; BALZER I, 1986, BIOCHIM BIOPHYS ACTA, V870, P350, DOI 10.1016/0167-4838(86)90239-6; BERGMEYER HU, 1967, BIOCHEM J, V102, P423, DOI 10.1042/bj1020423; BOUGNERES PF, 1981, J PEDIATR-US, V98, P742, DOI 10.1016/S0022-3476(81)80834-7; BRASS EP, 1988, BIOCHEM J, V250, P819, DOI 10.1042/bj2500819; DURAN M, 1978, CLIN CHIM ACTA, V82, P93, DOI 10.1016/0009-8981(78)90030-X; ENDEMANN G, 1987, BIOCHEM CELL BIOL, V65, P989, DOI 10.1139/o87-129; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Fukao T, 1997, PEDIATR RES, V42, P498, DOI 10.1203/00006450-199710000-00013; Fukao T, 2004, PROSTAG LEUKOTR ESS, V70, P243, DOI 10.1016/j.plefa.2003.11.001; HETENYI G, 1982, FED PROC, V41, P104; HOMMES FA, 1968, PEDIATR RES, V2, P519, DOI 10.1203/00006450-196811000-00010; HUTH W, 1973, H-S Z PHYSIOL CHEM, V354, P635, DOI 10.1515/bchm2.1973.354.1.635; HUTH W, 1985, BIOCHIM BIOPHYS ACTA, V830, P274, DOI 10.1016/0167-4838(85)90283-3; HUTH W, 1974, BIOCHEM BIOPH RES CO, V56, P1069, DOI 10.1016/S0006-291X(74)80297-4; HUTH W, 1982, EUR J BIOCHEM, V128, P413; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; Kasumov T, 2007, ARCH BIOCHEM BIOPHYS, V463, P110, DOI 10.1016/j.abb.2007.02.022; KATZ J, 1985, AM J PHYSIOL, V248, pR391, DOI 10.1152/ajpregu.1985.248.4.R391; KREBS HA, 1970, BIOCHEM J, V119, P525, DOI 10.1042/bj1190525; KUHARA T, 1983, BIOMED MASS SPECTROM, V10, P629, DOI 10.1002/bms.1200101202; LECLERC J, 1995, AM J PHYSIOL-ENDOC M, V268, pE446, DOI 10.1152/ajpendo.1995.268.3.E446; MCGARRY JD, 1971, J BIOL CHEM, V246, P1149; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; ROBINSON AM, 1980, PHYSIOL REV, V60, P143, DOI 10.1152/physrev.1980.60.1.143; Roe CR, 2008, NEUROLOGY, V71, P260, DOI 10.1212/01.wnl.0000318283.42961.e9; Roe CR, 2002, J CLIN INVEST, V110, P259, DOI [10.1172/JCI200215311, 10.1172/JCI0215311]; ROSIERS CD, 1988, ANAL BIOCHEM, V173, P96, DOI 10.1016/0003-2697(88)90165-0; ROSIERS CD, 1991, J BIOL CHEM, V266, P1574; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; STERN JR, 1956, J BIOL CHEM, V221, P1; SWEETMAN L, 1978, BIOMED MASS SPECTROM, V5, P198, DOI 10.1002/bms.1200050307; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; WILLIAMS.DH, 1971, BIOCHEM J, V121, P41, DOI 10.1042/bj1210041	35	33	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27799	27807		10.1074/jbc.M109.048744	http://dx.doi.org/10.1074/jbc.M109.048744			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19666922	Green Published, hybrid			2022-12-27	WOS:000270676300006
J	Mastroianni, JR; Ouellette, AJ				Mastroianni, Jennifer R.; Ouellette, Andre J.			alpha-Defensins in Enteric Innate Immunity FUNCTIONAL PANETH CELL alpha-DEFENSINS IN MOUSE COLONIC LUMEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL EPITHELIAL-CELLS; ANTIMICROBIAL PEPTIDES; BETA-DEFENSINS; CATHELICIDIN LL-37; MESSENGER-RNA; EXPRESSION; ACTIVATION; CRYPTDIN-4; SECRETION; BETA-DEFENSIN-3	Paneth cells are a secretory epithelial lineage that release dense core granules rich in host defense peptides and proteins from the base of small intestinal crypts. Enteric alpha-defensins, termed cryptdins (Crps) in mice, are highly abundant in Paneth cell secretions and inherently resistant to proteolysis. Accordingly, we tested the hypothesis that enteric alpha-defensins of Paneth cell origin persist in a functional state in the mouse large bowel lumen. To test this idea, putative Crps purified from mouse distal colonic lumen were characterized biochemically and assayed in vitro for bactericidal peptide activities. The peptides comigrated with cryptdin control peptides in acid-urea-PAGE and SDS-PAGE, providing identification as putative Crps. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry experiments showed that the molecular masses of the putative alpha-defensins matched those of the six most abundant known Crps, as well as N-terminally truncated forms of each, and that the peptides contain six Cys residues, consistent with identities as alpha-defensins. N-terminal sequencing definitively revealed peptides with N termini corresponding to full-length, (des-Leu)-truncated, and (des-Leu-Arg)-truncated N termini of Crps 1-4 and 6. Crps from mouse large bowel lumen were bactericidal in the low micromolar range. Thus, Paneth cell alpha-defensins secreted into the small intestinal lumen persist as intact and functional forms throughout the intestinal tract, suggesting that the peptides may mediate enteric innate immunity in the colonic lumen, far from their upstream point of secretion in small intestinal crypts.	[Mastroianni, Jennifer R.; Ouellette, Andre J.] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92697 USA; [Ouellette, Andre J.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Ouellette, AJ (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol & Lab Med, Norris Canc Ctr, 1450 Biggy St,NRT 7514,Mail Code 9601, Los Angeles, CA 90033 USA.	andre.ouellette@keck.usc.edu			National Institutes of Health [DK044632, AI059346]; Human Frontiers Science Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044632, R55DK044632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK044632 and AI059346. This work was also supported by the Human Frontiers Science Program.	ALEY SB, 1994, INFECT IMMUN, V62, P5397, DOI 10.1128/IAI.62.12.5397-5403.1994; Ayabe T, 2002, J BIOL CHEM, V277, P3793, DOI 10.1074/jbc.M107507200; Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Belas R, 2004, INFECT IMMUN, V72, P5159, DOI 10.1128/IAI.72.9.5159-5167.2004; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Boulton RA, 2003, WORLD J SURG, V27, P1014, DOI 10.1007/s00268-003-7054-0; Carlisle MD, 2009, J INNATE IMMUN, V1, P118, DOI 10.1159/000181015; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Cunliffe RN, 2004, J LEUKOCYTE BIOL, V75, P49, DOI 10.1189/jlb.0503249; EISENHAUER PB, 1992, INFECT IMMUN, V60, P3556, DOI 10.1128/IAI.60.9.3556-3565.1992; EISENHAUER PB, 1992, INFECT IMMUN, V60, P3446, DOI 10.1128/IAI.60.8.3446-3447.1992; Fahlgren A, 2004, CLIN EXP IMMUNOL, V137, P379, DOI 10.1111/j.1365-2249.2004.02543.x; Fernandez MI, 2008, J IMMUNOL, V180, P4924, DOI 10.4049/jimmunol.180.7.4924; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Ganz T, 2004, CR BIOL, V327, P539, DOI 10.1016/j.crvi.2003.12.007; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Hadjicharalambous C, 2008, BIOCHEMISTRY-US, V47, P12626, DOI 10.1021/bi800335e; HARWIG SSL, 1995, ADV EXP MED BIOL, V371, P251; HARWIG SSL, 1995, J CLIN INVEST, V95, P603, DOI 10.1172/JCI117704; Hase K, 2002, INFECT IMMUN, V70, P953, DOI 10.1128/IAI.70.2.953-963.2002; Hoover DM, 2003, ANTIMICROB AGENTS CH, V47, P2804, DOI 10.1128/AAC.47.9.2804-2809.2003; Iimura M, 2005, J IMMUNOL, V174, P4901, DOI 10.4049/jimmunol.174.8.4901; Kamdar K, 2008, J BIOL CHEM, V283, P32361, DOI 10.1074/jbc.M805296200; Kolls JK, 2008, NAT REV IMMUNOL, V8, P829, DOI 10.1038/nri2433; Lehrer RI, 2002, CURR OPIN HEMATOL, V9, P18, DOI 10.1097/00062752-200201000-00004; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; Mukherjee S, 2008, CELL MOL LIFE SCI, V65, P3019, DOI 10.1007/s00018-008-8182-3; O'Neil DA, 1999, J IMMUNOL, V163, P6718; Ou G, 2009, SCAND J IMMUNOL, V69, P150, DOI 10.1111/j.1365-3083.2008.02208.x; OUELLETTE AJ, 1992, FEBS LETT, V304, P146, DOI 10.1016/0014-5793(92)80606-H; Ouellette AJ, 2000, J BIOL CHEM, V275, P33969, DOI 10.1074/jbc.M004062200; Ouellette AJ, 2005, SPRINGER SEMIN IMMUN, V27, P133, DOI 10.1007/s00281-005-0202-x; OUELLETTE AJ, 1994, INFECT IMMUN, V62, P5040, DOI 10.1128/IAI.62.11.5040-5047.1994; OUELLETTE AJ, 1988, GASTROENTEROLOGY, V94, P114, DOI 10.1016/0016-5085(88)90618-X; OUELLETTE AJ, 1989, J CELL BIOL, V108, P1687, DOI 10.1083/jcb.108.5.1687; Patil A, 2004, PHYSIOL GENOMICS, V20, P1, DOI 10.1152/physiolgenomics.00150.2004; PEETERS T, 1975, GUT, V16, P553, DOI 10.1136/gut.16.7.553; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Qu XD, 1996, INFECT IMMUN, V64, P5161, DOI 10.1128/IAI.64.12.5161-5165.1996; Rodenburg W, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-84; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Satchell DP, 2003, PEPTIDES, V24, P1795, DOI 10.1016/j.peptides.2003.08.020; Satchell DP, 2003, J BIOL CHEM, V278, P13838, DOI 10.1074/jbc.M212115200; Schauber J, 2003, GUT, V52, P735, DOI 10.1136/gut.52.5.735; Schmidtchen A, 2002, MOL MICROBIOL, V46, P157, DOI 10.1046/j.1365-2958.2002.03146.x; Schutte BC, 2002, ANNU REV PHYSIOL, V64, P709, DOI 10.1146/annurev.physiol.64.081501.134340; Selsted M E, 1993, Genet Eng (N Y), V15, P131; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SELSTED ME, 1995, TRENDS CELL BIOL, V5, P114, DOI 10.1016/S0962-8924(00)88961-8; SELSTED ME, 1992, J CELL BIOL, V118, P929, DOI 10.1083/jcb.118.4.929; Shanahan F, 2002, BEST PRACT RES CL GA, V16, P915, DOI 10.1053/bega.2002.0342; Shirafuji Y, 2003, J BIOL CHEM, V278, P7910, DOI 10.1074/jbc.M210600200; SOMMERS SC, 1966, GASTROENTEROLOGY, V51, P841; Taggart CC, 2003, J IMMUNOL, V171, P931, DOI 10.4049/jimmunol.171.2.931; Takahashi A, 2001, FEBS LETT, V508, P484, DOI 10.1016/S0014-5793(01)03088-5; Tanabe H, 2004, J BIOL CHEM, V279, P11976, DOI 10.1074/jbc.M310251200; Tarver AP, 1998, INFECT IMMUN, V66, P1045, DOI 10.1128/IAI.66.3.1045-1056.1998; TRIER JS, 1966, GASTROENTEROLOGY, V51, P560; Weeks CS, 2006, J BIOL CHEM, V281, P28932, DOI 10.1074/jbc.M602041200; Wilson CL, 2009, J BIOL CHEM, V284, P8301, DOI 10.1074/jbc.M809744200; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	66	76	79	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27848	27856		10.1074/jbc.M109.050773	http://dx.doi.org/10.1074/jbc.M109.050773			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19687006	Green Published, hybrid			2022-12-27	WOS:000270676300011
J	Bass, R; Wagstaff, L; Ravenhill, L; Ellis, V				Bass, Rosemary; Wagstaff, Laura; Ravenhill, Lorna; Ellis, Vincent			Binding of Extracellular Maspin to beta 1 Integrins Inhibits Vascular Smooth Muscle Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSIVE MASPIN; INTEGRIN MONOCLONAL-ANTIBODY; MAMMARY EPITHELIAL-CELLS; PLASMINOGEN-ACTIVATOR; MATRIX METALLOPROTEINASES; FIBRONECTIN RECEPTOR; CRYSTAL-STRUCTURE; BREAST-CARCINOMA; CANCER CELLS; SERPIN	Maspin is a serpin that has multiple effects on cell behavior, including inhibition of migration. How maspin mediates these diverse effects remains unclear, as it is devoid of protease inhibitory activity. We have previously shown that maspin rapidly inhibits the migration of vascular smooth muscle cells(VSMC), suggesting the involvement of direct interactions with cell surface proteins. Here, using immunofluorescence microscopy, we demonstrate that maspin binds specifically to the surface of VSMC in the dedifferentiated, but not the differentiated, phenotype. Ligand blotting of VSMC lysates revealed the presence of several maspin-binding proteins, with a protein of 150 kDa differentially expressed between the two VSMC phenotypes. Western blotting suggested that this protein was the beta 1 integrin subunit, and subsequently both alpha 3 beta 1 and alpha 5 beta 1, but not alpha v beta 3, were shown to associate with maspin by coimmunoprecipitation. Specific binding of these integrins was also observed using maspin-affinity chromatography, using HT1080 cell lysates. Direct binding of maspin to alpha 5 beta 1 was confirmed using a recombinant alpha 5 beta 1-Fc fusion protein. Using conformation-dependent anti-beta 1 antibodies, maspin binding to VSMC was found to lead to a decrease in the activation status of the integrin. The functional involvement of alpha 5 beta 1 in mediating the effect of maspin was established by the inhibition of migration of CHO cells overexpressing human alpha 5 integrin, but not those lacking alpha 5 expression. Our observations suggest that maspin engages in specific interactions with a limited number of integrins on VSMC, leading to their inactivation, and that these interactions are responsible for the effects of maspin in the pericellular environment.	[Bass, Rosemary; Wagstaff, Laura; Ravenhill, Lorna; Ellis, Vincent] Univ E Anglia, Sch Biol Sci, Biomed Res Ctr, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Ellis, V (corresponding author), Univ E Anglia, Sch Biol Sci, Biomed Res Ctr, Norwich NR4 7TJ, Norfolk, England.	v.ellis@uea.ac.uk	Bass, Rosemary A/A-5328-2009; Ellis, Vincent/D-1860-2009	Bass, Rosemary A/0000-0003-4997-5207; Ellis, Vincent/0000-0003-1956-073X	British Heart Foundation [FS/05/063]; Norfolk and Waveney Big C Appeal, Biotechnology and Biological Sciences Research Council; EU [LSHC-CT-2003-503297]	British Heart Foundation(British Heart Foundation); Norfolk and Waveney Big C Appeal, Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU(European Commission)	This work was supported by grants from the British Heart Foundation (FS/05/063), Norfolk and Waveney Big C Appeal, Biotechnology and Biological Sciences Research Council, and by the EU Framework Programme 6 Cancerdegradome Project LSHC-CT-2003-503297.	AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; Al-Ayyoubi M, 2004, J BIOL CHEM, V279, P55540, DOI 10.1074/jbc.M409957200; Askari JA, 2009, J CELL SCI, V122, P165, DOI 10.1242/jcs.018556; Bailey CM, 2005, J BIOL CHEM, V280, P34210, DOI 10.1074/jbc.M503523200; Bass R, 2005, J BIOL CHEM, V280, P14811, DOI 10.1074/jbc.M414189200; Bass R, 2002, J BIOL CHEM, V277, P46845, DOI 10.1074/jbc.C200532200; Bass R, 2009, THROMB HAEMOSTASIS, V101, P954, DOI 10.1160/TH08-08-0558; BECERRA SP, 1995, J BIOL CHEM, V270, P25992, DOI 10.1074/jbc.270.43.25992; Biliran H, 2001, CANCER RES, V61, P8676; Blacque OE, 2002, J BIOL CHEM, V277, P10783, DOI 10.1074/jbc.M110992200; Brown EJ, 2002, CURR OPIN CELL BIOL, V14, P603, DOI 10.1016/S0955-0674(02)00360-5; Cella N, 2006, FASEB J, V20, P1510, DOI 10.1096/fj.05-5500fje; Coe APF, 2001, J BIOL CHEM, V276, P35854, DOI 10.1074/jbc.M103639200; Dollery CM, 2006, CARDIOVASC RES, V69, P625, DOI 10.1016/j.cardiores.2005.11.003; Filleur S, 2005, CANCER RES, V65, P5144, DOI 10.1158/0008-5472.CAN-04-3744; Filleur S, 2009, J CELL BIOCHEM, V106, P769, DOI 10.1002/jcb.22072; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Gao F, 2004, DEVELOPMENT, V131, P1479, DOI 10.1242/dev.01048; HAYRY P, 1993, IMMUNOL REV, V134, P33, DOI 10.1111/j.1600-065X.1993.tb00639.x; Humphries JD, 2005, J BIOL CHEM, V280, P10234, DOI 10.1074/jbc.M411102200; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Jiang N, 2002, ONCOGENE, V21, P4089, DOI 10.1038/sj.onc.1205507; Khalkhali-Ellis Z, 2007, CANCER RES, V67, P3535, DOI 10.1158/0008-5472.CAN-06-4767; Law RHP, 2005, J BIOL CHEM, V280, P22356, DOI 10.1074/jbc.M412043200; Li XH, 2006, CANCER RES, V66, P9323, DOI 10.1158/0008-5472.CAN-06-1578; Li ZG, 2005, ONCOGENE, V24, P2008, DOI 10.1038/sj.onc.1208449; Luo BH, 2006, CURR OPIN CELL BIOL, V18, P579, DOI 10.1016/j.ceb.2006.08.005; McGowen R, 2000, CANCER RES, V60, P4771; Mould AP, 1996, J BIOL CHEM, V271, P20365, DOI 10.1074/jbc.271.34.20365; MOULD AP, 1995, FEBS LETT, V363, P118, DOI 10.1016/0014-5793(95)00301-O; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; Ngamkitidechakul C, 2003, J BIOL CHEM, V278, P31796, DOI 10.1074/jbc.M302408200; Odero-Marah VA, 2003, CANCER BIOL THER, V2, P398, DOI 10.4161/cbt.2.4.471; OWENS GK, 1995, PHYSIOL REV, V75, P487; PEMBERTON PA, 1995, J BIOL CHEM, V270, P15832, DOI 10.1074/jbc.270.26.15832; Pemberton PA, 1997, J HISTOCHEM CYTOCHEM, V45, P1697, DOI 10.1177/002215549704501213; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; SCHREINER CL, 1989, J CELL BIOL, V109, P3157, DOI 10.1083/jcb.109.6.3157; SCHWARTZ RS, 1992, J AM COLL CARDIOL, V20, P1284, DOI 10.1016/0735-1097(92)90389-5; Sechler JL, 1997, MOL BIOL CELL, V8, P2563, DOI 10.1091/mbc.8.12.2563; Seftor REB, 1998, CANCER RES, V58, P5681; Sheng S, 1996, P NATL ACAD SCI USA, V93, P11669, DOI 10.1073/pnas.93.21.11669; SHENG SJ, 1994, J BIOL CHEM, V269, P30988; Sheng SJ, 1998, P NATL ACAD SCI USA, V95, P499, DOI 10.1073/pnas.95.2.499; Shi HY, 2007, CELL MOTIL CYTOSKEL, V64, P338, DOI 10.1002/cm.20187; Shi HY, 2001, CANCER RES, V61, P6945; Smith SL, 2003, ONCOGENE, V22, P8677, DOI 10.1038/sj.onc.1207127; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; Yin SP, 2005, J BIOL CHEM, V280, P34985, DOI 10.1074/jbc.M503522200; Zhang M, 2000, NAT MED, V6, P196, DOI 10.1038/72303; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	51	18	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27712	27720		10.1074/jbc.M109.038919	http://dx.doi.org/10.1074/jbc.M109.038919			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19638634	hybrid, Green Published			2022-12-27	WOS:000270232300072
J	Richard, B; Swanson, R; Olson, ST				Richard, Benjamin; Swanson, Richard; Olson, Steven T.			The Signature 3-O-Sulfo Group of the Anticoagulant Heparin Sequence Is Critical for Heparin Binding to Antithrombin but Is Not Required for Allosteric Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CONFORMATIONAL CHANGE; HIGH-AFFINITY HEPARIN; PROTEINASE REACTIONS; RAPID INHIBITION; BETA-SHEET; FACTOR-IXA; FACTOR-XA; PENTASACCHARIDE; MECHANISM; RESIDUES	Heparin and heparan sulfate glycosaminoglycans allosterically activate the serpin, antithrombin, by binding through a specific pentasaccharide sequence containing a critical 3-O-sulfo group. To elucidate the role of the 3-O-sulfo group in the activation mechanism, we compared the effects of deleting the 3-O-sulfo group or mutating the Lys(114) binding partner of this group on antithrombin-pentasaccharide interactions by equilibrium binding and rapid kinetic analyses. Binding studies over a wide range of ionic strength and pH showed that loss of the 3-O-sulfo group caused a massive similar to 60% loss in binding energy for the antithrombin-pentasaccharide interaction due to the disruption of a cooperative network of ionic and nonionic interactions. Despite this affinity loss, the 3-O-desulfonated pentasaccharide retained the ability to induce tryptophan fluorescence changes and to enhance factor Xa reactivity in antithrombin, indicative of normal conformational activation. Rapid kinetic studies showed that loss of the 3-O-sulfo group affected both the ability of the pentasaccharide to recognize native antithrombin and its ability to preferentially bind and stabilize activated antithrombin. By contrast, mutation of Lys(114) solely affected the preferential interaction of the pentasaccharide with activated antithrombin. These findings demonstrate that the 3-O-sulfo group functions as a key determinant of heparin pentasaccharide activation of antithrombin both by contributing to the Lys(114)-independent recognition of native antithrombin and by triggering a Lys(114)-dependent induced fit interaction with activated antithrombin that locks the serpin in the activated state.	[Richard, Benjamin; Swanson, Richard; Olson, Steven T.] Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Olson, ST (corresponding author), Univ Illinois, Ctr Mol Biol Oral Dis, Rm 530C Dent M-C 860,801 S Paulina St, Chicago, IL 60612 USA.	stolson@uic.edu		Richard, Benjamin/0000-0003-4531-1905	National Institutes of Health [HL-39888]; American Heart Association Fellowship [0920118G]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL039888, R37HL039888, R01HL039888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-39888 (to S. T. O.). This work was also supported by American Heart Association Fellowship 0920118G (to B. R.).	Arocas V, 1999, BIOCHEMISTRY-US, V38, P10196, DOI 10.1021/bi990686b; Arocas V, 2001, J BIOL CHEM, V276, P43809, DOI 10.1074/jbc.M105294200; Arocas V, 2000, BIOCHEMISTRY-US, V39, P8512, DOI 10.1021/bi9928243; ATHA DH, 1985, BIOCHEMISTRY-US, V24, P6723, DOI 10.1021/bi00344a063; ATHA DH, 1987, BIOCHEMISTRY-US, V26, P6454, DOI 10.1021/bi00394a024; Bedsted T, 2003, BIOCHEMISTRY-US, V42, P8143, DOI 10.1021/bi034363y; Bjork I, 1997, ADV EXP MED BIOL, V425, P17; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Church F. C., 2007, MOL CELLULAR ASPECTS, P509; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Desai U, 2000, J BIOL CHEM, V275, P18976, DOI 10.1074/jbc.M001340200; Desai UR, 1998, BIOCHEMISTRY-US, V37, P13033, DOI 10.1021/bi981426h; Desai UR, 1998, J BIOL CHEM, V273, P7478, DOI 10.1074/jbc.273.13.7478; ERSDALBADJU E, 1995, BIOCHEM J, V310, P323, DOI 10.1042/bj3100323; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; FERRO DR, 1986, J AM CHEM SOC, V108, P6773, DOI 10.1021/ja00281a052; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; GETTINS PGW, 1996, SERPINS STRUCTURE FU, P40; HajMohammadi S, 2003, J CLIN INVEST, V111, P989, DOI 10.1172/JCI200315809; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Ishiguro K, 2000, J CLIN INVEST, V106, P873, DOI 10.1172/JCI10489; Izaguirre G, 2006, J BIOL CHEM, V281, P13424, DOI 10.1074/jbc.M600415200; Izaguirre G, 2003, J BIOL CHEM, V278, P51433, DOI 10.1074/jbc.M309266200; Jairajpuri MA, 2003, J BIOL CHEM, V278, P15941, DOI 10.1074/jbc.M212319200; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; LINDAHL P, 1991, BIOCHEM J, V276, P387, DOI 10.1042/bj2760387; MARCUM JA, 1986, J BIOL CHEM, V261, P7507; NORDENMAN B, 1977, EUR J BIOCHEM, V78, P195, DOI 10.1111/j.1432-1033.1977.tb11730.x; NORDENMAN B, 1978, BIOCHEMISTRY-US, V17, P3339, DOI 10.1021/bi00609a026; OLSON ST, 1992, J BIOL CHEM, V267, P12528; OLSON ST, 1991, J BIOL CHEM, V266, P6342; Olson ST, 2004, THROMB HAEMOSTASIS, V92, P929, DOI 10.1160/TH04-06-0384; OLSON ST, 1981, J BIOL CHEM, V256, P1073; Olson ST, 2002, TRENDS CARDIOVAS MED, V12, P198, DOI 10.1016/S1050-1738(02)00160-3; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; PETERSON CB, 1985, J BIOL CHEM, V260, P610; Petitou M, 2003, BIOCHIMIE, V85, P83, DOI 10.1016/S0300-9084(03)00078-6; PETITOU M, 1988, CARBOHYD RES, V179, P163, DOI 10.1016/0008-6215(88)84116-8; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Schedin-Weiss S, 2002, BIOCHEMISTRY-US, V41, P4779, DOI 10.1021/bi012163l; Stratikos E, 1999, P NATL ACAD SCI USA, V96, P4808, DOI 10.1073/pnas.96.9.4808; STREUSAND VJ, 1995, J BIOL CHEM, V270, P9043, DOI 10.1074/jbc.270.16.9043; Turk B, 1997, BIOCHEMISTRY-US, V36, P6682, DOI 10.1021/bi9702492; vanBoven HH, 1997, SEMIN HEMATOL, V34, P188; WALENGA JM, 1988, THROMB RES, V52, P553, DOI 10.1016/0049-3848(88)90128-4	47	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27054	27064		10.1074/jbc.M109.029892	http://dx.doi.org/10.1074/jbc.M109.029892			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19661062	hybrid, Green Published			2022-12-27	WOS:000270232300007
J	Abdul-Sater, AA; Koo, E; Hacker, G; Ojcius, DM				Abdul-Sater, Ali A.; Koo, Evonne; Haecker, Georg; Ojcius, David M.			Inflammasome-dependent Caspase-1 Activation in Cervical Epithelial Cells Stimulates Growth of the Intracellular Pathogen Chlamydia trachomatis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENITAL-TRACT INFECTION; III SECRETION; PROINFLAMMATORY CYTOKINES; LYMPHOGRANULOMA-VENEREUM; NALP3 INFLAMMASOME; MACROPHAGES; RELEASE; PNEUMONIAE; METABOLISM; INCLUSION	Inflammasomes have been extensively characterized in monocytes and macrophages, but not in epithelial cells, which are the preferred host cells for many pathogens. Here we show that cervical epithelial cells express a functional inflammasome. Infection of the cells by Chlamydia trachomatis leads to activation of caspase-1, through a process requiring the NOD-like receptor family member NLRP3 and the inflammasome adaptor protein ASC. Secretion of newly synthesized virulence proteins from the chlamydial vacuole through a type III secretion apparatus results in efflux of K+ through glibenclamide-sensitive K+ channels, which in turn stimulates production of reactive oxygen species. Elevated levels of reactive oxygen species are responsible for NLRP3-dependent caspase-1 activation in the infected cells. In monocytes and macrophages, caspase-1 is involved in processing and secretion of pro-inflammatory cytokines such as interleukin-1 beta. However, in epithelial cells, which are not known to secrete large quantities of interleukin-1 beta, caspase-1 has been shown previously to enhance lipid metabolism. Here we show that, in cervical epithelial cells, caspase-1 activation is required for optimal growth of the intracellular chlamydiae.	[Abdul-Sater, Ali A.; Koo, Evonne; Ojcius, David M.] Univ Calif, Sch Nat Sci, Merced, CA 95343 USA; [Abdul-Sater, Ali A.; Koo, Evonne; Ojcius, David M.] Univ Calif, Hlth Sci Res Inst, Merced, CA 95343 USA; [Haecker, Georg] Univ Freiburg, Inst Med Microbiol & Hyg, D-79104 Freiburg, Germany	University of California System; University of California Merced; University of California System; University of California Merced; University of Freiburg	Ojcius, DM (corresponding author), Univ Calif, Sch Nat Sci, 5200 N Lake Rd, Merced, CA 95343 USA.	david.ojcius@gmail.com	Ojcius, David/ABE-6557-2020	Ojcius, David/0000-0003-1461-4495	University of California; Else Kroner-Fresenius-Stiftung	University of California(University of California System); Else Kroner-Fresenius-Stiftung	This work was supported by the University of California (to D. M. O.) and the Else Kroner-Fresenius-Stiftung (to G. H.).	Bea F, 2003, CIRC RES, V92, P394, DOI 10.1161/01.RES.0000059982.43865.75; BEbEar C, 2009, CLIN MICROBIOL INFEC, V15, P4, DOI 10.1111/j.1469-0691.2008.02647.x; Belland R, 2004, NAT REV MICROBIOL, V2, P530, DOI 10.1038/nrmicro931; Benko S, 2008, CYTOKINE, V43, P368, DOI 10.1016/j.cyto.2008.07.013; BIRKELUND S, 1994, INFECT IMMUN, V62, P4900, DOI 10.1128/IAI.62.11.4900-4908.1994; CAMERON AR, 1983, P NATL ACAD SCI-BIOL, V80, P3726, DOI 10.1073/pnas.80.12.3726; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Chamaillard M, 2003, CELL MICROBIOL, V5, P581, DOI 10.1046/j.1462-5822.2003.00304.x; CHANG GT, 1978, INFECT IMMUN, V19, P827, DOI 10.1128/IAI.19.3.827-832.1978; Cheng W, 2008, INFECT IMMUN, V76, P515, DOI 10.1128/IAI.01064-07; Cohen CR, 1999, SEX TRANSM INFECT, V75, P21, DOI 10.1136/sti.75.1.21; Coombes BK, 2002, CELL MICROBIOL, V4, P447, DOI 10.1046/j.1462-5822.2002.00203.x; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Darville T, 2003, J IMMUNOL, V171, P6187, DOI 10.4049/jimmunol.171.11.6187; Darville T, 1997, INFECT IMMUN, V65, P3065, DOI 10.1128/IAI.65.8.3065-3073.1997; Darville T, 2001, INFECT IMMUN, V69, P3556, DOI 10.1128/IAI.69.6.3556-3561.2001; Dautry-Varsat A, 2005, CELL MICROBIOL, V7, P1714, DOI 10.1111/j.1462-5822.2005.00627.x; Dinarello CA, 2006, AM J CLIN NUTR, V83, p447S; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Entrican G, 1999, CLIN EXP IMMUNOL, V117, P309; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Galle M, 2008, J CELL MOL MED, V12, P1767, DOI 10.1111/j.1582-4934.2007.00190.x; Gerbase AC, 1998, LANCET, V351, P2, DOI 10.1016/S0140-6736(98)90001-0; Gervassi A, 2004, INFECT IMMUN, V72, P7231, DOI 10.1128/IAI.72.12.7231-7239.2004; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Hackstadt T, 1997, TRENDS MICROBIOL, V5, P288, DOI 10.1016/S0966-842X(97)01061-5; Hatch GM, 1998, BIOCHEM BIOPH RES CO, V243, P356, DOI 10.1006/bbrc.1998.8101; Hess S, 2003, CELL MICROBIOL, V5, P785, DOI 10.1046/j.1462-5822.2003.00319.x; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; ITO JI, 1990, INFECT IMMUN, V58, P2021, DOI 10.1128/IAI.58.6.2021-2023.1990; Lamkanfi M, 2007, J LEUKOCYTE BIOL, V82, P220, DOI 10.1189/jlb.1206756; Lin XY, 2000, J BIOL CHEM, V275, P39920, DOI 10.1074/jbc.M007255200; Lu H, 2000, J IMMUNOL, V165, P1463, DOI 10.4049/jimmunol.165.3.1463; Mabey D, 2002, SEX TRANSM INFECT, V78, P90, DOI 10.1136/sti.78.2.90; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; McClarty Grant, 1994, Trends in Microbiology, V2, P157, DOI 10.1016/0966-842X(94)90665-3; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; Miyairi I, 2006, J INFECT DIS, V194, P350, DOI 10.1086/505432; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; O'Connell CM, 2006, J BIOL CHEM, V281, P1652, DOI 10.1074/jbc.M510182200; Ojcius DM, 1998, J BIOL CHEM, V273, P7052, DOI 10.1074/jbc.273.12.7052; Ojcius DM, 1998, J IMMUNOL, V161, P4220; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Prebeck S, 2003, MICROBES INFECT, V5, P463, DOI 10.1016/S1286-4579(03)00063-7; Rasmussen SJ, 1997, J CLIN INVEST, V99, P77, DOI 10.1172/JCI119136; ROTHERMEL CD, 1989, INFECT IMMUN, V57, P2705, DOI 10.1128/IAI.57.9.2705-2711.1989; Rzomp KA, 2003, INFECT IMMUN, V71, P5855, DOI 10.1128/IAI.71.10.5855-5870.2003; Schachter J, 1999, CHLAMYDIA, P139; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Shin H, 2007, CELL MICROBIOL, V9, P2893, DOI 10.1111/j.1462-5822.2007.01004.x; Slepenkin A, 2007, INFECT IMMUN, V75, P3478, DOI 10.1128/IAI.00023-07; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Sun GW, 2005, CELL MICROBIOL, V7, P1447, DOI 10.1111/j.1462-5822.2005.00569.x; Sutterwala FS, 2009, CLIN IMMUNOL, V130, P2, DOI 10.1016/j.clim.2008.08.011; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Tinmouth J, 2008, INT J STD AIDS, V19, P805, DOI 10.1258/ijsa.2008.008260; Ward ME, 1999, CHLAMYDIA, P171; Welter-Stahl L, 2006, CELL MICROBIOL, V8, P1047, DOI 10.1111/j.1462-5822.2006.00686.x; Wolf K, 2006, MOL MICROBIOL, V61, P1543, DOI 10.1111/j.1365-2958.2006.05347.x; Wyrick PB, 2000, CELL MICROBIOL, V2, P275, DOI 10.1046/j.1462-5822.2000.00059.x; Xia MS, 2003, J INFECT DIS, V187, P424, DOI 10.1086/367962; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007	74	92	96	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26789	26796		10.1074/jbc.M109.026823	http://dx.doi.org/10.1074/jbc.M109.026823			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19648107	Green Published, hybrid			2022-12-27	WOS:000269969600060
J	Hornemann, T; Penno, A; Rutti, MF; Ernst, D; Kivrak-Pfiffner, F; Rohrer, L; von Eckardstein, A				Hornemann, Thorsten; Penno, Anke; Ruetti, Markus F.; Ernst, Daniela; Kivrak-Pfiffner, Fatma; Rohrer, Lucia; von Eckardstein, Arnold			The SPTLC3 Subunit of Serine Palmitoyltransferase Generates Short Chain Sphingoid Bases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY; SPHINGOMYELIN SYNTHESIS; LIQUID-CHROMATOGRAPHY; KNOCKOUT MICE; SPHINGOLIPIDS; METABOLISM; IDENTIFICATION; INHIBITION; DISEASE; ELECTROSPRAY	The enzyme serine palmitoyltransferase (SPT) catalyzes the rate-limiting step in the de novo synthesis of sphingolipids. Previously the mammalian SPT was described as a heterodimer composed of two subunits, SPTLC1 and SPTLC2. Recently we identified a novel third SPT subunit (SPTLC3). SPTLC3 shows about 68% identity to SPTLC2 and also includes a pyridoxal phosphate consensus motif. Here we report that the overexpression of SPTLC3 in HEK293 cells leads to the formation of two new sphingoid base metabolites, namely C-16-sphinganine and C-16-sphingosine. SPTLC3-expressing cells have higher in vitro SPT activities with lauryl-and myristoyl-CoA than SPTLC2-expressing cells, and SPTLC3 mRNA expression levels correlate closely with the C-16-sphinganine synthesis rates in various human and murine cell lines. Approximately 15% of the total sphingolipids in human plasma contain a C-16 backbone and are found in the high density and low density but not the very low density lipoprotein fraction. In conclusion, we show that the SPTLC3 subunit generates C-16-sphingoid bases and that sphingolipids with a C-16 backbone constitute a significant proportion of human plasma sphingolipids.	[Hornemann, Thorsten; Penno, Anke; Ruetti, Markus F.; Ernst, Daniela; Kivrak-Pfiffner, Fatma; Rohrer, Lucia; von Eckardstein, Arnold] Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Hornemann, T (corresponding author), Univ Zurich Hosp, Inst Clin Chem, Ramistr 100, CH-8091 Zurich, Switzerland.	thorsten.hornemann@usz.ch			Foundation for Scientific Research (Forschungskommission, University of Zurich); Hartmann Muller Foundation; German Society for Clinical Chemistry and Laboratory Medicine (DGKL); EMDO Foundation; European Commission [LSHM-CT-2006-037631]	Foundation for Scientific Research (Forschungskommission, University of Zurich); Hartmann Muller Foundation; German Society for Clinical Chemistry and Laboratory Medicine (DGKL); EMDO Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Foundation for Scientific Research (Forschungskommission, University of Zurich), the Hartmann Muller Foundation, the German Society for Clinical Chemistry and Laboratory Medicine (DGKL), the EMDO Foundation, and European Commission Grant LSHM-CT-2006-037631.	Byrdwell WC, 2007, J CHROMATOGR A, V1146, P164, DOI 10.1016/j.chroma.2007.01.108; DUGGLEBY RG, 1981, ANAL BIOCHEM, V110, P9, DOI 10.1016/0003-2697(81)90104-4; Fyrst H, 2004, J LIPID RES, V45, P54, DOI 10.1194/jlr.M300005-JLR200; Fyrst H, 2008, J LIPID RES, V49, P597, DOI 10.1194/jlr.M700414-JLR200; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Han GS, 2006, J BIOL CHEM, V281, P39935, DOI 10.1074/jbc.M609365200; Hanada K, 1997, J BIOL CHEM, V272, P32108, DOI 10.1074/jbc.272.51.32108; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hojjati MR, 2005, J BIOL CHEM, V280, P10284, DOI 10.1074/jbc.M412348200; Hojjati MR, 2005, BBA-MOL CELL BIOL L, V1737, P44, DOI 10.1016/j.bbalip.2005.08.006; Hornemann T, 2007, BIOCHEM J, V405, P157, DOI 10.1042/BJ20070025; Hornemann T, 2006, J BIOL CHEM, V281, P37275, DOI 10.1074/jbc.M608066200; Jiang XC, 2000, ARTERIOSCL THROM VAS, V20, P2614, DOI 10.1161/01.ATV.20.12.2614; Karlsson AA, 1998, J MASS SPECTROM, V33, P1192, DOI 10.1002/(SICI)1096-9888(199812)33:12<1192::AID-JMS735>3.0.CO;2-J; KATSIKAS H, 1995, BBA-LIPID LIPID MET, V1258, P95, DOI 10.1016/0005-2760(95)00104-K; KELLEY JL, 1986, METHOD ENZYMOL, V128, P170; Merrill AH, 2005, GLYCOBIOLOGY, V15, p15G, DOI 10.1093/glycob/cwi070; MERRILL AH, 1985, J LIPID RES, V26, P617; MERRILL AH, 1984, J LIPID RES, V25, P185; Park TS, 2006, ATHEROSCLEROSIS, V189, P264, DOI 10.1016/j.atherosclerosis.2005.12.029; Park TS, 2004, CIRCULATION, V110, P3465, DOI 10.1161/01.CIR.0000148370.60535.22; Pruett ST, 2008, J LIPID RES, V49, P1621, DOI 10.1194/jlr.R800012-JLR200; Riley RT, 1999, NAT TOXINS, V7, P407, DOI 10.1002/1522-7189(199911/12)7:6<407::AID-NT84>3.0.CO;2-0; Saddoughi Sahar A., 2008, V49, P413, DOI 10.1007/978-1-4020-8831-5_16; SAMUELSSON B, 1969, J LIPID RES, V10, P47; Schissel SL, 1996, J CLIN INVEST, V98, P1455, DOI 10.1172/JCI118934; WILLIAMS RD, 1984, ARCH BIOCHEM BIOPHYS, V228, P282, DOI 10.1016/0003-9861(84)90069-9; WONG JTF, 1962, CAN J BIOCHEM PHYS, V40, P763; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yunoki K, 2008, LIPIDS, V43, P151, DOI 10.1007/s11745-007-3145-2; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009; Zitomer NC, 2009, J BIOL CHEM, V284, P4786, DOI 10.1074/jbc.M808798200	33	114	115	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26322	26330		10.1074/jbc.M109.023192	http://dx.doi.org/10.1074/jbc.M109.023192			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19648650	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000269969600012
J	Su, KL; Liao, YF; Hung, HC; Liu, GY				Su, Kuo-Liang; Liao, Ya-Fan; Hung, Hui-Chih; Liu, Guang-Yaw			Critical Factors Determining Dimerization of Human Antizyme Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN ORNITHINE-DECARBOXYLASE; METHOTREXATE-INDUCED APOPTOSIS; SIZE-DISTRIBUTION ANALYSIS; ANALYTICAL ULTRACENTRIFUGATION; ACTIVE-SITE; POLYAMINE METABOLISM; ANGSTROM RESOLUTION; HOMOLOGOUS PROTEIN; SUBSTRATE-BINDING; CELL-GROWTH	Ornithine decarboxylase (ODC) is the first enzyme involved in polyamine biosynthesis, and it catalyzes the decarboxylation of ornithine to putrescine. ODC is a dimeric enzyme, whereas antizyme inhibitor (AZI), a positive regulator of ODC that is homologous to ODC, exists predominantly as a monomer and lacks decarboxylase activity. The goal of this paper was to identify the essential amino acid residues that determine the dimerization of AZI. The nonconserved amino acid residues in the putative dimer interface of AZI (Ser-277, Ser-331, Glu-332, and Asp-389) were substituted with the corresponding residues in the putative dimer interface of ODC (Arg-277, Tyr-331, Asp-332, and Tyr-389, respectively). Analytical ultracentrifugation analysis was used to determine the size distribution of these AZI mutants. The size-distribution analysis data suggest that residue 331 may play a major role in the dimerization of AZI. Mutating Ser-331 to Tyr in AZI (AZI-S331Y) caused a shift from a monomer configuration to a dimer. Furthermore, in comparison with the single mutant AZI-S331Y, the AZI-S331Y/D389Y double mutant displayed a further reduction in the monomer-dimer K-d, suggesting that residue 389 is also crucial for AZI dimerization. Analysis of the triple mutant AZI-S331Y/D389Y/S277R showed that it formed a stable dimer (K-d value = 1.3 mu M). Finally, a quadruple mutant, S331Y/D389Y/S277R/E332D, behaved as a dimer with a K-d value of similar to 0.1 mu M, which is very close to that of the human ODC enzyme. The quadruple mutant, although forming a dimer, could still be disrupted by antizyme (AZ), further forming a heterodimer, and it could rescue the AZ-inhibited ODC activity, suggesting that the AZ-binding ability of the AZI dimer was retained.	[Su, Kuo-Liang; Hung, Hui-Chih] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Su, Kuo-Liang; Hung, Hui-Chih] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Liao, Ya-Fan; Liu, Guang-Yaw] Chung Shan Med Univ, Inst Immunol, Taichung, Taiwan; [Liu, Guang-Yaw] Chung Shan Med Univ Hosp, Div Allergy Immunol & Rheumatol, Taichung 40201, Taiwan	National Chung Hsing University; National Chung Hsing University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Hung, HC (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	hchung@dragon.nchu.edu.tw; liugy@csmu.edu.tw	Hung, Hui-Chih/G-4485-2013; Hung, Hui-Chih/L-8061-2019	Hung, Hui-Chih/0000-0003-0180-1822; Hung, Hui-Chih/0000-0003-0180-1822	National Science Council [NSC-98-2113M- 005-009, NSC-96-2314-B-040-008]; Ministry of Education, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was supported by National Science Council Grants NSC-98-2113M- 005-009 and NSC-96-2314-B-040-008 and in part by the Ministry of Education, Taiwan, under the Aiming for Top University plan.	Albeck S, 2008, PROTEIN SCI, V17, P793, DOI 10.1110/ps.073427208; Almrud JJ, 2000, J MOL BIOL, V295, P7, DOI 10.1006/jmbi.1999.3331; Auvinen M, 1997, CANCER RES, V57, P3016; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; Bercovich Z, 2004, J BIOL CHEM, V279, P54097, DOI 10.1074/jbc.M410234200; Choi KS, 2005, BIOCHEM BIOPH RES CO, V328, P206, DOI 10.1016/j.bbrc.2004.11.172; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Coffino P, 2001, BIOCHIMIE, V83, P319, DOI 10.1016/S0300-9084(01)01252-4; Coffino P, 1998, UBIQUITIN BIOL CELL, P411; COLEMAN CS, 1993, J BIOL CHEM, V268, P24572; COLEMAN CS, 1994, J BIOL CHEM, V269, P3155; Deng AH, 2003, DIABETES, V52, P1235, DOI 10.2337/diabetes.52.5.1235; Furumitsu Y, 2000, J RHEUMATOL, V27, P1352; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Hayashi S, 1996, TRENDS BIOCHEM SCI, V21, P27, DOI 10.1016/0968-0004(96)80882-6; HAYASHI S, 1984, ADV ENZYME REGUL, V23, P311, DOI 10.1016/0065-2571(85)90054-8; Hsu HC, 1999, AUTOIMMUNITY, V29, P299, DOI 10.3109/08916939908994750; Hsu PC, 2006, APOPTOSIS, V11, P389, DOI 10.1007/s10495-006-4002-0; Huang CC, 2005, APOPTOSIS, V10, P895, DOI 10.1007/s10495-005-2947-z; Jackson LK, 2003, J BIOL CHEM, V278, P22037, DOI 10.1074/jbc.M300188200; Jackson LK, 2004, BIOCHEMISTRY-US, V43, P12990, DOI 10.1021/bi048933l; Keren-Paz A, 2006, ONCOGENE, V25, P5163, DOI 10.1038/sj.onc.1209521; Kern AD, 1999, STRUCTURE, V7, P567, DOI 10.1016/S0969-2126(99)80073-2; Kim SW, 2006, J CELL SCI, V119, P2853, DOI 10.1242/jcs.02966; KITANI T, 1984, J BIOL CHEM, V259, P36; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; Liu GY, 2005, APOPTOSIS, V10, P569, DOI 10.1007/s10495-005-1891-2; Mangold U, 2006, CELL MOL LIFE SCI, V63, P2095, DOI 10.1007/s00018-005-5583-4; Mangold U, 2005, IUBMB LIFE, V57, P671, DOI 10.1080/15216540500307031; Mangold U, 2005, BIOCHEM J, V385, P21, DOI 10.1042/BJ20040547; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; Medina MA, 1999, BIOCHEM PHARMACOL, V57, P1341, DOI 10.1016/S0006-2952(99)00005-2; MITCHELL JLA, 1988, ARCH BIOCHEM BIOPHYS, V260, P585, DOI 10.1016/0003-9861(88)90485-7; MITCHELL JLA, 1990, BIOCHIM BIOPHYS ACTA, V1037, P115, DOI 10.1016/0167-4838(90)90109-S; Morrison LD, 1998, J NEUROCHEM, V71, P288; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Murakami Y, 1996, J BIOL CHEM, V271, P3340, DOI 10.1074/jbc.271.7.3340; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Nilsson J, 2000, BIOCHEM J, V346, P699, DOI 10.1042/0264-6021:3460699; OBrien TG, 1997, CANCER RES, V57, P2630; Osterman AL, 1997, BIOCHEMISTRY-US, V36, P4558, DOI 10.1021/bi962916h; OSTERMAN AL, 1995, J BIOL CHEM, V270, P11797, DOI 10.1074/jbc.270.20.11797; OSTERMAN AL, 1995, BIOCHEMISTRY-US, V34, P13431, DOI 10.1021/bi00041a021; PACKHAM G, 1994, MOL CELL BIOL, V14, P5741, DOI 10.1128/MCB.14.9.5741; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; Park JK, 2002, MOL PHARMACOL, V62, P1400, DOI 10.1124/mol.62.6.1400; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Pendeville H, 2001, MOL CELL BIOL, V21, P6549, DOI 10.1128/MCB.21.19.6549-6558.2001; POULIN R, 1992, J BIOL CHEM, V267, P150; Sakata K, 2000, BIOCHEM J, V347, P297, DOI 10.1042/0264-6021:3470297; Schluter KD, 2000, CARDIOVASC RES, V45, P410, DOI 10.1016/S0008-6363(99)00351-X; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seiler N, 1998, INT J ONCOL, V13, P993; Smith MK, 1997, CANCER RES, V57, P2104; SOLANO F, 1985, FEBS LETT, V190, P324, DOI 10.1016/0014-5793(85)81311-9; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Thomas T, 2001, CELL MOL LIFE SCI, V58, P244, DOI 10.1007/PL00000852; Thomson SC, 2001, J CLIN INVEST, V107, P217, DOI 10.1172/JCI10963; TOBIAS KE, 1993, BIOCHEMISTRY-US, V32, P5842, DOI 10.1021/bi00073a017; TSIRKA S, 1992, J BIOL CHEM, V267, P23057; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158; Zhang MS, 2004, J BIOL CHEM, V279, P20959, DOI 10.1074/jbc.M314043200	68	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26768	26777		10.1074/jbc.M109.007807	http://dx.doi.org/10.1074/jbc.M109.007807			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19635796	hybrid, Green Published			2022-12-27	WOS:000269969600058
J	Zhao, L; Pan, YL; Gang, Y; Wang, HH; Jin, HF; Tie, J; Xia, L; Zhang, YG; He, LJ; Yao, LP; Qiao, TD; Li, TT; Liu, ZG; Fan, DM				Zhao, Lina; Pan, Yanglin; Gang, Yi; Wang, Honghong; Jin, Haifeng; Tie, Jun; Xia, Lin; Zhang, Yongguo; He, Lijie; Yao, Liping; Qiao, Taidong; Li, Tingting; Liu, Zhiguo; Fan, Daiming			Identification of GAS1 as an Epirubicin Resistance-related Gene in Human Gastric Cancer Cells with a Partially Randomized Small Interfering RNA Library	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CISPLATIN-INDUCED APOPTOSIS; MAMMALIAN-CELLS; MULTIDRUG-RESISTANCE; FUNCTIONAL GENOMICS; DRUG-RESISTANCE; MEDIATED BCL-2; BREAST-CANCER; GROWTH ARREST; TUMOR-CELLS; SIRNA	Epirubicin has been widely used for chemotherapeutic treatment of gastric cancer; however, intrinsic and acquired chemoresistance remains an obstacle to successful management. The mechanisms underlying epirubicin resistance are still not well defined. Here we report the construction and application of a partially randomized retrovirus library of 4 x 10(6) small interfering RNAs to identify novel genes whose suppression confers epirubicin resistance in gastric cancer cells SGC7901. From 12 resistant cell colonies, two small interfering RNAs targeting GAS1 (growth arrest-specific 1) and PTEN (phosphatase and tensin homolog), respectively, were identified and validated. We identified a previously unrecognized chemoresistance role for GAS1. GAS1 suppression resulted in significant epirubicin resistance and cross-resistance to 5-fluorouracil and cisplatin in various gastric cancer cell lines. GAS1 suppression promoted multidrug resistance through apoptosis inhibition, partially by up-regulating the Bcl-2/Bax ratio that was abolished by Bcl-2 inhibition. GAS1 suppression induced chemoresistance partially by increasing drug efflux in an ATP-binding cassette transporter and drug-dependent manner. P-glycoprotein (P-gp) and BCRP (breast cancer resistance protein) but not MRP-1 were up-regulated, and targeted knockdown of P-gp and BCRP could partially reverse GAS1 suppression-induced epirubicin resistance. Verapamil, a P-gp inhibitor, could reverse P-gp substrate (epirubicin) but not non-P-gp substrate (5-fluorouracil and cisplatin) resistance in GAS1-suppressed gastric cancer cells. BCRP down-regulation could partially reverse 5-fluorouracil but not cisplatin resistance induced by GAS1 suppression, suggesting 5-fluorouracil but not cisplatin was a BCRP substrate. These results suggest that GAS1 might be a target to overcome multidrug resistance and provide a novel approach to identifying candidate genes that suppress chemoresistance of gastric cancers.	[Liu, Zhiguo; Fan, Daiming] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Liu, Zhiguo; Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Liu, ZG (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, 15 W Changle Rd, Xian 710032, Peoples R China.	liuzhiguo@fmmu.edu.cn; fandaim@fmmu.edu.cn	Cui, Tie Jun/Y-3224-2019	Tie, Jun/0000-0002-3669-0467; liu, zhiguo/0000-0002-8485-7356	National Natural Science Foundation of China [30672369, 30670970, 30400016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 30672369, 30670970, and 30400016.	Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Bartz SR, 2006, MOL CELL BIOL, V26, P9377, DOI 10.1128/MCB.01229-06; Bernards R, 2006, NAT METHODS, V3, P701, DOI 10.1038/NMETH921; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Blow N, 2008, NAT METHODS, V5, P361, DOI 10.1038/nmeth0408-361; Buchholz F, 2006, NAT METHODS, V3, P696, DOI 10.1038/NMETH912; Chen MH, 2007, EXPERT REV MOL DIAGN, V7, P281, DOI 10.1586/14737159.7.3.281; Chen MH, 2005, P NATL ACAD SCI USA, V102, P2356, DOI 10.1073/pnas.0401549101; Cullen LM, 2005, IMMUNOL CELL BIOL, V83, P217, DOI 10.1111/j.1440-1711.2005.01332.x; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Dahlgren C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn190; DELSAL G, 1992, CELL, V70, P595, DOI 10.1016/0092-8674(92)90429-G; Dominguez-Monzon G, 2009, INT J DEV NEUROSCI, V27, P305, DOI 10.1016/j.ijdevneu.2009.03.009; Dorn Alexandra, 1993, Paediatrie und Paedologie, V28, P157; Du Jing-ping, 2003, Zhonghua Yi Xue Za Zhi, V83, P328; Du Q, 2005, NUCLEIC ACIDS RES, V33, P1671, DOI 10.1093/nar/gki312; Fewell GD, 2006, DRUG DISCOV TODAY, V11, P975, DOI 10.1016/j.drudis.2006.09.008; Gobeil S, 2008, GENE DEV, V22, P2932, DOI 10.1101/gad.1714608; Guo Q, 2007, BIOCHEM BIOPH RES CO, V358, P272, DOI 10.1016/j.bbrc.2007.04.123; Huang RY, 2005, CANCER RES, V65, P5890, DOI 10.1158/0008-5472.CAN-04-4093; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Kaykas A, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-16; Kim R, 2004, CANCER-AM CANCER SOC, V101, P2177, DOI 10.1002/cncr.20636; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Konishi T, 2006, ONCOGENE, V25, P3160, DOI 10.1038/sj.onc.1209342; Lei XY, 2007, CLIN EXP PHARMACOL P, V34, P450, DOI 10.1111/j.1440-1681.2007.04593.x; Li W, 2007, CELL MOL LIFE SCI, V64, P1785, DOI 10.1007/s00018-007-7057-3; Liang ZC, 2005, IDRUGS, V8, P924; Liu H, 2008, ONCOL REP, V20, P963, DOI 10.3892/or_00000097; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Ramirez MA, 2008, INT J DEV NEUROSCI, V26, P497, DOI 10.1016/j.ijdevneu.2008.02.006; Luo B, 2004, P NATL ACAD SCI USA, V101, P5494, DOI 10.1073/pnas.0400551101; Macdonald JS, 2006, NEW ENGL J MED, V355, P76, DOI 10.1056/NEJMe068121; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Martinelli DC, 2007, CELL CYCLE, V6, P2650, DOI 10.4161/cc.6.21.4877; Martinelli DC, 2007, GENE DEV, V21, P1231, DOI 10.1101/gad.1546307; Matsumoto Sahohime, 2007, Methods Mol Biol, V360, P131; Michaud WA, 2009, CLIN CANCER RES, V15, P1645, DOI 10.1158/1078-0432.CCR-08-2581; Miyagishi M, 2003, OLIGONUCLEOTIDES, V13, P325, DOI 10.1089/154545703322617005; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Oki E, 2005, INT J CANCER, V117, P376, DOI 10.1002/ijc.21170; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Paddison PJ, 2002, P NATL ACAD SCI USA, V99, P1443, DOI 10.1073/pnas.032652399; Pan YL, 2006, FASEB J, V20, P1886, DOI 10.1096/fj.06-6138fje; Plati J, 2008, J CELL BIOCHEM, V104, P1124, DOI 10.1002/jcb.21707; Reynolds A, 2006, RNA, V12, P988, DOI 10.1261/rna.2340906; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Sen G, 2004, NAT GENET, V36, P183, DOI 10.1038/ng1288; Sherbakova E A, 2008, Mol Biol (Mosk), V42, P487; Shirane D, 2004, NAT GENET, V36, P190, DOI 10.1038/ng1290; Silva J, 2004, ONCOGENE, V23, P8401, DOI 10.1038/sj.onc.1208176; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Sims-Mourtada J, 2007, ONCOGENE, V26, P5674, DOI 10.1038/sj.onc.1210356; Singer O, 2004, P NATL ACAD SCI USA, V101, P5313, DOI 10.1073/pnas.0401209101; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Spagnuolo R, 2004, BLOOD, V103, P3005, DOI 10.1182/blood-2003-07-2459; Stavrovskaya AA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P592, DOI 10.1134/S0006297908050118; Stebel M, 2000, FEBS LETT, V481, P152, DOI 10.1016/S0014-5793(00)02004-4; Steelman LS, 2008, ONCOGENE, V27, P4086, DOI 10.1038/onc.2008.49; Villar J, 2009, CANCER RES, V69, P102, DOI 10.1158/0008-5472.CAN-08-2922; Wang YP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003171; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Wu HL, 2007, BIOL PROCED ONLINE, V9, P9, DOI 10.1251/bpo129; Yu HG, 2008, INT J CANCER, V122, P433, DOI 10.1002/ijc.23049; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Yuan JH, 2009, CANCER CHEMOTH PHARM, V63, P1103, DOI 10.1007/s00280-008-0838-z; Zamorano A, 2004, NEUROBIOL DIS, V15, P483, DOI 10.1016/j.nbd.2003.11.022; Zamorano A, 2003, J NEUROSCI RES, V71, P256, DOI 10.1002/jnr.10461; Zhang CX, 2007, ANTI-CANCER DRUG, V18, P581, DOI 10.1097/CAD.0b013e3280146296; Zhang DX, 2007, EXPERT REV ANTICANC, V7, P1369, DOI 10.1586/14737140.7.10.1369; Zhao YQ, 2002, CANCER LETT, V185, P211, DOI 10.1016/S0304-3835(02)00264-1; Zheng LX, 2004, P NATL ACAD SCI USA, V101, P135, DOI 10.1073/pnas.2136685100	73	39	39	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26273	26285		10.1074/jbc.M109.028068	http://dx.doi.org/10.1074/jbc.M109.028068			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19638344	Green Published			2022-12-27	WOS:000269969600007
J	Yang, CM; Hsieh, HL; Yao, CC; Hsiao, LD; Tseng, CP; Wu, CB				Yang, Chuen-Mao; Hsieh, Hsi-Lung; Yao, Chung-Chen; Hsiao, Li-Der; Tseng, Chin-Ping; Wu, Chou Bing			Protein Kinase C-delta Transactivates Platelet-derived Growth Factor Receptor-alpha in Mechanical Strain-induced Collagenase 3 (Matrix Metalloproteinase-13) Expression by Osteoblast-like Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BETA-RECEPTOR; SMOOTH-MUSCLE-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; INTERSTITIAL COLLAGENASE; SIGNAL-TRANSDUCTION; BONE-CELLS; IN-VITRO; PDGF; DIFFERENTIATION; PATHWAYS	Matrix metalloproteinase-13 (MMP-13, or collagenase 3) has been shown to degrade intact collagen and to participate in situations where rapid and effective remodeling of collagenous ECM is required. Mechanical strain induction of MMP-13 is an example of how osteoblasts respond to high mechanical forces and participate in the bone-remodeling mechanism. Using MC3T3-E1 osteoblast-like cells, we dissected the signaling molecules involved in MMP-13 induction by mechanical strain. Reverse transcription-PCR and zymogram analysis showed that platelet-derived growth factor receptor (PDGFR) inhibitor, AG1296, inhibited the mechanical strain-induced MMP-13 gene and activity. However, the induction was not affected by anti-PDGF-AA serum. Immunoblot analysis revealed time-dependent phosphorylation of PDGFR-alpha up to 2.7-fold increases within 3 min under strain. Transfection with shPDGFR-alpha (at 4 and 8 mu g/ml) abolished PDGFR-alpha and reduced MMP-13 expression. Moreover, time-dependent recruitments of phosphoinositide 3-kinase (PI3K) by PDGFR-alpha were detected by immunoprecipitation with anti-PDGFR-alpha serum followed by immunoblot with anti-PI3K serum. AG1296 inhibited PDGFR-alpha/PI3K aggregation and Akt phosphorylation. Interestingly, protein kinase C-delta (PKC-delta) inhibitor, rottlerin, inhibited not only PDGFR-alpha/PI3K aggregation but PDGFR-alpha phosphorylation. The sequential activations were further confirmed by mutants Delta PKC-delta, Delta Akt, and Delta ERK1. Consistently, the primary mouse osteoblast cells used the same identified signaling molecules to express MMP-13 under mechanical strain. These results demonstrate that, in osteoblast-like cells, the MMP-13 induction by mechanical strain requires the transactivation of PDGFR-alpha by PKC-delta and the cross-talk between PDGFR-alpha/PI3K/Akt and MEK/ERK pathways.	[Yang, Chuen-Mao] Chang Gung Univ, Dept Pharmacol, Tao Yuan 333, Taiwan; [Hsieh, Hsi-Lung] Chang Gung Inst Technol, Dept Nursing, Tao Yuan 333, Taiwan; [Yao, Chung-Chen] Natl Taiwan Univ, Div Orthodont, Sch Dent, Taipei 100, Taiwan; [Hsiao, Li-Der] Chang Gung Mem Hosp, Dept Orthodont, Tao Yuan 333, Taiwan; [Tseng, Chin-Ping] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan 333, Taiwan; [Wu, Chou Bing] Chang Gung Univ, Grad Inst Craniofacial & Dent Sci, Coll Med, Tao Yuan 333, Taiwan	Chang Gung University; Chang Gung University of Science & Technology; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Wu, CB (corresponding author), 5 Fu Shing St, Tao Yuan, Taiwan.	cbw@adm.cgmh.org.tw	Yao, Chung-Chen/D-1470-2018	Hsieh, Hsi-Lung/0000-0001-8302-2472; TSENG, CHING-PING/0000-0002-2587-210X; YAO, JANE CHUNG-CHEN/0000-0002-2293-7000; Yang, Chuen-Mao/0000-0002-3208-5438	Chang Gung Memorial Hospital, Taiwan [CMRPG331103]; National Science Council, Taiwan [NSC-96-2320-B-182-003, NSC-95-2314-B-002-212]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Grant CMRPG331103 (to C. B. W.) from Chang Gung Memorial Hospital, Taiwan and by Grants NSC-96-2320-B-182-003 (to C. M. Y.) and NSC-95-2314-B-002-212 (to C. C. Y.) from National Science Council, Taiwan.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURR DB, 1993, CALCIFIED TISSUE INT, V53, pS75, DOI 10.1007/BF01673407; Buxton PG, 2008, BONE, V43, P377, DOI 10.1016/j.bone.2008.03.028; Chang HH, 2008, J DENT RES, V87, P692, DOI 10.1177/154405910808700714; Chaudhary LR, 2001, J CELL BIOCHEM, V81, P304, DOI 10.1002/1097-4644(20010501)81:2<304::AID-JCB1045>3.3.CO;2-L; FROST HM, 1994, ANGLE ORTHOD, V64, P175; Frost HM, 1998, CALCIFIED TISSUE INT, V62, P89, DOI 10.1007/s002239900399; Frost HM, 1997, J BONE MINER RES, V12, P1539, DOI 10.1359/jbmr.1997.12.10.1539; GACK S, 1995, CELL GROWTH DIFFER, V6, P759; HART CE, 1988, SCIENCE, V240, P1529, DOI 10.1126/science.2836952; HASEGAWA S, 1985, CALCIFIED TISSUE INT, V37, P431, DOI 10.1007/BF02553714; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; HENRIET P, 1992, FEBS LETT, V310, P175, DOI 10.1016/0014-5793(92)81323-E; Hu YH, 1998, FASEB J, V12, P1135, DOI 10.1096/fasebj.12.12.1135; Huang CL, 2004, J BIOL CHEM, V279, P42279, DOI 10.1074/jbc.M402540200; Im HJ, 2007, J BIOL CHEM, V282, P11110, DOI 10.1074/jbc.M609040200; JONES DB, 1991, BIOMATERIALS, V12, P101, DOI 10.1016/0142-9612(91)90186-E; Karjalainen HM, 2003, BIORHEOLOGY, V40, P93; Kovalenko M, 1997, BIOCHEMISTRY-US, V36, P6260, DOI 10.1021/bi962553l; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; LAMBERT CA, 1992, LAB INVEST, V66, P444; LANYON LE, 1996, BONE S1, V18, P37; Lee AA, 1996, AM J PHYSIOL-CELL PH, V271, pC1400, DOI 10.1152/ajpcell.1996.271.4.C1400; Lee Yueh-Tse, 2009, Chang Gung Med J, V32, P320; LI WQ, 1994, MOL CELL BIOL, V14, P6727, DOI 10.1128/MCB.14.10.6727; Liedert A, 2006, BIOCHEM BIOPH RES CO, V349, P1, DOI 10.1016/j.bbrc.2006.07.214; Liu F, 2003, J CELL SCI, V116, P1787, DOI 10.1242/jcs.00376; Ma YH, 1999, BIOCHEM BIOPH RES CO, V265, P606, DOI 10.1006/bbrc.1999.1718; MA YH, 1994, J BIOL CHEM, V269, P30734; MARTIN RB, 1989, STRUCTURE FUNCTION A, P186; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Prenzel N, 2000, BREAST CANCER RES, V2, P184, DOI 10.1186/bcr52; Rydziel S, 2000, J CELL PHYSIOL, V184, P326, DOI 10.1002/1097-4652(200009)184:3<326::AID-JCP6>3.0.CO;2-S; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; SOMJEN D, 1980, BIOCHIM BIOPHYS ACTA, V627, P91, DOI 10.1016/0304-4165(80)90126-9; Soriano P, 1997, DEVELOPMENT, V124, P2691; StahleBackdahl M, 1997, LAB INVEST, V76, P717; Suzuma I, 2002, J BIOL CHEM, V277, P1047, DOI 10.1074/jbc.M105336200; Tallquist MD, 2003, DEVELOPMENT, V130, P507, DOI 10.1242/dev.00241; Tanimoto T, 2004, CIRC RES, V94, P1050, DOI 10.1161/01.RES.0000126404.41421.BE; Tseng CP, 2003, FEBS LETT, V541, P21, DOI 10.1016/S0014-5793(03)00281-3; Varghese S, 1996, ENDOCRINOLOGY, V137, P431, DOI 10.1210/en.137.2.431; Vincent TL, 2004, ARTHRITIS RHEUM, V50, P526, DOI 10.1002/art.20047; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang W, 1997, BIOCHEM MOL BIOL INT, V43, P339; Yang CM, 2004, J BIOL CHEM, V279, P22158, DOI 10.1074/jbc.M401343200	47	11	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26040	26050		10.1074/jbc.M109.040154	http://dx.doi.org/10.1074/jbc.M109.040154			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19633290	Green Published, hybrid			2022-12-27	WOS:000269738000060
J	Lorda-Diez, CI; Montero, JA; Martinez-Cue, C; Garcia-Porrero, JA; Hurle, JM				Lorda-Diez, Carlos I.; Montero, Juan A.; Martinez-Cue, Carmen; Garcia-Porrero, Juan A.; Hurle, Juan M.			Transforming Growth Factors beta Coordinate Cartilage and Tendon Differentiation in the Developing Limb Mesenchyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMAD TRANSCRIPTIONAL COREPRESSOR; CHICK LEG BUD; TGF-BETA; GENE-EXPRESSION; CHONDROCYTE DIFFERENTIATION; PROGENITOR CELLS; ENDOCHONDRAL OSSIFICATION; EMBRYONIC-DEVELOPMENT; PATTERN-FORMATION; KNOCKOUT MICE	Transforming growth factor beta (TGF beta) signaling has an increasing interest in regenerative medicine as a potential tool to repair cartilages, however the chondrogenic effect of this pathway in developing systems is controversial. Here we have analyzed the function of TGF beta signaling in the differentiation of the developing limb mesoderm in vivo and in high density micromass cultures. In these systems highest signaling activity corresponded with cells at stages preceding overt chondrocyte differentiation. Interestingly treatments with TGF beta s shifted the differentiation outcome of the cultures from chondrogenesis to fibrogenesis. This phenotypic reprogramming involved downregulation of Sox9 and Aggrecan and up-regulation of Scleraxis, and Tenomodulin through the Smad pathway. We further show that TGF beta signaling up-regulates Sox9 in the in vivo experimental model system in which TGF beta treatments induce ectopic chondrogenesis. Looking for clues explaining the dual role of TGF beta signaling, we found that TGF beta s appear to be direct inducers of the chondrogenic gene Sox9, but the existence of transcriptional repressors of TGF beta signaling modulates this role. We identified TGF-interacting factor Tgif1 and SKI-like oncogene SnoN as potential candidates for this inhibitory function. Tgif1 gene regulation by TGF beta signaling correlated with the differential chondrogenic and fibrogenic effects of this pathway, and its expression pattern in the limb marks the developing tendons. In functional experiments we found that Tgif1 reproduces the profibrogenic effect of TGF beta treatments.	Univ Cantabria, Dept Anat & Biol Celular, Santander 39011, Spain; [Martinez-Cue, Carmen] Univ Cantabria, Dept Fisiol & Farmacol, Santander 39011, Spain	Universidad de Cantabria; Universidad de Cantabria	Hurle, JM (corresponding author), Fac Med, C Cardenal Herrera Oria S-N, Santander 39011, Spain.	hurlej@unican.es	Montero, Juan A/K-4395-2014; Cue, Carmen Martinez/AAA-2850-2019; Lorda-Diez, Carlos I./J-7990-2019	Montero, Juan A/0000-0001-9099-5344; Lorda-Diez, Carlos I./0000-0002-3248-9918; Martinez-Cue, Carmen/0000-0002-2137-1156; Hurle, Juan M/0000-0002-4685-025X	Sciences and Innovation Ministry [BFU2008-03930]	Sciences and Innovation Ministry	This work was supported by the Sciences and Innovation Ministry ( Grant BFU2008-03930 to J. M. H.).	AHRENS PB, 1977, DEV BIOL, V60, P69, DOI 10.1016/0012-1606(77)90110-5; Akiyama H, 2007, MATRIX BIOL, V26, P224, DOI 10.1016/j.matbio.2006.12.002; Anthwal N, 2008, DEV DYNAM, V237, P1604, DOI 10.1002/dvdy.21567; Asou Y, 2002, J ORTHOPAED RES, V20, P827, DOI 10.1016/S0736-0266(01)00169-3; Baffi MO, 2004, DEV BIOL, V276, P124, DOI 10.1016/j.ydbio.2004.08.027; Bandyopadhyay A, 2008, DEV BIOL, V321, P162, DOI 10.1016/j.ydbio.2008.06.012; Bartholin L, 2006, MOL CELL BIOL, V26, P990, DOI 10.1128/MCB.26.3.990-1001.2006; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; BRAND B, 1985, AM J ANAT, V173, P321, DOI 10.1002/aja.1001730408; CARRINGTON JL, 1990, EXP CELL RES, V186, P368, DOI 10.1016/0014-4827(90)90318-5; CHEN P, 1991, EXP CELL RES, V195, P509, DOI 10.1016/0014-4827(91)90403-H; Chimal-Monroy J, 2003, DEV BIOL, V257, P292, DOI 10.1016/S0012-1606(03)00066-6; Chimal-Monroy J, 1999, INT J DEV BIOL, V43, P59; ChimalMonroy J, 1997, INT J DEV BIOL, V41, P91; CHUONG CM, 1991, AM J PATHOL, V138, P427; Dai CS, 2004, J AM SOC NEPHROL, V15, P1402, DOI 10.1097/01.ASN.0000130568.53923.FD; DENKER AE, 1995, DIFFERENTIATION, V59, P25, DOI 10.1046/j.1432-0436.1995.5910025.x; Dong YF, 2007, MOL ENDOCRINOL, V21, P2805, DOI 10.1210/me.2007-0199; Dunker N, 2002, ANAT EMBRYOL, V206, P73, DOI 10.1007/s00429-002-0273-6; Ferguson CM, 2004, J ORTHOP RES, V22, P687, DOI 10.1016/j.orthres.2003.10.023; Furumatsu T, 2009, INT J BIOCHEM CELL B, V41, P1198, DOI 10.1016/j.biocel.2008.10.032; Ganan Y, 1996, DEVELOPMENT, V122, P2349; Halper J, 2004, GROWTH FACTORS, V22, P121, DOI 10.1080/08977190410001712878; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HAYAMIZU TF, 1991, DEV BIOL, V145, P164, DOI 10.1016/0012-1606(91)90222-O; Healy C, 1999, DEV DYNAM, V215, P69, DOI 10.1002/(SICI)1097-0177(199905)215:1<69::AID-DVDY8>3.3.CO;2-E; HURLE JM, 1986, J EMBRYOL EXP MORPH, V94, P231; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Jin EJ, 2008, J CELL PHYSIOL, V214, P345, DOI 10.1002/jcp.21202; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; KIENY M, 1979, J EMBRYOL EXP MORPH, V49, P153; Knepper JL, 2006, DEV DYNAM, V235, P1482, DOI 10.1002/dvdy.20725; KULYK WM, 1989, DEV BIOL, V135, P424, DOI 10.1016/0012-1606(89)90191-7; Kuo CK, 2008, DEV DYNAM, V237, P1477, DOI 10.1002/dvdy.21547; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lejard V, 2007, J BIOL CHEM, V282, P17665, DOI 10.1074/jbc.M610113200; LEONARD CM, 1991, DEV BIOL, V145, P99, DOI 10.1016/0012-1606(91)90216-P; Lincoln J, 2006, DEV BIOL, V294, P292, DOI 10.1016/j.ydbio.2006.03.027; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo KX, 2004, CURR OPIN GENET DEV, V14, P65, DOI 10.1016/j.gde.2003.11.003; Merino R, 1998, DEV BIOL, V200, P35, DOI 10.1006/dbio.1998.8946; MILLAN FA, 1991, DEVELOPMENT, V111, P131; Minina E, 2005, GENE EXPR PATTERNS, V6, P102, DOI 10.1016/j.modgep.2005.04.012; Miura T, 2000, DEV DYNAM, V217, P241, DOI 10.1002/(SICI)1097-0177(200003)217:3<241::AID-DVDY2>3.0.CO;2-K; Montero JA, 2008, DEV BIOL, V321, P343, DOI 10.1016/j.ydbio.2008.06.022; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; NEWMAN SA, 1981, DEV BIOL, V84, P440, DOI 10.1016/0012-1606(81)90413-9; Newman Stuart A., 2007, Birth Defects Research, V81, P305, DOI 10.1002/bdrc.20112; Oka K, 2008, DEV BIOL, V321, P303, DOI 10.1016/j.ydbio.2008.03.046; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; ROARK EF, 1994, DEV DYNAM, V200, P103, DOI 10.1002/aja.1002000203; ROS MA, 1995, ANAT EMBRYOL, V192, P483; Salingcarnboriboon R, 2003, EXP CELL RES, V287, P289, DOI 10.1016/S0014-4827(03)00107-1; Sanford LP, 1997, DEVELOPMENT, V124, P2659; SCHOFIELD JN, 1990, EXP CELL RES, V191, P144, DOI 10.1016/0014-4827(90)90048-F; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Seo HS, 2007, DEV BIOL, V310, P304, DOI 10.1016/j.ydbio.2007.07.040; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Song JJ, 2007, J CELL PHYSIOL, V210, P398, DOI 10.1002/jcp.20850; Spagnoli A, 2007, J CELL BIOL, V177, P1105, DOI 10.1083/jcb.200611031; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; THORP BH, 1992, DEVELOPMENT, V114, P907; Tsuiki H, 1996, TERATOLOGY, V54, P191, DOI 10.1002/(SICI)1096-9926(199610)54:4<191::AID-TERA3>3.0.CO;2-4; Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; Wotton D, 2001, CURR TOP MICROBIOL, V254, P145; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yamagishi T, 1999, CELL TISSUE RES, V298, P85, DOI 10.1007/s004419900073; Zhang XP, 2004, BONE, V34, P809, DOI 10.1016/j.bone.2003.12.026	73	128	136	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29988	29996		10.1074/jbc.M109.014811	http://dx.doi.org/10.1074/jbc.M109.014811			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19717568	Green Published, hybrid			2022-12-27	WOS:000270896800077
J	Tyapochkin, E; Cook, PF; Chen, GP				Tyapochkin, Eduard; Cook, Paul F.; Chen, Guangping			para-Nitrophenyl Sulfate Activation of Human Sulfotransferase 1A1 Is Consistent with Intercepting the E center dot PAP Complex and Reformation of E center dot PAPS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHENOL SULFOTRANSFERASE; ESTROGEN SULFOTRANSFERASE; SUBSTRATE-INHIBITION; RETINOL DEHYDRATASE; MULTIPLE INHIBITION; CRYSTAL-STRUCTURE; BINDING SITE; ACTIVE-SITE; HUMAN LIVER; MECHANISM	Cytosolic sulfotransferase (SULT)-catalyzed sulfation regulates biological activities of various biosignaling molecules and metabolizes hydroxyl-containing drugs and xenobiotics. The universal sulfuryl group donor for SULT-catalyzed sulfation is adenosine 3'-phosphate 5'-phosphosulfate (PAPS), whereas the reaction products are a sulfated product and adenosine 3',5'-diphosphate (PAP). Although SULT-catalyzed kinetic mechanisms have been studied since the 1980s, they remain unclear. Human SULT1A1 is an important phase II drug-metabolizing enzyme. Previously, isotope exchange at equilibrium indicated steady-state ordered mechanism with PAPS and PAP binding to the free SULT1A1 (Tyapochkin, E., Cook, P. F., and Chen, G. (2008) Biochemistry 47, 11894-11899). On the basis of activation of SULT1A1 by para-nitrophenyl sulfate (pNPS), an ordered bypass mechanism has been proposed where pNPS sulfates PAP prior to its release from the E center dot PAP complex regenerating E center dot PAPS. Data are consistent with uncompetitive substrate inhibition by naphthol as a result of formation of the E center dot PAP center dot naphthol dead-end complex; formation of the complex is corroborated by naphthol/PAP double inhibition experiments. pNPS activation data demonstrate an apparent ping-pong behavior with pNPS adding to E center dot PAP, and competitive inhibition by naphthol consistent with formation of the E center dot PAP center dot naphthol complex. Exchange against forward reaction flux (PAPS plus naphthol) beginning with [S-35] PAPS and generating [S-35] naphthyl sulfate is also consistent with pNPS intercepting the E center dot PAP complex. Overall, data are consistent with the proposed ordered bypass mechanism.	[Cook, Paul F.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; [Tyapochkin, Eduard; Chen, Guangping] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Physiol Sci, Stillwater, OK 74078 USA	University of Oklahoma System; University of Oklahoma - Norman; Oklahoma State University System; Oklahoma State University - Stillwater	Cook, PF (corresponding author), Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA.	pcook@ou.edu; guangping.chen@okstate.edu			National Institutes of Health [GM078606]; Grayce B. Kerr endowment to the University of Oklahoma; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078606] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grayce B. Kerr endowment to the University of Oklahoma; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM078606 (to G. C.). This work was also supported by the Grayce B. Kerr endowment to the University of Oklahoma to support the research of P. F. C.	Barnett AC, 2004, J BIOL CHEM, V279, P18799, DOI 10.1074/jbc.M312253200; Beckmann JD, 2003, BBA-PROTEINS PROTEOM, V1648, P134, DOI 10.1016/S1570-9639(03)00116-X; Chapman E, 2004, ANGEW CHEM INT EDIT, V43, P3526, DOI 10.1002/anie.200300631; Chen GP, 1999, PROTEIN SCI, V8, P2151, DOI 10.1110/ps.8.10.2151; Chen GP, 2000, BIOCHEMISTRY-US, V39, P16000, DOI 10.1021/bi0021479; Cleland W W, 1979, Methods Enzymol, V63, P500; CLELAND WW, 1975, BIOCHEMISTRY-US, V14, P3220, DOI 10.1021/bi00685a029; COOK PF, 2007, ENZYME KINETICS MECH, P191; Coughtrie M. W. H., 2002, Pharmacogenomics Journal, V2, P297; Coughtrie MWH, 2001, DRUG METAB DISPOS, V29, P522; DUFFEL MW, 1981, J BIOL CHEM, V256, P1123; Duffel MW, 2001, DRUG METAB REV, V33, P369, DOI 10.1081/DMR-120001394; FALANY CN, 1995, J STEROID BIOCHEM, V52, P529, DOI 10.1016/0960-0760(95)00015-R; Falany CN, 1997, FASEB J, V11, P206, DOI 10.1096/fasebj.11.4.9068609; FERSHT A, 1985, ENZYME STRUCTURE MEC, P98; Frame LT, 2000, DRUG METAB DISPOS, V28, P1063; Gamage N, 2006, TOXICOL SCI, V90, P5, DOI 10.1093/toxsci/kfj061; Gamage NU, 2003, J BIOL CHEM, V278, P7655, DOI 10.1074/jbc.M207246200; Glatt H, 2000, CHEM-BIOL INTERACT, V129, P141, DOI 10.1016/S0009-2797(00)00202-7; Glatt H, 2000, TOXICOL LETT, V112, P341, DOI 10.1016/S0378-4274(99)00214-3; Kakuta Y, 1997, NAT STRUCT BIOL, V4, P904, DOI 10.1038/nsb1197-904; KIICK DM, 1986, BIOCHEMISTRY-US, V25, P227, DOI 10.1021/bi00349a032; KIM HJ, 1995, DRUG METAB DISPOS, V23, P840; LESKOVAC V, 2003, COMPREHENSIVE ENZYME, P91; Lin ES, 1998, ANAL BIOCHEM, V264, P111, DOI 10.1006/abio.1998.2800; Miksits M, 2005, XENOBIOTICA, V35, P1101, DOI 10.1080/00498250500354253; NORTHROP DB, 1974, J BIOL CHEM, V249, P2928; Pacifici GM, 2004, INT J CLIN PHARM TH, V42, P488; Pakhomova S, 2000, ACTA CRYSTALLOGR D, V56, P1641, DOI 10.1107/S0907444900012671; Pakhomova S, 2005, PROTEIN SCI, V14, P176, DOI 10.1110/ps.041061105; Pakhomova S, 2001, NAT STRUCT BIOL, V8, P447, DOI 10.1038/87617; Rehse PH, 2002, BIOCHEM J, V364, P165, DOI 10.1042/bj3640165; Runge-Morris M, 2005, CURR DRUG METAB, V6, P299, DOI 10.2174/1389200054633871; Shevtsov S, 2003, ENVIRON HEALTH PERSP, V111, P884, DOI 10.1289/ehp.6056; Tyapochkin E, 2008, BIOCHEMISTRY-US, V47, P11894, DOI 10.1021/bi801211t; Wang LQ, 2006, CURR DRUG METAB, V7, P83, DOI 10.2174/138920006774832596; YONETANI T, 1964, ARCH BIOCHEM BIOPHYS, V106, P243, DOI 10.1016/0003-9861(64)90184-5	37	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29357	29364		10.1074/jbc.M109.049312	http://dx.doi.org/10.1074/jbc.M109.049312			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19706609	Green Published, hybrid			2022-12-27	WOS:000270896800016
J	Xiao, LQ; Eto, M; Kazanietz, MG				Xiao, Liqing; Eto, Masumi; Kazanietz, Marcelo G.			ROCK Mediates Phorbol Ester-induced Apoptosis in Prostate Cancer Cells via p21(Cip1) Up-regulation and JNK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; LIGHT-CHAIN PHOSPHORYLATION; RHO-ASSOCIATED KINASE; PKC-DELTA; BARRIER FUNCTION; GENE-EXPRESSION; EXCHANGE FACTOR; ACTIVATION; PATHWAY; GTPASES	It is established that androgen-dependent prostate cancer cells undergo apoptosis upon treatment with phorbol esters and related analogs, an effect primarily mediated by PKC delta. Treatment of LNCaP prostate cancer cells with phorbol 12-myristate 13-acetate (PMA) causes a strong and sustained activation of RhoA and its downstream effector ROCK(Rho kinase) as well as the formation of stress fibers. These effects are impaired in cells subjected to PKC delta RNA interference depletion. Functional studies revealed that expression of a dominant negative RhoA mutant or treatment with the ROCK inhibitor Y-27632 inhibits the apoptotic effect of PMA in LNCaP cells. Remarkably, the cytoskeleton inhibitors cytochalasin B and blebbistatin blocked not only PMA-induced apoptosis but also the activation of JNK, a mediator of the cell death effect by the phorbol ester. In addition, we found that up-regulation of the cell cycle inhibitor p21(Cip1) is required for PMA-induced apoptosis and that inhibitors of ROCK or the cytoskeleton organization prevent p21(Cip1) induction. Real time PCR analysis and reporter gene assay revealed thatPMAinduces p21(Cip1) transcriptionally in a ROCK- and cytoskeleton-dependent manner. p21(Cip1) promoter analysis revealed that PMA induction is dependent on Sp1 elements in the p21(Cip1) promoter but independent of p53. Taken together, our studies implicate ROCK-mediated up-regulation of p21(Cip1) and the cytoskeleton in PKC delta-dependent apoptosis in prostate cancer cells.	[Xiao, Liqing; Kazanietz, Marcelo G.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Eto, Masumi] Thomas Jefferson Univ, Dept Mol Physiol & Biophys, Philadelphia, PA 19107 USA	University of Pennsylvania; Jefferson University	Kazanietz, MG (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 1256 Biomed Res Bldg 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	marcelog@upenn.edu	Eto, Masumi/ABE-4700-2020	Eto, Masumi/0000-0002-0651-5836	National Institutes of Health [RO1-CA89202, RO1-HL083261]; NATIONAL CANCER INSTITUTE [R01CA089202] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083261] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-CA89202 (to M. G. K.) and RO1-HL083261 (to M. E.).	Afrasiabi E, 2008, MOL CELL ENDOCRINOL, V292, P26, DOI 10.1016/j.mce.2008.04.018; Barry OP, 2001, CURR PHARM DESIGN, V7, P1725, DOI 10.2174/1381612013397041; Berenjeno IM, 2008, CLIN TRANSL ONCOL, V10, P726, DOI 10.1007/s12094-008-0279-5; Black JD, 2000, FRONT BIOSCI-LANDMRK, V5, pD406, DOI 10.2741/Black; Cen B, 2008, CANCER RES, V68, P5355, DOI 10.1158/0008-5472.CAN-07-6869; Chaigne-Delalande B, 2008, ARCH IMMUNOL THER EX, V56, P9, DOI 10.1007/s00005-008-0002-9; Chang YC, 2006, CELL DEATH DIFFER, V13, P2023, DOI 10.1038/sj.cdd.4401901; Chang ZF, 2006, J BIOMED SCI, V13, P173, DOI 10.1007/s11373-005-9056-4; Chu SJ, 2005, GENE, V348, P1, DOI 10.1016/j.gene.2005.01.013; Cohen O, 1999, J CELL BIOL, V146, P141; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Coleman ML, 2006, ONCOGENE, V25, P2708, DOI 10.1038/sj.onc.1209322; Croft DR, 2006, MOL CELL BIOL, V26, P4612, DOI 10.1128/MCB.02061-05; De Siervi A, 2004, CANCER RES, V64, P743, DOI 10.1158/0008-5472.CAN-03-2505; Del Re DP, 2007, J BIOL CHEM, V282, P8069, DOI 10.1074/jbc.M604298200; EL DW, 1993, CELL, V75, P817; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; FOJAS DB, 2001, EMBO J, V20, P5737; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gonzalez-Guerrico AM, 2005, J BIOL CHEM, V280, P38982, DOI 10.1074/jbc.M506767200; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Harrington EO, 2005, EXP CELL RES, V308, P407, DOI 10.1016/j.yexcr.2005.05.005; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jin YJ, 2001, J BIOL CHEM, V276, P30342, DOI 10.1074/jbc.M102404200; Kim CG, 2007, CELL SIGNAL, V19, P1290, DOI 10.1016/j.cellsig.2007.01.008; Lai JM, 2003, J CELL SCI, V116, P3491, DOI 10.1242/jcs.00660; Lai JM, 2002, MOL CELL BIOL, V22, P7581, DOI 10.1128/MCB.22.21.7581-7592.2002; Lashinger LM, 2005, CANCER RES, V65, P4902, DOI 10.1158/0008-5472.CAN-04-3701; Lee HH, 2004, J CELL SCI, V117, P5579, DOI 10.1242/jcs.01482; Liu PY, 2008, METHOD ENZYMOL, V439, P181, DOI 10.1016/S0076-6879(07)00414-4; Lyons LS, 2006, MOL ENDOCRINOL, V20, P1061, DOI 10.1210/me.2005-0346; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Meacci E, 2000, FEBS LETT, V482, P97, DOI 10.1016/S0014-5793(00)02039-1; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; Mills JC, 1998, J CELL BIOL, V140, P627, DOI 10.1083/jcb.140.3.627; Miralles F, 2006, CURR OPIN CELL BIOL, V18, P261, DOI 10.1016/j.ceb.2006.04.009; Nakagawa M, 2005, J BIOL CHEM, V280, P33926, DOI 10.1074/jbc.M505748200; Nawrocki ST, 2007, CANCER RES, V67, P6987, DOI 10.1158/0008-5472.CAN-07-0812; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Ohtsu H, 2005, ARTERIOSCL THROM VAS, V25, P1831, DOI 10.1161/01.ATV.0000175749.41799.9b; Orlando KA, 2006, EXP CELL RES, V312, P3298, DOI 10.1016/j.yexcr.2006.06.033; Pan J, 2005, J CELL PHYSIOL, V202, P536, DOI 10.1002/jcp.20151; Pan Q, 2006, CANCER RES, V66, P9379, DOI 10.1158/0008-5472.CAN-06-2646; Papadopoulou N, 2008, EXP CELL RES, V314, P3162, DOI 10.1016/j.yexcr.2008.07.012; Park JW, 2001, BIOCHEM BIOPH RES CO, V280, P244, DOI 10.1006/bbrc.2000.4105; Potin S, 2007, FEBS LETT, V581, P118, DOI 10.1016/j.febslet.2006.12.016; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Schavinsky-Khrapunsky Y, 2003, ONCOGENE, V22, P5315, DOI 10.1038/sj.onc.1206782; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Shi JJ, 2007, ARCH IMMUNOL THER EX, V55, P61, DOI 10.1007/s00005-007-0009-7; Slater SJ, 2001, BIOCHEMISTRY-US, V40, P4437, DOI 10.1021/bi001654n; Slater SJ, 2003, BIOCHEMISTRY-US, V42, P12105, DOI 10.1021/bi034860e; Tanaka Y, 2003, J BIOL CHEM, V278, P33753, DOI 10.1074/jbc.M303313200; Truman JP, 2005, J BIOL CHEM, V280, P23262, DOI 10.1074/jbc.M503701200; Unterseher F, 2004, EMBO J, V23, P3259, DOI 10.1038/sj.emboj.7600332; Wang Q, 2004, J BIOL CHEM, V279, P28831, DOI 10.1074/jbc.C400105200; Xiao LQ, 2009, MOL CARCINOGEN, V48, P187, DOI 10.1002/mc.20476; Yanazume T, 2002, J BIOL CHEM, V277, P8618, DOI 10.1074/jbc.M107924200; Yin LH, 2005, J BIOL CHEM, V280, P5533, DOI 10.1074/jbc.M405266200; Zhao X, 1997, J BIOL CHEM, V272, P22751, DOI 10.1074/jbc.272.36.22751	64	38	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29365	29375		10.1074/jbc.M109.007971	http://dx.doi.org/10.1074/jbc.M109.007971			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19667069	hybrid, Green Published			2022-12-27	WOS:000270896800017
J	Garcia-Hernandez, R; Moraleda-Munoz, A; Castaneda-Garcia, A; Perez, J; Munoz-Dorado, J				Garcia-Hernandez, Raquel; Moraleda-Munoz, Aurelio; Castaneda-Garcia, Alfredo; Perez, Juana; Munoz-Dorado, Jose			Myxococcus xanthus Pph2 Is a Manganese-dependent Protein Phosphatase Involved in Energy Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; SUBSTRATE-SPECIFICITY; PAS DOMAIN; PHOSPHORYLATION; KINASE; YEAST; 6-PHOSPHOFRUCTOKINASE; PHOSPHOPROTEOME; TRANSFORMATION; TRANSCRIPTION	The multicellular behavior of the myxobacterium Myxococcus xanthus requires the participation of an elevated number of signal-transduction mechanisms to coordinate the cell movements and the sequential changes in gene expression patterns that lead to the morphogenetic and differentiation events. These signal-transduction mechanisms are mainly based on two-component systems and on the reversible phosphorylation of protein targets mediated by eukaryotic-like protein kinases and phosphatases. Among all these factors, protein phosphatases are the elements that remain less characterized. Hence, we have studied in this work the physiological role and biochemical activity of the protein phosphatase of the family PPP (phosphoprotein phosphatases) designated as Pph2, which is forming part of the same operon as the two-component system phoPR1. Wehave demonstrated that this operon is induced upon starvation in response to the depletion of the cell energy levels. The increase in the expression of the operon contributes to an efficient use of the scarce energy resources available for developing cells to ensure the completion of the life cycle. In fact, a Delta pph2 mutant is defective in aggregation, sporulation yield, morphology of the myxospores, and germination efficiency. The yeast two-hybrid technology has shown that Pph2 interacts with the gene products of MXAN_1875 and 5630, which encode a hypothetical protein and a glutamine synthetase, respectively. Because Pph2 exhibits Ser/Thr, and to some extent Tyr, Mn2+-dependent protein phosphatase activity, it is expected that this function is accomplished by dephosphorylation of the specific protein substrates.	[Garcia-Hernandez, Raquel; Moraleda-Munoz, Aurelio; Castaneda-Garcia, Alfredo; Perez, Juana; Munoz-Dorado, Jose] Univ Granada, Fac Ciencias, Dept Microbiol, E-18071 Granada, Spain	University of Granada	Munoz-Dorado, J (corresponding author), Univ Granada, Fac Ciencias, Dept Microbiol, Avda Fuentenueva S-N, E-18071 Granada, Spain.	jdorado@ugr.es	Moraleda-Munoz, Aurelio/AAA-1599-2019; Castaneda, Alfredo/ABF-5497-2020; Torres, Juana Pérez/H-2480-2015; CastaÃeda, Alfredo/AAQ-5815-2020; Munoz-Dorado, Jose/N-6840-2016	Torres, Juana Pérez/0000-0001-8073-9398; CastaÃeda, Alfredo/0000-0002-1441-6125; Munoz-Dorado, Jose/0000-0001-7765-5687; Moraleda-Munoz, Aurelio/0000-0002-3330-5535	Junta de Andalucia [CVI1377)]; Ministerio de Ciencia y Tecnologia [BMC2003-02038, BFU2006-00972/BMC]	Junta de Andalucia(Junta de Andalucia); Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported in part by grants from Junta de Andalucia (CVI1377) and Ministerio de Ciencia y Tecnologia (BMC2003-02038 and BFU2006-00972/BMC), Spain. The yeast two-hybrid library was constructed under the supervision of Montserrat El as-Arnanz during a short term stay of A. C.-G. at the University of Murcia, granted by Ministerio de Ciencia y Tecnologia.	BARTON GJ, 1994, EUR J BIOCHEM, V220, P225, DOI 10.1111/j.1432-1033.1994.tb18618.x; Carrero-Lerida J, 2005, J BACTERIOL, V187, P4976, DOI 10.1128/JB.187.14.4976-4983.2005; Cho KY, 1999, MOL MICROBIOL, V34, P268, DOI 10.1046/j.1365-2958.1999.01594.x; COHEN P, 1991, METHOD ENZYMOL, V201, P389; Cozzone AJ, 2004, ARCH MICROBIOL, V181, P171, DOI 10.1007/s00203-003-0640-6; DUNCAN L, 1995, SCIENCE, V270, P641, DOI 10.1126/science.270.5236.641; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; Inouye S, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P191; Iwanicki A, 2002, BIOCHEM J, V366, P929, DOI 10.1042/BJ20011591; Jackson MD, 2001, CHEM REV, V101, P2313, DOI 10.1021/cr000247e; James P, 1996, GENETICS, V144, P1425; Julien B, 2000, P NATL ACAD SCI USA, V97, P9098, DOI 10.1073/pnas.97.16.9098; Kaiser C., 1994, METHODS YEAST GENETI; KASHEFI K, 1995, MOL MICROBIOL, V15, P483, DOI 10.1111/j.1365-2958.1995.tb02262.x; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200; Mai B, 1998, J BACTERIOL, V180, P4030, DOI 10.1128/JB.180.16.4030-4035.1998; Martinez-Canamero M, 2003, ANTON LEEUW INT J G, V83, P361, DOI 10.1023/A:1023360116904; Missiakas D, 1997, EMBO J, V16, P1670, DOI 10.1093/emboj/16.7.1670; Moraleda-Munoz A, 2003, J BACTERIOL, V185, P1376, DOI 10.1128/JB.185.4.1376-1383.2003; MORRISON CE, 1979, J BACTERIOL, V140, P1036, DOI 10.1128/JB.140.3.1036-1042.1979; Nariya H, 2003, MOL MICROBIOL, V49, P517, DOI 10.1046/j.1365-2958.2003.03572.x; Nariya H, 2002, MOL MICROBIOL, V46, P1353, DOI 10.1046/j.1365-2958.2002.03251.x; Perez J, 2008, P NATL ACAD SCI USA, V105, P15950, DOI 10.1073/pnas.0806851105; ROBZYK K, 1992, NUCLEIC ACIDS RES, V20, P3790, DOI 10.1093/nar/20.14.3790; Sambrook J., 2001, MOL CLONING LAB MANU; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schneiker S, 2007, NAT BIOTECHNOL, V25, P1281, DOI 10.1038/nbt1354; Shi L, 1998, FEMS MICROBIOL REV, V22, P229, DOI 10.1016/S0168-6445(98)00015-1; Shi L, 2001, J BACTERIOL, V183, P7053, DOI 10.1128/JB.183.24.7053-7057.2001; TAYLOR BL, 1983, ANNU REV MICROBIOL, V37, P551, DOI 10.1146/annurev.mi.37.100183.003003; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Treuner-Lange A, 2001, MOL MICROBIOL, V40, P126, DOI 10.1046/j.1365-2958.2001.02362.x; Umeyama T, 2000, GENE, V258, P55, DOI 10.1016/S0378-1119(00)00450-9; Vijay K, 2000, MOL MICROBIOL, V35, P180, DOI 10.1046/j.1365-2958.2000.01697.x; Voegtli WC, 2000, BIOCHEMISTRY-US, V39, P15365, DOI 10.1021/bi0021030; Wasch SID, 2002, APPL ENVIRON MICROB, V68, P2368, DOI 10.1128/AEM.68.5.2368-23750.2002; Watts KJ, 2006, J BACTERIOL, V188, P2154, DOI 10.1128/JB.188.6.2154-2162.2006; WEINBERG RA, 1990, J BACTERIOL, V172, P2294, DOI 10.1128/jb.172.5.2294-2302.1990; Whitworth DE, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P169; Whitworth DE, 2008, J BACTERIOL, V190, P1997, DOI 10.1128/JB.01781-07; Whitworth DE, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P1; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhang CC, 1998, J BACTERIOL, V180, P2616, DOI 10.1128/JB.180.10.2616-2622.1998; Zhang WW, 2004, MICROBIOL-SGM, V150, P4189, DOI 10.1099/mic.0.27480-0; ZHUO SQ, 1994, J BIOL CHEM, V269, P26234	46	3	4	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28720	28728		10.1074/jbc.M109.015248	http://dx.doi.org/10.1074/jbc.M109.015248			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19706604	Green Published, hybrid			2022-12-27	WOS:000270678900028
J	Irisawa, M; Inoue, J; Ozawa, N; Mori, K; Sato, R				Irisawa, Masato; Inoue, Jun; Ozawa, Nozomi; Mori, Kazutoshi; Sato, Ryuichiro			The Sterol-sensing Endoplasmic Reticulum (ER) Membrane Protein TRC8 Hampers ER to Golgi Transport of Sterol Regulatory Element-binding Protein-2 (SREBP-2)/SREBP Cleavage-activated Protein and Reduces SREBP-2 Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HMG COA REDUCTASE; KIDNEY CANCER GENE; COPII PROTEINS; TRANSCRIPTIONAL REGULATION; PROTEASOME PATHWAY; UBIQUITIN LIGASE; LIPID-SYNTHESIS; CHOLESTEROL; INSIG; SCAP	TRC8 (translocation in renal cancer from chromosome 8) is an intrinsic protein of the endoplasmic reticulum that contains a sterol-sensing domain and a RING finger motif encoding an E3 ubiquitin ligase. Here we show that TRC8 overexpression hinders sterol regulatory element-binding protein-2 (SREBP-2) processing, thereby reducing SREBP-2 target gene expression, TRC8 depletion has the opposite effect. Mutation analyses of TRC8 reveal that the ubiquitin ligase activity is dispensable for these effects. Activating transcription factor 6 (ATF6) is also processed in the Golgi by the same two proteases as those for SREBP, but ATF6 processing is not affected by TRC8. TRC8 is capable of binding both SREBP-2 and SREBP cleavage-activated protein (SCAP), thereby forming a TRC8.SREBP-2.SCAP complex. This complex formation hampers the interaction between SCAP and Sec24, one of the COPII proteins that are involved in SREBP-2 transport to the Golgi, thereby reducing SREBP-2 cleavage. TRC8 conjugated by ubiquitin is unstable, whereas the mutant TRC8, lacking the E3 ubiquitin ligase activity and only slightly modified by ubiquitin, is quite stable. TRC8 becomes stable when cells are cultured with a proteasome inhibitor or under a lipoprotein-depleted condition. Lipoprotein depletion impairs ubiquitination of TRC8. Taken together, TRC8 is a novel sterol-sensing endoplasmic reticulum membrane protein that hinders SREBP-2 processing through interaction with SREBP-2 and SCAP, regulating its own turnover rate by means of its E3 ubiquitin ligase activity.	[Irisawa, Masato; Inoue, Jun; Ozawa, Nozomi; Sato, Ryuichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Mori, Kazutoshi] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan	University of Tokyo; Kyoto University	Sato, R (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan.	aroysato@mail.ecc.u-tokyo.ac.jp	Mori, Kazutoshi/AAW-5449-2020; Mori, Kazutoshi/K-6106-2015; INOUE, Jun/O-7352-2016	INOUE, Jun/0000-0003-4145-3754	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [19108002] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Arito M, 2008, J BIOL CHEM, V283, P15224, DOI 10.1074/jbc.M800910200; Brauweiler A, 2007, ONCOGENE, V26, P2263, DOI 10.1038/sj.onc.1210017; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Engelking LJ, 2005, J CLIN INVEST, V115, P2489, DOI 10.1172/JCI25614; Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978; Espenshade PJ, 2002, P NATL ACAD SCI USA, V99, P11694, DOI 10.1073/pnas.182412799; Gemmill RM, 2002, ONCOGENE, V21, P3507, DOI 10.1038/sj.onc.1205437; Gemmill RM, 1998, P NATL ACAD SCI USA, V95, P9572, DOI 10.1073/pnas.95.16.9572; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hirano Y, 2003, J BIOL CHEM, V278, P16809, DOI 10.1074/jbc.M212448200; Hirano Y, 2001, J BIOL CHEM, V276, P36431, DOI 10.1074/jbc.M105200200; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Inoue J, 1998, J BIOCHEM-TOKYO, V123, P1191; Kanayama T, 2007, J BIOL CHEM, V282, P10290, DOI 10.1074/jbc.M700270200; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; Nadanaka S, 2004, MOL BIOL CELL, V15, P2537, DOI 10.1091/mbc.E03-09-0693; Okada T, 2003, J BIOL CHEM, V278, P31024, DOI 10.1074/jbc.M300923200; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; Sato R, 1999, J BIOL CHEM, V274, P24714, DOI 10.1074/jbc.274.35.24714; Sato R, 2000, J BIOL CHEM, V275, P12497, DOI 10.1074/jbc.275.17.12497; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Song BL, 2004, J BIOL CHEM, V279, P28798, DOI 10.1074/jbc.M402442200; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Sun LP, 2005, J BIOL CHEM, V280, P26483, DOI 10.1074/jbc.M504041200; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100; Yabe D, 2002, P NATL ACAD SCI USA, V99, P16672, DOI 10.1073/pnas.262669399; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Yellaturu CR, 2009, J BIOL CHEM, V284, P7518, DOI 10.1074/jbc.M805746200	35	42	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28995	29004		10.1074/jbc.M109.041376	http://dx.doi.org/10.1074/jbc.M109.041376			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19706601	hybrid, Green Published			2022-12-27	WOS:000270678900057
J	Ishida, H; Rainaldi, M; Vogel, HJ				Ishida, Hiroaki; Rainaldi, Mario; Vogel, Hans J.			Structural Studies of Soybean Calmodulin Isoform 4 Bound to the Calmodulin-binding Domain of Tobacco Mitogen-activated Protein Kinase Phosphatase-1 Provide Insights into a Sequential Target Binding Mode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE-DECARBOXYLASE; PEPTIDE INTERACTION; BACKBONE DYNAMICS; CRYSTAL-STRUCTURE; NITRIC-OXIDE; CALCIUM; COMPLEX; RECOGNITION; REVEALS; PROGRAM	The calcium regulatory protein calmodulin (CaM) binds in a calcium-dependent manner to numerous target proteins. The calmodulin-binding domain (CaMBD) region of Nicotiana tabacum MAPK phosphatase has an amino acid sequence that does not resemble the CaMBD of any other known Ca2+-CaM-binding proteins. Using a unique fusion protein strategy, we have been able to obtain a high resolution solution structure of the complex of soybean Ca2+-CaM4 (SCaM4) and this CaMBD. Complete isotope labeling of both parts of the complex in the fusion protein greatly facilitated the structure determination by NMR. The 12-residue CaMBD region was found to bind exclusively to the C-lobe of SCaM4. A specific Trp and Leu side chain are utilized to facilitate strong binding through a novel "double anchor" motif. Moreover, the orientation of the helical peptide on the surface of Ca2+-SCaM4 is distinct from other known complexes. The N-lobe of Ca2+-SCaM4 in the complex remains free for additional interactions and could possibly act as a calcium-dependent adapter protein. Signaling through the MAPK pathway and increases in intracellular Ca2+ are both hallmarks of the plant stress response, and our data support the notion that coordination of these responses may occur through the formation of a unique CaM-MAPK phosphatase multiprotein complex.	[Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Chem Res Grp, Calgary, AB T2N 1N4, Canada	University of Calgary	Vogel, HJ (corresponding author), Univ Calgary, Dept Biol Sci, Chem Res Grp, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	vogel@ucalgary.ca			Natural Sciences and Engineering Research Council of Canada; Canadian Institutes for Health Research; University of Calgary	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); University of Calgary	This work was supported by a discovery grant from the Natural Sciences and Engineering Research Council of Canada. The Bio-NMR Centre in Calgary was supported by the Canadian Institutes for Health Research and the University of Calgary.	Ataman ZA, 2007, STRUCTURE, V15, P1603, DOI 10.1016/j.str.2007.10.012; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Baum G, 1996, EMBO J, V15, P2988, DOI 10.1002/j.1460-2075.1996.tb00662.x; BAX A, 1994, J BIOMOL NMR, V4, P787, DOI 10.1007/BF00398409; Bhattacharya N, 2007, J MOL BIOL, V374, P977, DOI 10.1016/j.jmb.2007.09.063; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Edlich F, 2007, J BIOL CHEM, V282, P36496, DOI 10.1074/jbc.M705061200; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Hanover JA, 2007, J BIOL CHEM, V282, P33743, DOI 10.1074/jbc.M705875200; Heo WD, 1999, P NATL ACAD SCI USA, V96, P766, DOI 10.1073/pnas.96.2.766; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Ishida H, 2008, J BIOL CHEM, V283, P14619, DOI 10.1074/jbc.M801398200; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; Jee JunGoo, 2003, Journal of Structural and Functional Genomics, V4, P179, DOI 10.1023/A:1026122726574; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Katou S, 2005, J BIOL CHEM, V280, P39569, DOI 10.1074/jbc.M508115200; Klessig DF, 2000, P NATL ACAD SCI USA, V97, P8849, DOI 10.1073/pnas.97.16.8849; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Lee K, 2008, J BIOL CHEM, V283, P23581, DOI 10.1074/jbc.M801549200; LEE SH, 1995, J BIOL CHEM, V270, P21806, DOI 10.1074/jbc.270.37.21806; Lee SH, 2000, BIOCHEM J, V350, P299, DOI 10.1042/0264-6021:3500299; Lee SH, 1999, BBA-PROTEIN STRUCT M, V1433, P56, DOI 10.1016/S0167-4838(99)00149-1; Maximciuc AA, 2006, STRUCTURE, V14, P1547, DOI 10.1016/j.str.2006.08.011; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Mori MX, 2008, STRUCTURE, V16, P607, DOI 10.1016/j.str.2008.01.011; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pedley KF, 2005, CURR OPIN PLANT BIOL, V8, P541, DOI 10.1016/j.pbi.2005.07.006; Rainaldi M, 2007, J BIOL CHEM, V282, P6031, DOI 10.1074/jbc.M608970200; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sweitzer TD, 1996, P NATL ACAD SCI USA, V93, P14574, DOI 10.1073/pnas.93.25.14574; Tjandra N, 1996, J BIOMOL NMR, V8, P273, DOI 10.1007/BF00410326; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Wendehenne D, 2004, CURR OPIN PLANT BIOL, V7, P449, DOI 10.1016/j.pbi.2004.04.002; Yamakawa H, 2004, J BIOL CHEM, V279, P928, DOI 10.1074/jbc.M310277200; Yamakawa H, 2001, EUR J BIOCHEM, V268, P3916, DOI 10.1046/j.1432-1327.2001.02301.x; Yamauchi E, 2003, NAT STRUCT BIOL, V10, P226, DOI 10.1038/nsb900; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099; Yamniuk AP, 2007, PLANT SIGNAL BEHAV, V2, P354, DOI 10.4161/psb.2.5.4155; Yamniuk AP, 2005, BIOCHEMISTRY-US, V44, P3101, DOI 10.1021/bi047770y; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yamniuk AP, 2004, J BIOL CHEM, V279, P7698, DOI 10.1074/jbc.M310763200; Yap KL, 2003, J MOL BIOL, V328, P193, DOI 10.1016/S0022-2836(03)00271-7; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Ye QL, 2008, PROTEINS, V73, P19, DOI 10.1002/prot.22032; Ye QL, 2006, BIOCHEMISTRY-US, V45, P738, DOI 10.1021/bi0521801; Yoo JH, 2004, J BIOL CHEM, V279, P848, DOI 10.1074/jbc.M310709200; Yuan T, 1998, J BIOL CHEM, V273, P30328, DOI 10.1074/jbc.273.46.30328; ZHANG MJ, 1994, J BIOL CHEM, V269, P15546; Zielinski RE, 2002, PLANTA, V214, P446, DOI 10.1007/s004250100636; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	59	15	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28292	28305		10.1074/jbc.M109.025080	http://dx.doi.org/10.1074/jbc.M109.025080			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19667066	Green Published, hybrid			2022-12-27	WOS:000270676300056
J	Loiarro, M; Gallo, G; Fanto, N; De Santis, R; Carminati, P; Ruggiero, V; Sette, C				Loiarro, Maria; Gallo, Grazia; Fanto, Nicola; De Santis, Rita; Carminati, Paolo; Ruggiero, Vito; Sette, Claudio			Identification of Critical Residues of the MyD88 Death Domain Involved in the Recruitment of Downstream Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; NF-KAPPA-B; ADAPTER PROTEIN; TNF RECEPTOR; IRAK FAMILY; INTERLEUKIN-1; ACTIVATION; COMPLEX; MEMBER; DIFFERENTIATION	MyD88 couples the activation of the Toll-like receptors and interleukin-1 receptor superfamily with intracellular signaling pathways. Upon ligand binding, activated receptors recruit MyD88 via its Toll-interleukin-1 receptor domain. MyD88 then allows the recruitment of the interleukin-1 receptor-associated kinases (IRAKs). We performed a site-directed mutagenesis of MyD88 residues, conserved in death domains of the homologous FADD and Pelle proteins, and analyzed the effect of the mutations on MyD88 signaling. Our studies revealed that mutation of residues 52 (MyD88(E52A)) and 58 (MyD88(Y58A)) impaired recruitment of both IRAK1 and IRAK4, whereas mutation of residue 95 (MyD88(K95A)) only affected IRAK4 recruitment. Since all MyD88 mutants were defective in signaling, recruitment of both IRAKs appeared necessary for activation of the pathway. Moreover, overexpression of a green fluorescent protein (GFP)-tagged mini-MyD88 protein (GFP-MyD88-(27-72)), comprising the Glu(52) and Tyr(58) residues, interfered with recruitment of both IRAK1 and IRAK4 by MyD88 and suppressed NF-kappa B activation by the interleukin-1 receptor but not by the MyD88-independent TLR3. GFP-MyD88-(27-72) exerted its effect by titrating IRAK1 and suppressing IRAK1-dependent NF-kappa B activation. These experiments identify novel residues of MyD88 that are crucially involved in the recruitment of IRAK1 and IRAK4 and in downstream propagation of MyD88 signaling.	[Loiarro, Maria; Sette, Claudio] Fdn Santa Lucia Roma & Uno, Ist Ricovero & Cura Carattere Sci, Lab Neuroembryol, I-00143 Rome, Italy; [Gallo, Grazia; Fanto, Nicola; De Santis, Rita; Carminati, Paolo; Ruggiero, Vito] Sigma Tau Ind Farmaceutiche Riunite SpA, Dept Immunol Bldg LABIO, I-00040 Pomezia, RM, Italy; [Loiarro, Maria; Sette, Claudio] Univ Roma Tor Vergata, Dept Publ Hlth & Cell Biol, I-00133 Rome, Italy	IRCCS Santa Lucia; University of Rome Tor Vergata	Sette, C (corresponding author), Sigma Tau Ind Farmaceutiche Riunite SpA, Dept Immunol Bldg LABIO, Via Pontina Km 30-400, I-00040 Pomezia, RM, Italy.	vito.ruggiero@sigma-tau.it; claudio.sette@uniroma2.it	Sette, Claudio/S-4307-2019	Sette, Claudio/0000-0003-2864-8266; DE SANTIS, Rita/0000-0002-5037-0611	Istituto Superiore della Sanita [527/B/3A/5]; Association for International Cancer Research; Fondazione Italiana Sclerosi Multipla; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Istituto Superiore della Sanita; Association for International Cancer Research; Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from the Istituto Superiore della Sanita (ISS Project 527/B/3A/5), the Association for International Cancer Research, and the Fondazione Italiana Sclerosi Multipla.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bartfai T, 2003, P NATL ACAD SCI USA, V100, P7971, DOI 10.1073/pnas.0932746100; Berglund H, 2000, J MOL BIOL, V302, P171, DOI 10.1006/jmbi.2000.4011; Brikos C, 2007, MOL CELL PROTEOMICS, V6, P1551, DOI 10.1074/mcp.M600455-MCP200; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Ding GJF, 1998, J BIOL CHEM, V273, P28897, DOI 10.1074/jbc.273.44.28897; Fan J, 2007, J IMMUNOL, V178, P6573, DOI 10.4049/jimmunol.178.10.6573; FEINSTEIN E, 1995, TRENDS BIOCHEM SCI, V20, P342, DOI 10.1016/S0968-0004(00)89070-2; Fischer M, 2008, ANN NY ACAD SCI, V1143, P21, DOI 10.1196/annals.1443.012; Funderburg N, 2007, P NATL ACAD SCI USA, V104, P18631, DOI 10.1073/PNAS.0702130104; Gearing AJH, 2007, IMMUNOL CELL BIOL, V85, P490, DOI 10.1038/sj.icb.7100102; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hardiman G, 1996, ONCOGENE, V13, P2467; HOFMANN K, 1995, FEBS LETT, V371, P321, DOI 10.1016/0014-5793(95)00931-X; Hong-Geller Elizabeth, 2008, Curr Drug Discov Technol, V5, P29, DOI 10.2174/157016308783769441; HULTMARK D, 1994, BIOCHEM BIOPH RES CO, V199, P144, DOI 10.1006/bbrc.1994.1206; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Jeong EJ, 1999, J BIOL CHEM, V274, P16337, DOI 10.1074/jbc.274.23.16337; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li XX, 2001, P NATL ACAD SCI USA, V98, P4461, DOI 10.1073/pnas.071054198; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Loiarro M, 2007, J LEUKOCYTE BIOL, V82, P801, DOI 10.1189/jlb.1206746; LORD KA, 1990, ONCOGENE, V5, P387; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Neumann D, 2007, BIOCHEM BIOPH RES CO, V354, P1089, DOI 10.1016/j.bbrc.2007.01.104; O'Neill LA, 2003, CURR OPIN PHARMACOL, V3, P396, DOI 10.1016/S1471-4892(03)00080-8; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Scott MJ, 2008, J BIOL CHEM, V283, P29433, DOI 10.1074/jbc.M803905200; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ulrichts P, 2007, FEBS LETT, V581, P629, DOI 10.1016/j.febslet.2007.01.026; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1	41	59	74	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28093	28103		10.1074/jbc.M109.004465	http://dx.doi.org/10.1074/jbc.M109.004465			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19679662	Green Published, hybrid			2022-12-27	WOS:000270676300036
J	Graeff, R; Liu, Q; Kriksunov, IA; Kotaka, M; Oppenheimer, N; Hao, Q; Lee, HC				Graeff, Richard; Liu, Qun; Kriksunov, Irina A.; Kotaka, Masayo; Oppenheimer, Norman; Hao, Quan; Lee, Hon Cheung			Mechanism of Cyclizing NAD to Cyclic ADP-ribose by ADP-ribosyl Cyclase and CD38	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-MOBILIZING METABOLITE; ELECTRON-DENSITY MAPS; ACTIVE-SITE; INOSITOL TRISPHOSPHATE; COVALENT INTERMEDIATE; NAADP; CA2+; HYDROLYSIS; RELEASE; STORES	Mammalian CD38 and its Aplysia homolog, ADP-ribosyl cyclase (cyclase), are two prominent enzymes that catalyze the synthesis and hydrolysis of cyclic ADP-ribose (cADPR), a Ca2+ messenger molecule responsible for regulating a wide range of cellular functions. Although both use NAD as a substrate, the cyclase produces cADPR, whereas CD38 produces mainly ADPribose (ADPR). To elucidate the catalytic differences and the mechanism of cyclizing NAD, the crystal structure of a stable complex of the cyclase with an NAD analog, ribosyl-2'F-2'deoxynicotinamide adenine dinucleotide (ribo-2'-F-NAD), was determined. The results show that the analog was a substrate of the cyclase and that during the reaction, the nicotinamide group was released and a stable intermediate was formed. The terminal ribosyl unit at one end of the intermediate formed a close linkage with the catalytic residue (Glu-179), whereas the adenine ring at the other end stacked closely with Phe-174, suggesting that the latter residue is likely to be responsible for folding the linear substrate so that the two ends can be cyclized. Mutating Phe-174 indeed reduced cADPR production but enhanced ADPR production, converting the cyclase to be more CD38-like. Changing the equivalent residue in CD38, Thr-221 to Phe, correspondingly enhanced cADPR production, and the double mutation, Thr-221 to Phe and Glu-146 to Ala, effectively converted CD38 to a cyclase. This study provides the first detailed evidence of the cyclization process and demonstrates the feasibility of engineering the reactivity of the enzymes by mutation, setting the stage for the development of tools to manipulate cADPR metabolism in vivo.	[Liu, Qun; Kriksunov, Irina A.; Hao, Quan] Cornell Univ, Cornell High Energy Synchrotron Source, MacCHESS, Ithaca, NY 14853 USA; [Graeff, Richard; Lee, Hon Cheung] Univ Minnesota, Dept Physiol, Minneapolis, MN 55455 USA; [Kotaka, Masayo; Hao, Quan; Lee, Hon Cheung] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Oppenheimer, Norman] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	Cornell University; University of Minnesota System; University of Minnesota Twin Cities; University of Hong Kong; University of California System; University of California San Francisco	Hao, Q (corresponding author), Cornell Univ, Cornell High Energy Synchrotron Source, MacCHESS, Ithaca, NY 14853 USA.	qhao@hku.hk; leehc@hku.hk	Lee, Hon Cheung/C-4329-2009; Liu, Qun/A-8757-2011; Hao, Quan/C-4304-2009; Kotaka, Masayo/C-4483-2009	Liu, Qun/0000-0002-1179-290X; Hao, Quan/0000-0002-9642-0514; Kotaka, Masayo/0000-0001-9692-3843	National Institutes of Health [GM061568]; Hong Kong General Research Fund; National Science Foundation of China/Research Grant Council of Hong Kong (NSFC/RGC) Joint Research Scheme; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hong Kong General Research Fund; National Science Foundation of China/Research Grant Council of Hong Kong (NSFC/RGC) Joint Research Scheme(Hong Kong Research Grants CouncilNational Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM061568 (to H.C.L./Q.H.). This work was also supported by grants from the Hong Kong General Research Fund and the National Science Foundation of China/Research Grant Council of Hong Kong (NSFC/RGC) Joint Research Scheme (to H. C. L.).	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Bezin S, 2008, J BIOL CHEM, V283, P27859, DOI 10.1074/jbc.M804701200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Galione A, 2006, BIOCHEM SOC T, V34, P922, DOI 10.1042/BST0340922; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Graeff R, 2001, J BIOL CHEM, V276, P12169, DOI 10.1074/jbc.M011299200; Graeff RM, 1996, BIOCHEMISTRY-US, V35, P379, DOI 10.1021/bi952083f; Graeff RM, 2003, COMB CHEM HIGH T SCR, V6, P367; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Jin D, 2007, NATURE, V446, P41, DOI 10.1038/nature05526; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kato I, 1999, J BIOL CHEM, V274, P1869, DOI 10.1074/jbc.274.4.1869; KIM H, 1993, SCIENCE, V261, P1330, DOI 10.1126/science.8395705; Lam CMC, 2009, CELL CALCIUM, V45, P346, DOI 10.1016/j.ceca.2008.12.006; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; Lee HC, 2004, CURR MOL MED, V4, P227, DOI 10.2174/1566524043360753; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; LEE HC, 1993, BIOCHEM BIOPH RES CO, V191, P639, DOI 10.1006/bbrc.1993.1265; LEE HC, 1989, J BIOL CHEM, V264, P1608; LEE HC, 2002, CYCLIC ADP RIBOSE NA; Liu Q, 2008, CHEM BIOL, V15, P1068, DOI 10.1016/j.chembiol.2008.08.007; Liu Q, 2006, J BIOL CHEM, V281, P32861, DOI 10.1074/jbc.M606365200; Liu Q, 2009, J BIOL CHEM, V284, P27637, DOI 10.1074/jbc.M109.031005; Love ML, 2004, STRUCTURE, V12, P477, DOI 10.1016/j.str.2004.02.006; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Mothet JP, 1998, J PHYSIOL-LONDON, V507, P405, DOI 10.1111/j.1469-7793.1998.405bt.x; Munshi C, 2000, J BIOL CHEM, V275, P21566, DOI 10.1074/jbc.M909365199; Munshi C, 1999, J BIOL CHEM, V274, P30770, DOI 10.1074/jbc.274.43.30770; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Prasad GS, 1996, NAT STRUCT BIOL, V3, P957, DOI 10.1038/nsb1196-957; Sauve AA, 2000, J AM CHEM SOC, V122, P7855, DOI 10.1021/ja001139c; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SLEATH PR, 1991, J ORG CHEM, V56, P3608, DOI 10.1021/jo00011a029; TAKASAWA S, 1993, J BIOL CHEM, V268, P26052	39	56	57	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27629	27636		10.1074/jbc.M109.030965	http://dx.doi.org/10.1074/jbc.M109.030965			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19640843	hybrid, Green Published			2022-12-27	WOS:000270232300064
J	Park, KM; Yule, DI; Bowers, WJ				Park, Keigan M.; Yule, David I.; Bowers, William J.			Tumor Necrosis Factor-alpha-mediated Regulation of the Inositol 1,4,5-Trisphosphate Receptor Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; SMOOTH-MUSCLE-CELLS; CORTICAL-NEURONS; TRANSCRIPTIONAL REGULATION; SYNAPTIC PLASTICITY; GENE-TRANSCRIPTION; PROTEIN-KINASE; CA2+ RELEASE; KAPPA-B; C-JUN	Tumor necrosis factor-alpha (TNF-alpha), a proinflammatory cytokine, has been implicated as a central mediator in multiple homeostatic and pathologic processes. Signaling cascades downstream of its cellular cognate receptors, as well as the resultant transcriptional responses have received intense interest in regards to how such signals impact cellular physiology. Notably, TNF-alpha was shown to potentiate neuronal Ca2+ signaling by enhancing type-1 inositol 1,4,5-trisphosphate receptor (IP3R) steady-state mRNA levels. In the present study, we sought to determine the promoter region ultimately responsive to TNF-alpha exposure. We report that a sequence encompassing a specificity protein 1 (SP-1) binding site is necessary for TNF-alpha regulation. Electrophoretic mobility shift analysis demonstrated specific binding to this sequence, while site-directed mutagenesis of this site abrogated both JNK-mediated regulation as well as transcription factor binding. Expression of a dominant-negative SP-1 eliminated both the enhanced promoter activity and the elevated IP3R-mediated Ca2+ signals observed with TNF-alpha exposure. Overall, these data delineate a key pathway by which TNF-alpha in a neuronal environment modulates IP3R expression and intracellular Ca2+ homeostasis.	[Bowers, William J.] Univ Rochester, Med Ctr, Dept Neurol, Sch Med & Dent, Rochester, NY 14642 USA; [Park, Keigan M.; Bowers, William J.] Univ Rochester, Med Ctr, Ctr Neural Dev & Dis, Sch Med & Dent, Rochester, NY 14642 USA; [Park, Keigan M.; Yule, David I.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Sch Med & Dent, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Bowers, WJ (corresponding author), 601 Elmwood Ave,Box 645, Rochester, NY 14642 USA.	william_bowers@urmc.rochester.edu			National Institutes of Health [F31-NS056731, T32-DE07202, R01-DK54588, R01-DE14756, R01-AG023593, R01-AG026328]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R44DK054588, R43DK054588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS056731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023593, R01AG026328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant F31-NS056731, Oral Biology Training Grant T32-DE07202 (to K. M. P.), Grants R01-DK54588 and R01-DE14756 (to D.I.Y.), and Grants R01-AG023593 and R01-AG026328 (to W.J.B.).	Al-Sarraj A, 2005, J CELL BIOCHEM, V94, P153, DOI 10.1002/jcb.20305; Albensi BC, 2000, SYNAPSE, V35, P151; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Benasciutti E, 2004, BLOOD, V104, P256, DOI 10.1182/blood-2003-08-2661; Betzenhauser MJ, 2008, J BIOL CHEM, V283, P21579, DOI 10.1074/jbc.M801680200; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Bootman MD, 2001, SEMIN CELL DEV BIOL, V12, P3, DOI 10.1006/scdb.2000.0211; BRADFORD PG, 1991, BIOCHEM J, V280, P205, DOI 10.1042/bj2800205; BROWN PH, 1994, ONCOGENE, V9, P791; Butler MP, 2004, NEUROSCIENCE, V124, P319, DOI 10.1016/j.neuroscience.2003.11.040; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Chu SJ, 2005, GENE, V348, P1, DOI 10.1016/j.gene.2005.01.013; Cunningham AJ, 1996, NEUROSCI LETT, V203, P17, DOI 10.1016/0304-3940(95)12252-4; Deelman LE, 1998, GENE, V207, P219, DOI 10.1016/S0378-1119(97)00630-6; Di Filippo M, 2008, TRENDS PHARMACOL SCI, V29, P402, DOI 10.1016/j.tips.2008.06.005; DieckmannSchuppert A, 1997, CELL TISSUE RES, V288, P119, DOI 10.1007/s004410050799; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; FERRIS CD, 1991, BIOCHEM BIOPH RES CO, V175, P192, DOI 10.1016/S0006-291X(05)81219-7; FURUICHI T, 1993, RECEPTOR CHANNEL, V1, P11; Furutama D, 1996, J NEUROCHEM, V66, P1793; Giovannucci DR, 2000, J BIOL CHEM, V275, P33704, DOI 10.1074/jbc.M004278200; Giovannucci DR, 2002, J PHYSIOL-LONDON, V540, P469, DOI 10.1113/jphysiol.2001.013453; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; IINO M, 1991, J GEN PHYSIOL, V98, P681, DOI 10.1085/jgp.98.4.681; Janelsins MC, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-23; JOLLIFF K, 1991, NUCLEIC ACIDS RES, V19, P2267, DOI 10.1093/nar/19.9.2267; Kavurma MM, 2003, J BIOL CHEM, V278, P32537, DOI 10.1074/jbc.M305650200; KINOUCHI K, 1991, BIOCHEM BIOPH RES CO, V181, P1532, DOI 10.1016/0006-291X(91)92113-X; Koga T, 2007, AM J PHYSIOL-LUNG C, V293, pL693, DOI 10.1152/ajplung.00491.2006; Konishi Y, 1997, J NEUROCHEM, V69, P476; KRIEGLER M, 1988, CELL, V53, P45, DOI 10.1016/0092-8674(88)90486-2; Leissring MA, 1999, J BIOL CHEM, V274, P32535, DOI 10.1074/jbc.274.46.32535; Leppa S, 2001, MOL CELL BIOL, V21, P4369, DOI 10.1128/MCB.21.13.4369-4378.2001; LETOVSKY J, 1989, NUCLEIC ACIDS RES, V17, P2639, DOI 10.1093/nar/17.7.2639; Mackrill JJ, 1996, BIOCHEM J, V318, P871, DOI 10.1042/bj3180871; Ogoshi F, 2005, EXP NEUROL, V193, P384, DOI 10.1016/j.expneurol.2004.12.026; Park KM, 2008, J BIOL CHEM, V283, P33069, DOI 10.1074/jbc.M802209200; Puebla C, 2008, J CELL PHYSIOL, V215, P645, DOI 10.1002/jcp.21347; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Ramirez SH, 2001, J NEUROCHEM, V78, P874, DOI 10.1046/j.1471-4159.2001.00467.x; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Sneyd J, 2003, BIOPHYS J, V85, P1392, DOI 10.1016/S0006-3495(03)74572-X; Stutzmann GE, 2004, J NEUROSCI, V24, P508, DOI 10.1523/JNEUROSCI.4386-03.2004; Stutzmann GE, 2003, J NEUROSCI, V23, P758; TAKEI N, 1994, BRAIN RES, V652, P65, DOI 10.1016/0006-8993(94)90317-4; Wu DY, 2006, CELL RES, V16, P319, DOI 10.1038/sj.cr.7310040; Zhou QS, 2005, J BIOL CHEM, V280, P35062, DOI 10.1074/jbc.M504821200	49	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27557	27566		10.1074/jbc.M109.034504	http://dx.doi.org/10.1074/jbc.M109.034504			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19666470	Green Published, hybrid			2022-12-27	WOS:000270232300057
J	Sasaki, N; Ogasawara, M; Sekiguchi, T; Kusumoto, S; Satake, H				Sasaki, Naoko; Ogasawara, Michio; Sekiguchi, Toshio; Kusumoto, Shoichi; Satake, Honoo			Toll-like Receptors of the Ascidian Ciona intestinalis PROTOTYPES WITH HYBRID FUNCTIONALITIES OF VERTEBRATE TOLL-LIKE RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE GENE REPERTOIRE; PURPLE SEA-URCHIN; INFLAMMATORY RESPONSE; EVOLUTIONARY ORIGIN; EXPRESSION PATTERNS; SIGNALING PATHWAY; GENOMIC ANALYSIS; STRUCTURAL BASIS; HOST-DEFENSE; RECOGNITION	Key transmembrane proteins in the innate immune system, Toll-like receptors (TLRs), have been suggested to occur in the genome of non-mammalian organisms including invertebrates. However, authentic invertebrate TLRs have been neither structurally nor functionally investigated. In this paper, we originally present the structures, localization, ligand recognition, activities, and inflammatory cytokine production of all TLRs of the ascidian Ciona intestinalis, designated as Ci-TLR1 and Ci-TLR2. The amino acid sequence of Ci-TLR1 and Ci-TLR2 were found to possess unique structural organization with moderate sequence similarity to functionally characterized vertebrate TLRs. ci-tlr1 and ci-tlr2 genes were expressed predominantly in the stomach and intestine as well as in hemocytes. Ci-TLR1 and Ci-TLR2 expressed in HEK293 cells, unlike vertebrate TLRs, were localized to both the plasma membrane and endosomes. Intriguingly, both Ci-TLR1 and Ci-TLR2 stimulate NF-kappa B induction in response to multiple pathogenic ligands such as double-stranded RNA, and bacterial cell wall components that are differentially recognized by respective vertebrate TLRs, revealing that Ci-TLRs recognize broader pathogen-associated molecular patterns than vertebrate TLRs. The Ci-TLR-stimulating pathogenic ligands also induced the expression of Ci-TNF alpha in the intestine and stomach where Ci-TLRs are expressed. These results provide evidence that the TLR-triggered innate immune systems are essentially conserved in ascidians, and that Ci-TLRs possess "hybrid" biological and immunological functions, compared with vertebrate TLRs. Moreover, it is presumed that chordate TLR ancestors also acquired the Ci-TLR-like multiple cellular localization and pathogen-associated molecular pattern recognition.	[Sasaki, Naoko; Sekiguchi, Toshio; Kusumoto, Shoichi; Satake, Honoo] Suntory Inst Bioorgan Res, Osaka 6188503, Japan; [Ogasawara, Michio] Chiba Univ, Grad Sch Adv Integrat Sci, Inage Ku, Chiba 2638522, Japan	Suntory Holdings Ltd; Chiba University	Satake, H (corresponding author), Suntory Inst Bioorgan Res, 1-1-1 Wakayamadai, Osaka 6188503, Japan.	satake@sunbor.or.jp			MEXT, Japan	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Kazuko Hirayama and all members of Maizuru Fisheries Research Station for cultivation of the ascidians. All ascidians were provided by Kyoto University through the National Bio-Resource Project of the MEXT, Japan.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aoyama M, 2008, ENDOCRINOLOGY, V149, P4346, DOI 10.1210/en.2008-0323; Azumi K, 2003, IMMUNOGENETICS, V55, P570, DOI 10.1007/s00251-003-0606-5; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Bosch TCG, 2009, DEV COMP IMMUNOL, V33, P559, DOI 10.1016/j.dci.2008.10.004; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; Dunne A, 2005, FEBS LETT, V579, P3330, DOI 10.1016/j.febslet.2005.04.024; Figueiredo RT, 2007, J BIOL CHEM, V282, P20221, DOI 10.1074/jbc.M610737200; Flo TH, 2000, J IMMUNOL, V164, P2064, DOI 10.4049/jimmunol.164.4.2064; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Huang SF, 2008, GENOME RES, V18, P1112, DOI 10.1101/gr.069674.107; Ishii A, 2007, J IMMUNOL, V178, P397, DOI 10.4049/jimmunol.178.1.397; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kruger B, 2009, P NATL ACAD SCI USA, V106, P3390, DOI 10.1073/pnas.0810169106; Lettinga KD, 2002, J INFECT DIS, V186, P570, DOI 10.1086/341780; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Martin M, 2003, INFECT IMMUN, V71, P2498, DOI 10.1128/IAI.71.5.2498-2507.2003; Matsuo A, 2008, J IMMUNOL, V181, P3474, DOI 10.4049/jimmunol.181.5.3474; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Mizel SB, 2003, J IMMUNOL, V170, P6217, DOI 10.4049/jimmunol.170.12.6217; Nakamura N, 2000, J BIOL CHEM, V275, P6523, DOI 10.1074/jbc.275.9.6523; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; Nishiya T, 2005, J BIOL CHEM, V280, P37107, DOI 10.1074/jbc.M504951200; Ogasawara M, 2002, DEV GENES EVOL, V212, P173, DOI 10.1007/s00427-002-0230-7; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Parrinello N, 2008, CELL TISSUE RES, V334, P305, DOI 10.1007/s00441-008-0695-4; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Satake H, 2004, J BIOL CHEM, V279, P53798, DOI 10.1074/jbc.M408161200; SATAKE H, 2006, NEUROPEPTIDES HORMON; Sato M, 2003, J IMMUNOL, V171, P417, DOI 10.4049/jimmunol.171.1.417; Satoh N, 2009, ZOOL SCI, V26, P97, DOI 10.2108/zsj.26.97; Shibata K, 2000, J IMMUNOL, V165, P6538, DOI 10.4049/jimmunol.165.11.6538; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Terwilliger DP, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-16; Wu H, 2008, ENDOCRINOLOGY, V149, P4402, DOI 10.1210/en.2007-1776; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhao HM, 2004, MOL THER, V9, P241, DOI 10.1016/j.ymthe.2003.11.012	44	66	66	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27336	27343		10.1074/jbc.M109.032433	http://dx.doi.org/10.1074/jbc.M109.032433			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651780	hybrid, Green Published			2022-12-27	WOS:000270232300034
J	Tiwari, A; Liba, A; Sohn, SH; Seetharaman, SV; Bilsel, O; Matthews, CR; Hart, PJ; Valentine, JS; Hayward, LJ				Tiwari, Ashutosh; Liba, Amir; Sohn, Se Hui; Seetharaman, Sai V.; Bilsel, Osman; Matthews, C. Robert; Hart, P. John; Valentine, Joan Selverstone; Hayward, Lawrence J.			Metal Deficiency Increases Aberrant Hydrophobicity of Mutant Superoxide Dismutases That Cause Amyotrophic Lateral Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTOR-NEURON DEGENERATION; COPPER-BINDING-SITE; CU,ZN-SUPEROXIDE DISMUTASE; TRANSGENIC MICE; FAMILIAL ALS; 1-ANILINO-8-NAPHTHALENE SULFONATE; FOLDING MECHANISM; DISULFIDE STATUS; DIMER STABILITY; SOD1 MUTANTS	The mechanisms by which mutant variants of Cu/Zn-superoxide dismutase (SOD1) cause familial amyotrophic lateral sclerosis are not clearly understood. Evidence to date suggests that altered conformations of amyotrophic lateral sclerosis mutant SOD1s trigger perturbations of cellular homeostasis that ultimately cause motor neuron degeneration. In this study we correlated the metal contents and disulfide bond status of purified wild-type (WT) and mutant SOD1 proteins to changes in electrophoretic mobility and surface hydrophobicity as detected by 1-anilinonaphthalene-8-sulfonic acid (ANS) fluorescence. As-isolated WT and mutant SOD1s were copper-deficient and exhibited mobilities that correlated with their expected negative charge. However, upon disulfide reduction and demetallation at physiological pH, both WT and mutant SOD1s underwent a conformational change that produced a slower mobility indicative of partial unfolding. Furthermore, although ANS did not bind appreciably to the WT holoenzyme, incubation of metal-deficient WT or mutant SOD1s with ANS increased the ANS fluorescence and shifted its peak toward shorter wavelengths. This increased interaction with ANS was greater for the mutant SOD1s and could be reversed by the addition of metal ions, especially Cu2+, even for SOD1 variants incapable of forming the disulfide bond. Overall, our findings support the notion that misfolding associated with metal deficiency may facilitate aberrant interactions of SOD1 with itself or with other cellular constituents and may thereby contribute to neuronal toxicity.	[Tiwari, Ashutosh; Hayward, Lawrence J.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01655 USA; [Liba, Amir; Sohn, Se Hui; Valentine, Joan Selverstone] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Seetharaman, Sai V.; Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Bilsel, Osman; Matthews, C. Robert] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California Los Angeles; University of Texas System; University of Texas Health San Antonio; University of Massachusetts System; University of Massachusetts Worcester	Hayward, LJ (corresponding author), Univ Massachusetts, Sch Med, Dept Neurol, 55 Lake Ave N, Worcester, MA 01655 USA.	tiwari@mtu.edu; Lawrence.Hayward@umassmed.edu	Tiwari, Ashutosh/A-7458-2008; Valentine, Joan S/B-6665-2008	Tiwari, Ashutosh/0000-0001-7373-349X; Valentine, Joan S/0000-0002-7174-925X; Bilsel, Osman/0000-0003-0414-3060; Hayward, Lawrence/0000-0003-0579-0358	National Institutes of Health [NS44170, NS049134, NS39112, GM54836]; NINDS; ALS Association; ALS Therapy Alliance; Angel Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039112, R01NS044170, P01NS049134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ALS Association; ALS Therapy Alliance; Angel Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS44170 (to L.J.H.), NS049134 (to J. S. V.), NS39112 (to P. J. H.), and GM54836 (to C. R. M.) from NINDS. This work was also supported by grants from the ALS Association (to A. T. and L. J. H.), the ALS Therapy Alliance (to A. T. and L. J. H.), and The Angel Fund (to A. T.).	Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Banci L, 2003, BIOCHEMISTRY-US, V42, P9543, DOI 10.1021/bi034324m; Banci L, 2000, BIOCHEMISTRY-US, V39, P9108, DOI 10.1021/bi000067z; Banci L, 1998, BIOCHEMISTRY-US, V37, P11780, DOI 10.1021/bi9803473; Banci L, 2006, J BIOL CHEM, V281, P2333, DOI 10.1074/jbc.M506497200; Banci L, 2005, J BIOL CHEM, V280, P35815, DOI 10.1074/jbc.M506637200; Banci L, 2002, PROTEIN SCI, V11, P2479, DOI 10.1110/ps.0210802; Banci L, 2002, EUR J BIOCHEM, V269, P1905, DOI 10.1046/j.1432-1033.2002.02840.x; Banci L, 2007, BIOCHEMISTRY-US, V46, P9953, DOI 10.1021/bi700620r; Banci L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001677; Bilsel O, 1999, BIOCHEMISTRY-US, V38, P1018, DOI 10.1021/bi982365q; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Cao XH, 2008, J BIOL CHEM, V283, P16169, DOI 10.1074/jbc.M801522200; Crow JP, 1997, J NEUROCHEM, V69, P1936; DeLano W.L, PYMOL MOL GRAPHICS S; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; Elam JS, 2003, J BIOL CHEM, V278, P21032, DOI 10.1074/jbc.M300484200; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Gal J, 2007, J BIOL CHEM, V282, P11068, DOI 10.1074/jbc.M608787200; Gasymov OK, 2007, BBA-PROTEINS PROTEOM, V1774, P403, DOI 10.1016/j.bbapap.2007.01.002; GOLDBERG M, 1974, P NATL ACAD SCI USA, V71, P4684, DOI 10.1073/pnas.71.12.4684; Goto JJ, 1998, J BIOL CHEM, V273, P30104, DOI 10.1074/jbc.273.46.30104; Goto JJ, 2000, J BIOL CHEM, V275, P1007, DOI 10.1074/jbc.275.2.1007; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Hart PJ, 1999, BIOCHEMISTRY-US, V38, P2167, DOI 10.1021/bi982284u; Hart PJ, 1998, PROTEIN SCI, V7, P545; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Hornberg A, 2007, J MOL BIOL, V365, P333, DOI 10.1016/j.jmb.2006.09.048; Hough MA, 2004, P NATL ACAD SCI USA, V101, P5976, DOI 10.1073/pnas.0305143101; ICHIMURA S, 1977, BIOPOLYMERS, V16, P1449, DOI 10.1002/bip.1977.360160706; Jaarsma D, 2008, J NEUROSCI, V28, P2075, DOI 10.1523/JNEUROSCI.5258-07.2008; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Kabashi E, 2006, BBA-MOL BASIS DIS, V1762, P1038, DOI 10.1016/j.bbadis.2006.06.006; LEHRER SS, 1969, J BIOL CHEM, V244, P3613; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Lyons TJ, 1996, P NATL ACAD SCI USA, V93, P12240, DOI 10.1073/pnas.93.22.12240; Lyons TJ, 2000, J BIOL INORG CHEM, V5, P189, DOI 10.1007/s007750050363; Lyons TJ, 1998, J BIOL INORG CHEM, V3, P650, DOI 10.1007/s007750050279; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; Matulis D, 1999, BIOPOLYMERS, V49, P451, DOI 10.1002/(SICI)1097-0282(199905)49:6<451::AID-BIP3>3.0.CO;2-6; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Potter SZ, 2007, J AM CHEM SOC, V129, P4575, DOI 10.1021/ja066690+; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; Ricchelli F, 2005, CELL MOL LIFE SCI, V62, P1724, DOI 10.1007/s00018-005-5141-0; Roberts BR, 2007, J MOL BIOL, V373, P877, DOI 10.1016/j.jmb.2007.07.043; Rodriguez JA, 2002, J BIOL CHEM, V277, P15932, DOI 10.1074/jbc.M112088200; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; ROE JA, 1988, BIOCHEMISTRY-US, V27, P950, DOI 10.1021/bi00403a017; Schafer BW, 2000, J BIOL CHEM, V275, P30623, DOI 10.1074/jbc.M002260200; Schonbrunn E, 2000, P NATL ACAD SCI USA, V97, P6345, DOI 10.1073/pnas.120120397; Shaw BF, 2008, J BIOL CHEM, V283, P8340, DOI 10.1074/jbc.M707751200; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Shaw BF, 2006, J BIOL CHEM, V281, P18167, DOI 10.1074/jbc.M600623200; Shinder GA, 2001, J BIOL CHEM, V276, P12791, DOI 10.1074/jbc.M010759200; Shipp EL, 2003, BIOCHEMISTRY-US, V42, P1890, DOI 10.1021/bi026704y; SLAVIK J, 1982, BIOCHIM BIOPHYS ACTA, V694, P1, DOI 10.1016/0304-4157(82)90012-0; Stathopulos PB, 2006, J BIOL CHEM, V281, P6184, DOI 10.1074/jbc.M509496200; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Strange RW, 2007, P NATL ACAD SCI USA, V104, P10040, DOI 10.1073/pnas.0703857104; Strange RW, 2003, J MOL BIOL, V328, P877, DOI 10.1016/S0022-2836(03)00355-3; Subramaniam JR, 2002, NAT NEUROSCI, V5, P301, DOI 10.1038/nn823; Tiwari A, 2005, J BIOL CHEM, V280, P29771, DOI 10.1074/jbc.M504039200; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Tiwari A, 2005, NEURODEGENER DIS, V2, P115, DOI 10.1159/000089616; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; Wang J, 2007, J BIOL CHEM, V282, P345, DOI 10.1074/jbc.M604503200; Zhang FJ, 2007, J BIOL CHEM, V282, P16691, DOI 10.1074/jbc.M609743200; ZITZEWITZ JA, 1995, BIOCHEMISTRY-US, V34, P12812, DOI 10.1021/bi00039a042	83	51	53	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27746	27758		10.1074/jbc.M109.043729	http://dx.doi.org/10.1074/jbc.M109.043729			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651777	hybrid, Green Published			2022-12-27	WOS:000270232300075
J	Xi, XY; Guo, Y; Chen, H; Xu, CP; Zhang, HY; Hu, HB; Cui, LX; Ba, DN; He, W				Xi, Xueyan; Guo, Yang; Chen, Hui; Xu, Chunping; Zhang, Huiyuan; Hu, Hongbo; Cui, Lianxian; Ba, Denian; He, Wei			Antigen Specificity of gamma delta T Cells Depends Primarily on the Flanking Sequences of CDR3 delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDR3 LENGTH; RECEPTOR; REPERTOIRES; LYMPHOCYTES; REGION	The structural basis that determines the specificity of gamma delta T cell receptor (TCR) recognition remains undefined. Our previous data show that the complementary determining region of human TCR delta (CDR3 delta) is critical to ligand binding. Here we used linear and configurational approaches to examine the roles of V, N-D-N, or J regions in CDR3 delta-mediated antigen recognition. Surprisingly, we found that the binding activities of CDR3 delta from different gamma delta TCRs to their target tissues and ligands depend on the conserved flanking sequences (V and J) but not as much on the D region of CDR3 delta fragment. We further defined the key residues in the V and J regions of CDR3 delta fragments, including the cysteine residue in the V fragment and the leucine residue in the J fragment that determine their ligand binding specificity. Our results demonstrate that TCR delta primarily uses conserved flanking regions to bind ligands. This finding may provide an explanation for the limited number of gamma delta TCR ligands that have as yet been identified.	[He, Wei] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100005, Peoples R China; Sch Peking Union Med Coll, Natl Key Lab Med Mol Biol, Beijing 100005, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	He, W (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	heweiimu@public.bta.net.cn	Zhang, Huiyuan/J-2784-2016; Hu, Hongbo/J-8059-2016	Hu, Hongbo/0000-0002-8177-7641; Zhang, Huiyuan/0000-0002-1532-2462	Ministry of Science and Technology, China PR [2001CB510009, 2004CB518706, 2007CB512405]; National Natural Science Foundation of China PR [30490244]; National Program for Biomedical Hightech, the Ministry of Science and Technology, China [2006AA02Z480, 2006AA02A245, 2007AA021109]	Ministry of Science and Technology, China PR(National High Technology Research and Development Program of China); National Natural Science Foundation of China PR(National Natural Science Foundation of China (NSFC)); National Program for Biomedical Hightech, the Ministry of Science and Technology, China	This work was sponsored in part by Grants 2001CB510009, 2004CB518706, and 2007CB512405 from the National Program for Key Basic Research Projects, Ministry of Science and Technology, China PR Grant 30490244 from the National Natural Science Foundation of China PR, and three Grants (No. 2006AA02Z480, No. 2006AA02A245, and No. 2007AA021109) from the National Program for Biomedical Hightech, the Ministry of Science and Technology, China.	Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Brandes M, 2005, SCIENCE, V309, P264, DOI 10.1126/science.1110267; Brawley JV, 1999, J IMMUNOL, V163, P4946; Cao W, 2004, IMMUNOBIOLOGY, V209, P283, DOI 10.1016/j.imbio.2004.04.008; Chen H, 2008, J BIOL CHEM, V283, P12528, DOI 10.1074/jbc.M708067200; Chien YH, 2000, SPRINGER SEMIN IMMUN, V22, P239, DOI 10.1007/PL00006752; Ichiki Y, 2005, AUTOIMMUN REV, V4, P315, DOI 10.1016/j.autrev.2005.01.005; Koohsari H, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-21; Koralov SB, 2006, IMMUNITY, V25, P43, DOI 10.1016/j.immuni.2006.04.016; Li Z, 2007, AM J PATHOL, V171, P838, DOI 10.2353/ajpath.2007.070008; McVay LD, 1998, J IMMUNOL, V160, P5851; Moser B, 2006, TRENDS IMMUNOL, V27, P112, DOI 10.1016/j.it.2006.01.002; Peng G, 2007, IMMUNITY, V27, P334, DOI 10.1016/j.immuni.2007.05.020; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Yao XS, 2007, CELL MOL IMMUNOL, V4, P215; Xu CP, 2007, MOL IMMUNOL, V44, P302, DOI 10.1016/j.molimm.2006.03.010; Zocchi MR, 2004, FRONT BIOSCI-LANDMRK, V9, P2588, DOI 10.2741/1419	20	22	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27449	27455		10.1074/jbc.M109.011684	http://dx.doi.org/10.1074/jbc.M109.011684			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19666468	Green Published, hybrid			2022-12-27	WOS:000270232300047
J	Buch, TRH; Heling, D; Damm, E; Gudermann, T; Breit, A				Buech, Thomas R. H.; Heling, Dominik; Damm, Ellen; Gudermann, Thomas; Breit, Andreas			Pertussis Toxin-sensitive Signaling of Melanocortin-4 Receptors in Hypothalamic GT1-7 Cells Defines Agouti-related Protein as a Biased Agonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLYL-CYCLASE; BETA(2)-ADRENERGIC RECEPTOR; FUNCTIONAL-CHARACTERIZATION; LYSOPHOSPHATIDIC ACID; IN-VIVO; OBESITY; KINASE; MUTATIONS; GENE; NEURONS	Melanocortin-4 receptor (MC4R)-induced anorexigenic signaling in the hypothalamus controls body weight and energy homeostasis. So far, MC4R-induced signaling has been exclusively attributed to its coupling to G(s) proteins. In line with this monogamous G protein coupling profile, most MC4R mutants isolated from obese individuals showed a reduced ability to activate G(s). However, some mutants displayed enhanced G(s) coupling, suggesting that signaling pathways independent of G(s) may be involved in MC4R-mediated anorexigenic signaling. Here we report that the G(s) signaling-deficient MC4R-D90N mutant activates G proteins in a pertussis toxin-sensitive manner, indicating that this mutant is able to selectively interact with G(i/o) proteins. Analyzing a hypothalamic cell line (GT1-7 cells), we observed activation of pertussis toxin-sensitive G proteins by the wild-type MC4R as well, reflecting multiple coupling of the MC4R to G(s) and G(i/o) proteins in an endogenous cell system. Surprisingly, the agouti-related protein, which has been classified as a MC4R antagonist, selectively activates G(i/o) signaling in GT1-7 cells. Thus, the agouti-related protein antagonizes melanocortin-dependent G(s) activation not only by competitive antagonism but additionally by initiating G(i/o) protein-induced signaling as a biased agonist.	[Buech, Thomas R. H.; Damm, Ellen; Gudermann, Thomas; Breit, Andreas] Univ Munich, Walther Straub Inst Pharmakol & Toxikol, D-80336 Munich, Germany; [Heling, Dominik] Univ Marburg, Inst Pharmakol & Toxikol, D-35033 Marburg, Germany	University of Munich; Philipps University Marburg	Breit, A (corresponding author), Univ Munich, Walther Straub Inst Pharmakol & Toxikol, Goethestr 33, D-80336 Munich, Germany.	andreas.breit@lrz.uni-muenchen.de			Bundesministerium fur Bildung und Forschung; Nationales Genomforschungsnetzwerk Network [N2NV-S30T09]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Nationales Genomforschungsnetzwerk Network	This work was supported by the "Bundesministerium fur Bildung und Forschung" as a part of the NGFN-2 (Nationales Genomforschungsnetzwerk N2NV-S30T09) Network.	Biebermann H, 2003, DIABETES, V52, P2984, DOI 10.2337/diabetes.52.12.2984; Chai BX, 2006, PEPTIDES, V27, P2846, DOI 10.1016/j.peptides.2006.05.005; Czyzyk TA, 2008, P NATL ACAD SCI USA, V105, P276, DOI 10.1073/pnas.0710607105; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Dumont LM, 2001, MOL CELL ENDOCRINOL, V184, P173, DOI 10.1016/S0303-7207(01)00558-5; Ferraguti F, 1999, EUR J NEUROSCI, V11, P2073, DOI 10.1046/j.1460-9568.1999.00626.x; Fields TA, 1997, BIOCHEM J, V321, P561, DOI 10.1042/bj3210561; Fu LY, 2008, J NEUROSCI, V28, P5433, DOI 10.1523/JNEUROSCI.0749-08.2008; Galandrin S, 2008, MOL PHARMACOL, V74, P162, DOI 10.1124/mol.107.043893; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; GANTZ I, 1993, J BIOL CHEM, V268, P15174; Govaerts C, 2005, PEPTIDES, V26, P1909, DOI 10.1016/j.peptides.2004.11.042; Halls ML, 2007, J PHARMACOL EXP THER, V320, P281, DOI 10.1124/jpet.106.113225; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Harrison C, 2003, LIFE SCI, V74, P489, DOI 10.1016/j.lfs.2003.07.005; Hinney A, 2006, J CLIN ENDOCR METAB, V91, P1761, DOI 10.1210/jc.2005-2056; Hinney A, 2003, J CLIN ENDOCR METAB, V88, P4258, DOI 10.1210/jc.2003-030233; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Kask A, 1998, BIOCHEM BIOPH RES CO, V245, P90, DOI 10.1006/bbrc.1998.8389; Kask A, 2000, CAN J PHYSIOL PHARM, V78, P143, DOI 10.1139/cjpp-78-2-143; KAUPMANN K, 1993, FEBS LETT, V331, P53, DOI 10.1016/0014-5793(93)80296-7; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Khong K, 2001, NEUROENDOCRINOLOGY, V74, P193, DOI 10.1159/000054686; Laugwitz KL, 1996, P NATL ACAD SCI USA, V93, P116, DOI 10.1073/pnas.93.1.116; LAW SF, 1993, J BIOL CHEM, V268, P10721; Leaney JL, 2003, EUR J NEUROSCI, V18, P2110, DOI 10.1046/j.1460-9568.2003.02933.x; Lee CW, 2007, J BIOL CHEM, V282, P4310, DOI 10.1074/jbc.M610826200; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Michel MC, 2007, MOL PHARMACOL, V72, P1097, DOI 10.1124/mol.107.040923; Milovic S, 2004, J BIOL CHEM, V279, P34240, DOI 10.1074/jbc.M403448200; Nasman J, 2002, J NEUROCHEM, V83, P1252, DOI 10.1046/j.1471-4159.2002.01270.x; Nijenhuis WAJ, 2001, MOL ENDOCRINOL, V15, P164, DOI 10.1210/me.15.1.164; Noh SJ, 1998, J CELL PHYSIOL, V176, P412, DOI 10.1002/(SICI)1097-4652(199808)176:2<412::AID-JCP20>3.0.CO;2-3; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; PACE AM, 1995, MOL BIOL CELL, V6, P1685, DOI 10.1091/mbc.6.12.1685; Patel TB, 2001, GENE, V269, P13, DOI 10.1016/S0378-1119(01)00448-6; Reversi A, 2005, J BIOL CHEM, V280, P16311, DOI 10.1074/jbc.M409945200; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Schallmach E, 2006, NEUROPHARMACOLOGY, V50, P998, DOI 10.1016/j.neuropharm.2006.01.004; Schonbrunn A, 2008, MOL CELL ENDOCRINOL, V286, P35, DOI 10.1016/j.mce.2007.09.009; Shahabi NA, 1999, J NEUROIMMUNOL, V94, P48, DOI 10.1016/S0165-5728(98)00211-2; Shinyama H, 2003, ENDOCRINOLOGY, V144, P1301, DOI 10.1210/en.2002-220931; Smith MA, 2007, J PHYSIOL-LONDON, V578, P425, DOI 10.1113/jphysiol.2006.119479; Steiner D, 2005, J MOL NEUROSCI, V27, P195, DOI 10.1385/JMN:27:2:195; Sutton GM, 2005, ENDOCRINOLOGY, V146, P3739, DOI 10.1210/en.2005-0562; Tao YX, 2003, ENDOCRINOLOGY, V144, P4544, DOI 10.1210/en.2003-0524; Tolle V, 2008, DIABETES, V57, P86, DOI 10.2337/db07-0733; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Wu Q, 2008, J NEUROSCI, V28, P9218, DOI 10.1523/JNEUROSCI.2449-08.2008; XIAO RP, 1995, MOL PHARMACOL, V47, P322; Yeo GSH, 2003, HUM MOL GENET, V12, P561, DOI 10.1093/hmg/ddg057	51	77	79	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26411	26420		10.1074/jbc.M109.039339	http://dx.doi.org/10.1074/jbc.M109.039339			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19648111	Green Published, hybrid			2022-12-27	WOS:000269969600022
J	Nguyen, AD; Lee, SH; Debose-Boyd, RA				Nguyen, Andrew D.; Lee, Soo Hee; Debose-Boyd, Russell A.			Insig-mediated, Sterol-accelerated Degradation of the Membrane Domain of Hamster 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase in Insect Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HMG-COA REDUCTASE; COENZYME-A REDUCTASE; ENDOPLASMIC-RETICULUM DEGRADATION; ANCHORED UBIQUITIN LIGASE; ER-ASSOCIATED DEGRADATION; REGULATED DEGRADATION; SENSING DOMAIN; PROTEIN-DEGRADATION; BINDING; CHOLESTEROL	Sterol-accelerated degradation of the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase is one of several mechanisms through which cholesterol synthesis is controlled in mammalian cells. This degradation results from sterol-induced binding of the membrane domain of reductase to endoplasmic reticulum membrane proteins called Insig-1 and Insig-2, which are carriers of a ubiquitin ligase called gp78. The ensuing gp78-mediated ubiquitination of reductase is a prerequisite for its rapid, 26 S proteasome-mediated degradation from endoplasmic reticulum membranes, a reaction that slows a rate-limiting step in cholesterol synthesis. Here, we report that the membrane domain of hamster reductase is subject to sterol-accelerated degradation in Drosophila S2 cells, but only when mammalian Insig-1 or Insig-2 are co-expressed. This degradation mimics the reaction that occurs in mammalian cells with regard to its absolute requirement for the action of Insigs, sensitivity to proteasome inhibition, augmentation by nonsterol isoprenoids, and sterol specificity. RNA interference studies reveal that this degradation requires the Drosophila Hrd1 ubiquitin ligase and several other proteins, including a putative substrate selector, which associate with the enzyme in yeast and mammalian systems. These studies define Insigs as the minimal requirement for sterol-accelerated degradation of the membrane domain of reductase in Drosophila S2 cells.	[Debose-Boyd, Russell A.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Nguyen, Andrew D.; Lee, Soo Hee; Debose-Boyd, Russell A.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Debose-Boyd, RA (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	Russell.DeBose-Boyd@utsouthwestern.edu	Lee, Soo Hee/E-9494-2012	Nguyen, Andrew/0000-0002-9492-9472	National Institutes of Health [HL20948]; Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008203] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL20948 and the Perot Family Foundation.	Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bordallo J, 1999, FEBS LETT, V448, P244, DOI 10.1016/S0014-5793(99)00362-2; BROWN K, 1983, J BIOL CHEM, V258, P8512; BROWN MS, 1980, J LIPID RES, V21, P505; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; CLARK AJ, 1959, J BIOL CHEM, V234, P2578; Clayton RB, 1964, J LIPID RES, V15, P3; CORRELL CC, 1994, J BIOL CHEM, V269, P633; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Dobrosotskaya IY, 2003, J BIOL CHEM, V278, P35837, DOI 10.1074/jbc.M306476200; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; GERTLER FB, 1988, MOL CELL BIOL, V8, P2713, DOI 10.1128/MCB.8.7.2713; GIL G, 1985, CELL, V41, P249, DOI 10.1016/0092-8674(85)90078-9; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Horton JD, 2002, COLD SPRING HARB SYM, V67, P491, DOI 10.1101/sqb.2002.67.491; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kim TY, 2008, BIOCHEM BIOPH RES CO, V369, P741, DOI 10.1016/j.bbrc.2008.02.086; Ko HS, 2004, FEBS LETT, V566, P110, DOI 10.1016/j.febslet.2004.04.031; Lange Y, 2008, J BIOL CHEM, V283, P1445, DOI 10.1074/jbc.M706967200; Lee JN, 2004, J BIOL CHEM, V279, P45257, DOI 10.1074/jbc.M408235200; Lee PCW, 2007, J LIPID RES, V48, P318, DOI 10.1194/jlr.M600476-JLR200; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; LISCUM L, 1985, J BIOL CHEM, V260, P522; NAKANISHI M, 1988, J BIOL CHEM, V263, P8929; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Nohturfft A, 1998, J BIOL CHEM, V273, P17243, DOI 10.1074/jbc.273.27.17243; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Ravid T, 2000, J BIOL CHEM, V275, P35840, DOI 10.1074/jbc.M004793200; Roitelman J, 2004, J BIOL CHEM, V279, P6465, DOI 10.1074/jbc.M308094200; ROITELMAN J, 1992, J CELL BIOL, V117, P959, DOI 10.1083/jcb.117.5.959; ROITELMAN J, 1992, J BIOL CHEM, V267, P25264; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Seegmiller AC, 2002, DEV CELL, V2, P229, DOI 10.1016/S1534-5807(01)00119-8; Sever N, 2004, J BIOL CHEM, V279, P43136, DOI 10.1074/jbc.M406406200; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; SKALNIK DG, 1988, J BIOL CHEM, V263, P6836; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Walters KJ, 2004, BBA-MOL CELL RES, V1695, P73, DOI 10.1016/j.bbamcr.2004.10.005; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3	48	17	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26778	26788		10.1074/jbc.M109.032342	http://dx.doi.org/10.1074/jbc.M109.032342			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19638338	Green Published, hybrid			2022-12-27	WOS:000269969600059
J	Teng, HJ; Ballim, RD; Mowla, S; Prince, S				Teng, Huajian; Ballim, Reyna Deeya; Mowla, Shaheen; Prince, Sharon			Phosphorylation of Histone H3 by Protein Kinase C Signaling Plays a Critical Role in the Regulation of the Developmentally Important TBX2 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REGULATION; H3-SER10 PHOSPHORYLATION; CHROMATIN-STRUCTURE; MAP KINASE; EXPRESSION; ACTIVATION; CELLS; SP1; RECEPTOR; PROMOTER	The mechanism(s) regulating the expression of the TBX2 gene, a key regulator of development, is poorly understood and thus limits an understanding of its function(s). Here we demonstrate that 12-O-tetradecanoylphorbol-13-acetate (TPA) induces TBX2 expression in normal human fibroblasts in a protein kinase C (PKC)-dependent and MAPK-independent manner. Our data further reveal that TPA activates transcription of TBX2 through activating MSK1, which leads to an increase in phosphorylated histone H3 and the recruitment of Sp1 to the TBX2 gene. In addition, TPA was shown to activate MSK1 in a PKC-dependent and MAPK-independent manner. This study is the first to provide evidence that phosphorylation of histone H3 leads to the transcriptional activation of the TBX2 gene and to link MSK1 to PKC.	[Teng, Huajian; Ballim, Reyna Deeya; Mowla, Shaheen; Prince, Sharon] Univ Cape Town, Dept Human Biol, Fac Hlth Sci, ZA-7925 Cape Town, South Africa	University of Cape Town	Prince, S (corresponding author), Univ Cape Town, Dept Human Biol, Fac Hlth Sci, ZA-7925 Cape Town, South Africa.	sharon.prince@uct.ac.za	Mowla, Shaheen/AAR-8297-2021; Prince, Sharon/AFU-4911-2022	Mowla, Shaheen/0000-0001-6802-0495; Prince, Sharon/0000-0002-6975-5255	SA Medical Research Council; National Research Foundation; University of Cape Town	SA Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation; University of Cape Town	This work was supported by grants from the SA Medical Research Council, the National Research Foundation, and the University of Cape Town.	Abrahams A, 2008, J BIOL CHEM, V283, P2223, DOI 10.1074/jbc.M705651200; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; BOLLAG RJ, 1994, NAT GENET, V7, P383, DOI 10.1038/ng0794-383; CAMPBELL C, 1995, GENOMICS, V28, P255, DOI 10.1006/geno.1995.1139; Carreira S, 1998, MOL CELL BIOL, V18, P5099, DOI 10.1128/MCB.18.9.5099; Clayton AL, 2003, FEBS LETT, V546, P51, DOI 10.1016/S0014-5793(03)00451-4; DAngelo DD, 1996, J BIOL CHEM, V271, P19696, DOI 10.1074/jbc.271.33.19696; Davis E, 2008, ONCOGENE, V27, P976, DOI 10.1038/sj.onc.1210701; Ge Z, 2006, MOL CELL BIOL, V26, P230, DOI 10.1128/MCB.26.1.230-237.2006; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Han JW, 2001, J BIOL CHEM, V276, P42084, DOI 10.1074/jbc.M106688200; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Huang W, 2006, MOL CELL BIOL, V26, P1307, DOI 10.1128/MCB.26.4.1307-1317.2006; Huang W, 2004, J LIPID RES, V45, P1519, DOI 10.1194/jlr.M400088-JLR200; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johansen KM, 2006, CHROMOSOME RES, V14, P393, DOI 10.1007/s10577-006-1063-4; LAW DJ, 1995, MAMM GENOME, V6, P793, DOI 10.1007/BF00539006; LEE KAW, 1990, METHOD ENZYMOL, V181, P20; Lopez-Bergami P, 2005, MOL CELL, V19, P309, DOI 10.1016/j.molcel.2005.06.025; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; Mahlamaki EH, 2002, GENE CHROMOSOME CANC, V35, P353, DOI 10.1002/gcc.10122; Mauro A, 2002, J CELL SCI, V115, P3587, DOI 10.1242/jcs.00037; NAMBA M, 1980, GANN, V71, P300; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Nissim S, 2007, DEV BIOL, V304, P9, DOI 10.1016/j.ydbio.2006.12.010; Noe V, 2001, EUR J BIOCHEM, V268, P3163, DOI 10.1046/j.1432-1327.2001.02198.x; Park GY, 2006, J BIOL CHEM, V281, P18684, DOI 10.1074/jbc.M600733200; Porntadavity S, 2001, DNA CELL BIOL, V20, P473, DOI 10.1089/104454901316976109; Prince S, 2004, CANCER RES, V64, P1669, DOI 10.1158/0008-5472.CAN-03-3286; Salvador LM, 2001, J BIOL CHEM, V276, P40146, DOI 10.1074/jbc.M106710200; Samson SLA, 2002, J MOL ENDOCRINOL, V29, P265, DOI 10.1677/jme.0.0290265; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Schuettengruber B, 2003, MOL CELL BIOL, V23, P6993, DOI 10.1128/MCB.23.19.6993-7004.2003; Sinclair CS, 2002, CANCER RES, V62, P3587; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Suzuki T, 2004, DEV CELL, V6, P43, DOI 10.1016/S1534-5807(03)00401-5; Teng HJ, 2008, GENE, V423, P8, DOI 10.1016/j.gene.2008.06.017; Teng H, 2007, J CELL BIOCHEM, V102, P618, DOI 10.1002/jcb.21315; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Tone Y, 2007, J IMMUNOL, V179, P1760, DOI 10.4049/jimmunol.179.3.1760; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; Zheng XL, 2000, J BIOL CHEM, V275, P31747, DOI 10.1074/jbc.M000621200	46	13	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26368	26376		10.1074/jbc.M109.021360	http://dx.doi.org/10.1074/jbc.M109.021360			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19633291	Green Published, hybrid			2022-12-27	WOS:000269969600017
J	Wu, HM; Liu, SW; Hsu, MT; Hung, CL; Lai, CC; Cheng, WC; Wang, HJ; Li, YK; Wang, WC				Wu, Hsin-Mao; Liu, Sheng-Wen; Hsu, Ming-Tsung; Hung, Chiu-Lien; Lai, Chun-Chieh; Cheng, Wen-Chi; Wang, Hung-Jung; Li, Yaw-Kuen; Wang, Wen-Ching			Structure, Mechanistic Action, and Essential Residues of a GH-64 Enzyme, Laminaripentaose-producing beta-1,3-Glucanase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; GLYCOSYL; CLASSIFICATION; HYDROLASE; PROTEIN; ENDO-BETA-1,3-GLUCANASE; PURIFICATION; REFINEMENT; RESOLUTION; FAMILIES	Laminaripentaose-producing beta-1,3-glucanase (LPHase), a member of glycoside hydrolase family 64, cleaves a long-chain polysaccharide beta-1,3-glucan into specific pentasaccharide oligomers. The crystal structure of LPHase from Streptomyces matensis DIC-108 was solved to 1.62 angstrom resolution using multiple-wavelength anomalous dispersion methods. The LPHase structure reveals a novel crescent-like fold; it consists of a barrel domain and a mixed (alpha/beta) domain, forming a wide-open groove between the two domains. The liganded crystal structure was also solved to 1.80 angstrom, showing limited conformational changes. Within the wide groove, a laminaritetraose molecule is found to sit in an electronegatively charged central region and is proximal to several conserved residues including two carboxylates (Glu(154) and Asp(170)) and four other sugar-binding residues (Thr156, Asn(158), Trp(163), and Thr(167)). Molecular modeling using a laminarihexaose as a substrate suggests roles for Glu(154) and Asp(170) as acid and base catalysts, respectively, whereas the side chains of Thr(156), Asn(158), and Trp(163) demarcate subsite +5. Site-directed mutagenesis of Glu(154) and Asp(170) confirms that both carboxylates are essential for catalysis. Together, our results suggest that LPHase uses a direct displacement mechanism involving Glu(154) and Asp(170) to cleave a beta-1,3-glucan into specific alpha-pentasaccharide oligomers.	[Liu, Sheng-Wen; Li, Yaw-Kuen] Natl Chiao Tung Univ, Dept Appl Chem, Hsinchu 300, Taiwan; [Wu, Hsin-Mao; Hsu, Ming-Tsung; Hung, Chiu-Lien; Lai, Chun-Chieh; Cheng, Wen-Chi; Wang, Hung-Jung; Wang, Wen-Ching] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 300, Taiwan; [Wu, Hsin-Mao; Hsu, Ming-Tsung; Hung, Chiu-Lien; Lai, Chun-Chieh; Cheng, Wen-Chi; Wang, Hung-Jung; Wang, Wen-Ching] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu 300, Taiwan	National Yang Ming Chiao Tung University; National Tsing Hua University; National Tsing Hua University	Li, YK (corresponding author), Natl Chiao Tung Univ, Dept Appl Chem, Hsinchu 300, Taiwan.	ykl@cc.nctu.edu.tw; wcwang@mx.nthu.edu.tw	Wang, Wen-Ching/ABI-2253-2020	Hsu, Ming-Tsung/0000-0002-6940-1844; Wang, Wen-Ching/0000-0002-7422-3667	National Science Council [NSC 94-2311-B-009-001, NSC96-2313-B-007-001, NSC97-3112-B007-005]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported, in part, by grants from the National Science Council (NSC 94-2311-B-009-001, NSC96-2313-B-007-001, and NSC97-3112-B007-005), Taiwan.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ATKINS EDT, 1968, NATURE, V220, P784, DOI 10.1038/220784a0; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BLUHM TL, 1977, CAN J CHEM, V55, P293, DOI 10.1139/v77-044; Bohn JA, 1995, CARBOHYD POLYM, V28, P3, DOI 10.1016/0144-8617(95)00076-3; CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; COLMAN PM, 1994, PROTEIN SCI, V3, P1687, DOI 10.1002/pro.5560031007; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; DAY AG, 1985, BIOCHEM BIOPH RES CO, V133, P628, DOI 10.1016/0006-291X(85)90951-9; DESLANDES Y, 1980, MACROMOLECULES, V13, P1466, DOI 10.1021/ma60078a020; Fibriansah G, 2007, PROTEINS, V69, P683, DOI 10.1002/prot.21589; Fontaine T, 1997, J BACTERIOL, V179, P3154, DOI 10.1128/jb.179.10.3154-3163.1997; Fukuda K, 2008, BIOSCI BIOTECH BIOCH, V72, P3107, DOI 10.1271/bbb.80213; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; HENRISSAT B, 1999, CARBOHYDRATE ACTIVE; Ishida T, 2009, J BIOL CHEM, V284, P10100, DOI 10.1074/jbc.M808122200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KO TP, 1994, ACTA CRYSTALLOGR D, V50, P813, DOI 10.1107/S0907444994005512; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leone P, 2006, BIOCHIMIE, V88, P45, DOI 10.1016/j.biochi.2005.07.001; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakabayashi M, 1998, J FERMENT BIOENG, V85, P459, DOI 10.1016/S0922-338X(98)80062-7; Nishimura T, 2001, FEBS LETT, V499, P187, DOI 10.1016/S0014-5793(01)02551-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Raghuraman A, 2006, J MED CHEM, V49, P3553, DOI 10.1021/jm060092o; Receveur-Brechot V, 2006, PROTEINS, V63, P235, DOI 10.1002/prot.20876; SAITO H, 1977, BIOCHEMISTRY-US, V16, P908, DOI 10.1021/bi00624a015; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; VARGHESE JN, 1994, P NATL ACAD SCI USA, V91, P2785, DOI 10.1073/pnas.91.7.2785; Varghese JN, 1999, STRUCTURE, V7, P179, DOI 10.1016/S0969-2126(99)80024-0; Wasser SP, 2002, APPL MICROBIOL BIOT, V60, P258, DOI 10.1007/s00253-002-1076-7; YANG W, 1990, J BIOL CHEM, V265, P13553; Zekovic DB, 2005, CRIT REV BIOTECHNOL, V25, P205, DOI 10.1080/07388550500376166	42	21	23	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26708	26715		10.1074/jbc.M109.010983	http://dx.doi.org/10.1074/jbc.M109.010983			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19640850	Green Published, hybrid			2022-12-27	WOS:000269969600051
J	Bocksteins, E; Labro, AJ; Mayeur, E; Bruyns, T; Timmermans, JP; Adriaensen, D; Snyders, DJ				Bocksteins, Elke; Labro, Alain J.; Mayeur, Evy; Bruyns, Tine; Timmermans, Jean-Pierre; Adriaensen, Dirk; Snyders, Dirk J.			Conserved Negative Charges in the N-terminal Tetramerization Domain Mediate Efficient Assembly of Kv2.1 and Kv2.1/Kv6.4 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED K+ CHANNEL; GREEN FLUORESCENT PROTEIN; RESONANCE ENERGY-TRANSFER; POTASSIUM CHANNEL; ALPHA-SUBUNITS; FUNCTIONAL-CHARACTERIZATION; CRYSTAL-STRUCTURE; LIVING CELLS; T1 DOMAIN; SHAB	Voltage-gated potassium (Kv) channels are transmembrane tetramers of individual alpha-subunits. Eight different Shaker-related Kv subfamilies have been identified in which the tetramerization domain T1, located on the intracellular N terminus, facilitates and controls the assembly of both homo- and heterotetrameric channels. Only the Kv2 alpha-subunits are able to form heterotetramers with members of the silent Kv subfamilies (Kv5, Kv6, Kv8, and Kv9). The T1 domain contains two subdomains, A and B box, which presumably determine subfamily specificity by preventing incompatible subunits to assemble. In contrast, little is known about the involvement of the A/B linker sequence. Both Kv2 and silent Kv subfamilies contain a fully conserved and negatively charged sequence (CDD) in this linker that is lacking in the other subfamilies. Neutralizing these aspartates in Kv2.1 by mutating them to alanines did not affect the gating properties, but reduced the current density moderately. However, charge reversal arginine substitutions strongly reduced the current density of these homotetrameric mutant Kv2.1 channels and immunocytochemistry confirmed the reduced expression at the plasma membrane. Forster resonance energy transfer measurements using confocal microscopy showed that the latter was not due to impaired trafficking, but to a failure to assemble the tetramer. This was further confirmed with co-immunoprecipitation experiments. The corresponding arginine substitution in Kv6.4 prevented its heterotetrameric interaction with Kv2.1. These results indicate that these aspartates (especially the first one) in the A/B box linker of the T1 domain are required for efficient assembly of both homotetrameric Kv2.1 and heterotetrameric Kv2.1/silent Kv6.4 channels.	[Bocksteins, Elke; Labro, Alain J.; Mayeur, Evy; Bruyns, Tine; Snyders, Dirk J.] Univ Antwerp, CDE, Dept Biomed Sci, Lab Mol Biophys Physiol & Pharmacol, B-2610 Antwerp, Belgium; [Timmermans, Jean-Pierre; Adriaensen, Dirk] Univ Antwerp, CGB, Dept Vet Sci, Cell Biol & Histol Lab, B-2020 Antwerp, Belgium	University of Antwerp; University of Antwerp	Snyders, DJ (corresponding author), Univ Antwerp, CDE, Dept Biomed Sci, Lab Mol Biophys Physiol & Pharmacol, Univ Pl 1, B-2610 Antwerp, Belgium.	dirk.snyders@ua.ac.be	Snyders, Dirk/A-2713-2013	Snyders, Dirk/0000-0001-7142-6672; Timmermans, Jean-Pierre/0000-0003-2506-6252; Labro, Alain J/0000-0002-0871-7511	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); Belgian Federal Science Policy Office, Research Foundation Flanders [G.0085.04, G.0152.06, 1.5.044.07]; University of Antwerp [GOA50.4426]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Belgian Federal Science Policy Office, Research Foundation Flanders(Belgian Federal Science Policy OfficeFWO); University of Antwerp; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a Ph. D. grant of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) (to E. B.), Interuniversity Attraction Poles program P6/31 of the Belgian Federal Science Policy Office, Research Foundation Flanders (FWO, Fonds voor Wetenschappelijk Onderzoek Vlaanderen) Grants G.0085.04 and G.0152.06 (to D. J. S.) and 1.5.044.07 (to A. J. L.), and GOA50.4426 from the concerted action fund of the University of Antwerp.	Adair B, 2008, BIOPHYS J, V94, P2106, DOI 10.1529/biophysj.107.118562; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Castellano A, 1997, J NEUROSCI, V17, P4652; Delisle BP, 2004, CIRC RES, V94, P1418, DOI 10.1161/01.RES.0000128561.28701.ea; DREWE JA, 1992, J NEUROSCI, V12, P538; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Grailhe R, 2006, CHEMPHYSCHEM, V7, P1442, DOI 10.1002/cphc.200600057; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Hugnot JP, 1996, EMBO J, V15, P3322, DOI 10.1002/j.1460-2075.1996.tb00697.x; Ju M, 2003, J BIOL CHEM, V278, P12769, DOI 10.1074/jbc.M212973200; Kerschensteiner D, 1999, BIOPHYS J, V77, P248, DOI 10.1016/S0006-3495(99)76886-4; Kobertz WR, 1999, NAT STRUCT BIOL, V6, P1122; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; Kobrinsky E, 2006, J BIOL CHEM, V281, P19233, DOI 10.1074/jbc.M601231200; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Kramer JW, 1998, AM J PHYSIOL-CELL PH, V274, pC1501, DOI 10.1152/ajpcell.1998.274.6.C1501; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; LEE TE, 1994, BIOPHYS J, V66, P667, DOI 10.1016/S0006-3495(94)80840-9; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Lukasiewicz S, 2007, PHARMACOL REP, V59, P379; Schnitzler MMY, 2009, J BIOL CHEM, V284, P4695, DOI 10.1074/jbc.M808786200; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Mohapatra DP, 2008, J NEUROSCI, V28, P4982, DOI 10.1523/JNEUROSCI.0186-08.2008; Nanao MH, 2003, P NATL ACAD SCI USA, V100, P8670, DOI 10.1073/pnas.1432840100; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Ottschytsch N, 2002, P NATL ACAD SCI USA, V99, P7986, DOI 10.1073/pnas.122617999; Patel AJ, 1997, EMBO J, V16, P6615, DOI 10.1093/emboj/16.22.6615; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Pentcheva T, 2001, J IMMUNOL, V166, P6625, DOI 10.4049/jimmunol.166.11.6625; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Post MA, 1996, FEBS LETT, V399, P177, DOI 10.1016/S0014-5793(96)01316-6; Richardson FC, 2000, HEARING RES, V147, P21, DOI 10.1016/S0378-5955(00)00117-9; Salinas M, 1997, J BIOL CHEM, V272, P24371, DOI 10.1074/jbc.272.39.24371; Salinas M, 1997, J BIOL CHEM, V272, P8774, DOI 10.1074/jbc.272.13.8774; Sano Y, 2002, FEBS LETT, V512, P230, DOI 10.1016/S0014-5793(02)02267-6; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; Shepard AR, 1999, AM J PHYSIOL-CELL PH, V277, pC412, DOI 10.1152/ajpcell.1999.277.3.C412; Stocker M, 1998, BIOCHEM BIOPH RES CO, V248, P927, DOI 10.1006/bbrc.1998.9072; Tu LW, 1996, J BIOL CHEM, V271, P18904, DOI 10.1074/jbc.271.31.18904; Vega-Saenz de Miera E, 2004, MOL BRAIN RES, V123, P91, DOI 10.1016/j.molbrainres.2004.01.004; XU J, 1995, J BIOL CHEM, V270, P24761, DOI 10.1074/jbc.270.42.24761; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797; Zhu XR, 1999, RECEPTOR CHANNEL, V6, P337	45	14	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31625	31634		10.1074/jbc.M109.039479	http://dx.doi.org/10.1074/jbc.M109.039479			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19717558	hybrid, Green Published			2022-12-27	WOS:000271572700017
J	Stow, LR; Gumz, ML; Lynch, IJ; Greenlee, MM; Rudin, A; Cain, BD; Wingo, CS				Stow, Lisa R.; Gumz, Michelle L.; Lynch, I. Jeanette; Greenlee, Megan M.; Rudin, Alicia; Cain, Brian D.; Wingo, Charles S.			Aldosterone Modulates Steroid Receptor Binding to the Endothelin-1 Gene (edn1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDULLARY COLLECTING DUCT; EPITHELIAL SODIUM-CHANNEL; HUMAN MINERALOCORTICOID RECEPTOR; GLUCOCORTICOID-RECEPTOR; RESPONSE ELEMENT; BLOOD-PRESSURE; CELL-LINE; 5'-FLANKING REGION; ETB RECEPTORS; IMMUNOREACTIVE ENDOTHELIN	Aldosterone and endothelin-1 (ET-1) act on collecting duct cells of the kidney and are important regulators of renal sodium transport and cardiovascular physiology. We recently identified the ET-1 gene (edn1) as a novel aldosterone-induced transcript. However, aldosterone action on edn1 has not been characterized at the present time. In this report, we show that aldosterone stimulated edn1 mRNA in acutely isolated rat inner medullary collecting duct cells ex vivo and ET-1 peptide in rat inner medulla in vivo. Aldosterone induction of edn1 mRNA occurred in cortical, outer medullary, and inner medullary collecting duct cells in vitro. Inspection of the edn1 promoter revealed two putative hormone response elements. Levels of heterogeneous nuclear RNA synthesis demonstrated that edn1 mRNA stimulation occurred at the level of transcription. RNA knockdowns corroborated pharmacological studies and demonstrated both mineralocorticoid receptor and glucocorticoid receptor participated in this response. Aldosterone resulted in dose-dependent nuclear translocation and binding of mineralocorticoid receptor and glucocorticoid receptor to the edn1 hormone response elements. Hormone receptors mediated the association of chromatin remodeling complexes, histone modification, and RNA polymerase II at the edn1 promoter. Direct interaction between aldosterone and ET-1 has important implications for renal and cardiovascular function.	[Stow, Lisa R.; Greenlee, Megan M.; Wingo, Charles S.] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL 32610 USA; [Gumz, Michelle L.; Lynch, I. Jeanette; Rudin, Alicia; Wingo, Charles S.] Univ Florida, Dept Med, Div Nephrol, Gainesville, FL 32610 USA; [Cain, Brian D.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Stow, Lisa R.; Gumz, Michelle L.; Lynch, I. Jeanette; Greenlee, Megan M.; Rudin, Alicia; Wingo, Charles S.] Vet Affairs Med Ctr, Gainesville, FL 32608 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Wingo, CS (corresponding author), 1601 SW Archer Rd,Res 151, Gainesville, FL 32608 USA.	charles.wingo@medicine.ufl.edu	Gumz, Michelle/AGX-2097-2022	Gumz, Michelle/0000-0002-1342-0878; Mitzelfelt, Megan/0000-0002-6578-3670	National Institutes of Health [RO1-DK049750]; Research Service of the Department of Veteran Affairs; Department of Medicine of the University of Florida; American Heart Association Predoctoral Fellowships [AHA071572B, AHA0825467E]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007518, R01DK049750, R01DK082680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Service of the Department of Veteran Affairs; Department of Medicine of the University of Florida; American Heart Association Predoctoral Fellowships(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-DK049750 (to C. S. W.) from USPHS. This work was also supported by the Research Service of the Department of Veteran Affairs, the Department of Medicine of the University of Florida, and American Heart Association Predoctoral (AHA071572B) and Postdoctoral (AHA0825467E) Fellowships (to L. R. S. and M. L. G., respectively).	Ahn D, 2004, J CLIN INVEST, V114, P504, DOI 10.1172/JCI200421064; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; Aumais JP, 1996, J BIOL CHEM, V271, P12568, DOI 10.1074/jbc.271.21.12568; Barton M, 2008, CAN J PHYSIOL PHARM, V86, P485, DOI 10.1139/Y08-059; Baylis C, 1999, CLIN EXP PHARMACOL P, V26, P253, DOI 10.1046/j.1440-1681.1999.03026.x; Beato M, 2000, HUM REPROD UPDATE, V6, P225, DOI 10.1093/humupd/6.3.225; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Bhargava A, 2004, MOL CELL ENDOCRINOL, V217, P189, DOI 10.1016/j.mce.2003.10.020; Boesen EI, 2007, AM J PHYSIOL-RENAL, V292, pF185, DOI 10.1152/ajprenal.00021.2006; Bugaj V, 2008, AM J PHYSIOL-RENAL, V295, pF1063, DOI 10.1152/ajprenal.90321.2008; Deng WG, 2003, ANAL BIOCHEM, V323, P12, DOI 10.1016/j.ab.2003.08.007; Derfoul A, 1998, J BIOL CHEM, V273, P20702, DOI 10.1074/jbc.273.33.20702; Doi T, 2008, AM J PHYSIOL-HEART C, V295, pH1279, DOI 10.1152/ajpheart.00148.2008; EDWARDS RM, 1992, AM J PHYSIOL, V263, pF1020, DOI 10.1152/ajprenal.1992.263.6.F1020; Flores SY, 2005, J AM SOC NEPHROL, V16, P2279, DOI 10.1681/ASN.2004100828; Funder JW, 2009, MOL CELL ENDOCRINOL, V301, P2, DOI 10.1016/j.mce.2008.10.029; FUNDER JW, 1988, SCIENCE, V242, P583, DOI 10.1126/science.2845584; FUNDER JW, 1993, SCIENCE, V259, P1132, DOI 10.1126/science.8382375; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Gallego MS, 1996, AM J PHYSIOL-RENAL, V271, pF451, DOI 10.1152/ajprenal.1996.271.2.F451; Ge YQ, 2005, AM J PHYSIOL-RENAL, V289, pF692, DOI 10.1152/ajprenal.00100.2005; Ge YQ, 2005, AM J PHYSIOL-RENAL, V288, pF912, DOI 10.1152/ajprenal.00432.2004; Ge YQ, 2008, CAN J PHYSIOL PHARM, V86, P329, DOI 10.1139/Y08-028; Gilmore ES, 2001, J BIOL CHEM, V276, P42610, DOI 10.1074/jbc.M106919200; Gomez-Sanchez CE, 2006, ENDOCRINOLOGY, V147, P1343, DOI 10.1210/en.2005-0860; Gumz ML, 2009, J CLIN INVEST, V119, P2423, DOI 10.1172/JCI36908; Gumz ML, 2003, AM J PHYSIOL-RENAL, V285, pF664, DOI 10.1152/ajprenal.00353.2002; Guntupalli J, 1997, AM J PHYSIOL-CELL PH, V273, pC558, DOI 10.1152/ajpcell.1997.273.2.C558; He YZ, 2002, J BIOL CHEM, V277, P49256, DOI 10.1074/jbc.M205536200; Hellal-Levy C, 2000, MOL ENDOCRINOL, V14, P1210, DOI 10.1210/me.14.8.1210; Herrera M, 2005, AM J PHYSIOL-RENAL, V288, pF58, DOI 10.1152/ajprenal.00209.2004; Hoffman A, 2000, HYPERTENSION, V35, P732, DOI 10.1161/01.HYP.35.3.732; Hsieh TJ, 2000, AM J PHYSIOL-RENAL, V279, pF112, DOI 10.1152/ajprenal.2000.279.1.F112; Inscho EW, 2005, BRIT J PHARMACOL, V146, P1019, DOI 10.1038/sj.bjp.0706412; Itani OA, 2002, AM J PHYSIOL-ENDOC M, V283, pE971, DOI 10.1152/ajpendo.00021.2002; Khanna A, 2005, J AM SOC NEPHROL, V16, P1929, DOI 10.1681/ASN.2004121054; KITAMURA K, 1989, BIOCHEM BIOPH RES CO, V162, P38, DOI 10.1016/0006-291X(89)91958-X; KITAMURA K, 1989, BIOCHEM BIOPH RES CO, V161, P348, DOI 10.1016/0006-291X(89)91603-3; KIZER NL, 1995, AM J PHYSIOL-RENAL, V268, pF347, DOI 10.1152/ajprenal.1995.268.2.F347; Kohan DE, 2006, CURR OPIN NEPHROL HY, V15, P34, DOI 10.1097/01.mnh.0000186852.15889.1a; KOHAN DE, 1992, J BIOL CHEM, V267, P12336; Kohan DE, 2009, KIDNEY INT, V76, P481, DOI 10.1038/ki.2009.203; Kolla V, 1999, BIOCHEM BIOPH RES CO, V266, P5, DOI 10.1006/bbrc.1999.1765; Leach KM, 2003, NUCLEIC ACIDS RES, V31, P1292, DOI 10.1093/nar/gkg209; Li Y, 2005, MOL CELL, V19, P367, DOI 10.1016/j.molcel.2005.06.026; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Liu WH, 1995, P NATL ACAD SCI USA, V92, P12480, DOI 10.1073/pnas.92.26.12480; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Matsumura Y, 2000, J CARDIOVASC PHARM, V36, pS86, DOI 10.1097/00005344-200036051-00028; Matsumura Y, 2000, BRIT J PHARMACOL, V129, P1060, DOI 10.1038/sj.bjp.0703157; McManus F, 2008, NAT CLIN PRACT ENDOC, V4, P44, DOI 10.1038/ncpendmet0676; Mick VE, 2001, MOL ENDOCRINOL, V15, P575, DOI 10.1210/me.15.4.575; Montezano ACI, 2005, PEPTIDES, V26, P1454, DOI 10.1016/j.peptides.2005.03.038; Morris DJ, 2009, STEROIDS, V74, P1, DOI 10.1016/j.steroids.2008.10.005; Nishi M, 2004, J NEUROSCI, V24, P4918, DOI 10.1523/JNEUROSCI.5495-03.2004; Nishi M, 2007, NEUROENDOCRINOLOGY, V85, P186, DOI 10.1159/000101917; Odermatt A, 2009, STEROIDS, V74, P163, DOI 10.1016/j.steroids.2008.10.010; Ou XM, 2001, J BIOL CHEM, V276, P14299, DOI 10.1074/jbc.M005363200; Palii SS, 2006, BIOCHEM J, V395, P517, DOI 10.1042/BJ20051867; Pascual-Le Tallec L, 2005, MOL ENDOCRINOL, V19, P2211, DOI 10.1210/me.2005-0089; Pollock DM, 2000, AM J PHYSIOL-RENAL, V278, pF279, DOI 10.1152/ajprenal.2000.278.2.F279; Pollock DM, 2000, CURR OPIN NEPHROL HY, V9, P157, DOI 10.1097/00041552-200003000-00010; RAUCHMAN MI, 1993, AM J PHYSIOL, V265, pF416, DOI 10.1152/ajprenal.1993.265.3.F416; Rogerson FM, 2003, MOL CELL ENDOCRINOL, V200, P45, DOI 10.1016/S0303-7207(02)00413-6; Savory JGA, 2001, MOL CELL BIOL, V21, P781, DOI 10.1128/MCB.21.3.781-793.2001; Sayegh R, 1999, J BIOL CHEM, V274, P12431, DOI 10.1074/jbc.274.18.12431; Stricklett PK, 2006, AM J PHYSIOL-RENAL, V290, pF1315, DOI 10.1152/ajprenal.00450.2005; Thiaville MM, 2008, BIOCHEM J, V410, P473, DOI 10.1042/BJ20071252; ULICK S, 1979, J CLIN ENDOCR METAB, V49, P757, DOI 10.1210/jcem-49-5-757; Vallon V, 2005, AM J PHYSIOL-REG I, V289, pR395, DOI 10.1152/ajpregu.00731.2004; Vassileva I, 2003, HYPERTENSION, V41, P1359, DOI 10.1161/01.HYP.0000070958.39174.7E; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; WHORWOOD CB, 1994, ENDOCRINOLOGY, V135, P901, DOI 10.1210/en.135.3.901; Wolf SC, 2006, BIOCHEM PHARMACOL, V71, P1175, DOI 10.1016/j.bcp.2006.01.001; Wong S, 2007, ENDOCRINOLOGY, V148, P1511, DOI 10.1210/en.2006-0965; YORIKANE R, 1993, FEBS LETT, V332, P31, DOI 10.1016/0014-5793(93)80476-B	79	46	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30087	30096		10.1074/jbc.M109.030718	http://dx.doi.org/10.1074/jbc.M109.030718			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19638349	Green Published, hybrid			2022-12-27	WOS:000271090000011
J	Almaca, J; Tian, YM; Aldehni, F; Ousingsawat, J; Kongsuphol, P; Rock, JR; Harfe, BD; Schreiber, R; Kunzelmann, K				Almaca, Joana; Tian, Yuemin; Aldehni, Fadi; Ousingsawat, Jiraporn; Kongsuphol, Patthara; Rock, Jason R.; Harfe, Brian D.; Schreiber, Rainer; Kunzelmann, Karl			TMEM16 Proteins Produce Volume-regulated Chloride Currents That Are Reduced in Mice Lacking TMEM16A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASCITES TUMOR-CELLS; ANION CHANNELS; DECREASE; CALCIUM; CONDUCTANCE; CAMP; PROLIFERATION; STIMULATION; INHIBITION; ACTIVATION	All vertebrate cells regulate their cell volume by activating chloride channels of unknown molecular identity, thereby activating regulatory volume decrease. We show that the Ca2+-activated Cl- channel TMEM16A together with other TMEM16 proteins are activated by cell swelling through an autocrine mechanism that involves ATP release and binding to purinergic P2Y(2) receptors. TMEM16A channels are activated by ATP through an increase in intracellular Ca2+ and a Ca2+-independent mechanism engaging extracellular-regulated protein kinases (ERK1/2). The ability of epithelial cells to activate a Cl-conductance upon cell swelling, and to decrease their cell volume (regulatory volume decrease) was dependent on TMEM16 proteins. Activation of I-Cl,I-swell was reduced in the colonic epithelium and in salivary acinar cells from mice lacking expression of TMEM16A. Thus TMEM16 proteins appear to be a crucial component of epithelial volume-regulated Cl-channels and may also have a function during proliferation and apoptotic cell death.	[Schreiber, Rainer; Kunzelmann, Karl] Univ Regensburg, Inst Physiol, D-93053 Regensburg, Germany; [Rock, Jason R.; Harfe, Brian D.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA	University of Regensburg; State University System of Florida; University of Florida	Kunzelmann, K (corresponding author), Univ Regensburg, Inst Physiol, Univ Str 31, D-93053 Regensburg, Germany.	karl.kunzelmann@vkl.uni-regensburg.de	Tian, Yuemin/AAE-8827-2021	Almaca, Joana/0000-0002-9316-712X; Kunzelmann, Karl/0000-0002-4583-7037	Deutsche Forschungsgemeinschaft [SFB699, KU 756/8-2]; TargetScreen2 [EU-FP6-2005-LH-037365]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); TargetScreen2	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB699 and KU 756/8-2 and TargetScreen2 Grant EU-FP6-2005-LH-037365.	Adam G, 2005, PFLUG ARCH EUR J PHY, V449, P470, DOI 10.1007/s00424-004-1356-4; Altamirano J, 1998, J GEN PHYSIOL, V112, P145, DOI 10.1085/jgp.112.2.145; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Carles A, 2006, ONCOGENE, V25, P1821, DOI 10.1038/sj.onc.1209203; Chen B, 2007, J MEMBRANE BIOL, V215, P1, DOI 10.1007/s00232-007-9000-9; De la Fuente R, 2008, MOL PHARMACOL, V73, P758, DOI 10.1124/mol.107.043208; DIENER M, 1992, PFLUG ARCH EUR J PHY, V421, P530, DOI 10.1007/BF00375048; Franco R, 2008, J CELL PHYSIOL, V216, P14, DOI 10.1002/jcp.21406; Furst J, 2002, PFLUG ARCH EUR J PHY, V444, P1, DOI 10.1007/s00424-002-0805-1; HOFFMANN EK, 1984, J MEMBRANE BIOL, V78, P211, DOI 10.1007/BF01925969; Hoffmann EK, 2000, CELL PHYSIOL BIOCHEM, V10, P273, DOI 10.1159/000016356; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Katoh M, 2004, INT J MOL MED, V14, P759; KUNZELMANN K, 1994, PFLUG ARCH EUR J PHY, V428, P76, DOI 10.1007/BF00374754; Lan WZ, 2005, AM J PHYSIOL-GASTR L, V288, pG221, DOI 10.1152/ajpgi.00226.2004; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lang F, 2000, CELL PHYSIOL BIOCHEM, V10, P417, DOI 10.1159/000016367; Lang F, 2000, PFLUG ARCH EUR J PHY, V440, P902, DOI 10.1007/s004240000358; Okada Y, 2004, PFLUG ARCH EUR J PHY, V448, P287, DOI 10.1007/s00424-004-1276-3; Pedersen SF, 1998, J MEMBRANE BIOL, V163, P97, DOI 10.1007/s002329900374; PIFFERI S, 2009, PFLUGERS AR IN PRESS; RAFUNDO DF, 2004, AM J PHYSIOL-REG I, V287, pR833; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Stutzin A, 2006, ACTA PHYSIOL, V187, P27, DOI 10.1111/j.1748-1716.2006.01537.x; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; VALVERDE MA, 1995, P NATL ACAD SCI USA, V92, P9038, DOI 10.1073/pnas.92.20.9038; VALVERDE MA, 1993, PFLUG ARCH EUR J PHY, V425, P434, DOI 10.1007/BF00374869; van der Wijk T, 1999, BIOCHEM J, V343, P579, DOI 10.1042/0264-6021:3430579; Vennekens R, 1999, J PHYSIOL-LONDON, V515, P75, DOI 10.1111/j.1469-7793.1999.075ad.x; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	31	138	143	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28571	28578		10.1074/jbc.M109.010074	http://dx.doi.org/10.1074/jbc.M109.010074			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19654323	Green Published, hybrid			2022-12-27	WOS:000270678900011
J	Koslowski, M; Tureci, O; Biesterfeld, S; Seitz, G; Huber, C; Sahin, U				Koslowski, Michael; Tuereci, Oezlem; Biesterfeld, Stefan; Seitz, Gerhard; Huber, Christoph; Sahin, Ugur			Selective Activation of Trophoblast-specific PLAC1 in Breast Cancer by CCAAT/Enhancer-binding Protein beta (C/EBP beta) Isoform 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; PROLACTIN RECEPTOR; PLACENTAL CELLS; NUCLEAR FACTOR; MESSENGER-RNA; ALPHA; DIFFERENTIATION; PREGNANCY	The trophoblast-specific gene PLAC1 (placenta-specific 1) is ectopically expressed in a wide range of human malignancies, most frequently in breast cancer, and is essentially involved in cancer cell proliferation, migration, and invasion. Here we show that basal activity of the PLAC1 promoter is selectively controlled by ubiquitous transcription factor SP1 and isoform 2 of CCAAT/enhancer-binding protein beta that we found to be selectively expressed in placental tissue and cancer cells. Binding of both factors to their respective elements within the PLAC1 promoter was essential to attain full promoter activity. Estrogen receptor alpha (ER alpha) signaling further augmented transcription and translation of PLAC1 and most likely accounts for the positive correlation between PLAC1 expression levels and the ER alpha status we observed in primary breast cancer specimens. DNA affinity precipitation and chromatin immunoprecipitation assays revealed that transactivation of the PLAC1 promoter by ligand-activated ER alpha is based on a nonclassical pathway independent of estrogen-response elements, by tethering of ER alpha to DNA-bound CCAAT/enhancer-binding protein beta-2, and SP1. Our findings provide first insight into a novel and hitherto unknown regulatory mechanism governing selective activation of trophoblast-specific gene expression in breast cancer.	[Koslowski, Michael; Huber, Christoph; Sahin, Ugur] Johannes Gutenberg Univ Mainz, Dept Internal Med Expt & Translat Oncol 3, D-55131 Mainz, Germany; [Tuereci, Oezlem] Ganymed Pharmaceut AG, D-55131 Mainz, Germany; [Biesterfeld, Stefan] Johannes Gutenberg Univ Mainz, Inst Pathol, D-55131 Mainz, Germany; [Seitz, Gerhard] Bamberg Hosp, Inst Pathol, D-96049 Bamberg, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Sahin, U (corresponding author), Johannes Gutenberg Univ Mainz, Dept Internal Med Expt & Translat Oncol 3, Zahlbacherstr 63, D-55131 Mainz, Germany.	sahin@uni-mainz.de	Sahin, Ugur/L-4818-2017	Sahin, Ugur/0000-0003-0363-1564	Forschungsfond and the Center for Natural Sciences and Medicine of the Johannes Gutenberg University [SFB 432]; Federal Ministry of Education and Research	Forschungsfond and the Center for Natural Sciences and Medicine of the Johannes Gutenberg University; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the Combined Project Grant SFB 432, by the Forschungsfond and the Center for Natural Sciences and Medicine of the Johannes Gutenberg University, and by the GO-Bio funding of the Federal Ministry of Education and Research.	AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Bamberger AM, 2004, VIRCHOWS ARCH, V444, P149, DOI 10.1007/s00428-003-0935-7; Beard J, 1902, LANCET, V1, P1758; Begay V, 2004, MOL CELL BIOL, V24, P9744, DOI 10.1128/MCB.24.22.9744-9751.2004; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Bundy L, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-43; Bundy LM, 2003, ONCOGENE, V22, P869, DOI 10.1038/sj.onc.1206216; Caldon CE, 2006, J CELL BIOCHEM, V97, P261, DOI 10.1002/jcb.20690; Calkhoven CF, 2000, GENE DEV, V14, P1920; Chakrabarty A, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-14; CHEN HW, 1995, DNA CELL BIOL, V14, P681, DOI 10.1089/dna.1995.14.681; Chiu RWK, 2007, AM J PATHOL, V170, P941, DOI 10.2353/ajpath.2007.060641; CLARKE R, 1992, CRIT REV ONCOL HEMAT, V12, P1, DOI 10.1016/1040-8428(92)90062-U; Cross JC, 2002, MOL CELL ENDOCRINOL, V187, P207, DOI 10.1016/S0303-7207(01)00703-1; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Dirnhofer S, 1998, HUM PATHOL, V29, P377, DOI 10.1016/S0046-8177(98)90119-8; Dong J, 2006, J BIOL CHEM, V281, P18825, DOI 10.1074/jbc.M512826200; Eaton EM, 2001, J CELL PHYSIOL, V189, P91, DOI 10.1002/jcp.1139; Fant M, 2002, MOL REPROD DEV, V63, P430, DOI 10.1002/mrd.10200; Gottlicher M, 1998, J MOL MED-JMM, V76, P480, DOI 10.1007/s001090050242; Holland MP, 2004, ENDOCRINOLOGY, V145, P1096, DOI 10.1210/en.2003-0777; Holtkamp S, 2006, BLOOD, V108, P4009, DOI 10.1182/blood-2006-04-015024; HORNE CHW, 1976, LANCET, V2, P279; Hu ZZ, 1998, J BIOL CHEM, V273, P26225, DOI 10.1074/jbc.273.40.26225; ILES RK, 1991, J UROLOGY, V145, P453, DOI 10.1016/S0022-5347(17)38367-2; Koslowski M, 2007, CANCER RES, V67, P9528, DOI 10.1158/0008-5472.CAN-07-1350; Koslowski M, 2006, HUM MOL GENET, V15, P2392, DOI 10.1093/hmg/ddl163; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Kreiter S, 2008, J IMMUNOL, V180, P309, DOI 10.4049/jimmunol.180.1.309; Kreiter S, 2007, CANCER IMMUNOL IMMUN, V56, P1577, DOI 10.1007/s00262-007-0302-7; LAURENCE DJ, 1972, BRIT J CANCER, V26, P335, DOI 10.1038/bjc.1972.45; LEE YH, 1994, MOL CELL BIOL, V14, P1383, DOI 10.1128/MCB.14.2.1383; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; Massabbal E, 2005, MOL REPROD DEV, V71, P299, DOI 10.1002/mrd.20272; Omoto Y, 2003, ONCOGENE, V22, P5011, DOI 10.1038/sj.onc.1206787; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Rama S, 2001, MOL CELL ENDOCRINOL, V182, P233, DOI 10.1016/S0303-7207(01)00550-0; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; Safe S, 2008, J MOL ENDOCRINOL, V41, P263, DOI 10.1677/JME-08-0103; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; STEPHANOU A, 1995, BIOCHEM BIOPH RES CO, V206, P215, DOI 10.1006/bbrc.1995.1030; STRICKLAND S, 1992, CELL, V71, P355, DOI 10.1016/0092-8674(92)90503-5; Sutherland RL, 2004, J MAMMARY GLAND BIOL, V9, P95, DOI 10.1023/B:JOMG.0000023591.45568.77; Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P4517, DOI 10.1093/nar/27.22.4517; TODA K, 1995, J STEROID BIOCHEM, V53, P181, DOI 10.1016/0960-0760(95)00032-U; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Weier JF, 2005, DEV BIOL, V279, P420, DOI 10.1016/j.ydbio.2004.12.035; Wilczynski JR, 2006, CHEMOTHERAPY, V52, P107, DOI 10.1159/000092537; Zahnow CA, 2002, BREAST CANCER RES, V4, P109, DOI 10.1186/bcr428	50	24	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28607	28615		10.1074/jbc.M109.031120	http://dx.doi.org/10.1074/jbc.M109.031120			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19652226	Green Published, hybrid			2022-12-27	WOS:000270678900015
J	Martin-Visscher, LA; Gong, XD; Duszyk, M; Vederas, JC				Martin-Visscher, Leah A.; Gong, Xiandi; Duszyk, Marek; Vederas, John C.			The Three-dimensional Structure of Carnocyclin A Reveals That Many Circular Bacteriocins Share a Common Structural Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURE PREDICTION SERVER; PEPTIDE ANTIBIOTIC AS-48; LACTIC-ACID BACTERIA; BACILLUS-SUBTILIS; NK-LYSIN; ANTIBACTERIAL PEPTIDES; ANTIMICROBIAL PEPTIDE; CYCLIC BACTERIOCINS; LIPID-BILAYERS; CHEMICAL-SHIFT	Carnocyclin A (CclA) is a potent antimicrobial peptide from Carnobacterium maltaromaticum UAL307 that displays a broad spectrum of activity against numerous Gram-positive organisms. An amide bond links the N and C termini of this bacteriocin, imparting stability and structural integrity to this 60-amino acid peptide. CclA interacts with lipid bilayers in a voltage-dependent manner and forms anion selective pores. Several other circular bacteriocins have been reported, yet only one (enterocin AS-48) has been structurally characterized. We have now determined the solution structure of CclA by NMR and further examined its anion binding and membrane channel properties. The results reveal that CclA preferentially binds halide anions and has a structure that is surprisingly similar to that of AS-48 despite low sequence identity, different oligomeric state, and disparate function. CclA folds into a compact globular bundle, comprised of four helices surrounding a hydrophobic core. NMR studies show two fluoride ion binding modes for CclA. Our findings suggest that although other circular bacteriocins are likely to have diverse mechanisms of action, many may have a common structural motif. This shared three-dimensional arrangement resembles the fold of mammalian saposins, peptides that either directly lyse membranes or serve as activators of lipid-degrading enzymes.	[Martin-Visscher, Leah A.; Vederas, John C.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Gong, Xiandi; Duszyk, Marek] Univ Alberta, Dept Physiol, Edmonton, AB T6G 2G2, Canada	University of Alberta; University of Alberta	Vederas, JC (corresponding author), Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada.	john.vederas@ualberta.ca		Vederas, John/0000-0002-2996-0326	Natural Sciences and Engineering Research Council of Canada; Advanced Foods and Materials Network; Canada Research Chair in Bioorganic and Medicinal Chemistry	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Advanced Foods and Materials Network; Canada Research Chair in Bioorganic and Medicinal Chemistry(Canada Research Chairs)	This work was supported by the Natural Sciences and Engineering Research Council of Canada, the Advanced Foods and Materials Network, and the Canada Research Chair in Bioorganic and Medicinal Chemistry.	Ahn VE, 2006, PROTEIN SCI, V15, P1849, DOI 10.1110/ps.062256606; BABASAKI K, 1985, J BIOCHEM, V98, P585, DOI 10.1093/oxfordjournals.jbchem.a135315; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Craik DJ, 2006, SCIENCE, V311, P1563, DOI 10.1126/science.1125248; Craik DJ, 2003, J BACTERIOL, V185, P4011, DOI 10.1128/JB.185.14.4011-4021.2003; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; GALVEZ A, 1991, J BACTERIOL, V173, P886, DOI 10.1128/jb.173.2.886-892.1991; Gong XD, 2009, BBA-BIOMEMBRANES, V1788, P1797, DOI 10.1016/j.bbamem.2009.05.008; Gonzalez C, 2000, P NATL ACAD SCI USA, V97, P11221, DOI 10.1073/pnas.210301097; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hecht O, 2004, J BIOL CHEM, V279, P17834, DOI 10.1074/jbc.M312978200; Hille B., 1992, IONIC CHANNELS EXCIT; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jimenez MA, 2005, J PEPT SCI, V11, P29, DOI 10.1002/psc.589; John M, 2006, BIOCHEMISTRY-US, V45, P5206, DOI 10.1021/bi051944+; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kalmokoff ML, 2003, CAN J MICROBIOL, V49, P763, DOI 10.1139/W03-101; Kawai Y, 1998, BIOSCI BIOTECH BIOCH, V62, P2438, DOI 10.1271/bbb.62.2438; Kawai Y, 2004, APPL ENVIRON MICROB, V70, P2906, DOI 10.1128/AEM.70.5.2906-2911.2004; Kawulka K, 2003, J AM CHEM SOC, V125, P4726, DOI 10.1021/ja029654t; Kawulka KE, 2004, BIOCHEMISTRY-US, V43, P3385, DOI 10.1021/bi0359527; Kemperman R, 2003, APPL ENVIRON MICROB, V69, P1589, DOI 10.1128/AEM.69.3.1589-1597.2003; Lai CZ, 2009, J AM CHEM SOC, V131, P1598, DOI 10.1021/ja808047x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEER RJ, 1995, MICROBIOL-SGM, V141, P1629, DOI 10.1099/13500872-141-7-1629; Liepinsh E, 1997, NAT STRUCT BIOL, V4, P793, DOI 10.1038/nsb1097-793; Maqueda M, 2004, CURR PROTEIN PEPT SC, V5, P399, DOI 10.2174/1389203043379567; Maqueda M, 2008, FEMS MICROBIOL REV, V32, P2, DOI 10.1111/j.1574-6976.2007.00087.x; Martin-Visscher LA, 2008, APPL ENVIRON MICROB, V74, P4756, DOI 10.1128/AEM.00817-08; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Miteva M, 1999, FEBS LETT, V462, P155, DOI 10.1016/S0014-5793(99)01520-3; Nes IF, 2007, FOOD SCI BIOTECHNOL, V16, P675; SAMYN B, 1994, FEBS LETT, V352, P87, DOI 10.1016/0014-5793(94)00925-2; Sanchez-Barrena MJ, 2003, J MOL BIOL, V334, P541, DOI 10.1016/j.jmb.2003.09.060; Sawa N, 2009, APPL ENVIRON MICROB, V75, P1552, DOI 10.1128/AEM.02299-08; van Belkum MJ, 2000, NAT PROD REP, V17, P323, DOI 10.1039/a801347k; Wirawan RE, 2007, MICROBIOL-SGM, V153, P1619, DOI 10.1099/mic.0.2006/005967-0; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WRIGHT EM, 1977, PHYSIOL REV, V57, P109, DOI 10.1152/physrev.1977.57.1.109; ZERBE O, 2003, BIONMR DRUG RES, P79; Zheng GL, 1999, J BACTERIOL, V181, P7346, DOI 10.1128/JB.181.23.7346-7355.1999	46	68	70	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28674	28681		10.1074/jbc.M109.036459	http://dx.doi.org/10.1074/jbc.M109.036459			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19692336	Green Published, hybrid			2022-12-27	WOS:000270678900022
J	Wang, ZA; van der Wel, H; Vohra, Y; Buskas, T; Boons, GJ; West, CM				Wang, Zhuo A.; van der Wel, Hanke; Vohra, Yusuf; Buskas, Therese; Boons, Geert-Jan; West, Christopher M.			Role of a Cytoplasmic Dual-function Glycosyltransferase in O-2 Regulation of Development in Dictyostelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHARACTERIZATION; CYTOSOLIC GLYCOPROTEIN; UBIQUITIN LIGASES; MODIFIES SKP1; SPORE COAT; HYDROXYPROLINE; GLYCOSYLATION; DISCOIDEUM; FP21; HYDROXYLASE	In the social amoeba Dictyostelium, a terminal step in development is regulated by environmental O-2. Prolyl 4-hydroxylase- 1 (P4H1) was previously implicated in mediating the O-2 signal, and P4H1-null cells require elevated O-2 to culminate. The E3-ubiquitin ligase adaptor Skp1 is a P4H1 substrate, and here we investigate the function of PgtA, a dual function beta 3-galactosyltransferase/alpha 2-fucosyltransferase that contributes the 2nd and 3rd sugars of the pentasaccharide cap formed on Skp1 hydroxyproline. Although pgtA-null cells, whose Skp1 contains only a single sugar (N-acetylglucosamine or GlcNAc), show wild-type O-2 dependence of culmination, cells lacking AgtA, an alpha 3-galactosyltransferase required to extend the trisaccharide, require elevated O-2 as for P4H1-null cells. Skp1 is the only detectable protein modified by purified PgtA added to pgtA-null extracts. The basis for specificity of PgtA was investigated using native Skp1 acceptor glycoforms and a novel synthetic peptide containing GlcNAc alpha 1,4-hydroxy(trans) proline. Cysteine-alkylation of Skp1 strongly inhibited modification by the PgtA galactosyltransferase but not the fucosyltransferase. Furthermore, native and synthetic Skp1 glycopeptides were poorly galactosylated, not processively fucosylated, and negligibly inhibitory, whereas the fucosyltransferase was active toward small substrates. In addition, the galactosyltransferase exhibited an atypical concentration dependence on UDP-galactose. The results provide the first evidence that Skp1 is the functional target of P4H1 in O-2 regulation, indicate a gatekeeper function for the alpha 3-galactosyltransferase in the PgtA dual reaction, and identify an unexpected P4H1-dependent yet antagonistic function for PgtA that is reversed by AgtA.	[West, Christopher M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA; [Vohra, Yusuf; Buskas, Therese; Boons, Geert-Jan] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Vohra, Yusuf; Buskas, Therese; Boons, Geert-Jan] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	West, CM (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, 975 NE 10th St,BRC 417, Oklahoma City, OK 73104 USA.	Cwest2@ouhsc.edu	Wang, Zhuo/L-6912-2019; Boons, Geert-Jan P H/J-3211-2016; Vohra, Yusuf/C-6004-2014	Wang, Zhuo/0000-0002-4707-036X; Boons, Geert-Jan P H/0000-0003-3111-5954; Vohra, Yusuf/0000-0003-0385-2965	National Institutes of Health [R01-GM84383, 2R01-GM37539, 2R01CA088986]; NATIONAL CANCER INSTITUTE [R01CA088986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037539, R01GM084383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM84383 and 2R01-GM37539 (to C. M. W.) and 2R01CA088986 (to G. J. B.)	Banerjee S, 2009, GLYCOBIOLOGY, V19, P331, DOI 10.1093/glycob/cwn107; Ercan A, 2006, J BIOL CHEM, V281, P12713, DOI 10.1074/jbc.M513664200; Funakoshi Y, 2009, BBA-GEN SUBJECTS, V1790, P81, DOI 10.1016/j.bbagen.2008.09.009; GONZALEZYANES B, 1992, J BIOL CHEM, V267, P9595; GONZALEZYANES B, 1989, DEV BIOL, V133, P576, DOI 10.1016/0012-1606(89)90060-2; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Ketcham C, 2004, J BIOL CHEM, V279, P29050, DOI 10.1074/jbc.M313858200; KOZAROV E, 1995, J BIOL CHEM, V270, P3022, DOI 10.1074/jbc.270.7.3022; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Sassi S, 2001, GLYCOBIOLOGY, V11, P283, DOI 10.1093/glycob/11.4.283; SCHILLER B, 2009, BIOCH J IN PRESS; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; TELSER A, 1971, J BIOL CHEM, V246, P2252; Teng-umnuay P, 1998, J BIOL CHEM, V273, P18242, DOI 10.1074/jbc.273.29.18242; Teng-umnuay P, 1999, J BIOL CHEM, V274, P36392, DOI 10.1074/jbc.274.51.36392; van der Wel H, 2005, J BIOL CHEM, V280, P14645, DOI 10.1074/jbc.M500600200; van der Wel H, 2002, J BIOL CHEM, V277, P46527, DOI 10.1074/jbc.M208824200; van der Wel H, 2001, J BIOL CHEM, V276, P33952, DOI 10.1074/jbc.M102555200; West CM, 2006, METHOD ENZYMOL, V417, P389, DOI 10.1016/S0076-6879(06)17023-8; West CM, 2007, DEVELOPMENT, V134, P3349, DOI 10.1242/dev.000893; West CM, 2009, EUKARYOT CELL, V8, P27, DOI 10.1128/EC.00398-07; West CM, 1996, J BIOL CHEM, V271, P12024, DOI 10.1074/jbc.271.20.12024; West CM, 2004, BBA-GEN SUBJECTS, V1673, P29, DOI 10.1016/j.bbagen.2004.04.007; West CM, 1997, GENE, V200, P1, DOI 10.1016/S0378-1119(97)00194-7; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027	25	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28896	28904		10.1074/jbc.M109.022574	http://dx.doi.org/10.1074/jbc.M109.022574			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19687007	Green Published, hybrid			2022-12-27	WOS:000270678900046
J	Wei, G; de Leeuw, E; Pazgier, M; Yuan, WR; Zou, GZ; Wang, JF; Ericksen, B; Lu, WY; Lehrer, RI; Lu, WY				Wei, Gang; de Leeuw, Erik; Pazgier, Marzena; Yuan, Weirong; Zou, Guozhang; Wang, Jianfeng; Ericksen, Bryan; Lu, Wei-Yue; Lehrer, Robert I.; Lu, Wuyuan			Through the Looking Glass, Mechanistic Insights from Enantiomeric Human Defensins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NEUTROPHIL DEFENSINS; HUMAN ALPHA-DEFENSINS; D-AMINO ACIDS; CONSERVED SALT BRIDGE; ANTHRAX LETHAL TOXIN; HUMAN BETA-DEFENSINS; ANTIMICROBIAL PEPTIDES; LIPID-II; ESCHERICHIA-COLI; INNATE IMMUNITY	Despite the small size and conserved tertiary structure of defensins, little is known at a molecular level about the basis of their functional versatility. For insight into the mechanism(s) of defensin function, we prepared enantiomeric pairs of four human defensins, HNP1, HNP4, HD5, and HBD2, and studied their killing of bacteria, inhibition of anthrax lethal factor, and binding to HIV-1 gp120. Unstructured HNP1, HD5, and HBD3 and several other human alpha- and beta-defensins were also examined. Crystallographic analysis showed a plane of symmetry that related (L)HNP1 and (D)HNP1 to each other. Either D-enantiomerization or linearization significantly impaired the ability of HNP1 and HD5 to kill Staphylococcus aureus but not Escherichia coli. In contrast, (L)HNP4 and (D)HNP4 were equally bactericidal against both bacteria. D-Enantiomers were generally weaker inhibitors or binders of lethal factor and gp120 than their respective native, all-L forms, although activity differences were modest, particularly for HNP4. A strong correlation existed among these different functions. Our data indicate: (a) that HNP1 and HD5 kill E. coli by a process that is mechanistically distinct from their actions that kill S. aureus and (b) that chiral molecular recognition is not a stringent prerequisite for other functions of these defensins, including their ability to inhibit lethal factor and bind gp120 of HIV-1.	[Ericksen, Bryan; Lu, Wuyuan] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Wei, Gang; Lu, Wei-Yue] Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China; [Lehrer, Robert I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	University System of Maryland; University of Maryland Baltimore; Fudan University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lu, WY (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	wlu@ihv.umaryland.edu	Lu, Wuyuan/J-8452-2017; Lu, Weiyue/E-7938-2010; Lu, Wuyuan/B-2268-2010; Pazgier, Marzena/B-7295-2012; Ericksen, Bryan/F-9047-2012; Wei, Gang/AAH-7377-2019	Lu, Wuyuan/0000-0003-1318-9968; Wei, Gang/0000-0002-9600-0982; Ericksen, Bryan/0000-0002-8016-8289	National Institutes of Health [AI072732, AI061482]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061482, R01AI072732] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI072732 and AI061482 (to W. L.).	Aarbiou J, 2002, J LEUKOCYTE BIOL, V72, P167; Bevins CL, 2006, BIOCHEM SOC T, V34, P263, DOI 10.1042/BST0340263; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; BROCK TD, 1991, BIOL MICROORGANISMS, P54; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; CASTEELS P, 1994, BIOCHEM BIOPH RES CO, V199, P339, DOI 10.1006/bbrc.1994.1234; Castle M, 1999, J BIOL CHEM, V274, P32555, DOI 10.1074/jbc.274.46.32555; Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948; Cho Y, 1998, INFECT IMMUN, V66, P2486, DOI 10.1128/IAI.66.6.2486-2493.1998; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; de Leeuw E, 2007, FEBS LETT, V581, P515, DOI 10.1016/j.febslet.2006.12.036; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Funderburg N, 2007, P NATL ACAD SCI USA, V104, P18631, DOI 10.1073/PNAS.0702130104; Furci L, 2007, BLOOD, V109, P2928, DOI 10.1182/blood-2006-05-024489; Gallo SA, 2006, J BIOL CHEM, V281, P18787, DOI 10.1074/jbc.M602422200; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; GANZ T, 1990, EUR J HAEMATOL, V44, P1; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Guo CJ, 2004, AIDS, V18, P1217, DOI 10.1097/00002030-200405210-00020; Hancock REW, 2002, FEMS MICROBIOL LETT, V206, P143, DOI 10.1016/S0378-1097(01)00480-3; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; HECK SD, 1994, SCIENCE, V266, P1065, DOI 10.1126/science.7973665; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210; Kim C, 2005, P NATL ACAD SCI USA, V102, P4830, DOI 10.1073/pnas.0500508102; Klotman ME, 2008, J IMMUNOL, V180, P6176, DOI 10.4049/jimmunol.180.9.6176; Kluver E, 2005, BIOCHEMISTRY-US, V44, P9804, DOI 10.1021/bi050272k; KOKRYAKOV VN, 1993, FEBS LETT, V327, P231, DOI 10.1016/0014-5793(93)80175-T; KREIL G, 1994, SCIENCE, V266, P996, DOI 10.1126/science.7973683; Kreil G, 1997, ANNU REV BIOCHEM, V66, P337, DOI 10.1146/annurev.biochem.66.1.337; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; LEHRER RI, 1988, J CLIN INVEST, V81, P1829, DOI 10.1172/JCI113527; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Lehrer RI, 2007, CURR OPIN HEMATOL, V14, P16, DOI 10.1097/00062752-200701000-00005; Lehrer RI, 2009, J IMMUNOL, V183, P480, DOI 10.4049/jimmunol.0900244; Lehrer RI, 2009, INFECT IMMUN, V77, P4028, DOI 10.1128/IAI.00232-09; Leikina E, 2005, NAT IMMUNOL, V6, P995, DOI 10.1038/ni1248; Mackewicz CE, 2003, AIDS, V17, pF23, DOI 10.1097/00002030-200309260-00001; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; Mayer-Scholl A, 2005, PLOS PATHOG, V1, P179, DOI 10.1371/journal.ppat.0010023; MILTON RCD, 1992, SCIENCE, V256, P1445, DOI 10.1126/science.1604320; Min DH, 2004, NAT BIOTECHNOL, V22, P717, DOI 10.1038/nbt973; Miyasaki KT, 1998, J PERIODONTAL RES, V33, P91; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Munk C, 2003, AIDS RES HUM RETROV, V19, P875, DOI 10.1089/088922203322493049; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PANYUTICH AV, 1994, FEBS LETT, V356, P169, DOI 10.1016/0014-5793(94)01261-X; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Rajabi M, 2008, J BIOL CHEM, V283, P21509, DOI 10.1074/jbc.M801851200; Rehaume LM, 2008, CRIT REV IMMUNOL, V28, P185, DOI 10.1615/CritRevImmunol.v28.i3.10; Rosengren KJ, 2006, J BIOL CHEM, V281, P28068, DOI 10.1074/jbc.M604992200; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SELSTED ME, 1985, J CLIN INVEST, V76, P1436, DOI 10.1172/JCI112121; Shi JS, 2007, J IMMUNOL, V179, P1245, DOI 10.4049/jimmunol.179.2.1245; Sorensen OE, 2003, J IMMUNOL, V170, P5583, DOI 10.4049/jimmunol.170.11.5583; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sun LL, 2005, J VIROL, V79, P14318, DOI 10.1128/JVI.79.22.14318-14329.2005; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Taylor K, 2008, J BIOL CHEM, V283, P6631, DOI 10.1074/jbc.M709238200; TERRITO MC, 1989, J CLIN INVEST, V84, P2017, DOI 10.1172/JCI114394; van den Berg RH, 1998, BLOOD, V92, P3898, DOI 10.1182/blood.V92.10.3898.422k03_3898_3903; van Wetering S, 2002, INFLAMM RES, V51, P8, DOI 10.1007/PL00000282; WADE D, 1990, P NATL ACAD SCI USA, V87, P4761, DOI 10.1073/pnas.87.12.4761; Wang W, 2004, J IMMUNOL, V173, P515, DOI 10.4049/jimmunol.173.1.515; Wang W, 2003, J IMMUNOL, V170, P4708, DOI 10.4049/jimmunol.170.9.4708; Wang W, 2006, J BIOL CHEM, V281, P32755, DOI 10.1074/jbc.M603614200; Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299; Wu Z, 2004, J PEPT RES, V64, P118, DOI 10.1111/j.1399-3011.2004.00179.x; Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100; Wu ZB, 2005, J BIOL CHEM, V280, P43039, DOI 10.1074/jbc.M510562200; Wu ZB, 2005, FEBS LETT, V579, P162, DOI 10.1016/j.febslet.2004.11.062; Wu ZB, 2003, J AM CHEM SOC, V125, P2402, DOI 10.1021/ja0294257; Xie C, 2005, J BIOL CHEM, V280, P32921, DOI 10.1074/jbc.M503084200; Yang D, 2000, J LEUKOCYTE BIOL, V68, P9; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	87	88	91	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29180	29192		10.1074/jbc.M109.018085	http://dx.doi.org/10.1074/jbc.M109.018085			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19640840	Green Published, hybrid			2022-12-27	WOS:000270678900073
J	Alvarez-Castelao, B; Martin-Guerrero, I; Garcia-Orad, A; Castano, JG				Alvarez-Castelao, Beatriz; Martin-Guerrero, Idoia; Garcia-Orad, Africa; Castano, Jose G.			Cytomegalovirus Promoter Up-regulation Is the Major Cause of Increased Protein Levels of Unstable Reporter Proteins after Treatment of Living Cells with Proteasome Inhibitors (Withdrawn Publication. See vol. 291, pg. 8985, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication							ELEMENT-BINDING PROTEIN; SERUM RESPONSE FACTOR; EARLY GENE ENHANCER; KAPPA-B ACTIVATION; DEPENDENT PROTEOLYSIS; 26S PROTEASOME; EXPRESSION; PHOSPHORYLATION; KINASE; TRANSCRIPTION	Fluorescent unstable proteins obtained by the fusion of a fluorescent protein coding sequence with specific amino acid sequences that promote its fast degradation have become popular to gauge the activity of the ubiquitin/proteasome system in living cells. The steady-state levels of expression of these unstable proteins is low in agreement with their short half-lives, and they accumulate in the cell upon treatment with proteasome inhibitors. We show here that this accumulation is mainly due to transcriptional up-regulation of the cytomegalovirus promoter by proteasome inhibitors and mediated, at least in part, by AP1 transactivation. These simple facts put under quarantine conclusions reached about the activity of the ubiquitin/proteasome pathway in animal cells in culture or in transgenic mice, where popular cytomegalovirus-driven constructs are used, as transcriptional regulation of the expression of the reporter protein construct and not degradation of the unstable protein by the ubiquitin/proteasome system may contribute significantly to the interpretation of the results observed.	[Alvarez-Castelao, Beatriz; Castano, Jose G.] Univ Autonoma Madrid, Dept Bioquim, Inst Invest Biomed Alberto Sols, Madrid 28029, Spain; [Alvarez-Castelao, Beatriz; Castano, Jose G.] Fac Med UAM, Consejo Super Invest Cient UAM CSIC, Madrid 28029, Spain; [Alvarez-Castelao, Beatriz; Castano, Jose G.] Fac Med UAM, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28029, Spain; [Martin-Guerrero, Idoia; Garcia-Orad, Africa] Univ Pais Vasco UPV EHU, Dept Genet Antropol Fis & Fisiol Anim, Fac Med, Leioa 48940, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Consejo Superior de Investigaciones Cientificas (CSIC); CIBERNED; University of Basque Country	Castano, JG (corresponding author), Univ Autonoma Madrid, Dept Bioquim, Inst Invest Biomed Alberto Sols, Madrid 28029, Spain.	joseg.castano@uam.es	Alvarez-castelao, Beatriz/ABG-8826-2021; Martin-Guerrero, Idoia/AAF-3446-2020	Garcia.Orad, Africa/0000-0002-5575-3080; Martin-Guerrero, Idoia/0000-0002-0098-1908; G. Castano, Jose/0000-0002-6579-8442	Fundacion Mutua Madrilena [SAF-2008-00766, CM SAL-0202]; CIBERNED; Red Tematica de Investigacion Cooperativa Sanitaria [G3/179]; Basque Government SAIOTEIK	Fundacion Mutua Madrilena(Instituto de Salud Carlos III); CIBERNED(Instituto de Salud Carlos III); Red Tematica de Investigacion Cooperativa Sanitaria; Basque Government SAIOTEIK(Basque Government)	This work was supported by grants from SAF-2008-00766, CM SAL-0202 Fundacion Mutua Madrilena, and CIBERNED (to J.G.C) and by Red Tematica de Investigacion Cooperativa Sanitaria Grant G3/179 and Basque Government SAIOTEIK (to A. G.-C.).	ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Aragones J, 1996, J BIOL CHEM, V271, P10924, DOI 10.1074/jbc.271.18.10924; Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; Baens M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000054; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Biasini E, 2004, J NEUROCHEM, V88, P545, DOI 10.1046/j.1471-4159.2003.02152.x; Bruening W, 1998, NUCLEIC ACIDS RES, V26, P486, DOI 10.1093/nar/26.2.486; Bush KT, 1997, J BIOL CHEM, V272, P9086; Castrillo A, 2000, MOL CELL BIOL, V20, P1692, DOI 10.1128/MCB.20.5.1692-1698.2000; Chan YJ, 1996, J VIROL, V70, P8590, DOI 10.1128/JVI.70.12.8590-8605.1996; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Detich N, 2003, J BIOL CHEM, V278, P20812, DOI 10.1074/jbc.M211813200; DIDONATO JA, 1995, MOL CELL BIOL, V15, P1302; Fernandez M, 2005, J MOL ENDOCRINOL, V34, P699, DOI 10.1677/jme.1.01703; Gandara ML, 2003, MOL CELL BIOL, V23, P7377, DOI 10.1128/MCB.23.20.7377-7390.2003; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; Grassi G, 2003, CARCINOGENESIS, V24, P1625, DOI 10.1093/carcin/bgg118; HENNIGHAUSEN L, 1986, EMBO J, V5, P1367, DOI 10.1002/j.1460-2075.1986.tb04368.x; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kawazoe Y, 1998, EUR J BIOCHEM, V255, P356, DOI 10.1046/j.1432-1327.1998.2550356.x; Kinyamu HK, 2007, MOL CELL BIOL, V27, P4891, DOI 10.1128/MCB.02162-06; LEMBO D, 1994, J GEN VIROL, V75, P1685, DOI 10.1099/0022-1317-75-7-1685; Li XH, 2007, J CELL PHYSIOL, V212, P298, DOI 10.1002/jcp.21102; Li XQ, 1999, J BIOL CHEM, V274, P21244, DOI 10.1074/jbc.274.30.21244; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Luker GD, 2003, NAT MED, V9, P969, DOI 10.1038/nm894; Meier JL, 1996, INTERVIROLOGY, V39, P331, DOI 10.1159/000150504; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Nawaz Z, 2004, MOL ENDOCRINOL, V18, P493, DOI 10.1210/me.2003-0388; Neefjes J, 2004, NAT REV DRUG DISCOV, V3, P58, DOI 10.1038/nrd1282; NIETO A, 1990, BIOCHEM J, V267, P317, DOI 10.1042/bj2670317; NILLER HH, 1991, NUCLEIC ACIDS RES, V19, P3715, DOI 10.1093/nar/19.13.3715; Prosch S, 2001, J BIOL CHEM, V276, P40712, DOI 10.1074/jbc.M009815200; Qian SB, 2006, J BIOL CHEM, V281, P392, DOI 10.1074/jbc.M509126200; Ramanathan M, 2005, INFLAMMATION, V29, P94, DOI 10.1007/s10753-006-9005-z; SAMBUCETTI LC, 1989, EMBO J, V8, P4251, DOI 10.1002/j.1460-2075.1989.tb08610.x; Sandbo N, 2005, MOL PHARMACOL, V67, P789, DOI 10.1124/mol.104.006874; SCHMIDT EV, 1990, MOL CELL BIOL, V10, P4406, DOI 10.1128/MCB.10.8.4406; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; STAMMINGER T, 1990, J GEN VIROL, V71, P105, DOI 10.1099/0022-1317-71-1-105; Sun B, 2001, J CELL BIOCHEM, V83, P563, DOI 10.1002/jcb.1251; Taylor CT, 2000, P NATL ACAD SCI USA, V97, P12091, DOI 10.1073/pnas.220211797; Varshavsky A, 1995, COLD SPRING HARB SYM, V60, P461, DOI 10.1101/SQB.1995.060.01.051; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Walowitz JL, 1998, J BIOL CHEM, V273, P6656, DOI 10.1074/jbc.273.12.6656; Wheeler DG, 2001, J BIOL CHEM, V276, P31978, DOI 10.1074/jbc.M103667200; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158	51	14	14	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28253	28262		10.1074/jbc.M109.004101	http://dx.doi.org/10.1074/jbc.M109.004101			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19679666	hybrid, Green Published			2022-12-27	WOS:000270676300053
J	Bernal-Bayard, J; Ramos-Morales, F				Bernal-Bayard, Joaquin; Ramos-Morales, Francisco			Salmonella Type III Secretion Effector SlrP Is an E3 Ubiquitin Ligase for Mammalian Thioredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; INTESTINAL EPITHELIAL-CELLS; EARLY EMBRYONIC LETHALITY; UP-REGULATED PROTEIN-1; NF-KAPPA-B; PATHOGENICITY ISLAND-2; ESCHERICHIA-COLI; PEYERS-PATCHES; HOST-CELLS; APOPTOSIS	Salmonella enterica encodes two virulence-related type III secretion systems in Salmonella pathogenicity islands 1 and 2, respectively. These systems mediate the translocation of protein effectors into the eukaryotic host cell, where they alter cell signaling and manipulate host cell functions. However, the precise role of most effectors remains unknown. Using a genetic screen, we identified the small, reduction/oxidation-regulatory protein thioredoxin as a mammalian binding partner of the Salmonella effector SlrP. The interaction was confirmed by affinity chromatography and coimmunoprecipitation. In vitro, SlrP was able to mediate ubiquitination of ubiquitin and thioredoxin. A Cys residue conserved in other effectors of the same family that also possess E3 ubiquitin ligase activity was essential for this catalytic function. Stable expression of SlrP in HeLa cells resulted in a significant decrease of thioredoxin activity and in an increase of cell death. The physiological significance of these results was strengthened by the finding that Salmonella was able to trigger cell death and inhibit thioredoxin activity in HeLa cells several hours post-infection. This study assigns a functional role to the Salmonella effector SlrP as a binding partner and an E3 ubiquitin ligase for mammalian thioredoxin.	[Bernal-Bayard, Joaquin; Ramos-Morales, Francisco] Univ Seville, Dept Genet, Fac Biol, E-41080 Seville, Spain	University of Sevilla	Ramos-Morales, F (corresponding author), Univ Seville, Dept Genet, Fac Biol, Apartado 1095, E-41080 Seville, Spain.	framos@us.es	Ramos-Morales, Francisco/C-5734-2008; Bayard, Joaquin Bernal/E-9836-2016	Ramos-Morales, Francisco/0000-0002-1151-4547; Bayard, Joaquin Bernal/0000-0003-1199-3629	Spanish Ministry of Science and Innovation; ConsejerIa de Innovacion [SAF2007-60738, P08-CVI-03487]; Ciencia y Empresa; Junta de Andalucia	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ConsejerIa de Innovacion; Ciencia y Empresa; Junta de Andalucia(Junta de Andalucia)	This work was supported by Spanish Ministry of Science and Innovation and the European Regional Development Fund Grant SAF2007-60738 and Grant P08-CVI-03487 from ConsejerIa de Innovacion, Ciencia y Empresa, of the Junta de Andalucia.	Andersen JF, 1997, BIOCHEMISTRY-US, V36, P13979, DOI 10.1021/bi971004s; Angot A, 2007, PLOS PATHOG, V3, P1, DOI 10.1371/journal.ppat.0030003; Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arner ESJ, 1999, METHOD ENZYMOL, V300, P226; Bello RI, 2003, J BIOENERG BIOMEMBR, V35, P169, DOI 10.1023/A:1023702321148; Bertini R, 1999, J EXP MED, V189, P1783, DOI 10.1084/jem.189.11.1783; Bizzarri C, 2005, ANTIOXID REDOX SIGN, V7, P1189, DOI 10.1089/ars.2005.7.1189; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846; Coombes BK, 2005, J MOL BIOL, V348, P817, DOI 10.1016/j.jmb.2005.03.024; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Ellermeier CD, 2003, J BACTERIOL, V185, P5096, DOI 10.1128/JB.185.17.5096-5108.2003; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Fink SL, 2007, CELL MICROBIOL, V9, P2562, DOI 10.1111/j.1462-5822.2007.01036.x; Flick K, 2004, NAT CELL BIOL, V6, P634, DOI 10.1038/ncb1143; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Galan JE, 1996, CURR TOP MICROBIOL, V209, P43; Geddes K, 2005, INFECT IMMUN, V73, P6260, DOI 10.1128/IAI.73.10.6260-6271.2005; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Haraga A, 2006, CELL MICROBIOL, V8, P837, DOI 10.1111/j.1462-5822.2005.00670.x; HARPER JW, 1993, CELL, V75, P805; Hirota K, 1999, J BIOL CHEM, V274, P27891, DOI 10.1074/jbc.274.39.27891; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Johnson ES, 2002, NAT CELL BIOL, V4, pE295, DOI 10.1038/ncb1202-e295; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kim JM, 1998, J CLIN INVEST, V102, P1815, DOI 10.1172/JCI2466; Knodler LA, 2005, J BIOL CHEM, V280, P9058, DOI 10.1074/jbc.M412588200; Knodler LA, 2001, MICROBES INFECT, V3, P1321, DOI 10.1016/S1286-4579(01)01493-9; Kuhle V, 2004, CELL MOL LIFE SCI, V61, P2812, DOI 10.1007/s00018-004-4248-z; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Li W, 2008, CELL MOL LIFE SCI, V65, P2397, DOI 10.1007/s00018-008-8090-6; Lundberg U, 1999, J BACTERIOL, V181, P3433, DOI 10.1128/JB.181.11.3433-3437.1999; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Ly KT, 2007, CELL MICROBIOL, V9, P2103, DOI 10.1111/j.1462-5822.2007.00992.x; Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; OBERLEY TD, 1995, FREE RADICAL BIO MED, V19, P53, DOI 10.1016/0891-5849(95)00012-M; Paesold G, 2002, CELL MICROBIOL, V4, P771, DOI 10.1046/j.1462-5822.2002.00233.x; Pekkari K, 2005, BLOOD, V105, P1598, DOI 10.1182/blood-2004-04-1577; Penheiter KL, 1997, MOL MICROBIOL, V24, P697, DOI 10.1046/j.1365-2958.1997.3741745.x; Philpott DJ, 2001, CURR OPIN IMMUNOL, V13, P410; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Powis G, 2001, ANNU REV BIOPH BIOM, V30, P421, DOI 10.1146/annurev.biophys.30.1.421; Quezada CM, 2009, P NATL ACAD SCI USA, V106, P4864, DOI 10.1073/pnas.0811058106; Ramsden AE, 2007, TRENDS MICROBIOL, V15, P516, DOI 10.1016/j.tim.2007.10.002; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sherman F., 1986, METHODS YEAST GENETI; Singer AU, 2008, NAT STRUCT MOL BIOL, V15, P1293, DOI 10.1038/nsmb.1511; Spielberger JC, 2008, J CELL BIOCHEM, V104, P1879, DOI 10.1002/jcb.21762; Stavrinides J, 2008, CELL MICROBIOL, V10, P285, DOI 10.1111/j.1462-5822.2007.01078.x; Tsolis RM, 1999, INFECT IMMUN, V67, P6385; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2; Zhu YQ, 2008, NAT STRUCT MOL BIOL, V15, P1302, DOI 10.1038/nsmb.1517	63	70	74	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27587	27595		10.1074/jbc.M109.010363	http://dx.doi.org/10.1074/jbc.M109.010363			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19690162	Green Published, hybrid			2022-12-27	WOS:000270232300060
J	Fujimoto, K; Hanson, PT; Tran, H; Ford, EL; Han, ZQ; Johnson, JD; Schmidt, RE; Green, KG; Wice, BM; Polonsky, KS				Fujimoto, Kei; Hanson, Piia T.; Tran, Hung; Ford, Eric L.; Han, Zhiqiang; Johnson, James D.; Schmidt, Robert E.; Green, Karen G.; Wice, Burton M.; Polonsky, Kenneth S.			Autophagy Regulates Pancreatic Beta Cell Death in Response to Pdx1 Deficiency and Nutrient Deprivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-FAT DIET; MICE; APOPTOSIS; TUMORIGENESIS; BECLIN-1; DISEASE; FUSION; ISLETS; GENE; MASS	There are three types of cell death; apoptosis, necrosis, and autophagy. The possibility that activation of the macroautophagy (autophagy) pathway may increase beta cell death is addressed in this study. Increased autophagy was present in pancreatic islets from Pdx1(+/-) mice with reduced insulin secretion and beta cell mass. Pdx1 expression was reduced in mouse insulinoma 6 (MIN6) cells by delivering small hairpinRNAsusing a lentiviral vector. The MIN6 cells died after 7 days of Pdx1 deficiency, and autophagy was evident prior to the onset of cell death. Inhibition of autophagy prolonged cell survival and delayed cell death. Nutrient deprivation increased autophagy in MIN6 cells and mouse and human islets after starvation. Autophagy inhibition partly prevented amino acid starvation-induced MIN6 cell death. The in vivo effects of reduced autophagy were studied by crossing Pdx1(+/-) mice to Becn1(+/-) mice. After 1 week on a high fat diet, 4-week-old Pdx1(+/-) Becn1(+/-) mice showed normal glucose tolerance, preserved beta cell function, and increased beta cell mass compared with Pdx1(+/-) mice. This protective effect of reduced autophagy had worn off after 7 weeks on a high fat diet. Increased autophagy contributes to pancreatic beta cell death in Pdx1 deficiency and following nutrient deprivation. The role of autophagy should be considered in studies of pancreatic beta cell death and diabetes and as a target for novel therapeutic intervention.	[Fujimoto, Kei; Hanson, Piia T.; Tran, Hung; Ford, Eric L.; Han, Zhiqiang; Johnson, James D.; Wice, Burton M.; Polonsky, Kenneth S.] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, Dept Internal Med,Barnes Jewish Hosp, St Louis, MO 63110 USA; [Schmidt, Robert E.; Green, Karen G.] Washington Univ, Sch Med, Div Neuropathol, Dept Pathol & Immunol,Barnes Jewish Hosp, St Louis, MO 63110 USA	Barnes-Jewish Hospital; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL)	Polonsky, KS (corresponding author), Washington Univ, Sch Med, Dept Med, Campus Box 8066,660 S Euclid Ave, St Louis, MO 63110 USA.	Polonsky@im.wustl.edu		Johnson, James/0000-0002-7523-9433	Radioimmunoassay and Morphology Cores of the Diabetes Research and Training Center of Washington University [P60 DK-20579, DK-31842]; Washington University Digestive Diseases Research Center Morphology Core [5P30 DK052574]; Washington University [UL1RR024992]; Blum Kovler Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK031842, P30DK052574, R01DK088126, R01DK031842, P60DK020579] Funding Source: NIH RePORTER	Radioimmunoassay and Morphology Cores of the Diabetes Research and Training Center of Washington University; Washington University Digestive Diseases Research Center Morphology Core; Washington University; Blum Kovler Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Radioimmunoassay and Morphology Cores of the Diabetes Research and Training Center of Washington University Grants P60 DK-20579 and DK-31842 ( to K. S. P.), Washington University Digestive Diseases Research Center Morphology Core Grant 5P30 DK052574, Clinical and Translational Science Award to Washington University Grant UL1RR024992, and the Blum Kovler Foundation.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Althage MC, 2008, J BIOL CHEM, V283, P18365, DOI 10.1074/jbc.M710466200; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; Du L, 2009, J BIOL CHEM, V284, P2383, DOI 10.1074/jbc.M804396200; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; GREIDER MH, 1969, J CELL BIOL, V41, P162, DOI 10.1083/jcb.41.1.162; Hwang SO, 2008, BIOTECHNOL BIOENG, V99, P678, DOI 10.1002/bit.21589; Johnson JD, 2006, P NATL ACAD SCI USA, V103, P19575, DOI 10.1073/pnas.0604208103; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li YH, 2005, DIABETES, V54, P482, DOI 10.2337/diabetes.54.2.482; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Marsh BJ, 2007, MOL ENDOCRINOL, V21, P2255, DOI 10.1210/me.2007-0077; McKinnon CM, 2001, DIABETOLOGIA, V44, P1203, DOI 10.1007/s001250100628; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Sadasivan S, 2006, APOPTOSIS, V11, P1573, DOI 10.1007/s10495-006-7690-6; Scarlatti F, 2009, CELL DEATH DIFFER, V16, P12, DOI 10.1038/cdd.2008.101; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shvets E, 2008, AUTOPHAGY, V4, P1054, DOI 10.4161/auto.6823; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wang HY, 2002, DIABETES, V51, pS333, DOI 10.2337/diabetes.51.2007.S333; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645	33	94	98	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27664	27673		10.1074/jbc.M109.041616	http://dx.doi.org/10.1074/jbc.M109.041616			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19654319	Green Published, hybrid			2022-12-27	WOS:000270232300068
J	Uchida, Y; Ohshima, T; Yamashita, N; Ogawara, M; Sasaki, Y; Nakamura, F; Goshima, Y				Uchida, Yutaka; Ohshima, Toshio; Yamashita, Naoya; Ogawara, Miyuki; Sasaki, Yukio; Nakamura, Fumio; Goshima, Yoshio			Semaphorin3A Signaling Mediated by Fyn-dependent Tyrosine Phosphorylation of Collapsin Response Mediator Protein 2 at Tyrosine 32	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-CONE COLLAPSE; ALZHEIMERS-DISEASE; RHO-KINASE; CRMP-2; MIGRATION; TRANSPORT; TUBULIN; NEURONS; COMPLEX; UNC-33	Collapsin response mediator protein 2 (CRMP2) is an intracellular protein that mediates signaling of Semaphorin3A (Sema3A), a repulsive axon guidance molecule. Fyn, a Src-type tyrosine kinase, is involved in the Sema3A signaling. However, the relationship between CRMP2 and Fyn in this signaling pathway is still unknown. In our research, we demonstrated that Fyn phosphorylated CRMP2 at Tyr(32) residues in HEK293T cells. Immunohistochemical analysis using a phospho-specific antibody at Tyr(32) of CRMP showed that Tyr(32)-phosphorylated CRMP was abundant in the nervous system, including dorsal root ganglion neurons, the molecular and Purkinje cell layer of adult cerebellum, and hippocampal fimbria. Overexpression of a nonphosphorylated mutant (Tyr(32) to Phe(32)) of CRMP2 in dorsal root ganglion neurons interfered with Sema3A-induced growth cone collapse response. These results suggest that Fyn-dependent phosphorylation of CRMP2 at Tyr(32) is involved in Sema3A signaling.	[Uchida, Yutaka; Yamashita, Naoya; Ogawara, Miyuki; Sasaki, Yukio; Nakamura, Fumio; Goshima, Yoshio] Yokohama City Univ, Grad Sch Med, Dept Mol Pharmacol & Neurobiol, Yokohama, Kanagawa 2360004, Japan; [Ohshima, Toshio] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo 1698555, Japan; [Uchida, Yutaka; Ohshima, Toshio] RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; [Goshima, Yoshio] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Yokohama City University; Waseda University; RIKEN; Japan Science & Technology Agency (JST)	Goshima, Y (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Mol Pharmacol & Neurobiol, Yokohama, Kanagawa 2360004, Japan.	goshima@med.yokohama-cu.ac.jp	Sasaki, Yukio/P-7662-2015	Sasaki, Yukio/0000-0001-6143-7001	Ministry of Education, Culture, Sports, Science, and Technology; Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST))	This work was supported by grants-in-aid for scientific research on priority areas and targeted proteins research program from the Ministry of Education, Culture, Sports, Science, and Technology (to Y. G.) and Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (to Y. G.).	Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; Deo RC, 2004, EMBO J, V23, P9, DOI 10.1038/sj.emboj.7600021; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Gu YJ, 2000, J BIOL CHEM, V275, P17917, DOI 10.1074/jbc.C000179200; Kawano Y, 2005, MOL CELL BIOL, V25, P9920, DOI 10.1128/MCB.25.22.9920-9935.2005; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Lee G, 2004, J NEUROSCI, V24, P2304, DOI 10.1523/JNEUROSCI.4162-03.2004; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Li CX, 2004, J NEUROSCI, V24, P6161, DOI 10.1523/JNEUROSCI.1476-04.2004; MINTURN JE, 1995, J NEUROSCI, V15, P6757; Mitsui N, 2002, EMBO J, V21, P3274, DOI 10.1093/emboj/cdf328; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Ricard D, 2001, J NEUROSCI, V21, P7203, DOI 10.1523/JNEUROSCI.21-18-07203.2001; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Shapovalova Z, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-133; Stenmark P, 2007, J NEUROCHEM, V101, P906, DOI 10.1111/j.1471-4159.2006.04401.x; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; Varrin-Doyer M, 2009, J BIOL CHEM, V284, P13265, DOI 10.1074/jbc.M807664200; Yamashita N, 2006, J NEUROSCI, V26, P13357, DOI 10.1523/JNEUROSCI.4276-06.2006; Yoshida H, 1998, J BIOL CHEM, V273, P9761, DOI 10.1074/jbc.273.16.9761; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012	27	46	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27393	27401		10.1074/jbc.M109.000240	http://dx.doi.org/10.1074/jbc.M109.000240			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19652227	Green Published, hybrid			2022-12-27	WOS:000270232300041
J	Wu, CY; Roje, S; Sandoval, FJ; Bird, AJ; Winge, DR; Eide, DJ				Wu, Chang-Yi; Roje, Sanja; Sandoval, Francisco J.; Bird, Amanda J.; Winge, Dennis R.; Eide, David J.			Repression of Sulfate Assimilation Is an Adaptive Response of Yeast to the Oxidative Stress of Zinc Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATOR MET4; SACCHAROMYCES-CEREVISIAE; HOMOCYSTEINE TOXICITY; S-ADENOSYLMETHIONINE; GENE-EXPRESSION; REGULATED GENES; DNA-BINDING; SCFMET30; ZAP1; PROTEIN	The Zap1 transcription factor is a central player in the response of yeast to changes in zinc status. Previous studies identified over 80 genes activated by Zap1 in zinc-limited cells. In this report, we identified 36 genes repressed in a zinc-and Zap1-responsive manner. As a result, we have identified a new mechanism of Zap1-mediated gene repression whereby transcription of the MET3, MET14, and MET16 genes is repressed in zinc-limited cells. These genes encode the first three enzymes of the sulfate assimilation pathway. We found that MET30, encoding a component of the SCFMet30 ubiquitin ligase, is a direct Zap1 target gene. MET30 expression is increased in zinc-limited cells, and this leads to degradation of Met4, a transcription factor responsible for MET3, MET14, and MET16 expression. Thus, Zap1 is responsible for a decrease in sulfate assimilation in zinc-limited cells. We further show that cells that are unable to down-regulate sulfate assimilation under zinc deficiency experience increased oxidative stress. This increased oxidative stress is associated with an increase in the NADP(+)/NADPH ratio and may result from a decrease in NADPH-dependent antioxidant activities. These studies have led to new insights into how cells adapt to nutrient-limiting growth conditions.	[Wu, Chang-Yi; Eide, David J.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; [Roje, Sanja; Sandoval, Francisco J.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Bird, Amanda J.; Winge, Dennis R.] Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA	University of Wisconsin System; University of Wisconsin Madison; Washington State University; Utah System of Higher Education; University of Utah	Eide, DJ (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	deide@wisc.edu	Bird, Amanda Jane/ABD-2295-2021	Bird, Amanda Jane/0000-0002-1846-7050; Roje, Sanja/0000-0002-6302-5382	National Institutes of Health [GM56285]; National Science Foundation [MCB-0429968]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083292, R01GM056285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM56285 (to D.J.E.). This work was also supported by National Science Foundation Grant MCB-0429968 (to S. R.).	Ames BN, 2002, NAT REV CANCER, V2, P694, DOI 10.1038/nrc886; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Avram D, 1999, YEAST, V15, P473, DOI 10.1002/(SICI)1097-0061(199904)15:6<473::AID-YEA388>3.0.CO;2-Y; Barbey R, 2005, EMBO J, V24, P521, DOI 10.1038/sj.emboj.7600556; Bird A, 2000, J BIOL CHEM, V275, P16160, DOI 10.1074/jbc.M000664200; Bird AJ, 2004, EMBO J, V23, P1123, DOI 10.1038/sj.emboj.7600122; Bird AJ, 2006, EMBO J, V25, P5726, DOI 10.1038/sj.emboj.7601453; BURKE JP, 1985, P SOC EXP BIOL MED, V179, P187; Cai L, 2005, CURR MED CHEM, V12, P2753, DOI 10.2174/092986705774462950; Carman GM, 2007, BBA-MOL CELL BIOL L, V1771, P322, DOI 10.1016/j.bbalip.2006.05.006; Chandrasekaran S, 2006, MOL CELL, V24, P689, DOI 10.1016/j.molcel.2006.10.028; Chiang DY, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-16; Dainty SJ, 2008, EUKARYOT CELL, V7, P454, DOI 10.1128/EC.00408-07; De Nicola R, 2007, APPL ENVIRON MICROB, V73, P7680, DOI 10.1128/AEM.01445-07; DOHRMANN PR, 1992, GENE DEV, V6, P93, DOI 10.1101/gad.6.1.93; Flick K, 2004, NAT CELL BIOL, V6, P634, DOI 10.1038/ncb1143; Gao CY, 2000, BIOTECHNIQUES, V29, P1226, DOI 10.2144/00296st02; Gibon Y, 1997, ANAL BIOCHEM, V251, P153, DOI 10.1006/abio.1997.2283; Gitan RS, 1998, J BIOL CHEM, V273, P28617, DOI 10.1074/jbc.273.44.28617; Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x; Grose JH, 2006, P NATL ACAD SCI USA, V103, P7601, DOI 10.1073/pnas.0602494103; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Hambidge M, 2000, J NUTR, V130, p1344S, DOI 10.1093/jn/130.5.1344S; Herbig A, 2005, MOL MICROBIOL, V57, P834, DOI 10.1111/j.1365-2958.2005.04734.x; Higgins VJ, 2003, APPL ENVIRON MICROB, V69, P7535, DOI 10.1128/AEM.69.12.7535-7540.2003; Ho E, 2003, J NUTR, V133, P2543, DOI 10.1093/jn/133.8.2543; Ho E, 2002, P NATL ACAD SCI USA, V99, P16770, DOI 10.1073/pnas.222679399; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Isnard AD, 1996, J MOL BIOL, V262, P473, DOI 10.1006/jmbi.1996.0529; Kaiser P, 2000, CELL, V102, P303, DOI 10.1016/S0092-8674(00)00036-2; Kaiser P, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-16; Kosugi A, 2001, BIOSCI BIOTECH BIOCH, V65, P728, DOI 10.1271/bbb.65.728; Kuras L, 2002, MOL CELL, V10, P69, DOI 10.1016/S1097-2765(02)00561-0; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; OTEIZA PI, 1995, J NUTR, V125, P823; Patton EE, 2000, EMBO J, V19, P1613, DOI 10.1093/emboj/19.7.1613; Paulsen IT, 1998, FEBS LETT, V430, P116, DOI 10.1016/S0014-5793(98)00629-2; Perla-Kajan J, 2007, AMINO ACIDS, V32, P561, DOI 10.1007/s00726-006-0432-9; Powell SR, 2000, J NUTR, V130, p1447S, DOI 10.1093/jn/130.5.1447S; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rouillon A, 2000, EMBO J, V19, P282, DOI 10.1093/emboj/19.2.282; Rouillon A, 1999, J BIOL CHEM, V274, P28096, DOI 10.1074/jbc.274.40.28096; Slekar KH, 1996, J BIOL CHEM, V271, P28831, DOI 10.1074/jbc.271.46.28831; Smothers DB, 2000, MOL CELL BIOL, V20, P7845, DOI 10.1128/MCB.20.21.7845-7852.2000; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; THOMAS D, 1995, MOL CELL BIOL, V15, P6526; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; VANDEPUTTE C, 1994, CELL BIOL TOXICOL, V10, P415, DOI 10.1007/BF00755791; Waters BM, 2002, J BIOL CHEM, V277, P33749, DOI 10.1074/jbc.M206214200; Wu CY, 2007, J BIOL CHEM, V282, P2184, DOI 10.1074/jbc.M606639200; Wu CY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-370; Yen JL, 2005, MOL BIOL CELL, V16, P1872, DOI 10.1091/mbc.E04-12-1130; Yuan DS, 2000, GENETICS, V156, P45; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583; Zhao H, 1998, J BIOL CHEM, V273, P28713, DOI 10.1074/jbc.273.44.28713; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044; Zhao H, 1996, J BIOL CHEM, V271, P23203, DOI 10.1074/jbc.271.38.23203; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454; Zhou ZHS, 1999, BIOCHEMISTRY-US, V38, P15915, DOI 10.1021/bi992062b; Zimny J, 2006, J BIOL CHEM, V281, P22485, DOI 10.1074/jbc.M603656200	65	40	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27544	27556		10.1074/jbc.M109.042036	http://dx.doi.org/10.1074/jbc.M109.042036			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19656949	hybrid, Green Published			2022-12-27	WOS:000270232300056
J	Yang, JQ; Kalhan, SC; Hanson, RW				Yang, Jianqi; Kalhan, Satish C.; Hanson, Richard W.			What Is the Metabolic Role of Phosphoenolpyruvate Carboxykinase?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SMELT OSMERUS-MORDAX; RAINBOW SMELT; GLYCEROL SYNTHESIS; ADIPOSE-TISSUE; CYTOSOLIC FORM; MESSENGER-RNA; GLYCEROL-3-PHOSPHATE DEHYDROGENASE; FREEZE RESISTANCE; MUSCLE; LIVER		[Yang, Jianqi; Hanson, Richard W.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Yang, Jianqi; Kalhan, Satish C.; Hanson, Richard W.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Pathobiol, Cleveland, OH 44195 USA; [Yang, Jianqi; Kalhan, Satish C.; Hanson, Richard W.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Med, Cleveland, OH 44195 USA	Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Hanson, RW (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	rwh@case.edu		Kalhan, Satish/0000-0002-8012-4171	National Institutes of Health [DK58620]; Cleveland Clinic; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058620] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cleveland Clinic; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK58620 (to R. W. H.). This work was also supported by the Cleveland Clinic (to S. C. K.).	BEALE EG, 1985, J BIOL CHEM, V260, P748; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; COOK JS, 1986, P NATL ACAD SCI USA, V83, P7583, DOI 10.1073/pnas.83.20.7583; Driedzic WR, 2006, J EXP BIOL, V209, P1016, DOI 10.1242/jeb.02086; Frazier HN, 2009, CURR BIOL, V19, P859, DOI 10.1016/j.cub.2009.03.066; FREIDMANN B, 1971, ARCH BIOCHEM BIOPHYS, V143, P566, DOI 10.1016/0003-9861(71)90241-4; GARBER AJ, 1969, J BIOL CHEM, V244, P4696; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; Hakimi Parvin, 2005, Nutr Metab (Lond), V2, P33, DOI 10.1186/1743-7075-2-33; HANSON RW, 1994, P ENOLPYRUVATE CARBO; Jensen MD, 2001, AM J PHYSIOL-ENDOC M, V281, pE998, DOI 10.1152/ajpendo.2001.281.5.E998; Kalhan SC, 2008, METABOLISM, V57, P305, DOI 10.1016/j.metabol.2007.10.003; Kalhan SC, 2001, J BIOL CHEM, V276, P12928, DOI 10.1074/jbc.M006186200; Khayath N, 2006, MOL BIOCHEM PARASIT, V147, P145, DOI 10.1016/j.molbiopara.2006.02.002; Lewis JM, 2004, PHYSIOL BIOCHEM ZOOL, V77, P415, DOI 10.1086/383509; Liebscher RS, 2006, PHYSIOL BIOCHEM ZOOL, V79, P411, DOI 10.1086/499981; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Modaressi S, 1998, BIOCHEM J, V333, P359, DOI 10.1042/bj3330359; Mukhopadhyay B, 2001, J BIOL CHEM, V276, P16137, DOI 10.1074/jbc.M008960200; NEWSHOLME EA, 1978, BIOCHEM J, V176, P623, DOI 10.1042/bj1760623; NEWSOME WP, 1994, BIOCHEM J, V304, P555, DOI 10.1042/bj3040555; Novak CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005869; Nye C, 2008, TRENDS ENDOCRIN MET, V19, P356, DOI 10.1016/j.tem.2008.08.003; Nye CK, 2008, J BIOL CHEM, V283, P27565, DOI 10.1074/jbc.M804393200; Okamura T, 2007, MOL BIOL CELL, V18, P1519, DOI 10.1091/mbc.E06-10-0909; PATEL MS, 1975, METABOLISM, V24, P161, DOI 10.1016/0026-0495(75)90017-7; Raymond JA, 1997, COMP BIOCHEM PHYS B, V118, P387, DOI 10.1016/S0305-0491(97)00178-8; RESHEF L, 1969, J BIOL CHEM, V244, P1994; SAHLIN K, 1990, AM J PHYSIOL, V259, pC834, DOI 10.1152/ajpcell.1990.259.5.C834; She PX, 2003, DIABETES, V52, P1649, DOI 10.2337/diabetes.52.7.1649; SNELL K, 1977, BIOCHEM J, V162, P399, DOI 10.1042/bj1620399; SOLING HD, 1973, EUR J BIOCHEM, V37, P233, DOI 10.1111/j.1432-1033.1973.tb02980.x; SOLING HD, 1976, GLUCONEOGENESIS ITS, P369; Stark R, 2009, J BIOL CHEM, V284, P26578, DOI 10.1074/jbc.M109.011775; STINSHOFF K, 1977, CLIN CHEM, V23, P1029; TANNEN RL, 1978, AM J PHYSIOL, V235, P265; Treberg JR, 2002, COMP BIOCHEM PHYS A, V132, P433, DOI 10.1016/S1095-6433(02)00083-1; Walter JA, 2006, J EXP ZOOL PART A, V305A, P480, DOI 10.1002/jez.a.276; WATFORD M, 1981, J BIOL CHEM, V256, P23	39	172	176	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27025	27029		10.1074/jbc.R109.040543	http://dx.doi.org/10.1074/jbc.R109.040543			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19636077	Green Published, hybrid			2022-12-27	WOS:000270232300003
J	Lamour, NF; Subramanian, P; Wijesinghe, DS; Stahelin, RV; Bonventre, JV; Chalfant, CE				Lamour, Nadia F.; Subramanian, Preeti; Wijesinghe, Dayanjan S.; Stahelin, Robert V.; Bonventre, Joseph V.; Chalfant, Charles E.			Ceramide 1-Phosphate Is Required for the Translocation of Group IVA Cytosolic Phospholipase A(2) and Prostaglandin Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID RELEASE; TANDEM MASS-SPECTROMETRY; INTRACELLULAR CALCIUM; CATALYTIC DOMAIN; CELL-LINES; KINASE; LUNG; SPHINGOLIPIDS; EXPRESSION; PHOSPHORYLATION	Little is known about the regulation of eicosanoid synthesis proximal to the activation of cytosolic phospholipase A(2)alpha (cPLA(2)alpha), the initial rate-limiting step. The current view is that cPLA(2)alpha associates with intracellular/phosphatidylcholine-rich membranes strictly via hydrophobic interactions in response to an increase of intracellular calcium. In opposition to this accepted mechanism of two decades, ceramide 1-phosphate (C1P) has been shown to increase the membrane association of cPLA(2)alpha in vitro via a novel site in the cationic beta-groove of the C2 domain (Stahelin, R. V., Subramanian, P., Vora, M., Cho, W., and Chalfant, C. E. (2007) J. Biol. Chem. 282, 20467-204741). In this study we demonstrate that C1P is a proximal and required bioactive lipid for the translocation of cPLA(2)alpha to intracellular membranes in response to inflammatory agonists (e. g. calcium ionophore and ATP). Last, the absolute requirement of the C1P/cPLA(2)alpha interaction was demonstrated for the production of eicosanoids using murine embryonic fibroblasts (cPLA(2)alpha(-/-)) coupled to "rescue" studies. Therefore, this study provides a paradigm shift in how cPLA(2)alpha is activated during inflammation.	[Lamour, Nadia F.; Subramanian, Preeti; Wijesinghe, Dayanjan S.; Chalfant, Charles E.] Virginia Commonwealth Univ, Sch Med, Dept Biochem, Richmond, VA 23298 USA; [Stahelin, Robert V.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA; [Stahelin, Robert V.] Univ Notre Dame, Walther Ctr Canc Res, South Bend, IN 46556 USA; [Stahelin, Robert V.] Univ Notre Dame, Dept Chem & Biochem, South Bend, IN 46556 USA; [Bonventre, Joseph V.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Renal Div,Dept Med, Boston, MA 02115 USA; [Chalfant, Charles E.] Hunter Holmes McGuire Vet Adm Med Ctr, Richmond, VA 23249 USA; [Chalfant, Charles E.] Virginia Commonwealth Univ, Med Coll Virginia, Massey Canc Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; Indiana University System; Indiana University South Bend; University of Notre Dame; Walther Cancer Institute; University of Notre Dame; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University	Chalfant, CE (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Rm 2-016,Sanger Hall,1101 E Marshall St,POB 98061, Richmond, VA 23298 USA.	cechalfant@vcu.edu	Stahelin, Robert/L-3567-2019	, Preeti/0000-0002-6062-6158	National Institutes of Health [HL-072925, CA-117990, DK54741, DK39773]; Veterans Administration; Virginia Commonwealth University funds; American Heart Association [AHA0625502U];  [SDG 0735350N]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017393] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039773, R01DK054741, R56DK054741, R01DK039773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); Virginia Commonwealth University funds; American Heart Association(American Heart Association); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-072925 and CA-117990 (to C. E. C.) and DK54741 and DK39773 (to J. V. B.). This work was also supported by grants from the Veterans Administration (VA Merit Review I and a Research Career Scientist award (to C. E. C.)), Virginia Commonwealth University funds (to C. E. C.), and American Heart Association Postdoctoral Fellowship AHA0625502U (to N. F. L.) and Research Grant SDG 0735350N (to R. V. S.)).	Balsinde J, 2000, J IMMUNOL, V164, P5398, DOI 10.4049/jimmunol.164.10.5398; Blaine SA, 2005, CARCINOGENESIS, V26, P209, DOI 10.1093/carcin/bgh302; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boath A, 2008, J BIOL CHEM, V283, P8517, DOI 10.1074/jbc.M707107200; Casas J, 2006, MOL BIOL CELL, V17, P155, DOI 10.1091/mbc.e05-06-0545; CHANNON JY, 1990, J BIOL CHEM, V265, P5409; Chatterjee S, 1998, ARTERIOSCL THROM VAS, V18, P1523, DOI 10.1161/01.ATV.18.10.1523; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; CLARK JD, 1995, J LIPID MEDIAT CELL, V12, P83, DOI 10.1016/0929-7855(95)00012-F; Di Virgilio Francesco, 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P85; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; Fosslien E, 2000, CRIT REV CL LAB SCI, V37, P431, DOI 10.1080/10408360091174286; Goni FM, 2009, BBA-BIOMEMBRANES, V1788, P169, DOI 10.1016/j.bbamem.2008.09.002; Graf C, 2008, BIOCHEM BIOPH RES CO, V373, P159, DOI 10.1016/j.bbrc.2008.06.002; Hefner Y, 2000, J BIOL CHEM, V275, P37542, DOI 10.1074/jbc.M003395200; Hida T, 1998, CANCER RES, V58, P3761; HUBBARD WC, 1989, CANCER RES, V49, P826; Huwiler A, 2001, FASEB J, V15, P7; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Kramer RM, 1997, FEBS LETT, V410, P49, DOI 10.1016/S0014-5793(97)00322-0; Kutchera W, 1996, P NATL ACAD SCI USA, V93, P4816, DOI 10.1073/pnas.93.10.4816; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamour NF, 2007, J LIPID RES, V48, P1293, DOI 10.1194/jlr.M700083-JLR200; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Malaviya R, 2006, EUR J PHARMACOL, V539, P195, DOI 10.1016/j.ejphar.2006.03.018; MCLEMORE TL, 1988, CANCER RES, V48, P3140; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; Pavicevic Z, 2008, J LIPID RES, V49, P724, DOI 10.1194/jlr.M700419-JLR200; Perry DK, 2000, METHOD ENZYMOL, V312, P22; Pettus BJ, 2003, J BIOL CHEM, V278, P38206, DOI 10.1074/jbc.M304816200; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; REYNOLDS LJ, 1993, BIOCHIM BIOPHYS ACTA, V1167, P272, DOI 10.1016/0005-2760(93)90229-3; SHARP JD, 1991, J BIOL CHEM, V266, P14850; Stahelin RV, 2007, J BIOL CHEM, V282, P20467, DOI 10.1074/jbc.M701396200; Subramanian P, 2005, J BIOL CHEM, V280, P17601, DOI 10.1074/jbc.M414173200; Subramanian P, 2007, J LIPID RES, V48, P2701, DOI 10.1194/jlr.M700356-JLR200; Sullards MC, 2007, METHOD ENZYMOL, V432, P83, DOI 10.1016/S0076-6879(07)32004-1; TAY A, 1995, GENOMICS, V26, P138, DOI 10.1016/0888-7543(95)80093-2; Thomas W, 2006, STEROIDS, V71, P256, DOI 10.1016/j.steroids.2005.10.010; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tucker DE, 2009, J BIOL CHEM, V284, P9596, DOI 10.1074/jbc.M807299200; WIJESINGHE DS, 2009, J LIPID RES IN PRESS; Williams JL, 2001, CANCER RES, V61, P3285; Wirkner K, 2007, MOL NEUROBIOL, V36, P165, DOI 10.1007/s12035-007-0033-y; Wolff H, 1998, CANCER RES, V58, P4997; Zhang Yi, 2003, Sichuan Da Xue Xue Bao Yi Xue Ban, V34, P344	49	74	74	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26897	26907		10.1074/jbc.M109.001677	http://dx.doi.org/10.1074/jbc.M109.001677			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19632995	hybrid, Green Published			2022-12-27	WOS:000269969600070
J	Miller, G; Honig, A; Stein, H; Suzuki, N; Mittler, R; Zilberstein, A				Miller, Gad; Honig, Arik; Stein, Hanan; Suzuki, Nobuhiro; Mittler, Ron; Zilberstein, Aviah			Unraveling Delta(1)-Pyrroline-5-Carboxylate-Proline Cycle in Plants by Uncoupled Expression of Proline Oxidation Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC ASCORBATE PEROXIDASE-1; DELTA-AMINOTRANSFERASE CDNA; GENE-EXPRESSION; SALT STRESS; AMINO-ACIDS; PYRROLINE 5-CARBOXYLATE; DEHYDROGENASE GENES; ARABIDOPSIS; METABOLISM; WATER	The two-step oxidation of proline in all eukaryotes is performed at the inner mitochondrial membrane by the consecutive action of proline dehydrogenase (ProDH) that produces Delta(1)-pyrroline-5-carboxylate (P5C) and P5C dehydrogenase (P5CDH) that oxidizes P5C to glutamate. This catabolic route is down-regulated in plants during osmotic stress, allowing free Pro accumulation. We show here that overexpression of MsProDH in tobacco and Arabidopsis or impairment of P5C oxidation in the Arabidopsis p5cdh mutant did not change the cellular Pro to P5C ratio under ambient and osmotic stress conditions, indicating that P5C excess was reduced to Pro in a mitochondrial-cytosolic cycle. This cycle, involving ProDH and P5C reductase, exists in animal cells and now demonstrated in plants. As a part of the cycle, Pro oxidation by the ProDH-FAD complex delivers electrons to the electron transport chain. Hyperactivity of the cycle, e. g. when an excess of exogenous L-Pro is provided, generates mitochondrial reactive oxygen species (ROS) by delivering electrons to O-2, as demonstrated by the mitochondria-specific MitoSox staining of superoxide ions. Lack of P5CDH activity led to higher ROS production under dark and light conditions in the presence of Pro excess, as well as rendered plants hypersensitive to heat stress. Balancing mitochondrial ROS production during increased Pro oxidation is therefore critical for avoiding Pro-related toxic effects. Hence, normal oxidation of P5C to Glu by P5CDH is key to prevent P5C-Pro intensive cycling and avoid ROS production from electron run-off.	[Miller, Gad; Honig, Arik; Stein, Hanan; Zilberstein, Aviah] Tel Aviv Univ, Dept Plant Sci, IL-69978 Tel Aviv, Israel; [Miller, Gad; Suzuki, Nobuhiro; Mittler, Ron] Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA; [Mittler, Ron] Hebrew Univ Jerusalem, Dept Plant Sci, IL-91904 Jerusalem, Israel	Tel Aviv University; Nevada System of Higher Education (NSHE); University of Nevada Reno; Hebrew University of Jerusalem	Zilberstein, A (corresponding author), Tel Aviv Univ, Dept Plant Sci, IL-69978 Tel Aviv, Israel.	aviah@post.tau.ac.il	Mittler, Ron/ABE-6496-2020; Suzuki, Nobuhiro/Y-2851-2019	Suzuki, Nobuhiro/0000-0002-0225-1597	EU-FP5 [EU QLK5-CT-2002-00841]; Israel Science Foundation [1432/08]	EU-FP5(European Commission); Israel Science Foundation(Israel Science Foundation)	This work was supported by EU-FP5 Grant EU QLK5-CT-2002-00841 (to A. Z.) and Israel Science Foundation Grant 1432/08.	Abraham E, 2003, PLANT MOL BIOL, V51, P363, DOI 10.1023/A:1022043000516; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bonner CA, 1996, PLANT SCI, V113, P43, DOI 10.1016/0168-9452(95)04284-9; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Brosche M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r101; Budisa N, 1998, P NATL ACAD SCI USA, V95, P455, DOI 10.1073/pnas.95.2.455; Chen THH, 2002, CURR OPIN PLANT BIOL, V5, P250, DOI 10.1016/S1369-5266(02)00255-8; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; DELAUNEY AJ, 1993, J BIOL CHEM, V268, P18673; Deuschle K, 2004, PLANT CELL, V16, P3413, DOI 10.1105/tpc.104.023622; Deuschle K, 2001, PLANT J, V27, P345, DOI 10.1046/j.1365-313X.2001.01101.x; DEUTCH CE, 1992, J GEN MICROBIOL, V138, P1593, DOI 10.1099/00221287-138-8-1593; Di Martino C, 2006, PLANTA, V223, P1123, DOI 10.1007/s00425-005-0166-z; ELTHON TE, 1984, PLANT PHYSIOL, V75, P951, DOI 10.1104/pp.75.4.951; ELTHON TE, 1982, PLANT PHYSIOL, V70, P567, DOI 10.1104/pp.70.2.567; FOWDEN L, 1967, ADV ENZYMOL RAMB, V29, P89; HAGEDORN CH, 1983, ARCH BIOCHEM BIOPHYS, V225, P95, DOI 10.1016/0003-9861(83)90010-3; Hanson J, 2008, PLANT J, V53, P935, DOI 10.1111/j.1365-313X.2007.03385.x; Hare PD, 1997, PLANT GROWTH REGUL, V21, P79, DOI 10.1023/A:1005703923347; Hellmann H, 2000, PLANT PHYSIOL, V123, P779, DOI 10.1104/pp.123.2.779; Hu CAA, 2007, MOL CELL BIOCHEM, V295, P85, DOI 10.1007/s11010-006-9276-6; Hua XJ, 2001, PLANT J, V26, P157, DOI 10.1046/j.1365-313x.2001.01020.x; Hua XJ, 1997, PLANT PHYSIOL, V114, P1215, DOI 10.1104/pp.114.4.1215; KIM HR, 1994, ANAL BIOCHEM, V223, P205, DOI 10.1006/abio.1994.1574; KISHOR PBK, 1995, PLANT PHYSIOL, V108, P1387, DOI 10.1104/pp.108.4.1387; Kiyosue T, 1996, PLANT CELL, V8, P1323, DOI 10.1105/tpc.8.8.1323; KONCZ C, 1989, P NATL ACAD SCI USA, V86, P8467, DOI 10.1073/pnas.86.21.8467; Larkindale J, 2008, PLANT PHYSIOL, V146, P748, DOI 10.1104/pp.107.112060; Liu Y, 2008, ONCOGENE, V27, P6729, DOI 10.1038/onc.2008.322; Liu Y, 2006, ONCOGENE, V25, P5640, DOI 10.1038/sj.onc.1209564; Mani S, 2002, PLANT PHYSIOL, V128, P73, DOI 10.1104/pp.010572; Mattioni C, 1997, PHYSIOL PLANTARUM, V101, P787, DOI 10.1111/j.1399-3054.1997.tb01064.x; Maxwell SA, 2000, P NATL ACAD SCI USA, V97, P13009, DOI 10.1073/pnas.230445997; MEZL VA, 1976, ANAL BIOCHEM, V74, P430, DOI 10.1016/0003-2697(76)90223-2; Miller G, 2005, PLANTA, V222, P70, DOI 10.1007/s00425-005-1518-4; MIXSON AJ, 1988, J BIOL CHEM, V263, P10720; MOLLER IM, 2001, ANNU REV PLANT PHYS, V561, P591; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Nakashima K, 1998, PLANT PHYSIOL, V118, P1233, DOI 10.1104/pp.118.4.1233; Nanjo T, 1999, PLANT J, V18, P185, DOI 10.1046/j.1365-313X.1999.00438.x; Nanjo T, 2003, PLANT CELL PHYSIOL, V44, P541, DOI 10.1093/pcp/pcg066; NEMOTO N, 1991, JPN J CANCER RES, V82, P901, DOI 10.1111/j.1349-7006.1991.tb01919.x; Nomura M, 2004, P NATL ACAD SCI USA, V101, P12616, DOI 10.1073/pnas.0403349101; Oono Y, 2003, PLANT J, V34, P868, DOI 10.1046/j.1365-313X.2003.01774.x; Peng Z, 1996, MOL GEN GENET, V253, P334, DOI 10.1007/s004380050329; PHANG JM, 1985, CURR TOP CELL REGUL, V25, P91; RAYAPATI PJ, 1991, PLANT PHYSIOL, V95, P787, DOI 10.1104/pp.95.3.787; Raymond MJ, 2002, ANN BOT-LONDON, V89, P813, DOI 10.1093/aob/mcf082; Rhoads DM, 2006, PLANT PHYSIOL, V141, P357, DOI 10.1104/pp.106.079129; Ribarits A, 2007, PLANTA, V225, P1313, DOI 10.1007/s00425-006-0429-3; Rivera A, 2005, J BIOL CHEM, V280, P29346, DOI 10.1074/jbc.M504852200; Rizhsky L, 2004, J BIOL CHEM, V279, P11736, DOI 10.1074/jbc.M313350200; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Roosens NH, 1999, PLANT PHYSIOL, V121, P1281, DOI 10.1104/pp.121.4.1281; Roosens NHCJ, 1998, PLANT PHYSIOL, V117, P263, DOI 10.1104/pp.117.1.263; SAVOURE A, 1995, FEBS LETT, V372, P13, DOI 10.1016/0014-5793(95)00935-3; Suzuki N, 2008, J BIOL CHEM, V283, P9269, DOI 10.1074/jbc.M709187200; Szekely G, 2008, PLANT J, V53, P11, DOI 10.1111/j.1365-313X.2007.03318.x; Takagi H, 1997, APPL MICROBIOL BIOT, V47, P405, DOI 10.1007/s002530050948; Tanner JJ, 2008, AMINO ACIDS, V35, P719, DOI 10.1007/s00726-008-0062-5; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Verslues PE, 1999, PLANT PHYSIOL, V119, P1349, DOI 10.1104/pp.119.4.1349; Xue XN, 2009, BMB REP, V42, P28, DOI 10.5483/BMBRep.2009.42.1.028; Yang CW, 1999, PLANT GROWTH REGUL, V27, P189; YEH GC, 1988, J BIOL CHEM, V263, P13083; Yoon KA, 2004, J HUM GENET, V49, P134, DOI 10.1007/s10038-003-0122-3; Yoshiba Y, 1997, PLANT CELL PHYSIOL, V38, P1095, DOI 10.1093/oxfordjournals.pcp.a029093; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	72	177	184	9	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26482	26492		10.1074/jbc.M109.009340	http://dx.doi.org/10.1074/jbc.M109.009340			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19635803	Green Published, hybrid			2022-12-27	WOS:000269969600029
J	Terabayashi, T; Funato, Y; Fukuda, M; Miki, H				Terabayashi, Takeshi; Funato, Yosuke; Fukuda, Mitsunori; Miki, Hiroaki			A Coated Vesicle-associated Kinase of 104 kDa (CVAK104) Induces Lysosomal Degradation of Frizzled 5 (Fzd5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT SIGNALING PATHWAY; BETA-CATENIN; CYTOPLASMIC TAIL; FACTOR RECEPTOR; PROTEIN; ENDOCYTOSIS; MEMBRANE; INTERNALIZATION; PHOSPHORYLATION; LOCALIZATION	Receptor internalization is recognized as an important mechanism for controlling numerous cell surface receptors. This event contributes not only to regulate signal transduction but also to adjust the amount of cell surface receptors. Frizzleds (Fzds) are seven-pass transmembrane receptor family proteins for Wnt ligands. Recent studies indicated that Fzd5 is internalized in response to Wnt stimulation to activate downstream signaling pathways. After internalization, it appears that Fzd5 is recycled back to the plasma membrane. However, whether internalized Fzd5 is sorted to lysosomes for protein degradation remains unclear. We here report that a coated vesicle-associated kinase of 104 kDa (CVAK104) selectively induces lysosomal degradation of Fzd5. We identify CVAK104 as a novel binding partner of Dishevelled (Dvl), a scaffold protein in the Wnt signaling pathway. Interestingly, we find that CVAK104 also interacts with Fzd5 but not with Fzd1 or Fzd4. CVAK104 selectively induces intracellular accumulation of Fzd5 via the clathrin-mediated pathway, which is suppressed by coexpression of a dominant negative form of Rab5. Fzd5 is subsequently degraded by a lysosomal pathway. Indeed, knockdown of endogenous CVAK104 by RNA interference results in an increase in the amount of Fzd5. In contrast, Wnt treatment induces Fzd5 internalization but does not stimulate its degradation. Overexpression or knockdown of CVAK104 results in a significant suppression or activation of the Wnt/beta-catenin pathway, respectively. These results suggest that CVAK104 regulates the amount of Fzd5 by inducing lysosomal degradation, which probably contributes to the suppression of the Wnt signaling pathway.	[Terabayashi, Takeshi; Funato, Yosuke; Miki, Hiroaki] Osaka Univ, Inst Prot Res, Lab Intracellular Signaling, Suita, Osaka 5650871, Japan; [Fukuda, Mitsunori] Tohoku Univ, Grad Sch Life Sci, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci,Aoba Ku, Sendai, Miyagi 9808578, Japan	Osaka University; Tohoku University	Miki, H (corresponding author), Osaka Univ, Inst Prot Res, Lab Intracellular Signaling, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	hmiki@protein.osaka-u.ac.jp	Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853; Terabayashi, Takeshi/0000-0001-7102-784X	Ministry of Education, Culture, Sports, Science, and Technology-Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology-Japan and the Japan Society for the Promotion of Science.	Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Bartlett SE, 2005, P NATL ACAD SCI USA, V102, P11521, DOI 10.1073/pnas.0502418102; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Borner GHH, 2007, TRAFFIC, V8, P893, DOI 10.1111/j.1600-0854.2007.00576.x; Boutros M, 1999, MECH DEVELOP, V83, P27, DOI 10.1016/S0925-4773(99)00046-5; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Conner SD, 2005, J BIOL CHEM, V280, P21539, DOI 10.1074/jbc.M502462200; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; DEAN RT, 1984, BIOCHEM J, V217, P27, DOI 10.1042/bj2170027; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Duwel M, 2006, MOL BIOL CELL, V17, P4513, DOI 10.1091/mbc.E06-05-0390; Funato Y, 2006, NAT CELL BIOL, V8, P501, DOI 10.1038/ncb1405; Grampp T, 2007, J BIOL CHEM, V282, P24157, DOI 10.1074/jbc.M702626200; Gullapalli A, 2006, MOL BIOL CELL, V17, P1228, DOI 10.1091/mbc.E05-09-0899; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Hino SI, 2001, MOL CELL BIOL, V21, P330, DOI 10.1128/MCB.21.1.330-342.2001; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Michiue T, 2004, DEV DYNAM, V230, P79, DOI 10.1002/dvdy.20037; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Penton A, 2002, GENETICS, V161, P747; Piddini E, 2005, DEVELOPMENT, V132, P5479, DOI 10.1242/dev.02145; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Schutze S, 1999, J BIOL CHEM, V274, P10203, DOI 10.1074/jbc.274.15.10203; Semenov MV, 1997, GENOMICS, V42, P302, DOI 10.1006/geno.1997.4713; Shapiro MJ, 1996, J BIOL CHEM, V271, P32874, DOI 10.1074/jbc.271.51.32874; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Sun TQ, 2001, NAT CELL BIOL, V3, P628, DOI 10.1038/35083016; Terabayashi T, 2007, J NEUROSCI, V27, P13098, DOI 10.1523/JNEUROSCI.3986-07.2007; Terabayashi T, 2008, BIOCHEM BIOPH RES CO, V375, P660, DOI 10.1016/j.bbrc.2008.08.098; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; Wang HY, 2006, CELL SIGNAL, V18, P934, DOI 10.1016/j.cellsig.2005.12.008; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Yu A, 2007, DEV CELL, V12, P129, DOI 10.1016/j.devcel.2006.10.015; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	48	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26716	26724		10.1074/jbc.M109.039313	http://dx.doi.org/10.1074/jbc.M109.039313			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19643732	Green Published, hybrid			2022-12-27	WOS:000269969600052
J	Borucki, B; Lamparter, T				Borucki, Berthold; Lamparter, Tilman			A Polarity Probe for Monitoring Light-induced Structural Changes at the Entrance of the Chromophore Pocket in a Bacterial Phytochrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED PROTON RELEASE; AGROBACTERIUM-TUMEFACIENS; RECOMBINANT PHYTOCHROME; SIGNAL-TRANSDUCTION; CIRCULAR-DICHROISM; CRYSTAL-STRUCTURE; CPH1 PHYTOCHROME; BINDING DOMAIN; LUMI-R; AGP1	Light-induced structural changes at the entrance of the chromophore pocket of Agp1 phytochrome were investigated by using a thiol-reactive fluorescein derivative that is covalently attached to the genuine chromophore binding site (Cys-20) and serves as a polarity probe. In the apoprotein, the absorption spectrum of bound fluorescein is red-shifted with respect to that of the free label suggesting that the probe enters the hydrophobic chromophore pocket. Assembly of this construct with the chromophores phycocyanobilin or biliverdin is associated with a blue-shift of the fluorescein absorption band indicating the displacement of the probe out of the pocket. The probe does not affect the photochromic and kinetic properties of the noncovalent bilin adducts. Upon photoconversion to P-fr, the probe spectrum undergoes again a bathochromic shift and a strong rise in CD indicating a more hydrophobic and asymmetric environment. We propose that the environmental changes of the probe reflect conformational changes at the entrance of the chromophore pocket and are indicative for rearrangements of the chromophore ring A. Flash photolysis measurements showed that the absorption changes of the probe are kinetically coupled to the formation of Meta-R-C and P-fr. In the biliverdin adduct, an additional component occurs that probably reflects a transition between two Meta-R-C substates. Analogous results to that of the noncovalent phycocyanobilin adduct were obtained with the mutant V249C in which probe and chromophore are covalently attached. The conformational changes of the chromophore are correlated to proton transfer to the protein surface.	[Borucki, Berthold; Lamparter, Tilman] Free Univ Berlin, Dept Phys, Biophys Grp, D-14195 Berlin, Germany; [Lamparter, Tilman] Free Univ Berlin, Dept Biol, Inst Plant Physiol, D-14195 Berlin, Germany	Free University of Berlin; Free University of Berlin	Lamparter, T (corresponding author), Free Univ Berlin, Dept Phys, Biophys Grp, Arnimallee 14, D-14195 Berlin, Germany.	borucki@zedat.fu-berlin.de	Lamparter, Tilman/E-4421-2013	Lamparter, Tilman/0000-0003-4327-9737	Deutsche Forschungsgemeinschaft [BO 1911/1-2, Sfb 498 TP B2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants BO 1911/1-2 (to B. B.) and Sfb 498 TP B2 (to T. L.).	ALEXIEV U, 1995, FEBS LETT, V373, P81, DOI 10.1016/0014-5793(95)00985-I; Andel F, 1996, BIOCHEMISTRY-US, V35, P15997, DOI 10.1021/bi962175k; Bae G, 2008, ANNU REV PLANT BIOL, V59, P281, DOI 10.1146/annurev.arplant.59.032607.092859; Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; Borucki B, 2005, J BIOL CHEM, V280, P34358, DOI 10.1074/jbc.M505493200; Borucki B, 2005, J PHYS CHEM B, V109, P629, DOI 10.1021/jp046515k; Borucki B, 2003, BIOCHEMISTRY-US, V42, P13684, DOI 10.1021/bi035511n; Borucki B, 1999, J PHYS CHEM B, V103, P6371, DOI 10.1021/jp990679x; Borucki B, 2006, PHOTOCH PHOTOBIO SCI, V5, P553, DOI 10.1039/b603846h; Borucki B, 2009, BIOCHEMISTRY-US, V48, P6305, DOI 10.1021/bi900436v; Burghardt TP, 1998, BIOCHEMISTRY-US, V37, P8035, DOI 10.1021/bi980015y; Dasgupta J, 2009, P NATL ACAD SCI USA, V106, P1784, DOI 10.1073/pnas.0812056106; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; EILFELD PH, 1989, J PHOTOCH PHOTOBIO B, V3, P209, DOI 10.1016/1011-1344(89)80063-6; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; FARRENS DL, 1989, J AM CHEM SOC, V111, P9162, DOI 10.1021/ja00208a004; Fischer AJ, 2005, BIOCHEMISTRY-US, V44, P15203, DOI 10.1021/bi051633z; Foerstendorf H, 2001, BIOCHEMISTRY-US, V40, P14952, DOI 10.1021/bi0156916; Giraud E, 2008, PHOTOSYNTH RES, V97, P141, DOI 10.1007/s11120-008-9323-0; Hahn J, 2008, J AM CHEM SOC, V130, P11170, DOI 10.1021/ja8031086; HAHN TR, 1981, BIOCHEMISTRY-US, V20, P2602, DOI 10.1021/bi00512a036; HEBERLE J, 1992, P NATL ACAD SCI USA, V89, P5996, DOI 10.1073/pnas.89.13.5996; HEBERLE J, 1994, NATURE, V370, P379, DOI 10.1038/370379a0; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; Hubschmann T, 2001, EUR J BIOCHEM, V268, P2055, DOI 10.1046/j.1432-1327.2001.02083.x; Inomata K, 2005, J BIOL CHEM, V280, P24491, DOI 10.1074/jbc.M504710200; Inomata K, 2006, J BIOL CHEM, V281, P28162, DOI 10.1074/jbc.M603983200; Inomata K, 2009, BIOCHEMISTRY-US, V48, P2817, DOI 10.1021/bi802334u; Khorchid A, 2006, INT J BIOCHEM CELL B, V38, P307, DOI 10.1016/j.biocel.2005.08.018; LAGARIAS JC, 1980, J AM CHEM SOC, V102, P4821, DOI 10.1021/ja00534a042; LAGARIAS JC, 1989, P NATL ACAD SCI USA, V86, P5778, DOI 10.1073/pnas.86.15.5778; Lamparter T, 2004, FEBS LETT, V573, P1, DOI 10.1016/j.febslet.2004.07.050; Lamparter T, 2003, J BIOL CHEM, V278, P33786, DOI 10.1074/jbc.M305563200; Lamparter T, 2002, P NATL ACAD SCI USA, V99, P11628, DOI 10.1073/pnas.152263999; Lamparter T, 1997, P NATL ACAD SCI USA, V94, P11792, DOI 10.1073/pnas.94.22.11792; MATYSIK J, 1995, BIOCHEMISTRY-US, V34, P10497, DOI 10.1021/bi00033a023; Montgomery BL, 2002, TRENDS PLANT SCI, V7, P357, DOI 10.1016/S1360-1385(02)02304-X; Noack S, 2007, BIOCHEMISTRY-US, V46, P4164, DOI 10.1021/bi602419x; Otto H, 2003, BIOCHEMISTRY-US, V42, P5885, DOI 10.1021/bi026946y; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Quest B, 2004, EUR J BIOCHEM, V271, P1117, DOI 10.1111/j.1432-1033.2004.04015.x; Remberg A, 1997, BIOCHEMISTRY-US, V36, P13389, DOI 10.1021/bi971563z; Rohmer T, 2008, P NATL ACAD SCI USA, V105, P15229, DOI 10.1073/pnas.0805696105; RUDIGER W, 1983, P NATL ACAD SCI-BIOL, V80, P6244, DOI 10.1073/pnas.80.20.6244; Schafer E, 2002, EMBO REP, V3, P1042, DOI 10.1093/embo-reports/kvf222; Scheerer P, 2006, J STRUCT BIOL, V153, P97, DOI 10.1016/j.jsb.2005.11.002; SCHERRER P, 1994, BIOCHEMISTRY-US, V33, P13684, DOI 10.1021/bi00250a019; Schumann C, 2007, CHEMPHYSCHEM, V8, P1657, DOI 10.1002/cphc.200700210; Seibeck S, 2007, FEBS LETT, V581, P5425, DOI 10.1016/j.febslet.2007.10.043; van Thor JJ, 2007, J AM CHEM SOC, V129, P126, DOI 10.1021/ja0660709; van Thor JJ, 2006, BIOPHYS J, V91, P1811, DOI 10.1529/biophysj.106.084335; van Thor JJ, 2001, BIOCHEMISTRY-US, V40, P11460, DOI 10.1021/bi002651d; von Stetten D, 2007, J BIOL CHEM, V282, P2116, DOI 10.1074/jbc.M608878200; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; YAMAMOTO KT, 1993, BIOCHIM BIOPHYS ACTA, V1163, P227, DOI 10.1016/0167-4838(93)90156-L; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505; ZHANG CF, 1992, J AM CHEM SOC, V114, P4569, DOI 10.1021/ja00038a019	61	12	12	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26005	26016		10.1074/jbc.M109.049056	http://dx.doi.org/10.1074/jbc.M109.049056			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19640848	Green Published, hybrid			2022-12-27	WOS:000269738000057
J	Biterova, EI; Barycki, JJ				Biterova, Ekaterina I.; Barycki, Joseph J.			Mechanistic Details of Glutathione Biosynthesis Revealed by Crystal Structures of Saccharomyces cerevisiae Glutamate Cysteine Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; AMINO-ACID-SEQUENCE; KINETIC MECHANISM; CATALYTIC SUBUNIT; BINDING DETERMINANTS; LIVER GLUTATHIONE; MISSENSE MUTATION; HEAVY SUBUNIT; GENE CAUSES; INHIBITION	Glutathione is a thiol-disulfide exchange peptide critical for buffering oxidative or chemical stress, and an essential cofactor in several biosynthesis and detoxification pathways. The rate-limiting step in its de novo biosynthesis is catalyzed by glutamate cysteine ligase, a broadly expressed enzyme for which limited structural information is available in higher eukaryotic species. Structural data are critical to the understanding of clinical glutathione deficiency, as well as rational design of enzyme modulators that could impact human disease progression. Here, we have determined the structures of Saccharomyces cerevisiae glutamate cysteine ligase (ScGCL) in the presence of glutamate and MgCl2 (2.1 angstrom; R = 18.2%, R-free = 21.9%), and in complex with glutamate, MgCl2, and ADP (2.7 angstrom; R = 19.0%, R-free = 24.2%). Inspection of these structures reveals an unusual binding pocket for the alpha-carboxylate of the glutamate substrate and an ATP-independent Mg2+ coordination site, clarifying the Mg2+ dependence of the enzymatic reaction. The ScGCL structures were further used to generate a credible homology model of the catalytic subunit of human glutamate cysteine ligase (hGCLC). Examination of the hGCLC model suggests that post-translational modifications of cysteine residues may be involved in the regulation of enzymatic activity, and elucidates the molecular basis of glutathione deficiency associated with patient hGCLC mutations.	[Barycki, Joseph J.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Barycki, JJ (corresponding author), Univ Nebraska, Dept Biochem, 1901 Vine St, Lincoln, NE 68588 USA.	jbarycki2@unl.edu			National Institutes of Health [1R01 GM077289]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR007707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant Number 1R01 GM077289 (to J. J. B.).	Abbott JJ, 2002, BIOCHEMISTRY-US, V41, P2741, DOI 10.1021/bi0159128; Abbott JJ, 2001, J BIOL CHEM, V276, P42099, DOI 10.1074/jbc.M104672200; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andersen JK, 1996, J NEUROCHEM, V67, P2164; Anderson ME, 1998, CHEM-BIOL INTERACT, V112, P1; BEUTLER E, 1990, BLOOD, V75, P271; Beutler E, 1999, BLOOD, V94, P2890, DOI 10.1182/blood.V94.8.2890.420k16_2890_2894; Brekken DL, 1998, J BIOL CHEM, V273, P26317, DOI 10.1074/jbc.273.41.26317; BUHL R, 1989, LANCET, V2, P1294; CHRISTHAZELHOF E, 1976, BIOCHIM BIOPHYS ACTA, V450, P450, DOI 10.1016/0005-2760(76)90018-7; Copley SD, 2002, GENOME BIOL, V3; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraser JA, 2003, J BIOL CHEM, V278, P46369, DOI 10.1074/jbc.M308035200; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Griffith OW, 1999, ADV ENZYMOL RAMB, V73, P209, DOI 10.1002/9780470123195.ch7; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gysin R, 2007, P NATL ACAD SCI USA, V104, P16621, DOI 10.1073/pnas.0706778104; Hamilton D, 2003, BLOOD, V102, P725, DOI 10.1182/blood-2002-11-3622; Hibi T, 2004, P NATL ACAD SCI USA, V101, P15052, DOI 10.1073/pnas.0403277101; HIGASHI T, 1977, J BIOCHEM-TOKYO, V82, P117, DOI 10.1093/oxfordjournals.jbchem.a131659; Hirono A, 1996, BLOOD, V87, P2071; Hothorn M, 2006, J BIOL CHEM, V281, P27557, DOI 10.1074/jbc.M602770200; HUANG CS, 1993, J BIOL CHEM, V268, P19675; HUANG CS, 1993, J BIOL CHEM, V268, P20578; HUANG CS, 1988, P NATL ACAD SCI USA, V85, P2464, DOI 10.1073/pnas.85.8.2464; Huynh TT, 2003, J BIOL CHEM, V278, P39794, DOI 10.1074/jbc.M306306200; Jez JM, 2004, J BIOL CHEM, V279, P33463, DOI 10.1074/jbc.M405127200; Klatt P, 2000, EUR J BIOCHEM, V267, P4928, DOI 10.1046/j.1432-1327.2000.01601.x; Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Pereira MM, 2007, HAEMATOLOGICA, V92, pE102, DOI 10.3324/haematol.11238; Matte A, 1998, STRUCT FOLD DES, V6, P413, DOI 10.1016/S0969-2126(98)00043-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICHOLSON DW, 1992, J BIOL CHEM, V267, P17849; Ochi T, 1995, ARCH TOXICOL, V70, P96, DOI 10.1007/BF02733669; Ochi T, 1996, TOXICOLOGY, V112, P45, DOI 10.1016/0300-483X(96)03348-3; OHTAKE Y, 1991, YEAST, V7, P953, DOI 10.1002/yea.320070907; ORLOWSKI M, 1971, J BIOL CHEM, V246, P7095; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RICHMAN PG, 1975, J BIOL CHEM, V250, P1422; Ristoff E, 2000, BLOOD, V95, P2193; RODGERS DW, 1994, STRUCTURE, V2, P1135, DOI 10.1016/S0969-2126(94)00116-2; SCHANDLE VB, 1981, J BIOL CHEM, V256, P7590; SEELIG GF, 1984, J BIOL CHEM, V259, P9345; SOFIC E, 1992, NEUROSCI LETT, V142, P128, DOI 10.1016/0304-3940(92)90355-B; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; STRUMEYER DH, 1960, J BIOL CHEM, V235, pPC27; TATEISHI N, 1977, J NUTR, V107, P51, DOI 10.1093/jn/107.1.51; TATEISHI N, 1974, J BIOCHEM, V75, P93, DOI 10.1093/oxfordjournals.jbchem.a130387; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Tu ZH, 1998, BIOCHEM J, V336, P675, DOI 10.1042/bj3360675; VANBUSKIRK GE, 1978, EUR J BIOCHEM, V85, P589; Walsh AC, 1996, CYTOGENET CELL GENET, V75, P14, DOI 10.1159/000134447; Yang Y, 2007, BIOCHEM PHARMACOL, V74, P372, DOI 10.1016/j.bcp.2007.02.003; YIP B, 1976, J BIOL CHEM, V251, P3563	58	17	19	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32700	32708		10.1074/jbc.M109.025114	http://dx.doi.org/10.1074/jbc.M109.025114			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19726687	Green Published, hybrid			2022-12-27	WOS:000272028400054
J	Dobney, S; Chiasson, D; Lam, P; Smith, SP; Snedden, WA				Dobney, Stephanie; Chiasson, David; Lam, Polly; Smith, Steven P.; Snedden, Wayne A.			The Calmodulin-related Calcium Sensor CML42 Plays a Role in Trichome Branching	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE; BINDING-PROTEIN; TROPONIN-C; MAGNESIUM BINDING; ARABIDOPSIS; SPECTROSCOPY; GENES; ASSIGNMENT; INTERACTS; SPECTRA	Calcium (Ca2+) is a key second messenger in eukaryotes where it regulates a diverse array of cellular processes in response to external stimuli. An important Ca2+ sensor in both animals and plants is calmodulin (CaM). In addition to evolutionarily conserved CaM, plants possess a unique family of CaM-like (CML) proteins. The majority of these CMLs have not yet been studied, and investigation into their physical properties and cellular functions will provide insight into Ca2+ signal transduction in plants. Here we describe the characterization of CML42, a 191-amino acid Ca2+-binding protein from Arabidopsis. Ca2+ binding to recombinant CML42 was assessed by fluorescence spectroscopy, NMR spectroscopy, microcalorimetry, and CD spectroscopy. CML42 displays significant alpha-helical secondary structure, binds three molecules of Ca2+ with affinities ranging from 30 to 430 nM, and undergoes a Ca2+-induced conformational change that results in the exposure of one or more hydrophobic regions. Gene expression analysis revealed CML42 transcripts at various stages of development and in many cell types, including the support cells, which surround trichomes (leaf hairs) on the leaf surface. Using yeast two-hybrid screening we identified a putative CML42 interactor; kinesin-interacting Ca2+-binding protein (KIC). Because KIC is a protein known to function in trichome development, we examined transgenic CML42 knockout plants and found that they possess aberrant trichomes with increased branching. Collectively, our data support a role for CML42 as a Ca2+ sensor that functions during cell branching in trichomes.	[Snedden, Wayne A.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Smith, Steven P.] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada	Snedden, WA (corresponding author), Queens Univ, Dept Biol, 116 Barrie St, Kingston, ON K7L 3N6, Canada.	wayne.snedden@queensu.ca		Smith, Steven/0000-0003-2710-4400; Chiasson, David/0000-0002-0770-2684	National Science and Engineering Research Council (NSERC) of Canada [RGPIN-23887-05, RGPGP-312316]; Canadian Institutes of Health Research (CIHR) [PRG-80162]	National Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported in part by National Science and Engineering Research Council (NSERC) of Canada Grants RGPIN-23887-05 (to W. S.) and RGPGP-312316 (to S. P. S.). Operation and maintenance of equipment within the Protein Function Discovery Facility was supported by Canadian Institutes of Health Research (CIHR) Resource Grant PRG-80162.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bouche N, 2005, ANNU REV PLANT BIOL, V56, P435, DOI 10.1146/annurev.arplant.56.032604.144224; Chiasson D, 2005, PLANT MOL BIOL, V58, P887, DOI 10.1007/s11103-005-8395-x; ChinSang ID, 1996, GENE DEV, V10, P2314, DOI 10.1101/gad.10.18.2314; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Day IS, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0056; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FINN BE, 1995, NAT STRUCT BIOL, V2, P777, DOI 10.1038/nsb0995-777; Folkers U, 2002, EMBO J, V21, P1280, DOI 10.1093/emboj/21.6.1280; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Gilli R, 1998, BIOCHEMISTRY-US, V37, P5450, DOI 10.1021/bi972083a; Gong DM, 2004, PLANT PHYSIOL, V134, P919, DOI 10.1104/pp.103.037440; HERZBERG O, 1988, J MOL BIOL, V203, P761, DOI 10.1016/0022-2836(88)90208-2; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; Ishida T, 2008, ANNU REV PLANT BIOL, V59, P365, DOI 10.1146/annurev.arplant.59.032607.092949; JEFFERSON RA, 1987, EMBO J, V6, P3901; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KLIGMAN D, 1988, TRENDS BIOCHEM SCI, V13, P437, DOI 10.1016/0968-0004(88)90218-6; Krishnakumar S, 1999, DEVELOPMENT, V126, P3079; KRUDY GA, 1992, BIOCHEMISTRY-US, V31, P1595, DOI 10.1021/bi00121a003; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Luo DL, 1999, DEVELOPMENT, V126, P5547; MANNING MC, 1989, J PHARMACEUT BIOMED, V7, P1103, DOI 10.1016/0731-7085(89)80049-4; Marks MD, 2008, PLANT J, V56, P483, DOI 10.1111/j.1365-313X.2008.03611.x; MARTIN SR, 1986, BIOCHEM J, V238, P485, DOI 10.1042/bj2380485; McCormack E, 2003, NEW PHYTOL, V159, P585, DOI 10.1046/j.1469-8137.2003.00845.x; Oppenheimer DG, 1997, P NATL ACAD SCI USA, V94, P6261, DOI 10.1073/pnas.94.12.6261; POTTER JD, 1975, J BIOL CHEM, V250, P4628; Reddy ASN, 1996, J BIOL CHEM, V271, P7052, DOI 10.1074/jbc.271.12.7052; Reddy VS, 2004, PHYTOCHEMISTRY, V65, P1745, DOI 10.1016/j.phytochem.2004.04.033; Reddy VS, 2004, PLANT CELL, V16, P185, DOI 10.1105/tpc.016600; Reddy VS, 2002, J BIOL CHEM, V277, P9840, DOI 10.1074/jbc.M111626200; Schellmann S, 2005, INT J DEV BIOL, V49, P579, DOI 10.1387/ijdb.051983ss; SLUPSKY CM, 1995, PROTEIN SCI, V4, P1279, DOI 10.1002/pro.5560040704; Smith SP, 1997, J BIOMOL NMR, V10, P77, DOI 10.1023/A:1018397213369; TANAKA T, 1995, NATURE, V376, P444, DOI 10.1038/376444a0; Vanderbeld B, 2007, PLANT MOL BIOL, V64, P683, DOI 10.1007/s11103-007-9189-0; VIJAYKUMAR S, 1992, J MOL BIOL, V224, P413, DOI 10.1016/0022-2836(92)91004-9; Yang TB, 2003, TRENDS PLANT SCI, V8, P505, DOI 10.1016/j.tplants.2003.09.004; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; Zhang XG, 2004, PLANT CELL PHYSIOL, V45, P221, DOI 10.1093/pcp/pch016	49	72	84	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31647	31657		10.1074/jbc.M109.056770	http://dx.doi.org/10.1074/jbc.M109.056770			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19720824	Green Published, hybrid			2022-12-27	WOS:000271572700019
J	Kress, W; Mutschler, H; Weber-Ban, E				Kress, Wolfgang; Mutschler, Hannes; Weber-Ban, Eilika			Both ATPase Domains of ClpA Are Critical for Processing of Stable Protein Structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRIVES FIBER FORMATION; PLUS CHAPERONE CLPB; ESCHERICHIA-COLI; DEPENDENT PROTEASE; SUBSTRATE TRANSLOCATION; DEGRADATION MACHINE; MUTATIONAL ANALYSIS; COMPLEX-FORMATION; BINDING SITES; N-DOMAIN	ClpA is a ring-shaped hexameric chaperone that binds to both ends of the protease ClpP and catalyzes the ATP-dependent unfolding and translocation of substrate proteins through its central pore into the ClpP cylinder. Here we study the relevance of ATP hydrolysis in the two ATPase domains of ClpA. We designed ClpA Walker B variants lacking ATPase activity in the first (D1) or the second ATPase domain (D2) without impairing ATP binding. We found that the two ATPase domains of ClpA operate independently even in the presence of the protease ClpP or the adaptor protein ClpS. Notably, ATP hydrolysis in the first ATPase module is sufficient to process a small, single domain protein of low stability. Substrate proteins of moderate local stability were efficiently processed when D1 was inactivated. However, ATP hydrolysis in both domains was required for efficiently processing substrates of high local stability. Furthermore, we provide evidence for the ClpS-dependent directional translocation of N-end rule substrates from the N to C terminus and propose a mechanistic model for substrate handover from the adaptor protein to the chaperone.	[Kress, Wolfgang; Mutschler, Hannes; Weber-Ban, Eilika] Swiss Fed Inst Technol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Weber-Ban, E (corresponding author), Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Schafmattstr 20, CH-8093 Zurich, Switzerland.	eilika@mol.biol.ethz.ch	Mutschler, Hannes/K-5148-2015; Mutschler, Hannes/T-1390-2019	Mutschler, Hannes/0000-0001-8005-1657; Mutschler, Hannes/0000-0001-8005-1657; Weber-Ban, Eilika/0000-0002-5773-9274				Best RB, 2003, ANAL CHIM ACTA, V479, P87, DOI 10.1016/S0003-2670(02)01572-6; Bohon J, 2008, STRUCTURE, V16, P1157, DOI 10.1016/j.str.2008.04.016; BOLIN JT, 1982, J BIOL CHEM, V257, P13650; Burton RE, 2001, EMBO J, V20, P3092, DOI 10.1093/emboj/20.12.3092; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Erbse AH, 2008, FEBS J, V275, P1400, DOI 10.1111/j.1742-4658.2008.06304.x; FERSHT A, 2000, STRUCTURE MECH PROTE, P508; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; GOTTESMAN S, 1990, P NATL ACAD SCI USA, V87, P3513, DOI 10.1073/pnas.87.9.3513; Guo FS, 2002, J BIOL CHEM, V277, P46753, DOI 10.1074/jbc.M208104200; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Hinnerwisch J, 2005, J BIOL CHEM, V280, P40838, DOI 10.1074/jbc.M507879200; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hou JY, 2008, NAT STRUCT MOL BIOL, V15, P288, DOI 10.1038/nsmb.1392; HUANG GS, 1995, BIOCHEMISTRY-US, V34, P3884, DOI 10.1021/bi00012a003; HWANG BJ, 1988, J BIOL CHEM, V263, P8727; KATAYAMAFUJIMURA Y, 1987, J BIOL CHEM, V262, P4477; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kenniston JA, 2004, J STRUCT BIOL, V146, P130, DOI 10.1016/j.jsb.2003.10.023; Kress W, 2007, BIOCHEMISTRY-US, V46, P6183, DOI 10.1021/bi602616t; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Maglica Z, 2008, J MOL BIOL, V384, P503, DOI 10.1016/j.jmb.2008.09.046; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Maurizi MR, 1998, BIOCHEMISTRY-US, V37, P7778, DOI 10.1021/bi973093e; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Ninnis RL, 2009, EMBO J, V28, P1732, DOI 10.1038/emboj.2009.134; OTZEN DE, 1995, BIOCHEMISTRY-US, V34, P13051, DOI 10.1021/bi00040a016; Park EY, 2005, J BIOL CHEM, V280, P22892, DOI 10.1074/jbc.M500035200; Puorger C, 2008, STRUCTURE, V16, P631, DOI 10.1016/j.str.2008.01.013; Reid BG, 2001, P NATL ACAD SCI USA, V98, P3768, DOI 10.1073/pnas.071043698; Rieger CE, 1997, ANAL BIOCHEM, V246, P86, DOI 10.1006/abio.1996.9962; Sauer FG, 2002, CELL, V111, P543, DOI 10.1016/S0092-8674(02)01050-4; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Schaupp A, 2007, J MOL BIOL, V370, P674, DOI 10.1016/j.jmb.2007.04.070; SEOL JH, 1995, J BIOL CHEM, V270, P8087, DOI 10.1074/jbc.270.14.8087; SERRANO L, 1992, J MOL BIOL, V224, P783, DOI 10.1016/0022-2836(92)90562-X; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; SINGH SK, 1994, J BIOL CHEM, V269, P29537; Striebel F, 2009, CURR OPIN STRUC BIOL, V19, P209, DOI 10.1016/j.sbi.2009.02.006; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Vetsch M, 2006, EMBO REP, V7, P734, DOI 10.1038/sj.embor.7400722; Wang KH, 2008, J BIOL CHEM, V283, P24600, DOI 10.1074/jbc.M802213200; Wang KH, 2008, MOL CELL, V32, P406, DOI 10.1016/j.molcel.2008.08.032; Wang KH, 2007, GENE DEV, V21, P403, DOI 10.1101/gad.1511907; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Werbeck ND, 2008, J MOL BIOL, V378, P178, DOI 10.1016/j.jmb.2008.02.026; Xu JA, 1998, PROTEIN SCI, V7, P158, DOI 10.1002/pro.5560070117; Zavialov AV, 2003, CELL, V113, P587, DOI 10.1016/S0092-8674(03)00351-9; Zeth K, 2002, NAT STRUCT BIOL, V9, P906, DOI 10.1038/nsb869	55	37	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31441	31452		10.1074/jbc.M109.022319	http://dx.doi.org/10.1074/jbc.M109.022319			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19726681	Green Published, hybrid			2022-12-27	WOS:000271378400069
J	Corsino, P; Horenstein, N; Ostrov, D; Rowe, T; Law, M; Barrett, A; Aslanidi, G; Cress, WD; Law, B				Corsino, Patrick; Horenstein, Nicole; Ostrov, David; Rowe, Thomas; Law, Mary; Barrett, Amanda; Aslanidi, George; Cress, W. Douglas; Law, Brian			A Novel Class of Cyclin-dependent Kinase Inhibitors Identified by Molecular Docking Act through a Unique Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; TUMOR-GROWTH; PHASE-II; IN-VIVO; CANCER; CDK4; FLAVOPIRIDOL; AMPLIFICATION; AGGREGATION; SPECIFICITY	The cyclin-dependent kinase (Cdk) family is emerging as an important therapeutic target in the treatment of cancer. Cdks 1, 2, 4, and 6 are the key members that regulate the cell cycle, as opposed to Cdks that control processes such as transcription (Cdk7 and Cdk9). For this reason, Cdks 1, 2, 4, and 6 have been the subject of extensive cell cycle-related research, and consequently many inhibitors have been developed to target these proteins. However, the compounds that comprise the current list of Cdk inhibitors are largely ATP-competitive. Here we report the identification of a novel structural site on Cdk2, which is well conserved between the cell cycle Cdks. Small molecules identified by a high throughput in silico screen of this pocket exhibit cytostatic effects and act by reducing the apparent protein levels of cell cycle Cdks. Drug-induced cell cycle arrest is associated with decreased Rb phosphorylation and decreased expression of E2F-dependent genes. Multiple lines of evidence indicate that the primary mechanism of action of these compounds is the direct induction of Cdk1, Cdk2, and Cdk4 protein aggregation.	[Law, Brian] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Corsino, Patrick; Ostrov, David; Rowe, Thomas; Law, Mary; Law, Brian] Univ Florida, Shands Canc Ctr, Gainesville, FL 32610 USA; [Horenstein, Nicole] Univ Florida, Dept Chem, Gainesville, FL 32610 USA; [Ostrov, David; Barrett, Amanda] Univ Florida, Dept Pathol, Gainesville, FL 32610 USA; [Aslanidi, George] Univ Florida, Div Cellular & Mol Therapy, Dept Pediat, Gainesville, FL 32610 USA; [Cress, W. Douglas] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Law, B (corresponding author), 1376 Mowry Rd,Rm 275G, Gainesville, FL 32610 USA.	bklaw@pharmacology.ufl.edu	Law, Brian/L-6043-2019; Aslanidi, George/C-5680-2019	Aslanidi, George/0000-0002-2726-8627	National Institutes of Health [R01-CA93651, CA119997]; Florida Department of Health [07BB-8, 09BB-10, 08BB-05]; Susan G. Komen for the Cure [KG080510]; NATIONAL CANCER INSTITUTE [R01CA093651, P50CA119997, T32CA009126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Department of Health; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-CA93651 and CA119997. This work was also supported by Florida Department of Health Grants 07BB-8 and 09BB-10, the Susan G. Komen for the Cure Grant KG080510 (to B. L.), and Florida Department of Health Grant 08BB-05.	An HX, 1999, AM J PATHOL, V154, P113, DOI 10.1016/S0002-9440(10)65257-1; Andrews MJI, 2004, ORG BIOMOL CHEM, V2, P2735, DOI 10.1039/b409157d; Bagella L, 2007, ONCOGENE, V26, P1829, DOI 10.1038/sj.onc.1209987; BARTKOVA J, 1994, INT J CANCER, V57, P353, DOI 10.1002/ijc.2910570311; Benson C, 2007, BRIT J CANCER, V96, P29, DOI 10.1038/sj.bjc.6603509; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Christian BA, 2007, CURR OPIN ONCOL, V19, P573, DOI 10.1097/CCO.0b013e3282efb9da; Chytil A, 2004, J BIOL CHEM, V279, P47688, DOI 10.1074/jbc.M405938200; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; Frye SV, 2009, NAT CHEM BIOL, V5, P448, DOI 10.1038/nchembio.f.11; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Kanoe H, 1998, ANTICANCER RES, V18, P2317; Lacy ER, 2005, J MOL BIOL, V349, P764, DOI 10.1016/j.jmb.2005.04.019; Law BK, 2002, MOL CELL BIOL, V22, P8184, DOI 10.1128/MCB.22.23.8184-8198.2002; MAGARIAN EO, 1969, J PHARM SCI, V58, P1166, DOI 10.1002/jps.2600580937; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Malumbres M, 2003, ADV EXP MED BIOL, V532, P1; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; Moustakas DT, 2006, J COMPUT AID MOL DES, V20, P601, DOI 10.1007/s10822-006-9060-4; Raina K, 2007, CANCER RES, V67, P11083, DOI 10.1158/0008-5472.CAN-07-2222; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Sanchez I, 2005, SEMIN CELL DEV BIOL, V16, P311, DOI 10.1016/j.semcdb.2005.02.007; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Schwartz GK, 2001, J CLIN ONCOL, V19, P1985, DOI 10.1200/JCO.2001.19.7.1985; Shapiro GI, 2001, CLIN CANCER RES, V7, P1590; Singh RP, 2007, CARCINOGENESIS, V28, P2567, DOI 10.1093/carcin/bgm218; Slepchenko BM, 2003, MOL BIOL CELL, V14, P4695, DOI 10.1091/mbc.E03-04-0248; Terasaki M, 2003, MOL BIOL CELL, V14, P4685, DOI 10.1091/mbc.E03-04-0249; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577	35	15	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29945	29955		10.1074/jbc.M109.055251	http://dx.doi.org/10.1074/jbc.M109.055251			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19710018	Green Published, hybrid			2022-12-27	WOS:000270896800073
J	Ang, SK; Lu, H				Ang, Swee Kim; Lu, Hui			Deciphering Structural and Functional Roles of Individual Disulfide Bonds of the Mitochondrial Sulfhydryl Oxidase Erv1p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEMBRANE SPACE; PROTEIN IMPORT; RELAY SYSTEM; GENERATING DISULFIDES; PRECURSOR OXIDATION; REDOX ENVIRONMENT; CYTOCHROME-C; IN-VIVO; PATHWAYS; SHUTTLE	Erv1p is a FAD-dependent sulfhydryl oxidase of the mitochondrial intermembrane space. It contains three conserved disulfide bonds arranged in two CXXC motifs and one CX16C motif. Experimental evidence for the specific roles of the individual disulfide bonds is lacking. In this study, structural and functional roles of the disulfides were dissected systematically using a wide range of biochemical and biophysical methods. Three double cysteine mutants with each pair of cysteines mutated to serines were generated. All of the mutants were purified with the normal FAD binding properties as the wild type Erv1p, showing that none of the three disulfides are essential for FAD binding. Thermal denaturation and trypsin digestion studies showed that the CX16C disulfide plays an important role in stabilizing the folding of Erv1p. To understand the functional role of each disulfide, small molecules and the physiological substrate protein Mia40 were used as electron donors in oxygen consumption assays. We show that both CXXC disulfides are required for Erv1 oxidase activity. The active site disulfide is well protected thus requires the shuttle disulfide for its function. Although both mutants of the CXXC motifs were individually inactive, Erv1p activity was partially recovered by mixing these two mutants together, and the recovery was rapid. Thus, we provided the first experimental evidence of electron transfer between the shuttle and active site disulfides of Erv1p, and we propose that both intersubunit and intermolecular electron transfer can occur.	[Ang, Swee Kim; Lu, Hui] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Lu, H (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	hui.lu@manchester.ac.uk	Lu, Hui/AAB-5476-2021	Ang, Swee Kim/0000-0003-3058-6105; Lu, Hui/0000-0002-7029-2681	Royal Society; Biotechnology and Biological Sciences Research Council [BB/C514323]	Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the Royal Society and by Biotechnology and Biological Sciences Research Council Grant BB/C514323.	Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230; Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553; Collet JF, 2002, MOL MICROBIOL, V44, P1, DOI 10.1046/j.1365-2958.2002.02851.x; Coppock DL, 2006, ANTIOXID REDOX SIGN, V8, P300, DOI 10.1089/ars.2006.8.300; Dabir DV, 2007, EMBO J, V26, P4801, DOI 10.1038/sj.emboj.7601909; Fass D, 2008, BBA-MOL CELL RES, V1783, P557, DOI 10.1016/j.bbamcr.2007.11.009; Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Gross E, 2002, NAT STRUCT BIOL, V9, P61, DOI 10.1038/nsb740; Grumbt B, 2007, J BIOL CHEM, V282, P37461, DOI 10.1074/jbc.M707439200; Hell K, 2008, BBA-MOL CELL RES, V1783, P601, DOI 10.1016/j.bbamcr.2007.12.005; Hofhaus G, 2003, EUR J BIOCHEM, V270, P1528, DOI 10.1046/j.1432-1033.2003.03519.x; Hu JJ, 2008, J BIOL CHEM, V283, P29126, DOI 10.1074/jbc.M803028200; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Koehler CM, 2009, BBA-MOL CELL RES, V1793, P139, DOI 10.1016/j.bbamcr.2008.08.002; Krezel A, 2003, INORG CHEM, V42, P1994, DOI 10.1021/ic025969y; Lee JE, 2000, FEBS LETT, V477, P62, DOI 10.1016/S0014-5793(00)01767-1; Lu H, 2005, J MOL BIOL, V353, P897, DOI 10.1016/j.jmb.2005.09.002; Lu H, 2004, J BIOL CHEM, V279, P18952, DOI 10.1074/jbc.M313045200; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Morgan B, 2009, J BIOL CHEM, V284, P6818, DOI 10.1074/jbc.M808691200; Muller JM, 2008, MOL BIOL CELL, V19, P226, DOI 10.1091/mbc.E07-08-0814; ROTHWARF DM, 1992, P NATL ACAD SCI USA, V89, P7944, DOI 10.1073/pnas.89.17.7944; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Sevier CS, 2006, ANTIOXID REDOX SIGN, V8, P797, DOI 10.1089/ars.2006.8.797; Sevier CS, 2006, MOL BIOL CELL, V17, P2256, DOI 10.1091/mbc.E05-05-0417; Stojanovski D, 2008, J CELL BIOL, V183, P195, DOI 10.1083/jcb.200804095; Stojanovski D, 2008, BBA-MOL CELL RES, V1783, P610, DOI 10.1016/j.bbamcr.2007.10.004; Thorpe C, 2007, J BIOL CHEM, V282, P13929, DOI 10.1074/jbc.R600037200; Tokatlidis K, 2005, CELL, V121, P965, DOI 10.1016/j.cell.2005.06.019; Vitu E, 2006, J MOL BIOL, V362, P89, DOI 10.1016/j.jmb.2006.06.070; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200	35	45	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28754	28761		10.1074/jbc.M109.021113	http://dx.doi.org/10.1074/jbc.M109.021113			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19679655	Green Published, hybrid			2022-12-27	WOS:000270678900032
J	McKenna, JMD; Ostap, EM				McKenna, Jennine M. Dawicki; Ostap, E. Michael			Kinetics of the Interaction of myo1c with Phosphoinositides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; MYOSIN-I; PLASMA-MEMBRANE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PHOSPHOLIPID-VESICLES; REGULATORY DOMAIN; HAIR-CELLS; BINDING; PROTEIN; INSULIN	myo1c is a single-headed myosin that dynamically links membranes to the actin cytoskeleton. A putative pleckstrin homology domain has been identified in the myo1c tail that binds phosphoinositides and soluble inositol phosphates with high affinity. However, the kinetics of association and dissociation and the influence of phospholipid composition on the kinetics have not been determined. Stopped-flow spectroscopy was used to measure the binding and dissociation of a recombinant myo1c construct containing the tail and regulatory domains (myo1c(IQ-tail)) to and from 100-nm diameter large unilamellar vesicles (LUVs). We found the time course of association of myo1c(IQ-tail) with LUVs containing 2% phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2) followed a two-exponential time course, and the rate of the predominant fast phase depended linearly upon the total lipid concentration. The apparent second-order rate constant was approximately diffusion-limited. Increasing the molar ratio of anionic phospholipid by adding phosphatidylserine, additional PtdIns(4,5)P-2, or by situating PtdIns(4,5)P-2 in a more physiologically relevant lipid background increased the apparent association rate constant less than 2-fold. myo1c(IQ-tail) dissociated from PtdIns(4,5)P-2 at a slower rate (2.0 s(-1)) than the pleckstrin homology domain of phospholipase C-delta (13 s(-1)). The presence of additional anionic phospholipid reduced the myo1c(IQ-tail) dissociation rate constant > 50-fold but marginally changed the dissociation rate of phospholipase C-delta, suggesting that additional electrostatic interactions in myo1c(IQ-tail) help to stabilize binding. Remarkably, high concentrations of soluble inositol phosphates induce dissociation of myo1c(IQ-tail) from LUVs, suggesting that phosphoinositides are able to bind to and dissociate from myo1c(IQ-tail) as it remains bound to the membrane.	[McKenna, Jennine M. Dawicki; Ostap, E. Michael] Univ Penn, Sch Med, Dept Physiol, Penn Muscle Inst, Philadelphia, PA 19104 USA	University of Pennsylvania	Ostap, EM (corresponding author), B400 Richards Bldg, Philadelphia, PA 19104 USA.	ostap@mail.med.upenn.edu		Dawicki McKenna, Jennine/0000-0002-1293-640X	National Institutes of Health [GM057247]; National Institutes of Health Training [GM07229]; American Heart Association predoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057247, R37GM057247, T32GM007229] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association predoctoral fellowship(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM057247 to (E. M. O.).; Supported by National Institutes of Health Training Grant GM07229 and an American Heart Association predoctoral fellowship.	ADAMS RJ, 1989, NATURE, V340, P565, DOI 10.1038/340565a0; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Bose A, 2004, MOL CELL BIOL, V24, P5447, DOI 10.1128/MCB.24.12.5447-5458.2004; Brozinick JT, 2007, CURR DIABETES REV, V3, P111, DOI 10.2174/157339907780598199; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; COLLINS JH, 1992, ADV EXP MED BIOL, V321, P159; Corbin JA, 2004, BIOCHEMISTRY-US, V43, P16161, DOI 10.1021/bi049017a; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; Etournay R, 2005, J CELL SCI, V118, P2891, DOI 10.1242/jcs.02424; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; HAYDEN SM, 1990, J CELL BIOL, V111, P443, DOI 10.1083/jcb.111.2.443; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Hokanson DE, 2006, P NATL ACAD SCI USA, V103, P3118, DOI 10.1073/pnas.0505685103; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Huang SH, 2004, MOL CELL BIOL, V24, P9102, DOI 10.1128/MCB.24.20.9102-9123.2004; Insall RH, 2001, DEV CELL, V1, P743, DOI 10.1016/S1534-5807(01)00086-7; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Laakso JM, 2008, SCIENCE, V321, P133, DOI 10.1126/science.1159419; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Lemmon MA, 2001, BIOCHEM SOC T, V29, P377, DOI 10.1042/BST0290377; Lu YF, 1996, BIOCHEMISTRY-US, V35, P8193, DOI 10.1021/bi960280o; Macia E, 2000, BIOCHEMISTRY-US, V39, P5893, DOI 10.1021/bi992795w; Manceva S, 2007, BIOCHEMISTRY-US, V46, P11718, DOI 10.1021/bi700894h; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; MIYATA H, 1989, J CELL BIOL, V109, P1519, DOI 10.1083/jcb.109.4.1519; Nakamori Y, 2006, J CELL BIOL, V173, P665, DOI 10.1083/jcb.200601065; NOVAK KD, 1995, J CELL BIOL, V131, P1205, DOI 10.1083/jcb.131.5.1205; RUPPERT C, 1995, J CELL SCI, V108, P3775; Sokac AM, 2006, DEV CELL, V11, P629, DOI 10.1016/j.devcel.2006.09.002; Swanljung-Collins H, 1994, Adv Exp Med Biol, V358, P205; Tang N, 2007, J MUSCLE RES CELL M, V28, P285, DOI 10.1007/s10974-007-9124-7; Tang NY, 2002, J BIOL CHEM, V277, P42763, DOI 10.1074/jbc.M206388200; TONER M, 1988, BIOCHEMISTRY-US, V27, P7435, DOI 10.1021/bi00419a039; Tyska MJ, 2004, J CELL BIOL, V165, P395, DOI 10.1083/jcb.200310031; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	41	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28650	28659		10.1074/jbc.M109.049791	http://dx.doi.org/10.1074/jbc.M109.049791			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19706607	Green Published, hybrid			2022-12-27	WOS:000270678900020
J	O'Connell, MP; Fiori, JL; Kershner, EK; Frank, BP; Indig, FE; Taub, DD; Hoek, KS; Weeraratna, AT				O'Connell, Michael P.; Fiori, Jennifer L.; Kershner, Emily K.; Frank, Brittany P.; Indig, Fred E.; Taub, Dennis D.; Hoek, Keith S.; Weeraratna, Ashani T.			Heparan Sulfate Proteoglycan Modulation of Wnt5A Signal Transduction in Metastatic Melanoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; GROWTH; DOMAIN; MIGRATION; SYNDECAN-1; PERLECAN; PATHWAY; QSULF1; GENE; PHOSPHORYLATION	Heparan sulfate proteoglycans (HSPGs) are important modulators for optimizing signal transduction of many pathways, including the Wnt pathways. We demonstrate that HSPG glycosaminoglycan levels increased with increasing metastatic potential of melanoma cells. Previous studies have demonstrated that Wnt5A increases the invasiveness of melanoma cells. We further demonstrate that HSPGs potentiate Wnt5A signaling, since enzymatic removal of the HSPG backbone resulted in a decrease in cellular Wnt5A levels, an increase in secreted Wnt5A in cell media, a decrease in downstream signaling, and ultimately, a decrease in invasiveness. Specifically, syndecan 1 and syndecan 4 expression correlated to Wnt5A expression and melanoma malignancy. Knockdown of syndecan 1 or 4 caused decreases in cell invasion, which could be restored by treating the cells with recombinant Wnt5A. These data indicate that syndecan 1 and 4 correlate to increased metastatic potential in melanoma patients and are an important component of the Wnt5A autocrine signaling loop, the activation of which leads to increased metastasis of melanoma.	[Weeraratna, Ashani T.] NIA, Immunol Lab, Res Resources Branch, NIH, Baltimore, MD 21224 USA; [Fiori, Jennifer L.] NIA, Clin Invest Lab, Res Resources Branch, NIH, Baltimore, MD 21224 USA; [Indig, Fred E.] NIA, Confocal Imaging Unit, Res Resources Branch, NIH, Baltimore, MD 21224 USA; [Hoek, Keith S.] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Zurich; University Zurich Hospital	Weeraratna, AT (corresponding author), 251 Bayview Blvd,Suite 100,Rm08C226, Baltimore, MD 21224 USA.	weerarat@mail.nih.gov	O'Connell, Michael/F-9236-2017	O'Connell, Michael/0000-0002-8615-7660	National Institutes of Health Intramural Research Program of the NIA; NATIONAL INSTITUTE ON AGING [ZIAAG000442, ZICAG000615, Z01AG000450, Z01AG000615, ZIAAG000450] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NIA (Baltimore, MD).	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Bachy S, 2008, J CELL PHYSIOL, V214, P238, DOI 10.1002/jcp.21184; Baeg GH, 2001, DEVELOPMENT, V128, P87; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Chalkiadaki G, 2009, INT J BIOCHEM CELL B, V41, P1323, DOI 10.1016/j.biocel.2008.11.008; Choi S, 2005, J BIOL CHEM, V280, P42573, DOI 10.1074/jbc.M509238200; Colombres M, 2008, J CELL PHYSIOL, V216, P805, DOI 10.1002/jcp.21465; Da Forno PD, 2008, CLIN CANCER RES, V14, P5825, DOI 10.1158/1078-0432.CCR-07-5104; Datta S, 2006, INT J BIOCHEM CELL B, V38, P1855, DOI 10.1016/j.biocel.2006.03.022; Dews IC, 2007, P NATL ACAD SCI USA, V104, P20782, DOI 10.1073/pnas.0708909105; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Dissanayake SK, 2008, CANCER RES, V68, P10205, DOI 10.1158/0008-5472.CAN-08-2149; Dissanayake Samudra K., 2008, V468, P157, DOI 10.1007/978-1-59745-249-6_12; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Fjeldstad K, 2005, CURR DRUG TARGETS, V6, P665, DOI 10.2174/1389450054863662; Habuchi H, 2004, GLYCOCONJUGATE J, V21, P47, DOI 10.1023/B:GLYC.0000043747.87325.5e; HIRAGA T, 1995, BONE, V16, P349, DOI 10.1016/8756-3282(94)00048-4; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Ikuta Y, 2005, CLIN CANCER RES, V11, P8079, DOI 10.1158/1078-0432.CCR-05-1074; Jonsson M, 1998, BRIT J CANCER, V78, P430, DOI 10.1038/bjc.1998.511; Kramer KL, 2003, ANNU REV GENET, V37, P461, DOI 10.1146/annurev.genet.37.061103.090226; Lamanna WC, 2008, J BIOL CHEM, V283, P27724, DOI 10.1074/jbc.M802130200; Lin FB, 2005, J INVEST DERMATOL, V124, P906, DOI 10.1111/j.0022-202X.2005.23740.x; Lin XH, 2000, MATRIX BIOL, V19, P303, DOI 10.1016/S0945-053X(00)00073-1; Lopes CC, 2006, BRAZ J MED BIOL RES, V39, P157, DOI 10.1590/S0100-879X2006000200001; Mahtouk K, 2006, ONCOGENE, V25, P7180, DOI 10.1038/sj.onc.1209699; Matthews HK, 2008, DEVELOPMENT, V135, P1771, DOI 10.1242/dev.017350; Melrose J, 2008, BIOESSAYS, V30, P457, DOI 10.1002/bies.20748; Munoz R, 2006, NAT CELL BIOL, V8, P492, DOI 10.1038/ncb1399; O'Callaghan P, 2008, BRAIN PATHOL, V18, P548, DOI 10.1111/j.1750-3639.2008.00152.x; O'Connell MP, 2007, J CELL BIOCHEM, V102, P1493, DOI 10.1002/jcb.21370; O'Connell MP, 2009, J INVEST DERMATOL, V129, P1782, DOI 10.1038/jid.2008.433; Pilia G, 1996, NAT GENET, V12, P241, DOI 10.1038/ng0396-241; Reiland J, 2004, J BIOL CHEM, V279, P8047, DOI 10.1074/jbc.M304872200; Roy M, 2009, J CELL BIOCHEM, V106, P200, DOI 10.1002/jcb.22005; Timar J, 2006, CELL IMMUNOL, V244, P154, DOI 10.1016/j.cellimm.2006.12.009; TIMAR J, 1992, AM J PATHOL, V141, P467; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; Yan D, 2008, NAT CELL BIOL, V10, P761, DOI 10.1038/ncb0708-761; Yang Y, 2007, BLOOD, V110, P2041, DOI 10.1182/blood-2007-04-082495; Yi JY, 2006, THESCIENTIFICWORLDJO, V6, P457, DOI 10.1100/tsw.2006.92	47	61	63	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28704	28712		10.1074/jbc.M109.028498	http://dx.doi.org/10.1074/jbc.M109.028498			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19696445	Green Published, hybrid			2022-12-27	WOS:000270678900026
J	Takemura, M; Mishima, T; Wang, Y; Kasahara, J; Fukunaga, K; Ohashi, K; Mizuno, K				Takemura, Miyohiko; Mishima, Toshiaki; Wang, Yan; Kasahara, Jiro; Fukunaga, Kohji; Ohashi, Kazumasa; Mizuno, Kensaku			Ca2+/Calmodulin-dependent Protein Kinase IV-mediated LIM Kinase Activation Is Critical for Calcium Signal-induced Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH CONE MOTILITY; COFILIN PHOSPHORYLATION; ACTIN REORGANIZATION; CYTOSKELETAL DYNAMICS; DENDRITIC GROWTH; CELL-MIGRATION; PDZ DOMAIN; SLINGSHOT; ADF/COFILIN; EXTENSION	Actin cytoskeletal remodeling is essential for neurite outgrowth. LIM kinase 1 (LIMK1) regulates actin cytoskeletal remodeling by phosphorylating and inactivating cofilin, an actin filament-disassembling factor. In this study, we investigated the role of LIMK1 in calcium signal-induced neurite outgrowth. The calcium ionophore ionomycin induced LIMK1 activation and cofilin phosphorylation in Neuro-2a neuroblastoma cells. Knockdown of LIMK1 or expression of a kinase-dead mutant of LIMK1 suppressed ionomycin-induced cofilin phosphorylation and neurite outgrowth in Neuro-2a cells. Ionomycin-induced cofilin phosphorylation and neurite outgrowth were also blocked by KN-93, an inhibitor of Ca2+/calmodulin-dependent protein kinases (CaMKs), and STO-609, an inhibitor of CaMK kinase. An active form of CaMKIV but not CaMKI enhanced Thr-508 phosphorylation of LIMK1 and increased the kinase activity of LIMK1. Moreover, the active form of CaMKIV induced cofilin phosphorylation and neurite outgrowth, and a dominant negative form of CaMKIV suppressed ionomycin-induced neurite outgrowth. Taken together, our results suggest that LIMK1-mediated cofilin phosphorylation is critical for ionomycin-induced neurite outgrowth and that CaMKIV mediates ionomycin-induced LIMK1 activation.	[Takemura, Miyohiko; Mishima, Toshiaki; Ohashi, Kazumasa; Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan; [Wang, Yan] Jilin Univ, China Japan Union Hosp, Res Ctr Gene Therapy, Changchun 130033, Peoples R China; [Kasahara, Jiro; Fukunaga, Kohji] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sendai, Miyagi 9808578, Japan	Tohoku University; Jilin University; Tohoku University	Mizuno, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan.	kmizuno@biology.tohoku.ac.jp	Mizuno, Kensaku/G-8631-2015; Ohashi, Kazumasa/U-7028-2019; Fukunaga, Kohji/AAI-8811-2021	Ohashi, Kazumasa/0000-0001-7617-403X; Fukunaga, Kohji/0000-0001-8526-2824	Ministry of Education, Culture, Science, Sports and Technology of Japan	Ministry of Education, Culture, Science, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Science, Sports and Technology of Japan.	Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Amano T, 2002, J BIOL CHEM, V277, P22093, DOI 10.1074/jbc.M201444200; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02-03-0046; Bito H, 1997, CURR OPIN NEUROBIOL, V7, P419, DOI 10.1016/S0959-4388(97)80072-4; Chatila T, 1996, J BIOL CHEM, V271, P21542, DOI 10.1074/jbc.271.35.21542; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Endo M, 2003, J NEUROSCI, V23, P2527; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Han F, 2009, BRAIN RES, V1265, P205, DOI 10.1016/j.brainres.2009.02.014; Horita Y, 2008, J BIOL CHEM, V283, P6013, DOI 10.1074/jbc.M706538200; JENSEN KF, 1991, P NATL ACAD SCI USA, V88, P2850, DOI 10.1073/pnas.88.7.2850; Kasahara J, 1999, J BIOL CHEM, V274, P9061, DOI 10.1074/jbc.274.13.9061; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Kotera I, 2005, EMBO J, V24, P942, DOI 10.1038/sj.emboj.7600587; Kurita S, 2008, J BIOL CHEM, V283, P32542, DOI 10.1074/jbc.M804627200; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Meberg PJ, 1998, CELL MOTIL CYTOSKEL, V39, P172, DOI 10.1002/(SICI)1097-0169(1998)39:2<172::AID-CM8>3.0.CO;2-8; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Ohta Y, 2003, GENES CELLS, V8, P811, DOI 10.1046/j.1365-2443.2003.00678.x; Okano I, 1995, J BIOL CHEM, V270, P31321, DOI 10.1074/jbc.270.52.31321; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Rosso S, 2004, MOL BIOL CELL, V15, P3433, DOI 10.1091/mbc.E03-05-0328; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Sarmiere PD, 2004, J NEUROBIOL, V58, P103, DOI 10.1002/neu.10267; Schmitt JM, 2004, J BIOL CHEM, V279, P24064, DOI 10.1074/jbc.M401501200; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Spencer TK, 2008, MOL CELL NEUROSCI, V38, P110, DOI 10.1016/j.mcn.2008.02.005; Tai YL, 2008, J CELL SCI, V121, P2301, DOI 10.1242/jcs.026906; Takemoto-Kimura S, 2007, NEURON, V54, P755, DOI 10.1016/j.neuron.2007.05.021; Tokumitsu H, 2000, J BIOL CHEM, V275, P20090, DOI 10.1074/jbc.M002193200; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Tursun B, 2005, GENE DEV, V19, P2307, DOI 10.1101/gad.1340605; Uboha NV, 2007, J NEUROSCI, V27, P4413, DOI 10.1523/JNEUROSCI.0725-07.2007; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; Wayman GA, 2004, J NEUROSCI, V24, P3786, DOI 10.1523/JNEUROSCI.3294-03.2004; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Wu G, 1998, J NEUROCYTOL, V27, P1, DOI 10.1023/A:1006910001869; Wu JY, 2000, ENDOCRINOLOGY, V141, P4777, DOI 10.1210/en.141.12.4777; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yang N, 1999, BIOCHEM J, V338, P793, DOI 10.1042/0264-6021:3380793; Yang N, 1998, EXP CELL RES, V241, P242, DOI 10.1006/excr.1998.4053	54	55	57	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28554	28562		10.1074/jbc.M109.006296	http://dx.doi.org/10.1074/jbc.M109.006296			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19696021	Green Published, hybrid			2022-12-27	WOS:000270678900009
J	Inder, KL; Lau, C; Loo, D; Chaudhary, N; Goodall, A; Martin, S; Jones, A; van der Hoeven, D; Parton, RG; Hill, MM; Hancock, JF				Inder, Kerry L.; Lau, Chiyan; Loo, Dorothy; Chaudhary, Natasha; Goodall, Andrew; Martin, Sally; Jones, Alun; van der Hoeven, Dharini; Parton, Robert G.; Hill, Michelle M.; Hancock, John F.			Nucleophosmin and Nucleolin Regulate K-Ras Plasma Membrane Interactions and MAPK Signal Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-RAS; PROTEIN B23; SINGLE-MOLECULE; RIBOSOMAL-RNA; CELL-SURFACE; LIVING CELLS; HUMAN CANCER; NANOCLUSTERS; ASSOCIATION; ACTIVATION	The spatial organization of Ras proteins into nanoclusters on the inner leaflet of the plasma membrane is essential for high fidelity signaling through the MAPK pathway. Here we identify two selective regulators of K-Ras nanoclustering from a proteomic screen for K-Ras interacting proteins. Nucleophosmin (NPM) and nucleolin are predominantly localized to the nucleolus but also have extranuclear functions. We show that a subset of NPM and nucleolin localizes to the inner leaflet of plasma membrane and forms specific complexes with K-Ras but not other Ras isoforms. Active GTP-loaded and inactive GDP-loaded K-Ras both interact with NPM, although NPM-K-Ras binding is increased by growth factor receptor activation. NPM and nucleolin both stabilize K-Ras levels on the plasma membrane, but NPM concurrently increases the clustered fraction of GTP-K-Ras. The increase in nanoclustered GTP-K-Ras in turn enhances signal gain in the MAPK pathway. In summary these results reveal novel extranucleolar functions for NPM and nucleolin as regulators of K-Ras nanocluster formation and activation of the MAPK pathway. The study also identifies a new class of K-Ras nanocluster regulator that operates independently of the structural scaffold galectin-3.	[Inder, Kerry L.; Lau, Chiyan; Loo, Dorothy; Chaudhary, Natasha; Goodall, Andrew; Martin, Sally; Jones, Alun; Parton, Robert G.; Hill, Michelle M.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [van der Hoeven, Dharini; Hancock, John F.] Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia; [Loo, Dorothy; Hill, Michelle M.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld 4702, Australia	University of Queensland; University of Texas System; University of Texas Health Science Center Houston; University of Queensland; University of Queensland	Hill, MM (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	m.hill2@uq.edu.au; john.f.hancock@uth.tmc.edu	Parton, Robert G/C-5673-2009; Martin, Sally/A-7150-2010; Inder, Kerry/K-3769-2012; Hill, Michelle Mei Chih/G-4417-2010	Parton, Robert G/0000-0002-7494-5248; Martin, Sally/0000-0001-9294-5404; Inder, Kerry/0000-0002-7648-2398; Hill, Michelle Mei Chih/0000-0003-1134-0951; Lau, Chiyan/0000-0002-9129-8783; Hancock, John/0000-0003-0542-4710	National Institutes of Health [GM066717]; Australian Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM066717. This work was also supported by the Australian Cancer Research Foundation.	Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; BESAG J, 1977, APPL STAT, V26, P329; Birchenall-Roberts MC, 2006, BIOCHEM BIOPH RES CO, V348, P540, DOI 10.1016/j.bbrc.2006.07.094; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; BOS JL, 1989, CANCER RES, V49, P4682; Di Segni A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002310; DIGGLE PJ, 1986, J NEUROSCI METH, V18, P115, DOI 10.1016/0165-0270(86)90115-9; Diggle PJ, 2000, ADV APPL PROBAB, V32, P331, DOI 10.1017/S0001867800009952; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dundr M, 2000, J CELL BIOL, V150, P433, DOI 10.1083/jcb.150.3.433; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2006, BLOOD, V107, P4514, DOI 10.1182/blood-2005-11-4745; Ginisty H, 1998, EMBO J, V17, P1476, DOI 10.1093/emboj/17.5.1476; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Harding A, 2005, CURR BIOL, V15, P869, DOI 10.1016/j.cub.2005.04.020; Harding A, 2003, J BIOL CHEM, V278, P16747, DOI 10.1074/jbc.M301015200; Harding A, 2008, CELL CYCLE, V7, P127, DOI 10.4161/cc.7.2.5237; Harding AS, 2008, TRENDS CELL BIOL, V18, P364, DOI 10.1016/j.tcb.2008.05.006; Hibino K, 2003, CHEMPHYSCHEM, V4, P748, DOI 10.1002/cphc.200300731; Hill MM, 2004, EMBO J, V23, P2134, DOI 10.1038/sj.emboj.7600210; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; Inder K, 2008, MOL BIOL CELL, V19, P4776, DOI 10.1091/mbc.E08-04-0407; Lim MJ, 2006, CANCER DETECT PREV, V30, P481, DOI 10.1016/j.cdp.2006.10.008; Liu HT, 1999, CANCER LETT, V144, P45, DOI 10.1016/S0304-3835(99)00184-6; LIU QR, 1991, EUR J BIOCHEM, V200, P715, DOI 10.1111/j.1432-1033.1991.tb16236.x; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Okuwaki M, 2002, MOL BIOL CELL, V13, P2016, DOI 10.1091/mbc.02-03-0036; Plowman SJ, 2008, MOL CELL BIOL, V28, P4377, DOI 10.1128/MCB.00050-08; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; Savkur RS, 1998, NUCLEIC ACIDS RES, V26, P4508, DOI 10.1093/nar/26.19.4508; Shalom-Feuerstein R, 2008, CANCER RES, V68, P6608, DOI 10.1158/0008-5472.CAN-08-1117; Szebeni A, 1999, PROTEIN SCI, V8, P905; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Verhaak RGW, 2005, BLOOD, V106, P3747, DOI 10.1182/blood-2005-05-2168	41	53	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28410	28419		10.1074/jbc.M109.001537	http://dx.doi.org/10.1074/jbc.M109.001537			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19661056	Green Published, hybrid			2022-12-27	WOS:000270676300066
J	Mo, R; Chew, TL; Maher, MT; Bellipanni, G; Weinberg, ES; Gottardi, CJ				Mo, Rigen; Chew, Teng-Leong; Maher, Meghan T.; Bellipanni, Gianfranco; Weinberg, Eric S.; Gottardi, Cara J.			The Terminal Region of beta-Catenin Promotes Stability by Shielding the Armadillo Repeats from the Axin-scaffold Destruction Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; GENE-EXPRESSION; XENOPUS EMBRYOS; MOLECULAR-BASIS; APC; PHOSPHORYLATION; PROTEIN; BINDING; CELL; ADHESION	Post-translational stabilization of beta-catenin is a key step in Wnt signaling, but the features of beta-catenin required for stabilization are incompletely understood. We show that forms of beta-catenin lacking the unstructured C-terminal domain (CTD) show faster turnover than full-length or minimally truncated beta-catenins. Mutants that exhibit faster turnover show enhanced association with axin in co-transfected cells, and excess CTD polypeptide can compete binding of the beta-catenin armadillo (arm) repeat domain to axin in vitro, indicating that the CTD may restrict beta-catenin binding to the axin-scaffold complex. Fluorescent resonance energy transmission (FRET) analysis of cyan fluorescent protein (CFP)-arm-CTD-yellow fluorescent protein beta-catenin reveals that the CTD of beta-catenin can become spatially close to the N-terminal arm repeat region of beta-catenin. FRET activity is strongly diminished by the coexpression of beta-catenin binding partners, indicating that an unliganded groove is absolutely required for an orientation that allows FRET. Amino acids 733-759 are critical for beta-catenin FRET activity and stability. These data indicate that an N-terminal orientation of the CTD is required for beta-catenin stabilization and suggest a model where the CTD extends toward the N-terminal arm repeats, shielding these repeats from the beta-catenin destruction complex.	[Mo, Rigen; Maher, Meghan T.; Gottardi, Cara J.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Chew, Teng-Leong] Northwestern Univ, Feinberg Sch Med, Dept Cellular & Mol Biol, Chicago, IL 60611 USA; [Maher, Meghan T.] Northwestern Univ, Feinberg Sch Med, Integrated Grad Program Life Sci, Chicago, IL 60611 USA; [Gottardi, Cara J.] Northwestern Univ, Feinberg Sch Med, Robert Lurie Canc Ctr, Chicago, IL 60611 USA; [Bellipanni, Gianfranco; Weinberg, Eric S.] Univ Penn, Dept Biol, Philadelphia, PA 19106 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; University of Pennsylvania	Gottardi, CJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA.	c-gottardi@northwestern.edu	Gottardi, Cara J./AAU-4691-2021	Gottardi, Cara J./0000-0003-0912-7617	National Institutes of Health [T32 GM08061, P30 CA060553, R01 HD39272, GM076561]; American Heart Association [09PRE2261197, 0530304Z]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039272] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076561, T32GM008061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 GM08061 (to M. T. M.), P30 CA060553 (to the Northwestern Imaging Facility and Robert H. Lurie Comprehensive Cancer Center), R01 HD39272 (to E. S. W. and G. B.), and GM076561 (to C. J. G.). This work was also supported by American Heart Association Pre-doctoral Award 09PRE2261197 (to M. T. M.) and the American Heart Association Grant 0530304Z (to C. J. G.).	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; Bellipanni G, 2006, DEVELOPMENT, V133, P1299, DOI 10.1242/dev.02295; Cai DW, 2007, J CELL BIOL, V176, P51, DOI 10.1083/jcb.200605097; Castano J, 2002, J BIOL CHEM, V277, P31541, DOI 10.1074/jbc.M204376200; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chew TL, 2002, J CELL BIOL, V156, P543, DOI 10.1083/jcb.200110161; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; Cox RT, 1999, GENETICS, V153, P319; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; Daniels DL, 2002, MOL CELL, V10, P573, DOI 10.1016/S1097-2765(02)00631-7; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Dobrosotskaya IY, 2000, BIOCHEM BIOPH RES CO, V270, P903, DOI 10.1006/bbrc.2000.2471; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Giannini AL, 2000, EXP CELL RES, V255, P207, DOI 10.1006/excr.1999.4785; Gottardi CJ, 2008, STRUCTURE, V16, P336, DOI 10.1016/j.str.2008.02.005; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Gottardi CJ, 2004, AM J PHYSIOL-CELL PH, V286, pC747, DOI 10.1152/ajpcell.00433.2003; Gottardi CJ, 2001, CURR BIOL, V11, pR792, DOI 10.1016/S0960-9822(01)00473-0; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Guger KA, 2000, DEV BIOL, V223, P441, DOI 10.1006/dbio.2000.9770; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Jho EH, 1999, BIOCHEM BIOPH RES CO, V266, P28, DOI 10.1006/bbrc.1999.1760; Kanamori M, 2003, J BIOL CHEM, V278, P38758, DOI 10.1074/jbc.M306324200; Kelly C, 2000, DEVELOPMENT, V127, P3899; Kidd AR, 2005, CELL, V121, P761, DOI 10.1016/j.cell.2005.03.029; Lee E, 2001, J CELL BIOL, V154, P983, DOI 10.1083/jcb.200102074; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Loureiro J, 1998, CURR BIOL, V8, P622, DOI 10.1016/S0960-9822(98)70249-0; Luo W, 2007, EMBO J, V26, P1511, DOI 10.1038/sj.emboj.7601607; Maher MT, 2009, J CELL BIOL, V186, P219, DOI 10.1083/jcb.200811108; Nishimura W, 2002, J NEUROSCI, V22, P757, DOI 10.1523/JNEUROSCI.22-03-00757.2002; PEIFER M, 1994, DEVELOPMENT, V120, P369; Perego C, 2000, EMBO J, V19, P3978, DOI 10.1093/emboj/19.15.3978; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; RIGGLEMAN B, 1989, GENE DEV, V3, P96, DOI 10.1101/gad.3.1.96; Rubinfeld B, 2001, J BIOL CHEM, V276, P39037, DOI 10.1074/jbc.M105148200; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Shah S, 2006, MOL CELL, V21, P799, DOI 10.1016/j.molcel.2006.01.037; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Su YY, 2008, MOL CELL, V32, P652, DOI 10.1016/j.molcel.2008.10.023; Tago K, 2000, GENE DEV, V14, P1741; von Kries JP, 2000, NAT STRUCT BIOL, V7, P800; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Xing Y, 2004, MOL CELL, V15, P523, DOI 10.1016/j.molcel.2004.08.001; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603; Xing Y, 2008, STRUCTURE, V16, P478, DOI 10.1016/j.str.2007.12.021; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	56	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28222	28231		10.1074/jbc.M109.045039	http://dx.doi.org/10.1074/jbc.M109.045039			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19706613	Green Published, hybrid			2022-12-27	WOS:000270676300050
J	Pioszak, AA; Parker, NR; Gardella, TJ; Xu, HE				Pioszak, Augen A.; Parker, Naomi R.; Gardella, Thomas J.; Xu, H. Eric			Structural Basis for Parathyroid Hormone-related Protein Binding to the Parathyroid Hormone Receptor and Design of Conformation-selective Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR RECOGNITION; CRYSTAL-STRUCTURE; LIGAND-BINDING; FRAGMENT; PTH; IDENTIFICATION; HYPERCALCEMIA; REFINEMENT; MECHANISMS; DOMAIN	Parathyroid hormone (PTH) and PTH-related protein (PTHrP) are two related peptides that control calcium/phosphate homeostasis and bone development, respectively, through activation of the PTH/PTHrP receptor (PTH1R), a class B G protein-coupled receptor. Both peptides hold clinical interest for their capacities to stimulate bone formation. PTH and PTHrP display different selectivity for two distinct PTH1R conformations, but how their binding to the receptor differs is unclear. The high resolution crystal structure of PTHrP bound to the extracellular domain (ECD) of PTH1R reveals that PTHrP binds as an amphipathic a-helix to the same hydrophobic groove in the ECD as occupied by PTH, but in contrast to a straight, continuous PTH helix, the PTHrP helix is gently curved and C-terminally "unwound." The receptor accommodates the altered binding modes by shifting the side chain conformations of two residues within the binding groove: Leu-41 and Ile-115, the former acting as a rotamer toggle switch to accommodate PTH/PTHrP sequence divergence, and the latter adapting to the PTHrP curvature. Binding studies performed with PTH/PTHrP hybrid ligands having reciprocal exchanges of residues involved in different contacts confirmed functional consequences for the altered interactions and enabled the design of altered PTH and PTHrP peptides that adopt the ECD-binding mode of the opposite peptide. Hybrid peptides that bound the ECD poorly were selective for the G protein-coupled PTH1R conformation. These results establish a molecular model for better understanding of how two biologically distinct ligands can act through a single receptor and provide a template for designing better PTH/PTHrP therapeutics.	[Pioszak, Augen A.; Parker, Naomi R.; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Gardella, Thomas J.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02144 USA	Van Andel Institute; Harvard University; Massachusetts General Hospital	Pioszak, AA (corresponding author), Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA.	augie.pioszak@vai.org; eric.xu@vai.org	Xu, H. Eric/ABD-7487-2021	Xu, H. Eric/0000-0002-6829-8144	National Institutes of Health [DK071662, DK066202, HL089301, DK-11794]; Jay and Betty Van Andel Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK011794, R01DK071662, R01DK066202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jay and Betty Van Andel Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK071662, DK066202, and HL089301 (to H. E. X.), and DK-11794 (toT. J. G.).This work was also supported by the Jay and Betty Van Andel Foundation.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bergwitz C, 1996, J BIOL CHEM, V271, P26469, DOI 10.1074/jbc.271.43.26469; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURTIS WJ, 1987, J BIOL CHEM, V262, P7151; Dean T, 2006, MOL ENDOCRINOL, V20, P931, DOI 10.1210/me.2005-0349; Dean T, 2008, MOL ENDOCRINOL, V22, P156, DOI 10.1210/me.2007-0274; Delano W.L., 2002, DELANO SCI; Gardella T J, 2000, Rev Endocr Metab Disord, V1, P317, DOI 10.1023/A:1026522619828; Gensure RC, 2003, MOL ENDOCRINOL, V17, P2647, DOI 10.1210/me.2003-0275; Grauschopf U, 2000, BIOCHEMISTRY-US, V39, P8878, DOI 10.1021/bi0001426; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; Hoare SRJ, 2000, J BIOL CHEM, V275, P27274; Hoare SRJ, 2001, J BIOL CHEM, V276, P7741, DOI 10.1074/jbc.M009395200; Horwitz MJ, 2003, J CLIN ENDOCR METAB, V88, P569, DOI 10.1210/jc.2002-021122; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; KLEIN RF, 1987, ENDOCRINOLOGY, V120, P504, DOI 10.1210/endo-120-2-504; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P208, DOI 10.1016/S0076-6879(97)77013-7; Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Luck MD, 1999, MOL ENDOCRINOL, V13, P670, DOI 10.1210/me.13.5.670; Mann R, 2008, MOL PHARMACOL, V74, P605, DOI 10.1124/mol.108.048017; Marx UC, 2000, BIOCHEM BIOPH RES CO, V267, P213, DOI 10.1006/bbrc.1999.1958; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOSELEY JM, 1987, P NATL ACAD SCI USA, V84, P5048, DOI 10.1073/pnas.84.14.5048; Murray TM, 2005, ENDOCR REV, V26, P78, DOI 10.1210/er.2003-0024; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Okazaki M, 2008, P NATL ACAD SCI USA, V105, P16525, DOI 10.1073/pnas.0808750105; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Penel S, 2001, J MOL BIOL, V305, P961, DOI 10.1006/jmbi.2000.4339; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Plotkin H, 1998, J CLIN ENDOCR METAB, V83, P2786, DOI 10.1210/jc.83.8.2786; Potts JT, 2007, ANN NY ACAD SCI, V1117, P196, DOI 10.1196/annals.1402.088; Potts JT, 2005, J ENDOCRINOL, V187, P311, DOI 10.1677/joe.1.06057; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618; Weidler M, 1999, FEBS LETT, V444, P239, DOI 10.1016/S0014-5793(98)01658-5; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	44	96	105	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28382	28391		10.1074/jbc.M109.022905	http://dx.doi.org/10.1074/jbc.M109.022905			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19674967	Green Published, hybrid			2022-12-27	WOS:000270676300063
J	Beach, JR; Egelhoff, TT				Beach, Jordan R.; Egelhoff, Thomas T.			Myosin II Recruitment during Cytokinesis Independent of Centralspindlin-mediated Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY LIGHT-CHAIN; SMOOTH-MUSCLE MYOSIN; CONTRACTILE RING FORMATION; PROTEIN-KINASE-C; HEAVY-CHAIN; CORTICAL FLOW; CITRON-KINASE; HELA-CELLS; NONMUSCLE; ISOFORMS	During cell division, the mechanisms by which myosin II is recruited to the contractile ring are not fully understood. Much recent work has focused on a model in which spatially restricted de novo filament assembly occurs at the cell equator via localized myosin II regulatory light chain (RLC) phosphorylation, stimulated by the RhoA-activating centralspindlin complex. Here, we show that a recombinant myosin IIA protein that assembles constitutively and is incapable of binding RLC still displays strong localization to the furrow in mammalian cells. Furthermore, this RLC-deficient myosin II efficiently drives cytokinesis, demonstrating that centralspindlin-based RLC phosphorylation is not necessary for myosin II localization during furrowing. Myosin II truncation analysis further reveals two distinct myosin II tail properties that contribute to furrow localization: a central tail domain mediating cortical furrow binding to heterologous binding partners and a carboxyl-terminal region mediating co-assembly with existing furrow myosin IIA or IIB filaments.	[Beach, Jordan R.; Egelhoff, Thomas T.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Beach, Jordan R.; Egelhoff, Thomas T.] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University	Egelhoff, TT (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cell Biol, NC10,9500 Euclid Ave, Cleveland, OH 44195 USA.	Egelhot@ccf.org		Beach, Jordan/0000-0003-0633-4928	National Institutes of Health [GM 077224]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077224] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 077224 (to T. T. E.).	Bao JJ, 2007, J BIOL CHEM, V282, P22102, DOI 10.1074/jbc.M702731200; Bao JJ, 2005, J BIOL CHEM, V280, P19594, DOI 10.1074/jbc.M501573200; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Breckenridge MT, 2009, MOL BIOL CELL, V20, P338, DOI 10.1091/mbc.E08-04-0372; Canman JC, 2008, SCIENCE, V322, P1543, DOI 10.1126/science.1163086; CONTI MA, 1991, BIOCHEMISTRY-US, V30, P966, DOI 10.1021/bi00218a012; CRAIG R, 1983, NATURE, V302, P436, DOI 10.1038/302436a0; Dean SO, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000131; DeBiasio RL, 1996, MOL BIOL CELL, V7, P1259, DOI 10.1091/mbc.7.8.1259; Eda M, 2001, J CELL SCI, V114, P3273; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Joo E, 2007, DEV CELL, V13, P677, DOI 10.1016/j.devcel.2007.09.001; Kamijo K, 2006, MOL BIOL CELL, V17, P43, DOI 10.1091/mbc.e05-06-0569; Kelley CA, 1996, J CELL BIOL, V134, P675, DOI 10.1083/jcb.134.3.675; Kolega J, 1998, J CELL SCI, V111, P2085; Madaule P, 2000, MICROSC RES TECHNIQ, V49, P123, DOI 10.1002/(SICI)1097-0029(20000415)49:2<123::AID-JEMT3>3.0.CO;2-R; Mandato CA, 2000, CELL MOTIL CYTOSKEL, V45, P87, DOI 10.1002/(SICI)1097-0169(200002)45:2<87::AID-CM1>3.0.CO;2-0; Marini M, 2006, INT J MOL MED, V17, P729; Miyauchi K, 2006, BIOCHEM BIOPH RES CO, V350, P543, DOI 10.1016/j.bbrc.2006.09.065; Murakami N, 1998, BIOCHEMISTRY-US, V37, P1989, DOI 10.1021/bi971959a; Murakami N, 2000, BIOCHEMISTRY-US, V39, P11441, DOI 10.1021/bi000347e; Nakasawa T, 2005, BIOCHEMISTRY-US, V44, P174, DOI 10.1021/bi048807h; Piekny AJ, 2008, CURR BIOL, V18, P30, DOI 10.1016/j.cub.2007.11.068; Sato MK, 2007, MOL BIOL CELL, V18, P1009, DOI 10.1091/mbc.E06-08-0706; SELLERS JR, 1985, J CELL BIOL, V101, P1897, DOI 10.1083/jcb.101.5.1897; SELLERS JR, 1981, J BIOL CHEM, V256, P3137; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Totsukawa G, 1996, CELL STRUCT FUNCT, V21, P475, DOI 10.1247/csf.21.475; UYEDA TQP, 1993, SCIENCE, V262, P1867, DOI 10.1126/science.8266074; Watanabe S, 2008, MOL BIOL CELL, V19, P2328, DOI 10.1091/mbc.E07-10-1086; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Werner M, 2008, BIOCHEM SOC T, V36, P371, DOI 10.1042/BST0360371; Wong KCY, 2002, CURR BIOL, V12, P724, DOI 10.1016/S0960-9822(02)00790-X; YAMAKITA Y, 1994, J CELL BIOL, V124, P129, DOI 10.1083/jcb.124.1.129; Yamashiro S, 2003, MOL BIOL CELL, V14, P1745, DOI 10.1091/mbc.E02-07-0427; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097; Yumura S, 2005, MOL BIOL CELL, V16, P4256, DOI 10.1091/mbc.E05-03-0219; Yumura S, 2001, J CELL BIOL, V154, P137, DOI 10.1083/jcb.200011013; Yumura S, 2008, TRAFFIC, V9, P2089, DOI 10.1111/j.1600-0854.2008.00837.x; Zang JH, 1998, P NATL ACAD SCI USA, V95, P13652, DOI 10.1073/pnas.95.23.13652; Zhou M, 2008, MOL BIOL CELL, V19, P318, DOI 10.1091/mbc.E07-08-0783	41	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27377	27383		10.1074/jbc.M109.028316	http://dx.doi.org/10.1074/jbc.M109.028316			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19661065	Green Published, hybrid			2022-12-27	WOS:000270232300039
J	Radhakrishnan, A; Stein, A; Jahn, R; Fasshauer, D				Radhakrishnan, Anand; Stein, Alexander; Jahn, Reinhard; Fasshauer, Dirk			The Ca2+ Affinity of Synaptotagmin 1 Is Markedly Increased by a Specific Interaction of Its C2B Domain with Phosphatidylinositol 4,5-Bisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; MEMBRANE-PENETRATION ACTIVITY; NEUROTRANSMITTER RELEASE; BINDING-PROPERTIES; BOUND ORIENTATION; DISTINCT CA2+; C-2 DOMAINS; FUSION; CALCIUM; POSITION	The synaptic vesicle protein synaptotagmin 1 is thought to convey the calcium signal onto the core secretory machinery. Its cytosolic portion mainly consists of two C2 domains, which upon calcium binding are enabled to bind to acidic lipid bilayers. Despite major advances in recent years, it is still debated how synaptotagmin controls the process of neurotransmitter release. In particular, there is disagreement with respect to its calcium binding properties and lipid preferences. To investigate how the presence of membranes influences the calcium affinity of synaptotagmin, we have now measured these properties under equilibrium conditions using isothermal titration calorimetry and fluorescence resonance energy transfer. Our data demonstrate that the acidic phospholipid phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2), but not phosphatidylserine, markedly increases the calcium sensitivity of synaptotagmin. PI(4,5)P-2 binding is confined to the C2B domain but is not affected significantly by mutations of a lysine-rich patch. Together, our findings lend support to the view that synaptotagmin functions by binding in a trans configuration whereby the C2A domain binds to the synaptic vesicle and the C2B binds to the PI(4,5)P-2-enriched plasma membrane.	[Radhakrishnan, Anand; Stein, Alexander; Jahn, Reinhard; Fasshauer, Dirk] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany	Max Planck Society	Fasshauer, D (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, Fassberg 11, D-37077 Gottingen, Germany.	dfassha@gwdg.de	Fasshauer, Dirk/B-1563-2013; Stein, Alexander/I-4950-2012	Fasshauer, Dirk/0000-0002-1040-4282; Stein, Alexander/0000-0002-2696-0611; Jahn, Reinhard/0000-0003-1542-3498				Bai JH, 2002, P NATL ACAD SCI USA, V99, P1665, DOI 10.1073/pnas.032541099; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Catherine CR, 2005, MOL CELL NEUROSCI, V29, P462, DOI 10.1016/j.mcn.2005.03.015; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; Corbin JA, 2007, BIOCHEMISTRY-US, V46, P4322, DOI 10.1021/bi062140c; Coudevylle N, 2008, J BIOL CHEM, V283, P35918, DOI 10.1074/jbc.M804094200; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fiske CH, 1925, J BIOL CHEM, V66, P375; Frazier AA, 2003, BIOCHEMISTRY-US, V42, P96, DOI 10.1021/bi0268145; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Fuson KL, 2007, BIOCHEMISTRY-US, V46, P13041, DOI 10.1021/bi701651k; Guerrero-Valero M, 2007, J MOL BIOL, V371, P608, DOI 10.1016/j.jmb.2007.05.086; Guerrero-Valero M, 2009, P NATL ACAD SCI USA, V106, P6603, DOI 10.1073/pnas.0813099106; Herrick DZ, 2006, BIOCHEMISTRY-US, V45, P9668, DOI 10.1021/bi060874j; Hui EF, 2006, BIOPHYS J, V91, P1767, DOI 10.1529/biophysj.105.080325; LI C, 1995, J BIOL CHEM, V270, P24898, DOI 10.1074/jbc.270.42.24898; Li LY, 2006, J BIOL CHEM, V281, P15845, DOI 10.1074/jbc.M600888200; Mackler JM, 2001, J COMP NEUROL, V436, P4, DOI 10.1002/cne.1049; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Montaville P, 2008, PROTEIN SCI, V17, P1025, DOI 10.1110/ps.073326608; Naraghi M, 1997, CELL CALCIUM, V22, P255, DOI 10.1016/S0143-4160(97)90064-6; PERIN MS, 1991, J BIOL CHEM, V266, P623; POPOLI M, 1993, NEUROSCIENCE, V54, P323, DOI 10.1016/0306-4522(93)90255-E; Rickman C, 2004, J BIOL CHEM, V279, P12574, DOI 10.1074/jbc.M310710200; Rufener E, 2005, BIOCHEMISTRY-US, V44, P18, DOI 10.1021/bi048370d; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Shao XG, 1996, SCIENCE, V273, P248, DOI 10.1126/science.273.5272.248; Shao XG, 1998, BIOCHEMISTRY-US, V37, P16106, DOI 10.1021/bi981789h; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Torrecillas A, 2004, BIOCHEMISTRY-US, V43, P11727, DOI 10.1021/bi0489659; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013; Xu GY, 1998, J MOL BIOL, V280, P485, DOI 10.1006/jmbi.1998.1874; Zheng L, 2000, J BIOL CHEM, V275, P19700, DOI 10.1074/jbc.M001945200	45	84	84	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25749	25760		10.1074/jbc.M109.042499	http://dx.doi.org/10.1074/jbc.M109.042499			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19632983	Green Published, hybrid			2022-12-27	WOS:000269738000033
J	Stork, R; Campigna, E; Robert, B; Muller, D; Kontermann, RE				Stork, Roland; Campigna, Emmanuelle; Robert, Bruno; Mueller, Dafne; Kontermann, Roland E.			Biodistribution of a Bispecific Single-chain Diabody and Its Half-life Extended Derivatives	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SERUM-ALBUMIN; GENETICALLY-ENGINEERED ANTIBODIES; STREPTOCOCCAL PROTEIN-G; PHARMACOKINETIC PROPERTIES; MONOCLONAL-ANTIBODIES; BINDING DOMAIN; FV FRAGMENT; FC-RECEPTOR; AFFINITY; FUSION	Small recombinant antibody molecules such as bispecific single-chain diabodies (scDb) possessing a molecular mass of similar to 55 kDa are rapidly cleared from circulation. We have recently extended the plasma half-life of scDb applying various strategies including PEGylation, N-glycosylation and fusion to an albumin-binding domain (ABD) from streptococcal protein G. Here, we further analyzed the influence of these modifications on the biodistribution of a scDb directed against carcinoembryonic antigen (CEA) and CD3 capable of retargeting T cells to CEA-expressing tumor cells. We show that a prolonged circulation time results in an increased accumulation in CEA(+) tumors, which was most pronounced for scDb-ABD and PEGylated scDb. Interestingly, tumor accumulation of the scDb-ABD fusion protein was similar to 2-fold higher compared with PEGylated scDb, although both molecules exhibit similar plasma half-lives and similar affinities for CEA. Comparing half-lives in neonatal Fc receptor (FcRn) wild-type and FcRn heavy chain knock-out mice the contribution of the FcRn to the long plasma half-life of scDb-ABD was confirmed. The half-life of scDb-ABD was similar to 2-fold lower in the knock-out mice, while no differences were observed for PEGylated scDb. Binding of the scDb derivatives to target and effector cells was not or only marginally affected by the modifications, although, compared with scDb, a reduced cytotoxic activity was observed for scDb-ABD, which was further reduced in the presence of albumin. In summary, these findings demonstrate that the extended half-life of a bispecific scDb translates into improved accumulation in antigen-positive tumors but that modifications might also affect scDb-mediated cytotoxicity.	[Stork, Roland; Mueller, Dafne; Kontermann, Roland E.] Univ Stuttgart, Inst Zellbiol & Immunol, D-70569 Stuttgart, Germany; [Campigna, Emmanuelle; Robert, Bruno] Univ Montpellier 1, IRCM, U896, CRLC Val Aurelle Paul Lamarque, F-34298 Montpellier, France	University of Stuttgart; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM)	Kontermann, RE (corresponding author), Univ Stuttgart, Inst Zellbiol & Immunol, Allmandring 31, D-70569 Stuttgart, Germany.	roland.kontermann@izi.uni-stuttgart.de	Kontermann, Roland E./F-9263-2014; ROBERT, Bruno/AAB-7581-2020	ROBERT, Bruno/0000-0001-5573-6945; Mueller, Dafne/0000-0002-1544-3475	Deutsche Forschungsgemeinschaft [Ko1461/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (Ko1461/2).	Adams GP, 2006, CLIN CANCER RES, V12, P1599, DOI 10.1158/1078-0432.CCR-05-2217; Adams GP, 1998, CANCER RES, V58, P485; Amann M, 2009, CANCER IMMUNOL IMMUN, V58, P95, DOI 10.1007/s00262-008-0529-y; Andersen JT, 2006, EUR J IMMUNOL, V36, P3044, DOI 10.1002/eji.200636556; Asano R, 2006, CLIN CANCER RES, V12, P4036, DOI 10.1158/1078-0432.CCR-06-0059; Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; Batra SK, 2002, CURR OPIN BIOTECH, V13, P603, DOI 10.1016/S0958-1669(02)00352-X; Benedict CA, 1997, J IMMUNOL METHODS, V201, P223, DOI 10.1016/S0022-1759(96)00227-X; Borsi L, 2002, INT J CANCER, V102, P75, DOI 10.1002/ijc.10662; Chaudhury C, 2006, BIOCHEMISTRY-US, V45, P4983, DOI 10.1021/bi052628y; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Colcher D, 1998, Q J NUCL MED, V42, P225; Constantinou A, 2009, BIOCONJUGATE CHEM, V20, P924, DOI 10.1021/bc8005122; Dennis MS, 2007, CANCER RES, V67, P254, DOI 10.1158/0008-5472.CAN-06-2531; Friedrich SW, 2002, NEOPLASIA, V4, P449, DOI 10.1038/sj.neo.7900260; Johansson MU, 2002, J BIOL CHEM, V277, P8114, DOI 10.1074/jbc.M109943200; Jonsson A, 2008, PROTEIN ENG DES SEL, V21, P515, DOI 10.1093/protein/gzn028; JUWEID M, 1992, CANCER RES, V52, P5144; Kontermann RE, 2005, ACTA PHARMACOL SIN, V26, P1, DOI 10.1111/j.1745-7254.2005.00008.x; Kontermann RE, 2009, BIODRUGS, V23, P93, DOI 10.2165/00063030-200923020-00003; Kubetzko S, 2006, J BIOL CHEM, V281, P35186, DOI 10.1074/jbc.M604127200; Liao KW, 2000, GENE THER, V7, P339, DOI 10.1038/sj.gt.3301080; Linhult M, 2002, PROTEIN SCI, V11, P206, DOI 10.1110/ps.02802; Muller D, 2007, CURR OPIN MOL THER, V9, P319; Muller D, 2007, J BIOL CHEM, V282, P12650, DOI 10.1074/jbc.M700820200; Myszka DG, 1997, CURR OPIN BIOTECH, V8, P50, DOI 10.1016/S0958-1669(97)80157-7; Schlapschy M, 2007, PROTEIN ENG DES SEL, V20, P273, DOI 10.1093/protein/gzm020; Schlereth B, 2006, CANCER IMMUNOL IMMUN, V55, P503, DOI 10.1007/s00262-005-0001-1; Schlereth B, 2006, CANCER IMMUNOL IMMUN, V55, P785, DOI 10.1007/s00262-005-0082-x; SHOCKLEY TR, 1992, CANCER RES, V52, P367; Stork R, 2008, J BIOL CHEM, V283, P7804, DOI 10.1074/jbc.M709179200; Stork R, 2007, PROTEIN ENG DES SEL, V20, P569, DOI 10.1093/protein/gzm061; Tijink BM, 2008, MOL CANCER THER, V7, P2288, DOI 10.1158/1535-7163.MCT-07-2384; Wu AM, 1996, IMMUNOTECHNOLOGY, V2, P21, DOI 10.1016/1380-2933(95)00027-5; Xiong CY, 2006, PROTEIN ENG DES SEL, V19, P359, DOI 10.1093/protein/gzl020	35	78	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25612	25619		10.1074/jbc.M109.027078	http://dx.doi.org/10.1074/jbc.M109.027078			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19628871	Green Published, hybrid			2022-12-27	WOS:000269738000019
J	Kim, KK; Adelstein, RS; Kawamoto, S				Kim, Kee K.; Adelstein, Robert S.; Kawamoto, Sachiyo			Identification of Neuronal Nuclei (NeuN) as Fox-3, a New Member of the Fox-1 Gene Family of Splicing Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL STEM-CELLS; HEAVY CHAIN-B; DIAGNOSTIC HISTOPATHOLOGY; HUMAN TISSUES; MARKER NEUN; SPINAL-CORD; ADULT MICE; IN-VIVO; PROTEIN; EXPRESSION	NeuN (neuronal nuclei) is a neuron-specific nuclear protein which is identified by immunoreactivity with a monoclonal antibody, anti-NeuN. Anti-NeuN has been used widely as a reliable tool to detect most postmitotic neuronal cell types in neuroscience, developmental biology, and stem cell research fields as well as diagnostic histopathology. To date, however, the identity of its antigen, NeuN itself, has been unknown. Here, we identify NeuN as the Fox-3 gene product by providing the following evidence: 1) Mass spectrometry analysis of anti-NeuN immunoreactive protein yields the Fox-3 amino acid sequence. 2) Recombinant Fox-3 is recognized by anti-NeuN. 3) Short hairpin RNAs targeting Fox-3 mRNA down-regulate NeuN expression. 4) Fox-3 expression is restricted to neural tissues. 5) Anti-Fox-3 immunostaining and anti-NeuN immunostaining overlap completely in neuronal nuclei. We also show that a protein cross-reactive with anti-NeuN is the synaptic vesicle protein, synapsin I. Anti-NeuN recognizes synapsin I in immunoblots with one order of magnitude lower affinity than Fox-3, and does not recognize synapsin I using immunohistology. Fox-3 (also called hexaribonucleotide-binding protein 3 and D11Bwg0517e) contains an RNA recognition motif and is classified as a member of the Fox-1 gene family that binds specifically to an RNA element, UGCAUG. We demonstrate that Fox-3 functions as a splicing regulator using neural cell-specific alternative splicing of the non-muscle myosin heavy chain II-B pre-mRNA as a model. Identification of NeuN as Fox-3 clarifies an important element of neurobiology research.	[Kim, Kee K.; Adelstein, Robert S.; Kawamoto, Sachiyo] NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kawamoto, S (corresponding author), NHLBI, Mol Cardiol Lab, NIH, Bldg 10,Rm 6C209,10 Ctr Dr MSC 1762, Bethesda, MD 20892 USA.	kawamots@mail.nih.gov	Kim, Kee/F-8784-2011	Kim, Keekwang/0000-0002-1088-3383; Adelstein, Robert/0000-0002-8683-2144	Division of Intramural Research; NHLBI; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006019, ZIAHL004236, Z01HL004236, ZICHL005903, ZICHL005905] Funding Source: NIH RePORTER	Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the Division of Intramural Research, NHLBI, National Institutes of Health.	Auweter SD, 2006, EMBO J, V25, P163, DOI 10.1038/sj.emboj.7600918; Baraniak AP, 2006, MOL CELL BIOL, V26, P1209, DOI 10.1128/MCB.26.4.1209-1222.2006; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Brudno M, 2001, NUCLEIC ACIDS RES, V29, P2338, DOI 10.1093/nar/29.11.2338; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Fagel DM, 2009, J NEUROSCI, V29, P1202, DOI 10.1523/JNEUROSCI.4516-08.2009; Gauthier AS, 2007, NEURON, V54, P245, DOI 10.1016/j.neuron.2007.03.027; Gitler D, 2004, J NEUROSCI, V24, P3711, DOI 10.1523/JNEUROSCI.5225-03.2004; Goetz AK, 2006, P NATL ACAD SCI USA, V103, P11063, DOI 10.1073/pnas.0510926103; ITOH K, 1995, J BIOL CHEM, V270, P14533, DOI 10.1074/jbc.270.24.14533; Jin Y, 2003, EMBO J, V22, P905, DOI 10.1093/emboj/cdg089; Kao HT, 1998, P NATL ACAD SCI USA, V95, P4667, DOI 10.1073/pnas.95.8.4667; Kawamoto S, 1996, J BIOL CHEM, V271, P17613; Lieberman AP, 2001, BIOCHEM BIOPH RES CO, V282, P499, DOI 10.1006/bbrc.2001.4617; Lind D, 2005, J NEUROSCI RES, V79, P295, DOI 10.1002/jnr.20354; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Mar XF, 2006, MOL BIOL CELL, V17, P2138, DOI 10.1091/mbc.E05-10-0097; McKee AE, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-14; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; PHILLIPS CL, 1995, J MUSCLE RES CELL M, V16, P379, DOI 10.1007/BF00114503; Ponthier JL, 2006, J BIOL CHEM, V281, P12468, DOI 10.1074/jbc.M511556200; Preusser M, 2006, HISTOPATHOLOGY, V48, P438, DOI 10.1111/j.1365-2559.2006.02359.x; Shibata H, 2000, HUM MOL GENET, V9, P1303, DOI 10.1093/hmg/9.9.1303; Sigurjonsson OE, 2005, P NATL ACAD SCI USA, V102, P5227, DOI 10.1073/pnas.0501029102; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Unal-Cevik I, 2004, BRAIN RES, V1015, P169, DOI 10.1016/j.brainres.2004.04.032; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Weyer A, 2003, J NEUROSCI RES, V73, P400, DOI 10.1002/jnr.10655; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Wynder C, 2005, NAT CELL BIOL, V7, P1113, DOI 10.1038/ncb1312; Yang G, 2008, BLOOD, V111, P392, DOI 10.1182/blood-2007-01-068940; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zhou HL, 2007, MOL CELL BIOL, V27, P830, DOI 10.1128/MCB.01015-06	40	259	267	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31052	31061		10.1074/jbc.M109.052969	http://dx.doi.org/10.1074/jbc.M109.052969			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19713214	Green Published, hybrid			2022-12-27	WOS:000271378400034
J	Liu, WZ; Zhao, R; McFarland, C; Kieft, J; Niedzwiecka, A; Jankowska-Anyszka, M; Stepinski, J; Darzynkiewicz, E; Jones, DNM; Davis, RE				Liu, Weizhi; Zhao, Rui; McFarland, Craig; Kieft, Jeffrey; Niedzwiecka, Anna; Jankowska-Anyszka, Marzena; Stepinski, Janusz; Darzynkiewicz, Edward; Jones, David N. M.; Davis, Richard E.			Structural Insights into Parasite eIF4E Binding Specificity for m(7)G and m(2,2,7)G mRNA Caps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR 4E; SPLICED LEADER RNA; TRANSLATION INITIATION; CAENORHABDITIS-ELEGANS; PROTEIN EIF4E; ISOFORMS; RECOGNITION; AFFINITY; PHOSPHORYLATION; SIMULATION	The eukaryotic translation initiation factor eIF4E recognizes the mRNA cap, a key step in translation initiation. Here we have characterized eIF4E from the human parasite Schistosoma mansoni. Schistosome mRNAs have either the typical monomethylguanosine (m(7)G) or a trimethylguanosine (m(2,2,7)G) cap derived from spliced leader trans-splicing. Quantitative fluorescence titration analyses demonstrated that schistosome eIF4E has similar binding specificity for both caps. We present the first crystal structure of an eIF4E with similar binding specificity for m(7)G and m(2,2,7)G caps. The eIF4E.m(7) GpppG structure demonstrates that the schistosome protein binds monomethyl cap in a manner similar to that of single specificity eIF4Es and exhibits a structure similar to other known eIF4Es. The structure suggests an alternate orientation of a conserved, key Glu-90 in the cap-binding pocket that may contribute to dual binding specificity and a position for mRNA bound to eIF4E consistent with biochemical data. Comparison of NMR chemical shift perturbations in schistosome eIF4E on binding m(7)GpppG and m(2,2,7)GpppG identified key differences between the two complexes. Isothermal titration calorimetry demonstrated significant thermodynamics differences for the binding process with the two caps (m(7)Gversusm(2,2,7)G). Overall the NMR and isothermal titration calorimetry data suggest the importance of intrinsic conformational flexibility in the schistosome eIF4E that enables binding to m(2,2,7)G cap.	[Davis, Richard E.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Jones, David N. M.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [Niedzwiecka, Anna; Stepinski, Janusz; Darzynkiewicz, Edward] Univ Warsaw, Fac Phys, Inst Expt Phys, Div Biophys, PL-02089 Warsaw, Poland; [Jankowska-Anyszka, Marzena] Univ Warsaw, Fac Chem, PL-02093 Warsaw, Poland; [Niedzwiecka, Anna] Polish Acad Sci, Inst Phys, Biol Phys Grp, PL-02668 Warsaw, Poland	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Warsaw; University of Warsaw; Polish Academy of Sciences; Institute of Physics - Polish Academy of Sciences	Davis, RE (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, 12801 E 17th Ave, Aurora, CO 80045 USA.	Richard.davis@ucdenver.edu	Jones, David N/C-5764-2013; Niedzwiecka, Anna/E-8940-2010	Niedzwiecka, Anna/0000-0001-5208-0733	National Institutes of Health [AI049558, AI080805, GM081346, GM072560, GM080334]; Howard Hughes Medical Institute [55005604]; Polish Ministry of Science and Higher Education [N301-035936]; Warsaw University [BW 68/179203]; National Science Support Project [PBZ-MNiSW-07/I/2007]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049558, R03AI080805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081346, R01GM080334, R01GM072560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Warsaw University; National Science Support Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI049558 and AI080805 (to R. E. D.), GM081346 and GM072560 (to J. K.), and GM080334 (to R. Z.). This work was also supported by Howard Hughes Medical Institute Grant 55005604 (to E. D.), Polish Ministry of Science and Higher Education Grant N301-035936 (to A. N. and E. D.), Warsaw University Grant BW 68/179203 (to M. J.-A.), and a National Science Support Project Grant PBZ-MNiSW-07/I/2007 (to E. D.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Brehm K, 2000, J BIOL CHEM, V275, P38311, DOI 10.1074/jbc.M006091200; Brown CJ, 2007, J MOL BIOL, V372, P7, DOI 10.1016/j.jmb.2007.06.033; Cheng GF, 2007, MOL BIOCHEM PARASIT, V153, P95, DOI 10.1016/j.molbiopara.2007.02.003; Cohen LS, 2005, MOL CELL BIOL, V25, P8779, DOI 10.1128/MCB.25.20.8779-8791.2005; DAVIS RE, 1995, J BIOL CHEM, V270, P21813, DOI 10.1074/jbc.270.37.21813; Davis RE, 1996, PARASITOL TODAY, V12, P33, DOI 10.1016/0169-4758(96)80643-0; DAVIS RE, 1994, J BIOL CHEM, V269, P20026; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fechter P, 2005, J GEN VIROL, V86, P1239, DOI 10.1099/vir.0.80755-0; Friedland DE, 2005, BIOCHEMISTRY-US, V44, P4546, DOI 10.1021/bi047645m; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Ghosh B, 2009, ACS CHEM BIOL, V4, P367, DOI 10.1021/cb9000475; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Gu MG, 2005, CURR OPIN STRUC BIOL, V15, P99, DOI 10.1016/j.sbi.2005.01.009; Haq I, 1997, J MOL BIOL, V271, P244, DOI 10.1006/jmbi.1997.1170; Hotez P.J., 2008, EMERG INFECT DIS; Hu W, 2003, NAT GENET, V35, P139, DOI 10.1038/ng1236; Jankowska M, 1996, COLLECT CZECH CHEM C, V61, pS197; Jankowska-Anyszka M, 1998, J BIOL CHEM, V273, P10538, DOI 10.1074/jbc.273.17.10538; Joshi B, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-48; Keiper BD, 2000, J BIOL CHEM, V275, P10590, DOI 10.1074/jbc.275.14.10590; Lall S, 2004, J BIOL CHEM, V279, P45573, DOI 10.1074/jbc.M407475200; LIOU RF, 1990, MOL CELL BIOL, V10, P1764, DOI 10.1128/MCB.10.4.1764; Magee J, 2005, NUCLEIC ACIDS RES, V33, P6694, DOI 10.1093/nar/gki981; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; MARONEY PA, 1995, RNA, V1, P714; MARONEY PA, 1990, P NATL ACAD SCI USA, V87, P709, DOI 10.1073/pnas.87.2.709; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Miyoshi H, 2002, EMBO J, V21, P4680, DOI 10.1093/emboj/cdf473; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Monzingo AF, 2007, PLANT PHYSIOL, V143, P1504, DOI 10.1104/pp.106.093146; Niedzwiecka A, 2004, BIOCHEMISTRY-US, V43, P13305, DOI 10.1021/bi0491651; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; Niedzwiecka A, 2007, METHOD ENZYMOL, V430, P209, DOI 10.1016/S0076-6879(07)30009-8; PELLETIER J, 2007, TRANSLATIONAL CONTRO, P855; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Quiocho FA, 2000, CURR OPIN STRUC BIOL, V10, P78, DOI 10.1016/S0959-440X(99)00053-6; RAJKOVIC A, 1990, P NATL ACAD SCI USA, V87, P8879, DOI 10.1073/pnas.87.22.8879; Rhoads RE, 2009, J BIOL CHEM, V284, P16711, DOI 10.1074/jbc.R900002200; Rosettani P, 2007, J MOL BIOL, V368, P691, DOI 10.1016/j.jmb.2007.02.019; Ruszczynska K, 2003, BIOPHYS J, V85, P1450, DOI 10.1016/S0006-3495(03)74577-9; Rutkowska-Wlodarczyk I, 2008, BIOCHEMISTRY-US, V47, P2710, DOI 10.1021/bi701168z; Savioli L, 2004, PARASITOL INT, V53, P103, DOI 10.1016/j.parint.2004.01.001; Scheper GC, 2002, J BIOL CHEM, V277, P3303, DOI 10.1074/jbc.M103607200; SCHNEIDER RJ, 2007, TRANSLATIONAL CONTRO, P401; Seol Y, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158103; Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5; Spivak-Kroizman T, 2002, FEBS LETT, V516, P9, DOI 10.1016/S0014-5793(02)02445-6; STEPINSKI J, 1995, NUCLEOS NUCLEOT, V14, P717; Tomoo K, 2005, BBA-PROTEINS PROTEOM, V1753, P191, DOI 10.1016/j.bbapap.2005.07.023; Tomoo K, 2003, J MOL BIOL, V328, P365, DOI 10.1016/S0022-2836(03)00314-0; Tomoo K, 2002, BIOCHEM J, V362, P539, DOI 10.1042/0264-6021:3620539; Verjovski-Almeida S, 2003, NAT GENET, V35, P148, DOI 10.1038/ng1237; Volpon L, 2006, EMBO J, V25, P5138, DOI 10.1038/sj.emboj.7601380; von der Haar T, 2004, NAT STRUCT MOL BIOL, V11, P503, DOI 10.1038/nsmb779; von der Haar T, 2006, J MOL BIOL, V356, P982, DOI 10.1016/j.jmb.2005.12.034; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Yoffe Y, 2006, EUKARYOT CELL, V5, P1969, DOI 10.1128/EC.00230-06; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140; Zuberek J, 2004, BIOCHEMISTRY-US, V43, P5370, DOI 10.1021/bi030266t; Zuberek J, 2003, RNA, V9, P52, DOI 10.1261/rna.2133403	69	27	27	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31336	31349		10.1074/jbc.M109.049858	http://dx.doi.org/10.1074/jbc.M109.049858			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19710013	hybrid, Green Published			2022-12-27	WOS:000271378400060
J	Catalgol, B; Ziaja, I; Breusing, N; Jung, T; Hohn, A; Alpertunga, B; Schroeder, P; Chondrogianni, N; Gonos, ES; Petropoulos, I; Friguet, B; Klotz, LO; Krutmann, J; Grune, T				Catalgol, Betul; Ziaja, Isabella; Breusing, Nicolle; Jung, Tobias; Hoehn, Annika; Alpertunga, Buket; Schroeder, Peter; Chondrogianni, Niki; Gonos, Efstathios S.; Petropoulos, Isabelle; Friguet, Bertrand; Klotz, Lars-Oliver; Krutmann, Jean; Grune, Tilman			The Proteasome Is an Integral Part of Solar Ultraviolet A Radiation-induced Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHIONINE SULFOXIDE REDUCTASE; HUMAN DERMAL FIBROBLASTS; NF-KAPPA-B; SINGLET OXYGEN; C-JUN; OXIDIZED PROTEINS; OXIDATIVE STRESS; 26S PROTEASOME; UVA IRRADIATION; DEGRADATION	Solar ultraviolet (UV) A radiation is a well known trigger of signaling responses in human skin fibroblasts. One important consequence of this stress response is the increased expression of matrix metalloproteinase-1 (MMP-1), which causes extracellular protein degradation and thereby contributes to photoaging of human skin. In the present study we identify the proteasome as an integral part of the UVA-induced, intracellular signaling cascade in human dermal fibroblasts. UVA-induced singlet oxygen formation was accompanied by protein oxidation, the cross-linking of oxidized proteins, and an inhibition of the proteasomal system. This proteasomal inhibition subsequently led to an accumulation of c-Jun and phosphorylated c-Jun and activation of activator protein-1, i.e. transcription factors known to control MMP-1 expression. Increased transcription factor activation was also observed if the proteasome was inhibited by cross-linked proteins or lactacystin, indicating a general mechanism. Most importantly, inhibition of the proteasome was of functional relevance for UVA-induced MMP-1 expression, because overexpression of the proteasome or the protein repair enzyme methionine sulfoxide reductase prevented the UVA-induced induction of MMP-1. These studies show that an environmentally relevant stimulus can trigger a signaling pathway, which links intracellular and extracellular protein degradation. They also identify the proteasome as an integral part of the UVA stress response.	[Catalgol, Betul; Breusing, Nicolle; Jung, Tobias; Hoehn, Annika; Grune, Tilman] Univ Hohenheim, Inst Biol Chem & Nutr, D-70593 Stuttgart, Germany; [Catalgol, Betul; Alpertunga, Buket] Istanbul Univ, Fac Pharm, Dept Pharmaceut Toxicol, TR-34116 Istanbul, Turkey; [Ziaja, Isabella; Jung, Tobias; Schroeder, Peter; Klotz, Lars-Oliver; Krutmann, Jean; Grune, Tilman] Environm Med Res Inst, D-40225 Dusseldorf, Germany; [Chondrogianni, Niki; Gonos, Efstathios S.] Natl Hellen Res Fdn, Inst Biol Res & Biotechnol, Athens 11635, Greece; [Petropoulos, Isabelle; Friguet, Bertrand] Univ Paris 06, CNRS Physiol & Physiopathol 7079, F-75005 Paris, France	University Hohenheim; Istanbul University; National Hellenic Research Foundation; UDICE-French Research Universities; Sorbonne Universite	Krutmann, J (corresponding author), IUF, Aufm Hennekamp 50, D-40225 Dusseldorf, Germany.	krutmann@rz.uni-duesseldorf.de	Klotz, Lars Oliver/AAC-5051-2019; Yilmaz, Betul/AAH-9806-2021; Alpertunga, Buket/AAD-6135-2020	Klotz, Lars Oliver/0000-0002-1261-8911; Yilmaz, Betul/0000-0003-1762-0284; Hohn, Annika/0000-0003-1306-2668; Petropoulos, Isabelle/0000-0001-9205-7458; Grune, Tilman/0000-0003-4775-9973; Friguet, Bertrand/0000-0001-8085-1961; Jung, Tobias/0000-0002-9159-8444	Henkel AG; CoKGaA, Dursseldorf, Germany; Scientific and Technological Research Council of Turkey (TUBITAK); Eliteprogramme for Postdocs.; Deutsche Forschungsgemeinschaft [GK1033, SFB728/B4, SFB728/C1]; European Cooperation in Science and Technology [B35]	Henkel AG; CoKGaA, Dursseldorf, Germany; Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Eliteprogramme for Postdocs.; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Cooperation in Science and Technology(European Cooperation in Science and Technology (COST))	This work was supported by Henkel AG and CoKGaA, Dursseldorf, Germany. Supported by The Scientific and Technological Research Council of Turkey (TUBITAK). This work represents, in part, a Ph. D. thesis.; Recipient of LANDESSTIFTUNG Baden-Wurttemberg financial support of this research project by the Eliteprogramme for Postdocs.; Supported by Deutsche Forschungsgemeinschaft Grants GK1033, SFB728/B4, and SFB728/C1.; Supported by Deutsche Forschungsgemeinschaft, Bundesministerium fur r Umwelt (German Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety), and by European Cooperation in Science and Technology B35.	ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Basbous J, 2008, BIOCHIMIE, V90, P296, DOI 10.1016/j.biochi.2007.07.016; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Buss H, 1997, FREE RADICAL BIO MED, V23, P361, DOI 10.1016/S0891-5849(97)00104-4; Chondrogianni N, 2005, J BIOL CHEM, V280, P11840, DOI 10.1074/jbc.M413007200; Davies KJA, 2006, NEUROLOGY, V66, pS93, DOI 10.1212/01.wnl.0000192308.43151.63; Dean RT, 1997, BIOCHEM J, V324, P1; Demasi M, 2003, FEBS LETT, V542, P89, DOI 10.1016/S0014-5793(03)00353-3; DjavaheriMergny M, 1996, FEBS LETT, V384, P92, DOI 10.1016/0014-5793(96)00294-3; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; Fisher GJ, 1996, NATURE, V379, P335, DOI 10.1038/379335a0; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; Grune T, 2004, INT J BIOCHEM CELL B, V36, P2519, DOI 10.1016/j.biocel.2004.04.020; GRUNE T, 1995, J BIOL CHEM, V270, P2344, DOI 10.1074/jbc.270.5.2344; Grune T, 1996, J BIOL CHEM, V271, P15504, DOI 10.1074/jbc.271.26.15504; Grune T, 2001, FREE RADICAL BIO MED, V30, P1243, DOI 10.1016/S0891-5849(01)00515-9; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Hantke B, 2002, PHOTOCH PHOTOBIO SCI, V1, P826, DOI 10.1039/b207731k; Herrmann G, 1993, Exp Dermatol, V2, P92, DOI 10.1111/j.1600-0625.1993.tb00015.x; HOUGH R, 1987, J BIOL CHEM, V262, P8303; JarielEncontre I, 1997, MOL BIOL REP, V24, P51, DOI 10.1023/A:1006804723722; JARIELENCONTRE I, 1995, J BIOL CHEM, V270, P11623, DOI 10.1074/jbc.270.19.11623; Jung T, 2006, FREE RADICAL BIO MED, V40, P1303, DOI 10.1016/j.freeradbiomed.2005.11.023; Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008; Kantorow M, 2004, P NATL ACAD SCI USA, V101, P9654, DOI 10.1073/pnas.0403532101; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Klotz LO, 2003, PHOTOCH PHOTOBIO SCI, V2, P88, DOI 10.1039/b210750c; Klotz LO, 2002, BIOL CHEM, V383, P443, DOI 10.1515/BC.2002.047; Klotz LO, 1997, FEBS LETT, V408, P289, DOI 10.1016/S0014-5793(97)00440-7; Klotz LO, 2001, CURR PROBL DERMATOL, V29, P95; Klotz LO, 1999, EUR J BIOCHEM, V260, P917, DOI 10.1046/j.1432-1327.1999.00255.x; Krutmann J, 2005, SKIN AGING, P33; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUY H, 1994, PHOTODERMATOL PHOTO, V10, P126; McDuffee AT, 1997, J CELL PHYSIOL, V171, P143, DOI 10.1002/(SICI)1097-4652(199705)171:2<143::AID-JCP4>3.0.CO;2-O; Michalik A, 2004, NEUROBIOL DIS, V16, P202, DOI 10.1016/j.nbd.2003.12.020; Moskovitz J, 1998, P NATL ACAD SCI USA, V95, P14071, DOI 10.1073/pnas.95.24.14071; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Naru E, 2005, BRIT J DERMATOL, V153, P6, DOI 10.1111/j.1365-2133.2005.06964.x; Ogawa F, 2006, J INVEST DERMATOL, V126, P1128, DOI 10.1038/sj.jid.5700116; Ortega Z, 2007, CELL MOL LIFE SCI, V64, P2245, DOI 10.1007/s00018-007-7222-8; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Picot CR, 2007, EXP GERONTOL, V42, P859, DOI 10.1016/j.exger.2007.02.006; Picot CR, 2005, FREE RADICAL BIO MED, V39, P1332, DOI 10.1016/j.freeradbiomed.2005.06.017; Picot CR, 2004, FEBS LETT, V558, P74, DOI 10.1016/S0014-5793(03)01530-8; Polte T, 2004, FREE RADICAL BIO MED, V36, P1566, DOI 10.1016/j.freeradbiomed.2004.04.003; Powell SR, 2005, FREE RADICAL BIO MED, V38, P1093, DOI 10.1016/j.freeradbiomed.2005.01.003; Reinheckel T, 1998, BIOCHEM J, V335, P637, DOI 10.1042/bj3350637; Reinheckel T, 2000, ARCH BIOCHEM BIOPHYS, V377, P65, DOI 10.1006/abbi.2000.1717; Rittie L, 2005, SKIN AGING, P143; Salvat C, 1999, MOL BIOL REP, V26, P45, DOI 10.1023/A:1006960021281; Sander CS, 2002, J INVEST DERMATOL, V118, P618, DOI 10.1046/j.1523-1747.2002.01708.x; SCHARFFETTER K, 1991, ARCH DERMATOL RES, V283, P506, DOI 10.1007/BF00371923; Scharffetter-Kochanek K, 1997, BIOL CHEM, V378, P1247; SCHARFFETTERKOCHANEK K, 1993, FEBS LETT, V331, P304, DOI 10.1016/0014-5793(93)80357-Z; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Sitte N, 2000, FASEB J, V14, P1490, DOI 10.1096/fj.14.11.1490; Sitte N, 2000, FREE RADICAL BIO MED, V28, P701, DOI 10.1016/S0891-5849(99)00279-8; Sommerburg O, 1998, FREE RADICAL BIO MED, V24, P1369, DOI 10.1016/S0891-5849(98)00012-4; TSURUMI C, 1995, MOL CELL BIOL, V15, P5682; Tyrrell RM, 2004, ANTIOXID REDOX SIGN, V6, P835, DOI 10.1089/1523086041798033; Tyrrell RM, 1996, BIOESSAYS, V18, P139, DOI 10.1002/bies.950180210; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; VILE GF, 1995, PHOTOCHEM PHOTOBIOL, V62, P463, DOI 10.1111/j.1751-1097.1995.tb02369.x; von Montfort C, 2006, BIOL CHEM, V387, P1399, DOI 10.1515/BC.2006.175; Voss P, 2006, FREE RADICAL RES, V40, P673, DOI 10.1080/10715760500419357; Wan YS, 2001, CELL SIGNAL, V13, P139, DOI 10.1016/S0898-6568(00)00146-7; Wang XY, 2006, CHINESE MED J-PEKING, V119, P827, DOI 10.1097/00029330-200605020-00006; Wlaschek M, 1997, FEBS LETT, V413, P239, DOI 10.1016/S0014-5793(97)00919-8; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P1159, DOI 10.1073/pnas.0308215100	73	53	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30076	30086		10.1074/jbc.M109.044503	http://dx.doi.org/10.1074/jbc.M109.044503			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19690165	hybrid, Green Published			2022-12-27	WOS:000271090000010
J	Fan, JJ; Rone, MB; Papadopoulos, V				Fan, Jinjiang; Rone, Malena B.; Papadopoulos, Vassilios			Translocator Protein 2 Is Involved in Cholesterol Redistribution during Erythropoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL BENZODIAZEPINE-RECEPTOR; TRANSCRIPTION FACTOR GATA-1; HUMAN BREAST-CANCER; BINDING-SITES; STEROID-BIOSYNTHESIS; CELL-PROLIFERATION; MOUSE; TRANSPORT; EXPRESSION; ERYTHROBLASTS	Translocator protein (TSPO) is an 18-kDa cholesterol- and drug-binding protein conserved from bacteria to humans. While surveying for Tspo-like genes, we identified its paralogous gene, Tspo2, encoding an evolutionarily conserved family of proteins that arose by gene duplications before the divergence of avians and mammals. Comparative analysis of Tspo1 and Tspo2 functions suggested that Tspo2 has become subfunctionalized, typical of duplicated genes, characterized by the loss of diagnostic drug ligand-binding but retention of cholesterol-binding properties, hematopoietic tissue- and erythroid cell-specific distribution, and subcellular endoplasmic reticulum and nuclear membrane localization. Expression of Tspo2 in erythroblasts is strongly correlated with the down-regulation of the enzymes involved in cholesterol biosynthesis. Overexpression of TSPO2 in erythroid cells resulted in the redistribution of intracellular free cholesterol, an essential step in nucleus expulsion during erythrocyte maturation. Taken together, these data identify the TSPO2 family of proteins as mediators of cholesterol redistribution-dependent erythroblast maturation during mammalian erythropoiesis.	[Papadopoulos, Vassilios] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ H3H 2R9, Canada; McGill Univ, Dept Med, Montreal, PQ H3A 1A4, Canada; McGill Univ, Dept Biochem, Montreal, PQ H3A 1A4, Canada; McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3A 1A4, Canada	McGill University; McGill University; McGill University; McGill University	Papadopoulos, V (corresponding author), McGill Univ, Res Inst, Ctr Hlth, 2155 Guy St,5th Floor, Montreal, PQ H3H 2R9, Canada.	vassilios.papadopoulos@mcgill.ca	Fan, Jinjiang/C-2010-2009; Papadopoulos, Vassilios/AAI-2613-2019	Fan, Jinjiang/0000-0003-3102-4833; Papadopoulos, Vassilios/0000-0002-1183-8568	National Institutes of Health [HD37031, ES07747]; Canada Research Chair in Biochemical Pharmacology; Le Fonds de la Recherche en Sante du Quebec; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Research Chair in Biochemical Pharmacology; Le Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants HD37031 and ES07747. This work was also supported by a Canada Research Chair in Biochemical Pharmacology ( to V. P.). The Research Institute of the McGill University Health Center was supported by a center grant from Le Fonds de la Recherche en Sante du Quebec.	ANDERSON KP, 1995, MOL CELL BIOL, V15, P5957; [Anonymous], 2005, PHYLIP PHYLOGENY INF; Azarashvili T, 2007, CELL CALCIUM, V42, P27, DOI 10.1016/j.ceca.2006.11.004; BOLGER GT, 1985, BRAIN RES, V338, P366, DOI 10.1016/0006-8993(85)90170-2; BRODSKY I, 1966, CANCER RES, V26, P198; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Delavoie F, 2003, BIOCHEMISTRY-US, V42, P4506, DOI 10.1021/bi0267487; Donohue TJ, 1997, P NATL ACAD SCI USA, V94, P4821, DOI 10.1073/pnas.94.10.4821; Gavish M, 1999, PHARMACOL REV, V51, P629; Hardwick M, 1999, CANCER RES, V59, P831; Hauet T, 2005, MOL ENDOCRINOL, V19, P540, DOI 10.1210/me.2004-0307; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Holm TM, 2002, BLOOD, V99, P1817, DOI 10.1182/blood.V99.5.1817; Hui C, 2006, CELL SIGNAL, V18, P1844, DOI 10.1016/j.cellsig.2006.04.006; Infante RE, 2008, J BIOL CHEM, V283, P1064, DOI 10.1074/jbc.M707944200; ITO E, 1993, NATURE, V362, P466, DOI 10.1038/362466a0; JosephLiauzun E, 1997, J BIOL CHEM, V272, P28102, DOI 10.1074/jbc.272.44.28102; Keller MA, 2006, PHYSIOL GENOMICS, V28, P114, DOI 10.1152/physiolgenomics.00055.2006; Komor M, 2005, STEM CELLS, V23, P1154, DOI 10.1634/stemcells.2004-0171; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lacapere JJ, 2001, BIOCHEM BIOPH RES CO, V284, P536, DOI 10.1006/bbrc.2001.4975; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Li H, 2001, P NATL ACAD SCI USA, V98, P1267, DOI 10.1073/pnas.031461598; Li W, 2007, BIOCHEM PHARMACOL, V73, P491, DOI 10.1016/j.bcp.2006.10.025; Lindemann P, 2004, PLANT CELL PHYSIOL, V45, P723, DOI 10.1093/pcp/pch088; Liu J, 2006, J BIOL CHEM, V281, P38879, DOI 10.1074/jbc.M608820200; Meurs I, 2005, EXP HEMATOL, V33, P1309, DOI 10.1016/j.exphem.2005.07.004; Molineux G, 2006, ERYTHROPOIETINS ERYT; MONTFOORT A, 1978, LIPIDS, V13, P580, DOI 10.1007/BF02535819; Moritz KM, 1997, AM J PHYSIOL-REG I, V273, pR1829, DOI 10.1152/ajpregu.1997.273.6.R1829; MURPHY DB, 1986, J CELL BIOL, V102, P628, DOI 10.1083/jcb.102.2.628; Nakazawa F, 2009, GENE EXPR PATTERNS, V9, P114, DOI 10.1016/j.gep.2008.09.005; OLSON JMM, 1988, EUR J PHARMACOL, V152, P47, DOI 10.1016/0014-2999(88)90834-5; PAPADOPOULOS V, 1990, J BIOL CHEM, V265, P3772; Papadopoulos V, 2006, NEUROSCIENCE, V138, P749, DOI 10.1016/j.neuroscience.2005.05.063; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Reiner S, 2005, BIOCHEM SOC T, V33, P1186, DOI 10.1042/BST0331186; Rone MB, 2009, BIOCHEMISTRY-US, V48, P6909, DOI 10.1021/bi900854z; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; SASAKI K, 1982, ARCH HISTOL JAPON, V45, P247, DOI 10.1679/aohc.45.247; Shalev H, 2007, AM J HEMATOL, V82, P199, DOI 10.1002/ajh.20804; Simos G, 1996, J BIOL CHEM, V271, P12617, DOI 10.1074/jbc.271.21.12617; Snyder MJ, 1998, CELL TISSUE RES, V294, P161, DOI 10.1007/s004410051166; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; TAKETANI S, 1994, J BIOL CHEM, V269, P7527; VERMA A, 1987, P NATL ACAD SCI USA, V84, P2256, DOI 10.1073/pnas.84.8.2256; Wakabayashi J, 2003, GENES CELLS, V8, P619, DOI 10.1046/j.1365-2443.2003.00658.x; WHITELAW E, 1990, MOL CELL BIOL, V10, P6596, DOI 10.1128/MCB.10.12.6596; Woods MJ, 1996, BIOCHEM PHARMACOL, V52, P1805, DOI 10.1016/S0006-2952(96)00558-8; Yeliseev AA, 1997, P NATL ACAD SCI USA, V94, P5101, DOI 10.1073/pnas.94.10.5101; YELISEEV AA, 1995, J BIOL CHEM, V270, P21167, DOI 10.1074/jbc.270.36.21167; ZAVALA F, 1991, BIOCHEM BIOPH RES CO, V176, P1577, DOI 10.1016/0006-291X(91)90468-M	53	68	70	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30484	30497		10.1074/jbc.M109.029876	http://dx.doi.org/10.1074/jbc.M109.029876			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19729679	Green Published, hybrid			2022-12-27	WOS:000271090000051
J	Pick, H; Etter, S; Baud, O; Schmauder, R; Bordoli, L; Schwede, T; Vogel, H				Pick, Horst; Etter, Sylvain; Baud, Olivia; Schmauder, Ralf; Bordoli, Lorenza; Schwede, Torsten; Vogel, Horst			Dual Activities of Odorants on Olfactory and Nuclear Hormone Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ESTROGEN-RECEPTOR; FUNCTIONAL EXPRESSION; MOLECULAR-BASIS; PROGESTERONE-RECEPTORS; CRYSTAL-STRUCTURE; BINDING AFFINITY; STRUCTURAL BASIS; ER-ALPHA; LIGAND; PREDICTION	We have screened an odorant compound library and discovered molecules acting as chemical signals that specifically activate both G-protein-coupled olfactory receptors (ORs) on the cell surface of olfactory sensory neurons and the human nuclear estrogen receptor alpha (ER) involved in transcriptional regulation of cellular differentiation and proliferation in a wide variety of tissues. Hence, these apparent dual active odorants induce distinct signal transduction pathways at different subcellular localizations, which affect both neuronal signaling, resulting in odor perception, and the ER-dependent transcriptional control of specific genes. We demonstrate these effects using fluorescence-based in vitro and cellular assays. Among these odorants, we have identified synthetic sandalwood compounds, an important class of molecules used in the fragrance industry. For one estrogenic odorant we have also identified the cognate OR. This prompted us to compare basic molecular recognition principles of odorants on the two structurally and apparent functionally non-related receptors using computational modeling in combination with functional assays. Faced with the increasing evidence that ORs may perform chemosensory functions in a number of tissues outside of the nasal olfactory epithelium, the unraveling of these molecular ligand-receptor interaction principles is of critical importance. In addition the evidence that certain olfactory sensory neurons naturally co-express ORs and ERs may provide a direct functional link between the olfactory and hormonal systems in humans. Our results are therefore useful for defining the structural and functional characteristics of ER-specific odorants and the role of odorant molecules in cellular processes other than olfaction.	[Pick, Horst; Etter, Sylvain; Baud, Olivia; Schmauder, Ralf; Vogel, Horst] Ecole Polytech Fed Lausanne, Inst Sci & Ingenierie Chim, CH-1015 Lausanne, Switzerland; [Bordoli, Lorenza; Schwede, Torsten] Univ Basel, Swiss Inst Bioinformat, Biozentrum, CH-4056 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; University of Basel	Vogel, H (corresponding author), Ecole Polytech Fed Lausanne, Inst Sci & Ingenierie Chim, CH-1015 Lausanne, Switzerland.	Horst.Vogel@epfl.ch	Schwede, Torsten/A-4650-2008; Vogel, Horst/AAJ-5490-2021	Schwede, Torsten/0000-0003-2715-335X; Schmauder, Ralf/0000-0002-8441-4264	SystemsX program of the Swiss National Science Foundation; Ecole Polytechnique Fe de rale de Lausaunne	SystemsX program of the Swiss National Science Foundation(Swiss National Science Foundation (SNSF)); Ecole Polytechnique Fe de rale de Lausaunne	This work was supported by the SystemsX program of the Swiss National Science Foundation and by internal grants of the Ecole Polytechnique Fe de rale de Lausaunne.	Abaffy T, 2007, J BIOL CHEM, V282, P1216, DOI 10.1074/jbc.M609355200; Abdelrahim M, 2006, CANCER RES, V66, P2459, DOI 10.1158/0008-5472.CAN-05-3132; Anstead GM, 1997, STEROIDS, V62, P268, DOI 10.1016/S0039-128X(96)00242-5; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; Barni T, 1999, J CLIN ENDOCR METAB, V84, P4266, DOI 10.1210/jc.84.11.4266; Bieri S, 2004, CHEM SENSES, V29, P483, DOI 10.1093/chemse/bjh050; Bissantz C, 2004, J CHEM INF COMP SCI, V44, P1162, DOI 10.1021/ci034181a; Blair RM, 2000, TOXICOL SCI, V54, P138, DOI 10.1093/toxsci/54.1.138; Brown MB, 2006, DRUG DELIV, V13, P175, DOI 10.1080/10717540500455975; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Burger L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100203; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CRAMER CJ, 1992, J COMPUT AID MOL DES, V6, P629, DOI 10.1007/BF00126219; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Doszczak L, 2007, ANGEW CHEM INT EDIT, V46, P3367, DOI 10.1002/anie.200605002; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Fang H, 2000, ENVIRON HEALTH PERSP, V108, P723, DOI 10.1289/ehp.00108723; Feige JN, 2005, J BIOL CHEM, V280, P17880, DOI 10.1074/jbc.M500786200; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Floriano WB, 2004, CHEM SENSES, V29, P269, DOI 10.1093/chemse/bjh030; Fukuda N, 2004, J CELL SCI, V117, P5835, DOI 10.1242/jcs.01507; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Howes MJR, 2002, J PHARM PHARMACOL, V54, P1521, DOI 10.1211/002235702216; Htun H, 1999, MOL BIOL CELL, V10, P471, DOI 10.1091/mbc.10.2.471; Jacquier V, 2006, P NATL ACAD SCI USA, V103, P14325, DOI 10.1073/pnas.0603942103; Jacquier V, 2006, J NEUROCHEM, V97, P537, DOI 10.1111/j.1471-4159.2006.03771.x; Jankevics H, 2005, BIOCHEMISTRY-US, V44, P11676, DOI 10.1021/bi050744v; Kaminski RM, 2006, J PHARMACOL EXP THER, V317, P694, DOI 10.1124/jpet.105.098319; Katada S, 2005, J NEUROSCI, V25, P1806, DOI 10.1523/jneurosci.4723-04.2005; Kraft P, 2000, ANGEW CHEM INT EDIT, V39, P2981; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Likhite VS, 2006, MOL ENDOCRINOL, V20, P3120, DOI 10.1210/me.2006-0068; Lill MA, 2006, CHEMMEDCHEM, V1, P73, DOI 10.1002/cmdc.200500024; Man O, 2004, PROTEIN SCI, V13, P240, DOI 10.1110/ps.03296404; Matsuda K, 2008, J CELL BIOCHEM, V103, P136, DOI 10.1002/jcb.21393; Meegan MJ, 2007, J ENZYM INHIB MED CH, V22, P655, DOI 10.1080/14756360701503232; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Mueller SO, 2004, ANAL BIOANAL CHEM, V378, P582, DOI 10.1007/s00216-003-2238-x; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pick H, 2007, J MOL BIOL, V374, P1213, DOI 10.1016/j.jmb.2007.10.007; Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; REESE JC, 1992, J BIOL CHEM, V267, P9868; Rimkus GG, 1996, CHEMOSPHERE, V33, P2033, DOI 10.1016/0045-6535(96)00321-9; Romanelli RG, 2004, J BIOL CHEM, V279, P117, DOI 10.1074/jbc.M307955200; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schiniedeberg K, 2007, J STRUCT BIOL, V159, P400, DOI 10.1016/j.jsb.2007.04.013; Schreurs RHMM, 2002, TOXICOL APPL PHARM, V183, P1, DOI 10.1006/taap.2002.9458; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shepherd GM, 2006, NATURE, V444, P316, DOI 10.1038/nature05405; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shiau AK, 2002, NAT STRUCT BIOL, V9, P359, DOI 10.1038/nsb787; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Stenoien DL, 2001, MOL CELL BIOL, V21, P4404, DOI 10.1128/MCB.21.13.4404-4412.2001; Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998; Terasaki M, 2009, ENVIRON TOXICOL CHEM, V28, P204, DOI 10.1897/08-225.1; Touhara K, 2007, NEUROCHEM INT, V51, P132, DOI 10.1016/j.neuint.2007.05.020; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; van Lipzig MMH, 2004, J MED CHEM, V47, P1018, DOI 10.1021/jm0309607; Vedani A, 2005, J MED CHEM, V48, P3700, DOI 10.1021/jm050185q; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Yamasaki K, 2003, TOXICOL LETT, V142, P119, DOI 10.1016/S0378-4274(03)00019-5; Zozulya S, 2001, GENOME BIOL, V2	74	15	16	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30547	30555		10.1074/jbc.M109.040964	http://dx.doi.org/10.1074/jbc.M109.040964			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19723634	hybrid, Green Published			2022-12-27	WOS:000271090000057
J	Wang, LW; Leonhard-Melief, C; Haltiwanger, RS; Apte, SS				Wang, Lauren W.; Leonhard-Melief, Christina; Haltiwanger, Robert S.; Apte, Suneel S.			Post-translational Modification of Thrombospondin Type-1 Repeats in ADAMTS-like 1/Punctin-1 by C-Mannosylation of Tryptophan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-FUCOSYLATION; CARTILAGE DEGRADATION; EXTRACELLULAR-MATRIX; RNASE 2; PROTEIN; FAMILY; AGGRECANASE; METALLOPROTEASES; GLYCOSYLATION; GLYCOPROTEIN	Protein C-mannosylation is the attachment of alpha-mannopyranose to tryptophan via a C-C linkage. This post-translational modification typically occurs within the sequence motif WXXW, which is frequently present in thrombospondin type-1 repeats (TSRs). TSRs are especially numerous in and a defining feature of the ADAMTS superfamily. We investigated the presence and functional significance of C-mannosylation of ADAMTS-like 1/punctin-1, which contains four TSRs (two with predicted C-mannosylation sites), using mass spectrometry, metabolic labeling, site-directed mutagenesis, and expression in C-mannosylation-defective Chinese hamster ovary cell variants. Analysis of tryptic fragments of recombinant human punctin-1 by mass spectrometry identified a peptide derived from TSR1 containing the (36)WDAWGPWSECSRTC(49) sequence of interest modified with two mannose residues and a Glc-Fuc disaccharide (O-fucosylation). Tandem mass spectrometry (MS/MS) and MS/MS/MS analysis demonstrated the characteristic cross-ring cleavage of C-mannose and identified the modified residues as Trp(39) and Trp(42). C-Mannosylation of TSR1 of the related protease ADAMTS5 was also identified. Metabolic labeling of CHO-K1 cells or Lec35.1 cells demonstrated incorporation of D-[2,6-H-3] mannose in secreted punctin-1 from CHO-K1 cells but not Lec35.1 cells. Quantitation of punctin-1 secretion in Lec35.1 cells versus CHO-K1 cells suggested decreased secretion in Lec35.1 cells. Replacement of mannosylated Trp residues in TSR1 with either Ala or Phe affected punctin secretion efficiency. These data demonstrate that TSR1 from punctin-1 carries C-mannosylation in close proximity to O-linked fucose. Together, these modifications appear to provide a quality control mechanism for punctin-1 secretion.	[Wang, Lauren W.; Apte, Suneel S.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA; [Leonhard-Melief, Christina; Haltiwanger, Robert S.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Cleveland Clinic Foundation; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Apte, SS (corresponding author), Cleveland Clin, Dept Biomed Engn, 9500 Euclid Ave, Cleveland, OH 44195 USA.	aptes@ccf.org		Apte, Suneel/0000-0001-8441-1226	National Institutes of Health [AR49930, AR53890]; NATIONAL CANCER INSTITUTE [R01CA123071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049930, R56AR049930, R01AR053890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR49930 and AR53890 ( to S. S. A.) and CA12307101 ( to R. S. H.).	Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; Ahram D, 2009, AM J HUM GENET, V84, P274, DOI 10.1016/j.ajhg.2009.01.007; Anand M, 2001, MOL BIOL CELL, V12, P487, DOI 10.1091/mbc.12.2.487; Apte SS, 2004, INT J BIOCHEM CELL B, V36, P981, DOI 10.1016/j.biocel.2004.01.014; Arner EC, 2002, CURR OPIN PHARMACOL, V2, P322, DOI 10.1016/S1471-4892(02)00148-0; de Peredo AG, 2002, MOL CELL PROTEOMICS, V1, P11, DOI 10.1074/mcp.M100011-MCP200; Doucey MA, 1999, GLYCOBIOLOGY, V9, P435, DOI 10.1093/glycob/9.5.435; Doucey MA, 1998, MOL BIOL CELL, V9, P291, DOI 10.1091/mbc.9.2.291; Furmanek A, 2003, BIOCHEMISTRY-US, V42, P8452, DOI 10.1021/bi034112p; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Hall NG, 2003, MATRIX BIOL, V22, P501, DOI 10.1016/S0945-053X(03)00075-1; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hirohata S, 2002, J BIOL CHEM, V277, P12182, DOI 10.1074/jbc.M109665200; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; Hofsteenge J, 1999, J BIOL CHEM, V274, P32786, DOI 10.1074/jbc.274.46.32786; HOFSTEENGE J, 1994, BIOCHEMISTRY-US, V33, P13524, DOI 10.1021/bi00250a003; Hurskainen TL, 1999, J BIOL CHEM, V274, P25555, DOI 10.1074/jbc.274.36.25555; Julenius K, 2007, GLYCOBIOLOGY, V17, P868, DOI 10.1093/glycob/cwm050; Koo BH, 2007, MATRIX BIOL, V26, P431, DOI 10.1016/j.matbio.2007.03.003; Kozma K, 2006, J BIOL CHEM, V281, P36742, DOI 10.1074/jbc.M605912200; Krieg J, 1998, MOL BIOL CELL, V9, P301, DOI 10.1091/mbc.9.2.301; Krieg J, 1997, J BIOL CHEM, V272, P26687, DOI 10.1074/jbc.272.42.26687; Le Goff C, 2008, NAT GENET, V40, P1119, DOI 10.1038/ng.199; Luo Y, 2006, J BIOL CHEM, V281, P9385, DOI 10.1074/jbc.M511974200; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Perez-Vilar J, 2004, GLYCOBIOLOGY, V14, P325, DOI 10.1093/glycob/cwh041; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; Sato T, 2006, GLYCOBIOLOGY, V16, P1194, DOI 10.1093/glycob/cwl035; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Stone K. L., 1993, PRACTICAL GUIDE PROT, P43; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121	34	70	73	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30004	30015		10.1074/jbc.M109.038059	http://dx.doi.org/10.1074/jbc.M109.038059			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19671700	Green Published, hybrid			2022-12-27	WOS:000271090000002
J	Dela Cruz, CS; Viswanathan, SR; El-Guindy, AS; Shedd, D; Miller, G				Dela Cruz, Charles S.; Viswanathan, Srinivas R.; El-Guindy, Ayman S.; Shedd, Duane; Miller, George			Complex N-Linked Glycans on Asn-89 of Kaposi Sarcoma Herpes Virus-encoded Interleukin-6 Mediate Optimal Function by Affecting Cytokine Protein Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL INTERLEUKIN-6; GP130; CELLS; HOMOLOG; MIMICRY; GLYCOSYLATION; ACTIVATION; EXPRESSION; GENES; ROLES	Kaposi sarcoma-associated herpesvirus-encoded interleukin-6 (vIL-6) and its human cellular homologue (huIL-6) share similar biological functions. Our previous work showed that N-linked glycosylation was required for optimal function of vIL6 but not huIL-6 (1). Here we describe heterogeneity in the composition of the glycans of the two N-linked sites of vIL-6. The Asn-89 site of vIL-6, found to be required for optimal cytokine function, is composed of complex glycans. The Asn-78 site is composed of high mannose glycans, which are dispensable for cytokine function. N-Linked glycosylation at the Asn-89 site was required for intracellular production of functional vIL-6, but endoglycosidase-mediated removal of N-linked glycans from secreted vIL-6 did not impair protein function. With the use of a conformation-specific antibody and tryptic digestion assays, we showed that glycosylation at the Asn-89 site of vIL-6 affected protein conformation. Human IL-6, but not vIL-6, requires IL-6R alpha for binding to gp130. We tested the hypothesis that the Asn-89 complex glycan of vIL-6 alone was sufficient to confer binding to gp130 independently of IL-6R alpha. Two mutants of huIL-6, made to contain additional complex N-linked glycans in the region that interacts with IL-6R alpha, did not confer binding to gp130 independently of IL-6R alpha. Our findings support the conclusion that complex glycans on Asn-89 of vIL-6 specifically promote a protein conformation that allows the viral cytokine to bind gp130 independently of IL-6R alpha.	[Shedd, Duane; Miller, George] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; [Viswanathan, Srinivas R.; El-Guindy, Ayman S.; Miller, George] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Miller, George] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; [Dela Cruz, Charles S.] Yale Univ, Sch Med, Dept Pulm & Crit Care Internal Med, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University	Miller, G (corresponding author), Yale Univ, Sch Med, Dept Pediat, Rm 420 LSOG,333 Cedar St, New Haven, CT 06520 USA.	george.miller@yale.edu	Viswanathan, Srinivas/ABA-6316-2021	Viswanathan, Srinivas/0000-0003-1856-3023	National Institutes of Health [CA16038, CA12055]; NATIONAL CANCER INSTITUTE [R37CA012055, P01CA016038, R01CA012055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA16038 and CA12055 (to G. M.).	ADAM N, 2009, J VIROLOGY; Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Aoki Y, 2001, BLOOD, V98, P3042, DOI 10.1182/blood.V98.10.3042; Boulanger MJ, 2004, J MOL BIOL, V335, P641, DOI 10.1016/j.jmb.2003.10.070; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Burger R, 1998, BLOOD, V91, P1858, DOI 10.1182/blood.V91.6.1858.1858_1858_1863; Chang PJ, 2002, J VIROL, V76, P3168, DOI 10.1128/JVI.76.7.3168-3178.2002; Chatterjee M, 2002, SCIENCE, V298, P1432, DOI 10.1126/science.1074883; Chen DM, 2006, J VIROL, V80, P9811, DOI 10.1128/JVI.00872-06; Chen DM, 2009, J VIROL, V83, P722, DOI 10.1128/JVI.01517-08; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; Dela Cruz CS, 2004, J EXP MED, V199, P503, DOI 10.1084/jem.20031205; Deng HY, 2002, BLOOD, V100, P1919, DOI 10.1182/blood-2002-01-0015; El-Guindy AS, 2002, J VIROL, V76, P11199, DOI 10.1128/JVI.76.22.11199-11208.2002; Ellgaard L, 2001, CURR OPIN CELL BIOL, V13, P431, DOI 10.1016/S0955-0674(00)00233-7; Harrison RL, 2006, ADV VIRUS RES, V68, P159, DOI 10.1016/S0065-3527(06)68005-6; Hideshima T, 2000, CLIN CANCER RES, V6, P1180; High S, 2000, FEBS LETT, V476, P38, DOI 10.1016/S0014-5793(00)01666-5; Hoischen SH, 2000, EUR J BIOCHEM, V267, P3604, DOI 10.1046/j.1432-1327.2000.01389.x; Jones KD, 1999, BLOOD, V94, P2871; Meads MB, 2004, J BIOL CHEM, V279, P51793, DOI 10.1074/jbc.M407382200; Molden J, 1997, J BIOL CHEM, V272, P19625, DOI 10.1074/jbc.272.31.19625; Moore PS, 1996, SCIENCE, V274, P1739, DOI 10.1126/science.274.5293.1739; Nicholas J, 1997, NAT MED, V3, P287, DOI 10.1038/nm0397-287; Nicholas J, 2007, FRONT BIOSCI-LANDMRK, V12, P265, DOI 10.2741/2063; Osborne J, 1999, HUM IMMUNOL, V60, P921, DOI 10.1016/S0198-8859(99)00083-X; Papanicolaou DA, 1998, ANN INTERN MED, V128, P127, DOI 10.7326/0003-4819-128-2-199801150-00009; Pati S, 2001, J VIROL, V75, P8660, DOI 10.1128/JVI.75.18.8660-8673.2001; Simpson RJ, 1997, PROTEIN SCI, V6, P929, DOI 10.1002/pro.5560060501; Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797	31	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29269	29282		10.1074/jbc.M109.039115	http://dx.doi.org/10.1074/jbc.M109.039115			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19690161	Green Published, hybrid			2022-12-27	WOS:000270896800006
J	Lim, SK; Ju, JH; Zazopoulos, E; Jiang, H; Seo, JW; Chen, YH; Feng, ZY; Rajski, SR; Farnet, CM; Shen, B				Lim, Si-Kyu; Ju, Jianhua; Zazopoulos, Emmanuel; Jiang, Hui; Seo, Jeong-Woo; Chen, Yihua; Feng, Zhiyang; Rajski, Scott R.; Farnet, Chris M.; Shen, Ben			iso-Migrastatin, Migrastatin, and Dorrigocin Production in Streptomyces platensis NRRL 18993 Is Governed by a Single Biosynthetic Machinery Featuring an Acyltransferase-less Type I Polyketide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION INHIBITORS; GENE-CLUSTER; MOLECULAR CHARACTERIZATION; LACTIMIDOMYCIN; SYNTHETASE; CONGENERS; PROTEIN; KETOREDUCTASE; DISCOVERY; DISCRETE	iso-Migrastatin and related glutarimide-containing polyketides are potent inhibitors of tumor cell migration and their implied potential as antimetastatic agents for human cancers has garnered significant attention. Genome scanning of Streptomyces platensis NRRL 18993 unveiled two candidate gene clusters (088D and mgs); each encodes acyltransferase-less type I polyketide synthases commensurate with iso-migrastatin biosynthesis. Both clusters were inactivated by lambda-RED-mediated PCR-targeting mutagenesis in S. platensis; iso-migrastatin production was completely abolished in the Delta mgsF mutant SB11012 strain, whereas inactivation of 088D-orf7 yielded the SB11006 strain that exhibited no discernible change in iso-migrastatin biosynthesis. These data indicate that iso-migrastatin production is governed by the mgs cluster. Systematic gene inactivation allowed determination of the precise boundaries of the mgs cluster and the essentiality of the genes within the mgs cluster in iso-migrastatin production. The mgs cluster consists of 11 open reading frames that encode three acyltransferase-less type I polyketide synthases (MgsEFG), one discrete acyltransferase (MgsH), a type II thioesterase (MgsB), three post-PKS tailoring enzymes (MgsIJK), two glutarimide biosynthesis enzymes (MgsCD), and one regulatory protein (MgsA). A model for iso-migrastatin biosynthesis is proposed based on functional assignments derived from bioinformatics and is further supported by the results of in vivo gene inactivation experiments.	[Shen, Ben] Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, Madison, WI 53705 USA; [Shen, Ben] Univ Wisconsin, Natl Cooperat Drug Discovery Grp, Madison, WI 53705 USA; [Shen, Ben] Univ Wisconsin, Dept Chem, Madison, WI 53705 USA; [Zazopoulos, Emmanuel; Farnet, Chris M.] Thall Pharmaceut Inc, Montreal, PQ H4S 2C8, Canada	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Shen, B (corresponding author), Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, 777 Highland Ave, Madison, WI 53705 USA.	bshen@pharmacy.wisc.edu	Farnet, Chris/ABE-5463-2021; Seo, Jung-Hun/G-2659-2012	Seo, Jung-Hun/0000-0002-5039-2503; Farnet, Chris/0000-0003-4927-198X	National Institutes of Health [CA106150, CA113297]; NATIONAL CANCER INSTITUTE [R01CA106150, U19CA113297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA106150 and CA113297.	Anton N, 2004, J BACTERIOL, V186, P2567, DOI 10.1128/JB.186.9.2567-2575.2004; Aparicio JF, 1996, GENE, V169, P9, DOI 10.1016/0378-1119(95)00800-4; Boissier F, 2006, J BIOL CHEM, V281, P4434, DOI 10.1074/jbc.M510250200; Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5; Bruntner C, 1999, MOL GEN GENET, V262, P102; Butler AR, 1999, CHEM BIOL, V6, P287, DOI 10.1016/S1074-5521(99)80074-X; Caffrey P, 2003, CHEMBIOCHEM, V4, P654, DOI 10.1002/cbic.200300581; Chater KF, 2006, PHILOS T R SOC B, V361, P761, DOI 10.1098/rstb.2005.1758; Chen XH, 2006, J BACTERIOL, V188, P4024, DOI 10.1128/JB.00052-06; Chen Y, 2008, J BACTERIOL, V190, P5587, DOI 10.1128/JB.00592-08; Cheng YQ, 2009, METHOD ENZYMOL, V459, P165, DOI 10.1016/S0076-6879(09)04608-4; Cheng YQ, 2003, P NATL ACAD SCI USA, V100, P3149, DOI 10.1073/pnas.0537286100; Christiansen G, 2008, MOL BIOL EVOL, V25, P1695, DOI 10.1093/molbev/msn120; Doi-Katayama Y, 2000, J ANTIBIOT, V53, P484, DOI 10.7164/antibiotics.53.484; FERNANDEZMORENO MA, 1991, CELL, V66, P769, DOI 10.1016/0092-8674(91)90120-N; Gaul C, 2004, J AM CHEM SOC, V126, P11326, DOI 10.1021/ja048779q; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Heathcole ML, 2001, CHEM BIOL, V8, P207, DOI 10.1016/S1074-5521(01)00002-3; Ju JH, 2005, J AM CHEM SOC, V127, P11930, DOI 10.1021/ja053118u; Ju JH, 2005, J AM CHEM SOC, V127, P1622, DOI 10.1021/ja043808i; Ju JH, 2008, BIOORG MED CHEM LETT, V18, P5951, DOI 10.1016/j.bmcl.2008.07.072; Ju J, 2007, ORG LETT, V9, P5183, DOI 10.1021/ol702249g; Ju JH, 2006, ORG LETT, V8, P5865, DOI 10.1021/ol062470p; Ju JH, 2009, J AM CHEM SOC, V131, P1370, DOI 10.1021/ja808462p; KARWOWSKI JP, 1994, J ANTIBIOT, V47, P862, DOI 10.7164/antibiotics.47.862; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Korman TP, 2004, BIOCHEMISTRY-US, V43, P14529, DOI 10.1021/bi048133a; Larsen TM, 1999, BIOCHEMISTRY-US, V38, P16146, DOI 10.1021/bi9915768; Mao YQ, 1999, CHEM BIOL, V6, P251, DOI 10.1016/S1074-5521(99)80040-4; Miller MT, 2002, P NATL ACAD SCI USA, V99, P14752, DOI 10.1073/pnas.232361199; Miller MT, 2001, NAT STRUCT BIOL, V8, P684, DOI 10.1038/90394; Nakae K, 2000, J ANTIBIOT, V53, P1130, DOI 10.7164/antibiotics.53.1130; Nguyen T, 2008, NAT BIOTECHNOL, V26, P225, DOI 10.1038/nbt1379; Njardarson JT, 2004, J AM CHEM SOC, V126, P1038, DOI 10.1021/ja039714a; Partida-Martinez LP, 2007, CHEMBIOCHEM, V8, P41, DOI 10.1002/cbic.200600393; Piel J, 2004, ENVIRON MICROBIOL, V6, P921, DOI 10.1111/j.1462-2920.2004.00531.x; Reid R, 2003, BIOCHEMISTRY-US, V42, P72, DOI 10.1021/bi0268706; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez C, 2001, CHEM BIOL, V8, P725, DOI 10.1016/S1074-5521(01)00047-3; Shan DD, 2005, P NATL ACAD SCI USA, V102, P3772, DOI 10.1073/pnas.0500658102; Shen B, 2007, ACS SYM SER, V955, P154; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; SUGAWARA K, 1992, J ANTIBIOT, V45, P1433, DOI 10.7164/antibiotics.45.1433; Tang GL, 2004, CHEM BIOL, V11, P33, DOI 10.1016/j.chembiol.2003.12.014; Tang GL, 2007, J BIOL CHEM, V282, P20273, DOI 10.1074/jbc.M702814200; Tang L, 1996, MOL MICROBIOL, V22, P801, DOI 10.1046/j.1365-2958.1996.01528.x; White J, 1997, J BACTERIOL, V179, P627, DOI 10.1128/jb.179.3.627-633.1997; Wietzorrek A, 1997, MOL MICROBIOL, V25, P1181, DOI 10.1046/j.1365-2958.1997.5421903.x; Woo EJ, 2002, J ANTIBIOT, V55, P141, DOI 10.7164/antibiotics.55.141; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F; Xue YQ, 1998, P NATL ACAD SCI USA, V95, P12111, DOI 10.1073/pnas.95.21.12111; Zazopoulos E, 2003, NAT BIOTECHNOL, V21, P187, DOI 10.1038/nbt784	52	42	48	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29746	29756		10.1074/jbc.M109.046805	http://dx.doi.org/10.1074/jbc.M109.046805			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19726666	Green Published, hybrid			2022-12-27	WOS:000270896800056
J	Pradeepa, MM; Nikhil, G; Kishore, AH; Bharath, GN; Kundu, TK; Rao, MRS				Pradeepa, Madapura M.; Nikhil, Gupta; Kishore, Annavarapu Hari; Bharath, Giriyapura N.; Kundu, Tapas K.; Rao, Manchanahalli R. Satyanarayana			Acetylation of Transition Protein 2 (TP2) by KAT3B (p300) Alters Its DNA Condensation Property and Interaction with Putative Histone Chaperone NPM3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE SPERMATOGENESIS; NUCLEIC-ACIDS; KINASE-A; TRANSCRIPTION; SPERMIOGENESIS; IDENTIFICATION; INVOLVEMENT; SPERM; MICE; HYPERACETYLATION	The hallmark of mammalian spermiogenesis is the dramatic chromatin remodeling process wherein the nucleosomal histones are replaced by the transition proteins TP1, TP2, and TP4. Subsequently these transition proteins are replaced by the protamines P1 and P2. Hyperacetylation of histone H4 is linked to their replacement by transition proteins. Here we report that TP2 is acetylated in vivo as detected by anti-acetylated lysine antibody and mass spectrometric analysis. Further, recombinant TP2 is acetylated in vitro by acetyltransferase KAT3B (p300) more efficiently than by KAT2B (PCAF). In vivo p300 was demonstrated to acetylate TP2. p300 acetylates TP2 in its C-terminal domain, which is highly basic in nature and possesses chromatin-condensing properties. Mass spectrometric analysis showed that p300 acetylates four lysine residues in the C-terminal domain of TP2. Acetylation of TP2 by p300 leads to significant reduction in its DNA condensation property as studied by circular dichroism and atomic force microscopy analysis. TP2 also interacts with a putative histone chaperone, NPM3, wherein expression is elevated in haploid spermatids. Interestingly, acetylation of TP2 impedes its interaction with NPM3. Thus, acetylation of TP2 adds a new dimension to its role in the dynamic reorganization of chromatin during mammalian spermiogenesis.	[Pradeepa, Madapura M.; Nikhil, Gupta; Kishore, Annavarapu Hari; Bharath, Giriyapura N.; Kundu, Tapas K.; Rao, Manchanahalli R. Satyanarayana] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India; [Rao, Manchanahalli R. Satyanarayana] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Rao, MRS (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Jakkur PO, Bangalore 560064, Karnataka, India.	mrsrao@jncasr.ac.in	madapura, Pradeepa/AAS-1288-2020; , Proteomics Core UNC/AFQ-7201-2022	madapura, Pradeepa/0000-0001-9095-9247; Kundu, Tapas/0000-0001-7790-214X	Department of Biotechnology, Ministry of Science and Technology, New Delhi, India; Council of Scientific and Industrial Research, New Delhi, India	Department of Biotechnology, Ministry of Science and Technology, New Delhi, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the Department of Biotechnology, Ministry of Science and Technology, New Delhi, India.; Supported by a fellowship from the Council of Scientific and Industrial Research, New Delhi, India.; Supported by the J. C. Bose Fellowship from the Department of Science and Technology, Ministry of Science and Technology.	Allen MJ, 1997, NUCLEIC ACIDS RES, V25, P2221, DOI 10.1093/nar/25.11.2221; BASKARAN R, 1990, J BIOL CHEM, V265, P21039; BASKARAN R, 1991, BIOCHEM BIOPH RES CO, V179, P1491, DOI 10.1016/0006-291X(91)91741-T; Brewer L, 2002, J BIOL CHEM, V277, P38895, DOI 10.1074/jbc.M204755200; CHRISTENSEN ME, 1984, NUCLEIC ACIDS RES, V12, P4575, DOI 10.1093/nar/12.11.4575; Frehlick LJ, 2007, BIOESSAYS, V29, P49, DOI 10.1002/bies.20512; Govin J, 2006, J BIOL CHEM, V281, P37888, DOI 10.1074/jbc.M608147200; HANSEN JC, 1989, BIOCHEMISTRY-US, V28, P9129, DOI 10.1021/bi00449a026; Hazzouri M, 2000, EUR J CELL BIOL, V79, P950, DOI 10.1078/0171-9335-00123; Huang N, 2005, J BIOL CHEM, V280, P5496, DOI 10.1074/jbc.M407856200; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; KUNDU TK, 1995, BIOCHEMISTRY-US, V34, P5143, DOI 10.1021/bi00015a027; Kundu TK, 1996, BIOCHEMISTRY-US, V35, P15626, DOI 10.1021/bi961271i; Kundu TK, 1999, MOL CELL BIOL, V19, P1605; LEUBA SH, 1994, P NATL ACAD SCI USA, V91, P11621, DOI 10.1073/pnas.91.24.11621; MacArthur CA, 1997, GENOMICS, V42, P137, DOI 10.1006/geno.1997.4353; Marcon L, 2004, BIOL REPROD, V70, P910, DOI 10.1095/biolreprod.103.022541; Meetei AR, 2000, J BIOL CHEM, V275, P38500, DOI 10.1074/jbc.M002734200; Meetei AR, 2002, BIOCHEMISTRY-US, V41, P185, DOI 10.1021/bi0117652; Meistrich M., 1989, HISTONES OTHER BASIC, P165; Motoi N, 2008, DEV GROWTH DIFFER, V50, P307, DOI [10.1111/j.1440-169x.2008.01034.x, 10.1111/j.1440-169X.2008.01034.x]; Pradeepa MM, 2008, MOL CELL BIOL, V28, P4331, DOI 10.1128/MCB.00519-07; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Shirley CR, 2004, BIOL REPROD, V71, P1220, DOI 10.1095/biolreprod.104.029363; SINGH J, 1987, J BIOL CHEM, V262, P734; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Steen Hanno, 2002, Sci STKE, V2002, ppl16, DOI 10.1126/stke.2002.154.pl16; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Swaminathan V, 2005, MOL CELL BIOL, V25, P7534, DOI 10.1128/MCB.25.17.7534-7545.2005; Ullas KS, 2003, J BIOL CHEM, V278, P52673, DOI 10.1074/jbc.M308365200; ULLAS KS, 2009, J HISTOCHEM CYTOCHEM, V57, P951; Wouters-Tyrou D, 1998, BIOCHIMIE, V80, P117, DOI 10.1016/S0300-9084(98)80018-7; YANG X, 1996, NATURE, V382, P331; Yu YE, 2000, P NATL ACAD SCI USA, V97, P4683, DOI 10.1073/pnas.97.9.4683; Zhao M, 2004, BIOL REPROD, V71, P1016, DOI 10.1095/biolreprod.104.028191; Zhao M, 2001, MOL CELL BIOL, V21, P7243, DOI 10.1128/MCB.21.21.7243-7255.2001; Zirwes RF, 1997, P NATL ACAD SCI USA, V94, P11387, DOI 10.1073/pnas.94.21.11387	37	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29956	29967		10.1074/jbc.M109.052043	http://dx.doi.org/10.1074/jbc.M109.052043			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19710011	hybrid, Green Published			2022-12-27	WOS:000270896800074
J	Ishikawa, S; Taira, T; Niki, T; Takahashi-Niki, K; Maita, C; Maita, H; Ariga, H; Iguchi-Ariga, SMM				Ishikawa, Shizuma; Taira, Takahiro; Niki, Takeshi; Takahashi-Niki, Kazuko; Maita, Chinatsu; Maita, Hiroshi; Ariga, Hiroyoshi; Iguchi-Ariga, Sanae M. M.			Oxidative Status of DJ-1-dependent Activation of Dopamine Synthesis through Interaction of Tyrosine Hydroxylase and 4-Dihydroxy-L-phenylalanine (L-DOPA) Decarboxylase with DJ-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; ANDROGEN RECEPTOR; ANTIOXIDATIVE STRESS; ALPHA-SYNUCLEIN; CELL-DEATH; PROTEIN; MUTATIONS; GENE; PARK7; LOCALIZATION	Parkinson disease (PD) is caused by loss of dopamine, which is synthesized from tyrosine by two enzymes, tyrosine hydroxylase (TH) and 4-dihydroxy-L-phenylalanine decarboxylase (DDC). DJ-1 is a causative gene for the familial form of PD, but little is known about the roles of DJ-1 in dopamine synthesis. In this study, we found that DJ-1 directly bound to TH and DDC and positively regulated their activities in human dopaminergic cells. Mutants of DJ-1 found in PD patients, including heterozygous mutants, lost their activity and worked as dominant-negative forms toward wild-type DJ-1. When cells were treated with H2O2, 6-hydroxydopamine, or 1-methyl-4-phenylpyridinium, changes in activities of TH and DDC accompanied by oxidation of cysteine 106 of DJ-1 occurred. It was found that DJ-1 possessing Cys-106 with SH and SOH forms was active and that DJ-1 possessing Cys-106 with SO2H and SO3H forms was inactive in terms of stimulation of TH and DDC activities. These findings indicate an essential role of DJ-1 in dopamine synthesis and contribution of DJ-1 to the sporadic form of PD.	[Niki, Takeshi; Takahashi-Niki, Kazuko; Maita, Hiroshi; Ariga, Hiroyoshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Ishikawa, Shizuma; Maita, Chinatsu; Iguchi-Ariga, Sanae M. M.] Hokkaido Univ, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Taira, Takahiro] Yamanashi Univ, Interdisciplinary Grad Sch Med & Engn, Chuoh 4093898, Japan	Hokkaido University; Hokkaido University; University of Yamanashi	Ariga, H (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan.	hiro@pharm.hokudai.ac.jp	Maita, Hiroshi/D-5495-2012; Ariga, Sanae/H-9647-2013; Ariga, Hiroyoshi/B-5895-2013	Ariga, Hiroyoshi/0000-0001-7384-2143	Ministry of Education, Science, Culture, and Sports; National Institute of Biomedical Innovation in Japan; Grants-in-Aid for Scientific Research [21390014] Funding Source: KAKEN	Ministry of Education, Science, Culture, and Sports(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation in Japan(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Science, Culture, and Sports and by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation in Japan.	Abou-Sleiman PM, 2003, ANN NEUROL, V54, P283, DOI 10.1002/ana.10675; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Annesi G, 2005, ANN NEUROL, V58, P803, DOI 10.1002/ana.20666; Bandopadhyay R, 2004, BRAIN, V127, P420, DOI 10.1093/brain/awh054; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hague S, 2003, ANN NEUROL, V54, P271, DOI 10.1002/ana.10663; Hedrich K, 2004, NEUROLOGY, V62, P389, DOI 10.1212/01.WNL.0000113022.51739.88; Inden M, 2006, NEUROBIOL DIS, V24, P144, DOI 10.1016/j.nbd.2006.06.004; Itagaki C, 1999, BIOCHEMISTRY-US, V38, P15673, DOI 10.1021/bi9914255; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Meulener MC, 2006, P NATL ACAD SCI USA, V103, P12517, DOI 10.1073/pnas.0601891103; Miyazaki S, 2008, J NEUROCHEM, V105, P2418, DOI 10.1111/j.1471-4159.2008.05327.x; Mori K, 1998, J BIOL CHEM, V273, P29794, DOI 10.1074/jbc.273.45.29794; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Niki T, 2003, MOL CANCER RES, V1, P247; Shinbo YM, 2005, INT J ONCOL, V26, P641; SUTHERLAND C, 1993, EUR J BIOCHEM, V217, P715, DOI 10.1111/j.1432-1033.1993.tb18297.x; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Tehranian R, 2006, J NEUROCHEM, V99, P1188, DOI 10.1111/j.1471-4159.2006.04146.x; Tillman JE, 2007, CANCER RES, V67, P4630, DOI 10.1158/0008-5472.CAN-06-4556; Toska K, 2002, J NEUROCHEM, V83, P775, DOI 10.1046/j.1471-4159.2002.01172.x; Wang J, 2009, J BIOL CHEM, V284, P14011, DOI 10.1074/jbc.M901310200; Yanagida T, 2009, OXID MED CELL LONGEV, V2, P36, DOI 10.4161/oxim.2.1.7985; Yoshida T, 2008, EXP CELL RES, V314, P1217, DOI 10.1016/j.yexcr.2008.01.002; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030	36	67	68	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28832	28844		10.1074/jbc.M109.019950	http://dx.doi.org/10.1074/jbc.M109.019950			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19703902	hybrid, Green Published			2022-12-27	WOS:000270678900040
J	Lee, DW; Rajagopalan, S; Siddiq, A; Gwiazda, R; Yang, LC; Beal, MF; Ratan, RR; Andersen, JK				Lee, Donna W.; Rajagopalan, Subramanian; Siddiq, Ambreena; Gwiazda, Roberto; Yang, Lichuan; Beal, M. Flint; Ratan, Rajiv R.; Andersen, Julie K.			Inhibition of Prolyl Hydroxylase Protects against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Neurotoxicity MODEL FOR THE POTENTIAL INVOLVEMENT OF THE HYPOXIA-INDUCIBLE FACTOR PATHWAY IN PARKINSON DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; PARKINSONS-DISEASE; NEURODEGENERATIVE DISEASES; DOPAMINERGIC-NEURONS; CEREBRAL-ISCHEMIA; HEME OXYGENASE-1; GENE-EXPRESSION; KYNURENIC ACID; BASAL GANGLIA; IRON CONTENT	Hypoxia-inducible factor (HIF) plays an important role in cell survival by regulating iron, antioxidant defense, and mitochondrial function. Pharmacological inhibitors of the iron-dependent enzyme class prolyl hydroxylases (PHD), which target alpha subunits of HIF proteins for degradation, have recently been demonstrated to alleviate neurodegeneration associated with stroke and hypoxic-ischemic injuries. Here we report that inhibition of PHD by 3,4-dihydroxybenzoate (DHB) protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced nigral dopaminergic cell loss and up-regulates HIF-1 alpha within these neurons. Elevations in mRNA and protein levels of HIF-dependent genes heme oxygenase-1 (Ho-1) and manganese superoxide dismutase (Mnsod) following DHB pretreatment alone are also maintained in the presence of MPTP. MPTP-induced reductions in ferroportin and elevations in nigral and striatal iron levels were reverted to levels comparable with that of untreated controls with DHB pretreatment. Reductions in pyruvate dehydrogenase mRNA and activity resulting from MPTP were also found to be attenuated by DHB. In vitro, the HIF pathway was activated in N27 cells grown at 3% oxygen treated with either PHD inhibitors or an iron chelator. Concordant with our in vivo data, the MPP+-elicited increase in total iron as well as decreases in cell viability were attenuated in the presence of DHB. Taken together, these data suggest that protection against MPTP neurotoxicity may be mediated by alterations in iron homeostasis and defense against oxidative stress and mitochondrial dysfunction brought about by cellular HIF-1 alpha induction. This study provides novel data extending the possible therapeutic utility of HIF induction to a Parkinson disease model of neurodegeneration, which may prove beneficial not only in this disorder itself but also in other diseases associated with metal-induced oxidative stress.	[Lee, Donna W.; Rajagopalan, Subramanian; Andersen, Julie K.] Buck Inst Age Res, Novato, CA 94945 USA; [Siddiq, Ambreena; Ratan, Rajiv R.] Burke Cornell Med Res Inst, White Plains, NY 10605 USA; [Gwiazda, Roberto] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Yang, Lichuan; Beal, M. Flint] Cornell Univ, Weill Med Coll, New York, NY 10065 USA	Buck Institute for Research on Aging; University of California System; University of California Santa Cruz; Cornell University	Andersen, JK (corresponding author), 8001 Redwood Blvd, Novato, CA 94945 USA.	jandersen@buckinstitute.org		Andersen, Julie/0000-0003-1324-4875	National Institutes of Health [NS041264]; American Parkinson's Disease Association; Larry L. Hillblom Foundation fellowships; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041264] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Parkinson's Disease Association; Larry L. Hillblom Foundation fellowships; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS041264 (to J. K. A.). This work was also supported by the American Parkinson's Disease Association and Larry L. Hillblom Foundation fellowships (to D. W. L.).	AGARWAL A, 1995, KIDNEY INT, V48, P1298, DOI 10.1038/ki.1995.414; Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; BEAL MF, 1992, J NEUROL SCI, V108, P80; BEAL MF, 1990, J NEUROCHEM, V55, P1327, DOI 10.1111/j.1471-4159.1990.tb03143.x; Callapina M, 2005, EXP CELL RES, V306, P274, DOI 10.1016/j.yexcr.2005.02.018; Cohen G, 1997, P NATL ACAD SCI USA, V94, P4890, DOI 10.1073/pnas.94.10.4890; Connor JR, 1995, J NEUROL SCI, V134, P33, DOI 10.1016/0022-510X(95)00206-H; Cosi C, 1998, BRAIN RES, V809, P58, DOI 10.1016/S0006-8993(98)00829-4; Deudero JJP, 2008, J BIOL CHEM, V283, P11435, DOI 10.1074/jbc.M703875200; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; DEXTER DT, 1991, BRAIN, V114, P1953, DOI 10.1093/brain/114.4.1953; Ferris CD, 1999, NAT CELL BIOL, V1, P152, DOI 10.1038/11072; GRAHAM DG, 1978, MOL PHARMACOL, V14, P644; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Greenberg DA, 2004, TRENDS MOL MED, V10, P1, DOI 10.1016/j.molmed.2003.11.006; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Haavik J, 1997, J NEUROCHEM, V68, P328; Hamrick SEG, 2005, NEUROSCI LETT, V379, P96, DOI 10.1016/j.neulet.2004.12.080; He Y, 2003, FREE RADICAL BIO MED, V35, P540, DOI 10.1016/S0891-5849(03)00385-X; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Huang E, 2004, NEUROSCIENCE, V128, P487, DOI 10.1016/j.neuroscience.2004.06.055; HURN PD, 1995, STROKE, V26, P688, DOI 10.1161/01.STR.26.4.688; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Klivenyi P, 1998, NEUROBIOL DIS, V5, P253, DOI 10.1006/nbdi.1998.0191; Lan J, 1997, J NEURAL TRANSM, V104, P469, DOI 10.1007/BF01277665; Lee PJ, 1996, P NATL ACAD SCI USA, V93, P10393, DOI 10.1073/pnas.93.19.10393; Lesbordes-Brion JC, 2006, BLOOD, V108, P1402, DOI 10.1182/blood-2006-02-003376; Luo G, 1997, GENE EXPRESSION, V6, P287; MAJAMAA K, 1986, J BIOL CHEM, V261, P7819; Martin WRW, 2008, NEUROLOGY, V70, P1411, DOI 10.1212/01.wnl.0000286384.31050.b5; Martin-Puig S, 2004, J BIOL CHEM, V279, P9504, DOI 10.1074/jbc.M310658200; Molina-Holgado F, 2008, J NEUROCHEM, V105, P2466, DOI 10.1111/j.1471-4159.2008.05332.x; Mu DZ, 2003, NEUROBIOL DIS, V14, P524, DOI 10.1016/j.nbd.2003.08.020; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pichiule P, 2003, ADV EXP MED BIOL, V530, P611; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Ratan RR, 2004, STROKE, V35, P2687, DOI 10.1161/01.STR.0000143216.85349.9e; Rivard A, 2000, J BIOL CHEM, V275, P29643, DOI 10.1074/jbc.M001029200; Rouault Tracey A, 2006, Semin Pediatr Neurol, V13, P142, DOI 10.1016/j.spen.2006.08.002; Salazar J, 2008, P NATL ACAD SCI USA, V105, P18578, DOI 10.1073/pnas.0804373105; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Siddiq A, 2005, J BIOL CHEM, V280, P41732, DOI 10.1074/jbc.M504963200; SMITH DR, 1992, TOXICOL APPL PHARM, V116, P85, DOI 10.1016/0041-008X(92)90148-L; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; TANAKA M, 1991, J NEUROL SCI, V101, P198, DOI 10.1016/0022-510X(91)90046-A; TETRUD JW, 1989, NEUROLOGY, V39, P1483, DOI 10.1212/WNL.39.11.1483; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Tian Youyong, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P670, DOI 10.1007/s11596-006-0611-7; Vangeison G, 2008, J NEUROSCI, V28, P1988, DOI 10.1523/JNEUROSCI.5323-07.2008; Viatte L, 2005, BLOOD, V105, P4861, DOI 10.1182/blood-2004-12-4608; WANG GL, 1993, BLOOD, V82, P3610; Wang J, 2009, NEUROCHEM INT, V54, P43, DOI 10.1016/j.neuint.2008.10.003; Wang YM, 2007, J NEUROSCI, V27, P304, DOI 10.1523/JNEUROSCI.4433-06.2007; WARD RJ, 1995, BIOCHEM PHARMACOL, V49, P1821, DOI 10.1016/0006-2952(94)00521-M; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Wright WE, 2006, NAT PROTOC, V1, P2088, DOI 10.1038/nprot.2006.374; Wu LJC, 2004, BRAIN RES, V1001, P108, DOI 10.1016/j.brainres.2003.10.066; Xu HM, 2008, NEUROCHEM INT, V52, P1044, DOI 10.1016/j.neuint.2007.10.019; Yasuhara T, 2005, BRAIN RES, V1053, P10, DOI 10.1016/j.brainres.2005.05.027; Yasuhara T, 2004, EUR J NEUROSCI, V19, P1494, DOI 10.1111/j.1460-9568.2004.03254.x; Youdim MBH, 2004, ANN NY ACAD SCI, V1012, P306, DOI 10.1196/annals.1306.025; Zhang SZ, 2009, NEUROBIOL AGING, V30, P1466, DOI 10.1016/j.neurobiolaging.2007.11.025	67	84	94	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29065	29076		10.1074/jbc.M109.000638	http://dx.doi.org/10.1074/jbc.M109.000638			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19679656	Green Published, hybrid			2022-12-27	WOS:000270678900063
J	Polzien, L; Baljuls, A; Rennefahrt, UEE; Fischer, A; Schmitz, W; Zahedi, RP; Sickmann, A; Metz, R; Albert, S; Benz, R; Hekman, M; Rapp, UR				Polzien, Lisa; Baljuls, Angela; Rennefahrt, Ulrike E. E.; Fischer, Andreas; Schmitz, Werner; Zahedi, Rene P.; Sickmann, Albert; Metz, Renate; Albert, Stefan; Benz, Roland; Hekman, Mirko; Rapp, Ulf R.			Identification of Novel in Vivo Phosphorylation Sites of the Human Proapoptotic Protein BAD PORE-FORMING ACTIVITY OF BAD IS REGULATED BY PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; OUTER MITOCHONDRIAL-MEMBRANE; PROGRAMMED CELL-DEATH; BCL-2 FAMILY; GROWTH-FACTOR; PERMEABILITY TRANSITION; CYTOCHROME-C; ION-CHANNEL; POLYACRYLAMIDE-GELS; STRUCTURAL BIOLOGY	BAD is a proapoptotic member of the Bcl-2 protein family that is regulated by phosphorylation in response to survival factors. Although much attention has been devoted to the identification of phosphorylation sites in murine BAD, little data are available with respect to phosphorylation of human BAD protein. Using mass spectrometry, we identified here besides the established phosphorylation sites at serines 75, 99, and 118 several novel in vivo phosphorylation sites within human BAD (serines 25, 32/34, 97, and 124). Furthermore, we investigated the quantitative contribution of BAD targeting kinases in phosphorylating serine residues 75,99, and 118. Our results indicate that RAF kinases represent, besides protein kinase A, PAK, and Akt/protein kinase B, in vivo BAD-phosphorylating kinases. RAF-induced phosphorylation of BAD was reduced to control levels using the RAF inhibitor BAY 43-9006. This phosphorylation was not prevented by MEK inhibitors. Consistently, expression of constitutively active RAF suppressed apoptosis induced by BAD and the inhibition of colony formation caused by BAD could be prevented by RAF. In addition, using the surface plasmon resonance technique, we analyzed the direct consequences of BAD phosphorylation by RAF with respect to association with 14-3-3 and Bcl-2/Bcl-X-L proteins. Phosphorylation of BAD by active RAF promotes 14-3-3 protein association, in which the phosphoserine 99 represented the major binding site. Finally, we show here that BAD forms channels in planar bilayer membranes in vitro. This pore-forming capacity was dependent on phosphorylation status and interaction with 14-3-3 proteins. Collectively, our findings provide new insights into the regulation of BAD function by phosphorylation.	[Polzien, Lisa; Baljuls, Angela; Rennefahrt, Ulrike E. E.; Fischer, Andreas; Metz, Renate; Hekman, Mirko; Rapp, Ulf R.] Univ Wurzburg, Inst Med Radiat & Cell Res, D-97078 Wurzburg, Germany; [Schmitz, Werner] Univ Wurzburg, Inst Physiol Chem, D-97078 Wurzburg, Germany; [Albert, Stefan] Univ Wurzburg, Julius von Sachs Inst Biosci, D-97078 Wurzburg, Germany; [Benz, Roland] Univ Wurzburg, Inst Biotechnol, D-97078 Wurzburg, Germany; [Zahedi, Rene P.; Sickmann, Albert] Inst Sci Anal, Dept Bioanalyt, D-44139 Dortmund, Germany; [Sickmann, Albert] Ruhr Univ Bochum, Med Proteome Ctr, D-44801 Bochum, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; Ruhr University Bochum	Rapp, UR (corresponding author), Univ Wurzburg, Inst Med Radiat & Cell Res MSZ, Versbacher Str 5, D-97078 Wurzburg, Germany.	rappur@mail.uni-wuerzburg.de	Zahedi, René/A-9148-2012; Sickmann, Albert/A-1010-2011; Zahedi, Rene/HGU-5710-2022	Zahedi, René/0000-0002-4960-5460; Sickmann, Albert/0000-0002-2388-5265; Benz, Roland/0000-0002-9510-9265	Ministerium fur Innovation, Wissenschaft, Forschung, und Technologie des Landes Nordrhein-Westfalen; Bundesministerium fur Bildung und Forschung; Deutsche Forschungsgemeinschaft [SFB 487, C3]	Ministerium fur Innovation, Wissenschaft, Forschung, und Technologie des Landes Nordrhein-Westfalen; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Ministerium fur Innovation, Wissenschaft, Forschung, und Technologie des Landes Nordrhein-Westfalen and by the Bundesministerium fur Bildung und Forschung. This work was also supported by Deutsche Forschungsgemeinschaft Grant SFB 487, Project C3.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Aitken A, 2002, PLANT MOL BIOL, V50, P993, DOI 10.1023/A:1021261931561; Antignani A, 2006, CURR OPIN CELL BIOL, V18, P685, DOI 10.1016/j.ceb.2006.10.004; Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Baljuls A, 2008, J BIOL CHEM, V283, P27239, DOI 10.1074/jbc.M801782200; Basanez G, 1999, P NATL ACAD SCI USA, V96, P5492, DOI 10.1073/pnas.96.10.5492; BENZ R, 1994, BBA-REV BIOMEMBRANES, V1197, P167, DOI 10.1016/0304-4157(94)90004-3; BENZ R, 1992, BIOL CHEM H-S, V373, P295, DOI 10.1515/bchm3.1992.373.1.295; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; Dejean LM, 2006, CELL DEATH DIFFER, V13, P1387, DOI 10.1038/sj.cdd.4401949; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Donovan N, 2002, J BIOL CHEM, V277, P40944, DOI 10.1074/jbc.M206113200; Dramsi S, 2002, J BIOL CHEM, V277, P6399, DOI 10.1074/jbc.M109990200; Dumaz N, 2003, J BIOL CHEM, V278, P29819, DOI 10.1074/jbc.C300182200; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fesik SW, 2000, CELL, V103, P273, DOI 10.1016/S0092-8674(00)00119-7; Fischer A, 2009, J BIOL CHEM, V284, P3183, DOI 10.1074/jbc.M804795200; Fleischer A, 2004, MOL CANCER RES, V2, P674; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Fueller J, 2008, BIOCHEM BIOPH RES CO, V370, P552, DOI 10.1016/j.bbrc.2008.03.141; Galmiche A, 2008, J BIOL CHEM, V283, P14857, DOI 10.1074/jbc.M709098200; Galonek HL, 2006, NAT CELL BIOL, V8, P1317, DOI 10.1038/ncb1206-1317; Gnesutta N, 2001, J BIOL CHEM, V276, P14414, DOI 10.1074/jbc.M011046200; Gottlieb E, 2002, P NATL ACAD SCI USA, V99, P12801, DOI 10.1073/pnas.202477599; Gotz R, 2005, NAT NEUROSCI, V8, P1169, DOI 10.1038/nn1524; Green DR, 2005, J CLIN INVEST, V115, P2610, DOI 10.1172/JCI26321; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Hekman M, 2002, J BIOL CHEM, V277, P24090, DOI 10.1074/jbc.M200576200; Hekman M, 2004, J BIOL CHEM, V279, P14074, DOI 10.1074/jbc.M309620200; Hekman M, 2006, J BIOL CHEM, V281, P17321, DOI 10.1074/jbc.M600292200; HOSANG M, 1985, J CELL BIOCHEM, V29, P265, DOI 10.1002/jcb.240290310; HUANG RRC, 1990, MOL PHARMACOL, V37, P304; Jin SH, 2005, J BIOL CHEM, V280, P24698, DOI 10.1074/jbc.M413374200; Jonas EA, 2005, J BIOL CHEM, V280, P4491, DOI 10.1074/jbc.M410661200; Jonas EA, 2004, P NATL ACAD SCI USA, V101, P13590, DOI 10.1073/pnas.0401372101; Jonas EA, 2003, J NEUROSCI, V23, P8423; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kebache S, 2007, J BIOL CHEM, V282, P21873, DOI 10.1074/jbc.M611066200; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Klumpp S, 2004, NEUROCHEM INT, V45, P747, DOI 10.1016/j.neuint.2004.02.006; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Le Mellay V, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-14; Letai A, 2006, MOL CELL, V21, P728, DOI 10.1016/j.molcel.2006.03.005; Macdonald A, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-1; Manich M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003764; Martinez-Senac MD, 2002, BIOPHYS J, V82, P233, DOI 10.1016/S0006-3495(02)75390-3; Martinez-Senac MD, 2001, BIOCHEMISTRY-US, V40, P9983; Martinez-Senac MD, 2000, BIOCHEMISTRY-US, V39, P7744, DOI 10.1021/bi000256h; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Panka DJ, 2006, CANCER RES, V66, P1611, DOI 10.1158/0008-5472.CAN-05-0808; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Rapp UR, 2006, CANCER CELL, V9, P9, DOI 10.1016/j.ccr.2005.12.022; Rapp UR, 2004, BBA-MOL CELL RES, V1644, P149, DOI 10.1016/j.bbamcr.2003.10.015; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Reinders J, 2007, MOL CELL PROTEOMICS, V6, P1896, DOI 10.1074/mcp.M700098-MCP200; Roy SS, 2009, MOL CELL, V33, P377, DOI 10.1016/j.molcel.2009.01.018; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; Schendel SL, 1998, CELL DEATH DIFFER, V5, P372, DOI 10.1038/sj.cdd.4400365; Schendel SL, 1999, J BIOL CHEM, V274, P21932, DOI 10.1074/jbc.274.31.21932; Schlesinger PH, 1997, P NATL ACAD SCI USA, V94, P11357, DOI 10.1073/pnas.94.21.11357; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; She QB, 2002, J BIOL CHEM, V277, P24039, DOI 10.1074/jbc.M109907200; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Tang Y, 2000, J BIOL CHEM, V275, P9106, DOI 10.1074/jbc.275.13.9106; Troppmair J, 2003, BIOCHEM PHARMACOL, V66, P1341, DOI 10.1016/S0006-2952(03)00483-0; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Virdee K, 2000, CURR BIOL, V10, P1151, DOI 10.1016/S0960-9822(00)00702-8; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Wei MC, 2000, GENE DEV, V14, P2060; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu CF, 2004, MOL CELL, V13, P329, DOI 10.1016/S1097-2765(04)00028-0; Zahedi RP, 2008, J PROTEOME RES, V7, P526, DOI 10.1021/pr0704130; Zamzami N, 1996, J EXP MED, V183, P1533, DOI 10.1084/jem.183.4.1533; Zamzami N, 2003, CURR BIOL, V13, pR71, DOI 10.1016/S0960-9822(02)01433-1; Zamzami N, 1996, FEBS LETT, V384, P53, DOI 10.1016/0014-5793(96)00280-3; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang JY, 2005, CANCER RES, V65, P8372, DOI 10.1158/0008-5472.CAN-05-0576; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	100	36	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28004	28020		10.1074/jbc.M109.010702	http://dx.doi.org/10.1074/jbc.M109.010702			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19667065	Green Published, hybrid			2022-12-27	WOS:000270676300029
J	Risteli, M; Ruotsalainen, H; Salo, AM; Sormunen, R; Sipila, L; Baker, NL; Lamande, SR; Vimpari-Kauppinen, L; Myllyla, R				Risteli, Maija; Ruotsalainen, Heli; Salo, Antti M.; Sormunen, Raija; Sipila, Laura; Baker, Naomi L.; Lamande, Shireen R.; Vimpari-Kauppinen, Leena; Myllyla, Raili			Reduction of Lysyl Hydroxylase 3 Causes Deleterious Changes in the Deposition and Organization of Extracellular Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; TISSUE DISTRIBUTION; COLLAGEN; VI; FIBRONECTIN; GLUCOSYLTRANSFERASE; DEFICIENCY; EXPRESSION; CLONING; ENZYME	Lysyl hydroxylase 3 (LH3) is a multifunctional enzyme possessing lysyl hydroxylase, collagen galactosyltransferase, and glucosyltransferase (GGT) activities. We report here an important role for LH3 in the organization of the extracellular matrix (ECM) and cytoskeleton. Deposition of ECM was affected in heterozygous LH3 knock-out mouse embryonic fibroblasts (MEF+/-) and in skin fibroblasts collected from a member of a Finnish epidermolysis bullosa simplex (EBS) family known to be deficient in GGT activity. We show the GGT deficiency to be due to a transcriptional defect in one LH3 allele. The ECM abnormalities also lead to defects in the arrangement of the cytoskeleton in both cell lines. Ultrastructural abnormalities were observed in the skin of heterozygous LH3 knock-out mice indicating that even a moderate decrease in LH3 has deleterious consequences in vivo. The LH3 null allele in the EBS family member and the resulting abnormalities in the organization of the extracellular matrix, similar to those found in MEF+/-, may explain the correlation between the severity of the phenotype and the decrease in GGT activity reported in this family.	[Risteli, Maija; Ruotsalainen, Heli; Salo, Antti M.; Sipila, Laura; Myllyla, Raili] Univ Oulu, Dept Biochem, FI-90014 Oulu, Finland; [Sormunen, Raija] Univ Oulu, Dept Pathol, Bioctr Oulu, FI-90014 Oulu, Finland; [Baker, Naomi L.; Lamande, Shireen R.] Univ Melbourne, Royal Childrens Hosp, Dept Pediat, Parkville, Vic 3052, Australia; [Baker, Naomi L.; Lamande, Shireen R.] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Vimpari-Kauppinen, Leena] Kainuu Cent Hosp, Dermatol Clin, Kajaani 87140, Finland	Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Myllyla, R (corresponding author), Univ Oulu, Dept Biochem, POB 3000, FI-90014 Oulu, Finland.	raili.myllyla@oulu.fi		Lamande, Shireen/0000-0003-2938-2711; Ruotsalainen, Heli/0000-0003-4923-5196	Research Council for Biosciences and Environment within the Academy of Finland; Sigrid Juselius Foundation; Biocenter Oulu; Glycoscience Graduate School; Research and Science Foundation of Farmos; Societas Scientiarum Fermica; Maud Kuistila Memorial Foundation	Research Council for Biosciences and Environment within the Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biocenter Oulu; Glycoscience Graduate School; Research and Science Foundation of Farmos; Societas Scientiarum Fermica; Maud Kuistila Memorial Foundation	This work was supported by grants from the Research Council for Biosciences and Environment within the Academy of Finland, the Sigrid Juselius Foundation, Biocenter Oulu, Glycoscience Graduate School, Research and Science Foundation of Farmos, Societas Scientiarum Fermica, and the Maud Kuistila Memorial Foundation.	Aszodi A, 2006, ANNU REV CELL DEV BI, V22, P591, DOI 10.1146/annurev.cellbio.22.010305.104258; CHU ML, 1988, J BIOL CHEM, V263, P18601; ENGVALL E, 1986, J CELL BIOL, V102, P703, DOI 10.1083/jcb.102.3.703; Eyre D, 2002, MOL GENET METAB, V76, P211, DOI 10.1016/S1096-7192(02)00036-7; GEIGERB, 2001, NAT REV MOL CELL BIO, V2, P793; Ha-Vinh R, 2004, AM J MED GENET A, V131A, P115, DOI 10.1002/ajmg.a.30231; HAUTALA T, 1992, GENOMICS, V13, P62, DOI 10.1016/0888-7543(92)90202-4; Heikkinen J, 2000, J BIOL CHEM, V275, P36158, DOI 10.1074/jbc.M006203200; Hocking DC, 2000, J BIOL CHEM, V275, P10673, DOI 10.1074/jbc.275.14.10673; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; KIVIRIKKO KI, 1992, POSTTRANSLATIONAL MO; Lamande SR, 2006, J BIOL CHEM, V281, P16607, DOI 10.1074/jbc.M510192200; Li SH, 2003, AM J PATHOL, V163, P1045, DOI 10.1016/S0002-9440(10)63464-5; MCDONALD JA, 1982, J CELL BIOL, V92, P485, DOI 10.1083/jcb.92.2.485; Mercer DK, 2003, BIOCHEM BIOPH RES CO, V307, P803, DOI 10.1016/S0006-291X(03)01262-2; Minamitani T, 2004, EXP CELL RES, V298, P305, DOI 10.1016/j.yexcr.2004.04.030; MYLLYLA R, 1975, EUR J BIOCHEM, V52, P401, DOI 10.1111/j.1432-1033.1975.tb04008.x; Myllyla R, 2007, J CELL PHYSIOL, V212, P323, DOI 10.1002/jcp.21036; Passoja K, 1998, P NATL ACAD SCI USA, V95, P10482, DOI 10.1073/pnas.95.18.10482; Putnam AJ, 2001, AM J PHYSIOL-CELL PH, V280, pC556, DOI 10.1152/ajpcell.2001.280.3.C556; Rautavuoma K, 2004, P NATL ACAD SCI USA, V101, P14120, DOI 10.1073/pnas.0404966101; Rautavuoma K, 2000, MATRIX BIOL, V19, P73, DOI 10.1016/S0945-053X(99)00058-X; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Ruotsalainen H, 1999, MATRIX BIOL, V18, P325, DOI 10.1016/S0945-053X(99)00016-5; Sabatelli P, 2001, MATRIX BIOL, V20, P475, DOI 10.1016/S0945-053X(01)00160-3; Salo AM, 2006, J CELL PHYSIOL, V207, P644, DOI 10.1002/jcp.20596; Salo AM, 2008, AM J HUM GENET, V83, P495, DOI 10.1016/j.ajhg.2008.09.004; Sambrook J., 2001, MOL CLONING LAB MANU; SAVOLAINEN ER, 1981, NEW ENGL J MED, V304, P197, DOI 10.1056/NEJM198101223040403; Schneider VA, 2007, MATRIX BIOL, V26, P12, DOI 10.1016/j.matbio.2006.09.007; Schneider VA, 2006, NEURON, V50, P683, DOI 10.1016/j.neuron.2006.04.024; Sipila L, 2007, J BIOL CHEM, V282, P33381, DOI 10.1074/jbc.M704198200; Squarzoni S, 2006, J CELL PHYSIOL, V206, P160, DOI 10.1002/jcp.20443; Steinmann B., 2002, CONNECTIVE TISSUE IT, P431, DOI DOI 10.1002/0471221929.CH9; Timpl R, 1994, EXTRACELLULAR MATRIX, P207, DOI 10.1016/B978-0-12-775170-2.50012-3; Uzawa K, 2003, BIOCHEM BIOPH RES CO, V305, P484, DOI 10.1016/S0006-291X(03)00799-X; Valtavaara M, 1997, J BIOL CHEM, V272, P6831, DOI 10.1074/jbc.272.11.6831; Valtavaara M, 1998, J BIOL CHEM, V273, P12881, DOI 10.1074/jbc.273.21.12881; van der Slot AJ, 2004, MATRIX BIOL, V23, P251, DOI 10.1016/j.matbio.2004.06.001; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Wang CG, 2002, MATRIX BIOL, V21, P559, DOI 10.1016/S0945-053X(02)00071-9; Wang CG, 2009, J CELL MOL MED, V13, P508, DOI 10.1111/j.1582-4934.2008.00286.x; Yeowell HN, 1999, MATRIX BIOL, V18, P179, DOI 10.1016/S0945-053X(99)00013-X; Yeowell HN, 2000, MOL GENET METAB, V71, P212, DOI 10.1006/mgme.2000.3076	46	34	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28204	28211		10.1074/jbc.M109.038190	http://dx.doi.org/10.1074/jbc.M109.038190			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19696018	Green Published, hybrid			2022-12-27	WOS:000270676300048
J	Niiya, D; Egawa, N; Sakamoto, T; Kikkawa, Y; Shinkawa, T; Isobe, T; Koshikawa, N; Seiki, M				Niiya, Daigo; Egawa, Nagayasu; Sakamoto, Takeharu; Kikkawa, Yamato; Shinkawa, Takashi; Isobe, Toshiaki; Koshikawa, Naohiko; Seiki, Motoharu			Identification and Characterization of Lutheran Blood Group Glycoprotein as a New Substrate of Membrane-type 1 Matrix Metalloproteinase 1 (MT1-MMP) A SYSTEMIC WHOLE CELL ANALYSIS OF MT1-MMP-ASSOCIATING PROTEINS IN A431 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; EXTRACELLULAR-MATRIX; MASS-SPECTROMETRY; LAMININ; BINDING; INVASION; PROTEIN; CD44; PROTEOMICS; INHIBITOR	Membrane-type 1 matrix metalloproteinase 1 (MT1-MMP) is a potent modulator of the pericellular microenvironment and regulates cellular functions in physiological and pathological settings in mammals. MT1-MMP mediates its biological effects through cleavage of specific substrate proteins. However, our knowledge of MT1-MMP substrates remains limited. To identify new substrates of MT1-MMP, we purified proteins associating with MT1-MMP in human epidermoid carcinoma A431 cells and analyzed them by mass spectrometry. We identified 163 proteins, including membrane proteins, cytoplasmic proteins, and functionally unknown proteins. Sixty-four membrane proteins were identified, and they included known MT1-MMP substrates. Of these, eighteen membrane proteins were selected, and we confirmed their association with MT1-MMP using an immunoprecipitation assay. Co-expression of each protein together with MT1-MMP revealed that nine proteins were cleaved by MT1-MMP. Lutheran blood group glycoprotein (Lu) is one of the proteins cleaved by MT1-MMP, and we confirmed the cleavage of the endogenous Lu protein by endogenous MT1-MMP in A431 cells. Mutation of the cleavage site of Lu abrogated processing by MT1-MMP. Luprotein expressed in A431 cells bound to laminin-511, and knock down of MT1-MMP in these cells increased both their binding to laminin-511 and the amount of Lu protein on the cell surface. Thus, the identified membrane proteins associated with MT1-MMP are an enriched source of physiological MT1-MMP substrates.	[Niiya, Daigo; Egawa, Nagayasu; Sakamoto, Takeharu; Koshikawa, Naohiko; Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo 1088639, Japan; [Egawa, Nagayasu] Natl Canc Ctr, Res Inst, Div Virol, Chuo Ku, Tokyo 1040045, Japan; [Kikkawa, Yamato] Tokyo Univ Pharm & Life Sci, Lab Clin Biochem, Hachioji, Tokyo 1920392, Japan; [Shinkawa, Takashi; Isobe, Toshiaki] Tokyo Metropolitan Univ, Grad Sch Sci, Dept Chem, Tokyo 1920397, Japan	University of Tokyo; National Cancer Center - Japan; Tokyo University of Pharmacy & Life Sciences; Tokyo Metropolitan University	Seiki, M (corresponding author), 4-6-1 Shirokanedai,Minato Ku, Tokyo 1088639, Japan.	mseiki@ims.u-tokyo.ac.jp	Kikkawa, Yamato/D-1503-2010; Isobe, Toshiaki/Q-9279-2017; Koshikawa, Naohiko/S-7306-2017; Sakamoto, Takeharu/Y-6062-2019; Seiki, Motoharu/K-9443-2015	Koshikawa, Naohiko/0000-0002-4539-888X; Sakamoto, Takeharu/0000-0002-1225-1902; 	Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-aid for Scientific Research on Priority Areas "Integrative Research Toward the Conquest of Cancer" and was supported in part by Global COE Program from the Ministry of Education, Culture, Sports, Science and Technology.	Butler GS, 2008, MOL CELL BIOL, V28, P4896, DOI 10.1128/MCB.01775-07; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Egawa N, 2006, J BIOL CHEM, V281, P37576, DOI 10.1074/jbc.M606993200; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; El Nemer W, 1998, J BIOL CHEM, V273, P16686; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Hwang IK, 2004, BBA-PROTEINS PROTEOM, V1702, P79, DOI 10.1016/j.bbapap.2004.08.001; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Kaji H, 2003, NAT BIOTECHNOL, V21, P667, DOI 10.1038/nbt829; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Kikkawa Y, 2005, CONNECT TISSUE RES, V46, P193, DOI 10.1080/03008200500344074; Kikkawa Y, 2002, J BIOL CHEM, V277, P44864, DOI 10.1074/jbc.M208731200; Kikkawa Y, 2007, J BIOL CHEM, V282, P14853, DOI 10.1074/jbc.M611706200; Kridel SJ, 2002, J BIOL CHEM, V277, P23788, DOI 10.1074/jbc.M111574200; Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2; MacPherson LJ, 1997, J MED CHEM, V40, P2525, DOI 10.1021/jm960871c; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nakamura H, 2004, CANCER RES, V64, P876, DOI 10.1158/0008-5472.CAN-03-3502; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Ohtake Y, 2006, J CELL SCI, V119, P3822, DOI 10.1242/jcs.03158; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; Suenaga N, 2005, ONCOGENE, V24, P859, DOI 10.1038/sj.onc.1208258; Tam EM, 2004, P NATL ACAD SCI USA, V101, P6917, DOI 10.1073/pnas.0305862101; Tam EM, 2002, J BIOL CHEM, V277, P39005, DOI 10.1074/jbc.M206874200; Tomari T, 2009, CANCER SCI, V100, P1284, DOI 10.1111/j.1349-7006.2009.01173.x; Udani M, 1998, J CLIN INVEST, V101, P2550, DOI 10.1172/JCI1204; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	33	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27360	27369		10.1074/jbc.M109.029124	http://dx.doi.org/10.1074/jbc.M109.029124			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19667067	hybrid, Green Published			2022-12-27	WOS:000270232300037
J	Scholz, R; Suter, M; Weimann, T; Polge, C; Konarev, PV; Thali, RF; Tuerk, RD; Viollet, B; Wallimann, T; Schlattner, U; Neumann, D				Scholz, Roland; Suter, Marianne; Weimann, Theodore; Polge, Cecile; Konarev, Petr V.; Thali, Ramon F.; Tuerk, Roland D.; Viollet, Benoit; Wallimann, Theo; Schlattner, Uwe; Neumann, Dietbert			Homo-oligomerization and Activation of AMP-activated Protein Kinase Are Mediated by the Kinase Domain alpha G-Helix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; METABOLIC SYNDROME; INSULIN-RECEPTOR; STRUCTURAL BASIS; TYROSINE KINASE; CELL-GROWTH; RAT-LIVER; IN-VITRO; PHOSPHORYLATION; MECHANISM	AMP-activated protein kinase (AMPK) is a heterotrimeric complex playing a crucial role in maintaining cellular energy homeostasis. Recently, homodimerization of mammalian AMPK and yeast ortholog SNF1 was shown by us and others. In SNF1, it involved specific hydrophobic residues in the kinase domain alpha G-helix. Mutation of the corresponding AMPK alpha-subunit residues (Val-219 and Phe-223) to glutamate reduced the tendency of the kinase to form higher order homo-oligomers, as was determined by the following three independent techniques in vitro: (i) small angle x-ray scattering, (ii) surface plasmon resonance spectroscopy, and (iii) two-dimensional blue native/SDS-PAGE. Recombinant protein as well as AMPK in cell lysates of primary cells revealed distinct complexes of various sizes. In particular, the assembly of very high molecular mass complexes was dependent on both the alpha G-helix-mediated hydrophobic interactions and kinase activation. In vitro and when overexpressed in double knock-out (alpha 1(-/-), alpha 2(-/-)) mouse embryonic fibroblast cells, activation of mutant AMPK was impaired, indicating a critical role of the alpha G-helix residues for AMPK activation via its upstream kinases. Also inactivation by protein phosphatase 2C alpha was affected in mutant AMPK. Importantly, activation of mutant AMPK by LKB1 was restored by exchanging the corresponding and conserved hydrophobic alpha G-helix residues of LKB1 (Ile-260 and Phe-264) to positively charged amino acids. These mutations functionally rescued LKB1-dependent activation of mutant AMPK in vitro and in cell culture. Our data suggest a physiological role for the hydrophobic alpha G-helix residues in homo-oligomerization of heterotrimers and cellular interactions, in particular with upstream kinases, indicating an additional level of AMPK regulation.	[Scholz, Roland; Suter, Marianne; Thali, Ramon F.; Tuerk, Roland D.; Wallimann, Theo; Neumann, Dietbert] ETH, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Weimann, Theodore; Polge, Cecile; Schlattner, Uwe] Univ Grenoble 1, Lab Fundamental & Appl Bioenerget, INSERM, U884, F-38041 Grenoble, France; [Konarev, Petr V.] Russian Acad Sci, Inst Crystallog, Moscow 117333, Russia; [Konarev, Petr V.] DESY, EMBL, D-22603 Hamburg, Germany; [Viollet, Benoit] Univ Paris 05, CNRS, UMR 8104, Inst Cochin, F-75014 Paris, France; [Viollet, Benoit] INSERM, U567, Inst Cochin IC, F-75014 Paris, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Russian Academy of Sciences; FSRC Crystallography & Photonics RAS; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Neumann, D (corresponding author), ETH, Inst Cell Biol, Dept Biol, Schafmattstr 18,HPM D23, CH-8093 Zurich, Switzerland.	dietbert.neumann@cell.biol.ethz.ch	Scholz, Roland W./AAH-8385-2020; Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017; Wallimann, Theo/C-6047-2008; Polge, Cécile/AAM-2467-2020; Konarev, Petr V/W-1380-2017; Schlattner, Uwe/D-1267-2009	Scholz, Roland W./0000-0003-2506-3254; Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Wallimann, Theo/0000-0003-4957-5836; Polge, Cécile/0000-0002-8730-5776; Schlattner, Uwe/0000-0003-1159-5911; Neumann, Dietbert/0000-0002-4316-684X; Konarev, Petr/0000-0002-5606-1596	Swiss National Science Foundation [3100A0114137]; ETH; Krebsliga Zentralschweiz; FP-6 European Union Framework Programme Project [LSHM-CT-2004-005272]; French Agence Nationale de Recherche	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH(ETH Zurich); Krebsliga Zentralschweiz; FP-6 European Union Framework Programme Project(European Commission); French Agence Nationale de Recherche(French National Research Agency (ANR))	This work was supported by Swiss National Science Foundation Grant 3100A0114137, ETH graduate student grants (to R. F. T. and R. S.), the Krebsliga Zentralschweiz (to D. N.), FP-6 European Union Framework Programme Project LSHM-CT-2004-005272 EXGENESIS, INSERM, and the French Agence Nationale de Recherche ("Chaire d'Excellence" given to U.S.).	Amodeo GA, 2007, NATURE, V449, P492, DOI 10.1038/nature06127; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bellon S, 1999, STRUCTURE, V7, P1057, DOI 10.1016/S0969-2126(99)80173-7; Carling D, 2005, BIOCHIMIE, V87, P87, DOI 10.1016/j.biochi.2004.10.017; Chebotareva NA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1239, DOI 10.1007/s10541-005-0070-y; Cheetham GMT, 2002, J BIOL CHEM, V277, P42419, DOI 10.1074/jbc.C200426200; Chen ZP, 1999, FEBS LETT, V460, P343, DOI 10.1016/S0014-5793(99)01371-X; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Ellis RJ, 2003, NATURE, V425, P27, DOI 10.1038/425027a; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; FULTON AB, 1982, CELL, V30, P345, DOI 10.1016/0092-8674(82)90231-8; GROEN AK, 1982, EUR J BIOCHEM, V122, P87, DOI 10.1111/j.1432-1033.1982.tb05851.x; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; Hardie DG, 2008, FEBS LETT, V582, P81, DOI 10.1016/j.febslet.2007.11.018; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 1999, BIOCHEM SOC SYMP, P13; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; HJERTEN S, 1962, ARCH BIOCHEM BIOPHYS, V99, P466, DOI 10.1016/0003-9861(62)90295-3; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Huang JH, 2003, BIOCHEM BIOPH RES CO, V303, P532, DOI 10.1016/S0006-291X(03)00387-5; Huang X, 2003, STRUCTURE, V11, P21, DOI 10.1016/S0969-2126(02)00937-1; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Hudson ER, 2003, CURR BIOL, V13, P861, DOI 10.1016/S0960-9822(03)00249-5; Jin XS, 2007, STRUCTURE, V15, P1285, DOI 10.1016/j.str.2007.07.017; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Klumpp S, 2006, BIOCHEM SOC T, V34, P1370, DOI 10.1042/BST0341370; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Marley AE, 1996, BIOCHEM J, V320, P801, DOI 10.1042/bj3200801; Mitchelhill KI, 1997, J BIOL CHEM, V272, P24475, DOI 10.1074/jbc.272.39.24475; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Nayak V, 2006, STRUCTURE, V14, P477, DOI 10.1016/j.str.2005.12.008; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Neumann D, 2003, BIOCHEM SOC T, V31, P169, DOI 10.1042/bst0310169; Neumann D, 2007, MOL BIOTECHNOL, V36, P220, DOI 10.1007/s12033-007-0029-x; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Pellicena P, 2006, CURR OPIN STRUC BIOL, V16, P702, DOI 10.1016/j.sbi.2006.10.007; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Riek U, 2008, J BIOL CHEM, V283, P18331, DOI 10.1074/jbc.M708379200; Riek Uwe, 2009, Biotechniques, V46, pix, DOI 10.2144/000113130; Rosenberg OS, 2006, FEBS J, V273, P682, DOI 10.1111/j.1742-4658.2005.05088.x; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Rudolph MJ, 2005, BIOCHEM BIOPH RES CO, V337, P1224, DOI 10.1016/j.bbrc.2005.09.181; Saks V, 2008, INT J MOL SCI, V9, P751, DOI 10.3390/ijms9050751; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sanz P, 2008, CURR PROTEIN PEPT SC, V9, P478, DOI 10.2174/138920308785915254; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Taylor SS, 2005, CELL, V122, P823, DOI 10.1016/j.cell.2005.09.007; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Tokumitsu H, 2000, J BIOL CHEM, V275, P20090, DOI 10.1074/jbc.M002193200; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Tu Z, 2003, CELL SIGNAL, V15, P65, DOI 10.1016/S0898-6568(02)00056-6; Tuerk RD, 2009, ANAL BIOCHEM, V390, P141, DOI 10.1016/j.ab.2009.04.015; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Wang ZL, 1997, P NATL ACAD SCI USA, V94, P2327, DOI 10.1073/pnas.94.6.2327; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	90	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27425	27437		10.1074/jbc.M109.047670	http://dx.doi.org/10.1074/jbc.M109.047670			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651772	hybrid, Green Published			2022-12-27	WOS:000270232300045
J	Deng, XY; Gujjar, R; El Mazouni, F; Kaminsky, W; Malmquist, NA; Goldsmith, EJ; Rathod, PK; Phillips, MA				Deng, Xiaoyi; Gujjar, Ramesh; El Mazouni, Farah; Kaminsky, Werner; Malmquist, Nicholas A.; Goldsmith, Elizabeth J.; Rathod, Pradipsinh K.; Phillips, Margaret A.			Structural Plasticity of Malaria Dihydroorotate Dehydrogenase Allows Selective Binding of Diverse Chemical Scaffolds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN FLEXIBILITY; INHIBITORS; IDENTIFICATION; COMPLEXES; DESIGN; POTENT; BIOSYNTHESIS; EXPRESSION; ENZYMES; REVEAL	Malaria remains a major global health burden and current drug therapies are compromised by resistance. Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) was validated as a new drug target through the identification of potent and selective triazolopyrimidine-based DHODH inhibitors with anti-malarial activity in vivo. Here we report x-ray structure determination of PfDHODH bound to three inhibitors from this series, representing the first of the enzyme bound to malaria specific inhibitors. We demonstrate that conformational flexibility results in an unexpected binding mode identifying a new hydrophobic pocket on the enzyme. Importantly this plasticity allows PfDHODH to bind inhibitors from different chemical classes and to accommodate inhibitor modifications during lead optimization, increasing the value of PfDHODH as a drug target. A second discovery, based on small molecule crystallography, is that the triazolopyrimidines populate a resonance form that promotes charge separation. These intrinsic dipoles allow formation of energetically favorable H-bond interactions with the enzyme. The importance of delocalization to binding affinity was supported by site-directed mutagenesis and the demonstration that triazolopyrimidine analogs that lack this intrinsic dipole are inactive. Finally, the PfDHODH-triazolopyrimidine bound structures provide considerable new insight into species-selective inhibitor binding in this enzyme family. Together, these studies will directly impact efforts to exploit PfDHODH for the development of anti-malarial chemotherapy.	[Gujjar, Ramesh; Kaminsky, Werner; Rathod, Pradipsinh K.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Deng, Xiaoyi; El Mazouni, Farah; Malmquist, Nicholas A.; Phillips, Margaret A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Gujjar, Ramesh; Kaminsky, Werner; Rathod, Pradipsinh K.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Goldsmith, Elizabeth J.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Washington; University of Washington Seattle; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Southwestern Medical Center Dallas	Rathod, PK (corresponding author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.	rathod@chem.washington.edu; margaret.phillips@UTSouthwestern.edu	Deng, Xiaoyi/E-4394-2011; Kaminsky, Werner/AAF-2578-2020	Kaminsky, Werner/0000-0002-9100-4909; Malmquist, Nicholas/0000-0003-2822-8245	National Institutes of Health [U01AI075594, AI053680]; Malaria Medicines Venture; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053680, R21AI053680, R56AI053680, U01AI075594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Malaria Medicines Venture; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants U01AI075594 and AI053680 (to M. A. P. and P. K. R.). This work was also supported by a grant from Malaria Medicines Venture (to M. A. P. and P. K. R.).	Altomare A, 1999, J APPL CRYSTALLOGR, V32, P115, DOI 10.1107/S0021889898007717; Amaro RE, 2008, J COMPUT AID MOL DES, V22, P693, DOI 10.1007/s10822-007-9159-2; B-Rao C, 2009, DRUG DISCOV TODAY, V14, P394, DOI 10.1016/j.drudis.2009.01.003; Baldwin J, 2005, J BIOL CHEM, V280, P21847, DOI 10.1074/jbc.M501100200; Baldwin J, 2002, J BIOL CHEM, V277, P41827, DOI 10.1074/jbc.M206854200; Baumgartner R, 2006, J MED CHEM, V49, P1239, DOI 10.1021/jm0506975; Boa AN, 2005, BIOORGAN MED CHEM, V13, P1945, DOI 10.1016/j.bmc.2005.01.017; Bowman AL, 2007, J AM CHEM SOC, V129, P3634, DOI 10.1021/ja068256d; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Chene P, 2008, DRUG DISCOV TODAY, V13, P522, DOI 10.1016/j.drudis.2008.03.023; Copeland RA, 2000, J BIOL CHEM, V275, P33373, DOI 10.1074/jbc.M004451200; COPELAND RA, 1995, ARCH BIOCHEM BIOPHYS, V323, P79, DOI 10.1006/abbi.1995.0012; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P750, DOI 10.1107/S0907444997016247; Crespo A, 2008, MOL PHARMACEUT, V5, P430, DOI 10.1021/mp700148h; DeLano W.L., 2000, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farrugia L.J., 1997, J APPL CRYSTALLOGR, V30, P565, DOI 10.1107/S0021889897003117; FLACK HD, 1983, ACTA CRYSTALLOGR A, V39, P876, DOI 10.1107/S0108767383001762; Goldenberg MM, 1999, CLIN THER, V21, P1837, DOI 10.1016/S0149-2918(00)86732-6; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Gujjar R, 2009, J MED CHEM, V52, P1864, DOI 10.1021/jm801343r; GUTTERIDGE WE, 1970, J PROTOZOOL, V17, P89, DOI 10.1111/j.1550-7408.1970.tb05163.x; Heikkila T, 2006, BIOORG MED CHEM LETT, V16, P88, DOI 10.1016/j.bmcl.2005.09.045; Heikkila T, 2007, J MED CHEM, V50, P186, DOI 10.1021/jm060687j; Hornak V, 2007, DRUG DISCOV TODAY, V12, P132, DOI 10.1016/j.drudis.2006.12.011; Hurt DE, 2006, ACTA CRYSTALLOGR D, V62, P312, DOI 10.1107/S0907444905042642; JONES ME, 1980, ANNU REV BIOCHEM, V49, P253, DOI 10.1146/annurev.bi.49.070180.001345; KABSCH W, 1976, J MOL BIOL, V100, P283, DOI 10.1016/S0022-2836(76)80064-2; KIM HD, 1991, BIOCHEMISTRY-US, V30, P8171, DOI 10.1021/bi00247a012; Kleywegt G.J., 1994, PROTEIN CRYSTALLOGR, V31, P9; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P1878, DOI 10.1107/S0907444999010495; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Knecht W, 1998, BIOCHEM PHARMACOL, V56, P1259, DOI 10.1016/S0006-2952(98)00145-2; LAKASCHUS G, 1992, BIOCHEM PHARMACOL, V43, P1025, DOI 10.1016/0006-2952(92)90609-M; Liu SP, 2000, STRUCT FOLD DES, V8, P25, DOI 10.1016/S0969-2126(00)00077-0; Malmquist NA, 2008, BIOCHEMISTRY-US, V47, P2466, DOI 10.1021/bi702218c; MARCH J, 2006, ADV ORGANIC CHEM REA, P21; McCammon JA, 2005, BBA-PROTEINS PROTEOM, V1754, P221, DOI 10.1016/j.bbapap.2005.07.041; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAGY M, 1992, P NATL ACAD SCI USA, V89, P8966, DOI 10.1073/pnas.89.19.8966; Olsen NJ, 2004, NEW ENGL J MED, V350, P2167, DOI 10.1056/NEJMra032906; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Patel V, 2008, J BIOL CHEM, V283, P35078, DOI 10.1074/jbc.M804990200; Phillips MA, 2008, J MED CHEM, V51, P3649, DOI 10.1021/jm8001026; REYES P, 1982, MOL BIOCHEM PARASIT, V5, P275, DOI 10.1016/0166-6851(82)90035-4; Rosenthal PJ, 2008, NEW ENGL J MED, V358, P1829, DOI 10.1056/NEJMct0709050; Sheldrick G.M., 2015, ACTA CRYSTALLOGR C, V71, P3; Srivastava IK, 1999, MOL MICROBIOL, V33, P704, DOI 10.1046/j.1365-2958.1999.01515.x; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; Ullrich A, 2001, EUR J BIOCHEM, V268, P1861, DOI 10.1046/j.1432-1033.2001.02061.x; WAASMAIER D, 1995, ACTA CRYSTALLOGR A, V51, P416, DOI 10.1107/S0108767394013292; Walse B, 2008, BIOCHEMISTRY-US, V47, P8929, DOI 10.1021/bi8003318; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]	56	89	92	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26999	27009		10.1074/jbc.M109.028589	http://dx.doi.org/10.1074/jbc.M109.028589			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19640844	Green Published, hybrid			2022-12-27	WOS:000269969600079
J	Feliciano, DM; Edelman, AM				Feliciano, David M.; Edelman, Arthur M.			Repression of Ca2+/Calmodulin-dependent Protein Kinase IV Signaling Accelerates Retinoic Acid-induced Differentiation of Human Neuroblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; NEOCORTICAL VENTRICULAR ZONE; DEPENDENT GENE-EXPRESSION; THYROID-HORMONE; NEURONAL DEVELOPMENT; MOLECULAR-CLONING; NERVOUS-SYSTEM; CREB FAMILY; STEM-CELLS; TRANSCRIPTIONAL REGULATION	Neuroblastoma cells having stem cell-like qualities are widely employed models for the study of neural stem/progenitor cell proliferation and differentiation. We find that human BE(2) C neuroblastoma cells possess a signaling cascade initiated by Ca2+ influx via voltage-dependent calcium channels and the N-methyl-D-aspartate (NMDA) receptor and culminating in nuclear calmodulin-dependent protein kinase IV (CaMKIV)-mediated phosphorylation and activation of the transcription factors Ca2+/cyclic AMP-response element-binding protein (CREB) and ATF1 (activating transcription factor-1). This pathway functions to maintain BE(2) C cells in an undifferentiated, proliferative state. Parallel to this Ca2+-dependent pathway is a hormone-responsive program by which retinoic acid (RA) initiates the differentiation of BE(2) C cells toward a neuronal lineage. This is evidenced by RA-dependent induction of the cell cycle inhibitor p21/Cip1 (Cdk-interacting protein 1) and cell cycle arrest, induction of the neuroblastic marker doublecortin and of the neuron-specific intermediate filament protein, peripherin, and by RA-stimulated extension of neuritic processes. During neuronal differentiation there is a complex antagonistic interplay between these two major signaling pathways. RA down-regulates expression of CaMKIV and one of its upstream activators, CaMKK1 (calmodulin-dependent protein kinase kinase 1). This is accompanied by RA-induced suppression of activating phosphorylation of CREB with a time course paralleling that of CaMKIV down-regulation. RA-induced repression of the Ca2+/calmodulin-dependent protein kinase kinase/CaMKIV/CREB pathway appears to be involved in regulating the timing of neuronal differentiation, as shown by the effect of RNA interference of CaMKIV to markedly accelerate RA-dependent up-regulation of p21/Cip1 and doublecortin expression and RA-promoted neurite outgrowth. RA-induced repression of the CaMKIV signaling pathway may represent an early event in retinoid-dependent neuronal differentiation.	[Feliciano, David M.; Edelman, Arthur M.] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Edelman, AM (corresponding author), SUNY Buffalo, Dept Pharmacol & Toxicol, 102 Farber Hall,3435 Main St, Buffalo, NY 14214 USA.	aedelman@acsu.buffalo.edu	Feliciano, David/ADM-6724-2022	Feliciano, David/0000-0001-5985-9109	National Institutes of Health [R21NS050385]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS050385] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R21NS050385.	Aletta JM, 1996, J BIOL CHEM, V271, P20930, DOI 10.1074/jbc.271.34.20930; Ammer H, 1997, NEUROSCI LETT, V230, P143, DOI 10.1016/S0304-3940(97)00495-3; Anderson KA, 2004, J BIOL CHEM, V279, P31708, DOI 10.1074/jbc.M404523200; Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Anderson KA, 1997, MOL ENDOCRINOL, V11, P725, DOI 10.1210/me.11.6.725; Arnould T, 2002, EMBO J, V21, P53, DOI 10.1093/emboj/21.1.53; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bloodgood BL, 2007, CURR OPIN NEUROBIOL, V17, P345, DOI 10.1016/j.conb.2007.04.003; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Chow FA, 2005, J BIOL CHEM, V280, P20530, DOI 10.1074/jbc.M500067200; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Colomer J., 2007, V45, P169; Cui HJ, 2006, J BIOL CHEM, V281, P34696, DOI 10.1074/jbc.M604009200; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Edelman AM, 1996, J BIOL CHEM, V271, P10806, DOI 10.1074/jbc.271.18.10806; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Fuchs E, 2000, EUR J NEUROSCI, V12, P2211, DOI 10.1046/j.1460-9568.2000.00130.x; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; GORHAM JD, 1990, DEV BRAIN RES, V57, P235, DOI 10.1016/0165-3806(90)90049-5; Hansen MR, 2003, J NEUROSCI RES, V72, P169, DOI 10.1002/jnr.10551; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; ISHII K, 1990, J CELL PHYSIOL, V143, P569, DOI 10.1002/jcp.1041430323; JENSEN KF, 1991, P NATL ACAD SCI USA, V88, P2850, DOI 10.1073/pnas.88.7.2850; Kane CD, 2000, EMBO J, V19, P691, DOI 10.1093/emboj/19.4.691; Kasahara J, 2001, J BIOL CHEM, V276, P24044, DOI 10.1074/jbc.M100247200; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kim B, 1997, J BIOL CHEM, V272, P21268, DOI 10.1074/jbc.272.34.21268; Kitani T, 1997, J BIOCHEM-TOKYO, V122, P243; Kitsos CM, 2005, J BIOL CHEM, V280, P33101, DOI 10.1074/jbc.M505208200; Kotera I, 2005, EMBO J, V24, P942, DOI 10.1038/sj.emboj.7600587; Krebs J, 1996, J BIOL CHEM, V271, P11055, DOI 10.1074/jbc.271.19.11055; Lawson ND, 1999, EXP HEMATOL, V27, P1682, DOI 10.1016/S0301-472X(99)00108-3; Lee MM, 1999, J NEUROSCI RES, V55, P702, DOI 10.1002/(SICI)1097-4547(19990315)55:6<702::AID-JNR5>3.3.CO;2-E; Lemrow SM, 2004, J BIOL CHEM, V279, P11664, DOI 10.1074/jbc.M312613200; Liu YY, 2005, ENDOCRINOLOGY, V146, P776, DOI 10.1210/en.2004-1177; Liu YY, 2002, MOL ENDOCRINOL, V16, P2439, DOI 10.1210/me.2001-0324; Long FX, 2001, DEVELOPMENT, V128, P541; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; Matsushita M, 1999, J BIOL CHEM, V274, P10086, DOI 10.1074/jbc.274.15.10086; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; Mckenzie GJ, 2005, J NEUROCHEM, V93, P171, DOI 10.1111/j.1471-4159.2005.03010.x; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Miska EA, 2001, NUCLEIC ACIDS RES, V29, P3439, DOI 10.1093/nar/29.16.3439; MOORE TB, 1995, J PEDIAT HEMATOL ONC, V17, P311, DOI 10.1097/00043426-199511000-00006; Owens DF, 2000, DEV NEUROSCI-BASEL, V22, P25, DOI 10.1159/000017424; Owens DF, 1998, J NEUROSCI, V18, P5374, DOI 10.1523/JNEUROSCI.18-14-05374.1998; Perez-Garcia MJ, 2008, J BIOL CHEM, V283, P4133, DOI 10.1074/jbc.M705477200; Perez-Juste G, 1999, ONCOGENE, V18, P5393, DOI 10.1038/sj.onc.1202906; Perez-Juste G, 1999, J BIOL CHEM, V274, P5026, DOI 10.1074/jbc.274.8.5026; Ribar TJ, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0004.2000; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; ROSS RA, 1995, CELL GROWTH DIFFER, V6, P449; Ross RA, 2007, SEMIN CANCER BIOL, V17, P241, DOI 10.1016/j.semcancer.2006.04.006; Sato K, 2006, NAT MED, V12, P1410, DOI 10.1038/nm1515; See V, 2001, FASEB J, V15, P134, DOI 10.1096/fj.00-0106com; SELBERT MA, 1995, J BIOL CHEM, V270, P17616, DOI 10.1074/jbc.270.29.17616; STRUTHERS RS, 1991, NATURE, V350, P622, DOI 10.1038/350622a0; Sucharov CC, 2006, AM J PHYSIOL-CELL PH, V291, pC1029, DOI 10.1152/ajpcell.00059.2006; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Sun PQ, 1996, J BIOL CHEM, V271, P3066, DOI 10.1074/jbc.271.6.3066; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; Tokumitsu H, 2004, J BIOL CHEM, V279, P40296, DOI 10.1074/jbc.M406534200; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; TOKUMITSU H, 1995, J BIOL CHEM, V270, P19320, DOI 10.1074/jbc.270.33.19320; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Wang SL, 2001, CELL GROWTH DIFFER, V12, P351; Wayman GA, 2000, J CELL BIOL, V151, P811, DOI 10.1083/jcb.151.4.811; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; Westphal RS, 1998, SCIENCE, V280, P1258, DOI 10.1126/science.280.5367.1258; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Wu JY, 2000, NAT GENET, V25, P448, DOI 10.1038/78153; Yamamori E, 2004, J MOL ENDOCRINOL, V33, P639, DOI 10.1677/jme.1.01415; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221	81	19	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26466	26481		10.1074/jbc.M109.027680	http://dx.doi.org/10.1074/jbc.M109.027680			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19633294	hybrid, Green Published			2022-12-27	WOS:000269969600028
J	Kikuchi, K; Abdel-Aziz, HI; Taniguchi, Y; Yamazoe, M; Takeda, S; Hirota, K				Kikuchi, Koji; Abdel-Aziz, H. Ismail; Taniguchi, Yoshihito; Yamazoe, Mitsuyoshi; Takeda, Shunichi; Hirota, Kouji			Bloom DNA Helicase Facilitates Homologous Recombination between Diverged Homologous Sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; SISTER-CHROMATID EXCHANGES; V GENE CONVERSION; CHROMOSOMAL INTEGRITY; RECQ HELICASES; SGS1 HELICASE; DEAMINASE AID; RESECT DNA; BLM; ROLES	Bloom syndrome caused by inactivation of the Bloom DNA helicase (Blm) is characterized by increases in the level of sister chromatid exchange, homologous recombination (HR) associated with cross-over. It is therefore believed that Blm works as an anti-recombinase. Meanwhile, in Drosophila, DmBlm is required specifically to promote the synthesis-dependent strand anneal (SDSA), a type of HR not associating with cross-over. However, conservation of Blm function in SDSA through higher eukaryotes has been a matter of debate. Here, we demonstrate the function of Blm in SDSA type HR in chicken DT40 B lymphocyte line, where Ig gene conversion diversifies the immunoglobulin V gene through intragenic HR between diverged homologous segments. This reaction is initiated by the activation-induced cytidine deaminase enzyme-mediated uracil formation at the V gene, which in turn converts into abasic site, presumably leading to a single strand gap. Ig gene conversion frequency was drastically reduced in BLM-/- cells. In addition, BLM-/- cells used limited donor segments harboring higher identity compared with other segments in Ig gene conversion event, suggesting that Blm can promote HR between diverged sequences. To further understand the role of Blm in HR between diverged homologous sequences, we measured the frequency of gene targeting induced by an I-SceI-endonuclease-mediated double-strand break. BLM-/- cells showed a severer defect in the gene targeting frequency as the number of heterologous sequences increased at the double-strand break site. Conversely, the overexpression of Blm, even an ATPase-defective mutant, strongly stimulated gene targeting. In summary, Blm promotes HR between diverged sequences through a novel ATPase-independent mechanism.	[Kikuchi, Koji; Abdel-Aziz, H. Ismail; Taniguchi, Yoshihito; Yamazoe, Mitsuyoshi; Takeda, Shunichi; Hirota, Kouji] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Hirota, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Sakyo Ku, Kyoto 6068501, Japan.	khirota@rg.med.kyoto-u.ac.jp	Kikuchi, Koji/W-1048-2017; Taniguchi, Yoshihito/L-5746-2013	Kikuchi, Koji/0000-0002-7616-8200; Takeda, Shunichi/0000-0002-7924-7991; Manhi, Hoida/0000-0003-3503-211X	Program for Promotion of Basic Research Activities for Innovative Biosciences; Uehara Memorial Foundation; Naito Foundation; Kanae Foundation; NATIONAL CANCER INSTITUTE [R01CA100839, R56CA100839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH084119] Funding Source: NIH RePORTER	Program for Promotion of Basic Research Activities for Innovative Biosciences; Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Kanae Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by funds from the Program for Promotion of Basic Research Activities for Innovative Biosciences (to S. T.), grants from the Uehara Memorial Foundation and the Naito Foundation (to S. T.), and grants from the Kanae Foundation (to K. K.).	Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Branzei D, 2008, NATURE, V456, P915, DOI 10.1038/nature07587; BUERSTEDDE JM, 1990, EMBO J, V9, P921, DOI 10.1002/j.1460-2075.1990.tb08190.x; Bugreev DV, 2009, J BIOL CHEM, V284, P26349, DOI 10.1074/jbc.M109.029371; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Cobb JA, 2006, NUCLEIC ACIDS RES, V34, P4106, DOI 10.1093/nar/gkl557; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Flajnik MF, 2002, NAT REV IMMUNOL, V2, P688, DOI 10.1038/nri889; Fujimori A, 2001, EMBO J, V20, P5513, DOI 10.1093/emboj/20.19.5513; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Harris RS, 2002, CURR BIOL, V12, P435, DOI 10.1016/S0960-9822(02)00717-0; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; Imamura O, 2002, ONCOGENE, V21, P954, DOI 10.1038/sj.onc.1205143; Inbar O, 1999, MOL CELL BIOL, V19, P4134; Jessop L, 2008, MOL CELL, V31, P313, DOI 10.1016/j.molcel.2008.05.021; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Kawamoto T, 2005, MOL CELL, V20, P793, DOI 10.1016/j.molcel.2005.10.016; Kikuchi K, 2005, MOL CELL BIOL, V25, P6948, DOI 10.1128/MCB.25.16.6948-6955.2005; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kohzaki M, 2007, MOL CELL BIOL, V27, P2812, DOI 10.1128/MCB.02043-06; Lanning D, 2000, IMMUNOL REV, V175, P214, DOI 10.1034/j.1600-065X.2000.017516.x; McVey M, 2004, P NATL ACAD SCI USA, V101, P15694, DOI 10.1073/pnas.0406157101; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nakahara M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000356; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Oh SD, 2008, MOL CELL, V31, P324, DOI 10.1016/j.molcel.2008.07.006; Otsuki M, 2007, J CELL BIOL, V179, P53, DOI 10.1083/jcb.200702183; Otsuki M, 2007, BIOCHEM BIOPH RES CO, V355, P477, DOI 10.1016/j.bbrc.2007.01.175; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paques F, 1997, MOL CELL BIOL, V17, P6765, DOI 10.1128/MCB.17.11.6765; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; Saberi A, 2008, MOL CELL BIOL, V28, P6113, DOI 10.1128/MCB.00156-08; Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100; Seo H, 2005, NAT BIOTECHNOL, V23, P731, DOI 10.1038/nbt1092; So S, 2006, GENES CELLS, V11, P363, DOI 10.1111/j.1365-2443.2006.00944.x; So S, 2004, J BIOL CHEM, V279, P55433, DOI 10.1074/jbc.M409827200; Sonoda E, 2003, EMBO J, V22, P3188, DOI 10.1093/emboj/cdg308; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Takeda S, 2007, MOL CELL, V28, P351, DOI 10.1016/j.molcel.2007.10.016; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	52	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26360	26367		10.1074/jbc.M109.029348	http://dx.doi.org/10.1074/jbc.M109.029348			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19661064	Green Published, hybrid			2022-12-27	WOS:000269969600016
J	Tissieres, P; Araud, T; Ochoda, A; Drifte, G; Dunn-Siegrist, I; Pugin, J				Tissieres, Pierre; Araud, Tanguy; Ochoda, Agnieszka; Drifte, Genevieve; Dunn-Siegrist, Irene; Pugin, Jerome			Cooperation between PU.1 and CAAT/Enhancer-binding Protein beta Is Necessary to Induce the Expression of the MD-2 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL REGULATION; PROMOTER ARCHITECTURE; TRANSCRIPTION FACTORS; MESSENGER-RNAS; SOLUBLE MD-2; TLR4; ETS; LIPOPOLYSACCHARIDE; RESPONSIVENESS; ASSOCIATION	Myeloid differentiation factor 2 (MD-2) binds Gram-negative bacterial lipopolysaccharide with high affinity and is essential for Toll-like receptor 4-dependent signal transduction. MD-2 has recently been recognized as a type II acute phase protein. Plasma concentrations of the soluble form of MD-2 increase markedly during the course of severe infections. Its production is regulated in hepatocytes and myeloid cells by interleukin-6 (IL-6) but not IL-1 beta. In the present work we show that two transcription factors (TF), PU.1 and CAAT/enhancer-binding protein beta (C/EBP beta), participate in the activation of the human MD-2 gene in hepatocytic cells after stimulation with IL-6. PU.1 TF and proximal PU.1 binding sites in the MD-2 promoter were shown to be critical for the basal activity of the promoter as well as for IL-6-induced soluble MD-2 production. Deletions of proximal portions of the MD-2 promoter containing PU.1 and/or NF-IL-6 consensus binding sites as well as site-directed mutagenesis of these binding sites abrogated IL-6-dependent MD-2 gene activation. We show that the cooperation between C/EBP beta and PU.1 is critical for the transcriptional activation of the MD-2 gene by IL-6. PU.1 was essentially known as a TF involved in the differentiation of myeloid precursor cells and the expression of surface receptors of the innate immunity. Herein, we show that it also participates in the regulation of an acute phase protein, MD-2, in nonmyeloid cells cooperatively with C/EBP beta, a classical IL-6-inducible TF.	[Tissieres, Pierre; Ochoda, Agnieszka; Drifte, Genevieve; Dunn-Siegrist, Irene; Pugin, Jerome] Univ Hosp Geneva, CH-1211 Geneva 14, Switzerland; [Tissieres, Pierre; Araud, Tanguy; Ochoda, Agnieszka; Drifte, Genevieve; Dunn-Siegrist, Irene; Pugin, Jerome] Univ Geneva, Fac Med, Dept Microbiol & Mol Med, CH-1211 Geneva 14, Switzerland	University of Geneva; University of Geneva	Pugin, J (corresponding author), Univ Hosp Geneva, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.	jerome.pugin@unige.ch			Boninchi Foundation; Novartis Consumer Health Foundation; Roche Research Foundation [12-2005]; Swiss National Foundation for Scientific Research [32-105770]	Boninchi Foundation; Novartis Consumer Health Foundation; Roche Research Foundation; Swiss National Foundation for Scientific Research(Swiss National Science Foundation (SNSF))	This work was supported by the Boninchi Foundation, the Novartis Consumer Health Foundation, Roche Research Foundation Grant 12-2005, and Swiss National Foundation for Scientific Research Grant 32-105770.	Abreu MT, 2002, J BIOL CHEM, V277, P20431, DOI 10.1074/jbc.M110333200; Berclaz PY, 2007, AM J RESP CELL MOL, V36, P114, DOI 10.1165/rcmb.2006-0174OC; Bondeva T, 2007, AM J NEPHROL, V27, P308, DOI 10.1159/000102551; Bosisio D, 2002, BLOOD, V99, P3427, DOI 10.1182/blood.V99.9.3427; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; GRABE N, 1998, MOLEKULARE BIOINFORM; Grondin B, 2007, MOL CELL BIOL, V27, P2919, DOI 10.1128/MCB.00936-06; HAGEMEIER C, 1993, P NATL ACAD SCI USA, V90, P1580, DOI 10.1073/pnas.90.4.1580; HATTORI M, 1990, P NATL ACAD SCI USA, V87, P2364, DOI 10.1073/pnas.87.6.2364; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; HOHAUS S, 1995, MOL CELL BIOL, V15, P5830; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Jain V, 2008, BLOOD, V111, P4637, DOI 10.1182/blood-2007-11-126862; Kalvakolanu DV, 2005, J INTERF CYTOK RES, V25, P757, DOI 10.1089/jir.2005.25.757; Li CL, 2008, BIOL CELL, V100, P365, DOI 10.1042/BC20070140; Liang MD, 2006, J BIOL CHEM, V281, P9227, DOI 10.1074/jbc.M510700200; Lichtinger M, 2007, J BIOL CHEM, V282, P26874, DOI 10.1074/jbc.M703856200; MARUYAMA K, 1994, GENE, V138, P171; Mouri F, 2008, EUR J HAEMATOL, V80, P10, DOI 10.1111/j.1600-0609.2007.00981.x; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; NAGULAPALLI S, 1995, J IMMUNOL, V155, P4330; Ohta S, 2004, BIOCHEM BIOPH RES CO, V323, P1103, DOI 10.1016/j.bbrc.2004.08.203; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Nicola JP, 2009, ENDOCRINOLOGY, V150, P500, DOI 10.1210/en.2008-0345; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; Pugin J, 2004, BLOOD, V104, P4071, DOI 10.1182/blood-2003-04-1290; Reddy VA, 2002, BLOOD, V100, P483, DOI 10.1182/blood.V100.2.483; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Roger T, 2005, BIOCHEM J, V387, P355, DOI 10.1042/BJ20041243; Ross IL, 1998, J BIOL CHEM, V273, P6662, DOI 10.1074/jbc.273.12.6662; Sandanger O, 2009, J IMMUNOL, V182, P588, DOI 10.4049/jimmunol.182.1.588; SCOTT GK, 1994, J BIOL CHEM, V269, P19848; Scott MJ, 2008, J BIOL CHEM, V283, P29433, DOI 10.1074/jbc.M803905200; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Teghanemt A, 2008, J BIOL CHEM, V283, P21881, DOI 10.1074/jbc.M800672200; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Tissieres P, 2008, BLOOD, V111, P2122, DOI 10.1182/blood-2007-06-097782; Tissieres P, 2009, CURR OPIN INFECT DIS, V22, P286, DOI 10.1097/QCO.0b013e32832ae2fc; Tsukada J, 1997, BLOOD, V90, P3142, DOI 10.1182/blood.V90.8.3142; Viriyakosol S, 2006, J BIOL CHEM, V281, P11955, DOI 10.1074/jbc.M511627200; Wolfs TGAM, 2008, MOL IMMUNOL, V45, P3268, DOI 10.1016/j.molimm.2008.02.014; Yang ZY, 2000, J BIOL CHEM, V275, P21272, DOI 10.1074/jbc.M000145200; Yeamans C, 2007, BLOOD, V110, P3136, DOI 10.1182/blood-2007-03-080291; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554	49	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26261	26272		10.1074/jbc.M109.042580	http://dx.doi.org/10.1074/jbc.M109.042580			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19632992	Green Published, hybrid			2022-12-27	WOS:000269969600006
J	Keyamura, K; Abe, Y; Higashi, M; Ueda, T; Katayama, T				Keyamura, Kenji; Abe, Yoshito; Higashi, Masahiro; Ueda, Tadashi; Katayama, Tsutomu			DiaA Dynamics Are Coupled with Changes in Initial Origin Complexes Leading to Helicase Loading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CHROMOSOME; DNAA-ATP HYDROLYSIS; HUMAN GINS COMPLEX; N-TERMINAL DOMAIN; REPLICATION-ORIGIN; HELICOBACTER-PYLORI; PROTEIN COMPLEXES; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; E. COLI	Chromosomal replication initiation requires the regulated formation of dynamic higher order complexes. Escherichia coli ATP-DnaA forms a specific multimer on oriC, resulting in DNA unwinding and DnaB helicase loading. DiaA, a DnaA-binding protein, directly stimulates the formation of ATP-DnaA multimers on oriC and ensures timely replication initiation. In this study, DnaA Phe-46 was identified as the crucial DiaA-binding site required for DiaA-stimulated ATP-DnaA assembly on oriC. Moreover, we show that DiaA stimulation requires only a subgroup of DnaA molecules binding to oriC, that DnaA Phe-46 is also important in the loading of DnaB helicase onto the oriC-DnaA complexes, and that this process also requires only a subgroup of DnaA molecules. Despite the use of only a DnaA subgroup, DiaA inhibited DnaB loading on oriC-DnaA complexes, suggesting that DiaA and DnaB bind to a common DnaA subgroup. Acellular factor can relieve the DiaA inhibition, allowing DnaB loading. Consistently, DnaA F46A caused retarded initiations in vivo in a DiaA-independent manner. It is therefore likely that DiaA dynamics are crucial in the regulated sequential progress of DnaA assembly and DnaB loading. We accordingly propose a model for dynamic structural changes of initial oriC complexes loading DiaA or DnaB helicase.	[Katayama, Tsutomu] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Higashi Ku, Fukuoka 8128582, Japan; [Abe, Yoshito; Ueda, Tadashi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Prot Struct Funct & Design, Fukuoka 8128582, Japan	Kyushu University; Kyushu University	Katayama, T (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	katayama@phar.kyuhsu-u.ac.jp	Abe, Yoshito/D-8370-2012; Abe, Yoshito/AAH-6141-2021	Abe, Yoshito/0000-0002-0016-8490; Abe, Yoshito/0000-0002-0016-8490; Katayama, Tsutomu/0000-0001-9994-1684	Ministry of Education, Culture, Sports, Technology and Science of Japan	Ministry of Education, Culture, Sports, Technology and Science of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Technology and Science of Japan.	Abe Y, 2007, BIOMOL NMR ASSIGM, V1, P57, DOI 10.1007/s12104-007-9015-2; Abe Y, 2007, J BIOL CHEM, V282, P17816, DOI 10.1074/jbc.M701841200; BAKER TA, 1986, CELL, V45, P53, DOI 10.1016/0092-8674(86)90537-4; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Chang P, 2000, J BIOL CHEM, V275, P26187, DOI 10.1074/jbc.M001800200; Chang YP, 2007, P NATL ACAD SCI USA, V104, P12685, DOI 10.1073/pnas.0705558104; Choi JM, 2007, GENE DEV, V21, P1316, DOI 10.1101/gad.1548107; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Fang LH, 1999, MOL CELL, V4, P541, DOI 10.1016/S1097-2765(00)80205-1; Felczak MM, 2005, J BIOL CHEM, V280, P24627, DOI 10.1074/jbc.M503684200; Felczak MM, 2004, J BIOL CHEM, V279, P51156, DOI 10.1074/jbc.M409695200; Fujikawa N, 2003, NUCLEIC ACIDS RES, V31, P2077, DOI 10.1093/nar/gkg309; Fujimitsu K, 2008, J BACTERIOL, V190, P5368, DOI 10.1128/JB.00044-08; Ishida T, 2004, J BIOL CHEM, V279, P45546, DOI 10.1074/jbc.M402762200; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Kamada K, 2007, NAT STRUCT MOL BIOL, V14, P388, DOI 10.1038/nsmb1231; Katayama T, 1998, CELL, V94, P61, DOI 10.1016/S0092-8674(00)81222-2; Kato J, 2001, EMBO J, V20, P4253, DOI 10.1093/emboj/20.15.4253; Kawakami H, 2005, J BIOL CHEM, V280, P27420, DOI 10.1074/jbc.M502764200; Kawakami H, 2006, MOL MICROBIOL, V62, P1310, DOI 10.1111/j.1365-2958.2006.05450.x; Keyamura K, 2007, GENE DEV, V21, P2083, DOI 10.1101/gad.1561207; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Kurokawa K, 1999, EMBO J, V18, P6642, DOI 10.1093/emboj/18.23.6642; Labib K, 2007, TRENDS CELL BIOL, V17, P271, DOI 10.1016/j.tcb.2007.04.002; MARSZALEK J, 1994, J BIOL CHEM, V269, P4883; MASAI H, 1990, J BIOL CHEM, V265, P15134; McGarry KC, 2004, P NATL ACAD SCI USA, V101, P2811, DOI 10.1073/pnas.0400340101; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Natrajan G, 2007, MOL MICROBIOL, V65, P995, DOI 10.1111/j.1365-2958.2007.05843.x; Neuwald AF, 1999, GENOME RES, V9, P27; Nozaki S, 2008, MICROBIOL-SGM, V154, P3379, DOI 10.1099/mic.0.2008/019745-0; O'Donnell M, 2006, J BIOL CHEM, V281, P10653, DOI 10.1074/jbc.R500028200; Ozaki S, 2008, J BIOL CHEM, V283, P8351, DOI 10.1074/jbc.M708684200; Polaczek P, 1997, MOL MICROBIOL, V26, P261, DOI 10.1046/j.1365-2958.1997.5701931.x; Riber L, 2009, MOL MICROBIOL, V71, P107, DOI 10.1111/j.1365-2958.2008.06516.x; Ryan VT, 2002, MOL MICROBIOL, V46, P113, DOI 10.1046/j.1365-2958.2002.03129.x; Seitz H, 2000, MOL MICROBIOL, V37, P1270, DOI 10.1046/j.1365-2958.2000.02096.x; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; Su'etsugu M, 2005, J BIOL CHEM, V280, P6528, DOI 10.1074/jbc.M412060200; Su'etsugu M, 2008, J BIOL CHEM, V283, P36118, DOI 10.1074/jbc.M803158200; Sutton MD, 1998, J BIOL CHEM, V273, P34255, DOI 10.1074/jbc.273.51.34255; Terradot L, 2004, MOL CELL PROTEOMICS, V3, P809, DOI 10.1074/mcp.M400048-MCP200; Zakrzewska-Czerwinska J, 2007, FEMS MICROBIOL REV, V31, P378, DOI 10.1111/j.1574-6976.2007.00070.x; Zawilak-Pawlik A, 2007, MOL MICROBIOL, V65, P979, DOI 10.1111/j.1365-2958.2007.05853.x	46	65	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25038	25050		10.1074/jbc.M109.002717	http://dx.doi.org/10.1074/jbc.M109.002717			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19632993	Green Published, hybrid			2022-12-27	WOS:000269734000039
J	Huang, CC; Chiribau, CB; Majumder, M; Chiang, CM; Wek, RC; Kelm, RJ; Khalili, K; Snider, MD; Hatzoglou, M				Huang, Charlie C.; Chiribau, Calin-Bogdan; Majumder, Mithu; Chiang, Cheng-Ming; Wek, Ronald C.; Kelm, Robert J., Jr.; Khalili, Kamel; Snider, Martin D.; Hatzoglou, Maria			A Bifunctional Intronic Element Regulates the Expression of the Arginine/Lysine Transporter Cat-1 via Mechanisms Involving the Purine-rich Element Binding Protein A (Pur alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOME ENTRY SITE; GENE-EXPRESSION; MESSENGER-RNA; MEDIATED TRANSLATION; RESPONSE ELEMENT; TRANSCRIPTION; ACTIVATION; DIFFERENTIATION; IDENTIFICATION; PROLIFERATION	Expression of the arginine/lysine transporter Cat-1 is highly induced in proliferating and stressed cells via mechanisms that include transcriptional activation. A bifunctional INE (intronic element) within the first intron of the Cat-1 gene was identified and characterized in this study. The INE had high sequence homology to an amino acid response element and was shown to act as a transcriptional enhancer in unstressed cells by binding the transcription factor, purine-rich element binding protein A (Pur alpha). During endoplasmic reticulum stress, binding of Pur alpha to the INE decreased; the element acted as a positive regulator in early stress by binding of the transcription factor ATF4 and as a negative regulator in prolonged stress by binding the stress-induced C/EBP family member, CHOP. We conclude that transcriptional control of the Cat-1 gene is tightly controlled by multiple cis-DNA elements, contributing to regulation of cationic amino acid transport for cell growth and proliferation. In addition, we propose that genes may use stress-response elements such as the INE to support basal expression in the absence of stress.	[Huang, Charlie C.; Chiribau, Calin-Bogdan; Majumder, Mithu; Hatzoglou, Maria] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Snider, Martin D.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Wek, Ronald C.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Kelm, Robert J., Jr.] Univ Vermont, Coll Med, Dept Med, Burlington, VT 05405 USA; [Khalili, Kamel] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA; [Khalili, Kamel] Temple Univ, Sch Med, Ctr Neurovirol, Philadelphia, PA 19122 USA	Case Western Reserve University; Case Western Reserve University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Indiana University System; Indiana University-Purdue University Indianapolis; University of Vermont; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Hatzoglou, M (corresponding author), Case Western Reserve Univ, Sch Med, Dept Nutr, 10900 Euclid Ave, Cleveland, OH 44106 USA.	mxh8@case.edu			National Institutes of Health [R01DK060596, R01DK053307, R01CA103867, R01CA124760]; NATIONAL CANCER INSTITUTE [R01CA124760, R01CA103867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060596, R01DK053307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK060596 and R01DK053307 (to M.H.) and R01CA103867 and R01CA124760 (to C.-M.C.).	Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Edinger AL, 2003, DEV CELL, V5, P571, DOI 10.1016/S1534-5807(03)00291-0; Fernandez J, 2005, MOL CELL, V17, P405, DOI 10.1016/j.molcel.2004.12.024; Fernandez J, 2003, J BIOL CHEM, V278, P50000, DOI 10.1074/jbc.M305903200; Fernandez J, 2002, J BIOL CHEM, V277, P11780, DOI 10.1074/jbc.M110778200; Fernandez J, 2001, J BIOL CHEM, V276, P12285, DOI 10.1074/jbc.M009714200; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hatzoglou M, 2004, ANNU REV NUTR, V24, P377, DOI 10.1146/annurev.nutr.23.011702.073120; Inoue T, 2009, PROSTATE, V69, P861, DOI 10.1002/pros.20936; Ji J, 2007, MOL CELL BIOL, V27, P1531, DOI 10.1128/MCB.00629-06; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Johnson EM, 2003, ANTICANCER RES, V23, P2093; Kaye DM, 2000, CIRCULATION, V102, P2707, DOI 10.1161/01.CIR.102.22.2707; Kelm RJ, 1999, J BIOL CHEM, V274, P14238, DOI 10.1074/jbc.274.20.14238; Khalili K, 2003, MOL CELL BIOL, V23, P6857, DOI 10.1128/MCB.23.19.6857-6875.2003; Kilberg M, 2002, J NUTR, V132, P1801, DOI 10.1093/jn/132.7.1801; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Lopez AB, 2007, BIOCHEM J, V402, P163, DOI 10.1042/BJ20060941; MEISTERERNST M, 1991, CELL, V66, P981, DOI 10.1016/0092-8674(91)90443-3; Palii SS, 2006, BIOCHEM J, V395, P517, DOI 10.1042/BJ20051867; Pan YX, 2007, BIOCHEM J, V401, P299, DOI 10.1042/BJ20061261; PECK LJ, 1985, CELL, V40, P129, DOI 10.1016/0092-8674(85)90316-2; Perkins CP, 1997, GENE DEV, V11, P914, DOI 10.1101/gad.11.7.914; Sadakata T, 2000, MOL BRAIN RES, V77, P47, DOI 10.1016/S0169-328X(00)00039-5; Sharma VK, 2007, PHYSIOL GENOMICS, V31, P96, DOI 10.1152/physiolgenomics.00183.2006; Shima Y, 2006, BLOOD, V107, P1352, DOI 10.1182/blood-2005-08-3166; Su N, 2008, J BIOL CHEM, V283, P35106, DOI 10.1074/jbc.M806874200; Subramanian SV, 2004, MOL BIOL CELL, V15, P4532, DOI 10.1091/mbc.E04-04-0348; Wang XZ, 1998, EMBO J, V17, P3619, DOI 10.1093/emboj/17.13.3619; Yaman I, 2003, CELL, V113, P519, DOI 10.1016/S0092-8674(03)00345-3; Yaman I, 2002, J BIOL CHEM, V277, P41539, DOI 10.1074/jbc.M204850200; Yang ZY, 2007, CIRCULATION, V115, P1269, DOI 10.1161/CIRCULATIONAHA.106.665836	35	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32312	32320		10.1074/jbc.M109.024471	http://dx.doi.org/10.1074/jbc.M109.024471			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19720825	Green Published, hybrid			2022-12-27	WOS:000272028400013
J	Bai, SM; Nasser, MW; Wang, B; Hsu, SH; Datta, J; Kutay, H; Yadav, A; Nuovo, G; Kumar, P; Ghoshal, K				Bai, Shoumei; Nasser, Mohd W.; Wang, Bo; Hsu, Shu-Hao; Datta, Jharna; Kutay, Huban; Yadav, Arti; Nuovo, Gerard; Kumar, Pawan; Ghoshal, Kalpana			MicroRNA-122 Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells and Sensitizes These Cells to Sorafenib	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; SERUM RESPONSE FACTOR; TUMOR-SUPPRESSOR; DOWN-REGULATION; LUNG-CANCER; IN-VIVO; EXPRESSION; MIR-122; LIVER; DEGRADATION	MicroRNAs are negative regulators of protein coding genes. The liver-specific microRNA-122 (miR-122) is frequently suppressed in primary hepatocellular carcinomas (HCCs). In situ hybridization demonstrated that miR-122 is abundantly expressed in hepatocytes but barely detectable in primary human HCCs. Ectopic expression of miR-122 in nonexpressing HepG2, Hep3B, and SK-Hep-1 cells reversed their tumorigenic properties such as growth, replication potential, clonogenic survival, anchorage-independent growth, migration, invasion, and tumor formation in nude mice. Further, miR-122-expressing HCC cells retained an epithelial phenotype that correlated with reduced Vimentin expression. ADAM10 (a distintegrin and metalloprotease family 10), serum response factor (SRF), and insulin-like growth factor 1 receptor (Igf1R) that promote tumorigenesis were validated as targets of miR-122 and were repressed by the microRNA. Conversely, depletion of the endogenous miR-122 in Huh-7 cells facilitated their tumorigenic properties with concomitant up-regulation of these targets. Expression of SRF or Igf1R partially reversed tumor suppressor function of miR-122. Further, miR-122 impeded angiogenic properties of endothelial cells in vitro. Notably, ADAM10, SRF, and Igf1R were up-regulated in primary human HCCs compared with the matching liver tissue. Co-labeling studies demonstrated exclusive localization of miR-122 in the benign livers, whereas SRF predominantly expressed in HCC. More importantly, growth and clonogenic survival of miR-122-expressing HCC cells were significantly reduced upon treatment with sorafenib, a multi-kinase inhibitor clinically effective against HCC. Collectively, these results suggest that the loss of multifunctional miR-122 contributes to the malignant phenotype of HCC cells, and miR-122 mimetic alone or in combination with anticancer drugs can be a promising therapeutic regimen against liver cancer.	[Bai, Shoumei; Nasser, Mohd W.; Wang, Bo; Hsu, Shu-Hao; Datta, Jharna; Kutay, Huban; Ghoshal, Kalpana] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Yadav, Arti; Kumar, Pawan] Ohio State Univ, Dept Otolaryngol Head & Neck Surg, Columbus, OH 43210 USA; [Ghoshal, Kalpana] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Nuovo, Gerard] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ghoshal, K (corresponding author), 420 W 12th Ave, Columbus, OH 43210 USA.	Kalpana.Ghoshal@osumc.edu	Nasser, Mohd/Y-3355-2019; Wang, Bo/F-6519-2011; Kumar, Pawan/H-7777-2013	HSU, SHU-HAO/0000-0002-9444-4192; Wang, Bo/0000-0001-9234-035X	National Institutes of Health [CA122694, CA086978]; NATIONAL CANCER INSTITUTE [R01CA086978, R21CA122694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA122694 and CA086978.	Bai S, 2007, J BIOL CHEM, V282, P27171, DOI 10.1074/jbc.M700691200; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Braconi C, 2008, HEPATOLOGY, V47, P1807, DOI 10.1002/hep.22326; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chai JY, 2004, FASEB J, V18, P1264, DOI 10.1096/fj.03-1232fje; Chang JH, 2008, J VIROL, V82, P8215, DOI 10.1128/JVI.02575-07; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; COULOUARN C, 2009, ONCOGENE IN PRESS; Datta J, 2008, CANCER RES, V68, P5049, DOI 10.1158/0008-5472.CAN-07-6655; Datta J, 2007, CANCER RES, V67, P2736, DOI 10.1158/0008-5472.CAN-06-4433; Duffy MJ, 2009, CLIN CANCER RES, V15, P1140, DOI 10.1158/1078-0432.CCR-08-1585; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Finn RS, 2009, EXPERT REV ANTICANC, V9, P503, DOI 10.1586/ERA.09.6; Fornari F, 2009, CANCER RES, V69, P5761, DOI 10.1158/0008-5472.CAN-08-4797; FRANCO CA, 2009, CELL ADH MI IN PRESS, V3; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Hopfner M, 2006, BIOCHEM PHARMACOL, V71, P1435, DOI 10.1016/j.bcp.2006.02.006; Jopling CL, 2008, BIOCHEM SOC T, V36, P1220, DOI 10.1042/BST0361220; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzfeldt J, 2007, NUCLEIC ACIDS RES, V35, P2885, DOI 10.1093/nar/gkm024; Kumar P, 2008, MOL CANCER THER, V7, P2060, DOI 10.1158/1535-7163.MCT-08-0287; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Motiwala T, 2004, P NATL ACAD SCI USA, V101, P13844, DOI 10.1073/pnas.0405451101; Motiwala T, 2009, J BIOL CHEM, V284, P455, DOI 10.1074/jbc.M802840200; Nasser MW, 2008, J BIOL CHEM, V283, P33394, DOI 10.1074/jbc.M804788200; Nuovo GJ, 2009, NAT PROTOC, V4, P107, DOI 10.1038/nprot.2008.215; Park MY, 2007, INT J ONCOL, V31, P1309; Tanaka S, 2009, CANCER SCI, V100, P1, DOI 10.1111/j.1349-7006.2008.01006.x; Tarnawski A, 2005, BIOCHEM BIOPH RES CO, V334, P207, DOI 10.1016/j.bbrc.2005.05.204; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Visone R, 2008, GASTROENTEROLOGY, V135, P1866, DOI 10.1053/j.gastro.2008.10.074; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106	46	405	447	3	62	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32015	32027		10.1074/jbc.M109.016774	http://dx.doi.org/10.1074/jbc.M109.016774			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19726678	hybrid, Green Published			2022-12-27	WOS:000271572700057
J	Song, GS; Zhang, YX; Wang, L				Song, Guisheng; Zhang, Yuxia; Wang, Li			MicroRNA-206 Targets notch3, Activates Apoptosis, and Inhibits Tumor Cell Migration and Focus Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIR-206 EXPRESSION; BREAST-CANCER; MECHANISM; BIOGENESIS; RECEPTORS; ALPHA; SHP	MicroRNAs contribute to cancer development by acting as oncogenes or tumor suppressor genes. However, only a few microRNA target genes were determined. We identified a nearly perfect complementarity between miR-206 and the 3'-untranslated regions of both mouse and human notch3. Expression of miR-206 decreased the luciferase activity dose-dependently when cotransfected with the mouse or human notch3 3'-untranslated region-luciferase reporter containing the miR-206 target site in HeLa cells. This suppression was relieved by deletion and mutation of the miR-206-binding site and was partially recovered by expression of notch3 or by a specific inhibitor of miR-206. Interestingly, overexpression of miR-206 decreased the levels of both Notch3 protein and mRNA. Expression of miR-206 markedly induced apoptotic cell death and blocked the anti-apoptotic activity of Notch3. In addition, ectopic expression of miR-206 inhibited HeLa cell migration and focus formation. Therefore, we identified miR-206 as a pro-apoptotic activator of cell death, which was associated with its inhibition of notch3 signaling and tumor formation. The inhibition of cancer cell migration and focus formation by miR-206 strongly suggests that miR-206 may function as a novel tumor suppressor.	[Wang, Li] Univ Utah, Sch Med, Huntsman Canc Inst, Dept Med, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84132 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Wang, L (corresponding author), Univ Utah, Sch Med, Huntsman Canc Inst, Dept Med, 30 North 1900 East,SOM 3C310, Salt Lake City, UT 84132 USA.	l.wang@hsc.utah.edu	Vickers, Michael M/E-4095-2010; song, guisheng/E-4913-2011		National Institutes of Health [P30 CA042014]; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work performed by the Flow Cytometry Core was supported by National Institutes of Health Grant P30 CA042014 awarded to the Huntsman Cancer Institute.	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gupta A, 2006, NATURE, V442, P82, DOI 10.1038/nature04836; Hansen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000873; He N, 2008, GASTROENTEROLOGY, V134, P793, DOI 10.1053/j.gastro.2008.01.006; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kondo N, 2008, CANCER RES, V68, P5004, DOI 10.1158/0008-5472.CAN-08-0180; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Negrini M, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1867; Park SM, 2008, CYTOKINE GROWTH F R, V19, P303, DOI 10.1016/j.cytogfr.2008.04.011; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Roccaro AM, 2009, BLOOD, V113, P4391, DOI 10.1182/blood-2008-09-178228; Song GS, 2008, NUCLEIC ACIDS RES, V36, P5727, DOI 10.1093/nar/gkn567; Song GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006880; Tang YH, 2009, INT HEART J, V50, P377, DOI 10.1536/ihj.50.377; Vermeulen A, 2007, RNA, V13, P723, DOI 10.1261/rna.448107; Walden TB, 2009, J CELL PHYSIOL, V218, P444, DOI 10.1002/jcp.21621; Wang WL, 2002, J BIOL CHEM, V277, P21723, DOI 10.1074/jbc.M202224200; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070	26	180	188	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31921	31927		10.1074/jbc.M109.046862	http://dx.doi.org/10.1074/jbc.M109.046862			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19723635	Green Published, hybrid			2022-12-27	WOS:000271572700047
J	Wang, CH; Xin, XB; Xiang, RH; Ramos, FJ; Liu, ML; Lee, HJ; Chen, HZ; Mao, XM; Kikani, CK; Liu, F; Dong, LQ				Wang, Changhua; Xin, Xiaoban; Xiang, Ruihua; Ramos, Fresnida J.; Liu, Meilian; Lee, Hak Joo; Chen, Hongzhi; Mao, Xuming; Kikani, Chintan K.; Liu, Feng; Dong, Lily Q.			Yin-Yang Regulation of Adiponectin Signaling by APPL Isoforms in Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; PROTEIN APPL1; ACTIVATION; RECEPTORS; AKT; INTERACTS; PATHWAY; MICE	APPL1 is a newly identified adiponectin receptor-binding protein that positively mediates adiponectin signaling in cells. Here we report that APPL2, an isoform of APPL1 that forms a dimer with APPL1, can interacts with both AdipoR1 and AdipoR2 and acts as a negative regulator of adiponectin signaling in muscle cells. Overexpression of APPL2 inhibits the interaction between APPL1 and AdipoR1, leading to down-regulation of adiponectin signaling in C2C12 myotubes. In contrast, suppressing APPL2 expression by RNAi significantly enhances adiponectin-stimulated glucose uptake and fatty acid oxidation. In addition to targeting directly to and competing with APPL1 in binding with the adiponectin receptors, APPL2 also suppresses adiponectin and insulin signaling by sequestrating APPL1 from these two pathways. In addition to adiponectin, metformin also induces APPL1-APPL2 dissociation. Taken together, our results reveal that APPL isoforms function as an integrated Yin-Yang regulator of adiponectin signaling and mediate the crosstalk between adiponectin and insulin signaling pathways in muscle cells.	[Xin, Xiaoban; Xiang, Ruihua; Lee, Hak Joo; Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Mao, Xuming; Liu, Feng; Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Chen, Hongzhi; Kikani, Chintan K.; Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Liu, Feng; Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Barshop Ctr Longev & Aging Studies, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Dong, LQ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	dongq@uthscsa.edu	Xin, Xiaoban/D-2338-2012	Chen, Hongzhi/0000-0001-6060-3776; Kikani, Chintan/0000-0003-1140-0192	National Institutes of Health [R01 DK69930, R01 DK080344, R01 DK76902]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080344, R01DK076902, R01DK069930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK69930 and R01 DK080344 (to L. Q. D.) and R01 DK76902 (to F. L.). This work was also supported by a Career Development Award from the American Diabetes Association (to L. Q. D.).	Chandrasekar B, 2008, J BIOL CHEM, V283, P24889, DOI 10.1074/jbc.M804236200; Cheng KKY, 2007, DIABETES, V56, P1387, DOI 10.2337/db06-1580; Cheng KKY, 2009, CELL METAB, V9, P417, DOI 10.1016/j.cmet.2009.03.013; Chial HJ, 2008, TRAFFIC, V9, P215, DOI 10.1111/j.1600-0854.2007.00680.x; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Lim MA, 2004, ONCOGENE, V23, P9348, DOI 10.1038/sj.onc.1208147; Lin HV, 2007, DIABETES, V56, P1969, DOI 10.2337/db07-0127; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Mao XM, 2006, MINI-REV MED CHEM, V6, P1331, DOI 10.2174/138955706778992978; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Mullen KL, 2009, AM J PHYSIOL-REG I, V296, pR243, DOI 10.1152/ajpregu.90774.2008; Nechamen CA, 2004, BIOL REPROD, V71, P629, DOI 10.1095/biolreprod.103.025833; Nechamen CA, 2007, MOL CELL ENDOCRINOL, V260, P93, DOI 10.1016/j.mce.2006.08.014; Saito T, 2007, J BIOL CHEM, V282, P32280, DOI 10.1074/jbc.M704150200; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Wang CH, 2007, J BIOL CHEM, V282, P7991, DOI 10.1074/jbc.M700098200; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yang L, 2003, J BIOL CHEM, V278, P16820, DOI 10.1074/jbc.M213163200	20	105	113	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31608	31615		10.1074/jbc.M109.010355	http://dx.doi.org/10.1074/jbc.M109.010355			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19661063	hybrid, Green Published			2022-12-27	WOS:000271572700015
J	Ghosh, S; Marintcheva, B; Takahashi, M; Richardson, CC				Ghosh, Sharmistha; Marintcheva, Boriana; Takahashi, Masateru; Richardson, Charles C.			C-terminal Phenylalanine of Bacteriophage T7 Single-stranded DNA-binding Protein Is Essential for Strand Displacement Synthesis by T7 DNA Polymerase at a Nick in DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE 32 PROTEIN; ESCHERICHIA-COLI THIOREDOXIN; REPLICATION FORK; DEOXYRIBONUCLEIC-ACID; NUCLEIC-ACIDS; LIMITED PROTEOLYSIS; T7-DNA POLYMERASE; CRYSTAL-STRUCTURE; HELICASE-PRIMASE; COOH TERMINUS	Single-stranded DNA-binding protein (gp2.5), encoded by gene 2.5 of bacteriophage T7, plays an essential role in DNA replication. Not only does it remove impediments of secondary structure in the DNA, it also modulates the activities of the other replication proteins. The acidic C-terminal tail of gp2.5, bearing a C-terminal phenylalanine, physically and functionally interacts with the helicase and DNA polymerase. Deletion of the phenylalanine or substitution with a nonaromatic amino acid gives rise to a dominant lethal phenotype, and the altered gp2.5 has reduced affinity for T7 DNA polymerase. Suppressors of the dominant lethal phenotype have led to the identification of mutations in gene 5 that encodes the T7 DNA polymerase. The altered residues in the polymerase are solvent-exposed and lie in regions that are adjacent to the bound DNA. gp2.5 lacking the C-terminal phenylalanine has a lower affinity for gp5-thioredoxin relative to the wild-type gp2.5, and this affinity is partially restored by the suppressor mutations in DNA polymerase. gp2.5 enables T7 DNA polymerase to catalyze strand displacement DNA synthesis at a nick in DNA. The resulting 5'-single-stranded DNA tail provides a loading site for T7 DNA helicase. gp2.5 lacking the C-terminal phenylalanine does not support this event with wild-type DNA polymerase but does to a limited extent with T7 DNA polymerase harboring the suppressor mutations.	[Ghosh, Sharmistha; Marintcheva, Boriana; Takahashi, Masateru; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	ccr@hms.harvard.edu			National Institutes of Health [GM 54937]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397, R25GM054937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 54937 (to C. C. R.).	Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; BURKE RL, 1980, J BIOL CHEM, V255, P1484; CHASE JW, 1986, ANNU REV BIOCHEM, V55, P103, DOI 10.1146/annurev.biochem.55.1.103; Delagoutte E, 2001, BIOCHEMISTRY-US, V40, P4459, DOI 10.1021/bi001306l; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; ENGLER MJ, 1983, J BIOL CHEM, V258, P1165; Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102; He ZG, 2003, J BIOL CHEM, V278, P29538, DOI 10.1074/jbc.M304318200; Hollis T, 2001, P NATL ACAD SCI USA, V98, P9557, DOI 10.1073/pnas.171317698; HOSODA J, 1978, J BIOL CHEM, V253, P7547; Johnson DE, 2007, P NATL ACAD SCI USA, V104, P5312, DOI 10.1073/pnas.0701062104; KIM YT, 1994, J BIOL CHEM, V269, P5270; KIM YT, 1992, J BIOL CHEM, V267, P15032; KIM YT, 1993, P NATL ACAD SCI USA, V90, P10173, DOI 10.1073/pnas.90.21.10173; Kong DC, 1998, J BIOL CHEM, V273, P6556, DOI 10.1074/jbc.273.11.6556; KOWALCZYKOWSKI SC, 1981, J MOL BIOL, V145, P75, DOI 10.1016/0022-2836(81)90335-1; KRASSA KB, 1991, P NATL ACAD SCI USA, V88, P4010, DOI 10.1073/pnas.88.9.4010; Kumar JK, 2001, J BIOL CHEM, V276, P34905, DOI 10.1074/jbc.M104151200; LECHNER RL, 1983, J BIOL CHEM, V258, P1174; LECHNER RL, 1983, J BIOL CHEM, V258, P1185; Lee J, 2002, J MOL BIOL, V316, P19, DOI 10.1006/jmbi.2001.5325; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; Lee SJ, 2006, J BIOL CHEM, V281, P25841, DOI 10.1074/jbc.M604602200; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; LONBERG N, 1981, J MOL BIOL, V145, P123, DOI 10.1016/0022-2836(81)90337-5; Lu D, 2008, P NATL ACAD SCI USA, V105, P9169, DOI 10.1073/pnas.0800741105; Lu D, 2009, BIOCHEMISTRY-US, V48, P6764, DOI 10.1021/bi900361r; Marintcheva B, 2008, P NATL ACAD SCI USA, V105, P1855, DOI 10.1073/pnas.0711919105; Marintcheva B, 2006, J BIOL CHEM, V281, P25831, DOI 10.1074/jbc.M604601200; Marintcheva B, 2009, MOL MICROBIOL, V72, P869, DOI 10.1111/j.1365-2958.2009.06682.x; MARK DF, 1976, P NATL ACAD SCI USA, V73, P780, DOI 10.1073/pnas.73.3.780; NAKAI H, 1988, J BIOL CHEM, V263, P9831; Nelson SW, 2008, J BIOL CHEM, V283, P22838, DOI 10.1074/jbc.M802762200; NEWPORT JW, 1981, J MOL BIOL, V145, P105, DOI 10.1016/0022-2836(81)90336-3; Notarnicola SM, 1997, J BIOL CHEM, V272, P18425, DOI 10.1074/jbc.272.29.18425; O'Donnell M, 2006, J BIOL CHEM, V281, P10653, DOI 10.1074/jbc.R500028200; Rezende LF, 2002, J BIOL CHEM, V277, P50643, DOI 10.1074/jbc.M207359200; Savvides SN, 2004, PROTEIN SCI, V13, P1942, DOI 10.1110/ps.04661904; SHAMOO Y, 1995, NATURE, V376, P362, DOI 10.1038/376362a0; Shereda RD, 2009, J MOL BIOL, V386, P612, DOI 10.1016/j.jmb.2008.12.065; Shokri L, 2008, NUCLEIC ACIDS RES, V36, P5668, DOI 10.1093/nar/gkn551; TABOR S, 1990, J BIOL CHEM, V265, P8322; TABOR S, 1987, J BIOL CHEM, V262, P16212; TABOR S, 1989, J BIOL CHEM, V264, P6447; WILLIAMS KR, 1978, J BIOL CHEM, V253, P2463; WILLIAMS KR, 1983, J BIOL CHEM, V258, P3346; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614	50	25	25	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30339	30349		10.1074/jbc.M109.024059	http://dx.doi.org/10.1074/jbc.M109.024059			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19726688	Green Published, hybrid			2022-12-27	WOS:000271090000037
J	Mukherjee, S; Chen, LY; Papadimos, TJ; Huang, S; Zuraw, BL; Pan, ZK				Mukherjee, Sumanta; Chen, Ling-Yu; Papadimos, Thomas J.; Huang, Shuang; Zuraw, Bruce L.; Pan, Zhixing K.			Lipopolysaccharide-driven Th2 Cytokine Production in Macrophages Is Regulated by Both MyD88 and TRAM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-4; NF-KAPPA-B; ENDOTOXIN EXPOSURE; INHALED ENDOTOXIN; T-CELLS; RESPONSES; IL-4; INTERLEUKIN-4; EOSINOPHILS; ACTIVATION	Gram-negative bacterial lipopolysaccharide (LPS) activates macrophages by interacting with Toll-like receptor 4 (TLR4) and triggers the production of various pro-inflammatory Th1 type (type 1) cytokines such as IFN gamma, TNF alpha, and IL8. Though some recent studies cited macrophages as potential sources for Th2 type (type 2) cytokines, little however is known about the intracellular events that lead to LPS-induced type 2 cytokines in macrophages. To understand the mechanisms by which LPS induces type 2 cytokine gene expression, macrophages were stimulated with LPS, and the expression of IL-4 and IL-5 genes were examined. LPS, acting through TLR4, activates both type 1 and type 2 cytokine production both in vitro and in vivo by using macrophages from C3H/HeJ or C3H/HeOuJ mice. Although the baseline level of both TNF alpha and IL-4 protein was very low, TNF alpha was released rapidly after stimulation (within 4 h); however, IL-4 was released after 48 h LPS stimulation in secreted form. Silencing of myeloid differentiation protein (MyD88) and TRIF-related adaptor molecule (TRAM), using small interfering RNA abolished IL-4 induction induced by LPS whereas silencing of TRAM has no effect on TNF alpha induction, thereby indicating that LPS-induced TNF alpha is MyD88-dependent but IL-4 is required both MyD88 and TRAM. These findings suggest a novel function of LPS and the signaling pathways in the induction of IL-4 gene expression.	[Mukherjee, Sumanta; Chen, Ling-Yu; Papadimos, Thomas J.; Pan, Zhixing K.] Univ Toledo, Med Ctr, Dept Med, Toledo, OH 43614 USA; [Mukherjee, Sumanta; Chen, Ling-Yu; Papadimos, Thomas J.; Pan, Zhixing K.] Univ Toledo, Med Ctr, Dept Med Microbiol & Immunol, Toledo, OH 43614 USA; [Huang, Shuang; Pan, Zhixing K.] Scripps Res Inst, Dept Immunol & Mol & Expt Med, La Jolla, CA 92037 USA; [Zuraw, Bruce L.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Zuraw, Bruce L.] Vet Affairs Hlth Care Syst, La Jolla, CA 92093 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; Scripps Research Institute; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Pan, ZK (corresponding author), 3035 Arlington Ave, Toledo, OH 43614 USA.	kevin.pan@utoledo.edu		Papadimos, Thomas/0000-0002-4024-227X; Zuraw, Bruce/0000-0003-0640-6768	National Institutes of Health [M01RR00833]; USPHS [AI43524]; Sam and Ross Stein Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043524, R56AI043524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Sam and Ross Stein Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant M01RR00833 provided to the General Clinical Research Center of the Scripps Research Institute. This work was also supported by USPHS Grants AI43524 and by the Sam and Ross Stein Charitable Trust.	Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Buttner C, 1997, AM J RESP CELL MOL, V17, P315; Chen LY, 2003, AM J PHYSIOL-LUNG C, V284, pL607, DOI 10.1152/ajplung.00116.2002; Chen LY, 2002, J IMMUNOL, V169, P3934, DOI 10.4049/jimmunol.169.7.3934; Dabbagh K, 2002, J IMMUNOL, V168, P4524, DOI 10.4049/jimmunol.168.9.4524; Dombrowicz D, 2001, CURR OPIN IMMUNOL, V13, P716, DOI 10.1016/S0952-7915(01)00284-9; Doucet C, 1998, INT IMMUNOL, V10, P1421, DOI 10.1093/intimm/10.10.1421; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Eldridge MW, 2000, J ALLERGY CLIN IMMUN, V105, P475, DOI 10.1067/mai.2000.104552; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gereda JE, 2000, LANCET, V355, P1680, DOI 10.1016/S0140-6736(00)02239-X; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Goldstein DR, 2004, CURR OPIN IMMUNOL, V16, P538, DOI 10.1016/j.coi.2004.08.001; HOLT PG, 1995, PEDIAT ALLERG IMM-UK, V6, P1, DOI 10.1111/j.1399-3038.1995.tb00250.x; Honstettre A, 2004, J IMMUNOL, V172, P3695, DOI 10.4049/jimmunol.172.6.3695; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Luster AD, 2002, CURR OPIN IMMUNOL, V14, P129, DOI 10.1016/S0952-7915(01)00308-9; Matsukawa A, 1998, INFLAMM RES, V47, pS137; MICHEL O, 1992, AM REV RESPIR DIS, V146, P352, DOI 10.1164/ajrccm/146.2.352; Michel O, 1996, AM J RESP CRIT CARE, V154, P1641, DOI 10.1164/ajrccm.154.6.8970348; MICHEL O, 1989, J APPL PHYSIOL, V66, P1059, DOI 10.1152/jappl.1989.66.3.1059; Michel O, 1997, AM J RESP CRIT CARE, V156, P1157, DOI 10.1164/ajrccm.156.4.97-02002; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; MOQBEL R, 1995, J IMMUNOL, V155, P4939; MOSER R, 1992, J IMMUNOL, V149, P1432; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; PAUL WE, 1991, BLOOD, V77, P1859; PLAUT M, 1989, NATURE, V339, P64, DOI 10.1038/339064a0; Pouliot P, 2005, CLIN EXP ALLERGY, V35, P804, DOI 10.1111/j.1365-2222.2005.02246.x; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Svanborg C, 1999, CURR OPIN MICROBIOL, V2, P99, DOI 10.1016/S1369-5274(99)80017-4; Vogel Stefanie N, 2003, Mol Interv, V3, P466, DOI 10.1124/mi.3.8.466; Wan GH, 2000, CLIN EXP ALLERGY, V30, P426; Wenner CA, 1997, J IMMUNOL, V158, P765; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285	39	56	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29391	29398		10.1074/jbc.M109.005272	http://dx.doi.org/10.1074/jbc.M109.005272			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19638630	hybrid, Green Published			2022-12-27	WOS:000270896800020
J	Xu, J; Song, PH; Nakamura, S; Miller, M; Barone, S; Alper, SL; Riederer, B; Bonhagen, J; Arend, LJ; Amlal, H; Seidler, U; Soleimani, M				Xu, Jie; Song, Penghong; Nakamura, Suguru; Miller, Marian; Barone, Sharon; Alper, Seth L.; Riederer, Brigitte; Bonhagen, Janina; Arend, Lois J.; Amlal, Hassane; Seidler, Ursula; Soleimani, Manoocher			Deletion of the Chloride Transporter Slc26a7 Causes Distal Renal Tubular Acidosis and Impairs Gastric Acid Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDULLARY COLLECTING DUCT; CL-/HCO3-EXCHANGER; INTERCALATED CELLS; PARIETAL-CELLS; SULFATE TRANSPORTER; ANION-EXCHANGER; FUNCTIONAL-CHARACTERIZATION; BASOLATERAL MEMBRANE; INTRACELLULAR PH; MICE LACKING	SLC26A7 (human)/Slc26a7 (mouse) is a recently identified chloride-base exchanger and/or chloride transporter that is expressed on the basolateral membrane of acid-secreting cells in the renal outer medullary collecting duct(OMCD) and in gastric parietal cells. Here, we show that mice with genetic deletion of Slc26a7 expression develop distal renal tubular acidosis, as manifested by metabolic acidosis and alkaline urine pH. In the kidney, basolateral Cl-/HCO3- exchange activity in acid-secreting intercalated cells in the OMCD was significantly decreased in hypertonic medium (a normal milieu for the medulla) but was reduced only mildly in isotonic medium. Changing from a hypertonic to isotonic medium (relative hypotonicity) decreased the membrane abundance of Slc26a7 in kidney cells in vivo and in vitro. In the stomach, stimulated acid secretion was significantly impaired in isolated gastric mucosa and in the intact organ. We propose that SLC26A7 dysfunction should be investigated as a potential cause of unexplained distal renal tubular acidosis or decreased gastric acid secretion in humans.	[Amlal, Hassane; Soleimani, Manoocher] Univ Cincinnati, Ctr Genet Transport & Epithelial Biol, Cincinnati, OH 45267 USA; [Arend, Lois J.] Univ Cincinnati, Dept Pathol, Cincinnati, OH 45267 USA; [Miller, Marian] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Alper, Seth L.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Alper, Seth L.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Renal, Boston, MA 02115 USA; [Soleimani, Manoocher] Vet Affairs Med Ctr, Res Serv, Cincinnati, OH 45220 USA; [Xu, Jie; Barone, Sharon; Amlal, Hassane; Soleimani, Manoocher] Univ Cincinnati, Dept Med, Cincinnati, OH 45267 USA; [Song, Penghong; Riederer, Brigitte; Bonhagen, Janina; Seidler, Ursula] Leibniz Univ Hannover, Dept Gastroenterol, D-30625 Hannover, Germany; [Nakamura, Suguru] Murray State Univ, Dept Biol Sci, Murray, KY 42071 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cincinnati VA Medical Center; University System of Ohio; University of Cincinnati; Leibniz University Hannover; Murray State University	Soleimani, M (corresponding author), Univ Cincinnati, Ctr Genet Transport & Epithelial Biol, 231 Albert Sabin Way,MSB G259, Cincinnati, OH 45267 USA.	Manoocher.Soleimani@uc.edu	Arend, Lois/ABE-2002-2020; soleimani, m/U-6889-2017; Seidler, Ursula/HII-8049-2022	Arend, Lois/0000-0001-5434-7630; soleimani, m/0000-0002-3446-8870; Seidler, Ursula/0000-0002-9600-2769	Department of Veterans Affairs; National Institutes of Health [DK62809, DK 43495]; Deutsche Forschungsgemeinschaft Sachbeihilfe [Se 460/9-5, 9-6]; Ministry of Science in Lower Saxony; DCA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062809, R01DK043495, R56DK062809, R37DK043495] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft Sachbeihilfe(German Research Foundation (DFG)); Ministry of Science in Lower Saxony; DCA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by a Merit Review award from the Department of Veterans Affairs (to M. S.) and National Institutes of Health Grants DK62809 (to M. S.) and DK 43495 (to S. L. A.). This work was also supported by the Deutsche Forschungsgemeinschaft Sachbeihilfe Se 460/9-5 and 9-6 and Ministry of Science in Lower Saxony (to U. S.), and by grants from the DCA dialysis care group (to M. S.).	ALPER SL, 1989, P NATL ACAD SCI USA, V86, P5429, DOI 10.1073/pnas.86.14.5429; Barone S, 2004, J AM SOC NEPHROL, V15, P2002, DOI 10.1097/01.ASN.0000135060.83250.07; BERGLINDH T, 1977, GASTROENTEROLOGY, V73, P874; BISSIG M, 1994, J BIOL CHEM, V269, P3017; CAMPBELL VW, 1989, J BIOL CHEM, V264, P11381; Dorwart MR, 2007, J PHYSIOL-LONDON, V584, P333, DOI 10.1113/jphysiol.2007.135855; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; FORTE JG, 1975, J PHYSIOL-LONDON, V244, P33, DOI 10.1113/jphysiol.1975.sp010783; Gawenis LR, 2004, J BIOL CHEM, V279, P30531, DOI 10.1074/jbc.M403779200; Hassoun H, 1998, BLOOD, V92, P1785, DOI 10.1182/blood.V92.5.1785.417k17_1785_1792; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Karet FE, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000023433.08833.88; Kim KH, 2005, J BIOL CHEM, V280, P6463, DOI 10.1074/jbc.M409162200; Lohi H, 2002, J BIOL CHEM, V277, P14246, DOI 10.1074/jbc.M111802200; Lohi H, 2000, GENOMICS, V70, P102, DOI 10.1006/geno.2000.6355; McDaniel N, 2005, AM J PHYSIOL-GASTR L, V289, pG550, DOI 10.1152/ajpgi.00095.2005; Melvin JE, 1999, J BIOL CHEM, V274, P22855, DOI 10.1074/jbc.274.32.22855; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; MUALLEM S, 1985, J BIOL CHEM, V260, P6641; Petrovic S, 2004, AM J PHYSIOL-RENAL, V286, pF161, DOI 10.1152/ajprenal.00219.2003; Petrovic S, 2003, AM J PHYSIOL-GASTR L, V284, pG1093, DOI 10.1152/ajpgi.00454.2002; Petrovic S, 2003, AM J PHYSIOL-RENAL, V284, pF103, DOI 10.1152/ajprenal.00205.2002; RABON E, 1983, J EXP BIOL, V106, P119; Recalde S, 2006, AM J PATHOL, V169, P165, DOI 10.2353/ajpath.2006.051096; Romero Michael F, 2006, Novartis Found Symp, V273, P126; SCHUSTER VL, 1991, AM J PHYSIOL, V260, pF506, DOI 10.1152/ajprenal.1991.260.4.F506; SCHUSTER VL, 1993, ANNU REV PHYSIOL, V55, P267, DOI 10.1146/annurev.ph.55.030193.001411; SCHWARTZ GJ, 1988, AM J PHYSIOL, V255, pF1003, DOI 10.1152/ajprenal.1988.255.5.F1003; Schweinfest CW, 2006, J BIOL CHEM, V281, P37962, DOI 10.1074/jbc.M607527200; SCHWEINFEST CW, 1993, P NATL ACAD SCI USA, V90, P4166, DOI 10.1073/pnas.90.9.4166; Silver RB, 1999, AM J PHYSIOL-RENAL, V276, pF799, DOI 10.1152/ajprenal.1999.276.6.F799; Soleimani M, 2001, AM J PHYSIOL-RENAL, V280, pF356, DOI 10.1152/ajprenal.2001.280.2.F356; Soleimani Manoocher, 2006, Novartis Found Symp, V273, P91; Stehberger PA, 2007, J AM SOC NEPHROL, V18, P1408, DOI 10.1681/ASN.2006101072; STUARTTILLEY A, 1994, AM J PHYSIOL, V266, pC559, DOI 10.1152/ajpcell.1994.266.2.C559; Vincourt JB, 2003, FASEB J, V17, P890, DOI 10.1096/fj.02-0787fje; Wang ZH, 2002, AM J PHYSIOL-GASTR L, V282, pG573, DOI 10.1152/ajpgi.00338.2001; WEINER ID, 1993, AM J PHYSIOL, V265, pF406, DOI 10.1152/ajprenal.1993.265.3.F406; Xu J, 2005, AM J PHYSIOL-CELL PH, V289, pC493, DOI 10.1152/ajpcell.00030.2005; Xu J, 2006, J AM SOC NEPHROL, V17, P956, DOI 10.1681/ASN.2005111174; Xu J, 2008, P NATL ACAD SCI USA, V105, P17955, DOI 10.1073/pnas.0800616105; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	42	66	68	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29470	29479		10.1074/jbc.M109.044396	http://dx.doi.org/10.1074/jbc.M109.044396			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19723628	Green Published, hybrid			2022-12-27	WOS:000270896800029
J	Yue, JB; Wei, WJ; Lam, CMC; Zhao, YJ; Dong, M; Zhang, LR; Zhang, LH; Lee, HC				Yue, Jianbo; Wei, Wenjie; Lam, Connie M. C.; Zhao, Yong-Juan; Dong, Min; Zhang, Liang-Ren; Zhang, Li-He; Lee, Hon-Cheung			CD38/cADPR/Ca2+ Pathway Promotes Cell Proliferation and Delays Nerve Growth Factor-induced Differentiation in PC12 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-ADP-RIBOSE; EMBRYONAL CARCINOMA-CELLS; MEDIATED NEURONAL DIFFERENTIATION; ADENOSINE-DIPHOSPHORIBOSE CADPR; MUSCARINIC RECEPTOR ACTIVATION; ADENINE-DINUCLEOTIDE PHOSPHATE; CDK INHIBITOR P21(WAF1/CIP1); ARTERIAL SMOOTH-MUSCLE; INDUCED CA2+ RELEASE; NEURITE OUTGROWTH	Intracellular Ca2+ mobilization plays an important role in a wide variety of cellular processes, and multiple second messengers are responsible for mediating intracellular Ca2+ changes. Here we explored the role of one endogenous Ca2+-mobilizing nucleotide, cyclic adenosine diphosphoribose (cADPR), in the proliferation and differentiation of neurosecretory PC12 cells. We found that cADPR induced Ca2+ release in PC12 cells and that CD38 is the main ADP-ribosyl cyclase responsible for the acetylcholine (ACh)-induced cADPR production in PC12 cells. In addition, the CD38/cADPR signaling pathway is shown to be required for the ACh-induced Ca2+ increase and cell proliferation. Inhibition of the pathway, on the other hand, accelerated nerve growth factor (NGF)-induced neuronal differentiation in PC12 cells. Conversely, overexpression of CD38 increased cell proliferation but delayed NGF-induced differentiation. Our data indicate that cADPR plays a dichotomic role in regulating proliferation and neuronal differentiation of PC12 cells.	[Yue, Jianbo; Wei, Wenjie; Lam, Connie M. C.; Zhao, Yong-Juan; Lee, Hon-Cheung] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Dong, Min; Zhang, Liang-Ren; Zhang, Li-He] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 10019, Peoples R China	University of Hong Kong; Peking University	Yue, JB (corresponding author), Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China.	jyue@hku.hk; leehc@hku.hk	Dong, Min/D-5367-2016; Zhang, Liang/GWM-6088-2022; Zhao, Yongjuan/AAS-9919-2021; Yue, Jianbo/C-4463-2009; Yue, Jianbo/AAC-4588-2019; Lee, Hon Cheung/C-4329-2009; Yue, Jianbo/K-8002-2015	Dong, Min/0000-0001-6655-2818; Yue, Jianbo/0000-0001-6384-5447; Zhao, Yong Juan/0000-0003-4564-1912	Research Grant Council (RGC) grants from Hong Kong; National Natural Science Foundation of China (NSFC)/RGC [N_HKU 722/08, 20831160506, 90713005]; Leukemia and Lymphoma Society of America	Research Grant Council (RGC) grants from Hong Kong(Hong Kong Research Grants Council); National Natural Science Foundation of China (NSFC)/RGC(Hong Kong Research Grants CouncilNational Natural Science Foundation of China (NSFC)); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society)	This work was supported by Research Grant Council (RGC) grants from Hong Kong (to H. C. L. and J. Y.), National Natural Science Foundation of China (NSFC)/RGC Grant N_HKU 722/08 (to H. C. L.), NSFC grants from China (20831160506, to L. H. Z. and 90713005, to L. R. Z.), and a Special Fellow Award from the Leukemia and Lymphoma Society of America (to J. Y.).	BARRY VA, 1994, BIOCHEM J, V300, P589, DOI 10.1042/bj3000589; BARRY VA, 1994, J CELL SCI, V107, P451; Bennett DL, 1998, BIOCHEM J, V329, P349; Berkeley JL, 2000, J NEUROCHEM, V75, P487, DOI 10.1046/j.1471-4159.2000.0750487.x; BERRIDGE MJ, 1988, FASEB J, V2, P3074, DOI 10.1096/fasebj.2.15.2847949; Billon N, 1999, ONCOGENE, V18, P2872, DOI 10.1038/sj.onc.1202712; Billon N, 1996, ONCOGENE, V13, P2047; Brailoiu E, 2005, J BIOL CHEM, V280, P5646, DOI 10.1074/jbc.M408746200; Brailoiu E, 2006, J BIOL CHEM, V281, P15923, DOI 10.1074/jbc.M602249200; Bruzzone S, 2003, BIOCHEM J, V375, P395, DOI 10.1042/BJ20030556; Burry RW, 2001, J NEUROSCI RES, V63, P45, DOI 10.1002/1097-4547(20010101)63:1<45::AID-JNR6>3.0.CO;2-Y; Churaman D, 2008, CELL SIGNAL, V20, P2347, DOI 10.1016/j.cellsig.2008.09.005; Churamani D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000797; Clementi E, 1996, J BIOL CHEM, V271, P17739, DOI 10.1074/jbc.271.30.17739; Costa LG, 2001, GROWTH FACTORS, V18, P227, DOI 10.3109/08977190109029112; Diamandis P, 2007, NAT CHEM BIOL, V3, P268, DOI 10.1038/nchembio873; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; Erhardt JA, 1998, ONCOGENE, V16, P443, DOI 10.1038/sj.onc.1201577; Erhardt JA, 1998, J BIOL CHEM, V273, P23517, DOI 10.1074/jbc.273.36.23517; Galderisi U, 2003, ONCOGENE, V22, P5208, DOI 10.1038/sj.onc.1206558; Galione A, 2000, Sci STKE, V2000, ppe1; Galione A, 2002, CELL CALCIUM, V32, P343, DOI 10.1016/S0143416002001902; Ge ZD, 2003, J VASC RES, V40, P28, DOI 10.1159/000068936; GIZANGGINSBERG E, 1994, MOL ENDOCRINOL, V8, P249, DOI 10.1210/me.8.2.249; Graeff RM, 1997, METHOD ENZYMOL, V280, P230; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Gu XF, 2004, J MED CHEM, V47, P5674, DOI 10.1021/jm040092t; Guse AH, 2005, FEBS J, V272, P4590, DOI 10.1111/j.1742-4658.2005.04863.x; Guse AH, 2004, CURR MED CHEM, V11, P847, DOI 10.2174/0929867043455602; Guse AH, 1999, NATURE, V398, P70, DOI 10.1038/18024; Higashida H, 1997, J BIOL CHEM, V272, P31272, DOI 10.1074/jbc.272.50.31272; Higashida H, 2001, BIOL CHEM, V382, P23, DOI 10.1515/BC.2001.004; Higashida H, 2007, NEUROSCI RES, V57, P339, DOI 10.1016/j.neures.2006.11.008; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim SY, 2008, AM J PHYSIOL-RENAL, V294, pF982, DOI 10.1152/ajprenal.00483.2007; Koizumi S, 1999, NEURON, V22, P125, DOI 10.1016/S0896-6273(00)80684-4; Lee HC, 2004, CURR MOL MED, V4, P227, DOI 10.2174/1566524043360753; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; LEE HC, 1994, NATURE, V370, P307, DOI 10.1038/370307a0; LEVI A, 1988, MOL NEUROBIOL, V2, P201, DOI 10.1007/BF02935346; Ma W, 2000, EUR J NEUROSCI, V12, P1227, DOI 10.1046/j.1460-9568.2000.00010.x; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Marampon F, 2008, MOL BIOL CELL, V19, P2566, DOI 10.1091/mbc.E06-12-1110; Martins AHB, 2005, J BIOL CHEM, V280, P19576, DOI 10.1074/jbc.M502513200; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Morgan AJ, 2008, METHODS, V46, P194, DOI 10.1016/j.ymeth.2008.09.013; Morita K, 2006, J PHARMACOL SCI, V101, P40, DOI 10.1254/jphs.FP0050991; Munshi CB, 2002, J BIOL CHEM, V277, P49453, DOI 10.1074/jbc.M209313200; Noguchi N, 1997, J BIOL CHEM, V272, P3133, DOI 10.1074/jbc.272.6.3133; Park DS, 1997, J NEUROSCI, V17, P8975; Podesta M, 2000, FASEB J, V14, P680, DOI 10.1096/fasebj.14.5.680; Poluha W, 1997, J BIOL CHEM, V272, P24002, DOI 10.1074/jbc.272.38.24002; Resende RR, 2008, EXP CELL RES, V314, P1429, DOI 10.1016/j.yexcr.2008.01.003; Resende RR, 2008, CELL CALCIUM, V43, P107, DOI 10.1016/j.ceca.2007.04.007; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Scarfi S, 2008, STEM CELLS, V26, P2855, DOI 10.1634/stemcells.2008-0488; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; STEINER B, 1990, EMBO J, V9, P3539, DOI 10.1002/j.1460-2075.1990.tb07563.x; Tang WX, 2002, AM J PHYSIOL-HEART C, V282, pH1304, DOI 10.1152/ajpheart.00843.2001; Thomas JM, 2002, CURR BIOL, V12, P2018, DOI 10.1016/S0960-9822(02)01335-0; Thomas JM, 2001, BIOCHEM J, V359, P451, DOI 10.1042/0264-6021:3590451; TROY CM, 1992, J CELL BIOL, V117, P1085, DOI 10.1083/jcb.117.5.1085; vanGrunsven LA, 1996, ONCOGENE, V12, P855; WALSETH TF, 1993, BIOCHIM BIOPHYS ACTA, V1178, P235, DOI 10.1016/0167-4889(93)90199-Y; Wang YX, 2004, AM J PHYSIOL-CELL PH, V286, pC538, DOI 10.1152/ajpcell.00106.2003; Yamasaki M, 2005, CURR BIOL, V15, P874, DOI 10.1016/j.cub.2005.04.033; Yan GZ, 1997, J NEUROSCI, V17, P6122; YAN GZ, 1995, J NEUROSCI, V15, P6200; Zhang JS, 2005, BIOCHEM BIOPH RES CO, V335, P920, DOI 10.1016/j.bbrc.2005.07.163; Zocchi E, 1998, J BIOL CHEM, V273, P8017, DOI 10.1074/jbc.273.14.8017	71	41	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29335	29342		10.1074/jbc.M109.049767	http://dx.doi.org/10.1074/jbc.M109.049767			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19696022	Green Published, hybrid			2022-12-27	WOS:000270896800013
J	Poirier, S; Mayer, G; Poupon, V; McPherson, PS; Desjardins, R; Ly, K; Asselin, MC; Day, R; Duclos, FJ; Witmer, M; Parker, R; Prat, A; Seidah, NG				Poirier, Steve; Mayer, Gaetan; Poupon, Viviane; McPherson, Peter S.; Desjardins, Roxane; Ly, Kevin; Asselin, Marie-Claude; Day, Robert; Duclos, Franck J.; Witmer, Mark; Parker, Rex; Prat, Annik; Seidah, Nabil G.			Dissection of the Endogenous Cellular Pathways of PCSK9-induced Low Density Lipoprotein Receptor Degradation EVIDENCE FOR AN INTRACELLULAR ROUTE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPROTEIN CONVERTASE PCSK9; LDL RECEPTORS; IN-VITRO; MICE; HYPERCHOLESTEROLEMIA; CHOLESTEROL; EXPRESSION; PROTEIN; GENE; HEPATOCYTES	Elevated levels of plasma low density lipoprotein (LDL)-cholesterol, leading to familial hypercholesterolemia, are enhanced by mutations in at least three major genes, the LDL receptor (LDLR), its ligand apolipoprotein B, and the proprotein convertase PCSK9. Single point mutations in PCSK9 are associated with either hyper or hypocholesterolemia. Accordingly, PCSK9 is an attractive target for treatment of dyslipidemia. PCSK9 binds the epidermal growth factor domain A (EGF-A) of the LDLR and directs it to endosomes/lysosomes for destruction. Although the mechanism by which PCSK9 regulates LDLR degradation is not fully resolved, it seems to involve both intracellular and extracellular pathways. Here, we show that clathrin light chain small interfering RNAs that block intracellular trafficking from the trans-Golgi network to lysosomes rapidly increased LDLR levels within HepG2 cells in a PCSK9-dependent fashion without affecting the ability of exogenous PCSK9 to enhance LDLR degradation. In contrast, blocking the extracellular LDLR endocytosis/degradation pathway by a 4-, 6-, or 24-h incubation of cells with Dynasore or an EGF-AB peptide or by knockdown of endogenous autosomal recessive hypercholesterolemia did not significantly affect LDLR levels. The present data from HepG2 cells and mouse primary hepatocytes favor a model whereby depending on the dose and/or incubation period, endogenous PCSK9 enhances the degradation of the LDLR both extra and intracellularly. Therefore, targeting either pathway, or both, would be an effective method to reduce PCSK9 activity in the treatment of hypercholesterolemia and coronary heart disease.	[Poirier, Steve; Mayer, Gaetan; Asselin, Marie-Claude; Prat, Annik; Seidah, Nabil G.] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Poupon, Viviane; McPherson, Peter S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Desjardins, Roxane; Ly, Kevin; Day, Robert] Univ Sherbrooke, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada; [Duclos, Franck J.; Witmer, Mark; Parker, Rex] Bristol Myers Squibb Co, Princeton, NJ 08543 USA	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; University of Sherbrooke; Bristol-Myers Squibb	Seidah, NG (corresponding author), Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Prat, Annik/S-6757-2018; Seidah, Nabil/I-3596-2013	Prat, Annik/0000-0002-8007-5277; Seidah, Nabil/0000-0001-6503-9342	Canadian Institutes of Health Research [MOP-36496, CTP-82946, MOP-15396]; Strauss Foundation; Bristol-Myers Squibb; Canada Chair [201652]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Strauss Foundation; Bristol-Myers Squibb(Bristol-Myers Squibb); Canada Chair	This work was supported in part by Canadian Institutes of Health Research Grants MOP-36496 and CTP-82946 (to N. G. S.) and MOP-15396 (to P. S. M.), a Strauss Foundation grant (to N. G. S.), a Bristol-Myers Squibb research grant, and Canada Chair 201652 (to N. G. S.).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Alborn WE, 2007, CLIN CHEM, V53, P1814, DOI 10.1373/clinchem.2007.091280; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Bottomley MJ, 2009, J BIOL CHEM, V284, P1313, DOI 10.1074/jbc.M808363200; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; CUMMINGS RD, 1983, J BIOL CHEM, V258, P5261; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; DUBUC G, 2009, J LIPID RES IN PRESS; Grefhorst A, 2008, J LIPID RES, V49, P1303, DOI 10.1194/jlr.M800027-JLR200; Harada-Shiba M, 2004, CIRC RES, V95, P945, DOI 10.1161/01.RES.0000146946.78540.46; Jones C, 2003, J BIOL CHEM, V278, P29024, DOI 10.1074/jbc.M304855200; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Labonte P, 2009, HEPATOLOGY, V50, P17, DOI 10.1002/hep.22911; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Luo Y, 2009, J LIPID RES, V50, P1581, DOI 10.1194/jlr.M800542-JLR200; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poupon V, 2008, P NATL ACAD SCI USA, V105, P168, DOI 10.1073/pnas.0707269105; Qian YW, 2007, J LIPID RES, V48, P1488, DOI 10.1194/jlr.M700071-JLR200; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Shan LX, 2008, BIOCHEM BIOPH RES CO, V375, P69, DOI 10.1016/j.bbrc.2008.07.106; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Varret M, 2008, CLIN GENET, V73, P1, DOI 10.1111/j.1399-0004.2007.00915.x; Wang MD, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M700326200; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105	39	189	196	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28856	28864		10.1074/jbc.M109.037085	http://dx.doi.org/10.1074/jbc.M109.037085			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19635789	hybrid, Green Published			2022-12-27	WOS:000270678900042
J	Stiles, AR; McDonald, JG; Bauman, DR; Russell, DW				Stiles, Ashlee R.; McDonald, Jeffrey G.; Bauman, David R.; Russell, David W.			CYP7B1: One Cytochrome P450, Two Human Genetic Diseases, and Multiple Physiological Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							OXYSTEROL 7-ALPHA-HYDROXYLASE GENE; HEREDITARY SPASTIC PARAPLEGIA; BILE-ACID SYNTHESIS; 7 ALPHA-HYDROXYLASE; CHOLESTEROL 7-ALPHA-HYDROXYLASE; LIVER-DISEASE; ESTROGEN; MICE; 27-HYDROXYCHOLESTEROL; DISRUPTION	The CYP7B1 cytochrome P450 enzyme hydroxylates carbons 6 and 7 of the B ring of oxysterols and steroids. Hydroxylation reduces the biological activity of these substrates and facilitates their conversion to end products that are readily excreted from the body. CYP7B1 is expressed in the liver, reproductive tract, and brain and performs different physiological functions in each tissue. Hepatic CYP7B1 activity is crucial for the inactivation of oxysterols and their subsequent conversion into bile salts. Loss of CYP7B1 activity is associated with liver failure in children. In the reproductive tract, the enzyme metabolizes androgens that antagonize estrogen action; mice without CYP7B1 have abnormal prostates and ovaries. The role of CYP7B1 in brain is under investigation; recent studies show that spastic paraplegia type 5, a progressive neuropathy, is caused by loss-of-function mutations in the human gene.	[Stiles, Ashlee R.; McDonald, Jeffrey G.; Bauman, David R.; Russell, David W.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Russell, DW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	david.russell@utsouthwestern.edu		Russell, David/0000-0002-0277-403X	National Institutes of Health [HL20948, GM69338, DK81182]; National Institutes of Health Graduate Student Training [GM083831]; National Institutes of Health Postdoctoral Fellow Training [DK07745]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [PL1DK081182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338, T32GM083831] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Graduate Student Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Postdoctoral Fellow Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL20948, GM69338, and DK81182 (to D. W. R.). This work was also supported by the Robert A. Welch Foundation and the Perot Family Foundation. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.; Supported by National Institutes of Health Graduate Student Training Grant GM083831.; Supported by National Institutes of Health Postdoctoral Fellow Training Grant DK07745.	Baulieu EE, 2001, INT REV NEUROBIOL, V46, P1; BAUMAN DR, 2009, P NATL ACAD IN PRESS, V106; Biancheri R, 2009, NEUROMUSCULAR DISORD, V19, P62, DOI 10.1016/j.nmd.2008.10.009; BJORKHEM I, 2001, METABOLIC MOL BASES; Clayton PT, 2002, J INHERIT METAB DIS, V25, P501, DOI 10.1023/A:1021211520034; CRISCUOLO C, 2009, J NEUROL IN PRESS, V256; DANIELSSON H, 1967, EUR J BIOCHEM, V2, P44, DOI 10.1111/j.1432-1033.1967.tb00103.x; DICZFALUSY U, 2009, J LIPID RES IN PRESS, V50; Dulos J, 2005, ARTHRITIS RHEUM-US, V52, P770, DOI 10.1002/art.20950; DuSell CD, 2008, MOL ENDOCRINOL, V22, P65, DOI 10.1210/me.2007-0383; Goizet C, 2009, BRAIN, V132, P1589, DOI 10.1093/brain/awp073; Ishibashi S, 1996, J BIOL CHEM, V271, P18017, DOI 10.1074/jbc.271.30.18017; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16543, DOI 10.1074/jbc.M001810200; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16536, DOI 10.1074/jbc.M001811200; Martin C, 2004, J CLIN ENDOCR METAB, V89, P2928, DOI 10.1210/jc.2003-031847; Martin KO, 1997, J LIPID RES, V38, P1053; Omoto Y, 2005, P NATL ACAD SCI USA, V102, P2814, DOI 10.1073/pnas.0500198102; Pettersson H, 2008, FEBS J, V275, P1778, DOI 10.1111/j.1742-4658.2008.06336.x; PIERRE G, 2009, J INHERIT M IN PRESS, V32; Rose K, 2001, J BIOL CHEM, V276, P23937, DOI 10.1074/jbc.M011564200; Rose KA, 1997, P NATL ACAD SCI USA, V94, P4925, DOI 10.1073/pnas.94.10.4925; Russell DW, 2009, J LIPID RES, V50, pS120, DOI 10.1194/jlr.R800026-JLR200; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; Schule R, 2009, NEUROGENETICS, V10, P97, DOI 10.1007/s10048-008-0158-9; Schwarz M, 2001, J LIPID RES, V42, P1594; Schwarz M, 1996, J BIOL CHEM, V271, P18024, DOI 10.1074/jbc.271.30.18017; Schwarz M, 1997, J BIOL CHEM, V272, P23995, DOI 10.1074/jbc.272.38.23995; Setchell KDR, 1998, J CLIN INVEST, V102, P1690, DOI 10.1172/JCI2962; STAPLETON G, 1995, J BIOL CHEM, V270, P29739, DOI 10.1074/jbc.270.50.29739; Stoilov I, 2006, ARCH BIOCHEM BIOPHYS, V456, P30, DOI 10.1016/j.abb.2006.09.029; SUNDIN M, 1987, J BIOL CHEM, V262, P12293; TOLL A, 1994, EUR J BIOCHEM, V224, P309, DOI 10.1111/j.1432-1033.1994.00309.x; Tsaousidou MK, 2008, AM J HUM GENET, V82, P510, DOI 10.1016/j.ajhg.2007.10.001; Ueki I, 2008, J PEDIATR GASTR NUTR, V46, P465, DOI 10.1097/MPG.0b013e31815a9911; Umetani M, 2007, NAT MED, V13, P1185, DOI 10.1038/nm1641; Weihua Z, 2002, P NATL ACAD SCI USA, V99, P13589, DOI 10.1073/pnas.162477299; Wu ZL, 1999, J LIPID RES, V40, P2195	39	80	85	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28485	28489		10.1074/jbc.R109.042168	http://dx.doi.org/10.1074/jbc.R109.042168			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19687010	hybrid, Green Published			2022-12-27	WOS:000270678900002
J	Lin, CP; Ban, Y; Lyu, YL; Liu, LF				Lin, Chao-Po; Ban, Yi; Lyu, Yi Lisa; Liu, Leroy F.			Proteasome-dependent Processing of Topoisomerase I-DNA Adducts into DNA Double Strand Breaks at Arrested Replication Forks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COVALENT COMPLEXES; CLEAVABLE COMPLEXES; DRUG CAMPTOTHECIN; MULTIPLE-MYELOMA; PROSTATE-CANCER; CARCINOMA CELLS; TUMOR-CELLS; REPAIR; DEGRADATION; PROTEIN	Reversible topoisomerase I (Top1)-DNA cleavage complexes are the key DNA lesion induced by anticancer camptothecins (CPTs) (e.g. topotecan and irinotecan) as well as structurally perturbed DNAs (e.g. oxidatively damaged, UV-irradiated, or alkylated DNA). It has been proposed that Top1 cleavage complexes arrest advancing replication forks, triggering the formation of DNA double strand breaks (DSBs) because of replication fork runoff at the Top1 cleavage complex sites on the leading strand. In this study, we show that the formation of replication-dependent DSBs requires the ubiquitin-proteasome pathway in CPT-treated cells. First, the proteasome inhibitor MG-132 specifically inhibited CPT-induced but not ionizing radiation- or hydroxyurea-induced DSBs as revealed by both the neutral comet assay and measurements of the specific DNA damage signals (e.g. gamma-H2AX, phosphorylated ataxia telangiectasia mutated (Ser-1981), and phosphorylated Chk2 (Ser-33/35)) that are characteristic for DSBs. Knocking down the 20 S proteasome maturation protein also supported the requirement of the proteasome activity for CPT-induced DSBs. Second, CPT-induced DSB signals were shown to require ubiquitin, ubiquitin-activating enzyme (E1), a CUL-3-based ubiquitin ligase (E3), and the formation of Lys-48-finked polyubiquitin chains on Top1. Third, immunocytochemical studies revealed that the CPT-induced formation of gamma-H2AX foci occurred at the replication forks and was attenuated by co-treatment with the proteasome inhibitor MG-132. In the aggregate, these results support a replication fork collision model in which Top1 cleavage complexes at the arrested replication forks are degraded by proteasome prior to replication fork runoff on the leading strand to generate DSBs.	[Lin, Chao-Po; Ban, Yi; Lyu, Yi Lisa; Liu, Leroy F.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Liu, LF (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, 675 Hoes Lane, Piscataway, NJ 08854 USA.	lliu@umdnj.edu		Lin, Chao-Po/0000-0002-1457-1635; Liu, Leroy/0000-0001-9396-763X	National Institutes of Health [CA39662]; Department of Defense Idea [W81XWH-07-1-0407]; New Jersey Commission on Cancer Research [08-1079-CCR-EO]; NATIONAL CANCER INSTITUTE [R01CA039662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Idea(United States Department of Defense); New Jersey Commission on Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA39662 (to L. F. L.). This work was also supported by a Department of Defense Idea Award W81XWH-07-1-0407 (to Y. L. L.) and a New Jersey Commission on Cancer Research Grant 08-1079-CCR-EO (to Y. L. L.).	Aleo E, 2006, CANCER RES, V66, P9235, DOI 10.1158/0008-5472.CAN-06-0702; Andersen JB, 2006, BRIT J CANCER, V94, P1465, DOI 10.1038/sj.bjc.6603099; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; DARPA P, 1990, CANCER RES, V50, P6919; Debethune L, 2002, NUCLEIC ACIDS RES, V30, P1198, DOI 10.1093/nar/30.5.1198; Desai SD, 2006, CANCER RES, V66, P921, DOI 10.1158/0008-5472.CAN-05-1123; Desai SD, 2003, MOL CELL BIOL, V23, P2341, DOI 10.1128/MCB.23.7.2341-2350.2003; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Desai SD, 2001, CANCER RES, V61, P5926; Desai SD, 2008, MOL CANCER THER, V7, P1430, DOI 10.1158/1535-7163.MCT-07-2345; FINLEY D, 1984, CELL, V37, P43, DOI 10.1016/0092-8674(84)90299-X; Fricke B, 2007, EMBO REP, V8, P1170, DOI 10.1038/sj.embor.7401091; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Gudmundsdottir K, 2007, ONCOGENE, V26, P7601, DOI 10.1038/sj.onc.1210579; HOLM C, 1989, CANCER RES, V49, P6365; Hoyt MA, 2004, CELL MOL LIFE SCI, V61, P1596, DOI 10.1007/s00018-004-4133-9; HSIANG YH, 1988, CANCER RES, V48, P1722; HSIANG YH, 1989, CANCER RES, V49, P5077; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Interthal H, 2005, J BIOL CHEM, V280, P36518, DOI 10.1074/jbc.M508898200; Kiessling A, 2009, ONCOGENE, V28, P2606, DOI 10.1038/onc.2009.115; Krogan NJ, 2004, MOL CELL, V16, P1027, DOI 10.1016/j.molcel.2004.11.033; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Lin CP, 2008, J BIOL CHEM, V283, P21074, DOI 10.1074/jbc.M803493200; Lyu YL, 2007, CANCER RES, V67, P8839, DOI 10.1158/0008-5472.CAN-07-1649; Mao Y, 2001, J BIOL CHEM, V276, P40652, DOI 10.1074/jbc.M104009200; Mateos MV, 2006, BLOOD, V108, P2165, DOI 10.1182/blood-2006-04-019778; Mimnaugh EG, 2000, BIOCHEM PHARMACOL, V60, P1343, DOI 10.1016/S0006-2952(00)00455-X; Mitsiades N, 2003, BLOOD, V101, P2377, DOI 10.1182/blood-2002-06-1768; Moreau S, 1999, MOL CELL BIOL, V19, P556; Murakawa Y, 2007, CANCER RES, V67, P8536, DOI 10.1158/0008-5472.CAN-07-1166; Nitiss JL, 1996, MOL PHARMACOL, V50, P1095; Pajonk F, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-76; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Reid RJD, 1999, P NATL ACAD SCI USA, V96, P11440, DOI 10.1073/pnas.96.20.11440; Seiler JA, 2007, MOL CELL BIOL, V27, P5806, DOI 10.1128/MCB.02278-06; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Strumberg D, 2000, MOL CELL BIOL, V20, P3977, DOI 10.1128/MCB.20.11.3977-3987.2000; Takemura H, 2006, J BIOL CHEM, V281, P30814, DOI 10.1074/jbc.M603747200; Thiriet C, 2005, MOL CELL, V18, P617, DOI 10.1016/j.molcel.2005.05.008; TSAO YP, 1993, CANCER RES, V53, P5908; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Yang SW, 1996, P NATL ACAD SCI USA, V93, P11534, DOI 10.1073/pnas.93.21.11534; ZHANG H, 1990, CANCER CELL-MON REV, V2, P23; Zhang HF, 2004, CANCER RES, V64, P1114, DOI 10.1158/0008-5472.CAN-03-2858; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019	49	51	51	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28084	28092		10.1074/jbc.M109.030601	http://dx.doi.org/10.1074/jbc.M109.030601			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19666469	hybrid, Green Published			2022-12-27	WOS:000270676300035
J	Sherwood, T; Franke, R; Conneely, S; Joyner, J; Arumugan, P; Askwith, C				Sherwood, Thomas; Franke, Ruthie; Conneely, Shannon; Joyner, Jeffrey; Arumugan, Prakash; Askwith, Candice			Identification of Protein Domains That Control Proton and Calcium Sensitivity of ASIC1a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; TARANTULA TOXIN PSALMOTOXIN-1; HIPPOCAMPAL-NEURONS; SENSORY NEURONS; BINDING-SITES; NA+ CHANNEL; ACID; CA2+; H+; CURRENTS	The acid-sensing ion channels (ASICs) open in response to extracellular acidic pH, and individual subunits display differential sensitivity to protons and calcium. ASIC1a acts as a high affinity proton sensor, whereas ASIC2a requires substantially greater proton concentrations to activate. Using chimeras composed of ASIC1a and ASIC2a, we determined that two regions of the extracellular domain (residues 87-197 and 323-431) specify the high affinity proton response of ASIC1a. These two regions appear to undergo intersubunit interactions within the multimeric channel to specify proton sensitivity. Single amino acid mutations revealed that amino acids around Asp(357) play a prominent role in determining the pH dose response of ASIC1a. Within the same region, mutation F352L abolished PcTx1 modulation of ASIC1a. Surprisingly, we determined that another area of the extracellular domain was required for calcium-dependent regulation of ASIC1a activation, and this region functioned independently of high affinity proton sensing. These results indicate that specific regions play overlapping roles in pH-dependent gating and PcTx1-dependent modulation of ASIC1a activity, whereas a distinct region determines the calcium dependence of ASIC1a activation.	[Sherwood, Thomas; Franke, Ruthie; Conneely, Shannon; Joyner, Jeffrey; Arumugan, Prakash; Askwith, Candice] Ohio State Univ, Dept Neurosci, Sch Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Askwith, C (corresponding author), Ohio State Univ, Dept Neurosci, Sch Med, 4197 Graves Hall,333 W 10th Ave, Columbus, OH 43210 USA.	askwith.1@osu.edu		Conneely, Shannon/0000-0001-9076-3973	National Science Foundation [IBN-0416920]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062967] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Science Foundation Grant IBN-0416920.	Adams CM, 1998, J BIOL CHEM, V273, P30204, DOI 10.1074/jbc.273.46.30204; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Berdiev BK, 2001, J BIOL CHEM, V276, P38755, DOI 10.1074/jbc.M107266200; Chen XM, 2006, J GEN PHYSIOL, V127, P267, DOI 10.1085/jgp.200509409; Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303; Chen XM, 2007, J BIOL CHEM, V282, P30406, DOI 10.1074/jbc.M702229200; Cho JH, 2008, J NEUROPHYSIOL, V99, P426, DOI 10.1152/jn.00940.2007; Chu XP, 2006, J NEUROSCI, V26, P5329, DOI 10.1523/JNEUROSCI.0938-06.2006; Chu XP, 2004, J NEUROSCI, V24, P8678, DOI 10.1523/JNEUROSCI.2844-04.2004; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Paukert M, 2004, J GEN PHYSIOL, V124, P383, DOI 10.1085/jgp.200308973; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Pietra F, 2009, J CHEM INF MODEL, V49, P972, DOI 10.1021/ci800463h; Pignataro G, 2007, BRAIN, V130, P151, DOI 10.1093/brain/awl325; Qadri YJ, 2009, J BIOL CHEM, V284, P17625, DOI 10.1074/jbc.M109.003913; Salinas M, 2006, J PHYSIOL-LONDON, V570, P339, DOI 10.1113/jphysiol.2005.095810; Shaikh SA, 2008, BIOPHYS J, V95, P5153, DOI 10.1529/biophysj.108.141606; Smith ESJ, 2007, NEUROSCI LETT, V426, P12, DOI 10.1016/j.neulet.2007.07.047; SWICK AG, 1992, P NATL ACAD SCI USA, V89, P1812, DOI 10.1073/pnas.89.5.1812; Todorovic NA, 2005, ANN NY ACAD SCI, V1048, P331, DOI 10.1196/annals.1342.030; Voilley Nicolas, 2004, Current Drug Targets - Inflammation and Allergy, V3, P71, DOI 10.2174/1568010043483980; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wang WZ, 2006, J BIOL CHEM, V281, P29369, DOI 10.1074/jbc.M605122200; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xiong ZG, 2007, FRONT BIOSCI-LANDMRK, V12, P1376, DOI 10.2741/2154; Zhang P, 2006, J GEN PHYSIOL, V127, P109, DOI 10.1085/jgp.200509396	41	40	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27899	27907		10.1074/jbc.M109.029009	http://dx.doi.org/10.1074/jbc.M109.029009			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19654327	Green Published, hybrid			2022-12-27	WOS:000270676300017
J	Whittle, JRR; Schwartz, TU				Whittle, James R. R.; Schwartz, Thomas U.			Architectural Nucleoporins Nup157/170 and Nup133 Are Structurally Related and Descend from a Second Ancestral Element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; MULTIPLE SEQUENCE ALIGNMENT; MESSENGER-RNA EXPORT; CRYSTAL-STRUCTURE; POLY(A)(+) RNA; FUNCTIONALLY INTERACTS; VERTEBRATE HOMOLOG; PROTEIN; ORGANIZATION; ACCUMULATION	The nuclear pore complex (NPC) constitutes one of the largest protein assemblies in the eukaryotic cell and forms the exclusive gateway to the nucleus. The stable, similar to 15-20-MDa scaffold ring of the NPC is built from two multiprotein complexes arranged around a central 8-fold axis. Here we present crystal structures of two large architectural units, yNup170(979-1502) and hNup107(658-925).hNup133(517-156), each a constituent of one of the two multiprotein complexes. Conservation of domain arrangement and of tertiary structure suggests that Nup157/170 and Nup133 derived from a common ancestor. Together with the previously established ancestral coatomer element (ACE1), these two elements constitute the major a-helical building blocks of the NPC scaffold and define its branched, lattice-like architecture, similar to vesicle coats like COPII. We hypothesize that the extant NPC evolved early during eukaryotic evolution from a rudimentary structure composed of several identical copies of a few ancestral elements, later diversified and specified by gene duplication.	[Whittle, James R. R.; Schwartz, Thomas U.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Schwartz, TU (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave,Rm 68-480, Cambridge, MA 02139 USA.	tus@mit.edu	Schwartz, Thomas/K-9029-2017; Schwartz, Thomas/ABA-1770-2021	Schwartz, Thomas/0000-0001-8012-1512; Schwartz, Thomas/0000-0001-8012-1512	National Institutes of Health [GM77537]; Pew Scholar Award; National Science Foundation Graduate Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholar Award; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM77537 (to T. U.S.). This work was also supported by a Pew Scholar Award (to T. U. S.) and a National Science Foundation Graduate Research Fellowship (to J. R. R. W.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AITCHISON JD, 1995, J CELL BIOL, V131, P1133, DOI 10.1083/jcb.131.5.1133; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Bai SW, 2004, MOL CELL BIOL, V24, P6379, DOI 10.1128/MCB.24.14.6379-6392.2004; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170; Berke IC, 2004, J CELL BIOL, V167, P591, DOI 10.1083/jcb.200408109; Boehmer T, 2008, MOL CELL, V30, P721, DOI 10.1016/j.molcel.2008.04.022; BROHAWN SG, 2009, COMMUN INTEGR BIOL, V2, P1; Brohawn SG, 2008, SCIENCE, V322, P1369, DOI 10.1126/science.1165886; Brunger AT, 2009, ACTA CRYSTALLOGR D, V65, P128, DOI 10.1107/S0907444908043795; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; Debler EW, 2008, MOL CELL, V32, P815, DOI 10.1016/j.molcel.2008.12.001; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; DOYE V, 1994, EMBO J, V13, P6062, DOI 10.1002/j.1460-2075.1994.tb06953.x; Dultz E, 2008, J CELL BIOL, V180, P857, DOI 10.1083/jcb.200707026; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESWAR N, 2007, CURR PROTOC PROTEIN, V50; Fahrenkrog B, 2004, TRENDS BIOCHEM SCI, V29, P175, DOI 10.1016/j.tibs.2004.02.006; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Flemming D, 2009, J CELL BIOL, V185, P387, DOI 10.1083/jcb.200810016; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Gao HH, 2003, J BIOL CHEM, V278, P25331, DOI 10.1074/jbc.M301607200; GRANDI P, 1995, J CELL BIOL, V130, P1263, DOI 10.1083/jcb.130.6.1263; Grandi P, 1997, MOL BIOL CELL, V8, P2017, DOI 10.1091/mbc.8.10.2017; Handa N, 2006, J MOL BIOL, V363, P114, DOI 10.1016/j.jmb.2006.07.089; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; Hawryluk-Gara LA, 2008, MOL BIOL CELL, V19, P1753, DOI 10.1091/mbc.E07-08-0820; Heath CV, 1995, J CELL BIOL, V131, P1677, DOI 10.1083/jcb.131.6.1677; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hsia KC, 2007, CELL, V131, P1313, DOI 10.1016/j.cell.2007.11.038; Jeudy S, 2007, J BIOL CHEM, V282, P34904, DOI 10.1074/jbc.M705479200; Jovanovic-Talisman T, 2009, NATURE, V457, P1023, DOI 10.1038/nature07600; Kampmann M, 2009, NAT STRUCT MOL BIOL, V16, P782, DOI 10.1038/nsmb.1618; Kosova B, 1999, J BIOL CHEM, V274, P22646, DOI 10.1074/jbc.274.32.22646; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leksa NC, 2009, STRUCTURE, V17, P1082, DOI 10.1016/j.str.2009.06.003; LI O, 1995, MOL BIOL CELL, V6, P401, DOI 10.1091/mbc.6.4.401; Lim RYH, 2008, INT REV CEL MOL BIO, V267, P299, DOI 10.1016/S1937-6448(08)00632-1; Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980; Lutzmann M, 2005, J BIOL CHEM, V280, P18442, DOI 10.1074/jbc.M412787200; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; MADEJ T, 1995, PROTEINS, V23, P356, DOI 10.1002/prot.340230309; Mans BJ, 2004, CELL CYCLE, V3, P1612; Marelli M, 1998, J CELL BIOL, V143, P1813, DOI 10.1083/jcb.143.7.1813; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller BR, 2000, MOL BIOL CELL, V11, P3381, DOI 10.1091/mbc.11.10.3381; Nehrbass U, 1996, J CELL BIOL, V133, P1153, DOI 10.1083/jcb.133.6.1153; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Rabut G, 2004, CURR OPIN CELL BIOL, V16, P314, DOI 10.1016/j.ceb.2004.04.001; Rayala HJ, 2004, MOL CELL PROTEOMICS, V3, P145, DOI 10.1074/mcp.M300106-MCP200; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Schrader N, 2008, MOL CELL, V29, P46, DOI 10.1016/j.molcel.2007.10.022; Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shulga N, 2000, J CELL BIOL, V149, P1027, DOI 10.1083/jcb.149.5.1027; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; Siniossoglou S, 2000, J CELL BIOL, V149, P41, DOI 10.1083/jcb.149.1.41; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Weis K, 2007, CELL, V130, P405, DOI 10.1016/j.cell.2007.07.029; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Zabel U, 1996, J CELL BIOL, V133, P1141, DOI 10.1083/jcb.133.6.1141	81	61	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28442	28452		10.1074/jbc.M109.023580	http://dx.doi.org/10.1074/jbc.M109.023580			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19674973	Green Published, hybrid			2022-12-27	WOS:000270676300069
J	Piccirillo, S; Filomeni, G; Brune, B; Rotilio, G; Ciriolo, MR				Piccirillo, Sara; Filomeni, Giuseppe; Bruene, Bernhard; Rotilio, Giuseppe; Ciriolo, Maria R.			Redox Mechanisms Involved in the Selective Activation of Nrf2-mediated Resistance Versus p53-dependent Apoptosis in Adenocarcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; CACO-2 CELLS; CANCER-CELLS; P53 FUNCTION; DNA-DAMAGE; P38 MAPK; THIOREDOXIN; INDUCTION; KINASE; NRF2	We have investigated the role of reactive oxygen species and thiol-oxidizing agents in the induction of cell death and have shown that adenocarcinoma gastric(AGS) cells respond differently to the oxidative challenge according to the signaling pathways activated. In particular, apoptosis in AGS cells is induced via the mitochondrial pathway upon treatment with thiol-oxidizing agents, such as diamide. Apoptosis is associated with persistent oxidative damage, as evidenced by the increase in carbonylated proteins and the expression/activation of DNA damage-sensitive proteins histone H2A.X and DNA-dependent protein kinase. Resistance to hydrogen peroxide is instead associated with Keap1 oxidation and rapid translocation of Nrf2 into the nucleus. Sensitivity to diamide and resistance to hydrogen peroxide are correlated with GSH redox changes, with diamide severely increasing GSSG, and hydrogen peroxide transiently inducing protein-GSH mixed disulfides. We show that p53 is activated in response to diamide treatment by the oxidative induction of the Trx1/p38(MAPK) signaling pathway. Similar results were obtained with another carcinoma cell line, CaCo2, indicating that these findings are not limited to AGS cells. Our data suggest that thiol-oxidizing agents could be exploited as inducers of apoptosis in tumor histotypes resistant to ROS-producing chemotherapeutics.	[Piccirillo, Sara; Rotilio, Giuseppe; Ciriolo, Maria R.] Res Ctr IRCCS San Raffaele Pisana, I-00163 Rome, Italy; [Filomeni, Giuseppe; Rotilio, Giuseppe; Ciriolo, Maria R.] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; [Bruene, Bernhard] Goethe Univ Frankfurt, Inst Biochem 1, ZAFES, Fac Med, D-60590 Frankfurt, Germany	IRCCS San Raffaele Pisana; University of Rome Tor Vergata; Goethe University Frankfurt	Ciriolo, MR (corresponding author), Res Ctr IRCCS San Raffaele Pisana, Via Bonacolsi, I-00163 Rome, Italy.	ciriolo@bio.uniroma2.it	Ciriolo, Maria Rosa/K-6572-2016	Filomeni, Giuseppe/0000-0002-2719-1412; Ciriolo, Maria Rosa/0000-0002-7863-9029	Ministero dell'Universita e della Ricerca Scientifica; Ministero della Salute	Ministero dell'Universita e della Ricerca Scientifica(Ministry of Education, Universities and Research (MIUR)); Ministero della Salute(Ministry of Health, Italy)	This work was partially supported by grants from Ministero dell'Universita e della Ricerca Scientifica and Ministero della Salute.	Adler V, 1999, ONCOGENE, V18, P6104, DOI 10.1038/sj.onc.1203128; Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Behrend L, 2003, BIOCHEM SOC T, V31, P1441; Bersani NA, 2002, METHOD ENZYMOL, V347, P317; Cabello CM, 2007, CURR OPIN INVEST DR, V8, P1022; Chen C, 2004, FREE RADICAL BIO MED, V37, P1578, DOI 10.1016/j.freeradbiomed.2004.07.021; Chen C, 2004, FREE RADICAL BIO MED, V36, P1505, DOI 10.1016/j.freeradbiomed.2004.03.015; Cuadrado A, 2007, EMBO J, V26, P2115, DOI 10.1038/sj.emboj.7601657; Djelloul S, 1997, FEBS LETT, V406, P234, DOI 10.1016/S0014-5793(97)00208-1; Faraonio R, 2006, J BIOL CHEM, V281, P39776, DOI 10.1074/jbc.M605707200; Filomeni G, 2005, CANCER RES, V65, P11735, DOI 10.1158/0008-5472.CAN-05-3067; Filomeni G, 2005, CELL DEATH DIFFER, V12, P1555, DOI 10.1038/sj.cdd.4401754; Filomeni G, 2002, FASEB J, V16, P64, DOI 10.1096/fj.02-0105fje; Filomeni G, 2007, J BIOL CHEM, V282, P12010, DOI 10.1074/jbc.M610927200; Gomez-Lazaro M, 2008, J NEUROCHEM, V104, P1599, DOI 10.1111/j.1471-4159.2007.05115.x; Halvey PJ, 2005, BIOCHEM J, V386, P215, DOI 10.1042/BJ20041829; Han ZY, 1996, J BIOL CHEM, V271, P25035, DOI 10.1074/jbc.271.40.25035; Hildesheim J, 2002, CANCER RES, V62, P7305; Kang KW, 2002, MOL PHARMACOL, V62, P1001, DOI 10.1124/mol.62.5.1001; Kang MH, 2008, JNCI-J NATL CANCER I, V100, P580, DOI 10.1093/jnci/djn076; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim YC, 2003, ONCOGENE, V22, P1860, DOI 10.1038/sj.onc.1206369; Lee HR, 2008, MOL CELL BIOCHEM, V318, P23, DOI 10.1007/s11010-008-9853-y; Liu YM, 2002, CIRC RES, V90, P1259, DOI 10.1161/01.RES.0000022160.64355.62; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mayr M, 2002, FASEB J, V16, P1423, DOI 10.1096/fj.02-0042fje; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Na HK, 2006, MOL CARCINOGEN, V45, P368, DOI 10.1002/mc.20225; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Perfettini JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002458; Perfettini JL, 2005, J EXP MED, V201, P279, DOI 10.1084/jem.20041502; RAINWATER R, 1995, MOL CELL BIOL, V15, P3892; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; ROTILIO G, 1985, ENVIRON HEALTH PERSP, V64, P259, DOI 10.2307/3430015; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Seemann S, 2005, ONCOGENE, V24, P3853, DOI 10.1038/sj.onc.1208549; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Wingler K, 2000, GASTROENTEROLOGY, V119, P420, DOI 10.1053/gast.2000.9521; Xu WM, 2000, NAT CELL BIOL, V2, P339, DOI 10.1038/35014028	41	40	41	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27721	27733		10.1074/jbc.M109.014837	http://dx.doi.org/10.1074/jbc.M109.014837			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19643729	Green Published, hybrid			2022-12-27	WOS:000270232300073
J	Prasad, SVN; Duan, ZH; Gupta, MK; Surampudi, VSK; Volinia, S; Calin, GA; Liu, CG; Kotwal, A; Moravec, CS; Starling, RC; Perez, DM; Sen, S; Wu, QY; Plow, EF; Croce, CM; Karnik, S				Prasad, Sathyamangla V. Naga; Duan, Zhong-Hui; Gupta, Manveen K.; Surampudi, Venkata Suresh K.; Volinia, Stefano; Calin, George A.; Liu, Chang-Gong; Kotwal, Ashwin; Moravec, Christine S.; Starling, Randall C.; Perez, Dianne M.; Sen, Subha; Wu, Qingyu; Plow, Edward F.; Croce, Carlo M.; Karnik, Sadashiva			Unique MicroRNA Profile in End-stage Heart Failure Indicates Alterations in Specific Cardiovascular Signaling Networks.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CARDIAC-HYPERTROPHY; DILATED CARDIOMYOPATHY; EXPRESSION; SIGNATURES; DISEASE; ACTIVATION; TARGETS; GROWTH; MICE	It is well established that gene expression patterns are substantially altered in cardiac hypertrophy and heart failure, but the reasons for such differences are not clear. MicroRNAs ( miRNAs) are short noncoding RNAs that provide a novel mechanism for gene regulation. The goal of this study was to comprehensively test for alterations in miRNA expression using human heart failure samples with an aim to build signaling pathway networks using predicted targets for the miRNAs and to identify nodal molecules that control these networks. Genome-wide profiling of miRNAs was performed using custom-designed miRNA microarray followed by validation on an independent set of samples. Eight miRNAs are significantly altered in heart failure of which we have identified two novel miRNAs that are yet to be implicated in cardiac pathophysiology. To gain an unbiased global perspective on regulation by altered miRNAs, predicted targets of eight miRNAs were analyzed using the Ingenuity Pathways Analysis network algorithm to build signaling networks and identify nodal molecules. The majority of nodal molecules identified in our analysis are targets of altered miRNAs and are known regulators of cardiovascular signaling. A heart failure gene expression data base was used to analyze changes in expression patterns for these target nodal molecules. Indeed, expression of nodal molecules was altered in heart failure and inversely correlated to miRNA changes validating our analysis. Importantly, using network analysis we have identified a limited number of key functional targets that may regulate expression of the myriad proteins in heart failure and could be potential therapeutic targets.	[Prasad, Sathyamangla V. Naga; Gupta, Manveen K.; Surampudi, Venkata Suresh K.; Kotwal, Ashwin; Perez, Dianne M.; Sen, Subha; Wu, Qingyu; Plow, Edward F.; Karnik, Sadashiva] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Duan, Zhong-Hui] Univ Akron, Dept Comp Sci, Akron, OH 44325 USA; [Volinia, Stefano; Calin, George A.; Liu, Chang-Gong; Croce, Carlo M.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Moravec, Christine S.; Starling, Randall C.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; University System of Ohio; University of Akron; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Cleveland Clinic Foundation	Prasad, SVN (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, NB50,9500 Euclid Ave, Cleveland, OH 44195 USA.	prasads2@ccf.org	Volinia, Stefano/AAA-9264-2019; Calin, George/E-9390-2011; Young, Richard A/F-6495-2012; Volinia, Stefano/A-3029-2010; Karnik, Sadashiva/Y-2477-2019; Surampudi the, Venkata suresh kumar/N-3057-2014	Volinia, Stefano/0000-0003-0910-3893; Young, Richard A/0000-0001-8855-8647; Volinia, Stefano/0000-0003-0910-3893; Karnik, Sadashiva/0000-0003-0746-2753; Surampudi the, Venkata suresh kumar/0000-0003-0940-1014; Calin, George/0000-0001-6704-5615	National Institutes of Health [NIH RO1 HL089473]; American Heart Association; Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098279, R01HL089473, R01HL115964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part, by National Institutes of Health Grant NIH RO1 HL089473. This work was also supported by American Heart Association grant-in-aid (Great Rivers Affiliate) and funds from the Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic (to S.V.N.P.).	Barrans JD, 2002, AM J PATHOL, V160, P2035, DOI 10.1016/S0002-9440(10)61153-4; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Cuellar TL, 2005, J ENDOCRINOL, V187, P327, DOI 10.1677/joe.1.06426; Duffy JY, 2009, CRIT CARE MED, V37, P577, DOI 10.1097/CCM.0b013e318194ab65; Grzeskowiak R, 2003, CARDIOVASC RES, V59, P400, DOI 10.1016/S0008-6363(03)00426-7; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; Perrino C, 2007, CIRCULATION, V116, P2571, DOI 10.1161/CIRCULATIONAHA.107.706515; Prasad SVN, 2000, J BIOL CHEM, V275, P4693, DOI 10.1074/jbc.275.7.4693; Purcell NH, 2001, P NATL ACAD SCI USA, V98, P6668, DOI 10.1073/pnas.111155798; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Tan FL, 2002, P NATL ACAD SCI USA, V99, P11387, DOI 10.1073/pnas.162370099; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Van Rooij E, 2007, PHYSIOL GENOMICS, V31, P365, DOI 10.1152/physiolgenomics.00206.2007; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Young D, 2008, J MOL BIOL, V381, P559, DOI 10.1016/j.jmb.2008.05.076; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	31	117	122	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27487	27499		10.1074/jbc.M109.036541	http://dx.doi.org/10.1074/jbc.M109.036541			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19641226	Green Published, hybrid			2022-12-27	WOS:000270232300051
J	Saha, S; Biswas, KH; Kondapalli, C; Isloor, N; Visweswariah, SS				Saha, Sayanti; Biswas, Kabir Hassan; Kondapalli, Chandana; Isloor, Nishitha; Visweswariah, Sandhya S.			The Linker Region in Receptor Guanylyl Cyclases Is a Key Regulatory Module MUTATIONAL ANALYSIS OF GUANYLYL CYCLASE C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-STABLE ENTEROTOXIN; CONE-ROD DYSTROPHY; NATRIURETIC PEPTIDE RECEPTORS; MULTIPLE SEQUENCE ALIGNMENT; STRUCTURE PREDICTION SERVER; CRYSTAL-STRUCTURE; ADENYLYL-CYCLASE; MYCOBACTERIUM-TUBERCULOSIS; ESCHERICHIA-COLI; COILED-COILS	Receptor guanylyl cyclases are multidomain proteins, and ligand binding to the extracellular domain increases the levels of intracellular cGMP. The intracellular domain of these receptors is composed of a kinase homology domain (KHD), a linker of similar to 70 amino acids, followed by the C-terminal guanylyl cyclase domain. Mechanisms by which these receptors are allosterically regulated by ligand binding to the extracellular domain and ATP binding to the KHD are not completely understood. Here we examine the role of the linker region in receptor guanylyl cyclases by a series of point mutations in receptor guanylyl cyclase C. The linker region is predicted to adopt a coiled coil structure and aid in dimerization, but we find that the effects of mutations neither follow a pattern predicted for a coiled coil peptide nor abrogate dimerization. Importantly, this region is critical for repressing the guanylyl cyclase activity of the receptor in the absence of ligand and permitting ligand-mediated activation of the cyclase domain. Mutant receptors with high basal guanylyl cyclase activity show no further activation in the presence of non-ionic detergents, suggesting that hydrophobic interactions in the basal and inactive conformation of the guanylyl cyclase domain are disrupted by mutation. Equivalent mutations in the linker region of guanylyl cyclase A also elevated the basal activity and abolished ligand-and detergent-mediated activation. We, therefore, have defined a key regulatory role for the linker region of receptor guanylyl cyclases which serves as a transducer of information from the extracellular domain via the KHD to the catalytic domain.	[Saha, Sayanti; Biswas, Kabir Hassan; Kondapalli, Chandana; Isloor, Nishitha; Visweswariah, Sandhya S.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Visweswariah, SS (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	sandhya@mrdg.iisc.ernet.in	Biswas, Kabir H/AAG-9156-2019; Visweswariah, Sandhya/Q-7500-2019	Biswas, Kabir H/0000-0001-9194-4127; Visweswariah, Sandhya/0000-0003-2786-7344	Departments of Science and Technology and Biotechnology, Government of India; Council of Scientific and Industrial Research, Government of India; Department of Biotechnology	Departments of Science and Technology and Biotechnology, Government of India(Department of Biotechnology (DBT) IndiaDepartment of Science & Technology (India)); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology	This work was supported by grants from the Departments of Science and Technology and Biotechnology, Government of India.; Supported by a senior research fellowship from the Council of Scientific and Industrial Research, Government of India.; Supported by a post-doctoral fellowship from the Department of Biotechnology.	Abbey SE, 2002, J BIOL CHEM, V277, P42423, DOI 10.1074/jbc.M206686200; Antos LK, 2005, J BIOL CHEM, V280, P26928, DOI 10.1074/jbc.M505648200; Bhandari R, 2001, BIOCHEMISTRY-US, V40, P9196, DOI 10.1021/bi002595g; Biswas KH, 2009, J MOL EVOL, V68, P587, DOI 10.1007/s00239-009-9242-5; Bryan PM, 2006, BIOCHEMISTRY-US, V45, P1295, DOI 10.1021/bi051253d; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Duda T, 1999, BIOCHEMISTRY-US, V38, P13912, DOI 10.1021/bi9915972; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Forte LR, 1999, REGUL PEPTIDES, V81, P25, DOI 10.1016/S0167-0115(99)00033-6; FORTE LR, 1989, AM J PHYSIOL, V257, pF874, DOI 10.1152/ajprenal.1989.257.5.F874; Ghanekar Y, 2004, BIOCHEM J, V379, P653, DOI 10.1042/BJ20040001; HIRAYAMA T, 1993, MICROB PATHOGENESIS, V15, P283, DOI 10.1006/mpat.1993.1078; Jaleel M, 2006, BIOCHEMISTRY-US, V45, P1888, DOI 10.1021/bi052089x; Jaleel M, 2002, BIOL REPROD, V67, P1975, DOI 10.1095/biolreprod.102.006445; Kitiratschky VBD, 2008, INVEST OPHTH VIS SCI, V49, P5015, DOI 10.1167/iovs.08-1901; Koch KW, 2002, MOL CELL BIOCHEM, V230, P97, DOI 10.1023/A:1014209711793; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Linder JU, 2002, J BIOL CHEM, V277, P15271, DOI 10.1074/jbc.M200235200; Linder JU, 2004, EUR J BIOCHEM, V271, P2446, DOI 10.1111/j.1432-1033.2004.04172.x; Linder JU, 2003, CELL SIGNAL, V15, P1081, DOI 10.1016/S0898-6568(03)00130-X; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Nandi A, 1997, J CELL BIOCHEM, V66, P500, DOI 10.1002/(SICI)1097-4644(19970915)66:4<500::AID-JCB9>3.0.CO;2-P; Padayatti PS, 2004, PHARMACOL THERAPEUT, V104, P83, DOI 10.1016/j.pharmthera.2004.08.003; Qian X, 2000, ENDOCRINOLOGY, V141, P3210, DOI 10.1210/en.141.9.3210; Ramamurthy V, 2001, J BIOL CHEM, V276, P26218, DOI 10.1074/jbc.M010495200; Rauch A, 2008, P NATL ACAD SCI USA, V105, P15720, DOI 10.1073/pnas.0808473105; Seebeck B, 2008, PROTEINS, V71, P1237, DOI 10.1002/prot.21818; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Shiga T, 2005, ZOOL SCI, V22, P735, DOI 10.2108/zsj.22.735; SINGH S, 1991, BIOCHEM BIOPH RES CO, V179, P1455, DOI 10.1016/0006-291X(91)91736-V; Smith M, 2007, EYE, V21, P1220, DOI 10.1038/sj.eye.6702612; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tews I, 2005, SCIENCE, V308, P1020, DOI 10.1126/science.1107642; Tucker CL, 1999, P NATL ACAD SCI USA, V96, P9039, DOI 10.1073/pnas.96.16.9039; Vaandrager AB, 2002, MOL CELL BIOCHEM, V230, P73, DOI 10.1023/A:1014231722696; van den Akker F, 2000, NATURE, V406, P101, DOI 10.1038/35017602; Vijayachandra K, 2000, BIOCHEMISTRY-US, V39, P16075, DOI 10.1021/bi0013849; VISWESWARIAH SS, 1994, EUR J BIOCHEM, V219, P727, DOI 10.1111/j.1432-1033.1994.tb18551.x; Wedel BJ, 1997, P NATL ACAD SCI USA, V94, P459, DOI 10.1073/pnas.94.2.459; WILSON EM, 1995, BIOCHEMISTRY-US, V34, P4696, DOI 10.1021/bi00014a025; Winger JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-42; Young JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000884; Yu YB, 2002, ADV DRUG DELIVER REV, V54, P1113, DOI 10.1016/S0169-409X(02)00058-3; Zhou ZM, 2004, J BIOL CHEM, V279, P24935, DOI 10.1074/jbc.M402105200; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171	52	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27135	27145		10.1074/jbc.M109.020032	http://dx.doi.org/10.1074/jbc.M109.020032			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19648115	Green Published, hybrid			2022-12-27	WOS:000270232300014
J	Deikus, G; Bechhofer, DH				Deikus, Gintaras; Bechhofer, David H.			Bacillus subtilis trp Leader RNA RNase J1 ENDONUCLEASE CLEAVAGE SPECIFICITY AND PNPase PROCESSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; ESCHERICHIA-COLI; RIBOSOMAL-RNA; TRANSCRIPTION ATTENUATION; STEM-LOOP; IN-VIVO; DECAY; DEGRADATION; PROTEIN; ENDONUCLEASE	In the presence of ample tryptophan, transcription from the Bacillus subtilis trp operon promoter terminates to give a 140-nucleotide trp leader RNA. Turnover of trp leader RNA has been shown to depend on RNase J1 cleavage at a single-stranded, AU-rich region just upstream of the 3' transcription terminator. The small size of trp leader RNA and its strong dependence on RNase J1 cleavage for decay make it a suitable substrate for analyzing the requirements for RNase J1 target site specificity. trp leader RNAs with nucleotide changes around the RNase J1 target site were more stable than wild-type trp leader RNA, showing that sequences on either side of the cleavage site contribute to RNase J1 recognition. An analysis of decay intermediates from these mutants suggested limited 3'-to-5' exonuclease processing from the native 3' end. trp leader RNAs were designed that contained wild-type or mutant RNase J1 targets elsewhere on the molecule. The presence of an additional RNase J1 cleavage site resulted in faster RNA decay, depending on its location. Addition of a 5' tail containing 7 A residues caused destabilization of trp leader RNAs. Surprisingly, addition at the 5' end of a strong stem loop structure that is known to stabilize other RNAs did not result in a longer trp leader RNA half-life, suggesting that the RNase J1 cleavage site may be accessed directly. In the course of these experiments, we found evidence that polynucleotide phosphorylase processivity was inhibited by a GCGGCCGC sequence.	[Deikus, Gintaras; Bechhofer, David H.] NYU, Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; New York University	Bechhofer, DH (corresponding author), Box 1603,1 Gustave L Levy Pl, New York, NY 10029 USA.	david.bechhofer@mssm.edu			United States Public Health Service [GM48804]; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048804] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by United States Public Health Service Grant GM48804 (to D. H. B.) from the National Institutes of Health.	Babitzke P, 2001, J BACTERIOL, V183, P5795, DOI 10.1128/JB.183.20.5795-5802.2001; Bechhofer DH, 2009, PROG MOL BIOL TRANSL, V85, P231, DOI 10.1016/S0079-6603(08)00806-4; BROSIUS J, 1992, METHOD ENZYMOL, V216, P469; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; Choonee N, 2007, NUCLEIC ACIDS RES, V35, P1578, DOI 10.1093/nar/gkm011; Coburn GA, 1999, PROG NUCLEIC ACID RE, V62, P55; Daou-Chabo R, 2009, MOL MICROBIOL, V71, P1538, DOI 10.1111/j.1365-2958.2009.06620.x; de la Sierra-Gallay IL, 2008, NAT STRUCT MOL BIOL, V15, P206, DOI 10.1038/nsmb.1376; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Deikus G, 2004, P NATL ACAD SCI USA, V101, P2747, DOI 10.1073/pnas.0307343101; Deikus G, 2008, J BIOL CHEM, V283, P17158, DOI 10.1074/jbc.M801461200; Deikus G, 2007, J BIOL CHEM, V282, P20238, DOI 10.1074/jbc.M702747200; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Hambraeus G, 2003, MOL GENET GENOMICS, V269, P706, DOI 10.1007/s00438-003-0883-6; Hambraeus G, 2002, MICROBIOL-SGM, V148, P1795, DOI 10.1099/00221287-148-6-1795; Henkin TM, 2002, BIOESSAYS, V24, P700, DOI 10.1002/bies.10125; Jiang XQ, 2004, P NATL ACAD SCI USA, V101, P9211, DOI 10.1073/pnas.0401382101; Jiang XQ, 2000, J BACTERIOL, V182, P2468, DOI 10.1128/JB.182.9.2468-2475.2000; Kushner SR, 2002, J BACTERIOL, V184, P4658, DOI 10.1128/JB.184.17.4658-4665.2002; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; Mackie GA, 2000, J BIOL CHEM, V275, P25069, DOI 10.1074/jbc.C000363200; Mader U, 2008, MOL MICROBIOL, V70, P183, DOI 10.1111/j.1365-2958.2008.06400.x; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; Mcgraw AP, 2007, RNA, V13, P2020, DOI 10.1261/rna.719507; MCLAREN RS, 1991, J MOL BIOL, V221, P81, DOI 10.1016/0022-2836(91)90806-H; Ohki R, 2004, J BACTERIOL, V186, P7450, DOI 10.1128/JB.186.21.7450-7455.2004; Petit MA, 1998, MOL MICROBIOL, V29, P261, DOI 10.1046/j.1365-2958.1998.00927.x; Sharp JS, 2005, MOL MICROBIOL, V57, P484, DOI 10.1111/j.1365-2958.2005.04683.x; Spickler C, 2000, J BACTERIOL, V182, P2422, DOI 10.1128/JB.182.9.2422-2427.2000; Tock MR, 2000, J BIOL CHEM, V275, P8726, DOI 10.1074/jbc.275.12.8726; Yao SY, 2007, NUCLEIC ACIDS RES, V35, P4464, DOI 10.1093/nar/gkm460; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	35	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26394	26401		10.1074/jbc.M109.015875	http://dx.doi.org/10.1074/jbc.M109.015875			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19638340	Green Published, hybrid			2022-12-27	WOS:000269969600020
J	Ziegler, J; Brandt, W; Geissler, R; Facchini, PJ				Ziegler, Joerg; Brandt, Wolfgang; Geissler, Rene; Facchini, Peter J.			Removal of Substrate Inhibition and Increase in Maximal Velocity in the Short Chain Dehydrogenase/Reductase Salutaridine Reductase Involved in Morphine Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; OPIUM POPPY; ALCOHOL-DEHYDROGENASE; PAPAVER-SOMNIFERUM; CARBONYL REDUCTASE; BENZYLISOQUINOLINE ALKALOIDS; CRYSTAL-STRUCTURE; LEISHMANIA-MAJOR; METABOLISM; PROTEINS	Salutaridine reductase (SalR, EC 1.1.1.248) catalyzes the stereospecific reduction of salutaridine to 7(S)-salutaridinol in the biosynthesis of morphine. It belongs to a new, plant-specific class of short-chain dehydrogenases, which are characterized by their monomeric nature and increased length compared with related enzymes. Homology modeling and substrate docking suggested that additional amino acids form a novel alpha-helical element, which is involved in substrate binding. Site-directed mutagenesis and subsequent studies on enzyme kinetics revealed the importance of three residues in this element for substrate binding. Further replacement of eight additional residues led to the characterization of the entire substrate binding pocket. In addition, a specific role in salutaridine binding by either hydrogen bond formation or hydrophobic interactions was assigned to each amino acid. Substrate docking also revealed an alternative mode for salutaridine binding, which could explain the strong substrate inhibition of SalR. An alternate arrangement of salutaridine in the enzyme was corroborated by the effect of various amino acid substitutions on substrate inhibition. In most cases, the complete removal of substrate inhibition was accompanied by a substantial loss in enzyme activity. However, some mutations greatly reduced substrate inhibition while maintaining or even increasing the maximal velocity. Based on these results, a double mutant of SalR was created that exhibited the complete absence of substrate inhibition and higher activity compared with wild-type SalR.	[Ziegler, Joerg; Facchini, Peter J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Brandt, Wolfgang] Leibniz Inst Plant Biochem, Dept Bioorgan Chem, D-06120 Halle, Germany; [Geissler, Rene] Leibniz Inst Plant Biochem, Dept Nat Prod Biotechnol, D-06120 Halle, Germany	University of Calgary; Leibniz Institut fur Pflanzenbiochemie; Leibniz Institut fur Pflanzenbiochemie	Facchini, PJ (corresponding author), 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	pfacchin@ucalgary.ca	Ziegler, Jörg/W-7645-2019	Facchini, Peter/0000-0002-7693-290X	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a Natural Sciences and Engineering Research Council of Canada Discovery grant (to P. J. F.).	Allen RS, 2008, PLANT BIOTECHNOL J, V6, P22, DOI 10.1111/j.1467-7652.2007.00293.x; Allen RS, 2004, NAT BIOTECHNOL, V22, P1559, DOI 10.1038/nbt1033; BJELDANES LF, 1972, J ORG CHEM, V37, P1453, DOI 10.1021/jo00974a041; Bomati EK, 2005, PLANT CELL, V17, P1598, DOI 10.1105/tpc.104.029983; Burton RL, 2007, J BIOL CHEM, V282, P31517, DOI 10.1074/jbc.M704032200; Choi HW, 2008, PLANT PHYSIOL, V148, P383, DOI 10.1104/pp.108.119461; Davis EM, 2005, PLANT PHYSIOL, V137, P873, DOI 10.1104/pp.104.053306; DUFFEL MW, 1981, J BIOL CHEM, V256, P1123; Eszes CM, 1996, FEBS LETT, V399, P193, DOI 10.1016/S0014-5793(96)01317-8; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Frick S, 2004, TRANSGENIC RES, V13, P607, DOI 10.1007/s11248-004-2892-6; Frick S, 2007, METAB ENG, V9, P169, DOI 10.1016/j.ymben.2006.10.004; Gamage NU, 2005, J BIOL CHEM, V280, P41482, DOI 10.1074/jbc.M508289200; Gamage NU, 2003, J BIOL CHEM, V278, P7655, DOI 10.1074/jbc.M207246200; Gangloff A, 2001, BIOCHEM J, V356, P269, DOI 10.1042/0264-6021:3560269; Geissler R, 2007, PLANT PHYSIOL, V143, P1493, DOI 10.1104/pp.106.095166; GERARDY R, 1993, PHYTOCHEMISTRY, V34, P125, DOI 10.1016/S0031-9422(00)90793-3; GHOSH D, 1994, STRUCTURE, V2, P629, DOI 10.1016/S0969-2126(00)00064-2; Ghosh D, 2001, J BIOL CHEM, V276, P18457, DOI 10.1074/jbc.M100538200; Grothe T, 2001, J BIOL CHEM, V276, P30717, DOI 10.1074/jbc.M102688200; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; HENNESSEY JP, 1981, BIOCHEMISTRY-US, V20, P1085, DOI 10.1021/bi00508a007; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Korb O, 2009, J CHEM INF MODEL, V49, P84, DOI 10.1021/ci800298z; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin PJ, 2007, PLANT BIOTECHNOL J, V5, P26, DOI 10.1111/j.1467-7652.2006.00212.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Luba J, 1998, BIOCHEMISTRY-US, V37, P4093, DOI 10.1021/bi972693a; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Minami H, 2008, P NATL ACAD SCI USA, V105, P7393, DOI 10.1073/pnas.0802981105; Nare B, 1997, J BIOL CHEM, V272, P13883, DOI 10.1074/jbc.272.21.13883; Oppermann UCT, 1997, BIOCHEMISTRY-US, V36, P34, DOI 10.1021/bi961803v; Pellegrini E, 2002, J PHYS CHEM A, V106, P1316, DOI 10.1021/jp0135050; Persson B, 2003, CHEM-BIOL INTERACT, V143, P271, DOI 10.1016/S0009-2797(02)00223-5; POCKER Y, 1985, ALCOHOL, V2, P3, DOI 10.1016/0741-8329(85)90004-7; REARICK DE, 1970, TETRAHEDRON LETT, P507; Rehse PH, 2002, BIOCHEM J, V364, P165, DOI 10.1042/bj3640165; Ringer KL, 2003, ARCH BIOCHEM BIOPHYS, V418, P80, DOI 10.1016/S0003-9861(03)00390-4; SIPPL MJ, 1990, J MOL BIOL, V213, P859, DOI 10.1016/S0022-2836(05)80269-4; TANAKA M, 1992, J BIOL CHEM, V267, P13451; Tanaka N, 1996, STRUCTURE, V4, P33, DOI 10.1016/S0969-2126(96)00007-X; Warner JR, 2008, BIOCHEMISTRY-US, V47, P3258, DOI 10.1021/bi702431n; WINBERG JO, 1994, BIOCHEM J, V301, P901, DOI 10.1042/bj3010901; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730; Ziegler J, 2006, PLANT J, V48, P177, DOI 10.1111/j.1365-313X.2006.02860.x	45	18	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26758	26767		10.1074/jbc.M109.030957	http://dx.doi.org/10.1074/jbc.M109.030957			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19648114	Green Published, hybrid			2022-12-27	WOS:000269969600057
J	Myette, JR; Soundararajan, V; Behr, J; Shriver, Z; Raman, R; Sasisekharan, R				Myette, James R.; Soundararajan, Venkataramanan; Behr, Jonathan; Shriver, Zachary; Raman, Rahul; Sasisekharan, Ram			Heparin/Heparan Sulfate N-Sulfamidase from Flavobacterium heparinum STRUCTURAL AND BIOCHEMICAL INVESTIGATION OF CATALYTIC NITROGEN-SULFUR BOND CLEAVAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; RECOMBINANT EXPRESSION; SUBSTRATE-SPECIFICITY; MOLECULAR-CLONING; ESCHERICHIA-COLI; BINDING SITES; PURIFICATION; GLYCOSAMINOGLYCANS; ARYLSULFATASE; PROTEOGLYCANS	Sulfated polysaccharides such as heparin and heparan sulfate glycosaminoglycans (HSGAGs) are chemically and structurally heterogeneous biopolymers that that function as key regulators of numerous biological functions. The elucidation of HSGAG fine structure is fundamental to understanding their functional diversity, and this is facilitated by the use of select degrading enzymes of defined substrate specificity. Our previous studies have reported the cloning, characterization, recombinant expression, and structure-function analysis in Escherichia coli of the Flavobacterium heparinum 2-O-sulfatase and 6-O-sulfatase enzymes that cleave O-sulfate groups from specific locations of the HSGAG polymer. Building on these preceding studies, we report here the molecular cloning and recombinant expression in Escherichia coli of an N-sulfamidase, specific for HSGAGs. In addition, we examine the basic enzymology of this enzyme through molecular modeling studies and structure-function analysis of substrate specificity and basic biochemistry. We use the results from these studies to propose a novel mechanism for nitrogen-sulfur bond cleavage by the N-sulfamidase. Taken together, our structural and biochemical studies indicate that N-sulfamidase is a predominantly exolytic enzyme that specifically acts on N-sulfated and 6-O-desulfated glucosamines present as monosaccharides or at the nonreducing end of odd-numbered oligosaccharide substrates. In conjunction with the previously reported specificities for the F. heparinum 2-O-sulfatase, 6-O-sulfatase, and unsaturated glucuronyl hydrolase, we are able to now reconstruct in vitro the defined exolytic sequence for the heparin and heparan sulfate degradation pathway of F. heparinum and apply these enzymes in tandem toward the exo-sequencing of heparin-derived oligosaccharides.	MIT, Harvard Mit Div Hlth Sci & Technol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sasisekharan, R (corresponding author), 77 Massachusetts Ave,Rm 16-561, Cambridge, MA 02139 USA.	rams@mit.edu			National Institutes of Health [GM57073]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM057073, R01GM057073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM57073.	Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; BEIL S, 1995, EUR J BIOCHEM, V229, P385, DOI 10.1111/j.1432-1033.1995.0385k.x; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Boltes I, 2001, STRUCTURE, V9, P483, DOI 10.1016/S0969-2126(01)00609-8; Bond CS, 1997, STRUCTURE, V5, P277, DOI 10.1016/S0969-2126(97)00185-8; BRUCE JS, 1985, EUR J BIOCHEM, V148, P359, DOI 10.1111/j.1432-1033.1985.tb08847.x; CHEN FTA, 1995, ANAL BIOCHEM, V230, P273, DOI 10.1006/abio.1995.1474; Dierks T, 1998, J BIOL CHEM, V273, P25560, DOI 10.1074/jbc.273.40.25560; DIETRICH CP, 1973, J BIOL CHEM, V248, P6408; Ernst S, 1996, BIOCHEM J, V315, P589, DOI 10.1042/bj3150589; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Guda C, 2004, NUCLEIC ACIDS RES, V32, pW100, DOI 10.1093/nar/gkh464; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Hankin DM, 1996, J CHEM SOC DALTON, P4063, DOI 10.1039/dt9960004063; Hanson SR, 2004, ANGEW CHEM INT EDIT, V43, P5736, DOI 10.1002/anie.200300632; Kertesz MA, 2000, FEMS MICROBIOL REV, V24, P135, DOI 10.1016/S0168-6445(99)00033-9; Lai JP, 2004, GASTROENTEROLOGY, V126, P231, DOI 10.1053/j.gastro.2003.09.043; LINDAHL U, 1980, P NATL ACAD SCI-BIOL, V77, P6551, DOI 10.1073/pnas.77.11.6551; Liu J, 2002, J BIOL CHEM, V277, P33456, DOI 10.1074/jbc.M202034200; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Myette JR, 2009, J BIOL CHEM, V284, P35177, DOI 10.1074/jbc.M109.053801; Myette JR, 2003, J BIOL CHEM, V278, P12157, DOI 10.1074/jbc.M211420200; Myette JR, 2002, BIOCHEMISTRY-US, V41, P7424, DOI 10.1021/bi012147o; NAKAMURA T, 1988, J CLIN MICROBIOL, V26, P1070, DOI 10.1128/JCM.26.5.1070-1071.1988; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Prince JM, 2002, DEV DYNAM, V223, P497, DOI 10.1002/dvdy.10070; Raman R, 2003, J BIOL CHEM, V278, P12167, DOI 10.1074/jbc.M211425200; Rhomberg AJ, 1998, P NATL ACAD SCI USA, V95, P4176, DOI 10.1073/pnas.95.8.4176; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Sasisekharan R, 1996, J BIOL CHEM, V271, P3124, DOI 10.1074/jbc.271.6.3124; SASISEKHARAN R, 1995, BIOCHEMISTRY-US, V34, P14441, DOI 10.1021/bi00044a022; Sasisekharan R, 2006, ANNU REV BIOMED ENG, V8, P181, DOI 10.1146/annurev.bioeng.8.061505.095745; Shriver Z, 1999, J BIOL CHEM, V274, P4082, DOI 10.1074/jbc.274.7.4082; Venkataraman G, 1999, SCIENCE, V286, P537, DOI 10.1126/science.286.5439.537; Vives RR, 2006, CURR GENE THER, V6, P35, DOI 10.2174/156652306775515565	37	17	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35189	35200		10.1074/jbc.M109.053835	http://dx.doi.org/10.1074/jbc.M109.053835			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19726673	Green Published, hybrid			2022-12-27	WOS:000272439600072
J	Belfort, M				Belfort, Marlene			Scientific Serendipity Initiates an Intron Odyssey	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							ENDONUCLEASE I-TEVI; T-EVEN PHAGES; THYMIDYLATE SYNTHASE GENE; DISTANCE DETERMINATION; INTERVENING SEQUENCE; REMOTE CLEAVAGE; RNA; EXPRESSION; MOBILITY; DOMAIN		[Belfort, Marlene] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12208 USA; [Belfort, Marlene] SUNY Albany, Ctr Med Sci, Albany, NY 12208 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Belfort, M (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12208 USA.	belfort@wadsworth.org		Belfort, Marlene/0000-0002-1592-5618	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM039422, R01GM039422, R01GM044844] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM039422, R01 GM039422, GM44844, GM39422, R01 GM044844] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beauregard A, 2008, ANNU REV GENET, V42, P587, DOI 10.1146/annurev.genet.42.110807.091549; BELFORT M, 1985, CELL, V41, P375, DOI 10.1016/S0092-8674(85)80010-6; Belfort M, 2005, NUCL ACID M, V16, P1; BELFORT M, 1980, ARCH BIOCHEM BIOPHYS, V204, P340, DOI 10.1016/0003-9861(80)90042-9; BELFORT M, 1984, J BACTERIOL, V160, P371, DOI 10.1128/JB.160.1.371-378.1984; BELFORT M, 1986, GENE, V41, P93, DOI 10.1016/0378-1119(86)90271-4; BELFORT M, 1989, TRENDS GENET, V5, P209, DOI 10.1016/0168-9525(89)90083-8; BELFORT M, 1989, RNA CATALYSIS SPLICI; BELLPEDERSEN D, 1989, GENE, V82, P119, DOI 10.1016/0378-1119(89)90036-X; BELLPEDERSEN D, 1991, P NATL ACAD SCI USA, V88, P7719, DOI 10.1073/pnas.88.17.7719; BRYK M, 1995, J MOL BIOL, V247, P197, DOI 10.1006/jmbi.1994.0133; BRYK M, 1993, EMBO J, V12, P2141, DOI 10.1002/j.1460-2075.1993.tb05862.x; BRYK M, 1990, NATURE, V346, P394, DOI 10.1038/346394a0; CHU FK, 1985, J BIOL CHEM, V260, P680; CHU FK, 1986, CELL, V45, P157, DOI 10.1016/0092-8674(86)90379-X; CHU FK, 1984, P NATL ACAD SCI-BIOL, V81, P3049, DOI 10.1073/pnas.81.10.3049; CLYMAN J, 1992, GENE DEV, V6, P1269, DOI 10.1101/gad.6.7.1269; Coros CJ, 2009, MOL CELL, V34, P250, DOI 10.1016/j.molcel.2009.03.014; Dean AB, 2002, P NATL ACAD SCI USA, V99, P8554, DOI 10.1073/pnas.082253699; Derbyshire V, 1997, J MOL BIOL, V265, P494, DOI 10.1006/jmbi.1996.0754; Dunin-Horkawicz S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-98; Edgell DR, 2004, J MOL BIOL, V343, P1231, DOI 10.1016/j.jmb.2004.09.005; Edgell DR, 2004, NAT STRUCT MOL BIOL, V11, P936, DOI 10.1038/nsmb823; EHRENMAN K, 1986, P NATL ACAD SCI USA, V83, P5875, DOI 10.1073/pnas.83.16.5875; GOTT JM, 1988, GENE DEV, V2, P1791, DOI 10.1101/gad.2.12b.1791; GOTT JM, 1986, CELL, V47, P81, DOI 10.1016/0092-8674(86)90368-5; Huang YJ, 1999, GENETICS, V153, P1501; Kowalski JC, 1999, NUCLEIC ACIDS RES, V27, P2115, DOI 10.1093/nar/27.10.2115; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; LAMBOWITZ AM, 1989, CELL, V56, P323, DOI 10.1016/0092-8674(89)90232-8; Liu QQ, 2008, J MOL BIOL, V379, P1094, DOI 10.1016/j.jmb.2008.04.047; Liu QQ, 2006, NUCLEIC ACIDS RES, V34, P1755, DOI 10.1093/nar/gkl079; LOIZOS N, 1994, P NATL ACAD SCI USA, V91, P11983, DOI 10.1073/pnas.91.25.11983; MICHEL F, 1986, CELL, V46, P323, DOI 10.1016/0092-8674(86)90651-3; MUELLER JE, 1995, EMBO J, V14, P5724, DOI 10.1002/j.1460-2075.1995.tb00259.x; Mueller JE, 1996, GENE DEV, V10, P351, DOI 10.1101/gad.10.3.351; Parker MM, 1996, GENETICS, V143, P1057; PEDERSENLANE J, 1987, SCIENCE, V237, P182, DOI 10.1126/science.3037701; QUIRK SM, 1989, CELL, V56, P455, DOI 10.1016/0092-8674(89)90248-1; QUIRK SM, 1989, NUCLEIC ACIDS RES, V17, P301, DOI 10.1093/nar/17.1.301; Van Roey P, 2002, NAT STRUCT BIOL, V9, P806, DOI 10.1038/nsb853; Van Roey P, 2005, NUCL ACID M, V16, P67; Van Roey P, 2001, EMBO J, V20, P3631, DOI 10.1093/emboj/20.14.3631	43	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					29997	30003		10.1074/jbc.X109.055400	http://dx.doi.org/10.1074/jbc.X109.055400			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19710025	Green Published, hybrid			2022-12-27	WOS:000271090000001
J	Giannakis, M; Backhed, HK; Chen, SL; Faith, JJ; Wu, M; Guruge, JL; Engstrand, L; Gordon, JI				Giannakis, Marios; Backhed, Helene Kling; Chen, Swaine L.; Faith, Jeremiah J.; Wu, Meng; Guruge, Janaki L.; Engstrand, Lars; Gordon, Jeffrey I.			Response of Gastric Epithelial Progenitors to Helicobacter pylori Isolates Obtained from Swedish Patients with Chronic Atrophic Gastritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEINS; GENE-EXPRESSION; POSITIVE SELECTION; ESCHERICHIA-COLI; COMPARATIVE GENOMICS; PHASE VARIATION; STEM-CELLS; CANCER; INFECTION; COLONIZATION	Helicobacter pylori infection is associated with gastric adenocarcinoma in some humans, especially those that develop an antecedent condition, chronic atrophic gastritis (ChAG). Gastric epithelial progenitors (GEPs) in transgenic gnotobiotic mice with a ChAG-like phenotype harbor intracellular collections of H. pylori. To characterize H. pylori adaptations to ChAG, we sequenced the genomes of 24 isolates obtained from 6 individuals, each sampled over a 4-year interval, as they did or did not progress from normal gastric histology to ChAG and/or adenocarcinoma. H. pylori populations within study participants were largely clonal and remarkably stable regardless of disease state. GeneChip studies of the responses of a cultured mouse gastric stem cell-like line (mGEPs) to infection with sequenced strains yielded a 695-member dataset of transcripts that are (i) differentially expressed after infection with ChAG-associated isolates, but not with a "normal" or a heat-killed ChAG isolate, and (ii) enriched in genes and gene functions associated with tumorigenesis in general and gastric carcinogenesis in specific cases. Transcriptional profiling of a ChAG strain during mGEP infection disclosed a set of responses, including up-regulation of hopZ, an adhesin belonging to a family of outer membrane proteins. Expression profiles of wild-type and Delta hopZ strains revealed a number of pH-regulated genes modulated by HopZ, including hopP, which binds sialylated glycans produced by GEPs in vivo. Genetic inactivation of hopZ produced a fitness defect in the stomachs of gnotobiotic transgenic mice but not in wild-type littermates. This study illustrates an approach for identifying GEP responses specific to ChAG-associated H. Pylori strains and bacterial genes important for survival in a model of the ChAG gastric ecosystem.	[Giannakis, Marios; Backhed, Helene Kling; Chen, Swaine L.; Faith, Jeremiah J.; Wu, Meng; Guruge, Janaki L.; Gordon, Jeffrey I.] Washington Univ, Ctr Genome Sci, St Louis, MO 63108 USA; [Chen, Swaine L.] Washington Univ, Dept Mol Microbiol, St Louis, MO 63108 USA; [Backhed, Helene Kling; Engstrand, Lars] Smittskyddsinst, Swedish Inst Infect Dis Control, S-17182 Solna, Sweden; [Backhed, Helene Kling; Engstrand, Lars] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden	Washington University (WUSTL); Washington University (WUSTL); Swedish Institute for Infectious Disease Control; Karolinska Institutet	Gordon, JI (corresponding author), 4444 Forest Pk Blvd,Campus Box 8510, St Louis, MO 63108 USA.	jgordon@wustl.edu	Wu, Meng/P-9657-2019; Giannakis, Marios/Z-4908-2019	Chen, Swaine/0000-0002-0107-2861	National Institutes of Health [DK58529, DK52574, DK081620, DK64540]; Swedish Cancer Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058529, P50DK064540, K01DK081620, P30DK052574] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Cancer Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK58529, DK52574, DK081620, and DK64540 and the Swedish Cancer Foundation.	Aanensen DM, 2005, NUCLEIC ACIDS RES, V33, pW728, DOI 10.1093/nar/gki415; Ang S, 2001, INFECT IMMUN, V69, P1679, DOI 10.1128/IAI.69.3.1679-1686.2001; Appelmelk BJ, 2000, INFECT IMMUN, V68, P5928, DOI 10.1128/IAI.68.10.5928-5932.2000; Appelmelk BJ, 1999, INFECT IMMUN, V67, P5361, DOI 10.1128/IAI.67.10.5361-5366.1999; Aras RA, 2002, NUCLEIC ACIDS RES, V30, P5391, DOI 10.1093/nar/gkf686; Aro P, 2004, SCAND J GASTROENTERO, V39, P1280, DOI 10.1080/00365520410008141; Backstrom A, 2004, P NATL ACAD SCI USA, V101, P16923, DOI 10.1073/pnas.0404817101; Baudin E, 1998, BRIT J CANCER, V78, P1102, DOI 10.1038/bjc.1998.635; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binder BR, 2008, IMMUNOL LETT, V118, P116, DOI 10.1016/j.imlet.2008.03.017; Blaser MJ, 2007, NATURE, V449, P843, DOI 10.1038/nature06198; Blaser MJ, 1999, P NATL ACAD SCI USA, V96, P8359, DOI 10.1073/pnas.96.15.8359; BLASER MJ, 1994, J CLIN INVEST, V94, P4, DOI 10.1172/JCI117336; Bury-Mone S, 2004, MOL MICROBIOL, V53, P623, DOI 10.1111/j.1365-2958.2004.04137.x; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Chen Y, 2007, ARCH INTERN MED, V167, P821, DOI 10.1001/archinte.167.8.821; Cosgrove EJ, 2008, BIOINFORMATICS, V24, P2482, DOI 10.1093/bioinformatics/btn476; Davids W, 2002, J MOL EVOL, V54, P458, DOI 10.1007/s00239-001-0029-6; de Jonge R, 2004, J MED MICROBIOL, V53, P375, DOI 10.1099/jmm.0.45551-0; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Enroth H, 2000, CANCER EPIDEM BIOMAR, V9, P981; FERRERO RL, 1992, J BACTERIOL, V174, P4212, DOI 10.1128/JB.174.13.4212-4217.1992; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Giannakis M, 2008, P NATL ACAD SCI USA, V105, P4358, DOI 10.1073/pnas.0800668105; Hamajima N, 2006, CANCER SCI, V97, P1129, DOI 10.1111/j.1349-7006.2006.00290.x; Holtmann G, 2004, J GASTROENTEROL, V39, P1027, DOI 10.1007/s00535-004-1440-8; Hooper LV, 2002, METHOD MICROBIOL, V31, P559, DOI 10.1016/S0580-9517(02)31030-4; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Keates AC, 2008, INFECT IMMUN, V76, P3992, DOI 10.1128/IAI.00584-08; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lee HS, 2003, J PATHOL, V200, P39, DOI 10.1002/path.1288; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lundin A, 2005, INFECT IMMUN, V73, P4818, DOI 10.1128/IAI.73.8.4818-4822.2005; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Merrell DS, 2003, INFECT IMMUN, V71, P3529, DOI 10.1128/IAI.71.6.3529-3539.2003; Miao XP, 2007, WORLD J GASTROENTERO, V13, P2867, DOI 10.3748/wjg.v13.i20.2867; Necchi V, 2007, GASTROENTEROLOGY, V132, P1009, DOI 10.1053/j.gastro.2007.01.049; Oh JD, 2005, P NATL ACAD SCI USA, V102, P5186, DOI 10.1073/pnas.0407657102; Oh JD, 2006, P NATL ACAD SCI USA, V103, P9999, DOI 10.1073/pnas.0603784103; Owen RJ, 2003, J MED MICROBIOL, V52, P515, DOI 10.1099/jmm.0.04988-0; Peck B, 1999, NUCLEIC ACIDS RES, V27, P3325, DOI 10.1093/nar/27.16.3325; Petersen L, 2007, GENOME RES, V17, P1336, DOI 10.1101/gr.6254707; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rokkas T, 2007, CLIN GASTROENTEROL H, V5, P1413, DOI 10.1016/j.cgh.2007.08.010; Roth C, 2005, NUCLEIC ACIDS RES, V33, pD495, DOI 10.1093/nar/gki090; Salama N, 2000, P NATL ACAD SCI USA, V97, P14668, DOI 10.1073/pnas.97.26.14668; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Skoglund A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005885; Storskrubb T, 2005, SCAND J GASTROENTERO, V40, P302, DOI 10.1080/00365520410010625; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; Syder AJ, 1999, MOL CELL, V3, P263, DOI 10.1016/S1097-2765(00)80454-2; Takeno A, 2008, BRIT J CANCER, V99, P1307, DOI 10.1038/sj.bjc.6604682; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner KME, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-30; Wang G, 1999, MOL MICROBIOL, V31, P1265, DOI 10.1046/j.1365-2958.1999.01268.x; Xu Q, 2000, P NATL ACAD SCI USA, V97, P9671, DOI 10.1073/pnas.97.17.9671; Yamaoka Y, 2002, GASTROENTEROLOGY, V123, P1992, DOI 10.1053/gast.2002.37074; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Ye WM, 2004, JNCI-J NATL CANCER I, V96, P388, DOI 10.1093/jnci/djh057; Yoshida M, 2004, J BIOL CHEM, V279, P46008, DOI 10.1074/jbc.M404393200; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	65	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30383	30394		10.1074/jbc.M109.052738	http://dx.doi.org/10.1074/jbc.M109.052738			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19723631	Green Published, hybrid			2022-12-27	WOS:000271090000041
J	Licht, A; Brantl, S				Licht, Andreas; Brantl, Sabine			The Transcriptional Repressor CcpN from Bacillus subtilis Uses Different Repression Mechanisms at Different Promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI RNA-POLYMERASE; ESCHERICHIA-COLI; ALPHA-SUBUNIT; GLUCONEOGENIC GENES; SIGMA-FACTOR; PROTEIN P4; BINDING; ACTIVATION; INHIBITION; INITIATION	CcpN, a transcriptional repressor from Bacillus subtilis that is responsible for the carbon catabolite repression of three genes, has been characterized in detail in the past 4 years. However, nothing is known about the actual repression mechanism as yet. Here, we present a detailed study on how CcpN exerts its repression effect at its three known target promoters of the genes sr1, pckA, and gapB. Using gel shift assays under non-repressive and repressive conditions, we showed that CcpN and RNA polymerase can bind simultaneously and that CcpN does not prevent RNA polymerase (RNAP) binding to the promoter. Furthermore, we investigated the effect of CcpN on open complex formation and demonstrate that CcpN also does not act at this step of transcription initiation at the sr1 and pckA and presumably at the gapB promoter. Investigation of abortive transcript synthesis revealed that CcpN acts differently at the three promoters: At the sr1 and pckA promoter, promoter clearance is impeded by CcpN, whereas synthesis of abortive transcripts is repressed at the gapB promoter. Eventually, we demonstrated with Far Western blots and co-elution experiments that CcpN is able to interact with the RNAP alpha-subunit, which completes the picture of the requirements for the repressive action of CcpN. On the basis of the presented results, we propose a new working model for CcpN action.	[Licht, Andreas; Brantl, Sabine] Univ Jena, Arbeitsgrp Bakteriengenet, D-07743 Jena, Germany	Friedrich Schiller University of Jena	Licht, A (corresponding author), Philosophenweg 12, D-07743 Jena, Germany.	andreas.licht@uni-jena.de			Deutsche Forschungsgemeinschaft [BR1552/6-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grant BR1552/6-3 from the Deutsche Forschungsgemeinschaft (to S. B.).	Barragan MJL, 2005, J BIOL CHEM, V280, P10683, DOI 10.1074/jbc.M412259200; Campbell EA, 2008, CURR OPIN MICROBIOL, V11, P121, DOI 10.1016/j.mib.2008.02.016; CHOY HE, 1995, EMBO J, V14, P4523, DOI 10.1002/j.1460-2075.1995.tb00131.x; COLLADOVIDES J, 1991, MICROBIOL REV, V55, P371, DOI 10.1128/MMBR.55.3.371-394.1991; ELLINGER T, 1994, J MOL BIOL, V239, P466, DOI 10.1006/jmbi.1994.1389; Escolar L, 1998, J BACTERIOL, V180, P2579, DOI 10.1128/JB.180.9.2579-2582.1998; Fillinger S, 2000, J BIOL CHEM, V275, P14031, DOI 10.1074/jbc.275.19.14031; Fujita M, 1998, J BIOCHEM, V124, P89, DOI 10.1093/oxfordjournals.jbchem.a022102; Fujita M, 1998, GENE, V221, P185, DOI 10.1016/S0378-1119(98)00452-1; Gourse RL, 2000, MOL MICROBIOL, V37, P687, DOI 10.1046/j.1365-2958.2000.01972.x; Greene EA, 1996, J BIOL CHEM, V271, P11455, DOI 10.1074/jbc.271.19.11455; HELTZEL A, 1990, BIOCHEMISTRY-US, V29, P9572, DOI 10.1021/bi00493a011; Hughes KT, 1998, ANNU REV MICROBIOL, V52, P231, DOI 10.1146/annurev.micro.52.1.231; Ilag LL, 2004, STRUCTURE, V12, P269, DOI 10.1016/j.str.2004.01.007; KAWAMURA F, 1984, J BACTERIOL, V160, P442, DOI 10.1128/JB.160.1.442-444.1984; Kim JH, 2005, MOL MICROBIOL, V56, P155, DOI 10.1111/j.1365-2958.2005.04496.x; Licht A, 2005, MOL MICROBIOL, V58, P189, DOI 10.1111/j.1365-2958.2005.04810.x; Licht A, 2006, J MOL BIOL, V364, P434, DOI 10.1016/j.jmb.2006.09.021; Lopez PJ, 1998, J MOL BIOL, V276, P861, DOI 10.1006/jmbi.1997.1576; Lucht A, 2008, J MOL BIOL, V380, P17, DOI 10.1016/j.jmb.2008.05.002; Meijer WJJ, 2004, NUCLEIC ACIDS RES, V32, P1166, DOI 10.1093/nar/gkh290; Monsalve M, 1996, EMBO J, V15, P383, DOI 10.1002/j.1460-2075.1996.tb00368.x; Monsalve M, 1996, P NATL ACAD SCI USA, V93, P8913, DOI 10.1073/pnas.93.17.8913; RECORD MT, 1996, ESCHERICHIA COLI SAL; Rojo F, 2001, CURR OPIN MICROBIOL, V4, P145, DOI 10.1016/S1369-5274(00)00180-6; Schneider R, 1999, MOL MICROBIOL, V34, P953, DOI 10.1046/j.1365-2958.1999.01656.x; SCHOLTEN PM, 1986, NUCLEIC ACIDS RES, V14, P3981, DOI 10.1093/nar/14.10.3981; Schroder O, 2000, J MOL BIOL, V298, P737, DOI 10.1006/jmbi.2000.3708; Servant P, 2005, MOL MICROBIOL, V55, P1435, DOI 10.1111/j.1365-2958.2005.04473.x; Severinova E, 1998, J MOL BIOL, V279, P9, DOI 10.1006/jmbi.1998.1742; Shah IM, 2004, J MOL BIOL, V343, P513, DOI 10.1016/j.jmb.2004.08.057; SUMMERS AO, 1992, J BACTERIOL, V174, P3097, DOI 10.1128/jb.174.10.3097-3101.1992; Tannler S, 2008, J BACTERIOL, V190, P6178, DOI 10.1128/JB.00552-08; Tannler S, 2008, METAB ENG, V10, P216, DOI 10.1016/j.ymben.2008.06.002; Turinsky AJ, 1998, J BACTERIOL, V180, P5961, DOI 10.1128/JB.180.22.5961-5967.1998; Ujiie H, 2009, J BIOCHEM, V145, P59, DOI 10.1093/jb/mvn143; WAGNER R, 2000, TRANSCRIPTIONAL REGU; WILLIAMS DR, 1993, NUCLEIC ACIDS RES, V21, P1141, DOI 10.1093/nar/21.5.1141; Yoshida K, 2001, NUCLEIC ACIDS RES, V29, P683, DOI 10.1093/nar/29.3.683; Zhang Y, 2006, J BACTERIOL, V188, P4300, DOI 10.1128/JB.00220-06; Zorrilla S, 2008, BIOPHYS J, V95, P4403, DOI 10.1529/biophysj.108.135863	41	20	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30032	30038		10.1074/jbc.M109.033076	http://dx.doi.org/10.1074/jbc.M109.033076			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19726675	Green Published, hybrid			2022-12-27	WOS:000271090000005
J	Peng, GD; Han, M; Du, YM; Lin, AN; Yu, L; Zhang, YQ; Jing, NH				Peng, Guangdun; Han, Mei; Du, Yimin; Lin, Anning; Yu, Lei; Zhang, Yuqiu; Jing, Naihe			SIP30 Is Regulated by ERK in Peripheral Nerve Injury-induced Neuropathic Pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC CONSTRICTION INJURY; PRIMARY SENSORY NEURONS; TRANSCRIPTION FACTOR CREB; PROTEIN-KINASE CASCADE; DORSAL-HORN NEURONS; SPINAL-CORD-INJURY; SCIATIC-NERVE; MECHANICAL ALLODYNIA; INFLAMMATORY PAIN; GROWTH-FACTOR	ERK plays an important role in chronic neuropathic pain. However, the underlying mechanism is largely unknown. Here we show that in chronic constriction injury-treated rat spinal cords, up-regulation of SIP30 (SNAP25-interacting protein 30), which is involved in the development and maintenance of chronic constriction injury-induced neuropathic pain, correlates with ERK activation and that the up-regulation of SIP30 is suppressed by intrathecal delivery of the MEK inhibitor U0126. In PC12 cells, up-regulation of SIP30 by nerve growth factor is also dependent on ERK activation. We found that there is an ERK-responsive region in the rat sip30 promoter. Activation of ERK promotes the recruitment of the transcription factor cyclic AMP-response element-binding protein to the sip30 gene promoter. Taken together, our results provide a potential downstream target of ERK activation-mediated neuropathic pain.	[Han, Mei; Zhang, Yuqiu] Fudan Univ, Inst Brain Sci, Inst Neurobiol, Shanghai 200032, Peoples R China; [Han, Mei; Zhang, Yuqiu] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China; [Peng, Guangdun; Jing, Naihe] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China; [Du, Yimin] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Lin, Anning] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Yu, Lei] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; [Yu, Lei] Rutgers State Univ, Ctr Alcohol Studies, Piscataway, NJ 08854 USA	Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; University of Chicago; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Zhang, YQ (corresponding author), Fudan Univ, Inst Brain Sci, Inst Neurobiol, Shanghai 200032, Peoples R China.	yuqiuzhang@fudan.edu.cn; njing@sibs.ac.cn	Peng, Guangdun/AAH-9044-2019; Zhang, Yu-Qiu/CAF-6295-2022; Zhang, Yu-Qiu/AAS-2516-2020	Peng, Guangdun/0000-0002-8586-0637	National Natural Science Foundation of China [30623003, 30721065, 30821002, 30830034, 30870835]; National Key Basic Research and Development Program of China [005CB522704, 2006CB943902, 2007CB512303, 2007CB512502, 2007CB947101, 2008KR0695, 2009CB941100]; Shanghai Key Project of Basic Science Research [06DJ14001, 06DZ22032, 08DJ1400501]; Council of Shanghai Municipal Government for Science and Technology [088014199];  [National High- Tech Research and Development Program of China 2006AA02Z186]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program of China(National Basic Research Program of China); Shanghai Key Project of Basic Science Research; Council of Shanghai Municipal Government for Science and Technology; 	This work was supported in part by the National Natural Science Foundation of China Grants 30623003, 30721065, 30821002, 30830034, and 30870835, National Key Basic Research and Development Program of China Grants 005CB522704, 2006CB943902, 2007CB512303, 2007CB512502, 2007CB947101, 2008KR0695, and 2009CB941100, National High- Tech Research and Development Program of China Grant 2006AA02Z186, Shanghai Key Project of Basic Science Research Grants 06DJ14001, 06DZ22032, and 08DJ1400501, and the Council of Shanghai Municipal Government for Science and Technology Grant 088014199.	Bark C, 2004, J NEUROSCI, V24, P8796, DOI 10.1523/JNEUROSCI.1940-04.2004; Basbaum AI, 1999, CURR BIOL, V9, pR429, DOI 10.1016/S0960-9822(99)80273-5; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; Ciruela A, 2003, BRIT J PHARMACOL, V138, P751, DOI 10.1038/sj.bjp.0705103; Crown ED, 2006, EXP NEUROL, V199, P397, DOI 10.1016/j.expneurol.2006.01.003; Dai Y, 2002, J NEUROSCI, V22, P7737; Euskirchen G, 2004, MOL CELL BIOL, V24, P3804, DOI 10.1128/MCB.24.9.3804-3814.2004; Frassoni C, 2005, NEUROSCIENCE, V131, P813, DOI 10.1016/j.neuroscience.2004.11.042; Galan A, 2003, MOL BRAIN RES, V116, P126, DOI 10.1016/S0169-328X(03)00284-5; Galan A, 2002, NEUROSCI LETT, V322, P37, DOI 10.1016/S0304-3940(02)00078-2; Gao X, 2001, BIOCHEM BIOPH RES CO, V284, P1098, DOI 10.1006/bbrc.2001.5089; Garry EM, 2005, MOL CELL NEUROSCI, V30, P523, DOI 10.1016/j.mcn.2005.08.016; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hefti FF, 2006, TRENDS PHARMACOL SCI, V27, P85, DOI 10.1016/j.tips.2005.12.001; Herzberg U, 1997, NEUROREPORT, V8, P1613, DOI 10.1097/00001756-199705060-00012; Hoeger-Bement MK, 2003, J NEUROSCI, V23, P5437; Hou QL, 2006, BIOCHEM BIOPH RES CO, V347, P955, DOI 10.1016/j.bbrc.2006.06.184; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Ji R R, 2007, Handb Exp Pharmacol, P359; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Ji RR, 2002, J NEUROSCI, V22, P478, DOI 10.1523/JNEUROSCI.22-02-00478.2002; Ji RR, 1997, J NEUROSCI, V17, P1776; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Ji RR, 2006, NEURON GLIA BIOL, V2, P259, DOI 10.1017/S1740925X07000403; Ji Ru-Rong, 2004, Curr Opin Investig Drugs, V5, P71; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Josiah DT, 2006, PSYCHOPHARMACOLOGY, V188, P152, DOI 10.1007/s00213-006-0481-5; Karim F, 2001, J NEUROSCI, V21, P3771, DOI 10.1523/JNEUROSCI.21-11-03771.2001; Kawasaki Y, 2004, J NEUROSCI, V24, P8310, DOI 10.1523/JNEUROSCI.2396-04.2004; Lee HK, 2002, J NEUROCHEM, V81, P1338, DOI 10.1046/j.1471-4159.2002.00937.x; Lim G, 2003, PAIN, V105, P275, DOI 10.1016/S0304-3959(03)00242-2; Ma WY, 2003, BRAIN RES, V988, P97, DOI 10.1016/S0006-8993(03)03348-1; Ma WY, 2001, PAIN, V93, P295, DOI 10.1016/S0304-3959(01)00335-9; Malik-Hall M, 2005, EUR J NEUROSCI, V21, P3387, DOI 10.1111/j.1460-9568.2005.04173.x; Marie-Claire C, 2007, NEUROPHARMACOLOGY, V52, P430, DOI 10.1016/j.neuropharm.2006.08.012; McMahon SB, 1996, PHILOS T R SOC B, V351, P431, DOI 10.1098/rstb.1996.0039; Moalem G, 2004, NEUROSCIENCE, V129, P767, DOI 10.1016/j.neuroscience.2004.08.035; MOLANDER C, 1984, J COMP NEUROL, V230, P133, DOI 10.1002/cne.902300112; Obata K, 2004, EUR J NEUROSCI, V20, P2881, DOI 10.1111/j.1460-9568.2004.03754.x; Obata K, 2004, LIFE SCI, V74, P2643, DOI 10.1016/j.lfs.2004.01.007; Obata K, 2007, J NEUROCHEM, V102, P1569, DOI 10.1111/j.1471-4159.2007.04656.x; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Ro LS, 1999, PAIN, V79, P265, DOI 10.1016/S0304-3959(98)00164-X; Sah DWY, 2003, NAT REV DRUG DISCOV, V2, P460, DOI 10.1038/nrd1107; Sandkuhler J, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-9; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shen CY, 2008, J BIOL CHEM, V283, P17721, DOI 10.1074/jbc.M800013200; Song XS, 2005, ACTA PHARMACOL SIN, V26, P789, DOI 10.1111/j.1745-7254.2005.00123.x; Sweatt JD, 1999, LEARN MEMORY, V6, P399, DOI 10.1101/lm.6.5.399; Takaishi K, 1996, PAIN, V66, P297, DOI 10.1016/0304-3959(96)03023-0; Tseng TJ, 2007, EXP NEUROL, V206, P17, DOI 10.1016/j.expneurol.2007.04.006; Verderio C, 2004, NEURON, V41, P599, DOI 10.1016/S0896-6273(04)00077-7; Wang XD, 2005, EUR J NEUROSCI, V22, P1090, DOI 10.1111/j.1460-9568.2005.04282.x; Xin WJ, 2006, J NEUROSCI RES, V84, P934, DOI 10.1002/jnr.21013; Xu NJ, 2004, J BIOL CHEM, V279, P40601, DOI 10.1074/jbc.M406896200; Yu CG, 2005, MOL BRAIN RES, V138, P244, DOI 10.1016/j.molbrainres.2005.04.013; ZHANG YQ, 2009, PAIN; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022; Zhuang ZY, 2006, J NEUROSCI, V26, P3551, DOI 10.1523/JNEUROSCI.5290-05.2006	65	26	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30138	30147		10.1074/jbc.M109.036756	http://dx.doi.org/10.1074/jbc.M109.036756			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19723624	Green Published, hybrid			2022-12-27	WOS:000271090000017
J	Spindler, V; Heupel, WM; Efthymiadis, A; Schmidt, E; Eming, R; Rankl, C; Hinterdorfer, P; Muller, T; Drenckhahn, D; Waschke, J				Spindler, Volker; Heupel, Wolfgang-Moritz; Efthymiadis, Athina; Schmidt, Enno; Eming, Ruediger; Rankl, Christian; Hinterdorfer, Peter; Mueller, Thomas; Drenckhahn, Detlev; Waschke, Jens			Desmocollin 3-mediated Binding Is Crucial for Keratinocyte Cohesion and Is Impaired in Pemphigus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; ADHESIVE INTERFACE; TRANS-INTERACTION; DESMOGLEIN 3; N-CADHERIN; VULGARIS; SKIN; IGG; DESMOSOME; AUTOANTIBODIES	Desmocollin (Dsc) 1-3 and desmoglein (Dsg) 1-4, transmembrane proteins of the cadherin family, form the adhesive core of desmosomes. Here we provide evidence that Dsc3 homo- and heterophilic trans-interaction is crucial for epidermal integrity. Single molecule atomic force microscopy (AFM) revealed homophilic trans-interaction of Dsc3. Dsc3 displayed heterophilic interaction with Dsg1 but not with Dsg3. A monoclonal antibody targeted against the extracellular domain reduced homophilic and heterophilic binding as measured by AFM, caused intraepidermal blistering in a model of human skin, and a loss of intercellular adhesion in cultured keratinocytes. Because autoantibodies against Dsg1 are associated with skin blistering in pemphigus, we characterized the role of Dsc3 binding for pemphigus pathogenesis. In contrast to AFM experiments, laser tweezer trapping revealed that pemphigus autoantibodies reduced binding of Dsc3-coated beads to the keratinocyte cell surface. These data indicate that loss of heterophilic Dsc3/Dsg1 binding may contribute to pemphigus skin blistering.	[Spindler, Volker; Heupel, Wolfgang-Moritz; Efthymiadis, Athina; Drenckhahn, Detlev; Waschke, Jens] Univ Wurzburg, Inst Anat & Cell Biol, D-97070 Wurzburg, Germany; [Schmidt, Enno] Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Eming, Ruediger] Univ Marburg, Dept Dermatol, D-35037 Marburg, Germany; [Rankl, Christian; Hinterdorfer, Peter] Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Mueller, Thomas] Univ Wurzburg, Dept Mol Plant Physiol & Biophys, D-97082 Wurzburg, Germany	University of Wurzburg; University of Lubeck; Philipps University Marburg; Johannes Kepler University Linz; University of Wurzburg	Waschke, J (corresponding author), Univ Wurzburg, Inst Anat & Cell Biol, Koellikerstr 6, D-97070 Wurzburg, Germany.	jens.waschke@mail.uni-wuerzburg.de	Heupel, Wolfgang-Moritz/B-7788-2009; Schmidt, Enno/C-4008-2009; Spindler, Volker/G-1704-2019; Hinterdorfer, Peter/C-4235-2013	Schmidt, Enno/0000-0002-1206-8913; Spindler, Volker/0000-0002-1302-5421; Hinterdorfer, Peter/0000-0003-2583-1305; Mueller, Thomas/0000-0003-1862-7357; Rankl, Christian/0000-0002-7354-7651	Deutsche Forschungsgemeinschaft [SFB487, TP B5, B2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB487 (TP B5 and B2).	AMAGAI, 1994, J INVEST DERMATOL, V103, P608, DOI 10.1111/1523-1747.ep12397292; Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697; Baumgartner W, 2003, J NEUROSCI, V23, P11008; Baumgartner W, 2008, J MOL BIOL, V378, P44, DOI 10.1016/j.jmb.2008.02.023; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Berkowitz P, 2005, J BIOL CHEM, V280, P23778, DOI 10.1074/jbc.M501365200; Berkowitz P, 2008, J INVEST DERMATOL, V128, P738, DOI 10.1038/sj.jid.5701080; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; Berkowitz P, 2008, AM J PATHOL, V173, P1628, DOI 10.2353/ajpath.2008.080391; Bolling MC, 2007, BRIT J DERMATOL, V157, P168, DOI 10.1111/j.1365-2133.2007.07920.x; Chen JL, 2008, J CELL SCI, V121, P2844, DOI 10.1242/jcs.031518; Ebner A, 2007, BIOCONJUGATE CHEM, V18, P1176, DOI 10.1021/bc070030s; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Getsios S, 2004, NAT REV MOL CELL BIO, V5, P271, DOI 10.1038/nrm1356; Gotsch U, 1997, J CELL SCI, V110, P583; Heupel WM, 2008, MOL CELL NEUROSCI, V37, P548, DOI 10.1016/j.mcn.2007.12.003; Heupel WM, 2008, J IMMUNOL, V181, P1825, DOI 10.4049/jimmunol.181.3.1825; Heupel WM, 2009, J BIOL CHEM, V284, P8589, DOI 10.1074/jbc.M808813200; Hisamatsu Y, 2004, BRIT J DERMATOL, V151, P73, DOI 10.1111/j.1365-2133.2004.05995.x; Koch PJ, 1997, J CELL BIOL, V137, P1091, DOI 10.1083/jcb.137.5.1091; Kottke MD, 2006, J CELL SCI, V119, P797, DOI 10.1242/jcs.02888; Mahoney MG, 2006, EXP DERMATOL, V15, P101, DOI 10.1111/j.1600-0625.2006.00391.x; Marcozzi C, 1998, J CELL SCI, V111, P495; MULLER R, 2009, CLIN EXP DE IN PRESS; Nuber UA, 1996, EUR J CELL BIOL, V71, P1; Perret E, 2002, EMBO J, V21, P2537, DOI 10.1093/emboj/21.11.2537; Posy S, 2008, J MOL BIOL, V378, P954, DOI 10.1016/j.jmb.2008.02.063; Schmidt E, 2009, AM J PHYSIOL-CELL PH, V296, pC162, DOI 10.1152/ajpcell.00161.2008; Sharma PM, 2009, J INVEST DERMATOL, V129, P2309, DOI 10.1038/jid.2009.41; Spindler V, 2007, AM J PATHOL, V171, P906, DOI 10.2353/ajpath.2007.070028; Stanley JR, 2006, NEW ENGL J MED, V355, P1800, DOI 10.1056/NEJMra061111; Syed SEH, 2002, BIOCHEM J, V362, P317, DOI 10.1042/0264-6021:3620317; Tsunoda K, 2003, J IMMUNOL, V170, P2170, DOI 10.4049/jimmunol.170.4.2170; Waschke J, 2005, J CLIN INVEST, V115, P3157, DOI 10.1172/JCI23475; Waschke J, 2008, HISTOCHEM CELL BIOL, V130, P21, DOI 10.1007/s00418-008-0420-0; Waschke J, 2007, J MEMBRANE BIOL, V216, P83, DOI 10.1007/s00232-007-9037-9; Waschke J, 2006, J CELL BIOL, V175, P721, DOI 10.1083/jcb.200605125; Wendeler MW, 2007, J MOL BIOL, V370, P220, DOI 10.1016/j.jmb.2007.04.062; Yokouchi M, 2009, J INVEST DERMATOL, V129, P2156, DOI 10.1038/jid.2009.61	39	84	84	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30556	30564		10.1074/jbc.M109.024810	http://dx.doi.org/10.1074/jbc.M109.024810			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19717567	hybrid, Green Published			2022-12-27	WOS:000271090000058
J	Muller, B; Anders, M; Akiyama, H; Welsch, S; Glass, B; Nikovics, K; Clavel, F; Tervo, HM; Keppler, OT; Krausslich, HG				Mueller, Barbara; Anders, Maria; Akiyama, Hisashi; Welsch, Sonja; Glass, Baerbel; Nikovics, Krisztina; Clavel, Francois; Tervo, Hanna-Mari; Keppler, Oliver T.; Kraeusslich, Hans-Georg			HIV-1 Gag Processing Intermediates Trans-dominantly Interfere with HIV-1 Infectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TERMINAL CAPSID MUTANTS; VIRAL PROTEASE; T-CELLS; PARTICLE MATURATION; BLOCK INFECTIVITY; VIRION MATURATION; CLEAVAGE SITES; INFECTED-CELLS; TYPE-1	Protease inhibitors (PI) act by blocking human immunodeficiency virus (HIV) polyprotein processing, but there is no direct quantitative correlation between the degree of impairment of Gag processing and virion infectivity at low PI concentrations. To analyze the consequences of partial processing, virus particles were produced in the presence of limiting PI concentrations or by co-transfection of wild-type proviral plasmids with constructs carrying mutations in one or more cleavage sites. Low PI concentrations caused subtle changes in polyprotein processing associated with a pronounced reduction of particle infectivity. Dissection of individual stages of viral entry indicated a block in accumulation of reverse transcriptase products, whereas virus entry, enzymatic reverse transcriptase activity, and replication steps following reverse transcription were not affected. Co-expression of low amounts of partially processed forms of Gag together with wild-type HIV generally exerted a trans-dominant effect, which was most prominent for a construct carrying mutations at both cleavage sites flanking the CA domain. Interestingly, co-expression of low amounts of Gag mutated at the CA-SP1 cleavage site also affected processing activity at this site in the wild-type virus. The results indicate that low amounts (<5%) of Gag processing intermediates can display a trans-dominant effect on HIV particle maturation, with the maturation cleavage between CA and SP1 being of particular importance. These effects are likely to be important for the strong activity of PI at concentrations achieved in vivo and also bear relevance for the mechanism of action of the antiviral drug bevirimat.	[Mueller, Barbara; Tervo, Hanna-Mari; Keppler, Oliver T.; Kraeusslich, Hans-Georg] Univ Klinikum Heidelberg, Dept Virol, D-69120 Heidelberg, Germany; [Welsch, Sonja] EMBL, D-69117 Heidelberg, Germany; [Nikovics, Krisztina; Clavel, Francois] Hop St Louis, Inst Univ Hematol, INSERM, U941, F-75475 Paris, France	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Muller, B (corresponding author), Univ Klinikum Heidelberg, Dept Virol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.	barbara_mueller@med.uni-heidelberg.de	Muller, Barbara/AAC-4483-2020	Muller, Barbara/0000-0001-5726-5585; Akiyama, Hisashi/0000-0001-9228-0465; Welsch, Sonja/0000-0002-6049-6664	European Union [LSHP-CT-2007-036793]; Deutsche Forschungsgemeinschaft [MU885/4-2]	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by European Union FP6 Grant LSHP-CT-2007-036793 (HIV PI resistance) and by Deutsche Forschungsgemeinschaft Grant MU885/4-2.	Accola MA, 2000, J VIROL, V74, P6198, DOI 10.1128/JVI.74.13.6198-6202.2000; ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Anderson N, 2009, FOREST CHRON, V85, P110, DOI 10.5558/tfc85110-1; Bartonova V, 2008, J BIOL CHEM, V283, P32024, DOI 10.1074/jbc.M804230200; Bohne J, 2004, FEBS LETT, V563, P113, DOI 10.1016/S0014-5793(04)00277-7; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Carlson LA, 2008, CELL HOST MICROBE, V4, P592, DOI 10.1016/j.chom.2008.10.013; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Coren LV, 2007, J VIROL, V81, P10047, DOI 10.1128/JVI.02496-06; Dam E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000345; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Goffinet C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-53; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; Jiang JY, 2006, VIROLOGY, V346, P460, DOI 10.1016/j.virol.2005.11.008; Justesen US, 2008, DAN MED BULL, V55, P165; KAPLAN AH, 1993, J VIROL, V67, P4050, DOI 10.1128/JVI.67.7.4050-4055.1993; Kol N, 2007, BIOPHYS J, V92, P1777, DOI 10.1529/biophysj.106.093914; KRAUSSLICH HG, 1992, J VIROL, V66, P567; LAMBERT DM, 1992, ANTIMICROB AGENTS CH, V36, P982, DOI 10.1128/AAC.36.5.982; Lampe M, 2007, VIROLOGY, V360, P92, DOI 10.1016/j.virol.2006.10.005; Lanman J, 2004, NAT STRUCT MOL BIOL, V11, P676, DOI 10.1038/nsmb790; Li F, 2003, P NATL ACAD SCI USA, V100, P13555, DOI 10.1073/pnas.2234683100; MEEK TD, 1990, NATURE, V343, P90, DOI 10.1038/343090a0; Moore MD, 2008, VIROLOGY, V379, P152, DOI 10.1016/j.virol.2008.06.030; Muller B, 2004, J VIROL, V78, P10803, DOI 10.1128/JVI.78.19.10803-10813.2004; Murakami T, 2004, J VIROL, V78, P1026, DOI 10.1128/JVI.78.2.1026-1031.2004; PARK J, 1993, VIROLOGY, V194, P843, DOI 10.1006/viro.1993.1328; Pettit SC, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-66; PETTIT SC, 1994, J VIROL, V68, P8017, DOI 10.1128/JVI.68.12.8017-8027.1994; Pettit SC, 2005, J VIROL, V79, P10601, DOI 10.1128/JVI.79.16.10601-10607.2005; Pettit SC, 2004, J VIROL, V78, P8477, DOI 10.1128/JVI.78.16.8477-8485.2004; Pettit SC, 2002, J VIROL, V76, P10226, DOI 10.1128/JVI.76.20.10226-10233.2002; Race E, 1999, AIDS, V13, P2061, DOI 10.1097/00002030-199910220-00008; ROSE JR, 1995, J VIROL, V69, P2751; Rulli SJ, 2006, VIROLOGY, V347, P364, DOI 10.1016/j.virol.2005.12.012; Salzwedel K, 2007, AIDS REV, V9, P162; Sham HL, 1998, ANTIMICROB AGENTS CH, V42, P3218, DOI 10.1128/AAC.42.12.3218; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; Tang SX, 2003, J VIROL, V77, P12592, DOI 10.1128/JVI.77.23.12592-12602.2003; Tang SX, 2001, J VIROL, V75, P9357, DOI 10.1128/JVI.75.19.9357-9366.2001; Tervo HM, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-58; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Welker R, 2000, J VIROL, V74, P1168, DOI 10.1128/JVI.74.3.1168-1177.2000; Wiegers K, 1998, J VIROL, V72, P2846, DOI 10.1128/JVI.72.4.2846-2854.1998; Wyma DJ, 2000, J VIROL, V74, P9381, DOI 10.1128/JVI.74.20.9381-9387.2000; Wyma DJ, 2004, J VIROL, V78, P3429, DOI 10.1128/JVI.78.7.3429-3435.2004; Zhou J, 2004, J VIROL, V78, P922, DOI 10.1128/JVI.78.2.922-929.2004	47	78	78	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29692	29703		10.1074/jbc.M109.027144	http://dx.doi.org/10.1074/jbc.M109.027144			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19666477	Green Published, hybrid			2022-12-27	WOS:000270896800051
J	Snow, JW; Orkin, SH				Snow, Jonathan W.; Orkin, Stuart H.			Translational Isoforms of FOG1 Regulate GATA1-interacting Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; ZINC-FINGER PROTEIN; ERYTHROID-CELLS; CO-REPRESSOR; NORMAL ERYTHROPOIESIS; MAMMALIAN-CELLS; BINDING-PROTEIN; GENE-EXPRESSION; MESSENGER-RNA; ACTIVATION	Erythropoietic and megakaryocytic programs are directed by the transcription factor GATA1. Friend of GATA1 (FOG1), a protein interaction partner of GATA1, is critical for GATA1 function in multiple contexts. Previous work has shown that FOG1 recruits two multi-protein complexes, the nucleosome remodeling domain (NuRD) complex and a C-terminal binding protein (CTBP)-containing complex, into association with GATA1 to mediate activation and repression of target genes. To elucidate mechanisms that might differentially regulate the association of FOG1, as well as GATA1, with these two complexes, we characterized a previously unrecognized translational isoform of FOG1. We found that an N-terminally truncated version of FOG1 is produced from an internal ATG and that this isoform, designated FOG1S, lacks the nucleosome remodeling domain-binding domain, altering the complexes with which it interacts. Both isoforms interact with the C-terminal binding protein complex, which we show also contains lysine-specific demethylase 1 (LSD1). FOG1S is preferentially excluded from the nucleus by unknown mechanisms. These data reveal two novel mechanisms for the regulation of GATA1 interaction with FOG1-dependent protein complexes through the production of two translational isoforms with differential interaction profiles and independent nuclear localization controls.	[Snow, Jonathan W.; Orkin, Stuart H.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Snow, Jonathan W.; Orkin, Stuart H.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Snow, Jonathan W.; Orkin, Stuart H.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Childrens Hosp, Div Hematol, 300 Longwood Ave, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu			National Institutes of Health [HL32259, HL32262]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262, R01HL032259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL32259 and HL32262 (to S. H. O.).	Calkhoven CF, 2000, GENE DEV, V14, P1920; Calkhoven CF, 2003, GENE DEV, V17, P959, DOI 10.1101/gad.251903; Calkhoven CF, 2002, TRENDS MOL MED, V8, P577, DOI 10.1016/S1471-4914(02)02424-3; Cantor AB, 2002, MOL CELL BIOL, V22, P4268, DOI 10.1128/MCB.22.12.4268-4279.2002; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Dale RM, 2007, BIOCHEM BIOPH RES CO, V357, P683, DOI 10.1016/j.bbrc.2007.04.008; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; Fox AH, 1999, EMBO J, V18, P2812, DOI 10.1093/emboj/18.10.2812; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Garriga-Canut M, 2004, J BIOL CHEM, V279, P23597, DOI 10.1074/jbc.M313987200; Gobert S, 1996, EMBO J, V15, P2434, DOI 10.1002/j.1460-2075.1996.tb00601.x; GREGORY GD, 2008, BLOOD ASH ANN M; Holmes M, 1999, J BIOL CHEM, V274, P23491, DOI 10.1074/jbc.274.33.23491; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Katz SG, 2002, MOL CELL BIOL, V22, P3121, DOI 10.1128/MCB.22.9.3121-3128.2002; Koipally J, 2002, J BIOL CHEM, V277, P13007, DOI 10.1074/jbc.M111371200; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Lackner DH, 2008, INT REV CEL MOL BIO, V271, P199, DOI 10.1016/S1937-6448(08)01205-7; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lin AC, 2004, J BIOL CHEM, V279, P55017, DOI 10.1074/jbc.M411240200; Meijer HA, 2002, BIOCHEM J, V367, P1, DOI 10.1042/BJ20011706; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; ORKIN SH, 1992, BLOOD, V80, P575; Peset I, 2008, TRENDS CELL BIOL, V18, P379, DOI 10.1016/j.tcb.2008.06.005; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Quadrini KJ, 2008, EXP CELL RES, V314, P1595, DOI 10.1016/j.yexcr.2008.01.033; Rodriguez P, 2005, EMBO J, V24, P2354, DOI 10.1038/sj.emboj.7600702; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Sankaran VG, 2008, GENE DEV, V22, P463, DOI 10.1101/gad.1627208; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; Tan JS, 2006, BLOOD, V107, P2557, DOI 10.1182/blood-2005-07-2957; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; Vyas P, 1999, BLOOD, V93, P2867; Vyas P, 2007, CURR OPIN PEDIATR, V19, P9, DOI 10.1097/MOP.0b013e328013e7b2; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; WEISS MJ, 1995, EXP HEMATOL, V23, P99; Weiss MJ, 2005, ANN NY ACAD SCI, V1054, P103, DOI 10.1196/annals.1345.013; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Woo AJ, 2008, MOL CELL BIOL, V28, P2675, DOI 10.1128/MCB.01945-07; Zhou MX, 2001, J EXP MED, V194, P1461, DOI 10.1084/jem.194.10.1461; Ziegler E. C., 2005, SCI STKE, pre6, DOI DOI 10.1126/STKE.2842005RE6; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	52	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29310	29319		10.1074/jbc.M109.043497	http://dx.doi.org/10.1074/jbc.M109.043497			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19654328	hybrid, Green Published			2022-12-27	WOS:000270896800010
J	Toth, AM; Li, ZQ; Cattaneo, R; Samuel, CE				Toth, Ann M.; Li, Zhiqun; Cattaneo, Roberto; Samuel, Charles E.			RNA-specific Adenosine Deaminase ADAR1 Suppresses Measles Virus-induced Apoptosis and Activation of Protein Kinase PKR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLICE-SITE VARIANTS; EDITING ENZYME ADAR1; DNA BINDING DOMAIN; PRE-MESSENGER-RNA; C-PROTEIN; HUMAN-CELLS; INTERFERON ACTION; EXPRESSION; BRAIN; RECEPTORS	ADAR1 (adenosine deaminase acting on RNA) catalyzes the conversion of adenosine to inosine, a process known as A-to-I editing. Extensive A-to-I editing has been described in viral RNAs isolated from the brains of patients persistently infected with measles virus, although the precise role of ADAR during measles virus infection remains unknown. We generated human HeLa cells stably deficient in ADAR1 ("ADAR1(kd) cells") through short hairpin RNA-mediated knockdown, and using these cells, we tested the effect of ADAR1 deficiency on measles virus (MVvac strain) growth and virus-induced cell death. We found that the growth of mutant viruses lacking expression of the viral accessory proteins V and C (V-ko and C-ko, respectively) was decreased in ADAR1-deficient cells compared with ADAR1-sufficient cells. In addition, apoptosis was enhanced in ADAR1-deficient cells following infection with wild type and V-ko virus but not following infection with C-ko virus or treatment with tumor necrosis factor-alpha or staurosporine. Furthermore, in C-ko-infected ADAR1-sufficient cells when ADAR1 did not protect against apoptosis, caspase cleavage of the ADAR1 p150 protein was detected. Finally, enhanced apoptosis in ADAR1(kd) cells following infection with wild type and V-ko virus correlated with enhanced activation of PKR kinase and interferon regulatory factor IRF-3. Taken together, these results demonstrate that ADAR1 is a proviral, antiapoptotic host factor in the context of measles virus infection and suggest that the antiapoptotic activity of ADAR1 is achieved through suppression of activation of proapoptotic and double-stranded RNA-dependent activities, as exemplified by PKR and IRF-3.	[Toth, Ann M.; Samuel, Charles E.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Li, Zhiqun; Samuel, Charles E.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA; [Cattaneo, Roberto] Mayo Clin, Coll Med, Dept Mol Med & Virol, Rochester, MN 55905 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Mayo Clinic	Samuel, CE (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	samuel@lifesci.ucsb.edu			National Institutes of Health, NIAID [AI-12520, AI-20611, AI-63476]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020611, R01AI063476, R01AI012520, R37AI012520] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grants AI-12520 and AI-20611 (to C. E. S.) and AI-63476 (to R. C.).	Abraham N, 1999, J BIOL CHEM, V274, P5953, DOI 10.1074/jbc.274.9.5953; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BACZKO K, 1993, VIROLOGY, V197, P188, DOI 10.1006/viro.1993.1579; Bankamp B, 2005, VIROLOGY, V336, P120, DOI 10.1016/j.virol.2005.03.009; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; BASS BL, 1987, CELL, V48, P607, DOI 10.1016/0092-8674(87)90239-X; CATTANEO R, 1994, CURR OPIN GENET DEV, V4, P895, DOI 10.1016/0959-437X(94)90076-0; CATTANEO R, 1989, VIROLOGY, V173, P415, DOI 10.1016/0042-6822(89)90554-0; CATTANEO R, 1988, CELL, V55, P255, DOI 10.1016/0092-8674(88)90048-7; Clerzius G, 2009, J VIROL, V83, P10119, DOI 10.1128/JVI.02457-08; Devaux P, 2004, J VIROL, V78, P11632, DOI 10.1128/JVI.78.21.11632-11640.2004; Devaux P, 2007, VIROLOGY, V360, P72, DOI 10.1016/j.virol.2006.09.049; DORIA M, 2009, NUCL ACIDS IN PRESS; Garg RK, 2002, POSTGRAD MED J, V78, P63, DOI 10.1136/pmj.78.916.63; George CX, 1999, P NATL ACAD SCI USA, V96, P4621, DOI 10.1073/pnas.96.8.4621; Griffin DE., 2007, FIELDS VIROLOGY, P1551; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Herbert A, 1997, P NATL ACAD SCI USA, V94, P8421, DOI 10.1073/pnas.94.16.8421; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Iizasa H, 2009, NAT IMMUNOL, V10, P16, DOI 10.1038/ni0109-16; Jayan GC, 2002, J VIROL, V76, P12399, DOI 10.1128/JVI.76.23.12399-12404.2002; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Kumar M, 1997, P NATL ACAD SCI USA, V94, P3542, DOI 10.1073/pnas.94.8.3542; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Liu Y, 1999, J BIOL CHEM, V274, P5070, DOI 10.1074/jbc.274.8.5070; Liu Y, 1999, J BIOL CHEM, V274, P18351, DOI 10.1074/jbc.274.26.18351; Liu Y, 1997, J BIOL CHEM, V272, P4419, DOI 10.1074/jbc.272.7.4419; LUO GX, 1990, J VIROL, V64, P1021, DOI 10.1128/JVI.64.3.1021-1027.1990; Navaratnarajah CK, 2009, CURR TOP MICROBIOL, V329, P59; Nie YZ, 2007, J VIROL, V81, P917, DOI 10.1128/JVI.01527-06; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; PATTERSON JB, 1995, VIROLOGY, V210, P508, DOI 10.1006/viro.1995.1370; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; Phuphuakrat A, 2008, J VIROL, V82, P10864, DOI 10.1128/JVI.00238-08; Poulsen H, 2001, MOL CELL BIOL, V21, P7862, DOI 10.1128/MCB.21.22.7862-7871.2001; REBAGLIATI MR, 1987, CELL, V48, P599, DOI 10.1016/0092-8674(87)90238-8; Reutter GL, 2001, VIROLOGY, V285, P100, DOI 10.1006/viro.2001.0962; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Seeburg PH, 2003, CURR OPIN NEUROBIOL, V13, P279, DOI 10.1016/S0959-4388(03)00062-X; Taylor DR, 2005, J VIROL, V79, P6291, DOI 10.1128/JVI.79.10.6291-6298.2005; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Toth AM, 2006, PROG NUCLEIC ACID RE, V81, P369, DOI 10.1016/S0079-6603(06)81010-X; Toth AM, 2009, J VIROL, V83, P961, DOI 10.1128/JVI.01669-08; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; WEIER HUG, 1995, GENOMICS, V30, P372, DOI 10.1006/geno.1995.0034; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zahn RC, 2007, J VIROL, V81, P457, DOI 10.1128/JVI.00067-06; Zhang P, 2008, J VIROL, V82, P840, DOI 10.1128/JVI.01891-07; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07; Zhang P, 2008, J BIOL CHEM, V283, P34580, DOI 10.1074/jbc.M807029200	56	113	119	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29350	29356		10.1074/jbc.M109.045146	http://dx.doi.org/10.1074/jbc.M109.045146			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19710021	Green Published, hybrid			2022-12-27	WOS:000270896800015
J	Campa, F; Yoon, HY; Ha, VL; Szentpetery, Z; Balla, T; Randazzo, PA				Campa, Fanny; Yoon, Hye-Young; Ha, Vi Luan; Szentpetery, Zsofia; Balla, Tamas; Randazzo, Paul A.			A PH Domain in the Arf GTPase-activating Protein (GAP) ARAP1 Binds Phosphatidylinositiol 3,4,5-Trisphosphate and Regulates Arf GAP Activity Independently of Recruitment to the Plasma Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; INOSITOL-LIPID-BINDING; MYRISTOYLATED ARF1; STRUCTURAL BASIS; ASAP1; ADAPTER; FAMILY; ROLES; GGA; IDENTIFICATION	ARAP1 is a phosphatidylinositol 3,4,5-trisphosphate (PtdIns-(3,4,5)P-3)-dependent Arf GTPase-activating protein (GAP) with five PH domains that regulates endocytic trafficking of the epidermal growth factor receptor (EGFR). Two tandem PH domains are immediately N-terminal of the Arf GAP domain, and one of these fits the consensus sequence for PtdIns(3,4,5)P-3 binding. Here, we tested the hypothesis that PtdIns(3,4,5)P-3-dependent recruitment mediated by the first PH domain of ARAP1 regulates the in vivo and in vitro function of ARAP1. We found that PHI of ARAP1 specifically bound to PtdIns(3,4,5)P-3, but with relatively low affinity (approximate to 1.6 mu M), and the PH domains did not mediate PtdIns(3,4,5)P-3-dependent recruitment to membranes in cells. However, PtdIns(3,4,5)P-3 binding to the PH domain stimulated GAP activity and was required for in vivo function of ARAP1 as a regulator of endocytic trafficking of the EGFR. Based on these results, we propose a variation on the model for the function of phosphoinositide-binding PH domains. In our model, ARAP1 is recruited to membranes independently of PtdIns(3,4,5)P-3, the subsequent production of which triggers enzymatic activity.	[Campa, Fanny; Yoon, Hye-Young; Ha, Vi Luan; Randazzo, Paul A.] NCI, Lab Cellular & Mol Biol, NIH, Bethesda, MD 20892 USA; [Szentpetery, Zsofia; Balla, Tamas] NICHD, Program Dev Neurosci, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Randazzo, PA (corresponding author), NCI, Lab Cellular & Mol Biol, NIH, Bldg 37,Rm 2042, Bethesda, MD 20892 USA.	randazzo@helix.nih.gov		Balla, Tamas/0000-0002-9077-3335	National Institutes of Health; NICHID; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000196] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000196] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC007365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHID; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health grants from the NCI Intramural Program and NICHID.	Balla T, 2005, J CELL SCI, V118, P2093, DOI 10.1242/jcs.02387; Che MM, 2005, METHOD ENZYMOL, V404, P147, DOI 10.1016/S0076-6879(05)04015-2; Che MM, 2005, CELL SIGNAL, V17, P1276, DOI 10.1016/j.cellsig.2005.01.007; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Cuthbert EJ, 2008, AM J PHYSIOL-CELL PH, V294, pC263, DOI 10.1152/ajpcell.00292.2007; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Dowler S, 1999, BIOCHEM J, V342, P7, DOI 10.1042/0264-6021:3420007; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Furst J, 2005, J BIOL CHEM, V280, P31276, DOI 10.1074/jbc.M500541200; Gervais V, 2004, NAT STRUCT MOL BIOL, V11, P616, DOI 10.1038/nsmb782; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Ha VL, 2005, METHOD ENZYMOL, V404, P164, DOI 10.1016/S0076-6879(05)04016-4; Hirsch DS, 2003, TRAFFIC, V4, P26, DOI 10.1034/j.1600-0854.2003.40105.x; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Jacques KM, 2002, J BIOL CHEM, V277, P47235, DOI 10.1074/jbc.M208875200; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Kam JL, 2000, J BIOL CHEM, V275, P9653, DOI 10.1074/jbc.275.13.9653; Krugmann S, 2006, J CELL SCI, V119, P425, DOI 10.1242/jcs.02755; Krugmann S, 2004, CURR BIOL, V14, P1380, DOI 10.1016/j.cub.2004.07.058; Krugmann S, 2002, MOL CELL, V9, P95, DOI 10.1016/S1097-2765(02)00434-3; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Lemmon MA, 1998, CURR TOP MICROBIOL, V228, P39; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Liu YH, 2002, MOL BIOL CELL, V13, P2147, DOI 10.1091/mbc.E02-01-0018; Logsdon JM, 2003, PROTEINS CELL REG, V1, P1; Luo R, 2008, CELL SIGNAL, V20, P1968, DOI 10.1016/j.cellsig.2008.07.007; Luo RB, 2007, BIOCHEM J, V402, P439, DOI 10.1042/BJ20061217; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Nie ZZ, 2006, CURR BIOL, V16, P130, DOI 10.1016/j.cub.2005.11.069; Nie ZZ, 2005, J CELL SCI, V118, P3555, DOI 10.1242/jcs.02486; Nie ZZ, 2003, DEV CELL, V5, P513, DOI 10.1016/S1534-5807(03)00234-X; Oda A, 2003, J BIOL CHEM, V278, P6456, DOI 10.1074/jbc.M210817200; Park WS, 2008, MOL CELL, V30, P381, DOI 10.1016/j.molcel.2008.04.008; Prehoda KE, 1999, CELL, V97, P471, DOI 10.1016/S0092-8674(00)80757-6; RANDAZZO PA, 1992, METHOD ENZYMOL, V219, P362; RANDAZZO PA, 1995, METHOD ENZYMOL, V250, P394; RANDAZZO PA, 1994, J BIOL CHEM, V269, P10758; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; Randazzo PA, 2001, METHOD ENZYMOL, V329, P343; RANDAZZO PA, 2000, SCI STKE, V59, pRE1; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Randazzo Paul A, 2002, Methods Mol Biol, V189, P169; Rossman KL, 2003, J BIOL CHEM, V278, P18393, DOI 10.1074/jbc.M300127200; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Stacey TTI, 2004, J CELL SCI, V117, P6071, DOI 10.1242/jcs.01526; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Thomas CC, 2001, BIOCHEM J, V358, P287, DOI 10.1042/0264-6021:3580287; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 2002, J BIOL CHEM, V277, P27412, DOI 10.1074/jbc.M109672200; Yoon HY, 2005, METHOD ENZYMOL, V404, P316, DOI 10.1016/S0076-6879(05)04028-0; Yoon HY, 2006, J CELL SCI, V119, P4650, DOI 10.1242/jcs.03237; Yoon HY, 2008, TRAFFIC, V9, P2236, DOI 10.1111/j.1600-0854.2008.00839.x; Zhu GY, 2007, EMBO J, V26, P3484, DOI 10.1038/sj.emboj.7601771	60	24	24	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28069	28083		10.1074/jbc.M109.028266	http://dx.doi.org/10.1074/jbc.M109.028266			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19666464	hybrid, Green Published			2022-12-27	WOS:000270676300034
J	Hayashi, I; Takatori, S; Urano, Y; Iwanari, H; Isoo, N; Osawa, S; Fukuda, MA; Kodama, T; Hamakubo, T; Li, T; Wong, PC; Tomita, T; Iwatsubo, T				Hayashi, Ikuo; Takatori, Sho; Urano, Yasuomi; Iwanari, Hiroko; Isoo, Noriko; Osawa, Satoko; Fukuda, Maiko A.; Kodama, Tatsuhiko; Hamakubo, Takao; Li, Tong; Wong, Philip C.; Tomita, Taisuke; Iwatsubo, Takeshi			Single Chain Variable Fragment against Nicastrin Inhibits the gamma-Secretase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ANTIBODY FRAGMENTS; COMPLEX-FORMATION; CATALYTIC PORE; BETA-SECRETASE; C-TERMINUS; PRESENILIN; TRAFFICKING; PATHWAY; STABILIZATION	gamma-Secretase is a membrane protein complex that catalyzes intramembrane proteolysis of a variety of substrates including the amyloid beta precursor protein of Alzheimer disease. Nicastrin (NCT), a single-pass membrane glycoprotein that harbors a large extracellular domain, is an essential component of the gamma-secretase complex. Here we report that overexpression of a single chain variable fragment (scFv) against NCT as an intrabody suppressed the gamma-secretase activity. Biochemical analyses revealed that the scFv disrupted the proper folding and the appropriate glycosyl maturation of the endogenous NCT, which are required for the stability of the gamma-secretase complex and the intrinsic proteolytic activity, respectively, implicating the dual role of NCT in the gamma-secretase complex. Our results also highlight the importance of the calnexin cycle in the functional maturation of the gamma-secretase complex. The engineered intrabodies may serve as rationally designed, molecular targeting tools for the discovery of novel actions of the membrane proteins.	[Hayashi, Ikuo; Takatori, Sho; Isoo, Noriko; Osawa, Satoko; Fukuda, Maiko A.; Tomita, Taisuke; Iwatsubo, Takeshi] Univ Tokyo, Dept Neuropathol & Neurosci, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Urano, Yasuomi; Iwanari, Hiroko; Kodama, Tatsuhiko; Hamakubo, Takao] Univ Tokyo, Adv Sci & Technol Res Ctr, Lab Syst Biol & Med, Meguro Ku, Tokyo 1538904, Japan; [Iwanari, Hiroko] Perseus Prote Inc, Meguro Ku, Tokyo 1530041, Japan; [Li, Tong; Wong, Philip C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Tomita, Taisuke; Iwatsubo, Takeshi] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Bunkyo Ku, Tokyo 1130033, Japan; [Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Med, Dept Neuropathol, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; Johns Hopkins University; Japan Science & Technology Agency (JST); University of Tokyo	Tomita, T (corresponding author), Univ Tokyo, Dept Neuropathol & Neurosci, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	taisuke@mol.f.u-tokyo.ac.jp	Tomita, Taisuke/L-5427-2015	Tomita, Taisuke/0000-0002-0075-5943; Takatori, Sho/0000-0002-3925-4011; Urano, Yasuomi/0000-0002-4901-1937	Ministry of Education, Culture, Sports, Science, and Technology, Japan; National Institute of Biomedical Innovation; Japan Science and Technology Corporation (EST); Core Research for Evolutional Science and Technology of EST, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Japan Science and Technology Corporation (EST)(Japan Science & Technology Agency (JST)); Core Research for Evolutional Science and Technology of EST, Japan(Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by grants-in-aid for Young Scientists (S) from the Japan Society for the Promotion of Science, Scientific Research on Priority Areas Research on Pathomechanisms of Brain Disorders from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, by Targeted Proteins Research Program of the Japan Science and Technology Corporation (EST), and by Core Research for Evolutional Science and Technology of EST, Japan.	Arbel M, 2005, P NATL ACAD SCI USA, V102, P7718, DOI 10.1073/pnas.0502427102; Capell A, 2005, J BIOL CHEM, V280, P6471, DOI 10.1074/jbc.M409106200; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Chavez-Gutierrez L, 2008, J BIOL CHEM, V283, P20096, DOI 10.1074/jbc.M803040200; de Armas HN, 2007, STRUCTURE, V15, P1105, DOI 10.1016/j.str.2007.07.009; Fagan R, 2001, TRENDS BIOCHEM SCI, V26, P213, DOI 10.1016/S0968-0004(01)01789-3; Farady CJ, 2007, J MOL BIOL, V369, P1041, DOI 10.1016/j.jmb.2007.03.078; Fuwa H, 2007, ACS CHEM BIOL, V2, P408, DOI 10.1021/cb700073y; Gal-Tanamy M, 2005, J MOL BIOL, V347, P991, DOI 10.1016/j.jmb.2005.02.020; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Hayashi I, 2004, J BIOL CHEM, V279, P38040, DOI 10.1074/jbc.M405597200; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Isoo N, 2007, J BIOL CHEM, V282, P12388, DOI 10.1074/jbc.M611549200; Kaether C, 2002, J CELL BIOL, V158, P551, DOI 10.1083/jcb.200201123; Kaether C, 2007, EMBO REP, V8, P743, DOI 10.1038/sj.embor.7401027; Kato K, 2007, GLYCOBIOLOGY, V17, P1031, DOI 10.1093/glycob/cwm046; Keller SH, 1998, J BIOL CHEM, V273, P17064, DOI 10.1074/jbc.273.27.17064; Kim J, 2007, J CELL BIOL, V179, P951, DOI 10.1083/jcb.200709012; Kim SH, 2004, J BIOL CHEM, V279, P48615, DOI 10.1074/jbc.C400396200; Kimberly WT, 2002, J BIOL CHEM, V277, P35113, DOI 10.1074/jbc.M204446200; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Li T, 2003, J NEUROSCI, V23, P3272; Marcus NY, 2000, J BIOL CHEM, V275, P1987, DOI 10.1074/jbc.275.3.1987; Mikkelsen JH, 2008, J BIOL CHEM, V283, P16772, DOI 10.1074/jbc.M802429200; Miller TW, 2005, MOL THER, V12, P394, DOI 10.1016/j.ymthe.2005.04.003; Morais VA, 2006, BBA-MOL BASIS DIS, V1762, P802, DOI 10.1016/j.bbadis.2006.06.018; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Niimura M, 2005, J BIOL CHEM, V280, P12967, DOI 10.1074/jbc.M409829200; Ogura T, 2006, BIOCHEM BIOPH RES CO, V343, P525, DOI 10.1016/j.bbrc.2006.02.158; Paganetti P, 2005, J CELL BIOL, V168, P863, DOI 10.1083/jcb.200410047; Ratovitski T, 1997, J BIOL CHEM, V272, P24536, DOI 10.1074/jbc.272.39.24536; Saitoh R, 2007, J IMMUNOL METHODS, V322, P104, DOI 10.1016/j.jim.2007.02.005; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; SAUL R, 1983, ARCH BIOCHEM BIOPHYS, V221, P593, DOI 10.1016/0003-9861(83)90181-9; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shirotani K, 2003, J BIOL CHEM, V278, P16474, DOI 10.1074/jbc.C300095200; Sidhu SS, 2007, CURR OPIN STRUC BIOL, V17, P481, DOI 10.1016/j.sbi.2007.08.007; Spasic D, 2008, J CELL SCI, V121, P413, DOI 10.1242/jcs.015255; Spasic D, 2007, J CELL BIOL, V176, P629, DOI 10.1083/jcb.200609180; Stocks M, 2005, CURR OPIN CHEM BIOL, V9, P359, DOI 10.1016/j.cbpa.2005.06.003; Takahashi Y, 2003, J BIOL CHEM, V278, P18664, DOI 10.1074/jbc.M301619200; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Tomita T, 1999, J NEUROSCI, V19, P10627, DOI 10.1523/JNEUROSCI.19-24-10627.1999; Tomita T, 2002, FEBS LETT, V520, P117, DOI 10.1016/S0014-5793(02)02802-8; Tomita T, 2001, J BIOL CHEM, V276, P33273, DOI 10.1074/jbc.M011152200; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Tomita T, 2009, EXPERT REV NEUROTHER, V9, P661, DOI [10.1586/ern.09.24, 10.1586/ERN.09.24]; Verbeke K, 2004, J THROMB HAEMOST, V2, P298, DOI 10.1111/j.1538-7933.2004.00583.x; Walker ES, 2006, J NEUROCHEM, V98, P300, DOI 10.1111/j.1471-4159.2006.03881.x; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Wolfe MS, 2009, SEMIN CELL DEV BIOL, V20, P219, DOI 10.1016/j.semcdb.2008.12.011; Yang DS, 2002, J BIOL CHEM, V277, P28135, DOI 10.1074/jbc.M110871200; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	57	20	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27838	27847		10.1074/jbc.M109.055061	http://dx.doi.org/10.1074/jbc.M109.055061			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19684016	Green Published, hybrid			2022-12-27	WOS:000270676300010
J	Kriegs, M; Burckstummer, T; Himmelsbach, K; Bruns, M; Frelin, L; Ahlen, G; Sallberg, M; Hildt, E				Kriegs, Malte; Buerckstuemmer, Tilmann; Himmelsbach, Kyoshi; Bruns, Michael; Frelin, Lars; Ahlen, Gustaf; Sallberg, Matti; Hildt, Eberhard			The Hepatitis C Virus Non-structural NS5A Protein Impairs Both the Innate and Adaptive Hepatic Immune Response in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; TRANSGENIC MICE; GENE-EXPRESSION; 5A PROTEIN; INTERFERON; CLEARANCE; INFECTION; KINASE; LIVER; REPLICATION	The role of hepatitis C virus (HCV) protein non-structural (NS) 5A in HCV-associated pathogenesis is still enigmatic. To investigate the in vivo role of NS5A for viral persistence and virus-associated pathogenesis a transgenic (Tg) mouse model was established. Mice with liver-targeted NS5A transgene expression were generated using the albumin promoter. Alterations in the hepatic immune response were determined by Western blot, infection by lymphocytic choriomeningitis virus (LCMV), and using transient NS3/4A Tg mice generated by hydrodynamic injection. Cytotoxic T lymphocyte (CTL) activity was investigated by the Cr-release assay. The stable NS5A Tg mice did not reveal signs of spontaneous liver disease. The intrahepatic immunity was disrupted in the NS5A Tg mice as determined by clearance of LCMV infection or transiently NS3/4A Tg hepatocytes in vivo. This impaired immunity was explained by a reduced induction of interferon beta, 2',5'-OAS, and PKR after LCMV infection and an impairment of the CTL-mediated elimination of NS3-expressing hepatocytes. In conclusion, these data indicate that in the present transgenic mouse model, NS5A does not cause spontaneous liver disease. However, we discovered that NS5A could impair both the innate and the adaptive immune response to promote chronic HCV infection.	[Himmelsbach, Kyoshi; Hildt, Eberhard] Univ Kiel, Inst Infect Med, D-24105 Kiel, Germany; [Kriegs, Malte; Himmelsbach, Kyoshi; Hildt, Eberhard] Univ Freiburg, Dept Internal Med 2, D-79106 Freiburg, Germany; [Kriegs, Malte; Bruns, Michael] Heinrich Pette Inst Expt Virol & Immunol, D-20251 Homburg, Germany; [Kriegs, Malte; Buerckstuemmer, Tilmann] Robert Koch Inst, D-13353 Berlin, Germany; [Kriegs, Malte; Frelin, Lars; Ahlen, Gustaf; Sallberg, Matti] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Div Clin Microbiol F68, S-14186 Stockholm, Sweden	University of Kiel; University of Freiburg; Heinrich Pette Institute; Robert Koch Institute; Karolinska Institutet; Karolinska University Hospital	Hildt, E (corresponding author), Univ Kiel, Inst Infect Med, Brunswiker Str 4, D-24105 Kiel, Germany.	hildt@infmed.uni-kiel.de	Hildt, Eberhard/A-1040-2015; Ahlén, Gustaf/GLN-2986-2022	Frelin, Lars/0000-0001-7452-1667; Burckstummer, Tilmann/0000-0001-5681-8045; Buerckstuemmer, Tilmann/0000-0002-5961-0829; Himmelsbach, Kiyoshi/0000-0002-1840-6012; Ahlen, Gustaf/0000-0002-2681-6433	Swedish Society of Medical Research; Swedish Society of Medicine; Royal Swedish Academy of Sciences; Goljes Memorial Fund; Ruth and Richard Juhlin Foundation; Karolinska Institutet; DFG-excellence cluster	Swedish Society of Medical Research; Swedish Society of Medicine; Royal Swedish Academy of Sciences; Goljes Memorial Fund; Ruth and Richard Juhlin Foundation; Karolinska Institutet(Karolinska Institutet); DFG-excellence cluster(German Research Foundation (DFG))	This work was supported in part by grants from the Swedish Society of Medical Research, the Swedish Society of Medicine, the Royal Swedish Academy of Sciences, Goljes Memorial Fund, the Ruth and Richard Juhlin Foundation, and the Karolinska Institutet (to L. F.). This work was also supported by a grant from the DFG-excellence cluster (to E. H.).	Ahlen G, 2005, J INFECT DIS, V192, P2112, DOI 10.1086/498218; Appel N, 2005, J VIROL, V79, P3187, DOI 10.1128/JVI.79.5.3187-3194.2005; ASSMANNWISCHER U, 1985, MED MICROBIOL IMMUN, V174, P249, DOI 10.1007/BF02124809; Blindenbacher A, 2003, GASTROENTEROLOGY, V124, P1465, DOI 10.1016/S0016-5085(03)00290-7; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; BRINSTER RL, 1988, P NATL ACAD SCI USA, V85, P836, DOI 10.1073/pnas.85.3.836; BRUNS M, 1988, VIROLOGY, V166, P133, DOI 10.1016/0042-6822(88)90154-7; Burckstummer T, 2006, FEBS LETT, V580, P575, DOI 10.1016/j.febslet.2005.12.071; Cheng G, 2006, P NATL ACAD SCI USA, V103, P8499, DOI 10.1073/pnas.0602957103; CHISARI FV, 1989, MOL BIOL MED, V6, P143; Disson O, 2004, GASTROENTEROLOGY, V126, P859, DOI 10.1053/j.gastro.2003.12.005; Donauer J, 2003, TRANSPLANTATION, V76, P539, DOI 10.1097/01.TP.0000079459.89608.B7; Frelin L, 2004, GENE THER, V11, P522, DOI 10.1038/sj.gt.3302184; Frelin L, 2003, GENE THER, V10, P686, DOI 10.1038/sj.gt.3301933; Gale M, 1999, J VIROL, V73, P6506, DOI 10.1128/JVI.73.8.6506-6516.1999; Gale MJ, 1997, VIROLOGY, V230, P217, DOI 10.1006/viro.1997.8493; Ghosh AK, 1999, J GEN VIROL, V80, P1179, DOI 10.1099/0022-1317-80-5-1179; Girard S, 2004, HEPATOLOGY, V40, P708, DOI 10.1002/hep.20371; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Hengel H, 2005, TRENDS IMMUNOL, V26, P396, DOI 10.1016/j.it.2005.05.004; HIJIKATA M, 1993, P NATL ACAD SCI USA, V90, P10773, DOI 10.1073/pnas.90.22.10773; Hildt E, 2002, EMBO J, V21, P525, DOI 10.1093/emboj/21.4.525; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Jorns J, 2003, ANAT EMBRYOL, V207, P85, DOI 10.1007/s00429-003-0331-8; KANEKO T, 1994, BIOCHEM BIOPH RES CO, V205, P320, DOI 10.1006/bbrc.1994.2667; LAUER U, 1992, J VIROL, V66, P5284, DOI 10.1128/JVI.66.9.5284-5289.1992; LEHMANNGRUBE F, 1985, J IMMUNOL, V134, P608; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Macdonald A, 2004, J GEN VIROL, V85, P2485, DOI 10.1099/vir.0.80204-0; Majumder M, 2003, FEBS LETT, V555, P528, DOI 10.1016/S0014-5793(03)01337-1; Majumder M, 2002, VIROLOGY, V294, P94, DOI 10.1006/viro.2001.1309; Malmgaard L, 2002, J VIROL, V76, P4520, DOI 10.1128/JVI.76.9.4520-4525.2002; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Pietschmann T, 2001, J VIROL, V75, P1252, DOI 10.1128/JVI.75.3.1252-1264.2001; PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268; Qadri I, 2002, BBA-MOL CELL RES, V1592, P193, DOI 10.1016/S0167-4889(02)00315-4; Saher G, 1999, J BIOL CHEM, V274, P27651, DOI 10.1074/jbc.274.39.27651; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Stobart MJ, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-5; Street A, 2004, J BIOL CHEM, V279, P12232, DOI 10.1074/jbc.M312245200; Tan SL, 1999, P NATL ACAD SCI USA, V96, P5533, DOI 10.1073/pnas.96.10.5533; WERNER S, 1993, EMBO J, V12, P2635, DOI 10.1002/j.1460-2075.1993.tb05924.x	43	29	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28343	28351		10.1074/jbc.M109.038877	http://dx.doi.org/10.1074/jbc.M109.038877			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19674968	Green Published, hybrid			2022-12-27	WOS:000270676300060
J	Leonardi, R; Frank, MW; Jackson, PD; Rock, CO; Jackowski, S				Leonardi, Roberta; Frank, Matthew W.; Jackson, Pamela D.; Rock, Charles O.; Jackowski, Suzanne			Elimination of the CDP-ethanolamine Pathway Disrupts Hepatic Lipid Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-PHOSPHOETHANOLAMINE CYTIDYLYLTRANSFERASE; FAT-SPECIFIC PROTEIN-27; PLASMA HIGH-DENSITY; PPAR-GAMMA; PHOSPHATIDYLSERINE DECARBOXYLATION; IN-VIVO; GENE; BIOSYNTHESIS; PHOSPHATIDYLETHANOLAMINE; EXPRESSION	Phosphoethanolamine cytidylyltransferase (ECT) catalyzes the rate-controlling step in a major pathway for the synthesis of phosphatidylethanolamine (PtdEtn). Hepatocyte-specific deletion of the ECT gene in mice resulted in normal appearing animals without overt signs of liver injury or inflammation. The molecular species of PtdEtn in the ECT-deficient livers were significantly altered compared with controls and matched the composition of the phosphatidylserine (PtdSer) pool, illustrating the complete reliance on the PtdSer decarboxylase pathway for PtdEtn synthesis. PtdSer structure was controlled by the substrate specificity of PtdSer synthase that selectively converted phosphatidylcholine molecular species containing stearate paired with a polyunsaturated fatty acid to PtdSer. There was no evidence for fatty acid remodeling of PtdEtn. The elimination of diacylglycerol utilization by the CDP-ethanolamine pathway led to a 10-fold increase in triacylglycerols in the ECT-deficient hepatocytes that became engorged with lipid droplets. Triacylglycerol accumulation was associated with a significant elevation in the expression of the transcription factors and target genes that drive de novo lipogenesis. The absence of the ECT pathway for diacylglycerol utilization at the endoplasmic reticulum triggers increased fatty acid synthesis to support the formation of triacylglycerols leading to liver steatosis.	[Leonardi, Roberta; Frank, Matthew W.; Jackson, Pamela D.; Rock, Charles O.; Jackowski, Suzanne] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Jackowski, S (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	suzanne.jackowski@stjude.org	Jackowski, Suzanne/N-8168-2018	Jackowski, Suzanne/0000-0002-6855-1429; Frank, Matthew/0000-0002-4914-1440	National Institutes of Health [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062896] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health CORE Support Grant CA21765. This work was also supported by the American Lebanese Syrian Associated Charities.	Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100; Agren JJ, 2005, BBA-MOL CELL BIOL L, V1734, P34, DOI 10.1016/j.bbalip.2005.02.001; ALVAREZ JG, 1992, J CHROMATOGR-BIOMED, V577, P142, DOI 10.1016/0378-4347(92)80609-T; Arikketh D, 2008, J BIOL CHEM, V283, P12888, DOI 10.1074/jbc.M800714200; Bakovic M, 2007, BIOCHEM CELL BIOL, V85, P283, DOI 10.1139/O07-006; Bergo MO, 2002, J BIOL CHEM, V277, P47701, DOI 10.1074/jbc.M207734200; Bladergroen BA, 1999, BIOCHEM J, V343, P107, DOI 10.1042/0264-6021:3430107; Bleijerveld OB, 2007, J BIOL CHEM, V282, P28362, DOI 10.1074/jbc.M703786200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; DEMANT EJF, 1982, ARCH BIOCHEM BIOPHYS, V213, P186, DOI 10.1016/0003-9861(82)90454-4; Denechaud PD, 2008, J CLIN INVEST, V118, P956, DOI 10.1172/JCI34314; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Fullerton MD, 2007, MOL CELL BIOL, V27, P3327, DOI 10.1128/MCB.01527-06; Fullerton MD, 2009, J BIOL CHEM, V284, P25704, DOI 10.1074/jbc.M109.023846; GOLDBERG DM, 1981, BIOCHEM J, V196, P337, DOI 10.1042/bj1960337; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; Henneberry AL, 1999, BIOCHEM J, V339, P291, DOI 10.1042/0264-6021:3390291; Horibata Y, 2007, J LIPID RES, V48, P503, DOI 10.1194/jlr.C600019-JLR200; Hunt MC, 1999, BIOCHEM SOC T, V27, P378, DOI 10.1042/bst0270378; Ivanova PT, 2007, METHOD ENZYMOL, V432, P21, DOI 10.1016/S0076-6879(07)32002-8; Jackowski S, 2004, MOL CELL BIOL, V24, P4720, DOI 10.1128/MCB.24.11.4720-4733.2004; Jackowski S, 2000, BBA-MOL CELL BIOL L, V1483, P301, DOI 10.1016/S1388-1981(99)00203-6; Jacobs RL, 2008, J BIOL CHEM, V283, P2147, DOI 10.1074/jbc.M706628200; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Kevala JH, 2001, ANAL BIOCHEM, V292, P130, DOI 10.1006/abio.2001.5076; Krank J, 2007, METHOD ENZYMOL, V432, P1, DOI 10.1016/S0076-6879(07)32001-6; Kuge O, 1998, P NATL ACAD SCI USA, V95, P4199, DOI 10.1073/pnas.95.8.4199; Kuge O, 1999, J BIOL CHEM, V274, P23844, DOI 10.1074/jbc.274.34.23844; Lykidis A, 2001, J BIOL CHEM, V276, P2174, DOI 10.1074/jbc.M008794200; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; MUDRA DR, 2001, CURRENT PROTOCOLS TO; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Nakashima A, 1997, J BIOL CHEM, V272, P9567; Poloumienko A, 2004, GENE, V325, P145, DOI 10.1016/j.gene.2003.10.005; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; PREISS JE, 1987, METHOD ENZYMOL, V141, P294; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Saito K, 1998, J BIOL CHEM, V273, P17199, DOI 10.1074/jbc.273.27.17199; Sasaki H, 1997, P NATL ACAD SCI USA, V94, P7320, DOI 10.1073/pnas.94.14.7320; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; SCHMID PC, 1995, ARCH BIOCHEM BIOPHYS, V319, P168, DOI 10.1006/abbi.1995.1279; Shindou H, 2009, J LIPID RES, V50, pS46, DOI 10.1194/jlr.R800035-JLR200; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; SUNDLER R, 1973, BIOCHIM BIOPHYS ACTA, V306, P218, DOI 10.1016/0005-2760(73)90227-0; SUNDLER R, 1974, FEBS LETT, V43, P303, DOI 10.1016/0014-5793(74)80667-8; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Tian Y, 2008, J CELL BIOL, V181, P945, DOI 10.1083/jcb.200706152; Tian Y, 2007, MOL CELL BIOL, V27, P975, DOI 10.1128/MCB.01512-06; Tie A, 2007, J LIPID RES, V48, P2172, DOI 10.1194/jlr.M600536-JLR200; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Vance DE, 2008, CURR OPIN LIPIDOL, V19, P229, DOI 10.1097/MOL.0b013e3282fee935; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; VOELKER DR, 1984, P NATL ACAD SCI-BIOL, V81, P2669, DOI 10.1073/pnas.81.9.2669; Voelker DR, 2003, J LIPID RES, V44, P441, DOI 10.1194/jlr.R200020-JLR200; Walkey CJ, 1998, J BIOL CHEM, V273, P27043, DOI 10.1074/jbc.273.42.27043; Zhang YL, 2006, J BIOL CHEM, V281, P37603, DOI 10.1074/jbc.M604709200; Zhu L, 2008, J LIPID RES, V49, P2197, DOI 10.1194/jlr.M800259-JLR200	65	64	67	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27077	27089		10.1074/jbc.M109.031336	http://dx.doi.org/10.1074/jbc.M109.031336			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19666474	hybrid, Green Published			2022-12-27	WOS:000270232300009
J	Liu, P; Li, HL; Cepeda, J; Xia, Y; Kempf, JA; Ye, H; Zhang, LQ; Ye, SQ				Liu, Peng; Li, Hailong; Cepeda, Javier; Xia, Yue; Kempf, Jessica A.; Ye, Hong; Zhang, Li Qin; Ye, Shui Qing			Regulation of Inflammatory Cytokine Expression in Pulmonary Epithelial Cells by Pre-B-cell Colony-enhancing Factor via a Nonenzymatic and AP-1-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE RESPIRATORY-DISTRESS; ACUTE LUNG INJURY; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; BIOSYNTHETIC ENZYME; NAD BIOSYNTHESIS; KAPPA-B; GENE; NAMPT/PBEF/VISFATIN; IDENTIFICATION; TRANSCRIPTION	Although our previous studies found Pre-B-cell colony-enhancing factor (PBEF) as a highly up-regulated gene in acute lung injury that could stimulate expressions of other inflammatory cytokines, the underlying molecular mechanisms remain to be fully elucidated. Growing evidence indicates that PBEF is a nicotinamide phosphoribosyltransferase involved in the mammalian salvage pathway of NAD synthesis. This study was designed to determine whether the effect of PBEF to stimulate expressions of inflammatory cytokines depends on its enzymatic activity. We prepared two human PBEF mutant (H247E and H247A) recombinant proteins and overexpressing constructs for their overexpressions in A549 cells and confirmed that enzymatic activities of both mutants were nearly or completely abolished. Two mutants stimulated interleukin-8 (IL-8) expression at both the mRNA level and protein level just as equally effective as the wild-type PBEF did. These effects were due to the increased transcription, not the mRNA stability, of the IL-8 gene. Reporter gene assays and gel shift experiments indicated that AP-1 transcription factor is required to mediate these effects. SB203580, a p38 MAPK pathway inhibitor, and JNK inhibitor 1 can attenuate these effects. Both PBEF mutants similarly stimulated the expression of two other inflammatory cytokines: IL-16 and CCR3. These results indicate that PBEF stimulated expression of IL-8, IL-16, and CCR3 via its non-enzymatic activity. This effect is AP-1-dependent, in part via the p38 MAPK pathway and the JNK pathway. This finding reveals a new insight, which may manifest a novel role of PBEF in the pathogenesis of acute lung injury and other inflammatory disorders.	[Liu, Peng; Li, Hailong; Xia, Yue; Kempf, Jessica A.; Ye, Hong; Zhang, Li Qin; Ye, Shui Qing] Univ Missouri, Dept Surg, Columbia, MO 65212 USA; [Liu, Peng; Li, Hailong; Xia, Yue; Kempf, Jessica A.; Ye, Hong; Zhang, Li Qin; Ye, Shui Qing] Univ Missouri, Dept Mol Biol & Immunol, Columbia, MO 65212 USA; [Liu, Peng] Dalian Med Univ, Affiliated Hosp 1, Sino UK Ctr Regenerat Med, Dalian, Peoples R China; [Cepeda, Javier] Yale Univ, Dept Epidemiol & Publ Hlth, New Haven, CT 06511 USA; [Xia, Yue] Wuhan Univ, Renmin Hosp, Dept Urol, Wuhan 430072, Peoples R China; [Ye, Hong] China Three Gorges Univ, Med Sci Coll, Dept Gynecol & Obstet, Yichang, Peoples R China	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Dalian Medical University; Yale University; Wuhan University; China Three Gorges University	Ye, SQ (corresponding author), Univ Missouri, Dept Surg, Med Sci Bldg,N512,DC097-00,1 Hosp Dr, Columbia, MO 65212 USA.	yes@health.missouri.edu			National Institutes of Health [HL 080042]; University of Missouri-Columbia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Missouri-Columbia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL 080042 (to S. Q. Y.). This work was also supported by a University of Missouri-Columbia Start-up fund.	ASHBAUGH DG, 1967, LANCET, V2, P319; Bajwa EK, 2007, CRIT CARE MED, V35, P1290, DOI 10.1097/01.CCM.0000260243.22758.4F; Brasier AR, 1998, J BIOL CHEM, V273, P3551, DOI 10.1074/jbc.273.6.3551; Brentano F, 2007, ARTHRITIS RHEUM, V56, P2829, DOI 10.1002/art.22833; Casola A, 2002, VIROLOGY, V298, P8, DOI 10.1006/viro.2002.1475; Casola A, 2000, J IMMUNOL, V164, P5944, DOI 10.4049/jimmunol.164.11.5944; Dahl TB, 2007, CIRCULATION, V115, P972, DOI 10.1161/CIRCULATIONAHA.106.665893; De Lucca GV, 2006, CURR OPIN DRUG DISC, V9, P516; Frank JA, 2003, CRIT CARE, V7, P233, DOI 10.1186/cc1829; Goodman RB, 2003, CYTOKINE GROWTH F R, V14, P523, DOI 10.1016/S1359-6101(03)00059-5; Hasmann M, 2003, CANCER RES, V63, P7436; Holen K, 2008, INVEST NEW DRUG, V26, P45, DOI 10.1007/s10637-007-9083-2; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Li HL, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-15; Li YK, 2008, J BIOL CHEM, V283, P34833, DOI 10.1074/jbc.M805866200; Liu P, 2009, CELL BIOL INT, V33, P19, DOI 10.1016/j.cellbi.2008.10.015; Martin PR, 2001, J BACTERIOL, V183, P1168, DOI 10.1128/JB.183.4.1168-1174.2001; Mukaida N, 2003, AM J PHYSIOL-LUNG C, V284, pL566, DOI 10.1152/ajplung.00233.2002; Phua J, 2009, AM J RESP CRIT CARE, V179, P220, DOI 10.1164/rccm.200805-722OC; Pilz S, 2007, J ENDOCRINOL INVEST, V30, P138, DOI 10.1007/BF03347412; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Tilg H, 2008, CLIN SCI, V114, P275, DOI 10.1042/CS20070196; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Wang S, 2008, KIDNEY INT, V73, P318, DOI 10.1038/sj.ki.5002692; Wang T, 2006, NAT STRUCT MOL BIOL, V13, P661, DOI 10.1038/nsmb1114; Wang YL, 1998, J BIOL CHEM, V273, P34623, DOI 10.1074/jbc.273.51.34623; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware Lorraine B, 2005, Crit Care Med, V33, pS217, DOI 10.1097/01.CCM.0000155788.39101.7E; Xu JS, 2008, NAT IMMUNOL, V9, P880, DOI 10.1038/ni.1628; Ye SQ, 2005, MICROVASC RES, V70, P142, DOI 10.1016/j.mvr.2005.08.003; Ye SQ, 2005, AM J RESP CRIT CARE, V171, P361, DOI 10.1164/rccm.200404-563OC; Zhai RG, 2008, NATURE, V452, P887, DOI 10.1038/nature06721; Zhu YM, 2003, J BIOL CHEM, V278, P29366, DOI 10.1074/jbc.M301785200	36	34	42	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27344	27351		10.1074/jbc.M109.002519	http://dx.doi.org/10.1074/jbc.M109.002519			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19654329	Green Published, hybrid			2022-12-27	WOS:000270232300035
J	Mertz, JA; Chadee, AB; Byun, H; Russell, R; Dudley, JP				Mertz, Jennifer A.; Chadee, Amanda B.; Byun, Hyewon; Russell, Rick; Dudley, Jaquelin P.			Mapping of the Functional Boundaries and Secondary Structure of the Mouse Mammary Tumor Virus Rem-responsive Element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENV MESSENGER-RNA; CONSTITUTIVE TRANSPORT ELEMENT; INFECTIOUS-ANEMIA VIRUS; B LEUKEMOGENIC VIRUS; HTLV-I REX; NUCLEAR EXPORT; GENE-EXPRESSION; CONFORMATIONAL SWITCH; TARGET SEQUENCE; SIGNAL PEPTIDE	Mouse mammary tumor virus (MMTV) is a complex retrovirus that encodes at least three regulatory and accessory proteins, including Rem. Rem is required for nuclear export of unspliced viral RNA and efficient expression of viral proteins. Our previous data indicated that sequences at the envelope-3' long terminal repeat junction are required for proper export of viral RNA. To further map the Rem-responsive element (RmRE), reporter vectors containing various portions of the viral envelope gene and the 3' long terminal repeat were tested in the presence and absence of Rem in transient transfection assays. A 476-bp fragment that spans the envelope-long terminal repeat junction had activity equivalent to the entire 3'-end of the mouse mammary tumor virus genome, but further deletions at the 5'- or 3'- ends reduced Rem responsiveness. RNase structure mapping of the full-length RmRE and a 3'-truncation suggested multiple domains with local base pairing and intervening single-stranded segments. A secondary structure model constrained by these data is reminiscent of the RNA response elements of other complex retroviruses, with numerous local stem-loops and long-range base pairs near the 5'- and 3'- boundaries, and differs substantially from an earlier model generated without experimental constraints. Covariation analysis provides limited support for basic features of our model. Reporter assays in human and mouse cell lines revealed similar boundaries, suggesting that the RmRE does not require cell type-specific proteins to form a functional structure.	[Mertz, Jennifer A.; Byun, Hyewon; Dudley, Jaquelin P.] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Chadee, Amanda B.; Russell, Rick] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Mertz, Jennifer A.; Chadee, Amanda B.; Byun, Hyewon; Russell, Rick; Dudley, Jaquelin P.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Dudley, JP (corresponding author), Univ Texas Austin, Sect Mol Genet & Microbiol, 1 Univ Stn,A5000,NMS 2-104, Austin, TX 78712 USA.	jdudley@uts.cc.utexas.edu	Russell, Rick/A-9256-2012		National Institutes of Health [CA-116813, GM-070456]; NATIONAL CANCER INSTITUTE [R01CA116813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-116813 ( to J.P.D.) and GM-070456 ( to R. R.).	AHMED YF, 1990, GENE DEV, V4, P1014, DOI 10.1101/gad.4.6.1014; ARRIGO SJ, 1991, GENE DEV, V5, P808, DOI 10.1101/gad.5.5.808; Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; Askjaer P, 1998, J BIOL CHEM, V273, P11463, DOI 10.1074/jbc.273.19.11463; Belshan M, 2000, MOL CELL BIOL, V20, P3550, DOI 10.1128/MCB.20.10.3550-3557.2000; Belshan M, 1998, J VIROL, V72, P4421, DOI 10.1128/JVI.72.5.4421-4426.1998; BERGMAN AC, 1994, VIROLOGY, V204, P420, DOI 10.1006/viro.1994.1547; Bhadra S, 2006, PLOS PATHOG, V2, P1134, DOI 10.1371/journal.ppat.0020128; BOGERD H, 1993, J VIROL, V67, P2496, DOI 10.1128/JVI.67.5.2496-2502.1993; Brandt S, 2007, PLOS PATHOG, V3, P518, DOI 10.1371/journal.ppat.0030054; Caporale M, 2009, J VIROL, V83, P4591, DOI 10.1128/JVI.01833-08; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; DONISKELLER H, 1977, NUCLEIC ACIDS RES, V4, P2527, DOI 10.1093/nar/4.8.2527; Dultz E, 2008, J BIOL CHEM, V283, P9966, DOI 10.1074/jbc.M705712200; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; ENGLAND TE, 1978, NATURE, V275, P560, DOI 10.1038/275560a0; Ernst RK, 1997, MOL CELL BIOL, V17, P135, DOI 10.1128/MCB.17.1.135; Ernst RK, 1997, RNA, V3, P210; Fuchs G, 2006, NAT STRUCT MOL BIOL, V13, P1002, DOI 10.1038/nsmb1156; GOLOVKINA TV, 1992, CELL, V69, P637, DOI 10.1016/0092-8674(92)90227-4; Gosser Y, 2001, NAT STRUCT BIOL, V8, P146, DOI 10.1038/84138; Groom HCT, 2009, J GEN VIROL, V90, P1141, DOI 10.1099/vir.0.007963-0; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; HANLY SM, 1989, GENE DEV, V3, P1534, DOI 10.1101/gad.3.10.1534; HELD W, 1993, CELL, V74, P529, DOI 10.1016/0092-8674(93)80054-I; HOLLAND SM, 1990, J VIROL, V64, P5966, DOI 10.1128/JVI.64.12.5966-5975.1990; Indik S, 2005, VIROLOGY, V337, P1, DOI 10.1016/j.virol.2005.03.040; KJEMS J, 1991, P NATL ACAD SCI USA, V88, P683, DOI 10.1073/pnas.88.3.683; Kusuhara K, 1999, J VIROL, V73, P8112, DOI 10.1128/JVI.73.10.8112-8119.1999; LAWRENCE JB, 1991, NEW BIOL, V3, P1220; Lee JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002272; Legiewicz M, 2008, P NATL ACAD SCI USA, V105, P14365, DOI 10.1073/pnas.0804461105; MADORE SJ, 1994, VIROLOGY, V202, P186, DOI 10.1006/viro.1994.1334; Magin C, 2000, VIROLOGY, V274, P11, DOI 10.1006/viro.2000.0438; Magin-Lachmann C, 2001, J VIROL, V75, P10359, DOI 10.1128/JVI.75.21.10359-10371.2001; MAJORS JE, 1983, J VIROL, V47, P495, DOI 10.1128/JVI.47.3.495-504.1983; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; MANN DA, 1994, J MOL BIOL, V241, P193, DOI 10.1006/jmbi.1994.1488; Mertz JA, 2005, J VIROL, V79, P14737, DOI 10.1128/JVI.79.23.14737-14747.2005; Mertz JA, 2001, J VIROL, V75, P2174, DOI 10.1128/JVI.75.5.2174-2184.2001; Mertz JA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-10; MOORE R, 1987, J VIROL, V61, P480, DOI 10.1128/JVI.61.2.480-490.1987; Mullner M, 2008, NUCLEIC ACIDS RES, V36, P6284, DOI 10.1093/nar/gkn608; Mustafa F, 2003, J VIROL, V77, P3866, DOI 10.1128/JVI.77.6.3866-3870.2003; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; OLSEN HS, 1990, GENE DEV, V4, P1357, DOI 10.1101/gad.4.8.1357; Paca RE, 2000, J VIROL, V74, P9507, DOI 10.1128/JVI.74.20.9507-9514.2000; Payne SL, 2001, CURR PROTEIN PEPT SC, V2, P381, DOI 10.2174/1389203013381008; Perales C, 2005, BBA-MOL CELL RES, V1743, P169, DOI 10.1016/j.bbamcr.2004.09.030; Rizvi TA, 2009, VIROLOGY, V385, P464, DOI 10.1016/j.virol.2008.12.027; SALMONS B, 1985, VIROLOGY, V144, P101, DOI 10.1016/0042-6822(85)90309-5; SEIKI M, 1988, P NATL ACAD SCI USA, V85, P7124, DOI 10.1073/pnas.85.19.7124; TOYOSHIMA H, 1990, J VIROL, V64, P2825, DOI 10.1128/JVI.64.6.2825-2832.1990; Yang J, 2000, RNA, V6, P1551, DOI 10.1017/S135583820000100X; Yang J, 1999, RNA, V5, P1645, DOI 10.1017/S1355838299991616; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	57	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25642	25652		10.1074/jbc.M109.012476	http://dx.doi.org/10.1074/jbc.M109.012476			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19632991	Green Published, hybrid			2022-12-27	WOS:000269738000022
J	Dettori, R; Sonzogni, S; Meyer, L; Lopez-Garcia, LA; Morrice, NA; Zeuzem, S; Engel, M; Piiper, A; Neimanis, S; Frodin, M; Biondi, RM				Dettori, Rosalia; Sonzogni, Silvina; Meyer, Lucas; Lopez-Garcia, Laura A.; Morrice, Nick A.; Zeuzem, Stefan; Engel, Matthias; Piiper, Albrecht; Neimanis, Sonja; Frodin, Morten; Biondi, Ricardo M.			Regulation of the Interaction between Protein Kinase C-related Protein Kinase 2 (PRK2) and Its Upstream Kinase, 3-Phosphoinositide-dependent Protein Kinase 1 (PDK1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROPHOBIC MOTIF PHOSPHORYLATION; DOCKING-SITE; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; RAT-LIVER; RNA POLYMERASE; BINDING POCKET; AGC KINASES; ACTIVATION; MECHANISM	The members of the AGC kinase family frequently exhibit three conserved phosphorylation sites: the activation loop, the hydrophobic motif (HM), and the zipper (Z)/turn-motif (TM) phosphorylation site. 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates the activation loop of numerous AGC kinases, including the protein kinase C-related protein kinases (PRKs). Here we studied the docking interaction between PDK1 and PRK2 and analyzed the mechanisms that regulate this interaction. In vivo labeling of recombinant PRK2 by P-32(i) revealed phosphorylation at two sites, the activation loop and the Z/TM in the C-terminal extension. We provide evidence that phosphorylation of the Z/TM site of PRK2 inhibits its interaction with PDK1. Our studies further provide a mechanistic model to explain different steps in the docking interaction and regulation. Interestingly, we found that the mechanism that negatively regulates the docking interaction of PRK2 to the upstream kinase PDK1 is directly linked to the activation mechanism of PRK2 itself. Finally, our results indicate that the mechanisms underlying the regulation of the interaction between PRK2 and PDK1 are specific for PRK2 and do not apply for other AGC kinases.	[Dettori, Rosalia; Sonzogni, Silvina; Meyer, Lucas; Lopez-Garcia, Laura A.; Zeuzem, Stefan; Piiper, Albrecht; Neimanis, Sonja; Biondi, Ricardo M.] Johann Wolfgang Goethe Univ Hosp, Dept Internal Med 1, Res Grp PhosphoSites, D-60590 Frankfurt, Germany; [Engel, Matthias] Univ Saarland, Dept Pharmaceut & Med Chem, D-66041 Saarbrucken, Germany; [Morrice, Nick A.] Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland; [Frodin, Morten] BRIC, DK-2200 Copenhagen N, Denmark	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Saarland University; University of Dundee	Biondi, RM (corresponding author), Goethe Univ Frankfurt, Dept Internal Med 1, Res Grp PhosphoSites, D-60590 Frankfurt, Germany.	biondi@med.uni-frankfurt.de	Zeuzem, Stefan/AAE-7435-2019	Biondi, Ricardo/0000-0002-8873-7167; Frodin, Morten/0000-0003-3691-9820	Europrofession Foundation; BMBF Go-Bio; DFG [BI 1044/5-1]	Europrofession Foundation; BMBF Go-Bio(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	This work was supported by the Europrofession Foundation (Saarbrucken, Germany), BMBF Go-Bio, and DFG (BI 1044/5-1).	Balendran A, 2000, FEBS LETT, V484, P217, DOI 10.1016/S0014-5793(00)02162-1; Balendran A, 2000, J BIOL CHEM, V275, P20806, DOI 10.1074/jbc.M000421200; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Biondi RM, 2000, EMBO J, V19, P979, DOI 10.1093/emboj/19.5.979; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Campbell David G, 2002, J Biomol Tech, V13, P119; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Engel M, 2006, EMBO J, V25, P5469, DOI 10.1038/sj.emboj.7601416; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; GABRIELLI B, 1984, FEBS LETT, V175, P219, DOI 10.1016/0014-5793(84)80740-1; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; Hindie V, 2009, NAT CHEM BIOL, V5, P758, DOI 10.1038/nchembio.208; Huang X, 2003, STRUCTURE, V11, P21, DOI 10.1016/S0969-2126(02)00937-1; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Kim SJ, 2009, J VIRAL HEPATITIS, V16, P697, DOI 10.1111/j.1365-2893.2009.01108.x; Kim SJ, 2004, J BIOL CHEM, V279, P50031, DOI 10.1074/jbc.M408617200; Kitagawa M, 1996, BIOCHEM BIOPH RES CO, V220, P963, DOI 10.1006/bbrc.1996.0515; Lim WG, 2008, ARCH BIOCHEM BIOPHYS, V479, P170, DOI 10.1016/j.abb.2008.09.008; Lim WG, 2006, CELL SIGNAL, V18, P1473, DOI 10.1016/j.cellsig.2005.11.009; Lim WG, 2005, CELL SIGNAL, V17, P1084, DOI 10.1016/j.cellsig.2004.12.003; Mayor F, 2007, CELL CYCLE, V6, P528, DOI 10.4161/cc.6.5.3920; MORRICE NA, 1994, J BIOL CHEM, V269, P20040; MUKAI H, 1994, BIOCHEM BIOPH RES CO, V199, P897, DOI 10.1006/bbrc.1994.1313; Mukai H, 2003, J BIOCHEM, V133, P17, DOI 10.1093/jb/mvg019; PALMER RH, 1995, EUR J BIOCHEM, V227, P344, DOI 10.1111/j.1432-1033.1995.tb20395.x; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Romano RA, 2009, PROTEIN SCI, V18, P1486, DOI 10.1002/pro.146; Schmidt A, 2007, EMBO J, V26, P1624, DOI 10.1038/sj.emboj.7601637; Smith KJ, 2004, STRUCTURE, V12, P1067, DOI 10.1016/j.str.2004.02.040; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yu WP, 1997, J BIOL CHEM, V272, P10030; Zhao B, 2007, PROTEIN SCI, V16, P2761, DOI 10.1110/ps.073161707	39	23	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30318	30327		10.1074/jbc.M109.051151	http://dx.doi.org/10.1074/jbc.M109.051151			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19723632	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000271090000035
J	Fritsch, A; Spassov, S; Elfert, S; Schlosser, A; Gache, Y; Meneguzzi, G; Bruckner-Tuderman, L				Fritsch, Anja; Spassov, Sashko; Elfert, Susanne; Schlosser, Andreas; Gache, Yannick; Meneguzzi, Guerrino; Bruckner-Tuderman, Leena			Dominant-negative Effects of COL7A1 Mutations Can be Rescued by Controlled Overexpression of Normal Collagen VII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSTROPHIC EPIDERMOLYSIS-BULLOSA; GENE-THERAPY; PROCOLLAGEN-VII; OSTEOGENESIS IMPERFECTA; ANCHORING FIBRILS; TRIPLE-HELIX; MOUSE MODEL; HUMAN SKIN; MECHANISMS; EXPRESSION	Dominant-negative interference by glycine substitution mutations in the COL7A1 gene causes dominant dystrophic epidermolysis bullosa (DDEB), a skin fragility disorder with mechanically induced blistering. Although qualitative and quantitative alterations of the COL7A1 gene product, collagen VII, underlie DDEB, the lack of direct correlation between mutations and the clinical phenotype has rendered DDEB less amenable to therapeutic targeting. To delineate the molecular mechanisms of DDEB, we used recombinant expression of wildtype (WT) and mutant collagen VII, which contained a naturally occurring COL7A1 mutation, G1776R, G2006D, or G2015E, for characterization of the triple helical molecules. The mutants were co-expressed with WT in equal amounts and could form heterotrimeric hybrid triple helices, as demonstrated by affinity purification and mass spectrometry. The thermal stability of the mutant molecules was strongly decreased, as evident in their sensitivity to trypsin digestion. The helix-to-coil transition, T-m, of the mutant molecules was 31-34 degrees C, and of WT collagen VII 41 degrees C. Co-expression of WT with G1776R- or G2006D-collagen VII resulted in partial intracellular retention of the collagen, and mutant collagen VII had reduced ability to support cell adhesion. Intriguingly, controlled overexpression of WT collagen VII gradually improved the thermal stability of the collective of collagen VII molecules. Co-expression in a ratio of 90% WT:10% mutant increased the T-m to 41 degrees C for G1776R- collagen VII and to 39 degrees C for G2006D- and G2015E-collagen VII. Therefore, increasing the expression of WT collagen VII in the skin of patients with DDEB can be considered a valid therapeutic approach.	[Fritsch, Anja; Spassov, Sashko; Elfert, Susanne; Bruckner-Tuderman, Leena] Univ Med Ctr Freiburg, Dept Dermatol, D-79104 Freiburg, Germany; [Elfert, Susanne] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Bruckner-Tuderman, Leena] Univ Freiburg, LIFENET, Sch Life Sci, FRIAS, D-79104 Freiburg, Germany; [Schlosser, Andreas] Univ Freiburg, Ctr Syst Biol ZBSA, Core Facil Prote, D-79104 Freiburg, Germany; [Gache, Yannick; Meneguzzi, Guerrino] Univ Nice Sophia Antipolis, INSERM U634, F-06103 Nice 2, France	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Bruckner-Tuderman, L (corresponding author), Univ Med Ctr Freiburg, Dept Dermatol, Hauptstr 7, D-79104 Freiburg, Germany.	bruckner-tuderman@uniklinik-freiburg.de	Spassov, Sashko/C-2105-2013	Spassov, Sashko/0000-0002-3585-3682; Meneguzzi, Guerrino/0000-0002-1609-6540; Gache, Yannick/0000-0002-5638-4854	Federal Ministry for Education and Research; BMBF; Debra International; German Research Foundation	Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF)); Debra International; German Research Foundation(German Research Foundation (DFG))	This work was supported in part by grants from the Federal Ministry for Education and Research, BMBF (EB-Network, Project 9), Debra International, and the German Research Foundation (Bioss and FRIAS Lifenet programs).	BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; BRUCKNERTUDERMAN L, 1995, J CELL BIOL, V131, P551, DOI 10.1083/jcb.131.2.551; BURGESON RE, 1993, J INVEST DERMATOL, V101, P252, DOI 10.1111/1523-1747.ep12365129; Cao TY, 2001, J CELL BIOL, V152, P651, DOI 10.1083/jcb.152.3.651; Chen M, 1997, J BIOL CHEM, V272, P14516, DOI 10.1074/jbc.272.23.14516; Conese M, 2004, GENE THER, V11, P1735, DOI 10.1038/sj.gt.3302362; Dharma B, 2001, CLIN EXP DERMATOL, V26, P93, DOI 10.1046/j.1365-2230.2001.0801.x; Fine JD, 2008, J AM ACAD DERMATOL, V58, P931, DOI 10.1016/j.jaad.2008.02.004; Fritsch A, 2008, J CLIN INVEST, V118, P1669, DOI 10.1172/JCI34292; Gache Y, 2004, HUM GENE THER, V15, P921, DOI 10.1089/hum.2004.15.921; Goto M, 2006, J INVEST DERMATOL, V126, P2614, DOI 10.1038/sj.jid.5700435; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Hammami-Hauasli N, 1998, J BIOL CHEM, V273, P19228, DOI 10.1074/jbc.273.30.19228; Has C, 2008, EXPERT REV DERMATOL, V3, P721; Hengge UR, 2008, J INVEST DERMATOL, V128, P499, DOI 10.1038/sj.jid.5701241; Hyde TJ, 2006, J BIOL CHEM, V281, P36937, DOI 10.1074/jbc.M605135200; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; Kern JS, 2009, MOL THER, V17, P1605, DOI 10.1038/mt.2009.144; Kern JS, 2006, J INVEST DERMATOL, V126, P1006, DOI 10.1038/sj.jid.5700219; Makareeva E, 2008, J BIOL CHEM, V283, P4787, DOI 10.1074/jbc.M705773200; Marini S, 2000, J BIOL CHEM, V275, P18657, DOI 10.1074/jbc.M000283200; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; Mecklenbeck S, 2002, HUM GENE THER, V13, P1655, DOI 10.1089/10430340260201743; Mecklenbeck S, 1999, J INVEST DERMATOL, V112, P398, DOI 10.1046/j.1523-1747.1999.00518.x; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Ortiz-Urda S, 2002, NAT MED, V8, P1166, DOI 10.1038/nm766; Pace RA, 2008, ANN NEUROL, V64, P294, DOI 10.1002/ana.21439; Persikov AV, 2004, HUM MUTAT, V24, P330, DOI 10.1002/humu.20091; Rattenholl A, 2002, J BIOL CHEM, V277, P26372, DOI 10.1074/jbc.M203247200; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Villone D, 2008, J BIOL CHEM, V283, P24506, DOI 10.1074/jbc.M802415200; Vindevoghel L, 1997, J BIOL CHEM, V272, P10196; Woodley DT, 2008, J BIOL CHEM, V283, P17838, DOI 10.1074/jbc.M709452200; Xu K, 2008, J BIOL CHEM, V283, P34337, DOI 10.1074/jbc.M805485200	34	35	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30248	30256		10.1074/jbc.M109.045294	http://dx.doi.org/10.1074/jbc.M109.045294			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19726672	Green Published, hybrid			2022-12-27	WOS:000271090000028
J	Gray, CH; McGarry, LC; Spence, HJ; Riboldi-Tunnicliffe, A; Ozanne, BW				Gray, Christopher H.; McGarry, Lynn C.; Spence, Heather J.; Riboldi-Tunnicliffe, Alan; Ozanne, Bradford W.			Novel beta-Propeller of the BTB-Kelch Protein Krp1 Provides a Binding Site for Lasp-1 That Is Necessary for Pseudopodial Extension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPEAT SUPERFAMILY; SUBSTRATE ADAPTER; CRYSTAL-STRUCTURE; KEAP1; UBIQUITINATION; PATHWAY; TARGETS; DOMAIN; PROTHYMOSIN; EXPRESSION	Kelch-related protein 1 (Krp1) is up-regulated in oncogene-transformed fibroblasts. The Kelch repeats interact directly with the actin-binding protein Lasp-1 in membrane ruffles at the tips of pseudopodia, where both proteins are necessary for pseudopodial elongation. Herein, we investigate the molecular basis for this interaction. Probing an array of overlapping decapeptides of Rattus norvegicus ( Rat) Krp1 with recombinant Lasp-1 revealed two binding sites; one ((YDPMENECYLT327)-Y-317) precedes the first of five Kelch repeats, and the other ((TEVNDIWKYEDD574)-T-563) is in the last of the five Kelch repeats. Mutational analysis established that both binding sites are necessary for Krp1-Lasp-1 interaction in vitro and function in vivo. The crystal structure of the C-terminal domain of rat Krp1 (amino acids 289-606) reveals that both binding sites are brought into close proximity by the formation of a novel six-bladed beta-propeller, where the first blade is not formed by a Kelch repeat.	[Gray, Christopher H.; McGarry, Lynn C.; Spence, Heather J.; Ozanne, Bradford W.] Beatson Inst Canc Res, Invas & Metastasis Lab, Glasgow G61 1BD, Lanark, Scotland; [Riboldi-Tunnicliffe, Alan] Univ Glasgow, Dept Chem, Fac Biol Life Sci, Glasgow G12 8QQ, Lanark, Scotland	Beatson Institute; University of Glasgow	Gray, CH (corresponding author), Beatson Inst Canc Res, Invas & Metastasis Lab, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	c.gray@beatson.gla.ac.uk		Riboldi-Tunnicliffe, Alan/0000-0003-2244-2486	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was funded by Cancer Research UK ( to B. W. O.).	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beamer LJ, 2005, ACTA CRYSTALLOGR D, V61, P1335, DOI [10.1107/S0907444905022626, 10.1107/S090744905022626]; BORK P, 1994, J MOL BIOL, V236, P1277, DOI 10.1016/0022-2836(94)90056-6; Chew CS, 1998, AM J PHYSIOL-CELL PH, V275, pC56, DOI 10.1152/ajpcell.1998.275.1.C56; Copple IM, 2008, TOXICOLOGY, V246, P24, DOI 10.1016/j.tox.2007.10.029; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Greenberg CC, 2008, EXP CELL RES, V314, P1177, DOI 10.1016/j.yexcr.2007.12.009; Grunewald TGP, 2007, BRIT J CANCER, V96, P296, DOI 10.1038/sj.bjc.6603545; Grunewald TGP, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-31; HENNIGAN RF, 1994, ONCOGENE, V9, P3591; ITO N, 1994, J MOL BIOL, V238, P794, DOI 10.1006/jmbi.1994.1335; Karapetian RN, 2005, MOL CELL BIOL, V25, P1089, DOI 10.1128/MCB.25.3.1089-1099.2005; Li XC, 2004, J BIOL CHEM, V279, P54750, DOI 10.1074/jbc.M410073200; Lin YH, 2004, J CELL BIOL, V165, P421, DOI 10.1083/jcb.200311045; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; Lu SJ, 2003, J CELL SCI, V116, P2169, DOI 10.1242/jcs.00425; Padmanabhan B, 2008, ACTA CRYSTALLOGR F, V64, P233, DOI 10.1107/S1744309108004995; Prag S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-42; Rondou P, 2008, J BIOL CHEM, V283, P11083, DOI 10.1074/jbc.M708473200; Salinas GD, 2006, J BIOL CHEM, V281, P40164, DOI 10.1074/jbc.M608194200; Spence HJ, 2006, MOL CELL BIOL, V26, P1480, DOI 10.1128/MCB.26.4.1480-1495.2006; Spence HJ, 2000, ONCOGENE, V19, P1266, DOI 10.1038/sj.onc.1203433; Taylor A, 1998, MOL CELL BIOCHEM, V183, P105, DOI 10.1023/A:1006824331819; TOMASETTO C, 1995, FEBS LETT, V373, P245, DOI 10.1016/0014-5793(95)01040-L; VARKEY JP, 1995, GENE DEV, V9, P1074, DOI 10.1101/gad.9.9.1074; Williams SK, 2005, J NEUROSCI RES, V81, P622, DOI 10.1002/jnr.20588; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200	31	26	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30498	30507		10.1074/jbc.M109.023259	http://dx.doi.org/10.1074/jbc.M109.023259			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19726686	Green Published, hybrid			2022-12-27	WOS:000271090000052
J	Khan, MA; Walden, WE; Goss, DJ; Theil, EC				Khan, Mateen A.; Walden, William E.; Goss, Dixie J.; Theil, Elizabeth C.			Direct Fe2+ Sensing by Iron-responsive Messenger RNA.Repressor Complexes Weakens Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FERRITIN IRE-RNA; REGULATORY PROTEINS; TRANSLATIONAL CONTROL; HAIRPIN LOOP; MITOCHONDRIAL ACONITASE; INTERNAL LOOP/BULGE; MOLECULAR CONTROL; NMR-SPECTROSCOPY; RIBOSOMAL-RNA; METAL-ION	Fe2+ is now shown to weaken binding between ferritin and mitochondrial aconitase messenger RNA noncoding regulatory structures ((iron-responsive element) (IRE)-RNAs) and the regulatory proteins (IRPs), which adds a direct role of iron to regulation that can complement the well known regulatory protein modification and degradative pathways related to iron-induced mRNA translation. We observe that the K-d value increases 17-fold in 5'-untranslated region IRE-RNA.repressor complexes; Fe2+, is studied in the absence of O-2. Other metal ions, Mn2+ and Mg2+ have similar effects to Fe2+ but the required Mg2+ concentration is 100 times greater than for Fe2+ or Mn2+. Metal ions also weaken ethidium bromide binding to IRE-RNA with no effect on IRP fluorescence, using Mn2+ as an O-2-resistant surrogate for Fe2+, indicating that metal ions bound IRERNA but not IRP. Fe2+ decreases IRP repressor complex stability of ferritin IRE-RNA 5-10 times compared with 2-5 times for mitochondrial aconitase IRE-RNA, over the same concentration range, suggesting that differences among IRE-RNA structures contribute to the differences in the iron responses observed in vivo. The results show the IRE-RNA.repressor complex literally responds to Fe2+, selectively for each IRE-mRNA.	[Khan, Mateen A.; Goss, Dixie J.] CUNY Hunter Coll, Dept Chem, New York, NY 10065 USA; [Walden, William E.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Theil, Elizabeth C.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; [Theil, Elizabeth C.] Univ Calif Berkeley, Dept Nutr Sci & Toxicolol, Berkeley, CA 94720 USA	City University of New York (CUNY) System; Hunter College (CUNY); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California Berkeley	Goss, DJ (corresponding author), 695 Pk Ave, New York, NY 10065 USA.	dgoss@hunter.cuny.edu; etheil@chori.org		Khan, Mateen A./0000-0002-2300-4595	National Institutes of Health [DK20251, DK47281]; National Science Foundation [MCB0814051]; Professional Staff Congress-City University of New York Faculty Award; Children's Hospital Oakland Research Institute Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047281, R37DK020251, R01DK020251, R56DK020251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Professional Staff Congress-City University of New York Faculty Award; Children's Hospital Oakland Research Institute Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK20251 (to E. C. T.) and DK47281 (to W. E. W.). This work was also supported by National Science Foundation Grant MCB0814051 (to D. J. G. and M. K.), a Professional Staff Congress-City University of New York Faculty Award (to D. J. G.), and the Children's Hospital Oakland Research Institute Foundation (to E. C. T.).	Addess KJ, 1997, J MOL BIOL, V274, P72, DOI 10.1006/jmbi.1997.1377; Butt J, 1996, P NATL ACAD SCI USA, V93, P4345, DOI 10.1073/pnas.93.9.4345; Chen OS, 1997, J NUTR, V127, P238, DOI 10.1093/jn/127.2.238; Clarke SL, 2006, EMBO J, V25, P544, DOI 10.1038/sj.emboj.7600954; Coppins RL, 2007, CURR OPIN MICROBIOL, V10, P176, DOI 10.1016/j.mib.2007.03.006; Deck KM, 2009, J BIOL CHEM, V284, P12701, DOI 10.1074/jbc.M807717200; DICKEY LF, 1988, J BIOL CHEM, V263, P3071; DIX DJ, 1993, J MOL BIOL, V231, P230, DOI 10.1006/jmbi.1993.1278; Erlitzki R, 2002, J BIOL CHEM, V277, P42579, DOI 10.1074/jbc.M207918200; Firpo MA, 1996, J BIOL CHEM, V271, P4693; Gdaniec Z, 1998, BIOCHEMISTRY-US, V37, P1505, DOI 10.1021/bi9719814; Gunshin H, 2001, FEBS LETT, V509, P309, DOI 10.1016/S0014-5793(01)03189-1; GUO B, 1994, J BIOL CHEM, V269, P24252; HARRELL CM, 1991, P NATL ACAD SCI USA, V88, P4166, DOI 10.1073/pnas.88.10.4166; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hintze KJ, 2005, P NATL ACAD SCI USA, V102, P15048, DOI 10.1073/pnas.0505148102; Hintze KJ, 2007, J BIOL CHEM, V282, P34365, DOI 10.1074/jbc.M700254200; Ke YH, 1998, J BIOL CHEM, V273, P23637, DOI 10.1074/jbc.273.37.23637; Ke YH, 2000, BIOCHEMISTRY-US, V39, P6235, DOI 10.1021/bi9924765; Khan MA, 2008, J BIOL CHEM, V283, P1340, DOI 10.1074/jbc.M703356200; Kim HY, 1996, J BIOL CHEM, V271, P24226, DOI 10.1074/jbc.271.39.24226; Laing LG, 1996, BIOCHEMISTRY-US, V35, P13586, DOI 10.1021/bi961310q; Leipuviene R, 2007, CELL MOL LIFE SCI, V64, P2945, DOI 10.1007/s00018-007-7198-4; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lipfert J, 2007, J MOL BIOL, V365, P1393, DOI 10.1016/j.jmb.2006.10.022; Martick M, 2008, NATURE, V454, P899, DOI 10.1038/nature07117; MELEFORS O, 1993, J BIOL CHEM, V268, P5974; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Nelson JA, 2008, RNA, V14, P605, DOI 10.1261/rna.912608; Oshikane H, 2006, SCIENCE, V312, P1950, DOI 10.1126/science.1128470; Phillips JD, 1996, BIOCHEMISTRY-US, V35, P15704, DOI 10.1021/bi960653l; Piccinelli P, 2007, RNA, V13, P952, DOI 10.1261/rna.464807; Rangan P, 2004, J MOL BIOL, V339, P41, DOI 10.1016/j.jmb.2004.03.059; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Selezneva AI, 2006, ACTA CRYSTALLOGR F, V62, P249, DOI 10.1107/S1744309106004192; Shenvi CL, 2005, RNA, V11, P1898, DOI 10.1261/rna.2192805; SIERZPUTOWSKAGRACZ H, 1995, NUCLEIC ACIDS RES, V23, P146, DOI 10.1093/nar/23.1.146; Theil EC, 2000, J BIOL CHEM, V275, P40659, DOI 10.1074/jbc.R000019200; Thorp HH, 1996, INORG CHEM, V35, P2773, DOI 10.1021/ic951094u; Vicens Q, 2008, RNA, V14, P2013, DOI 10.1261/rna.1027208; Vogt M, 2006, J AM CHEM SOC, V128, P16764, DOI 10.1021/ja057035p; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wang B, 2008, BIOCHEMISTRY-US, V47, P3454, DOI 10.1021/bi702372x; WANG YH, 1990, NUCLEIC ACIDS RES, V18, P4463, DOI 10.1093/nar/18.15.4463; ZAHRINGER J, 1976, P NATL ACAD SCI USA, V73, P857, DOI 10.1073/pnas.73.3.857	46	30	30	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30122	30128		10.1074/jbc.M109.041061	http://dx.doi.org/10.1074/jbc.M109.041061			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19720833	hybrid, Green Published			2022-12-27	WOS:000271090000015
J	Kienesberger, PC; Lee, D; Pulinilkunnil, T; Brenner, DS; Cai, LZ; Magnes, C; Koefeler, HC; Streith, IE; Rechberger, GN; Haemmerle, G; Flier, JS; Zechner, R; Kim, YB; Kershaw, EE				Kienesberger, Petra C.; Lee, Daeho; Pulinilkunnil, Thomas; Brenner, Daniel S.; Cai, Lingzhi; Magnes, Christoph; Koefeler, Harald C.; Streith, Ingo E.; Rechberger, Gerald N.; Haemmerle, Guenter; Flier, Jeffrey S.; Zechner, Rudolf; Kim, Young-Bum; Kershaw, Erin E.			Adipose Triglyceride Lipase Deficiency Causes Tissue-specific Changes in Insulin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; TRIACYLGLYCEROL LIPASE; GLUCOSE-HOMEOSTASIS; LIPID-ACCUMULATION; ENERGY-METABOLISM; KNOCKOUT MICE; RESISTANCE; LIPOTOXICITY; SENSITIVITY; PROTEIN	Triacylglycerol accumulation in insulin target tissues is associated with insulin resistance. Paradoxically, mice with global targeted deletion of adipose triglyceride lipase (ATGL), the rate-limiting enzyme in triacylglycerol hydrolysis, display improved glucose tolerance and insulin sensitivity despite triacylglycerol accumulation in multiple tissues. To determine the molecular mechanisms for this phenotype, ATGL-deficient (ATGL(-/-)) and wild-type mice were injected with saline or insulin (10 units/kg, intraperitoneally), and then phosphorylation and activities of key insulin-signaling proteins were determined in insulin target tissues (liver, adipose tissue, and muscle). Insulin signaling and/or glucose transport was also evaluated in isolated adipocytes and skeletal muscle ex vivo. In ATGL(-/-) mice, insulin-stimulated phosphatidylinositol 3-kinase and Akt activities as well as phosphorylation of critical residues of IRS1 (Tyr(P)-612) and Akt (Ser(P)-473) were increased in skeletal muscle in vivo. Insulin-stimulated phosphatidylinositol 3-kinase activity and total insulin receptor and insulin receptor substrate 1, but not other parameters, were also increased in white adipose tissue in vivo. In contrast, in vivo measures of insulin signaling were decreased in brown adipose tissue and liver. Interestingly, the enhanced components of insulin signaling identified in skeletal muscle and white adipose tissue in vivo and their expected downstream effects on glucose transport were not present ex vivo. ATGL deficiency altered intramyocellular lipids as well as serum factors known to influence insulin sensitivity. Thus, skeletal muscle, rather than other tissues, primarily contributes to enhanced insulin sensitivity in ATGL(-/-) mice in vivo despite triacylglycerol accumulation, and both local and systemic factors contribute to tissue-specific effects of global ATGL deficiency on insulin action.	[Kienesberger, Petra C.; Streith, Ingo E.; Rechberger, Gerald N.; Haemmerle, Guenter; Zechner, Rudolf] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Kienesberger, Petra C.; Lee, Daeho; Brenner, Daniel S.; Flier, Jeffrey S.; Kim, Young-Bum; Kershaw, Erin E.] Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol & Metab, Boston, MA 02215 USA; [Kienesberger, Petra C.; Lee, Daeho; Brenner, Daniel S.; Flier, Jeffrey S.; Kim, Young-Bum] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Lee, Daeho] Cheju Natl Univ, Coll Med, Dept Internal Med, Cheju 690756, South Korea; [Pulinilkunnil, Thomas] Univ Alberta, Fac Med & Dent, Dept Pediat, Cardiovasc Res Ctr, Edmonton, AB T6G 2S2, Canada; [Cai, Lingzhi; Kershaw, Erin E.] Univ Pittsburgh, Dept Med, Div Endocrinol & Metab, Pittsburgh, PA 15261 USA; [Magnes, Christoph] Inst Med Technol & Hlth Management, A-8036 Graz, Austria; [Koefeler, Harald C.] Med Univ Graz, Med Res Ctr, Core Facil Mass Spectrometry Lipid, A-8010 Graz, Austria	University of Graz; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Jeju National University; University of Alberta; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Medical University of Graz	Kim, YB (corresponding author), 330 Brookline Ave,CLS-736, Boston, MA 02215 USA.	ykim2@bidmc.harvard.edu; kershawe@pitt.edu	Pulinilkunnil, Thomas C/L-5511-2016; Pulinilkunnil, Thomas/H-4387-2019; Kershaw, Erin E/G-9587-2013; Flier, jeffrey/AAG-6223-2019	Pulinilkunnil, Thomas C/0000-0003-1228-893X; Pulinilkunnil, Thomas/0000-0003-1228-893X; Kershaw, Erin E/0000-0002-3887-4868; Zechner, Rudolf/0000-0001-5483-1182; Kofeler, Harald/0000-0002-2725-9616; Haemmerle, Guenter/0000-0001-9900-5896; Magnes, Christoph/0000-0002-5153-7444; Rechberger, Gerald N./0000-0002-0071-317X; Kienesberger, Petra/0000-0001-9643-8338	National Institutes of Health [K08-DK065833, R03-DK077697, R37-DK028082, DK043051, P30-DK57521]; Austrian Ministry of Science and Research [F30]; Wittgenstein Award [Z136]; Austrian Science Foundation [W901]; American Diabetes Association [1-09-RA-87]; Austrian Science Fund (FWF) [Z 136, W 901, F 3002] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043051, K08DK065833, R37DK028082, P30DK057521, R37DK043051, R03DK077697] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Ministry of Science and Research; Wittgenstein Award(Austrian Science Fund (FWF)); Austrian Science Foundation(Austrian Science Fund (FWF)); American Diabetes Association(American Diabetes Association); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K08-DK065833 and R03-DK077697 (to E. E. K.), R37-DK028082 (to J. S. F.), DK043051 (to Y. B. K.), and P30-DK57521 (to the Beth Israel Deaconess Medical Center Metabolic Physiology Core Facility). This work was also supported by Austrian Ministry of Science and Research GEN-AU Grant GOLD-Genomics of Lipid-associated Disorders (to R. Z.), F30 (SFB LIPOTOX) (to R. Z.), Wittgenstein Award Z136 (to R. Z.), Austrian Science Foundation Grant W901 DK (to R. Z. and P. C. K.), and American Diabetes Association Grant 1-09-RA-87 (to Y. B. K.).	Adamo KB, 1998, J APPL PHYSIOL, V84, P908, DOI 10.1152/jappl.1998.84.3.908; CUSHMAN SW, 1978, J LIPID RES, V19, P269; CZECH MP, 1976, J CLIN INVEST, V57, P1523, DOI 10.1172/JCI108422; FOLCH J, 1957, J BIOL CHEM, V226, P497; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Guan XL, 2006, YEAST, V23, P465, DOI 10.1002/yea.1362; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Huijsman E, 2009, AM J PHYSIOL-ENDOC M, V297, pE505, DOI 10.1152/ajpendo.00190.2009; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kahn CR, 2000, J PEDIATR ENDOCR MET, V13, P1377; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kim YB, 1999, J CLIN INVEST, V104, P733, DOI 10.1172/JCI6928; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; KOOPMANS SJ, 1995, METABOLISM, V44, P291, DOI 10.1016/0026-0495(95)90157-4; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Levin MC, 2007, AM J PHYSIOL-ENDOC M, V293, pE1772, DOI 10.1152/ajpendo.00158.2007; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Machann J, 2004, DIABETES OBES METAB, V6, P239, DOI 10.1111/j.1462-8902.2004.00339.x; Magnes C, 2008, ANAL CHEM, V80, P5736, DOI 10.1021/ac800031u; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Minokoshi Y, 2003, J BIOL CHEM, V278, P33609, DOI 10.1074/jbc.R300019200; Park SY, 2005, AM J PHYSIOL-ENDOC M, V289, pE30, DOI 10.1152/ajpendo.00251.2004; Peyot ML, 2009, J BIOL CHEM, V284, P16848, DOI 10.1074/jbc.M109.006650; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Timmers S, 2008, PHYSIOL BEHAV, V94, P242, DOI 10.1016/j.physbeh.2007.12.002; Tozzo E, 1997, ENDOCRINOLOGY, V138, P1604, DOI 10.1210/en.138.4.1604; Unger RH, 2003, ENDOCRINOLOGY, V144, P5159, DOI 10.1210/en.2003-0870; van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Voshol PJ, 2003, ENDOCRINOLOGY, V144, P3456, DOI 10.1210/en.2002-0036; Wolf G, 2007, NUTR REV, V65, P251, DOI 10.1111/j.1753-4887.2007.tb00302.x; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	41	95	99	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30218	30229		10.1074/jbc.M109.047787	http://dx.doi.org/10.1074/jbc.M109.047787			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19723629	hybrid, Green Published			2022-12-27	WOS:000271090000025
J	Qi, Q; August, A				Qi, Qian; August, Avery			The Tec Family Kinase Itk Exists as a Folded Monomer in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL RECEPTOR; BRUTONS TYROSINE KINASE; CYCLOPHILIN-A; REGULATORY DOMAINS; STRUCTURAL BASIS; HOMOLOGY DOMAIN; ACTIVE ITK; ACTIVATION; SRC; BTK	Tec family tyrosine kinases transduce signals from antigen and other receptors. In particular, Itk plays an important role in T-cell development and activation. Itk has an N-terminal pleckstrin homology domain, a Tec Homology domain with a proline-rich region, SH3 and SH2 domains and a kinase domain, the structure each of which has been determined. However, the full structure of Itk and other Tec kinases remain elusive. Models of Itk suggest either a head to tail dimer, with the SH2 domain interacting with the SH3 domain, or a folded monomer with the SH3 domain interacting with the proline-rich region. We show here that in vivo Itk exists as a monomer, with the pleckstrin homology domain less than 80 angstrom from the C terminus. Zn2+ coordinating residues in the Tec Homology domain, not the proline-rich region, are critical for this intramolecular interaction. These data have implications for our understanding of Tec family kinase structure.	[August, Avery] Penn State Univ, Ctr Mol Immunol & Infect Dis, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Qi, Qian] Penn State Univ, Immunol & Infect Dis Grad Program, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	August, A (corresponding author), Penn State Univ, Ctr Mol Immunol & Infect Dis, Dept Vet & Biomed Sci, 115 Henning Bldg, University Pk, PA 16802 USA.	axa45@psu.edu	Qi, Qian/E-7454-2012		National Institutes of Health [AI51626, AI065566]; Pennsylvania Dept. of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051626, R01AI065566, R56AI065566] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Dept. of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI51626 and AI065566 (to A. A.). The Center for Molecular Immunology and Infectious Disease at Penn State was supported in part by a grant from the Pennsylvania Dept. of Health.	Andreotti AH, 1997, NATURE, V385, P93, DOI 10.1038/385093a0; Au-Yeung BB, 2007, J IMMUNOL, V179, P111, DOI 10.4049/jimmunol.179.1.111; Au-Yeung BB, 2006, J IMMUNOL, V176, P3895, DOI 10.4049/jimmunol.176.7.3895; August A, 2002, INT J BIOCHEM CELL B, V34, P1184, DOI 10.1016/S1357-2725(02)00068-7; AUGUST A, 1994, P NATL ACAD SCI USA, V91, P9347, DOI 10.1073/pnas.91.20.9347; August A, 1997, P NATL ACAD SCI USA, V94, P11227, DOI 10.1073/pnas.94.21.11227; Bence K, 1997, NATURE, V389, P296, DOI 10.1038/38520; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Braaten D, 2001, EMBO J, V20, P1300, DOI 10.1093/emboj/20.6.1300; Brazin KN, 2000, J MOL BIOL, V302, P607, DOI 10.1006/jmbi.2000.4091; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; Broussard C, 2006, IMMUNITY, V25, P93, DOI 10.1016/j.immuni.2006.05.011; Bunnell SC, 1996, J BIOL CHEM, V271, P25646, DOI 10.1074/jbc.271.41.25646; Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Ching KA, 2000, J IMMUNOL, V165, P256, DOI 10.4049/jimmunol.165.1.256; Colgan J, 2004, IMMUNITY, V21, P189, DOI 10.1016/j.immuni.2004.07.005; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Gibson S, 1996, J BIOL CHEM, V271, P7079, DOI 10.1074/jbc.271.12.7079; Gonfloni S, 2000, NAT STRUCT BIOL, V7, P281; Hao SL, 2006, FEBS LETT, V580, P2691, DOI 10.1016/j.febslet.2006.04.023; Hao SL, 2002, FEBS LETT, V525, P53, DOI 10.1016/S0014-5793(02)03066-1; Hu JF, 2008, J IMMUNOL, V180, P6544, DOI 10.4049/jimmunol.180.10.6544; Hu J, 2007, EUR J IMMUNOL, V37, P2892, DOI 10.1002/eji.200737311; Hyvonen M, 1997, EMBO J, V16, P3396, DOI 10.1093/emboj/16.12.3396; Jiang Y, 1998, NATURE, V395, P808, DOI 10.1038/27454; King PD, 1996, INT IMMUNOL, V8, P1707, DOI 10.1093/intimm/8.11.1707; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Ma YC, 1998, P NATL ACAD SCI USA, V95, P12197, DOI 10.1073/pnas.95.21.12197; Marquez JA, 2003, EMBO J, V22, P4616, DOI 10.1093/emboj/cdg448; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; O Atherly L, 2006, IMMUNITY, V25, P79, DOI 10.1016/j.immuni.2006.05.012; Oda A, 2000, BLOOD, V95, P1663; Okoh MP, 1999, BIOCHEM BIOPH RES CO, V265, P151, DOI 10.1006/bbrc.1999.1407; Parrini MC, 1999, CHEM BIOL, V6, P679, DOI 10.1016/S1074-5521(00)80015-0; Qi Q, 2006, J BIOL CHEM, V281, P38529, DOI 10.1074/jbc.M609180200; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Schaeffer EM, 2001, NAT IMMUNOL, V2, P1183, DOI 10.1038/ni734; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Smith CIE, 2001, BIOESSAYS, V23, P436, DOI 10.1002/bies.1062; Takemoto K, 2003, J CELL BIOL, V160, P235, DOI 10.1083/jcb.200207111; Tomlinson MG, 1999, J BIOL CHEM, V274, P13577, DOI 10.1074/jbc.274.19.13577; Woods ML, 2001, EMBO J, V20, P1232, DOI 10.1093/emboj/20.6.1232; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamashita Y, 1998, BLOOD, V91, P1496, DOI 10.1182/blood.V91.5.1496.1496_1496_1507	46	13	13	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29882	29892		10.1074/jbc.M109.003129	http://dx.doi.org/10.1074/jbc.M109.003129			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19717557	hybrid, Green Published			2022-12-27	WOS:000270896800068
J	Sin, WC; Tse, M; Planque, N; Perbal, B; Lampe, PD; Naus, CC				Sin, Wun-Chey; Tse, Mimi; Planque, Nathalie; Perbal, Bernard; Lampe, Paul D.; Naus, Christian C.			Matricellular Protein CCN3 (NOV) Regulates Actin Cytoskeleton Reorganization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION PROTEIN; C6 GLIOMA-CELLS; INTERCELLULAR COMMUNICATION; CONNEXIN43 INTERACTS; RETROVIRAL DELIVERY; POSSIBLE MECHANISM; DOWN-REGULATION; TUMOR-CELLS; N-CADHERIN; ADHESION	CCN3 (NOV), a putative ligand for integrin receptors, is tightly associated with the extracellular matrix and mediates diverse cellular functions, including cell adhesion and proliferation. CCN3 has been shown to negatively regulate growth although it promotes migration in a cell type-specific manner. In this study, overexpression of CCN3 reduces growth and increases intercellular adhesion of breast cancer cells. Interestingly, CCN3 overexpression also led to the formation of multiple pseudopodia that are enriched in actin, CCN3, and vinculin. Breast cancer cells preincubated with exogenous CCN3 protein also induced the same phenotype, indicating that secreted CCN3 is sufficient to induce changes in cell morphology. Surprisingly, extracellular CCN3 is internalized to the early endosomes but not to the membrane protrusions, suggesting pseudopodia- enriched CCN3 may derive from a different source. The presence of an intracellular variant of CCN3 will be consistent with our finding that the cytoplasmic tail of the gap junction protein connexin43 (Cx43) associates with CCN3. Cx43 is a channel protein permitting intercellular communication to occur. However, neither the channel properties nor the protein levels of Cx43 are affected by the CCN3 protein. In contrast, CCN3 proteins are down-regulated in the absence of Cx43. Finally, we showed that overexpression of CCN3 increases the activity of the small GTPase Rac1, thereby revealing a pathway that links Cx43 directly to actin reorganization.	[Sin, Wun-Chey] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Planque, Nathalie; Perbal, Bernard] Univ Paris 07, F-75005 Paris, France; [Lampe, Paul D.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	University of British Columbia; UDICE-French Research Universities; Universite Paris Cite; Fred Hutchinson Cancer Center	Sin, WC (corresponding author), Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	wcsin@interchange.ubc.ca; cnaus@interchange.ubc.ca			Canadian Institutes of Health Research [MOP 81202]; European PROTHETS (Prognosis and Therapeutic Targets of Ewing Family of Tumors) FP6 [503036]; French Ministry of Education; National Institutes of Health [GM55632]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055632] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); European PROTHETS (Prognosis and Therapeutic Targets of Ewing Family of Tumors) FP6(European Commission); French Ministry of Education; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Operating Grant MOP 81202 (to C. C. N. and W. C. S.) from the Canadian Institutes of Health Research and European PROTHETS (Prognosis and Therapeutic Targets of Ewing Family of Tumors) FP6 Contract 503036 and the French Ministry of Education (to B. P.). This work was also supported in part by National Institutes of Health Grant GM55632 (to P. D. L.).	Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Bates DC, 2007, GLIA, V55, P1554, DOI 10.1002/glia.20569; Benini S, 2005, ONCOGENE, V24, P4349, DOI 10.1038/sj.onc.1208620; Bleau AM, 2007, J CELL BIOCHEM, V101, P1475, DOI 10.1002/jcb.21262; Bleau AM, 2005, FRONT BIOSCI-LANDMRK, V10, P998, DOI 10.2741/1594; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Butkevich E, 2004, CURR BIOL, V14, P650, DOI 10.1016/j.cub.2004.03.063; Chen Y., 2005, MOL IMAGING FRET MIC, P126; Cotrina ML, 2008, GLIA, V56, P1791, DOI 10.1002/glia.20728; D'Souza-Schorey C, 1998, MOL CELL BIOL, V18, P3936, DOI 10.1128/MCB.18.7.3936; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Fu CT, 2004, J BIOL CHEM, V279, P36943, DOI 10.1074/jbc.M403952200; Fukunaga-Kalabis M, 2008, ONCOGENE, V27, P2552, DOI 10.1038/sj.onc.1210896; Fukunaga-Kalabis M, 2006, J CELL BIOL, V175, P563, DOI 10.1083/jcb.200602132; Gellhaus A, 2004, J BIOL CHEM, V279, P36931, DOI 10.1074/jbc.M404073200; Giepmans BNG, 2004, CARDIOVASC RES, V62, P233, DOI 10.1016/j.cardiores.2003.12.009; Giepmans BNG, 2001, CURR BIOL, V11, P1364, DOI 10.1016/S0960-9822(01)00424-9; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Girish V, 2004, Indian J Cancer, V41, P47; GOLDBERG GS, 1995, BIOTECHNIQUES, V18, P490; Gupta N, 2001, J CLIN PATHOL-MOL PA, V54, P293, DOI 10.1136/mp.54.5.293; Hedlund TE, 1999, PROSTATE, V41, P154; Herve JC, 2004, BBA-BIOMEMBRANES, V1662, P22, DOI 10.1016/j.bbamem.2003.10.022; Hirschi KK, 1996, CELL GROWTH DIFFER, V7, P861; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Iacobas DA, 2005, PHYSIOL GENOMICS, V20, P211, DOI 10.1152/physiolgenomics.00229.2003; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Lafont J, 2005, CELL COMMUN ADHES, V12, P41, DOI 10.1080/15419060500383069; Laurent M, 2003, FASEB J, V17, P1919, DOI 10.1096/fj.02-1023fje; Lazar N, 2007, J CELL COMMUN SIGNAL, V1, P91, DOI 10.1007/s12079-007-0009-8; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Li CL, 2002, J CLIN PATHOL-MOL PA, V55, P250, DOI 10.1136/mp.55.4.250; Lin CG, 2005, J BIOL CHEM, V280, P8229, DOI 10.1074/jbc.M404903200; Lin CG, 2003, J BIOL CHEM, V278, P24200, DOI 10.1074/jbc.M302028200; Matsuda T, 2006, J MOL CELL CARDIOL, V40, P495, DOI 10.1016/j.yjmcc.2005.12.010; McLachlan E, 2006, CANCER RES, V66, P9886, DOI 10.1158/0008-5472.CAN-05-4302; McLeod TL, 2001, CELL COMMUN ADHES, V8, P441, DOI 10.3109/15419060109080767; Mesnil M, 2005, BBA-BIOMEMBRANES, V1719, P125, DOI 10.1016/j.bbamem.2005.11.004; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; NAUS CCG, 1992, CELL MOL NEUROBIOL, V12, P163, DOI 10.1007/BF00713370; Naus CCG, 2002, CAN J PHYSIOL PHARM, V80, P136, DOI 10.1139/Y02-009; Perbal B, 1999, P NATL ACAD SCI USA, V96, P869, DOI 10.1073/pnas.96.3.869; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Perbal Bernard, 2006, Cell Commun Signal, V4, P6, DOI 10.1186/1478-811X-4-6; Planque N, 2006, J CELL BIOCHEM, V99, P105, DOI 10.1002/jcb.20887; Planque N, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-15; Powers MJ, 1998, MICROSC RES TECHNIQ, V43, P379, DOI 10.1002/(SICI)1097-0029(19981201)43:5<379::AID-JEMT4>3.0.CO;2-0; Qin H, 2002, J BIOL CHEM, V277, P29132, DOI 10.1074/jbc.M200797200; Sakamoto K, 2002, J BIOL CHEM, V277, P29399, DOI 10.1074/jbc.M203727200; Scemes E, 2007, NEURON GLIA BIOL, V3, P199, DOI 10.1017/S1740925X08000069; Shao Q, 2005, CANCER RES, V65, P2705, DOI 10.1158/0008-5472.CAN-04-2367; Simon AM, 1998, TRENDS CELL BIOL, V8, P477, DOI 10.1016/S0962-8924(98)01372-5; Sin WC, 2008, J CELL BIOCHEM, V103, P1772, DOI 10.1002/jcb.21571; Stout C, 2004, CURR OPIN CELL BIOL, V16, P507, DOI 10.1016/j.ceb.2004.07.014; Stuart HC, 2008, J BIOL CHEM, V283, P34785, DOI 10.1074/jbc.M804014200; Vallacchi V, 2008, CANCER RES, V68, P715, DOI 10.1158/0008-5472.CAN-07-2103; VAN AL, 1997, GENE DEV, V11, P2295; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Wahab NA, 2001, BIOCHEM J, V359, P89, DOI 10.1042/0264-6021:3590089; Wong NC, 1998, CLIN EXP METASTAS, V16, P50; Xu X, 2001, CELL COMMUN ADHES, V8, P321, DOI 10.3109/15419060109080746; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049	67	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29935	29944		10.1074/jbc.M109.042630	http://dx.doi.org/10.1074/jbc.M109.042630			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19706598	Green Published, hybrid			2022-12-27	WOS:000270896800072
J	Woloszynek, JC; Kovacs, A; Ohlemiller, KK; Roberts, M; Sands, MS				Woloszynek, Josh C.; Kovacs, Atilla; Ohlemiller, Kevin K.; Roberts, Marie; Sands, Mark S.			Metabolic Adaptations to Interrupted Glycosaminoglycan Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUCOLIPIDOSIS TYPE-IV; LYSOSOMAL STORAGE DISORDERS; MURINE MODEL; MARROW TRANSPLANTATION; AUTOPHAGY; DISEASE; MICE; DYSFUNCTION; THERAPY; FAT	Lysosomal storage diseases (LSD) are metabolic disorders characterized by accumulation of undegraded material. The mucopolysaccharidoses (MPS) are LSDs defined by the storage of glycosaminoglycans. Previously, we hypothesized that cells affected with LSD have increased energy expenditure for biosynthesis because of deficiencies of raw materials sequestered within the lysosome. Thus, LSDs can be characterized as diseases of deficiency as well as overabundance (lysosomal storage). In this study, metabolite analysis identified deficiencies in simple sugars, nucleotides, and lipids in the livers of MPSI mice. In contrast, most amino acids, amino acid derivatives, dipeptides, and urea were elevated. These data suggest that protein catabolism, perhaps because of increased autophagy, is at least partially fulfilling intermediary metabolism. Thus, maintaining glycosaminoglycan synthesis in the absence of recycled precursors results in major shifts in the energy utilization of the cells. A high fat diet increased simple sugars and some fats and lowered the apparent protein catabolism. Interestingly, autophagy, which is increased in several LSDs, is responsive to dietary intervention and is reduced in MPSVII and MPSI mice fed a high fat diet. Although long term dietary treatment improved body weight in MPSVII mice, it failed to improve life span or retinal function. In addition, the ventricular hypertrophy and proximal aorta dilation observed in MPSVII mice were unchanged by a high fat, simple sugar diet. As the mechanism of this energy imbalance is better understood, a more targeted nutrient approach may yet prove beneficial as an adjunct therapy to traditional approaches.	[Woloszynek, Josh C.; Kovacs, Atilla; Roberts, Marie; Sands, Mark S.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Woloszynek, Josh C.; Sands, Mark S.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Ohlemiller, Kevin K.] Washington Univ, Sch Med, Dept Otolaryngol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Sands, MS (corresponding author), Washington Univ, Sch Med, Dept Med, 660 S Euclid, St Louis, MO 63110 USA.	msands@dom.wustl.edu		Sands, Mark/0000-0002-5559-0832	National Institutes of Health [HD-0055461, NS-43205, DC-004665, NS-057105, DC-08321]; Mucopolysaccharidosis Society; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD055461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043205, R56NS043205, P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008321, R55DC008321, P30DC004665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mucopolysaccharidosis Society; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants HD-0055461 and NS-43205 (to M. S. S.) and DC-004665, NS-057105, and DC-08321 (to K. K. O.). This work was also supported by a grant from the Mucopolysaccharidosis Society (to J. C. W. and M. S. S.).	BEAMER WG, 1982, MOUSE NEWSLETT, V67, P21; Du H, 2001, J LIPID RES, V42, P489; FRATANTONI JC, 1968, SCIENCE, V162, P570, DOI 10.1126/science.162.3853.570; Fukuda T, 2006, ANN NEUROL, V59, P700, DOI 10.1002/ana.20807; Galvin N, 2008, PEDIATR DEVEL PATHOL, V11, P185, DOI 10.2350/07-03-0242.1; Heldermon CD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000772; HORIUCHI M, 1993, FEBS LETT, V326, P267, DOI 10.1016/0014-5793(93)81805-A; Ko DC, 2005, PLOS GENET, V1, P81, DOI 10.1371/journal.pgen.0010007; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Kumagai AK, 1999, DIABETES-METAB RES, V15, P261, DOI 10.1002/(SICI)1520-7560(199907/08)15:4<261::AID-DMRR43>3.0.CO;2-Z; Ohlemiller KK, 2000, EXP EYE RES, V71, P469, DOI 10.1006/exer.2000.0897; Pacheco CD, 2009, HUM MOL GENET, V18, P956, DOI 10.1093/hmg/ddn423; Roe CR, 2006, J INHERIT METAB DIS, V29, P332, DOI 10.1007/s10545-006-0290-3; Roe CR, 2002, J CLIN INVEST, V110, P259, DOI [10.1172/JCI200215311, 10.1172/JCI0215311]; ROME LH, 1986, BIOCHEM J, V235, P707, DOI 10.1042/bj2350707; Schaheen L, 2006, DEV BIOL, V293, P382, DOI 10.1016/j.ydbio.2006.02.008; Schuldt AJT, 2004, P NATL ACAD SCI USA, V101, P603, DOI 10.1073/pnas.0305284101; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Takamura A, 2008, BIOCHEM BIOPH RES CO, V367, P616, DOI 10.1016/j.bbrc.2007.12.187; VANDERVUSSE GJ, 1992, PHYSIOL REV, V72, P881, DOI 10.1152/physrev.1992.72.4.881; Vellodi A, 2005, BRIT J HAEMATOL, V128, P413, DOI 10.1111/j.1365-2141.2004.05293.x; Venkatachalam K, 2008, CELL, V135, P838, DOI 10.1016/j.cell.2008.09.041; Venugopal B, 2007, AM J HUM GENET, V81, P1070, DOI 10.1086/521954; Venugopal B, 2009, J CELL PHYSIOL, V219, P344, DOI 10.1002/jcp.21676; Vergarajauregui S, 2008, HUM MOL GENET, V17, P2723, DOI 10.1093/hmg/ddn174; Walkley SU, 2009, J INHERIT METAB DIS, V32, P181, DOI 10.1007/s10545-008-1040-5; Wang Wei, 2007, Expert Rev Cardiovasc Ther, V5, P1123, DOI 10.1586/14779072.5.6.1123; Woloszynek JC, 2004, BIOCHEM J, V379, P461, DOI 10.1042/BJ20031048; Woloszynek JC, 2007, J BIOL CHEM, V282, P35765, DOI 10.1074/jbc.M705124200	29	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29684	29691		10.1074/jbc.M109.020818	http://dx.doi.org/10.1074/jbc.M109.020818			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19700765	hybrid, Green Published			2022-12-27	WOS:000270896800050
J	Haerteis, S; Krueger, B; Korbmacher, C; Rauh, R				Haerteis, Silke; Krueger, Bettina; Korbmacher, Christoph; Rauh, Robert			The delta-Subunit of the Epithelial Sodium Channel (ENaC) Enhances Channel Activity and Alters Proteolytic ENaC Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE NA+ CHANNEL; GAMMA-SUBUNIT; FUNCTIONAL EXPRESSION; ELASTASE ACTIVATION; LIDDLE-SYNDROME; ALPHA-SUBUNIT; CLONING; CLEAVAGE; INHIBITION; PROTEINS	The epithelial sodium channel (ENaC) is probably a heterotrimer with three well characterized subunits (alpha beta gamma). In humans an additional delta-subunit (delta-hENaC) exists but little is known about its function. Using the Xenopus laevis oocyte expression system, we compared the functional properties of alpha beta gamma- and delta beta gamma-hENaC and investigated whether delta beta gamma-hENaC can be proteolytically activated. The amiloride-sensitive ENaC whole-cell current (Delta I-ami) was about 11-fold larger in oocytes expressing delta beta gamma-hENaC than in oocytes expressing alpha beta gamma-hENaC. The 2-fold larger single-channel Na+ conductance of delta beta gamma-hENaC cannot explain this difference. Using a chemiluminescence assay, we demonstrated that an increased channel surface expression is also not the cause. Thus, overall channel activity of delta beta gamma-hENaC must be higher than that of alpha beta gamma-hENaC. Experiments exploiting the properties of the known beta S520C mutant ENaC confirmed this conclusion. Moreover, chymotrypsin had a reduced stimulatory effect on delta beta gamma-hENaC whole-cell currents compared with its effect on alpha beta gamma-hENaC whole-cell currents (2-fold versus 5-fold). This suggests that the cell surface pool of so-called near-silent channels that can be proteolytically activated is smaller for delta beta gamma-hENaC than for alpha beta gamma-hENaC. Proteolytic activation of delta beta gamma-hENaC was associated with the appearance of a delta-hENaC cleavage product at the cell surface. Finally, we demonstrated that a short inhibitory 13-mer peptide corresponding to a region of the extracellular loop of human alpha-ENaC inhibited Delta I-ami in oocytes expressing alpha beta gamma-hENaC but not in those expressing delta beta gamma-hENaC. We conclude that the delta-subunit of ENaC alters proteolytic channel activation and enhances base-line channel activity.	[Haerteis, Silke; Krueger, Bettina; Korbmacher, Christoph; Rauh, Robert] Univ Erlangen Nurnberg, Inst Zellulare & Mol Physiol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Korbmacher, C (corresponding author), Univ Erlangen Nurnberg, Inst Zellulare & Mol Physiol, Waldstr 6, D-91054 Erlangen, Germany.	christoph.korbmacher@physiologie2.med.uni-erlangen.de	Haerteis, Silke/AGS-5314-2022; Rauh, Robert/F-4129-2014	Rauh, Robert/0000-0002-9406-3939; Haerteis, Silke/0000-0002-9440-3307	Deutsche Forschungsgemeinschaft [SFB423]; Johannes and Frieda Marohn Stiftung; BioMedTec International Graduate School "Lead Structures of Cell Function" of the Elitenetwork Bavaria	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Johannes and Frieda Marohn Stiftung; BioMedTec International Graduate School "Lead Structures of Cell Function" of the Elitenetwork Bavaria	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB423 (Kidney Injury, Pathogenesis and Regenerative Mechanisms, Project A12 (to C. K.)), by the Johannes and Frieda Marohn Stiftung (to C. K.), an Elitenetwork Bavaria fellowship (to S. H.), and the BioMedTec International Graduate School "Lead Structures of Cell Function" of the Elitenetwork Bavaria (to S. H.).	Abriel H, 1999, J PHYSIOL-LONDON, V516, P31, DOI 10.1111/j.1469-7793.1999.031aa.x; Adebamiro A, 2007, J GEN PHYSIOL, V130, P611, DOI 10.1085/jgp.200709781; Anantharam A, 2006, J PHYSIOL-LONDON, V574, P333, DOI 10.1113/jphysiol.2006.109173; Babini E, 2003, J BIOL CHEM, V278, P28418, DOI 10.1074/jbc.M301315200; Biasio W, 2004, J BIOL CHEM, V279, P5429, DOI 10.1074/jbc.M311155200; Brockway LM, 2002, AM J PHYSIOL-CELL PH, V283, pC126, DOI 10.1152/ajpcell.00457.2001; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; Canessa CM, 2007, NATURE, V449, P293, DOI 10.1038/449293a; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Carattino MD, 2008, AM J PHYSIOL-RENAL, V294, pF47, DOI 10.1152/ajprenal.00399.2007; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Charles RP, 2008, J BIOL CHEM, V283, P2622, DOI 10.1074/jbc.M708829200; Chraibi A, 1998, J GEN PHYSIOL, V111, P127, DOI 10.1085/jgp.111.1.127; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; Diakov A, 2004, J BIOL CHEM, V279, P38134, DOI 10.1074/jbc.M403260200; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Drummond HA, 2006, AM J PHYSIOL-CELL PH, V290, pC404, DOI 10.1152/ajpcell.00210.2005; Drummond HA, 2008, HYPERTENSION, V51, P1265, DOI 10.1161/HYPERTENSIONAHA.107.093401; DURIEUX ME, 1994, FEBS LETT, V337, P235, DOI 10.1016/0014-5793(94)80198-3; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Giraldez T, 2007, J NEUROCHEM, V102, P1304, DOI 10.1111/j.1471-4159.2007.04622.x; Golestaneh N, 2001, BIOCHEM BIOPH RES CO, V280, P1300, DOI 10.1006/bbrc.2001.4275; Harris M, 2008, J BIOL CHEM, V283, P7455, DOI 10.1074/jbc.M707399200; Harris M, 2007, J BIOL CHEM, V282, P58, DOI 10.1074/jbc.M605125200; Hernandez-Gonzalez EO, 2006, J BIOL CHEM, V281, P5623, DOI 10.1074/jbc.M508172200; Hughey RP, 2007, CURR OPIN NEPHROL HY, V16, P444, DOI 10.1097/MNH.0b013e32821f6072; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Ji HL, 2006, J BIOL CHEM, V281, P8233, DOI 10.1074/jbc.M512293200; Ji HL, 2004, J BIOL CHEM, V279, P26939, DOI 10.1074/jbc.M401143200; Ji HL, 2004, J BIOL CHEM, V279, P8428, DOI 10.1074/jbc.M312012200; Kellenberger S, 2002, J PHYSIOL-LONDON, V543, P413, DOI 10.1113/jphysiol.2002.022020; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 1998, J CLIN INVEST, V101, P2741, DOI 10.1172/JCI2837; Knight KK, 2008, J BIOL CHEM, V283, P27477, DOI 10.1074/jbc.M804176200; Konstas AA, 2002, J BIOL CHEM, V277, P29406, DOI 10.1074/jbc.M203018200; Konstas AA, 2001, PFLUG ARCH EUR J PHY, V442, P752, DOI 10.1007/s004240100597; Konstas AA, 2000, PFLUG ARCH EUR J PHY, V441, P341, DOI 10.1007/s004240000430; Kusche-Vihrog K, 2008, PFLUG ARCH EUR J PHY, V455, P849, DOI 10.1007/s00424-007-0341-0; Lu M, 2008, J BIOL CHEM, V283, P11981, DOI 10.1074/jbc.M708001200; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; Nesterov V, 2008, AM J PHYSIOL-RENAL, V295, pF1052, DOI 10.1152/ajprenal.00031.2008; Nie HG, 2009, AM J RESP CELL MOL, V40, P543, DOI 10.1165/rcmb.2008-0166OC; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Planes C, 2007, CURR TOP DEV BIOL, V78, P23, DOI 10.1016/S0070-2153(06)78002-4; Rauh R, 2006, PFLUG ARCH EUR J PHY, V452, P290, DOI 10.1007/s00424-005-0026-5; Rossier BC, 2002, J GEN PHYSIOL, V120, P67, DOI 10.1085/jgp.20028638; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Ruffieux-Daidie D, 2008, J AM SOC NEPHROL, V19, P2170, DOI 10.1681/ASN.2007101130; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Staub O, 2000, KIDNEY INT, V57, P809, DOI 10.1046/j.1523-1755.2000.00919.x; Stockand JD, 2008, IUBMB LIFE, V60, P620, DOI 10.1002/iub.89; Svenningsen P, 2009, J AM SOC NEPHROL, V20, P299, DOI 10.1681/ASN.2008040364; VOILLEY N, 1995, GENOMICS, V28, P560, DOI 10.1006/geno.1995.1188; VOILLEY N, 1994, P NATL ACAD SCI USA, V91, P247, DOI 10.1073/pnas.91.1.247; Volk T, 2004, PFLUG ARCH EUR J PHY, V447, P884, DOI 10.1007/s00424-003-1193-x; Waldmann R, 1996, GENOMICS, V34, P262, DOI 10.1006/geno.1996.0282; WALDMANN R, 1995, J BIOL CHEM, V270, P27411, DOI 10.1074/jbc.270.46.27411; Wielputz MO, 2007, J BIOL CHEM, V282, P28264, DOI 10.1074/jbc.M702168200; Yamamura H, 2005, J PHARMACOL EXP THER, V315, P965, DOI 10.1124/jpet.105.092775; Yamamura H, 2005, MOL PHARMACOL, V68, P1142, DOI 10.1124/mol.104.010850; Yamamura H, 2004, J BIOL CHEM, V279, P44483, DOI 10.1074/jbc.M408929200; Yamamura H, 2004, J BIOL CHEM, V279, P12529, DOI 10.1074/jbc.M400274200; Yamamura H, 2008, BIOCHEM BIOPH RES CO, V373, P155, DOI 10.1016/j.bbrc.2008.06.008; Yamamura H, 2006, BIOCHEM BIOPH RES CO, V349, P317, DOI 10.1016/j.bbrc.2006.08.043; Yamamura H, 2008, EUR J PHARMACOL, V600, P32, DOI 10.1016/j.ejphar.2008.10.022; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	75	50	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29024	29040		10.1074/jbc.M109.018945	http://dx.doi.org/10.1074/jbc.M109.018945			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19717556	Green Published, hybrid			2022-12-27	WOS:000270678900060
J	Kress, D; Brugel, D; Schall, I; Linder, D; Buckel, W; Essen, LO				Kress, Daniel; Bruegel, Daniela; Schall, Iris; Linder, Dietmar; Buckel, Wolfgang; Essen, Lars-Oliver			An Asymmetric Model for Na+-translocating Glutaconyl-CoA Decarboxylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ACIDAMINOCOCCUS-FERMENTANS; CARBOXYLTRANSFERASE DOMAIN; ESCHERICHIA-COLI; SODIUM-PUMP; PURIFICATION; COENZYME; TRANSFERASE; NUCLEATUM; SUBUNIT	Glutaconyl-CoA decarboxylase (Gcd) couples the biotin-dependent decarboxylation of glutaconyl-CoA with the generation of an electrochemical Na+ gradient. Sequencing of the genes encoding all subunits of the Clostridium symbiosum decarboxylase membrane complex revealed that it comprises two distinct biotin carrier subunits, GcdC(1) and GcdC(2), which differ in the length of a central alanine- and proline-rich linker domain. Co-crystallization of the decarboxylase subunit GcdA with the substrate glutaconyl-CoA, the product crotonyl-CoA, and the substrate analogue glutaryl-CoA, respectively, resulted in a high resolution model for substrate binding and catalysis revealing remarkable structural changes upon substrate binding. Unlike the GcdA structure from Acidaminococcus fermentans, these data suggest that in intact Gcd complexes, GcdA is associated as a tetramer crisscrossed by a network of solvent-filled tunnels.	[Buckel, Wolfgang] Univ Marburg, Mikrobiol Lab, Fachbereich Biol, D-35032 Marburg, Germany; [Kress, Daniel; Essen, Lars-Oliver] Univ Marburg, Fachbereich Chem, D-35032 Marburg, Germany; [Linder, Dietmar] Univ Giessen, Fachbereich Med, D-35392 Giessen, Germany; [Buckel, Wolfgang] Max Planck Inst Terr Mikrobiol, D-35043 Marburg, Germany	Philipps University Marburg; Philipps University Marburg; Justus Liebig University Giessen; Max Planck Society	Buckel, W (corresponding author), Univ Marburg, Mikrobiol Lab, Fachbereich Biol, D-35032 Marburg, Germany.	buckel@staff.uni-marburg.de; essen@chemie.uni-marburg.de	Essen, Lars-Oliver/L-3862-2016	Essen, Lars-Oliver/0000-0003-4272-4026	Deutsche Forschungsgemeinschaft [1070]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Priority Program 1070) (to L.-O.E. and W.B.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEATRIX B, 1990, ARCH MICROBIOL, V154, P362, DOI 10.1007/BF00276532; BENDRAT K, 1993, EUR J BIOCHEM, V211, P697, DOI 10.1111/j.1432-1033.1993.tb17598.x; Berger S, 1996, ANGEW CHEM INT EDIT, V35, P2132, DOI 10.1002/anie.199621321; Bilder P, 2006, BIOCHEMISTRY-US, V45, P1712, DOI 10.1021/bi0520479; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Braune A, 1999, MOL MICROBIOL, V31, P473, DOI 10.1046/j.1365-2958.1999.01189.x; BUCKEL W, 1986, METHOD ENZYMOL, V125, P547; BUCKEL W, 1981, EUR J BIOCHEM, V118, P315, DOI 10.1111/j.1432-1033.1981.tb06404.x; Buckel W, 2001, APPL MICROBIOL BIOT, V57, P263, DOI 10.1007/s002530100773; BUCKEL W, 1983, EUR J BIOCHEM, V136, P427, DOI 10.1111/j.1432-1033.1983.tb07760.x; BUCKEL W, 1986, EUR J BIOCHEM, V156, P251, DOI 10.1111/j.1432-1033.1986.tb09575.x; Buckel W, 2001, BBA-BIOENERGETICS, V1505, P15, DOI 10.1016/S0005-2728(00)00273-5; DeLano W.L, PYMOL MOL GRAPHICS S; Diacovich L, 2004, BIOCHEMISTRY-US, V43, P14027, DOI 10.1021/bi049065v; Dimroth P, 1998, ARCH MICROBIOL, V170, P69, DOI 10.1007/s002030050616; DIMROTH P, 1984, BIOCHEMISTRY-US, V23, P5360, DOI 10.1021/bi00317a039; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Hall PR, 2003, EMBO J, V22, P2334, DOI 10.1093/emboj/cdg244; Hamed RB, 2008, CELL MOL LIFE SCI, V65, P2507, DOI 10.1007/s00018-008-8082-6; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hans M, 1999, EUR J BIOCHEM, V265, P404, DOI 10.1046/j.1432-1327.1999.00748.x; HARTEL U, 1993, ARCH MICROBIOL, V159, P174, DOI 10.1007/BF00250279; Heiner CR, 1998, GENOME RES, V8, P557, DOI 10.1101/gr.8.5.557; Hwang IT, 2003, BIOTECHNIQUES, V35, P1180, DOI 10.2144/03356st03; KANEUCHI C, 1976, INT J SYST BACTERIOL, V26, P195, DOI 10.1099/00207713-26-2-195; Kapatral V, 2003, GENOME RES, V13, P1180, DOI 10.1101/gr.566003; Kapatral V, 2002, J BACTERIOL, V184, P2005, DOI 10.1128/JB.184.7.2005-2018.2002; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liao DI, 2000, NAT STRUCT BIOL, V7, P749, DOI 10.1038/78973; MACK M, 1994, EUR J BIOCHEM, V226, P41, DOI 10.1111/j.1432-1033.1994.tb20024.x; MEAD GC, 1971, J GEN MICROBIOL, V67, P47, DOI 10.1099/00221287-67-1-47; MICHEL C, 1991, J CHROMATOGR, V587, P93, DOI 10.1016/0021-9673(91)85202-Q; Mouttaki H, 2007, APPL ENVIRON MICROB, V73, P930, DOI 10.1128/AEM.02227-06; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Novy R., 2001, INNOVATIONS, V12, P1; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P1, DOI 10.1007/s10863-007-9070-5; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Ponstingl H, 2003, J APPL CRYSTALLOGR, V36, P1116, DOI 10.1107/S0021889803012421; Pos KM, 2009, BBA-PROTEINS PROTEOM, V1794, P782, DOI 10.1016/j.bbapap.2008.12.015; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Sambrook J., 2001, MOL CLONING LAB MANU; Selmer T, 1999, J BIOL CHEM, V274, P20772, DOI 10.1074/jbc.274.30.20772; SIMON EJ, 1953, J AM CHEM SOC, V75, P2520, DOI 10.1021/ja01106a522; Studer R, 2007, J MOL BIOL, V367, P547, DOI 10.1016/j.jmb.2006.12.035; Textor S, 1997, ARCH MICROBIOL, V168, P428, DOI 10.1007/s002030050518; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Wendt KS, 2003, EMBO J, V22, P3493, DOI 10.1093/emboj/cdg358; Yaffe E, 2008, NUCLEIC ACIDS RES, V36, pW210, DOI 10.1093/nar/gkn223; Zhang HL, 2003, SCIENCE, V299, P2064, DOI 10.1126/science.1081366; ZIEGENHORN J, 1976, CLIN CHEM, V22, P151	58	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28401	28409		10.1074/jbc.M109.037762	http://dx.doi.org/10.1074/jbc.M109.037762			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19654317	Green Published, hybrid			2022-12-27	WOS:000270676300065
J	Carlson, GM; Holyoak, T				Carlson, Gerald M.; Holyoak, Todd			Structural Insights into the Mechanism of Phosphoenolpyruvate Carboxykinase Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CRYSTAL-STRUCTURE; PHOSPHORYL-TRANSFER; PEP-CARBOXYKINASE; STEREOCHEMICAL COURSE; CYTOSOLIC PEPCK; GTP; ANALOGS; INHIBITION; REVEALS; LOOP		[Carlson, Gerald M.; Holyoak, Todd] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Holyoak, T (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	tholyoak@kumc.edu						Aich S, 2008, INT J BIOCHEM CELL B, V40, P1597, DOI 10.1016/j.biocel.2007.12.002; ASH DE, 1990, J BIOL CHEM, V265, P7377; Castillo D, 2009, BIOCHIMIE, V91, P295, DOI 10.1016/j.biochi.2008.10.005; Cotelesage JJH, 2005, INT J BIOCHEM CELL B, V37, P1829, DOI 10.1016/j.biocel.2005.03.008; Cotelesage JJH, 2007, INT J BIOCHEM CELL B, V39, P1204, DOI 10.1016/j.biocel.2007.03.015; Dunten P, 2002, J MOL BIOL, V316, P257, DOI 10.1006/jmbi.2001.5364; GUIDINGER PF, 1990, ARCH BIOCHEM BIOPHYS, V278, P131, DOI 10.1016/0003-9861(90)90241-P; Hanson R W, 1994, Adv Enzymol Relat Areas Mol Biol, V69, P203; HEBDA CA, 1982, J BIOL CHEM, V257, P5515; Holyoak T, 2006, BIOCHEMISTRY-US, V45, P8254, DOI 10.1021/bi060269g; KONOPKA JM, 1986, BIOCHEMISTRY-US, V25, P5571, DOI 10.1021/bi00367a034; Krautwurst H, 1998, BIOCHEMISTRY-US, V37, P6295, DOI 10.1021/bi971515e; LEWIS CT, 1989, J BIOL CHEM, V264, P27; MAKINEN AL, 1989, J BIOL CHEM, V264, P12148; Matte A, 1996, J MOL BIOL, V256, P126, DOI 10.1006/jmbi.1996.0072; Matte A, 1998, STRUCT FOLD DES, V6, P413, DOI 10.1016/S0969-2126(98)00043-4; Mukhopadhyay B, 2001, J BIOL CHEM, V276, P16137, DOI 10.1074/jbc.M008960200; SHEU KF, 1984, BIOCHEMISTRY-US, V23, P1779, DOI 10.1021/bi00303a030; Stiffin RM, 2008, BIOCHEMISTRY-US, V47, P2099, DOI 10.1021/bi7020662; Sudom AM, 2001, J MOL BIOL, V314, P83, DOI 10.1006/jmbi.2001.5120; Sullivan SM, 2008, P NATL ACAD SCI USA, V105, P13829, DOI 10.1073/pnas.0805364105; Sullivan SM, 2007, BIOCHEMISTRY-US, V46, P10078, DOI 10.1021/bi701038x; Tari LW, 1997, NAT STRUCT BIOL, V4, P990, DOI 10.1038/nsb1297-990; Tari LW, 1996, NAT STRUCT BIOL, V3, P355, DOI 10.1038/nsb0496-355; Trapani S, 2001, J MOL BIOL, V313, P1059, DOI 10.1006/jmbi.2001.5093; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543	26	27	28	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27037	27041		10.1074/jbc.R109.040568	http://dx.doi.org/10.1074/jbc.R109.040568			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19638345	hybrid, Green Published			2022-12-27	WOS:000270232300005
J	Nedumaran, B; Hong, S; Xie, YB; Kim, YH; Seo, WY; Lee, MW; Lee, CH; Koo, SH; Choi, HS				Nedumaran, Balachandar; Hong, Sungpyo; Xie, Yuan-Bin; Kim, Yong-Hoon; Seo, Woo-Young; Lee, Min-Woo; Lee, Chul Ho; Koo, Seung-Hoi; Choi, Hueng-Sik			DAX-1 Acts as a Novel Corepressor of Orphan Nuclear Receptor HNF4 alpha and Negatively Regulates Gluconeogenic Enzyme Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL HYPOPLASIA CONGENITA; HORMONE-RECEPTOR; DNA-BINDING; HEPATIC GLUCONEOGENESIS; TRANSCRIPTION FACTOR; COACTIVATOR TORC2; PROTEIN-KINASE; INSULIN; TRANSACTIVATION; SHP	DAX-1 (dosage-sensitive sex reversal adrenal hypoplasia congenital critical region on X chromosome, gene 1) is an atypical member of the nuclear receptor family and acts as a corepressor of a number of nuclear receptors. HNF4 alpha (hepatocyte nuclear factor 4 alpha) is a liver-enriched transcription factor that controls the expression of a variety of genes involved in cholesterol, fatty acid, and glucose metabolism. Here we show that DAX-1 inhibits transcriptional activity of HNF4 alpha and modulates hepatic gluconeogenic gene expression. Hepatic DAX-1 expression is increased by insulin and SIK1 (salt-inducible kinase 1), whereas it is decreased in high fat diet-fed and diabetic mice. Coimmunoprecipitation assay from mouse liver samples depicts that endogenous DAX-1 interacts with HNF4 alpha in vivo. In vivo chromatin immunoprecipitation assay affirms that the recruitment of DAX-1 on the phosphoenolpyruvate carboxykinase (PEPCK) gene promoter is inversely correlated with the recruitment of PGC-1 alpha and HNF4 alpha under fasting and refeeding, showing that DAX-1 could compete with the coactivator PGC-1 alpha for binding to HNF4 alpha. Adenovirus-mediated expression of DAX-1 decreased both HNF4 alpha- and forskolin-mediated gluconeogenic gene expressions. In addition, knockdown of DAX-1 partially reverses the insulin-mediated inhibition of gluconeogenic gene expression in primary hepatocytes. Finally, DAX-1 inhibits PEPCK and glucose-6-phosphatase gene expression and significantly lowers fasting blood glucose level in high fat diet-fed mice, suggesting that DAX-1 can modulate hepatic gluconeogenesis in vivo. Overall, this study demonstrates that DAX-1 acts as a corepressor of HNF4 alpha to negatively regulate hepatic gluconeogenic gene expression in liver.	[Nedumaran, Balachandar; Xie, Yuan-Bin; Choi, Hueng-Sik] Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea; [Hong, Sungpyo; Seo, Woo-Young; Lee, Min-Woo; Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea; [Kim, Yong-Hoon; Lee, Chul Ho] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea	Chonnam National University; Sungkyunkwan University (SKKU); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Choi, HS (corresponding author), Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea.	hsc@chonnam.ac.kr	Nedumaran, Balachandar/V-9958-2019; Koo, Seung-Hoi/E-2763-2015	Koo, Seung-Hoi/0000-0001-8769-2879	Ministry of Science and Technology [M10500000047-06J0000-04710]; Korea Research Foundation [2006-005-J03003]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Korea Research Foundation(National Research Foundation of Korea)	This study was supported by the Korea Science and Engineering Foundation through the National Research Laboratory Program funded by Ministry of Science and Technology Grant M10500000047-06J0000-04710 and Korea Research Foundation Grant 2006-005-J03003.	Agoulnik IU, 2003, J BIOL CHEM, V278, P31136, DOI 10.1074/jbc.M305153200; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Bansal P, 2008, AM J PHYSIOL-ENDOC M, V295, pE751, DOI 10.1152/ajpendo.90295.2008; Crawford PA, 1998, MOL CELL BIOL, V18, P2949, DOI 10.1128/MCB.18.5.2949; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Drewes T, 1996, MOL CELL BIOL, V16, P925; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; HadzopoulouCladaras M, 1997, J BIOL CHEM, V272, P539; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Hattersley AT, 1998, DIABETIC MED, V15, P15, DOI 10.1002/(SICI)1096-9136(199801)15:1<15::AID-DIA562>3.0.CO;2-M; Holter E, 2002, MOL ENDOCRINOL, V16, P515, DOI 10.1210/me.16.3.515; Inoue Y, 2006, J LIPID RES, V47, P215, DOI 10.1194/jlr.M500430-JLR200; Iyer AK, 2004, MOL GENET METAB, V83, P60, DOI 10.1016/j.ymgme.2004.07.018; Iyer AK, 2006, MOL ENDOCRINOL, V20, P2326, DOI 10.1210/me.2005-0383; JIANG GQ, 1995, MOL CELL BIOL, V15, P5131; Jiang YW, 2001, P NATL ACAD SCI USA, V98, P10102, DOI 10.1073/pnas.131200398; Kim GS, 2008, BIOCHEM BIOPH RES CO, V370, P264, DOI 10.1016/j.bbrc.2008.03.098; Kim JY, 2004, MOL ENDOCRINOL, V18, P2880, DOI 10.1210/me.2004-0211; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lalli E, 2000, MOL CELL BIOL, V20, P4910, DOI 10.1128/MCB.20.13.4910-4921.2000; Lausen J, 2000, NUCLEIC ACIDS RES, V28, P430, DOI 10.1093/nar/28.2.430; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Li TG, 2008, J LIPID RES, V49, P1981, DOI 10.1194/jlr.M800140-JLR200; Ma K, 2005, J BIOL CHEM, V280, P29525, DOI 10.1074/jbc.M502236200; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Matsumoto M, 2006, NAT MED, V12, P33, DOI 10.1038/nm0106-33; Miao J, 2006, J BIOL CHEM, V281, P14537, DOI 10.1074/jbc.M510713200; Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843; Park YY, 2005, NUCLEIC ACIDS RES, V33, P6756, DOI 10.1093/nar/gki976; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rada-Iglesias A, 2005, HUM MOL GENET, V14, P3435, DOI 10.1093/hmg/ddi378; Ragazzon B, 2006, ENDOCRINOLOGY, V147, P1805, DOI 10.1210/en.2005-1279; Ruse MD, 2002, MOL CELL BIOL, V22, P1626, DOI 10.1128/MCB.22.6.1626-1638.2002; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Smith CA, 2000, J MOL ENDOCRINOL, V24, P23, DOI 10.1677/jme.0.0240023; Song KH, 2004, MOL ENDOCRINOL, V18, P1929, DOI 10.1210/me.2004-0043; Sugita J, 2001, GENE, V280, P67, DOI 10.1016/S0378-1119(01)00739-9; Suzuki T, 2003, MOL CELL BIOL, V23, P238, DOI 10.1128/MCB.23.1.238-249.2003; Tamai KT, 1996, MOL ENDOCRINOL, V10, P1561, DOI 10.1210/me.10.12.1561; Torres-Padilla ME, 2002, J BIOL CHEM, V277, P44677, DOI 10.1074/jbc.M207545200; Wang DS, 2002, BIOCHEM BIOPH RES CO, V297, P632, DOI 10.1016/S0006-291X(02)02252-0; Wang JC, 1998, J BIOL CHEM, V273, P30847, DOI 10.1074/jbc.273.47.30847; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Xie XF, 2009, MOL ENDOCRINOL, V23, P434, DOI 10.1210/me.2007-0531; Xie YB, 2008, BIOCHEM J, V416, P463, DOI 10.1042/BJ20080782; Yamagata K, 2004, J BIOL CHEM, V279, P23158, DOI 10.1074/jbc.M314322200; Yoshida E, 1997, BIOCHEM BIOPH RES CO, V241, P664, DOI 10.1006/bbrc.1997.7871; ZANARIA E, 1994, NATURE, V372, P635, DOI 10.1038/372635a0; Zazopoulos E, 1997, NATURE, V390, P311, DOI 10.1038/36899; Zhang H, 2000, J BIOL CHEM, V275, P39855, DOI 10.1074/jbc.C000567200	53	37	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27511	27523		10.1074/jbc.M109.034660	http://dx.doi.org/10.1074/jbc.M109.034660			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651776	Green Published, hybrid			2022-12-27	WOS:000270232300053
J	Perkins, DI; Trudell, JR; Crawford, DK; Asatryan, L; Alkana, RL; Davies, DL				Perkins, Daya I.; Trudell, James R.; Crawford, Daniel K.; Asatryan, Liana; Alkana, Ronald L.; Davies, Daryl L.			Loop 2 Structure in Glycine and GABA(A) Receptors Plays a Key Role in Determining Ethanol Sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; EXTRACELLULAR DOMAIN; GENERAL-ANESTHETICS; ALCOHOL DEPENDENCE; ACTIVATED CURRENT; CRYSTAL-STRUCTURE; TONIC INHIBITION; AGONIST BINDING; 5-HT3 RECEPTORS; P2X RECEPTORS	The present study tests the hypothesis that the structure of extracellular domain Loop 2 can markedly affect ethanol sensitivity in glycine receptors (GlyRs) and gamma-aminobutyric acid type A receptors (GABA(A)Rs). To test this, we mutated Loop 2 in the alpha 1 subunit of GlyRs and in the gamma subunit of alpha 1 beta 2 gamma 2GABA(A)Rs and measured the sensitivity of wild type and mutant receptors expressed in Xenopus oocytes to agonist, ethanol, and other agents using two-electrode voltage clamp. Replacing Loop 2 of alpha 1GlyR subunits with Loop 2 from the delta GABA(A)R (delta L2), but not the gamma GABA(A)R subunit, reduced ethanol threshold and increased the degree of ethanol potentiation without altering general receptor function. Similarly, replacing Loop 2 of the gamma subunit of GABAARs with delta L2 shifted the ethanol threshold from 50 mM in WT to 1 mM in the GABA(A) gamma-delta L2 mutant. These findings indicate that the structure of Loop 2 can profoundly affect ethanol sensitivity in GlyRs and GABAARs. The delta L2 mutations did not affect GlyR or GABA(A)R sensitivity, respectively, to Zn2+ or diazepam, which suggests that these delta L2-induced changes in ethanol sensitivity do not extend to all allosteric modulators and may be specific for ethanol or ethanol-like agents. To explore molecular mechanisms underlying these results, we threaded the WT and delta L2 GlyR sequences onto the x-ray structure of the bacterial Gloeobacter violaceus pentameric ligand-gated ion channel homologue (GLIC). In addition to being the first GlyR model threaded on GLIC, the juxtaposition of the two structures led to a possible mechanistic explanation for the effects of ethanol on GlyR-based on changes in Loop 2 structure.	[Perkins, Daya I.; Alkana, Ronald L.] Univ So Calif, Sch Pharm, Alcohol & Brain Res Labs, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Asatryan, Liana; Davies, Daryl L.] Univ So Calif, Sch Pharm, Alcohol & Brain Res Labs, Titus Family Dept Clin Pharm & Pharmaceut Econ &, Los Angeles, CA 90089 USA; [Trudell, James R.] Stanford Sch Med, Dept Anesthesia, Palo Alto, CA 94305 USA; [Trudell, James R.] Stanford Sch Med, Beckman Program Mol & Genet Med, Palo Alto, CA 94305 USA; [Crawford, Daniel K.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA	University of Southern California; University of Southern California; Stanford University; Stanford University; University of California System; University of California Los Angeles	Alkana, RL (corresponding author), Univ So Calif, Sch Pharm, Alcohol & Brain Res Labs, Dept Pharmacol & Pharmaceut Sci, 1985 Zonal Ave,PSC 506, Los Angeles, CA 90089 USA.	alkana@usc.edu	Davies, Daryl L/P-1137-2016	Davies, Daryl L/0000-0003-2940-7739; Crawford, Daniel/0000-0002-0169-8645	National Institutes of Health (NIH), NIAAA [AA017569, AA03972, AA013890, AA013922, AA017293, AA013378]; NIH, NIGMS [G64371]; USC School of Pharmacy; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013922, F31AA017569, R01AA013378, R01AA003972, R21AA013890] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIH, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); USC School of Pharmacy; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NIAAA, Grants AA017569 (to D. I. P), AA03972 (to R. L. A.), AA013890 and AA013922 (to D. L. D.), AA017293 (to L. A.), and AA013378 (to J. R. T.) and NIH, NIGMS, Grant G64371 (to J. R. T.). This work was also supported by the USC School of Pharmacy. This work was conducted as partial fulfillment of the requirements for the Ph. D. degree in Molecular Pharmacology and Toxicology, University of Southern California (D. I. P.).	Asatryan L, 2008, NEUROPHARMACOLOGY, V55, P835, DOI 10.1016/j.neuropharm.2008.06.044; BETZ H, 1991, TRENDS NEUROSCI, V14, P458, DOI 10.1016/0166-2236(91)90045-V; BLOOMENTHAL AB, 1994, MOL PHARMACOL, V46, P1156; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Borghese CM, 2007, ALCOHOL, V41, P155, DOI 10.1016/j.alcohol.2007.03.006; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cardoso RA, 1999, J PHARMACOL EXP THER, V289, P774; Castaldo P, 2004, J BIOL CHEM, V279, P25598, DOI 10.1074/jbc.M311021200; Chen ZW, 2005, MOL PHARMACOL, V68, P152, DOI 10.1124/mol.104.009878; Cheng MH, 2008, PROTEINS, V71, P972, DOI 10.1002/prot.21784; Crawford DK, 2008, J BIOL CHEM, V283, P27698, DOI 10.1074/jbc.M802384200; Crawford DK, 2007, J NEUROCHEM, V102, P2097, DOI 10.1111/j.1471-4159.2007.04680.x; Davies DL, 2005, NEUROPHARMACOLOGY, V49, P243, DOI 10.1016/j.neuropharm.2005.03.015; Davies DL, 2004, J NEUROCHEM, V89, P1175, DOI 10.1111/j.1471-4159.2004.02390.x; Davies DL, 2003, ALCOHOL CLIN EXP RES, V27, P743, DOI 10.1097/01.ALC.0000065722.31109.A1; Davies DL, 2002, ALCOHOL CLIN EXP RES, V26, P773, DOI 10.1111/j.1530-0277.2002.tb02604.x; Davies DL, 2001, ALCOHOL CLIN EXP RES, V25, P1098; DEITRICH RA, 1989, PHARMACOL REV, V41, P489; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Fleming RL, 2007, J NEUROPHYSIOL, V97, P3806, DOI 10.1152/jn.00101.2007; Glykys J, 2007, NAT NEUROSCI, V10, P40, DOI 10.1038/nn1813; GRANT KA, 1995, DRUG ALCOHOL DEPEN, V38, P155, DOI 10.1016/0376-8716(95)01120-N; Hanchar HJ, 2006, P NATL ACAD SCI USA, V103, P8546, DOI 10.1073/pnas.0509903103; Hanchar HJ, 2005, NAT NEUROSCI, V8, P339, DOI 10.1038/nn1398; Harris RA, 1999, ALCOHOL CLIN EXP RES, V23, P1563, DOI 10.1097/00000374-199910000-00001; Heilig M, 2006, PHARMACOL THERAPEUT, V111, P855, DOI 10.1016/j.pharmthera.2006.02.001; HONIG BH, 1984, P NATL ACAD SCI-BIOL, V81, P5412, DOI 10.1073/pnas.81.17.5412; Jenkins A, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0002.2001; Johnson BA, 2007, JAMA-J AM MED ASSOC, V298, P1641, DOI 10.1001/jama.298.14.1641; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Kash TL, 2004, NEUROSCI LETT, V371, P230, DOI 10.1016/j.neulet.2004.09.002; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Koski A, 2002, ALCOHOL CLIN EXP RES, V26, P956, DOI 10.1097/01.ALC.0000021337.78063.67; Krasowski MD, 1999, CELL MOL LIFE SCI, V55, P1278, DOI 10.1007/s000180050371; Krasowski MD, 2000, BRIT J PHARMACOL, V129, P731, DOI 10.1038/sj.bjp.0703087; LAUBE B, 1995, J PHYSIOL-LONDON, V483, P613, DOI 10.1113/jphysiol.1995.sp020610; Liang J, 2006, J NEUROSCI, V26, P1749, DOI 10.1523/JNEUROSCI.4702-05.2006; Lobo IA, 2008, J NEUROCHEM, V104, P1649, DOI 10.1111/j.1471-4159.2007.05090.x; LYNCH JW, 1995, J BIOL CHEM, V270, P13799, DOI 10.1074/jbc.270.23.13799; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Mascia MP, 2000, P NATL ACAD SCI USA, V97, P9305, DOI 10.1073/pnas.160128797; Mascia MP, 1996, BRIT J PHARMACOL, V119, P1331, DOI 10.1111/j.1476-5381.1996.tb16042.x; Mascia MP, 1996, MOL PHARMACOL, V50, P402; McGinnis JM, 1999, P ASSOC AM PHYSICIAN, V111, P109, DOI 10.1046/j.1525-1381.1999.09256.x; Mihic SJ, 1996, J PHARMACOL EXP THER, V277, P411; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Mody I, 2007, ALCOHOL, V41, P145, DOI 10.1016/j.alcohol.2007.03.009; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; O'Mara M, 2005, BIOPHYS J, V88, P3286, DOI 10.1529/biophysj.104.051664; O'Mara M, 2003, P NATL ACAD SCI USA, V100, P4310, DOI 10.1073/pnas.0630652100; Ogden E J D, 2004, Traffic Inj Prev, V5, P185; Olsen RW, 2007, ALCOHOL, V41, P201, DOI 10.1016/j.alcohol.2007.04.006; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Perkins DI, 2008, J NEUROCHEM, V106, P1337, DOI 10.1111/j.1471-4159.2008.05476.x; Price KL, 2007, J BIOL CHEM, V282, P25623, DOI 10.1074/jbc.M702524200; Santhakumar V, 2007, ALCOHOL, V41, P211, DOI 10.1016/j.alcohol.2007.04.011; SOMMER B, 1992, TRENDS PHARMACOL SCI, V13, P291, DOI 10.1016/0165-6147(92)90088-N; Steensland P, 2007, P NATL ACAD SCI USA, V104, P12518, DOI 10.1073/pnas.0705368104; Sundstrom-Poromaa I, 2002, NAT NEUROSCI, V5, P721, DOI 10.1038/nn888; Valenzuela CF, 1998, ALCOHOL CLIN EXP RES, V22, P1132, DOI 10.1097/00000374-199808000-00023; Volpicelli JR, 2001, J CLIN PSYCHIAT, V62, P4; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Wang J, 2007, J BIOL CHEM, V282, P26210, DOI 10.1074/jbc.M702314200; Wei WZ, 2004, J NEUROSCI, V24, P8379, DOI 10.1523/JNEUROSCI.2040-04.2004; Weight FF, 1999, NEUROCHEM INT, V35, P143, DOI 10.1016/S0197-0186(99)00056-X; Weiner JL, 1997, J NEUROPHYSIOL, V77, P1306, DOI 10.1152/jn.1997.77.3.1306; WHITE G, 1990, BRAIN RES, V507, P332, DOI 10.1016/0006-8993(90)90292-J; Woodward JJ, 2004, MOL BRAIN RES, V125, P86, DOI 10.1016/j.molbrainres.2004.03.005; Ye JH, 2002, NEUROPHARMACOLOGY, V43, P788, DOI 10.1016/S0028-3908(02)00179-X; Ye Q, 1998, J BIOL CHEM, V273, P3314, DOI 10.1074/jbc.273.6.3314; Yevenes GE, 2006, J BIOL CHEM, V281, P39300, DOI 10.1074/jbc.M608272200; Zhou Q, 1996, J PHARMACOL EXP THER, V278, P732	73	34	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27304	27314		10.1074/jbc.M109.023598	http://dx.doi.org/10.1074/jbc.M109.023598			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19656948	Green Published, hybrid			2022-12-27	WOS:000270232300031
J	Pless, SA; Lynch, JW				Pless, Stephan A.; Lynch, Joseph W.			Magnitude of a Conformational Change in the Glycine Receptor beta 1-beta 2 Loop Is Correlated with Agonist Efficacy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; DISTINCT STRUCTURAL-CHANGES; LIGAND-BINDING DOMAIN; GATED ION-CHANNEL; X-RAY-STRUCTURE; GABA(A) RECEPTOR; SINGLE-CHANNEL; ACTIVATION; SITE; PHARMACOLOGY	The efficacy of agonists at Cys-loop ion channel receptors is determined by the rate they isomerize receptors to a pre-open flip state. Once the flip state is reached, the shut-open reaction is similar for low and high efficacy agonists. The present study sought to identify a conformational change associated with the closed-flip transition in the beta 1-glycine receptor. We employed voltage-clamp fluorometry to compare ligand-binding domain conformational changes induced by the following agonists, listed from highest to lowest affinity and efficacy: glycine > beta-alanine > taurine. Voltage-clamp fluorometry involves labeling introduced cysteines with environmentally sensitive fluorophores and inferring structural rearrangements from ligand-induced fluorescence changes. Agonist affinity and efficacy correlated inversely with maximum fluorescence magnitudes at labeled residues in ligand-binding domain loops D and E, suggesting that large conformational changes in this region preclude efficacious gating. However, agonist affinity and efficacy correlated directly with maximum fluorescence magnitudes from a label attached to A52C in loop 2, near the transmembrane domain interface. Because glycine experiences the largest affinity increase between closed and flip states, we propose that the magnitude of this fluorescence signal is directly proportional to the agonist affinity increase. In contrast, labeled residues in loops C, F, and the pre-M1 domain yielded agonist-independent fluorescence responses. Our results support the conclusion that a closed-flip conformation change, with a magnitude proportional to the agonist affinity increase from closed to flip states, occurs in the microenvironment of Ala-52.	[Lynch, Joseph W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Lynch, JW (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	j.lynch@uq.edu.au	Lynch, Joseph/C-8636-2009	Pless, Stephan/0000-0001-6654-114X	Australian Research Council; National Health and Medical Research Council of Australia (NHMRC)	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Research Council and the National Health and Medical Research Council of Australia (NHMRC).	Beato M, 2004, J NEUROSCI, V24, P895, DOI 10.1523/JNEUROSCI.4420-03.2004; Beato M, 2002, J GEN PHYSIOL, V119, P443, DOI 10.1085/jgp.20028530; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Burzomato V, 2004, J NEUROSCI, V24, P10924, DOI 10.1523/JNEUROSCI.3424-04.2004; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chang YC, 2002, NAT NEUROSCI, V5, P1163, DOI 10.1038/nn926; Chang YC, 1999, NAT NEUROSCI, V2, P219, DOI 10.1038/6313; Dahan DS, 2004, P NATL ACAD SCI USA, V101, P10195, DOI 10.1073/pnas.0301885101; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hogg RC, 2007, BIOCHEM PHARMACOL, V73, P459, DOI 10.1016/j.bcp.2006.08.010; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Khatri A, 2009, BIOPHYS J, V96, P45, DOI 10.1016/j.bpj.2008.09.011; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Lewis TM, 2003, J PHYSIOL-LONDON, V549, P361, DOI 10.1113/jphysiol.2002.037796; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; McLaughlin JT, 2007, MOL PHARMACOL, V71, P1312, DOI 10.1124/mol.106.033092; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Mourot A, 2008, J NEUROCHEM, V105, P413, DOI 10.1111/j.1471-4159.2007.05151.x; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; Muroi Y, 2006, BIOCHEMISTRY-US, V45, P7013, DOI 10.1021/bi060222v; Muroi Y, 2009, BIOPHYS J, V96, P499, DOI 10.1016/j.bpj.2008.09.037; Pless SA, 2008, J NEUROSCI, V28, P10937, DOI 10.1523/JNEUROSCI.2540-08.2008; Pless SA, 2008, CLIN EXP PHARMACOL P, V35, P1137, DOI 10.1111/j.1440-1681.2008.04954.x; Pless SA, 2007, J BIOL CHEM, V282, P36057, DOI 10.1074/jbc.M706468200; Pless SA, 2009, J BIOL CHEM, V284, P15847, DOI 10.1074/jbc.M809343200; Pless SA, 2009, J NEUROCHEM, V108, P1585, DOI 10.1111/j.1471-4159.2009.05930.x; Plested AJR, 2007, J PHYSIOL-LONDON, V581, P51, DOI 10.1113/jphysiol.2006.126920; RAJENDRA S, 1995, NEURON, V14, P169, DOI 10.1016/0896-6273(95)90251-1; Saint Jan DD, 2001, J PHYSIOL-LONDON, V535, P741; SCHMIEDEN V, 1992, EMBO J, V11, P2025, DOI 10.1002/j.1460-2075.1992.tb05259.x; SCHMIEDEN V, 1995, MOL PHARMACOL, V48, P919; TALEB O, 1994, EMBO J, V13, P1318, DOI 10.1002/j.1460-2075.1994.tb06384.x; Wagner DA, 2001, J NEUROSCI, V21, P67, DOI 10.1523/JNEUROSCI.21-01-00067.2001	38	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27370	27376		10.1074/jbc.M109.048405	http://dx.doi.org/10.1074/jbc.M109.048405			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19643731	Green Published, hybrid			2022-12-27	WOS:000270232300038
J	Plassmeyer, ML; Reiter, K; Shimp, RL; Kotova, S; Smith, PD; Hurt, DE; House, B; Zou, XY; Zhang, YL; Hickman, M; Uchime, O; Herrera, R; Nguyen, V; Glen, J; Lebowitz, J; Jin, AJ; Miller, LH; MacDonald, NJ; Wu, YM; Narum, DL				Plassmeyer, Matthew L.; Reiter, Karine; Shimp, Richard L., Jr.; Kotova, Svetlana; Smith, Paul D.; Hurt, Darrell E.; House, Brent; Zou, Xiaoyan; Zhang, Yanling; Hickman, Merrit; Uchime, Onyinyechukwu; Herrera, Raul; Nguyen, Vu; Glen, Jacqueline; Lebowitz, Jacob; Jin, Albert J.; Miller, Louis H.; MacDonald, Nicholas J.; Wu, Yimin; Narum, David L.			Structure of the Plasmodium falciparum Circumsporozoite Protein, a Leading Malaria Vaccine Candidate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE ANALYSES; CD8+ T-CELLS; IMMUNOLOGICAL CHARACTERIZATION; PROTECTIVE ANTIGEN; HEPARAN-SULFATE; LAYERED FOLD; SPOROZOITES; IMMUNITY; PEPTIDE; RECOGNITION	The Plasmodium falciparum circumsporozoite protein (CSP) is critical for sporozoite function and invasion of hepatocytes. Given its critical nature, a phase III human CSP malaria vaccine trial is ongoing. The CSP is composed of three regions as follows: an N terminus that binds heparin sulfate proteoglycans, a four amino acid repeat region (NANP), and a C terminus that contains a thrombospondin-like type I repeat (TSR) domain. Despite the importance of CSP, little is known about its structure. Therefore, recombinant forms of CSP were produced by expression in both Escherichia coli (Ec) and then refolded (EcCSP) or in the methylotrophic yeast Pichia pastoris (PpCSP) for structural analyses. To analyze the TSR domain of recombinant CSP, conformation-dependent monoclonal antibodies that recognized unfixed P. falciparum sporozoites and inhibited sporozoite invasion of HepG2 cells in vitro were identified. These monoclonal antibodies recognized all recombinant CSPs, indicating the recombinant CSPs contain a properly folded TSR domain structure. Characterization of both EcCSP and PpCSP by dynamic light scattering and velocity sedimentation demonstrated that both forms of CSP appeared as highly extended proteins (R-h 4.2 and 4.58 nm, respectively). Furthermore, high resolution atomic force microscopy revealed flexible, rod-like structures with a ribbon-like appearance. Using this information, we modeled the NANP repeat and TSR domain of CSP. Consistent with the biochemical and biophysical results, the repeat region formed a rod-like structure about 21-25 nm in length and 1.5 nm in width. Thus native CSP appears as a glycosylphosphatidylinositol-anchored, flexible rod-like protein on the sporozoite surface.	[Plassmeyer, Matthew L.; Reiter, Karine; Shimp, Richard L., Jr.; Zhang, Yanling; Hickman, Merrit; Uchime, Onyinyechukwu; Herrera, Raul; Nguyen, Vu; Glen, Jacqueline; Miller, Louis H.; MacDonald, Nicholas J.; Wu, Yimin; Narum, David L.] NIAID, Malaria Vaccine Dev Branch, NIH, Rockville, MD 20852 USA; [Kotova, Svetlana; Smith, Paul D.; Lebowitz, Jacob; Jin, Albert J.] Natl Inst Biomed Imaging & Bioengn, Lab Bioengn & Phys Sci, NIH, Bethesda, MD 20892 USA; [Hurt, Darrell E.] NIAID, Bioinformat & Computat Biosci Branch, Off Cyber Infrastruct Computat Biol, NIH, Bethesda, MD 20892 USA; [House, Brent; Zou, Xiaoyan] USN, Naval Med Res Ctr, Silver Spring, MD 20910 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Naval Medical Research Center (NMRC); United States Department of Defense; United States Navy	Narum, DL (corresponding author), NIAID, Malaria Vaccine Dev Branch, NIH, 5640 Fishers Ln,Twinbrook 1, Rockville, MD 20852 USA.	dnarum@niaid.nih.gov	Hurt, Darrell E/B-5076-2013; Zou, Xiaoyan/E-5564-2010	Hurt, Darrell E/0000-0002-9829-8567; Narum, David/0000-0003-3041-5402; Jin, Albert/0000-0003-3826-1081	National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001004, ZIAAI000241, ZIAAI001003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health (Intramural Research Program, including NIAID and National Institute of Biomedical Imaging and Bioengineering).	Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Amino R, 2008, CELL HOST MICROBE, V3, P88, DOI 10.1016/j.chom.2007.12.007; Ancsin JB, 2004, J BIOL CHEM, V279, P21824, DOI 10.1074/jbc.M401979200; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bisang C, 1998, J AM CHEM SOC, V120, P7439, DOI 10.1021/ja980444j; BISANG C, 1995, J AM CHEM SOC, V117, P7904, DOI 10.1021/ja00135a008; Boddey JA, 2009, TRAFFIC, V10, P285, DOI 10.1111/j.1600-0854.2008.00864.x; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Bongfen SE, 2009, VACCINE, V27, P328, DOI 10.1016/j.vaccine.2008.09.097; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; CERAMI C, 1992, CELL, V70, P1021, DOI 10.1016/0092-8674(92)90251-7; Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; COCHRANE AH, 1984, INFECT IMMUN, V45, P592, DOI 10.1128/IAI.45.3.592-595.1984; Coppi A, 2007, CELL HOST MICROBE, V2, P316, DOI 10.1016/j.chom.2007.10.002; DeLano W.L, PYMOL MOL GRAPHICS S; Eswar N., 2007, CURRENT PROTOCOLS PR; Franke ED, 2000, INFECT IMMUN, V68, P3403, DOI 10.1128/IAI.68.6.3403-3411.2000; Frevert U, 2004, TRENDS PARASITOL, V20, P417, DOI 10.1016/j.pt.2004.07.007; Frevert Ute, 2008, V47, P182; Ghasparian A, 2006, CHEM COMMUN, P174, DOI 10.1039/b510812h; HERRINGTON DA, 1987, NATURE, V328, P257, DOI 10.1038/328257a0; HOLLINGDALE MR, 1982, J IMMUNOL, V128, P1929; HOLLINGDALE MR, 1983, AM J TROP MED HYG, V32, P682, DOI 10.4269/ajtmh.1983.32.682; Jin AJ, 2006, BIOPHYS J, V90, P3333, DOI 10.1529/biophysj.105.068742; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karplus K, 2003, PROTEINS, V53, P491, DOI 10.1002/prot.10540; KUMAR S, 1988, NATURE, V334, P258, DOI 10.1038/334258a0; Matsushima N, 2008, CURR PROTEIN PEPT SC, V9, P591, DOI 10.2174/138920308786733886; Meiler J, 2003, P NATL ACAD SCI USA, V100, P12105, DOI 10.1073/pnas.1831973100; Meiler J, 2001, J MOL MODEL, V7, P360, DOI 10.1007/s008940100038; Mota MM, 2002, NAT MED, V8, P1318, DOI 10.1038/nm785; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Nanzer AP, 1997, J MOL BIOL, V267, P1012, DOI 10.1006/jmbi.1997.0911; Nardin EH, 2000, J INFECT DIS, V182, P1486, DOI 10.1086/315871; Narum DL, 2008, INFECT IMMUN, V76, P4876, DOI 10.1128/IAI.01717-07; Narum DL, 2000, INFECT IMMUN, V68, P2899, DOI 10.1128/IAI.68.5.2899-2906.2000; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; NUSSENZWEIG RS, 1969, NATURE, V222, P488, DOI 10.1038/222488a0; OZAKI LS, 1984, J PARASITOL, V70, P831, DOI 10.2307/3281779; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prudencio M, 2007, CELL HOST MICROBE, V2, P286, DOI 10.1016/j.chom.2007.10.008; Rathore D, 2005, J BIOL CHEM, V280, P20524, DOI 10.1074/jbc.M414254200; Rathore D, 2002, J BIOL CHEM, V277, P7092, DOI 10.1074/jbc.M106862200; Rodrigues EG, 2000, PARASITE IMMUNOL, V22, P157, DOI 10.1046/j.1365-3024.2000.00289.x; Roggero MA, 1995, MOL IMMUNOL, V32, P1301, DOI 10.1016/0161-5890(95)00136-0; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Singh AP, 2007, CELL, V131, P492, DOI 10.1016/j.cell.2007.09.013; Singh S, 2003, INFECT IMMUN, V71, P6766, DOI 10.1128/IAI.71.12.6766-6774.2003; Singh S, 2007, P NATL ACAD SCI USA, V104, P20043, DOI 10.1073/pnas.0709999104; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stowers AW, 2001, YEAST, V18, P137, DOI 10.1002/1097-0061(20010130)18:2&lt;137::AID-YEA657&gt;3.0.CO;2-X; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Tossavainen H, 2006, PROTEIN SCI, V15, P1760, DOI 10.1110/ps.052068506; Tsai CW, 2009, MOL BIOCHEM PARASIT, V164, P45, DOI 10.1016/j.molbiopara.2008.11.006; Tsai CW, 2006, J BIOTECHNOL, V121, P458, DOI 10.1016/j.jbiotec.2005.08.025; WEISS WR, 1993, J IMMUNOL, V151, P2690; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; WEISS WR, 1990, J EXP MED, V171, P763, DOI 10.1084/jem.171.3.763; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; YOSHIDA N, 1981, J EXP MED, V154, P1225, DOI 10.1084/jem.154.4.1225	67	109	121	0	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26951	26963		10.1074/jbc.M109.013706	http://dx.doi.org/10.1074/jbc.M109.013706			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19633296	Green Published, hybrid			2022-12-27	WOS:000269969600075
J	Victor, XV; Nguyen, TKN; Ethirajan, M; Tran, VM; Nguyen, KV; Kuberan, B				Victor, Xylophone V.; Nguyen, Thao K. N.; Ethirajan, Manivannan; Tran, Vy M.; Nguyen, Khiem V.; Kuberan, Balagurunathan			Investigating the Elusive Mechanism of Glycosaminoglycan Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-D-XYLOSIDE; PROTEIN-LINKAGE REGION; HEPARAN-SULFATE BIOSYNTHESIS; CHONDROITIN SULFATE; PROTEOGLYCAN SYNTHESIS; PROTEOCHONDROITIN SULFATE; TUMOR SUPPRESSORS; IN-VITRO; CARBOHYDRATE; CARTILAGE	Glycosaminoglycan (GAG) biosynthesis requires numerous biosynthetic enzymes and activated sulfate and sugar donors. Although the sequence of biosynthetic events is resolved using reconstituted systems, little is known about the emergence of cell-specific GAG chains (heparan sulfate, chondroitin sulfate, and dermatan sulfate) with distinct sulfation patterns. We have utilized a library of click-xylosides that have various aglycones to decipher the mechanism of GAG biosynthesis in a cellular system. Earlier studies have shown that both the concentration of the primers and the structure of the aglycone moieties can affect the composition of the newly synthesized GAG chains. However, it is largely unknown whether structural features of aglycone affect the extent of sulfation, sulfation pattern, disaccharide composition, and chain length of GAG chains. In this study, we show that aglycones can switch not only the type of GAG chains, but also their fine structures. Our findings provide suggestive evidence for the presence of GAGOSOMES that have different combinations of enzymes and their isoforms regulating the synthesis of cell-specific combinatorial structures. We surmise that click-xylosides are differentially recognized by the GAGOSOMES to generate distinct GAG structures as observed in this study. These novel click-xylosides offer new avenues to profile the cell-specific GAG chains, elucidate the mechanism of GAG biosynthesis, and to decipher the biological actions of GAG chains in model organisms.	[Victor, Xylophone V.; Ethirajan, Manivannan; Nguyen, Khiem V.; Kuberan, Balagurunathan] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Nguyen, Thao K. N.; Tran, Vy M.; Kuberan, Balagurunathan] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Kuberan, B (corresponding author), Univ Utah, Dept Med Chem, Skaggs Hall,Rm 307,30 S 2000 E, Salt Lake City, UT 84112 USA.	KUBY@pharm.utah.edu	Nguyen, Khiem/D-3544-2013; Tran, Vy/GWC-8836-2022	Balagurunathan, Kuberan/0000-0001-9203-8118; Nguyen, Thao/0000-0001-5740-6085	National Institutes of Health [GM075168]; Human Frontiers Science Program; Vietnam Education Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); Vietnam Education Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM075168 (to B. K.). This work was also supported by Human Frontiers Science Program (to B. K.) and the Vietnam Education Fund (to T. K. N. N. and K. V. N.).	BOURDON MA, 1987, P NATL ACAD SCI USA, V84, P3194, DOI 10.1073/pnas.84.10.3194; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; CARRINO DA, 1994, MATRIX BIOL, V14, P121, DOI 10.1016/0945-053X(94)90002-7; Cheng F, 1997, GLYCOCONJUGATE J, V14, P297, DOI 10.1023/A:1018562426363; COSTER L, 1991, BIOCHEM J, V276, P533, DOI 10.1042/bj2760533; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; FRANSSON LA, 1985, J BIOL CHEM, V260, P4722; FRITZ TA, 1994, J BIOL CHEM, V269, P300; GALLIGANI L, 1975, J BIOL CHEM, V250, P5400; GIBSON KD, 1977, BIOCHEM J, V168, P65, DOI 10.1042/bj1680065; GIBSON KD, 1977, BIOCHEM J, V162, P217, DOI 10.1042/bj1620217; GREGORY JD, 1964, J BIOL CHEM, V239, P3312; GREVE H, 1988, J BIOL CHEM, V263, P12886; HANDLEY CJ, 1977, BIOCHIM BIOPHYS ACTA, V500, P132; HJELLE JT, 1979, J EMBRYOL EXP MORPH, V53, P179; HOPWOOD JJ, 1977, J BIOL CHEM, V252, P4777; JACOBSSON I, 1984, J BIOL CHEM, V259, P1056; KANWAR YS, 1984, J CELL BIOL, V99, P715, DOI 10.1083/jcb.99.2.715; Kim BT, 2003, J BIOL CHEM, V278, P41618, DOI 10.1074/jbc.M304831200; Kobayashi S, 2000, BIOCHEM BIOPH RES CO, V268, P860, DOI 10.1006/bbrc.2000.2219; Kuberan B, 2003, NAT BIOTECHNOL, V21, P1343, DOI 10.1038/nbt885; Kuberan B, 2003, J AM CHEM SOC, V125, P12424, DOI 10.1021/ja036737g; Kuberan B, 2004, J BIOL CHEM, V279, P5053, DOI 10.1074/jbc.C300492200; Kuberan B, 2008, CHEMBIOCHEM, V9, P198, DOI 10.1002/cbic.200700494; Lander A D, 1993, Curr Opin Neurobiol, V3, P716, DOI 10.1016/0959-4388(93)90143-M; Ledin J, 2006, J BIOL CHEM, V281, P35727, DOI 10.1074/jbc.M604113200; LEVITT D, 1973, P NATL ACAD SCI USA, V70, P2201, DOI 10.1073/pnas.70.8.2201; LIDHOLT K, 1988, BIOCHEM J, V254, P571, DOI 10.1042/bj2540571; LINDAHL U, 1965, J BIOL CHEM, V240, P2817; LINDAHL U, 1965, J BIOL CHEM, V240, P2821; LOHMANDER LS, 1986, ARCH BIOCHEM BIOPHYS, V250, P211, DOI 10.1016/0003-9861(86)90719-8; LOHMANDER LS, 1989, J BIOL CHEM, V264, P18775; Lugemwa FN, 1996, J BIOL CHEM, V271, P19159, DOI 10.1074/jbc.271.32.19159; Malmberg J, 2006, BIOORGAN MED CHEM, V14, P6659, DOI 10.1016/j.bmc.2006.05.068; Mani K, 2004, GLYCOBIOLOGY, V14, P387, DOI 10.1093/glycob/cwh035; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; MORRISSKAY GM, 1982, J ANAT, V134, P491; MUIR H, 1958, BIOCHEM J, V69, P195, DOI 10.1042/bj0690195; NISHIMOTO SK, 1982, J BIOL CHEM, V257, P1712; OEGEMA TR, 1984, J BIOL CHEM, V259, P1720; OKAYAMA M, 1973, J BIOCHEM-TOKYO, V74, P1069; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; PLATT JL, 1987, DEV BIOL, V123, P293, DOI 10.1016/0012-1606(87)90388-5; Powell AK, 2004, GLYCOBIOLOGY, V14, p17R, DOI 10.1093/glycob/cwh051; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; RAPRAEGER A, 1989, J CELL BIOL, V109, P2509, DOI 10.1083/jcb.109.5.2509; Safaiyan F, 1999, J BIOL CHEM, V274, P36267, DOI 10.1074/jbc.274.51.36267; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; SANDY JD, 1980, BIOCHEM J, V188, P119, DOI 10.1042/bj1880119; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Sasisekharan R, 2000, CURR OPIN CHEM BIOL, V4, P626, DOI 10.1016/S1367-5931(00)00145-9; Seidler DG, 2002, J BIOL CHEM, V277, P42409, DOI 10.1074/jbc.M208442200; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; SHIBATA S, 1992, J BIOL CHEM, V267, P6548; SILBERT JE, 1993, BIOCHEM J, V296, P119, DOI 10.1042/bj2960119; SOBUE M, 1987, BIOCHEM J, V241, P591, DOI 10.1042/bj2410591; SUGAHARA K, 1992, EUR J BIOCHEM, V204, P401, DOI 10.1111/j.1432-1033.1992.tb16649.x; SUGAHARA K, 1992, J BIOL CHEM, V267, P6027; SUGAHARA K, 1992, J BIOL CHEM, V267, P1528; Sugumaran G, 1998, BIOCHEM J, V329, P203, DOI 10.1042/bj3290203; VERTEL BM, 1993, J BIOL CHEM, V268, P11105; YOST HJ, 1990, DEVELOPMENT, V110, P865	63	69	70	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25842	25853		10.1074/jbc.M109.043208	http://dx.doi.org/10.1074/jbc.M109.043208			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19628873	Green Published, hybrid			2022-12-27	WOS:000269738000042
J	Kim, HW; Haider, HK; Jiang, SJ; Ashraf, M				Kim, Ha Won; Haider, Husnain K.; Jiang, Shujia; Ashraf, Muhammad			Ischemic Preconditioning Augments Survival of Stem Cells via miR-210 Expression by Targeting Caspase-8-associated Protein 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFARCTED HEART; INTERMITTENT HYPOXIA; OXIDATIVE STRESS; NUCLEAR-BODIES; ACTIVATION; MICRORNAS; APOPTOSIS; FLASH; TRANSPLANTATION; TRANSCRIPTION	MicroRNAs (miRs) participate in most cellular functions by posttranscriptional regulation of gene expression albeit with little information regarding their role in ischemic preconditioning (IP) of stem cells. We report that IP of bone marrow-derived mesenchymal stem cells (MSCs) with two cycles of 30-min ischemia/reoxygenation (I/R) supported their survival under subsequent longer exposure to anoxia and following engraftment in the infarcted heart. IP significantly reduced apoptosis in MSCs through activation of Akt (Ser(473)) and ERK1/2 (Thr(202)/Tyr(204)) and nuclear translocation of hypoxia-inducible factor-1 alpha (HIF-1 alpha). We observed concomitant induction of miR-210 in the preconditioned MSCs ((MSCs)-M-PC). Inhibition of HIF-1 alpha or of miR-210 abrogated the cytoprotective effects of preconditioning. Extrapolation of these data to in vivo studies in a rat model of acute myocardial infarction predominantly improved stem cell survival after engraftment with a role for miR-210. Notably, multiple I/R cycles more effectively regulated the miR-210 and hence promoted MSC survival compared with single-cycle hypoxia of an equal duration. Real time PCR array for rat apoptotic genes, computational target gene analyses, and luciferase reporter assay identified FLICE-associated huge protein (FLASH)/caspase-8-associated protein-2 (Casp8ap2) in (MSCs)-M-PC as the target gene of miR-210. Induction of FLASH/CASP8AP2 in miR-210 knocked-down (MSCs)-M-PC resulted in increased cell apoptosis. Taken together, these data demonstrated that cytoprotection afforded by IP was regulated by miR210 induction via FLASH/Casp8ap2 suppression. These results highlighted that IP by multiple short episodes of I/R is a novel strategy to promote stem cell survival.	[Kim, Ha Won; Haider, Husnain K.; Jiang, Shujia; Ashraf, Muhammad] Univ Cincinnati, Dept Pathol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Ashraf, M (corresponding author), Univ Cincinnati, Dept Pathol, Cincinnati, OH 45267 USA.	ashrafm@ucmail.uc.edu	Haider, Khawaja/AAI-6819-2020; Ashraf, Muhammad/ABB-3463-2021	Haider, Khawaja/0000-0002-7907-4808; Kim, Ha Won/0000-0001-6272-4248	National Institutes of Health [R37-HL074272, HL-080686, HL087246, HL087288, HL089535]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089535, R37HL074272, R01HL087288, R01HL087246, R01HL080686] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R37-HL074272, HL-080686, and HL087246 ( to M. A.) and HL087288 and HL089535 ( to H. K. H).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Barcaroli D, 2006, P NATL ACAD SCI USA, V103, P14808, DOI 10.1073/pnas.0604227103; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Dai Y, 2007, J MOL CELL CARDIOL, V42, P1036, DOI 10.1016/j.yjmcc.2007.04.001; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Foshay Kara M, 2007, Curr Stem Cell Res Ther, V2, P264, DOI 10.2174/157488807782793781; Gross Eric R, 2007, Drug Discov Today Dis Mech, V4, P165, DOI 10.1016/j.ddmec.2007.10.005; Haider HK, 2008, J MOL CELL CARDIOL, V45, P554, DOI 10.1016/j.yjmcc.2008.05.004; Haider HK, 2008, CIRC RES, V103, P1300, DOI 10.1161/CIRCRESAHA.108.186742; Hausenloy DJ, 2006, CARDIOVASC RES, V70, P240, DOI 10.1016/j.cardiores.2006.01.017; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071; Imai Y, 1999, NATURE, V398, P777, DOI 10.1038/19709; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krieghoff-Henning E, 2008, BBA-MOL CELL RES, V1783, P2185, DOI 10.1016/j.bbamcr.2008.07.002; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lu G, 2009, CIRCULATION, V119, P2587, DOI 10.1161/CIRCULATIONAHA.108.827691; Milovic-Holm K, 2007, EMBO J, V26, P391, DOI 10.1038/sj.emboj.7601504; Nanduri J, 2008, RESP PHYSIOL NEUROBI, V164, P277, DOI 10.1016/j.resp.2008.07.006; Niagara MI, 2007, CIRC RES, V100, P545, DOI 10.1161/01.RES.0000258460.41160.ef; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Shujia J, 2008, CARDIOVASC RES, V77, P525, DOI 10.1093/cvr/cvm077; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Yuan GX, 2004, J PHYSIOL-LONDON, V557, P773, DOI 10.1113/jphysiol.2003.058503	25	267	282	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33161	33168		10.1074/jbc.M109.020925	http://dx.doi.org/10.1074/jbc.M109.020925			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19721136	hybrid, Green Published			2022-12-27	WOS:000272028500020
J	Cheng, XL; Shen, Z; Yin, LT; Lu, SH; Cui, YP				Cheng, Xiaolong; Shen, Zheng; Yin, Litian; Lu, Shih-Hsin; Cui, Yongping			ECRG2 Regulates Cell Migration/Invasion through Urokinase-type Plasmin Activator Receptor (uPAR)/beta 1 Integrin Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWN-REGULATION; TUMOR-GROWTH; CANCER; INVASION; CARCINOMA; BINDING; GENE; UPAR; INVASIVENESS; SUPPRESSION	ECRG2 is a novel gene that shows sequence similarity to KAZAL-type serine protease inhibitor. We have previously demonstrated that ECRG2 inhibits migration/invasion of lung cancer PG cells. However, the mechanism by which ECRG2 performs these activities is a compelling question. Urokinase-type plasmin activator (uPA) binding to uPAR induces migration/invasion through multiple interactors including integrins. In this study, we found that ECRG2 binds specifically to the kringle domain of uPA. Moreover, we demonstrated that ECRG2 forms a complex with uPA.uPAR, that such a complex modifies the dynamical association of uPAR with beta 1 integrins, and that disruption inhibits Src/MAP (mitogen-activated protein) kinase pathway, resulting in suppression of cell migration/invasion in an in vitro Matrigel migration/invasion assay. Conversely, depletion of ECRG2 markedly enhanced the association of uPAR with beta 1 integrins, elevated basal Src/MAP kinase activation, and stimulated HT1080, MDA-MB-231, and MCF-7 cell migration/invasion. Together, our results provide evidence that ECRG2 is involved in the regulation of migration/invasion through uPA/uPAR/beta 1 integrins/Src/MAP kinase pathway and may represent a novel therapeutic target for cancer.	[Cui, Yongping] Shanxi Med Univ, Dept Cell Biol & Genet, Taiyuan 030001, Shanxi, Peoples R China; [Cheng, Xiaolong] Shanxi Med Univ, Dept Anat, Taiyuan 030001, Shanxi, Peoples R China; [Shen, Zheng] Univ S Florida, Hlth Sci Ctr, Dept Mol Pharmacol & Physiol, Tampa, FL 33612 USA; [Yin, Litian] Shanxi Univ, Key Lab Chem Biol & Mol Engn, Minist Educ, Inst Biotechnol, Taiyuan 030006, Shanxi, Peoples R China; [Lu, Shih-Hsin] Peking Union Med Coll, Dept Etiol & Carcinogenesis, Inst Canc, Beijing 100021, Peoples R China; [Lu, Shih-Hsin] Chinese Acad Med Sci, Beijing 100021, Peoples R China; [Cui, Yongping] Shanxi Med Univ, Key Lab Cellular Physiol, Minist Educ, Taiyuan 030001, Shanxi, Peoples R China	Shanxi Medical University; Shanxi Medical University; State University System of Florida; University of South Florida; Shanxi University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Shanxi Medical University	Cui, YP (corresponding author), Shanxi Med Univ, Dept Cell Biol & Genet, Taiyuan 030001, Shanxi, Peoples R China.	cuiy0922@yahoo.com			National Nature Science Foundation of China [30971518, 30500588]; Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi	This work was supported by National Nature Science Foundation of China Grants 30971518 and 30500588 and by the Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi (to Y.C.).	Aguirre-Ghiso JA, 2003, CANCER RES, V63, P1684; Ahmed N, 2003, BRIT J CANCER, V89, P374, DOI 10.1038/sj.bjc.6601098; Bass R, 2002, J BIOL CHEM, V277, P46845, DOI 10.1074/jbc.C200532200; Bauer TW, 2005, CANCER RES, V65, P7775, DOI 10.1158/0008-5472.CAN-05-0946; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Chapman HA, 2001, THROMB HAEMOSTASIS, V86, P124; Cheng XL, 2008, J BIOL CHEM, V283, P5888, DOI 10.1074/jbc.M708145200; Cui YP, 2003, BIOCHEM BIOPH RES CO, V302, P904, DOI 10.1016/S0006-291X(03)00122-0; Czekay RP, 2003, J CELL BIOL, V160, P781, DOI 10.1083/jcb.200208117; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Franco P, 2006, J CELL SCI, V119, P3424, DOI 10.1242/jcs.03067; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Geng Y, 2008, ARCH BIOCHEM BIOPHYS, V479, P153, DOI 10.1016/j.abb.2008.08.023; Ghiso JAA, 1999, J CELL BIOL, V147, P89, DOI 10.1083/jcb.147.1.89; Gond CS, 2007, INT J ONCOL, V31, P19; Huang G, 2005, HYBRIDOMA, V24, P86, DOI 10.1089/hyb.2005.24.86; Huang G, 2007, CARCINOGENESIS, V28, P2274, DOI 10.1093/carcin/bgm140; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Sidenius N, 2003, CANCER METAST REV, V22, P205, DOI 10.1023/A:1023099415940; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Sitrin RG, 2004, AM J RESP CELL MOL, V30, P233, DOI 10.1165/rcmb.2003-0079OC; Smith SL, 2003, ONCOGENE, V22, P8677, DOI 10.1038/sj.onc.1207127; Stefansson S, 1996, NATURE, V383, P441, DOI 10.1038/383441a0; Sturge J, 2003, J CELL BIOL, V162, P789, DOI 10.1083/jcb.200302124; Su Tao, 1998, Zhonghua Zhongliu Zazhi, V20, P254; Suzuki M, 2004, J BIOL CHEM, V279, P14899, DOI 10.1074/jbc.M313130200; Tang CH, 2008, CELL MOL LIFE SCI, V65, P1916, DOI 10.1007/s00018-008-7573-9; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; Wei Y, 2001, MOL BIOL CELL, V12, P2975, DOI 10.1091/mbc.12.10.2975; Wei Y, 1999, J CELL BIOL, V144, P1285, DOI 10.1083/jcb.144.6.1285	31	20	23	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30897	30906		10.1074/jbc.M109.011213	http://dx.doi.org/10.1074/jbc.M109.011213			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19717562	Green Published, hybrid			2022-12-27	WOS:000271378400018
J	Lee, EF; Czabotar, PE; Yang, H; Sleebs, BE; Lessene, G; Colman, PM; Smith, BJ; Fairlie, WD				Lee, Erinna F.; Czabotar, Peter E.; Yang, Hong; Sleebs, Brad E.; Lessene, Guillaume; Colman, Peter M.; Smith, Brian J.; Fairlie, W. Douglas			Conformational Changes in Bcl-2 Pro-survival Proteins Determine Their Capacity to Bind Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; BH3 MIMETIC ABT-737; CELL-DEATH; BH3-ONLY PROTEINS; PEPTIDE COMPLEX; X-L; MEMBRANE PERMEABILIZATION; MAXIMUM-LIKELIHOOD; CRYSTAL-STRUCTURE; MULTIPLE-MYELOMA	Antagonists of anti-apoptotic Bcl-2 family members hold promise as cancer therapeutics. Apoptosis is triggered when a peptide containing a BH3 motif or a small molecule BH3 peptidomimetic, such as ABT 737, binds to the relevant Bcl-2 family members. ABT-737 is an antagonist of Bcl-2, Bcl-x(L), and Bcl-w but not of Mcl-1. Here we describe new structures of mutant BH3 peptides bound to Bcl-x(L) and Mcl-1. These structures suggested a rationale for the failure of ABT-737 to bind Mcl-1, but a designed variant of ABT-737 failed to acquire binding affinity for Mcl-1. Rather, it was selective for Bcl-x(L), a result attributable in part to significant backbone refolding and movements of helical segments in its ligand binding site. To date there are few reported crystal structures of organic ligands in complex with their pro-survival protein targets. Our structure of this new organic ligand provided insights into the structural transitions that occur within the BH3 binding groove, highlighting significant differences in the structural properties of members of the Bcl-2 pro-survival protein family. Such differences are likely to influence and be important in the quest for compounds capable of selectively antagonizing the different family members.	[Lee, Erinna F.; Czabotar, Peter E.; Yang, Hong; Sleebs, Brad E.; Lessene, Guillaume; Colman, Peter M.; Smith, Brian J.; Fairlie, W. Douglas] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia	Walter & Eliza Hall Institute	Smith, BJ (corresponding author), Walter & Eliza Hall Inst Med Res, Struct Biol Div, 1G Royal Pde, Parkville, Vic 3052, Australia.	bsmith@wehi.edu.au; fairlie@wehi.edu.au	Smith, Brian J/F-8282-2011; Fairlie, Walter/M-8401-2015; Lee, Erinna/N-1523-2015; Sleebs, Brad/J-9639-2014	Smith, Brian J/0000-0003-0498-1910; Fairlie, Walter/0000-0002-2498-1160; Lee, Erinna/0000-0003-1255-9808; Sleebs, Brad/0000-0001-9117-1048; Czabotar, Peter/0000-0002-2594-496X	Australian National Health and Medical Research Council Program fellowships [461221, 575561]; Leukemia and Lymphoma Society [SCOR 7015-02]; Cancer Council of Victoria Grant-in-aid [461239]; Leukemia Foundation of Australia Phillip Desbrow post doctoral fellowship; Australian Cancer Research Foundation	Australian National Health and Medical Research Council Program fellowships(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Cancer Council of Victoria Grant-in-aid(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Leukemia Foundation of Australia Phillip Desbrow post doctoral fellowship; Australian Cancer Research Foundation	This work was supported by Australian National Health and Medical Research Council Program fellowships ( to W. D. F. and P. M. C.) and Grant 461221 ( to P. M. C.) and Project Grant 575561 ( to P. E. C.), Leukemia and Lymphoma Society Grant SCOR 7015-02, Cancer Council of Victoria Grant-in-aid 461239 ( to W. D. F.) and a fellowship ( to E. F. L.), Leukemia Foundation of Australia Phillip Desbrow post doctoral fellowship ( to E. F. L.), and by the Australian Cancer Research Foundation ( to P. M. C.).	Ackler S, 2008, MOL CANCER THER, V7, P3265, DOI 10.1158/1535-7163.MCT-08-0268; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bruncko M, 2007, J MED CHEM, V50, P641, DOI 10.1021/jm061152t; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200; Degterev A, 2001, NAT CELL BIOL, V3, P173, DOI 10.1038/35055085; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enyedy IJ, 2001, J MED CHEM, V44, P4313, DOI 10.1021/jm010016f; Feng W, 2007, J MOL BIOL, V372, P223, DOI 10.1016/j.jmb.2007.06.069; Feng WY, 2003, BRIT J HAEMATOL, V121, P332, DOI 10.1046/j.1365-2141.2003.04268.x; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Fletcher JI, 2008, CELL CYCLE, V7, P39, DOI 10.4161/cc.7.1.5178; Fu XR, 2007, J MOL BIOL, V371, P1099, DOI 10.1016/j.jmb.2007.04.069; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Lee EF, 2008, CELL DEATH DIFFER, V15, P1609, DOI 10.1038/cdd.2008.86; Lee EF, 2007, CELL DEATH DIFFER, V14, P1711, DOI 10.1038/sj.cdd.4402178; Lee EF, 2008, J CELL BIOL, V180, P341, DOI 10.1083/jcb.200708096; Lee EF, 2009, ANGEW CHEM INT EDIT, V48, P4318, DOI 10.1002/anie.200805761; Lessene G, 2008, NAT REV DRUG DISCOV, V7, P989, DOI 10.1038/nrd2658; Lin X, 2007, ONCOGENE, V26, P3972, DOI 10.1038/sj.onc.1210166; Liu XQ, 2006, J EXP MED, V203, P2953, DOI 10.1084/jem.20061151; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Mohammad RM, 2007, CLIN CANCER RES, V13, P2226, DOI 10.1158/1078-0432.CCR-06-1574; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Prakesch M, 2008, BIOORGAN MED CHEM, V16, P7443, DOI 10.1016/j.bmc.2008.06.023; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Shoemaker AR, 2008, CLIN CANCER RES, V14, P3268, DOI 10.1158/1078-0432.CCR-07-4622; Shoemaker AR, 2006, CANCER RES, V66, P8731, DOI 10.1158/0008-5472.CAN-06-0367; Smits C, 2008, STRUCTURE, V16, P818, DOI 10.1016/j.str.2008.02.009; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Tzung SP, 2001, NAT CELL BIOL, V3, P183, DOI 10.1038/35055095; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vogler M, 2009, CELL DEATH DIFFER, V16, P1030, DOI 10.1038/cdd.2009.48; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wuilleme-Toumi S, 2005, LEUKEMIA, V19, P1248, DOI 10.1038/sj.leu.2403784; Yin H, 2005, J AM CHEM SOC, V127, P10191, DOI 10.1021/ja050122x; Yin H, 2005, J AM CHEM SOC, V127, P5463, DOI 10.1021/ja0446404; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang B, 2002, BLOOD, V99, P1885, DOI 10.1182/blood.V99.6.1885; Zobel K, 2006, ACS CHEM BIOL, V1, P525, DOI 10.1021/cb600276q	60	77	79	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30508	30517		10.1074/jbc.M109.040725	http://dx.doi.org/10.1074/jbc.M109.040725			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19726685	Green Published, hybrid			2022-12-27	WOS:000271090000053
J	Hu, YL; Guimond, SE; Travers, P; Cadman, S; Hohenester, E; Turnbull, JE; Kim, SH; Bouloux, PM				Hu, Youli; Guimond, Scott E.; Travers, Paul; Cadman, Steven; Hohenester, Erhard; Turnbull, Jeremy E.; Kim, Soo-Hyun; Bouloux, Pierre-Marc			Novel Mechanisms of Fibroblast Growth Factor Receptor 1 Regulation by Extracellular Matrix Protein Anosmin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; LINKED KALLMANNS-SYNDROME; FIBRONECTIN TYPE-III; FACTOR FGF RECEPTOR; HEPARAN-SULFATE; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; HORMONE NEURONS; AXONAL GROWTH; ACTIVATION	Activation of fibroblast growth factor (FGF) signaling is initiated by a multiprotein complex formation between FGF, FGF receptor (FGFR), and heparan sulfate proteoglycan on the cell membrane. Cross-talk with other factors could affect this complex assembly and modulate the biological response of cells to FGF. We have previously demonstrated that anosmin-1, a glycosylated extracellular matrix protein, interacts with the FGFR1 signaling complex and enhances its activity in an IIIc isoform-specific and HS-dependent manner. The molecular mechanism of anosmin-1 action on FGFR1 signaling, however, remains unknown. Here, we show that anosmin-1 directly binds to FGFR1 with high affinity. This interaction involves domains in the N terminus of anosmin-1 (cysteine-rich region, whey acidic protein-like domain and the first fibronectin type III domain) and the D2-D3 extracellular domains of FGFR1. In contrast, anosmin-1 binds to FGFR2IIIc with much lower affinity and displays negligible binding to FGFR3IIIc. We also show that FGFR1-bound anosmin-1, although capable of binding to FGF2 alone, cannot bind to a FGF2.heparin complex, thus preventing FGFR1.FGF2.heparin complex formation. By contrast, heparin-bound anosmin-1 binds to pre-formed FGF2.FGFR1 complex, generating an anosmin-1.FGFR1.FGF2.heparin complex. Furthermore, a functional interaction between anosmin-1 and the FGFR1 signaling complex is demonstrated by immunofluorescence co-localization and Transwell migration assays where anosmin-1 was shown to induce opposing effects during chemotaxis of human neuronal cells. Our study provides molecular and cellular evidence for a modulatory action of anosmin-1 on FGFR1 signaling, whereby binding of anosmin-1 to FGFR1 and heparin can play a dual role in assembly and activity of the ternary FGFR1.FGF2.heparin complex.	[Hu, Youli; Kim, Soo-Hyun; Bouloux, Pierre-Marc] UCL, Ctr Neuroendocrinol, Sch Med, London NW3 2PF, England; [Guimond, Scott E.; Turnbull, Jeremy E.] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; [Travers, Paul] Univ Edinburgh, Scottish Ctr Regenerat Med, Edinburgh EH16 4SB, Midlothian, Scotland; [Hohenester, Erhard] Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England	University of London; University College London; UCL Medical School; University of Liverpool; University of Edinburgh; Imperial College London	Hu, YL (corresponding author), UCL, Ctr Neuroendocrinol, Sch Med, Royal Free Campus, London NW3 2PF, England.	y.hu@medsch.ucl.ac.uk; skim@sgul.ac.uk	Kim, Soo Hyun/ABG-8773-2020	Kim, Soo Hyun/0000-0002-9394-1437; Guimond, Scott/0000-0002-5903-418X	Biotechnology and Biological Sciences Research Council [BB/F007167/1]; BBSRC [BB/F007167/1, BB/F006616/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F006616/1] Funding Source: researchfish; Medical Research Council [G0700711B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/F007167/1.	Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; Andrenacci D, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-47; Bottcher RT, 2004, NAT CELL BIOL, V6, P38, DOI 10.1038/ncb1082; Bribian A, 2006, MOL CELL NEUROSCI, V33, P2, DOI 10.1016/j.mcn.2006.05.009; Bulow HE, 2002, P NATL ACAD SCI USA, V99, P6346, DOI 10.1073/pnas.092128099; Carafoli F, 2008, J MOL BIOL, V377, P524, DOI 10.1016/j.jmb.2008.01.030; Cariboni A, 2004, HUM MOL GENET, V13, P2781, DOI 10.1093/hmg/ddh309; Christensen C, 2006, FEBS LETT, V580, P3386, DOI 10.1016/j.febslet.2006.05.008; Chung WCJ, 2008, ENDOCRINOLOGY, V149, P4997, DOI 10.1210/en.2007-1634; Detillieux KA, 2003, CARDIOVASC RES, V57, P8, DOI 10.1016/S0008-6363(02)00708-3; Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122; Doherty P, 2000, MOL CELL NEUROSCI, V16, P283, DOI 10.1006/mcne.2000.0907; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; Freeman KW, 2003, CANCER RES, V63, P6237; Gill JC, 2004, ENDOCRINOLOGY, V145, P3830, DOI 10.1210/en.2004-0214; Gonzalez-Martinez D, 2004, J NEUROSCI, V24, P10384, DOI 10.1523/JNEUROSCI.3400-04.2004; Goodger SJ, 2008, J BIOL CHEM, V283, P13001, DOI 10.1074/jbc.M704531200; Guimond SE, 1999, CURR BIOL, V9, P1343, DOI 10.1016/S0960-9822(00)80060-3; Hardelin JP, 2008, SEX DEV, V2, P181, DOI 10.1159/000152034; Harmer NJ, 2004, J MOL BIOL, V339, P821, DOI 10.1016/j.jmb.2004.04.031; Hu YL, 2005, J MOL BIOL, V350, P553, DOI 10.1016/j.jmb.2005.04.031; Hu YL, 2004, BIOCHEM J, V384, P495, DOI 10.1042/BJ20041078; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; Kim SH, 2008, J NEUROENDOCRINOL, V20, P141, DOI 10.1111/j.1365-2826.2007.01627.x; Kiselyov VV, 2003, STRUCTURE, V11, P691, DOI 10.1016/S0969-2126(03)00096-0; Kulahin N, 2008, MOL CELL NEUROSCI, V37, P528, DOI 10.1016/j.mcn.2007.12.001; LEGOUIS R, 1991, CELL, V67, P423, DOI 10.1016/0092-8674(91)90193-3; MIKI T, 1991, SCIENCE, V251, P72, DOI 10.1126/science.1846048; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Mohammadi M, 2005, CURR OPIN STRUC BIOL, V15, P506, DOI 10.1016/j.sbi.2005.09.002; Olsen SK, 2004, P NATL ACAD SCI USA, V101, P935, DOI 10.1073/pnas.0307287101; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; Ostrovsky O, 2002, J BIOL CHEM, V277, P2444, DOI 10.1074/jbc.M108540200; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Pitteloud N, 2007, J CLIN INVEST, V117, P457, DOI 10.1172/JCI29884; Pitteloud N, 2006, MOL CELL ENDOCRINOL, V254, P60, DOI 10.1016/j.mce.2006.04.021; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; Robertson A, 2001, BIOCHEM J, V357, P647, DOI 10.1042/0264-6021:3570647; Saffell JL, 1997, NEURON, V18, P231, DOI 10.1016/S0896-6273(00)80264-0; Sanchez-Heras E, 2006, J BIOL CHEM, V281, P35208, DOI 10.1074/jbc.M608655200; Sandilands E, 2007, EMBO REP, V8, P1162, DOI 10.1038/sj.embor.7401097; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Tsai PS, 2005, MOL ENDOCRINOL, V19, P225, DOI 10.1210/me.2004-0330; Tsang M, 2002, NAT CELL BIOL, V4, P165, DOI 10.1038/ncb749; VANNELLI GB, 1995, J NEUROSCI, V15, P4382; Zhang WQ, 2006, J BIOL CHEM, V281, P37302, DOI 10.1074/jbc.M604905200	48	56	61	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29905	29920		10.1074/jbc.M109.049155	http://dx.doi.org/10.1074/jbc.M109.049155			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19696444	Green Published, hybrid			2022-12-27	WOS:000270896800070
J	Morita, T; Sobue, K				Morita, Tsuyoshi; Sobue, Kenji			Specification of Neuronal Polarity Regulated by Local Translation of CRMP2 and Tau via the mTOR-p70S6K Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; HIPPOCAMPAL-NEURONS; SYNAPTIC PLASTICITY; NERVOUS-SYSTEM; RHEB GTPASE; MTOR; RAPAMYCIN; MECHANISMS; PROTEIN; S6K1	Mammalian target of rapamycin (mTOR) is an important regulator of neuronal development and functions. Although it was reported recently that mTOR signaling is critical for neuronal polarity, the underlying mechanism remains unclear. Here, we describe the molecular pathway of mTOR-dependent axon specification, in which the collapsing response mediator protein 2 (CRMP2) and Tau are major downstream targets. The activity of mTOR effector 70-kDa ribosomal protein S6 kinase (p70S6K) specifically increases in the axon during neuronal polarity formation. The mTOR inhibitor rapamycin suppresses the translation of some neuronal polarity proteins, including CRMP2 and Tau, thereby inhibiting axon formation. In contrast, constitutively active p70S6K up-regulates the translation of these molecules, thus inducing multiple axons. Exogenous CRMP2 and Tau facilitate axon formation, even in the presence of rapamycin. In the 5'-untranslated region of Tau and CRMP2 mRNAs, we identified a 5'-terminal oligopyrimidine tract, which mediates mTOR-governed protein synthesis. The 5'-terminal oligopyrimidine tract sequences of CRMP2 and Tau mRNAs strongly contribute to the up-regulation of their translation in the axon in response to the axonal activation of the mTOR-p70S6K pathway. Taken together, we conclude that the local translation of CRMP2 and Tau, regulated by mTOR-p70S6K, is critical for the specification of neuronal polarity.	[Morita, Tsuyoshi; Sobue, Kenji] Osaka Univ, Dept Neurosci, Grad Sch Med, Suita, Osaka 5650871, Japan; [Sobue, Kenji] Osaka Univ, Res Ctr Child Mental Dev, Grad Sch Med, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Sobue, K (corresponding author), Osaka Univ, Dept Neurosci, Grad Sch Med, Yamadaoka 2-2, Suita, Osaka 5650871, Japan.	sobue@nbiochem.med.osaka-u.ac.jp			Japan Society for the Promotion of Science [20240038]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-aid for Scientific Research 20240038 from the Japan Society for the Promotion of Science ( to K. S.).	Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Aronov S, 2001, J NEUROSCI, V21, P6577, DOI 10.1523/JNEUROSCI.21-17-06577.2001; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; Choi YJ, 2008, GENE DEV, V22, P2485, DOI 10.1101/gad.1685008; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Hamilton TL, 2006, BIOCHEM SOC T, V34, P12, DOI 10.1042/BST0340012; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Li YH, 2008, J BIOL CHEM, V283, P33784, DOI 10.1074/jbc.M802431200; LITMAN P, 1993, NEURON, V10, P627, DOI 10.1016/0896-6273(93)90165-N; Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; PENG I, 1986, J CELL BIOL, V102, P252, DOI 10.1083/jcb.102.1.252; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Swiech L, 2008, BBA-PROTEINS PROTEOM, V1784, P116, DOI 10.1016/j.bbapap.2007.08.015; Tabancay AP, 2003, J BIOL CHEM, V278, P39921, DOI 10.1074/jbc.M306553200; Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001; Zhang WG, 2006, PROTEIN EXPRES PURIF, V46, P414, DOI 10.1016/j.pep.2005.08.012	26	96	106	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27734	27745		10.1074/jbc.M109.008177	http://dx.doi.org/10.1074/jbc.M109.008177			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19648118	hybrid, Green Published			2022-12-27	WOS:000270232300074
J	Swee, LK; Ingold-Salamin, K; Tardivel, A; Willen, L; Gaide, O; Favre, M; Demotz, S; Mikkola, M; Schneider, P				Swee, Lee Kim; Ingold-Salamin, Karine; Tardivel, Aubry; Willen, Laure; Gaide, Olivier; Favre, Manuel; Demotz, Stephane; Mikkola, Marja; Schneider, Pascal			Biological Activity of Ectodysplasin A Is Conditioned by Its Collagen and Heparan Sulfate Proteoglycan-binding Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; ECTODERMAL DYSPLASIA; TNF; EXPRESSION; LIGAND; FORM; SHH; IDENTIFICATION; REQUIREMENT	Mutations in the TNF family ligand EDA1 cause X-linked hypohidrotic ectodermal dysplasia (XLHED), a condition characterized by defective development of skin appendages. The EDA1 protein displays a proteolytic processing site responsible for its conversion to a soluble form, a collagen domain, and a trimeric TNF homology domain (THD) that binds the receptor EDAR. In-frame deletions in the collagen domain reduced the thermal stability of EDA1. Removal of the collagen domain decreased its activity about 100-fold, as measured with natural and engineered EDA1-responsive cell lines. The collagen domain could be functionally replaced by multimerization domains or by cross-linking antibodies, suggesting that it functions as an oligomerization unit. Surprisingly, mature soluble EDA1 containing the collagen domain was poorly active when administered in newborn, EDA-deficient (Tabby) mice. This was due to a short stretch of basic amino acids located at the N terminus of the collagen domain that confers EDA1 with proteoglycan binding ability. In contrast to wild-type EDA1, EDA1 with mutations in this basic sequence was a potent inducer of tail hair development in vivo. Thus, the collagen domain activates EDA1 by multimerization, whereas the proteoglycan-binding domain may restrict the distribution of endogeneous EDA1 in vivo.	[Swee, Lee Kim; Ingold-Salamin, Karine; Tardivel, Aubry; Willen, Laure; Gaide, Olivier; Schneider, Pascal] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Mikkola, Marja] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Favre, Manuel; Demotz, Stephane] Apoxis SA, CH-1004 Lausanne, Switzerland	University of Lausanne; University of Helsinki	Schneider, P (corresponding author), Univ Lausanne, Dept Biochem, Boveresses 155, CH-1066 Epalinges, Switzerland.	pascal.schneider@unil.ch		Schneider, Pascal/0000-0003-0677-9409	Swiss National Science Foundation; NCCR Molecular Oncology	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR Molecular Oncology(Swiss National Science Foundation (SNSF))	This work was supported by grants from the Swiss National Science Foundation and the NCCR Molecular Oncology.	Alcamo E, 2001, J IMMUNOL, V167, P1592, DOI 10.4049/jimmunol.167.3.1592; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Chen YW, 2001, P NATL ACAD SCI USA, V98, P7218, DOI 10.1073/pnas.131076098; Franch-Marro X, 2005, DEVELOPMENT, V132, P659, DOI 10.1242/dev.01639; Gaide O, 2003, NAT MED, V9, P614, DOI 10.1038/nm861; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Hammerschmidt B, 2007, DEV BIOL, V305, P246, DOI 10.1016/j.ydbio.2007.02.010; Han C, 2004, DEVELOPMENT, V131, P601, DOI 10.1242/dev.00958; Haswell LE, 2001, EUR J IMMUNOL, V31, P3094, DOI 10.1002/1521-4141(2001010)31:10<3094::AID-IMMU3094>3.0.CO;2-F; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Holler N, 2000, J IMMUNOL METHODS, V237, P159, DOI 10.1016/S0022-1759(99)00239-2; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Hymowitz SG, 2003, STRUCTURE, V11, P1513, DOI 10.1016/j.str.2003.11.009; Ingold K, 2005, J EXP MED, V201, P1375, DOI 10.1084/jem.20042309; Jackson RA, 2006, GENE, V379, P79, DOI 10.1016/j.gene.2006.04.028; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Lortat-Jacob H, 2002, P NATL ACAD SCI USA, V99, P1229, DOI 10.1073/pnas.032497699; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mikkola ML, 2008, CYTOKINE GROWTH F R, V19, P219, DOI 10.1016/j.cytogfr.2008.04.008; Monreal AW, 1998, AM J HUM GENET, V63, P380, DOI 10.1086/301984; Mou C, 2006, P NATL ACAD SCI USA, V103, P9075, DOI 10.1073/pnas.0600825103; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Pummila M, 2007, DEVELOPMENT, V134, P117, DOI 10.1242/dev.02708; Schmidt-Ullrich R, 2001, DEVELOPMENT, V128, P3843; Schmidt-Ullrich R, 2006, DEVELOPMENT, V133, P1045, DOI 10.1242/dev.02278; Schneider P, 2000, METHOD ENZYMOL, V322, P325; Schneider P, 2001, J BIOL CHEM, V276, P18819, DOI 10.1074/jbc.M101280200; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Srivastava AK, 2001, HUM MOL GENET, V10, P2973, DOI 10.1093/hmg/10.26.2973; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523	36	43	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27567	27576		10.1074/jbc.M109.042259	http://dx.doi.org/10.1074/jbc.M109.042259			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19657145	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000270232300058
J	Cottle, DL; McGrath, MJ; Wilding, BR; Cowling, BS; Kane, JM; D'Arcy, CE; Holdsworth, M; Hatzinisiriou, I; Prescott, M; Brown, S; Mitchell, CA				Cottle, Denny L.; McGrath, Meagan J.; Wilding, Brendan R.; Cowling, Belinda S.; Kane, Jordan M.; D'Arcy, Colleen E.; Holdsworth, Melissa; Hatzinisiriou, Irene; Prescott, Mark; Brown, Susan; Mitchell, Christina A.			SLIMMER (FHL1B/KyoT3) Interacts with the Proapoptotic Protein Siva-1 (CD27BP) and Delays Skeletal Myoblast Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RBP-J; MUSCULAR-DYSTROPHY; LIM PROTEIN; BINDING PROTEIN; SATELLITE CELLS; ALPHA-ACTININ; MUSCLE; EXPRESSION; GENE; FHL1	The fhl1 gene encoding four-and-a-half LIM protein-1 (FHL1) and its spliced isoform, SLIMMER, is mutated in reducing body myopathy, X-linked myopathy with postural muscle atrophy, scapuloperoneal myopathy, and rigid spine syndrome. In this study we have identified a novel function for SLIMMER in delaying skeletal muscle apoptosis via an interaction with the proapoptotic protein Siva-1. Siva-1 was identified as a SLIMMER-specific-interacting protein using yeast two-hybrid screening, direct-binding studies, and glutathione S-transferase pulldown analysis of murine skeletal muscle lysates. In C2C12 skeletal myoblasts, SLIMMER and Siva co-localized in the nucleus; however, both proteins exhibited redistribution to the cytoplasm following the differentiation of mononucleated myoblasts to multinucleated myotubes. In sections of mature skeletal muscle from wild type mice, SLIMMER and Siva-1 colocalized at the Z-line. SLIMMER and Siva-1 were also enriched in Pax-7-positive satellite cells, muscle stem cells that facilitate repair and regeneration. Significantly, SLIMMER delayed Siva-1-dependent apoptosis in C2C12 myoblasts. In skeletal muscle sections from the mdx mouse model of Duchenne muscular dystrophy, SLIMMER and Siva-1 co-localized in the nucleus of apoptotic myofibers. Therefore, SLIMMER may protect skeletal muscle from apoptosis.	[Cottle, Denny L.; McGrath, Meagan J.; Wilding, Brendan R.; Cowling, Belinda S.; Kane, Jordan M.; D'Arcy, Colleen E.; Holdsworth, Melissa; Hatzinisiriou, Irene; Prescott, Mark; Brown, Susan; Mitchell, Christina A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	Monash University	Mitchell, CA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Bldg 76,Wellington Rd, Clayton, Vic 3800, Australia.	christina.mitchell@med.monash.edu.au	Cottle, Denny/AAN-1574-2020; Cottle, Denny/G-4278-2013; Cowling, Belinda S/O-2730-2016	Cottle, Denny/0000-0001-5047-6515; Cowling, Belinda S/0000-0001-6915-2596; McGrath, Meagan/0000-0002-9414-6558; Mitchell, Christina A/0000-0001-9372-3192	National Health and Medical Research Council, Australia [9284272]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Grant 9284272 from the National Health and Medical Research Council, Australia.	Arsic N, 2004, MOL THER, V10, P844, DOI 10.1016/j.ymthe.2004.08.007; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Brown S, 1999, J BIOL CHEM, V274, P27083, DOI 10.1074/jbc.274.38.27083; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Chu F, 2005, CANCER RES, V65, P5301, DOI 10.1158/0008-5472.CAN-04-3270; Chu F, 2004, APOPTOSIS, V9, P83, DOI 10.1023/B:APPT.0000012125.01799.4c; Coghill ID, 2003, J BIOL CHEM, V278, P24139, DOI 10.1074/jbc.M213259200; Cottle DL, 2007, J CELL SCI, V120, P1423, DOI 10.1242/jcs.004739; Cowling BS, 2008, J CELL BIOL, V183, P1033, DOI 10.1083/jcb.200804077; Daoud SS, 2003, CANCER RES, V63, P2782; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; Dirks AJ, 2005, SPORTS MED, V35, P473, DOI 10.2165/00007256-200535060-00002; E SY, 2009, J BIOL CHEM, V284, P14558, DOI 10.1074/jbc.M900185200; Fimia GM, 2000, MOL CELL BIOL, V20, P8613, DOI 10.1128/MCB.20.22.8613-8622.2000; Fortin A, 2004, J BIOL CHEM, V279, P28706, DOI 10.1074/jbc.M400376200; Greene WK, 1999, GENE, V232, P203, DOI 10.1016/S0378-1119(99)00125-0; Henke A, 2000, J VIROL, V74, P4284, DOI 10.1128/JVI.74.9.4284-4290.2000; Ikezoe K, 2004, ACTA NEUROPATHOL, V107, P439, DOI 10.1007/s00401-004-0831-5; Jacobs SBR, 2007, CELL DEATH DIFFER, V14, P1374, DOI 10.1038/sj.cdd.4402128; Jejurikar SS, 2006, EXP GERONTOL, V41, P828, DOI 10.1016/j.exger.2006.06.053; Jejurikar SS, 2003, APOPTOSIS, V8, P573, DOI 10.1023/A:1026127307457; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; LANE BP, 1977, J HISTOCHEM CYTOCHEM, V25, P69, DOI 10.1177/25.1.833423; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Liang L, 2008, BBA-GENE REGUL MECH, V1779, P805, DOI 10.1016/j.bbagrm.2008.08.001; Lin FT, 2007, J BIOL CHEM, V282, P37759, DOI 10.1074/jbc.M705025200; Ljungberg K, 2007, J VIROL, V81, P13412, DOI 10.1128/JVI.01799-07; Marzetti E, 2008, FREE RADICAL BIO MED, V44, P160, DOI 10.1016/j.freeradbiomed.2007.05.028; McGrath MJ, 2006, J BIOL CHEM, V281, P7666, DOI 10.1074/jbc.M512552200; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Morgan MJ, 1999, BIOCHEM BIOPH RES CO, V255, P245, DOI 10.1006/bbrc.1999.0179; OKA C, 1995, DEVELOPMENT, V121, P3291; Padanilam BJ, 1998, KIDNEY INT, V54, P1967, DOI 10.1046/j.1523-1755.1998.00197.x; Pollack M, 2001, J GERONTOL A-BIOL, V56, pB475, DOI 10.1093/gerona/56.11.B475; Prasad KVS, 1997, P NATL ACAD SCI USA, V94, P6346, DOI 10.1073/pnas.94.12.6346; Py B, 2004, J IMMUNOL, V172, P4008, DOI 10.4049/jimmunol.172.7.4008; Qin HY, 2005, FEBS LETT, V579, P1220, DOI 10.1016/j.febslet.2005.01.022; Qin HY, 2004, NUCLEIC ACIDS RES, V32, P1492, DOI 10.1093/nar/gkh295; Qin LF, 2002, LIFE SCI, V70, P1677, DOI 10.1016/S0024-3205(01)01554-5; Quinzi CM, 2008, AM J HUM GENET, V82, P208, DOI 10.1016/j.ajhg.2007.09.013; Raj GV, 2004, PROSTATE, V61, P105, DOI 10.1002/pros.20083; Sandri M, 2001, J NEUROPATH EXP NEUR, V60, P302, DOI 10.1093/jnen/60.3.302; Sandri M, 1998, LAB INVEST, V78, P1005; Sandri M, 1999, INT J BIOCHEM CELL B, V31, P1373, DOI 10.1016/S1357-2725(99)00063-1; Sandri M, 1998, NEUROSCI LETT, V252, P123, DOI 10.1016/S0304-3940(98)00563-1; Schessl J, 2008, J CLIN INVEST, V118, P904, DOI 10.1172/JCI34450; Schessl J, 2009, BRAIN, V132, P452, DOI 10.1093/brain/awn325; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Severino A, 2007, J CELL PHYSIOL, V212, P118, DOI 10.1002/jcp.21011; Shalaby S, 2009, NEUROLOGY, V72, P375, DOI 10.1212/01.wnl.0000341311.84347.a0; Shalaby S, 2008, NEUROMUSCULAR DISORD, V18, P959, DOI 10.1016/j.nmd.2008.09.012; Siu PM, 2005, AM J PHYSIOL-CELL PH, V288, pC338, DOI 10.1152/ajpcell.00239.2004; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; Taniguchi Y, 1998, MOL CELL BIOL, V18, P644, DOI 10.1128/MCB.18.1.644; TIDBALL JG, 1995, J CELL SCI, V108, P2197; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; Whitman SA, 2005, PFLUG ARCH EUR J PHY, V450, P437, DOI 10.1007/s00424-005-1473-8; Windpassinger C, 2008, AM J HUM GENET, V82, P88, DOI 10.1016/j.ajhg.2007.09.004; Xue L, 2002, P NATL ACAD SCI USA, V99, P6925, DOI 10.1073/pnas.102182299; Yoon Y, 1999, ONCOGENE, V18, P7174, DOI 10.1038/sj.onc.1203144; 2008, MOL DIAGN THER, V12, P99	62	13	13	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26964	26977		10.1074/jbc.M109.036293	http://dx.doi.org/10.1074/jbc.M109.036293			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19643733	Green Published, hybrid			2022-12-27	WOS:000269969600076
J	Munkonge, FM; Amin, V; Hyde, SC; Green, AM; Pringle, IA; Gill, DR; Smith, JWS; Hooley, RP; Xenariou, S; Ward, MA; Leeds, N; Leung, KY; Chan, M; Hillery, E; Geddes, DM; Griesenbach, U; Postel, EH; Dean, DA; Dunn, MJ; Alton, EWFW				Munkonge, Felix M.; Amin, Vaksha; Hyde, Stephen C.; Green, Anne-Marie; Pringle, Ian A.; Gill, Deborah R.; Smith, Joel W. S.; Hooley, Robert P.; Xenariou, Stefania; Ward, Malcolm A.; Leeds, Nicola; Leung, Kit-Yi; Chan, Mario; Hillery, Elizabeth; Geddes, Duncan M.; Griesenbach, Uta; Postel, Edith H.; Dean, David A.; Dunn, Michael J.; Alton, Eric W. F. W.			Identification and Functional Characterization of Cytoplasmic Determinants of Plasmid DNA Nuclear Import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENE EXPRESSION; MAMMALIAN-CELLS; GENE-TRANSFER; DIPHOSPHATE KINASE; PROTEIN; LOCALIZATION; SEQUENCES; TRANSPORT; REQUIRES; SIGNALS	Import of exogenous plasmid DNA (pDNA) into mammalian cell nuclei represents a key intracellular obstacle to efficient non-viral gene delivery. This includes access of the pDNA to the nuclei of non-dividing cells where the presence of an intact nuclear membrane is limiting for gene transfer. Here we identify, isolate, and characterize, cytoplasmic determinants of pDNA nuclear import into digitonin-permeabilized HeLa cells. Depletion of putative DNA-binding proteins, on the basis of their ability to bind immobilized pDNA, abolished pDNA nuclear import supporting the critical role of cytoplasmic factors in this process. Elution of pDNA-bound proteins, followed by two-dimensional sodium dodecyl polyacrylamide gel electrophoresis identified several candidate DNA shuttle proteins. We show that two of these, NM23-H2, a ubiquitous c-Myc transcription-activating nucleoside diphosphate kinase, and the core histone H2B can both reconstitute pDNA nuclear import. Further, we demonstrate a significant increase in gene transfer in non-dividing HeLa cells transiently transfected with pDNA containing binding sequences from two of the DNA shuttle proteins, NM23-H2 and the homeobox transcription factor Chx10. These data support the hypothesis that exogenous pDNA binds to cytoplasmic shuttle proteins and is then translocated to the nucleus using the minimal import machinery. Importantly, increasing the binding of pDNA to shuttle proteins by re-engineering reporter plasmids with shuttle binding sequences enhances gene transfer. Increasing the potential for exogenously added pDNA to bind intracellular transport cofactors may enhance the potency of non-viral gene transfer.	[Munkonge, Felix M.; Smith, Joel W. S.; Hooley, Robert P.; Xenariou, Stefania; Alton, Eric W. F. W.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Fac Med, Dept Gene Therapy, London SW3 6LR, England; [Munkonge, Felix M.; Hyde, Stephen C.; Green, Anne-Marie; Pringle, Ian A.; Gill, Deborah R.; Smith, Joel W. S.; Hooley, Robert P.; Xenariou, Stefania; Chan, Mario; Hillery, Elizabeth; Geddes, Duncan M.; Griesenbach, Uta; Alton, Eric W. F. W.] Kings Coll London, UK Cyst Fibrosis Gene Therapy Consortium, London SE5 8AF, England; [Amin, Vaksha; Ward, Malcolm A.; Leeds, Nicola; Leung, Kit-Yi] Kings Coll London, Inst Psychiat, S Wing Lab, London SE5 8AF, England; [Hyde, Stephen C.; Green, Anne-Marie; Pringle, Ian A.; Gill, Deborah R.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 0NR, England; [Postel, Edith H.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, New Brunswick, NJ 08903 USA; [Dean, David A.] Univ Rochester, Sch Med & Dent, Div Neonatol, Rochester, NY 14642 USA; [Dunn, Michael J.] Univ Coll Dublin, Proteome Res Ctr, UCD Conway Inst Bimol & Biomed Res, Dublin 4, Ireland	Imperial College London; University of London; King's College London; University of London; King's College London; University of Oxford; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Rochester; University College Dublin	Munkonge, FM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Fac Med, Dept Gene Therapy, London SW3 6LR, England.	f.munkonge@imperial.ac.uk		Griesenbach, Uta/0000-0002-8254-4540; Gill, Deborah/0000-0002-5264-054X; Hyde, Stephen/0000-0002-8877-4005	National Institutes of Health [HL59956]; Cystic Fibrosis Trust, UK; Wellcome Trust Senior Clinical Fellowship; NATIONAL CANCER INSTITUTE [R01CA076496] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059956] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Trust, UK; Wellcome Trust Senior Clinical Fellowship(Wellcome Trust); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL59956 (to D. A. D.). This work was also supported by the Cystic Fibrosis Trust, UK and a Wellcome Trust Senior Clinical Fellowship (to E. W. F. W. A.).	Al-Mohanna MA, 2001, CARCINOGENESIS, V22, P573, DOI 10.1093/carcin/22.4.573; Basner-Tschakarjan E, 2004, GENE THER, V11, P765, DOI 10.1038/sj.gt.3302221; Cartier R, 2002, GENE THER, V9, P157, DOI 10.1038/sj.gt.3301635; Dean DA, 1999, EXP CELL RES, V253, P713, DOI 10.1006/excr.1999.4716; Fritz JD, 1996, HUM GENE THER, V7, P1395, DOI 10.1089/hum.1996.7.12-1395; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hillery E, 2006, ANAL BIOCHEM, V352, P169, DOI 10.1016/j.ab.2006.02.021; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Karmirantzou M, 2001, PROTEIN ENG, V14, P465, DOI 10.1093/protein/14.7.465; Kim JW, 2004, MOL CELL BIOL, V24, P5923, DOI 10.1128/MCB.24.13.5923-5936.2004; Kuramoto T, 2006, J GENE MED, V8, P53, DOI 10.1002/jgm.812; Langer T, 2000, HISTOCHEM CELL BIOL, V113, P455; Langle-Rouault F, 1998, J VIROL, V72, P6181; Leung SM, 1997, J BIOL CHEM, V272, P2607, DOI 10.1074/jbc.272.5.2607; Mesika A, 2001, MOL THER, V3, P653, DOI 10.1006/mthe.2001.0312; Miller AM, 2008, GENE THER, V15, P1107, DOI 10.1038/gt.2008.83; Munkonge FM, 2003, ADV DRUG DELIVER REV, V55, P749, DOI 10.1016/S0169-409X(03)00050-4; Nair R, 2004, NUCLEIC ACIDS RES, V32, pW517, DOI 10.1093/nar/gkh441; Nishikawa M, 2001, HUM GENE THER, V12, P861, DOI 10.1089/104303401750195836; OKUNO Y, 1993, EXP CELL RES, V206, P134, DOI 10.1006/excr.1993.1129; Percin EF, 2000, NAT GENET, V25, P397, DOI 10.1038/78071; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Postel EH, 1999, J BIOL CHEM, V274, P22821, DOI 10.1074/jbc.274.32.22821; Thanaketpaisarn O, 2008, J BIOTECHNOL, V133, P36, DOI 10.1016/j.jbiotec.2007.08.047; Tseng WC, 1999, BBA-GENE STRUCT EXPR, V1445, P53, DOI 10.1016/S0167-4781(99)00039-1; Tsukahara F, 2004, J BIOL CHEM, V279, P8867, DOI 10.1074/jbc.M308848200; Vacik J, 1999, GENE THER, V6, P1006, DOI 10.1038/sj.gt.3300924; Wilson GL, 1999, J BIOL CHEM, V274, P22025, DOI 10.1074/jbc.274.31.22025	29	35	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26978	26987		10.1074/jbc.M109.034850	http://dx.doi.org/10.1074/jbc.M109.034850			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19638341	hybrid, Green Published			2022-12-27	WOS:000269969600077
J	Lima, WF; Wu, HJ; Nichols, JG; Sun, H; Murray, HM; Crooke, ST				Lima, Walt F.; Wu, Hongjiang; Nichols, Josh G.; Sun, Hong; Murray, Heather M.; Crooke, Stanley T.			Binding and Cleavage Specificities of Human Argonaute2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; MESSENGER-RNA; SILENCING COMPLEX; PAZ DOMAIN; C-ELEGANS; INTERFERENCE; PROTEIN; SIRNA	The endonuclease Argonaute2 (Ago2) mediates the degradation of the target mRNA within the RNA-induced silencing complex. We determined the binding and cleavage properties of recombinant human Ago2. Human Ago2 was unable to cleave preformed RNA duplexes and exhibited weaker binding affinity for RNA duplexes compared with the single strand RNA. The enzyme exhibited greater RNase H activity in the presence of Mn2+ compared with Mg2+. Human Ago2 exhibited weaker binding affinities and reduced cleavage activities for antisense RNAs with either a 5'-terminal hydroxyl or abasic nucleotide. Binding kinetics suggest that the 5'-terminal heterocycle base nucleates the interaction between the enzyme and the antisense RNA, and the 5'-phosphate stabilizes the interaction. Mn2+ ameliorated the effects of the 5'-terminal hydroxyl or abasic nucleotide on Ago2 cleavage activity and binding affinity. Nucleotide substitutions at the 3' terminus of the antisense RNA had no effect on human Ago2 cleavage activity, whereas 2'-methoxyethyl substitutions at position 2 reduced binding and cleavage activity and 12-14 reduced the cleavage activity. RNase protection assays indicated that human Ago2 interacts with the first 14 nucleotides at the 5'-pole of the antisense RNA. Human Ago2 preloaded with the antisense RNA exhibited greater binding affinities for longer sense RNAs suggesting that the enzyme interacts with regions in the sense RNA outside the site for antisense hybridization. Finally, transiently expressed human Ago2 immunoprecipitated from HeLa cells contained the double strand RNA-binding protein human immunodeficiency virus, type 1, trans-activating response RNA-binding protein, and deletion mutants of Ago2 showed that trans-activating response RNA-binding protein interacts with the PIWI domain of the enzyme.	[Lima, Walt F.; Wu, Hongjiang; Nichols, Josh G.; Sun, Hong; Murray, Heather M.; Crooke, Stanley T.] Isis Pharmaceut Inc, Dept Biol Mol & Struct, Carlsbad, CA 92008 USA	Isis Pharmaceuticals Inc	Lima, WF (corresponding author), Isis Pharmaceut Inc, Dept Biol Mol & Struct, Carlsbad, CA 92008 USA.	wlima@isisph.com	Murray, Heather/GQY-8016-2022					Ausubel FM., 1988, CURRENT PROTOCOLS MO; Baker BF, 1997, J BIOL CHEM, V272, P11994, DOI 10.1074/jbc.272.18.11994; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Egli M, 1996, BIOCHEMISTRY-US, V35, P8489, DOI 10.1021/bi9607214; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; FEDOROFF OY, 1993, J MOL BIOL, V233, P509, DOI 10.1006/jmbi.1993.1528; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; Goedken ER, 2001, J BIOL CHEM, V276, P7266, DOI 10.1074/jbc.M009626200; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; IKEHARA M, 1986, P NATL ACAD SCI USA, V83, P4695, DOI 10.1073/pnas.83.13.4695; KATAYANAGI K, 1993, PROTEINS, V17, P337, DOI 10.1002/prot.340170402; KATAYANAGI K, 1992, J MOL BIOL, V223, P1029, DOI 10.1016/0022-2836(92)90260-Q; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Lima WF, 2009, J BIOL CHEM, V284, P2535, DOI 10.1074/jbc.M803748200; Lima WF, 1997, BIOCHEMISTRY-US, V36, P390, DOI 10.1021/bi962230p; Lima WF, 2004, J BIOL CHEM, V279, P36317, DOI 10.1074/jbc.M405035200; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; McKay RA, 1999, J BIOL CHEM, V274, P1715, DOI 10.1074/jbc.274.3.1715; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; SAENGER W, 1984, PRINCIPLES NUCLEIC A, P24; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Tomari Y, 2005, CURR BIOL, V15, pR61, DOI 10.1016/j.cub.2004.12.057; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wu HJ, 1999, J BIOL CHEM, V274, P28270, DOI 10.1074/jbc.274.40.28270; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	41	84	97	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26017	26028		10.1074/jbc.M109.010835	http://dx.doi.org/10.1074/jbc.M109.010835			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19625255	Green Published, hybrid			2022-12-27	WOS:000269738000058
J	Ceribelli, M; Benatti, P; Imbriano, C; Mantovani, R				Ceribelli, Michele; Benatti, Paolo; Imbriano, Carol; Mantovani, Roberto			NF-YC Complexity Is Generated by Dual Promoters and Alternative Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ANALYSIS; TRANSCRIPTION FACTORS; 3RD SUBUNIT; B-SUBUNIT; CBF-C; BINDING; GENES; DOMAINS; IDENTIFICATION; RECRUITMENT	The CCAAT box is a DNA element present in the majority of human promoters, bound by the trimeric NF-Y, composed of NF-YA, NF-YB, and NF-YC subunits. We describe and characterize novel isoforms of one of the two histone-like subunits, NF-YC. The locus generates a minimum of four splicing products, mainly located within the Q-rich activation domain. The abundance of each isoform is cell-dependent; only one major NF-YC isoform is present in a given cell type. The 37- and 50-kDa isoforms are mutually exclusive, and preferential pairings with NF-YA isoforms possess different transcriptional activities, with specific combinations being more active on selected promoters. The transcriptional regulation of the NF-YC locus is also complex, and mRNAs arise from the two promoters P1 and P2. Transient transfections, chromatin immunoprecipitations, and reverse transcription-PCRs indicate that P1 has a robust housekeeping activity; P2 possesses a lower basal activity, but it is induced in response to DNA damage in a p53-dependent way. Alternative promoter usage directly affects NF-YC splicing, with the 50-kDa transcript being excluded from P2. Specific functional inactivation of the 37- kDa isoform affects the basal levels of G(1)/S blocking and proapoptotic genes but not G(2)/M promoters. In summary, our data highlight an unexpected degree of complexity and regulation of the NF-YC gene, demonstrating the existence of a discrete cohort of NF-Y trimer subtypes resulting from the functional diversification of Q-rich transactivating subunits and a specific role of the 37- kDa isoform in suppression of the DNA damage-response under growing conditions.	Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20133 Milan, Italy; [Benatti, Paolo; Imbriano, Carol] Univ Modena & Reggio Emilia, Dipartimento Biol Anim, I-41100 Modena, Italy	University of Milan; Universita di Modena e Reggio Emilia		mantor@unimi.it	Imbriano, Carol/C-9376-2015; Imbriano, Carol/ABD-8204-2021	Imbriano, Carol/0000-0003-2864-4820; Imbriano, Carol/0000-0003-2864-4820	Associazione Italiana per la Ricerca sul Cancro; CARIPLO-Nobel	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); CARIPLO-Nobel(Fondazione Cariplo)	Supported by My First AIRC Grant from the Associazione Italiana per la Ricerca sul Cancro.; Supported by AIRC and CARIPLO-Nobel grants. To whom correspondence should be addressed. Fax: 390250315044; E-mail: mantor@unimi.it.	Bellorini M, 1997, GENE, V193, P119, DOI 10.1016/S0378-1119(97)00109-1; Bellorini M, 1997, NUCLEIC ACIDS RES, V25, P2174, DOI 10.1093/nar/25.11.2174; Benatti P, 2008, NUCLEIC ACIDS RES, V36, P1415, DOI 10.1093/nar/gkm1046; Bhattacharya A, 2003, CANCER RES, V63, P8167; Borrelli S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-85; Castrignano T, 2008, BIOINFORMATICS, V24, P1300, DOI 10.1093/bioinformatics/btn113; Ceribelli M, 2008, MOL CELL BIOL, V28, P2047, DOI 10.1128/MCB.01861-07; Ceribelli M, 2006, CELL CYCLE, V5, P1102, DOI 10.4161/cc.5.10.2777; Chen FF, 2002, BIOCHEM J, V364, P571, DOI 10.1042/BJ20011703; Coustry F, 1996, J BIOL CHEM, V271, P14485, DOI 10.1074/jbc.271.24.14485; di Silvio A, 1999, NUCLEIC ACIDS RES, V27, P2578; Donati G, 2006, NUCLEIC ACIDS RES, V34, P3116, DOI 10.1093/nar/gkl304; DORN A, 1987, CELL, V50, P863, DOI 10.1016/0092-8674(87)90513-7; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; FitzGerald PC, 2004, GENOME RES, V14, P1562, DOI 10.1101/gr.1953904; Frontini M, 2002, J BIOL CHEM, V277, P5841, DOI 10.1074/jbc.M103651200; Ge YB, 2002, BBA-GENE STRUCT EXPR, V1579, P73, DOI 10.1016/S0167-4781(02)00509-2; Grskovic M, 2007, PLOS GENET, V3, P1524, DOI 10.1371/journal.pgen.0030145; Huang HY, 2006, NUCLEIC ACIDS RES, V34, pW429, DOI 10.1093/nar/gkl333; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Kabe Y, 2005, MOL CELL BIOL, V25, P512, DOI 10.1128/MCB.25.1.512-522.2005; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Lee J, 2007, PLOS COMPUT BIOL, V3, P721, DOI 10.1371/journal.pcbi.0030067; LI XY, 1992, J BIOL CHEM, V267, P8984; Liberati C, 1999, J MOL BIOL, V285, P1441, DOI 10.1006/jmbi.1998.2384; Lipscombe D, 2005, CURR OPIN NEUROBIOL, V15, P358, DOI 10.1016/j.conb.2005.04.002; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; Marino-Ramirez L, 2004, NUCLEIC ACIDS RES, V32, P949, DOI 10.1093/nar/gkh246; Miao F, 2005, MOL CELL BIOL, V25, P4650, DOI 10.1128/MCB.25.11.4650-4661.2005; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Siefers N, 2009, PLANT PHYSIOL, V149, P625, DOI 10.1104/pp.108.130591; Singer GAC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-349; Sinha S, 1996, GENOMICS, V37, P260, DOI 10.1006/geno.1996.0555; SINHA S, 1995, P NATL ACAD SCI USA, V92, P1624, DOI 10.1073/pnas.92.5.1624; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Suzuki Y, 2001, GENOME RES, V11, P677, DOI 10.1101/gr.GR-1640R; Suzuki Yutaka, 2004, In Silico Biology, V4, P429; Tabach Y, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100030; Testa A, 2005, J BIOL CHEM, V280, P13606, DOI 10.1074/jbc.M414039200; Xin DD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002377; Yang J, 2005, NEW PHYTOL, V165, P623, DOI 10.1111/j.1469-8137.2004.01260.x; Zhu J, 2005, P NATL ACAD SCI USA, V102, P11728, DOI 10.1073/pnas.0503405102; Zhu Z, 2005, GENOME RES, V15, P848, DOI 10.1101/gr.3394405	49	26	27	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34189	34200		10.1074/jbc.M109.008417	http://dx.doi.org/10.1074/jbc.M109.008417			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19690168	Green Published, hybrid			2022-12-27	WOS:000272165200051
J	Kim, S; Mangin, P; Dangelmaier, C; Lillian, R; Jackson, SP; Daniel, JL; Kunapuli, SP				Kim, Soochong; Mangin, Pierre; Dangelmaier, Carol; Lillian, Rivka; Jackson, Shaun P.; Daniel, James L.; Kunapuli, Satya P.			Role of Phosphoinositide 3-Kinase beta in Glycoprotein VI-mediated Akt Activation in Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-GAMMA-CHAIN; PROTEIN-KINASE-B; COLLAGEN RECEPTOR; TYROSINE PHOSPHORYLATION; FACTOR-I; ANTITHROMBOTIC THERAPY; ADENOSINE-DIPHOSPHATE; SIGNAL-TRANSDUCTION; T-CELLS; C-SRC	Glycoprotein (GP) VI is a critical platelet collagen receptor. Phosphoinositide 3-kinase (PI3K) plays an important role in GPVI-mediated platelet activation, yet the major PI3K isoforms involved in this process have not been identified. In addition, stimulation of GPVI results in the activation of Akt, a downstream effector of PI3K. Thus, we investigated the contribution of PI3K isoforms to GPVI-mediated platelet activation and Akt activation. A protein kinase C inhibitor GF 109203X or a P2Y(12) receptor antagonist AR-C69931MX partly reduced GPVI-induced Akt phosphorylation. Platelets from mice dosed with clopidogrel also showed partial Akt phosphorylation, indicating that GPVI-mediated Akt phosphorylation is regulated by both secretion-dependent and -independent pathways. In addition, GPVI-induced Akt phosphorylation in the presence of ADP antagonists was completely inhibited by PI3K inhibitor LY294002 and PI3K beta inhibitor TGX-221 indicating an essential role of PI3K beta in Akt activation directly downstream of GPVI. Moreover, GPVI-mediated platelet aggregation, secretion, and intracellular Ca2+ mobilization were significantly inhibited by TGX-221, and less strongly inhibited by PI3K alpha inhibitor PIK75, but were not affected by PI3K gamma inhibitor AS252424 and PI3K delta inhibitor IC87114. Consistently, GPVI-induced integrin alpha(IIb)beta(3) activation of PI3K gamma(-/-) and PI3K delta(-/-) platelets also showed no significant difference compared with wild-type platelets. These results demonstrate that GPVI-induced Akt activation in platelets is dependent in part on G(1) stimulation through P2Y12 receptor activation by secreted ADP. In addition, a significant portion of GPVI-dependent, ADP-independent Akt activation also exists, and PI3K beta plays an essential role in GPVI-mediated platelet aggregation and Akt activation.	[Kunapuli, Satya P.] Temple Univ, Dept Physiol, Sch Med, Philadelphia, PA 19140 USA; [Kim, Soochong; Kunapuli, Satya P.] Temple Univ, Sol Sherry Thrombosis Res Ctr, Sch Med, Philadelphia, PA 19140 USA; [Dangelmaier, Carol; Daniel, James L.; Kunapuli, Satya P.] Temple Univ, Dept Pharmacol, Sch Med, Philadelphia, PA 19140 USA; [Mangin, Pierre; Lillian, Rivka; Jackson, Shaun P.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Monash University	Kunapuli, SP (corresponding author), Temple Univ, Dept Physiol, Sch Med, 3420 N Broad St, Philadelphia, PA 19140 USA.	spk@temple.edu	Mangin, Pierre/H-9354-2016	Jackson, Shaun/0000-0002-4750-1991	National Institutes of Health [HL60683, HL80444]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060683, R01HL080444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL60683 and HL80444 ( to S. P. K.).	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Asazuma N, 2000, J BIOL CHEM, V275, P33427, DOI 10.1074/jbc.M001439200; Barry FA, 2002, J BIOL CHEM, V277, P12874, DOI 10.1074/jbc.M200482200; Baurand A, 2001, EUR J PHARMACOL, V412, P213, DOI 10.1016/S0014-2999(01)00733-6; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; CANOBBIO I, 2009, BLOOD IN PRESS; Chen JH, 2004, BLOOD, V104, P1703, DOI 10.1182/blood-2003-10-3428; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; Cho MJ, 2002, BLOOD, V99, P2442, DOI 10.1182/blood.V99.7.2442; CLAPHAM DE, 1997, ANN REV PHARM TOXICO, V167, P203; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; DANIEL JL, 1994, BIOCHEM J, V302, P617, DOI 10.1042/bj3020617; Ezumi Y, 1998, J EXP MED, V188, P267, DOI 10.1084/jem.188.2.267; Geiger J, 1999, ARTERIOSCL THROM VAS, V19, P2007, DOI 10.1161/01.ATV.19.8.2007; Gibbins J, 1996, J BIOL CHEM, V271, P18095, DOI 10.1074/jbc.271.30.18095; Gibbins JM, 1998, J BIOL CHEM, V273, P34437, DOI 10.1074/jbc.273.51.34437; Gibbins JM, 1997, FEBS LETT, V413, P255, DOI 10.1016/S0014-5793(97)00926-5; Gilio K, 2009, J BIOL CHEM, V284, P33750, DOI 10.1074/jbc.M109.048439; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hayakawa M, 2006, BIOORGAN MED CHEM, V14, P6847, DOI 10.1016/j.bmc.2006.06.046; Hers I, 2007, BLOOD, V110, P4243, DOI 10.1182/blood-2006-10-050633; Hirsch E, 2001, FASEB J, V15, P2019, DOI 10.1096/fj.00-0810fje; Hu YH, 2000, J MED CHEM, V43, P3045, DOI 10.1021/jm000117y; Ichinohe T, 1997, J BIOL CHEM, V272, P63; ICHINOHE T, 1995, J BIOL CHEM, V270, P28029; Ingall AH, 1999, J MED CHEM, V42, P213, DOI 10.1021/jm981072s; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Kauffenstein G, 2001, FEBS LETT, V505, P281, DOI 10.1016/S0014-5793(01)02824-1; Kim S, 2006, BLOOD, V107, P947, DOI 10.1182/blood-2005-07-3040; Kim S, 2004, J BIOL CHEM, V279, P4186, DOI 10.1074/jbc.M306162200; Kim S, 2007, BLOOD, V110, P4206, DOI 10.1182/blood-2007-03-080804; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kowalska MA, 2000, BLOOD, V96, P50, DOI 10.1182/blood.V96.1.50.013k40_50_57; Kroner C, 2000, J BIOL CHEM, V275, P27790, DOI 10.1074/jbc.M000540200; Lagrue AH, 1999, FEBS LETT, V448, P95, DOI 10.1016/S0014-5793(99)00340-3; Lova P, 2003, J BIOL CHEM, V278, P131, DOI 10.1074/jbc.M204821200; Maxwell MJ, 2004, J BIOL CHEM, V279, P32196, DOI 10.1074/jbc.M400746200; Nakatani K, 1999, J BIOL CHEM, V274, P21528, DOI 10.1074/jbc.274.31.21528; Nieswandt B, 2000, J BIOL CHEM, V275, P23998, DOI 10.1074/jbc.M003803200; Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Quek LS, 1998, CURR BIOL, V8, P1137, DOI 10.1016/S0960-9822(98)70471-3; Quek LS, 2000, BLOOD, V96, P4246; Quinter PG, 2007, J THROMB HAEMOST, V5, P362, DOI 10.1111/j.1538-7836.2007.02309.x; Quinton TM, 2002, BIOCHEM J, V368, P535, DOI 10.1042/BJ20020226; Quinton TM, 2002, BLOOD, V99, P3228, DOI 10.1182/blood.V99.9.3228; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Senis YA, 2005, PLATELETS, V16, P191, DOI 10.1080/09537100400016711; Smith U, 2000, BIOCHEM BIOPH RES CO, V268, P315, DOI 10.1006/bbrc.2000.2145; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Trumel C, 1999, BLOOD, V94, P4156, DOI 10.1182/blood.V94.12.4156.424k29_4156_4165; Tsuji M, 1997, J BIOL CHEM, V272, P23528, DOI 10.1074/jbc.272.38.23528; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Watson SP, 1998, IMMUNOL TODAY, V19, P260, DOI 10.1016/S0167-5699(98)01267-5; Watson SP, 2001, THROMB HAEMOSTASIS, V86, P276; Woulfe D, 2004, J CLIN INVEST, V113, P441, DOI 10.1172/JCI200420267; Yang J, 2000, P NATL ACAD SCI USA, V97, P9984, DOI 10.1073/pnas.180194597	61	98	101	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33763	33772		10.1074/jbc.M109.048553	http://dx.doi.org/10.1074/jbc.M109.048553			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19700402	hybrid, Green Published			2022-12-27	WOS:000272165200006
J	Lian, N; Wang, WG; Li, LZ; Elefteriou, F; Yang, XL				Lian, Na; Wang, Weiguang; Li, Lingzhen; Elefteriou, Florent; Yang, Xiangli			Vimentin Inhibits ATF4-mediated Osteocalcin Transcription and Osteoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE LACKING VIMENTIN; INTERMEDIATE-FILAMENT; TRANSGENIC MICE; BONE-FORMATION; CELLS; EXPRESSION; PROTEINS; GENE; BINDING; ATF4	Activating transcription factor 4 (ATF4) is an osteoblast-enriched transcription factor that regulates osteocalcin transcription and osteoblast terminal differentiation. To identify functional partners of ATF4, we applied ROS17/2.8 osteoblast nuclear extracts and purified recombinant His-ATF4 onto a Ni+ affinity matrix chromatography column. Vimentin was identified by liquid chromatography-mass spectrometry. Coimmunoprecipitation and pulldown assays revealed that vimentin interacted with ATF4 with its first leucine zipper domain. DNA cotransfection and gel retardation demonstrated that vimentin inhibited the transactivation activity of ATF4 on osteocalcin by preventing it to bind OSE1, the ATF4 binding site on the osteocalcin promoter. Northern hybridization revealed that vimentin was expressed at a high level in immature osteoblasts and a low level in fully differentiated osteoblasts. Down-regulation of vimentin by small interfering RNA induced endogenous osteocalcin transcription in immature osteoblasts. Conversely, ectopic overexpression of vimentin in osteoblasts inhibited osteoblast differentiation as shown by lower alkaline phosphatase activity, delayed mineralization, and decreased expression of osteoblast marker genes such as bone sialoprotein and osteocalcin. Together, our data uncover a novel mechanism whereby a cytoskeletal protein, vimentin, acts as a break on differentiation in immature osteoblasts by interacting with ATF4.	[Li, Lingzhen; Elefteriou, Florent; Yang, Xiangli] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Lian, Na; Wang, Weiguang; Li, Lingzhen; Elefteriou, Florent; Yang, Xiangli] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Lian, Na; Wang, Weiguang; Li, Lingzhen; Elefteriou, Florent; Yang, Xiangli] Vanderbilt Univ, Med Ctr, Ctr Bone Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Yang, XL (corresponding author), 2215B Garland Ave,1225F MRB 4, Nashville, TN 37232 USA.	xiangli.yang@vanderbilt.edu	Elefteriou, Florent/P-2586-2017; Elefteriou, Florent/GMW-8429-2022	Elefteriou, Florent/0000-0002-2972-5633; Elefteriou, Florent/0000-0002-2972-5633; Elefteriou, Xiangli/0000-0002-2333-8747	Vanderbilt University career developmental; University of Texas Health Science Center at San Antonio; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE017111] Funding Source: NIH RePORTER	Vanderbilt University career developmental; University of Texas Health Science Center at San Antonio; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Vanderbilt University career developmental funds and new investigator award from University of Texas Health Science Center at San Antonio (to X.Y.).	Aubin J E, 2001, Rev Endocr Metab Disord, V2, P81, DOI 10.1023/A:1010011209064; AUBIN JE, 1995, BONE, V17, P77; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; CAPETANAKI Y, 1990, ONCOGENE, V5, P645; CAPETANAKI Y, 1989, J CELL BIOL, V109, P1653, DOI 10.1083/jcb.109.4.1653; CAPETANAKI YG, 1984, P NATL ACAD SCI-BIOL, V81, P6909, DOI 10.1073/pnas.81.22.6909; Colucci-Guyon E, 1999, GLIA, V25, P33, DOI 10.1002/(SICI)1098-1136(19990101)25:1<33::AID-GLIA4>3.0.CO;2-J; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Eckes B, 2000, J CELL SCI, V113, P2455; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hartig R, 1998, J CELL SCI, V111, P3573; Henrion D, 1997, J CLIN INVEST, V100, P2909, DOI 10.1172/JCI119840; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; LOMRI A, 1990, BONE, V11, P445, DOI 10.1016/8756-3282(90)90141-K; LOMRI A, 1988, BIOCHIM BIOPHYS ACTA, V970, P333, DOI 10.1016/0167-4889(88)90133-4; MONTEIRO MJ, 1994, J CELL BIOL, V127, P1327, DOI 10.1083/jcb.127.5.1327; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; OLSON EN, 1989, ONCOGENE, V4, P907; ROGERS KR, 1995, EUR J CELL BIOL, V66, P136; Schinke T, 1999, NAT GENET, V21, P150, DOI 10.1038/5928; Schinke T, 1999, J BIOL CHEM, V274, P30182, DOI 10.1074/jbc.274.42.30182; SINGH B, 1989, VIROLOGY, V173, P144, DOI 10.1016/0042-6822(89)90230-4; STEINERT PM, 1990, CELL, V60, P521, DOI 10.1016/0092-8674(90)90651-T; TAPSCOTT SJ, 1981, DEV BIOL, V86, P40, DOI 10.1016/0012-1606(81)90313-4; Terzi F, 1997, J CLIN INVEST, V100, P1520, DOI 10.1172/JCI119675; VINSON CR, 1993, GENE DEV, V7, P1047, DOI 10.1101/gad.7.6.1047; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Yang XL, 2000, J BIOL CHEM, V275, P1065, DOI 10.1074/jbc.275.2.1065; Yu VWC, 2009, GENE EXPR PATTERNS, V9, P335, DOI 10.1016/j.gep.2009.02.002; Yu VWC, 2005, J CELL BIOL, V169, P591, DOI 10.1083/jcb.200412139	37	48	49	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30518	30525		10.1074/jbc.M109.052373	http://dx.doi.org/10.1074/jbc.M109.052373			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19726676	hybrid, Green Published			2022-12-27	WOS:000271090000054
J	Jivan, A; Earnest, S; Juang, YC; Cobb, MH				Jivan, Arif; Earnest, Svetlana; Juang, Yu-Chi; Cobb, Melanie H.			Radial Spoke Protein 3 Is a Mammalian Protein Kinase A-anchoring Protein That Binds ERK1/2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE; IN-VITRO; CHLAMYDOMONAS FLAGELLA; SEQUENCE MOTIFS; DOCKING MOTIF; IDENTIFICATION; ACTIVATION; ERK2; PHOSPHORYLATION; ASSOCIATION	Initially identified in Chlamydomonas, RSP3 (radial spoke protein 3) is 1 of more than 20 identified radial spoke structural components of motile cilia and is required for axonemal sliding and flagellar motility. The mammalian orthologs for this and other radial spoke proteins, however, remain to be characterized. We found mammalian RSP3 to bind to the MAPK ERK2 through a yeast two-hybrid screen designed to identify interacting proteins that have a higher affinity for the phosphorylated, active form of the protein kinase. Consistent with the screening result, the human homolog, RSPH3, interacts with and is a substrate for ERK1/2. Moreover, RSPH3 is a protein kinase A-anchoring protein (AKAP) that scaffolds the cAMP-dependent protein kinase holoenzyme. The binding of RSPH3 to the regulatory subunits of cAMP-dependent protein kinase, RII alpha and RII beta, is regulated by ERK1/2 activity and phosphorylation. Here we describe an ERK1/2-interacting AKAP and suggest a mechanism by which cAMP-dependent protein kinase-AKAP binding can be modulated by the activity of other enzymes.	[Jivan, Arif; Earnest, Svetlana; Juang, Yu-Chi; Cobb, Melanie H.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Cobb, MH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	Melanie.Cobb@UTSouthwestern.edu		Cobb, Melanie/0000-0003-0833-5473	National Institutes of Health [R37 DK34128]; THECB Advanced Research Program; Welch Foundation [I1243]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); THECB Advanced Research Program; Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 DK34128. This work was also supported by a grant from the THECB Advanced Research Program and Grant I1243 from the Welch Foundation (to M. H. C.).	Amieux PS, 2002, ANN NY ACAD SCI, V968, P75, DOI 10.1111/j.1749-6632.2002.tb04328.x; Beavo J A, 1975, Adv Cyclic Nucleotide Res, V5, P241; BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Elion EA, 2001, J CELL SCI, V114, P3967; Gaillard AR, 2006, MOL BIOL CELL, V17, P2626, DOI 10.1091/mbc.E06-02-0095; Gaillard AR, 2001, J CELL BIOL, V153, P443, DOI 10.1083/jcb.153.2.443; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; GOTOH Y, 1991, NATURE, V349, P251, DOI 10.1038/349251a0; GREGORY JS, 1989, J BIOL CHEM, V264, P18397; Hausken ZE, 1996, J BIOL CHEM, V271, P29016, DOI 10.1074/jbc.271.46.29016; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Lee HY, 2000, J BIOL CHEM, V275, P32193, DOI 10.1074/jbc.M005490200; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; LUCK D, 1977, P NATL ACAD SCI USA, V74, P3456, DOI 10.1073/pnas.74.8.3456; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; PIPERNO G, 1981, J CELL BIOL, V88, P73, DOI 10.1083/jcb.88.1.73; Polychronopoulos S, 2006, J BIOL CHEM, V281, P25601, DOI 10.1074/jbc.M605185200; Proft M, 2004, CELL, V118, P351, DOI 10.1016/j.cell.2004.07.016; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; REIMANN EM, 1983, METHOD ENZYMOL, V99, P51; RESZKA AA, 1995, P NATL ACAD SCI USA, V92, P8881, DOI 10.1073/pnas.92.19.8881; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Robinson FL, 2002, J BIOL CHEM, V277, P14844, DOI 10.1074/jbc.M107776200; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; RUBIN CS, 1994, BBA-MOL CELL RES, V1224, P467; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Shapiro PS, 1998, J CELL BIOL, V142, P1533, DOI 10.1083/jcb.142.6.1533; Sheridan DL, 2008, J BIOL CHEM, V283, P19511, DOI 10.1074/jbc.M801074200; Tanoue T, 2001, EMBO J, V20, P466, DOI 10.1093/emboj/20.3.466; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; Wirschell M, 2008, CELL MOTIL CYTOSKEL, V65, P238, DOI 10.1002/cm.20257; Xu BE, 1999, J BIOL CHEM, V274, P34029, DOI 10.1074/jbc.274.48.34029; XU SC, 1995, P NATL ACAD SCI USA, V92, P6808, DOI 10.1073/pnas.92.15.6808; Yang PF, 2006, J CELL SCI, V119, P1165, DOI 10.1242/jcs.02811; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; Yazicioglu MN, 2007, J BIOL CHEM, V282, P28759, DOI 10.1074/jbc.M703460200; Zecevic M, 1998, J CELL BIOL, V142, P1547, DOI 10.1083/jcb.142.6.1547	46	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29437	29445		10.1074/jbc.M109.048181	http://dx.doi.org/10.1074/jbc.M109.048181			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19684019	Green Published, hybrid			2022-12-27	WOS:000270896800025
J	Lin, DH; Yue, P; Pan, CY; Sun, P; Zhang, X; Han, ZG; Roos, M; Caplan, M; Giebisch, G; Wang, WH				Lin, Dao-Hong; Yue, Peng; Pan, Chu-Yang; Sun, Peng; Zhang, Xin; Han, Zeguang; Roos, Marcel; Caplan, Michael; Giebisch, Gerhard; Wang, Wen-Hui			POSH Stimulates the Ubiquitination and the Clathrin-independent Endocytosis of ROMK1 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICAL COLLECTING DUCT; PROTEIN-TYROSINE KINASE; EPITHELIAL NA+ CHANNEL; K+ CHANNEL; POTASSIUM CHANNEL; SODIUM-CHANNEL; SURFACE EXPRESSION; DISTAL NEPHRON; JNK ACTIVATION; LIGASE POSH	POSH (plenty of SH3) is a scaffold protein that has been shown to act as an E3 ubiquitin ligase. Here we report that POSH stimulates the ubiquitination of Kir1.1 (ROMK) and enhances the internalization of this potassium channel. Immunostaining reveals the expression of POSH in the renal cortical collecting duct. Immunoprecipitation of renal tissue lysate with ROMK antibody and glutathione S-transferase pulldown experiments demonstrated the association between ROMK and POSH. Moreover, immunoprecipitation of lysates of HEK293T cells transfected with ROMK1 or with constructs encoding the ROMK-N terminus or ROMK1-C-Terminus demonstrated that POSH binds to ROMK1 on its N terminus. To study the effect of POSH on ROMK1 channels, we measured potassium currents with electrophysiological methods in HEK293T cells and in oocytes transfected or injected with ROMK1 and POSH. POSH decreased potassium currents, and the inhibitory effect of POSH on ROMK channels was dose-dependent. Biotinylation assay further showed that POSH decreased surface expression of ROMK channels in HEK293T cells transfected with ROMK1 and POSH. The effect of POSH on ROMK1 channels was specific because POSH did not inhibit sodium current in oocytes injected with ENaC-alpha, beta, and gamma subunits. Moreover, POSH still decreased the potassium current in oocytes injected with a ROMK1 mutant (R1 Delta 373-378), in which a clathrin-dependent tyrosine-based internalization signal residing between amino acid residues 373 and 378 is deleted. However, the inhibitory effect of POSH on ROMK channels was absent in cells expressing with dominant negative dynamin and POSH Delta RING, in which the RING domain was deleted. Expression of POSH also increased the ubiquitination of ROMK1, whereas expression of POSH Delta RING diminished its ubiquitination in HEK293T cells. The notion that POSH may serve as an E3 ubiquitin ligase is also supported by in vitro ubiquitination assays in which adding POSH increased the ROMK ubiquitination. We conclude that POSH inhibits ROMK channels by enhancing dynamin-dependent and clathrin-independent endocytosis and by stimulating ubiquitination of ROMK channels.	[Wang, Wen-Hui] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA; [Roos, Marcel; Caplan, Michael; Giebisch, Gerhard] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Zhang, Xin; Han, Zeguang] Chinese Natl Human Genome Ctr, Shanghai Minist Key Lab Dis & Hlth Genom, Shanghai 210203, Peoples R China	New York Medical College; Yale University	Wang, WH (corresponding author), New York Med Coll, Dept Pharmacol, 15 Dana Rd, Valhalla, NY 10595 USA.	wenhui_wang@nymc.edu		Caplan, Michael/0000-0001-5768-4405; Han, Ze-Guang/0000-0002-1018-1752	National Institutes of Health [DK54983, DK17433, DK072614]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054983, P01DK017433, R01DK072614, R56DK072614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK54983, DK17433, and DK072614.	Alroy I, 2005, P NATL ACAD SCI USA, V102, P1478, DOI 10.1073/pnas.0408717102; Babilonia E, 2005, J BIOL CHEM, V280, P10790, DOI 10.1074/jbc.M414610200; BOIM MA, 1995, AM J PHYSIOL-RENAL, V268, pF1132, DOI 10.1152/ajprenal.1995.268.6.F1132; Chu PY, 2003, AM J PHYSIOL-RENAL, V285, pF1179, DOI 10.1152/ajprenal.00150.2003; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; He GC, 2007, J CLIN INVEST, V117, P1078, DOI 10.1172/JCI30087; Hebert SC, 2005, PHYSIOL REV, V85, P319, DOI 10.1152/physrev.00051.2003; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; Hryciw DH, 2004, J BIOL CHEM, V279, P54996, DOI 10.1074/jbc.M411491200; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Kahle KT, 2003, NAT GENET, V35, P372, DOI 10.1038/ng1271; Kellenberger S, 1998, J CLIN INVEST, V101, P2741, DOI 10.1172/JCI2837; Kim GH, 2006, CELL SIGNAL, V18, P553, DOI 10.1016/j.cellsig.2005.05.026; Kohda Y, 1998, KIDNEY INT, V54, P1214, DOI 10.1046/j.1523-1755.1998.00120.x; Konstas AA, 2002, J BIOL CHEM, V277, P29406, DOI 10.1074/jbc.M203018200; Lazrak A, 2006, P NATL ACAD SCI USA, V103, P1615, DOI 10.1073/pnas.0510609103; Lin DH, 2008, J BIOL CHEM, V283, P7674, DOI 10.1074/jbc.M705574200; Lin DH, 2004, AM J PHYSIOL-RENAL, V286, pF881, DOI 10.1152/ajprenal.00301.2003; Lin DH, 2005, P NATL ACAD SCI USA, V102, P4306, DOI 10.1073/pnas.0409767102; Lin DH, 2002, J BIOL CHEM, V277, P44278, DOI 10.1074/jbc.M203702200; Lu M, 2002, J BIOL CHEM, V277, P37881, DOI 10.1074/jbc.M206644200; Macica CM, 1996, AM J PHYSIOL-RENAL, V271, pF588, DOI 10.1152/ajprenal.1996.271.3.F588; Mennitt PA, 1997, J AM SOC NEPHROL, V8, P1823; Moral Z, 2001, J BIOL CHEM, V276, P7156, DOI 10.1074/jbc.M008671200; O'Connell AD, 2005, P NATL ACAD SCI USA, V102, P9954, DOI 10.1073/pnas.0504332102; PALMER LG, 1994, J GEN PHYSIOL, V104, P693, DOI 10.1085/jgp.104.4.693; Palmer LG, 1999, AM J PHYSIOL-RENAL, V277, pF821, DOI 10.1152/ajprenal.1999.277.6.F821; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Ring AM, 2007, P NATL ACAD SCI USA, V104, P4025, DOI 10.1073/pnas.0611728104; Rougier JS, 2005, AM J PHYSIOL-CELL PH, V288, pC692, DOI 10.1152/ajpcell.00460.2004; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Staub O, 2000, KIDNEY INT, V57, P809, DOI 10.1046/j.1523-1755.2000.00919.x; Staub O, 1997, AM J PHYSIOL-CELL PH, V272, pC1871, DOI 10.1152/ajpcell.1997.272.6.C1871; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Sterling H, 2002, J BIOL CHEM, V277, P4317, DOI 10.1074/jbc.M109739200; Tuvia S, 2007, J CELL BIOL, V177, P51, DOI 10.1083/jcb.200611036; Wang WH, 1997, ANNU REV PHYSIOL, V59, P413, DOI 10.1146/annurev.physiol.59.1.413; Wei Y, 2001, AM J PHYSIOL-RENAL, V281, pF206, DOI 10.1152/ajprenal.2001.281.2.F206; Xu ZH, 2006, J BIOL CHEM, V281, P303, DOI 10.1074/jbc.M509060200; Xu ZH, 2003, EMBO J, V22, P252, DOI 10.1093/emboj/cdg021; Yoo D, 2003, J BIOL CHEM, V278, P23066, DOI 10.1074/jbc.M212301200; Zeng WZ, 2002, AM J PHYSIOL-RENAL, V283, pF630, DOI 10.1152/ajprenal.00378.2001	45	19	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29614	29624		10.1074/jbc.M109.041582	http://dx.doi.org/10.1074/jbc.M109.041582			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19710010	Green Published, hybrid			2022-12-27	WOS:000270896800043
J	Blasingame, E; Tuton-Blasingame, T; Larkin, L; Falick, AM; Zhao, L; Fong, J; Vaidyanathan, V; Visperas, A; Geurts, P; Hu, XY; La Mattina, C; Vierra, C				Blasingame, Eric; Tuton-Blasingame, Tiffany; Larkin, Leah; Falick, Arnold M.; Zhao, Liang; Fong, Justine; Vaidyanathan, Veena; Visperas, Anabelle; Geurts, Paul; Hu, Xiaoyi; La Mattina, Coby; Vierra, Craig			Pyriform Spidroin 1, a Novel Member of the Silk Gene Family That Anchors Dragline Silk Fibers in Attachment Discs of the Black Widow Spider, Latrodectus hesperus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGG CASE SILK; FINE-STRUCTURAL ASPECTS; COB WEAVER; PROTEIN EVOLUTION; WRAPPING SILK; FIBROIN; GLANDS; MODEL; SUBSTITUTION; SECRETION	Spiders spin high performance threads that have diverse mechanical properties for specific biological applications. To better understand the molecular mechanism by which spiders anchor their threads to a solid support, we solubilized the attachment discs from black widow spiders and performed in-solution tryptic digests followed by MS/MS analysis to identify novel peptides derived from glue silks. Combining matrix-assisted laser desorption ionization tandem time-of-flight mass spectrometry and cDNA library screening, we isolated a novel member of the silk gene family called pysp1 and demonstrate that its protein product is assembled into the attachment disc silks. Alignment of the PySp1 amino acid sequence to other fibroins revealed conservation in the non-repetitive C-terminal region of the silk family. MS/MS analysis also confirmed the presence of MaSp1 and MaSp2, two important components of dragline silks, anchored within the attachment disc materials. Characterization of the ultrastructure of attachment discs using scanning electron microscopy studies support the localization of PySp1 to small diameter fibers embedded in a glue-like cement, which network with large diameter dragline silk threads, producing a strong, adhesive material. Consistent with elevated PySp1 mRNA levels detected in the pyriform gland, MS analysis of the luminal contents extracted from the pyriform gland after tryptic digestion support the assertion that PySp1 represents one of the major constituents manufactured in the pyriform gland. Taken together, our data demonstrate that PySp1 is spun into attachment disc silks to help affix dragline fibers to substrates, a critical function during spider web construction for prey capture and locomotion.	[Blasingame, Eric; Tuton-Blasingame, Tiffany; Larkin, Leah; Fong, Justine; Vaidyanathan, Veena; Visperas, Anabelle; Geurts, Paul; La Mattina, Coby; Vierra, Craig] Univ Pacific, Dept Biol Sci, Stockton, CA 95211 USA; [Zhao, Liang] Univ Pacific, Dept Chem, Stockton, CA 95211 USA; [Hu, Xiaoyi] Abbott Labs, Santa Clara, CA 95054 USA; [Falick, Arnold M.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of the Pacific; University of the Pacific; Abbott Laboratories; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Vierra, C (corresponding author), 3601 Pacific Ave, Stockton, CA 95211 USA.	cvierra@pacific.edu	Zhao, Liang/I-4777-2015	Zhao, Liang/0000-0002-2126-6778	National Science Foundation RUI [MCB-0544087]	National Science Foundation RUI(National Science Foundation (NSF))	This work was supported by National Science Foundation RUI Grant MCB-0544087.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; Casem ML, 1999, INT J BIOL MACROMOL, V24, P103, DOI 10.1016/S0141-8130(98)00078-6; Challis RJ, 2006, INSECT MOL BIOL, V15, P45, DOI 10.1111/j.1365-2583.2005.00606.x; Colgin MA, 1998, PROTEIN SCI, V7, P667, DOI 10.1002/pro.5560070315; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Foelix R., 2011, BIOL SPIDERS; Garb JE, 2005, P NATL ACAD SCI USA, V102, P11379, DOI 10.1073/pnas.0502473102; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0; Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112; Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204; Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Hu X, 2006, CELL MOL LIFE SCI, V63, P1986, DOI 10.1007/s00018-006-6090-y; Hu XY, 2007, BIOCHEMISTRY-US, V46, P3294, DOI 10.1021/bi602507e; Hu XY, 2005, BIOCHEMISTRY-US, V44, P10020, DOI 10.1021/bi050494i; Hu XY, 2005, J BIOL CHEM, V280, P21220, DOI 10.1074/jbc.M412316200; KOVOOR J, 1980, TISSUE CELL, V12, P547, DOI 10.1016/0040-8166(80)90044-0; KOVOOR J, 1982, TISSUE CELL, V14, P519, DOI 10.1016/0040-8166(82)90044-1; La Mattina C, 2008, BIOCHEMISTRY-US, V47, P4692, DOI 10.1021/bi800140q; Maddison W.P., 1986, MACCLADE VERSION 10; Mitchell B, 2000, BBA-GENE STRUCT EXPR, V1492, P320, DOI 10.1016/S0167-4781(00)00109-3; Moon Myung-Jin, 2006, Entomological Research, V36, P133, DOI 10.1111/j.1748-5967.2006.00023.x; Nguyen L, 2001, NUCLEIC ACIDS RES, V29, P4423, DOI 10.1093/nar/29.21.4423; Parkhe AD, 1997, J MOL RECOGNIT, V10, P1, DOI 10.1002/(SICI)1099-1352(199701/02)10:1<1::AID-JMR338>3.0.CO;2-7; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; SHULTZ JW, 1987, BIOL REV, V62, P89, DOI 10.1111/j.1469-185X.1987.tb01263.x; SIMMONS A, 1994, MACROMOLECULES, V27, P5235, DOI 10.1021/ma00096a060; Sponner A, 2004, BIOMACROMOLECULES, V5, P840, DOI 10.1021/bm034378b; Sponner A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000998; Tian MZ, 2005, BIOCHEMISTRY-US, V44, P8006, DOI 10.1021/bi050366u; van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299; Vasanthavada K, 2007, J BIOL CHEM, V282, P35088, DOI 10.1074/jbc.M705791200; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; WORK RW, 1977, TEXT RES J, V47, P650, DOI 10.1177/004051757704701003; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; Zhao AC, 2006, BIOCHEMISTRY-US, V45, P3348, DOI 10.1021/bi052414g; Zwickl DJ, 2006, THESIS	40	72	78	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29097	29108		10.1074/jbc.M109.021378	http://dx.doi.org/10.1074/jbc.M109.021378			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19666476	hybrid, Green Published			2022-12-27	WOS:000270678900066
J	Bruck, I; Kaplan, D				Bruck, Irina; Kaplan, Daniel			Dbf4-Cdc7 Phosphorylation of Mcm2 Is Required for Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC DNA-REPLICATION; KINASE REGULATORY SUBUNIT; CDC7 PROTEIN-KINASE; S-PHASE; ATP HYDROLYSIS; BUDDING YEAST; HELICASE; INITIATION; CDC7-DBF4; COMPLEX	The Dbf4-Cdc7 kinase (DDK) is required for the activation of the origins of replication, and DDK phosphorylates Mcm2 in vitro. We find that budding yeast Cdc7 alone exists in solution as a weakly active multimer. Dbf4 forms a likely heterodimer with Cdc7, and this species phosphorylates Mcm2 with substantially higher specific activity. Dbf4 alone binds tightly to Mcm2, whereas Cdc7 alone binds weakly to Mcm2, suggesting that Dbf4 recruits Cdc7 to phosphorylate Mcm2. DDK phosphorylates two serine residues of Mcm2 near the N terminus of the protein, Ser-164 and Ser-170. Expression of mcm2-S170A is lethal to yeast cells that lack endogenous MCM2 (mcm2 Delta); however, this lethality is rescued in cells harboring the DDK bypass mutant mcm5-bob1. We conclude thatDDKphosphorylation of Mcm2 is required for cell growth.	[Bruck, Irina; Kaplan, Daniel] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Kaplan, D (corresponding author), Vanderbilt Univ, Dept Biol Sci, Stn B,Box 35-1634, Nashville, TN 37235 USA.	Daniel.Kaplan@Vanderbilt.Edu		Kaplan, Daniel/0000-0003-2760-7745	American Cancer Society Research Scholar [RSG-08-124-01-CCG]; Vanderbilt Ingram Cancer Center; Vanderbilt University	American Cancer Society Research Scholar(American Cancer Society); Vanderbilt Ingram Cancer Center; Vanderbilt University	This work was supported by American Cancer Society Research Scholar Grant RSG-08-124-01-CCG (to D. K. and I. B.), a pilot grant from the Vanderbilt Ingram Cancer Center (to D. K.), and a Discovery Grant from Vanderbilt University (to D. K.).	Barry ER, 2007, NUCLEIC ACIDS RES, V35, P988, DOI 10.1093/nar/gkl1117; Bochman ML, 2008, MOL CELL BIOL, V28, P5865, DOI 10.1128/MCB.00161-08; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Brown GW, 1998, J BIOL CHEM, V273, P22083, DOI 10.1074/jbc.273.34.22083; Cho WH, 2006, P NATL ACAD SCI USA, V103, P11521, DOI 10.1073/pnas.0604990103; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Donaldson AD, 1998, GENE DEV, V12, P491, DOI 10.1101/gad.12.4.491; DOWELL SJ, 1994, SCIENCE, V265, P1243, DOI 10.1126/science.8066465; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Francis LI, 2009, GENE DEV, V23, P643, DOI 10.1101/gad.1759609; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; Hoang ML, 2007, MOL CELL BIOL, V27, P7594, DOI 10.1128/MCB.00997-07; Jares P, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-5; Kasiviswanathan R, 2004, J BIOL CHEM, V279, P28358, DOI 10.1074/jbc.M403202200; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; Masai H, 2000, J BIOL CHEM, V275, P29042, DOI 10.1074/jbc.M002713200; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Nougarede R, 2000, MOL CELL BIOL, V20, P3795, DOI 10.1128/MCB.20.11.3795-3806.2000; Ogino K, 2001, J BIOL CHEM, V276, P31376, DOI 10.1074/jbc.M102197200; Oshiro G, 1999, MOL CELL BIOL, V19, P4888; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Pasero P, 1999, GENE DEV, V13, P2159, DOI 10.1101/gad.13.16.2159; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Shellman YG, 1998, MOL GEN GENET, V259, P429, DOI 10.1007/s004380050833; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Tanaka S, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-16; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tsuji T, 2006, MOL BIOL CELL, V17, P4459, DOI 10.1091/mbc.E06-03-0241; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	36	52	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28823	28831		10.1074/jbc.M109.039123	http://dx.doi.org/10.1074/jbc.M109.039123			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19692334	Green Published, hybrid			2022-12-27	WOS:000270678900039
J	Brelidze, TI; Carlson, AE; Zagotta, WN				Brelidze, Tinatin I.; Carlson, Anne E.; Zagotta, William N.			Absence of Direct Cyclic Nucleotide Modulation of mEAG1 and hERG1 Channels Revealed with Fluorescence and Electrophysiological Methods	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; AMP RECEPTOR PROTEIN; HUMAN INWARD RECTIFIER; LONG QT SYNDROME; EAG K+ CHANNELS; POTASSIUM CHANNEL; ESCHERICHIA-COLI; BINDING DOMAIN; CARDIAC-ARRHYTHMIA; PACEMAKER CHANNELS	Similar to CNG and HCN channels, EAG and ERG channels contain a cyclic nucleotide binding domain (CNBD) in their C terminus. While cyclic nucleotides have been shown to facilitate opening of CNG and HCN channels, their effect on EAG and ERG channels is less clear. Here we explored cyclic nucleotide binding and modulation of mEAG1 and hERG1 channels with fluorescence and electrophysiology. Binding of cyclic nucleotides to the isolated CNBD of mEAG1 and hERG1 channels was examined with two independent fluorescence-based methods: changes in tryptophan fluorescence and fluorescence of an analog of cAMP, 8-NBD-cAMP. As a positive control for cyclic nucleotide binding we used changes in the fluorescence of the isolated CNBD of mHCN2 channels. Our results indicated that cyclic nucleotides do not bind to the isolated CNBD domain of mEAG1 channels and bind with low affinity (K-d >= 51 mu M) to the isolated CNBD of hERG1 channels. Consistent with the results on the isolated CNBD, application of cyclic nucleotides to inside-out patches did not affect currents recorded from mEAG1 channels. Surprisingly, despite its low affinity binding to the isolated CNBD, cAMP also had no effect on currents from hERG1 channels even at high concentrations. Our results indicate that cyclic nucleotides do not directly modulate mEAG1 and hERG1 channels. Further studies are necessary to determine if the CNBD in the EAG family of K+ channels might harbor a binding site for a ligand yet to be uncovered.	[Brelidze, Tinatin I.; Carlson, Anne E.; Zagotta, William N.] Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Brelidze, Tinatin I.; Zagotta, William N.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Sch Med, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA.	zagotta@u.washington.edu		Brelidze, Tinatin/0000-0003-3046-8184	National Institutes of Health [2R01EY010329-16, F32 HL095241]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [R01EY010329] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL095241] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 2R01EY010329-16 (to W.N.Z.) and F32 HL095241 (to A. E.Q. This work was also supported by the Howard Hughes Medical Institute.	Akhavan A, 2005, J CELL SCI, V118, P2803, DOI 10.1242/jcs.02423; Altieri SL, 2008, J MOL BIOL, V381, P655, DOI 10.1016/j.jmb.2008.06.011; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Aydar E, 2001, J PHYSIOL-LONDON, V534, P1, DOI 10.1111/j.1469-7793.2001.t01-3-00001.x; Bauer CK, 2001, J MEMBRANE BIOL, V182, P1; Becchetti A, 2002, EUR J NEUROSCI, V16, P415, DOI 10.1046/j.1460-9568.2002.02079.x; BELDUZ AO, 1993, NUCLEIC ACIDS RES, V21, P1827, DOI 10.1093/nar/21.8.1827; Berthet M, 1999, CIRCULATION, V99, P1464, DOI 10.1161/01.CIR.99.11.1464; BRUGGEMANN A, 1993, NATURE, V365, P445, DOI 10.1038/365445a0; BUBIS J, 1988, J BIOL CHEM, V263, P9668; Cayabyab FS, 2002, J BIOL CHEM, V277, P13673, DOI 10.1074/jbc.M108211200; Chen GQ, 1997, PROTEIN ENG, V10, P1061, DOI 10.1093/protein/10.9.1061; Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030; Crociani O, 2003, J BIOL CHEM, V278, P2947, DOI 10.1074/jbc.M210789200; Cui J, 2001, J BIOL CHEM, V276, P17244, DOI 10.1074/jbc.M010904200; Cui J, 2000, CURR BIOL, V10, P671, DOI 10.1016/S0960-9822(00)00516-9; Cukkemane A, 2007, EMBO REP, V8, P749, DOI 10.1038/sj.embor.7401025; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; de Queiroz FM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-42; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Farias LMB, 2004, CANCER RES, V64, P6996, DOI 10.1158/0008-5472.CAN-04-1204; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; Finn JT, 1996, ANNU REV PHYSIOL, V58, P395, DOI 10.1146/annurev.ph.58.030196.002143; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; Frings S, 1998, J GEN PHYSIOL, V111, P583, DOI 10.1085/jgp.111.4.583; Gavrilova-Ruch O, 2002, J MEMBRANE BIOL, V188, P137, DOI 10.1007/s00232-001-0181-3; Gomez-Varela D, 2007, CANCER RES, V67, P7343, DOI 10.1158/0008-5472.CAN-07-0107; GRONENBORN AM, 1988, BIOCHEM J, V253, P801, DOI 10.1042/bj2530801; GUY HR, 1991, SCIENCE, V254, P730, DOI 10.1126/science.1658932; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAYNES L, 1985, NATURE, V317, P61, DOI 10.1038/317061a0; Hemmerlein B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-41; Herzberg IM, 1998, J PHYSIOL-LONDON, V511, P3, DOI 10.1111/j.1469-7793.1998.003bi.x; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Kiehn J, 1998, J BIOL CHEM, V273, P25285, DOI 10.1074/jbc.273.39.25285; Kiehn J, 1996, CIRCULATION, V94, P2572, DOI 10.1161/01.CIR.94.10.2572; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Li XD, 1997, J BIOL CHEM, V272, P705, DOI 10.1074/jbc.272.2.705; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; LUDWIG J, 1994, EMBO J, V13, P4451, DOI 10.1002/j.1460-2075.1994.tb06767.x; Meyer R, 1998, J PHYSIOL-LONDON, V508, P49, DOI 10.1111/j.1469-7793.1998.049br.x; MOORE J, 1992, J BACTERIOL, V174, P8030, DOI 10.1128/JB.174.24.8030-8035.1992; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Nimigean CM, 2007, J MOL BIOL, V371, P1325, DOI 10.1016/j.jmb.2007.06.030; OGREID D, 1988, J BIOL CHEM, V263, P17397; Ouadid-Ahidouch H, 2001, RECEPTOR CHANNEL, V7, P345; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Passner JM, 1997, P NATL ACAD SCI USA, V94, P2843, DOI 10.1073/pnas.94.7.2843; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Robertson GA, 1996, NEUROPHARMACOLOGY, V35, P841, DOI 10.1016/0028-3908(96)00113-X; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1991, CIRC RES, V68, P77, DOI 10.1161/01.RES.68.1.77; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Schonherr R, 1996, J PHYSIOL-LONDON, V493, P635, DOI 10.1113/jphysiol.1996.sp021410; SHABB JB, 1992, J BIOL CHEM, V267, P5723; Smith GAM, 2002, J BIOL CHEM, V277, P18528, DOI 10.1074/jbc.M200592200; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Thomas D, 1999, J BIOL CHEM, V274, P27457, DOI 10.1074/jbc.274.39.27457; Tibbs GR, 1998, J BIOL CHEM, V273, P4497, DOI 10.1074/jbc.273.8.4497; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Weber C, 2006, J BIOL CHEM, V281, P13030, DOI 10.1074/jbc.M600883200; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; ZHONG Y, 1993, J NEUROSCI, V13, P4669; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	70	85	86	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27989	27997		10.1074/jbc.M109.016337	http://dx.doi.org/10.1074/jbc.M109.016337			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19671703	Green Published, hybrid			2022-12-27	WOS:000270676300027
J	Bao, R; Zhou, CZ; Jiang, CH; Lin, SX; Chi, CW; Chen, YX				Bao, Rui; Zhou, Cong-Zhao; Jiang, Chunhui; Lin, Sheng-Xiang; Chi, Cheng-Wu; Chen, Yuxing			The Ternary Structure of the Double-headed Arrowhead Protease Inhibitor API-A Complexed with Two Trypsins Reveals a Novel Reactive Site Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOWMAN-BIRK INHIBITOR; CRYSTAL-STRUCTURE; PROTEINASE-INHIBITORS; 2.3 ANGSTROM; CHYMOTRYPSIN INHIBITOR; ERYTHRINA-CAFFRA; PORCINE TRYPSIN; BOVINE TRYPSIN; BARLEY-SEEDS; KUNITZ	The double-headed arrowhead protease inhibitors API-A and -B from the tubers of Sagittaria sagittifolia (Linn) feature two distinct reactive sites, unlike other members of their family. Although the two inhibitors have been extensively characterized, the identities of the two P1 residues in both API-A and -B remain controversial. The crystal structure of a ternary complex at 2.48 angstrom resolution revealed that the two trypsins bind on opposite sides of API-A and are 34 angstrom apart. The overall fold of API-A belongs to the beta-trefoil fold and resembles that of the soybean Kunitz-type trypsin inhibitors. The two P1 residues were unambiguously assigned as Leu(87) and Lys(145), and their identities were further confirmed by site-directed mutagenesis. Reactive site 1, composed of residues P5 Met(83) to P5' Ala(92), adopts a novel conformation with the Leu87 completely embedded in the S1 pocket even though it is an unfavorable P1 residue for trypsin. Reactive site 2, consisting of residues P5 Cys(141) to P5' Glu(150), binds trypsin in the classic mode by employing a two-disulfide-bonded loop. Analysis of the two binding interfaces sheds light on atomic details of the inhibitor specificity and also promises potential improvements in enzyme activity by engineering of the reactive sites.	[Bao, Rui; Jiang, Chunhui; Chi, Cheng-Wu] Tongji Univ, Inst Prot Res, Shanghai 200092, Peoples R China; [Zhou, Cong-Zhao; Chen, Yuxing] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Zhou, Cong-Zhao; Chen, Yuxing] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Lin, Sheng-Xiang; Chi, Cheng-Wu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	Tongji University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chi, CW (corresponding author), Tongji Univ, Inst Prot Res, Shanghai 200092, Peoples R China.	zwqi@sibs.ac.cn; cyxing@ustc.edu.cn	Zhou, Cong-Zhao/E-9174-2011; bao, rui/AAM-9906-2020; Chen, Yuxing/P-4156-2014	Zhou, Cong-Zhao/0000-0002-6881-7151; bao, rui/0000-0002-6083-8716; Chen, Yuxing/0000-0002-7560-1922; jiang, chunhui/0000-0003-2074-0033; Lin, Sheng-Xiang/0000-0001-9149-375X	Ministry of Science and Technology of China [2006CB910202, 2006CB806501]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by Ministry of Science and Technology of China Projects 2006CB910202 and 2006CB806501.	Araujo APU, 2005, BIOL CHEM, V386, P561, DOI 10.1515/BC.2005.066; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTELS K, 2003, AUTOMAR USERS GUIDE; Bauer RA, 2008, NUCLEIC ACIDS RES, V36, pW47, DOI 10.1093/nar/gkn285; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Bunnage ME, 2007, J MED CHEM, V50, P6095, DOI 10.1021/jm0702433; Capaldi S, 2007, J STRUCT BIOL, V158, P71, DOI 10.1016/j.jsb.2006.10.017; CHANG HY, 1979, SCI SINICA, V22, P1443; Dattagupta JK, 1999, PROTEINS, V35, P321, DOI 10.1002/(SICI)1097-0134(19990515)35:3<321::AID-PROT6>3.3.CO;2-P; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de la Sierra IL, 1999, J MOL BIOL, V285, P1195, DOI 10.1006/jmbi.1998.2351; de Meester P, 1998, ACTA CRYSTALLOGR D, V54, P589, DOI 10.1107/S0907444997015849; DeLano WL, 2002, PYMOL USERS MANUAL; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fodor K, 2006, BIOCHEMISTRY-US, V45, P2114, DOI 10.1021/bi0517133; Helland R, 1999, ACTA CRYSTALLOGR D, V55, P139, DOI 10.1107/S090744499801052X; ISHIKAWA A, 1994, PLANT CELL PHYSIOL, V35, P303; Ishikura H, 2007, LIFE SCI, V80, P1999, DOI 10.1016/j.lfs.2007.02.044; Kobayashi H, 2004, CANCER-AM CANCER SOC, V100, P869, DOI 10.1002/cncr.20034; Koepke J, 2000, J MOL BIOL, V298, P477, DOI 10.1006/jmbi.2000.3677; Krauchenco S, 2003, BIOCHEM BIOPH RES CO, V312, P1303, DOI 10.1016/j.bbrc.2003.11.062; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Leung D, 2000, J MED CHEM, V43, P305, DOI 10.1021/jm990412m; Li J, 2002, ACTA BIOCH BIOPH SIN, V34, P662; LIN GD, 1993, EUR J BIOCHEM, V212, P549, DOI 10.1111/j.1432-1033.1993.tb17692.x; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Luo MJ, 1997, J BIOCHEM-TOKYO, V121, P991; MIZOBATA T, 1992, J BIOL CHEM, V267, P17773; MURZIN AG, 1992, J MOL BIOL, V223, P531, DOI 10.1016/0022-2836(92)90668-A; Ng TB, 2003, BIOL CHEM, V384, P289, DOI 10.1515/BC.2003.032; Nielsen PK, 2004, BBA-PROTEINS PROTEOM, V1696, P157, DOI 10.1016/j.bbapap.2003.09.019; ONESTI S, 1991, J MOL BIOL, V217, P153, DOI 10.1016/0022-2836(91)90618-G; Park EY, 2004, J MOL BIOL, V343, P173, DOI 10.1016/j.jmb.2004.08.027; Raj SSS, 2002, J BIOCHEM, V132, P927, DOI 10.1093/oxfordjournals.jbchem.a003306; Ravichandran S, 2001, PROTEIN ENG, V14, P349, DOI 10.1093/protein/14.5.349; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Schmidt AE, 2005, J BIOL CHEM, V280, P27832, DOI 10.1074/jbc.M504105200; Song HK, 1999, J MOL BIOL, V293, P1133, DOI 10.1006/jmbi.1999.3239; Song HK, 1998, J MOL BIOL, V275, P347, DOI 10.1006/jmbi.1997.1469; STRUKELJ B, 1992, BIOL CHEM H-S, V373, P477, DOI 10.1515/bchm3.1992.373.2.477; SWEET RM, 1974, BIOCHEMISTRY-US, V13, P4212, DOI 10.1021/bi00717a024; Vallee F, 1998, STRUCTURE, V6, P649, DOI 10.1016/S0969-2126(98)00066-5; Xie ZW, 1997, BIOCHEMISTRY-US, V36, P5846, DOI 10.1021/bi962993c; XIE ZW, 1996, SCI SINICA, V28, P700; YANG HL, 1992, J BIOCHEM-TOKYO, V111, P537, DOI 10.1093/oxfordjournals.jbchem.a123792; Zhu YS, 1999, J PROTEIN CHEM, V18, P505, DOI 10.1023/A:1020690931043	47	46	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26676	26684		10.1074/jbc.M109.022095	http://dx.doi.org/10.1074/jbc.M109.022095			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19640842	hybrid, Green Published			2022-12-27	WOS:000269969600048
J	Dumoutier, L; de Meester, C; Tavernier, J; Renauld, JC				Dumoutier, Laure; de Meester, Carole; Tavernier, Jan; Renauld, Jean-Christophe			New Activation Modus of STAT3 A TYROSINE-LESS REGION OF THE INTERLEUKIN-22 RECEPTOR RECRUITS STAT3 BY INTERACTING WITH ITS COILED-COIL DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I INTERFERON RECEPTOR; SIGNAL TRANSDUCER; CYTOKINE RECEPTORS; STIMULATING FACTOR; MOUSE MODEL; PSORIASIS; IL-22; KERATINOCYTES; TYROSINE; DIFFERENTIATION	Activation of STAT proteins by cytokines is initiated by their Src homology 2 domain-mediated association with phosphotyrosine residues from the cytoplasmic domain of a receptor. Here, we show that the C terminus of the interleukin-22 receptor (IL-22R) recruits in a tyrosine-independent manner the coiled-coil domain of STAT3. Mutation of all IL-22R cytoplasmic tyrosines did not abolish activation of STAT3, in contrast to that of STAT1 and STAT5. Coimmunoprecipitation and glutathione S-transferase pulldown experiments showed that the coiled-coil domain of STAT3 is constitutively associated with the C-terminal part of IL-22R, and a chimeric STAT3-STAT5 protein containing the coiled-coil domain of STAT3 could be activated by this tyrosine-independent mechanism. Deletion of the C-terminal part of IL-22R dramatically decreased its ability to activate STAT3 and to mediate IL-22 activity in cell lines, demonstrating that preassociation of STAT3 with this cytokine receptor, independent from the interaction between the Src homology 2 domain and phosphotyrosines, is required for its full activity.	[Renauld, Jean-Christophe] Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Dumoutier, Laure; de Meester, Carole; Renauld, Jean-Christophe] Catholic Univ Louvain, de Duve Inst, Expt Med Unit, B-1200 Brussels, Belgium; [Tavernier, Jan] Flanders Interuniv Inst Biotechnol, Dept Med Prot Res, B-9000 Ghent, Belgium; [Tavernier, Jan] Univ Ghent, Fac Med & Hlth Sci, B-9000 Ghent, Belgium	Ludwig Institute for Cancer Research; Universite Catholique Louvain; Ghent University	Renauld, JC (corresponding author), Ludwig Inst Canc Res, Ave Hippocrate 74, B-1200 Brussels, Belgium.	renauld@bru.licr.org	Tavernier, Jan/AAG-3636-2019; Renauld, Jean-Christophe/B-7268-2012	Renauld, Jean-Christophe/0000-0003-1736-2131; Dumoutier, Laure/0000-0002-6645-684X	Belgian Federal Service for Scientific Technical and Cultural Affairs; Actions de Recherche Concertees, Communaute Francaise de Belgique, Direction de la Recherche Scientifique	Belgian Federal Service for Scientific Technical and Cultural Affairs; Actions de Recherche Concertees, Communaute Francaise de Belgique, Direction de la Recherche Scientifique	This work was supported in part by the Belgian Federal Service for Scientific Technical and Cultural Affairs and the Actions de Recherche Concertees, Communaute Francaise de Belgique, Direction de la Recherche Scientifique.	Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Boniface K, 2005, EUR CYTOKINE NETW, V16, P309; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Demoulin JB, 1999, J BIOL CHEM, V274, P25855, DOI 10.1074/jbc.274.36.25855; Demoulin JB, 1996, MOL CELL BIOL, V16, P4710; DRUEZ C, 1990, J IMMUNOL, V145, P2494; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Fujitani Y, 1997, ONCOGENE, V14, P751, DOI 10.1038/sj.onc.1200907; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Ilangumaran S, 2004, SEMIN IMMUNOL, V16, P351, DOI 10.1016/j.smim.2004.08.015; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Li XX, 1997, MOL CELL BIOL, V17, P2048, DOI 10.1128/MCB.17.4.2048; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Ma J, 2006, CELL SIGNAL, V18, P1117, DOI 10.1016/j.cellsig.2005.06.016; McBride KM, 2000, EMBO J, V19, P6196, DOI 10.1093/emboj/19.22.6196; Nadeau OW, 1999, J BIOL CHEM, V274, P4045, DOI 10.1074/jbc.274.7.4045; Ndubuisi MI, 1999, J BIOL CHEM, V274, P25499, DOI 10.1074/jbc.274.36.25499; Nguyen VP, 2002, J BIOL CHEM, V277, P9713, DOI 10.1074/jbc.m111161200; Ohtani T, 2000, IMMUNITY, V12, P95, DOI 10.1016/S1074-7613(00)80162-4; Renauld JC, 2003, NAT REV IMMUNOL, V3, P667, DOI 10.1038/nri1153; Russell-Harde D, 2000, J BIOL CHEM, V275, P23981, DOI 10.1074/jbc.M002518200; Sano S, 2005, CANCER RES, V65, P5720, DOI 10.1158/0008-5472.CAN-04-4359; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Sotiropoulos A, 1996, MOL ENDOCRINOL, V10, P998, DOI 10.1210/me.10.8.998; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Strehlow I, 1998, J BIOL CHEM, V273, P28049, DOI 10.1074/jbc.273.43.28049; Ward AC, 1999, BLOOD, V93, P113, DOI 10.1182/blood.V93.1.113.401k33_113_124; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wolk K, 2009, J MOL MED, V87, P523, DOI 10.1007/s00109-009-0457-0; Yan H, 1996, EMBO J, V15, P1064, DOI 10.1002/j.1460-2075.1996.tb00444.x; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhong MH, 2005, P NATL ACAD SCI USA, V102, P3966, DOI 10.1073/pnas.0501063102; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	38	52	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26377	26384		10.1074/jbc.M109.007955	http://dx.doi.org/10.1074/jbc.M109.007955			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19632985	Green Published, hybrid			2022-12-27	WOS:000269969600018
J	Rauen, T; Raffetseder, U; Frye, BC; Djudjaj, S; Muhlenberg, PJT; Eitner, F; Lendahl, U; Bernhagen, J; Dooley, S; Mertens, PR				Rauen, Thomas; Raffetseder, Ute; Frye, Bjoern C.; Djudjaj, Sonja; Muehlenberg, Philipp J. T.; Eitner, Frank; Lendahl, Urban; Bernhagen, Juergen; Dooley, Steven; Mertens, Peter R.			YB-1 Acts as a Ligand for Notch-3 Receptors and Modulates Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							Y-BOX PROTEIN-1; AUTOSOMAL-DOMINANT ARTERIOPATHY; MUSCLE-CELL PHENOTYPE; SUBCORTICAL INFARCTS; MESSENGER-RNA; EXTRACELLULAR DOMAIN; GLOMERULAR-DISEASE; BINDING PROTEIN-1; CCL5 EXPRESSION; PATHWAY	Y-box (YB) protein-1 is secreted by mesangial and immune cells after cytokine challenge, but extracellular functions are unknown. Here, we demonstrate that extracellular YB-1 associates with outer cell membrane components and interacts with extracellular Notch-3 receptor domains. The interaction appears to be specific for Notch-3, as YB-1-green fluorescent protein binds to the extracellular domains and full-length forms of Notch-3 but not to Notch-1. YB-1-green fluorescent protein and Notch-3 proteins co-localize at cell membranes, and extracellular YB-1 activates Notch-3 signaling, resulting in nuclear translocation of the Notch-3 intracellular domain and up-regulation of Notch target genes. The YB-1/Notch-3 interaction may be of particular relevance for inflammatory mesangioproliferative disease, as both proteins co-localize in an experimental nephritis model and receptor activation temporally and spatially correlates with YB-1 expression.	[Djudjaj, Sonja; Mertens, Peter R.] Otto VonGuericke Univ Magdegurg, Dept Hypertens & Nephrol, D-39120 Magdeburg, Germany; [Rauen, Thomas; Raffetseder, Ute; Frye, Bjoern C.; Djudjaj, Sonja; Muehlenberg, Philipp J. T.; Eitner, Frank] Univ Hosp RWTH Aachen, Dept Nephrol & Clin Immunol, D-52057 Aachen, Germany; [Lendahl, Urban] Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Bernhagen, Juergen] Univ Hosp RWTH Aachen, Inst Biochem & Mol Cell Biol, Dept Cell & Mol Biol, D-52057 Aachen, Germany; [Dooley, Steven] Univ Heidelberg, Univ Hosp Mannheim, Med Clin 2, D-68167 Mannheim, Germany	Otto von Guericke University; RWTH Aachen University; RWTH Aachen University Hospital; Karolinska Institutet; RWTH Aachen University; RWTH Aachen University Hospital; Ruprecht Karls University Heidelberg	Mertens, PR (corresponding author), Otto VonGuericke Univ Magdegurg, Dept Hypertens & Nephrol, Leipziger Str 44, D-39120 Magdeburg, Germany.	peter.mertens@med.ovgu.de	Dooley, Steven/T-6491-2018; Mertens, Peter/AAI-7310-2020; Djudjaj, Sonja/ABH-4777-2020	Dooley, Steven/0000-0002-4840-6240; Djudjaj, Sonja/0000-0003-2352-7537; Lendahl, Urban/0000-0001-9543-8141; Raffetseder, Ute/0000-0002-7236-9793	Deutsche Forschungsgemeinschaft [D0373/81]; START program;  [SFB 542]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); START program(Austrian Science Fund (FWF)); 	This work was funded by SFB 542 projects A11, C4, and C12 (to P. R. M.) A7 (to J. B.), Deutsche Forschungsgemeinschaft Project D0373/81 (to S. D.), and the START program (Faculty of Medicine, RWTH-Aachen, Germany). 1 These authors contributed equally to this work.	Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Capowski EE, 2001, J IMMUNOL, V167, P5970, DOI 10.4049/jimmunol.167.10.5970; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; de Celis JF, 2000, DEVELOPMENT, V127, P1291; Dooley S, 2006, J BIOL CHEM, V281, P1784, DOI 10.1074/jbc.M510215200; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Floege J, 1999, AM J PATHOL, V154, P169, DOI 10.1016/S0002-9440(10)65263-7; Frye BC, 2009, EMBO REP, V10, P783, DOI 10.1038/embor.2009.81; Guerrot D, 2008, AM J KIDNEY DIS, V52, P340, DOI 10.1053/j.ajkd.2008.04.017; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; JOHNSON RJ, 1991, J CLIN INVEST, V87, P847, DOI 10.1172/JCI115089; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Joutel A, 2004, AM J HUM GENET, V74, P338, DOI 10.1086/381506; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Kanamori M, 2007, J NEUROSURG, V106, P417, DOI 10.3171/jns.2007.106.3.417; Karlstrom H, 2002, P NATL ACAD SCI USA, V99, P17119, DOI 10.1073/pnas.252624099; Katoh M, 2007, INT J ONCOL, V31, P461; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Krohn R, 2007, CIRCULATION, V116, P1812, DOI 10.1161/CIRCULATIONAHA.107.708016; Kusaba T, 2007, CLIN NEPHROL, V67, P182; MACDONALD GH, 1995, J BIOL CHEM, V270, P3527, DOI 10.1074/jbc.270.8.3527; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Mertens PR, 2008, NEPHROL DIAL TRANSPL, V23, P2743, DOI 10.1093/ndt/gfn279; Mertens PR, 1997, J BIOL CHEM, V272, P22905, DOI 10.1074/jbc.272.36.22905; Miyamoto A, 2006, J BIOL CHEM, V281, P10089, DOI 10.1074/jbc.M600298200; Morrow D, 2005, AM J PHYSIOL-CELL PH, V289, pC1188, DOI 10.1152/ajpcell.00198.2005; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; Nishimura M, 1998, GENOMICS, V49, P69, DOI 10.1006/geno.1998.5213; Patel K, 2003, J CELL PHYSIOL, V195, P435, DOI 10.1002/jcp.10267; Raffetseder U, 2003, J BIOL CHEM, V278, P18241, DOI 10.1074/jbc.M212518200; Raffetseder U, 2009, KIDNEY INT, V75, P185, DOI 10.1038/ki.2008.457; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Ruzanov PV, 1999, J CELL SCI, V112, P3487; Sakamoto K, 2002, DEV BIOL, V241, P313, DOI 10.1006/dbio.2001.0517; Scehnet JS, 2007, BLOOD, V109, P4753, DOI 10.1182/blood-2006-12-063933; Schnabel M, 2002, INT J MOL MED, V9, P229; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shiras A, 2007, STEM CELLS, V25, P1478, DOI 10.1634/stemcells.2006-0585; Sorokin AV, 2005, EMBO J, V24, P3602, DOI 10.1038/sj.emboj.7600830; Sweeney C, 2004, FASEB J, V18, P1421, DOI 10.1096/fj.04-1700fje; Teachey DT, 2008, BLOOD, V111, P705, DOI 10.1182/blood-2007-05-087353; Uchiumi T, 2006, J BIOL CHEM, V281, P40440, DOI 10.1074/jbc.M605948200; van Roeyen CRC, 2005, J AM SOC NEPHROL, V16, P2985, DOI 10.1681/ASN.2004111009	47	77	83	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26928	26940		10.1074/jbc.M109.046599	http://dx.doi.org/10.1074/jbc.M109.046599			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19640841	Green Published, hybrid			2022-12-27	WOS:000269969600073
J	Wang, C; Yan, RL; Luo, DX; Watabe, K; Liao, DF; Cao, DL				Wang, Chun; Yan, Ruilan; Luo, Dixian; Watabe, Kounosuke; Liao, Duan-Fang; Cao, Deliang			Aldo-keto Reductase Family 1 Member B10 Promotes Cell Survival by Regulating Lipid Synthesis and Eliminating Carbonyls	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA-CARBOXYLASE; FATTY-ACID SYNTHASE; BREAST-CANCER CELLS; OXIDATIVE STRESS; GROWTH-INHIBITION; STRUCTURAL BASIS; PROSTATE-CANCER; AKR1B10; EXPRESSION; ALDEHYDES	Aldo-keto reductase family 1 member B10 (AKR1B10) is primarily expressed in the normal human colon and small intestine but overexpressed in liver and lung cancer. Our previous studies have shown that AKR1B10 mediates the ubiquitin-dependent degradation of acetyl-CoA carboxylase-alpha. In this study, we demonstrate that AKR1B10 is critical to cell survival. In human colon carcinoma cells (HCT-8) and lung carcinoma cells (NCI-H460), small-interfering RNA-induced AKR1B10 silencing resulted in caspase-3-mediated apoptosis. In these cells, the total and subspecies of cellular lipids, particularly of phospholipids, were decreased by more than 50%, concomitant with 2-3-fold increase in reactive oxygen species, mitochondrial cytochrome c efflux, and caspase-3 cleavage. AKR1B10 silencing also increased the levels of alpha,beta-unsaturated carbonyls, leading to the 2-3-fold increase of cellular lipid peroxides. Supplementing the HCT-8 cells with palmitic acid (80 mu M), the end product of fatty acid synthesis, partially rescued the apoptosis induced by AKR1B10 silencing, whereas exposing the HCT-8 cells to epalrestat, an AKR1B10 inhibitor, led to more than 2-fold elevation of the intracellular lipid peroxides, resulting in apoptosis. These data suggest that AKR1B10 affects cell survival through modulating lipid synthesis, mitochondrial function, and oxidative status, as well as carbonyl levels, being an important cell survival protein.	[Wang, Chun; Yan, Ruilan; Luo, Dixian; Watabe, Kounosuke; Cao, Deliang] So Illinois Univ, Sch Medicine, Dept Med Microbiol Immunol & Cell Biol, SimmonsCooper Canc Inst, Springfield, IL 62702 USA; [Wang, Chun; Liao, Duan-Fang] Univ S China, Coll Sci & Technol, Inst Pharm & Pharmacol, Hengyang 421001, Peoples R China	Southern Illinois University System; Southern Illinois University; University of South China	Cao, DL (corresponding author), So Illinois Univ, Sch Medicine, Dept Med Microbiol Immunol & Cell Biol, SimmonsCooper Canc Inst, 913 N Rutledge St, Springfield, IL 62702 USA.	dcao@siumed.edu			National Institutes of Health [CA122327, CA122622]; American Cancer Society [RSG-04-031-01-CCE]; National Major Basic Research Program of China (973 Program) [2006CB 503808]; NATIONAL CANCER INSTITUTE [R21CA122327, R21CA122622] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National Major Basic Research Program of China (973 Program)(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA122327 and CA122622 through the NCI. This work was also supported by American Cancer Society Grant RSG-04-031-01-CCE and National Major Basic Research Program of China (973 Program) Grant 2006CB 503808.	Abu-Elheiga L, 2005, P NATL ACAD SCI USA, V102, P12011, DOI 10.1073/pnas.0505714102; Balendiran GK, 2009, CHEM-BIOL INTERACT, V178, P134, DOI 10.1016/j.cbi.2008.10.044; BERHANE K, 1994, P NATL ACAD SCI USA, V91, P1480, DOI 10.1073/pnas.91.4.1480; BOOTH RJ, 1993, CLIN EXP PHARMACOL P, V20, P207, DOI 10.1111/j.1440-1681.1993.tb01672.x; Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Cao DL, 1998, J BIOL CHEM, V273, P11429, DOI 10.1074/jbc.273.19.11429; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; Choudhary S, 2005, TOXICOL APPL PHARM, V204, P122, DOI 10.1016/j.taap.2004.08.023; Crosas B, 2003, BIOCHEM J, V373, P973, DOI 10.1042/BJ20021818; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; Dragnev K H, 2000, Oncologist, V5, P361, DOI 10.1634/theoncologist.5-5-361; EDER E, 1993, TOXICOL LETT, V67, P87, DOI 10.1016/0378-4274(93)90048-3; Fediuc S, 2006, J LIPID RES, V47, P412, DOI 10.1194/jlr.M500438-JLR200; Fukumoto S, 2005, CLIN CANCER RES, V11, P1776, DOI 10.1158/1078-0432.CCR-04-1238; Gallego O, 2007, P NATL ACAD SCI USA, V104, P20764, DOI 10.1073/pnas.0705659105; Hashimoto M, 2003, J BIOL CHEM, V278, P5044, DOI 10.1074/jbc.M210129200; HAUPTLORENZ S, 1985, BIOCHEM PHARMACOL, V34, P3803, DOI 10.1016/0006-2952(85)90428-9; HAYSTEAD TAJ, 1986, BIOCHEM J, V234, P279, DOI 10.1042/bj2340279; Hyndman DJ, 1998, BBA-GENE STRUCT EXPR, V1399, P198, DOI 10.1016/S0167-4781(98)00109-2; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; Ji C, 2001, CHEM RES TOXICOL, V14, P1090, DOI 10.1021/tx000186f; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Li CP, 2008, PATHOL RES PRACT, V204, P295, DOI 10.1016/j.prp.2006.12.012; Ma J, 2008, J BIOL CHEM, V283, P3418, DOI 10.1074/jbc.M707650200; Magnard C, 2002, ONCOGENE, V21, P6729, DOI 10.1038/sj.onc.1205915; Martin HJ, 2009, CHEM-BIOL INTERACT, V178, P145, DOI 10.1016/j.cbi.2008.10.021; Moreau K, 2006, J BIOL CHEM, V281, P3172, DOI 10.1074/jbc.M504652200; Nagaraj NS, 2006, TOXICOL LETT, V165, P182, DOI 10.1016/j.toxlet.2006.03.008; Okada K, 1999, J BIOL CHEM, V274, P23787, DOI 10.1074/jbc.274.34.23787; Penning TM, 2005, CLIN CANCER RES, V11, P1687, DOI 10.1158/1078-0432.CCR-05-0071; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Quinn AM, 2008, CHEM RES TOXICOL, V21, P2207, DOI 10.1021/tx8002005; Raza H, 2006, TOXICOL APPL PHARM, V216, P309, DOI 10.1016/j.taap.2006.06.001; Ruiz FX, 2009, CHEM-BIOL INTERACT, V178, P171, DOI 10.1016/j.cbi.2008.10.027; Scuric Z, 1998, HEPATOLOGY, V27, P943, DOI 10.1002/hep.510270408; Spite M, 2007, BIOCHEM J, V405, P95, DOI 10.1042/BJ20061743; Swinnen JV, 2002, INT J CANCER, V98, P19, DOI 10.1002/ijc.10127; Uchida K, 1998, P NATL ACAD SCI USA, V95, P4882, DOI 10.1073/pnas.95.9.4882; Verma M, 2008, EUR J PHARMACOL, V584, P213, DOI 10.1016/j.ejphar.2008.01.036; WITTERS LA, 1994, INT J BIOCHEM, V26, P589, DOI 10.1016/0020-711X(94)90018-3; Yan RL, 2007, INT J CANCER, V121, P2301, DOI 10.1002/ijc.22933; Yoshitake H, 2007, INT J GYNECOL CANCER, V17, P1300, DOI 10.1111/j.1525-1438.2007.00932.x; Zhong LL, 2009, BIOCHEM BIOPH RES CO, V387, P245, DOI 10.1016/j.bbrc.2009.06.123; Zu XY, 2007, TOXICOL SCI, V97, P562, DOI 10.1093/toxsci/kfm033	45	107	112	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26742	26748		10.1074/jbc.M109.022897	http://dx.doi.org/10.1074/jbc.M109.022897			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19643728	hybrid, Green Published			2022-12-27	WOS:000269969600055
J	Dong, SM; Cheng, YH; Yang, J; Li, JY; Liu, XJ; Wang, XB; Wang, D; Krall, TJ; Delphin, ES; Zhang, CX				Dong, Shimin; Cheng, Yunhui; Yang, Jian; Li, Jingyuan; Liu, Xiaojun; Wang, Xiaobin; Wang, Dong; Krall, Thomas J.; Delphin, Ellise S.; Zhang, Chunxiang			MicroRNA Expression Signature and the Role of MicroRNA-21 in the Early Phase of Acute Myocardial Infarction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-ELEGANS; GROWTH; IDENTIFICATION; GENES; MICE; CARCINOMA; APOPTOSIS; LIN-14; RATS; AP-1	Several recent reports have suggested that microRNAs (miRNAs) might play critical roles in acute myocardial infarction (AMI). However, the miRNA expression signature in the early phase of AMI has not been identified. In this study, the miRNA expression signature was investigated in rat hearts 6 h after AMI. Compared with the expression signature in the non-infarcted areas, 38 miRNAs were differentially expressed in infarcted areas and 33 miRNAs were aberrantly expressed in the border areas. Remarkably, miR-21 expression was significantly down-regulated in infarcted areas, but was up-regulated in border areas. The down-regulation of miR-21 in the infarcted areas was inhibited by ischemic preconditioning, a known cardiac protective method. Overexpression of miR-21 via adenovirus expressing miR-21 (Ad-miR-21) decreased myocardial infarct size by 29% at 24 h and decreased the dimension of left ventricles at 2 weeks after AMI. Using both gain-of-function and loss-of-function approaches in cultured cardiac myocytes, we identified that miR-21 had a protective effect on ischemia-induced cell apoptosis that was associated with its target gene programmed cell death 4 and activator protein 1 pathway. The protective effect of miR-21 against ischemia-induced cardiac myocyte damage was further confirmed in vivo by decreased cell apoptosis in the border and infarcted areas of the infarcted rat hearts after treatment with Ad-miR-21. The results suggest that miRNAs such as miR-21 may play critical roles in the early phase of AMI.	[Dong, Shimin; Cheng, Yunhui; Yang, Jian; Li, Jingyuan; Liu, Xiaojun; Wang, Xiaobin; Wang, Dong; Krall, Thomas J.; Delphin, Ellise S.; Zhang, Chunxiang] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Anesthesiol, RNA & Cardiovasc Res Lab, Newark, NJ 07101 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Zhang, CX (corresponding author), 185 S Orange Ave,MSB E548, Newark, NJ 07101 USA.	zhangc3@umdnj.edu	Vickers, Michael M/E-4095-2010; Cheng, Yunhui/D-3922-2012; zhang, xiang chun/HCH-7063-2022; Li, Jingyuan/G-2723-2012; Liu, Xiaojun/C-1650-2009; Cheng, Yunhui/A-4683-2011	zhang, xiang chun/0000-0001-8303-6495; Liu, Xiaojun/0000-0003-4758-7040; 	National Institutes of Health [HL080133]; American Heart Association [09GRNT2250567]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080133, R01HL095707] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL080133 and American Heart Association Grant 09GRNT2250567.	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Burke AP, 2007, MED CLIN N AM, V91, P553, DOI 10.1016/j.mcna.2007.03.005; Chen HH, 2009, BRIT J ORAL MAX SURG, V47, P14, DOI 10.1016/j.bjoms.2008.06.008; Cho MA, 2007, J ENDOCRINOL, V195, P255, DOI 10.1677/JOE-06-0193; Eckle T, 2006, AM J PHYSIOL-HEART C, V291, pH2533, DOI 10.1152/ajpheart.00472.2006; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Hajjar RJ, 1998, P NATL ACAD SCI USA, V95, P5251, DOI 10.1073/pnas.95.9.5251; Hwang SK, 2007, GENE THER, V14, P1353, DOI 10.1038/sj.gt.3302983; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kolakowski S, 2006, J CARDIAC SURG, V21, P559, DOI 10.1111/j.1540-8191.2006.00296.x; Kong Yong, 2005, GeoActa, V3, P62; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Pasquinelli AE, 2005, CURR OPIN GENET DEV, V15, P200, DOI 10.1016/j.gde.2005.01.002; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Tang XL, 2006, AM J PHYSIOL-HEART C, V291, pH2308, DOI 10.1152/ajpheart.00479.2006; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yin C, 2008, FEBS LETT, V582, P4137, DOI 10.1016/j.febslet.2008.11.014; ZAUG AJ, 1986, SCIENCE, V231, P470, DOI 10.1126/science.3941911; Zheng B, 2004, BASIC RES CARDIOL, V99, P264, DOI 10.1007/s00395-004-0470-y	30	387	436	0	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29514	29525		10.1074/jbc.M109.027896	http://dx.doi.org/10.1074/jbc.M109.027896			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19706597	Green Published, hybrid			2022-12-27	WOS:000270896800034
J	Frase, H; Shi, QC; Testero, SA; Mobashery, S; Vakulenko, SB				Frase, Hilary; Shi, Qicun; Testero, Sebastian A.; Mobashery, Shahriar; Vakulenko, Sergei B.			Mechanistic Basis for the Emergence of Catalytic Competence against Carbapenem Antibiotics by the GES Family of beta-Lactamases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KLEBSIELLA-PNEUMONIAE; PSEUDOMONAS-AERUGINOSA; SUBSTRATE PROFILE; RESISTANCE; TURNOVER; IMIPENEM; SUBSTITUTIONS; EVOLUTION; BACTERIA; LOOP	A major mechanism of bacterial resistance to beta-lactam antibiotics (penicillins, cephalosporins, carbapenems, etc.) is the production of beta-lactamases. A handful of class A beta-lactamases have been discovered that have acquired the ability to turn over carbapenem antibiotics. This is a disconcerting development, as carbapenems are often considered last resort antibiotics in the treatment of difficult infections. The GES family of beta-lactamases constitutes a group of extended spectrum resistance enzymes that hydrolyze penicillins and cephalosporins avidly. A single amino acid substitution at position 170 has expanded the breadth of activity to include carbapenems. The basis for this expansion of activity is investigated in this first report of detailed steady-state and pre-steady-state kinetics of carbapenem hydrolysis, performed with a class A carbapenemase. Monitoring the turnover of imipenem (a carbapenem) by GES-1 (Gly-170) revealed the acylation step as rate-limiting. GES-2 (Asn-170) has an enhanced rate of acylation, compared with GES-1, and no longer has a single rate-determining step. Both the acylation and deacylation steps are of equal magnitude. GES-5 (Ser-170) exhibits an enhancement of the rate constant for acylation by a remarkable 5000-fold, whereby the enzyme acylation event is no longer rate-limiting. This carbapenemase exhibits k(cat)/K-m of 3 x 10(5) M-1 s(-1), which is sufficient for manifestation of resistance against imipenem.	[Frase, Hilary; Shi, Qicun; Testero, Sebastian A.; Mobashery, Shahriar; Vakulenko, Sergei B.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame	Vakulenko, SB (corresponding author), Univ Notre Dame, Dept Chem & Biochem, 417 Nieuwland Sci Hall, Notre Dame, IN 46556 USA.	svakulen@nd.edu	Testero, Sebastian A./AAF-6532-2019	Testero, Sebastian A./0000-0002-0185-5751	NIAID NIH HHS [R01 AI089726] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089726] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; Babic M, 2006, DRUG RESIST UPDATE, V9, P142, DOI 10.1016/j.drup.2006.05.005; Bae IK, 2007, DIAGN MICR INFEC DIS, V58, P465, DOI 10.1016/j.diagmicrobio.2007.02.013; Clinical and Laboratory Standards Institute, 2006, METH DIL ANT SUSC TE, V7; Fersht A., 1999, STRUCTURE MECH PROTE, P103; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Giakkoupi P, 2000, ANTIMICROB AGENTS CH, V44, P2247, DOI 10.1128/AAC.44.9.2247-2253.2000; Kim SY, 2007, DIAGN MICR INFEC DIS, V57, P85, DOI 10.1016/j.diagmicrobio.2006.05.008; Maveyraud L, 1998, J AM CHEM SOC, V120, P9748, DOI 10.1021/ja9818001; Mavroidi A, 2001, J ANTIMICROB CHEMOTH, V48, P627, DOI 10.1093/jac/48.5.627; Meroueh SO, 2005, J AM CHEM SOC, V127, P15397, DOI 10.1021/ja051592u; Mourey L, 1998, J AM CHEM SOC, V120, P9382, DOI 10.1021/ja9817996; Nordmann P, 2002, CLIN MICROBIOL INFEC, V8, P321, DOI 10.1046/j.1469-0691.2002.00401.x; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Page MGP, 2008, CLIN MICROBIOL INFEC, V14, P63, DOI 10.1111/j.1469-0691.2007.01863.x; PALZKILL T, 1994, MOL MICROBIOL, V12, P217, DOI 10.1111/j.1365-2958.1994.tb01011.x; Poirel L, 2000, ANTIMICROB AGENTS CH, V44, P622, DOI 10.1128/AAC.44.3.622-632.2000; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P3593, DOI 10.1128/AAC.49.8.3593-3597.2005; Poirel L, 2001, ANTIMICROB AGENTS CH, V45, P2598, DOI 10.1128/AAC.45.9.2598-2603.2001; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; RATCLIFFE RW, 1989, J ORG CHEM, V54, P653, DOI 10.1021/jo00264a028; Smith CA, 2007, ACTA CRYSTALLOGR D, V63, P982, DOI 10.1107/S0907444907036955; TAIBI P, 1995, J AM CHEM SOC, V117, P7600, DOI 10.1021/ja00134a003; TaibiTronche P, 1996, J AM CHEM SOC, V118, P7441, DOI 10.1021/ja9529753; Vakulenko SB, 1999, J BIOL CHEM, V274, P23052, DOI 10.1074/jbc.274.33.23052; Vourli S, 2004, FEMS MICROBIOL LETT, V234, P209, DOI 10.1016/j.femsle.2004.03.028; Wachino J, 2004, ANTIMICROB AGENTS CH, V48, P2905, DOI 10.1128/AAC.48.8.2905-2910.2004; Wachino J, 2004, ANTIMICROB AGENTS CH, V48, P1960, DOI 10.1128/AAC.48.6.1960-1967.2004; Walther-Rasmussen J, 2007, J ANTIMICROB CHEMOTH, V60, P470, DOI 10.1093/jac/dkm226; ZAFARALLA G, 1992, BIOCHEMISTRY-US, V31, P3847, DOI 10.1021/bi00130a016	30	54	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29509	29513		10.1074/jbc.M109.011262	http://dx.doi.org/10.1074/jbc.M109.011262			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19656947	Green Published, hybrid			2022-12-27	WOS:000270896800033
J	Schichl, YM; Resch, U; Hofer-Warbinek, R; de Martin, R				Schichl, Yvonne M.; Resch, Ulrike; Hofer-Warbinek, Renate; de Martin, Rainer			Tristetraprolin Impairs NF-kappa B/p65 Nuclear Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; AU-RICH ELEMENT; MESSENGER-RNA TARGETS; NECROSIS-FACTOR-ALPHA; ZINC-FINGER PROTEINS; SWISS 3T3 CELLS; TRANSCRIPTION FACTOR; ENDOTHELIAL-CELLS; NUCLEOTIDE-SEQUENCE; GROWTH-FACTOR	Tristetraprolin (TTP) is a prototypic family member of CCCH-type tandem zinc-finger domain proteins that regulate mRNA destabilization in eukaryotic cells. TTP binds to AU-rich elements (AREs) in the 3'-untranslated region of certain mRNAs, including tumor necrosis factor alpha, granulocyte macrophage colony-stimulating factor, and immediate early response 3, thereby facilitating their ARE-mediated decay. Expression of TTP is up-regulated by a variety of agents, including inflammatory mediators such as tumor necrosis factor alpha, a prominent activator of the nuclear factor kappa B (NF-kappa B) family of transcription factors. Accordingly, TTP is involved in the negative feedback regulation of NF-kappa B through promoting mRNA degradation. We describe here a novel, ARE-mediated decay-independent function of TTP on the termination of NF-kappa B response: TTP suppresses the transcriptional activity of NF-kappa B-dependent promoters independent of its mRNA-destabilizing property. In TTP knockout mouse embryonic fibroblasts, lack of TTP leads to enhanced nuclear p65 levels, which is associated with the up-regulation of specific, ARE-less NF-kappa B target genes. We find that attenuation of NF-kappa B activity is at least in part due to an interference of TTP with the nuclear import of the p65 subunit of the transcription factor. This novel role of TTP may synergize with its mRNA-degrading function to contribute to the efficient regulation of proinflammatory gene expression.	[Schichl, Yvonne M.; Resch, Ulrike; Hofer-Warbinek, Renate; de Martin, Rainer] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, A-1090 Vienna, Austria	Medical University of Vienna	Schichl, YM (corresponding author), Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Lazarettg 19, A-1090 Vienna, Austria.	yvonne.schichl@gmx.net; rainer.demartin@meduniwien.ac.at		Resch, Ulrike/0000-0002-8380-9555	Austrian Science Foundation [P19217-B13]	Austrian Science Foundation(Austrian Science Fund (FWF))	This work was supported by a grant from the Austrian Science Foundation, Project P19217-B13 (to R. d. M.).	Baker A, 1997, GENE THER, V4, P773, DOI 10.1038/sj.gt.3300471; Beutler B, 1995, J CARDIOVASC PHARM, V25, pS1, DOI 10.1097/00005344-199500252-00002; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; BLANK V, 1991, EMBO J, V10, P4159, DOI 10.1002/j.1460-2075.1991.tb04994.x; Campbell KJ, 2004, BIOCHEM SOC T, V32, P1087, DOI 10.1042/BST0321087; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carman JA, 2004, BIOCHEM BIOPH RES CO, V315, P445, DOI 10.1016/j.bbrc.2004.01.080; Carrick DM, 2006, J AUTOIMMUN, V26, P182, DOI 10.1016/j.jaut.2006.01.004; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Devin A, 2000, IMMUNITY, V12, P419, DOI 10.1016/S1074-7613(00)80194-6; DUBOIS RN, 1990, J BIOL CHEM, V265, P19185; Emmons J, 2008, RNA, V14, P888, DOI 10.1261/rna.748408; Fagerlund R, 2005, J BIOL CHEM, V280, P15942, DOI 10.1074/jbc.M500814200; GOMPERTS M, 1990, ONCOGENE, V5, P1081; Harant H, 1996, J BIOL CHEM, V271, P26954, DOI 10.1074/jbc.271.43.26954; Harhaj EW, 1999, MOL CELL BIOL, V19, P7088; Hau HH, 2007, J CELL BIOCHEM, V100, P1477, DOI 10.1002/jcb.21130; Heximer SP, 1998, DNA CELL BIOL, V17, P249, DOI 10.1089/dna.1998.17.249; HEXIMER SP, 1993, DNA CELL BIOL, V12, P73, DOI 10.1089/dna.1993.12.73; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Hofer-Warbinek R, 2000, J BIOL CHEM, V275, P22064, DOI 10.1074/jbc.M910346199; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Ishmael FT, 2008, J IMMUNOL, V180, P8342, DOI 10.4049/jimmunol.180.12.8342; KANEDA N, 1992, GENE, V118, P289, DOI 10.1016/0378-1119(92)90202-Z; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lai WS, 2001, J BIOL CHEM, V276, P23144, DOI 10.1074/jbc.M100680200; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; LAI WS, 1990, J BIOL CHEM, V265, P16556; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; Li Q, 2007, ONCOGENE, V26, P7885, DOI 10.1038/sj.onc.1210597; LIM RW, 1987, ONCOGENE, V1, P263; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; MA QF, 1991, ONCOGENE, V6, P1277; Moroianu J, 1999, J CELL BIOCHEM, P76; Rout MP, 2001, J BIOL CHEM, V276, P16593, DOI 10.1074/jbc.R100015200; Sauer I, 2006, BLOOD, V107, P4790, DOI 10.1182/blood-2005-07-3058; Schabbauer G, 2007, THROMB HAEMOSTASIS, V97, P988, DOI 10.1160/TH07-01-0037; SCHMITZ ML, 1995, J BIOL CHEM, V270, P15576, DOI 10.1074/jbc.270.26.15576; Solan NJ, 2002, J BIOL CHEM, V277, P1405, DOI 10.1074/jbc.M109619200; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Taylor GA, 1996, MOL ENDOCRINOL, V10, P140, DOI 10.1210/me.10.2.140; Vanden Berghe W, 1999, J BIOL CHEM, V274, P32091, DOI 10.1074/jbc.274.45.32091; VARNUM BC, 1989, ONCOGENE, V4, P119; Winzen R, 2007, MOL CELL BIOL, V27, P8388, DOI 10.1128/MCB.01493-07; Worthington MT, 2002, J BIOL CHEM, V277, P48558, DOI 10.1074/jbc.M206505200; Xylourgidis N, 2006, J CELL SCI, V119, P4409, DOI 10.1242/jcs.03201; Zhang WJ, 1997, ARTERIOSCL THROM VAS, V17, P465, DOI 10.1161/01.ATV.17.3.465	52	70	71	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29571	29581		10.1074/jbc.M109.031237	http://dx.doi.org/10.1074/jbc.M109.031237			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19654331	Green Published, hybrid			2022-12-27	WOS:000270896800039
J	Kirschbaum, K; Kriebel, M; Kranz, EU; Potz, O; Volkmer, H				Kirschbaum, Katja; Kriebel, Martin; Kranz, Eva Ursula; Poetz, Oliver; Volkmer, Hansjuergen			Analysis of Non-canonical Fibroblast Growth Factor Receptor 1 (FGFR1) Interaction Reveals Regulatory and Activating Domains of Neurofascin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION MOLECULE L1; DEPENDENT NEURITE OUTGROWTH; ANKYRIN-BINDING-ACTIVITY; CELL-ADHESION; CHICK NEUROFASCIN; AXONAL SURFACE; RPTP-ALPHA; N-CAM; NCAM; PHOSPHORYLATION	Fibroblast growth factor receptors (FGFRs) are important for many different mechanisms, including cell migration, proliferation, differentiation, and survival. Here, we show a new link between FGFR1 and the cell adhesion molecule neurofascin, which is important for neurite outgrowth. After overexpression in HEK293 cells, embryonal neurofascin isoform NF166 was able to associate with FGFR1, whereas the adult isoform NF186, differing from NF166 in additional extracellular sequences, was deficient. Pharmacological inhibitors and overexpression of dominant negative components of the FGFR signaling pathway pointed to the activation of FGFR1 after association with neurofascin in neurite outgrowth assays in chick tectal neurons and rat PC12-E2 cells. Both extra- and intracellular domains of embryonal neurofascin isoform NF166 were able to form complexes with FGFR1 independently. However, the cytosolic domain was both necessary and sufficient for the activation of FGFR1. Cytosolic serine residues 56 and 100 were shown to be essential for the neurite outgrowth-promoting activity of neurofascin, whereas both amino acid residues were dispensable for FGFR1 association. In conclusion, the data suggest a neurofascin intracellular domain, which activates FGFR1 for neurite outgrowth, whereas the extracellular domain functions as an additional, regulatory FGFR1 interaction domain in the course of development.	[Kirschbaum, Katja; Kriebel, Martin; Kranz, Eva Ursula; Volkmer, Hansjuergen] Univ Tubingen, Dept Mol Biol, D-72770 Reutlingen, Germany; [Poetz, Oliver] Univ Tubingen, Dept Biochem Nat Wissensch, D-72770 Reutlingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Volkmer, H (corresponding author), Univ Tubingen, Dept Mol Biol, Markwiesenstr 55, D-72770 Reutlingen, Germany.	volkmer@nmi.de	Volkmer, Hansjuergen/AAU-9641-2021	Volkmer, Hansjuergen/0000-0002-3867-0603	European Union 6th Framework Program [LSHM-CT-2005-512012]; Bundesministerium fur Bildung und Forschung [0312114]	European Union 6th Framework Program(European Commission); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by European Union 6th Framework Program Grant LSHM-CT-2005-512012 and by Bundesministerium fur Bildung und Forschung Grant 0312114.	Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; BEGGS HE, 1994, J CELL BIOL, V127, P825, DOI 10.1083/jcb.127.3.825; Beggs HE, 1997, J BIOL CHEM, V272, P8310, DOI 10.1074/jbc.272.13.8310; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; Bodrikov V, 2008, J CELL BIOL, V182, P1185, DOI 10.1083/jcb.200803045; Boget S, 2001, EUR J ENDOCRINOL, V145, P303, DOI 10.1530/eje.0.1450303; Burkarth N, 2007, MOL CELL NEUROSCI, V36, P59, DOI 10.1016/j.mcn.2007.06.001; Cambon K, 2004, J NEUROSCI, V24, P4197, DOI 10.1523/JNEUROSCI.0436-04.2004; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; DAVIS JQ, 1994, J BIOL CHEM, V269, P27163; Ditlevsen DK, 2008, J NEUROSCI RES, V86, P727, DOI 10.1002/jnr.21551; Doherty P, 1996, MOL CELL NEUROSCI, V8, P99, DOI 10.1006/mcne.1996.0049; Doherty P, 2000, MOL CELL NEUROSCI, V16, P283, DOI 10.1006/mcne.2000.0907; Garver TD, 1997, J CELL BIOL, V137, P703, DOI 10.1083/jcb.137.3.703; Groth C, 2002, INT J DEV BIOL, V46, P393; Hansen RK, 2007, J NEUROCHEM, V103, P1396, DOI 10.1111/j.1471-4159.2007.04894.x; Hassel B, 1997, J BIOL CHEM, V272, P28742, DOI 10.1074/jbc.272.45.28742; Heiland PC, 1998, EUR J CELL BIOL, V75, P97, DOI 10.1016/S0171-9335(98)80052-6; HILDEBRANDT H, 2008, NEUROCHEM R IN PRESS; IGNELZI MA, 1994, NEURON, V12, P873, DOI 10.1016/0896-6273(94)90339-5; Jenkins SM, 2002, P NATL ACAD SCI USA, V99, P2303, DOI 10.1073/pnas.042601799; Jessen U, 2001, J NEUROCHEM, V79, P1149, DOI 10.1046/j.1471-4159.2001.00636.x; Kiselyov VV, 2003, STRUCTURE, V11, P691, DOI 10.1016/S0969-2126(03)00096-0; Kolkova K, 2005, J NEUROCHEM, V92, P886, DOI 10.1111/j.1471-4159.2004.02919.x; Kolkova K, 2000, J NEUROSCI, V20, P2238; Koroll M, 2001, J BIOL CHEM, V276, P10646, DOI 10.1074/jbc.M010647200; Koticha D, 2006, DEV BIOL, V293, P1, DOI 10.1016/j.ydbio.2005.05.028; Koticha D, 2005, MOL CELL NEUROSCI, V30, P137, DOI 10.1016/j.mcn.2005.06.007; Krushel LA, 1999, J BIOL CHEM, V274, P2432, DOI 10.1074/jbc.274.4.2432; Kulahin N, 2008, MOL CELL NEUROSCI, V37, P528, DOI 10.1016/j.mcn.2007.12.001; Leshchyns'ka I, 2003, J CELL BIOL, V161, P625, DOI 10.1083/jcb.200303020; Little EB, 1998, CELL ADHES COMMUN, V6, P415, DOI 10.3109/15419069809109150; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Murakami M, 2008, CARDIOVASC RES, V78, P223, DOI 10.1093/cvr/cvm086; Ornitz DM, 2001, GENOME BIOL, V2; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Pruss T, 2006, MOL CELL NEUROSCI, V31, P354, DOI 10.1016/j.mcn.2005.10.009; Pruss T, 2004, EUR J NEUROSCI, V20, P3184, DOI 10.1111/j.1460-9568.2004.03773.x; Ratcliffe CF, 2001, J CELL BIOL, V154, P427, DOI 10.1083/jcb.200102086; RATHJEN FG, 1987, CELL, V51, P841, DOI 10.1016/0092-8674(87)90107-3; Ren Q, 1998, J NEUROCHEM, V70, P1839; Ronn LCB, 2000, J NEUROCHEM, V75, P665, DOI 10.1046/j.1471-4159.2000.0750665.x; Saffell JL, 1997, NEURON, V18, P231, DOI 10.1016/S0896-6273(00)80264-0; Sanchez-Heras E, 2006, J BIOL CHEM, V281, P35208, DOI 10.1074/jbc.M608655200; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Schaefer AW, 1999, J BIOL CHEM, V274, P37965, DOI 10.1074/jbc.274.53.37965; Schmid RS, 2000, J NEUROSCI, V20, P4177; Schmid RS, 1999, J NEUROBIOL, V38, P542, DOI 10.1002/(SICI)1097-4695(199903)38:4<542::AID-NEU9>3.3.CO;2-T; Tuvia S, 1997, P NATL ACAD SCI USA, V94, P12957, DOI 10.1073/pnas.94.24.12957; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; VOLKMER H, 1992, J CELL BIOL, V118, P149, DOI 10.1083/jcb.118.1.149; Volkmer H, 1996, J CELL BIOL, V135, P1059, DOI 10.1083/jcb.135.4.1059; VOLKMER H, 2001, CELL ADHESION, P1; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; WILLIAMS EJ, 1992, J CELL BIOL, V119, P883, DOI 10.1083/jcb.119.4.883; Yokote H, 2005, P NATL ACAD SCI USA, V102, P18866, DOI 10.1073/pnas.0509741102; Zhang X, 1998, J BIOL CHEM, V273, P30785, DOI 10.1074/jbc.273.46.30785	57	14	15	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28533	28542		10.1074/jbc.M109.004440	http://dx.doi.org/10.1074/jbc.M109.004440			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19666467	hybrid, Green Published			2022-12-27	WOS:000270678900007
J	Song, HH; Suehiro, J; Kanki, Y; Kawai, Y; Inoue, K; Daida, H; Yano, K; Ohhashi, T; Oettgen, P; Aird, WC; Kodama, T; Minami, T				Song, Haihua; Suehiro, Jun-ichi; Kanki, Yasuharu; Kawai, Yoshiko; Inoue, Kenji; Daida, Hiroyuki; Yano, Kiichiro; Ohhashi, Toshio; Oettgen, Peter; Aird, William C.; Kodama, Tatsuhiko; Minami, Takashi			Critical Role for GATA3 in Mediating Tie2 Expression and Function in Large Vessel Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-2; ADHESION MOLECULE-1 EXPRESSION; SYNDROME CRITICAL REGION-1; GENE-EXPRESSION; TRANSGENIC MICE; IN-VITRO; THROMBIN STIMULATION; PROMOTER; ANGIOPOIETIN-1; DIFFERENTIATION	Endothelial phenotypes are highly regulated in space and time by both transcriptional and post-transcriptional mechanisms. There is increasing evidence that the GATA family of transcription factors function as signal transducers, coupling changes in the extracellular environment to changes in downstream target gene expression. Here we show that human primary endothelial cells derived from large blood vessels express GATA2, -3, and -6. Of these factors, GATA3 was expressed at the highest levels. In DNA microarrays of human umbilical vein endothelial cells (HUVEC), small interfering RNA-mediated knockdown of GATA3 resulted in reduced expression of genes associated with angiogenesis, including Tie2. At a functional level, GATA3 knockdown inhibited angiopoietin (Ang)-1-mediated but not vascular endothelial cell growth factor (VEGF)-mediated AKT signaling, cell migration, survival, and tube formation. In electrophoretic gel mobility shift assays and chromatin immunoprecipitation, GATA3 was shown to bind to regulatory regions within the 5'-untranslated region of the Tie2 gene. In co-immunoprecipitation and co-transfection assays, GATA3 and the Ets transcription factor, ELF1, physically interacted and synergized to transactivate the Tie2 promoter. GATA3 knockdown blocked the ability of Ang-1 to attenuate vascular endothelial cell growth factor stimulation of vascular cell adhesion molecule-1 expression and monocytic cell adhesion. Moreover, exposure of human umbilical vein endothelial cells to tumor necrosis factor-alpha resulted in marked down-regulation of GATA3 expression and reduction in Tie2 expression. Together, these findings suggest that GATA3 is indispensable for Ang-1-Tie2-mediated signaling in large vessel endothelial cells.	[Yano, Kiichiro; Aird, William C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Mol & Vasc Med, Boston, MA 02215 USA; [Kodama, Tatsuhiko; Minami, Takashi] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo 1538904, Japan; [Kodama, Tatsuhiko; Minami, Takashi] Univ Tokyo, Translat Syst Biol & Med Initiat, Tokyo 1138655, Japan; [Kawai, Yoshiko; Ohhashi, Toshio] Shinshu Univ, Sch Med, Dept Physiol, Matsumoto, Nagano 3908621, Japan; [Inoue, Kenji; Daida, Hiroyuki] Juntendo Univ, Dept Cardiovasc Med Dis Old Ages, Sch Med, Tokyo 1138421, Japan; [Oettgen, Peter] Harvard Inst Med, Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Tokyo; University of Tokyo; Shinshu University; Juntendo University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Aird, WC (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Mol & Vasc Med, 330 Brookline Ave, Boston, MA 02215 USA.	waird@bidmc.harvard.edu; minami@med.rcast.u-tokyo.ac.jp	Oettgen, Peter/AAF-5026-2021		National Institutes of Health [PO1 HL76540, R01HL082927]; NHLBI; Ministry of Education, Culture, Sports, Science, and Technology in Japan; Takeda Science Foundation in Japan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082927, P01HL076540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation in Japan(Takeda Science Foundation (TSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL76540 (to W. C. A. and P. O.) and R01HL082927 (to W. C. A.) from NHLBI. This work was also supported by the fund for Science and Technology from the Ministry of Education, Culture, Sports, Science, and Technology in Japan and in part by Takeda Science Foundation in Japan (to T. M.).	Abid MR, 2008, ARTERIOSCL THROM VAS, V28, P2042, DOI 10.1161/ATVBAHA.108.175109; Adryan B, 2004, BIOINFORMATICS, V20, P2851, DOI 10.1093/bioinformatics/bth289; BROCK TG, 1994, J BIOL CHEM, V269, P22059; Cowan PJ, 1998, J BIOL CHEM, V273, P11737, DOI 10.1074/jbc.273.19.11737; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; DeBusk LM, 2004, EXP CELL RES, V298, P167, DOI 10.1016/j.yexcr.2004.04.013; DORFMAN DM, 1992, J BIOL CHEM, V267, P1279; Dube A, 1999, CIRC RES, V84, P1177, DOI 10.1161/01.RES.84.10.1177; Fadel BM, 1999, J BIOL CHEM, V274, P20376, DOI 10.1074/jbc.274.29.20376; Fadel BM, 1998, BIOCHEM J, V330, P335; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Fujikawa K, 1999, EXP CELL RES, V253, P663, DOI 10.1006/excr.1999.4693; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; JAHROUDI N, 1994, MOL CELL BIOL, V14, P999, DOI 10.1128/MCB.14.2.999; Kawai Yoshiko, 2007, Lymphatic Research and Biology, V5, P115, DOI 10.1089/lrb.2007.1003; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Lin JHC, 1996, ATHEROSCLEROSIS, V127, P185, DOI 10.1016/S0021-9150(96)05951-5; Maeda M, 2005, DEV GROWTH DIFFER, V47, P591; Minami T, 2003, J BIOL CHEM, V278, P6976, DOI 10.1074/jbc.M208974200; Minami T, 2004, J BIOL CHEM, V279, P20626, DOI 10.1074/jbc.M308730200; Minami T, 2003, ARTERIOSCL THROM VAS, V23, P2041, DOI 10.1161/01.ATV.0000089326.63053.9A; Minami T, 2001, J BIOL CHEM, V276, P47632, DOI 10.1074/jbc.M108363200; Minami T, 2001, J BIOL CHEM, V276, P5395, DOI 10.1074/jbc.M008798200; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; MINAMI T, 2007, ENDOTHELIAL BIOMEDIC, P806; Minami T, 2006, J BIOL CHEM, V281, P20503, DOI 10.1074/jbc.M513112200; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; Peng YW, 2003, J BIOL CHEM, V278, P8385, DOI 10.1074/jbc.M213156200; Peters KG, 2004, RECENT PROG HORM RES, V59, P51, DOI 10.1210/rp.59.1.51; Sako K, 2009, J BIOL CHEM, V284, P5592, DOI 10.1074/jbc.M806928200; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; SCHLAEGER TM, 1995, DEVELOPMENT, V121, P1089; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; Sharifi BG, 2006, ARTERIOSCL THROM VAS, V26, P1273, DOI 10.1161/01.ATV.0000222017.05085.8e; Simoncini T, 2000, CIRC RES, V87, P19, DOI 10.1161/01.RES.87.1.19; SOUDAIS C, 1995, DEVELOPMENT, V121, P3877; Tomi M, 2004, MOL VIS, V10, P537; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Umetani M, 2001, ARTERIOSCL THROM VAS, V21, P917, DOI 10.1161/01.ATV.21.6.917; Velazquez OC, 2002, FASEB J, V16, P1316, DOI 10.1096/fj.01-1011fje; WEISS MJ, 1995, EXP HEMATOL, V23, P99; ZHANG R, 1995, J BIOL CHEM, V270, P15320, DOI 10.1074/jbc.270.25.15320	49	45	45	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29109	29124		10.1074/jbc.M109.041145	http://dx.doi.org/10.1074/jbc.M109.041145			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19674970	Green Published, hybrid			2022-12-27	WOS:000270678900067
J	Wakita, C; Maeshima, T; Yamazaki, A; Shibata, T; Ito, S; Akagawa, M; Ojika, M; Yodoi, J; Uchida, K				Wakita, Chika; Maeshima, Takuya; Yamazaki, Atsushi; Shibata, Takahiro; Ito, Sohei; Akagawa, Mitsugu; Ojika, Makoto; Yodoi, Junji; Uchida, Koji			Stereochemical Configuration of 4-Hydroxy-2-nonenal-Cysteine Adducts and Their Stereoselective Formation in a Redox-regulated Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOREDOXIN REDUCTASE; POSSIBLE INVOLVEMENT; LIPID-PEROXIDATION; REACTIVE ALDEHYDE; GLUTATHIONE; INHIBITION; MECHANISMS; DISEASES; PEPTIDE; SYSTEMS	4-Hydroxy-2-nonenal (HNE), a major racemic product of lipid peroxidation, preferentially reacts with cysteine residues to form a stable HNE-cysteine Michael addition adduct possessing three chiral centers. Here, to gain more insight into sulfhydryl modification by HNE, we characterized the stereochemical configuration of the HNE-cysteine adducts and investigated their stereoselective formation in redox-regulated proteins. To characterize the HNE-cysteine adducts by NMR, the authentic (R)-HNE- and (S)-HNE-cysteine adducts were prepared by incubating N-acetylcysteine with each HNE enantiomer, both of which provided two peaks in reversed-phase high performance liquid chromatography (HPLC). The NMR analysis revealed that each peak was a mixture of anomeric isomers. In addition, mutarotation at the anomeric center was also observed in the analysis of the nuclear Overhauser effect. To analyze these adducts in proteins, we adapted a pyridylamination-based approach, using 2-aminopyridine in the presence of sodium cyanoborohydride, which enabled analyzing the individual (R)-HNE-and (S)-HNE-cysteine adducts by reversed-phase HPLC following acid hydrolysis. Using the pyridylamination method along with mass spectrometry, we characterized the stereoselective formation of the HNE-cysteine adducts in human thioredoxin and found that HNE preferentially modifies Cys(73) and, to the lesser extent, the active site Cys(32). More interestingly, the (R)-HNE-and (S)-HNE-cysteine adducts were almost equally formed at Cys(73), whereas Cys(32) exhibited a remarkable preference for the adduct formation with (R)-HNE. Finally, the utility of the method for the determination of the HNE-cysteine adducts was confirmed by an in vitro study using HeLa cells. The present results not only offer structural insight into sulfhydryl modification by lipid peroxidation products but also provide a platform for the chemical analysis of protein S-associated aldehydes in vitro and in vivo.	[Wakita, Chika; Maeshima, Takuya; Yamazaki, Atsushi; Shibata, Takahiro; Ojika, Makoto; Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Ito, Sohei] Univ Shizuoka, Sch Food & Nutr Sci, Shizuoka 4228526, Japan; [Akagawa, Mitsugu] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka 5998531, Japan; [Yodoi, Junji] Kyoto Univ, Inst Virus Res, Dept Biol Responses, Kyoto 6068507, Japan	Nagoya University; University of Shizuoka; Osaka Metropolitan University; Kyoto University	Uchida, K (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	uchidak@agr.nagoya-u.ac.jp	Ito, Sohei/M-5930-2019; Ito, Sohei/A-4266-2010; Shibata, Takahiro/I-6872-2014	Ito, Sohei/0000-0002-9937-3100; Shibata, Takahiro/0000-0003-3194-607X; Uchida, Koji/0000-0003-3894-5299	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research on innovative areas (Research in a Proposed Research Area) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to K. U.).	ALLEVI P, 1993, J ORG CHEM, V58, P5000, DOI 10.1021/jo00070a043; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Balogh LM, 2008, J BIOL CHEM, V283, P16702, DOI 10.1074/jbc.M801725200; Casagrande S, 2002, P NATL ACAD SCI USA, V99, P9745, DOI 10.1073/pnas.152168599; DEMONTARBY L, 1988, TETRAHEDRON LETT, V29, P3937, DOI 10.1016/S0040-4039(00)80387-1; Deneke SM, 2000, CURR TOP CELL REGUL, V36, P151; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fang JG, 2006, J AM CHEM SOC, V128, P1879, DOI 10.1021/ja057358l; Go YM, 2007, AM J PATHOL, V171, P1670, DOI 10.2353/ajpath.2007.070218; GUTTERIDGE JMC, 1990, TRENDS BIOCHEM SCI, V15, P129, DOI 10.1016/0968-0004(90)90206-Q; Hartley DP, 1997, CHEM RES TOXICOL, V10, P895, DOI 10.1021/tx960181b; HASE S, 1978, BIOCHEM BIOPH RES CO, V85, P257, DOI 10.1016/S0006-291X(78)80037-0; Hashimoto M, 2003, J BIOL CHEM, V278, P5044, DOI 10.1074/jbc.M210129200; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Jordan BF, 2005, CLIN CANCER RES, V11, P529; Kirkpatrick DL, 1998, BIOCHEM PHARMACOL, V55, P987, DOI 10.1016/S0006-2952(97)00597-2; Marnett LJ, 2003, J CLIN INVEST, V111, P583, DOI 10.1172/JCI200318022; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; QIN J, 1995, STRUCTURE, V3, P289, DOI 10.1016/S0969-2126(01)00159-9; Qin J, 1996, STRUCTURE, V4, P613, DOI 10.1016/S0969-2126(96)00065-2; Sasada T, 1999, FREE RADICAL BIO MED, V27, P504, DOI 10.1016/S0891-5849(99)00101-X; SCHAUENSTEIN E, 1971, MONATSH CHEM, V102, P517, DOI 10.1007/BF00909348; Schneider C, 2001, J BIOL CHEM, V276, P20831, DOI 10.1074/jbc.M101821200; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SZWEDA LI, 1993, J BIOL CHEM, V268, P3342; TAGAYA Y, 1989, EMBO J, V8, P757, DOI 10.1002/j.1460-2075.1989.tb03436.x; UCHIDA K, 1992, P NATL ACAD SCI USA, V89, P4544, DOI 10.1073/pnas.89.10.4544; Uchida K, 2000, FREE RADICAL BIO MED, V28, P1685, DOI 10.1016/S0891-5849(00)00226-4; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; UCHIDA K, 1992, P NATL ACAD SCI USA, V89, P5611, DOI 10.1073/pnas.89.12.5611; UCHIDA K, 1993, J BIOL CHEM, V268, P6388; UCHIDA K, 1994, BIOCHEMISTRY-US, V33, P12487, DOI 10.1021/bi00207a016; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2; YODOI J, 1992, IMMUNOL TODAY, V13, P405, DOI 10.1016/0167-5699(92)90091-K	36	40	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28810	28822		10.1074/jbc.M109.019927	http://dx.doi.org/10.1074/jbc.M109.019927			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19692331	Green Published, hybrid			2022-12-27	WOS:000270678900038
J	Isobe, T; Hattori, T; Kitagawa, K; Uchida, C; Kotake, Y; Kosugi, I; Oda, T; Kitagawa, M				Isobe, Tomoyasu; Hattori, Takayuki; Kitagawa, Kyoko; Uchida, Chiharu; Kotake, Yojiro; Kosugi, Isao; Oda, Toshiaki; Kitagawa, Masatoshi			Adenovirus E1A Inhibits SCFFbw7 Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-ALPHA; PHOSPHORYLATION-DEPENDENT UBIQUITINATION; TUMOR-SUPPRESSOR; CYCLIN-E; CONJUGATING ENZYME; NEDD8 MODIFICATION; RING FINGER; C-MYC; DEGRADATION; PROTEIN	The SCFFbw7 ubiquitin ligase complex plays important roles in cell growth, survival, and differentiation via the ubiquitin-proteasome-mediated regulation of protein stability. Fbw7 (also known as Fbxw7, Sel-10, hCdc4, or hAgo), a substrate recognition subunit of SCFFbw7 ubiquitin ligase, facilitates the degradation of several proto-oncogene products by the proteasome. Given that mutations in Fbw7 are found in various types of human cancers, Fbw7 is considered to be a potent tumor suppressor. In the present study, we show that E1A, an oncogene product derived from adenovirus, interferes with the activity of the SCFFbw7 ubiquitin ligase. E1A interacted with SCFFbw7 and attenuated the ubiquitylation of its target proteins in vivo. Furthermore, using in vitro purified SCFFbw7 component proteins, we found that E1A directly bound to Roc1/Rbx1 and CUL1 and that E1A inhibited the ubiquitin ligase activity of the Roc1/Rbx1-CUL1 complex but not that of another RING-type ubiquitin ligase, Mdm2. Ectopically expressed E1A interacted with cellular endogenous Roc1/Rbx1 and CUL1 and decelerated the degradation of several protooncogene products that were degraded by SCFFbw7 ubiquitin ligase. Moreover, after wild-type adenovirus infection, adenovirus-derived E1A interacted with endogenous Roc1/Rbx1 and decelerated degradation of the endogenous target protein of SCFFbw7. These observations demonstrated that E1A perturbs protein turnover regulated by SCFFbw7 through the inhibition of SCFFbw7 ubiquitin ligase. Our findings may help to explain the mechanism whereby adenovirus infection induces unregulated proliferation.	[Isobe, Tomoyasu; Hattori, Takayuki; Kitagawa, Kyoko; Uchida, Chiharu; Kotake, Yojiro; Oda, Toshiaki; Kitagawa, Masatoshi] Hamamatsu Univ Sch Med, Dept Biochem 1, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Kosugi, Isao] Hamamatsu Univ Sch Med, Dept Pathol 2, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Kitagawa, M (corresponding author), Hamamatsu Univ Sch Med, Dept Biochem 1, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	kitamasa@hama-med.ac.jp			Ministry of Education, Science, Sports, Culture, and Technology of Japan	Ministry of Education, Science, Sports, Culture, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from the Ministry of Education, Science, Sports, Culture, and Technology of Japan (to M. K. and K. K.) and by the Centers of Excellence Program of Hamamatsu University School of Medicine from the Ministry of Education, Science, Sports, Culture, and Technology of Japan (to M. K.).	Brockmann D, 2003, CURR TOP MICROBIOL, V272, P97; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chew EH, 2007, CELL SIGNAL, V19, P1071, DOI 10.1016/j.cellsig.2006.12.002; Chinnadurai G, 2004, CURR TOP MICROBIOL, V273, P139; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Dias DC, 2002, P NATL ACAD SCI USA, V99, P16601, DOI 10.1073/pnas.252646399; EGAN C, 1987, VIROLOGY, V160, P292, DOI 10.1016/0042-6822(87)90077-8; EGAN C, 1988, MOL CELL BIOL, V8, P3955, DOI 10.1128/MCB.8.9.3955; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Furukawa M, 2002, J BIOL CHEM, V277, P15758, DOI 10.1074/jbc.M108565200; Furukawa M, 2000, MOL CELL BIOL, V20, P8185, DOI 10.1128/MCB.20.21.8185-8197.2000; Gallimore PH, 2001, ONCOGENE, V20, P7824, DOI 10.1038/sj.onc.1204913; Hatakeyama S, 1999, P NATL ACAD SCI USA, V96, P3859, DOI 10.1073/pnas.96.7.3859; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; Isobe T, 2006, BIOCHEM BIOPH RES CO, V339, P367, DOI 10.1016/j.bbrc.2005.11.028; Jensen JP, 1995, J BIOL CHEM, V270, P30408, DOI 10.1074/jbc.270.51.30408; JONES N, 1979, P NATL ACAD SCI USA, V76, P3665, DOI 10.1073/pnas.76.8.3665; Kanei-Ishii C, 2008, J BIOL CHEM, V283, P30540, DOI 10.1074/jbc.M804340200; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Kitagawa K, 2009, ONCOGENE, V28, P2393, DOI 10.1038/onc.2009.111; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Louis N, 1997, VIROLOGY, V233, P423, DOI 10.1006/viro.1997.8597; LOWE SW, 1993, GENE DEV, V7, P535, DOI 10.1101/gad.7.4.535; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Nakajima T, 1998, J BIOL CHEM, V273, P20036, DOI 10.1074/jbc.273.32.20036; Nakajima T, 1996, J BIOL CHEM, V271, P24842, DOI 10.1074/jbc.271.40.24842; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Onoyama I, 2007, J EXP MED, V204, P2875, DOI 10.1084/jem.20062299; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Samuelson AV, 2005, J BIOL CHEM, V280, P21915, DOI 10.1074/jbc.M414564200; Spruck CH, 2002, CANCER RES, V62, P4535; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Suzuki H, 2000, J BIOL CHEM, V275, P2877, DOI 10.1074/jbc.275.4.2877; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Turnell AS, 2005, NATURE, V438, P690, DOI 10.1038/nature04151; Tworkowski KA, 2008, P NATL ACAD SCI USA, V105, P6103, DOI 10.1073/pnas.0802095105; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; Wada H, 2000, J BIOL CHEM, V275, P17008, DOI 10.1074/jbc.275.22.17008; Welcker M, 2005, J BIOL CHEM, V280, P7654, DOI 10.1074/jbc.M413377200; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; WHYTE P, 1989, CELL, V56, P67, DOI 10.1016/0092-8674(89)90984-7; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Wu JT, 2006, TRENDS CELL BIOL, V16, P362, DOI 10.1016/j.tcb.2006.05.001; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Wu K, 2000, MOL CELL BIOL, V20, P1382, DOI 10.1128/MCB.20.4.1382-1393.2000; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	69	24	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27766	27779		10.1074/jbc.M109.006809	http://dx.doi.org/10.1074/jbc.M109.006809			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19679664	Green Published, hybrid			2022-12-27	WOS:000270676300003
J	Hanson, RW				Hanson, Richard W.			Thematic Minireview Series: A Perspective on the Biology of Phosphoenolpyruvate Carboxykinase 55 Years After Its Discovery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							GTP GENE; CRYSTAL-STRUCTURE; LIVER; TRANSCRIPTION; MECHANISM; EXPRESSION; PEPCK; IDENTIFICATION; INSULIN; PROTEIN		Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University	Hanson, RW (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	rwh@case.edu						ASH DE, 1990, J BIOL CHEM, V265, P7377; BENVENISTY N, 1987, P NATL ACAD SCI USA, V84, P1132, DOI 10.1073/pnas.84.5.1132; BENVENISTY N, 1985, P NATL ACAD SCI USA, V82, P267, DOI 10.1073/pnas.82.2.267; Carlson GM, 2009, J BIOL CHEM, V284, P27037, DOI 10.1074/jbc.R109.040568; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Chakravarty K, 2004, J BIOL CHEM, V279, P15385, DOI 10.1074/jbc.M309905200; Chakravarty K, 2001, J BIOL CHEM, V276, P34816, DOI 10.1074/jbc.M103310200; Cissell MA, 1999, BBA-GENE STRUCT EXPR, V1445, P299, DOI 10.1016/S0167-4781(99)00049-4; Curthoys NP, 2001, AM J PHYSIOL-RENAL, V281, pF381, DOI 10.1152/ajprenal.2001.281.3.F381; Dunten P, 2002, J MOL BIOL, V316, P257, DOI 10.1006/jmbi.2001.5364; GRANNER DK, 1992, DIABETES CARE, V15, P369, DOI 10.2337/diacare.15.3.369; Hall RK, 2007, MOL ENDOCRINOL, V21, P550, DOI 10.1210/me.2006-0307; HANSON RW, 1972, AM J CLIN NUTR, V25, P1010; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Hanson RW, 2003, BIOCHIMIE, V85, P1199, DOI 10.1016/j.biochi.2003.10.022; Holyoak T, 2006, BIOCHEMISTRY-US, V45, P8254, DOI 10.1021/bi060269g; IP YT, 1990, MOL CELL BIOL, V10, P3782, DOI 10.1128/MCB.10.7.3782; Krautwurst H, 1998, BIOCHEMISTRY-US, V37, P6295, DOI 10.1021/bi971515e; LEWIS CT, 1989, BIOCHEMISTRY-US, V28, P9248, DOI 10.1021/bi00450a003; LEWIS CT, 1993, J BIOL CHEM, V268, P1628; MAKINEN AL, 1989, J BIOL CHEM, V264, P12148; Matte A, 1996, J MOL BIOL, V256, P126, DOI 10.1006/jmbi.1996.0072; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; PATEL YM, 1994, J BIOL CHEM, V269, P5619; ROESLER WJ, 1989, J BIOL CHEM, V264, P9657; She PX, 2003, DIABETES, V52, P1649, DOI 10.2337/diabetes.52.7.1649; Stark R, 2009, J BIOL CHEM, V284, P26578, DOI 10.1074/jbc.M109.011775; Sullivan SM, 2008, P NATL ACAD SCI USA, V105, P13829, DOI 10.1073/pnas.0805364105; Sullivan SM, 2007, BIOCHEMISTRY-US, V46, P10078, DOI 10.1021/bi701038x; UTTER MF, 1953, J AM CHEM SOC, V75, P758, DOI 10.1021/ja01099a522; Yang JQ, 2009, J BIOL CHEM, V284, P27031, DOI 10.1074/jbc.R109.040535; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543; ZIMMER DB, 1990, J HISTOCHEM CYTOCHEM, V38, P171, DOI 10.1177/38.2.1688895	33	34	34	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27021	27023		10.1074/jbc.R109.040519	http://dx.doi.org/10.1074/jbc.R109.040519			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19636078	hybrid, Green Published			2022-12-27	WOS:000270232300002
J	Xu, L; Kappler, CS; Mani, SK; Shepherd, NR; Renaud, L; Snider, P; Conway, SJ; Menick, DR				Xu, Lin; Kappler, Christiana S.; Mani, Santhosh K.; Shepherd, Neal R.; Renaud, Ludivine; Snider, Paige; Conway, Simon J.; Menick, Donald R.			Chronic Administration of KB-R7943 Induces Up-regulation of Cardiac NCX1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGER; NA-CA EXCHANGE; RABBIT VENTRICULAR MYOCYTES; SIGNAL-TRANSDUCING FUNCTION; FAILING HUMAN HEART; NA+-CA2+ EXCHANGER; GENE-EXPRESSION; NA+/CA2+ EXCHANGE; REPERFUSION INJURY; CYCLING PROTEINS	The NCX1 (sodium-calcium exchanger) is up-regulated in human heart failure and in many animal models of heart failure. The potential benefits and risks of therapeutically blocking NCX1 in heart failure and during ischemia-reperfusion are being actively investigated. In this study, we demonstrate that prolonged administration of the NCX1 inhibitor KB-R7943 resulted in the up-regulation of Ncx1 gene expression in both isolated adult cardiomyocytes and intact mouse hearts. Ncx1 up-regulation is mediated by the activation of p38. Importantly, p38 is not activated by KB-R7943 treatment in heart tubes from Ncx1(-/-) mice at 9.5 days postcoitum but is activated in heart tubes from Ncx1(+/+) mice. p38 activation does not appear to be in response to changes in cytosolic calcium concentration, [Ca2+](i). Interestingly, chronic KB-R7943 treatment in mice leads to the formation of an NCX1-p38 complex. Our study demonstrates for the first time that the electrogenic sarcolemma membrane cardiac NCX1 can act as a regulator of "activity-dependent signal transduction" leading to changes in gene expression.	[Xu, Lin; Kappler, Christiana S.; Mani, Santhosh K.; Shepherd, Neal R.; Renaud, Ludivine; Menick, Donald R.] Med Univ S Carolina, Gazes Cardiac Res Inst, Div Cardiol, Dept Med, Charleston, SC 29425 USA; [Snider, Paige; Conway, Simon J.] Indiana Univ, Sch Med, Wells Ctr Pediat Res, Riley Heart Res Ctr, Indianapolis, IN 46202 USA	Medical University of South Carolina; Indiana University System; Indiana University-Purdue University Indianapolis	Menick, DR (corresponding author), Med Univ S Carolina, Gazes Cardiac Res Inst, Div Cardiol, Dept Med, 114 Doughty St,Box 250773, Charleston, SC 29425 USA.	menickd@musc.edu	Renaud, Ludivine/T-1209-2019		National Institutes of Health [P01 HL085098, R01 HL066223, P01 HL48788, RR16434, T32HL07260, T32HL079995]; The Riley Children's Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016434] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066223, T32HL007260, P01HL048788, P01HL085098, T32HL079995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Riley Children's Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 HL085098 (to S. J. C.) and Grants R01 HL066223 and P01 HL48788, Project 3 (to D. R. M.). This work was also supported by The Riley Children's Foundation, Indiana University Department of Pediatrics/Cardiology. Supported in part by National Institutes of Health Grant RR16434.; Supported in part by National Institutes of Health Grant T32HL07260.; Supported in part by National Institutes of Health Grant T32HL079995.	AARONS RD, 1980, J CLIN INVEST, V65, P949, DOI 10.1172/JCI109781; AdachiAkahane S, 1997, J GEN PHYSIOL, V109, P717, DOI 10.1085/jgp.109.6.717; Ahmmed GU, 2000, CIRC RES, V86, P558, DOI 10.1161/01.RES.86.5.558; Andrews C, 2003, CARDIOVASC RES, V59, P46, DOI 10.1016/S0008-6363(03)00329-8; BASSANI RA, 1994, J MOL CELL CARDIOL, V26, P1335, DOI 10.1006/jmcc.1994.1152; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; BERS DM, 1990, AM J PHYSIOL, V258, pC944, DOI 10.1152/ajpcell.1990.258.5.C944; BERS DM, 1989, CIRC RES, V65, P334, DOI 10.1161/01.RES.65.2.334; Birinyi P, 2008, CARDIOVASC RES, V78, P476, DOI 10.1093/cvr/cvn031; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; de Hurtado MCC, 2002, J MOL CELL CARDIOL, V34, P1539, DOI 10.1006/jmcc.2002.2107; DIAZ RG, 1973, LANCET, V1, P1068; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Haas M, 2000, J BIOL CHEM, V275, P27832; HASENFUSS G, 1994, CIRC RES, V75, P434, DOI 10.1161/01.RES.75.3.434; Hasenfuss G, 1999, CIRCULATION, V99, P641, DOI 10.1161/01.CIR.99.5.641; Hasenfuss G, 1996, BASIC RES CARDIOL, V91, P17, DOI 10.1007/BF00795357; Hasenfuss G, 1997, BASIC RES CARDIOL, V92, P87, DOI 10.1007/BF00794072; Hobai IA, 2000, CIRC RES, V87, P690, DOI 10.1161/01.RES.87.8.690; Hobai IA, 2004, CIRC RES, V95, P292, DOI 10.1161/01.RES.0000136817.28691.2d; Kang JX, 1997, P NATL ACAD SCI USA, V94, P2724, DOI 10.1073/pnas.94.6.2724; KENT RL, 1989, AM J PHYSIOL, V257, pH1717, DOI 10.1152/ajpheart.1989.257.5.H1717; KENT RL, 1993, AM J PHYSIOL, V265, pH1024, DOI 10.1152/ajpheart.1993.265.3.H1024; Koushik SV, 2001, FASEB J, V15, P1209, DOI 10.1096/fj.00-0696fje; Lee C, 2005, CAN J CARDIOL, V21, P509; Liang QR, 2003, J MOL CELL CARDIOL, V35, P1385, DOI 10.1016/j.yjmcc.2003.10.001; Litwin SE, 1997, CIRC RES, V81, P1083; MacDonald AC, 2008, EUR J PHARMACOL, V580, P214, DOI 10.1016/j.ejphar.2007.10.055; Menick DR, 1996, ANN NY ACAD SCI, V779, P489, DOI 10.1111/j.1749-6632.1996.tb44823.x; MILLER RR, 1975, NEW ENGL J MED, V293, P416, DOI 10.1056/NEJM197508282930902; Mohammadi K, 2001, J BIOL CHEM, V276, P42050, DOI 10.1074/jbc.M107892200; Morgan PE, 1999, J MOL CELL CARDIOL, V31, P1873, DOI 10.1006/jmcc.1999.1019; Muller JG, 2002, CIRC RES, V90, P158, DOI 10.1161/hh0202.103231; Nagy ZA, 2004, BRIT J PHARMACOL, V143, P827, DOI 10.1038/sj.bjp.0706026; Niu CF, 2007, EUR J PHARMACOL, V573, P161, DOI 10.1016/j.ejphar.2007.06.033; O'Rourke B, 2008, CIRC RES, V102, P1301, DOI 10.1161/CIRCRESAHA.108.178095; Ozdemir S, 2008, CIRC RES, V102, P1398, DOI 10.1161/CIRCRESAHA.108.173922; Pogwizd SM, 2001, CIRC RES, V88, P1159, DOI 10.1161/hh1101.091193; Pogwizd SM, 1999, CIRC RES, V85, P1009; PORZIG H, 1993, AM J PHYSIOL, V265, pC748, DOI 10.1152/ajpcell.1993.265.3.C748; Ranu HK, 2002, J MOL CELL CARDIOL, V34, P389, DOI 10.1006/jmcc.2001.1521; Reuter H, 2004, J PHYSIOL-LONDON, V554, P779, DOI 10.1113/jphysiol.2003.055046; Satoh H, 2000, CIRCULATION, V101, P1441, DOI 10.1161/01.CIR.101.12.1441; Schillinger W, 2000, CIRC RES, V87, P581, DOI 10.1161/01.RES.87.7.581; Sipido KR, 2002, CARDIOVASC RES, V53, P782, DOI 10.1016/S0008-6363(01)00470-9; Smajilovic S, 2007, CARDIOVASC RES, V75, P457, DOI 10.1016/j.cardiores.2007.03.015; Studer R, 1997, BASIC RES CARDIOL, V92, P53, DOI 10.1007/BF00794068; STUDER R, 1994, CIRC RES, V75, P443, DOI 10.1161/01.RES.75.3.443; Tanaka H, 2002, BRIT J PHARMACOL, V135, P1096, DOI 10.1038/sj.bjp.0704574; Tfelt-Hansen J, 2006, AM J PHYSIOL-HEART C, V290, pH1165, DOI 10.1152/ajpheart.00821.2005; Tian J, 2001, AM J PHYSIOL-HEART C, V281, pH1899, DOI 10.1152/ajpheart.2001.281.5.H1899; Xu L, 2005, J MOL CELL CARDIOL, V38, P735, DOI 10.1016/j.yjmcc.2005.03.002; Xu L, 2006, J BIOL CHEM, V281, P34430, DOI 10.1074/jbc.M607446200; Xu Q, 2002, MOL BIOL CELL, V13, P1940, DOI 10.1091/mbc.02-02-0016; Zechner D, 1997, J CELL BIOL, V139, P115, DOI 10.1083/jcb.139.1.115	55	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27265	27272		10.1074/jbc.M109.022855	http://dx.doi.org/10.1074/jbc.M109.022855			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19661061	Green Published, hybrid			2022-12-27	WOS:000270232300027
J	Younce, CW; Azfer, A; Kolattukudy, PE				Younce, Craig W.; Azfer, Asim; Kolattukudy, Pappachan E.			MCP-1 (Monocyte Chemotactic Protein-1)-induced Protein, a Recently Identified Zinc Finger Protein, Induces Adipogenesis in 3T3-L1 Pre-adipocytes without Peroxisome Proliferator-activated Receptor gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; ADIPOSE-TISSUE; INSULIN-RESISTANCE; PPAR-GAMMA; TRANSCRIPTION FACTOR; C/EBP-ALPHA; OBESITY; ANGIOGENESIS; PATHWAY; DIFFERENTIATION	Adipogenesis is a key differentiation process relevant to obesity and associated diseases such as type 2 diabetes. This process involves temporally regulated genes controlled by a set of transcription factors, CCAAT/enhancer-binding proteins (C/EBP) beta, C/EBP delta, and C/EBP alpha and peroxisome proliferator-activated receptor gamma (PPAR gamma). Currently, PPAR gamma is universally accepted as the master regulator that is necessary and sufficient to induce adipogenesis as no known factor can induce adipogenesis without PPAR gamma. We present evidence that a novel zinc finger protein, MCP-1-induced protein (MCPIP), can induce adipogenesis without PPAR gamma. Classical adipogenesis-inducing medium induces MCP-1 production and expression of MCPIP in 3T3-L1 cells before the induction of the C/EBP family of transcription factors and PPAR gamma. Knockdown of MCPIP prevents their expression and adipogenesis as measured by expression of adipocyte markers and lipid droplet accumulation. Treatment of 3T3-L1 cells with MCP-1 or forced expression of MCPIP induces expression of C/EBP beta, C/EBP delta, C/EBP alpha, and PPAR gamma and adipogenesis without any other inducer. Forced expression of MCPIP induces expression of the C/EBP family of transcription factors and adipogenesis in PPAR gamma(-/-) mouse embryonic fibroblasts. Thus, MCPIP is a newly identified protein that can induce adipogenesis without PPAR gamma.	[Younce, Craig W.; Azfer, Asim; Kolattukudy, Pappachan E.] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Kolattukudy, PE (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA.	pk@mail.ucf.edu	kolattukudy, pappachan e/A-1350-2012		National Institutes of Health [HL-69458]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069458, R56HL069458] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-69458.	Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Gerhardt CC, 2001, MOL CELL ENDOCRINOL, V175, P81, DOI 10.1016/S0303-7207(01)00394-X; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hemmrich K, 2007, OBESITY, V15, P2951, DOI 10.1038/oby.2007.352; Hogaboam GM, 1999, J IMMUNOL, V163, P2193; Hong KH, 2005, BLOOD, V105, P1405, DOI 10.1182/blood-2004-08-3178; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Inouye KE, 2007, DIABETES, V56, P2242, DOI 10.2337/db07-0425; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kobara M, 2008, J APPL PHYSIOL, V104, P601, DOI 10.1152/japplphysiol.00254.2007; Lagathu C, 2006, DIABETOLOGIA, V49, P2162, DOI 10.1007/s00125-006-0335-z; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Niu J, 2008, J BIOL CHEM, V283, P14542, DOI 10.1074/jbc.M802139200; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Sarafi MN, 1997, J EXP MED, V185, P99, DOI 10.1084/jem.185.1.99; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Wang BH, 2005, AM J PHYSIOL-ENDOC M, V288, pE731, DOI 10.1152/ajpendo.00475.2004; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Zhou LM, 2006, CIRC RES, V98, P1177, DOI 10.1161/01.RES.0000220106.64661.71	28	51	56	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27620	27628		10.1074/jbc.M109.025320	http://dx.doi.org/10.1074/jbc.M109.025320			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19666473	Green Published, hybrid			2022-12-27	WOS:000270232300063
J	De Angeli, A; Moran, O; Wege, S; Filleur, S; Ephritikhine, G; Thomine, S; Barbier-Brygoo, H; Gambale, F				De Angeli, Alexis; Moran, Oscar; Wege, Stefanie; Filleur, Sophie; Ephritikhine, Genevieve; Thomine, Sebastien; Barbier-Brygoo, Helene; Gambale, Franco			ATP Binding to the C Terminus of the Arabidopsis thaliana Nitrate/Proton Antiporter, AtCLCa, Regulates Nitrate Transport into Plant Vacuoles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLC-1 CHLORIDE CHANNELS; CYTOPLASMIC DOMAIN; MOLECULAR-DYNAMICS; SWISS-MODEL; PROTEIN; INHIBITION; CELLS; SIMULATIONS; ENVIRONMENT; REDUCTASE	Nitrate, one of the major nitrogen sources for plants, is stored in the vacuole. Nitrate accumulation within the vacuole is primarily mediated by the NO3-/H+ exchanger AtCLCa, which belongs to the chloride channel (CLC) family. Crystallography analysis of hCLC5 suggested that the C-terminal domain, composed by two cystathionine beta-synthetase motifs in all eukaryotic members of the CLC family is able to interact with ATP. However, interaction of nucleotides with a functional CLC protein has not been unambiguously demonstrated. Here we show that ATP reversibly inhibits AtCLCa by interacting with the C-terminal domain. Applying the patch clamp technique to isolated Arabidopsis thaliana vacuoles, we demonstrate that ATP reduces AtCLCa activity with a maximum inhibition of 60%. ATP inhibition of nitrate influx into the vacuole at cytosolic physiological nitrate concentrations suggests that ATP modulation is physiologically relevant. ADP and AMP do not decrease the AtCLCa transport activity; nonetheless, AMP (but not ADP) competes with ATP, preventing inhibition. A molecular model of the C terminus of AtCLCa was built by homology to hCLC5 C terminus. The model predicted the effects of mutations of the ATP binding site on the interaction energy between ATP and AtCLCa that were further confirmed by functional expression of site-directed mutated AtCLCa.	[De Angeli, Alexis; Moran, Oscar; Gambale, Franco] CNR, Ist Biofis, I-16149 Genoa, Italy; [Wege, Stefanie; Filleur, Sophie; Ephritikhine, Genevieve; Thomine, Sebastien; Barbier-Brygoo, Helene] CNRS, Inst Sci Vegetal, F-91198 Gif Sur Yvette, France; [Filleur, Sophie; Ephritikhine, Genevieve] Univ Paris 07, UFR Sci Vivant, F-75205 Paris 13, France	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite	De Angeli, A (corresponding author), Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland.	deangeli@access.uzh.ch	BARBIER-BRYGOO, HELENE/A-8435-2013; filleur, sophie/AAH-3070-2019; Moran, Oscar/W-4277-2019; Thomine, Sébastien/V-9029-2019; Wege, Stefanie/AAB-4083-2019	Wege, Stefanie/0000-0002-7232-5889; Thomine, Sebastien/0000-0003-0045-1701	EU_RTN [MRTN-CT-2006 035833]; Consiglio Nazionale delle Ricerche-CNRS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071462] Funding Source: NIH RePORTER	EU_RTN; Consiglio Nazionale delle Ricerche-CNRS(Consiglio Nazionale delle Ricerche (CNR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by EU_RTN Project VaTEP Contract MRTN-CT-2006 035833 and Consiglio Nazionale delle Ricerche-CNRS bilateral project "Biophysical properties of the AtCLCa antiporter in A. thaliana."	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Accardi A, 2008, J GEN PHYSIOL, V131, P104, DOI 10.1085/jgp.200709953; AQVIST J, 1994, PROTEIN ENG, V7, P385, DOI 10.1093/protein/7.3.385; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Bennetts B, 2005, J BIOL CHEM, V280, P32452, DOI 10.1074/jbc.M502890200; Bennetts B, 2007, J BIOL CHEM, V282, P32780, DOI 10.1074/jbc.M703259200; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Cookson SJ, 2005, PLANT PHYSIOL, V138, P1097, DOI 10.1104/pp.105.062349; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; De Angeli A, 2009, PHILOS T R SOC B, V364, P195, DOI 10.1098/rstb.2008.0128; Forde BG, 2000, BBA-BIOMEMBRANES, V1465, P219, DOI 10.1016/S0005-2736(00)00140-1; GAMBALE F, 1994, EUR BIOPHYS J BIOPHY, V22, P399, DOI 10.1007/BF00180161; Geelen D, 2000, PLANT J, V21, P259, DOI 10.1046/j.1365-313x.2000.00680.x; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hansson T, 1998, J COMPUT AID MOL DES, V12, P27, DOI 10.1023/A:1007930623000; HEDRICH R, 1989, EMBO J, V8, P2835, DOI 10.1002/j.1460-2075.1989.tb08430.x; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hosy E, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-14; JonesHertzog DK, 1997, J MED CHEM, V40, P1539, DOI 10.1021/jm960684e; KAISER WM, 1991, PLANT PHYSIOL, V96, P368, DOI 10.1104/pp.96.2.368; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Markovic S, 2007, STRUCTURE, V15, P715, DOI 10.1016/j.str.2007.04.013; MARTINOIA E, 1981, NATURE, V289, P292, DOI 10.1038/289292a0; Meyer S, 2006, STRUCTURE, V14, P299, DOI 10.1016/j.str.2005.10.008; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Tseng PY, 2007, J GEN PHYSIOL, V130, P217, DOI 10.1085/jgp.200709817; Wang W, 1999, PROTEINS, V34, P395, DOI 10.1002/(SICI)1097-0134(19990215)34:3<395::AID-PROT11>3.3.CO;2-W; Zhang XD, 2008, J GEN PHYSIOL, V132, P421, DOI 10.1085/jgp.200810023; Zifarelli G, 2008, J GEN PHYSIOL, V131, P109, DOI 10.1085/jgp.200709899	35	59	59	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26526	26532		10.1074/jbc.M109.005132	http://dx.doi.org/10.1074/jbc.M109.005132			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19636075	hybrid, Green Published			2022-12-27	WOS:000269969600034
J	Fulcher, JA; Chang, MH; Wang, S; Almazan, T; Hashimi, ST; Eriksson, AU; Wen, XS; Pang, M; Baum, LG; Singh, RR; Lee, B				Fulcher, Jennifer A.; Chang, Margaret H.; Wang, Shuo; Almazan, Tim; Hashimi, Sara T.; Eriksson, Anna U.; Wen, Xiangshu; Pang, Mabel; Baum, Linda G.; Singh, Ram Raj; Lee, Benhur			Galectin-1 Co-clusters CD43/CD45 on Dendritic Cells and Induces Cell Activation and Migration through Syk and Protein Kinase C Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELLS; EXTRACELLULAR-MATRIX; CROSS-LINKING; MATURATION; TOLERANCE; RECEPTOR; CD43; DANGER; IMMUNE; RESPONSES	Galectin-1 is a galactoside-binding lectin expressed in multiple tissues that has pleiotropic immunomodulatory functions. We previously showed that galectin-1 activates human monocyte-derived dendritic cells (MDDCs) and triggers a specific genetic program that up-regulates DC migration through the extracellular matrix, an integral property of mucosal DCs. Here, we identify the galectin-1 receptors on MDDCs and immediate downstream effectors of galectin-1-induced MDDC activation and migration. Galectin-1 binding to surface CD43 and CD45 on MDDCs induced an unusual unipolar co-clustering of these receptors and activates a dose-dependent calcium flux that is abrogated by lactose. Using a kinome screen and a systems biology approach, we identified Syk and protein kinase C tyrosine kinases as mediators of the DC activation effects of galectin-1. Galectin-1, but not lipopolysaccharide, stimulated Syk phosphorylation and recruitment of phosphorylated Syk to the CD43 and CD45 co-cluster on MDDCs. Inhibitors of Syk and protein kinase C signaling abrogated galectin-1-induced DC activation as monitored by interleukin-6 production; and MMP-1, -10, and -12 gene up-regulation; and enhanced migration through the extracellular matrix. The latter two are specific features of galectin-1-activated DCs. Interestingly, we also found that galectin-1 can prime DCs to respond more quickly to low dose lipopolysaccharide stimulation. Finally, we underscore the biological relevance of galectin-1-enhanced DC migration by showing that intradermal injection of galectin-1 in MRL-fas mice, which have a defect in skin DC emigration, increased the in vivo migration of dermal DCs to draining lymph nodes.	[Fulcher, Jennifer A.; Chang, Margaret H.; Pang, Mabel; Baum, Linda G.; Singh, Ram Raj; Lee, Benhur] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Wang, Shuo; Almazan, Tim; Hashimi, Sara T.; Lee, Benhur] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Eriksson, Anna U.; Wen, Xiangshu; Singh, Ram Raj] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Rheumatol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lee, B (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, 257 BSRB,615 Charles E Young Dr E, Los Angeles, CA 90095 USA.	bleebhl@ucla.edu	Lee, Benhur/A-8554-2016; Singh, Ram/AFQ-2369-2022; Fulcher, Jennifer A./AAG-1495-2020	Lee, Benhur/0000-0003-0760-1709; Fulcher, Jennifer A./0000-0001-9895-8636	National Institutes of Health [AI060694, AI080778, AR056465, AI07126-30, HL096392, GM08042]; NATIONAL CANCER INSTITUTE [T32CA009120, P30CA016042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL096392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060694, T32AI007126, R01AI080778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI060694 (to B. L. and L. G. B.), Grants AI080778 and AR056465 (to R. R. S.), Training Grants AI07126-30 (to J. A. F.), Grant HL096392 (to M. H. C.), and Grant GM08042 (to J. A. F. and M. H. C.).	Ahmed H, 1996, J BIOCHEM, V120, P1007; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; ALVARADO M, 1995, EUR J IMMUNOL, V25, P1051, DOI 10.1002/eji.1830250429; Arndt PG, 2004, J BIOL CHEM, V279, P10883, DOI 10.1074/jbc.M309901200; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BAUM LG, 1995, GLYCOCONJUGATE J, V12, P63, DOI 10.1007/BF00731870; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; Breuilh L, 2007, INFECT IMMUN, V75, P5148, DOI 10.1128/IAI.02006-06; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; CHO MJ, 1995, J BIOL CHEM, V270, P5198, DOI 10.1074/jbc.270.10.5198; Corinti S, 1999, J IMMUNOL, V162, P6331; Dai SY, 2005, J IMMUNOL, V175, P2974, DOI 10.4049/jimmunol.175.5.2974; Dupasquier M, 2004, J INVEST DERMATOL, V123, P876, DOI 10.1111/j.0022-202X.2004.23427.x; Elola MT, 2005, J BIOMED SCI, V12, P13, DOI 10.1007/s11373-004-8169-5; Eriksson AU, 2008, J IMMUNOL, V181, P7468, DOI 10.4049/jimmunol.181.11.7468; Fulcher JA, 2006, J IMMUNOL, V177, P216, DOI 10.4049/jimmunol.177.1.216; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Geisel J, 2007, J IMMUNOL, V179, P5811, DOI 10.4049/jimmunol.179.9.5811; He JL, 2004, J BIOL CHEM, V279, P4705, DOI 10.1074/jbc.M311183200; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Kikuchi K, 2003, IMMUNOL LETT, V89, P149, DOI 10.1016/S0165-2478(03)00134-2; Luft T, 2004, BLOOD, V104, P1066, DOI 10.1182/blood-2003-12-4146; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Matzinger P, 1998, SEMIN IMMUNOL, V10, P399, DOI 10.1006/smim.1998.0143; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Miura Y, 2001, BIOCHEM BIOPH RES CO, V288, P80, DOI 10.1006/bbrc.2001.5729; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Pace KE, 1999, J IMMUNOL, V163, P3801; Pace KE, 2003, METHOD ENZYMOL, V363, P499; Park SJ, 2004, J IMMUNOL, V173, P3844, DOI 10.4049/jimmunol.173.6.3844; PedrazaAlva G, 1996, J BIOL CHEM, V271, P27564, DOI 10.1074/jbc.271.44.27564; Perone MJ, 2006, J IMMUNOL, V176, P7207, DOI 10.4049/jimmunol.176.12.7207; Puig-Kroger A, 2001, BLOOD, V98, P2175, DOI 10.1182/blood.V98.7.2175; Rabinovich GA, 2002, BBA-GEN SUBJECTS, V1572, P274, DOI 10.1016/S0304-4165(02)00314-8; Rabinovich GA, 2002, GLYCOCONJUGATE J, V19, P565, DOI 10.1023/B:GLYC.0000014087.41914.72; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Shimomura H, 2003, INFECT IMMUN, V71, P5225, DOI 10.1128/IAI.71.9.5225-5230.2003; SILVERMAN LB, 1989, J IMMUNOL, V142, P4194; Spertini F, 2004, IMMUNOLOGY, V113, P441, DOI 10.1111/j.1365-2567.2004.01986.x; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Vines CM, 2001, IMMUNITY, V15, P507, DOI 10.1016/S1074-7613(01)00221-7; WONG RCK, 1990, J IMMUNOL, V144, P1455	50	66	69	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26860	26870		10.1074/jbc.M109.037507	http://dx.doi.org/10.1074/jbc.M109.037507			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19635795	Green Published, hybrid			2022-12-27	WOS:000269969600067
J	Selvaraj, V; Soundarapandian, MM; Chechneva, O; Williams, AJ; Sidorov, MK; Soulika, AM; Pleasure, DE; Deng, WB				Selvaraj, Vimal; Soundarapandian, Mangala M.; Chechneva, Olga; Williams, Ambrose J.; Sidorov, Maxim K.; Soulika, Athena M.; Pleasure, David E.; Deng, Wenbin			PARP-1 Deficiency Increases the Severity of Disease in a Mouse Model of Multiple Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; NF-KAPPA-B; POLY(ADP-RIBOSE) POLYMERASE INHIBITORS; APOPTOSIS-INDUCING FACTOR; GENE-EXPRESSION; CELL-DEATH; T-CELLS; DNA-DAMAGE; ANTIGEN PRESENTATION	Poly(ADP-ribose) polymerase-1 (PARP-1) has been implicated in the pathogenesis of several central nervous system (CNS) disorders. However, the role of PARP-1 in autoimmune CNS injury remains poorly understood. Therefore, we studied experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis in mice with a targeted deletion of PARP-1. We identified inherent physiological abnormalities in the circulating and splenic immune composition between PARP-1(-/-) and wild type (WT) mice. Upon EAE induction, PARP-1(-/-) mice had an earlier onset and developed a more severe EAE compared with WT cohorts. Splenic response was significantly higher in PARP-1(-/-) mice largely because of B cell expansion. Although formation of Th1 and Th17 effector T lymphocytes was unaffected, PARP-1(-/-) mice had significantly earlier CD4(+) T lymphocyte and macrophage infiltration into the CNS during EAE. However, we did not detect significant differences in cytokine profiles between PARP-1(-/-) and WT spinal cords at the peak of EAE. Expression analysis of different PARP isozymes in EAE spinal cords showed that PARP-1 was down-regulated in WT mice and that PARP-3 but not PARP-2 was dramatically up-regulated in both PARP-1(-/-) and WT mice, suggesting that these PARP isozymes could have distinct roles in different CNS pathologies. Together, our results indicate that PARP-1 plays an important role in regulating the physiological immune composition and in immune modulation during EAE; our finding identifies a new aspect of immune regulation by PARPs in autoimmune CNS pathology.	[Selvaraj, Vimal; Soundarapandian, Mangala M.; Chechneva, Olga; Williams, Ambrose J.; Sidorov, Maxim K.; Deng, Wenbin] Univ Calif Davis, Dept Cell Biol, Sch Med, Sacramento, CA 95817 USA; [Selvaraj, Vimal; Soundarapandian, Mangala M.; Chechneva, Olga; Williams, Ambrose J.; Sidorov, Maxim K.; Deng, Wenbin] Univ Calif Davis, Dept Human Anat, Sch Med, Sacramento, CA 95817 USA; [Pleasure, David E.] Univ Calif Davis, Dept Neurol, Sch Med, Sacramento, CA 95817 USA; [Soulika, Athena M.; Pleasure, David E.; Deng, Wenbin] Shriners Hosp Children, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Deng, WB (corresponding author), 2425 Stockton Blvd, Sacramento, CA 95817 USA.	wbdeng@ucdavis.edu	Selvaraj, Vimal/AAC-2853-2022		National Institutes of Health [RO1 NS059043, RO1 ES015988, RO1 NS025044]; National Multiple Sclerosis Society; Shriners Hospitals for Children; California Institute for Regenerative Medicine; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059043, R01NS025044] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Shriners Hospitals for Children; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 NS059043 and RO1 ES015988 (to W. D.) and RO1 NS025044 (to D. P. and A. S.). This work was also supported by grants from the National Multiple Sclerosis Society (to W. D.) and Shriners Hospitals for Children (to W. D.) and a postdoctoral fellowship from the California Institute for Regenerative Medicine (to M. M. S.).	Aldinucci A, 2007, J IMMUNOL, V179, P305, DOI 10.4049/jimmunol.179.1.305; Ambrose HE, 2009, IMMUNOLOGY, V127, P178, DOI 10.1111/j.1365-2567.2008.02921.x; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Andrabi SA, 2008, ANN NY ACAD SCI, V1147, P233, DOI 10.1196/annals.1427.014; Benveniste EN, 1997, J MOL MED-JMM, V75, P165, DOI 10.1007/s001090050101; Bullard DC, 2007, J IMMUNOL, V178, P851, DOI 10.4049/jimmunol.178.2.851; Caiafa P, 2009, FASEB J, V23, P672, DOI 10.1096/fj.08-123265; Carrillo A, 2004, NUCLEIC ACIDS RES, V32, P757, DOI 10.1093/nar/gkh239; CASSELL DJ, 1994, J EXP MED, V180, P1829, DOI 10.1084/jem.180.5.1829; CHAMBON P, 1963, BIOCHEM BIOPH RES CO, V11, P39, DOI 10.1016/0006-291X(63)90024-X; Chiarugi A, 2002, BRIT J PHARMACOL, V137, P761, DOI 10.1038/sj.bjp.0704934; Chiarugi A, 2005, PHARMACOL RES, V52, P15, DOI 10.1016/j.phrs.2005.02.018; Cho IH, 2008, BRAIN, V131, P3019, DOI 10.1093/brain/awn230; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; Decker Patrice, 2002, Current Pharmaceutical Biotechnology, V3, P275, DOI 10.2174/1389201023378265; Falcone M, 1997, J EXP MED, V185, P901, DOI 10.1084/jem.185.5.901; Fernet M, 2000, INT J RADIAT BIOL, V76, P1621, DOI 10.1080/09553000050201118; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; FINKELMAN FD, 1995, J EXP MED, V182, P279, DOI 10.1084/jem.182.2.279; Fritz RB, 1996, J NEUROSCI RES, V45, P471, DOI 10.1002/(SICI)1097-4547(19960815)45:4<471::AID-JNR17>3.0.CO;2-3; Gamble MJ, 2007, NAT STRUCT MOL BIOL, V14, P548, DOI 10.1038/nsmb1248; Gonzalez-Rey E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001071; Goto S, 2002, STROKE, V33, P1101, DOI 10.1161/01.STR.0000014203.65693.1E; Graziani G, 2005, PHARMACOL RES, V52, P109, DOI 10.1016/j.phrs.2005.02.013; Guastafierro T, 2008, J BIOL CHEM, V283, P21873, DOI 10.1074/jbc.M801170200; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Ha HC, 2002, P NATL ACAD SCI USA, V99, P3270, DOI 10.1073/pnas.052712399; Ha HC, 2004, P NATL ACAD SCI USA, V101, P5087, DOI 10.1073/pnas.0306895101; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Juedes AE, 2001, J IMMUNOL, V166, P5168, DOI 10.4049/jimmunol.166.8.5168; Kameoka M, 2000, BIOCHEM J, V346, P641, DOI 10.1042/0264-6021:3460641; Kauppinen TM, 2007, NEUROCHEM INT, V50, P954, DOI 10.1016/j.neuint.2006.11.010; Kauppinen TM, 2009, J CEREBR BLOOD F MET, V29, P820, DOI 10.1038/jcbfm.2009.9; Kauppinen TM, 2006, P NATL ACAD SCI USA, V103, P7136, DOI 10.1073/pnas.0508606103; Kauppinen TM, 2005, J NEUROSCI RES, V81, P190, DOI 10.1002/jnr.20525; Kauppinen UM, 2005, J IMMUNOL, V174, P2288, DOI 10.4049/jimmunol.174.4.2288; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Koh DW, 2005, PHARMACOL RES, V52, P5, DOI 10.1016/j.phrs.2005.02.011; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; KRIEGER JI, 1985, J IMMUNOL, V135, P2937; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; KUCHROO VK, 1993, J IMMUNOL, V151, P4371; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Masutani M, 2005, CELL MOL LIFE SCI, V62, P769, DOI 10.1007/s00018-004-4509-x; Meder VS, 2005, J CELL SCI, V118, P211, DOI 10.1242/jcs.01606; METLAY JP, 1989, J EXP MED, V169, P239, DOI 10.1084/jem.169.1.239; Modjtahedi N, 2006, TRENDS CELL BIOL, V16, P264, DOI 10.1016/j.tcb.2006.03.008; Moroni F, 2001, CELL DEATH DIFFER, V8, P921, DOI 10.1038/sj.cdd.4400884; Moroni F, 2008, CURR OPIN PHARMACOL, V8, P96, DOI 10.1016/j.coph.2007.10.005; NOTTBOHM AC, 2007, NEW FRONTIERS POSTGE, P163; Ogino H, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-41; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Overbergh L, 1999, CYTOKINE, V11, P305, DOI 10.1006/cyto.1998.0426; Phulwani NK, 2008, J NEUROCHEM, V106, P578, DOI 10.1111/j.1471-4159.2008.05403.x; PIELASMITH TH, 1992, J IMMUNOL, V148, P41; Quenet D, 2009, INT J BIOCHEM CELL B, V41, P60, DOI 10.1016/j.biocel.2008.07.023; Rouleau M, 2007, J CELL BIOCHEM, V100, P385, DOI 10.1002/jcb.21051; Saenz L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-171; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Scott GS, 2004, J PHARMACOL EXP THER, V310, P1053, DOI 10.1124/jpet.103.063214; Shall S, 2000, MUTAT RES-DNA REPAIR, V460, P1, DOI 10.1016/S0921-8777(00)00016-1; Simbulan-Rosenthal CM, 2000, P NATL ACAD SCI USA, V97, P11274, DOI 10.1073/pnas.200285797; Suarez-Pinzon WL, 2003, DIABETES, V52, P1683, DOI 10.2337/diabetes.52.7.1683; Sugimura K, 2008, J CELL BIOL, V183, P1203, DOI 10.1083/jcb.200806068; Tartier L, 2003, MUTAGENESIS, V18, P411, DOI 10.1093/mutage/geg015; Valdor R, 2008, MOL IMMUNOL, V45, P1863, DOI 10.1016/j.molimm.2007.10.044; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Wolf SD, 1996, J EXP MED, V184, P2271, DOI 10.1084/jem.184.6.2271; Yelamos J, 2006, EMBO J, V25, P4350, DOI 10.1038/sj.emboj.7601301; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zampieri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004717; Zerfaoui M, 2008, CELL SIGNAL, V20, P186, DOI 10.1016/j.cellsig.2007.10.007	80	26	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26070	26084		10.1074/jbc.M109.013474	http://dx.doi.org/10.1074/jbc.M109.013474			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19628872	Green Published, hybrid			2022-12-27	WOS:000269738000063
J	Garbarino, J; Padamsee, M; Wilcox, L; Oelkers, PM; D'Ambrosio, D; Ruggles, KV; Ramsey, N; Jabado, O; Turkish, A; Sturley, SL				Garbarino, Jeanne; Padamsee, Mahajabeen; Wilcox, Lisa; Oelkers, Peter M.; D'Ambrosio, Diana; Ruggles, Kelly V.; Ramsey, Nicole; Jabado, Omar; Turkish, Aaron; Sturley, Stephen L.			Sterol and Diacylglycerol Acyltransferase Deficiency Triggers Fatty Acid-mediated Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; INDUCED INSULIN-RESISTANCE; GRAPHICAL USER-INTERFACE; GENE-EXPRESSION DATA; LIPID PARTICLES; TRIGLYCERIDE-METABOLISM; ENDOPLASMIC-RETICULUM; INDUCED APOPTOSIS; MICROARRAY DATA; ACYL-COENZYME	Deletion of the acyltransferases responsible for triglyceride and steryl ester synthesis in Saccharomyces cerevisiae serves as a genetic model of diseases where lipid overload is a component. The yeast mutants lack detectable neutral lipids and cytoplasmic lipid droplets and are strikingly sensitive to unsaturated fatty acids. Expression of human diacylglycerol acyltransferase 2 in the yeast mutants was sufficient to reverse these phenotypes. Similar to mammalian cells, fatty acid-mediated death in yeast is apoptotic and presaged by transcriptional induction of stress-response pathways, elevated oxidative stress, and activation of the unfolded protein response. To identify pathways that protect cells from lipid excess, we performed genetic interaction and transcriptional profiling screens with the yeast acyltransferase mutants. We thus identified diacylglycerol kinase-mediated phosphatidic acid biosynthesis and production of phosphatidylcholine via methylation of phosphatidylethanolamine as modifiers of lipotoxicity. Accordingly, the combined ablation of phospholipid and triglyceride biosynthesis increased sensitivity to saturated fatty acids. Similarly, normal sphingolipid biosynthesis and vesicular transport were required for optimal growth upon denudation of triglyceride biosynthesis and also mediated resistance to exogenous fatty acids. In metazoans, many of these processes are implicated in insulin secretion thus linking lipotoxicity with early aspects of pancreatic beta-cell dysfunction, diabetes, and the metabolic syndrome.	[D'Ambrosio, Diana; Turkish, Aaron; Sturley, Stephen L.] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10032 USA; [Jabado, Omar] Columbia Univ, Dept Epidemiol, Med Ctr, New York, NY 10032 USA; [Ruggles, Kelly V.; Ramsey, Nicole; Sturley, Stephen L.] Columbia Univ, Inst Human Nutr, Med Ctr, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Sturley, SL (corresponding author), Columbia Univ, Dept Pediat, Med Ctr, 630 W 168th St, New York, NY 10032 USA.	sls37@columbia.edu		Ruggles, Kelly/0000-0002-0152-0863; Padamsee, Mahajabeen/0000-0002-0741-3014	National Institutes of Health [DK54320, T32 HL007343, K12HD043389]; NIDDK [2P30-DK63608-07]; American Diabetes Association; American Heart Association; Heart and Stroke Foundation of Canada; American Liver Foundation; Children's Digestive Health and Nutrition Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD043389] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054320, P30DK063608, T32DK007647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); American Liver Foundation; Children's Digestive Health and Nutrition Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK54320 (to S. L. S.) and Grant 2P30-DK63608-07 from NIDDK (pilot award from Diabetes and Endocrinology Research Center to Columbia University). This work was also supported by the American Diabetes Association and the American Heart Association.; Supported by the Heart and Stroke Foundation of Canada.; Supported in part by National Institutes of Health Grant T32 HL007343 (fellowship in arteriosclerosis research).; Supported in part by National Institutes of Health Child Health Research Career Development Award K12HD043389, the American Liver Foundation, American Association for the Study of Liver Diseases Sheila Sherlock Award, and the Young Investigator Development Award of the Children's Digestive Health and Nutrition Foundation.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Ausubel FM, 1998, CURRENT PROTOCOLS MO; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Carman GM, 1996, J BIOL CHEM, V271, P13293, DOI 10.1074/jbc.271.23.13293; Cartwright I J, 1993, Methods Mol Biol, V19, P153; Chang BHJ, 2007, AM J PHYSIOL-GASTR L, V292, pG1465, DOI 10.1152/ajpgi.00566.2006; Cury-Boaventura MF, 2005, CLIN SCI, V108, P245, DOI 10.1042/CS20040281; Cury-Boaventura MF, 2004, CLIN NUTR, V23, P721, DOI 10.1016/j.clnu.2003.12.004; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; ESPOSITO MS, 1969, J BACTERIOL, V100, P180, DOI 10.1128/JB.100.1.180-186.1969; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Gable K, 2000, J BIOL CHEM, V275, P7597, DOI 10.1074/jbc.275.11.7597; Garbarino J, 2005, BIOCHEM SOC T, V33, P1182, DOI 10.1042/BST20051182; Garbarino J, 2009, CURR OPIN CLIN NUTR, V12, P110, DOI 10.1097/MCO.0b013e32832182ee; GAYNOR PM, 1991, BIOCHIM BIOPHYS ACTA, V1090, P326, DOI 10.1016/0167-4781(91)90197-T; Han GS, 2008, J BIOL CHEM, V283, P20443, DOI 10.1074/jbc.M802866200; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Hartz CS, 2006, J NUTR, V136, P3005, DOI 10.1093/jn/136.12.3005; HENRY SA, 1973, J BACTERIOL, V114, P1158, DOI 10.1128/JB.114.3.1158-1163.1973; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; HULTIN M, 1994, J LIPID RES, V35, P1850; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Irizarry RA, 2003, STAT APPL GENET MOL, V2, DOI DOI 10.2202/1544-6115.1002; Kao G, 2007, CELL, V128, P577, DOI 10.1016/j.cell.2006.12.031; Kudo T, 2006, J PHARMACOL EXP THER, V318, P1203, DOI 10.1124/jpet.106.105759; LAW SWT, 1976, CAN J MICROBIOL, V22, P1710, DOI 10.1139/m76-252; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Millard PJ, 1997, APPL ENVIRON MICROB, V63, P2897, DOI 10.1128/AEM.63.7.2897-2905.1997; MITCHELL AG, 1995, J BIOL CHEM, V270, P29766; Mo C, 2003, BBA-MOL CELL BIOL L, V1633, P68, DOI 10.1016/S1388-1981(03)00088-X; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; ORRWEAVER TL, 1981, P NATL ACAD SCI-BIOL, V78, P6354, DOI 10.1073/pnas.78.10.6354; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; Packter NM, 1995, ARCH MICROBIOL, V164, P420, DOI 10.1007/BF02529740; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Sandager L, 2000, BIOCHEM SOC T, V28, P700; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schwarz S, 2006, APOPTOSIS, V11, P1111, DOI 10.1007/s10495-006-6982-1; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Sorger D, 2004, J BIOL CHEM, V279, P31190, DOI 10.1074/jbc.M403251200; Sorger D, 2002, J BACTERIOL, V184, P519, DOI 10.1128/JB.184.2.519-524.2002; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; STUKEY JE, 1989, J BIOL CHEM, V264, P16537; Turkish A, 2007, AM J PHYSIOL-GASTR L, V292, pG953, DOI 10.1152/ajpgi.00509.2006; Turkish AR, 2005, J BIOL CHEM, V280, P14755, DOI 10.1074/jbc.M500025200; Walkey CJ, 1996, J LIPID RES, V37, P2341; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wilcox LJ, 2002, J BIOL CHEM, V277, P32466, DOI 10.1074/jbc.M204707200; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; Zhang Q, 2003, J BIOL CHEM, V278, P47145, DOI 10.1074/jbc.M306998200; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	64	114	116	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30994	31005		10.1074/jbc.M109.050443	http://dx.doi.org/10.1074/jbc.M109.050443			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19690167	Green Published, hybrid			2022-12-27	WOS:000271378400029
J	Beigneux, AP; Gin, P; Davies, BSJ; Weinstein, MM; Bensadoun, A; Fong, LG; Young, SG				Beigneux, Anne P.; Gin, Peter; Davies, Brandon S. J.; Weinstein, Michael M.; Bensadoun, Andre; Fong, Loren G.; Young, Stephen G.			Highly Conserved Cysteines within the Ly6 Domain of GPIHBP1 Are Crucial for the Binding of Lipoprotein Lipase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENT REGULATORY PROTEIN; SITE-DIRECTED MUTAGENESIS; PLASMINOGEN-ACTIVATOR; CRYSTAL-STRUCTURE; HEPARIN-BINDING; LIGAND-BINDING; CELL-SURFACE; IDENTIFICATION; CHYLOMICRONS; RECEPTOR	GPIHBP1, a glycosylphosphatidylinositol-anchored endothelial cell protein of the lymphocyte antigen 6 (Ly6) family, binds lipoprotein lipase (LPL) avidly and is required for the lipolytic processing of triglyceride-rich lipoproteins. GPIHBP1 contains two key structural motifs, an acidic domain and an Ly6 motif (a three-fingered domain specified by 10 cysteines). The acidic domain is required for LPL binding, but the importance of the Ly6 domain is less clear. To explore that issue, we transfected cells with a wild-type GPIHBP1 expression vector or mutant GPIHBP1 vectors in which specific cysteines in the Ly6 domain were changed to alanine. The mutant GPIHBP1 proteins reached the cell surface, as judged by antibody binding studies and by the ability of a phosphatidylinositol-specific phospholipase C to release these proteins from the cell surface. However, cells expressing the cysteine mutants could not bind LPL. The acidic domain of the cysteine mutants appeared to remain accessible, as judged by binding studies with an antibody against the acidic domain. We also developed a cell-free assay of LPL binding. We created a rat monoclonal antibody against the carboxyl terminus of mouse GPIHBP1 and used that antibody to coat agarose beads. We then tested the ability of soluble forms of GPIHBP1 that had been immobilized on monoclonal antibody-coated beads to bind LPL. In this assay, wild-type soluble GPIHBP1 bound LPL avidly, but the cysteine mutants did not. Thus, our studies suggest that a structurally intact Ly6 domain (in addition to the acidic domain) is essential for LPL binding.	[Beigneux, Anne P.; Gin, Peter; Davies, Brandon S. J.; Weinstein, Michael M.; Fong, Loren G.; Young, Stephen G.] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Weinstein, Michael M.; Young, Stephen G.] Univ Calif Los Angeles, Dept Human Genet, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Bensadoun, Andre] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cornell University	Beigneux, AP (corresponding author), 675 Charles E Young Dr S, Los Angeles, CA 90095 USA.	abeigneux@mednet.ucla.edu		Young, Stephen/0000-0001-7270-3176; Davies, Brandon/0000-0002-7168-8522	National Institutes of Health [R01 HL094732, P01 HL090553, R01 HL087228]; American Heart Association National Office; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094732, P01HL090553, R01HL087228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association National Office(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL094732 (to A. P. B.), P01 HL090553 (to S. G. Y.), and R01 HL087228 (to S. G. Y.). This work was also supported by Scientist Development Award from the American Heart Association National Office (to A. P. B.).	Beigneux AP, 2008, J LIPID RES, V49, P1312, DOI 10.1194/jlr.M700593-JLR200; Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; Beigneux AP, 2009, CURR OPIN LIPIDOL, V20, P211, DOI 10.1097/MOL.0b013e32832ac026; Beigneux AP, 2009, ARTERIOSCL THROM VAS, V29, P956, DOI 10.1161/ATVBAHA.109.186577; Dallinga-Thie GM, 2009, ARTERIOSCL THROM VAS, V29, pE10; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Favre B, 2007, J INVEST DERMATOL, V127, P301, DOI 10.1038/sj.jid.5700551; Fry BG, 2003, J MOL EVOL, V57, P110, DOI 10.1007/s00239-003-2461-2; Gardsvoll H, 1999, J BIOL CHEM, V274, P37995, DOI 10.1074/jbc.274.53.37995; Gin P, 2008, J BIOL CHEM, V283, P29554, DOI 10.1074/jbc.M802579200; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; HATA A, 1993, J BIOL CHEM, V268, P8447; Huang YX, 2007, ACTA CRYSTALLOGR D, V63, P714, DOI 10.1107/S0907444907015557; Ioka RX, 2003, J BIOL CHEM, V278, P7344, DOI 10.1074/jbc.M211932200; KIEFFER B, 1994, BIOCHEMISTRY-US, V33, P4471, DOI 10.1021/bi00181a006; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; MA YH, 1994, J LIPID RES, V35, P2049; Mallya M, 2006, PROTEIN SCI, V15, P2244, DOI 10.1110/ps.062242606; Petranka J, 1996, BLOOD CELL MOL DIS, V22, P281, DOI 10.1006/bcmd.1996.0111; Ploug M, 1998, BIOCHEMISTRY-US, V37, P16494, DOI 10.1021/bi981203r; Sendak RA, 1998, J LIPID RES, V39, P1310; Young SG, 2007, CURR OPIN LIPIDOL, V18, P389, DOI 10.1097/MOL.0b013e3281527914	22	57	61	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30240	30247		10.1074/jbc.M109.046391	http://dx.doi.org/10.1074/jbc.M109.046391			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19726683	Green Published, hybrid			2022-12-27	WOS:000271090000027
J	Morita, I; Kakuda, S; Takeuchi, Y; Itoh, S; Kawasaki, N; Kizuka, Y; Kawasaki, T; Oka, S				Morita, Ippei; Kakuda, Shinako; Takeuchi, Yusuke; Itoh, Satsuki; Kawasaki, Nana; Kizuka, Yasuhiko; Kawasaki, Toshisuke; Oka, Shogo			HNK-1 Glyco-epitope Regulates the Stability of the Glutamate Receptor Subunit GluR2 on the Neuronal Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM DEPRESSION; AMPA RECEPTORS; CARBOHYDRATE EPITOPE; SYNAPTIC PLASTICITY; N-CADHERIN; FUNCTIONAL EXPRESSION; L2/HNK-1 CARBOHYDRATE; MEMORY CONSOLIDATION; ADHESION MOLECULES; PERINEURONAL NETS	HNK-1 (human natural killer-1) glyco-epitope, a sulfated glucuronic acid attached to N-acetyllactosamine on the nonreducing termini of glycans, is highly expressed in the nervous system. Our previous report showed that mice lacking a glucuronyltransferase (GlcAT-P), a key enzyme for biosynthesis of the HNK-1 epitope, showed reduced long term potentiation at hippocampal CA1 synapses. In this study, we identified an alpha-amino-3-hydroxy-5-methylisoxazole propionate (AMPA)-type glutamate receptor subunit, GluR2, which directly contributes to excitatory synaptic transmission and synaptic plasticity, as a novel HNK-1 carrier molecule. We demonstrated that the HNK-1 epitope is specifically expressed on the N-linked glycan(s) on GluR2 among the glutamate receptors tested, and the glycan structure, including HNK-1 on GluR2, was determined using liquid chromatography-tandem mass spectrometry. As for the function of HNK-1 on GluR2, we found that the GluR2 not carrying HNK-1 was dramatically endocytosed and expressed less on the cell surface compared with GluR2 carrying HNK-1 in both cultured hippocampal neurons and heterologous cells. These results suggest that HNK-1 stabilizes GluR2 on neuronal surface membranes and regulates the number of surface AMPA receptors. Moreover, we showed that the expression of the HNK-1 epitope enhanced the interaction between GluR2 and N-cadherin, which has important roles in AMPA receptor trafficking. Our findings suggest that the HNK-1 epitope on GluR2 regulates cell surface stability of GluR2 by modulating the interaction with N-cadherin.	[Morita, Ippei; Kizuka, Yasuhiko] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Kyoto 6068507, Japan; [Kakuda, Shinako; Takeuchi, Yusuke; Oka, Shogo] Kyoto Univ, Grad Sch Med, Dept Biol Chem, Kyoto 6068507, Japan; [Itoh, Satsuki; Kawasaki, Nana] Natl Inst Hlth Sci, Div Biol Chem & Biol, Tokyo 1588501, Japan; [Kawasaki, Toshisuke] Ritsumeikan Univ, Res Ctr Glycobiotechnol, Shiga 5258577, Japan	Kyoto University; Kyoto University; National Institute of Health Sciences - Japan; Ritsumeikan University	Oka, S (corresponding author), Kawahara Cho 53,Sakyo Ku, Kyoto 6068507, Japan.	shogo@hs.med.kyoto-u.ac.jp		Kizuka, Yasuhiko/0000-0002-3181-9743	Ministry of Education, Culture, Sports, Science and Technology [21370053]; Mizutani Foundation for Glycoscience	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mizutani Foundation for Glycoscience	This work was supported in part by Grant-in-aid for Scientific Research (B) 21370053 (to S. O.) from the Ministry of Education, Culture, Sports, Science and Technology and by the Mizutani Foundation for Glycoscience (to S. O.).	Bakker H, 1997, J BIOL CHEM, V272, P29942, DOI 10.1074/jbc.272.47.29942; Bassani S, 2009, NEUROSCIENCE, V158, P55, DOI 10.1016/j.neuroscience.2008.10.007; BRONNERFRASER M, 1987, DEV BIOL, V123, P321, DOI 10.1016/0012-1606(87)90390-3; Bruckner G, 2000, J COMP NEUROL, V428, P616, DOI 10.1002/1096-9861(20001225)428:4<616::AID-CNE3>3.0.CO;2-K; Chung HJ, 2000, J NEUROSCI, V20, P7258; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Dityatev A, 2003, NAT REV NEUROSCI, V4, P456, DOI 10.1038/nrn1115; Everts I, 1997, MOL PHARMACOL, V52, P861, DOI 10.1124/mol.52.5.861; Hall RA, 1997, J NEUROCHEM, V68, P625; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Kastning K, 2007, P NATL ACAD SCI USA, V104, P2991, DOI 10.1073/pnas.0611170104; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Kizuka Y, 2006, J BIOL CHEM, V281, P13644, DOI 10.1074/jbc.M601453200; Kizuka Y, 2008, GLYCOBIOLOGY, V18, P331, DOI 10.1093/glycob/cwn012; KUNEMUND V, 1988, J CELL BIOL, V106, P213, DOI 10.1083/jcb.106.1.213; Kuster B, 1997, ANAL BIOCHEM, V250, P82, DOI 10.1006/abio.1997.2199; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Liedtke S, 2001, GLYCOBIOLOGY, V11, P373, DOI 10.1093/glycob/11.5.373; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; MARTINI R, 1992, EUR J NEUROSCI, V4, P628, DOI 10.1111/j.1460-9568.1992.tb00171.x; Maruo K, 2003, BRAIN RES, V977, P294, DOI 10.1016/S0006-8993(03)02838-5; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; Morita I, 2008, J BIOCHEM, V143, P719, DOI 10.1093/jb/mvm221; Nakamura M, 2004, EUR J NEUROSCI, V20, P2929, DOI 10.1111/j.1460-9568.2004.03768.x; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Nuriya M, 2006, J NEUROCHEM, V97, P652, DOI 10.1111/j.1471-4159.2006.03740.x; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Pasternack A, 2003, J NEUROCHEM, V84, P1184, DOI 10.1046/j.1471-4159.2003.01611.x; Pradel G, 1999, J NEUROBIOL, V39, P197, DOI 10.1002/(SICI)1097-4695(199905)39:2<197::AID-NEU4>3.0.CO;2-9; RABOUILLE C, 1995, J CELL SCI, V108, P1617; Saghatelyan AK, 2000, EUR J NEUROSCI, V12, P3331, DOI 10.1046/j.1460-9568.2000.00216.x; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; SAKIMURA K, 1990, FEBS LETT, V272, P73, DOI 10.1016/0014-5793(90)80452-O; Santos SD, 2009, NEUROSCIENCE, V158, P105, DOI 10.1016/j.neuroscience.2008.02.037; Seiki T, 1999, BIOCHEM BIOPH RES CO, V255, P182, DOI 10.1006/bbrc.1999.0151; Standley S, 1998, J NEUROCHEM, V70, P2434; Strekalova T, 2001, MOL CELL NEUROSCI, V17, P1102, DOI 10.1006/mcne.2001.0991; Terayama K, 1997, P NATL ACAD SCI USA, V94, P6093, DOI 10.1073/pnas.94.12.6093; Uemura K, 2006, NEUROSCI LETT, V402, P278, DOI 10.1016/j.neulet.2006.04.018; Wintergerst ES, 1996, NEUROSCI LETT, V209, P173, DOI 10.1016/0304-3940(96)12643-4; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200; Yoshihara T, 2009, J BIOL CHEM, V284, P12550, DOI 10.1074/jbc.M809188200	45	40	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30209	30217		10.1074/jbc.M109.024208	http://dx.doi.org/10.1074/jbc.M109.024208			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19729452	hybrid, Green Published			2022-12-27	WOS:000271090000024
J	Fan, YH; Mao, RF; Zhao, YL; Yu, Y; Sun, WJ; Song, P; Shi, ZC; Zhang, DK; Yvon, E; Zhang, H; Fu, SB; Yang, JH				Fan, Yihui; Mao, Renfang; Zhao, Yanling; Yu, Yang; Sun, Wenjing; Song, Ping; Shi, Zhongcheng; Zhang, Dekai; Yvon, Eric; Zhang, Hong; Fu, Songbin; Yang, Jianhua			Tumor Necrosis Factor-alpha Induces RelA Degradation via Ubiquitination at Lysine 195 to Prevent Excessive Nuclear Factor-kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; INTERLEUKIN-6 GENE; TERMINATION; LIGASE; PROTEINS; INSIGHTS; P65/RELA; P65	Ubiquitination-mediated degradation of the RelA subunit of nuclear factor-kappa B (NF-kappa B) is critical for the termination of NF-kappa B activation. However, the precise mechanism for the ubiquitination of RelA is still not fully understood. Here we report that tumor necrosis factor-alpha (TNF alpha) induces RelA polyubiquitination at the lysine 195 residue, and this ubiquitination event is critical for the degradation of RelA and termination of TNF alpha-mediated NF-kappa B activation. Overexpression of a RelA mutant with an arginine substitution for the lysine 195 residue dramatically inhibits RelA polyubiquitination and induces a stronger NF-kappa B activation compared with the wild type. Reconstitution of RelA-deficient mouse embryo fibroblast cells with wild-type RelA or RelA containing a K195R mutation revealed the importance of this site in TNF alpha-mediated RelA polyubiquitination, degradation, and attenuation of NF-kappa B activation. Our finding is the first report that substitution of a key RelA lysine residue with arginine inhibits TNF alpha-induced RelA ubiquitination and enhances TNF alpha-induced NF-kappa B activation.	[Fan, Yihui; Yu, Yang; Sun, Wenjing; Yang, Jianhua] Baylor Coll Med, Texas Childrens Canc Ctr, Dan L Duncan Canc Ctr, Dept Pediat, Houston, TX 77030 USA; [Mao, Renfang; Zhang, Hong] Baylor Coll Med, Texas Childrens Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Song, Ping; Yvon, Eric] Baylor Coll Med, Texas Childrens Canc Ctr, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Shi, Zhongcheng; Zhang, Dekai] Texas A&M Univ, Inst Biosci & Technol, Ctr Extracellular Matrix Biol, Houston, TX 77030 USA; [Yvon, Eric] Univ Paris 04, Ecole Prat Hautes Etud, F-75007 Paris, France; [Fan, Yihui; Zhao, Yanling; Fu, Songbin] Harbin Med Coll, Med Genet Lab, Harbin 150081, Peoples R China	Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Texas Children's Cancer Center; Texas A&M University System; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Harbin Medical University	Yang, JH (corresponding author), Baylor Coll Med, Texas Childrens Canc Ctr, Dan L Duncan Canc Ctr, Dept Pediat, 1 Baylor Plaza,BCM320,6621 Fannin St,MC3-3320, Houston, TX 77030 USA.	jianhuay@bcm.edu			National Institutes of Health [1R21CA106513-01A2]; American Cancer Society [RSG-06-070-01-TBE]; Virginia and L. E. Simmons Family Foundation; Fleming and Davenport Award; NATIONAL CANCER INSTITUTE [R21CA106513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Virginia and L. E. Simmons Family Foundation; Fleming and Davenport Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R21CA106513-01A2. This work was also supported by American Cancer Society Grant RSG-06-070-01-TBE (to J. Y.), the Virginia and L. E. Simmons Family Foundation (to J. Y.), and the Fleming and Davenport Award (to H. Z.).	Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; Carmody RJ, 2007, SCIENCE, V317, P675, DOI 10.1126/science.1142953; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Mao XC, 2009, GENE DEV, V23, P849, DOI 10.1101/gad.1748409; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; Natoli G, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.11pe1; Rodrigues L, 2009, EMBO J, V28, P1283, DOI 10.1038/emboj.2009.74; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; SHIMIZU H, 1990, MOL CELL BIOL, V10, P561, DOI 10.1128/MCB.10.2.561; Sun SC, 2008, TRENDS IMMUNOL, V29, P469, DOI 10.1016/j.it.2008.07.003; Sun WJ, 2009, CELL SIGNAL, V21, P95, DOI 10.1016/j.cellsig.2008.09.012; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Yu Y, 2008, J BIOL CHEM, V283, P24497, DOI 10.1074/jbc.M802825200; ZHANG Y, 1990, MOL CELL BIOL, V10, P3818, DOI 10.1128/MCB.10.7.3818	23	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29290	29297		10.1074/jbc.M109.018994	http://dx.doi.org/10.1074/jbc.M109.018994			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19706600	Green Published, hybrid			2022-12-27	WOS:000270896800008
J	Farrell, KB; Tusnady, GE; Eiden, MV				Farrell, Karen B.; Tusnady, Gabor E.; Eiden, Maribeth V.			New Structural Arrangement of the Extracellular Regions of the Phosphate Transporter SLC20A1, the Receptor for Gibbon Ape Leukemia Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE PROTEIN TOPOLOGY; CELL-SURFACE RECEPTORS; RETROVIRUS RECEPTOR; PREDICTION; INFECTION; FAMILY; DOMAIN; ENTRY; IDENTIFICATION; REVEALS	Infection of a host cell by a retrovirus requires an initial interaction with a cellular receptor. For numerous gammaretroviruses, such as the gibbon ape leukemia virus, woolly monkey virus, feline leukemia virus subgroup B, feline leukemia virus subgroup T, and 10A1 murine leukemia virus, this receptor is the human type III sodium-dependent inorganic phosphate transporter, SLC20A1, formerly known as PiT1. Understanding the critical receptor functionalities and interactions with the virus that lead to successful infection requires that we first know the surface structure of the cellular receptor. Previous molecular modeling from the protein sequence, and limited empirical data, predicted a protein with 10 transmembrane helices. Here we undertake the biochemical approach of substituted cysteine accessibility mutagenesis to resolve the topology of this receptor in live cells. We discover that there are segments of the protein that are unexpectedly exposed to the outside milieu. By using information determined by substituted cysteine accessibility mutagenesis to set constraints in HMMTOP, a hidden Markov model-based transmembrane topology prediction method, we now propose a comprehensive topological model for SLC20A1, a transmembrane protein with 12 transmembrane helices and 7 extracellular regions, that varies from previous models and should permit approaches that define both virus interaction and transport function.	[Farrell, Karen B.; Eiden, Maribeth V.] NIH, Sect Mol Virol, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA; [Tusnady, Gabor E.] Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, H-1113 Budapest, Hungary	National Institutes of Health (NIH) - USA; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences	Eiden, MV (corresponding author), 49 Convent Dr,MSC 4483,Bldg 49,Rm 5A60, Bethesda, MD 20892 USA.	eidenm@mail.nih.gov	Tusnády, Gábor E./AAI-1136-2021; Tusnády, Gábor E/A-3207-2009	Tusnády, Gábor E./0000-0001-8105-0285; Tusnády, Gábor E/0000-0001-8105-0285	National Institutes of Health; Bolyai Janos scholarship; Hungarian Research and Development Funds [OTKA K75460]; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002592, Z01MH002592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bolyai Janos scholarship(Hungarian Academy of Sciences); Hungarian Research and Development Funds; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported by a Bolyai Janos scholarship and Hungarian Research and Development Funds OTKA K75460 ( to G. E. T.).	Bernsel A, 2005, PROTEIN SCI, V14, P1723, DOI 10.1110/ps.051395305; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; Chaudry GJ, 1997, J VIROL, V71, P8078, DOI 10.1128/JVI.71.10.8078-8081.1997; Eiden MV, 1996, J VIROL, V70, P1080, DOI 10.1128/JVI.70.2.1080-1085.1996; Farrell KB, 2002, J VIROL, V76, P7683, DOI 10.1128/JVI.76.15.7683-7693.2002; Feldman SA, 2004, J VIROL, V78, P595, DOI 10.1128/JVI.78.2.595-602.2004; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Hein S, 2003, J VIROL, V77, P5926, DOI 10.1128/JVI.77.10.5926-5932.2003; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; JOHANN SV, 1993, J VIROL, V67, P6733, DOI 10.1128/JVI.67.11.6733-6736.1993; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kavanaugh MP, 1996, KIDNEY INT, V49, P959, DOI 10.1038/ki.1996.135; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LANDER MR, 1984, J VIROL, V52, P695, DOI 10.1128/JVI.52.2.695-698.1984; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; Malhotra S, 1996, J VIROL, V70, P321, DOI 10.1128/JVI.70.1.321-326.1996; MILLER DG, 1994, J VIROL, V68, P8270, DOI 10.1128/JVI.68.12.8270-8276.1994; OHARA B, 1990, CELL GROWTH DIFFER, V1, P119; OLAH Z, 1994, J BIOL CHEM, V269, P25426; Pedersen L, 1997, J VIROL, V71, P7619, DOI 10.1128/JVI.71.10.7619-7622.1997; Rost B, 2001, J STRUCT BIOL, V134, P204, DOI 10.1006/jsbi.2001.4336; Salaun C, 2001, J VIROL, V75, P5584, DOI 10.1128/JVI.75.12.5584-5592.2001; Tusnady GE, 2008, NUCLEIC ACIDS RES, V36, pD234, DOI 10.1093/nar/gkm751; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; VANZEIJL M, 1994, P NATL ACAD SCI USA, V91, P1168, DOI 10.1073/pnas.91.3.1168; Virkki LV, 2007, AM J PHYSIOL-RENAL, V293, pF643, DOI 10.1152/ajprenal.00228.2007; WILSON CA, 1995, J VIROL, V69, P534, DOI 10.1128/JVI.69.1.534-537.1995; Zhu QS, 2007, METHODS, V41, P439, DOI 10.1016/j.ymeth.2006.08.004	30	22	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29979	29987		10.1074/jbc.M109.022566	http://dx.doi.org/10.1074/jbc.M109.022566			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19717569	Green Published, hybrid			2022-12-27	WOS:000270896800076
J	Greenstein, AE; Hammel, M; Cavazos, A; Alber, T				Greenstein, Andrew E.; Hammel, Michal; Cavazos, Alexandra; Alber, Tom			Interdomain Communication in the Mycobacterium tuberculosis Environmental Phosphatase Rv1364c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTI-SIGMA-FACTOR; PROTEIN-PROTEIN INTERACTIONS; X-RAY SOLUTION; BACILLUS-SUBTILIS; TRANSCRIPTION FACTOR; FACTOR ANTAGONISTS; SIGNALING PATHWAY; SCATTERING SAXS; ENERGY STRESS; EXPRESSION	An "environmental phosphatase" controls bacterial transcriptional responses through alternative sigma factor subunits of RNA polymerase and a partner switching mechanism has been proposed to mediate phosphatase regulation. In many bacteria, the environmental phosphatase and multiple regulators are encoded in separate genes whose products form transient complexes. In contrast, in the Mycobacterium tuberculosis homolog, Rv1364c, the phosphatase is fused to two characteristic regulatory modules with sequence similarities to anti-sigma factor kinases and anti-anti-sigma factor proteins. Here we exploit this fusion to explore interactions between the phosphatase and the regulatory domains. We show quantitatively that the anti-sigma factor kinase domain activates the phosphatase domain, the kinase-phosphatase fusion protein autophosphorylates in Escherichia coli, and phosphorylation is antagonized by the phosphatase activity. Small angle x-ray scattering defines solution structures consistent with the interdomain communication observed biochemically. Taken together, these data indicate that Rv1364c provides a single chain framework to understand the structure, function, and regulation of environmental phosphatases throughout the bacterial kingdom.	[Alber, Tom] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Hammel, Michal] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Alber, T (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 374B Stanley Hall 3220, Berkeley, CA 94720 USA.	tom@ucxray.berkeley.edu		Greenstein, Andrew/0000-0002-1470-1970; Hammel, Michal/0000-0002-5610-9289	National Institutes of Health TB Structural Genomics Consortium [P01 AI68135]; National Science Foundation graduate research fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068135] Funding Source: NIH RePORTER	National Institutes of Health TB Structural Genomics Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation graduate research fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health TB Structural Genomics Consortium Grant P01 AI68135 (to T. A.) and a National Science Foundation graduate research fellowship (to A. G.). 1 Current address: Gilead Sciences, 333 Lakeside Dr., Foster City, CA 94404.	Bashyam MD, 2004, INFECT GENET EVOL, V4, P301, DOI 10.1016/j.meegid.2004.04.003; Beaucher J, 2002, MOL MICROBIOL, V45, P1527, DOI 10.1046/j.1365-2958.2002.03135.x; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Campbell EA, 2008, CURR OPIN MICROBIOL, V11, P121, DOI 10.1016/j.mib.2008.02.016; Chen CC, 2004, J BACTERIOL, V186, P6830, DOI 10.1128/JB.186.20.6830-6836.2004; Chen CC, 2003, MOL MICROBIOL, V49, P1657, DOI 10.1046/j.1365-2958.2003.03663.x; Clarkson J, 2004, J MOL BIOL, V342, P1187, DOI 10.1016/j.jmb.2004.07.090; Delumeau O, 2002, J BACTERIOL, V184, P5583, DOI 10.1128/JB.184.20.5583-5589.2002; Fjeld CC, 1999, J BIOL CHEM, V274, P20336, DOI 10.1074/jbc.274.29.20336; Geiman DE, 2004, INFECT IMMUN, V72, P1733, DOI 10.1128/IAI.72.3.1733-1745.2004; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; Guinier A., 1955, SMALL ANGLE SCATTERI; Hampshire T, 2004, TUBERCULOSIS, V84, P228, DOI 10.1016/j.tube.2003.12.010; Hughes KT, 1998, ANNU REV MICROBIOL, V52, P231, DOI 10.1146/annurev.micro.52.1.231; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Kim TJ, 2004, J BACTERIOL, V186, P6124, DOI 10.1128/jb.186.18.6124-6132.2004; Kim TJ, 2004, J MOL BIOL, V341, P135, DOI 10.1016/j.jmb.2004.05.043; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Pane-Farre J, 2005, J MOL MICROB BIOTECH, V9, P65, DOI 10.1159/000088837; Parida BK, 2005, TUBERCULOSIS, V85, P347, DOI 10.1016/j.tube.2005.08.001; Porod G., 1982, SMALL ANGLE XRAY SCA, P17, DOI DOI 10.1002/ACTP.1985.010360520; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rodrigue S, 2006, FEMS MICROBIOL REV, V30, P926, DOI 10.1111/j.1574-6976.2006.00040.x; Sachdeva P, 2008, FEBS J, V275, P6295, DOI 10.1111/j.1742-4658.2008.06753.x; Said-Salim B, 2006, MOL MICROBIOL, V62, P1251, DOI 10.1111/j.1365-2958.2006.05455.x; Song TS, 2003, MOL MICROBIOL, V50, P949, DOI 10.1046/j.1365-2958.2003.03739.x; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Urbauer JL, 2002, P NATL ACAD SCI USA, V99, P1831, DOI 10.1073/pnas.032464699; Vijay K, 2000, MOL MICROBIOL, V35, P180, DOI 10.1046/j.1365-2958.2000.01697.x; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WOOLFSON DN, 1995, PROTEIN SCI, V4, P1596, DOI 10.1002/pro.5560040818; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Yang XF, 1996, GENE DEV, V10, P2265, DOI 10.1101/gad.10.18.2265; Zhang Y, 2004, FRONT BIOSCI-LANDMRK, V9, P1136, DOI 10.2741/1291	37	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29828	29835		10.1074/jbc.M109.056168	http://dx.doi.org/10.1074/jbc.M109.056168			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19700407	Green Published, hybrid			2022-12-27	WOS:000270896800063
J	Chanda, D; Li, TG; Song, KH; Kim, YH; Sim, JG; Lee, CH; Chiang, JYL; Choi, HS				Chanda, Dipanjan; Li, Tiangang; Song, Kwang-Hoon; Kim, Yong-Hoon; Sim, Jeonggu; Lee, Chul Ho; Chiang, John Y. L.; Choi, Hueng-Sik			Hepatocyte Growth Factor Family Negatively Regulates Hepatic Gluconeogenesis via Induction of Orphan Nuclear Receptor Small Heterodimer Partner in Primary Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HEPG2 LIVER-CELLS; SIGNALING PATHWAY; GENE-EXPRESSION; DIABETIC-NEPHROPATHY; MICE; UPSTREAM; INSULIN; HYPERGLYCEMIA; PROMOTER	Hepatic gluconeogenesis is tightly balanced by opposing stimulatory (glucagon) and inhibitory (insulin) signaling pathways. Hepatocyte growth factor (HGF) is a pleiotropic growth factor that mediates diverse biological processes. In this study, we investigated the effect of HGF and its family member, macrophage-stimulating factor (MSP), on hepatic gluconeogenesis in primary hepatocytes. HGF and MSP significantly repressed expression of the key hepatic gluconeogenic enzyme genes, phosphoenolpyruvate carboxykinase (PEPCK), and glucose-6-phosphatase (Glc-6-Pase) and reduced glucose production. HGF and MSP activated small heterodimer partner (SHP) gene promoter and induced SHP mRNA and protein levels, and the effect of HGF and MSP on SHP gene expression was demonstrated to be mediated via activation of the AMP-activated protein kinase (AMPK) signaling pathway. We demonstrated that upstream stimulatory factor-1 (USF-1) specifically mediated HGF effect on SHP gene expression, and inhibition of USF-1 by dominant negative USF-1 significantly abrogated HGF-mediated activation of the SHP promoter. Elucidation of the mechanism showed that USF-1 bound to E-box-1 in the SHP promoter, and HGF increased USF-1 DNA binding on the SHP promoter via AMPK and DNA-dependent protein kinase-mediated pathways. Adenoviral overexpression of USF-1 significantly repressed PEPCK and Glc-6-Pase gene expression and reduced glucose production. Knockdown of endogenous SHP expression significantly reversed this effect. Finally, knockdown of SHP or inhibition of AMPK signaling reversed the ability of HGF to suppress hepatocyte nuclear factor 4 alpha-mediated up-regulation of PEPCK and Glc-6-Pase gene expression along with the HGF- and MSP-mediated suppression of gluconeogenesis. Overall, our results suggest a novel signaling pathway through HGF/AMPK/USF-1/SHP to inhibit hepatic gluconeogenesis.	[Chanda, Dipanjan; Sim, Jeonggu; Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea; [Li, Tiangang; Song, Kwang-Hoon; Chiang, John Y. L.] Northeastern Ohio Univ Coll Med & Pharm, Dept Integrat Med Sci, Rootstown, OH 44272 USA; [Kim, Yong-Hoon; Lee, Chul Ho] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea	Chonnam National University; Northeast Ohio Medical University (NEOMED); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Choi, HS (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea.	hsc@chonnam.ac.kr	Chanda, Dipanjan/AAU-3996-2021; Chiang, John Y. L./G-2658-2011	Chanda, Dipanjan/0000-0003-0685-187X; Chiang, John Y. L./0000-0001-9360-7650	National Institutes of Health [DK44442, DK58379]; Korea Science and Engineering Foundation [NRL-ROA-2005-000-10047-0]; Korea Research Foundation [2006-005-J03003]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK044442, R01DK044442, R37DK058379, R01DK058379] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korea Research Foundation(National Research Foundation of Korea); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK44442 and DK58379 (to J. Y. L. C.). This work was also supported by Korea Science and Engineering Foundation through the National Research Laboratory Program Grant NRL-ROA-2005-000-10047-0 and by Korea Research Foundation Grant 2006-005-J03003) (to H. S. C.).	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200; Chanda D, 2008, AM J PHYSIOL-ENDOC M, V295, pE368, DOI 10.1152/ajpendo.00800.2007; Chanda D, 2008, ENDOCR J, V55, P253, DOI 10.1507/endocrj.K07E-103; Chen QY, 1997, HEPATOLOGY, V26, P59; Cruzado JM, 2004, DIABETES, V53, P1119, DOI 10.2337/diabetes.53.4.1119; Dai CS, 2004, J AM SOC NEPHROL, V15, P2637, DOI 10.1097/01.ASN.0000139479.09658.EE; Dai CS, 2003, J BIOL CHEM, V278, P27080, DOI 10.1074/jbc.M211947200; Danilkovitch A, 1999, J LEUKOCYTE BIOL, V65, P345, DOI 10.1002/jlb.65.3.345; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Garcia-Ocana A, 2000, J BIOL CHEM, V275, P1226, DOI 10.1074/jbc.275.2.1226; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hiratsuka A, 2005, J CLIN ENDOCR METAB, V90, P2927, DOI 10.1210/jc.2004-1588; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Imagawa S, 2006, ARTERIOSCL THROM VAS, V26, P2407, DOI 10.1161/01.ATV.0000240318.61359.e3; Iynedjian PB, 1998, BIOCHEM J, V333, P705, DOI 10.1042/bj3330705; Kato N, 2005, DIABETES, V54, P846, DOI 10.2337/diabetes.54.3.846; Kim HJ, 2003, NUCLEIC ACIDS RES, V31, P6860, DOI 10.1093/nar/gkg906; Kim JH, 2008, J MOL BIOL, V383, P502, DOI 10.1016/j.jmb.2008.08.036; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; KODAMA H, 1994, DIABETOLOGIA, V37, P739, DOI 10.1007/s001250050173; Lee YS, 2007, INT REV CYTOL, V261, P117, DOI 10.1016/S0074-7696(07)61003-1; Liu HY, 2008, J BIOL CHEM, V283, P30642, DOI 10.1074/jbc.M803698200; McElwee KJ, 2004, J INVEST DERMATOL, V123, P34, DOI 10.1111/j.0022-202X.2004.22712.x; Nakamura S, 1998, J HYPERTENS, V16, P2019, DOI 10.1097/00004872-199816121-00025; Park MK, 2003, EXP MOL MED, V35, P494, DOI 10.1038/emm.2003.64; Rehman J, 2003, J AM COLL CARDIOL, V41, P1408, DOI 10.1016/S0735-1097(03)00231-6; Roccisana J, 2005, DIABETES, V54, P2090, DOI 10.2337/diabetes.54.7.2090; Satani K, 2006, DIABETIC MED, V23, P617, DOI 10.1111/j.1464-5491.2006.01849.x; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Shiota G, 1995, J MED, V26, P295; Song KH, 2007, HEPATOLOGY, V46, P1993, DOI 10.1002/hep.21878; TOMIYA T, 1992, HEPATOLOGY, V15, P1, DOI 10.1002/hep.1840150102; van Deursen D, 2008, DIABETOLOGIA, V51, P2078, DOI 10.1007/s00125-008-1125-6; Vazquez-Chantada M, 2009, HEPATOLOGY, V49, P608, DOI 10.1002/hep.22660; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; Xie YB, 2009, NUCLEIC ACIDS RES, V37, P4100, DOI 10.1093/nar/gkp333; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yanai K, 1997, J BIOL CHEM, V272, P30558, DOI 10.1074/jbc.272.48.30558; You WK, 2008, BMB REP, V41, P833, DOI 10.5483/BMBRep.2008.41.12.833	40	45	49	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28510	28521		10.1074/jbc.M109.022244	http://dx.doi.org/10.1074/jbc.M109.022244			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19720831	Green Published, hybrid			2022-12-27	WOS:000270678900005
J	Oh, M; Kim, H; Yang, IW; Park, JH; Cong, WT; Baek, MC; Bareiss, S; Ki, H; Lu, Q; No, J; Kwon, I; Choi, JK; Kim, K				Oh, Minsoo; Kim, Hangun; Yang, Ilhwan; Park, Ja-Hye; Cong, Wei-Tao; Baek, Moon-Chang; Bareiss, Sonja; Ki, Hyunkyoung; Lu, Qun; No, Jinhyung; Kwon, Inho; Choi, Jung-Kap; Kim, Kwonseop			GSK-3 Phosphorylates delta-Catenin and Negatively Regulates Its Stability via Ubiquitination/Proteosome-mediated Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; BETA-CATENIN; NEURODEGENERATIVE DISEASE; ALZHEIMERS-DISEASE; ADHERENS JUNCTION; ARMADILLO PROTEIN; E-CADHERIN; PRESENILIN-1; EXPRESSION; MECHANISM	delta-Catenin was first identified because of its interaction with presenilin-1, and its aberrant expression has been reported in various human tumors and in patients with Cri-du-Chat syndrome, a form of mental retardation. However, the mechanism whereby delta-catenin is regulated in cells has not been fully elucidated. We investigated the possibility that glycogen-synthase kinase-3 (GSK-3) phosphorylates delta-catenin and thus affects its stability. Initially, we found that the level of delta-catenin was greater and the half-life of delta-catenin was longer in GSK-3 beta(-/-) fibroblasts than those in GSK-3 beta(+/+)fibroblasts. Furthermore, four different approaches designed to specifically inhibit GSK-3 activity, i.e. GSK-3-specific chemical inhibitors, Wnt-3a conditioned media, small interfering RNAs, and GSK-3 alpha and -3 beta kinase dead constructs, consistently showed that the levels of endogenous delta-catenin in CWR22Rv-1 prostate carcinoma cells and primary cortical neurons were increased by inhibiting GSK-3 activity. In addition, it was found that both GSK-3 alpha and -3 beta interact with and phosphorylate delta-catenin. The phosphorylation of Delta C207-delta-catenin (lacking 207 C-terminal residues) and T1078A delta-catenin by GSK-3 was noticeably reduced compared with that of wild type delta-catenin, and the data from liquid chromatography-tandem mass spectrometry analyses suggest that the Thr(1078) residue of delta-catenin is one of the GSK-3 phosphorylation sites. Treatment with MG132 or ALLN, specific inhibitors of proteosome-dependent proteolysis, increased delta-catenin levels and caused an accumulation of ubiquitinated delta-catenin. It was also found that GSK-3 triggers the ubiquitination of delta-catenin. These results suggest that GSK-3 interacts with and phosphorylates delta-catenin and thereby negatively affects its stability by enabling its ubiquitination/proteosome-mediated proteolysis.	[Ki, Hyunkyoung; No, Jinhyung; Kwon, Inho; Choi, Jung-Kap; Kim, Kwonseop] Chonnam Natl Univ, Coll Pharm, Kwangju 500757, South Korea; [Ki, Hyunkyoung; No, Jinhyung; Kwon, Inho; Choi, Jung-Kap; Kim, Kwonseop] Chonnam Natl Univ, Res Inst Drug Dev, Kwangju 500757, South Korea; [Park, Ja-Hye; Baek, Moon-Chang] Kyungpook Natl Univ, Sch Med, Dept Mol Med, Taegu 700422, South Korea; [Cong, Wei-Tao] Wenzhou Med Coll, Sch Pharm, Wenzhou 325000, Peoples R China; [Bareiss, Sonja; Lu, Qun; Kim, Kwonseop] E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC 27834 USA	Chonnam National University; Chonnam National University; Kyungpook National University; Wenzhou Medical University; University of North Carolina; East Carolina University	Kim, K (corresponding author), Chonnam Natl Univ, Coll Pharm, Bldg 1-211,300 Yongbong Dong, Kwangju 500757, South Korea.	koskim@chonnam.ac.kr			National Institutes of Health [AG026630, CA111891]; Korea Healthcare Technology R D Project [A084462]; Korean Ministry for Health, Welfare Family Affairs; New Technology R D Project; NATIONAL CANCER INSTITUTE [R01CA111891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG026630] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Healthcare Technology R D Project; Korean Ministry for Health, Welfare Family Affairs; New Technology R D Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG026630 (to Q. L.) and CA111891 (to Q. L.). This work was also supported by Korea Healthcare Technology R & D Project Grant A084462, funds from the Korean Ministry for Health, Welfare& Family Affairs (to K. K.), and a grant from the New Technology R & D Project (Gwang-Ju Technopark, Korea).	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Abu-Elneel K, 2008, J BIOL CHEM, V283, P32781, DOI 10.1074/jbc.M804688200; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Ho C, 2000, J COMP NEUROL, V420, P261; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Ide N, 1999, BIOCHEM BIOPH RES CO, V256, P456, DOI 10.1006/bbrc.1999.0364; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Jones SB, 2002, NEUROSCIENCE, V115, P1009, DOI 10.1016/S0306-4522(02)00532-8; Kaytor MD, 2002, CURR OPIN NEUROBIOL, V12, P275, DOI 10.1016/S0959-4388(02)00320-3; Kim H, 2005, J BIOL CHEM, V280, P22462, DOI 10.1074/jbc.M502769200; Kim JS, 2006, BIOCHEM BIOPH RES CO, V351, P903, DOI 10.1016/j.bbrc.2006.10.135; Kim K, 2002, EXP CELL RES, V275, P171, DOI 10.1006/excr.2002.5503; Kosik KS, 2005, TRENDS CELL BIOL, V15, P172, DOI 10.1016/j.tcb.2005.01.004; Lau KF, 1999, J PEPT RES, V54, P85, DOI 10.1034/j.1399-3011.1999.00083.x; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lu Q, 2005, HUM PATHOL, V36, P1037, DOI 10.1016/j.humpath.2005.07.012; Lu Q, 2002, J NEUROSCI RES, V67, P618, DOI 10.1002/jnr.10151; Lu Q, 1999, J CELL BIOL, V144, P519, DOI 10.1083/jcb.144.3.519; Maccioni RB, 2001, ARCH MED RES, V32, P367, DOI 10.1016/S0188-4409(01)00316-2; Mackie S, 2005, FEBS J, V272, P4202, DOI 10.1111/j.1742-4658.2005.04832.x; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Megy S, 2006, FEBS LETT, V580, P5411, DOI 10.1016/j.febslet.2006.08.084; Paffenholz R, 1997, DIFFERENTIATION, V61, P293, DOI 10.1046/j.1432-0436.1997.6150293.x; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Rodova M, 2004, MOL CELL BIOL, V24, P7188, DOI 10.1128/MCB.24.16.7188-7196.2004; Russell WK, 2001, ANAL CHEM, V73, P2682, DOI 10.1021/ac001332p; Setoyama D, 2007, P NATL ACAD SCI USA, V104, P18001, DOI 10.1073/pnas.0706952104; Silverman JB, 2007, J NEUROSCI, V27, P8505, DOI 10.1523/JNEUROSCI.1395-07.2007; Soond SM, 2008, J BIOL CHEM, V283, P16077, DOI 10.1074/jbc.M800384200; Tanahashi H, 1999, NEUROREPORT, V10, P563, DOI 10.1097/00001756-199902250-00022; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Tesco G, 2000, ANN NY ACAD SCI, V920, P227; Trinidad JC, 2008, MOL CELL PROTEOMICS, V7, P684, DOI 10.1074/mcp.M700170-MCP200; Wei S, 2008, J BIOL CHEM, V283, P26759, DOI 10.1074/jbc.M802160200; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Xia XB, 2003, BIOCHEMISTRY-US, V42, P9195, DOI 10.1021/bi034597h; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208; Zhou JH, 1997, NEUROREPORT, V8, P2085, DOI 10.1097/00001756-199705260-00054	39	36	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28579	28589		10.1074/jbc.M109.002659	http://dx.doi.org/10.1074/jbc.M109.002659			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19706605	Green Published, hybrid			2022-12-27	WOS:000270678900012
J	Yamaguchi, Y; Park, JH; Inouye, M				Yamaguchi, Yoshihiro; Park, Jung-Ho; Inouye, Masayori			MqsR, a Crucial Regulator for Quorum Sensing and Biofilm Formation, Is a GCU-specific mRNA Interferase in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIN-ANTITOXIN MODULE; GENE-EXPRESSION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; DNA GYRASE; CELL-DEATH; C QSEBC; MECHANISM; CLEAVAGE; SYSTEM	The mqsR gene has been shown to be positively regulated by the quorum-sensing autoinducer AI-2, which in turn activates a two-component system, the qseB-qseC operon. This operon plays an important role in biofilm formation in Escherichia coli. However, its cellular function has remained unknown. Here, we found that 1 base downstream of mqsR there is a gene, ygiT, that is co-transcribed with mqsR. Induction of mqsR caused cell growth arrest, whereas ygiT co-induction recovered cell growth. We demonstrate that MqsR (98 amino acid residues), which has no homology to the well characterized mRNA interferase MazF, is a potent inhibitor of protein synthesis that functions by degrading cellular mRNAs. In vivo and in vitro primer extension experiments showed that MqsR is an mRNA interferase specifically cleaving mRNAs at GCU. The mRNA interferase activity of purified MqsR was inhibited by purified YgiT (131 residues). MqsR forms a stable 2: 1 complex with YgiT, and the complex likely functions as a repressor for the mqsR-ygiT operon by specifically binding to two different palindromic sequences present in the 5'-untranslated region of this operon.	[Yamaguchi, Yoshihiro; Park, Jung-Ho; Inouye, Masayori] Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Inouye, M (corresponding author), Robert Wood Johnson Med Sch, Dept Biochem, 675 Hoes Lane, Piscataway, NJ 08854 USA.	inouye@umdnj.edu		Yamaguchi, Yoshihiro/0000-0003-4663-6963; Park, Jung-Ho/0000-0003-0441-4457	National Institutes of Health [1RO1 GM081567]; Takara Bio Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Takara Bio Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1RO1 GM081567. This work was also supported by Takara Bio Inc.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bahassi EM, 1999, J BIOL CHEM, V274, P10936, DOI 10.1074/jbc.274.16.10936; Baker KE, 2003, MOL MICROBIOL, V47, P75, DOI 10.1046/j.1365-2958.2003.03292.x; Balestrino D, 2005, J BACTERIOL, V187, P2870, DOI 10.1128/JB.187.8.2870-2880.2005; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Billy E, 2001, P NATL ACAD SCI USA, V98, P14428, DOI 10.1073/pnas.261562698; Brown JM, 2003, J BACTERIOL, V185, P6600, DOI 10.1128/JB.185.22.6600-6608.2003; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Clarke MB, 2005, MOL MICROBIOL, V58, P441, DOI 10.1111/j.1365-2958.2005.04819.x; Dao-Thi MH, 2002, J BIOL CHEM, V277, P3733, DOI 10.1074/jbc.M105505200; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; Engelberg-Kulka H, 2004, TRENDS MICROBIOL, V12, P66, DOI 10.1016/j.tim.2003.12.008; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; Hurley JM, 2009, J BIOL CHEM, V284, P18605, DOI 10.1074/jbc.M109.008763; Inoue T, 2007, J BACTERIOL, V189, P950, DOI 10.1128/JB.01294-06; Inouye M, 2006, J CELL PHYSIOL, V209, P670, DOI 10.1002/jcp.20801; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kampranis SC, 1999, J MOL BIOL, V293, P733, DOI 10.1006/jmbi.1999.3182; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Li GY, 2008, J MOL BIOL, V380, P107, DOI 10.1016/j.jmb.2008.04.039; LIU YC, 1990, BIOTECHNIQUES, V9, P558; Madl T, 2006, J MOL BIOL, V364, P170, DOI 10.1016/j.jmb.2006.08.082; Makarova KS, 2006, BIOINFORMATICS, V22, P2581, DOI 10.1093/bioinformatics/btl418; Marianovsky I, 2001, J BIOL CHEM, V276, P5975, DOI 10.1074/jbc.M008832200; McNab R, 2003, J BACTERIOL, V185, P274, DOI 10.1128/JB.185.1.274-284.2003; MIZUNO T, 1984, P NATL ACAD SCI-BIOL, V81, P1966, DOI 10.1073/pnas.81.7.1966; Motiejunaite R, 2007, FEMS MICROBIOL LETT, V268, P112, DOI 10.1111/j.1574-6968.2006.00563.x; Oberer M, 2007, PROTEIN SCI, V16, P1676, DOI 10.1110/ps.062680707; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Puerta-Fernandez E, 2003, FEMS MICROBIOL REV, V27, P75, DOI 10.1016/S0168-6445(03)00020-2; Ren D, 2004, APPL MICROBIOL BIOT, V64, P515, DOI 10.1007/s00253-003-1517-y; SARMIENTOS P, 1983, CELL, V32, P1337, DOI 10.1016/0092-8674(83)90314-8; Schmidt O, 2007, J MOL BIOL, V372, P894, DOI 10.1016/j.jmb.2007.07.016; Sperandio V, 2002, MOL MICROBIOL, V43, P809, DOI 10.1046/j.1365-2958.2002.02803.x; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; Wang XX, 2009, ISME J, V3, P1164, DOI 10.1038/ismej.2009.59; Webb JS, 2003, J BACTERIOL, V185, P4585, DOI 10.1128/JB.185.15.4585-4592.2003; Yamaguchi Y, 2009, PROG MOL BIOL TRANSL, V85, P467, DOI 10.1016/S0079-6603(08)00812-X; Yoshida T, 2006, J BIOL CHEM, V281, P17114, DOI 10.1074/jbc.M602112200; Zhang JJ, 2004, J BIOL CHEM, V279, P20678, DOI 10.1074/jbc.M314284200; Zhang JJ, 2003, J BIOL CHEM, V278, P32300, DOI 10.1074/jbc.M304767200; Zhang JJ, 2002, J BACTERIOL, V184, P5323, DOI 10.1128/JB.184.19.5323-5329.2002; Zhang YL, 2005, J BIOL CHEM, V280, P26080, DOI 10.1074/jbc.M502050200; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang YL, 2005, J BIOL CHEM, V280, P3143, DOI 10.1074/jbc.M411811200; Zhang Y, 2009, J BIOL CHEM, V284, P6627, DOI 10.1074/jbc.M808779200	57	130	149	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28746	28753		10.1074/jbc.M109.032904	http://dx.doi.org/10.1074/jbc.M109.032904			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19690171	hybrid, Green Published			2022-12-27	WOS:000270678900031
J	Singh, P; Salih, M; Tuana, BS				Singh, Puneet; Salih, Maysoon; Tuana, Balwant S.			alpha-Kinase Anchoring Protein alpha KAP Interacts with SERCA2A to Spatially Position Ca2+/Calmodulin-dependent Protein Kinase II and Modulate Phospholamban Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE SARCOPLASMIC-RETICULUM; AKAP SIGNALING COMPLEXES; SKELETAL-MUSCLE; RYANODINE RECEPTOR; CAM KINASE; CARDIAC-HYPERTROPHY; CA2+ RELEASE; CALMODULIN; HEART; CHANNELS	The sarco-endoplasmic reticulum calcium ATPase 2a (SERCA2a) is critical for sequestering cytosolic calcium into the sarco-endoplasmic reticulum (SR) and regulating cardiac muscle relaxation. Protein-protein interactions indicated that it exists in complex with Ca2+/calmodulin-dependent protein kinase II (CaMKII) and its anchoring protein alpha KAP. Confocal imaging of isolated cardiomyocytes revealed the colocalization of CAMKII and alpha KAP with SERCA2a at the SR. Deletion analysis indicated that SERCA2a and CaMKII bind to different regions in the association domain of alpha KAP but not with each other. Although deletion of the putative N-terminal hydrophobic amino acid stretch in alpha KAP prevented its membrane targeting, it did not influence binding to SERCA2a or CaMKII. Both CaMKII delta(C) and the novel CaMKII beta(4) isoforms were found to exist in complex with alpha KAP and SERCA2a at the SR and were able to phosphorylate Thr-17 on phospholamban (PLN), an accessory subunit and known regulator of SERCA2a activity. Interestingly, the presence of alpha KAP was also found to significantly modulate the Ca2+/calmodulin-dependent phosphorylation of Thr-17 on PLN. These data demonstrate that aKAP exhibits a novel interaction with SERCA2a and may serve to spatially position CaMKII isoforms at the SR and to uniquely modulate the phosphorylation of PLN.	[Singh, Puneet; Salih, Maysoon; Tuana, Balwant S.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada	University of Ottawa	Tuana, BS (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	btuana@uottawa.ca			Canadian Institute of Health Research [9596]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institute of Health Research Grant 9596 (to B. S. T.).	Alto N, 2002, DIABETES, V51, pS385, DOI 10.2337/diabetes.51.2007.S385; Bayer KU, 1998, EMBO J, V17, P5598, DOI 10.1093/emboj/17.19.5598; Bayer KU, 1996, MOL CELL BIOL, V16, P29; Bkaily G, 1997, MOL CELL BIOCHEM, V172, P171, DOI 10.1023/A:1006840228104; BRANDL CJ, 1986, CELL, V44, P597, DOI 10.1016/0092-8674(86)90269-2; Catterall WA, 2006, J RECEPT SIG TRANSD, V26, P577, DOI 10.1080/10799890600915100; Chen Z, 2007, J BIOL CHEM, V282, P20968, DOI 10.1074/jbc.M703516200; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; Kapiloff MS, 2001, J CELL SCI, V114, P3167; Kennedy DJ, 2006, AM J PHYSIOL-HEART C, V291, pH3003, DOI 10.1152/ajpheart.00603.2006; Kim YK, 2003, J BIOL CHEM, V278, P47622, DOI 10.1074/jbc.M305909200; Kolb SJ, 1998, J BIOL CHEM, V273, P31555, DOI 10.1074/jbc.273.47.31555; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Lygren B, 2007, EMBO REP, V8, P1061, DOI 10.1038/sj.embor.7401081; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; MACLENNAN DH, 1984, ADV CYCLIC NUCL PROT, V17, P393; Maier LS, 2003, CIRC RES, V92, P904, DOI 10.1161/01.RES.0000069685.20258.F1; Manni S, 2008, J BIOL CHEM, V283, P24145, DOI 10.1074/jbc.M802278200; Mattiazzi A, 2005, CARDIOVASC RES, V68, P366, DOI 10.1016/j.cardiores.2005.08.010; McConnachie G, 2006, TRENDS MOL MED, V12, P317, DOI 10.1016/j.molmed.2006.05.008; Nori A, 2003, BIOCHEM J, V370, P873, DOI 10.1042/BJ20021624; Pitt GS, 2007, CARDIOVASC RES, V73, P641, DOI 10.1016/j.cardiores.2006.10.019; Singh P, 2005, MOL CELL BIOCHEM, V270, P215, DOI 10.1007/s11010-005-5234-y; Singh P, 2004, J BIOL CHEM, V279, P35176, DOI 10.1074/jbc.M402282200; Smith FD, 2006, TRENDS BIOCHEM SCI, V31, P316, DOI 10.1016/j.tibs.2006.04.009; SRINIVASAN M, 1994, J CELL BIOL, V126, P839, DOI 10.1083/jcb.126.4.839; Stange M, 2003, J BIOL CHEM, V278, P51693, DOI 10.1074/jbc.M310406200; TUANA BS, 1988, FEBS LETT, V235, P219, DOI 10.1016/0014-5793(88)81266-3; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; WEGENER AD, 1989, J BIOL CHEM, V264, P11468; Yamaguchi N, 2007, J CLIN INVEST, V117, P1344, DOI 10.1172/JCI29515; Yamaguchi N, 2007, CIRC RES, V100, P293, DOI 10.1161/01.RES.0000259327.56377.55; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200	36	17	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28212	28221		10.1074/jbc.M109.044990	http://dx.doi.org/10.1074/jbc.M109.044990			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19671701	Green Published, hybrid			2022-12-27	WOS:000270676300049
J	Watanabe, M; Wake, H; Moorhouse, AJ; Nabekura, J				Watanabe, Miho; Wake, Hiroaki; Moorhouse, Andrew J.; Nabekura, Junichi			Clustering of Neuronal K+-Cl- Cotransporters in Lipid Rafts by Tyrosine Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPOCAMPAL-NEURONS; GABA(A) RECEPTOR; EXCITATORY ACTIONS; CREATINE-KINASE; KCC2 EXPRESSION; STRUCTURAL UNIT; DOWN-REGULATION; GNRH NEURONS; LOCALIZATION; CHLORIDE	The neuronal K+-Cl- cotransporter (KCC2) is a membrane transport protein that extrudes Cl- from neurons and helps maintain low intracellular [Cl-] and hyperpolarizing GABAergic synaptic potentials. Depolarizing gamma-aminobutyric acid (GABA) responses in neonatal neurons and following various forms of neuronal injury are associated with reduced levels of KCC2 expression. Despite the importance for plasticity of inhibitory transmission, less is known about cellular mechanisms involved in more dynamic changes in KCC2 function. In this study, we investigated the role of tyrosine phosphorylation in KCC2 localization and function in hippocampal neurons and in cultured GT1-7 cells. Mutation to the putative tyrosine phosphorylation site within the long intracellular carboxyl terminus of KCC2(Y1087D) or application of the tyrosine kinase inhibitor genistein shifted the GABA reversal potential (E-GABA) to more depolarized values, indicating reduced KCC2 function. This was associated with a change in the expression pattern of KCC2 from a punctate distribution to a more uniform distribution, suggesting that functional tyrosine-phosphorylated KCC2 forms clusters in restricted membrane domains. Sodium vanadate, a tyrosine phosphatase inhibitor, increased the proportion of KCC2 associated with lipid rafts membrane domains. Loss of tyrosine phosphorylation also reduced oligomerization of KCC2. A loss of the punctuate distribution and oligomerization of KCC2 and a more depolarized E-GABA Were seen when the 28-amino-acid carboxyl terminus of KCC2 was deleted. These results indicate that direct tyrosine phosphorylation of KCC2 results in membrane clusters and functional transport activity, suggesting a mechanism by which intracellular Cl- concentrations and GABA responses can be rapidly modulated.	[Watanabe, Miho; Wake, Hiroaki; Nabekura, Junichi] Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 4448585, Japan; [Wake, Hiroaki; Nabekura, Junichi] Japan Sci & Technol Corp, Core Res Evolutionary Sci & Technol, Saitama 3330012, Japan; [Moorhouse, Andrew J.] Univ New S Wales, Sch Med Sci, Dept Physiol, Sydney, NSW 2052, Australia; [Nabekura, Junichi] Grad Univ Adv Studies SOKENDAI, Dept Physiol Sci, Hayama 2400193, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Science & Technology Agency (JST); University of New South Wales Sydney; Graduate University for Advanced Studies - Japan	Nabekura, J (corresponding author), Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 4448585, Japan.	nabekura@nips.ac.jp	Moorhouse, Andrew J/B-8526-2011	Moorhouse, Andrew J/0000-0001-7957-2498; WAKE, Hiroaki/0000-0002-8543-4590	The Ministry of Education, Culture, Sports, Science and Technology, Japan [19040030, 18077009, 21790234]; Japan Science and Technology Agency and Core Research for the Evolutionary Science and Technology, Japan Science and Technology Corporation	The Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency and Core Research for the Evolutionary Science and Technology, Japan Science and Technology Corporation(Japan Science & Technology Agency (JST))	This work was supported by Grant-in-Aids for Scientific Research on Priority Areas 19040030 (to M. W.) and 18077009 (to J. N.) and Grant-in-Aids for Young Scientists (B) 21790234 (to M. W.) from The Ministry of Education, Culture, Sports, Science and Technology, Japan and by grants from the Japan Science and Technology Agency and Core Research for the Evolutionary Science and Technology, Japan Science and Technology Corporation (to J. N.).	Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Casula S, 2001, J BIOL CHEM, V276, P41870, DOI 10.1074/jbc.M107155200; Dalskov SM, 2005, NEUROCHEM INT, V46, P489, DOI 10.1016/j.neuint.2004.11.010; Davies A, 2006, J NEUROSCI, V26, P8748, DOI 10.1523/JNEUROSCI.2764-06.2006; de Jong JC, 2003, J BIOL CHEM, V278, P24302, DOI 10.1074/jbc.M303101200; de la Escalera GM, 2001, ARCH MED RES, V32, P486, DOI 10.1016/S0188-4409(01)00320-4; Fiumelli H, 2005, NEURON, V48, P773, DOI 10.1016/j.neuron.2005.10.025; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Garbarini N, 2008, CELL PHYSIOL BIOCHEM, V22, P31, DOI 10.1159/000149781; Hering H, 2003, J NEUROSCI, V23, P3262; Inoue K, 2006, J NEUROCHEM, V96, P598, DOI 10.1111/j.1471-4159.2005.03560.x; Inoue K, 2004, FEBS LETT, V564, P131, DOI 10.1016/S0014-5793(04)00328-X; Kahle KT, 2005, P NATL ACAD SCI USA, V102, P16783, DOI 10.1073/pnas.0508307102; Kakazu Y, 2000, J NEUROPHYSIOL, V84, P281, DOI 10.1152/jn.2000.84.1.281; Kakazu Y, 1999, J NEUROSCI, V19, P2843; Kelsch W, 2001, J NEUROSCI, V21, P8339, DOI 10.1523/JNEUROSCI.21-21-08339.2001; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; Kitamura A, 2008, NEUROSCI RES, V62, P270, DOI 10.1016/j.neures.2008.09.002; Lee HHC, 2007, J BIOL CHEM, V282, P29777, DOI 10.1074/jbc.M705053200; Martens JR, 2004, TRENDS PHARMACOL SCI, V25, P16, DOI 10.1016/j.tips.2003.11.007; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Moore-Hoon ML, 2000, BIOCHEMISTRY-US, V39, P3718, DOI 10.1021/bi992301v; Nabekura J, 2002, J NEUROSCI, V22, P4412, DOI 10.1523/JNEUROSCI.22-11-04412.2002; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Reid KH, 2000, BRAIN RES, V864, P134, DOI 10.1016/S0006-8993(00)02121-1; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Song LY, 2002, MOL BRAIN RES, V103, P91, DOI 10.1016/S0169-328X(02)00190-0; Starremans PGJF, 2003, J AM SOC NEPHROL, V14, P3039, DOI 10.1097/01.ASN.0000097370.29737.5B; Suzuki S, 2004, J CELL BIOL, V167, P1205, DOI 10.1083/jcb.200404106; Toyoda H, 2003, J NEUROPHYSIOL, V89, P1353, DOI 10.1152/jn.00721.2002; Ueno T, 2002, J BIOL CHEM, V277, P4945, DOI 10.1074/jbc.M109439200; vandenPol AN, 1996, J NEUROSCI, V16, P4283; Wake H, 2007, J NEUROSCI, V27, P1642, DOI 10.1523/JNEUROSCI.3104-06.2007; Watanabe M, 2004, ENDOCRINOLOGY, V145, P2375, DOI 10.1210/en.2003-1257; WETSEL WC, 1992, P NATL ACAD SCI USA, V89, P4149, DOI 10.1073/pnas.89.9.4149; Williams JR, 1999, J BIOL CHEM, V274, P12656, DOI 10.1074/jbc.274.18.12656; Xia FZ, 2004, J BIOL CHEM, V279, P24685, DOI 10.1074/jbc.M314314200	40	72	72	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27980	27988		10.1074/jbc.M109.043620	http://dx.doi.org/10.1074/jbc.M109.043620			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19679663	hybrid, Green Published			2022-12-27	WOS:000270676300026
J	Hughes, KJ; Meares, GP; Chambers, KT; Corbett, JA				Hughes, Katherine J.; Meares, Gordon P.; Chambers, Kari T.; Corbett, John A.			Repair of Nitric Oxide-damaged DNA in beta-Cells Requires JNK-dependent GADD45 alpha Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT PANCREATIC-ISLETS; BASE EXCISION-REPAIR; C-JUN; INSULIN-SECRETION; KINASE PATHWAY; P53-REGULATED PROTEIN; GENE-TRANSCRIPTION; DIABETES-MELLITUS; TERMINAL KINASE; P53 ACTIVATION	Proinflammatory cytokines induce nitric oxide-dependent DNA damage and ultimately beta-cell death. Not only does nitric oxide cause beta-cell damage, it also activates a functional repair process. In this study, the mechanisms activated by nitric oxide that facilitate the repair of damaged beta-cell DNA are examined. JNK plays a central regulatory role because inhibition of this kinase attenuates the repair of nitric oxide-induced DNA damage. p53 is a logical target of JNK-dependent DNA repair; however, nitric oxide does not stimulate p53 activation or accumulation in beta-cells. Further, knockdown of basal p53 levels does not affect DNA repair. In contrast, expression of growth arrest and DNA damage (GADD) 45 alpha, a DNA repair gene that can be regulated by p53-dependent and p53-independent pathways, is stimulated by nitric oxide in a JNK-dependent manner, and knockdown of GADD45 alpha expression attenuates the repair of nitric oxide-induced beta-cell DNA damage. These findings show that beta-cells have the ability to repair nitric oxide-damaged DNA and that JNK and GADD45 alpha mediate the p53-independent repair of this DNA damage.	[Meares, Gordon P.; Corbett, John A.] Univ Alabama, Comprehens Diabet Ctr, Dept Med, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA; [Hughes, Katherine J.; Chambers, Kari T.] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	University of Alabama System; University of Alabama Birmingham; Saint Louis University	Corbett, JA (corresponding author), Univ Alabama, Comprehens Diabet Ctr, Dept Med, Div Endocrinol Diabet & Metab, 1206 Shelby,1530 3rd Ave S, Birmingham, AL 35294 USA.	corbettj@UAB.edu	Meares, Gordon/AAJ-6716-2020	Meares, Gordon/0000-0002-0805-0155	National Institutes of Health [DK52194, AI44458]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051, R01AI044458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	work was supported, in whole or in part, by National Institutes of Health Grants DK52194 and AI44458 (to J. A. C.).	Ammendrup A, 2000, DIABETES, V49, P1468, DOI 10.2337/diabetes.49.9.1468; Andreka P, 2001, CIRC RES, V88, P305, DOI 10.1161/01.RES.88.3.305; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Burney S, 1999, MUTAT RES-FUND MOL M, V424, P37, DOI 10.1016/S0027-5107(99)00006-8; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; CARRIER F, 1994, J BIOL CHEM, V269, P32672; CORBETT JA, 1992, BIOCHEM J, V287, P229, DOI 10.1042/bj2870229; CORBETT JA, 1991, J BIOL CHEM, V266, P21351; CORBETT JA, 1992, J CLIN INVEST, V90, P2384, DOI 10.1172/JCI116129; CORBETT JA, 1994, BIOCHEM J, V299, P719, DOI 10.1042/bj2990719; DELANEY CA, 1993, FEBS LETT, V333, P291, DOI 10.1016/0014-5793(93)80673-I; Eizirik DL, 1996, MOL CELL ENDOCRINOL, V118, P71, DOI 10.1016/0303-7207(96)03768-9; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Gjerset RA, 1999, CELL GROWTH DIFFER, V10, P545; Graziewicz M, 1996, CARCINOGENESIS, V17, P2501, DOI 10.1093/carcin/17.11.2501; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hayakawa J, 2003, J BIOL CHEM, V278, P20582, DOI 10.1074/jbc.M210992200; Heitmeier MR, 1997, J BIOL CHEM, V272, P13697, DOI 10.1074/jbc.272.21.13697; Hofseth LJ, 2003, P NATL ACAD SCI USA, V100, P143, DOI 10.1073/pnas.0237083100; HUGHES JH, 1990, J CLIN INVEST, V86, P856, DOI 10.1172/JCI114785; Jaiswal M, 2001, CANCER RES, V61, P6388; Jin SQ, 2001, ONCOGENE, V20, P2683, DOI 10.1038/sj.onc.1204390; Jung HJ, 2007, ONCOGENE, V26, P7517, DOI 10.1038/sj.onc.1210557; Kelly Colleen B, 2003, Methods Mol Med, V83, P3; Konca K, 2003, MUTAT RES-GEN TOX EN, V534, P15, DOI 10.1016/S1383-5718(02)00251-6; Kow YW, 2002, FREE RADICAL BIO MED, V33, P886, DOI 10.1016/S0891-5849(02)00902-4; Maekawa T, 2008, ONCOGENE, V27, P1045, DOI 10.1038/sj.onc.1210727; MandrupPoulsen T, 1996, DIABETOLOGIA, V39, P1005, DOI 10.1007/BF00400649; MESSMER UK, 1994, FEBS LETT, V355, P23; MISLER S, 1992, DIABETES, V41, P1221, DOI 10.2337/diabetes.41.10.1221; Niles JC, 2006, NITRIC OXIDE-BIOL CH, V14, P109, DOI 10.1016/j.niox.2005.11.001; Potapova O, 2001, J BIOL CHEM, V276, P28546, DOI 10.1074/jbc.M102075200; Potapova O, 1997, J BIOL CHEM, V272, P14041, DOI 10.1074/jbc.272.22.14041; Rabinovitch A, 1998, BIOCHEM PHARMACOL, V55, P1139, DOI 10.1016/S0006-2952(97)00492-9; Rosales AL, 2004, FREE RADICAL RES, V38, P665, DOI 10.1080/10715760410001697609; Scarim AL, 2003, ENDOCRINOLOGY, V144, P3415, DOI 10.1210/en.2002-0112; Scarim AL, 1997, ENDOCRINOLOGY, V138, P5301, DOI 10.1210/en.138.12.5301; SEEBERG E, 1995, TRENDS BIOCHEM SCI, V20, P391, DOI 10.1016/S0968-0004(00)89086-6; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Smith ML, 2002, MUTAGENESIS, V17, P149, DOI 10.1093/mutage/17.2.149; SOUTHERN C, 1990, FEBS LETT, V276, P42, DOI 10.1016/0014-5793(90)80502-A; Steer SA, 2006, PLOS MED, V3, P253, DOI 10.1371/journal.pmed.0030017; Tamir S, 1996, CHEM RES TOXICOL, V9, P821, DOI 10.1021/tx9600311; Tong T, 2001, EXP CELL RES, V269, P64, DOI 10.1006/excr.2001.5312; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Wang XJ, 2002, J BIOL CHEM, V277, P15697, DOI 10.1074/jbc.M112068200; Watcharasit P, 2002, P NATL ACAD SCI USA, V99, P7951, DOI 10.1073/pnas.122062299; WELSH N, 1991, ENDOCRINOLOGY, V129, P3167, DOI 10.1210/endo-129-6-3167; White BH, 1997, J NEUROSCI, V17, P1582; Zhou JM, 2001, EMBO J, V20, P914, DOI 10.1093/emboj/20.4.914	52	32	33	3	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27402	27408		10.1074/jbc.M109.046912	http://dx.doi.org/10.1074/jbc.M109.046912			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19648647	Green Published, hybrid			2022-12-27	WOS:000270232300042
J	Yang, JQ; Reshef, L; Cassuto, H; Aleman, G; Hanson, RW				Yang, Jianqi; Reshef, Lea; Cassuto, Hanoch; Aleman, Gabriela; Hanson, Richard W.			Aspects of the Control of Phosphoenolpyruvate Carboxykinase Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DEVELOPING RAT-LIVER; GTP GENE; TRANSGENIC MICE; REGULATE TRANSCRIPTION; CHROMATIN-STRUCTURE; ADIPOSE-TISSUE; RESPONSE UNIT; HIGH-LEVEL; EXPRESSION; BINDING		[Yang, Jianqi; Aleman, Gabriela; Hanson, Richard W.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Reshef, Lea; Cassuto, Hanoch] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, IL-991120 Jerusalem, Israel	Case Western Reserve University; Hebrew University of Jerusalem	Hanson, RW (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	rwh@case.edu	Alemán, Gabriela/AAR-1781-2021; ALEMAN, GABRIELA/AAB-6484-2020	Aleman, Gabriela/0000-0003-0755-2302	National Institutes of Health [DK25541]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025541] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK25541 (to R. W. H.).	BALLARD FJ, 1967, BIOCHEM J, V104, P866, DOI 10.1042/bj1040866; BENVENISTY N, 1987, P NATL ACAD SCI USA, V84, P1132, DOI 10.1073/pnas.84.5.1132; BENVENISTY N, 1985, P NATL ACAD SCI USA, V82, P267, DOI 10.1073/pnas.82.2.267; Cassuto H, 1997, FEBS LETT, V412, P597, DOI 10.1016/S0014-5793(97)00867-3; Cassuto H, 2005, J BIOL CHEM, V280, P33873, DOI 10.1074/jbc.M504119200; Cassuto H, 2003, GENE, V318, P177, DOI 10.1016/S0378-1119(03)00775-3; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Chakravarty K, 2004, J BIOL CHEM, V279, P15385, DOI 10.1074/jbc.M309905200; Chakravarty K, 2001, J BIOL CHEM, V276, P34816, DOI 10.1074/jbc.M103310200; CHEYETTE TE, 1992, NUCLEIC ACIDS RES, V20, P3427, DOI 10.1093/nar/20.13.3427; Cissell MA, 1999, BBA-GENE STRUCT EXPR, V1445, P299, DOI 10.1016/S0167-4781(99)00049-4; Curthoys NP, 2001, AM J PHYSIOL-RENAL, V281, pF381, DOI 10.1152/ajprenal.2001.281.3.F381; Devine JH, 1999, J BIOL CHEM, V274, P13604, DOI 10.1074/jbc.274.19.13604; EISENBERGER CL, 1992, MOL CELL BIOL, V12, P1396, DOI 10.1128/MCB.12.3.1396; GRANNER D, 1983, NATURE, V305, P549, DOI 10.1038/305549a0; GREAVES DR, 1989, CELL, V56, P979, DOI 10.1016/0092-8674(89)90631-4; GREENGARD O, 1972, J CELL BIOL, V52, P261, DOI 10.1083/jcb.52.2.261; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Hall RK, 2007, MOL ENDOCRINOL, V21, P550, DOI 10.1210/me.2006-0307; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; HOPGOOD MF, 1973, BIOCHEM J, V134, P445, DOI 10.1042/bj1340445; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; IP YT, 1989, MOL CELL BIOL, V9, P1289, DOI 10.1128/MCB.9.3.1289; IP YT, 1990, MOL CELL BIOL, V10, P3770, DOI 10.1128/MCB.10.7.3770; LAMERS WH, 1982, P NATL ACAD SCI-BIOL, V79, P5137, DOI 10.1073/pnas.79.17.5137; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; PATEL YM, 1994, J BIOL CHEM, V269, P5619; PHILIPPI.H, 1972, BIOCHEM J, V126, P1127, DOI 10.1042/bj1261127; RESHEF L, 1972, BIOCHEM J, V127, P809, DOI 10.1042/bj1270809; ROESLER WJ, 1989, J BIOL CHEM, V264, P9657; Roesler WJ, 2000, MOL CELL ENDOCRINOL, V162, P1, DOI 10.1016/S0303-7207(00)00198-2; TALBOT D, 1991, EMBO J, V10, P1391, DOI 10.1002/j.1460-2075.1991.tb07659.x; Taylor L, 2004, BIOCHEM MOL BIOL EDU, V32, P291, DOI 10.1002/bmb.2004.494032050388; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Williams CP, 1999, MOL CELL ENDOCRINOL, V148, P67, DOI 10.1016/S0303-7207(98)00234-2; Yang JQ, 2009, J BIOL CHEM, V284, P27042, DOI 10.1074/jbc.M109.047340; ZIMMER DB, 1990, J HISTOCHEM CYTOCHEM, V38, P171, DOI 10.1177/38.2.1688895	37	66	68	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27031	27035		10.1074/jbc.R109.040535	http://dx.doi.org/10.1074/jbc.R109.040535			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19636079	Green Published, hybrid			2022-12-27	WOS:000270232300004
J	Jeninga, EH; Bugge, A; Nielsen, R; Kersten, S; Hamers, N; Dani, C; Wabitsch, M; Berger, R; Stunnenberg, HG; Mandrup, S; Kalkhoven, E				Jeninga, Ellen H.; Bugge, Anne; Nielsen, Ronni; Kersten, Sander; Hamers, Nicole; Dani, Christian; Wabitsch, Martin; Berger, Ruud; Stunnenberg, Hendrik G.; Mandrup, Susanne; Kalkhoven, Eric			Peroxisome Proliferator-activated Receptor gamma Regulates Expression of the Anti-lipolytic G-protein-coupled Receptor 81 (GPR81/Gpr81)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC-ACID RECEPTOR; TYPE-2 DIABETES-MELLITUS; MATURE 3T3-L1 ADIPOCYTES; NECROSIS-FACTOR-ALPHA; HUMAN ADIPOSE-TISSUE; FREE FATTY-ACIDS; PPAR-GAMMA; PUMA-G; INSULIN-RESISTANCE; MOLECULAR-IDENTIFICATION	The ligand-inducible nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR gamma) plays a key role in the differentiation, maintenance, and function of adipocytes and is the molecular target for the insulin-sensitizing thiazoledinediones (TZDs). Although a number of PPAR gamma target genes that may contribute to the reduction of circulating free fatty acids after TZD treatment have been identified, the relevant PPAR gamma target genes that may exert the anti-lipolytic effect of TZDs are unknown. Here we identified the anti-lipolytic human G-protein-coupled receptor 81 (GPR81), GPR109A, and the (human-specific) GPR109B genes as well as the mouse Gpr81 and Gpr109A genes as novel TZD-induced genes in mature adipocytes. GPR81/Gpr81 is a direct PPAR gamma target gene, because mRNA expression of GPR81/Gpr81 (and GPR109A/Gpr109A) increased in mature human and murine adipocytes as well as in vivo in epididymal fat pads of mice upon rosiglitazone stimulation, whereas small interfering RNA-mediated knockdown of PPAR gamma in differentiated 3T3-L1 adipocytes showed a significant decrease in Gpr81 protein expression. In addition, chromatin immunoprecipitation sequencing analysis in differentiated 3T3-L1 cells revealed a conserved PPAR: retinoid X receptor-binding site in the proximal promoter of the Gpr81 gene, which was proven to be functional by electromobility shift assay and reporter assays. Importantly, small interfering RNA-mediated knockdown of Gpr81 partly reversed the inhibitory effect of TZDs on lipolysis in 3T3-L1 adipocytes. The coordinated PPAR gamma-mediated regulation of the GPR81/Gpr81 and GPR109A/Gpr109A genes (and GPR109B in humans) presents a novel mechanism by which TZDs may reduce circulating free fatty acid levels and perhaps ameliorate insulin resistance in obese patients.	[Jeninga, Ellen H.; Hamers, Nicole; Berger, Ruud; Kalkhoven, Eric] UMC Utrecht, Dept Metab & Endocrine Dis, NL-3584 EA Utrecht, Netherlands; [Jeninga, Ellen H.; Hamers, Nicole; Berger, Ruud; Kalkhoven, Eric] Netherlands Metabol Ctr, NL-2333 CC Leiden, Netherlands; [Bugge, Anne; Nielsen, Ronni; Mandrup, Susanne] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; [Kersten, Sander] Wageningen Univ, Nutr Metab & Genom Grp, NL-6703 HD Wageningen, Netherlands; [Dani, Christian] Univ Nice Sophia Antipolis, CNRS, UMR6543, Inst Dev Biol & Canc, F-06108 Nice 2, France; [Wabitsch, Martin] Univ Ulm, Dept Pediat & Adolescent Med, Div Pediat Endocrinol, D-89075 Ulm, Germany; [Stunnenberg, Hendrik G.] Nijmegen Ctr Mol Life Sci, Dept Mol Biol, NL-6525 GA Nijmegen, Netherlands; [Kalkhoven, Eric] Univ Med Ctr Utrecht, Dept Pediat Immunol, NL-3584 EA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; University of Southern Denmark; Wageningen University & Research; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Ulm University; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center	Kalkhoven, E (corresponding author), UMC Utrecht, Dept Metab & Endocrine Dis, Rm KE-03-139-2,Lundlaan 6, NL-3584 EA Utrecht, Netherlands.	e.kalkhoven@umcutrecht.nl	DANI, Christian/G-3639-2014; Mandrup, Susanne/B-6693-2008; Kersten, Sander/A-1116-2011; Stunnenberg, Hendrik G./D-6875-2012	DANI, Christian/0000-0003-3228-0230; Kersten, Sander/0000-0003-4488-7734; Stunnenberg, Hendrik G./0000-0002-0066-1576; Mandrup, Susanne/0000-0002-0961-5787; Nielsen, Ronni/0000-0001-6331-7660; Bugge, Anne/0000-0001-5885-4541	Federation of European Biochemical Societies; Netherlands Metabolomics Centre; Danish Natural Science Research Council; STREP Project X-TRANET	Federation of European Biochemical Societies; Netherlands Metabolomics Centre; Danish Natural Science Research Council(Danish Natural Science Research Council); STREP Project X-TRANET	This work was supported in part by a short term fellowship of the Federation of European Biochemical Societies (to E. H. J.), the research programme of The Netherlands Metabolomics Centre, which is part of The Netherlands Genomics Initiative/Netherlands Organization for Scientific Research, the Danish Natural Science Research Council, and the STREP Project X-TRANET, as part of European Union FP6.	Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Bays H, 2004, J CLIN ENDOCR METAB, V89, P463, DOI 10.1210/jc.2003-030723; Boden G, 2003, METABOLISM, V52, P753, DOI 10.1016/S0026-0495(03)00055-6; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; BOYD AE, 1974, METABOLISM, V23, P531, DOI 10.1016/0026-0495(74)90081-X; Cai TQ, 2008, BIOCHEM BIOPH RES CO, V377, P987, DOI 10.1016/j.bbrc.2008.10.088; Dalen KT, 2004, DIABETES, V53, P1243, DOI 10.2337/diabetes.53.5.1243; DEPERGOLA G, 1989, HORM METAB RES, V21, P210, DOI 10.1055/s-2007-1009193; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Ge HF, 2008, ENDOCRINOLOGY, V149, P4519, DOI 10.1210/en.2008-0059; Ge H, 2008, J LIPID RES, V49, P797, DOI 10.1194/jlr.M700513-JLR200; Glass CK, 2000, GENE DEV, V14, P121; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; Hong YH, 2005, ENDOCRINOLOGY, V146, P5092, DOI 10.1210/en.2005-0545; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Irukayama-Tomobe Y, 2009, P NATL ACAD SCI USA, V106, P3930, DOI 10.1073/pnas.0811844106; James WPT, 2008, J INTERN MED, V263, P336, DOI 10.1111/j.1365-2796.2008.01922.x; Jeninga EH, 2007, MOL ENDOCRINOL, V21, P1049, DOI 10.1210/me.2006-0485; JENSEN MD, 1989, J CLIN INVEST, V83, P1168, DOI 10.1172/JCI113997; Kershaw EE, 2007, AM J PHYSIOL-ENDOC M, V293, pE1736, DOI 10.1152/ajpendo.00122.2007; Large V, 2004, DIABETES METAB, V30, P294, DOI 10.1016/S1262-3636(07)70121-0; Lee DK, 2001, GENE, V275, P83, DOI 10.1016/S0378-1119(01)00651-5; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lenhard JM, 1997, BIOCHEM PHARMACOL, V54, P801, DOI 10.1016/S0006-2952(97)00229-3; Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200; Mayerson AB, 2002, DIABETES, V51, P797, DOI 10.2337/diabetes.51.3.797; McTernan PG, 2002, DIABETES, V51, P1493, DOI 10.2337/diabetes.51.5.1493; Miles JM, 2003, DIABETES, V52, P675, DOI 10.2337/diabetes.52.3.675; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Nielsen R, 2006, MOL CELL BIOL, V26, P5698, DOI 10.1128/MCB.02266-05; Offermanns S, 2006, TRENDS PHARMACOL SCI, V27, P384, DOI 10.1016/j.tips.2006.05.008; Okazaki H, 2002, DIABETES, V51, P3368, DOI 10.2337/diabetes.51.12.3368; Racette SB, 2002, METABOLISM, V51, P169, DOI 10.1053/meta.2002.29981; REYNISDOTTIR S, 1995, CLIN SCI, V89, P421, DOI 10.1042/cs0890421; Rodriguez AM, 2004, BIOCHEM BIOPH RES CO, V315, P255, DOI 10.1016/j.bbrc.2004.01.053; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sandelin A, 2005, MOL ENDOCRINOL, V19, P595, DOI 10.1210/me.2004-0101; Schaub A, 2001, EUR J IMMUNOL, V31, P3714, DOI 10.1002/1521-4141(200112)31:12<3714::AID-IMMU3714>3.0.CO;2-1; Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5; Souza SC, 1998, DIABETES, V47, P691, DOI 10.2337/diabetes.47.4.691; Stienstra R, 2008, J BIOL CHEM, V283, P22620, DOI 10.1074/jbc.M710314200; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Wang P, 2007, DIABETOLOGIA, V50, P654, DOI 10.1007/s00125-006-0565-0; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Yajima H, 2007, BIOCHEM BIOPH RES CO, V352, P526, DOI 10.1016/j.bbrc.2006.11.054	53	56	58	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26385	26393		10.1074/jbc.M109.040741	http://dx.doi.org/10.1074/jbc.M109.040741			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19633298	Green Published, hybrid			2022-12-27	WOS:000269969600019
J	Qian, SB; Waldron, L; Choudhary, N; Klevit, RE; Chazin, WJ; Patterson, C				Qian, Shu-Bing; Waldron, Lauren; Choudhary, Neelima; Klevit, Rachel E.; Chazin, Walter J.; Patterson, Cam			Engineering a Ubiquitin Ligase Reveals Conformational Flexibility Required for Ubiquitin Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 LIGASE; PROTEIN; CHIP; COMPLEX; DOMAIN; UBIQUITYLATION; MECHANISMS; P53; ACTIVATION; CHAPERONE	Protein ubiquitination regulates numerous cellular functions in eukaryotes. The prevailing view about the role of RING or U-box ubiquitin ligases (E3) is to provide precise positioning between the attached substrate and the ubiquitin-conjugating enzyme (E2). However, the mechanism of ubiquitin transfer remains obscure. Using the carboxyl terminus of Hsc70-interacting protein as a model E3, we show herein that although U-box binding is required, it is not sufficient to trigger the transfer of ubiquitin onto target substrates. Furthermore, additional regions of the E3 protein that have no direct contact with E2 play critical roles in mediating ubiquitin transfer from E2 to attached substrates. By combining computational structure modeling and protein engineering approaches, we uncovered a conformational flexibility of E3 that is required for substrate ubiquitination. Using an engineered version of the carboxyl terminus of Hsc70-interacting protein ubiquitin ligase as a research tool, we demonstrate a striking flexibility of ubiquitin conjugation that does not affect substrate specificity. Our results not only reveal conformational changes of E3 during ubiquitin transfer but also provide a promising approach to custom-made E3 for targeted proteolysis.	[Qian, Shu-Bing] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Qian, Shu-Bing; Waldron, Lauren; Choudhary, Neelima; Patterson, Cam] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27599 USA; [Klevit, Rachel E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Chazin, Walter J.] Vanderbilt Univ, Dept Biochem, Struct Biol Ctr, Nashville, TN 37232 USA; [Chazin, Walter J.] Vanderbilt Univ, Dept Chem, Struct Biol Ctr, Nashville, TN 37232 USA	Cornell University; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; Vanderbilt University; Vanderbilt University	Qian, SB (corresponding author), Cornell Univ, Div Nutr Sci, 301 Biotech Bldg, Ithaca, NY 14853 USA.	sq38@cornell.edu; cpatters@med.unc.edu	Klevit, Rachel/AAI-7038-2021	Klevit, Rachel/0000-0002-3476-969X; Wasson, Lauren/0000-0002-5193-5215	National Institutes of Health [GM61728, HL65619, AG024282, GM75156]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL065619, R01HL065619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061728, R01GM075156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG024282] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM61728, HL65619, and AG024282 ( to C. P.) and GM75156 ( to W. J. C.).	Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; CHEN ZJ, 1991, J BIOL CHEM, V266, P15698; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; Dube P, 2005, MOL CELL, V20, P867, DOI 10.1016/j.molcel.2005.11.008; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Kawai H, 2003, MOL CELL BIOL, V23, P4939, DOI 10.1128/MCB.23.14.4939-4947.2003; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Marine JC, 2005, BIOCHEM BIOPH RES CO, V331, P750, DOI 10.1016/j.bbrc.2005.03.151; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Meulmeester E, 2003, MOL CELL BIOL, V23, P4929, DOI 10.1128/MCB.23.14.4929-4938.2003; Nikolay R, 2004, J BIOL CHEM, V279, P2673, DOI 10.1074/jbc.M311112200; Ohi MD, 2005, MOL CELL BIOL, V25, P451, DOI 10.1128/MCB.25.1.451-460.2005; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Paltoglou S, 2007, ONCOGENE, V26, P604, DOI 10.1038/sj.onc.1209818; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Patterson Cam, 2002, Sci STKE, V2002, ppe4; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Xu Z, 2006, BIOCHEMISTRY-US, V45, P4749, DOI 10.1021/bi0601508; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zhou PB, 2005, CURR OPIN CHEM BIOL, V9, P51, DOI 10.1016/j.cbpa.2004.10.012	32	31	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26797	26802		10.1074/jbc.M109.032334	http://dx.doi.org/10.1074/jbc.M109.032334			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19648119	Green Published, hybrid			2022-12-27	WOS:000269969600061
J	Esposito, F; Pierantoni, GM; Battista, S; Melillo, RM; Scala, S; Chieffi, P; Fedele, M; Fusco, A				Esposito, Francesco; Pierantoni, Giovanna Maria; Battista, Sabrina; Melillo, Rosa Marina; Scala, Stefania; Chieffi, Paolo; Fedele, Monica; Fusco, Alfredo			Interaction between HMGA1 and Retinoblastoma Protein Is Required for Adipocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BINDING-PROTEIN; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; TRANSCRIPTION FACTORS; REGULATED EXPRESSION; VIRUS INDUCTION; MAMMALIAN CDC6; C/EBP FAMILY; C GENE; BETA	It is generally accepted that the regulation of adipogenesis prevents obesity. However, the mechanisms controlling adipogenesis have not been completely defined. We have previously demonstrated that HMGA1 proteins play a critical role in adipogenesis. In fact, suppression of HMGA1 protein synthesis by antisense technology dramatically increased growth rate and impaired adipocyte differentiation in 3T3-L1 cells. Furthermore, we showed that HMGA1 strongly potentiates the capacity of the CCAAT/enhancer-binding protein beta (C/EBP beta) transcriptional factor to transactivate the leptin promoter, an adipocytic-specific promoter. In this study we demonstrate that HMGA1 physically interacts with retinoblastoma protein (RB), which is also required in adipocyte differentiation. Moreover, we show that RB, C/EBP beta, and HMGA1 proteins all cooperate in controlling both Id1 and leptin gene transcriptions, which are down- and up-regulated during adipocyte differentiation, respectively. We also demonstrate that HMGA1/RB interaction regulates CDC25A and CDC6 promoter activities, which are induced by E2F-1 protein during early adipocyte differentiation, by displacing HDAC1 from the RB-E2F1 complex. Furthermore, by using Hmga1(-/-) embryonic stem cells, which failed to undergo adipocyte differentiation, we show the crucial role of HMGA1 proteins in adipocyte differentiation due to its pivotal involvement in the formation of the RB-C/EBP beta complex. Altogether these data demonstrate a key role of the interaction between HMGA1 and RB in adipocyte differentiation.	[Pierantoni, Giovanna Maria] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, Fac Med & Chirurg Napoli, I-80131 Naples, Italy; [Esposito, Francesco; Battista, Sabrina; Melillo, Rosa Marina; Fedele, Monica; Fusco, Alfredo] Univ Naples Federico II, Ist Endocrinol & Oncol Sperimentale, Consiglio Nazl Ric, I-80131 Naples, Italy; [Scala, Stefania] Ist Nazl Tumori, Dipartimento Immunol Clin, I-80131 Naples, Italy; [Chieffi, Paolo] Univ Naples 2, Dipartimento Med Sperimentale, I-80138 Naples, Italy; [Fusco, Alfredo] Ctr Ingn Genet Biotecnol Avanzate, Naples Oncogenom Ctr, I-80131 Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; Universita della Campania Vanvitelli	Pierantoni, GM (corresponding author), Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, Fac Med & Chirurg Napoli, Via S Pansini 5, I-80131 Naples, Italy.	gmpieran@unina.it; afusco@napoli.com	melillo, rosa marina/O-5255-2015; Pierantoni, Giovanna Maria/O-7527-2015; Scala, Stefania/K-1380-2016; Battista, Sabrina/AAY-2981-2020; Chieffi, Paolo/ABA-7892-2020	Pierantoni, Giovanna Maria/0000-0003-4078-8528; Scala, Stefania/0000-0001-9524-2616; Battista, Sabrina/0000-0001-5899-9759; chieffi, paolo/0000-0001-8483-5635	Associazione Italiana Ricerca sul Cancro; Ministero dell'Universita e della Ricerca Scientifica e Tecnologica; Naples Oncogenomic Center; Associazione Partenopea per le Ricerche Oncologiche	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Universita e della Ricerca Scientifica e Tecnologica(Ministry of Education, Universities and Research (MIUR)); Naples Oncogenomic Center; Associazione Partenopea per le Ricerche Oncologiche	This work was supported in part by grants from the Associazione Italiana Ricerca sul Cancro, the Ministero dell'Universita e della Ricerca Scientifica e Tecnologica, the Naples Oncogenomic Center, and the Associazione Partenopea per le Ricerche Oncologiche.	Arlotta P, 2000, J BIOL CHEM, V275, P14394, DOI 10.1074/jbc.M000564200; Baldassarre G, 2001, P NATL ACAD SCI USA, V98, P7970, DOI 10.1073/pnas.141224998; Battista S, 1999, CANCER RES, V59, P4793; Battista S, 2003, FASEB J, V17, P1496, DOI 10.1096/fj.02-0977fje; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; Chiappetta G, 1996, ONCOGENE, V13, P2439; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; CHUVPILO S, 1993, NUCLEIC ACIDS RES, V21, P5694, DOI 10.1093/nar/21.24.5694; Condorelli G, 1997, J CELL BIOCHEM, V67, P423, DOI 10.1002/(SICI)1097-4644(19971215)67:4<423::AID-JCB1>3.0.CO;2-U; Dani C, 1997, J CELL SCI, V110, P1279; DU W, 1994, P NATL ACAD SCI USA, V91, P11318, DOI 10.1073/pnas.91.24.11318; Fajas L, 2003, ANN MED, V35, P79, DOI 10.1080/07853890310009999; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; Falvo JV, 1995, CELL, V83, P1101, DOI 10.1016/0092-8674(95)90137-X; Fedele M, 2001, CARCINOGENESIS, V22, P1583, DOI 10.1093/carcin/22.10.1583; Fedele M, 2006, CANCER CELL, V9, P459, DOI 10.1016/j.ccr.2006.04.024; Galbiati L, 2005, CELL CYCLE, V4, P930, DOI 10.4161/cc.4.7.1784; GOODRICH DW, 1991, CELL, V67, P293, DOI 10.1016/0092-8674(91)90181-W; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; Hateboer G, 1998, MOL CELL BIOL, V18, P6679, DOI 10.1128/MCB.18.11.6679; HE YF, 1995, J BIOL CHEM, V270, P28887, DOI 10.1074/jbc.270.48.28887; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; Hwang CS, 1996, P NATL ACAD SCI USA, V93, P873, DOI 10.1073/pnas.93.2.873; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; LOVELLBADGE R, 1995, NATURE, V376, P725, DOI 10.1038/376725a0; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Melillo RM, 2001, MOL CELL BIOL, V21, P2485, DOI 10.1128/MCB.21.7.2485-2495.2001; Moldes M, 1997, MOL CELL BIOL, V17, P1796, DOI 10.1128/MCB.17.4.1796; NEVINS JR, 1992, SCIENCE, V258, P424; Ohtani K, 1998, ONCOGENE, V17, P1777, DOI 10.1038/sj.onc.1202105; Pierantoni GM, 2006, CELL DEATH DIFFER, V13, P1554, DOI 10.1038/sj.cdd.4401839; Pierantoni GM, 2007, J CLIN INVEST, V117, P693, DOI 10.1172/JCI29852; Richon VM, 1997, J BIOL CHEM, V272, P10117, DOI 10.1074/jbc.272.15.10117; Saisanit S, 1997, MOL CELL BIOL, V17, P844, DOI 10.1128/MCB.17.2.844; SAMUELSSON L, 1991, EMBO J, V10, P3787, DOI 10.1002/j.1460-2075.1991.tb04948.x; Santoni-Rugiu E, 2000, MOL CELL BIOL, V20, P3497, DOI 10.1128/MCB.20.10.3497-3509.2000; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Whitaker LL, 1998, MOL CELL BIOL, V18, P4032, DOI 10.1128/MCB.18.7.4032; WOBUS AM, 1994, ROUX ARCH DEV BIOL, V204, P36, DOI [10.1007/BF00744871, 10.1007/BF00189066]; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168	53	16	17	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25993	26004		10.1074/jbc.M109.034280	http://dx.doi.org/10.1074/jbc.M109.034280			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19633359	Green Published, hybrid			2022-12-27	WOS:000269738000056
J	Rajagopal, C; Stone, KL; Francone, VP; Mains, RE; Eipper, BA				Rajagopal, Chitra; Stone, Kathryn L.; Francone, Victor P.; Mains, Richard E.; Eipper, Betty A.			Secretory Granule to the Nucleus ROLE OF A MULTIPLY PHOSPHORYLATED INTRINSICALLY UNSTRUCTURED DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMIDATING MONOOXYGENASE; PEPTIDE-PROCESSING ENZYME; CYTOSOLIC ROUTING DETERMINANTS; COOH-TERMINAL DOMAIN; MEMBRANE-PROTEIN; ATT-20 CELLS; ENDOCRINE-CELLS; EXPRESSION; TRAFFICKING; KINASE	Intrinsically unstructured domains occur in one-third of all proteins and are characterized by conformational flexibility, protease sensitivity, and the occurrence of multiple phosphorylation. They provide large interfaces for diverse protein-protein interactions. Peptidylglycine alpha-amidating monooxygenase (PAM), an enzyme essential for neuropeptide biosynthesis, is a secretory granule membrane protein. As one of the few proteins spanning the granule membrane, PAM is a candidate to relay information about the status of the granule pool and conditions in the granule lumen. Here, we show that the PAM cytosolic domain is unstructured. Mass spectroscopy and two-dimensional gel electrophoresis demonstrated phosphorylation at 10-12 sites in the cytosolic domain. Stimulation of exocytosis resulted in coupled phosphorylation and dephosphorylation of specific sites and in the endoproteolytic release of a soluble, proteasome-sensitive cytosolic domain fragment. Analysis of granule-rich tissues, such as pituitary and heart, showed that a similar fragment was generated endogenously and translocated to the nucleus. This multiply phosphorylated unstructured domain may act as a signaling molecule that relays information from secretory granules to both cytosol and nucleus.	[Francone, Victor P.; Mains, Richard E.; Eipper, Betty A.] Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06030 USA; [Rajagopal, Chitra; Eipper, Betty A.] Univ Connecticut, Ctr Hlth, Dept Mol Microbiol & Struct Biol, Farmington, CT 06030 USA; [Stone, Kathryn L.] Yale Univ, WM Keck Facil, New Haven, CT 06510 USA	University of Connecticut; University of Connecticut; Yale University	Eipper, BA (corresponding author), Univ Connecticut, Ctr Hlth, Dept Neurosci, 263 Farmington Ave, Farmington, CT 06030 USA.	eipper@uchc.edu	, Chitra/AAC-9698-2021	, Chitra/0000-0003-2962-459X	National Institutes of Health, NIDDK [DK32949]; NIDA [P30 DA018343]; National Institutes of Health [UL1 RR024139, 1S10RR024617]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024617, UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK032949, R56DK032949, R01DK032949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grant DK32949; by NIDA Neuroproteomics Center Grant P30 DA018343; and by instrumentation obtained with funds from National Institutes of Health NCRR Clinical and Translational Science Award UL1 RR024139 and Shared Instrumentation Grant 1S10RR024617.	Alam MR, 2001, MOL BIOL CELL, V12, P629, DOI 10.1091/mbc.12.3.629; Alam MR, 1996, J BIOL CHEM, V271, P28636, DOI 10.1074/jbc.271.45.28636; Bell-Parikh LC, 2001, J BIOL CHEM, V276, P29854, DOI 10.1074/jbc.M103936200; Bengoechea-Alonso MT, 2007, CURR OPIN CELL BIOL, V19, P215, DOI 10.1016/j.ceb.2007.02.004; BOHELER KR, 1992, J BIOL CHEM, V267, P12979; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Caldwell BD, 1999, J BIOL CHEM, V274, P34646, DOI 10.1074/jbc.274.49.34646; Ciccotosto GD, 1999, J CELL BIOL, V144, P459, DOI 10.1083/jcb.144.3.459; Dafforn TR, 2004, EMBO REP, V5, P1046, DOI 10.1038/sj.embor.7400276; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; El Meskini R, 2001, J BIOL CHEM, V276, P3384, DOI 10.1074/jbc.M008062200; Ferraro F, 2005, J BIOL CHEM, V280, P25424, DOI 10.1074/jbc.M414156200; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; HIROSAWA M, 1993, COMPUT APPL BIOSCI, V9, P161; Hsu JM, 2004, J BIOL CHEM, V279, P32592, DOI 10.1074/jbc.M404950200; HUSTEN EJ, 1993, J BIOL CHEM, V268, P9709; Jonker HRA, 2006, FEBS J, V273, P1430, DOI 10.1111/j.1742-4658.2006.05165.x; Kalthoff C, 2002, J BIOL CHEM, V277, P8209, DOI 10.1074/jbc.M111587200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lenz P, 2006, CURR BIOL, V16, P2150, DOI 10.1016/j.cub.2006.09.013; Mains RE, 1999, J BIOL CHEM, V274, P2929, DOI 10.1074/jbc.274.5.2929; MALTESE JY, 1993, ENDOCRINOLOGY, V133, P2579, DOI 10.1210/en.133.6.2579; MILGRAM SL, 1992, J CELL BIOL, V117, P717, DOI 10.1083/jcb.117.4.717; MILGRAM SL, 1993, J CELL BIOL, V121, P23, DOI 10.1083/jcb.121.1.23; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Ort T, 2001, EMBO J, V20, P4013, DOI 10.1093/emboj/20.15.4013; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Schwartz MF, 2002, MOL CELL, V9, P1055, DOI 10.1016/S1097-2765(02)00532-4; Sherwood V, 2008, MOL BIOL CELL, V19, P1772, DOI 10.1091/mbc.E07-07-0652; Steveson TC, 2001, J BIOL CHEM, V276, P40326, DOI 10.1074/jbc.M011460200; Steveson TC, 1999, J BIOL CHEM, V274, P21128, DOI 10.1074/jbc.274.30.21128; Stone Kathryn L., 2007, V386, P57, DOI 10.1007/978-1-59745-430-8_2; STONE KL, 2004, CURR PROTOCOLS PROTE; TAUSK FA, 1992, MOL ENDOCRINOL, V6, P2185, DOI 10.1210/me.6.12.2185; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Trajkovski M, 2004, J CELL BIOL, V167, P1063, DOI 10.1083/jcb.200408172; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Wasmeier C, 2001, J BIOL CHEM, V276, P31919, DOI 10.1074/jbc.M102580200; Yang Y, 2008, J TURBUL, V9, P1, DOI 10.1080/14685240801905360; Yao I, 2002, J NEUROSCI, V22, P5354; YUN HY, 1993, ARCH BIOCHEM BIOPHYS, V301, P77, DOI 10.1006/abbi.1993.1117; YUN HY, 1995, J BIOL CHEM, V270, P30075	48	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25723	25734		10.1074/jbc.M109.035782	http://dx.doi.org/10.1074/jbc.M109.035782			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19635792	Green Published, hybrid			2022-12-27	WOS:000269738000030
J	Berrisford, JM; Sazanov, LA				Berrisford, John M.; Sazanov, Leonid A.			Structural Basis for the Mechanism of Respiratory Complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; ESCHERICHIA-COLI NADH; IRON-SULFUR CLUSTERS; ELECTRON-TRANSFER; QUINONE OXIDOREDUCTASE; SUPEROXIDE-PRODUCTION; CRYSTAL-STRUCTURE; 49-KDA SUBUNIT; FES CLUSTERS; PROTEIN	Complex I plays a central role in cellular energy production, coupling electron transfer between NADH and quinone to proton translocation. The mechanism of this highly efficient enzyme is currently unknown. Mitochondrial complex I is a major source of reactive oxygen species, which may be one of the causes of aging. Dysfunction of complex I is implicated in many human neurodegenerative diseases. We have determined several x-ray structures of the oxidized and reduced hydrophilic domain of complex I from Thermus thermophilus at up to 3.1 angstrom resolution. The structures reveal the mode of interaction of complex I with NADH, explaining known kinetic data and providing implications for the mechanism of reactive oxygen species production at the flavin site of complex I. Bound metals were identified in the channel at the interface with the frataxin-like subunit Nqo15, indicating possible iron-binding sites. Conformational changes upon reduction of the complex involve adjustments in the nucleotide-binding pocket, as well as small but significant shifts of several alpha-helices at the interface with the membrane domain. These shifts are likely to be driven by the reduction of nearby iron-sulfur clusters N2 and N6a/b. Cluster N2 is the electron donor to quinone and is coordinated by unique motif involving two consecutive (tandem) cysteines. An unprecedented "on/off switch" (disconnection) of coordinating bonds between the tandem cysteines and this cluster was observed upon reduction. Comparison of the structures suggests a novel mechanism of coupling between electron transfer and proton translocation, combining conformational changes and protonation/deprotonation of tandem cysteines.	[Berrisford, John M.; Sazanov, Leonid A.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England		Sazanov, LA (corresponding author), MRC, Mitochondrial Biol Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	sazanov@mrc-mbu.cam.ac.uk	Sazanov, Leonid A/ABF-2125-2021	Sazanov, Leonid A/0000-0002-0977-7989; Berrisford, John/0000-0003-4442-5871	Medical Research Council; Medical Research Council [MC_U105674180] Funding Source: researchfish; MRC [MC_U105674180] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Baranova EA, 2007, J STRUCT BIOL, V159, P238, DOI 10.1016/j.jsb.2007.01.009; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; BELOGRUDOV G, 1994, BIOCHEMISTRY-US, V33, P4571, DOI 10.1021/bi00181a018; Berrisford JM, 2008, BIOCHEMISTRY-US, V47, P10262, DOI 10.1021/bi801160u; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Carroll J, 2006, P NATL ACAD SCI USA, V103, P16170, DOI 10.1073/pnas.0607719103; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Chartron J, 2006, J MOL BIOL, V364, P152, DOI 10.1016/j.jmb.2006.08.080; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dutton PL, 1998, BBA-BIOENERGETICS, V1364, P245, DOI 10.1016/S0005-2728(98)00031-0; ERNSTER L, 1965, NATURE, V207, P940, DOI 10.1038/207940a0; Euro L, 2008, BIOCHEMISTRY-US, V47, P3185, DOI 10.1021/bi702063t; Fato R, 2008, NEUROCHEM RES, V33, P2487, DOI 10.1007/s11064-008-9747-0; FEARNLEY IM, 1992, BIOCHIM BIOPHYS ACTA, V1140, P105, DOI 10.1016/0005-2728(92)90001-I; Flemming D, 2003, J BIOL CHEM, V278, P47602, DOI 10.1074/jbc.M308967200; Flemming D, 2006, J BIOL CHEM, V281, P24781, DOI 10.1074/jbc.M602499200; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Friedrich T, 2001, J BIOENERG BIOMEMBR, V33, P169, DOI 10.1023/A:1010722717257; Grgic L, 2004, J BIOL CHEM, V279, P21193, DOI 10.1074/jbc.M313180200; Grivennikova VG, 2006, BBA-BIOENERGETICS, V1757, P553, DOI 10.1016/j.bbabio.2006.03.013; Hinchliffe P, 2006, BIOCHEMISTRY-US, V45, P4413, DOI 10.1021/bi0600998; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Karlberg T, 2006, STRUCTURE, V14, P1535, DOI 10.1016/j.str.2006.08.010; Kashani-Poor N, 2001, J BIOL CHEM, V276, P24082, DOI 10.1074/jbc.M102296200; KOWAL AT, 1986, J BIOL CHEM, V261, P9239; KRISHNAMOORTHY G, 1988, J BIOL CHEM, V263, P17566; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lesk AM, 1995, CURR OPIN STRUC BIOL, V5, P775, DOI 10.1016/0959-440X(95)80010-7; Mamedova AA, 2004, J BIOL CHEM, V279, P23830, DOI 10.1074/jbc.M401539200; Mathiesen C, 2003, FEBS LETT, V549, P7, DOI 10.1016/S0014-5793(03)00767-1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Rasmussen T, 2001, BIOCHEMISTRY-US, V40, P6124, DOI 10.1021/bi0026977; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2000, J MOL BIOL, V302, P455, DOI 10.1006/jmbi.2000.4079; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; Schapira AHV, 1998, BBA-BIOENERGETICS, V1364, P261, DOI 10.1016/S0005-2728(98)00032-2; SLED VD, 1994, BIOCHEMISTRY-US, V33, P10069, DOI 10.1021/bi00199a034; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Verkhovskaya ML, 2008, P NATL ACAD SCI USA, V105, P3763, DOI 10.1073/pnas.0711249105; Vinogradov AD, 1998, BBA-BIOENERGETICS, V1364, P169, DOI 10.1016/S0005-2728(98)00026-7; Vinogradov AD, 2008, BBA-BIOENERGETICS, V1777, P729, DOI 10.1016/j.bbabio.2008.04.014; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; Yano T, 2005, BIOCHEMISTRY-US, V44, P1744, DOI 10.1021/bi048132i	55	195	199	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29773	29783		10.1074/jbc.M109.032144	http://dx.doi.org/10.1074/jbc.M109.032144			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19635800	hybrid, Green Published			2022-12-27	WOS:000270896800058
J	Telci, D; Collighan, RJ; Basaga, H; Griffin, M				Telci, Dilek; Collighan, Russell John; Basaga, Huveyda; Griffin, Martin			Increased TG2 Expression Can Result in Induction of Transforming Growth Factor beta 1, Causing Increased Synthesis and Deposition of Matrix Proteins, Which Can Be Regulated by Nitric Oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; TUBULAR EPITHELIAL-CELLS; SWISS 3T3 FIBROBLASTS; TISSUE TRANSGLUTAMINASE; EXTRACELLULAR-MATRIX; CROSS-LINKING; CANCER-CELLS; BINDING-PROTEIN; ENDOTHELIAL-CELLS; BETA(1) INTEGRIN	In fibrotic conditions increases in TG2 activity has been linked to an increase in the deposition of extracellular matrix proteins. Using TG2 transfected Swiss 3T3 fibroblasts expressing TG2 under the control of the tetracycline-regulated inducible promoter, we demonstrate that induction of TG2 not only stimulates an increase in collagen and fibronectin deposition but also an increase in the expression of these proteins. Increased TG2 expression in these fibroblasts led to NF-kappa B activation, resulting in the increased expression of transforming growth factor (TGF) beta(1). In addition, cells overexpressing TG2 demonstrated an increase in biologically active TGF beta(1) in the extracellular environment. A specific site-directed inhibitor of TG abolished the NF-kappa B and TGF beta 1 activation and the subsequent elevation in the synthesis and deposition of extracellular matrix proteins, confirming that this process depends on the induction of transglutaminase activity. Treatment of TG2-induced fibroblasts with nontoxic doses of nitric oxide donor S-nitroso-N-acetylpenicillamine resulted in decreased TG2 activity and apprehension of the inactive enzyme on the cell surface. This was paralleled by a reduction in activation of NF-kappa B and TGF beta(1) production with a subsequent decrease in collagen expression and deposition. These findings support a role for NO in the regulation of TG2 function in the extracellular environment.	[Telci, Dilek; Collighan, Russell John; Griffin, Martin] Aston Univ, Sch Life & Hlth, Birmingham B4 7ET, W Midlands, England; [Telci, Dilek] Yeditepe Univ, Dept Genet & Bioengn, TR-34755 Istanbul, Turkey; [Basaga, Huveyda] Sabanci Univ, Fac Engn & Nat Sci, Biol Sci & Bioengn Program, TR-34956 Istanbul, Turkey	Aston University; Yeditepe University; Sabanci University	Griffin, M (corresponding author), Aston Univ, Sch Life & Hlth, Aston Triangle, Birmingham B4 7ET, W Midlands, England.	M.Griffin@aston.ac.uk	Telci, Dilek/N-5053-2019; Telci, Dilek/B-5880-2017	Telci, Dilek/0000-0002-2793-6533; Telci, Dilek/0000-0002-2793-6533; Griffin, Martin/0000-0003-3824-306X	Aston University; European Union [MRTN-CT-2006-036032]; Scientific & Technological Research Council of Turkey Health Sciences Division [104S606]	Aston University; European Union(European Commission); Scientific & Technological Research Council of Turkey Health Sciences Division(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported in part by Aston University, Grant MRTN-CT-2006-036032 from the European Union, and Grant 104S606 from the Scientific & Technological Research Council of Turkey Health Sciences Division.	Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; ANDO T, 1995, KIDNEY INT, V47, P733, DOI 10.1038/ki.1995.112; Balklava Z, 2002, J BIOL CHEM, V277, P16567, DOI 10.1074/jbc.M109836200; Caccamo D, 2005, J NEUROSCI RES, V82, P858, DOI 10.1002/jnr.20683; Cao LY, 2008, CARCINOGENESIS, V29, P1893, DOI 10.1093/carcin/bgn158; Cho BR, 2008, CORONARY ARTERY DIS, V19, P459, DOI 10.1097/MCA.0b013e3283108fc3; Craven PA, 1997, DIABETES, V46, P671, DOI 10.2337/diabetes.46.4.671; Ferrero R, 1999, BRIT J PHARMACOL, V127, P779, DOI 10.1038/sj.bjp.0702607; Fisher M, 2009, MATRIX BIOL, V28, P20, DOI 10.1016/j.matbio.2008.10.003; FREUND KF, 1994, BIOCHEMISTRY-US, V33, P10109, DOI 10.1021/bi00199a039; Gaudry CA, 1999, J BIOL CHEM, V274, P30707, DOI 10.1074/jbc.274.43.30707; Gaudry CA, 1999, EXP CELL RES, V252, P104, DOI 10.1006/excr.1999.4633; GRIFFIN M, 1979, BRIT J EXP PATHOL, V60, P653; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Griffin M, 2008, BIOORG MED CHEM LETT, V18, P5559, DOI 10.1016/j.bmcl.2008.09.006; Gross SR, 2003, J INVEST DERMATOL, V121, P412, DOI 10.1046/j.1523-1747.2003.12353.x; Haroon ZA, 1999, FASEB J, V13, P1787, DOI 10.1096/fasebj.13.13.1787; Johnson TS, 2007, J AM SOC NEPHROL, V18, P3078, DOI 10.1681/ASN.2006070690; Johnson TS, 2003, J AM SOC NEPHROL, V14, P2052, DOI 10.1097/01.ASN.0000079614.63463.DD; Johnson TS, 1999, J AM SOC NEPHROL, V10, P2146; Kalk P, 2006, BRIT J PHARMACOL, V148, P853, DOI 10.1038/sj.bjp.0706792; Kang DH, 2002, AM J PATHOL, V161, P239, DOI 10.1016/S0002-9440(10)64175-2; Kelley TJ, 1998, J CLIN INVEST, V102, P1200, DOI 10.1172/JCI2357; Kim DS, 2006, CANCER RES, V66, P10936, DOI 10.1158/0008-5472.CAN-06-1521; Kutuk O, 2003, TRENDS MOL MED, V9, P549, DOI 10.1016/j.molmed.2003.10.007; Lai TS, 2001, BIOCHEMISTRY-US, V40, P4904, DOI 10.1021/bi002321t; Le M, 2001, CONNECT TISSUE RES, V42, P245, DOI 10.3109/03008200109016839; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Leblanc A, 1999, PROTEIN EXPRES PURIF, V17, P89, DOI 10.1006/prep.1999.1107; Leon L, 2008, NITRIC OXIDE-BIOL CH, V19, P77, DOI 10.1016/j.niox.2008.04.014; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Mann AP, 2006, CANCER RES, V66, P8788, DOI 10.1158/0008-5472.CAN-06-1457; Melino G, 1997, NATURE, V388, P432, DOI 10.1038/41237; Niculescu-Duvaz I, 2007, NEPHRON EXP NEPHROL, V105, pE108, DOI 10.1159/000100492; Nunes I, 1997, J CELL BIOL, V136, P1151, DOI 10.1083/jcb.136.5.1151; Pechkovsky DV, 2008, J BIOL CHEM, V283, P12898, DOI 10.1074/jbc.M708226200; PEREZ JR, 1994, MOL CELL BIOL, V14, P5326, DOI 10.1128/MCB.14.8.5326; Pistea A, 2008, J VASC RES, V45, P10, DOI 10.1159/000109073; Prabhakar S, 2007, J AM SOC NEPHROL, V18, P2945, DOI 10.1681/ASN.2006080895; Raghunath M, 1996, J CLIN INVEST, V98, P1174, DOI 10.1172/JCI118901; Rameshwar P, 2000, J IMMUNOL, V165, P2271, DOI 10.4049/jimmunol.165.4.2271; Ritter SJ, 1998, J BIOL CHEM, V273, P12798, DOI 10.1074/jbc.273.21.12798; Saura M, 2005, CIRC RES, V97, P1115, DOI 10.1161/01.RES.0000191538.76771.66; Shweke N, 2008, AM J PATHOL, V173, P631, DOI 10.2353/ajpath.2008.080025; Skill NJ, 2004, J BIOL CHEM, V279, P47754, DOI 10.1074/jbc.M402698200; Stephens P, 2004, J CELL SCI, V117, P3389, DOI 10.1242/jcs.01188; Studer RK, 1999, ARTHRITIS RHEUM-US, V42, P248, DOI 10.1002/1529-0131(199902)42:2<248::AID-ANR6>3.0.CO;2-S; TAIPALE J, 1994, J CELL BIOL, V124, P171, DOI 10.1083/jcb.124.1.171; Telci D, 2006, FRONT BIOSCI-LANDMRK, V11, P867, DOI 10.2741/1843; Telci D, 2008, J BIOL CHEM, V283, P20937, DOI 10.1074/jbc.M801763200; UPCHURCH HF, 1991, J CELL PHYSIOL, V149, P375, DOI 10.1002/jcp.1041490304; Verderio E, 1999, J HISTOCHEM CYTOCHEM, V47, P1417, DOI 10.1177/002215549904701108; Verderio E, 1998, EXP CELL RES, V239, P119, DOI 10.1006/excr.1997.3874; Verderio EAM, 2003, J BIOL CHEM, V278, P42604, DOI 10.1074/jbc.M303303200; Wani J, 2007, BIOL CHEM, V388, P497, DOI 10.1515/BC.2007.056; Zhu JL, 1999, GASTROENTEROLOGY, V117, P1198, DOI 10.1016/S0016-5085(99)70406-3	56	55	57	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29547	29558		10.1074/jbc.M109.041806	http://dx.doi.org/10.1074/jbc.M109.041806			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19657147	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000270896800037
J	Kabat, JL; Barberan-Soler, S; Zahler, AM				Kabat, Jennifer L.; Barberan-Soler, Sergio; Zahler, Alan M.			HRP-2, the Caenorhabditis elegans Homolog of Mammalian Heterogeneous Nuclear Ribonucleoproteins Q and R, Is an Alternative Splicing Factor That Binds to UCUAUC Splicing Regulatory Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNC-52 TRANSCRIPTS; RNA RECOGNITION; HNRNP; PROTEIN; MOTIFS; GENE; CELLS; EXONS; INTERFERENCE; CONSERVATION	Alternative splicing is regulated by cis sequences in the pre-mRNA that serve as binding sites for trans-acting alternative splicing factors. In a previous study, we used bioinformatics and molecular biology to identify and confirm that the intronic hexamer sequence UCUAUC is a nematode alternative splicing regulatory element. In this study, we used RNA affinity chromatography to identify trans factors that bind to this sequence. HRP-2, the Caenorhabditis elegans homolog of human heterogeneous nuclear ribonucleoproteins Q and R, binds to UCUAUC in the context of unc-52 intronic regulatory sequences as well as to RNAs containing tandem repeats of this sequence. The three Us in the hexamer are the most important determinants of this binding specificity. We demonstrate, using RNA interference, that HRP-2 regulates the alternative splicing of two genes, unc-52 and lin-10, both of which have cassette exons flanked by an intronic UCUAUC motif. We propose that HRP-2 is a protein responsible for regulating alternative splicing through binding interactions with the UCUAUC sequence.	[Zahler, Alan M.] Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Zahler, AM (corresponding author), Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	zahler@biology.ucsc.edu		Zahler, Alan/0000-0003-0027-1647; Barberan-Soler, Sergio/0000-0002-5243-6813	National Institutes of Health [R01-GM061646]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM061646 (to A. M. Z.).	Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Caputi M, 2001, J BIOL CHEM, V276, P43850, DOI 10.1074/jbc.M102861200; Chasin LA, 2007, ADV EXP MED BIOL, V623, P85, DOI 10.1007/978-0-387-77374-2_6; Chen HH, 2008, MOL CELL BIOL, V28, P6929, DOI 10.1128/MCB.01332-08; Dominguez C, 2006, NUCLEIC ACIDS RES, V34, P3634, DOI 10.1093/nar/gkl488; Fairbrother WG, 2004, NUCLEIC ACIDS RES, V32, pW187, DOI 10.1093/nar/gkh393; House AE, 2008, J BIOL CHEM, V283, P1217, DOI 10.1074/jbc.R700031200; Jensen KB, 2000, P NATL ACAD SCI USA, V97, P5740, DOI 10.1073/pnas.090553997; Jin Y, 2003, EMBO J, V22, P905, DOI 10.1093/emboj/cdg089; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kabat JL, 2006, PLOS COMPUT BIOL, V2, P734, DOI 10.1371/journal.pcbi.0020086; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kinnaird JH, 2004, EXP CELL RES, V298, P418, DOI 10.1016/j.yexcr.2004.04.043; Kuroyanagi H, 2006, NAT METHODS, V3, P909, DOI 10.1038/NMETH944; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Longman D, 2000, EMBO J, V19, P1625, DOI 10.1093/emboj/19.7.1625; Lundquist EA, 1996, DEVELOPMENT, V122, P1601; MAINS PE, 1999, C ELEGANS PRACTICAL, P227; Mourelatos Z, 2001, EMBO J, V20, P5443, DOI 10.1093/emboj/20.19.5443; Ponthier JL, 2006, J BIOL CHEM, V281, P12468, DOI 10.1074/jbc.M511556200; ROGALSKI TM, 1995, GENETICS, V139, P159; Roller AB, 2000, GENETICS, V154, P1169; Rossoll W, 2002, HUM MOL GENET, V11, P93, DOI 10.1093/hmg/11.1.93; Rukov JL, 2007, MOL BIOL EVOL, V24, P909, DOI 10.1093/molbev/msm023; Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; Spike CA, 2002, DEVELOPMENT, V129, P4999; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Venables JP, 2008, MOL CELL BIOL, V28, P6033, DOI 10.1128/MCB.00726-08; Voelker RB, 2007, GENOME RES, V17, P1023, DOI 10.1101/gr.6017807; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	40	19	20	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28490	28497		10.1074/jbc.M109.023101	http://dx.doi.org/10.1074/jbc.M109.023101			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19706616	hybrid, Green Published			2022-12-27	WOS:000270678900003
J	Liao, MC; Ahmed, M; Smith, SO; Van Nostrand, WE				Liao, Mei-Chen; Ahmed, Mahiuddin; Smith, Steven O.; Van Nostrand, William E.			Degradation of Amyloid beta Protein by Purified Myelin Basic Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIN-CONVERTING ENZYME; A-BETA; ALZHEIMERS-DISEASE; GELATINASE-A; IN-VITRO; PEPTIDE; BRAIN; MATTER; AGGREGATION; CLEAVAGE	The progressive accumulation of beta-amyloid (A beta) in senile plaques and in the cerebral vasculature is the hallmark of Alzheimer disease and related disorders. Impaired clearance of A beta from the brain likely contributes to the prevalent sporadic form of Alzheimer disease. Several major pathways for A beta clearance include receptor-mediated cellular uptake, blood-brain barrier transport, and direct proteolytic degradation. Myelin basic protein (MBP) is the major structural protein component of myelin and plays a functional role in the formation and maintenance of the myelin sheath. MBP possesses endogenous serine proteinase activity and can undergo autocatalytic cleavage liberating distinct fragments. Recently, we showed that MBP binds A beta and inhibits A beta fibril formation (Hoos, M. D., Ahmed, M., Smith, S. O., and Van Nostrand, W. E. (2007) J. Biol. Chem. 282, 9952-9961; Hoos, M. D., Ahmed, M., Smith, S. O., and Van Nostrand, W. E. (2009) Biochemistry 48, 4720-4727). Here we show that A beta 40 and A beta 42 peptides are degraded by purified human brain MBP and recombinant human MBP, but not an MBP fragment that lacks autolytic activity. MBP-mediated A beta degradation is inhibited by serine proteinase inhibitors. Similarly, Cos-1 cells expressing MBP degrade exogenous A beta 40 and A beta 42. In addition, we demonstrate that purified MBP also degrades assembled fibrillar A beta in vitro. Mass spectrometry analysis identified distinct degradation products generated from A beta digestion by MBP. Lastly, we demonstrate in situ that purified MBP can degrade parenchymal amyloid plaques as well as cerebral vascular amyloid that form in brain tissue of A beta precursor protein transgenic mice. Together, these findings indicate that purified MBP possesses A beta degrading activity in vitro.	[Van Nostrand, William E.] SUNY Stony Brook, Dept Neurosurg, Stony Brook, NY 11794 USA; [Liao, Mei-Chen; Van Nostrand, William E.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Ahmed, Mahiuddin; Smith, Steven O.] SUNY Stony Brook, Struct Biol Ctr, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Van Nostrand, WE (corresponding author), SUNY Stony Brook, Dept Neurosurg, HSC T-12-080, Stony Brook, NY 11794 USA.	William.VanNostrand@stonybrook.edu	Smith, Steven/HDM-9496-2022		National Institutes of Health [RO1-NS035781, RO1-AG027317]; Alzheimer's Association [IIRG-06-26805]; Cure Alzheimer's Fund; Stony Brook University; Collaborative Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Cure Alzheimer's Fund; Stony Brook University; Collaborative Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-NS035781 (to W. E. V. N.) and RO1-AG027317 (to S. O. S.). This work was also supported by Alzheimer's Association Grant IIRG-06-26805, the Cure Alzheimer's Fund (to W. E. V. N.), the proteomics center at Stony Brook University and a Collaborative Research Center grant.	Atwood CS, 2002, PEPTIDES, V23, P1343, DOI 10.1016/S0196-9781(02)00070-0; Backstrom JR, 1996, J NEUROSCI, V16, P7910; Bartzokis G, 2003, ARCH NEUROL-CHICAGO, V60, P393, DOI 10.1001/archneur.60.3.393; BURDICK D, 1992, J BIOL CHEM, V267, P546; CHEIFETZ S, 1985, BIOCHEMISTRY-US, V24, P1909, DOI 10.1021/bi00329a016; D'Souza CA, 2005, BIOCHEMISTRY-US, V44, P12905, DOI 10.1021/bi051152f; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Eckman EA, 2003, J BIOL CHEM, V278, P2081, DOI 10.1074/jbc.C200642200; Evin G, 2002, PEPTIDES, V23, P1285, DOI 10.1016/S0196-9781(02)00063-3; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Givogri MI, 2000, J NEUROSCI RES, V59, P153, DOI 10.1002/(SICI)1097-4547(20000115)59:2<153::AID-JNR1>3.3.CO;2-6; Hoos MD, 2007, J BIOL CHEM, V282, P9952, DOI 10.1074/jbc.M603494200; Hoos MD, 2009, BIOCHEMISTRY-US, V48, P4720, DOI 10.1021/bi900037s; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hu JG, 2001, J BIOL CHEM, V276, P47863, DOI 10.1074/jbc.M104068200; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Korneck B, 2003, BRAIN RES BULL, V61, P321, DOI 10.1016/S0361-9230(03)00095-9; Ledesma MD, 2000, EMBO REP, V1, P530; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; OMLIN FX, 1982, J CELL BIOL, V95, P242, DOI 10.1083/jcb.95.1.242; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Roher AE, 2002, BIOCHEMISTRY-US, V41, P11080, DOI 10.1021/bi026173d; ROHER AE, 1994, BIOCHEM BIOPH RES CO, V205, P1755, DOI 10.1006/bbrc.1994.2872; Staugaitis SM, 1996, BIOESSAYS, V18, P13, DOI 10.1002/bies.950180106; Stout JC, 1996, ARCH NEUROL-CHICAGO, V53, P742, DOI 10.1001/archneur.1996.00550080056013; Van Nostrand WE, 1999, BIOCHEMISTRY-US, V38, P11570, DOI 10.1021/bi990610f; Wang DS, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/58406; Wang DS, 2004, NEUROSCI RES, V48, P93, DOI 10.1016/j.neures.2003.10.002; WISNIEWSKI HM, 1989, ACTA NEUROPATHOL, V78, P337, DOI 10.1007/BF00688170; WOOD DD, 1989, J BIOL CHEM, V264, P5121; YAMADA T, 1995, ACTA NEUROPATHOL, V89, P199; Yamin R, 2007, J NEUROCHEM, V100, P458, DOI 10.1111/j.1471-4159.2006.04251.x; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Yoshiike Y, 2007, BIOCHEMISTRY-US, V46, P9805, DOI 10.1021/bi700455c	38	40	42	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28917	28925		10.1074/jbc.M109.050856	http://dx.doi.org/10.1074/jbc.M109.050856			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19692707	Green Published, hybrid			2022-12-27	WOS:000270678900048
J	Ban, R; Matsuzaki, H; Akashi, T; Sakashita, G; Taniguchi, H; Park, SY; Tanaka, H; Furukawa, K; Urano, T				Ban, Reiko; Matsuzaki, Hideki; Akashi, Tomohiro; Sakashita, Gyosuke; Taniguchi, Hisaaki; Park, Sam-Yong; Tanaka, Hirofumi; Furukawa, Koichi; Urano, Takeshi			Mitotic Regulation of the Stability of Microtubule Plus-end Tracking Protein EB3 by Ubiquitin Ligase SIAH-1 and Aurora Mitotic Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITS CELL-GROWTH; NEGATIVE REGULATORS; BINDING-PROTEINS; SPINDLE; ACTIVATION; DYNAMICS; MITOSIS; PHOSPHORYLATION; DEGRADATION; APC	Microtubule plus-end tracking proteins (+TIPs) control microtubule dynamics in fundamental processes such as cell cycle, intracellular transport, and cell motility, but how +TIPs are regulated during mitosis remains largely unclear. Here we show that the endogenous end-binding protein family EB3 is stable during mitosis, facilitates cell cycle progression at prometaphase, and then is down-regulated during the transition to G, phase. The ubiquitin-protein isopeptide ligase SIAH-1 facilitates EB3 polyubiquitination and subsequent proteasome-mediated degradation, whereas SIAH-1 knockdown increases EB3 stability and steady-state levels. Two mitotic kinases, Aurora-A and Aurora-B, phosphorylate endogenous EB3 at Ser-176, and the phosphorylation triggers disruption of the EB3-SIAH-1 complex, resulting in EB3 stabilization during mitosis. Our results provide new insight into a regulatory mechanism of +TIPs in cell cycle transition.	[Ban, Reiko; Sakashita, Gyosuke; Urano, Takeshi] Shimane Univ, Dept Biochem, Sch Med, Izumo, Shimane 6938501, Japan; [Ban, Reiko; Sakashita, Gyosuke; Furukawa, Koichi; Urano, Takeshi] Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi 4668550, Japan; [Akashi, Tomohiro] Nagoya Univ, Grad Sch Med, Div Mol Mycol & Med, Nagoya, Aichi 4668550, Japan; [Matsuzaki, Hideki; Taniguchi, Hisaaki] Univ Tokushima, Inst Enzyme Res, Tokushima 7708503, Japan; [Park, Sam-Yong] Yokohama City Univ, Prot Design Lab, Yokohama, Kanagawa 2300045, Japan; [Tanaka, Hirofumi] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Tokyo 1920392, Japan	Shimane University; Nagoya University; Nagoya University; Tokushima University; Yokohama City University; Tokyo University of Pharmacy & Life Sciences	Ban, R (corresponding author), Shimane Univ, Dept Biochem, Sch Med, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	banrei@med.shimane-u.ac.jp; turano@med.shimane-u.ac.jp	Akashi, Tomohiro/I-7245-2014	Urano, Takeshi/0000-0003-3383-3554	grant-in-aid for scientific research	grant-in-aid for scientific research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for scientific research (to G. S., K. F., and T. U.).	Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Andrews PD, 2003, CURR OPIN CELL BIOL, V15, P672, DOI 10.1016/j.ceb.2003.10.013; Ban R, 2004, J BIOL CHEM, V279, P16394, DOI 10.1074/jbc.M313257200; Berrueta L, 1998, P NATL ACAD SCI USA, V95, P10596, DOI 10.1073/pnas.95.18.10596; Bruzzoni-Giovanelli H, 1999, ONCOGENE, V18, P7101, DOI 10.1038/sj.onc.1203187; Bu W, 2001, ONCOGENE, V20, P3185, DOI 10.1038/sj.onc.1204429; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Cassimeris L, 1999, CURR OPIN CELL BIOL, V11, P134, DOI 10.1016/S0955-0674(99)80017-9; Engelender S, 2008, AUTOPHAGY, V4, P372, DOI 10.4161/auto.5604; Ferrari S, 2006, CELL MOL LIFE SCI, V63, P781, DOI 10.1007/s00018-005-5515-3; Ferrari S, 2005, BIOCHEM J, V390, P293, DOI 10.1042/BJ20050343; Fiucci G, 2004, P NATL ACAD SCI USA, V101, P3510, DOI 10.1073/pnas.0400177101; Frew IJ, 2002, MOL CELL BIOL, V22, P8155, DOI 10.1128/MCB.22.23.8155-8164.2002; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Gadea BB, 2006, P NATL ACAD SCI USA, V103, P4493, DOI 10.1073/pnas.0600702103; Geraldo S, 2008, NAT CELL BIOL, V10, P1181, DOI 10.1038/ncb1778; Goshima G, 2005, J CELL BIOL, V171, P229, DOI 10.1083/jcb.200505107; Green RA, 2005, MOL BIOL CELL, V16, P4609, DOI 10.1091/mbc.E05-03-0259; Gutierrez GJ, 2006, TRENDS BIOCHEM SCI, V31, P324, DOI 10.1016/j.tibs.2006.04.001; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Honda K, 2000, ONCOGENE, V19, P2812, DOI 10.1038/sj.onc.1203609; House CM, 2006, STRUCTURE, V14, P695, DOI 10.1016/j.str.2005.12.013; House CM, 2003, P NATL ACAD SCI USA, V100, P3101, DOI 10.1073/pnas.0534783100; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; James P, 1996, GENETICS, V144, P1425; Juwana JP, 1999, INT J CANCER, V81, P275, DOI 10.1002/(SICI)1097-0215(19990412)81:2<275::AID-IJC18>3.0.CO;2-Z; Kinoshita K, 2006, J MUSCLE RES CELL M, V27, P107, DOI 10.1007/s10974-005-9045-2; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Li XY, 2004, J BIOL CHEM, V279, P47201, DOI 10.1074/jbc.M403029200; MARTINEAU SN, 1995, J CELL BIOL, V131, P191, DOI 10.1083/jcb.131.1.191; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Matsuzawa S, 1998, EMBO J, V17, P2736, DOI 10.1093/emboj/17.10.2736; Moore A, 2004, TRENDS CELL BIOL, V14, P537, DOI 10.1016/j.tcb.2004.09.001; MORGAN DO, 2007, CELL CYCLE PRINCIPLE, P46; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Morrison EE, 2007, CELL MOL LIFE SCI, V64, P307, DOI 10.1007/s00018-007-6360-3; Nakagawa H, 2000, ONCOGENE, V19, P210, DOI 10.1038/sj.onc.1203308; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Ohashi S, 2006, ONCOGENE, V25, P7691, DOI 10.1038/sj.onc.1209754; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Peth A, 2007, J MOL BIOL, V368, P550, DOI 10.1016/j.jmb.2007.02.052; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Santelli E, 2005, J BIOL CHEM, V280, P34278, DOI 10.1074/jbc.M506707200; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Steinmetz MO, 2007, J STRUCT BIOL, V158, P137, DOI 10.1016/j.jsb.2006.07.018; Straube A, 2007, CURR BIOL, V17, P1318, DOI 10.1016/j.cub.2007.06.058; SU LK, 1995, CANCER RES, V55, P2972; Sugiyama K, 2002, ONCOGENE, V21, P3103, DOI 10.1038/sj.onc.1205432; Sumara I, 2008, TRENDS CELL BIOL, V18, P84, DOI 10.1016/j.tcb.2007.12.001; Sun L, 2008, P NATL ACAD SCI USA, V105, P7153, DOI 10.1073/pnas.0710018105; Taguchi S, 2002, FEBS LETT, V519, P59, DOI 10.1016/S0014-5793(02)02711-4; TIMAUER JS, 2002, MOL BIOL CELL, V13, P3614; Vaughan KT, 2005, J CELL BIOL, V171, P197, DOI 10.1083/jcb.200509150; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743; Xu ZH, 2006, J BIOL CHEM, V281, P303, DOI 10.1074/jbc.M509060200; Yun S, 2008, J BIOL CHEM, V283, P1034, DOI 10.1074/jbc.M705874200	63	45	45	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28367	28381		10.1074/jbc.M109.000273	http://dx.doi.org/10.1074/jbc.M109.000273			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19696028	hybrid, Green Published			2022-12-27	WOS:000270676300062
J	Tschumi, A; Nai, C; Auchli, Y; Hunziker, P; Gehrig, P; Keller, P; Grau, T; Sander, P				Tschumi, Andreas; Nai, Corrado; Auchli, Yolanda; Hunziker, Peter; Gehrig, Peter; Keller, Peter; Grau, Thomas; Sander, Peter			Identification of Apolipoprotein N-Acyltransferase (Lnt) in Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE LIPOPROTEIN; LIPID-MODIFIED PROTEINS; ESCHERICHIA-COLI; TUBERCULOSIS; PHOSPHATIDYLETHANOLAMINE; PROLIPOPROTEIN; GLYCOSYLATION; INACTIVATION; SYNTHASE; MANNOSE	Lipoproteins of Gram-negative and Gram-positive bacteria carry a thioether-bound diacylglycerol but differ by a fatty acid amide bound to the alpha-amino group of the universally conserved cysteine. In Escherichia coli the N-terminal acylation is catalyzed by the N-acyltransferase Lnt. Using E. coli Lnt as a query in a BLASTp search, we identified putative lnt genes also in Gram-positive mycobacteria. The Mycobacterium tuberculosis lipoprotein LppX, heterologously expressed in Mycobacterium smegmatis, was N-acylated at the N-terminal cysteine, whereas LppX expressed in a M. smegmatis lnt::aph knock-out mutant was accessible for N-terminal sequencing. Western blot analyses of a truncated and tagged form of LppX indicated a smaller size of about 0.3 kDa in the lnt::aph mutant compared with the parental strain. Matrix-assisted laser desorption ionization time-of-flight/time-of-flight analyses of a trypsin digest of LppX proved the presence of the diacylglycerol modification in both strains, the parental strain and lnt:: aph mutant. N-Acylation was found exclusively in the M. smegmatis parental strain. Complementation of the lnt:: aph mutant with M. tuberculosis ppm1 restored N-acylation. The substrate for N-acylation is a C16 fatty acid, whereas the two fatty acids of the diacylglycerol residue were identified as C16 and C19:0 fatty acid, the latter most likely tuberculostearic acid. We demonstrate that mycobacterial lipoproteins are triacylated. For the first time to our knowledge, we identify Lnt activity in Gram-positive bacteria and assigned the responsible genes. In M. smegmatis and M. tuberculosis the open reading frames are annotated as MSMEG_3860 and M. tuberculosis ppm1, respectively.	[Tschumi, Andreas; Nai, Corrado; Keller, Peter; Grau, Thomas; Sander, Peter] Univ Zurich, Inst Med Mikrobiol, CH-8006 Zurich, Switzerland; [Auchli, Yolanda; Hunziker, Peter; Gehrig, Peter] Funct Genom Ctr Zurich, CH-8057 Zurich, Switzerland; [Sander, Peter] Natl Zentrum Mykobakterien, CH-8006 Zurich, Switzerland	University of Zurich	Sander, P (corresponding author), Gloriastr 30-32, CH-8006 Zurich, Switzerland.	psander@imm.uzh.ch	Sander, Peter/D-2548-2009; Keller, Peter M/D-8675-2013; Tschumi, Andreas/D-3721-2009; Keller, Peter M/C-6876-2012	Sander, Peter/0000-0003-1581-0682; Keller, Peter M/0000-0002-2890-5384; Keller, Peter M/0000-0002-2890-5384; Nai, Corrado/0000-0002-6232-6634	Swiss National Science Foundation [3100A0-120326]; European Union [LSHP-CT-2006-037217]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission)	This work was supported in part by the Swiss National Science Foundation Grant 3100A0-120326 and the European Union TB-Drug Grant LSHP-CT-2006-037217.	Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; Baulard AR, 2003, J BIOL CHEM, V278, P2242, DOI 10.1074/jbc.M207922200; Baumgartner M, 2007, J BACTERIOL, V189, P313, DOI 10.1128/JB.00976-06; Buwitt-Beckmann U, 2006, J BIOL CHEM, V281, P9049, DOI 10.1074/jbc.M512525200; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dobos KM, 1996, J BACTERIOL, V178, P2498, DOI 10.1128/jb.178.9.2498-2506.1996; Drage MG, 2009, CELL IMMUNOL, V258, P29, DOI 10.1016/j.cellimm.2009.03.008; Eichler J, 2005, MICROBIOL MOL BIOL R, V69, P393, DOI 10.1128/MMBR.69.3.393-425.2005; Fukuda A, 2002, J BIOL CHEM, V277, P43512, DOI 10.1074/jbc.M206816200; Goren M. B., 1979, TUBERCULOSIS, P63; GUPTA SD, 1993, J BIOL CHEM, V268, P16551; GUPTA SD, 1991, J BIOL CHEM, V266, P9983; Gurcha SS, 2002, BIOCHEM J, V365, P441, DOI 10.1042/BJ20020107; HAYASHI S, 1985, J BIOL CHEM, V260, P5753; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Hutchings MI, 2009, TRENDS MICROBIOL, V17, P13, DOI 10.1016/j.tim.2008.10.001; Isaacs RCA, 2006, BIOORG MED CHEM LETT, V16, P338, DOI 10.1016/j.bmcl.2005.09.083; JACKOWSKI S, 1986, J BIOL CHEM, V261, P1328; Kurokawa K, 2009, J BIOL CHEM, V284, P8406, DOI 10.1074/jbc.M809618200; LAI JS, 1980, J BACTERIOL, V144, P451, DOI 10.1128/JB.144.1.451-453.1980; LIN JJC, 1980, J BIOL CHEM, V255, P1160; Michell SL, 2003, J BIOL CHEM, V278, P16423, DOI 10.1074/jbc.M207959200; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Navarre WW, 1996, J BACTERIOL, V178, P441, DOI 10.1128/jb.178.2.441-446.1996; Pecora ND, 2006, J IMMUNOL, V177, P422, DOI 10.4049/jimmunol.177.1.422; Rampini SK, 2008, MICROBIOL-SGM, V154, P2991, DOI 10.1099/mic.0.2008/018895-0; Rezwan M, 2007, MICROBIOL-SGM, V153, P652, DOI 10.1099/mic.0.2006/000216-0; Robichon C, 2005, J BIOL CHEM, V280, P974, DOI 10.1074/jbc.M411059200; Robichon C, 2003, MOL MICROBIOL, V49, P1145, DOI 10.1046/j.1365-2958.2003.03654.x; Sander P, 2004, MOL MICROBIOL, V52, P1543, DOI 10.1111/j.1365-2958.2004.04041.x; SANDER P, 1995, MOL MICROBIOL, V16, P991, DOI 10.1111/j.1365-2958.1995.tb02324.x; Sander P, 2001, Methods Mol Med, V54, P93, DOI 10.1385/1-59259-147-7:093; Sander P, 1997, MOL MICROBIOL, V26, P469, DOI 10.1046/j.1365-2958.1997.5811946.x; SANKARAN K, 1995, METHOD ENZYMOL, V248, P169; Sartain MJ, 2009, GLYCOBIOLOGY, V19, P38, DOI 10.1093/glycob/cwn102; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Sulzenbacher G, 2006, EMBO J, V25, P1436, DOI 10.1038/sj.emboj.7601048; Sutcliffe IC, 2004, FEMS MICROBIOL REV, V28, P645, DOI 10.1016/j.femsre.2004.06.002; Tawaratsumida K, 2009, J BIOL CHEM, V284, P9147, DOI 10.1074/jbc.M900429200; Ujihara T, 2008, ANAL BIOCHEM, V374, P429, DOI 10.1016/j.ab.2007.11.014; Venema R, 2003, J BIOL CHEM, V278, P14739, DOI 10.1074/jbc.M209857200; Vidal-Ingigliardi D, 2007, J BACTERIOL, V189, P4456, DOI 10.1128/JB.00099-07; Wu HC, 1996, ESCHERICHIA COLI SAL, V1, P1005; Yakushi T, 2000, NAT CELL BIOL, V2, P212, DOI 10.1038/35008635; YOUNG DB, 1991, RES MICROBIOL, V142, P55, DOI 10.1016/0923-2508(91)90097-T; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	48	57	62	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27146	27156		10.1074/jbc.M109.022715	http://dx.doi.org/10.1074/jbc.M109.022715			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19661058	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000270232300015
J	Yang, JQ; Kong, XY; Martins-Santos, MES; Aleman, G; Chaco, E; Liu, GE; Wu, SY; Samols, D; Hakimi, P; Chiang, CM; Hanson, RW				Yang, Jianqi; Kong, Xiaoying; Martins-Santos, Maria Emilia S.; Aleman, Gabriela; Chaco, Ernestine; Liu, George E.; Wu, Shwu-Yuan; Samols, David; Hakimi, Parvin; Chiang, Cheng-Ming; Hanson, Richard W.			Activation of SIRT1 by Resveratrol Represses Transcription of the Gene for the Cytosolic Form of Phosphoenolpyruvate Carboxykinase (GTP) by Deacetylating Hepatic Nuclear Factor 4 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; IN-VIVO; INSULIN; EXPRESSION; GLYCERONEOGENESIS; INDUCTION; GLUCONEOGENESIS; GLUCOCORTICOIDS; IDENTIFICATION; ACETYLATION	The SIRT1 activators isonicotinamide (IsoNAM), resveratrol, fisetin, and butein repressed transcription of the gene for the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) (PEPCK-C). An evolutionarily conserved binding site for hepatic nuclear factor (HNF) 4 alpha (-272/-252) was identified, which was required for transcriptional repression of the PEPCK-C gene promoter caused by these compounds. This site contains an overlapping AP-1 binding site and is adjacent to the C/EBP binding element (-248/-234); the latter is necessary for hepatic transcription of PEPCK-C. AP-1 competed with HNF4 alpha for binding to this site and also decreased HNF4 alpha stimulation of transcription from the PEPCK-C gene promoter. Chromatin immunoprecipitation experiments demonstrated that HNF4 alpha and AP-1, but not C/EBP beta, reciprocally bound to this site prior to and after treating HepG2 cells with IsoNAM. IsoNAM treatment resulted in deacetylation of HNF4 alpha, which decreased its binding affinity to the PEPCK-C gene promoter. In HNF4 alpha-null Chinese hamster ovary cells, IsoNAM and resveratrol failed to repress transcription from the PEPCK-C gene promoter; overexpression of HNF4 alpha in Chinese hamster ovary cells re-established transcriptional inhibition. Exogenous SIRT1 expression repressed transcription, whereas knockdown of SIRT1 by RNA interference reversed this effect. IsoNAM decreased the level of mRNA for PEPCK-C but had no effect on mRNA for glucose-6-phosphatase in AML12 mouse hepatocytes. We conclude that SIRT1 activation inhibited transcription of the gene for PEPCK-C in part by deacetylation of HNF4 alpha. However, SIRT1 deacetylation of other key regulatory proteins that control PEPCK-C gene transcription also likely contributed to the inhibitory effect.	[Yang, Jianqi; Kong, Xiaoying; Martins-Santos, Maria Emilia S.; Aleman, Gabriela; Chaco, Ernestine; Samols, David; Hakimi, Parvin; Hanson, Richard W.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Liu, George E.] USDA ARS, ANRI, Bovine Funct Genom Lab, Beltsville Agr Res Ctr, Beltsville, MD 20705 USA; [Wu, Shwu-Yuan; Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA	Case Western Reserve University; United States Department of Agriculture (USDA); University of Texas System; University of Texas Southwestern Medical Center Dallas	Hanson, RW (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	rwh@case.edu	ALEMAN, GABRIELA/AAB-6484-2020; Hakimi, Parvin/AAB-1643-2021; Alemán, Gabriela/AAR-1781-2021; Liu, George/K-3371-2019	Liu, George/0000-0003-0192-6705; Aleman, Gabriela/0000-0003-0755-2302	National Institutes of Health [DK058620, DK025541, CA103867, CA124760]; NATIONAL CANCER INSTITUTE [R01CA124760, R01CA103867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025541, R01DK058620] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK058620 and DK025541 (to R. W. H.) and CA103867 and CA124760 (to C-M. C.).	Ahmad F, 1999, J IMMUNOL, V162, P4864; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Anastasiou D, 2006, PHYSIOLOGY, V21, P404, DOI 10.1152/physiol.00031.2006; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Beale EG, 2007, CELL BIOCHEM BIOPHYS, V48, P89, DOI 10.1007/s12013-007-0025-6; BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Cesena TI, 2007, J BIOL CHEM, V282, P956, DOI 10.1074/jbc.M511451200; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Chakravarty K, 2004, J BIOL CHEM, V279, P15385, DOI 10.1074/jbc.M309905200; Chakravarty K, 2001, J BIOL CHEM, V276, P34816, DOI 10.1074/jbc.M103310200; Croniger CM, 2001, J BIOL CHEM, V276, P629, DOI 10.1074/jbc.M007576200; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Dey S, 2008, CARCINOGENESIS, V29, P1920, DOI 10.1093/carcin/bgn175; EISENBERGER CL, 1992, MOL CELL BIOL, V12, P1396, DOI 10.1128/MCB.12.3.1396; Erion DM, 2009, P NATL ACAD SCI USA, V106, P11288, DOI 10.1073/pnas.0812931106; Franckhauser S, 2006, DIABETES, V55, P273, DOI 10.2337/diabetes.55.02.06.db05-0482; Franckhauser S, 2002, DIABETES, V51, P624, DOI 10.2337/diabetes.51.3.624; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; GRANNER D, 1983, NATURE, V305, P549, DOI 10.1038/305549a0; GURNEY AL, 1992, J BIOL CHEM, V267, P18133; HALL RK, 1995, P NATL ACAD SCI USA, V92, P412, DOI 10.1073/pnas.92.2.412; HANSON RW, 1994, P ENOLPYRUVATE CARBO; IMAI E, 1993, J BIOL CHEM, V268, P5353; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Leahy P, 1999, J BIOL CHEM, V274, P8813, DOI 10.1074/jbc.274.13.8813; Leroyer SN, 2006, J BIOL CHEM, V281, P13141, DOI 10.1074/jbc.M512943200; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; LIU JS, 1991, J BIOL CHEM, V266, P19095; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; MEYUHAS O, 1976, BIOCHEM J, V158, P9, DOI 10.1042/bj1580009; MEYUHAS O, 1976, BIOCHEM J, V158, P1; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; MOHN KL, 1991, MOL CELL BIOL, V11, P381, DOI 10.1128/MCB.11.1.381; NECHUSHTAN H, 1987, NUCLEIC ACIDS RES, V15, P6405, DOI 10.1093/nar/15.16.6405; Nye CK, 2008, J BIOL CHEM, V283, P27565, DOI 10.1074/jbc.M804393200; Olswang Y, 2002, P NATL ACAD SCI USA, V99, P625, DOI 10.1073/pnas.022616299; PATEL YM, 1994, J BIOL CHEM, V269, P5619; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; RESHEF L, 1972, BIOCHEM J, V127, P809, DOI 10.1042/bj1270809; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; RESHEFF L, 1970, J BIOL CHEM, V245, P5979; Roden M, 2004, NEWS PHYSIOL SCI, V19, P92, DOI 10.1152/nips.01459.2003; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; ROESLER WJ, 1989, J BIOL CHEM, V264, P9657; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; Sauve AA, 2004, CURR MED CHEM, V11, P807, DOI 10.2174/0929867043455675; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; SQUINTO SP, 1989, MOL ENDOCRINOL, V3, P433, DOI 10.1210/mend-3-3-433; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Waltner-Law ME, 2002, J BIOL CHEM, V277, P34933, DOI 10.1074/jbc.M204672200; Wang JC, 1999, MOL ENDOCRINOL, V13, P604, DOI 10.1210/me.13.4.604; Wu SY, 2006, GENE DEV, V20, P2383, DOI 10.1101/gad.1448206; Xu M, 2003, EMBO J, V22, P893, DOI 10.1093/emboj/cdg094; Yang JQ, 2005, J BIOL CHEM, V280, P38689, DOI 10.1074/jbc.M503486200; Yang JQ, 2001, J BIOL CHEM, V276, P25742, DOI 10.1074/jbc.M102821200; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	63	57	59	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27042	27053		10.1074/jbc.M109.047340	http://dx.doi.org/10.1074/jbc.M109.047340			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651778	hybrid, Green Published			2022-12-27	WOS:000270232300006
J	Zhong, N; Ramaswamy, G; Weisgraber, KH				Zhong, Ning; Ramaswamy, Gayathri; Weisgraber, Karl H.			Apolipoprotein E4 Domain Interaction Induces Endoplasmic Reticulum Stress and Impairs Astrocyte Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; CEREBRAL GLUCOSE-METABOLISM; E TYPE-4 ALLELE; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASE; THERAPEUTIC TARGET; BRAIN; PATHWAYS; HEALTH; ROLES	Domain interaction, a structural property of apolipoprotein E4 (apoE4), is predicted to contribute to the association of apoE4 with Alzheimer disease. Arg-61 apoE mice, a gene-targeted mouse model specific for domain interaction, have lower brain apoE levels and synaptic, functional, and cognitive deficits. We hypothesized that domain interaction elicits an endoplasmic reticulum (ER) stress in astrocytes and an unfolded protein response that targets Arg-61 apoE for degradation. Primary Arg-61 apoE astrocytes had less intracellular apoE than wildtype astrocytes, and unfolded protein response markers OASIS (old astrocyte specifically induced substance), ATF4, and XBP-1 and downstream effectors were up-regulated. ER stress appears to cause global astrocyte dysfunction as glucose uptake was decreased in Arg-61 apoE astrocytes, and astrocyte-conditioned medium promoted neurite outgrowth less efficiently than wildtype medium in Neuro-2a cell cultures. We showed age-dependent up-regulation of brain OASIS levels and processing in Arg-61 apoE mice. ER stress and astrocyte dysfunction represent a new paradigm underlying the association of apoE4 with neurodegeneration.	[Zhong, Ning; Ramaswamy, Gayathri; Weisgraber, Karl H.] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Weisgraber, Karl H.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Weisgraber, Karl H.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weisgraber, KH (corresponding author), Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA.	kweisgraber@gladstone.ucsf.edu		Zhong, Ning/0000-0002-3696-5301	National Institutes of Health [PO1 AG022074, RO1 AG20235]; National Center for Research Resources [CO6 RR0118928]; American Health Assistance Foundation [A2006-231]; Alzheimer's Association Zenith Award [AG028793]; NATIONAL INSTITUTE ON AGING [P01AG022074, R01AG020235, R01AG028793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Health Assistance Foundation(BrightFocus Foundation); Alzheimer's Association Zenith Award(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 AG022074 (to K. W.), RO1 AG20235 (to K. W.), and CO6 RR0118928 from the National Center for Research Resources. This work was also supported in part by American Health Assistance Foundation Pilot Grant for Alzheimer's Disease Research A2006-231 (to N. Z.), Alzheimer's Association Zenith Award AG028793 (to K. W.).	Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Bredesen DE, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-27; de Leon MJ, 2001, P NATL ACAD SCI USA, V98, P10966, DOI 10.1073/pnas.191044198; Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053; Forman MS, 2003, TRENDS NEUROSCI, V26, P407, DOI 10.1016/S0166-2236(03)00197-8; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Hatters DM, 2005, J BIOL CHEM, V280, P26477, DOI 10.1074/jbc.M503910200; Hol EM, 2008, J MOL NEUROSCI, V34, P23, DOI 10.1007/s12031-007-0013-8; Huang Y, 2006, CURR OPIN DRUG DISC, V9, P627; Huang YD, 2004, J MOL NEUROSCI, V23, P189, DOI 10.1385/JMN:23:3:189; Huang YD, 2006, NEUROLOGY, V66, pS79, DOI 10.1212/01.wnl.0000192102.41141.9e; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Lee KU, 2003, J NEUROPSYCH CLIN N, V15, P78, DOI 10.1176/appi.neuropsych.15.1.78; Leira F, 2002, TOXICOL IN VITRO, V16, P267, DOI 10.1016/S0887-2333(02)00002-4; Lin DT, 2007, NEUROBIOL AGING, V28, P99, DOI 10.1016/j.neurobiolaging.2005.11.004; Loaiza A, 2003, J NEUROSCI, V23, P7337; Ma YJ, 2004, J BIOL CHEM, V279, P13792, DOI 10.1074/jbc.M313724200; Mahley RW, 2006, ACTA NEUROL SCAND, V114, P8, DOI 10.1111/j.1600-0404.2006.00679.x; Mahley RW, 2007, CURR ALZHEIMER RES, V4, P537, DOI 10.2174/156720507783018334; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Markowitz Alison J B, 2007, Cellscience, V4, P111; Masliah E, 1996, ANN NEUROL, V40, P759, DOI 10.1002/ana.410400512; Morrow JA, 2002, J BIOL CHEM, V277, P50380, DOI 10.1074/jbc.M204898200; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Nehlig A, 2007, GLIA, V55, P1238, DOI 10.1002/glia.20376; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298; Ramaswamy G, 2005, J NEUROSCI, V25, P10658, DOI 10.1523/JNEUROSCI.1922-05.2005; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; Reiman EM, 2005, P NATL ACAD SCI USA, V102, P8299, DOI 10.1073/pnas.0500579102; Reiman EM, 2001, P NATL ACAD SCI USA, V98, P3334, DOI 10.1073/pnas.061509598; Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; SMALL GW, 1995, JAMA-J AM MED ASSOC, V273, P942, DOI 10.1001/jama.273.12.942; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; Yamada K, 2007, NAT PROTOC, V2, P753, DOI 10.1038/nprot.2007.76; Ye SM, 2005, P NATL ACAD SCI USA, V102, P18700, DOI 10.1073/pnas.0508693102; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200; Zhong N, 2008, ALZHEIMERS DEMENT, V4, P179, DOI 10.1016/j.jalz.2008.01.006; Zhong N, 2009, J BIOL CHEM, V284, P6027, DOI 10.1074/jbc.R800009200	51	56	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27273	27280		10.1074/jbc.M109.014464	http://dx.doi.org/10.1074/jbc.M109.014464			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19666463	Green Published, hybrid			2022-12-27	WOS:000270232300028
J	Du, W; Wu, JF; Walsh, EM; Zhang, YJ; Chen, CY; Xiao, ZXJ				Du, Wei; Wu, Junfeng; Walsh, Erica M.; Zhang, Yujun; Chen, Chang Yan; Xiao, Zhi-Xiong Jim			Nutlin-3 Affects Expression and Function of Retinoblastoma Protein ROLE OF RETINOBLASTOMA PROTEIN IN CELLULAR RESPONSE TO NUTLIN-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED APOPTOSIS; MDM2 ANTAGONISTS; TUMOR-CELLS; P53; INHIBITION; ACTIVATION; RB; CANCER; E2F; PHOSPHORYLATION	The retinoblastoma protein (Rb) plays a pivotal role in regulating cell proliferation and apoptosis. Nutlin-3, a small molecule MDM2 antagonist blocking interaction between MDM2 and p53, activates p53 resulting in cell growth arrest or apoptosis in various cancer cells. However, the molecular basis for the different cellular responses upon nutlin-3 treatment is not fully understood. In this study, we show that nutlin-3 activates p53 resulting in a dramatic increase in MDM2 expression and a marked reduction in total Rb protein levels. Interestingly, nutlin-3 reduces the levels of hypophosphorylated Rb and induces massive apoptosis in SJSA-1 cells, which can be largely rescued by knockdown of MDM2 or by expression of constitutively active Rb. By contrast, nutlin-3 treatment of several human cancer cells, including A549, U2-OS, and HCT116, results in an accumulation of hypophosphorylated Rb and cell cycle arrest but not apoptosis. Furthermore, we show that down-regulation of Rb by nutlin-3 does not lead to E2F1 activation nor does E2F1 play a critical role for nutlin-3-induced apoptosis in SJSA-1 cells. Taken together, these results suggest that Rb plays a critical role in influencing cellular response to activation of p53 pathway by nutlin-3.	[Du, Wei; Wu, Junfeng; Walsh, Erica M.; Xiao, Zhi-Xiong Jim] Boston Univ, Sch Med, Grad Program Cellular & Mol Biol, Boston, MA 02118 USA; [Du, Wei; Wu, Junfeng; Walsh, Erica M.; Xiao, Zhi-Xiong Jim] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Zhang, Yujun; Xiao, Zhi-Xiong Jim] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Chen, Chang Yan] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Boston, MA 02215 USA	Boston University; Boston University; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Xiao, ZXJ (corresponding author), K423 715 Albany St, Boston, MA 02118 USA.	jxiao@bu.edu			National Institutes of Health [CA79804, GM70017]; NATIONAL CANCER INSTITUTE [R01CA079804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA79804 and GM70017 (to Z.X.X.).	Ambrosini G, 2007, ONCOGENE, V26, P3473, DOI 10.1038/sj.onc.1210136; ARVA NC, 2008, ETHN DIS S2, V18; Carvajal D, 2005, CANCER RES, V65, P1918, DOI 10.1158/0008-5472.CAN-04-3576; Chang DLF, 2007, ONCOGENE, V26, P4627, DOI 10.1038/sj.onc.1210254; Cheok CF, 2007, MOL CANCER RES, V5, P1133, DOI 10.1158/1541-7786.MCR-07-0161; Giono LE, 2007, MOL CELL BIOL, V27, P4166, DOI 10.1128/MCB.01967-06; HSICH JK, 1999, MOL CELL, V3, P181; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; Kan CE, 2007, CANCER RES, V67, P9862, DOI 10.1158/0008-5472.CAN-07-0259; Kitagawa M, 2008, ONCOGENE, V27, P5303, DOI 10.1038/onc.2008.164; Knudsen ES, 1998, GENE DEV, V12, P2278, DOI 10.1101/gad.12.15.2278; Knudsen ES, 1997, MOL CELL BIOL, V17, P5771, DOI 10.1128/MCB.17.10.5771; Kojima K, 2006, BLOOD, V108, P993, DOI 10.1182/blood-2005-12-5148; Kumamoto K, 2008, CANCER RES, V68, P3193, DOI 10.1158/0008-5472.CAN-07-2780; La Thangue NB, 2003, NAT CELL BIOL, V5, P587, DOI 10.1038/ncb0703-587; Lau LMS, 2008, ONCOGENE, V27, P997, DOI 10.1038/sj.onc.1210707; Maimets T, 2008, ONCOGENE, V27, P5277, DOI 10.1038/onc.2008.166; Patton JT, 2006, CANCER RES, V66, P3169, DOI 10.1158/0008-5472.CAN-05-3832; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sdek P, 2004, J BIOL CHEM, V279, P53317, DOI 10.1074/jbc.M406062200; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Wang J, 2001, ONCOGENE, V20, P4740, DOI 10.1038/sj.onc.1204655; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; XIAO ZX, 1995, J MOL BIOL, V248, P255, DOI 10.1006/jmbi.1995.0219; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738	31	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26315	26321		10.1074/jbc.M109.046904	http://dx.doi.org/10.1074/jbc.M109.046904			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19648117	hybrid, Green Published			2022-12-27	WOS:000269969600011
J	Gazit, K; Moshonov, S; Elfakess, R; Sharon, M; Mengus, G; Davidson, I; Dikstein, R				Gazit, Kfir; Moshonov, Sandra; Elfakess, Rofa; Sharon, Michal; Mengus, Gabrielle; Davidson, Irwin; Dikstein, Rivka			TAF4/4b.TAF12 Displays a Unique Mode of DNA Binding and Is Required for Core Promoter Function of a Subset of Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTOR; HISTONE OCTAMER; DOWNSTREAM; INITIATOR; COMPLEX; ELEMENT; TAFS; RECOGNITION; DROSOPHILA	The major core promoter-binding factor in polymerase II transcription machinery is TFIID, a complex consisting of TBP, the TATA box-binding protein, and 13 to 14 TBP-associated factors (TAFs). Previously we found that the histone H2A-like TAF paralogs TAF4 and TAF4b possess DNA-binding activity. Whether TAF4/TAF4b DNA binding directs TFIID to a specific core promoter element or facilitates TFIID binding to established core promoter elements is not known. Here we analyzed the mode of TAF4b.TAF12 DNA binding and show that this complex binds DNA with high affinity. The DNA length required for optimal binding is similar to 70 bp. Although the complex displays a weak sequence preference, the nucleotide composition is less important than the length of the DNA for high affinity binding. Comparative expression profiling of wild-type and a DNA-binding mutant of TAF4 revealed common core promoter features in the down-regulated genes that include a TATA-box and an Initiator. Further examination of the PEL98 gene from this group showed diminished Initiator activity and TFIID occupancy in TAF4 DNA-binding mutant cells. These findings suggest that DNA binding by TAF4/4b-TAF12 facilitates the association of TFIID with the core promoter of a subset of genes.	[Gazit, Kfir; Moshonov, Sandra; Elfakess, Rofa; Sharon, Michal; Dikstein, Rivka] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Mengus, Gabrielle; Davidson, Irwin] Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Weizmann Institute of Science; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Dikstein, R (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	rivka.dikstein@weizmann.ac.il		MENGUS, Gabrielle/0000-0002-2844-1778; Davidson, Irwin/0000-0001-5533-1171; Sharon, Michal/0000-0003-3933-0595	Israel Science Foundation; Helen and Martin Kimmel Stem Cell Research Institute	Israel Science Foundation(Israel Science Foundation); Helen and Martin Kimmel Stem Cell Research Institute	This work was supported by grants from the Israel Science Foundation and the Helen and Martin Kimmel Stem Cell Research Institute.	Ainbinder E, 2004, MOL CELL BIOL, V24, P2444, DOI 10.1128/MCB.24.6.2444-2454.2004; Amir-Zilberstein L, 2007, MOL CELL BIOL, V27, P5246, DOI 10.1128/MCB.00586-07; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; EMANUEL PA, 1993, P NATL ACAD SCI USA, V90, P8449, DOI 10.1073/pnas.90.18.8449; Gershenzon NI, 2005, BIOINFORMATICS, V21, P1295, DOI 10.1093/bioinformatics/bti172; Hoffmann A, 1997, P NATL ACAD SCI USA, V94, P8928, DOI 10.1073/pnas.94.17.8928; Hoffmann A, 1996, NATURE, V380, P356, DOI 10.1038/380356a0; Juven-Gershon T, 2006, BIOCHEM SOC T, V34, P1047, DOI 10.1042/BST0341047; KAUFMANN J, 1994, GENE DEV, V8, P821, DOI 10.1101/gad.8.7.821; Matangkasombut O, 2004, ADV PROTEIN CHEM, V67, P67; Mengus G, 2005, EMBO J, V24, P2753, DOI 10.1038/sj.emboj.7600748; Moshonov S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-92; NAKATANI Y, 1990, NATURE, V348, P86, DOI 10.1038/348086a0; Oelgeschlager T, 1996, NATURE, V382, P735, DOI 10.1038/382735a0; PURNELL BA, 1994, GENE DEV, V8, P830, DOI 10.1101/gad.8.7.830; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; Selleck W, 2001, NAT STRUCT BIOL, V8, P695, DOI 10.1038/90408; Shao HS, 2005, MOL CELL BIOL, V25, P206, DOI 10.1128/MCB.25.1.206-219.2005; Sharon M, 2007, ANNU REV BIOCHEM, V76, P167, DOI 10.1146/annurev.biochem.76.061005.090816; Silkov A, 2002, J BIOL CHEM, V277, P17821, DOI 10.1074/jbc.M200696200; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Smale ST, 2001, GENE DEV, V15, P2503, DOI 10.1101/gad.937701; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Verrijzer CP, 1996, TRENDS BIOCHEM SCI, V21, P338, DOI 10.1016/0968-0004(96)10044-X; WANG JC, 1993, BIOCHIM BIOPHYS ACTA, V1216, P73, DOI 10.1016/0167-4781(93)90039-G; Werten S, 2002, J BIOL CHEM, V277, P45502, DOI 10.1074/jbc.M206587200; Xie XL, 1996, NATURE, V380, P316, DOI 10.1038/380316a0; Yamit-Hezi E, 2000, J BIOL CHEM, V275, P18180, DOI 10.1074/jbc.275.24.18180; ZHOU Q, 1992, GENE DEV, V6, P1964, DOI 10.1101/gad.6.10.1964	31	27	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26286	26296		10.1074/jbc.M109.011486	http://dx.doi.org/10.1074/jbc.M109.011486			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19635797	Green Published, hybrid			2022-12-27	WOS:000269969600008
J	Ventura, E; Sassi, F; Fossati, S; Parodi, A; Blalock, W; Balza, E; Castellani, P; Borsi, L; Carnemolla, B; Zardi, L				Ventura, Elisa; Sassi, Francesca; Fossati, Sara; Parodi, Arianna; Blalock, William; Balza, Enrica; Castellani, Patrizia; Borsi, Laura; Carnemolla, Barbara; Zardi, Luciano			Use of Uteroglobin for the Engineering of Polyvalent, Polyspecific Fusion Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ED-B DOMAIN; FIBRONECTIN ISOFORM; BLASTOCYST DEVELOPMENT; RECOMBINANT ANTIBODY; TARGETED DELIVERY; BLOOD-VESSELS; TNF-ALPHA; ANGIOGENESIS; MARKER; EXPRESSION	We report a novel strategy to engineer and express stable and soluble human recombinant polyvalent/polyspecific fusion proteins. The procedure is based on the use of a central skeleton of uteroglobin, a small and very soluble covalently linked homodimeric protein that is very resistant to proteolytic enzymes and to pH variations. Using a human recombinant antibody (scFv) specific for the angiogenesis marker domain B of fibronectin, interleukin 2, and an scFv able to neutralize tumor necrosis factor-alpha, we expressed various biologically active uteroglobin fusion proteins. The results demonstrate the possibility to generate monospecific divalent and tetravalent antibodies, immunocytokines, and dual specificity tetravalent antibodies. Furthermore, compared with similar fusion proteins in which uteroglobin was not used, the use of uteroglobin improved properties of solubility and stability. Indeed, in the reported cases it was possible to vacuum dry and reconstitute the proteins without any aggregation or loss in protein and biological activity.	[Zardi, Luciano] Ctr Biotecnol Avanzate, Lab Recombinant Therapeut Prot, I-16132 Genoa, Italy; [Fossati, Sara; Parodi, Arianna; Blalock, William; Zardi, Luciano] Ist Giannina Gaslini, Unit Innovat Therapies, I-16132 Genoa, Italy; [Balza, Enrica; Castellani, Patrizia; Borsi, Laura] Ist Nazl Ric Canc, Cell Biol Lab, I-16132 Genoa, Italy; [Carnemolla, Barbara] Ist Nazl Ric Canc, Immunol Lab, I-16132 Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST	Zardi, L (corresponding author), Ctr Biotecnol Avanzate, Lab Recombinant Therapeut Prot, Largo Rosanna Benzi 10, I-16132 Genoa, Italy.	zardi43@yahoo.it	Blalock, William L/C-6959-2019; Castellani, Patrizia/J-7333-2018	Blalock, William L/0000-0002-8045-4840; Castellani, Patrizia/0000-0002-6326-5853; Ventura, Elisa/0000-0002-5999-7613	Comitato Interministeriale Programmazione Economica, Rome, Regione Liguria, Genoa; European Union [FP6 LSHC-CT-2003-503233-STROMA, FP6 LSHC-CT-2006-037489-ImmunoPDT]; Istituto Superiore di Sanita, Rome [ISS2006]; Italian Ministry of Health, Rome [RF-IST-2006-384590]; Alleanza Contro il Cancro [ACC2007]	Comitato Interministeriale Programmazione Economica, Rome, Regione Liguria, Genoa(Regione Liguria); European Union(European Commission); Istituto Superiore di Sanita, Rome; Italian Ministry of Health, Rome(Ministry of Health, Italy); Alleanza Contro il Cancro	This work was supported by the Comitato Interministeriale Programmazione Economica, Rome, Regione Liguria, Genoa (to L. Z.), European Union Grants FP6 LSHC-CT-2003-503233-STROMA and FP6 LSHC-CT-2006-037489-ImmunoPDT (to L. Z.), Istituto Superiore di Sanita, Rome, Grant ISS2006, rare diseases (to B. C. and L. B.), Italian Ministry of Health, Rome, Grant RF-IST-2006-384590 (to L. B.), and Alleanza Contro il Cancro Grant ACC2007 (to L. B.).	BEIER HM, 1968, BIOCHIM BIOPHYS ACTA, V160, P289, DOI 10.1016/0005-2795(68)90108-6; Birchler MT, 2003, LARYNGOSCOPE, V113, P1231, DOI 10.1097/00005537-200307000-00023; Borsi L, 2003, BLOOD, V102, P4384, DOI 10.1182/blood-2003-04-1039; Borsi L, 2002, INT J CANCER, V102, P75, DOI 10.1002/ijc.10662; Carnemolla B, 2002, BLOOD, V99, P1659, DOI 10.1182/blood.V99.5.1659; CARNEMOLLA B, 1989, J CELL BIOL, V108, P1139, DOI 10.1083/jcb.108.3.1139; Carnemolla B, 1996, INT J CANCER, V68, P397, DOI 10.1002/(SICI)1097-0215(19961104)68:3<397::AID-IJC20>3.3.CO;2-D; Castellani P, 2002, AM J PATHOL, V161, P1695, DOI 10.1016/S0002-9440(10)64446-X; CASTELLANI P, 1994, INT J CANCER, V59, P612, DOI 10.1002/ijc.2910590507; CORTI A, 1994, J IMMUNOL METHODS, V177, P191, DOI 10.1016/0022-1759(94)90156-2; CURIGLIANO G, 2007, J CLIN ONCOL, V25, pS18; DELCONTE G, 2008, J CLIN ONCOL, V26, pS15; Demartis S, 1999, J MOL BIOL, V286, P617, DOI 10.1006/jmbi.1998.2476; HILLSON JL, 1993, J EXP MED, V178, P331, DOI 10.1084/jem.178.1.331; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; KACZMAREK J, 1994, INT J CANCER, V59, P11, DOI 10.1002/ijc.2910590104; Klug J, 2000, ANN NY ACAD SCI, V923, P348; Kosmehl H, 1996, VIRCHOWS ARCH, V429, P311; Kriangkum J, 2001, BIOMOL ENG, V18, P31, DOI 10.1016/S1389-0344(01)00083-1; KRISHNAN RS, 1967, SCIENCE, V158, P490, DOI 10.1126/science.158.3800.490; Li EQ, 1997, PROTEIN ENG, V10, P731, DOI 10.1093/protein/10.6.731; Marvin JS, 2005, ACTA PHARMACOL SIN, V26, P649, DOI 10.1111/j.1745-7254.2005.00119.x; Meazza R, 1996, BRIT J CANCER, V74, P788, DOI 10.1038/bjc.1996.437; Menrad A, 2005, EXPERT OPIN THER TAR, V9, P491, DOI 10.1517/14728222.9.3.491; MORIZE I, 1987, J MOL BIOL, V194, P725, DOI 10.1016/0022-2836(87)90250-6; MUKHERJEE AB, 2000, UTEROGLOGLOBIN CLARA; Mukherjee AB, 2007, ENDOCR REV, V28, P707, DOI 10.1210/er.2007-0018; Neri D, 2005, NAT REV CANCER, V5, P436, DOI 10.1038/nrc1627; Pilon AL, 2000, ANN NY ACAD SCI, V923, P280; Pini A, 1998, J BIOL CHEM, V273, P21769, DOI 10.1074/jbc.273.34.21769; Santimaria M, 2003, CLIN CANCER RES, V9, P571; Sauer S, 2009, BLOOD, V113, P2265, DOI 10.1182/blood-2008-06-160416; Tarli L, 1999, BLOOD, V94, P192, DOI 10.1182/blood.V94.1.192.413k22_192_198; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Trachsel E, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2115; Viti F, 1999, CANCER RES, V59, P347; Wu CB, 2007, NAT BIOTECHNOL, V25, P1290, DOI 10.1038/nbt1345; ZARDI L, 1987, EMBO J, V6, P2337, DOI 10.1002/j.1460-2075.1987.tb02509.x	38	6	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26646	26654		10.1074/jbc.M109.025924	http://dx.doi.org/10.1074/jbc.M109.025924			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19632988	Green Published, hybrid			2022-12-27	WOS:000269969600045
J	Fan, C; Chen, QY; Wang, QK				Fan, Chun; Chen, Qiuyun; Wang, Qing Kenneth			Functional Role of Transcriptional Factor TBX5 in Pre-mRNA Splicing and Holt-Oram Syndrome via Association with SC35	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE FAMILY; MUTATIONS; PROTEIN; HEART; COACTIVATOR; BINDING; LIMB; SPECIFICITY; MECHANISMS; INTERACTS	TBX5 is a T-box transcriptional factor required for cardio-genesis and limb development. TBX5 mutations cause Holt-Oram syndrome characterized by congenital heart defects and upper limb deformations. Here we establish a novel function for TBX5 in pre-mRNA splicing, and we show that this function is relevant to the pathogenesis of Holt-Oram syndrome, providing a novel pathogenic mechanism for the disease. Proteomics in combination with affinity purification identifies splicing factor SC35 as a candidate TBX5-associating protein. Co-immunoprecipitation and glutathione S-transferase pulldown assays confirm the complex formation between TBX5 and SC35. TBX5 can bind to RNA homopolymers (polyribonucleotides) and to the 5'-splice site, which overrides the binding of SC35 to the same RNA. Overexpression of TBX5 increases the efficiency of pre-mRNA splicing and regulates alternative splice site selection. However, co-expression of TBX5 and SC35 antagonizes each other's positive effect on splicing. The most severe TBX5 mutation, G80R, with complete penetrance of the cardiac phenotype, strongly affects pre-mRNA splicing, whereas other mutations with incomplete penetrance of the cardiac phenotype, including R237Q, do not alter the splicing activity of TBX5. This study establishes TBX5 as the first cardiac gene and the first human disease gene with dual roles in both transcriptional activation and pre-mRNA splicing.	Cleveland Clin, Ctr Cardiovasc Genet, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA; Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ, Wuhan 430074, Peoples R China; Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan 430074, Peoples R China	Cleveland Clinic Foundation; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, QK (corresponding author), Cleveland Clin, Ctr Cardiovasc Genet NE40, Cleveland, OH 44195 USA.	wangq2@ccf.org			China Natural Science Foundation [30670857]	China Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported in part by China Natural Science Foundation Grant 30670857 ( to Q. W.).	Basson CT, 1999, P NATL ACAD SCI USA, V96, P2919, DOI 10.1073/pnas.96.6.2919; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Ding JH, 2004, EMBO J, V23, P885, DOI 10.1038/sj.emboj.7600054; Fan C, 2003, J Med Genet, V40, pe29, DOI 10.1136/jmg.40.3.e29; Fan C, 2003, J BIOL CHEM, V278, P8780, DOI 10.1074/jbc.M208120200; FU XD, 1992, SCIENCE, V256, P535, DOI 10.1126/science.1373910; Gallego ME, 1997, EMBO J, V16, P1772, DOI 10.1093/emboj/16.7.1772; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Ge H, 1998, MOL CELL, V2, P751, DOI 10.1016/S1097-2765(00)80290-7; Ghosh TK, 2001, HUM MOL GENET, V10, P1983, DOI 10.1093/hmg/10.18.1983; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Inoue A, 1996, NUCLEIC ACIDS RES, V24, P2990, DOI 10.1093/nar/24.15.2990; Koshiba-Takeuchi K, 2006, NAT GENET, V38, P175, DOI 10.1038/ng1707; Li QY, 1997, NAT GENET, V15, P21; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Papaioannou VE, 1998, BIOESSAYS, V20, P9, DOI 10.1002/(SICI)1521-1878(199801)20:1<9::AID-BIES4>3.0.CO;2-Q; Prasad J, 1999, MOL CELL BIOL, V19, P6991; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; SUN Q, 1993, GENE DEV, V7, P2598, DOI 10.1101/gad.7.12b.2598; Tacke R, 1999, CURR OPIN CELL BIOL, V11, P358, DOI 10.1016/S0955-0674(99)80050-7; Tian XL, 2004, CARDIOVASC RES, V61, P256, DOI 10.1016/j.cardiores.2003.11.007; Tian XL, 2004, NATURE, V427, P640, DOI 10.1038/nature02320; Wang KG, 2003, J OPT B-QUANTUM S O, V5, P44, DOI 10.1088/1464-4266/5/1/306; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Yang L, 1998, J BIOL CHEM, V273, P27761, DOI 10.1074/jbc.273.43.27761; Zahler AM, 2004, J BIOL CHEM, V279, P10077, DOI 10.1074/jbc.M312743200; Zhang C, 2003, J BIOL CHEM, V278, P35325, DOI 10.1074/jbc.M305191200	33	34	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25653	25663		10.1074/jbc.M109.041368	http://dx.doi.org/10.1074/jbc.M109.041368			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19648116	hybrid, Green Published			2022-12-27	WOS:000269738000023
J	Imamura, K; Wallace, SS; Doublie, S				Imamura, Kayo; Wallace, Susan S.; Doublie, Sylvie			Structural Characterization of a Viral NEIL1 Ortholog Unliganded and Bound to Abasic Site-containing DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; COLI ENDONUCLEASE-VIII; OXIDATIVELY DAMAGED DNA; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; DIFFRACTION DATA; GLYCOSYLASES NEIL1; ZINC-FINGER; FPG PROTEIN; RECOGNITION	Endonuclease VIII (Nei) is a DNA glycosylase of the base excision repair pathway that recognizes and excises oxidized pyrimidines. We determined the crystal structures of a NEIL1 ortholog from the giant Mimivirus (MvNei1) unliganded and bound to DNA containing tetrahydrofuran (THF), which is the first structure of any Nei with an abasic site analog. The MvNei1 structures exhibit the same overall architecture as other enzymes of the Fpg/Nei family, which consists of two globular domains joined by a linker region. MvNei1 harbors a zincless finger, first described in human NEIL1, rather than the signature zinc finger generally found in the Fpg/Nei family. In contrast to Escherichia coli Nei, where a dramatic conformational change was observed upon binding DNA, the structure of MvNei1 bound to DNA does not reveal any substantial movement compared with the unliganded enzyme. A protein segment encompassing residues 217-245 in MvNei1 corresponds to the "missing loop" in E. coli Nei and the "alpha F-beta 10 loop" in E. coli Fpg, which has been reported to be involved in lesion recognition. Interestingly, the corresponding loop in MvNei1 is ordered in both the unliganded and furan-bound structures, unlike other Fpg/Nei enzymes where the loop is generally ordered in the unliganded enzyme or in complexes with a lesion, and disordered otherwise. In the MvNei1.tetrahydrofuran complex a tyrosine located at the tip of the putative lesion recognition loop stacks against the furan ring; the tyrosine is predicted to adopt a different conformation to accommodate a modified base.	[Wallace, Susan S.] Univ Vermont, Dept Microbiol & Mol Genet, Markey Ctr Mol Genet, Burlington, VT 05405 USA	University of Vermont	Wallace, SS (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Markey Ctr Mol Genet, Stafford Hall,95 Carrigan Dr, Burlington, VT 05405 USA.	Susan.Wallace@uvm.edu; Sylvie.Doublie@uvm.edu		Wallace, Susan S./0000-0002-3906-0321; Imamura, Kayo/0000-0002-2141-8495; Doublie, Sylvie/0000-0002-6294-5304	NCI [P01CA098993]; U. S. Department of Energy; NIH; NATIONAL CANCER INSTITUTE [P01CA098993] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U. S. Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01CA098993 awarded by the NCI. Financial support of National Synchrotron Light Source comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the U. S. Department of Energy, and from the National Center for Research Resources of NIH.	Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; Bandaru V, 2007, DNA REPAIR, V6, P1629, DOI 10.1016/j.dnarep.2007.05.011; Bandaru V, 2006, METHOD ENZYMOL, V408, P15, DOI 10.1016/S0076-6879(06)08002-5; Blaisdell JO, 2007, NUCLEIC ACIDS RES, V35, P1601, DOI 10.1093/nar/gkm021; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Castaing B, 1999, NUCLEIC ACIDS RES, V27, P608, DOI 10.1093/nar/27.2.608; CHETSANGA CJ, 1981, BIOCHEMISTRY-US, V20, P5201, DOI 10.1021/bi00521a016; CHUNG MH, 1991, MUTAT RES, V254, P1, DOI 10.1016/0921-8777(91)90035-N; Coste F, 2004, J BIOL CHEM, V279, P44074, DOI 10.1074/jbc.M405928200; Coste F, 2008, CHEM BIOL, V15, P706, DOI 10.1016/j.chembiol.2008.05.014; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; de Jesus KP, 2005, NUCLEIC ACIDS RES, V33, P5936, DOI 10.1093/nar/gki879; Denver DR, 2003, MOL BIOL EVOL, V20, P1603, DOI 10.1093/molbev/msg177; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Doublie S, 2004, P NATL ACAD SCI USA, V101, P10284, DOI 10.1073/pnas.0402051101; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fromme JC, 2004, CURR OPIN STRUC BIOL, V14, P43, DOI 10.1016/j.sbi.2004.01.003; Fromme JC, 2003, J BIOL CHEM, V278, P51543, DOI 10.1074/jbc.M307768200; Ghedin E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-62; Gilboa R, 2002, J BIOL CHEM, V277, P19811, DOI 10.1074/jbc.M202058200; Golan G, 2005, NUCLEIC ACIDS RES, V33, P5006, DOI 10.1093/nar/gki796; GOYAL RN, 1982, J ELECTROANAL CHEM, V135, P75, DOI 10.1016/0022-0728(82)90006-7; Hailer MK, 2005, DNA REPAIR, V4, P41, DOI 10.1016/j.dnarep.2004.07.006; Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Jia L, 2007, BIOCHEMISTRY-US, V46, P5305, DOI 10.1021/bi062269m; Jiang DY, 1997, J BIOL CHEM, V272, P32230, DOI 10.1074/jbc.272.51.32230; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Krokan HE, 1997, BIOCHEM J, V325, P1; Kropachev KY, 2006, BIOCHEMISTRY-US, V45, P12039, DOI 10.1021/bi060663e; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAVERY R, 1989, J BIOMOL STRUCT DYN, V6, P655, DOI 10.1080/07391102.1989.10507728; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Luo WC, 2000, ORG LETT, V2, P613, DOI 10.1021/ol9913643; McCoy AJ, 2004, ACTA CRYSTALLOGR D, V60, P1220, DOI 10.1107/S0907444904009990; MELAMEDE RJ, 1994, BIOCHEMISTRY-US, V33, P1255, DOI 10.1021/bi00171a028; Morland I, 2002, NUCLEIC ACIDS RES, V30, P4926, DOI 10.1093/nar/gkf618; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Serre L, 2002, EMBO J, V21, P2854, DOI 10.1093/emboj/cdf304; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sidorkina OM, 1998, NUCLEIC ACIDS RES, V26, P5351, DOI 10.1093/nar/26.23.5351; Sugahara M, 2000, EMBO J, V19, P3857, DOI 10.1093/emboj/19.15.3857; Suzan-Monti M, 2006, VIRUS RES, V117, P145, DOI 10.1016/j.virusres.2005.07.011; Takao M, 2002, J BIOL CHEM, V277, P42205, DOI 10.1074/jbc.M206884200; TCHOU J, 1991, P NATL ACAD SCI USA, V88, P4690, DOI 10.1073/pnas.88.11.4690; TCHOU J, 1993, J BIOL CHEM, V268, P26738; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wallace SS, 2003, DNA REPAIR, V2, P441, DOI 10.1016/S1568-7864(02)00182-9; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zharkov DO, 2003, DNA REPAIR, V2, P839, DOI 10.1016/S1568-7864(03)00084-3; Zharkov DO, 2002, EMBO J, V21, P789, DOI 10.1093/emboj/21.4.789	58	34	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26174	26183		10.1074/jbc.M109.021907	http://dx.doi.org/10.1074/jbc.M109.021907			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19625256	Green Published, hybrid			2022-12-27	WOS:000269738000072
J	Plumlee, CR; Lee, C; Beg, AA; Decker, T; Shuman, HA; Schindler, C				Plumlee, Courtney R.; Lee, Carolyn; Beg, Amer A.; Decker, Thomas; Shuman, Howard A.; Schindler, Christian			Interferons Direct an Effective Innate Response to Legionella pneumophila Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTRACELLULAR MULTIPLICATION; TRANSCRIPTION FACTORS; TARGETED DISRUPTION; MACROPHAGE IMMUNITY; MOUSE MACROPHAGES; GAMMA-INTERFERON; CYTOPLASMIC DNA; VIRAL-INFECTION; DENDRITIC CELLS	Legionella pneumophila remains an important opportunistic pathogen of human macrophages. Its more limited ability to replicate in murine macrophages has been attributed to redundant innate sensor systems that detect and effectively respond to this infection. The current studies evaluate the role of one of these innate response systems, the type I interferon (IFN-I) autocrine loop. The ability of L. pneumophila to induce IFN-I expression was found to be dependent on IRF-3, but not NF-kappa B. Secreted IFN-Is then in turn suppress the intracellular replication of L. pneumophila. Surprisingly, this suppression is mediated by a pathway that is independent of Stat1, Stat2, Stat3, but correlates with the polarization of macrophages toward the M1 or classically activated phenotype.	[Lee, Carolyn; Shuman, Howard A.; Schindler, Christian] Columbia Univ, Dept Microbiol & Immunol, New York, NY 10032 USA; [Plumlee, Courtney R.] Columbia Univ, Dept Biol Sci, New York, NY 10032 USA; [Schindler, Christian] Columbia Univ, Dept Med, New York, NY 10032 USA; [Beg, Amer A.] Univ S Florida, Moffitt Canc Ctr, Tampa, FL 33612 USA; [Decker, Thomas] Univ Vienna, A-1030 Vienna, Austria	Columbia University; Columbia University; Columbia University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Vienna	Schindler, C (corresponding author), Columbia Univ, Dept Microbiol & Immunol, HHSC 908,701 W 168th St, New York, NY 10032 USA.	cws4@columbia.edu			National Institutes of Health [AI 058211, HL 55413, 5T32 AI07525, 5T32 DK007328, AI 059715, AI23549]; Austrian Science Foundation [P20522-B05]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007525, R01AI059715, R01AI023549, R01AI058211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007328] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [F 2803] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Foundation(Austrian Science Fund (FWF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported, in whole or in part, by National Institutes of Health Grants AI 058211 (to C. S.), HL 55413 (to C. S.), 5T32 AI07525 (to C. R. P.), 5T32 DK007328 (to C. R. P.), AI 059715 (to A. A. B.), and AI23549 (to H. A. S.). This research was also supported by the Austrian Science Foundation (FWF) Grant P20522-B05 (to T. D.).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Abu-Zant A, 2007, CELL MICROBIOL, V9, P246, DOI 10.1111/j.1462-5822.2006.00785.x; Akamine M, 2007, MICROBIOL IMMUNOL, V51, P279, DOI 10.1111/j.1348-0421.2007.tb03909.x; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Archer KA, 2006, INFECT IMMUN, V74, P3325, DOI 10.1128/IAI.02049-05; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Chen J, 2004, SCIENCE, V303, P1358, DOI 10.1126/science.1094226; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Coers J, 2007, CELL MICROBIOL, V9, P2344, DOI 10.1111/j.1462-5822.2007.00963.x; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Deng JC, 2001, INFECT IMMUN, V69, P6382, DOI 10.1128/IAI.69.10.6382-6390.2001; Escalante CR, 2002, STRUCTURE, V10, P383, DOI 10.1016/S0969-2126(02)00723-2; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Filipe-Santos O, 2006, SEMIN IMMUNOL, V18, P347, DOI 10.1016/j.smim.2006.07.010; Fong CHY, 2008, J EXP MED, V205, P1269, DOI 10.1084/jem.20080124; Fortier A, 2005, TRENDS MICROBIOL, V13, P328, DOI 10.1016/j.tim.2005.05.007; GEBRAN SJ, 1994, INFECT IMMUN, V62, P3197, DOI 10.1128/IAI.62.8.3197-3205.1994; Gimeno R, 2005, MOL CELL BIOL, V25, P5456, DOI 10.1128/MCB.25.13.5456-5465.2005; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Hawn TR, 2007, J IMMUNOL, V179, P6981, DOI 10.4049/jimmunol.179.10.6981; Hawn TR, 2006, J INFECT DIS, V193, P1693, DOI 10.1086/504525; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Hilbi H, 2001, MOL MICROBIOL, V42, P603, DOI 10.1046/j.1365-2958.2001.02645.x; Hiscott J, 2006, TRENDS MOL MED, V12, P53, DOI 10.1016/j.molmed.2005.12.003; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hovel-Miner G, 2009, J BACTERIOL, V191, P2461, DOI 10.1128/JB.01578-08; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Losick VP, 2006, J EXP MED, V203, P2177, DOI 10.1084/jem.20060766; Losick VP, 2009, INFECT IMMUN, V77, P196, DOI 10.1128/IAI.01011-08; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; NASH TW, 1988, J IMMUNOL, V140, P3978; Neild AL, 2004, CELL MICROBIOL, V6, P1011, DOI 10.1111/j.1462-5822.2004.00450.x; Ninio S, 2007, TRENDS MICROBIOL, V15, P372, DOI 10.1016/j.tim.2007.06.006; Opitz B, 2006, J BIOL CHEM, V281, P36173, DOI 10.1074/jbc.M604638200; Park C, 1999, NUCLEIC ACIDS RES, V27, P4191, DOI 10.1093/nar/27.21.4191; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Sabria Miguel, 2003, Am J Respir Med, V2, P235; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schiavoni G, 2004, J IMMUNOL, V173, P1266, DOI 10.4049/jimmunol.173.2.1266; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schindler C, 2008, SEMIN CELL DEV BIOL, V19, P311, DOI 10.1016/j.semcdb.2008.08.010; Schneider K, 2008, CELL HOST MICROBE, V3, P67, DOI 10.1016/j.chom.2007.12.008; Segal G, 2005, FEMS MICROBIOL REV, V29, P65, DOI 10.1016/j.femsre.2004.07.001; Song L, 2006, BLOOD, V108, P3237, DOI 10.1182/blood-2006-04-020271; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Sutterwala FS, 2006, J ENDOTOXIN RES, V12, P251, DOI 10.1179/096805106X118771; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tam MA, 2008, CELL MICROBIOL, V10, P1517, DOI 10.1111/j.1462-5822.2008.01144.x; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Timmer AM, 2008, J EXP MED, V205, P1255, DOI 10.1084/jem.20081056; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Wang JM, 2007, J IMMUNOL, V178, P6777, DOI 10.4049/jimmunol.178.11.6777; Wang XY, 2007, J IMMUNOL, V178, P6770, DOI 10.4049/jimmunol.178.11.6770; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305; Zhao WL, 2008, J IMMUNOL, V180, P5483, DOI 10.4049/jimmunol.180.8.5483; Zhao WL, 2007, J IMMUNOL, V179, P463, DOI 10.4049/jimmunol.179.1.463	71	60	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30058	30066		10.1074/jbc.M109.018283	http://dx.doi.org/10.1074/jbc.M109.018283			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19720834	Green Published, hybrid			2022-12-27	WOS:000271090000008
J	Guo, XJ; Nie, L; Esmailzadeh, L; Zhang, JS; Bender, JR; Sadeghi, MM				Guo, Xiaojia; Nie, Lei; Esmailzadeh, Leila; Zhang, Jiasheng; Bender, Jeffrey R.; Sadeghi, Mehran M.			Endothelial and Smooth Muscle-derived Neuropilin-like Protein Regulates Platelet-derived Growth Factor Signaling in Human Vascular Smooth Muscle Cells by Modulating Receptor Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BETA-RECEPTOR; TYROSINE PHOSPHORYLATION; NEGATIVE REGULATION; PROLIFERATION; MIGRATION; KINASE; ACTIVATION; BINDING; CBL; SITE	Endothelial and smooth muscle cell-derived neuropilin-like protein (ESDN) is up-regulated in the neointima of remodeling arteries and modulates vascular smooth muscle cell (VSMC) growth. Platelet-derived growth factor (PDGF) is the prototypic growth factor for VSMCs and plays a key role in vascular remodeling. Here, we sought to further define ESDN function in primary human VSMCs. ESDN down-regulation by RNA interference significantly enhanced PDGF-induced VSMC DNA synthesis and migration. This was associated with increased ERK1/2, Src, and PDGF receptor (PDGFR)beta phosphorylation, without altering total PDGFR beta expression levels. In binding assays, ESDN down-regulation significantly increased I-125-PDGF maximum binding (B-max) to PDGF receptors on VSMCs without altering the binding constant (K-d), raising the possibility that ESDN regulates PDGFR processing. ESDN down-regulation significantly reduced ligand-induced PDGFR beta ubiquitination. This was associated with a significant reduction in the expression level of c-Cbl, an E3 ubiquitin ligase that ubiquitinylates PDGFR beta. Thus, ESDN modulates PDGF signaling in VSMCs via regulation of PDGFR surface levels. The ESDN effect is mediated, at least in part, through effects on PDGFR beta ubiquitination. ESDN may serve as a target for regulating PDGFR beta signaling in VSMCs.	[Guo, Xiaojia; Nie, Lei; Esmailzadeh, Leila; Zhang, Jiasheng; Sadeghi, Mehran M.] Vet Affairs Connecticut Healthcare Syst, West Haven, CT 06516 USA; [Guo, Xiaojia; Nie, Lei; Esmailzadeh, Leila; Zhang, Jiasheng; Sadeghi, Mehran M.] Yale Univ, Sch Med, Cardiovasc Mol Imaging Lab, New Haven, CT 06520 USA; [Bender, Jeffrey R.] Yale Univ, Sch Med, Sect Cardiovasc Med, Raymond & Beverly Sackler Fdn Cardiovasc Lab, New Haven, CT 06520 USA; [Guo, Xiaojia; Nie, Lei; Esmailzadeh, Leila; Zhang, Jiasheng; Bender, Jeffrey R.; Sadeghi, Mehran M.] Yale Univ, Sch Med, Interdept Program Vasc Biol & Therapeut, New Haven, CT 06520 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Yale University; Yale University	Sadeghi, MM (corresponding author), Vet Affairs Connecticut Healthcare Syst, 950 Campbell Ave,111B, West Haven, CT 06516 USA.	mehran.sadeghi@yale.edu			National Institutes of Health [HL70295, RO1 HL085093]; Department of Veterans Affairs merit award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070295, R01HL085093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs merit award(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Program Project HL70295 and RO1 HL085093. This work was also supported by a Department of Veterans Affairs merit award (to M. M. S.).	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; ERPEL T, 1995, CURR OPIN CELL BIOL, V7, P176, DOI 10.1016/0955-0674(95)80025-5; Huang M, 2007, ARTERIOSCL THROM VAS, V27, P2597, DOI 10.1161/ATVBAHA.107.154211; JACKSON CL, 1993, ARTERIOSCLER THROMB, V13, P1218, DOI 10.1161/01.ATV.13.8.1218; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Juliano RL, 2004, BIOCHEM SOC T, V32, P443, DOI 10.1042/BST0320443; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; Kim M, 2008, MOL CANCER RES, V6, P222, DOI 10.1158/1541-7786.MCR-07-0142; Kobuke K, 2001, J BIOL CHEM, V276, P34105, DOI 10.1074/jbc.M105293200; Koshikawa K, 2002, ONCOGENE, V21, P2822, DOI 10.1038/sj.onc.1205405; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P21478; Lewis CD, 2001, PLATELETS, V12, P352; Miyake S, 1999, J BIOL CHEM, V274, P16619, DOI 10.1074/jbc.274.23.16619; MORI S, 1992, J BIOL CHEM, V267, P6429; MORI S, 1995, J BIOL CHEM, V270, P29447, DOI 10.1074/jbc.270.49.29447; MORI S, 1993, J BIOL CHEM, V268, P577; Mureebe L, 1997, SURGERY, V122, P138, DOI 10.1016/S0039-6060(97)90002-7; Nakata S, 2007, J BIOL CHEM, V282, P37815, DOI 10.1074/jbc.M707461200; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Persson C, 2004, MOL CELL BIOL, V24, P2190, DOI 10.1128/MCB.24.5.2190-2201.2004; Reddi AL, 2007, J BIOL CHEM, V282, P29336, DOI 10.1074/jbc.M701797200; Sadeghi MM, 2007, AM J TRANSPLANT, V7, P2098, DOI 10.1111/j.1600-6143.2007.01919.x; Sambi BS, 2006, CELL SIGNAL, V18, P971, DOI 10.1016/j.cellsig.2005.08.003; Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600; Spencer JA, 2005, P NATL ACAD SCI USA, V102, P2946, DOI 10.1073/pnas.0500058102; Sundberg C, 1996, J CELL BIOL, V132, P741, DOI 10.1083/jcb.132.4.741; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Weber DS, 2004, CIRC RES, V94, P1219, DOI 10.1161/01.RES.0000126848.54740.4A; Welser JV, 2007, CIRC RES, V101, P672, DOI 10.1161/CIRCRESAHA.107.151415; Yoshida T, 2007, AM J PHYSIOL-CELL PH, V292, pC886, DOI 10.1152/ajpcell.00449.2006; Zhan YM, 2003, ARTERIOSCL THROM VAS, V23, P795, DOI 10.1161/01.ATV.0000066132.32063.F2	31	18	19	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29376	29382		10.1074/jbc.M109.049684	http://dx.doi.org/10.1074/jbc.M109.049684			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19696027	hybrid, Green Published			2022-12-27	WOS:000270896800018
J	Choi, Y; Seeliger, MA; Panjarian, SB; Kim, H; Deng, X; Sim, T; Couch, B; Koleske, AJ; Smithgall, TE; Gray, NS				Choi, Yongmun; Seeliger, Markus A.; Panjarian, Shoghag B.; Kim, Hakjoong; Deng, Xianming; Sim, Taebo; Couch, Brian; Koleske, Anthony J.; Smithgall, Thomas E.; Gray, Nathanael S.			N-Myristoylated c-Abl Tyrosine Kinase Localizes to the Endoplasmic Reticulum upon Binding to an Allosteric Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; BCR-ABL; GENE-PRODUCT; PROTEIN; ACTIN; PROLIFERATION; TRANSLOCATION; ACTIVATION; EXPRESSION; LEUKEMIA	Allosteric kinase inhibitors hold promise for revealing unique features of kinases that may not be apparent using conventional ATP-competitive inhibitors. Here we explore the activity of a previously reported allosteric inhibitor of BCR-Abl kinase, GNF-2, against two cellular isoforms of Abl tyrosine kinase: one that carries a myristate in the N terminus and the other that is deficient in N-myristoylation. Our results show that GNF-2 inhibits the kinase activity of non-myristoylated c-Abl more potently than that of myristoylated c-Abl by binding to the myristate-binding pocket in the C-lobe of the kinase domain. Unexpectedly, indirect immunofluorescence reveals a translocation of myristoylated c-Abl to the endoplasmic reticulum in GNF-2-treated cells, whereas GNF-2 has no detectable effect on the localization of non-myristoylated c-Abl. These results indicate that GNF-2 competes with the NH2-terminal myristate for binding to the c-Abl kinase myristate-binding pocket and that the exposed myristoyl group accounts for the localization to the endoplasmic reticulum. We also demonstrate that GNF-2 can inhibit enzymatic and cellular kinase activity of Arg, a kinase highly homologous to c-Abl, which is also likely to be regulated through intramolecular binding of an NH2-terminal myristate lipid. These results suggest that non-ATP-competitive inhibitors, such as GNF-2, can serve as chemical tools that can discriminate between c-Abl isoform-specific behaviors.	[Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Choi, Yongmun; Deng, Xianming; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Seeliger, Markus A.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Seeliger, Markus A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Panjarian, Shoghag B.; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA; [Couch, Brian; Koleske, Anthony J.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University	Gray, NS (corresponding author), AGM 628A,250 Longwood Ave, Boston, MA 02115 USA.	nathanael_gray@dfci.harvard.edu	Kim, Hak/AAI-5399-2020; Seeliger, Markus A/D-6409-2013	Kim, Hak/0000-0002-9265-9181; Seeliger, Markus/0000-0003-0990-1756; Deng, Xianming/0000-0002-9354-5864	National Institutes of Health [R01 CA130876-01A1, NS39475, MH77306, R01 CA101828]; Novartis Institute of Biomedical Research; NATIONAL CANCER INSTITUTE [R01CA101828, R01CA130876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH077306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Institute of Biomedical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA130876-01A1; NS39475 and MH77306 (to A. J. K.); and R01 CA101828 (to T. E. S.). This work was also supported by the Novartis Institute of Biomedical Research (to N. S. G.).	Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; BARKER SC, 1995, BIOCHEMISTRY-US, V34, P14843, DOI 10.1021/bi00045a027; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Diskin R, 2008, J MOL BIOL, V375, P70, DOI 10.1016/j.jmb.2007.09.002; FOULKES JG, 1985, J BIOL CHEM, V260, P8070; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Ito Y, 2001, MOL CELL BIOL, V21, P6233, DOI 10.1128/MCB.21.18.6233-6242.2001; Kalies KU, 1998, J CELL BIOL, V141, P887, DOI 10.1083/jcb.141.4.887; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; KRUH GD, 1990, P NATL ACAD SCI USA, V87, P5802, DOI 10.1073/pnas.87.15.5802; Lin J, 2008, ONCOGENE, V27, P4385, DOI 10.1038/onc.2008.86; Lin J, 2007, ONCOGENE, V26, P6989, DOI 10.1038/sj.onc.1210500; Miller AL, 2004, J CELL BIOL, V165, P407, DOI 10.1083/jcb.200308055; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Sirvent A, 2007, ONCOGENE, V26, P7313, DOI 10.1038/sj.onc.1210543; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Wang JYJ, 2004, NAT CELL BIOL, V6, P3, DOI 10.1038/ncb0104-3; Weisberg E, 2007, NAT REV CANCER, V7, P345, DOI 10.1038/nrc2126; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Wong S, 2004, P NATL ACAD SCI USA, V101, P17456, DOI 10.1073/pnas.0407061101; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Woodring PJ, 2001, J BIOL CHEM, V276, P27104, DOI 10.1074/jbc.M100559200; Zhou V, 2009, ANAL BIOCHEM, V385, P300, DOI 10.1016/j.ab.2008.11.015	31	42	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29005	29014		10.1074/jbc.M109.026633	http://dx.doi.org/10.1074/jbc.M109.026633			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19679652	hybrid, Green Published			2022-12-27	WOS:000270678900058
J	Jin, Y; Watt, RM; Danchin, A; Huang, JD				Jin, Ye; Watt, Rory M.; Danchin, Antoine; Huang, Jian-dong			Use of a Riboswitch-controlled Conditional Hypomorphic Mutation to Uncover a Role for the Essential csrA Gene in Bacterial Autoaggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA SECONDARY STRUCTURE; OUTER-MEMBRANE PROTEIN; ESCHERICHIA-COLI; BIOFILM FORMATION; ANTIGEN 43; EXPRESSION; BINDING; AGGREGATION; TRANSLATION; PREDICTION	Essential genes encode biological functions critical for cell survival. Correspondingly, their null mutants are often difficult to obtain, which impedes subsequent genetic and functional analysis. Here, we describe the development and utility of a theophylline-responsive riboswitch that enables target gene expression to be specifically "tuned" from low to high levels, which may be used to generate conditional hypomorphic mutants. Low levels of gene activity in the absence of the ligand (theophylline) permit cell survival, enabling gene activities to be investigated. Normal gene expression levels and wild-type phenotypes can be restored by the addition of the ligand. We demonstrate the utility of this approach with csrA, an essential gene in Escherichia coli that encodes the global regulatory protein CsrA. We placed the theophylline-responsive riboswitch immediately upstream of the csrA ribosome binding site, with the resulting mutant named switch-csrA. Hypomorphism of switch-csrA and its specific responsiveness to theophylline were verified by phenotypic examination and translation analysis. The utility of switch-csrA revealed a previously unidentified function for CsrA, namely its role as a repressor of cellular autoaggregation. Specifically, switch-csrA in the non-ligand-bound form produced low levels of CsrA, and its cells autoaggregated. Theophylline binding induced conformational changes in the riboswitch and permitted efficient csrA translation; consequently, autoaggregation did not occur. Our results indicate that CsrA modulates autoaggregation via the polysaccharide adhesin poly-beta-1,6-N-acetyl-D-glucosamine. In summary, the use of ligand-responsive riboswitches to construct conditional hypomorphic mutants represents a novel approach for investigating the activities of essential genes, which effectively complements traditional genetic approaches.	[Jin, Ye; Huang, Jian-dong] Univ Hong Kong, Li Ka Shing Fac Med, Dept Biochem, Pok Fu Lam, Hong Kong, Peoples R China; [Watt, Rory M.] Univ Hong Kong, Fac Dent, Pok Fu Lam, Hong Kong, Peoples R China; [Danchin, Antoine] Inst Pasteur, CNRS, URA2171, F-75724 Paris 15, France	University of Hong Kong; University of Hong Kong; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Huang, JD (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Biochem, Pok Fu Lam, Hong Kong, Peoples R China.	jdhuang@hkucc.hku.hk	Watt, Rory M./B-2177-2009; /C-4277-2009	Watt, Rory M./0000-0002-8718-1988; Danchin, Antoine/0000-0002-6350-5001; /0000-0001-7531-2816	University of Hong Kong Committee on Research and Conference; Research Grants Council of Hong Kong [HKU 7485/06M]	University of Hong Kong Committee on Research and Conference(University of Hong Kong); Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by the University of Hong Kong Committee on Research and Conference Grants Seed Funding Program for Basic Research and by Research Grants Council of Hong Kong Grant HKU 7485/06M (to J. D. H.).	Baker CS, 2007, J BACTERIOL, V189, P5472, DOI 10.1128/JB.00529-07; Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114; BRUNEL C, 1995, J MOL BIOL, V253, P277, DOI 10.1006/jmbi.1995.0552; Danese PN, 2000, MOL MICROBIOL, V37, P424, DOI 10.1046/j.1365-2958.2000.02008.x; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Dubey AK, 2003, J BACTERIOL, V185, P4450, DOI 10.1128/JB.185.15.4450-4460.2003; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Henderson IR, 1997, FEMS MICROBIOL LETT, V149, P115, DOI 10.1016/S0378-1097(97)00065-7; Herring CD, 2004, J BACTERIOL, V186, P2673, DOI 10.1128/JB.186.9.2673-2681.2004; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Jin Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-165; Jonas K, 2008, MOL MICROBIOL, V70, P236, DOI 10.1111/j.1365-2958.2008.06411.x; Judson N, 2000, NAT BIOTECHNOL, V18, P740, DOI 10.1038/77305; Liu MY, 1997, J BIOL CHEM, V272, P17502, DOI 10.1074/jbc.272.28.17502; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Mushegian A, 1999, CURR OPIN GENET DEV, V9, P709, DOI 10.1016/S0959-437X(99)00023-4; OCHIAI K, 1993, J MED MICROBIOL, V39, P183, DOI 10.1099/00222615-39-3-183; Sherlock O, 2005, INFECT IMMUN, V73, P1954, DOI 10.1128/IAI.73.4.1954-1963.2005; Sherlock O, 2004, J BACTERIOL, V186, P8058, DOI 10.1128/JB.186.23.8058-8065.2004; Suess B, 2004, NUCLEIC ACIDS RES, V32, P1610, DOI 10.1093/nar/gkh321; Timmermans J, 2009, J BACTERIOL, V191, P1722, DOI 10.1128/JB.01573-08; Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; Win MN, 2007, P NATL ACAD SCI USA, V104, P14283, DOI 10.1073/pnas.0703961104; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zimmermann GR, 2000, RNA, V6, P659, DOI 10.1017/S1355838200000169	28	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28738	28745		10.1074/jbc.M109.028076	http://dx.doi.org/10.1074/jbc.M109.028076			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19706608	Green Published, hybrid			2022-12-27	WOS:000270678900030
J	Melnikova, VO; Balasubramanian, K; Villares, GJ; Dobroff, AS; Zigler, M; Wang, H; Petersson, F; Price, JE; Schroit, A; Prieto, VG; Hung, MC; Bar-Eli, M				Melnikova, Vladislava O.; Balasubramanian, Krishnakumar; Villares, Gabriel J.; Dobroff, Andrey S.; Zigler, Maya; Wang, Hua; Petersson, Frederik; Price, Janet E.; Schroit, Alan; Prieto, Victor G.; Hung, Mien-Chie; Bar-Eli, Menashe			Crosstalk between Protease-activated Receptor 1 and Platelet-activating Factor Receptor Regulates Melanoma Cell Adhesion Molecule (MCAM/MUC18) Expression and Melanoma Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ENDOTHELIAL-CELLS; BREAST-CANCER CELLS; KAPPA-B ACTIVATION; TUMOR-GROWTH; THROMBIN RECEPTOR; MALIGNANT-MELANOMA; SIGNALING PATHWAYS; INVASION; PHOSPHORYLATION; OVEREXPRESSION	The cellular and molecular pathways that regulate platelet activation, blood coagulation, and inflammation are emerging as critical players in cancer progression and metastasis. Here, we demonstrate a novel signaling mechanism whereby protease-activated receptor 1 (PAR1) mediates expression of melanoma cell adhesion molecule MCAM/MUC18 (MUC18), a critical marker of melanoma metastasis, via activation of platelet-activating factor receptor (PAFR) and cAMP-responsive element-binding protein (CREB). We found that PAR1 silencing with small hairpin RNA inhibits MUC18 expression in metastatic melanoma cells by inhibiting CREB phosphorylation, activity, and binding to the MUC18 promoter. We further demonstrate that the PAF/PAFR pathway mediates MUC18 expression downstream of PAR1. Indeed, PAR1 silencing down-regulates PAFR expression and PAF production, PAFR silencing blocks MUC18 expression, and re-expression of PAFR in PAR1-silenced cells rescues MUC18 expression. We further demonstrate that the PAR1-PAFR-MUC18 pathway mediates melanoma cell adhesion to microvascular endothelial cells, transendothelial migration, and metastatic retention in the lungs. Rescuing PAFR expression in PAR1-silenced cells fully restores metastatic phenotype of melanoma, indicating that PAFR plays critical role in the molecular mechanism of PAR1 action. Our results link the two pro-inflammatory G-protein-coupled receptors, PAR1 and PAFR, with the metastatic dissemination of melanoma and suggest that PAR1, PAFR, and MUC18 are attractive therapeutic targets for preventing melanoma metastasis.	[Melnikova, Vladislava O.; Balasubramanian, Krishnakumar; Villares, Gabriel J.; Dobroff, Andrey S.; Zigler, Maya; Wang, Hua; Price, Janet E.; Schroit, Alan; Bar-Eli, Menashe] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Prieto, Victor G.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Petersson, Frederik] Karolinska Univ Hosp, Karolinska Inst, Dept Pathol & Oncol, SE-17176 Stockholm, Sweden	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Karolinska Institutet; Karolinska University Hospital	Bar-Eli, M (corresponding author), 1515 Holcombe Blvd,Unit 173, Houston, TX 77030 USA.	mbareli@mdanderson.org	Hung, Mien-Chie/ABD-5911-2021; Dobroff, Andrey/A-9814-2016	Hung, Mien-Chie/0000-0003-4317-4740; Dobroff, Andrey/0000-0003-2162-9951	National Institutes of Health [RO1CA760980]; Career Development Award, NIH SPORE in Skin Cancer [P50CA093459]; Melanoma Research Foundation; NATIONAL CANCER INSTITUTE [P50CA093459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Development Award, NIH SPORE in Skin Cancer; Melanoma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1CA760980 (to M.B.-E.). This work was also supported by Career Development Award P50CA093459 from NIH SPORE in Skin Cancer and from Melanoma Research Foundation (to V. M.).	Anfosso F, 1998, J BIOL CHEM, V273, P26852, DOI 10.1074/jbc.273.41.26852; Auguste P, 2007, AM J PATHOL, V170, P1781, DOI 10.2353/ajpath.2007.060886; Biancone L, 2003, CLIN CANCER RES, V9, P4214; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; BROMBERG ME, 1995, P NATL ACAD SCI USA, V92, P8205, DOI 10.1073/pnas.92.18.8205; Bussolati B, 2000, AM J PATHOL, V157, P1713, DOI 10.1016/S0002-9440(10)64808-0; Chay CH, 2002, UROLOGY, V60, P760, DOI 10.1016/S0090-4295(02)01969-6; Chen DX, 2008, J EXP MED, V205, P1739, DOI 10.1084/jem.20071427; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; Countryman NB, 2000, J INVEST DERMATOL, V115, P267, DOI 10.1046/j.1523-1747.2000.00058.x; Dardik R, 1998, BRIT J CANCER, V77, P2069, DOI 10.1038/bjc.1998.349; DeNardo DG, 2008, CANCER METAST REV, V27, P11, DOI 10.1007/s10555-007-9100-0; Deo DD, 2004, J BIOL CHEM, V279, P3497, DOI 10.1074/jbc.M304497200; Dobroff AS, 2009, J BIOL CHEM, V284, P26194, DOI 10.1074/jbc.M109.019836; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Even-Ram SC, 2001, J BIOL CHEM, V276, P10952, DOI 10.1074/jbc.M007027200; FISCHER EG, 1995, CANCER RES, V55, P1629; GASIC GJ, 1968, P NATL ACAD SCI USA, V61, P46, DOI 10.1073/pnas.61.1.46; Glinskii OV, 2005, NEOPLASIA, V7, P522, DOI 10.1593/neo.04646; Johnson JP, 1999, CANCER METAST REV, V18, P345, DOI 10.1023/A:1006304806799; Keese CR, 2002, BIOTECHNIQUES, V33, P842, DOI 10.2144/02334rr01; Kim MP, 2009, CELL TISSUE RES, V335, P249, DOI 10.1007/s00441-008-0682-9; KLEPFISH A, 1993, INT J CANCER, V53, P978; KRAVCHENKO VV, 1995, J BIOL CHEM, V270, P14928, DOI 10.1074/jbc.270.25.14928; LAURI D, 1991, LAB INVEST, V65, P525; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martin CB, 2001, ONCOGENE, V20, P1953, DOI 10.1038/sj.onc.1204281; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Melnikova VO, 2006, J BIOL CHEM, V281, P2911, DOI 10.1074/jbc.M508683200; Mercer PF, 2007, ANN NY ACAD SCI, V1096, P86, DOI 10.1196/annals.1397.073; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Mills L, 2002, CANCER RES, V62, P5106; Mintz-Weber CS, 2000, J BIOL CHEM, V275, P34672, DOI 10.1074/jbc.M003812200; Mourad-Zeidan AA, 2008, AM J PATHOL, V173, P1839, DOI 10.2353/ajpath.2008.080380; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Nierodzik ML, 1998, BLOOD, V92, P3694, DOI 10.1182/blood.V92.10.3694.422k40_3694_3700; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pei Y, 1998, J IMMUNOL, V161, P1954; Robert EG, 2001, CURR PHARM DESIGN, V7, P1615, DOI 10.2174/1381612013397203; Ruf W, 2006, SEMIN THROMB HEMOST, V32, P61, DOI 10.1055/s-2006-939555; Rummel MM, 1996, CANCER RES, V56, P2218; Satyamoorthy K, 2001, ONCOGENE, V20, P4676, DOI 10.1038/sj.onc.1204616; Seo KH, 2004, CANCER RES, V64, P6482, DOI 10.1158/0008-5472.CAN-03-2774; Shi IM, 1999, J PATHOL, V189, P4, DOI 10.1002/(SICI)1096-9896(199909)189:1<4::AID-PATH332>3.0.CO;2-P; Shih IM, 1997, CANCER RES, V57, P3835; SHIH IM, 1994, CANCER RES, V54, P2514; Sreevidya CS, 2008, CANCER RES, V68, P3978, DOI 10.1158/0008-5472.CAN-07-6132; Tellez C, 2003, J BIOL CHEM, V278, P46632, DOI 10.1074/jbc.M309159200; Tellez CS, 2007, J INVEST DERMATOL, V127, P387, DOI 10.1038/sj.jid.5700539; Timar J, 2005, ONCOLOGY-BASEL, V69, P185, DOI 10.1159/000088069; Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048; Villares GJ, 2008, CANCER RES, V68, P9078, DOI 10.1158/0008-5472.CAN-08-2397; Villares GJ, 2009, CANCER RES, V69, P6730, DOI 10.1158/0008-5472.CAN-09-0300; Walterscheid JP, 2002, J EXP MED, V195, P171, DOI 10.1084/jem.20011450; WELCH DR, 1991, INT J CANCER, V47, P227, DOI 10.1002/ijc.2910470211; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; WOJTUKIEWICZ MZ, 1992, THROMB RES, V68, P233, DOI 10.1016/0049-3848(92)90081-K; Xie SH, 1997, CANCER RES, V57, P2295; Xie SH, 1997, ONCOGENE, V15, P2069, DOI 10.1038/sj.onc.1201358	61	62	69	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28845	28855		10.1074/jbc.M109.042150	http://dx.doi.org/10.1074/jbc.M109.042150			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19703903	hybrid, Green Published			2022-12-27	WOS:000270678900041
J	Bonten, EJ; Campos, Y; Zaitsev, V; Nourse, A; Waddell, B; Lewis, W; Taylor, G; d'Azzo, A				Bonten, Erik J.; Campos, Yvan; Zaitsev, Viateslav; Nourse, Amanda; Waddell, Brett; Lewis, William; Taylor, Garry; d'Azzo, Alessandra			Heterodimerization of the Sialidase NEU1 with the Chaperone Protective Protein/Cathepsin A Prevents Its Premature Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL BETA-GALACTOSIDASE; SIZE-DISTRIBUTION ANALYSIS; NEURAMINIDASE; PROTEIN; BINDING; MODEL; GALACTOSIALIDOSIS; SIALIDOSIS; MEMBRANE; DOMAIN	Lysosomal neuraminidase-1 (NEU1) forms a multienzyme complex with beta-galactosidase and protective protein/cathepsin A (PPCA). Because of its association with PPCA, which acts as a molecular chaperone, NEU1 is transported to the lysosomal compartment, catalytically activated, and stabilized. However, the mode(s) of association between these two proteins both en route to the lysosome and in the multienzyme complex has remained elusive. Here, we have analyzed the hydrodynamic properties of PPCA, NEU1, and a complex of the two proteins and identified multiple binding sites on both proteins. One of these sites on NEU1 that is involved in binding to PPCA can also bind to other NEU1 molecules, albeit with lower affinity. Therefore, in the absence of PPCA, as in the lysosomal storage disease galactosialidosis, NEU1 self-associates into chain-like oligomers. Binding of PPCA can reverse self-association of NEU1 by causing the disassembly of NEU1-oligomers and the formation of a PPCA-NEU1 heterodimeric complex. The identification of binding sites between the two proteins allowed us to create innovative structural models of the NEU1 oligomer and the PPCA-NEU1 heterodimeric complex. The proposed mechanism of interaction between NEU1 and its accessory protein PPCA provides a rationale for the secondary deficiency of NEU1 in galactosialidosis.	[Bonten, Erik J.; Campos, Yvan; d'Azzo, Alessandra] St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Nourse, Amanda; Waddell, Brett; Lewis, William] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Zaitsev, Viateslav; Taylor, Garry] Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9UA, Fife, Scotland	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of St Andrews	Bonten, EJ (corresponding author), St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA.	erik.bonten@stjude.org; alessandra.dazzo@stjude.org	Taylor, Garry/G-3017-2014	Nourse, Amanda/0000-0003-4595-5321	National Institutes of Health [GM60905, DK52025]; Assisi Foundation of Memphis; American Lebanese Syrian Associated Charities; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060950, R13GM060905] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Assisi Foundation of Memphis; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM60905 and DK52025. This work was also supported by the Assisi Foundation of Memphis and the American Lebanese Syrian Associated Charities.	Ando K, 1996, J BIOCHEM-TOKYO, V119, P639; Bonten E, 1996, GENE DEV, V10, P3156, DOI 10.1101/gad.10.24.3156; Bonten EJ, 2000, J BIOL CHEM, V275, P37657, DOI 10.1074/jbc.M007380200; BONTEN EJ, 1995, J BIOL CHEM, V270, P26441, DOI 10.1074/jbc.270.44.26441; Bonten EJ, 2004, FASEB J, V18, P971, DOI 10.1096/fj.03-0941fje; Brown CJ, 2008, S AFR J BUS MANAG, V39, P1; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Chaudhury S, 2007, PROTEINS, V69, P793, DOI 10.1002/prot.21731; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comelli EM, 2003, GENE, V321, P155, DOI 10.1016/j.gene.2003.08.005; d'Azzo A., 2001, METABOLIC MOL BASES, V3, P3811; de Geest N, 2002, HUM MOL GENET, V11, P1455, DOI 10.1093/hmg/11.12.1455; DOMINGUES RMCP, 1992, ZBL BAKT-INT J MED M, V277, P340, DOI 10.1016/S0934-8840(11)80912-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; FISHER KJ, 1991, J BIOL CHEM, V266, P12105; GALJAARD H, 1979, ANN CLIN BIOCHEM, V16, P343, DOI 10.1177/000456327901600192; GALJART NJ, 1988, CELL, V54, P755, DOI 10.1016/S0092-8674(88)90999-3; GASKELL A, 1995, STRUCTURE, V3, P1197, DOI 10.1016/S0969-2126(01)00255-6; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; HADDAD EB, 1992, EUR J PHARMACOL, V211, P273, DOI 10.1016/0014-2999(92)90540-K; Harding S. E., 2001, PROTEIN LIGAND INTER; HECHLER V, 1990, MOL CELL BIOCHEM, V93, P87; IGARASHI M, 1990, J IMMUNOL METHODS, V135, P91, DOI 10.1016/0022-1759(90)90260-3; Johansson A, 1999, CANCER RES, V59, P48; KARASUNO T, 1992, EUR J IMMUNOL, V22, P2003, DOI 10.1002/eji.1830220808; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Laune D, 1997, J BIOL CHEM, V272, P30937, DOI 10.1074/jbc.272.49.30937; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Meller J, 2001, PROTEINS, V45, P241, DOI 10.1002/prot.1145; Monti E, 2004, GENOMICS, V83, P445, DOI 10.1016/j.ygeno.2003.08.019; NAKAMURA M, 1991, CANCER RES, V51, P1940; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NILSSON J, 1982, EXP CELL RES, V142, P333, DOI 10.1016/0014-4827(82)90375-5; OHYASHIKI T, 1987, BIOCHIM BIOPHYS ACTA, V905, P57, DOI 10.1016/0005-2736(87)90008-3; POTIER M, 1990, BIOCHEM J, V267, P197, DOI 10.1042/bj2670197; PURI A, 1992, BIOCHEMISTRY-US, V31, P10108, DOI 10.1021/bi00156a034; Rottier RJ, 1998, HUM MOL GENET, V7, P313, DOI 10.1093/hmg/7.2.313; RUDENKO G, 1995, STRUCTURE, V3, P1249, DOI 10.1016/S0969-2126(01)00260-X; Rudenko G, 1998, P NATL ACAD SCI USA, V95, P621, DOI 10.1073/pnas.95.2.621; Saito M., 1995, BIOL SIALIC ACIDS; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sato K, 1996, BIOCHEM BIOPH RES CO, V221, P826, DOI 10.1006/bbrc.1996.0681; SCHEIBE R, 1990, BIOMED BIOCHIM ACTA, V49, P547; SCHENKMAN S, 1994, J BIOL CHEM, V269, P7970; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seyrantepe V, 2004, J BIOL CHEM, V279, P37021, DOI 10.1074/jbc.M404531200; STENBERG PE, 1991, J CELL PHYSIOL, V147, P7, DOI 10.1002/jcp.1041470103; Teodorescu O, 2004, PROTEINS, V54, P41, DOI 10.1002/prot.10474; Thomas G.H., METABOLIC MOL BASES, V3, P3507; Tovchigrechko A, 2005, PROTEINS, V60, P296, DOI 10.1002/prot.20573; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; van der Spoel A, 2000, J BIOL CHEM, V275, P10035, DOI 10.1074/jbc.275.14.10035; van der Spoel A, 1998, EMBO J, V17, P1588, DOI 10.1093/emboj/17.6.1588; VANDONGEN JM, 1985, EUR J CELL BIOL, V39, P179; Vinogradova MV, 1998, BIOCHEM J, V330, P641; Wang DN, 2005, MOL GENET METAB, V85, P181, DOI 10.1016/j.ymgme.2005.03.007; Wang D, 2009, BBA-GEN SUBJECTS, V1790, P275, DOI 10.1016/j.bbagen.2009.01.006; WU GS, 1991, J NEUROCHEM, V56, P95, DOI 10.1111/j.1471-4159.1991.tb02567.x; Yamaguchi K, 2005, BIOCHEM J, V390, P85, DOI 10.1042/BJ20050017; YAMAMOTO Y, 1987, INT J BIOCHEM, V19, P435, DOI 10.1016/0020-711X(87)90064-4; Yogalingam G, 2008, DEV CELL, V15, P74, DOI 10.1016/j.devcel.2008.05.005; ZHOU XY, 1995, GENE DEV, V9, P2623, DOI 10.1101/gad.9.21.2623	64	55	56	6	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28430	28441		10.1074/jbc.M109.031419	http://dx.doi.org/10.1074/jbc.M109.031419			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19666471	Green Published, hybrid			2022-12-27	WOS:000270676300068
J	Cheng, RCK; Tikhonov, DB; Zhorov, BS				Cheng, Ricky C. K.; Tikhonov, Denis B.; Zhorov, Boris S.			Structural Model for Phenylalkylamine Binding to L-type Calcium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTRICTED MOLECULAR FLEXIBILITY; CA2+ CHANNEL; OPTICAL ISOMERS; BENZOTHIAZEPINE BINDING; POTASSIUM CHANNEL; ALPHA-1 SUBUNIT; K+ CHANNEL; PHARMACOLOGICAL EVALUATION; DIHYDROPYRIDINE-BINDING; VERAPAMIL ANALOGS	Phenylalkylamines (PAAs), a major class of L-type calcium channel (LTCC) blockers, have two aromatic rings connected by a flexible chain with a nitrile substituent. Structural aspects of ligand-channel interactions remain unclear. We have built a KvAP-based model of LTCC and used Monte Carlo energy minimizations to dock devapamil, verapamil, gallopamil, and other PAAs. The PAA-LTCC models have the following common features: (i) the meta-methoxy group in ringA, which is proximal to the nitrile group, accepts an H-bond from a PAA-sensing Tyr_IIIS6; (ii) the meta-methoxy group in ring B accepts an H-bond from a PAA-sensing Tyr_IVS6; (iii) the ammonium group is stabilized at the focus of P-helices; and (iv) the nitrile group binds to a Ca2+ ion coordinated by the selectivity filter glutamates in repeats III and IV. The latter feature can explain Ca2+ potentiation of PAA action and the presence of an electronegative atom at a similar position of potent PAA analogs. Tyr substitution of a Thr in IIIS5 is known to enhance action of devapamil and verapamil. Our models predict that the para-methoxy group in ring A of devapamil and verapamil accepts an H-bond from this engineered Tyr. The model explains structure-activity relationships of PAAs, effects of LTCC mutations on PAA potency, data on PAA access to LTCC, and Ca2+ potentiation of PAA action. Common and class-specific aspects of action of PAAs, dihydropyridines, and benzothiazepines are discussed in view of the repeat interface concept.	[Cheng, Ricky C. K.; Tikhonov, Denis B.; Zhorov, Boris S.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Tikhonov, Denis B.] Russian Acad Sci, IM Sechenov Evolutionary Physiol & Biochem Inst, St Petersburg 194223, Russia	McMaster University; North-Western State Medical University named after I.I. Mechnikov; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Zhorov, BS (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.	zhorov@mcmaster.ca	Tikhonov, Denis/AAK-9148-2020; Zhorov, Boris/T-9892-2019; Zhorov, Boris S./V-8072-2019	Zhorov, Boris/0000-0002-3630-7114; Tikhonov, Denis/0000-0001-8523-4305	Canadian Institutes of Health Research [MOP-53229]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-53229 (to B. S. Z.). Computations were performed using the facilities of the Shared Hierarchical Academic Research Computing Network (SHARCNET).	ALMERS W, 1984, J PHYSIOL-LONDON, V353, P585, DOI 10.1113/jphysiol.1984.sp015352; BAYER R, 1975, N-S ARCH PHARMACOL, V290, P69, DOI 10.1007/BF00499990; Berjukov S, 1996, BRIT J PHARMACOL, V119, P1197, DOI 10.1111/j.1476-5381.1996.tb16022.x; Beyl S, 2007, J BIOL CHEM, V282, P3864, DOI 10.1074/jbc.M609153200; Bruhova I, 2008, MOL PHARMACOL, V74, P1033, DOI 10.1124/mol.108.049759; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; CATTERALL WA, 1992, TRENDS PHARMACOL SCI, V13, P256, DOI 10.1016/0165-6147(92)90079-L; Cleary L., 2004, Autonomic & Autacoid Pharmacology, V24, P63, DOI 10.1111/j.1474-8673.2004.00317.x; DEI S, 1993, J MED CHEM, V36, P439, DOI 10.1021/jm00056a003; DeLano W.L, PYMOL MOL GRAPHICS S; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Dilmac N, 2004, MOL PHARMACOL, V66, P1236, DOI 10.1124/mol.104.000893; Doring F, 1996, J BIOL CHEM, V271, P11745, DOI 10.1074/jbc.271.20.11745; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dudley SC, 2000, J GEN PHYSIOL, V116, P679, DOI 10.1085/jgp.116.5.679; Faraldo-Gomez JD, 2007, J MOL BIOL, V365, P649, DOI 10.1016/j.jmb.2006.09.069; FERRY DR, 1985, BRIT J PHARMACOL, V84, P811, DOI 10.1111/j.1476-5381.1985.tb17375.x; Freeze BS, 2006, MOL PHARMACOL, V70, P718, DOI 10.1124/mol.106.023473; GLOSSMANN H, 1990, REV PHYSL BIOCH PHAR, V114, P1; GOLL A, 1986, N-S ARCH PHARMACOL, V334, P303, DOI 10.1007/BF00508786; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; HERING S, 1993, MOL PHARMACOL, V43, P820; HESCHELER J, 1982, PFLUG ARCH EUR J PHY, V393, P287, DOI 10.1007/BF00581411; HOCKERMAN GH, 1995, J BIOL CHEM, V270, P22119, DOI 10.1074/jbc.270.38.22119; Hockerman GH, 1997, J BIOL CHEM, V272, P18759, DOI 10.1074/jbc.272.30.18759; Hockerman GH, 1997, ANNU REV PHARMACOL, V37, P361, DOI 10.1146/annurev.pharmtox.37.1.361; Huber I, 2000, BIOCHEM J, V347, P829, DOI 10.1042/0264-6021:3470829; Huber IG, 2004, J BIOL CHEM, V279, P55211, DOI 10.1074/jbc.M409008200; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Johnson BD, 1996, MOL PHARMACOL, V50, P1388; KAUMANN AJ, 1976, N-S ARCH PHARMACOL, V292, P21, DOI 10.1007/BF00506485; Lacinova L, 2005, GEN PHYSIOL BIOPHYS, V24, P3; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; LEE KS, 1983, NATURE, V302, P790, DOI 10.1038/302790a0; LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611; Lipkind GM, 2003, MOL PHARMACOL, V63, P499, DOI 10.1124/mol.63.3.499; Lipkind GM, 2001, BIOCHEMISTRY-US, V40, P6786, DOI 10.1021/bi010269a; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; LUDWIG C, 1977, BRIT J PHARMACOL, V59, P411, DOI 10.1111/j.1476-5381.1977.tb08394.x; MANNHOLD R, 1986, ARCH PHARM, V319, P990, DOI 10.1002/ardp.19863191107; MANNHOLD R, 1978, N-S ARCH PHARMACOL, V302, P217, DOI 10.1007/BF00517988; NAKAYAMA H, 1991, P NATL ACAD SCI USA, V88, P9203, DOI 10.1073/pnas.88.20.9203; Nawrath H, 1997, N-S ARCH PHARMACOL, V355, P79; Pagel PS, 1998, EUR J PHARMACOL, V348, P213, DOI 10.1016/S0014-2999(98)00145-9; SATOH K, 1980, J CARDIOVASC PHARM, V2, P309, DOI 10.1097/00005344-198005000-00008; Schuster A, 1996, EMBO J, V15, P2365, DOI 10.1002/j.1460-2075.1996.tb00592.x; SEYDL K, 1993, PFLUG ARCH EUR J PHY, V424, P552, DOI 10.1007/BF00374922; Sokolov S, 2001, CIRC RES, V89, P700, DOI 10.1161/hh2001.098983; STRIESSNIG J, 1991, P NATL ACAD SCI USA, V88, P10769, DOI 10.1073/pnas.88.23.10769; STRIESSNIG J, 1990, P NATL ACAD SCI USA, V87, P9108, DOI 10.1073/pnas.87.23.9108; TEODORI E, 1994, EUR J MED CHEM, V29, P139, DOI 10.1016/0223-5234(94)90211-9; Tikhonov DB, 2005, BIOPHYS J, V88, P184, DOI 10.1529/biophysj.104.048173; Tikhonov DB, 2008, J BIOL CHEM, V283, P17594, DOI 10.1074/jbc.M800141200; Tikhonov DB, 2007, BIOPHYS J, V93, P1557, DOI 10.1529/biophysj.106.100248; Tikhonov DB, 2009, J BIOL CHEM, V284, P19006, DOI 10.1074/jbc.M109.011296; Triggle DJ, 2003, CELL MOL NEUROBIOL, V23, P293, DOI 10.1023/A:1023632419813; TRIGGLE DJ, 1991, J CARDIOVASC PHARM, V18, pS1; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Zhorov BS, 2004, J NEUROCHEM, V88, P782, DOI 10.1111/j.1471-4159.2004.02261.x; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	62	39	40	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28332	28342		10.1074/jbc.M109.027326	http://dx.doi.org/10.1074/jbc.M109.027326			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19700404	hybrid, Green Published			2022-12-27	WOS:000270676300059
J	Park, SY; Choi, JH; Ryu, HS; Pak, YK; Park, KS; Lee, HK; Lee, W				Park, Seung-Yoon; Choi, Jung Hyun; Ryu, Hyun Su; Pak, Youngmi Kim; Park, Kyong Soo; Lee, Hong Kyu; Lee, Wan			C1q Tumor Necrosis Factor alpha-related Protein Isoform 5 Is Increased in Mitochondrial DNA-depleted Myocytes and Activates AMP-activated Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA CARBOXYLASE; FATTY-ACID OXIDATION; SKELETAL-MUSCLE; GLUT4 TRANSLOCATION; GLUCOSE-TRANSPORT; INSULIN-RESISTANCE; CONTRACTION; CELLS; GENE; ACRP30/ADIPONECTIN	Depletion of mtDNA in myocytes causes insulin resistance and alters nuclear gene expression that may be involved in rescuing processes against cellular stress. Here we show that the expression of C1q tumor necrosis factor a-related protein isoform 5 (C1QTNF5) is drastically increased following depletion of mtDNA in myocytes. C1QTNF5 is homologous to adiponectin in respect to domain structure, and its expression and secretion from myocytes correlated negatively with the cellular mtDNA content. Similar to adiponectin, C1QTNF5 induced the phosphorylation of AMP-activated protein kinase (AMPK), leading to increased cell surface recruitment of GLUT4 and increased glucose uptake. Treatment of cells with purified recombinant C1QTNF5 increased the phosphorylation of acetyl-CoA carboxylase and stimulated fatty acid oxidation. C1QTNF5-mediated phosphorylation of AMPK or acetyl-CoA carboxylase was unaffected by depletion of adiponectin receptors such as AdipoR1 or AdipoR2, which indicated that adiponectin receptors do not participate in C1QTNF5-induced activation of AMPK. Serum C1QTNF5 levels were significantly higher in obese/diabetic animals (OLETF rats, ob/ob mice, and db/db mice). These results highlight C1QTNF5 as a putative biomarker for mitochondrial dysfunction and a potent activator of AMPK.	[Park, Seung-Yoon; Choi, Jung Hyun; Ryu, Hyun Su; Lee, Wan] Dongguk Univ, Coll Med, Dept Biochem, Kyungju 780714, South Korea; [Pak, Youngmi Kim] Kyung Hee Univ, Dept Nanopharmaceut & Life Sci, Age Related & Brain Dis Res Ctr, Seoul 130701, South Korea; [Park, Kyong Soo; Lee, Hong Kyu] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110744, South Korea	Dongguk University; Kyung Hee University; Seoul National University (SNU)	Lee, W (corresponding author), Dongguk Univ, Coll Med, Dept Biochem, Kyungju 780714, South Korea.	wanlee@dongguk.ac.kr	Pak, Youngmi Kim/AAI-1091-2020; Park, Kyong Soo/C-2265-2008; Lee, Wan/B-6252-2013	Pak, Youngmi Kim/0000-0001-7424-3484; Park, Kyong Soo/0000-0003-3597-342X; Lee, Wan/0000-0002-5181-2135	Korea Health 21 RD Project [00-PJ3-PG6-GN07-0001]; Korea Healthcare Technology RD Project [A080151]; Ministry of Health and Welfare [MI 08KMOI 0008-08KI 301-00810]; Ministryof Education, Science and Technology, KOSEF, Republic of Korea [M10642140004-06N4214-00410]	Korea Health 21 RD Project; Korea Healthcare Technology RD Project; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministryof Education, Science and Technology, KOSEF, Republic of Korea(Korea Science and Engineering Foundation)	This work was supported by Grant 00-PJ3-PG6-GN07-0001 of the Korea Health 21 R&D Project (to W. L.) and Grant A080151 of the Korea Healthcare Technology R&D Project (to S. Y. P.) from the Ministry of Health and Welfare, by Grant MI 08KMOI 0008-08KI 301-00810 of 21 C Frontier Functional Proteomics Project from Ministryof Education, Science and Technology (to W.L.), and by Grant M10642140004-06N4214-00410 from KOSEF (to Y. K. P.), Republic of Korea.	Akiyama H, 2006, FEBS J, V273, P2257, DOI 10.1111/j.1742-4658.2006.05240.x; Biswas G, 2005, GENE, V354, P132, DOI 10.1016/j.gene.2005.03.028; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Fang X, 2005, J MOL ENDOCRINOL, V35, P465, DOI 10.1677/jme.1.01877; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Hayward C, 2003, HUM MOL GENET, V12, P2657, DOI 10.1093/hmg/ddg289; KANAI F, 1993, J BIOL CHEM, V268, P14523; KAWANO K, 1994, DIABETES RES CLIN PR, V24, pS317, DOI 10.1016/0168-8227(94)90269-0; Kim JY, 2002, AM J PHYSIOL-ENDOC M, V282, pE1014, DOI 10.1152/ajpendo.00233.2001; Kottom TJ, 2004, INFECT IMMUN, V72, P4628, DOI 10.1128/IAI.72.8.4628-4636.2004; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Lasser G, 2006, BLOOD, V107, P423, DOI 10.1182/blood-2005-04-1425; Maeda T, 2006, J CELL PHYSIOL, V206, P537, DOI 10.1002/jcp.20493; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Palanivel R, 2007, CARDIOVASC RES, V75, P148, DOI 10.1016/j.cardiores.2007.04.011; Park SY, 2005, J BIOL CHEM, V280, P9855, DOI 10.1074/jbc.M409399200; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Somwar R, 2002, J BIOL CHEM, V277, P50386, DOI 10.1074/jbc.M205277200; Tang YT, 2005, GENOMICS, V86, P100, DOI 10.1016/j.ygeno.2005.03.001; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Vavvas D, 1997, J BIOL CHEM, V272, P13255, DOI 10.1074/jbc.272.20.13255; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yoon MJ, 2006, DIABETES, V55, P2562, DOI 10.2337/db05-1322	30	82	85	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27780	27789		10.1074/jbc.M109.005611	http://dx.doi.org/10.1074/jbc.M109.005611			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19651784	hybrid, Green Published			2022-12-27	WOS:000270676300004
J	Geiss-Friedlander, R; Parmentier, N; Moller, U; Urlaub, H; Van den Eynde, BJ; Melchior, F				Geiss-Friedlander, Ruth; Parmentier, Nicolas; Moeller, Ulrike; Urlaub, Henning; Van den Eynde, Benoit J.; Melchior, Frauke			The Cytoplasmic Peptidase DPP9 Is Rate-limiting for Degradation of Proline-containing Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; ANTIGEN PRESENTATION; THIMET OLIGOPEPTIDASE; ENDOPLASMIC-RETICULUM; DRUG DISCOVERY; AMINOPEPTIDASE; PROTEASOMES; GENERATION; INHIBITORS; ERAP1	Protein degradation is an essential process that continuously takes place in all living cells. Regulated degradation of most cellular proteins is initiated by proteasomes, which produce peptides of varying length. These peptides are rapidly cleaved to single amino acids by cytoplasmic peptidases. Proline-containing peptides pose a specific problem due to structural constrains imposed by the pyrrolidine ring that prevents most peptidases from cleavage. Here we show that DPP9, a poorly characterized cytoplasmic prolyl-peptidase, is rate-limiting for destruction of proline-containing substrates both in cell extracts and in intact cells. We identified the first natural substrate for DPP9, the RU1(34-42) antigenic peptide (VPYGSFKHV). RU1(34-42) is degraded in vitro by DPP9, and down-regulation of DPP9 in intact cells results in increased presentation of this antigen. Together our findings demonstrate an important role for DPP9 in peptide turnover and antigen presentation.	[Geiss-Friedlander, Ruth; Moeller, Ulrike; Melchior, Frauke] Univ Gottingen, Fac Med, Dept Biochem 1, D-37073 Gottingen, Germany; [Parmentier, Nicolas; Van den Eynde, Benoit J.] Univ Catholique Louvain, Ludwig Inst Canc Res, Brussels Branch, B-1200 Brussels, Belgium; [Parmentier, Nicolas; Van den Eynde, Benoit J.] Univ Catholique Louvain, Cellular Genet Unit, B-1200 Brussels, Belgium; [Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Melchior, Frauke] Univ Heidelberg, ZMBH, D-69120 Heidelberg, Germany	University of Gottingen; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; Max Planck Society; Ruprecht Karls University Heidelberg	Geiss-Friedlander, R (corresponding author), Univ Gottingen, Fac Med, Dept Biochem 1, Humboldtallee 23, D-37073 Gottingen, Germany.	rgeiss@gwdg.de; f.melchior@zmbh.uni-heidelberg.de	Geiss-Friedlander, Ruth/AAT-8768-2020; Melchior, Frauke/E-2014-2014; Geiss-Friedlander, Ruth/G-3569-2013	Geiss-Friedlander, Ruth/0000-0002-1720-3440; Melchior, Frauke/0000-0001-9546-8797; Geiss-Friedlander, Ruth/0000-0002-1720-3440	European Union [LSHC-CT-2006-518234]; Fonds J. Maisin (Belgium); Fondation contre le Cancer (Belgium); Fonds National de la Recherche Scientifique (Belgium)	European Union(European Commission); Fonds J. Maisin (Belgium); Fondation contre le Cancer (Belgium); Fonds National de la Recherche Scientifique (Belgium)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by grants from the European Union (Rubicon NoE and LSHC-CT-2006-518234), the Fonds J. Maisin (Belgium), and the Fondation contre le Cancer (Belgium).; Supported by a Televie grant from the Fonds National de la Recherche Scientifique (Belgium).	Abbott CA, 2000, EUR J BIOCHEM, V267, P6140, DOI 10.1046/j.1432-1327.2000.01617.x; Ajami K, 2004, BBA-GENE STRUCT EXPR, V1679, P18, DOI 10.1016/j.bbaexp.2004.03.010; Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Conarello SL, 2003, P NATL ACAD SCI USA, V100, P6825, DOI 10.1073/pnas.0631828100; Connolly BA, 2008, J MED CHEM, V51, P6005, DOI 10.1021/jm800390n; Craiu A, 1997, P NATL ACAD SCI USA, V94, P10850, DOI 10.1073/pnas.94.20.10850; Daniel S, 1998, J IMMUNOL, V161, P617; DE MI, 2003, ADV EXP MED BIOL, V524, P3; Drucker DJ, 2007, DIABETES CARE, V30, P1335, DOI 10.2337/dc07-0228; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Kloetzel PM, 2004, NAT IMMUNOL, V5, P661, DOI 10.1038/ni1090; Lankas GR, 2005, DIABETES, V54, P2988, DOI 10.2337/diabetes.54.10.2988; Levy F, 2002, J IMMUNOL, V169, P4161, DOI 10.4049/jimmunol.169.8.4161; Marguet D, 2000, P NATL ACAD SCI USA, V97, P6874, DOI 10.1073/pnas.120069197; McIntosh CHS, 2008, FRONT BIOSCI-LANDMRK, V13, P1753, DOI 10.2741/2797; Morel S, 2000, IMMUNITY, V12, P107, DOI 10.1016/S1074-7613(00)80163-6; MORTZ E, 1994, BIOL MASS SPECTROM, V23, P249, DOI 10.1002/bms.1200230503; NEISIG A, 1995, J IMMUNOL, V154, P1273; Olsen C, 2002, GENE, V299, P185, DOI 10.1016/S0378-1119(02)01059-4; Polgar L, 2002, CELL MOL LIFE SCI, V59, P349, DOI 10.1007/s00018-002-8427-5; Qi SY, 2003, BIOCHEM J, V373, P179, DOI 10.1042/BJ20021914; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Rosenblum JS, 2003, CURR OPIN CHEM BIOL, V7, P496, DOI 10.1016/S1367-5931(03)00084-X; Saric T, 2001, J BIOL CHEM, V276, P36474, DOI 10.1074/jbc.M105517200; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2005, IMMUNOL REV, V207, P42, DOI 10.1111/j.0105-2896.2005.00313.x; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Silva CL, 1999, BIOCHEM BIOPH RES CO, V255, P591, DOI 10.1006/bbrc.1999.0250; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; Tang HK, 2009, ARCH BIOCHEM BIOPHYS, V485, P120, DOI 10.1016/j.abb.2009.02.015; Uebel S, 1997, P NATL ACAD SCI USA, V94, P8976, DOI 10.1073/pnas.94.17.8976; Van der Veken P, 2007, CURR TOP MED CHEM, V7, P621, DOI 10.2174/156802607780091046; VANENDERT PM, 1995, J EXP MED, V182, P1883, DOI 10.1084/jem.182.6.1883; Wu JJ, 2009, BIOCHEM PHARMACOL, V78, P203, DOI 10.1016/j.bcp.2009.03.032; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250; York IA, 2003, IMMUNITY, V18, P429, DOI 10.1016/S1074-7613(03)00058-X; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860	44	69	70	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27211	27219		10.1074/jbc.M109.041871	http://dx.doi.org/10.1074/jbc.M109.041871			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19667070	hybrid, Green Published			2022-12-27	WOS:000270232300021
J	Castel, AL; Tomkinson, AE; Pearson, CE				Castel, Arturo Lopez; Tomkinson, Alan E.; Pearson, Christopher E.			CTG/CAG Repeat Instability Is Modulated by the Levels of Human DNA Ligase I and Its Interaction with Proliferating Cell Nuclear Antigen A DISTINCTION BETWEEN REPLICATION AND SLIPPED-DNA REPAIR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; HUMAN MISMATCH REPAIR; POLYMERASE-DELTA; CAG REPEAT; STRAIN 46BR; TRINUCLEOTIDE REPEAT; STRUCTURAL BASIS; HUMAN PROTEINS; FREE-EXTRACTS; CLAMP LOADER	Mechanisms contributing to disease-associated trinucleotide repeat instability are poorly understood. DNA ligation is an essential step common to replication and repair, both potential sources of repeat instability. Using derivatives of DNA ligase I (hLigI)-deficient human cells (46BR.1G1), we assessed the effect of hLigI activity, overexpression, and its interaction with proliferating cell nuclear antigen (PCNA) upon the ability to replicate and repair trinucleotide repeats. Compared with LigI(+/+), replication progression through repeats was poor, and repair tracts were broadened beyond the slipped-repeat for all mutant extracts. Increased repeat instability was linked only to hLigI overexpression and expression of a mutant hLigI incapable of interacting with PCNA. The endogenous mutant version of hLigI with reduced ligation activity did not alter instability. We distinguished the DNA processes through which hLigI contributes to trinucleotide instability. The highest levels of repeat instability were observed under the hLigI overexpression and were linked to reduced slipped-DNAs repair efficiencies. Therefore, the replication-mediated instability can partly be attributed to errors during replication but also to the poor repair of slipped-DNAs formed during this process. However, repair efficiencies were unaffected by expression of a PCNA interaction mutant of hLigI, limiting this instability to the replication process. The addition of purified proteins suggests that disruption of LigI and PCNA interactions influences trinucleotide repeat instability. The variable levels of age- and tissue-specific trinucleotide repeat instability observed in myotonic dystrophy patients and transgenic mice may be influenced by varying steady state levels of DNA ligase I in these tissues and during different developmental windows.	Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1L7, Canada; [Pearson, Christopher E.] Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; [Tomkinson, Alan E.] Univ Maryland, Sch Med, Radiat Oncol Res Lab, Dept Radiat Oncol, Baltimore, MD 21201 USA; [Tomkinson, Alan E.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Pearson, CE (corresponding author), Hosp Sick Children, Dept Genet & Genome Biol, TMDT Bldg,101 Coll St,E Tower,15th Floor,Rm 15-31, Toronto, ON M5G 1L7, Canada.	cepearson.Sickkids@gmail.com	Castel, Arturo López/AAL-9778-2020	Pearson, Christopher/0000-0001-9545-4205	National Institutes of Health [GM57479]; The Hospital for Sick Children; Canadian Institutes of Health Research; Muscular Dystrophy Association U. S. A; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057479] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Hospital for Sick Children; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Muscular Dystrophy Association U. S. A(Muscular Dystrophy Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM57479 (to A. T.).; Supported by a RESTRACOMP postdoctoral fellowship (The Hospital for Sick Children) and by grants to Christopher Pearson from the Canadian Institutes of Health Research and the Muscular Dystrophy Association U. S. A.	Araujo SJ, 2000, GENE DEV, V14, P349; Baida A, 2003, DNA REPAIR, V2, P827, DOI 10.1016/S1568-7864(03)00069-7; Balakrishnan L, 2009, J BIOL CHEM, V284, P15158, DOI 10.1074/jbc.M109.000505; BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; Bentley DJ, 1996, NAT GENET, V13, P489, DOI 10.1038/ng0896-489; Bentley DJ, 2002, J CELL SCI, V115, P1551; Bhagwat AS, 1999, NUCLEIC ACIDS RES, V27, P4028, DOI 10.1093/nar/27.20.4028; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Callahan JL, 2003, MOL CELL BIOL, V23, P7849, DOI 10.1128/MCB.23.21.7849-7860.2003; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Chen X, 2006, METHOD ENZYMOL, V409, P39, DOI 10.1016/S0076-6879(05)09003-8; Corrette-Bennett SE, 2004, NUCLEIC ACIDS RES, V32, P6268, DOI 10.1093/nar/gkh965; Ferrari G, 2003, J BIOL CHEM, V278, P37761, DOI 10.1074/jbc.M304462200; Freudenreich CH, 1997, MOL CELL BIOL, V17, P2090, DOI 10.1128/MCB.17.4.2090; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Goetz JDM, 2005, DNA REPAIR, V4, P649, DOI 10.1016/j.dnarep.2005.02.004; Gomes-Pereira M, 2004, HUM MOL GENET, V13, P1815, DOI 10.1093/hmg/ddh186; Harrison C, 2002, CANCER RES, V62, P4065; HENDERSON LM, 1985, P NATL ACAD SCI USA, V82, P2044, DOI 10.1073/pnas.82.7.2044; Ireland MJ, 2000, GENETICS, V155, P1657; Ivanov I, 2006, NUCLEIC ACIDS RES, V34, P6023, DOI 10.1093/nar/gkl744; Jessberger R, 1997, NUCLEIC ACIDS RES, V25, P289, DOI 10.1093/nar/25.2.289; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; KANG SM, 1995, J BIOL CHEM, V270, P27014, DOI 10.1074/jbc.270.45.27014; Kokoska RJ, 1999, GENETICS, V151, P511; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Lee YCA, 2008, INT J CANCER, V122, P1630, DOI 10.1002/ijc.23274; LEHMANN AR, 1988, CANCER RES, V48, P6343; Levin DS, 2000, CURR BIOL, V10, P919, DOI 10.1016/S0960-9822(00)00619-9; Levin DS, 2004, J BIOL CHEM, V279, P55196, DOI 10.1074/jbc.M409250200; Levin DS, 1997, P NATL ACAD SCI USA, V94, P12863, DOI 10.1073/pnas.94.24.12863; Longley MJ, 1997, J BIOL CHEM, V272, P10917; LONN U, 1989, CARCINOGENESIS, V10, P981, DOI 10.1093/carcin/10.6.981; Lopez A, 2005, MUTAT RES-FUND MOL M, V570, P253, DOI 10.1016/j.mrfmmm.2004.11.005; Mackenney VJ, 1997, J BIOL CHEM, V272, P11550; Maga G, 2001, P NATL ACAD SCI USA, V98, P14298, DOI 10.1073/pnas.251193198; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; Martin IV, 2002, GENOME BIOL, V3; Mayanagia K, 2009, P NATL ACAD SCI USA, V106, P4647, DOI 10.1073/pnas.0811196106; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Mirkin SM, 2006, CURR OPIN STRUC BIOL, V16, P351, DOI 10.1016/j.sbi.2006.05.004; Mirkin SM, 2005, NAT STRUCT MOL BIOL, V12, P635, DOI 10.1038/nsmb0805-635; Mocquet V, 2008, EMBO J, V27, P155, DOI 10.1038/sj.emboj.7601948; MONTECUCCO A, 1992, NUCLEIC ACIDS RES, V20, P6209, DOI 10.1093/nar/20.23.6209; Montecucco A, 1998, EMBO J, V17, P3786, DOI 10.1093/emboj/17.13.3786; Mortusewicz O, 2006, NUCLEIC ACIDS RES, V34, P3523, DOI 10.1093/nar/gkl492; Mossi R, 1998, J BIOL CHEM, V273, P14322, DOI 10.1074/jbc.273.23.14322; NOCENTINI S, 1981, CHROMOSOME DAMAGE RE, P329; Ohshima K, 1997, J BIOL CHEM, V272, P16798, DOI 10.1074/jbc.272.27.16798; Panigrahi GB, 2005, NAT STRUCT MOL BIOL, V12, P654, DOI 10.1038/nsmb959; Panigrahi GB, 2002, J BIOL CHEM, V277, P13926, DOI 10.1074/jbc.M109761200; Pascal JM, 2006, MOL CELL, V24, P279, DOI 10.1016/j.molcel.2006.08.015; Pascucci B, 1999, J BIOL CHEM, V274, P33696, DOI 10.1074/jbc.274.47.33696; Pearson CE, 2002, NUCLEIC ACIDS RES, V30, P4534, DOI 10.1093/nar/gkf572; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; POIRIER V, 1985, CARCINOGENESIS, V6, P837, DOI 10.1093/carcin/6.6.837; Prasad R, 1996, J BIOL CHEM, V271, P16000, DOI 10.1074/jbc.271.27.16000; PRIGENT C, 1994, MOL CELL BIOL, V14, P310, DOI 10.1128/MCB.14.1.310; Ramsden DA, 1997, NATURE, V388, P488, DOI 10.1038/41351; Refsland EW, 2005, GENETICS, V171, P923, DOI 10.1534/genetics.105.043448; Riva F, 2004, EXP CELL RES, V293, P357, DOI 10.1016/j.yexcr.2003.10.025; Rossi R, 1999, EMBO J, V18, P5745, DOI 10.1093/emboj/18.20.5745; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Savouret C, 2003, EMBO J, V22, P2264, DOI 10.1093/emboj/cdg202; Savouret C, 2004, MOL CELL BIOL, V24, P629, DOI 10.1128/MCB.24.2.629-637.2004; Schweitzer JK, 1999, GENETICS, V152, P953; Schweitzer JK, 1998, HUM MOL GENET, V7, P69, DOI 10.1093/hmg/7.1.69; Smirnova E, 2005, BIOCHEM J, V389, P13, DOI 10.1042/BJ20050211; SOMIA NV, 1993, MUTAT RES, V294, P51, DOI 10.1016/0921-8777(93)90057-N; Song W, 2007, J BIOL CHEM, V282, P22721, DOI 10.1074/jbc.M703774200; Soza S, 2009, MOL CELL BIOL, V29, P2032, DOI 10.1128/MCB.01730-08; Sporbert A, 2005, NUCLEIC ACIDS RES, V33, P3521, DOI 10.1093/nar/gki665; SQUIRES S, 1983, CARCINOGENESIS, V4, P565, DOI 10.1093/carcin/4.5.565; Subramanian J, 2005, GENETICS, V171, P427, DOI 10.1534/genetics.105.042861; Sun DY, 2001, CLIN CANCER RES, V7, P4143; TEO IA, 1983, CARCINOGENESIS, V4, P559, DOI 10.1093/carcin/4.5.559; TEO IA, 1983, MUTAT RES, V107, P371, DOI 10.1016/0027-5107(83)90177-X; Timson DJ, 2000, MUTAT RES-DNA REPAIR, V460, P301, DOI 10.1016/S0921-8777(00)00033-1; Tom S, 2001, J BIOL CHEM, V276, P24817, DOI 10.1074/jbc.M101673200; van den Broek WJAA, 2002, HUM MOL GENET, V11, P191, DOI 10.1093/hmg/11.2.191; Veeraraghavan J, 2003, J BIOL CHEM, V278, P42854, DOI 10.1074/jbc.M305137200; Vijayakumar S, 2007, NUCLEIC ACIDS RES, V35, P1624, DOI 10.1093/nar/gkm006; Vijayakumar S, 2009, MOL CELL BIOL, V29, P2042, DOI 10.1128/MCB.01732-08; Vispe S, 2000, J BIOL CHEM, V275, P27386; Vitolo B, 2005, EUR J HISTOCHEM, V49, P349; Wang WS, 2006, J BIOL CHEM, V281, P20865, DOI 10.1074/jbc.M602289200; WEBSTER ADB, 1992, LANCET, V339, P1508, DOI 10.1016/0140-6736(92)91266-B; Wheeler VC, 2003, HUM MOL GENET, V12, P273, DOI 10.1093/hmg/ddg056; Wu XH, 1999, BIOCHEMISTRY-US, V38, P2628, DOI 10.1021/bi982592s; Yang JH, 2007, GENE, V393, P110, DOI 10.1016/j.gene.2007.01.025; YANG SW, 1992, J BIOL CHEM, V267, P2345; Yang Z, 2003, AM J HUM GENET, V73, P1092, DOI 10.1086/379523; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	94	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26631	26645		10.1074/jbc.M109.034405	http://dx.doi.org/10.1074/jbc.M109.034405			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19628465	Green Published, hybrid			2022-12-27	WOS:000269969600044
J	Djakovic, SN; Schwarz, LA; Barylko, B; DeMartino, GN; Patrick, GN				Djakovic, Stevan N.; Schwarz, Lindsay A.; Barylko, Barbara; DeMartino, George N.; Patrick, Gentry N.			Regulation of the Proteasome by Neuronal Activity and Calcium/Calmodulin-dependent Protein Kinase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; 26 S PROTEASOME; SYNAPTIC PLASTICITY; DENDRITIC SPINES; ORNITHINE-DECARBOXYLASE; HIPPOCAMPAL-NEURONS; FLUORESCENT PROTEIN; SURFACE EXPRESSION; UBIQUITIN SYSTEM; GAMMA-INTERFERON	Protein degradation via the ubiquitin proteasome system has been shown to regulate changes in synaptic strength that underlie multiple forms of synaptic plasticity. It is plausible, therefore, that the ubiquitin proteasome system is itself regulated by synaptic activity. By utilizing live-cell imaging strategies we report the rapid and dynamic regulation of the proteasome in hippocampal neurons by synaptic activity. We find that the blockade of action potentials (APs) with tetrodotoxin inhibited the activity of the proteasome, whereas the up-regulation of APs with bicuculline dramatically increased the activity of the proteasome. In addition, the regulation of the proteasome is dependent upon external calcium entry in part through N-methyl-D-aspartate receptors and L-type voltage-gated calcium channels and requires the activity of calcium/calmodulin-dependent protein kinase II (CaMKII). Using in vitro and in vivo assays we find that CaMKII stimulates proteasome activity and directly phosphorylates Rpt6, a subunit of the 19 S (PA700) sub-complex of the 26 S proteasome. Our data provide a novel mechanism whereby CaMKII may regulate the proteasome in neurons to facilitate remodeling of synaptic connections through protein degradation.	[Patrick, Gentry N.] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [DeMartino, George N.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of California System; University of California San Diego; University of Texas System; University of Texas Southwestern Medical Center Dallas	Patrick, GN (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	gpatrick@ucsd.edu	Schwarz, Lindsay/N-8125-2018	Schwarz, Lindsay/0000-0002-0613-5518	National Institutes of Health [DK46181, NS054732]; University of California San Diego; National Science Foundation; Ray Thomas Edwards Foundation; American Cancer Society [IRG-07-002]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046181, R01DK046181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS054732] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Diego(University of California System); National Science Foundation(National Science Foundation (NSF)); Ray Thomas Edwards Foundation; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK46181 (to G. N. D.) and NS054732 (to G. N. P.).; Supported by a University of California San Diego Neuroplasticity of Aging training grant.; Supported by a National Science Foundation graduate student fellowship.; Supported by the Ray Thomas Edwards Foundation, American Cancer Society Grant IRG-07-002, and University of California San Diego Startup funds.	Aizawa H, 1996, BIOCHEM BIOPH RES CO, V218, P224, DOI 10.1006/bbrc.1996.0039; Artinian J, 2008, EUR J NEUROSCI, V27, P3009, DOI 10.1111/j.1460-9568.2008.06262.x; Bence NF, 2005, METHOD ENZYMOL, V399, P481, DOI 10.1016/S0076-6879(05)99033-2; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Blackstone C, 2002, FRONT BIOSCI, V7, pD872, DOI 10.2741/blacksto; Bose S, 2004, BIOCHEM J, V378, P177, DOI 10.1042/BJ20031122; Cao XH, 2008, NEURON, V60, P353, DOI 10.1016/j.neuron.2008.08.027; Cavazzini M, 2005, CELL CALCIUM, V38, P355, DOI 10.1016/j.ceca.2005.06.013; Chen H, 2003, P NATL ACAD SCI USA, V100, P14908, DOI 10.1073/pnas.2136625100; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; Ding M, 2007, SCIENCE, V317, P947, DOI 10.1126/science.1145727; Dong CG, 2008, LEARN MEMORY, V15, P335, DOI 10.1101/lm.984508; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; FONG YL, 1989, J BIOL CHEM, V264, P16759; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; Glickman MH, 2005, FEBS LETT, V579, P3214, DOI 10.1016/j.febslet.2005.04.048; Guo L, 2007, NEUROSCIENCE, V145, P100, DOI 10.1016/j.neuroscience.2006.11.042; Haas KF, 2007, MOL CELL NEUROSCI, V35, P64, DOI 10.1016/j.mcn.2007.02.002; Hegde AN, 2004, PROG NEUROBIOL, V73, P311, DOI 10.1016/j.pneurobio.2004.05.005; HENDIL KB, 1995, BIOCHEM J, V305, P245, DOI 10.1042/bj3050245; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoyt MA, 2005, METHOD ENZYMOL, V398, P399, DOI 10.1016/S0076-6879(05)98033-6; Hoyt MA, 2003, J BIOL CHEM, V278, P12135, DOI 10.1074/jbc.M211802200; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; Karpova A, 2006, J NEUROSCI, V26, P4949, DOI 10.1523/JNEUROSCI.4573-05.2006; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lu HJ, 2008, MOL CELL PROTEOMICS, V7, P2073, DOI 10.1074/mcp.M800064-MCP200; LUDEMANN R, 1993, J BIOL CHEM, V268, P17413; MA CP, 1994, J BIOL CHEM, V269, P3539; Makhinson M, 1999, J NEUROSCI, V19, P2500; Martin KC, 2006, J NEUROSCI, V26, P7131, DOI 10.1523/JNEUROSCI.1801-06.2006; Mason GGF, 1998, FEBS LETT, V430, P269, DOI 10.1016/S0014-5793(98)00676-0; Mayford M, 2007, CURR OPIN NEUROBIOL, V17, P313, DOI 10.1016/j.conb.2007.05.001; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Murray PF, 2002, ARCH BIOCHEM BIOPHYS, V404, P116, DOI 10.1016/S0003-9861(02)00248-5; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Patrick GN, 2006, CURR OPIN NEUROBIOL, V16, P90, DOI 10.1016/j.conb.2006.01.007; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Piccoli G, 2007, J PROTEOME RES, V6, P3203, DOI 10.1021/pr0701308; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; REALINI C, 1995, J BIOL CHEM, V270, P29664; Rivett AJ, 2001, BIOCHIMIE, V83, P363; Rose J, 2009, NEURON, V61, P351, DOI 10.1016/j.neuron.2008.12.030; Santella L, 2005, CELL MOL LIFE SCI, V62, P2405, DOI 10.1007/s00018-005-5083-6; Santella L, 1998, CELL CALCIUM, V23, P123, DOI 10.1016/S0143-4160(98)90110-5; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; SCHOLZ WK, 1991, J NEUROSCI, V11, P2422; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shen H, 2007, J NEUROSCI, V27, P8903, DOI 10.1523/JNEUROSCI.1571-07.2007; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Speese SD, 2003, CURR BIOL, V13, P899, DOI 10.1016/S0960-9822(03)00338-5; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Valverde RHF, 2005, J BIOL CHEM, V280, P30611, DOI 10.1074/jbc.M501880200; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; WALDMANN R, 1990, BIOCHEMISTRY-US, V29, P1679, DOI 10.1021/bi00459a002; Wang XR, 2008, MOL CELL PROTEOMICS, V7, P46, DOI 10.1074/mcp.M700261-MCP200; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Willeumier K, 2006, J NEUROSCI, V26, P11333, DOI 10.1523/JNEUROSCI.1684-06.2006; Yao I, 2007, CELL, V130, P943, DOI 10.1016/j.cell.2007.06.052; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Yuste R, 1999, J NEUROSCI, V19, P1976; Zhang FX, 2007, PHYSIOLOGY, V22, P373, DOI 10.1152/physiol.00026.2007; Zhang FX, 2007, J BIOL CHEM, V282, P22460, DOI 10.1074/jbc.M702439200; Zhao YL, 2003, CURR BIOL, V13, P887, DOI 10.1016/S0960-9822(03)00332-4	81	168	170	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26655	26665		10.1074/jbc.M109.021956	http://dx.doi.org/10.1074/jbc.M109.021956			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19638347	Green Published, hybrid			2022-12-27	WOS:000269969600046
J	Esper, RM; Loeb, JA				Esper, Raymond M.; Loeb, Jeffrey A.			Neurotrophins Induce Neuregulin Release through Protein Kinase C delta Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; PERIPHERAL NERVOUS-SYSTEM; ACETYLCHOLINE-RECEPTOR SYNTHESIS; NEU DIFFERENTIATION FACTOR; NECROSIS-FACTOR-ALPHA; GLIAL GROWTH-FACTOR; PKC-DELTA; IN-VIVO; MULTIPLE-SCLEROSIS; CANCER-CELLS	Proper, graded communication between different cell types is essential for normal development and function. In the nervous system, heart, and for some cancer cells, part of this communication requires signaling by soluble and membrane-bound factors produced by the NRG1 gene. We have previously shown that glial-derived neurotrophic factors activate a rapid, localized release of soluble neuregulin from neuronal axons that can, in turn promote proper axoglial development (Esper, R. M., and Loeb, J. A. (2004) J. Neurosci. 24, 6218-6227). Here we elucidate the mechanism of this localized, regulated release by implicating the delta isoform of protein kinase C (PKC). Blocking the PKC delta isoform with either rottlerin, a selective antagonist, or small interference RNA blocks the regulated release of neuregulin from both transfected cells and primary neuronal cultures. PKC activation also leads to the rapid phosphorylation of the pro-NRG1 cytoplasmic tail on serine residues adjacent to the membrane-spanning segment, that, when mutated markedly reduce the rate of NRG1 activity release. These findings implicate this specific PKC isoform as an important factor for the cleavage and neurotrophin-regulated release of soluble NRG1 forms that have important effects in nervous system development and disease.	[Loeb, Jeffrey A.] Wayne State Univ, Dept Neurol, Detroit, MI 48201 USA; [Esper, Raymond M.; Loeb, Jeffrey A.] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Loeb, JA (corresponding author), Wayne State Univ, Dept Neurol, Elliman 3122,421 E Canfield Ave, Detroit, MI 48201 USA.	jloeb@med.wayne.edu			National Multiple Sclerosis Society [RG-3410-A-2, RG-3410B3]	National Multiple Sclerosis Society(National Multiple Sclerosis Society)	This work was supported by National Multiple Sclerosis Society Grants RG-3410-A-2 and RG-3410B3 (to J.A.L.).	Adlkofer K, 2000, GLIA, V29, P104, DOI 10.1002/(SICI)1098-1136(20000115)29:2<104::AID-GLIA2>3.0.CO;2-2; Arevalo JC, 2006, CELL MOL LIFE SCI, V63, P1523, DOI 10.1007/s00018-006-6010-1; ARIS JP, 1993, BIOCHIM BIOPHYS ACTA, V1174, P171, DOI 10.1016/0167-4781(93)90111-P; ARRIBAS J, 1995, J CELL BIOL, V128, P433, DOI 10.1083/jcb.128.3.433; Atlas E, 2003, MOL CANCER RES, V1, P165; BANKER G, 1998, CULTURING NERVE CELL; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Brinkmann BG, 2008, NEURON, V59, P581, DOI 10.1016/j.neuron.2008.06.028; Calaora V, 2001, J NEUROSCI, V21, P4740, DOI 10.1523/JNEUROSCI.21-13-04740.2001; Cannella B, 1998, P NATL ACAD SCI USA, V95, P10100, DOI 10.1073/pnas.95.17.10100; Carraway KL, 1997, NATURE, V387, P512, DOI 10.1038/387512a0; Chang H, 1997, NATURE, V387, P509, DOI 10.1038/387509a0; Corbit KC, 1999, MOL CELL BIOL, V19, P4209; CORFAS G, 1993, P NATL ACAD SCI USA, V90, P1624, DOI 10.1073/pnas.90.4.1624; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Diaz-Rodriguez E, 2000, BIOCHEM J, V346, P359, DOI 10.1042/0264-6021:3460359; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Ernfors P, 2001, CELL MOL LIFE SCI, V58, P1036, DOI 10.1007/PL00000918; Esper RM, 2006, BRAIN RES REV, V51, P161, DOI 10.1016/j.brainresrev.2005.11.006; Esper RM, 2004, J NEUROSCI, V24, P6218, DOI 10.1523/JNEUROSCI.1692-04.2004; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; Farinas I, 1999, MICROSC RES TECHNIQ, V45, P233, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<233::AID-JEMT7>3.0.CO;2-Y; Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Gilmour LMR, 2002, CLIN CANCER RES, V8, P3933; Goekjian PG, 1999, CURR MED CHEM, V6, P877; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Hahn D, 2003, J BIOL CHEM, V278, P42829, DOI 10.1074/jbc.M211169200; Han B, 1999, J BIOL CHEM, V274, P26407, DOI 10.1074/jbc.274.37.26407; Harari D, 1999, ONCOGENE, V18, P2681, DOI 10.1038/sj.onc.1202631; Hinkle CL, 2003, BIOCHEMISTRY-US, V42, P2127, DOI 10.1021/bi026709v; Hippenmeyer S, 2002, NEURON, V36, P1035, DOI 10.1016/S0896-6273(02)01101-7; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; HUNG AY, 1994, EMBO J, V13, P534, DOI 10.1002/j.1460-2075.1994.tb06291.x; Ishiguro H, 1998, Nihon Shinkei Seishin Yakurigaku Zasshi, V18, P137; Isohara T, 1999, BIOCHEM BIOPH RES CO, V258, P300, DOI 10.1006/bbrc.1999.0637; JAYASURIYA H, 1989, J NAT PROD, V52, P325, DOI 10.1021/np50062a018; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kikkawa U, 2002, J BIOCHEM, V132, P831, DOI 10.1093/oxfordjournals.jbchem.a003294; Lanni C, 2004, EUR J BIOCHEM, V271, P3068, DOI 10.1111/j.1432-1033.2004.04240.x; Le Gall SM, 2003, J BIOL CHEM, V278, P45255, DOI 10.1074/jbc.M307745200; Li QF, 2001, J BIOL CHEM, V276, P38068; LI WQ, 1995, J BIOL CHEM, V270, P8311, DOI 10.1074/jbc.270.14.8311; Liu XF, 1998, J BIOL CHEM, V273, P34335, DOI 10.1074/jbc.273.51.34335; Liu XF, 1998, P NATL ACAD SCI USA, V95, P13024, DOI 10.1073/pnas.95.22.13024; Loeb JA, 1998, MOL CELL NEUROSCI, V11, P77, DOI 10.1006/mcne.1998.0676; LOEB JA, 1995, J CELL BIOL, V130, P127, DOI 10.1083/jcb.130.1.127; Loeb JA, 1997, J NEUROSCI, V17, P1416; Loeb JA, 2002, J NEUROSCI, V22, P2206, DOI 10.1523/JNEUROSCI.22-06-02206.2002; Loeb JA, 1999, DEVELOPMENT, V126, P781; LOEB JA, 2003, J NEUROCYTO IN PRESS; Loeb JA, 2007, NEUROLOGY, V68, pS38, DOI 10.1212/01.wnl.0000275231.97764.43; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Montero JC, 2000, MOL CELL NEUROSCI, V16, P631, DOI 10.1006/mcne.2000.0896; Negro A, 2004, RECENT PROG HORM RES, V59, P1, DOI 10.1210/rp.59.1.1; ODRISCOLL KR, 1995, MOL BIOL CELL, V6, P449, DOI 10.1091/mbc.6.4.449; Ozaki M, 2004, J NEUROCHEM, V91, P176, DOI 10.1111/j.1471-4159.2004.02719.x; Pankonin MS, 2009, BRAIN RES, V1258, P1, DOI 10.1016/j.brainres.2008.12.047; Pankonin MS, 2005, J BIOL CHEM, V280, P383, DOI 10.1074/jbc.M402645200; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Plo I, 2004, J NEUROSCI RES, V77, P465, DOI 10.1002/jnr.20189; Sandrock AW, 1997, SCIENCE, V276, P599, DOI 10.1126/science.276.5312.599; Sankaranarayanan S, 2008, J PHARMACOL EXP THER, V324, P957, DOI 10.1124/jpet.107.130039; Shirai Y, 2002, J BIOCHEM, V132, P663, DOI 10.1093/oxfordjournals.jbchem.a003271; Shirakabe K, 2001, J BIOL CHEM, V276, P9352, DOI 10.1074/jbc.M007913200; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Steinthorsdottir V, 2004, GENE, V342, P97, DOI 10.1016/j.gene.2004.07.029; Susarla BTS, 2003, J NEUROCHEM, V86, P635, DOI 10.1046/j.1471-4159.2003.01886.x; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Thabard W, 2001, BIOCHEM J, V358, P193, DOI 10.1042/0264-6021:3580193; Wang QMJ, 1999, J BIOL CHEM, V274, P37233, DOI 10.1074/jbc.274.52.37233; WEN DZ, 1994, MOL CELL BIOL, V14, P1909, DOI 10.1128/MCB.14.3.1909; WEN DZ, 1992, CELL, V69, P559, DOI 10.1016/0092-8674(92)90456-M; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Winseck AK, 2002, J NEUROSCI, V22, P4509, DOI 10.1523/JNEUROSCI.22-11-04509.2002; Wooten MW, 1998, CELL SIGNAL, V10, P265, DOI 10.1016/S0898-6568(97)00127-7; Zhan Wen-Zhi, 2003, Shengli Xuebao, V55, P617; Zhang DX, 1997, P NATL ACAD SCI USA, V94, P9562, DOI 10.1073/pnas.94.18.9562; ZIRRGIEBEL U, 1995, J NEUROCHEM, V65, P2241	88	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26251	26260		10.1074/jbc.M109.002915	http://dx.doi.org/10.1074/jbc.M109.002915			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19648576	Green Published, hybrid			2022-12-27	WOS:000269969600005
J	Dobroff, AS; Wang, H; Melnikova, VO; Villares, GJ; Zigler, M; Huang, L; Bar-Eli, M				Dobroff, Andrey S.; Wang, Hua; Melnikova, Vladislava O.; Villares, Gabriel J.; Zigler, Maya; Huang, Li; Bar-Eli, Menashe			Silencing cAMP-response Element-binding Protein (CREB) Identifies CYR61 as a Tumor Suppressor Gene in Melanoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOGENIC FACTOR CYR61; CHAIN FV FRAGMENT; LUNG-CANCER CELLS; BREAST-CANCER; CCN FAMILY; TRANSCRIPTIONAL REGULATION; MALIGNANT-MELANOMA; DOWN-REGULATION; GROWTH-FACTOR; EXPRESSION	Metastatic progression of melanoma is associated with overexpression and activity of cAMP-response element-binding protein (CREB). However, the mechanism by which CREB contributes to tumor progression and metastasis remains unclear. Here, we demonstrate that stably silencing CREB expression in two human metastatic melanoma cell lines, A375SM and C8161-c9, suppresses tumor growth and experimental metastasis. Analysis of cDNA microarrays revealed that CREB silencing leads to increased expression of cysteine-rich protein 61 (CCN1/CYR61) known to mediate adhesion, chemostasis, survival, and angiogenesis. Promoter analysis and chromatin immunoprecipitation assays demonstrated that CREB acts as a negative regulator of CCN1/CYR61 transcription by directly binding to its promoter. Re-expression of CREB in CREB-silenced cells rescued the low CCN1/CYR61 expression phenotype. CCN1/CYR61 overexpression resulted in reduced tumor growth and metastasis and inhibited the activity of matrix metalloproteinase-2. Furthermore, its overexpression decreased melanoma cell motility and invasion through Matrigel, which was abrogated by silencing CCN1/CYR61 in low metastatic melanoma cells. Moreover, a significant decrease in angiogenesis as well as an increase in apoptosis was seen in tumors overexpressing CCN1/CYR61. Our results demonstrate that CREB promotes melanoma growth and metastasis by down-regulating CCN1/CYR61 expression, which acts as a suppressor of melanoma cell motility, invasion and angiogenesis.	[Dobroff, Andrey S.; Wang, Hua; Melnikova, Vladislava O.; Villares, Gabriel J.; Zigler, Maya; Huang, Li; Bar-Eli, Menashe] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Bar-Eli, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Unit 173,1515 Holcombe Blvd, Houston, TX 77030 USA.	mbareli@mdanderson.org	Dobroff, Andrey/A-9814-2016	Dobroff, Andrey/0000-0003-2162-9951	National Institute of Health [CA76098]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil); NATIONAL CANCER INSTITUTE [R01CA076098] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institute of Health Grant CA76098 (to M. B.-E.). This work was also supported by a grant from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil) (to A. S. D.).	Aggarwal S, 2008, CANCER RES, V68, P981, DOI 10.1158/0008-5472.CAN-06-0249; Aucoin R, 2004, J CELL BIOCHEM, V93, P215, DOI 10.1002/jcb.20231; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200; Chen Y, 2007, J CELL BIOCHEM, V100, P1337, DOI 10.1002/jcb.21194; Chien WW, 2004, J BIOL CHEM, V279, P53087, DOI 10.1074/jbc.M410254200; de Braud F, 2003, CRIT REV ONCOL HEMAT, V47, P35, DOI 10.1016/S1040-8428(02)00077-X; de Gruijl FR, 1999, EUR J CANCER, V35, P2003, DOI 10.1016/S0959-8049(99)00283-X; DESDOUETS C, 1995, MOL CELL BIOL, V15, P3301; Gershenwald JE, 2001, ONCOGENE, V20, P3363, DOI 10.1038/sj.onc.1204450; Hofmann UB, 2003, CANCER RES, V63, P8221; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Holloway SE, 2005, J AM COLL SURGEONS, V200, P371, DOI 10.1016/j.jamcollsurg.2004.10.005; Huang S, 1998, EMBO J, V17, P4358, DOI 10.1093/emboj/17.15.4358; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Jean D, 2000, MOL CELL BIOCHEM, V212, P19, DOI 10.1023/A:1007128101751; Jean D, 1998, J BIOL CHEM, V273, P24884, DOI 10.1074/jbc.273.38.24884; Jean D, 2001, CRIT REV IMMUNOL, V21, P275; Jean D, 2000, ONCOGENE, V19, P2721, DOI 10.1038/sj.onc.1203569; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kunz M, 2003, J BIOL CHEM, V278, P45651, DOI 10.1074/jbc.M301373200; Kurschat P, 1999, J BIOL CHEM, V274, P21056, DOI 10.1074/jbc.274.30.21056; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Leslie MC, 2007, GENE THER, V14, P316, DOI 10.1038/sj.gt.3302864; LI LM, 1989, JNCI-J NATL CANCER I, V81, P1406, DOI 10.1093/jnci/81.18.1406; Lin MT, 2005, CLIN CANCER RES, V11, P5809, DOI 10.1158/1078-0432.CCR-04-2639; Maeta N, 2007, ONCOLOGY-BASEL, V73, P118, DOI 10.1159/000121000; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McDonald SL, 2004, CANCER BIOL THER, V3, P110, DOI 10.4161/cbt.3.1.662; Melnikova VO, 2006, PIGM CELL RES, V19, P395, DOI 10.1111/j.1600-0749.2006.00331.x; Melnikova VO, 2006, J BIOL CHEM, V281, P2911, DOI 10.1074/jbc.M508683200; Menendez JA, 2003, ENDOCR-RELAT CANCER, V10, P141, DOI 10.1677/erc.0.0100141; Mitra Aparna, 2003, Journal of Environmental Pathology Toxicology and Oncology, V22, P167, DOI 10.1615/JEnvPathToxOncol.v22.i3.20; Mourad-Zeidan AA, 2008, AM J PATHOL, V173, P1839, DOI 10.2353/ajpath.2008.080380; Nguyen N, 2006, CANCER RES, V66, P2658, DOI 10.1158/0008-5472.CAN-05-2082; Nyormoi O, 2003, CLIN EXP METASTAS, V20, P251, DOI 10.1023/A:1022991302172; O'Kelly J, 2008, INT J ONCOL, V33, P59; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P103, DOI 10.1136/mp.54.2.103; Pilarsky CP, 1998, PROSTATE, V36, P85; RUTBERG SE, 1994, MOL CARCINOGEN, V10, P82, DOI 10.1002/mc.2940100205; Sampath D, 2001, J CLIN ENDOCR METAB, V86, P1707, DOI 10.1210/jc.86.4.1707; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Smith AP, 2004, CANCER BIOL THER, V3, P104, DOI 10.4161/cbt.3.1.661; Tamura I, 2001, AM J PHYSIOL-CELL PH, V281, pC1524, DOI 10.1152/ajpcell.2001.281.5.C1524; Todorovic V, 2005, J CELL BIOL, V171, P559, DOI 10.1083/jcb.200504015; Tong XJ, 2004, ONCOGENE, V23, P4847, DOI 10.1038/sj.onc.1207628; Tong XJ, 2001, J BIOL CHEM, V276, P47709, DOI 10.1074/jbc.M107878200; Tsai MS, 2002, ONCOGENE, V21, P964, DOI 10.1038/sj/onc/1205131; VERSCHRAEGEN CF, 1991, ANTICANCER RES, V11, P529; Villares GJ, 2008, CANCER RES, V68, P9078, DOI 10.1158/0008-5472.CAN-08-2397; Walker TM, 2002, ARCH OPHTHALMOL-CHIC, V120, P1719; WELCH DR, 1991, INT J CANCER, V47, P227, DOI 10.1002/ijc.2910470211; White PC, 2006, ONCOGENE, V25, P2170, DOI 10.1038/sj.onc.1209255; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Xie D, 2001, CANCER RES, V61, P8917; Xie SH, 1997, ONCOGENE, V15, P2069, DOI 10.1038/sj.onc.1201358; Yang YM, 1996, ONCOGENE, V12, P2223; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	58	68	76	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26194	26206		10.1074/jbc.M109.019836	http://dx.doi.org/10.1074/jbc.M109.019836			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19632997	Green Published, hybrid			2022-12-27	WOS:000269738000074
J	Koliwad, SK; Kuo, TY; Shipp, LE; Gray, NE; Backhed, F; So, AYL; Farese, RV; Wang, JC				Koliwad, Suneil K.; Kuo, Taiyi; Shipp, Lauren E.; Gray, Nora E.; Backhed, Fredrik; So, Alex Yick-Lun; Farese, Robert V., Jr.; Wang, Jen-Chywan			Angiopoietin-like 4 (ANGPTL4, Fasting-induced Adipose Factor) Is a Direct Glucocorticoid Receptor Target and Participates in Glucocorticoid-regulated Triglyceride Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REGULATION; PROTEIN-4; GENE; MICE; CHROMATIN; HYPERLIPIDEMIA; ANGIOGENESIS; OBESITY; PLASMA; DIET	Glucocorticoids are important regulators of lipid homeostasis, and chronically elevated glucocorticoid levels induce hypertriglyceridemia, hepatic steatosis, and visceral obesity. The occupied glucocorticoid receptor (GR) is a transcription factor. However, those genes regulating lipid metabolism under GR control are not fully known. Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor), a protein inhibitor of lipoprotein lipase, is synthesized and secreted during fasting, when circulating glucocorticoid levels are physiologically increased. We therefore tested whether the ANGPTL4 gene (Angptl4) is transcriptionally controlled by GR. We show that treatment with the synthetic glucocorticoid dexamethasone increased Angptl4 mRNA levels in primary hepatocytes and adipocytes (2-3-fold) and in the livers and white adipose tissue of mice (similar to 4-fold). We tested the mechanism of this increase in H4IIE hepatoma cells and found that dexamethasone treatment increased the transcriptional rate of Angptl4. Using bioinformatics and chromatin immunoprecipitation, we identified a GR binding site with in the rat Angptl4 sequence. A reporter plasmid containing this site was markedly activated by dexamethasone, indicative of a functional glucocorticoid response element. Dexamethasone treatment also increased histone H4 acetylation and DNase I accessibility in genomic regions near this site, further supporting that it is a glucocorticoid response element. Glucocorticoids promote the flux of triglycerides from white adipose tissue to liver. We found that mice lacking ANGPTL4 (Angptl4(-/-)) had reductions in dexamethasone-induced hypertriglyceridemia and hepatic steatosis, suggesting that ANGPTL4 is required for this flux. Overall, we establish that ANGPTL4 is a direct GR target that participates in glucocorticoid-regulated triglyceride metabolism.	[Koliwad, Suneil K.; Farese, Robert V., Jr.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94143 USA; [Koliwad, Suneil K.; Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [So, Alex Yick-Lun] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Koliwad, Suneil K.; Farese, Robert V., Jr.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Kuo, Taiyi; Shipp, Lauren E.; Gray, Nora E.; Wang, Jen-Chywan] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Backhed, Fredrik] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Wallenberg Lab, SE-41345 Gothenburg, Sweden; [Backhed, Fredrik] Univ Gothenburg, Dept Mol & Clin Med, SE-41345 Gothenburg, Sweden	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of Gothenburg; University of Gothenburg	Wang, JC (corresponding author), Morgan Hall,Rm 315, Berkeley, CA 94720 USA.	walwang@berkeley.edu	Backhed, Fredrik/ABE-6613-2020; Wang, Jen-Chywan/AAX-4445-2020	Backhed, Fredrik/0000-0002-4871-8818; Wang, Jen-Chywan/0000-0001-6030-6886; Kuo, Taiyi/0000-0001-6167-0284	American Heart Association Beginning [0565157Y]; A. P. Giannini Foundation Fellowship	American Heart Association Beginning(American Heart Association); A. P. Giannini Foundation Fellowship	This work was supported by American Heart Association Beginning Grant-in-aid 0565157Y ( to J.C.W.) and an A. P. Giannini Foundation Fellowship ( to S. K. K.).	Akiyama TE, 2004, J BIOL CHEM, V279, P20874, DOI 10.1074/jbc.M312802200; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Deblois G, 2008, MOL ENDOCRINOL, V22, P1999, DOI 10.1210/me.2007-0546; Desai U, 2007, P NATL ACAD SCI USA, V104, P11766, DOI 10.1073/pnas.0705041104; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Dolinsky VW, 2004, BIOCHEM J, V378, P967, DOI 10.1042/BJ20031320; Fletcher TM, 2000, MOL CELL BIOL, V20, P6466, DOI 10.1128/MCB.20.17.6466-6475.2000; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Kersten S, 2005, BIOCHEM SOC T, V33, P1059, DOI 10.1042/BST0331059; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; LEMBERGER T, 1994, J BIOL CHEM, V269, P24527; Lemke U, 2008, CELL METAB, V8, P212, DOI 10.1016/j.cmet.2008.08.001; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li C, 2006, CURR OPIN LIPIDOL, V17, P152, DOI 10.1097/01.mol.0000217896.67444.05; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Macfarlane DP, 2008, J ENDOCRINOL, V197, P189, DOI 10.1677/JOE-08-0054; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Seckl JR, 2004, RECENT PROG HORM RES, V59, P359, DOI 10.1210/rp.59.1.359; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; SNYDER F, 1959, BIOCHIM BIOPHYS ACTA, V34, P244; So AYL, 2008, P NATL ACAD SCI USA, V105, P5745, DOI 10.1073/pnas.0801551105; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Walker BR, 2006, DIABETIC MED, V23, P1281, DOI 10.1111/j.1464-5491.2006.01998.x; Walker BR, 2007, EUR J ENDOCRINOL, V157, P545, DOI 10.1530/EJE-07-0455; Wang B, 2007, PFLUG ARCH EUR J PHY, V455, P479, DOI 10.1007/s00424-007-0301-8; Wang JC, 2006, GENE DEV, V20, P689, DOI 10.1101/gad.1400506; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Yang YH, 2008, ARTERIOSCL THROM VAS, V28, P835, DOI 10.1161/ATVBAHA.107.157776; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200	39	126	131	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25593	25601		10.1074/jbc.M109.025452	http://dx.doi.org/10.1074/jbc.M109.025452			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19628874	Green Published, hybrid			2022-12-27	WOS:000269738000017
J	Tang, FM; Kokontis, J; Lin, YT; Liao, ST; Lin, AN; Xiang, JL				Tang, Fangming; Kokontis, John; Lin, Yuting; Liao, Shutsung; Lin, Anning; Xiang, Jialing			Androgen via p21 Inhibits Tumor Necrosis Factor alpha-induced JNK Activation and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; NF-KAPPA-B; C-JUN KINASE; PROTEIN-KINASE; IKK-BETA; RECEPTOR; IDENTIFICATION; PHOSPHORYLATION; PROGRESSION; REPRESSION	The male hormone androgen is a growth/survival factor for its target tissues or organs. Yet, the underlying mechanism is incompletely understood. Here, we report that androgen via p21 inhibits tumor necrosis factor alpha-induced JNK activation and apoptosis. Inhibition by androgen requires the transcription activity of androgen receptor (AR) and de novo protein synthesis. Androgen center dot AR induces expression of p21 that in turn inhibits tumor necrosis factor alpha-induced JNK and apoptosis. Furthermore, genetic interruption of p21 alleles abolishes the inhibition by androgen. Our results reveal a novel cross-talk between androgen center dot AR and JNK, thereby providing a molecular mechanism underlying the survival function of androgen.	[Tang, Fangming; Kokontis, John; Liao, Shutsung; Lin, Anning] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Lin, Yuting; Xiang, Jialing] IIT, Dept Biol Chem & Phys Sci, Chicago, IL 60616 USA	University of Chicago; Illinois Institute of Technology	Lin, AN (corresponding author), Univ Chicago, Ben May Dept Canc Res, 929 E 57th St, Chicago, IL 60637 USA.	anninglin@bsd.uchcicago.edu; xiang@iit.edu			National Institutes of Health [CA090516, CA128114, GM71409, ES015868]; NATIONAL CANCER INSTITUTE [R01CA058073, K01CA090516, R01CA128114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071409] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA090516 and CA128114 (to J.X.) and GM71409 and ES015868 (to A.L.).	ANDERSON KM, 1968, NATURE, V219, P277, DOI 10.1038/219277a0; BRUCHOVSKY N, 1968, J BIOL CHEM, V243, P2012; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chuu CP, 2005, CANCER RES, V65, P2082, DOI 10.1158/0008-5472.CAN-04-3992; DAI TN, 1995, ONCOGENE, V10, P849; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dawson N A, 2000, Curr Oncol Rep, V2, P409; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Deng HB, 2008, J BIOL CHEM, V283, P20754, DOI 10.1074/jbc.M800024200; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Huang S, 2003, MOL CELL, V11, P1491, DOI 10.1016/S1097-2765(03)00180-1; Huggins C, 1941, ARCH SURG-CHICAGO, V43, P209, DOI 10.1001/archsurg.1941.01210140043004; Isaacs JT, 2000, JNCI-J NATL CANCER I, V92, P1367, DOI 10.1093/jnci/92.17.1367; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; KOKONTIS J, 1994, CANCER RES, V54, P1566; Kokontis JM, 2005, PROSTATE, V65, P287, DOI 10.1002/pros.20285; Kokontis JM, 1998, MOL ENDOCRINOL, V12, P941, DOI 10.1210/me.12.7.941; Kokontis JM, 1999, VITAM HORM, V55, P219; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Lin YT, 2006, MOL CELL BIOL, V26, P1908, DOI 10.1128/MCB.26.5.1908-1916.2006; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Lorenzo PI, 2008, NEOPLASIA, V10, P418, DOI 10.1593/neo.07985; Lu S, 1999, MOL ENDOCRINOL, V13, P376, DOI 10.1210/me.13.3.376; Lu XH, 1997, J BIOL CHEM, V272, P24751, DOI 10.1074/jbc.272.40.24751; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Roy AK, 2001, ANN NY ACAD SCI, V949, P44; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; Shim J, 1996, NATURE, V381, P804, DOI 10.1038/381804a0; Singh SV, 2007, CANCER RES, V67, P7439, DOI 10.1158/0008-5472.CAN-07-0120; Tang FM, 2002, MOL CELL BIOL, V22, P8571, DOI 10.1128/MCB.22.24.8571-8579.2002; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Tang GL, 2001, MOL CELL, V8, P1005, DOI 10.1016/S1097-2765(01)00380-X; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Waller AS, 2000, J MOL ENDOCRINOL, V24, P339, DOI 10.1677/jme.0.0240339; Wolff JM, 2000, EUR UROL, V38, P365, DOI 10.1159/000020310; Yu CF, 2004, MOL CELL, V13, P329, DOI 10.1016/S1097-2765(04)00028-0; Zheng CJ, 1999, J BIOL CHEM, V274, P28966, DOI 10.1074/jbc.274.41.28966	46	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32353	32358		10.1074/jbc.M109.042994	http://dx.doi.org/10.1074/jbc.M109.042994			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19723627	hybrid, Green Published			2022-12-27	WOS:000272028400018
J	Hardy, AB; Fox, JEM; Giglou, PR; Wijesekara, N; Bhattacharjee, A; Sultan, S; Gyulkhandanyan, AV; Gaisano, HY; MacDonald, PE; Wheeler, MB				Hardy, Alexandre B.; Fox, Jocelyn E. Manning; Giglou, Pejman Raeisi; Wijesekara, Nadeeja; Bhattacharjee, Alpana; Sultan, Sobia; Gyulkhandanyan, Armen V.; Gaisano, Herbert Y.; MacDonald, Patrick E.; Wheeler, Michael B.			Characterization of Erg K+ Channels in alpha- and beta-Cells of Mouse and Human Islets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCORPION BUTHUS-EUPEUS; INSULIN-SECRETION; ELECTRICAL-ACTIVITY; POTASSIUM CHANNEL; ION CHANNELS; ELECTROPHYSIOLOGICAL CHARACTERIZATION; GLUCAGON-SECRETION; NERVOUS-SYSTEM; RAT PANCREAS; ATP-CHANNELS	Voltage-gated eag-related gene (Erg) K+ channels regulate the electrical activity of many cell types. Data regarding Erg channel expression and function in electrically excitable glucagon and insulin producing cells of the pancreas is limited. In the present study Erg1 mRNA and protein were shown to be highly expressed in human and mouse islets and in alpha-TC6 and Min6 cells alpha- and beta-cell lines, respectively. Whole cell patch clamp recordings demonstrated the functional expression of Erg1 in alpha- and beta-cells, with rBeKm1, an Erg1 antagonist, blocking inward tail currents elicited by a double pulse protocol. Additionally, a small interference RNA approach targeting the kcnh2 gene (Erg1) induced a significant decrease of Erg1 inward tail current in Min6 cells. To investigate further the role of Erg channels in mouse and human islets, ratiometric Fura-2 AM Ca2+-imaging experiments were performed on isolated alpha- and beta-cells. Blocking Erg channels with rBeKm1 induced a transient cytoplasmic Ca2+ increase in both alpha- and beta-cells. This resulted in an increased glucose-dependent insulin secretion, but conversely impaired glucagon secretion under low glucose conditions. Together, these data present Erg1 channels as new mediators of alpha- and beta-cell repolarization. However, antagonism of Erg1 has divergent effects in these cells; to augment glucose-dependent insulin secretion and inhibit low glucose stimulated glucagon secretion.	[Hardy, Alexandre B.; Fox, Jocelyn E. Manning; Giglou, Pejman Raeisi; Wijesekara, Nadeeja; Bhattacharjee, Alpana; Sultan, Sobia; Gyulkhandanyan, Armen V.; Wheeler, Michael B.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Fox, Jocelyn E. Manning; MacDonald, Patrick E.] Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2E1, Canada; [Fox, Jocelyn E. Manning; MacDonald, Patrick E.] Univ Alberta, Alberta Diabet Inst, Edmonton, AB T6G 2E1, Canada; [Gaisano, Herbert Y.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Alberta; University of Alberta; University of Toronto	Wheeler, MB (corresponding author), Univ Toronto, Dept Physiol, 1 Kings Coll Circle,Rm 3352, Toronto, ON M5S 1A8, Canada.	michael.wheeler@utoronto.ca	Wijesekara, Nadeeja/AAW-7230-2021	Wheeler, Michael B./0000-0002-7480-7267; MacDonald, Patrick/0000-0002-5439-6288	Canadian Institutes of Health [MOP 49521]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by an operating grant from the Canadian Institutes of Health Research (MOP 49521 to M. B. W.).	Ammala Carina, 1997, Digestion, V58, P81; Barg S, 2000, DIABETES, V49, P1500, DOI 10.2337/diabetes.49.9.1500; Bauer CK, 2003, PFLUG ARCH EUR J PHY, V445, P589, DOI 10.1007/s00424-002-0980-0; Berts A, 1996, ENDOCRINOLOGY, V137, P693, DOI 10.1210/en.137.2.693; Bokvist K, 1999, PFLUG ARCH EUR J PHY, V438, P428, DOI 10.1007/s004240051058; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Filippov AK, 1996, FEBS LETT, V384, P277, DOI 10.1016/0014-5793(96)00333-X; Gomis A, 1998, BRIT J PHARMACOL, V123, P443, DOI 10.1038/sj.bjp.0701628; Gopel SO, 2000, J PHYSIOL-LONDON, V528, P497, DOI 10.1111/j.1469-7793.2000.00497.x; Gopel SO, 2000, J PHYSIOL-LONDON, V528, P509, DOI 10.1111/j.1469-7793.2000.00509.x; Gromada J, 2004, DIABETES, V53, pS181, DOI 10.2337/diabetes.53.suppl_3.S181; Gurrola GB, 1999, FASEB J, V13, P953, DOI 10.1096/fasebj.13.8.953; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Gyulkhandanyan AV, 2008, J BIOL CHEM, V283, P10184, DOI 10.1074/jbc.M707005200; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; HENQUIN JC, 1979, BIOCHIM BIOPHYS ACTA, V587, P579, DOI 10.1016/0304-4165(79)90010-2; Jacobson DA, 2007, CELL METAB, V6, P229, DOI 10.1016/j.cmet.2007.07.010; Korolkova YV, 2001, J BIOL CHEM, V276, P9868, DOI 10.1074/jbc.M005973200; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Lecchi M, 2002, J NEUROSCI, V22, P3414; Leung YM, 2005, ENDOCRINOLOGY, V146, P4766, DOI 10.1210/en.2005-0803; Liu SG, 1996, BIOPHYS J, V70, P2704, DOI 10.1016/S0006-3495(96)79840-5; MacDonald PE, 2007, PLOS BIOL, V5, P1236, DOI 10.1371/journal.pbio.0050143; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; MacDonald PE, 2003, DIABETOLOGIA, V46, P1046, DOI 10.1007/s00125-003-1159-8; MacDonald PE, 2002, J BIOL CHEM, V277, P44938, DOI 10.1074/jbc.M205532200; MacDonald PE, 2001, MOL ENDOCRINOL, V15, P1423, DOI 10.1210/me.15.8.1423; Moss AJ, 2002, CIRCULATION, V105, P794, DOI 10.1161/hc0702.105124; Muhlbauer E, 2007, CELL MOL LIFE SCI, V64, P768, DOI 10.1007/s00018-007-6478-3; O'Gorman D, 2005, TRANSPLANTATION, V80, P801, DOI 10.1097/01.tp.0000172216.47547.d5; Pessia M, 2008, J PHYSIOL-LONDON, V586, P4877, DOI 10.1113/jphysiol.2008.155762; Quoix N, 2009, DIABETES, V58, P412, DOI 10.2337/db07-1298; RAJAN AS, 1990, DIABETES CARE, V13, P340, DOI 10.2337/diacare.13.3.340; Restano-Cassulini R, 2006, MOL PHARMACOL, V69, P1673, DOI 10.1124/mol.105.019729; RORSMAN P, 1994, DIABETES METAB, V20, P138; Rorsman P, 2008, TRENDS ENDOCRIN MET, V19, P277, DOI 10.1016/j.tem.2008.07.003; Rosati B, 2000, FASEB J, V14, P2601, DOI 10.1096/fj.00-0077com; Royer A, 2005, CARDIOVASC RES, V65, P128, DOI 10.1016/j.cardiores.2004.09.030; Salehi A, 1999, J PHYSIOL-LONDON, V514, P579, DOI 10.1111/j.1469-7793.1999.579ae.x; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1990, AM J PHYSIOL, V259, pH1881, DOI 10.1152/ajpheart.1990.259.6.H1881; Satin LS, 2000, ENDOCRINE, V13, P251, DOI 10.1385/ENDO:13:3:251; Schledermann W, 2001, J PHYSIOL-LONDON, V532, P143, DOI 10.1111/j.1469-7793.2001.0143g.x; Schwarz JR, 2004, J CELL MOL MED, V8, P22, DOI 10.1111/j.1582-4934.2004.tb00256.x; Sher E, 2003, J BIOENERG BIOMEMBR, V35, P687, DOI 10.1023/B:JOBB.0000008032.49504.48; Shi WM, 1997, J NEUROSCI, V17, P9423; VALDEOLMILLOS M, 1992, J PHYSIOL-LONDON, V455, P173, DOI 10.1113/jphysiol.1992.sp019295; WETTWER E, 1991, J CARDIOVASC PHARM, V17, P480, DOI 10.1097/00005344-199103000-00018; Yeung SYM, 2007, AM J PHYSIOL-CELL PH, V292, pC468, DOI 10.1152/ajpcell.00142.2006; Zaza A, 1997, J PHYSIOL-LONDON, V505, P677, DOI 10.1111/j.1469-7793.1997.677ba.x; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	51	34	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30441	30452		10.1074/jbc.M109.040659	http://dx.doi.org/10.1074/jbc.M109.040659			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19690348	Green Published, hybrid			2022-12-27	WOS:000271090000047
J	Passarini, F; Wientjes, E; Hienerwadel, R; Croce, R				Passarini, Francesca; Wientjes, Emilie; Hienerwadel, Rainer; Croce, Roberta			Molecular Basis of Light Harvesting and Photoprotection in CP24 UNIQUE FEATURES OF THE MOST RECENT ANTENNA COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYSTEM-II ANTENNA; TIME-RESOLVED FLUORESCENCE; HIGHER-PLANT ANTENNA; GREEN PLANTS; CHLAMYDOMONAS-REINHARDTII; CHLOROPHYLL FLUORESCENCE; ZEAXANTHIN FORMATION; CHROMOPHORE-BINDING; THERMAL DISSIPATION; ENERGY-DISSIPATION	CP24 is a minor antenna complex of Photosystem II, which is specific for land plants. It has been proposed that this complex is involved in the process of excess energy dissipation, which protects plants from photodamage in high light conditions. Here, we have investigated the functional architecture of the complex, integrating mutation analysis with time-resolved spectroscopy. A comprehensive picture is obtained about the nature, the spectroscopic properties, and the role in the quenching in solution of the pigments in the individual binding sites. The lowest energy absorption band in the chlorophyll a region corresponds to chlorophylls 611/612, and it is not the site of quenching in CP24. Chlorophylls 613 and 614, which are present in the major light-harvesting complex of Photosystem appear to be absent in CP24. In contrast to all other light-harvesting complexes, CP24 is stable when the L1 carotenoid binding site is empty and upon mutations in the third helix, whereas mutations in the first helix strongly affect the folding/stability of the pigment-protein complex. The absence of lutein in L1 site does not have any effect on the quenching, whereas substitution of violaxanthin in the L2 site with lutein or zeaxanthin results in a complex with enhanced quenched fluorescence. Triplet-minus-singlet measurements indicate that zeaxanthin and lutein in site L2 are located closer to chlorophylls than violaxanthin, thus suggesting that they can act as direct quenchers via a strong interaction with a neighboring chlorophyll. The results provide the molecular basis for the zeaxanthin-dependent quenching in isolated CP24.	[Passarini, Francesca; Wientjes, Emilie; Croce, Roberta] Univ Groningen, Dept Biophys Chem, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Hienerwadel, Rainer] Univ Aix Marseille 2, Fac Sci Luminy, Dept Biol, Lab Genet & Biophys Plantes, F-13288 Marseille, France	University of Groningen; CEA; UDICE-French Research Universities; Aix-Marseille Universite	Croce, R (corresponding author), Univ Groningen, Dept Biophys Chem, Groningen Biomol Sci & Biotechnol Inst, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	R.Croce@rug.nl	Croce, Roberta/N-4067-2014; Wientjes, Emilie/AAC-8491-2019; Croce, Roberta/ABG-3595-2021; Croce, Roberta/F-1174-2014; Croce, Roberta/HGU-9554-2022; Wientjes, Emilie/M-6387-2014	Croce, Roberta/0000-0003-3469-834X; Wientjes, Emilie/0000-0003-2625-8045; Croce, Roberta/0000-0003-3469-834X; Croce, Roberta/0000-0003-3469-834X; Wientjes, Emilie/0000-0003-2625-8045	Netherlands Organization for Scientific Research Earth and Life Science, VIDI; Frans/Nederlandse Academie via a Van Gogh	Netherlands Organization for Scientific Research Earth and Life Science, VIDI(Netherlands Organization for Scientific Research (NWO)); Frans/Nederlandse Academie via a Van Gogh	This work was supported by The Netherlands Organization for Scientific Research Earth and Life Science through a VIDI grant and by the Frans/Nederlandse Academie via a Van Gogh grant.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Ballottari M, 2009, J BIOL CHEM, V284, P8103, DOI 10.1074/jbc.M808326200; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; Barzda V, 1998, BIOCHEMISTRY-US, V37, P546, DOI 10.1021/bi972123a; Bassi R, 1999, P NATL ACAD SCI USA, V96, P10056, DOI 10.1073/pnas.96.18.10056; Bassi R, 2000, PHOTOSYNTH RES, V64, P243, DOI 10.1023/A:1006409506272; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Bode S, 2009, P NATL ACAD SCI USA, V106, P12311, DOI 10.1073/pnas.0903536106; BOEKEMA EJ, 1995, P NATL ACAD SCI USA, V92, P175, DOI 10.1073/pnas.92.1.175; Bonente G, 2008, PHOTOCHEM PHOTOBIOL, V84, P1359, DOI 10.1111/j.1751-1097.2008.00456.x; BRIANTAIS JM, 1994, PHOTOSYNTH RES, V40, P287, DOI 10.1007/BF00034778; Caffarri S, 2004, BIOCHEMISTRY-US, V43, P9467, DOI 10.1021/bi036265i; Caffarri S, 2007, FEBS LETT, V581, P4704, DOI 10.1016/j.febslet.2007.08.066; Cinque G, 2000, PHOTOSYNTH RES, V64, P233, DOI 10.1023/A:1006467617697; Crimi M, 2001, EUR J BIOCHEM, V268, P260, DOI 10.1046/j.1432-1033.2001.01874.x; Croce R, 1999, J BIOL CHEM, V274, P29613, DOI 10.1074/jbc.274.42.29613; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Croce R, 2007, BIOCHEMISTRY-US, V46, P3846, DOI 10.1021/bi602531k; DAINESE P, 1991, J BIOL CHEM, V266, P8136; de Bianchi S, 2008, PLANT CELL, V20, P1012, DOI 10.1105/tpc.107.055749; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; DEMMIGADAMS B, 1990, PLANT PHYSIOL, V92, P293, DOI 10.1104/pp.92.2.293; DEXTER DL, 1953, J CHEM PHYS, V21, P836, DOI 10.1063/1.1699044; Digris AV, 1999, EUR BIOPHYS J BIOPHY, V28, P526, DOI 10.1007/s002490050235; Elrad D, 2002, PLANT CELL, V14, P1801, DOI 10.1105/tpc.002154; Finazzi G, 2006, BIOCHEMISTRY-US, V45, P1490, DOI 10.1021/bi0521588; Frank HA, 2001, BIOCHEMISTRY-US, V40, P1220, DOI 10.1021/bi001160q; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Horton P, 2005, J EXP BOT, V56, P365, DOI 10.1093/jxb/eri023; Ihalainen JA, 2005, J PHYS CHEM B, V109, P21150, DOI 10.1021/jp0519316; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Johnson MP, 2009, PLANT PHYSIOL, V149, P1061, DOI 10.1104/pp.108.129957; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; Koziol AG, 2007, PLANT PHYSIOL, V143, P1802, DOI 10.1104/pp.092536; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Lampoura SS, 2002, BIOCHEMISTRY-US, V41, P9139, DOI 10.1021/bi025724x; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Miloslavina Y, 2008, FEBS LETT, V582, P3625, DOI 10.1016/j.febslet.2008.09.044; Morosinotto T, 2002, J BIOL CHEM, V277, P36913, DOI 10.1074/jbc.M205339200; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Mozzo M, 2008, BBA-BIOENERGETICS, V1777, P1263, DOI 10.1016/j.bbabio.2008.04.036; Mozzo M, 2008, J BIOL CHEM, V283, P6184, DOI 10.1074/jbc.M708961200; Mozzo M, 2006, BBA-BIOENERGETICS, V1757, P1607, DOI 10.1016/j.bbabio.2006.06.018; Pagano A, 1998, J BIOL CHEM, V273, P17154, DOI 10.1074/jbc.273.27.17154; Palacios MA, 2002, J PHYS CHEM B, V106, P5782, DOI 10.1021/jp014078t; PETER GF, 1991, J BIOL CHEM, V266, P16745; PLUMLEY FG, 1987, P NATL ACAD SCI USA, V84, P146, DOI 10.1073/pnas.84.1.146; Remelli R, 1999, J BIOL CHEM, V274, P33510, DOI 10.1074/jbc.274.47.33510; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; RUBAN AV, 1994, PLANT PHYSIOL, V104, P227, DOI 10.1104/pp.104.1.227; SIEFERMANNHARMS D, 1987, PHYSIOL PLANTARUM, V69, P561, DOI 10.1111/j.1399-3054.1987.tb09240.x; Somsen OJG, 2005, CHEMPHYSCHEM, V6, P1622, DOI 10.1002/cphc.200400648; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Teramoto H, 2001, PLANT CELL PHYSIOL, V42, P849, DOI 10.1093/pcp/pce115; van Amerongen H, 2001, J PHYS CHEM B, V105, P604, DOI 10.1021/jp0028406; van Oort B, 2008, BIOPHYS J, V95, P5851, DOI 10.1529/biophysj.108.140467; Wehner A, 2006, J BIOL CHEM, V281, P21924, DOI 10.1074/jbc.M602915200; Young A. J, 1993, CAROTENOIDS PHOTOSYN	64	48	48	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29536	29546		10.1074/jbc.M109.036376	http://dx.doi.org/10.1074/jbc.M109.036376			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19700403	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000270896800036
J	Beamish, H; de Boer, L; Giles, N; Stevens, F; Oakes, V; Gabrielli, B				Beamish, Heather; de Boer, Leonore; Giles, Nichole; Stevens, Frankie; Oakes, Vanessa; Gabrielli, Brian			Cyclin A/cdk2 Regulates Adenomatous Polyposis Coli-dependent Mitotic Spindle Anchoring	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS EGG EXTRACTS; CELL-CYCLE; CHROMOSOME ALIGNMENT; S-PHASE; APC; MITOSIS; INSTABILITY; PROTEIN; CANCER; EB1	Mutations in adenomatous polyposis coli (APC) protein is a major contributor to tumor initiation and progression in several tumor types. These mutations affect APC function in the Wnt-beta-catenin signaling and influence mitotic spindle anchoring to the cell cortex and orientation. Here we report that the mitotic anchoring and orientation function of APC is regulated by cyclin A/cdk2. Knockdown of cyclin A and inhibition of cdk2 resulted in cells arrested in mitosis with activation of the spindle assembly checkpoint. The mitotic spindle was unable to form stable attachments to the cell cortex, and this resulted in the spindles failing to locate to the central position in the cells and undergo dramatic rotation. We have demonstrated that cyclin A/cdk2 specifically associates with APC in late G2 phase and phosphorylates it at Ser-1360, located in the mutation cluster region of APC. Mutation of APC Ser-1360 to Ala results in identical off-centered mitotic spindles. Thus, this cyclin A/cdk2-dependent phosphorylation of APC affects astral microtubule attachment to the cortical surface in mitosis.	[Beamish, Heather; de Boer, Leonore; Giles, Nichole; Stevens, Frankie; Oakes, Vanessa; Gabrielli, Brian] Univ Queensland, Diamantina Inst Canc Immunol & Metab Med, Princess Alexandra Hosp, Brisbane, Qld 4102, Australia	University of Queensland	Gabrielli, B (corresponding author), Univ Queensland, Diamantina Inst Canc Immunol & Metab Med, Princess Alexandra Hosp, Brisbane, Qld 4102, Australia.	brianG@uq.edu.au	Gabrielli, Brian G/B-3655-2011	Gabrielli, Brian G/0000-0003-3933-1651; Stevens, Frankie/0000-0002-2556-473X	National Health and Medical Research Council of Australia; Cancer Council of Queensland	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Queensland(Cancer Council Queensland)	This work was supported in part by the National Health and Medical Research Council of Australia and the Cancer Council of Queensland.	Aaltonen K, 2006, BRIT J CANCER, V94, P1697, DOI 10.1038/sj.bjc.6603147; Aoki K, 2007, ONCOGENE, V26, P3511, DOI 10.1038/sj.onc.1210141; Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Askham JM, 2000, ONCOGENE, V19, P1950, DOI 10.1038/sj.onc.1203498; BUENDIA B, 1992, J CELL BIOL, V116, P1431, DOI 10.1083/jcb.116.6.1431; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; De Boer L, 2008, ONCOGENE, V27, P4261, DOI 10.1038/onc.2008.74; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Dikovskaya D, 2007, J CELL BIOL, V176, P183, DOI 10.1083/jcb.200610099; Draviam VM, 2006, EMBO J, V25, P2814, DOI 10.1038/sj.emboj.7601168; Fung TK, 2007, MOL BIOL CELL, V18, P1861, DOI 10.1091/mbc.E06-12-1092; Furuno N, 1999, J CELL BIOL, V147, P295, DOI 10.1083/jcb.147.2.295; Gabrielli BG, 1996, J CELL SCI, V109, P1081; Goldstone S, 2001, ONCOGENE, V20, P921, DOI 10.1038/sj.onc.1204177; Gong DQ, 2007, CURR BIOL, V17, P85, DOI 10.1016/j.cub.2006.11.066; Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103; Green RA, 2005, MOL BIOL CELL, V16, P4609, DOI 10.1091/mbc.E05-03-0259; Hadjihannas MV, 2006, P NATL ACAD SCI USA, V103, P10747, DOI 10.1073/pnas.0604206103; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; KNOBLICH JA, 1993, EMBO J, V12, P65, DOI 10.1002/j.1460-2075.1993.tb05632.x; McCartney BM, 2001, NAT CELL BIOL, V3, P933, DOI 10.1038/ncb1001-933; Mitra J, 2004, ONCOGENE, V23, P3361, DOI 10.1038/sj.onc.1207446; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Nathke I, 2006, NAT REV CANCER, V6, P967, DOI 10.1038/nrc2010; O'Connell MJ, 2000, TRENDS CELL BIOL, V10, P296, DOI 10.1016/S0962-8924(00)01773-6; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; ROSENBLATT J, 1992, P NATL ACAD SCI USA, V89, P2824, DOI 10.1073/pnas.89.7.2824; Rusan NM, 2008, J CELL BIOL, V181, P719, DOI 10.1083/jcb.200802107; Skoufias DA, 2001, P NATL ACAD SCI USA, V98, P4492, DOI 10.1073/pnas.081076898; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Stevens FE, 2008, ONCOGENE, V27, P1345, DOI 10.1038/sj.onc.1210779; Strausfeld UP, 1996, J CELL SCI, V109, P1555; Tournier S, 2004, MOL BIOL CELL, V15, P3345, DOI 10.1091/mbc.E04-03-0256; Trzepacz C, 1997, J BIOL CHEM, V272, P21681, DOI 10.1074/jbc.272.35.21681; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Warrener R, 2003, FASEB J, V17, P1550, DOI 10.1096/fj.02-1003fje; Zhang JY, 2007, J CELL BIOL, V178, P773, DOI 10.1083/jcb.200702138	39	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29015	29023		10.1074/jbc.M109.042820	http://dx.doi.org/10.1074/jbc.M109.042820			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19703905	Green Published, hybrid			2022-12-27	WOS:000270678900059
J	Li, H; Dong, B; Park, SW; Lee, HS; Chen, W; Liu, JW				Li, Hai; Dong, Bin; Park, Sahng Wook; Lee, Hyun-Sook; Chen, Wei; Liu, Jingwen			Hepatocyte Nuclear Factor 1 alpha Plays a Critical Role in PCSK9 Gene Transcription and Regulation by the Natural Hypocholesterolemic Compound Berberine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; CONVERTASE SUBTILISIN/KEXIN TYPE-9; CORONARY-ARTERY-DISEASE; ELEMENT-BINDING PROTEIN; LDL CHOLESTEROL; PLASMA-CHOLESTEROL; TARGETING PCSK9; HEPG2 CELLS; EXPRESSION	PCSK9 is a natural inhibitor of LDL receptor (LDLR) that binds the extracellular domain of LDLR and triggers its intracellular degradation. PCSK9 and LDLR are coordinately regulated at the transcriptional level by sterols through their promoter-imbedded sterol response elements (SRE) and co-induced by statins. Identification of regulatory networks modulating PCSK9 transcription is important for developing selective repressors of PCSK9 to improve statin efficacy by prolonging the up-regulation of LDLR. Interestingly, the plant-derived hypocholesterolemic compound berberine (BBR) up-regulates LDLR expression while down-regulating PCSK9. In our investigations to define mechanisms underlying the transcriptional suppression of PCSK9 by BBR in HepG2 cells, we have identified a highly conserved hepatocyte nuclear factor 1 (HNF1) binding site residing 28 bp upstream from SRE as a critical sequence motif for PCSK9 transcription and its regulation by BBR. Mutation of the HNF1 site reduced PCSK9 promoter activity > 90%. A battery of functional assays identified HNF1 alpha as the predominant trans-activator for PCSK9 gene working through this sequence motif. We further provide evidence suggesting that HNF1 site works cooperatively with SRE as HNF1 mutation significantly attenuated the activity of nuclear SREBP2 to transactivate PCSK9 promoter. Finally, we show that a coordinate modest reduction of HNF1 alpha and nuclear SREBP2 by BBR led to a strong suppression of PCSK9 transcription through these two critical regulatory sequences. This is the first described example of SREBP pairing with HNF1 to control an important regulatory pathway in cholesterol homeostasis. This work also provides a mechanism for how BBR suppresses PCSK9 transcription.	[Li, Hai; Dong, Bin; Chen, Wei; Liu, Jingwen] Dept Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Park, Sahng Wook; Lee, Hyun-Sook] Yonsei Univ, Brain Korea Project Med Sci 21, Dept Biochem & Mol Biol, Ctr Chron Metab Dis Res,Inst Genet Sci,Coll Med, Seoul 120752, South Korea	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Yonsei University; Yonsei University Health System	Liu, JW (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, 3801 Miranda Ave, Palo Alto, CA 94304 USA.	Jingwen.Liu@med.va.gov		Park, Sahng Wook/0000-0002-9594-7074	National Institutes of Health, NCCAM [1RO1 AT002543-01A1, 1R21AT003195-01A2]; Department of Veterans Affairs; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT002543, R21AT003195] Funding Source: NIH RePORTER	National Institutes of Health, NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported, in whole or in part, by National Institutes of Health Grants 1RO1 AT002543-01A1 and 1R21AT003195-01A2 from NCCAM. This work was also supported by the Department of Veterans Affairs (Office of Research and Development, Medical Research Service).	Abidi P, 2005, ARTERIOSCL THROM VAS, V25, P2170, DOI 10.1161/01.ATV.0000181761.16341.2b; Abidi P, 2006, J LIPID RES, V47, P2134, DOI 10.1194/jlr.M600195-JLR200; Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Attie AD, 2005, CELL METAB, V1, P290, DOI 10.1016/j.cmet.2005.04.006; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Cameron J, 2008, ATHEROSCLEROSIS, V201, P266, DOI 10.1016/j.atherosclerosis.2008.02.004; Cao Guoqing, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P238, DOI 10.2174/187153008786848286; Careskey HE, 2008, J LIPID RES, V49, P394, DOI 10.1194/jlr.M700437-JLR200; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Costet P, 2006, J BIOL CHEM, V281, P6211, DOI 10.1074/jbc.M508582200; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Egea M, 2008, GEN COMP ENDOCR, V155, P359, DOI 10.1016/j.ygcen.2007.06.018; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Graham MJ, 2007, J LIPID RES, V48, P763, DOI 10.1194/jlr.C600025-JLR200; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Jeong HJ, 2008, J LIPID RES, V49, P399, DOI 10.1194/jlr.M700443-JLR200; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kong WJ, 2009, METABOLISM, V58, P109, DOI 10.1016/j.metabol.2008.08.013; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Kourimate S, 2008, J BIOL CHEM, V283, P9666, DOI 10.1074/jbc.M705831200; Langhi C, 2008, FEBS LETT, V582, P949, DOI 10.1016/j.febslet.2008.02.038; Leren TP, 2004, CLIN GENET, V65, P419, DOI 10.1111/j.0009-9163.2004.0238.x; Li H, 2009, J LIPID RES, V50, P820, DOI 10.1194/jlr.M800375-JLR200; Magana MM, 2000, J BIOL CHEM, V275, P4726, DOI 10.1074/jbc.275.7.4726; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; MENDEL DB, 1991, GENE DEV, V5, P1042, DOI 10.1101/gad.5.6.1042; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Qadri I, 2009, TOXICOL APPL PHARM, V234, P281, DOI 10.1016/j.taap.2008.10.005; Qian YW, 2007, J LIPID RES, V48, P1488, DOI 10.1194/jlr.M700071-JLR200; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; REYCAMPOS J, 1991, EMBO J, V10, P1445, DOI 10.1002/j.1460-2075.1991.tb07665.x; Rowley CW, 2006, AM J PHYSIOL-GASTR L, V290, pG466, DOI 10.1152/ajpgi.00431.2005; SANCHEZ HB, 1995, J BIOL CHEM, V270, P1161, DOI 10.1074/jbc.270.3.1161; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Servitja JM, 2009, MOL CELL BIOL, V29, P2945, DOI 10.1128/MCB.01389-08; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	46	240	259	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28885	28895		10.1074/jbc.M109.052407	http://dx.doi.org/10.1074/jbc.M109.052407			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19687008	Green Published, hybrid			2022-12-27	WOS:000270678900045
J	Rujiviphat, J; Meglei, G; Rubinstein, JL; McQuibban, GA				Rujiviphat, Jarungjit; Meglei, Gabriela; Rubinstein, John L.; McQuibban, G. Angus			Phospholipid Association Is Essential for Dynamin-related Protein Mgm1 to Function in Mitochondrial Membrane Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MORPHOLOGY; YEAST	Mgm1, the yeast ortholog of mammalian OPA1, is a key component in mitochondrial membrane fusion and is required for maintaining mitochondrial dynamics and morphology. We showed recently that the purified short isoform of Mgm1 (s-Mgm1) possesses GTPase activity, self- assembles into low order oligomers, and interacts specifically with negatively charged phospholipids (Meglei, G., and McQuibban, G. A. (2009) Biochemistry 48, 1774-1784). Here, we demonstrate that s-Mgm1 binds to a mixture of phospholipids characteristic of the mitochondrial inner membrane. Binding to physiologically representative lipids results in similar to 50-fold stimulation of s-Mgm1 GTPase activity. s-Mgm1 point mutants that are defective in oligomerization and lipid binding do not exhibit such stimulation and do not function in vivo. Electron microscopy and lipid turbidity assays demonstrate that s-Mgm1 promotes liposome interaction. Furthermore, s-Mgm1 assembles onto liposomes as oligomeric rings with 3-fold symmetry. The projection map of negatively stained s-Mgm1 shows six monomers, consistent with two stacked trimers. Taken together, our data identify a lipid-binding domain in Mgm1, and the structural analysis suggests a model of how Mgm1 promotes the fusion of opposing mitochondrial inner membranes.	[Rujiviphat, Jarungjit; Meglei, Gabriela; Rubinstein, John L.; McQuibban, G. Angus] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Rubinstein, John L.] Univ Toronto, Mol Struct & Funct Program, Hosp Sick Children, Inst Res, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	McQuibban, GA (corresponding author), Univ Toronto, Dept Biochem, 1 Kings Coll Circle,Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	angus.mcquibban@utoronto.ca		Rubinstein, John/0000-0003-0566-2209	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by an operating grant from the Canadian Institutes of Health Research (to G. A. M.).	Connell E, 2008, ANAL BIOCHEM, V377, P83, DOI 10.1016/j.ab.2008.02.016; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Mears JA, 2008, METHOD CELL BIOL, V88, P237, DOI 10.1016/S0091-679X(08)00413-5; Meglei G, 2009, BIOCHEMISTRY-US, V48, P1774, DOI 10.1021/bi801723d; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Park J, 2009, DIS MODEL MECH, V2, P336, DOI 10.1242/dmm.003178; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Schlame M, 1997, BBA-LIPID LIPID MET, V1348, P207, DOI 10.1016/S0005-2760(97)00119-7; Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2; Whitworth AJ, 2008, DIS MODEL MECH, V1, P168, DOI 10.1242/dmm.000109; Zick M, 2009, FEBS LETT, V583, P2237, DOI 10.1016/j.febslet.2009.05.053	15	55	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28682	28686		10.1074/jbc.M109.044933	http://dx.doi.org/10.1074/jbc.M109.044933			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19703904	Green Published, hybrid			2022-12-27	WOS:000270678900023
J	Wethkamp, N; Klempnauer, KH				Wethkamp, Nils; Klempnauer, Karl-Heinz			Daxx Is a Transcriptional Repressor of CCAAT/Enhancer-binding Protein beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; PML-RAR-ALPHA; C/EBP-BETA; INTERACTING PROTEIN; SUMO MODIFICATION; FAMILY-MEMBERS; NF-M; ACTIVATION; APOPTOSIS; CELLS	CCAAT/enhancer-binding Protein beta (C/EBP beta) is a member of the bZIP transcription factor family that is expressed in various tissues, including cells of the hematopoietic system. C/EBP beta is involved in tissue-specific gene expression and thereby takes part in fundamental cellular processes such as proliferation and differentiation. Here, we show that the activity of C/EBP beta is negatively regulated by the transcriptional co-repressor Daxx. C/EBP beta was found to directly interact with Daxx after overexpression as well as on the endogenous level. Glutathione S-transferase pulldown assays showed that Daxx binds via amino acids 190-400 to the C-terminal part of C/EBP beta. Coexpression of C/EBP beta changed the sub-nuclear Daxx distribution pattern from predominantly POD-localized to nucleoplasmic. Daxx suppressed basal and p300-enhanced transcriptional activity of C/EBP beta. Furthermore, Daxx decreased the C/EBP beta dependent phosphorylation of p300, which in turn was associated with a diminished level of p300-mediated C/EBP beta acetylation. Co-expression of promyelocytic leukemia protein abrogated the repressive effect of Daxx on C/EBP beta as well as the direct interaction of Daxx and C/EBP beta, presumably by re-recruiting Daxx to PML-oncogenic domains. In acute promyelocytic leukemia (APL) cells, C/EBP beta activity is known to be required for all-trans-retinoic acid-induced cell differentiation and disease remission. We show that all-trans-retinoic acid as well as arsenic trioxide treatment leads to a reduced C/EBP beta fraction associated with Daxx suggesting a relief of Daxx-dependent C/EBP beta repression as an important molecular event leading to APL cell differentiation. Overall, our data identify Daxx as a new negative regulator of C/EBP beta and provide first clues for a link between abrogation of Daxx-C/EBP beta complex formation and APL remission.	[Wethkamp, Nils; Klempnauer, Karl-Heinz] Univ Munster, Inst Biochem, D-48149 Munster, Germany	University of Munster	Klempnauer, KH (corresponding author), Univ Munster, Inst Biochem, Wilhelm Klemm Str 2, D-48149 Munster, Germany.	klempna@uni-muenster.de			Deutsche Forschungsgemeinschaft; Deutsche Krebshilfe	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by grants from the Deutsche Forschungsgemeinschaft and the Deutsche Krebshilfe.	Aikawa Y, 2006, EMBO J, V25, P3955, DOI 10.1038/sj.emboj.7601273; Amin HM, 2001, BRIT J HAEMATOL, V115, P287, DOI 10.1046/j.1365-2141.2001.03123.x; Berberich-Siebelt F, 2006, J IMMUNOL, V176, P4843, DOI 10.4049/jimmunol.176.8.4843; Boellmann F, 2004, P NATL ACAD SCI USA, V101, P4100, DOI 10.1073/pnas.0304768101; Calkhoven CF, 2000, GENE DEV, V14, P1920; Cesena TI, 2008, MOL CELL ENDOCRINOL, V289, P94, DOI 10.1016/j.mce.2008.03.009; Cesena TI, 2007, J BIOL CHEM, V282, P956, DOI 10.1074/jbc.M511451200; Chang CC, 2005, J BIOL CHEM, V280, P10164, DOI 10.1074/jbc.M409161200; Chayka O, 2005, MOL CELL BIOL, V25, P499, DOI 10.1128/MCB.25.1.499-511.2005; Chen LY, 2003, MOL CELL BIOL, V23, P7108, DOI 10.1128/MCB.23.20.7108-7121.2003; Choy L, 2003, J BIOL CHEM, V278, P9609, DOI 10.1074/jbc.M212259200; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; Duprez E, 2003, EMBO J, V22, P5806, DOI 10.1093/emboj/cdg556; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; Eaton EM, 2003, J BIOL CHEM, V278, P33416, DOI 10.1074/jbc.M305680200; Emelyanov AV, 2002, J BIOL CHEM, V277, P11156, DOI 10.1074/jbc.M111763200; Gostissa M, 2004, J BIOL CHEM, V279, P48013, DOI 10.1074/jbc.M310801200; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; Hofmann TG, 2003, CANCER RES, V63, P8271; Hollenbach AD, 1999, EMBO J, V18, P3702, DOI 10.1093/emboj/18.13.3702; Hollenbach AD, 2002, J CELL SCI, V115, P3319; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Kim EJ, 2003, NUCLEIC ACIDS RES, V31, P5356, DOI 10.1093/nar/gkg741; Ko YG, 2001, J BIOL CHEM, V276, P39103, DOI 10.1074/jbc.M105928200; KOKEN MHM, 1994, EMBO J, V13, P1073, DOI 10.1002/j.1460-2075.1994.tb06356.x; Kovacs KA, 2003, J BIOL CHEM, V278, P36959, DOI 10.1074/jbc.M303147200; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Kuo HY, 2005, P NATL ACAD SCI USA, V102, P16973, DOI 10.1073/pnas.0504460102; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lehembre F, 2001, ONCOGENE, V20, P1, DOI 10.1038/sj.onc.1204063; Li H, 2000, MOL CELL BIOL, V20, P1784, DOI 10.1128/MCB.20.5.1784-1796.2000; Li RZ, 2000, ONCOGENE, V19, P745, DOI 10.1038/sj.onc.1203385; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lin DY, 2002, J BIOL CHEM, V277, P25446, DOI 10.1074/jbc.M200633200; Lin DY, 2004, MOL CELL BIOL, V24, P10529, DOI 10.1128/MCB.24.24.10529-10541.2004; Lin DY, 2003, J BIOL CHEM, V278, P15958, DOI 10.1074/jbc.M300387200; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; Mistry AR, 2003, BLOOD REV, V17, P71, DOI 10.1016/S0268-960X(02)00075-9; Morozov VM, 2008, ONCOGENE, V27, P2177, DOI 10.1038/sj.onc.1210865; Nerlov C, 2008, CURR OPIN CELL BIOL, V20, P180, DOI 10.1016/j.ceb.2008.02.002; Oelgeschlager M, 1996, EMBO J, V15, P2771, DOI 10.1002/j.1460-2075.1996.tb00637.x; Park J, 2007, J MOL BIOL, V368, P388, DOI 10.1016/j.jmb.2007.02.047; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Piwien-Pilipuk G, 2002, J BIOL CHEM, V277, P44557, DOI 10.1074/jbc.M206886200; Plachetka A, 2008, MOL CELL BIOL, V28, P2102, DOI 10.1128/MCB.01943-07; Pless O, 2008, J BIOL CHEM, V283, P26357, DOI 10.1074/jbc.M802132200; Puto LA, 2008, GENE DEV, V22, P998, DOI 10.1101/gad.1632208; Schwartz C, 2003, EMBO J, V22, P882, DOI 10.1093/emboj/cdg076; Shih HM, 2007, BIOCHEM SOC T, V35, P1397, DOI 10.1042/BST0351397; Sundfeldt K, 1999, BRIT J CANCER, V79, P1240, DOI 10.1038/sj.bjc.6690199; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7; Wiper-Bergeron N, 2007, P NATL ACAD SCI USA, V104, P2703, DOI 10.1073/pnas.0607378104; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Zhong S, 2000, J EXP MED, V191, P631, DOI 10.1084/jem.191.4.631; Zhu J, 2005, CANCER CELL, V7, P143, DOI 10.1016/j.ccr.2005.01.005; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299	61	23	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28783	28794		10.1074/jbc.M109.041186	http://dx.doi.org/10.1074/jbc.M109.041186			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19690170	Green Published, hybrid			2022-12-27	WOS:000270678900035
J	Hasdemir, B; Murphy, JE; Cottrell, GS; Bunnett, NW				Hasdemir, Burcu; Murphy, Jane E.; Cottrell, Graeme S.; Bunnett, Nigel W.			Endosomal Deubiquitinating Enzymes Control Ubiquitination and Down-regulation of Protease-activated Receptor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; ARRESTIN-DEPENDENT ENDOCYTOSIS; BETA-ARRESTIN; COUPLED RECEPTORS; BETA(2)-ADRENERGIC RECEPTOR; MEDIATES UBIQUITINATION; EPITHELIAL-CELLS; SUBSTANCE-P; UBPY; TRAFFICKING	The E3 ubiquitin ligase c-Cbl ubiquitinates the G protein-coupled receptor protease-activated receptor 2 (PAR(2)), which is required for postendocytic sorting of activated receptors to lysosomes, where degradation terminates signaling. The mechanisms of PAR(2) deubiquitination and its importance in trafficking and signaling of endocytosed PAR(2) are unknown. We report that receptor deubiquitination occurs between early endosomes and lysosomes and involves the endosomal deubiquitinating proteases AMSH and UBPY. Expression of the catalytically inactive mutants, AMSH(D348A) and UBPY(C786S), caused an increase in PAR(2) ubiquitination and trapped the receptor in early endosomes, thereby preventing lysosomal trafficking and degradation. Small interfering RNA knockdown of AMSH or UBPY also impaired deubiquitination, lysosomal trafficking, and degradation of PAR(2). Trapping PAR(2) in endosomes through expression of AMSH(D348A) or UBPY(C786S) did not prolong the association of PAR(2) with beta-arrestin2 or the duration of PAR(2)-induced ERK2 activation. Thus, AMSH and UBPY are essential for trafficking and down-regulation of PAR(2) but not for regulating PAR(2) dissociation from beta-arrestin2 or PAR(2)-mediated ERK2 activation.	[Bunnett, Nigel W.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bunnett, NW (corresponding author), Univ Calif San Francisco, Dept Surg, 513 Parnassus Ave, San Francisco, CA 94143 USA.	nigel.bunnett@ucsf.edu		Bunnett, Nigel W./0000-0003-3367-0644; Cottrell, Graeme/0000-0001-9098-7627	National Institutes of Health [DK43207, DK57480, DK39957]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043207, R01DK039957, R37DK039957, R56DK043207] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK43207, DK57480, and DK39957.	Alwan HAJ, 2007, J BIOL CHEM, V282, P1658, DOI 10.1074/jbc.M604711200; Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Asao H, 1997, J BIOL CHEM, V272, P32785, DOI 10.1074/jbc.272.52.32785; Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Bohm SK, 1996, J BIOL CHEM, V271, P22003; Bowers K, 2006, J BIOL CHEM, V281, P5094, DOI 10.1074/jbc.M508632200; Chen LY, 2002, TRAFFIC, V3, P110, DOI 10.1034/j.1600-0854.2002.030204.x; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Compton SJ, 2002, BIOCHEM J, V368, P495, DOI 10.1042/BJ20020706; Cottrell GS, 2009, J BIOL CHEM, V284, P22411, DOI 10.1074/jbc.M109.026674; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Dulon S, 2003, AM J RESP CELL MOL, V28, P339, DOI 10.1165/rcmb.4908; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; GARLAND AM, 1994, BIOCHEM J, V303, P177, DOI 10.1042/bj3030177; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Hasdemir B, 2007, J BIOL CHEM, V282, P29646, DOI 10.1074/jbc.M702974200; Hislop JN, 2009, J BIOL CHEM, V284, P19361, DOI 10.1074/jbc.M109.001644; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Li HS, 2005, TRAFFIC, V6, P324, DOI 10.1111/j.1600-0854.2005.00274.x; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 2003, J MOL ENDOCRINOL, V30, P117, DOI 10.1677/jme.0.0300117; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Mizuno E, 2006, TRAFFIC, V7, P1017, DOI 10.1111/j.1600-0854.2006.00452.x; Naviglio S, 1998, EMBO J, V17, P3241, DOI 10.1093/emboj/17.12.3241; Niendorf S, 2007, MOL CELL BIOL, V27, P5029, DOI 10.1128/MCB.01566-06; Nystedt S, 1996, J BIOL CHEM, V271, P14910, DOI 10.1074/jbc.271.25.14910; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Padilla BE, 2007, J CELL BIOL, V179, P981, DOI 10.1083/jcb.200704053; Roosterman D, 2007, P NATL ACAD SCI USA, V104, P11838, DOI 10.1073/pnas.0701910104; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shenoy SK, 2009, P NATL ACAD SCI USA, V106, P6650, DOI 10.1073/pnas.0901083106; Tanaka N, 1999, J BIOL CHEM, V274, P19129, DOI 10.1074/jbc.274.27.19129; Urbe S, 2006, BIOCHEM SOC T, V34, P754, DOI 10.1042/BST0340754; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154	48	71	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28453	28466		10.1074/jbc.M109.025692	http://dx.doi.org/10.1074/jbc.M109.025692			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19684015	hybrid, Green Published			2022-12-27	WOS:000270676300070
J	Li, ZQ; Li, Y; Chakraborty, M; Fan, YF; Bui, HH; Peake, DA; Kuo, MS; Xiao, X; Cao, GQ; Jiang, XC				Li, Zhiqiang; Li, Yan; Chakraborty, Mahua; Fan, Yifan; Bui, Hai H.; Peake, David A.; Kuo, Ming-Shang; Xiao, Xiao; Cao, Guoqing; Jiang, Xian-Cheng			Liver-specific Deficiency of Serine Palmitoyltransferase Subunit 2 Decreases Plasma Sphingomyelin and Increases Apolipoprotein E Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEINS; RICH MEMBRANE RAFTS; CHOLESTEROL ACYLTRANSFERASE REACTION; PALMITOYL-COA TRANSFERASE; CORONARY-ARTERY-DISEASE; ATHEROGENIC LIPOPROTEINS; SPHINGOLIPID SYNTHESIS; LIPID EMULSIONS; RISK-FACTOR; MICE	Sphingomyelin (SM) is one of the major lipid components of plasma lipoproteins. Serine palmitoyltransferase (SPT) is the key enzyme in SM biosynthesis. Mice totally lacking in SPT are embryonic lethal. The liver is the major site for plasma lipoprotein biosynthesis, secretion, and degradation, and in this study we utilized a liver-specific knock-out approach for evaluating liver SPT activity and also its role in plasma SM and lipoprotein metabolism. We found that a deficiency of liver-specific Sptlc2 (a subunit of SPT) decreased liver SPT protein mass and activity by 95 and 92%, respectively, but had no effect on other tissues. Liver Sptlc2 deficiency decreased plasma SM levels (in both high density lipoprotein and non-high density lipoprotein fractions) by 36 and 35% (p<0.01), respectively, and increased phosphatidylcholine levels by 19% (p<0.05), thus increasing the phosphatidylcholine/SM ratio by 77% (p<0.001),compared with controls. This deficiency also decreased SM levels in the liver by 38% (p<0.01) and in the hepatocyte plasma membranes (based on a lysenin-mediated cell lysis assay). Liver-specific Sptlc2 deficiency significantly increased hepatocyte apoE secretion and thus increased plasma apoE levels 3.5-fold (p<0.0001). Furthermore, plasma from Sptlc2 knock-out mice had a significantly stronger potential for promoting cholesterol efflux from macrophages than from wild-type mice (p<0.01) because of a greater amount of apoE in the circulation. As a result of these findings, we believe that the ability to control liver SPT activity could result in regulation of lipoprotein metabolism and might have an impact on the development of atherosclerosis.	[Li, Zhiqiang; Li, Yan; Chakraborty, Mahua; Fan, Yifan; Jiang, Xian-Cheng] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA; [Bui, Hai H.; Peake, David A.; Kuo, Ming-Shang; Cao, Guoqing] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Xiao, Xiao] Univ N Carolina, Eshelman Sch Pharm, Div Mol Pharmaceut, Chapel Hill, NC 27599 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Eli Lilly; University of North Carolina; University of North Carolina Chapel Hill	Jiang, XC (corresponding author), Suny Downstate Med Ctr, 450 Clarkson Ave,Box 5, Brooklyn, NY 11203 USA.	XJiang@downstate.edu	fan, yi/GYU-1036-2022	Chakraborty, Mahua/0000-0003-1598-0665	National Institutes of Health [HL-64735, HL-69817]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064735, R01HL069817] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-64735 and HL-69817 (to X.- C. J.). This work was also supported by an American Heart Association grant-in-aid (to X.- C. J.).	Arimoto I, 1998, LIPIDS, V33, P773, DOI 10.1007/s11745-998-0269-8; Arimoto I, 1998, J LIPID RES, V39, P143; Bolin DJ, 1996, J BIOL CHEM, V271, P19152, DOI 10.1074/jbc.271.32.19152; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Devlin CM, 2008, ARTERIOSCL THROM VAS, V28, P1723, DOI 10.1161/ATVBAHA.108.173344; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Gkantiragas I, 2001, MOL BIOL CELL, V12, P1819, DOI 10.1091/mbc.12.6.1819; GORDON V, 1983, J BIOL CHEM, V258, P6202; Grassme H, 2002, J IMMUNOL, V168, P298, DOI 10.4049/jimmunol.168.1.298; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; GRONBERG L, 1991, BIOCHEMISTRY-US, V30, P10746, DOI 10.1021/bi00108a020; Guyton JR, 1996, ARTERIOSCL THROM VAS, V16, P4, DOI 10.1161/01.ATV.16.1.4; Hailemariam TK, 2008, ARTERIOSCL THROM VAS, V28, P1519, DOI 10.1161/ATVBAHA.108.168682; Hanada K, 1997, J BIOL CHEM, V272, P32108, DOI 10.1074/jbc.272.51.32108; Hoekstra D, 2000, CURR OPIN CELL BIOL, V12, P496, DOI 10.1016/S0955-0674(00)00122-8; HOFF HF, 1985, ANN NY ACAD SCI, V454, P183, DOI 10.1111/j.1749-6632.1985.tb11857.x; Hojjati MR, 2006, J LIPID RES, V47, P673, DOI 10.1194/jlr.D500040-JLR200; Hojjati MR, 2005, BBA-MOL CELL BIOL L, V1737, P44, DOI 10.1016/j.bbalip.2005.08.006; Hornemann T, 2006, J BIOL CHEM, V281, P37275, DOI 10.1074/jbc.M608066200; INNERARITY TL, 1982, ARTERIOSCLEROSIS, V2, P114, DOI 10.1161/01.ATV.2.2.114; Ishitsuka R, 2004, BIOPHYS J, V86, P296, DOI 10.1016/S0006-3495(04)74105-3; Jeong TS, 1998, J CLIN INVEST, V101, P905, DOI 10.1172/JCI870; Jiang XC, 2000, ARTERIOSCL THROM VAS, V20, P2614, DOI 10.1161/01.ATV.20.12.2614; Jones Jr, 2005, METH MOLEC MED, V103, P245; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; Kitajima K, 2006, ARTERIOSCL THROM VAS, V26, P1852, DOI 10.1161/01.ATV.0000231520.26490.54; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Leventhal AR, 2001, J BIOL CHEM, V276, P44976, DOI 10.1074/jbc.M106455200; Li ZQ, 2007, BBA-MOL CELL BIOL L, V1771, P1186, DOI 10.1016/j.bbalip.2007.05.007; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Lucic D, 2007, BIOCHEMISTRY-US, V46, P11196, DOI 10.1021/bi701106v; MCINTOSH TJ, 1992, BIOCHEMISTRY-US, V31, P2020, DOI 10.1021/bi00122a018; MERRILL AH, 1990, BIOCHIM BIOPHYS ACTA, V1044, P1, DOI 10.1016/0005-2760(90)90211-F; Nilsson A, 2006, J LIPID RES, V47, P154, DOI 10.1194/jlr.M500357-JLR200; PLUMP AS, 1995, ANNU REV NUTR, V15, P495, DOI 10.1146/annurev.nu.15.070195.002431; Ridgway ND, 2000, BBA-MOL CELL BIOL L, V1484, P129, DOI 10.1016/S1388-1981(00)00006-8; RODRIGUEZ JL, 1976, ATHEROSCLEROSIS, V23, P73, DOI 10.1016/0021-9150(76)90119-2; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Rye KA, 1996, J BIOL CHEM, V271, P4243; Saito H, 2000, BBA-MOL CELL BIOL L, V1486, P312, DOI 10.1016/S1388-1981(00)00071-8; Schissel SL, 1996, J CLIN INVEST, V98, P1455, DOI 10.1172/JCI118934; Schissel SL, 1998, J BIOL CHEM, V273, P2738, DOI 10.1074/jbc.273.5.2738; Schlitt A, 2006, NUTR METABOLISM, V3, DOI 10.1186/1743-7075-3-5; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Subbaiah PV, 2005, J LIPID RES, V46, P2699, DOI 10.1194/jlr.M500263-JLR200; SUBBAIAH PV, 1993, J BIOL CHEM, V268, P20156; Weiss B, 1997, EUR J BIOCHEM, V249, P239, DOI 10.1111/j.1432-1033.1997.00239.x; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Xian-Cheng J, 2005, J BIOL CHEM, V280, P18336, DOI 10.1074/jbc.M500007200; Yamaji A, 1998, J BIOL CHEM, V273, P5300, DOI 10.1074/jbc.273.9.5300; Yasuda S, 2003, J BIOL CHEM, V278, P4176, DOI 10.1074/jbc.M209602200; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	53	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					27010	27019		10.1074/jbc.M109.042028	http://dx.doi.org/10.1074/jbc.M109.042028			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19648608	Green Published, hybrid			2022-12-27	WOS:000269969600080
J	Choudhuri, K; Parker, M; Milicic, A; Cole, DK; Shaw, MK; Sewell, AK; Stewart-Jones, G; Dong, T; Gould, KG; van der Merwe, PA				Choudhuri, Kaushik; Parker, Mathew; Milicic, Anita; Cole, David K.; Shaw, Michael K.; Sewell, Andrew K.; Stewart-Jones, Guillaume; Dong, Tao; Gould, Keith G.; van der Merwe, P. Anton			Peptide-Major Histocompatibility Complex Dimensions Control Proximal Kinase-Phosphatase Balance during T Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN RECOGNITION; RECEPTOR; LYMPHOCYTES; RESPONSES; BINDING; LIGAND; MODEL; CHAIN	T cell antigen recognition requires binding of the T cell receptor (TCR) to a complex between peptide antigen and major histocompatibility complex molecules (pMHC), and this recognition occurs at the interface between the T cell and the antigen-presenting cell. The TCR and pMHC molecules are small compared with other abundant cell surface molecules, and it has been suggested that small size is functionally important. We show here that elongation of both mouse and human MHC class I molecules abrogates T cell antigen recognition as measured by cytokine production and target cell killing. This elongation disrupted tyrosine phosphorylation and Zap70 recruitment at the contact region without affecting TCR or coreceptor binding. Contact areas with elongated forms of pMHC showed an increase in intermembrane distance and less efficient segregation of CD3 from the large tyrosine phosphatase CD45. These findings demonstrate that T cell antigen recognition is strongly dependent on pMHC size and are consistent with models of TCR triggering requiring segregation or mechanical pulling of the TCR.	[Parker, Mathew; Gould, Keith G.] Univ London Imperial Coll Sci Technol & Med, Dept Immunol, Wright Fleming Inst, London W2 1PG, England; [Choudhuri, Kaushik; Shaw, Michael K.; van der Merwe, P. Anton] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Milicic, Anita] Univ Oxford, Jenner Inst, Oxford OX1 3RE, England; [Stewart-Jones, Guillaume; Dong, Tao] Univ Oxford, MRC, Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX1 3RE, England; [Cole, David K.; Sewell, Andrew K.] Cardiff Univ, Dept Med Biochem & Immunol, Sch Med, Cardiff CF14 4XN, S Glam, Wales	Imperial College London; University of Oxford; University of Oxford; Jenner Institute; University of Oxford; Cardiff University	Gould, KG (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Immunol, Wright Fleming Inst, Norfolk Pl, London W2 1PG, England.	k.gould@imperial.ac.uk; anton.vandermerwe@path.ox.ac.uk	van der Merwe, P. Anton/F-8539-2011; Cole, David/C-8387-2012; Stewart-Jones, Guillaume/E-7013-2013; Milicic, Anita/B-7693-2011; Sewell, Andrew/GPT-4220-2022	Milicic, Anita/0000-0002-7984-1317; Sewell, Andrew/0000-0003-3194-3135; Cole, David/0000-0003-0028-9396; Gould, Keith/0000-0003-0913-5422; Choudhuri, Kaushik/0000-0002-3911-027X; Dong, Tao/0000-0003-3545-3758	Wellcome Trust; United Kingdom Medical Research Council; Medical Research Council [G9722488, MC_U137884178, G0600520, G0400091] Funding Source: researchfish; MRC [G9722488, G0400091, MC_U137884178, G0600520] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by the Wellcome Trust and by the United Kingdom Medical Research Council.	Barclay A. N., 1997, LEUCOCYTE ANTIGEN FA, V2nd; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; Choudhuri K, 2005, CURR BIOL, V15, pR382, DOI 10.1016/j.cub.2005.05.001; Choudhuri K, 2007, SEMIN IMMUNOL, V19, P255, DOI 10.1016/j.smim.2007.04.005; Davis M., 2003, FUNDAMENTAL IMMUNOLO, P227; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; Hutchinson SL, 2003, J BIOL CHEM, V278, P24285, DOI 10.1074/jbc.M300633200; Kuhns MS, 2006, IMMUNITY, V24, P133, DOI 10.1016/j.immuni.2006.01.006; Laugel B, 2007, EUR J IMMUNOL, V37, P905, DOI 10.1002/eji.200636718; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Ma ZY, 2008, FASEB J, V22, P1002, DOI 10.1096/fj.07-9331hyp; MAMALAKI C, 1992, P NATL ACAD SCI USA, V89, P11342, DOI 10.1073/pnas.89.23.11342; Palmowski MJ, 2009, J IMMUNOL, V182, P4565, DOI 10.4049/jimmunol.0803893; Price DA, 1998, CURR BIOL, V8, P355, DOI 10.1016/S0960-9822(98)70138-1; Purbhoo MA, 2001, J BIOL CHEM, V276, P32786, DOI 10.1074/jbc.M102498200; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Schamel WWA, 2006, TRENDS IMMUNOL, V27, P176, DOI 10.1016/j.it.2006.02.005; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Trautmann A, 2003, TRENDS IMMUNOL, V24, P425, DOI 10.1016/S1471-4906(03)00182-0; Valitutti S, 1996, J EXP MED, V183, P1917, DOI 10.1084/jem.183.4.1917; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; van der Merwe PA, 2001, IMMUNITY, V14, P665, DOI 10.1016/S1074-7613(01)00155-8; VANDERMERWE PA, 1995, CURR BIOL, V5, P74; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEISS A, 2003, FUNDAMENTAL IMMUNOLO, P321; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044	32	35	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26096	26105		10.1074/jbc.M109.039966	http://dx.doi.org/10.1074/jbc.M109.039966			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19628870	Green Published, hybrid			2022-12-27	WOS:000269738000065
J	Martin, JL; Lin, MZ; McGowan, EM; Baxter, RC				Martin, Janet L.; Lin, Mike Z.; McGowan, Eileen M.; Baxter, Robert C.			Potentiation of Growth Factor Signaling by Insulin-like Growth Factor-binding Protein-3 in Breast Epithelial Cells Requires Sphingosine Kinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; FACTOR RECEPTOR; SURFACE BINDING; DNA-SYNTHESIS; IGF ACTION; FACTOR-I; APOPTOSIS; EXPRESSION; IGFBP-3; SPHINGOSINE-1-PHOSPHATE	We have investigated the mechanism underlying potentiation of epidermal growth factor receptor (EGFR) and type 1 insulin-like growth factor receptor (IGFR1) signaling by IGF-binding protein-3 (IGFBP-3) in MCF-10A breast epithelial cells, focusing on a possible involvement of the sphingosine kinase (SphK) system. IGFBP-3 potentiated EGF-stimulated EGF receptor activation and DNA synthesis, and this was blocked by inhibitors of SphK activity or small interference RNA-mediated silencing of SphK1, but not SphK2, expression. Similarly, IGFR1 phosphorylation and DNA synthesis stimulated by LR3-IGF-I (an IGF-I analog not bound by IGFBP-3), were enhanced by IGFBP-3, and this was blocked by SphK1 silencing. SphK1 expression and activity were stimulated by IGFBP-3 similar to 2-fold over 24 h. Silencing of sphingosine 1-phosphate receptor 1 (S1P(1)) or S1P(3), but not S1P(2), abolished the effect of IGFBP-3 on EGF-stimulated EGFR activation. The effects of IGFBP-3 could be reproduced with exogenous S1P or medium conditioned by cells treated with IGFBP-3, and this was also blocked by inhibition of S1P1 and S1P3. These data indicate that potentiation of growth factor signaling by IGFBP-3 in MCF-10A cells requires SphK1 activity and S1P1/S1P3, suggesting that S1P, the product of SphK activity and ligand for S1P1 and S1P3, is the "missing link" mediating IGF and EGFR transactivation and cell growth stimulation by IGFBP-3.	[Martin, Janet L.; Lin, Mike Z.; Baxter, Robert C.] Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Hormones & Canc Grp, St Leonards, NSW 2065, Australia; [McGowan, Eileen M.] Centenary Inst, Sydney, NSW 2050, Australia	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; University of Sydney; Centenary Institute	Martin, JL (corresponding author), Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Hormones & Canc Grp, St Leonards, NSW 2065, Australia.	janetlm@med.usyd.edu.au	Baxter, Robert C/F-3927-2012	Baxter, Robert C/0000-0001-5061-2142; McGowan, Eileen/0000-0001-6371-3751	National Health and Medical Research Council [302153]; Cancer Institute New South Wales Career Development and Support Fellowship; Cancer Institute New South Wales Early Career Award	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales Career Development and Support Fellowship; Cancer Institute New South Wales Early Career Award	This work was supported, in whole or in part, by National Health and Medical Research Council Grant 302153 ( to J.L.M. and R. C. B.). This work was also supported by a Cancer Institute New South Wales Career Development and Support Fellowship ( to J.L.M.) and a Cancer Institute New South Wales Early Career Award ( to E. M.).	Ahmad T, 2004, J BIOL CHEM, V279, P1713, DOI 10.1074/jbc.M306156200; Ali O, 2003, HORM METAB RES, V35, P726; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; BASOLO F, 1991, MOL CARCINOGEN, V4, P25, DOI 10.1002/mc.2940040106; BAXTER RC, 1986, J CLIN INVEST, V78, P1504, DOI 10.1172/JCI112742; Bhattacharyya N, 2006, J BIOL CHEM, V281, P24588, DOI 10.1074/jbc.M509463200; Butt AJ, 2004, J CLIN ENDOCR METAB, V89, P1950, DOI 10.1210/jc.2003-030914; Butt AJ, 2002, ENDOCRINOLOGY, V143, P2693, DOI 10.1210/en.143.7.2693; Butt AJ, 2000, J BIOL CHEM, V275, P39174, DOI 10.1074/jbc.M908888199; CHEN JC, 1994, J CELL PHYSIOL, V158, P69, DOI 10.1002/jcp.1041580110; CONOVER CA, 1992, ENDOCRINOLOGY, V130, P3191, DOI 10.1210/en.130.6.3191; Conover CA, 2000, ENDOCRINOLOGY, V141, P3098, DOI 10.1210/en.141.9.3098; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; DEMELLOW JSM, 1988, BIOCHEM BIOPH RES CO, V156, P199, DOI 10.1016/S0006-291X(88)80824-6; El-Shewy HM, 2006, J BIOL CHEM, V281, P31399, DOI 10.1074/jbc.M605339200; Firth SM, 1998, BIOCHEM BIOPH RES CO, V246, P325, DOI 10.1006/bbrc.1998.8615; Firth SM, 1999, PROTEIN EXPRES PURIF, V16, P202, DOI 10.1006/prep.1999.1075; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Forbes BE, 2002, EUR J BIOCHEM, V269, P961, DOI 10.1046/j.0014-2956.2001.02735.x; Granata R, 2007, J THROMB HAEMOST, V5, P835, DOI 10.1111/j.1538-7836.2007.02431.x; Granata R, 2004, FASEB J, V18, P1456, DOI 10.1096/fj.04-1618fje; Grill CJ, 2000, J CELL PHYSIOL, V183, P273, DOI 10.1002/(SICI)1097-4652(200005)183:2<273::AID-JCP14>3.3.CO;2-A; Hansel DE, 2004, CLIN CANCER RES, V10, P6152, DOI 10.1158/1078-0432.CCR-04-0285; Kettunen E, 2004, CANCER GENET CYTOGEN, V149, P98, DOI 10.1016/s0165-4608(03)00300-5; Kim JH, 2000, IUBMB LIFE, V50, P119, DOI 10.1080/713803698; Kwon YG, 2001, J BIOL CHEM, V276, P10627, DOI 10.1074/jbc.M011449200; Lee KW, 2005, J BIOL CHEM, V280, P16942, DOI 10.1074/jbc.M412757200; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Liu BR, 2000, J BIOL CHEM, V275, P33607, DOI 10.1074/jbc.M002547200; Martin JL, 1999, J BIOL CHEM, V274, P16407, DOI 10.1074/jbc.274.23.16407; Martin JL, 2003, J BIOL CHEM, V278, P2969, DOI 10.1074/jbc.M210739200; McCaig C, 2002, J CELL SCI, V115, P4293, DOI 10.1242/jcs.00097; MURPHY LJ, 1995, J MOL ENDOCRINOL, V15, P293, DOI 10.1677/jme.0.0150293; OH YM, 1993, J BIOL CHEM, V268, P14964; Okami J, 2004, CANCER RES, V64, P5338, DOI 10.1158/0008-5472.CAN-04-0089; Perks C, 2003, HORM METAB RES, V35, P828; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Rocha RL, 1996, J NATL CANCER I, V88, P601, DOI 10.1093/jnci/88.9.601; Rosenfeldt HM, 2001, BIOCHEM SOC T, V29, P836, DOI 10.1042/0300-5127:0290836; Salomone S, 2008, BRIT J PHARMACOL, V153, P140, DOI 10.1038/sj.bjp.0707581; Schedlich LJ, 2004, BIOCHEM BIOPH RES CO, V314, P83, DOI 10.1016/j.bbrc.2003.12.049; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2007, J BIOL CHEM, V282, P2125, DOI 10.1074/jbc.R600028200; Sukocheva O, 2006, J CELL BIOL, V173, P301, DOI 10.1083/jcb.200506033; Sukocheva OA, 2003, MOL ENDOCRINOL, V17, P2002, DOI 10.1210/me.2003-0119; Tanimoto T, 2004, CIRC RES, V94, P1050, DOI 10.1161/01.RES.0000126404.41421.BE; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Wang D, 2008, MOL CANCER THER, V7, P1993, DOI 10.1158/1535-7163.MCT-08-0088; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; Xin CY, 2004, J BIOL CHEM, V279, P35255, DOI 10.1074/jbc.M312091200; Yamazaki K, 2003, ONCOGENE, V22, P847, DOI 10.1038/sj.onc.1206153; Yu H, 1996, BRIT J CANCER, V74, P1242, DOI 10.1038/bjc.1996.523	53	62	62	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25542	25552		10.1074/jbc.M109.007120	http://dx.doi.org/10.1074/jbc.M109.007120			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19633297	Green Published, hybrid			2022-12-27	WOS:000269738000011
J	Dong, XP; Wang, X; Shen, DB; Chen, S; Liu, M; Wang, YB; Mills, E; Cheng, XP; Delling, M; Xu, HX				Dong, Xian-ping; Wang, Xiang; Shen, Dongbiao; Chen, Su; Liu, Meiling; Wang, Yanbin; Mills, Eric; Cheng, Xiping; Delling, Markus; Xu, Haoxing			Activating Mutations of the TRPML1 Channel Revealed by Proline-scanning Mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUCOLIPIDOSIS TYPE-IV; VARITINT-WADDLER PHENOTYPE; RECEPTOR POTENTIAL CHANNEL; LYSOSOMAL EXOCYTOSIS; MEMBRANE-PROTEIN; RELEASE CHANNEL; CATION CHANNEL; CELLS; CALCIUM; MOUSE	The mucolipin TRP (TRPML) proteins are a family of endolysosomal cation channels with genetically established importance in humans and rodent. Mutations of human TRPML1 cause type IV mucolipidosis, a devastating pediatric neurodegenerative disease. Our recent electrophysiological studies revealed that, although a TRPML1-mediated current can only be recorded in late endosome and lysosome (LEL) using the lysosome patch clamp technique, a proline substitution in TRPML1 (TRPML1(V432P)) results in a large whole cell current. Thus, it remains unknown whether the large TRPML1(V432P)-mediated current results from an increased surface expression ( trafficking), elevated channel activity (gating), or both. Here we performed systemic Pro substitutions in a region previously implicated in the gating of various 6 transmembrane cation channels. We found that several Pro substitutions displayed gain-of-function (GOF) constitutive activities at both the plasma membrane ( PM) and endolysosomal membranes. Although wild-type TRPML1 and non-GOF Pro substitutions localized exclusively in LEL and were barely detectable in the PM, the GOF mutations with high constitutive activities were not restricted to LEL compartments, and most significantly, exhibited significant surface expression. Because lysosomal exocytosis is Ca2+-dependent, constitutive Ca2+ permeability due to Pro substitutions may have resulted in stimulus-independent intralysosomal Ca2+ release, hence the surface expression and whole cell current of TRPML1. Indeed, surface staining of lysosome-associated membrane protein-1 (Lamp-1) was dramatically increased in cells expressing GOF TRPML1 channels. We conclude that TRPML1 is an inwardly rectifying, proton-impermeable, Ca2+ and Fe2+/Mn2+ dually permeable cation channel that may be gated by unidentified cellular mechanisms through a conformational change in the cytoplasmic face of the transmembrane 5 (TM5). Furthermore, activation of TRPML1 in LEL may lead to the appearance of TRPML1 proteins at the PM.	[Cheng, Xiping; Xu, Haoxing] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Delling, Markus] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA	University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital	Xu, HX (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	haoxingx@umich.edu	xu, hao/GWQ-7394-2022	Dong, Xianping/0000-0002-4496-7104	National Institutes of Health [NS062792]; University of Michigan; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS062792 (to H. X.). This work was also supported by startup funds (to H. X.) from the Department of Molecular, Cellular, and Developmental Biology and Biological Science Scholar Program, University of Michigan, and by a pilot grant (to H. X.) from the University of Michigan Initiative on Rare Disease Research.	Altarescu G, 2002, NEUROLOGY, V59, P306, DOI 10.1212/WNL.59.3.306; Atiba-Davies M, 2007, BBA-MOL BASIS DIS, V1772, P1028, DOI 10.1016/j.bbadis.2007.01.007; Bach G, 2001, MOL GENET METAB, V73, P197, DOI 10.1006/mgme.2001.3195; Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; Bassi MT, 2000, AM J HUM GENET, V67, P1110, DOI 10.1016/S0002-9297(07)62941-3; Cerny J, 2004, EMBO REP, V5, P883, DOI 10.1038/sj.embor.7400243; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cuajungco MP, 2008, PFLUG ARCH EUR J PHY, V457, P463, DOI 10.1007/s00424-008-0523-4; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Goldin E, 2008, INVEST OPHTH VIS SCI, V49, P3134, DOI 10.1167/iovs.07-1649; Grimm C, 2007, P NATL ACAD SCI USA, V104, P19583, DOI 10.1073/pnas.0709846104; Jaiswal JK, 2002, J CELL BIOL, V159, P625, DOI 10.1083/jcb.200208154; Kim HJ, 2008, EMBO J, V27, P1197, DOI 10.1038/emboj.2008.56; Kim HJ, 2007, J BIOL CHEM, V282, P36138, DOI 10.1074/jbc.C700190200; Kiselyov K, 2005, J BIOL CHEM, V280, P43218, DOI 10.1074/jbc.M508210200; Kress GJ, 2002, J NEUROSCI, V22, P5848; LaPlante JM, 2006, MOL GENET METAB, V89, P339, DOI 10.1016/j.ymgme.2006.05.016; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Luzio JP, 2007, BIOCHEM SOC T, V35, P1088, DOI 10.1042/BST0351088; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Miedel MT, 2008, J EXP MED, V205, P1477, DOI 10.1084/jem.20072194; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Nagata K, 2008, P NATL ACAD SCI USA, V105, P353, DOI 10.1073/pnas.0707963105; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Pryor PR, 2006, TRAFFIC, V7, P1388, DOI 10.1111/j.1600-0854.2006.00475.x; Raychowdhury MK, 2004, HUM MOL GENET, V13, P617, DOI 10.1093/hmg/ddh067; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Tieleman DP, 2001, PROTEINS, V44, P63, DOI 10.1002/prot.1073; Treusch S, 2004, P NATL ACAD SCI USA, V101, P4483, DOI 10.1073/pnas.0400709101; van Aken AFJ, 2008, J PHYSIOL-LONDON, V586, P5403, DOI 10.1113/jphysiol.2008.156992; Venkatachalam K, 2006, J BIOL CHEM, V281, P17517, DOI 10.1074/jbc.M600807200; Venkatachalam K, 2008, CELL, V135, P838, DOI 10.1016/j.cell.2008.09.041; Venugopal B, 2007, AM J HUM GENET, V81, P1070, DOI 10.1086/521954; Vergarajauregui S, 2006, TRAFFIC, V7, P337, DOI 10.1111/j.1600-0854.2006.00387.x; Vergarajauregui S, 2008, BIOCHEM J, V410, P417, DOI 10.1042/BJ20070713; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Xu HX, 2004, PLOS BIOL, V2, P378, DOI 10.1371/journal.pbio.0020050; Zeevi DA, 2007, BBA-MOL BASIS DIS, V1772, P851, DOI 10.1016/j.bbadis.2007.01.004; ZHANG F, 2009, J CELL MOL IN PRESS; Zhang F, 2007, J BIOL CHEM, V282, P25259, DOI 10.1074/jbc.M701614200; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620; Zhao Y, 2004, NEURON, V41, P859, DOI 10.1016/S0896-6273(04)00116-3	46	81	82	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32040	32052		10.1074/jbc.M109.037184	http://dx.doi.org/10.1074/jbc.M109.037184			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19638346	Green Published, hybrid			2022-12-27	WOS:000271572700059
J	Ohneda, K; Ohmori, S; Ishijima, Y; Nakano, M; Yamamoto, M				Ohneda, Kinuko; Ohmori, Shin'ya; Ishijima, Yasushi; Nakano, Mayu; Yamamoto, Masayuki			Characterization of a Functional ZBP-89 Binding Site That Mediates Gata1 Gene Expression during Hematopoietic Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; IN-VIVO; SELF-ASSOCIATION; CELL-DEVELOPMENT; SP1; ENHANCER; ELEMENT; FAMILY; IDENTIFICATION; REQUIREMENTS	GATA-1 is a lineage-restricted transcription factor that plays essential roles in hematopoietic development. The Gata1 gene hematopoietic enhancer allowed Gata1 reporter expression in erythroid cells and megakaryocytes of transgenic mice. The Gata1 hematopoietic enhancer activity is strictly dependent on a GATA site located in the 5' region of the enhancer. However, the importance of the GC-rich region adjacent to the 3'-end of this GATA site has been also suggested. In this study, we show that this GC-rich region contains five contiguous deoxyguanosine residues (G(5) string) that are bound by multiple nuclear proteins. Interestingly, deletion of one deoxyguanosine residue from the G(5) string (G(4) mutant) specifically eliminates binding to ZBP-89, a Kruppel-like transcription factor, but not to Sp3 and other binding factors. We demonstrate that GATA-1 and ZBP-89 occupy chromatin regions of the Gata1 enhancer and physically associate in vitro through zinc finger domains. Gel mobility shift assays and DNA affinity precipitation assays suggest that binding of ZBP-89 to this region is reduced in the absence of GATA-1 binding to the G1HE. Luciferase reporter assays demonstrate that ZBP-89 activates the Gata1 enhancer depending on the G(5) string sequence. Finally, transgenic mouse studies reveal that the G4 mutation significantly reduced the reporter activity of the Gata1 hematopoietic regulatory domain encompassing an 8.5-kbp region of the Gata1 gene. These data provide compelling evidence that the G(5) string is necessary for Gata1 gene expression in vivo and ZBP-89 is the functional trans-acting factor for this cis-acting region.	[Ohneda, Kinuko; Ohmori, Shin'ya; Ishijima, Yasushi] Takasaki Univ Hlth & Welf, Fac Pharm, Dept Pharm, Takasaki, Gunma 3700033, Japan; [Nakano, Mayu] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan; [Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 9808575, Japan	University of Tsukuba; Tohoku University	Ohneda, K (corresponding author), 60 Nakaorui Machi, Takasaki, Gunma 3700033, Japan.	kohneda@takasaki-u.ac.jp	Ohneda, Kinuko/AAC-8822-2019; Yamamoto, Masayuki/A-4873-2010	Yamamoto, Masayuki/0000-0002-9073-9436	Naito Foundation; Japan Science and Technology Corporation; Ministry of Education, Science, Sports and Culture	Naito Foundation(Naito Memorial Foundation); Japan Science and Technology Corporation(Japan Science & Technology Agency (JST)); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Naito Foundation (to K. O.), Japan Science and Technology Corporation-ERATO Environmental Response Project (to M. Y.), and the Ministry of Education, Science, Sports and Culture (to M. Y. and K. O.).	Antona V, 1998, CYTOGENET CELL GENET, V83, P90, DOI 10.1159/000015138; Bai LC, 2000, J BIOL CHEM, V275, P30725, DOI 10.1074/jbc.M004249200; Billon N, 1999, ONCOGENE, V18, P2872, DOI 10.1038/sj.onc.1202712; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Ferreira R, 2007, BLOOD, V109, P5481, DOI 10.1182/blood-2006-11-060491; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Gregory RC, 1996, BLOOD, V87, P1793, DOI 10.1182/blood.V87.5.1793.bloodjournal8751793; Gutierrez L, 2007, BLOOD, V110, P1933, DOI 10.1182/blood-2006-09-048322; Guyot B, 2006, J BIOL CHEM, V281, P13733, DOI 10.1074/jbc.M602052200; Hasegawa T, 1999, BIOCHEM BIOPH RES CO, V256, P249, DOI 10.1006/bbrc.1999.0275; Hasegawa T, 1997, J BIOL CHEM, V272, P4915, DOI 10.1074/jbc.272.8.4915; Hogan B, 1994, MANIPULATING MOUSE E; Jacquelin B, 2001, J BIOL CHEM, V276, P23518, DOI 10.1074/jbc.M102019200; Jin Y, 1998, BLOOD, V92, P2777, DOI 10.1182/blood.V92.8.2777.420k27_2777_2790; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Law GL, 1998, J BIOL CHEM, V273, P19955, DOI 10.1074/jbc.273.32.19955; Lepage A, 1999, BLOOD, V94, P3366, DOI 10.1182/blood.V94.10.3366.422k35_3366_3380; Li XG, 2006, DEVELOPMENT, V133, P3641, DOI 10.1242/dev.02540; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Lyons SE, 2002, P NATL ACAD SCI USA, V99, P5454, DOI 10.1073/pnas.082695299; Merchant JL, 1996, MOL CELL BIOL, V16, P6644; MERIKA M, 1995, MOL CELL BIOL, V15, P2437; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Motohashi H, 2000, CELL, V103, P865, DOI 10.1016/S0092-8674(00)00190-2; NICOLIS S, 1991, NUCLEIC ACIDS RES, V19, P5285, DOI 10.1093/nar/19.19.5285; Nishikawa K, 2003, MOL CELL BIOL, V23, P8295, DOI 10.1128/MCB.23.22.8295-8305.2003; Nishimura S, 2000, MOL CELL BIOL, V20, P713, DOI 10.1128/MCB.20.2.713-723.2000; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; Ohneda K, 2002, GENES CELLS, V7, P1243, DOI 10.1046/j.1365-2443.2002.00595.x; Onodera K, 1997, P NATL ACAD SCI USA, V94, P4487, DOI 10.1073/pnas.94.9.4487; Shimizu R, 2001, EMBO J, V20, P5250, DOI 10.1093/emboj/20.18.5250; Shimizu R, 2007, J BIOL CHEM, V282, P15862, DOI 10.1074/jbc.M701936200; Suzuki M, 2006, BLOOD, V108, P726, DOI 10.1182/blood-2005-10-4064; Suzuki M, 2009, MOL CELL BIOL, V29, P1163, DOI 10.1128/MCB.01572-08; Suzuki N, 2003, BLOOD, V102, P3575, DOI 10.1182/blood-2003-04-1154; Suzuki T, 2005, ARTERIOSCL THROM VAS, V25, P1135, DOI 10.1161/01.ATV.0000165656.65359.23; Takahashi S, 2000, BLOOD, V96, P910, DOI 10.1182/blood.V96.3.910.015k29_910_916; Takahashi S, 1997, J BIOL CHEM, V272, P12611, DOI 10.1074/jbc.272.19.12611; TSAI SF, 1991, GENE DEV, V5, P919, DOI 10.1101/gad.5.6.919; Vernimmen D, 2007, EMBO J, V26, P2041, DOI 10.1038/sj.emboj.7601654; Vyas P, 1999, DEVELOPMENT, V126, P2799; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Wang ZY, 1999, BLOOD, V93, P4208, DOI 10.1182/blood.V93.12.4208.412k17_4208_4221; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Whyatt D, 2000, NATURE, V406, P519, DOI 10.1038/35020086; Whyatt David J., 1997, Genes and Function, V1, P11; Wieczorek E, 2000, J BIOL CHEM, V275, P12879, DOI 10.1074/jbc.275.17.12879; Woo AJ, 2008, MOL CELL BIOL, V28, P2675, DOI 10.1128/MCB.01945-07	48	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30187	30199		10.1074/jbc.M109.026948	http://dx.doi.org/10.1074/jbc.M109.026948			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19723625	Green Published, hybrid			2022-12-27	WOS:000271090000022
J	Hao, MM; Bogan, JS				Hao, Mingming; Bogan, Jonathan S.			Cholesterol Regulates Glucose-stimulated Insulin Secretion through Phosphatidylinositol 4,5-Bisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE K+ CHANNELS; MEMBRANE DOMAINS; PHOSPHOLIPASE-C; PLASMA-MEMBRANE; DETERGENT RESISTANCE; ACTIN DYNAMICS; CELL-MEMBRANES; LIPID DOMAINS; LIVING CELLS; ATP CHANNELS	Membrane cholesterol modulates the ability of glucose to stimulate insulin secretion from pancreatic beta-cells. The molecular mechanism by which this occurs is not understood. Here, we show that in cultured beta-cells, cholesterol acts through phosphatidylinositol 4,5-bisphosphate (PIP(2)) to regulate actin dynamics, plasma membrane potential, and glucose-stimulated insulin secretion. Cholesterol-overloaded beta-cells exhibited decreased PIP(2) hydrolysis, with diminished glucose-induced actin reorganization, membrane depolarization, and insulin secretion. The converse findings were observed in cholesterol-depleted cells. These results support a model in which cholesterol depletion is coupled through PIP(2) to enhance both plasma membrane Ca(2+) influx from the extracellular space, as well as inositol 1,4,5-triphosphate-stimulated Ca(2+) efflux from intracellular stores. The inability to increase cytosolic Ca(2+) may be the main underlying factor to account for impaired glucose-stimulated insulin secretion in cholesterol-overloaded beta-cells.	[Hao, Mingming] Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, New Haven, CT 06520 USA; [Bogan, Jonathan S.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University	Hao, MM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, POB 208020, New Haven, CT 06520 USA.	mingming.hao@yale.edu	Bogan, Jonathan S/A-1575-2010	Bogan, Jonathan S/0000-0001-6463-8466	National Institutes of Health [K01DK078625, R01DK075772]; W. M. Keck Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075772, K01DK078625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K01DK078625 (to M. H.) and R01DK075772 (to J. S. B.). This work was also supported by a grant from the W. M. Keck Foundation (to J. S. B.).	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Alekseev AE, 1998, J GEN PHYSIOL, V111, P381, DOI 10.1085/jgp.111.2.381; Arbuzova A, 2000, BBA-BIOMEMBRANES, V1464, P35, DOI 10.1016/S0005-2736(99)00243-6; Ashcroft FM, 1999, DIABETOLOGIA, V42, P903, DOI 10.1007/s001250051247; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; BEHNKE O, 1984, EUR J CELL BIOL, V35, P200; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brunham LR, 2008, J CLIN INVEST, V118, P403, DOI 10.1172/JCI33296; Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546; Chevallier J, 2008, J BIOL CHEM, V283, P27871, DOI 10.1074/jbc.M801463200; Cremesti AE, 2002, FEBS LETT, V531, P47, DOI 10.1016/S0014-5793(02)03489-0; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Epand RM, 2008, BBA-BIOMEMBRANES, V1778, P1576, DOI 10.1016/j.bbamem.2008.03.016; Epand RM, 2004, BIOCHEM J, V379, P527, DOI 10.1042/BJ20040204; EPPS DE, 1994, CHEM PHYS LIPIDS, V69, P137, DOI 10.1016/0009-3084(94)90035-3; Frey D, 2000, J CELL BIOL, V149, P1443, DOI 10.1083/jcb.149.7.1443; Fryirs M, 2009, CURR OPIN LIPIDOL, V20, P159, DOI 10.1097/MOL.0b013e32832ac180; Gagescu R, 2000, MOL BIOL CELL, V11, P2775, DOI 10.1091/mbc.11.8.2775; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; Golub T, 2005, J CELL BIOL, V169, P151, DOI 10.1083/jcb.200407058; Hao M, 2007, DIABETES, V56, P2328, DOI 10.2337/db07-0056; Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; Hao MM, 2001, P NATL ACAD SCI USA, V98, P13072, DOI 10.1073/pnas.231377398; Haugh JM, 2002, J CELL SCI, V115, P303; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; HITCHCOCK SE, 1980, J BIOL CHEM, V255, P5668; Hope HR, 1996, MOL BIOL CELL, V7, P843, DOI 10.1091/mbc.7.6.843; HOWELL S L, 1986, Diabetes Metabolism Reviews, V2, P107; HUANG ZJ, 1992, ANAL BIOCHEM, V200, P199, DOI 10.1016/0003-2697(92)90299-M; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; Johnson CM, 2008, J BIOL CHEM, V283, P29920, DOI 10.1074/jbc.M805921200; Kiyokawa E, 2005, J BIOL CHEM, V280, P24072, DOI 10.1074/jbc.M502244200; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; LAYCHOCK SG, 1983, BIOCHEM J, V216, P101, DOI 10.1042/bj2160101; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Lin CW, 2005, DIABETES, V54, P2852, DOI 10.2337/diabetes.54.10.2852; Linder MD, 2007, MOL BIOL CELL, V18, P47, DOI 10.1091/mbc.E06-07-0575; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Lyssenko V, 2005, DIABETES, V54, P166, DOI 10.2337/diabetes.54.1.166; Musse AA, 2009, NEUROSCI LETT, V450, P32, DOI 10.1016/j.neulet.2008.11.022; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Nevins AK, 2003, AM J PHYSIOL-CELL PH, V285, pC698, DOI 10.1152/ajpcell.00093.2003; ORCI L, 1972, SCIENCE, V175, P1128, DOI 10.1126/science.175.4026.1128; Patra SK, 1999, J LIPOSOME RES, V9, P247, DOI 10.3109/08982109909024788; Petersen NH, 2008, J LIPID RES, V49, P2023, DOI 10.1194/jlr.M800145-JLR200; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; RIDLEY AJ, 1994, BIOESSAYS, V16, P321, DOI 10.1002/bies.950160506; Rodi PM, 2008, BIOPHYS CHEM, V135, P14, DOI 10.1016/j.bpc.2008.02.015; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Shaw JE, 2006, J STRUCT BIOL, V155, P458, DOI 10.1016/j.jsb.2006.04.015; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Sun Y, 2003, J BIOL CHEM, V278, P5813, DOI 10.1074/jbc.M208687200; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Tamarina NA, 2005, DIABETES, V54, P3073, DOI 10.2337/diabetes.54.11.3073; Thore S, 2005, J CELL SCI, V118, P4463, DOI 10.1242/jcs.02577; Thore S, 2004, J BIOL CHEM, V279, P19396, DOI 10.1074/jbc.C400088200; Thore S, 2007, DIABETES, V56, P818, DOI 10.2337/db06-0843; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Tomas A, 2006, J CELL SCI, V119, P2156, DOI 10.1242/jcs.02942; Tong J, 2008, BIOPHYS J, V94, P125, DOI 10.1529/biophysj.107.110536; Trapp S, 1998, J GEN PHYSIOL, V112, P333, DOI 10.1085/jgp.112.3.333; van Meer G, 2004, CURR OPIN CELL BIOL, V16, P373, DOI 10.1016/j.ceb.2004.06.004; van Rheenen J, 2005, EMBO J, V24, P1664, DOI 10.1038/sj.emboj.7600655; van Rheenen J, 2002, MOL BIOL CELL, V13, P3257, DOI 10.1091/mbc.E02-04-0231; Wang JY, 2002, J BIOL CHEM, V277, P34401, DOI 10.1074/jbc.M203954200; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Wassall SR, 2004, CHEM PHYS LIPIDS, V132, P79, DOI 10.1016/j.chemphyslip.2004.09.007; Wilson JR, 2001, FEBS LETT, V492, P101, DOI 10.1016/S0014-5793(01)02241-4; Wustner D, 2002, J BIOL CHEM, V277, P30325, DOI 10.1074/jbc.M202626200; Xu C, 2003, J CELL BIOL, V161, P779, DOI 10.1083/jcb.200301070	75	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29489	29498		10.1074/jbc.M109.038034	http://dx.doi.org/10.1074/jbc.M109.038034			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19729450	Green Published, hybrid			2022-12-27	WOS:000270896800031
J	Pelish, TM; McClain, MS				Pelish, Teal M.; McClain, Mark S.			Dominant-negative Inhibitors of the Clostridium perfringens epsilon-Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYLORI VACUOLATING TOXIN; STAPHYLOCOCCAL ALPHA-HEMOLYSIN; PROTEIN-PROTEIN INTERACTIONS; ANTHRAX PROTECTIVE ANTIGEN; ESCHERICHIA-COLI; MDCK CELLS; IN-VIVO; CRYSTAL-STRUCTURE; MEMBRANE; MUTANT	The Clostridium perfringens epsilon-toxin is responsible for a severe, often lethal intoxication. In this study, we characterized dominant-negative inhibitors of the epsilon-toxin. Site-specific mutations were introduced into the gene encoding epsilon-toxin, and recombinant proteins were expressed in Escherichia coli. Paired cysteine substitutions were introduced at locations predicted to form a disulfide bond. One cysteine in each mutant was introduced into the membrane insertion domain of the toxin; the second cysteine was introduced into the protein backbone. Mutant proteins with cysteine substitutions at amino acid positions I51/A114 and at V56/F118 lacked detectable cytotoxic activity in a MDCK cell assay. Cytotoxic activity could be reconstituted in both mutant proteins by incubation with dithiothreitol, indicating that the lack of cytotoxic activity was attributable to the formation of a disulfide bond. Fluorescent labeling of the cysteines also indicated that the introduced cysteines participated in a disulfide bond. When equimolar mixtures of wildtype epsilon-toxin and mutant proteins were added to MDCK cells, the I51C/A114C and V56C/F118C mutant proteins each inhibited the activity of wild-type epsilon-toxin. Further analysis of the inhibitory activity of the I51C/A114C and V56C/F118C mutant proteins indicated that these proteins inhibit the ability of the active toxin to form stable oligomeric complexes in the context of MDCK cells. These results provide further insight into the properties of dominant-negative inhibitors of oligomeric pore-forming toxins and provide the basis for developing new therapeutics for treating intoxication by epsilon-toxin.	[McClain, Mark S.] Vanderbilt Univ, Sch Med, Div Infect Dis, Dept Med, Nashville, TN 37232 USA	Vanderbilt University	McClain, MS (corresponding author), Vanderbilt Univ, Sch Med, Div Infect Dis, Dept Med, A2200 Med Ctr N, Nashville, TN 37232 USA.	mark.mcclain@vanderbilt.edu	McClain, Mark S/A-6942-2009	McClain, Mark S/0000-0002-9857-4883	National Institutes of Health, NIAID [R21 AI065435, R01 AI079123]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI065435, R01AI079123] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 AI065435 and R01 AI079123 (to M. S. M.) from NIAID.	Adamson RH, 2005, INFECT IMMUN, V73, P4879, DOI 10.1128/IAI.73.8.4879-4887.2005; Ahuja N, 2003, BIOCHEM BIOPH RES CO, V307, P446, DOI 10.1016/S0006-291X(03)01227-0; Aulinger BA, 2005, INFECT IMMUN, V73, P3408, DOI 10.1128/IAI.73.6.3408-3414.2005; Beers M.H., 2005, MERCK MANUAL DIAGNOS; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; CAMERON CM, 1980, ONDERSTEPOORT J VET, V47, P287; Cheley S, 1997, PROTEIN ENG, V10, P1433, DOI 10.1093/protein/10.12.1433; Cole AR, 2004, NAT STRUCT MOL BIOL, V11, P797, DOI 10.1038/nsmb804; delaRosa C, 1997, J ANIM SCI, V75, P2328; Dorca-Arevalo J, 2008, VET MICROBIOL, V131, P14, DOI 10.1016/j.vetmic.2008.02.015; EVANS SV, 1990, J MOL BIOL, V213, P885, DOI 10.1016/S0022-2836(05)80270-0; Gardner D E, 1972, N Z Vet J, V20, P167, DOI 10.1080/00480169.1972.34041; Genisset C, 2006, INFECT IMMUN, V74, P1786, DOI 10.1128/IAI.74.3.1786-1794.2006; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; GLEESONWHITE MH, 1955, LANCET, V1, P384; Hauer P J, 1999, Dev Biol Stand, V101, P85; Hotze EM, 2001, J BIOL CHEM, V276, P8261, DOI 10.1074/jbc.M009865200; Ivie SE, 2008, INFECT IMMUN, V76, P2843, DOI 10.1128/IAI.01664-07; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; KOHN J, 1955, LANCET, V1, P385; KOIDE T, 1973, EUR J BIOCHEM, V32, P417, DOI 10.1111/j.1432-1033.1973.tb02624.x; MacKenzie CR, 1999, J BIOL CHEM, V274, P22604, DOI 10.1074/jbc.274.32.22604; McClain MS, 2007, INFECT IMMUN, V75, P1785, DOI 10.1128/IAI.01643-06; McClain MS, 2003, INFECT IMMUN, V71, P2266, DOI 10.1128/IAI.71.4.2266-2271.2003; McClain MS, 2001, J BACTERIOL, V183, P6499, DOI 10.1128/JB.183.22.6499-6508.2001; Minami J, 1997, MICROBIOL IMMUNOL, V41, P527, DOI 10.1111/j.1348-0421.1997.tb01888.x; Minard KI, 2007, FREE RADICAL BIO MED, V42, P106, DOI 10.1016/j.freeradbiomed.2006.09.024; Miyata S, 2002, J BIOL CHEM, V277, P39463, DOI 10.1074/jbc.M206731200; Miyata S, 2001, J BIOL CHEM, V276, P13778, DOI 10.1074/jbc.M011527200; Mourez M, 2003, P NATL ACAD SCI USA, V100, P13803, DOI 10.1073/pnas.2436299100; NAGAHAMA M, 1991, TOXICON, V29, P211, DOI 10.1016/0041-0101(91)90105-Z; Nagahama M, 1998, J NAT TOXINS, V7, P291; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Oyston PCF, 1998, MICROBIOL-SGM, V144, P333, DOI 10.1099/00221287-144-2-333; PARKER MW, 1994, NATURE, V367, P292, DOI 10.1038/367292a0; PAYNE DW, 1994, FEMS MICROBIOL LETT, V116, P161, DOI 10.1016/0378-1097(94)90068-X; Petit L, 1997, J BACTERIOL, V179, P6480, DOI 10.1128/jb.179.20.6480-6487.1997; Petit L, 2003, CELL MICROBIOL, V5, P155, DOI 10.1046/j.1462-5822.2003.00262.x; Petit L, 2001, J BIOL CHEM, V276, P15736, DOI 10.1074/jbc.M010412200; Rodriguez-Almazan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005545; Rossjohn J, 1998, J STRUCT BIOL, V121, P92, DOI 10.1006/jsbi.1997.3947; Rossjohn J, 1998, BIOCHEMISTRY-US, V37, P741, DOI 10.1021/bi9721039; SAKURAI J, 1987, FEMS MICROBIOL LETT, V41, P317; SAKURAI J, 1987, TOXICON, V25, P279, DOI 10.1016/0041-0101(87)90256-X; SAKURAI J, 1985, BIOCHEM BIOPH RES CO, V128, P760, DOI 10.1016/0006-291X(85)90112-3; SAKURAI J, 1987, MICROB PATHOGENESIS, V3, P469, DOI 10.1016/0882-4010(87)90017-9; SAKURAI J, 1986, MICROB PATHOGENESIS, V1, P417, DOI 10.1016/0882-4010(86)90003-3; Sellman BR, 2001, SCIENCE, V292, P695, DOI 10.1126/science.109563; Singh Y, 2001, J BIOL CHEM, V276, P22090, DOI 10.1074/jbc.M010222200; Smith LDS, 1984, PATHOGENIC ANAEROBIC, V3rd; Soler-Jover A, 2004, J HISTOCHEM CYTOCHEM, V52, P931, DOI 10.1369/jhc.4A6254.2004; Soler-Jover A, 2007, TOXICON, V50, P530, DOI 10.1016/j.toxicon.2007.04.025; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; SOWDHAMINI R, 1989, PROTEIN ENG, V3, P95, DOI 10.1093/protein/3.2.95; Spyres LM, 2003, INFECT IMMUN, V71, P3294, DOI 10.1128/IAI.71.6.3294-3301.2003; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Torres VJ, 2006, INFECT IMMUN, V74, P2093, DOI 10.1128/IAI.74.4.2093-2101.2006; Uzal FA, 1998, VET REC, V143, P472, DOI 10.1136/vr.143.17.472; Uzal FA, 1998, VET REC, V142, P722, DOI 10.1136/vr.142.26.722; Vinion-Dubiel AD, 1999, J BIOL CHEM, V274, P37736, DOI 10.1074/jbc.274.53.37736; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wai SN, 2003, J BACTERIOL, V185, P5491, DOI 10.1128/JB.185.18.5491-5499.2003; Weng YP, 2004, J BIOL CHEM, V279, P6805, DOI 10.1074/jbc.M308675200; Willhite DC, 2002, INFECT IMMUN, V70, P3824, DOI 10.1128/IAI.70.7.3824-3832.2002; WORTHINGTON R W, 1975, Onderstepoort Journal of Veterinary Research, V42, P25; Yan M, 2003, MOL MED, V9, P46, DOI 10.1007/BF03402106; Yano H, 2003, ANAL CHEM, V75, P4682, DOI 10.1021/ac0343329	67	29	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29446	29453		10.1074/jbc.M109.021782	http://dx.doi.org/10.1074/jbc.M109.021782			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19720828	Green Published, hybrid			2022-12-27	WOS:000270896800026
J	Silva, G; Jeney, V; Chora, A; Larsen, R; Balla, J; Soares, MP				Silva, Gabriela; Jeney, Viktoria; Chora, Angelo; Larsen, Rasmus; Balla, Jozsef; Soares, Miguel P.			Oxidized Hemoglobin Is an Endogenous Proinflammatory Agonist That Targets Vascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ADENOVIRUS-MEDIATED EXPRESSION; HEME OXYGENASE 1; RED-BLOOD-CELLS; HYDROGEN-PEROXIDE; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; BACTERIAL-ENDOTOXIN; NALP3 INFLAMMASOME; CROSS-LINKING	Several pathologic conditions are associated with hemolysis, i.e. release of ferrous (Fe(II)) hemoglobin from red blood cells. Oxidation of cell-free hemoglobin produces (Fe(III)) methemoglobin. More extensive oxidation produces (Fe(III)/Fe(IV)=O) ferryl hemoglobin. Both cell-free methemoglobin and ferryl hemoglobin are thought to contribute to the pathogenesis of hemolytic disorders. We show hereby that ferryl hemoglobin, but not hemoglobin or methemoglobin, acts as a potent proinflammatory agonist that induces vascular endothelial cells in vitro to rearrange the actin cytoskeleton, forming intercellular gaps and disrupting the integrity of the endothelial cell monolayer. Furthermore, ferryl hemoglobin induces the expression of proinflammatory genes in endothelial cells in vitro, e.g. E-selectin, Icam-1, and Vcam-1, through the activation of the nuclear factor kappa B family of transcription factors. This proinflammatory effect, which requires actin polymerization, involves the activation of the c-Jun N-terminal kinase and the p38 mitogen-activated protein kinase signal transduction pathways. When administered to naive mice, ferryl hemoglobin induces the recruitment of polymorphonuclear cells, demonstrating that it acts as a proinflammatory agonist in vivo. In conclusion, oxidized hemoglobin, i.e. ferryl hemoglobin, acts as a proinflammatory agonist that targets vascular endothelial cells.	[Soares, Miguel P.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Jeney, Viktoria; Balla, Jozsef] Univ Debrecen, Dept Med, Med & Hlth Sci Ctr, H-4032 Debrecen, Hungary	Instituto Gulbenkian de Ciencia; University of Debrecen	Soares, MP (corresponding author), Inst Gulbenkian Ciencias, Rua Quinta Grande 6, P-2780156 Oeiras, Portugal.	mpsoares@igc.gulbenkian.pt	Larsen, Rasmus/I-9204-2012; Ferreira Chora, Angelo/AAZ-6503-2021; Soares, Miguel P/G-4188-2011; Jeney, Viktória/AAF-5355-2019; Jeney, Viktoria/A-6779-2011	Ferreira Chora, Angelo/0000-0002-7941-7196; Balla, Jozsef/0000-0001-7923-2645; Silva, Gabriela/0000-0002-4004-9904; Soares, Miguel/0000-0002-9314-4833	Fundacao para a Ciencia e a Tecnologia, Portugal [POCTI/BIA-BCM/56829/2004, POCTI/SAU-MNO/56066/2004, POCTI/SAU/56066/2007]; European Commission's Sixth Framework Program, XENOME [LSHB-CT-2006-037377]; GEMI fund (Linde Healthcare)	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); European Commission's Sixth Framework Program, XENOME; GEMI fund (Linde Healthcare)	This work was supported by Grants POCTI/BIA-BCM/56829/2004, POCTI/SAU-MNO/56066/2004, and POCTI/SAU/56066/2007 from Fundacao para a Ciencia e a Tecnologia, Portugal, European Commission's Sixth Framework Program, XENOME (LSHB-CT-2006-037377), and the GEMI fund (Linde Healthcare) (to M. P. S.).	Anrather J, 2005, J BIOL CHEM, V280, P244, DOI 10.1074/jbc.M409344200; APPELMELK BJ, 1992, ANAL BIOCHEM, V207, P311, DOI 10.1016/0003-2697(92)90017-2; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BALLA J, 1993, P NATL ACAD SCI USA, V90, P9285, DOI 10.1073/pnas.90.20.9285; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; BUBB MR, 1994, J BIOL CHEM, V269, P14869; BULLARD DC, 1995, J CLIN INVEST, V95, P1782, DOI 10.1172/JCI117856; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; COLUCCI M, 1983, J CLIN INVEST, V71, P1893, DOI 10.1172/JCI110945; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Ferreira A, 2008, J MOL MED, V86, P1097, DOI 10.1007/s00109-008-0368-5; Giulivi C, 2001, J BIOL CHEM, V276, P24129, DOI 10.1074/jbc.M010697200; GIULIVI C, 1994, METHOD ENZYMOL, V231, P490; Giulivi C, 1998, FREE RADICAL BIO MED, V24, P269, DOI 10.1016/S0891-5849(97)00226-8; Goldman DW, 1998, AM J PHYSIOL-HEART C, V275, pH1046, DOI 10.1152/ajpheart.1998.275.3.H1046; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; Hoshino K, 1999, J IMMUNOL, V162, P3749; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Jia YP, 2007, J BIOL CHEM, V282, P4894, DOI 10.1074/jbc.M609955200; Kaneko M, 1996, ARTERIOSCL THROM VAS, V16, P1047, DOI 10.1161/01.ATV.16.8.1047; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Kawashima A, 2002, HUM PATHOL, V33, P125, DOI 10.1053/hupa.2002.30217; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Liu XY, 2003, AM J PHYSIOL-CELL PH, V285, pC1036, DOI 10.1152/ajpcell.00164.2003; MAPLES KR, 1990, ARCH BIOCHEM BIOPHYS, V277, P402, DOI 10.1016/0003-9861(90)90596-Q; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masuoka N, 2006, J BIOL CHEM, V281, P21728, DOI 10.1074/jbc.M513818200; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Melamed-Frank M, 2001, BLOOD, V98, P3693, DOI 10.1182/blood.V98.13.3693; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; OWEN JA, 1958, NATURE, V182, P1373, DOI 10.1038/1821373a0; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Reeder BJ, 2002, BIOCHEM SOC T, V30, P745, DOI 10.1042/bst0300745; Reeder BJ, 2008, J BIOL CHEM, V283, P30780, DOI 10.1074/jbc.M804709200; ROTH RI, 1994, BLOOD, V83, P2860, DOI 10.1182/blood.V83.10.2860.2860; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Schechter AN, 2008, BLOOD, V112, P3927, DOI 10.1182/blood-2008-04-078188; Seldon MP, 2007, J IMMUNOL, V179, P7840, DOI 10.4049/jimmunol.179.11.7840; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Silva G, 2006, J IMMUNOL, V177, P1894, DOI 10.4049/jimmunol.177.3.1894; Soares MP, 2009, TRENDS MOL MED, V15, P50, DOI 10.1016/j.molmed.2008.12.004; Soares MP, 2004, J IMMUNOL, V172, P3553, DOI 10.4049/jimmunol.172.6.3553; Soares MP, 1998, J IMMUNOL, V161, P4572; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Su DH, 1997, INFECT IMMUN, V65, P1258, DOI 10.1128/IAI.65.4.1258-1266.1997; Svistunenko DA, 1997, J BIOL CHEM, V272, P7114, DOI 10.1074/jbc.272.11.7114; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; Vallelian F, 2008, FREE RADICAL BIO MED, V45, P1150, DOI 10.1016/j.freeradbiomed.2008.07.013; Vollaard NBJ, 2005, FREE RADICAL BIO MED, V39, P1216, DOI 10.1016/j.freeradbiomed.2005.06.012; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; WEISS SJ, 1982, J BIOL CHEM, V257, P2947; WINTERBOURN C, 1985, REACTIONS SUPEROXIDE; Wrighton CJ, 1996, J EXP MED, V183, P1013, DOI 10.1084/jem.183.3.1013; Wu KK, 1996, ANNU REV MED, V47, P315; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Ziouzenkova O, 1999, J BIOL CHEM, V274, P18916, DOI 10.1074/jbc.274.27.18916	67	99	102	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29582	29595		10.1074/jbc.M109.045344	http://dx.doi.org/10.1074/jbc.M109.045344			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19700768	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000270896800040
J	Bouzakri, K; Ribaux, P; Halban, PA				Bouzakri, Karim; Ribaux, Pascale; Halban, Philippe A.			Silencing Mitogen-activated Protein 4 Kinase 4 (MAP4K4) Protects Beta Cells from Tumor Necrosis Factor-alpha-induced Decrease of IRS-2 and Inhibition of Glucose-stimulated Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 DIABETES-MELLITUS; HUMAN SKELETAL-MUSCLE; C-REACTIVE PROTEIN; TNF-ALPHA; SYSTEMIC INFLAMMATION; SIGNALING PATHWAY; INDUCED APOPTOSIS; GENE-EXPRESSION; ISLET CELLS; RESISTANCE	Obesity and type 2 diabetes present partially overlapping phenotypes with systemic inflammation as a common feature, raising the hypothesis that elevated cytokine levels may contribute to peripheral insulin resistance as well as the decreased beta cell functional mass observed in type 2 diabetes. In healthy humans, TNF-alpha infusion induces skeletal muscle insulin resistance. We now explore the impact of TNF-alpha on primary beta cell function and the underlying signaling pathways. Human and rat primary beta cells were sorted by FACS and cultured for 24 h +/- 20 ng/ml TNF-alpha to explore the impact on apoptosis, proliferation, and short-term insulin secretion (1 h, 2.8 mM glucose followed by 1 h, 16.7 mM glucose at the end of the 24-h culture period) as well as key signaling protein phosphorylation and expression. Prior exposure to TNF-alpha for 24 It inhibits glucose-stimulated insulin secretion from primary beta cells. This is associated with a decrease in glucose-stimulated phosphorylation of key proteins in the insulin signaling pathway including Akt, AS160, and other Akt substrates, ERK as well as the insulin receptor. Strikingly, TNF-alpha treatment decreased IRS-2 protein level by 46 +/- 7% versus control, although mRNA expression was unchanged. While TNF-alpha treatment increased MAP4K4 mRNA expression by 33 +/- 5%, knockdown of MAP4K4 by siRNA-protected beta cells against the detrimental effects of TNF-alpha on both insulin secretion and signaling. We thus identify MAP4K4 as a key upstream mediator of TNF-alpha action on the beta cell, making it a potential therapeutic target for preservation of beta cell function in type 2 diabetes.	[Bouzakri, Karim; Ribaux, Pascale; Halban, Philippe A.] Univ Geneva, Univ Med Ctr, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland	University of Geneva	Bouzakri, K (corresponding author), Univ Geneva, Univ Med Ctr, Dept Genet Med & Dev, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	karim.bouzakri@unige.ch			Investigator-initiated Studies Program	Investigator-initiated Studies Program	This work was supported in part by a research grant from the Investigator-initiated Studies Program of MSD.	Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; Bertazza L, 2008, FRONT BIOSCI-LANDMRK, V13, P2736, DOI 10.2741/2881; Bosco D, 2000, DIABETES, V49, P233, DOI 10.2337/diabetes.49.2.233; Bouzakri K, 2008, DIABETES, V57, P1195, DOI 10.2337/db07-1469; Bouzakri K, 2007, J BIOL CHEM, V282, P7783, DOI 10.1074/jbc.M608602200; Briaud I, 2005, J BIOL CHEM, V280, P2282, DOI 10.1074/jbc.M412179200; Cantley J, 2007, DIABETOLOGIA, V50, P1248, DOI 10.1007/s00125-007-0637-9; Cornu M, 2009, DIABETES, V58, P1816, DOI 10.2337/db09-0063; Deshmukh A, 2006, DIABETES, V55, P1776, DOI 10.2337/db05-1419; Donath MY, 2008, DIABETES CARE, V31, pS161, DOI 10.2337/dc08-s243; Donath MY, 2008, ENDOCR REV, V29, P334, DOI 10.1210/er.2007-0033; Duncan BB, 2003, DIABETES, V52, P1799, DOI 10.2337/diabetes.52.7.1799; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Elion EA, 2000, CURR OPIN MICROBIOL, V3, P573, DOI 10.1016/S1369-5274(00)00143-0; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FEINGOLD KR, 1992, DIABETES, V41, P97, DOI 10.2337/diab.41.2.S97; Ferrannini E, 2007, J CLIN ENDOCR METAB, V92, P396, DOI 10.1210/jc.2006-0944; Freeman DJ, 2002, DIABETES, V51, P1596, DOI 10.2337/diabetes.51.5.1596; Gual P, 2003, DIABETES METAB, V29, P566, DOI 10.1016/S1262-3636(07)70071-X; Hagerkvist R, 2005, ANN NY ACAD SCI, V1040, P114, DOI 10.1196/annals.1327.014; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Jiang ZY, 2005, J BIOL CHEM, V280, P21622, DOI 10.1074/jbc.m414464200; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kim HE, 2008, J ENDOCRINOL, V198, P549, DOI 10.1677/JOE-08-0131; Kubota N, 2004, J CLIN INVEST, V114, P917, DOI 10.1172/JCI200421484; Kulkarni RN, 2004, DIABETES, V53, P1517, DOI 10.2337/diabetes.53.6.1517; Kwon G, 1999, J BIOL CHEM, V274, P18702, DOI 10.1074/jbc.274.26.18702; Lawrence M, 2008, ACTA PHYSIOL, V192, P11, DOI 10.1111/j.1748-1716.2007.01785.x; Li D, 2008, DIABETES, V57, P635, DOI 10.2337/db07-0717; Lingohr MK, 2006, J BIOL CHEM, V281, P15884, DOI 10.1074/jbc.M600356200; Machida N, 2004, J BIOL CHEM, V279, P15711, DOI 10.1074/jbc.C300542200; McKenzie MD, 2008, DIABETES, V57, P1284, DOI 10.2337/db07-1692; Mishima Y, 2001, DIABETES RES CLIN PR, V52, P119, DOI 10.1016/S0168-8227(00)00247-3; Morino K, 2008, DIABETES, V57, P2644, DOI 10.2337/db06-0454; Muller D, 2006, DIABETES, V55, P2835, DOI 10.2337/db06-0532; Ohsugi M, 2005, J BIOL CHEM, V280, P4992, DOI 10.1074/jbc.M411727200; Ortis F, 2008, DIABETOLOGIA, V51, P1213, DOI 10.1007/s00125-008-0999-7; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; Plomgaard P, 2005, DIABETES, V54, P2939, DOI 10.2337/diabetes.54.10.2939; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Ribaux P, 2007, ENDOCRINOLOGY, V148, P5582, DOI 10.1210/en.2007-0325; ROUILLER DG, 1991, DEV BIOL, V148, P233, DOI 10.1016/0012-1606(91)90332-W; Saghizadeh M, 1996, J CLIN INVEST, V97, P1111, DOI 10.1172/JCI118504; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Tesz GJ, 2007, J BIOL CHEM, V282, P19302, DOI 10.1074/jbc.M700665200; Tomas A, 2006, J CELL SCI, V119, P2156, DOI 10.1242/jcs.02942; Winkler G, 1998, DIABETES RES CLIN PR, V42, P169, DOI 10.1016/S0168-8227(98)00109-0; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wrede CE, 2002, J BIOL CHEM, V277, P49676, DOI 10.1074/jbc.M208756200; Yermen B, 2007, DIABETES, V56, P80, DOI 10.2337/db06-0769; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zohn IE, 2006, CELL, V125, P957, DOI 10.1016/j.cell.2006.03.048	53	41	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27892	27898		10.1074/jbc.M109.048058	http://dx.doi.org/10.1074/jbc.M109.048058			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19690174	hybrid, Green Published			2022-12-27	WOS:000270676300016
J	Chelico, L; Pham, P; Petruska, J; Goodman, MF				Chelico, Linda; Pham, Phuong; Petruska, John; Goodman, Myron F.			Biochemical Basis of Immunological and Retroviral Responses to DNA-targeted Cytosine Deamination by Activation-induced Cytidine Deaminase and APOBEC3G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SINGLE-STRANDED-DNA; CLASS SWITCH RECOMBINATION; SOMATIC HYPERMUTATION; FUNCTIONAL IMPLICATIONS; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; WILD-TYPE; IN-VITRO; AID; MODEL	Activation-induced cytidine deaminase (AID) and APOBEC3G catalyze deamination of cytosine to uracil on single-stranded DNA, thereby setting in motion a regulated hypermutagenic process essential for human well-being. However, if regulation fails, havoc ensues. AID plays a central role in the synthesis of high affinity antibodies, and APOBEC3G inactivates human immunodeficiency virus-1. This minireview highlights biochemical and structural properties of AID and APOBEC3G, showing how studies using the purified enzymes provide valuable insight into the considerably more complex biology governing antibody generation and human immunodeficiency virus inactivation.	[Chelico, Linda; Pham, Phuong; Petruska, John; Goodman, Myron F.] Univ So Calif, Dept Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA	University of Southern California	Goodman, MF (corresponding author), Univ So Calif, Dept Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA.	mgoodman@usc.edu		Chelico, Linda/0000-0003-4673-8978	National Institutes of Health [R37GM21422, ES013192]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013192, R56ES013192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM021422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37GM21422 and ES013192. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Bennett RP, 2008, J BIOL CHEM, V283, P33329, DOI 10.1074/jbc.M803726200; Blagodatski A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000332; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; BRANSTEITTER R, 2009, CELL MOL LIFE SCI, DOI DOI 10.1007/S00018-00009-00070-Y; Browne EP, 2009, VIROLOGY, V387, P313, DOI 10.1016/j.virol.2009.02.026; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chen KM, 2007, FEBS LETT, V581, P4761, DOI 10.1016/j.febslet.2007.08.076; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Conticello SG, 2008, MOL CELL, V31, P474, DOI 10.1016/j.molcel.2008.07.009; FRIEDER D, 2009, MOL CELL BIOL, DOI DOI 10.1128/MCB.00647-00609; Furukawa A, 2009, EMBO J, V28, P440, DOI 10.1038/emboj.2008.290; Gallois-Montbrun S, 2008, J VIROL, V82, P5636, DOI 10.1128/JVI.00287-08; Harjes E, 2009, J MOL BIOL, V389, P819, DOI 10.1016/j.jmb.2009.04.031; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Huthoff H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000330; Kohli RM, 2009, J BIOL CHEM, V284, P22898, DOI 10.1074/jbc.M109.025536; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; MacCarthy T, 2009, P NATL ACAD SCI USA, V106, P8629, DOI 10.1073/pnas.0903803106; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; Okazaki Il-mi, 2007, Adv Immunol, V94, P245, DOI 10.1016/S0065-2776(06)94008-5; Pauklin S, 2009, J EXP MED, V206, P99, DOI 10.1084/jem.20080521; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Pham P, 2008, J BIOL CHEM, V283, P31754, DOI 10.1074/jbc.M805524200; Pham P, 2008, J BIOL CHEM, V283, P17428, DOI 10.1074/jbc.M802121200; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Rausch JW, 2009, J BIOL CHEM, V284, P7047, DOI 10.1074/jbc.M807258200; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Reynaud CA, 2009, PHILOS T R SOC B, V364, P613, DOI 10.1098/rstb.2008.0206; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Schanz S, 2009, P NATL ACAD SCI USA, V106, P5593, DOI 10.1073/pnas.0901726106; Shen HM, 2009, J EXP MED, V206, P1057, DOI 10.1084/jem.20082678; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Suspene R, 2006, NUCLEIC ACIDS RES, V34, P4677, DOI 10.1093/nar/gkl555; Unniraman S, 2007, SCIENCE, V317, P1227, DOI 10.1126/science.1145065; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Wang M, 2009, NAT STRUCT MOL BIOL, V16, P769, DOI 10.1038/nsmb.1623; Wedekind JE, 2006, J BIOL CHEM, V281, P38122, DOI 10.1074/jbc.C600253200; Zaheen A, 2009, BLOOD, V114, P547, DOI 10.1182/blood-2009-03-211763; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000378	50	13	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27761	27765		10.1074/jbc.R109.052449	http://dx.doi.org/10.1074/jbc.R109.052449			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19684020	Green Published, hybrid			2022-12-27	WOS:000270676300002
J	Kawai-Yamada, M; Hori, Z; Ogawa, T; Ihara-Ohori, Y; Tamura, K; Nagano, M; Ishikawa, T; Uchimiya, H				Kawai-Yamada, Maki; Hori, Zenta; Ogawa, Taro; Ihara-Ohori, Yuri; Tamura, Katsunori; Nagano, Minoru; Ishikawa, Toshiki; Uchimiya, Hirofumi			Loss of Calmodulin Binding to Bax Inhibitor-1 Affects Pseudomonas-mediated Hypersensitive Response-associated Cell Death in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; PLANT HOMOLOG; SUPPRESSOR; OVEREXPRESSION; RESISTANCE; YEAST; GENE; ISOFORMS; KINASE; RICE	Bax inhibitor-1 (BI-1) is a cell death suppressor protein conserved across a variety of organisms. The Arabidopsis atbi1-1 plant is a mutant in which the C-terminal 6 amino acids of the expressed BI-1 protein have been replaced by T-DNA insertion. This mutant BI-1 protein (AtBI-CM) produced in Escherichia coli can no longer bind to calmodulin. A promoter-reporter assay demonstrated compartmentalized expression of BI-1 during hypersensitive response, introduced by the inoculation of Pseudomonas syringae possessing the avrRTP2 gene, Pst(avr-RPT2). In addition, both BI-1 knockdown plants and atbi1-1 showed increased sensitivity to Pst(avrRPT2)-induced cell death. The results indicated that the loss of calmodulin binding reduces the cell death suppressor activity of BI-1 in planta.	[Kawai-Yamada, Maki; Ishikawa, Toshiki] Saitama Univ, Dept Environm Sci & Technol, Sakura Ku, Saitama 3388570, Japan; [Kawai-Yamada, Maki] Saitama Univ, Inst Environm Sci & Technol, Sakura Ku, Saitama 3388570, Japan; [Uchimiya, Hirofumi] Iwate Biotechnol Res Ctr, Kitakami, Iwate 0240003, Japan; [Kawai-Yamada, Maki; Hori, Zenta; Ogawa, Taro; Ihara-Ohori, Yuri; Tamura, Katsunori; Nagano, Minoru; Ishikawa, Toshiki; Uchimiya, Hirofumi] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Kawai-Yamada, Maki; Ishikawa, Toshiki] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama 3320012, Japan	Saitama University; Saitama University; Iwate Biotechnology Research Center; University of Tokyo; Japan Science & Technology Agency (JST)	Kawai-Yamada, M (corresponding author), Saitama Univ, Dept Environm Sci & Technol, Sakura Ku, 255 Shimo Okubo, Saitama 3388570, Japan.	mkawai@mail.saitama-u.ac.jp	Ishikawa, Toshiki/F-6970-2018; Uchimiya, Hirofumi/B-3813-2012; Kawai-Yamada, Maki/B-2739-2012	Ishikawa, Toshiki/0000-0001-8083-6542; Kawai-Yamada, Maki/0000-0002-8732-052X	Ministry of Agriculture, Forestry and Fisheries of Japan; CREST, EST, Japan	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); CREST, EST, Japan	This work was supported by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan and a grant from CREST, EST, Japan.	Bolduc N, 2002, FEBS LETT, V532, P111, DOI 10.1016/S0014-5793(02)03650-5; Chae HJ, 2004, MOL CELL, V15, P355, DOI 10.1016/j.molcel.2004.06.038; DIXON RA, 1994, ANNU REV PHYTOPATHOL, V32, P479, DOI 10.1146/annurev.py.32.090194.002403; DONG XN, 1991, PLANT CELL, V3, P61, DOI 10.1105/tpc.3.1.61; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Heath MC, 1998, NEW PHYTOL, V138, P251, DOI 10.1046/j.1469-8137.1998.00897.x; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Huckelhoven R, 2004, APOPTOSIS, V9, P299, DOI 10.1023/B:APPT.0000025806.71000.1c; Huckelhoven R, 2003, P NATL ACAD SCI USA, V100, P5555, DOI 10.1073/pnas.0931464100; Ihara-Ohori Y, 2007, PLANT PHYSIOL, V143, P650, DOI 10.1104/pp.106.090878; Kawai M, 1999, FEBS LETT, V464, P143, DOI 10.1016/S0014-5793(99)01695-6; Kawai-Yamada M, 2004, PLANT CELL, V16, P21, DOI 10.1105/tpc.014613; Kawai-Yamada M, 2001, P NATL ACAD SCI USA, V98, P12295, DOI 10.1073/pnas.211423998; Kohler C, 2000, FEBS LETT, V471, P133, DOI 10.1016/S0014-5793(00)01383-1; Lam E, 2001, NATURE, V411, P848, DOI 10.1038/35081184; Liao BR, 1996, ARCH BIOCHEM BIOPHYS, V327, P53, DOI 10.1006/abbi.1996.0092; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Matsumura H, 2003, PLANT J, V33, P425, DOI 10.1046/j.1365-313X.2003.01639.x; McCormack E, 2005, TRENDS PLANT SCI, V10, P383, DOI 10.1016/j.tplants.2005.07.001; McCormack E, 2003, NEW PHYTOL, V159, P585, DOI 10.1046/j.1469-8137.2003.00845.x; Nagano M, 2009, PLANT J, V58, P122, DOI 10.1111/j.1365-313X.2008.03765.x; Oshima R, 2007, FEBS LETT, V581, P4627, DOI 10.1016/j.febslet.2007.08.054; Pan L, 2000, PLANT PHYSIOL, V122, P447, DOI 10.1104/pp.122.2.447; Pike SM, 2005, PLANT PHYSIOL, V138, P1009, DOI 10.1104/pp.104.047142; Reddy VS, 1999, J BIOL CHEM, V274, P31727, DOI 10.1074/jbc.274.44.31727; Sanchez P, 2000, PLANT J, V21, P393, DOI 10.1046/j.1365-313x.2000.00690.x; Watanabe N, 2006, PLANT J, V45, P884, DOI 10.1111/j.1365-313X.2006.02654.x; Watanabe N, 2008, J BIOL CHEM, V283, P3200, DOI 10.1074/jbc.M706659200; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Yu IC, 2000, MOL PLANT MICROBE IN, V13, P277, DOI 10.1094/MPMI.2000.13.3.277	32	30	31	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27998	28003		10.1074/jbc.M109.037234	http://dx.doi.org/10.1074/jbc.M109.037234			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19674971	hybrid, Green Published			2022-12-27	WOS:000270676300028
J	Muniandy, PA; Thapa, D; Thazhathveetil, AK; Liu, ST; Seidman, MM				Muniandy, Parameswary A.; Thapa, Dennis; Thazhathveetil, Arun Kalliat; Liu, Su-ting; Seidman, Michael M.			Repair of Laser-localized DNA Interstrand Cross-links in G(1) Phase Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; DOUBLE-STRAND BREAKS; UV-DAMAGED DNA; CYCLOBUTANE PYRIMIDINE DIMERS; COMPLEMENTATION GROUP-E; PIGMENTOSUM GROUP-E; IN-VIVO; ESCHERICHIA-COLI; BINDING PROTEIN; MITOMYCIN-C	Interstrand cross-links (ICLs) are absolute blocks to transcription and replication and can provoke genomic instability and cell death. Studies in bacteria define a two-stage repair scheme, the first involving recognition and incision on either side of the cross-link on one strand (unhooking), followed by recombinational repair or lesion bypass synthesis. The resultant monoadduct is removed in a second stage by nucleotide excision repair. In mammalian cells, there are multiple, but poorly defined, pathways, with much current attention on repair in S phase. However, many questions remain, including the efficiency of repair in the absence of replication, the factors involved in cross-link recognition, and the timing and demarcation of the first and second repair cycles. We have followed the repair of laser-localized lesions formed by psoralen (cross-links/monoadducts) and angelicin (only monoadducts) in mammalian cells. Both were repaired in G, phase by nucleotide excision repair-dependent pathways. Removal of psoralen adducts was blocked in XPC-deficient cells but occurred with wild type kinetics in cells deficient in DDB2 protein (XPE). XPC protein was rapidly recruited to psoralen adducts. However, accumulation of DDB2 was slow and XPC-dependent. Inhibition of repair DNA synthesis did not interfere with DDB2 recruitment to angelicin but eliminated recruitment to psoralen. Our results demonstrate an efficient ICL repair pathway in G, phase cells dependent on XPC, with entry of DDB2 only after repair synthesis that completes the first repair cycle. DDB2 accumulation at sites of cross-link repair is a marker for the start of the second repair cycle.	[Muniandy, Parameswary A.; Thapa, Dennis; Seidman, Michael M.] NIA, LMG, NIH, Baltimore, MD 21224 USA; [Thazhathveetil, Arun Kalliat] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Liu, Su-ting] BASF Co, Hong Kong, Hong Kong, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Northwestern University; BASF	Seidman, MM (corresponding author), NIA, LMG, NIH, 251 Bayview Blvd, Baltimore, MD 21224 USA.	seidmanm@grc.nia.nih.gov			National Institutes of Health, NIA; Fanconi Anemia Research Fund; NATIONAL INSTITUTE ON AGING [Z01AG000746, ZIAAG000746] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Fanconi Anemia Research Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the National Institutes of Health, NIA, Intramural Research Program. This work was also supported by the Fanconi Anemia Research Fund.	Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Barber LJ, 2005, MOL CELL BIOL, V25, P2297, DOI 10.1128/MCB.25.6.2297-2309.2005; Berardini M, 1999, J BACTERIOL, V181, P2878, DOI 10.1128/JB.181.9.2878-2882.1999; Bergstralh DT, 2008, TRENDS GENET, V24, P70, DOI 10.1016/j.tig.2007.11.003; BREDBERG A, 1985, BIOCHIM BIOPHYS ACTA, V824, P268, DOI 10.1016/0167-4781(85)90058-2; COLE RS, 1976, J MOL BIOL, V103, P39, DOI 10.1016/0022-2836(76)90051-6; COLE RS, 1973, P NATL ACAD SCI USA, V70, P1064, DOI 10.1073/pnas.70.4.1064; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; De Silva IU, 2000, MOL CELL BIOL, V20, P7980, DOI 10.1128/MCB.20.21.7980-7990.2000; Derheimer FA, 2009, MOL PHARMACOL, V75, P599, DOI 10.1124/mol.108.051698; Dinant C, 2007, J CELL SCI, V120, P2731, DOI 10.1242/jcs.004523; Dip R, 2004, DNA REPAIR, V3, P1409, DOI 10.1016/j.dnarep.2004.05.005; Dronkert MLG, 2001, MUTAT RES-DNA REPAIR, V486, P217, DOI 10.1016/S0921-8777(01)00092-1; Eichman BF, 2001, J MOL BIOL, V308, P15, DOI 10.1006/jmbi.2001.4567; El-Mahdy MA, 2006, J BIOL CHEM, V281, P13404, DOI 10.1074/jbc.M511834200; Emmert S, 2000, P NATL ACAD SCI USA, V97, P2151, DOI 10.1073/pnas.040559697; Fitch ME, 2003, J BIOL CHEM, V278, P46906, DOI 10.1074/jbc.M307254200; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Fujiwara Y, 1999, J BIOL CHEM, V274, P20027, DOI 10.1074/jbc.274.28.20027; Grompe M, 2001, HUM MOL GENET, V10, P2253, DOI 10.1093/hmg/10.20.2253; Grossmann KF, 2001, MUTAT RES-DNA REPAIR, V487, P73, DOI 10.1016/S0921-8777(01)00106-9; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Hanasoge S, 2007, CARCINOGENESIS, V28, P2298, DOI 10.1093/carcin/bgm157; Hong Z, 2008, J CELL SCI, V121, P3146, DOI 10.1242/jcs.026393; Houtsmuller AB, 1999, SCIENCE, V284, P958, DOI 10.1126/science.284.5416.958; ISLAS AL, 1994, BIOCHEMISTRY-US, V33, P10794, DOI 10.1021/bi00201a029; Jaspers NGJ, 2007, AM J HUM GENET, V80, P457, DOI 10.1086/512486; JOHNSTON BH, 1977, SCIENCE, V197, P906, DOI 10.1126/science.887929; Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103; Kong X, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp221; Kruhlak MJ, 2006, CELL CYCLE, V5, P1910, DOI 10.4161/cc.5.17.3169; Kuraoka I, 2000, J BIOL CHEM, V275, P26632, DOI 10.1074/jbc.C000337200; Kusumoto R, 2001, MUTAT RES-DNA REPAIR, V485, P219, DOI 10.1016/S0921-8777(00)00082-3; Lai CF, 2008, ANAL CHEM, V80, P8790, DOI 10.1021/ac801520m; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; Lan L, 2004, DNA REPAIR, V3, P135, DOI 10.1016/j.dnarep.2003.10.005; Luijsterburg MS, 2007, J CELL SCI, V120, P2706, DOI 10.1242/jcs.008367; Maillard O, 2008, MUTAT RES-REV MUTAT, V658, P271, DOI 10.1016/j.mrrev.2008.01.007; Maillard O, 2007, PLOS BIOL, V5, P717, DOI 10.1371/journal.pbio.0050079; Maillard O, 2007, TRENDS BIOCHEM SCI, V32, P494, DOI 10.1016/j.tibs.2007.08.008; Matsumoto M, 2007, J CELL SCI, V120, P1104, DOI 10.1242/jcs.03391; McHugh PJ, 2006, CELL CYCLE, V5, P1044, DOI 10.4161/cc.5.10.2763; McHugh PJ, 2001, LANCET ONCOL, V2, P483, DOI 10.1016/S1470-2045(01)00454-5; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; Mitchell JR, 2003, CURR OPIN CELL BIOL, V15, P232, DOI 10.1016/S0955-0674(03)00018-8; Mocquet V, 2007, EMBO J, V26, P2923, DOI 10.1038/sj.emboj.7601730; Moggs JG, 1996, J BIOL CHEM, V271, P7177, DOI 10.1074/jbc.271.12.7177; Moser J, 2005, DNA REPAIR, V4, P571, DOI 10.1016/j.dnarep.2005.01.001; Mu D, 2000, MOL CELL BIOL, V20, P2446, DOI 10.1128/MCB.20.7.2446-2454.2000; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Niedernhofer LJ, 2003, J BIOL CHEM, V278, P31426, DOI 10.1074/jbc.M212549200; Nishi R, 2009, DNA REPAIR, V8, P767, DOI 10.1016/j.dnarep.2009.02.004; Noronha AM, 2002, BIOCHEMISTRY-US, V41, P760, DOI 10.1021/bi011610u; Palom Y, 2002, CHEM RES TOXICOL, V15, P1398, DOI 10.1021/tx020044g; PAYNE A, 1994, MUTAT RES-FUND MOL M, V310, P89, DOI 10.1016/0027-5107(94)90012-4; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Reynolds MF, 2009, CANCER RES, V69, P1071, DOI 10.1158/0008-5472.CAN-08-2306; Richards S, 2005, NUCLEIC ACIDS RES, V33, P5382, DOI 10.1093/nar/gki851; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rothfuss A, 2004, MOL CELL BIOL, V24, P123, DOI 10.1128/MCB.24.1.123-134.2004; Saffran WA, 2004, J BIOL CHEM, V279, P36462, DOI 10.1074/jbc.M402323200; Sarkar S, 2006, EMBO J, V25, P1285, DOI 10.1038/sj.emboj.7600993; SARTORELLI AC, 1994, ONCOL RES, V6, P501; Scharer OD, 2009, NAT STRUCT MOL BIOL, V16, P102, DOI 10.1038/nsmb0209-102; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; SLADEK FM, 1989, P NATL ACAD SCI USA, V86, P3982, DOI 10.1073/pnas.86.11.3982; SLADEK FM, 1989, J BIOL CHEM, V264, P6755; Smeaton MB, 2008, BIOCHEMISTRY-US, V47, P9920, DOI 10.1021/bi800925e; SPIELMANN HP, 1995, P NATL ACAD SCI USA, V92, P2345, DOI 10.1073/pnas.92.6.2345; Staresincic L, 2009, EMBO J, V28, P1111, DOI 10.1038/emboj.2009.49; Sugasawa K, 2002, DNA REPAIR, V1, P95, DOI 10.1016/S1568-7864(01)00008-8; Tang J, 2002, DNA REPAIR, V1, P601, DOI 10.1016/S1568-7864(02)00052-6; Thazhathveetil AK, 2007, BIOCONJUGATE CHEM, V18, P431, DOI 10.1021/bc060309t; Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wang X, 2001, MOL CELL BIOL, V21, P713, DOI 10.1128/MCB.21.3.713-720.2001; Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4; Wittschieben BO, 2005, J BIOL CHEM, V280, P39982, DOI 10.1074/jbc.M507854200; Wu Q, 2005, EMBO REP, V6, P551, DOI 10.1038/sj.embor.7400418; Yang W, 2008, CELL RES, V18, P184, DOI 10.1038/cr.2007.116; Zhang NX, 2007, DNA REPAIR, V6, P1670, DOI 10.1016/j.dnarep.2007.06.002; Zhang NX, 2005, J BIOL CHEM, V280, P40559, DOI 10.1074/jbc.M508453200; Zhang NX, 2002, MOL CELL BIOL, V22, P2388, DOI 10.1128/MCB.22.7.2388-2397.2002; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700; Zheng HY, 2003, MOL CELL BIOL, V23, P754, DOI 10.1128/MCB.23.2.754-761.2003	88	72	72	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27908	27917		10.1074/jbc.M109.029025	http://dx.doi.org/10.1074/jbc.M109.029025			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19684342	hybrid, Green Published			2022-12-27	WOS:000270676300018
J	Parnas, A; Nadler, M; Nisemblat, S; Horovitz, A; Mandel, H; Azem, A				Parnas, Avital; Nadler, Michal; Nisemblat, Shahar; Horovitz, Amnon; Mandel, Hanna; Azem, Abdussalam			The MitCHAP-60 Disease Is Due to Entropic Destabilization of the Human Mitochondrial Hsp60 Oligomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY SPASTIC PARAPLEGIA; ESCHERICHIA-COLI; MOLECULAR CHAPERONE; YEAST MITOCHONDRIA; IN-VITRO; GROEL; PROTEIN; MUTATION; PURIFICATION; HEAT-SHOCK-PROTEIN-60	The 60-kDa heat shock protein (mHsp60) is a vital cellular complex that mediates the folding of many of the mitochondrial proteins. Its function is executed in cooperation with the co-chaperonin, mHsp 10, and requires ATP. Recently, the discovery of a new mHsp60-associated neurodegenerative disorder, MitCHAP-60 disease, has been reported. The disease is caused by a point mutation at position 3 (D3G) of the mature mitochondrial Hsp60 protein, which renders it unable to complement the deletion of the homologous bacterial protein in Escherichia coli (Magen, D., Georgopoulos, C., Bross, P., Ang, D., Segev, Y., Goldsher, D., Nemirovski, A., Shahar, E., Ravid, S., Luder, A., Heno, B., Gershoni-Baruch, R., Skorecki, K., and Mandel, H. (2008) Am. J. Hum. Genet. 83, 30 - 42). The molecular basis of the MitCHAP-60 disease is still unknown. In this study, we present an in vitro structural and functional analysis of the purified wild-type human mHsp60 and the MitCHAP-60 mutant. We show that the D3G mutation leads to destabilization of the mHsp60 oligomer and causes its disassembly at low protein concentrations. We also show that the mutant protein has impaired protein folding and ATPase activities. An additional mutant that lacks the first three amino, acids (N-del), including Asp-3, is similarly impaired in refolding activity. Surprisingly, however, this mutant exhibits profound stabilization of its oligomeric structure. These results suggest that the D3G mutation leads to entropic destabilization of the mHsp60 oligomer, which severely impairs its chaperone function, thereby causing the disease.	[Parnas, Avital; Nisemblat, Shahar; Azem, Abdussalam] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69778 Tel Aviv, Israel; [Nadler, Michal; Horovitz, Amnon] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Mandel, Hanna] Technion Israel Inst Technol, Rappaport Fac Med, IL-31096 Haifa, Israel; [Mandel, Hanna] Technion Israel Inst Technol, Res Inst, IL-31096 Haifa, Israel; [Mandel, Hanna] Metab Dis Unit, IL-31096 Haifa, Israel	Tel Aviv University; Weizmann Institute of Science; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology	Horovitz, A (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69778 Tel Aviv, Israel.	amnon.horovitz@weizmann.ac.il; azema@tauex.tau.ac.il			Israel Science Foundation [1902/08]; Eshkol Fellowship from the Ministry of Science	Israel Science Foundation(Israel Science Foundation); Eshkol Fellowship from the Ministry of Science	This work was supported by a grant from the Morasha program of the Israel Science Foundation (Grant 1902/08) (to A. A. and H. M.) and by an Eshkol Fellowship from the Ministry of Science (to A. P.).	Altamirano MM, 1997, P NATL ACAD SCI USA, V94, P3576, DOI 10.1073/pnas.94.8.3576; Bonshtien AL, 2007, J BIOL CHEM, V282, P4463, DOI 10.1074/jbc.M606433200; Bonshtien AL, 2009, CELL STRESS CHAPERON, V14, P509, DOI 10.1007/s12192-009-0104-2; Bross P, 2008, J BIOL CHEM, V283, P15694, DOI 10.1074/jbc.M800548200; Brune M, 1998, BIOCHEMISTRY-US, V37, P10370, DOI 10.1021/bi9804277; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Buckle AM, 1997, P NATL ACAD SCI USA, V94, P3571, DOI 10.1073/pnas.94.8.3571; Cappello F, 2007, CANCER BIOL THER, V6, P487, DOI 10.4161/cbt.6.4.4087; CHANDRASEKHAR GN, 1986, J BIOL CHEM, V261, P2414; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; Deocaris CC, 2006, CELL STRESS CHAPERON, V11, P116, DOI 10.1379/CSC-144R.1; DICKSON R, 1994, J BIOL CHEM, V269, P26858; Hansen J, 2007, J NEUROL, V254, P897, DOI 10.1007/s00415-006-0470-y; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; Hard F. U., 1996, NATURE, V381, P571; HOROVITZ A, 1993, J BIOL CHEM, V268, P9957; HOROVITZ A, 1993, J MOL BIOL, V231, P58, DOI 10.1006/jmbi.1993.1256; Horovitz A, 2005, CURR OPIN STRUC BIOL, V15, P646, DOI 10.1016/j.sbi.2005.10.001; Horovitz A, 1998, CURR OPIN STRUC BIOL, V8, P93, DOI 10.1016/S0959-440X(98)80015-8; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; Iosefson O, 2007, PROTEIN SCI, V16, P316, DOI 10.1110/ps.062459607; Knowlton A A, 2003, Cardiovasc Toxicol, V3, P263, DOI 10.1385/CT:3:3:263; LANDRY SJ, 1993, NATURE, V364, P255, DOI 10.1038/364255a0; Landry SJ, 1996, P NATL ACAD SCI USA, V93, P11622, DOI 10.1073/pnas.93.21.11622; Levy-Rimler G, 2002, FEBS LETT, V529, P1, DOI 10.1016/S0014-5793(02)03178-2; Levy-Rimler G, 2001, EUR J BIOCHEM, V268, P3465, DOI 10.1046/j.1432-1327.2001.02243.x; Lin Z, 2006, CRIT REV BIOCHEM MOL, V41, P211, DOI 10.1080/10409230600760382; Magen D, 2008, AM J HUM GENET, V83, P30, DOI 10.1016/j.ajhg.2008.05.016; Nielsen KL, 1998, MOL CELL, V2, P93, DOI 10.1016/S1097-2765(00)80117-3; Osterloh A, 2004, J BIOL CHEM, V279, P47906, DOI 10.1074/jbc.M408440200; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; PICKETTS DJ, 1989, J BIOL CHEM, V264, P12001; Richardson A, 2001, J BIOL CHEM, V276, P4981, DOI 10.1074/jbc.M008628200; ROSPERT S, 1993, P NATL ACAD SCI USA, V90, P10967, DOI 10.1073/pnas.90.23.10967; Viitanen PV, 1998, METHOD ENZYMOL, V290, P203, DOI 10.1016/S0076-6879(98)90020-9; WHITE ZW, 1995, J BIOL CHEM, V270, P20404, DOI 10.1074/jbc.270.35.20404; Xanthoudakis S, 1999, EMBO J, V18, P2049, DOI 10.1093/emboj/18.8.2049; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001	39	42	43	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28198	28203		10.1074/jbc.M109.031997	http://dx.doi.org/10.1074/jbc.M109.031997			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19706612	Green Published, hybrid			2022-12-27	WOS:000270676300047
J	Bender, J; Rydzewski, K; Broich, M; Schunder, E; Heuner, K; Flieger, A				Bender, Jennifer; Rydzewski, Kerstin; Broich, Markus; Schunder, Eva; Heuner, Klaus; Flieger, Antje			Phospholipase PlaB of Legionella pneumophila Represents a Novel Lipase Family PROTEIN RESIDUES ESSENTIAL FOR LIPOLYTIC ACTIVITY, SUBSTRATE SPECIFICITY, AND HEMOLYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; PSEUDOMONAS-AERUGINOSA; LYSOPHOSPHOLIPASE-A; GENE; EXOU; INFECTION; VIRULENCE; ENZYMES; CLONING; LYSOPHOSPHATIDYLCHOLINE	Legionella pneumophila possesses several phospholipases capable of host cell manipulation and lung damage. Recently, we discovered that the major cell-associated hemolytic phospholipase A(PlaB) shares no homology to described phospholipases and is dispensable for intracellular replication in vitro. Nevertheless, here we show that PlaB is the major lipolytic activity in L. pneumophila cell infections and that PlaB utilizes a typical catalytic triad of Ser-Asp-His for effective hydrolysis of phospholipid substrates. Crucial residues were found to be located within the N-terminal half of the protein, and amino acids embedding these active sites were unique for PlaB and homologs. We further showed that catalytic activity toward phosphatidylcholine but not phosphatidylglycerol is directly linked to hemolytic potential of PlaB. Although the function of the prolonged PlaB C terminus remains to be elucidated, it is essential for lipolysis, since the removal of 15 amino acids already abolishes enzyme activity. Additionally, we determined that PlaB preferentially hydrolyzes long-chain fatty acid substrates containing 12 or more carbon atoms. Since phospholipases play an important role as bacterial virulence factors, we examined cell-associated enzymatic activities among L. pneumophila clinical isolates and non-pneumophila species. All tested clinical isolates showed comparable activities, whereas of the non-pneumophila species, only Legionella gormanii and Legionella spiritensis possessed lipolytic activities similar to those of L. pneumophila and comprised plaB-like genes. Interestingly, phosphatidylcholine-specific phospholipase A activity and hemolytic potential were more pronounced in L. pneumophila. Therefore, hydrolysis of the eukaryotic membrane constituent phosphatidylcholine triggered by PlaB could be an important virulence tool for Legionella pathogenicity.	[Bender, Jennifer; Broich, Markus; Flieger, Antje] Robert Koch Inst, Div Bacterial Infect, D-38855 Wernigerode, Germany; [Bender, Jennifer; Rydzewski, Kerstin; Schunder, Eva; Heuner, Klaus; Flieger, Antje] Robert Koch Inst, Project Grp P26, D-13353 Berlin, Germany	Robert Koch Institute; Robert Koch Institute	Flieger, A (corresponding author), Robert Koch Inst, Div Bacterial Infect, FG11,Burgstr 37, D-38855 Wernigerode, Germany.	fliegera@rki.de		Flieger, Antje/0000-0003-3819-2979	Deutsche Forschungsgemeinschaft [HE 2845/4-1, FL 359/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (Bonn, Germany) Grants HE 2845/4-1 and FL 359/4-1 (to K. H. and A. F., respectively).	Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Banerji S, 2005, INFECT IMMUN, V73, P2899, DOI 10.1128/IAI.73.5.2899-2909.2005; Banerji S, 2004, MICROBIOL-SGM, V150, P522, DOI 10.1099/mic.0.26957-0; Banerji S, 2008, INT J MED MICROBIOL, V298, P169, DOI 10.1016/j.ijmm.2007.11.004; BENDER J, 2009, MICROBIOLOG IN PRESS; Bi WL, 1998, ANAL BIOCHEM, V256, P137, DOI 10.1006/abio.1997.2516; BLACKMON JA, 1981, AM J PATHOL, V103, P429; CIANCIOTTO NP, 1992, P NATL ACAD SCI USA, V89, P5188, DOI 10.1073/pnas.89.11.5188; Devaux PF, 2004, TRAFFIC, V5, P241, DOI 10.1111/j.1600-0854.2004.0170.x; EDELSTEIN PH, 1981, J CLIN MICROBIOL, V14, P298, DOI 10.1128/JCM.14.3.298-303.1981; FANG GD, 1989, MEDICINE, V68, P116, DOI 10.1097/00005792-198903000-00005; Flieger A, 2000, J BACTERIOL, V182, P1321, DOI 10.1128/JB.182.5.1321-1327.2000; Flieger A, 2000, FEMS MICROBIOL LETT, V188, P129; Flieger A, 2004, INFECT IMMUN, V72, P2648, DOI 10.1128/IAI.72.5.2648-2658.2004; Flieger A, 2002, INFECT IMMUN, V70, P6094, DOI 10.1128/IAI.70.11.6094-6106.2002; Flieger A, 2001, J BACTERIOL, V183, P2121, DOI 10.1128/JB.183.6.2121-2124.2001; Hirakata Y, 2000, J INFECT DIS, V181, P765, DOI 10.1086/315276; Istivan TS, 2006, MICROBIOL-SGM, V152, P1263, DOI 10.1099/mic.0.28609-0; JAEGER KE, 1993, FEBS LETT, V332, P143, DOI 10.1016/0014-5793(93)80501-K; JEPRAS RI, 1985, J HYG-CAMBRIDGE, V95, P29, DOI 10.1017/S0022172400062252; Jepson M, 2000, MICROBES INFECT, V2, P1277, DOI 10.1016/S1286-4579(00)01281-8; Kirby JE, 1998, MOL MICROBIOL, V27, P323, DOI 10.1046/j.1365-2958.1998.00680.x; Liles MR, 1999, MOL MICROBIOL, V31, P959, DOI 10.1046/j.1365-2958.1999.01239.x; Muder RR, 2002, CLIN INFECT DIS, V35, P990, DOI 10.1086/342884; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Phillips RM, 2003, J BIOL CHEM, V278, P41326, DOI 10.1074/jbc.M302472200; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Sato H, 2003, EMBO J, V22, P2959, DOI 10.1093/emboj/cdg290; Sato H, 2004, MOL MICROBIOL, V53, P1279, DOI 10.1111/j.1365-2958.2004.04194.x; Schmiel DH, 1999, MICROBES INFECT, V1, P1103, DOI 10.1016/S1286-4579(99)00205-1; Schulert GS, 2003, J INFECT DIS, V188, P1695, DOI 10.1086/379372; Snijder HJ, 2000, BBA-MOL CELL BIOL L, V1488, P91, DOI 10.1016/S1388-1981(00)00113-X; Tannaes T, 2001, INFECT IMMUN, V69, P7334, DOI 10.1128/IAI.69.12.7334-7340.2001; Teo JWP, 2003, GENE, V312, P181, DOI 10.1016/S0378-1119(03)00615-2; Titball RV, 1999, ANAEROBE, V5, P51, DOI 10.1006/anae.1999.0191; UPTON C, 1995, TRENDS BIOCHEM SCI, V20, P178, DOI 10.1016/S0968-0004(00)89002-7; VERNET T, 1993, J BIOL CHEM, V268, P26212; WELTZIEN HU, 1979, BIOCHIM BIOPHYS ACTA, V559, P259, DOI 10.1016/0304-4157(79)90004-2; WINN WC, 1981, HUM PATHOL, V12, P401, DOI 10.1016/S0046-8177(81)80021-4	39	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27185	27194		10.1074/jbc.M109.026021	http://dx.doi.org/10.1074/jbc.M109.026021			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19640837	Green Published, hybrid			2022-12-27	WOS:000270232300019
J	Nemes, Z; Petrovski, G; Aerts, M; Sergeant, K; Devreese, B; Fesus, L				Nemes, Zoltan; Petrovski, Goran; Aerts, Maarten; Sergeant, Kjell; Devreese, Bart; Fesus, Laszlo			Transglutaminase-mediated Intramolecular Cross-linking of Membrane-bound alpha-Synuclein Promotes Amyloid Formation in Lewy Bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE TRANSGLUTAMINASE; PARKINSONS-DISEASE; NEUROFIBRILLARY TANGLES; ALZHEIMERS-DISEASE; FIBRIL FORMATION; CALCIUM-IONS; AGGREGATION; PROTEIN; MECHANISMS; SUBSTRATE	The alpha-synuclein immunopositive and chaotrope-insoluble material from human brains with Lewy body pathology was analyzed by mass spectrometry. From the proteinase K-cleavable peripheral fraction of Lewy bodies, which was densely crosslinked by gamma-glutamyl-epsilon-lysine bonds between HspB1 and ubiquitin in a pattern similar to neurofibrillary tangles (Nemes, Z., Devreese, B., Steinert, P. M., Van Beeumen, J., and Fesus, L. (2004) FASEB J. 18, 1135-1137), 53 proteins were identified. In the core of Lewy bodies only alpha-synuclein was found, and it contained a low amount of intramolecular cross-links between Gln-99 and Lys-58. In vitro cross-linking of alpha-synuclein by transglutaminases 1-3 and 5 produced a heterogeneous population of variably cross-linked alpha-synucleins in solution, which inhibited the aggregation of the protein into amyloid. However, in the presence of phosphatidylserine-rich membranes and micromolar calcium concentrations, the cross-linking by transglutaminases 1, 2, and 5 showed specificity toward the utilization of Gln-99 and Lys-58. As shown by thioflavin T fluorescence monitoring, the formation of this cross-link accelerated the aggregation of native alpha-synuclein. Chemical cross-linking of residues 58-99 triggered amyloid formation, whereas such bonding of residues 99 to 10 was inhibitory. Our findings reveal the pivotal role of membrane attachment and transglutaminase-mediated intermolecular cross-linking for the propagative misfolding and aggregation of alpha-synuclein.	[Nemes, Zoltan] Univ Debrecen, Res Ctr Mol Med, Hungarian Acad Sci, Signaling & Apoptosis Res Grp,Dept Psychiat, H-4012 Debrecen, Hungary; [Petrovski, Goran; Fesus, Laszlo] Univ Debrecen, Signaling & Apoptosis Res Grp, Hungarian Acad Sci, Res Ctr Mol Med,Dept Biochem & Mol Biol, H-4012 Debrecen, Hungary; [Aerts, Maarten; Sergeant, Kjell; Devreese, Bart] Univ Ghent, Lab Prot Biochem & Prot Engn, B-9000 Ghent, Belgium	Hungarian Academy of Sciences; University of Debrecen; Hungarian Academy of Sciences; University of Debrecen; Ghent University	Nemes, Z (corresponding author), 98 Nagyerdei Krt, H-4012 Debrecen, Hungary.	znemes@dote.hu	Devreese, Bart/B-2011-2009; Aerts, Maarten/O-6194-2014; sergeant, kjell/M-9789-2015; Petrovski, Goran/A-8983-2012; Devreese, Bart/K-2841-2019; Sergeant, Kjell/E-5419-2012	Devreese, Bart/0000-0002-9764-2581; Aerts, Maarten/0000-0003-0125-6721; sergeant, kjell/0000-0003-2071-3510; Devreese, Bart/0000-0002-9764-2581; Sergeant, Kjell/0000-0003-2071-3510; Petrovski, Goran/0000-0003-2905-9252	Hungarian Scientific Research Fund OTKA TS [044798]; Hungarian Ministry of Health [ETT115/03]; Hungarian Ministry of Education [OM00427/04]; Flemish-Hungarian Intergovernmental Research [B33/04, B/06093]; Fund for Scientific Research/Flanders [G0422.98]; European Union [MRTNCT2006- 036032, MRTN-CT-2006-035624, LSHB-CT-2007-037730]	Hungarian Scientific Research Fund OTKA TS(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Ministry of Health; Hungarian Ministry of Education; Flemish-Hungarian Intergovernmental Research; Fund for Scientific Research/Flanders(FWO); European Union(European Commission)	This work was supported in part by the Hungarian Scientific Research Fund OTKA TS 044798, the Hungarian Ministry of Health Grant ETT115/03, the Hungarian Ministry of Education Grant OM00427/04, the Flemish-Hungarian Intergovernmental Research Grants B33/04 and B/06093, the Fund for Scientific Research/Flanders G0422.98, and European Union Grants MRTNCT2006- 036032, MRTN-CT-2006-035624, and LSHB-CT-2007-037730.	Andringa G, 2004, FASEB J, V18, P932, DOI 10.1096/fj.03-0829fje; BERS DM, 1994, METHOD CELL BIOL, V40, P3; Beyer K, 2007, J NEUROPATH EXP NEUR, V66, P965, DOI 10.1097/nen.0b013e3181587d64; Beyer K, 2007, CELL BIOCHEM BIOPHYS, V47, P285, DOI 10.1007/s12013-007-0014-9; Candi E, 1998, J BIOL CHEM, V273, P13693, DOI 10.1074/jbc.273.22.13693; Candi E, 2004, BIOCHEM J, V381, P313, DOI 10.1042/BJ20031474; CANDI E, 1995, J BIOL CHEM, V270, P26382, DOI 10.1074/jbc.270.44.26382; Candi E, 1999, J BIOL CHEM, V274, P7226, DOI 10.1074/jbc.274.11.7226; Casadio R, 1999, EUR J BIOCHEM, V262, P672, DOI 10.1046/j.1432-1327.1999.00437.x; Citron BA, 2001, J BIOL CHEM, V276, P3295, DOI 10.1074/jbc.M004776200; Colosimo C, 2003, J NEUROL NEUROSUR PS, V74, P852, DOI 10.1136/jnnp.74.7.852; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Csosz E, 2008, J MOL BIOL, V383, P390, DOI 10.1016/j.jmb.2008.08.026; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; HARSFALVI J, 1987, BIOCHIM BIOPHYS ACTA, V923, P42, DOI 10.1016/0304-4165(87)90123-1; Hashimoto M, 2004, J MOL NEUROSCI, V24, P343, DOI 10.1385/JMN:24:3:343; JENSEN PH, 1995, BIOCHEM J, V310, P91, DOI 10.1042/bj3100091; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Junn E, 2003, P NATL ACAD SCI USA, V100, P2047, DOI 10.1073/pnas.0438021100; Kim HC, 2001, J STRUCT BIOL, V135, P73, DOI 10.1006/jsbi.2001.4384; Kim SY, 1999, J BIOL CHEM, V274, P30715, DOI 10.1074/jbc.274.43.30715; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Konno T, 2005, BIOCHEMISTRY-US, V44, P2072, DOI 10.1021/bi047722d; Lee HJ, 2002, J BIOL CHEM, V277, P48976, DOI 10.1074/jbc.M208192200; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Muma NA, 2007, J NEUROPATH EXP NEUR, V66, P258, DOI 10.1097/nen.0b013e31803d3b02; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Nemes Z, 2005, ANAL BIOCHEM, V342, P1, DOI 10.1016/j.ab.2004.10.015; Nemes Z, 2004, FASEB J, V18, P1135, DOI 10.1096/fj.04-1493fje; Nemes Z, 1999, J BIOL CHEM, V274, P11013, DOI 10.1074/jbc.274.16.11013; Rhoades E, 2006, BIOPHYS J, V90, P4692, DOI 10.1529/biophysj.105.079251; Schmid AW, 2009, J BIOL CHEM, V284, P13128, DOI 10.1074/jbc.M809067200; Segers-Nolten IMJ, 2008, PROTEIN SCI, V17, P1395, DOI 10.1110/ps.036103.108; Signorini M, 1996, BIOL CHEM H-S, V377, P167, DOI 10.1515/bchm3.1996.377.3.167; SLAUGHTER TF, 1992, ANAL BIOCHEM, V205, P166, DOI 10.1016/0003-2697(92)90594-W; Smethurst PA, 1996, BIOCHEM J, V313, P803, DOI 10.1042/bj3130803; Steinert PM, 1996, J BIOL CHEM, V271, P26242, DOI 10.1074/jbc.271.42.26242; Suh MD, 2004, ARCH PHARM RES, V27, P850, DOI 10.1007/BF02980178; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Wang Q, 2005, FASEB J, V19, P869, DOI 10.1096/fj.04-3210fje	42	25	25	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27252	27264		10.1074/jbc.M109.033969	http://dx.doi.org/10.1074/jbc.M109.033969			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19651786	hybrid, Green Published			2022-12-27	WOS:000270232300026
J	Korotkov, KV; Gray, MD; Kreger, A; Turley, S; Sandkvist, M; Hol, WGJ				Korotkov, Konstantin V.; Gray, Miranda D.; Kreger, Allison; Turley, Stewart; Sandkvist, Maria; Hol, Wim G. J.			Calcium Is Essential for the Major Pseudopilin in the Type 2 Secretion System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II PROTEIN SECRETION; THERMAL SHIFT ASSAYS; IV PILUS STRUCTURE; PSEUDOMONAS-AERUGINOSA; VIBRIO-CHOLERAE; ESCHERICHIA-COLI; DIFFRACTION DATA; DRUG DISCOVERY; PILIN; COMPLEX	The pseudopilus is a key feature of the type 2 secretion system (T2SS) and is made up of multiple pseudopilins that are similar in fold to the type 4 pilins. However, pilins have disulfide bridges, whereas the major pseudopilins of T2SS do not. A key question is therefore how the pseudopilins, and in particular, the most abundant major pseudopilin, GspG, obtain sufficient stability to perform their function. Crystal structures of Vibrio cholerae, Vibrio vulnificus, and enterohemorrhagic Escherichia coli (EHEC) GspG were elucidated, and all show a calcium ion bound at the same site. Conservation of the calcium ligands fully supports the suggestion that calcium ion binding by the major pseudopilin is essential for the T2SS. Functional studies of GspG with mutated calcium ion-coordinating ligands were performed to investigate this hypothesis and show that in vivo protease secretion by the T2SS is severely impaired. Taking all evidence together, this allows the conclusion that, in complete contrast to the situation in the type 4 pili system homologs, in the T2SS, the major protein component of the central pseudopilus is dependent on calcium ions for activity.	[Korotkov, Konstantin V.; Kreger, Allison; Turley, Stewart; Hol, Wim G. J.] Univ Washington, Dept Biochem, Struct Biol Ctr, Seattle, WA 98195 USA; [Gray, Miranda D.; Sandkvist, Maria] Univ Michigan, Dept Microbiol & Immunol, Sch Med, Ann Arbor, MI 48109 USA	University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan	Hol, WGJ (corresponding author), 1959 Pacific Ave NE,Hlth Sci Bldg K418, Seattle, WA 98195 USA.	wghol@u.washington.edu		Korotkov, Konstantin/0000-0002-2182-6843	National Institutes of Health [AI34501, AI49294]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034501, R56AI049294, R01AI049294, R56AI034501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI34501 ( to W.G.J.H.) and AI49294 ( to M. S.).	Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; DeLano W.L, PYMOL MOL GRAPHICS S; Durand E, 2003, J BACTERIOL, V185, P2749, DOI 10.1128/JB.185.9.2749-2758.2003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hansen JK, 2006, J MOL MICROB BIOTECH, V11, P192, DOI 10.1159/000094054; Johnson TL, 2006, FEMS MICROBIOL LETT, V255, P175, DOI 10.1111/j.1574-6968.2006.00102.x; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Keizer DW, 2001, J BIOL CHEM, V276, P24186, DOI 10.1074/jbc.M100659200; Kohler R, 2004, MOL MICROBIOL, V54, P647, DOI 10.1111/j.1365-2958.2004.04307.x; Korotkov KV, 2008, NAT STRUCT MOL BIOL, V15, P462, DOI 10.1038/nsmb.1426; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nunn D, 1999, TRENDS CELL BIOL, V9, P402, DOI 10.1016/S0962-8924(99)01634-7; NUNN DN, 1991, P NATL ACAD SCI USA, V88, P3281, DOI 10.1073/pnas.88.8.3281; NUNN DN, 1993, J BACTERIOL, V175, P4375, DOI 10.1128/JB.175.14.4375-4382.1993; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Peabody CR, 2003, MICROBIOL-SGM, V149, P3051, DOI 10.1099/mic.0.26364-0; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; PUGSLEY AP, 1993, MOL MICROBIOL, V10, P665, DOI 10.1111/j.1365-2958.1993.tb00938.x; Sandkvist M, 1997, J BACTERIOL, V179, P6994, DOI 10.1128/jb.179.22.6994-7003.1997; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; Sauvonnet N, 2000, EMBO J, V19, P2221, DOI 10.1093/emboj/19.10.2221; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sikora AE, 2007, J BACTERIOL, V189, P8484, DOI 10.1128/JB.00583-07; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Yanez ME, 2008, J MOL BIOL, V377, P91, DOI 10.1016/j.jmb.2007.08.041; Yanez ME, 2008, J MOL BIOL, V375, P471, DOI 10.1016/j.jmb.2007.10.035	39	36	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25466	25470		10.1074/jbc.C109.037655	http://dx.doi.org/10.1074/jbc.C109.037655			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19640838	Green Published, hybrid			2022-12-27	WOS:000269738000003
